FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Lin, ZY
   Duan, ZX
   Guo, XD
   Li, JF
   Lu, HW
   Zheng, QX
   Quan, DP
   Yang, SH
AF Lin, Zhen-Yu
   Duan, Zhi-Xia
   Guo, Xiao-Dong
   Li, Jing-Feng
   Lu, Hong-Wei
   Zheng, Qi-Xin
   Quan, Da-Ping
   Yang, Shu-Hua
TI Bone induction by biomimetic PLGA-(PEG-ASP)n copolymer loaded with a
   novel synthetic BMP-2-related peptide in vitro and in vivo
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Tissue engineering; Osteogenesis; BMP-2; Synthetic peptide; Biomimetic
   material; Poly (lactic-co-glycolic acid)
ID MORPHOGENETIC PROTEIN; CONTROLLED-RELEASE; CELL-ADHESION; BMP-2;
   HYDROXYAPATITE; NANOPARTICLES; SCAFFOLDS; MATRIX; GROWTH; REPAIR
AB BMP-2 is one of the most important growth factors of bone regeneration. Polylactide-co-glycolic acid (PLGA), which is used as a biodegradable scaffold for delivering therapeutic agents, has been intensively investigated. In previous studies, we synthesized a novel BMP-2-related peptide (designated P24) and found that it could enhance the osteoblastic differentiation of bone marrow stromal cells (BMSCs). The objective of this study was to construct a biomimetic composite by incorporating P24 into a modified PLGA-(PEG-ASP)n copolymer to promote bone formation. In vitro, our results demonstrated that PLGA-(PEG-ASP)n scaffolds were shown to be an efficient system for sustained release of P24. Significantly more BMSCs attached to the P24/PLGA-(PEG-ASP)nand PLGA-(PEG-ASP)n membranes than to PLGA, and the cells in the two groups subsequently proliferated more vigorously than those in the PLGA group. The expression of osteogenic markers in P24/PLGA-(PEG-ASP)n group was stronger than that in the PLGA-(PEG-ASP)n and PLGA groups. Radiographic and histological examination, Western blotting and RT-PCR showed that P24/PLGA-(PEG-ASP)n scaffold could induce more effective ectopic bone formation in vivo, as compared with PLGA-(PEG-ASP)n or gelatin sponge alone. It is concluded that the PLGA-(PEG-ASP)n copolymer is a good P24 carrier and can serve as a good scaffold for controlled release of P24. This novel P24/PLGA-(PEG-ASP)n composite promises to be an excellent biomaterial for inducing bone regeneration. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Lin, Zhen-Yu; Duan, Zhi-Xia; Guo, Xiao-Dong; Li, Jing-Feng; Lu, Hong-Wei; Zheng, Qi-Xin; Yang, Shu-Hua] Huazhong Univ Sci & Technol, Union Hosp Tongji Med Coll, Dept Orthoped, Wuhan 430022, Peoples R China.
   [Quan, Da-Ping] Sun Yat Sen Univ, Sch Chem & Chem Engn, Inst Polymer Sci, Guangzhou 510275, Guangdong, Peoples R China.
RP Guo, XD (reprint author), Huazhong Univ Sci & Technol, Union Hosp Tongji Med Coll, Dept Orthoped, Wuhan 430022, Peoples R China.
EM xiaodongguo@yahoo.cn
RI guo, xiaodong/K-2600-2013
FU National Natural Science Foundation of China [30973027]; National High
   Technology Research and Development Program of China [2006AA02A124];
   Ministry of Education of China [NCET-05-0647]
FX This work was financially supported by the National Natural Science
   Foundation of China (projects 30973027), the "863" Key Project of the
   National High Technology Research and Development Program of China
   (Grant No. 2006AA02A124), and the Program for New Century Talents in
   University from the Ministry of Education of China (NCET-05-0647).
CR Ahmed F, 2004, J CONTROL RELEASE, V96, P37, DOI 10.1016/j.jconrel.2003.12.021
   ATSUHIRO S, 2003, BIOCHIM BIOPHYS ACTA, V1651, P60
   BHARAGAVA U, 1986, BONE, V9, P155
   Duan ZX, 2008, J HUAZHONG U SCI-MED, V28, P426, DOI 10.1007/s11596-008-0411-3
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x
   GUO XD, 2005, J WUHAN UNIV TECHNOL, V20, P234
   Hedberg EL, 2002, J CONTROL RELEASE, V84, P137, DOI 10.1016/S0168-3659(02)00261-4
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   IMRE R, 1983, ACTA HISTOCHEM, V73, P17, DOI 10.1016/S0065-1281(83)80067-1
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Kasten P, 2003, BIOMATERIALS, V24, P2593, DOI 10.1016/S0142-9612(03)00062-0
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Li YP, 2001, J CONTROL RELEASE, V71, P203, DOI 10.1016/S0168-3659(01)00218-8
   Lin XH, 2005, J BONE MINER RES, V20, P693, DOI 10.1359/JBMR.041104
   LIN XH, 2006, J ORTHOP RES, V25, P531
   LUO BH, 2005, J FUNC POLYM, V18, P127
   MIYAMOTO S, 1993, CLIN ORTHOP RELAT R, P333
   Niu X, 2009, POLYM DEGRAD STABIL, V94, P176, DOI 10.1016/j.polymdegradstab.2008.11.008
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Panyam J, 2003, J CONTROL RELEASE, V92, P173, DOI 10.1016/S0168-3659(03)00328-6
   Saito A, 2004, J BIOMED MATER RES A, V70A, P115, DOI 10.1002/jbm.a.30071
   Seol YJ, 2006, J BIOMED MATER RES A, V77A, P599, DOI 10.1002/jbm.a.30639
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Wozney JM, 2004, CURR OPIN BIOTECH, V15, P392, DOI 10.1016/j.copbio.2004.08.001
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Yuan Q, 2007, KEY ENG MATER, V334-335, P1261, DOI 10.4028/www.scientific.net/KEM.334-335.1261
   Zhao J, 2005, MACROMOL BIOSCI, V5, P636, DOI 10.1002/mabi.200500043
NR 29
TC 64
Z9 72
U1 2
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUN 1
PY 2010
VL 144
IS 2
BP 190
EP 195
DI 10.1016/j.jconrel.2010.02.016
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 609JP
UT WOS:000278652800011
PM 20184932
DA 2018-10-20
ER

PT J
AU Wongsasulak, S
   Patapeejumruswong, M
   Weiss, J
   Supaphol, P
   Yoovidhya, T
AF Wongsasulak, Saowakon
   Patapeejumruswong, Manashuen
   Weiss, Jochen
   Supaphol, Pitt
   Yoovidhya, Tipaporn
TI Electrospinning of food-grade nanofibers from cellulose acetate and egg
   albumen blends
SO JOURNAL OF FOOD ENGINEERING
LA English
DT Article
DE Biomaterial; Cellulose acetate; Electrospinning; Egg albumen; Nanofibers
ID FORMIC-ACID; MOLECULAR-WEIGHT; DRUG-DELIVERY; FIBER MATS; RELEASE;
   POLYMER; SURFACTANT; EMULSIONS; CHITOSAN; WATER
AB Edible nanofibrous thin films were fabricated for the first time from blend solutions of cellulose acetate (CA) in 85% acetic acid and egg albumen (EA) in 50% formic acid by electrospinning. The mass percentage ratios of CA-EA in the mixed solvents varied from 100:0 to 91:9, 77:23, 66:34 and 0:100. Effects of the blend ratios on the solution properties and morphology of the resulting electrospun products were studied. The results showed that EA lacked sufficient entanglement and also possessed very high surface tension, thereby being unable to form nanofibers. The addition of CA and surfactant (Tween40 (R)) decreased both the electrical conductivity and the surface tension of the blends (p < 0.05), which facilitated the formation of CA-EA blend nanofibers. Scanning electron microscopic images showed that the continuity of the blend fibers was improved with an increase in the EA ratio. Fourier-transformed infrared spectroscopy and thermo-gravimetric analysis results indicated that the obtained fibers were composed of both CA and EA constituents. This study demonstrated a potential to fabricate edible nanofibers from natural food biopolymers using the electrospinning technique. Due to the properties of EA, these nanofibers could provide new functionalities with respect to in vivo-controlled release of nutraceuticals and drugs. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Wongsasulak, Saowakon; Patapeejumruswong, Manashuen; Yoovidhya, Tipaporn] King Mongkuts Univ Technol Thonburi, Fac Engn, Dept Food Engn, Bangkok 10140, Thailand.
   [Weiss, Jochen] Univ Hohenheim, Dept Food Sci & Biotechnol, D-70599 Stuttgart, Germany.
   [Supaphol, Pitt] Chulalongkorn Univ, Ctr Petr Petrochem & Adv Mat, Petr & Petrochem Coll, Bangkok 10330, Thailand.
RP Wongsasulak, S (reprint author), King Mongkuts Univ Technol Thonburi, Fac Engn, Dept Food Engn, Bangkok 10140, Thailand.
EM saowakon.won@kmutt.ac.th
RI Supaphol, Pitt/C-4353-2008
FU Thailand Research Fund (TRF) [TRG 5080008]
FX This research project was financially supported by a grant from the
   Thailand Research Fund (TRF, Grant No. TRG 5080008).
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   BRANDENBURG K, 1996, INFRARED SPECTROSCOP, P207
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   George L, 2004, SPECTROCHIM ACTA A, V60, P3225, DOI 10.1016/j.saa.2004.03.004
   Gunasekaran S, 2007, J FOOD ENG, V83, P31, DOI 10.1016/j.jfoodeng.2006.11.001
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Han SO, 2008, MATER LETT, V62, P759, DOI 10.1016/j.matlet.2007.06.059
   Jung YH, 2005, MACROMOL RES, V13, P385, DOI 10.1007/BF03218470
   Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008
   Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Klinkesorn U, 2009, FOOD HYDROCOLLOID, V23, P1374, DOI 10.1016/j.foodhyd.2008.11.002
   Kriegel C, 2009, POLYMER, V50, P189, DOI 10.1016/j.polymer.2008.09.041
   Kriegel C, 2008, CRIT REV FOOD SCI, V48, P775, DOI 10.1080/10408390802241325
   Kuhn PS, 1998, CHEM PHYS LETT, V298, P51, DOI 10.1016/S0009-2614(98)01205-6
   LAPASIN R, 1995, SECONDARY TERTIARY S
   LEEDEN VDM, 2000, J BIOTECHNOL, V79, P211
   Li Y, 2009, J FOOD SCI, V74, pC233, DOI 10.1111/j.1750-3841.2009.01093.x
   LICHAN ECY, 1995, EGG SCI TECHNOLOGY, P105
   Ma ZW, 2005, J MEMBRANE SCI, V265, P115, DOI 10.1016/j.memsci.2005.04.044
   MARTIN DC, 1997, PROTEIN BASED MAT
   Mun S, 2006, J COLLOID INTERF SCI, V296, P581, DOI 10.1016/j.jcis.2005.09.023
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Peng HS, 2008, COLLOID SURFACE B, V66, P206, DOI 10.1016/j.colsurfb.2008.06.021
   Ranganath SH, 2008, BIOMATERIALS, V29, P2996, DOI 10.1016/j.biomaterials.2008.04.002
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Son WK, 2006, CARBOHYD POLYM, V65, P430, DOI 10.1016/j.carbpol.2006.01.037
   Sozer N, 2009, TRENDS BIOTECHNOL, V27, P82, DOI 10.1016/j.tibtech.2008.10.010
   STUART BH, 2004, ORGANIC MOL INFRARED, P7193
   Suwantong O, 2007, POLYMER, V48, P7546, DOI 10.1016/j.polymer.2007.11.019
   Tadros T, 2009, ADV COLLOID INTERFAC, V147-48, P281, DOI 10.1016/j.cis.2008.10.005
   Taepaiboon P, 2007, EUR J PHARM BIOPHARM, V67, P387, DOI 10.1016/j.ejpb.2007.03.018
   Tungprapa S, 2007, POLYMER, V48, P5030, DOI 10.1016/j.polymer.2007.06.061
   Uchegbu F., 2006, POLYM DRUG DELIVERY
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Wongsasulak S, 2007, FOOD RES INT, V40, P249, DOI 10.1016/j.foodres.2006.03.011
   Wongsasulak S, 2007, POLYMER, V48, P448, DOI 10.1016/j.polymer.2006.11.025
   Xu XL, 2005, J CONTROL RELEASE, V108, P33, DOI 10.1016/j.jconrel.2005.07.021
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 46
TC 83
Z9 85
U1 6
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0260-8774
EI 1873-5770
J9 J FOOD ENG
JI J. Food Eng.
PD JUN
PY 2010
VL 98
IS 3
BP 370
EP 376
DI 10.1016/j.jfoodeng.2010.01.014
PG 7
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA 576AK
UT WOS:000276115700012
DA 2018-10-20
ER

PT J
AU Lewis, JS
   Gittard, SD
   Narayan, RJ
   Berry, CJ
   Brigmon, RL
   Ramamurti, R
   Singh, RN
AF Lewis, J. S.
   Gittard, S. D.
   Narayan, R. J.
   Berry, C. J.
   Brigmon, R. L.
   Ramamurti, R.
   Singh, R. N.
TI Assessment of Microbial Biofilm Growth on Nanocrystalline Diamond in a
   Continuous Perfusion Environment
SO JOURNAL OF MANUFACTURING SCIENCE AND ENGINEERING-TRANSACTIONS OF THE
   ASME
LA English
DT Article
DE nanocrystalline diamond; biofilm; chemical vapor deposition; thin films
ID PSEUDOMONAS-FLUORESCENS; BACTERIAL BIOFILMS; ESCHERICHIA-COLI;
   AERUGINOSA; RESISTANCE; SURFACE; AGENTS; SUSCEPTIBILITY; SPECTROSCOPY;
   ATTACHMENT
AB A major concern with medical and dental biomaterials is colonization of these materials with microbial biofilms. One material processed using chemical vapor deposition and other conventional top-down nanomanufacturing technologies that has recently been considered for use in preventing growth of microorganisms is the nanocrystalline diamond. Nanocrystalline diamond coatings have been evaluated for use as coatings on medical implants (e. g., hip prostheses) and surgical tools due to their low coefficient of friction, high corrosion resistance, high hardness, and high wear resistance. In this study, the microstructural properties and microorganism interaction behavior of nanocrystalline diamond coatings were examined. A device for examining microbial biofilms known as a CDC biofilm reactor was used to examine the interaction between a fluorescent microorganism, Pseudomonas fluorescens, and nanocrystalline diamond coatings in a continuous perfusion environment. Biofilm formation was evident on the nanocrystalline diamond surface after 24 h. No correlation between grain size or morphology and cell density was observed; large variations in P. fluorescens growth on the coatings were observed, even for the samples with similar grain sizes and morphologies. The results of this study suggest that nanocrystalline diamond coatings do not prevent Pseudomonas fluorescens biofilm development in a continuous perfusion environment. Additional treatment of the nanocrystalline diamond coatings with antimicrobial and/or antifouling agents would be necessary to prevent formation of microbial biofilms. The development of novel continuous flow technologies for evaluating the growth of microbial biofilms on biomaterials will provide a better understanding of biomaterial-microorganism interaction and will enable the creation of enhanced antimicrobial biomaterials. [DOI: 10.1115/1.4001583]
C1 [Lewis, J. S.; Gittard, S. D.; Narayan, R. J.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.
   [Lewis, J. S.; Gittard, S. D.; Narayan, R. J.] N Carolina State Univ, Chapel Hill, NC 27599 USA.
   [Berry, C. J.; Brigmon, R. L.] Savannah River Natl Lab, Environm Biotechnol Sect, Aiken, SC 29808 USA.
   [Ramamurti, R.; Singh, R. N.] Univ Cincinnati, Dept Chem & Mat Engn, Cincinnati, OH 45221 USA.
RP Narayan, RJ (reprint author), Univ N Carolina, Joint Dept Biomed Engn, 152 MacNider Hall,Campus Box 7575, Chapel Hill, NC 27599 USA.
EM roger_narayan@unc.edu
RI Lewis, Jamal/B-1734-2013; Narayan, Roger/J-2789-2013
OI Narayan, Roger/0000-0002-4876-9869
FU U.S. Department of Energy [DE-AC09-08SR22470]
FX This document was prepared in conjunction with work accomplished under
   Contract No. DE-AC09-08SR22470 with the U.S. Department of Energy.
CR Amaral M, 2008, DIAM RELAT MATER, V17, P848, DOI 10.1016/j.diamond.2007.12.070
   Amaral M, 2007, DIAM RELAT MATER, V16, P790, DOI 10.1016/j.diamond.2006.12.045
   Amaral M, 2008, J NANOMATER, DOI 10.1155/2008/894352
   Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900
   Banning N, 2003, MICROBIOL-SGM, V149, P47, DOI 10.1099/mic.0.25938-0
   Brigmon RL, 1998, J MICROBIOL METH, V32, P1, DOI 10.1016/S0167-7012(97)00092-4
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Delille A, 2007, APPL ENVIRON MICROB, V73, P5782, DOI 10.1128/AEM.00838-07
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   DUDDRIDGE JE, 1982, BIOTECHNOL BIOENG, V24, P153, DOI 10.1002/bit.260240113
   EVANS DJ, 1991, J ANTIMICROB CHEMOTH, V27, P177, DOI 10.1093/jac/27.2.177
   FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988
   Gershman MD, 2008, CLIN INFECT DIS, V47, P1372, DOI 10.1086/592968
   Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0
   Grabarczyk J., 2007, J ACHIEVEMENTS MAT M, V20, P107
   Heydorn A, 2002, APPL ENVIRON MICROB, V68, P2008, DOI 10.1128/AEM.68.4.2008-2017.2002
   Hsueh PR, 1998, J CLIN MICROBIOL, V36, P2914
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   KHABBAZ RF, 1984, AM J MED, V76, P62, DOI 10.1016/0002-9343(84)90751-4
   LEWIS JS, 2007, THESIS N CAROLINA ST
   Lindsay D, 2006, J HOSP INFECT, V64, P313, DOI 10.1016/j.jhin.2006.06.028
   Manfredi R, 2000, INFECT DIS CLIN PRAC, V9, P79, DOI 10.1097/00019048-200009020-00010
   Musk DJ, 2006, CURR MED CHEM, V13, P2163, DOI 10.2174/092986706777935212
   Narayan RJ, 2006, DIAM RELAT MATER, V15, P1935, DOI 10.1016/j.diamond.2006.08.024
   Ramamurti R, 2006, J VAC SCI TECHNOL A, V24, P179, DOI 10.1116/1.2150228
   Shanov V, 2002, J MATER ENG PERFORM, V11, P220, DOI 10.1361/105994902770344303
   Sihorkar V, 2001, PHARM RES-DORDR, V18, P1247, DOI 10.1023/A:1013073508318
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Trafny EA, 1998, INT J ANTIMICROB AG, V10, P223, DOI 10.1016/S0924-8579(98)00042-9
   Walker C, 2007, ORAL MICROBIOL IMMUN, V22, P152, DOI 10.1111/j.1399-302X.2007.00336.x
   Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000
   Webb JS, 2003, CURR OPIN MICROBIOL, V6, P578, DOI 10.1016/j.mib.2003.10.014
NR 35
TC 0
Z9 0
U1 0
U2 15
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1087-1357
J9 J MANUF SCI E-T ASME
JI J. Manuf. Sci. Eng.-Trans. ASME
PD JUN
PY 2010
VL 132
IS 3
AR 030919
DI 10.1115/1.4001583
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 612HJ
UT WOS:000278887100019
DA 2018-10-20
ER

PT J
AU Zhang, WD
   Han, LH
   Chen, SC
AF Zhang, Wande
   Han, Li-Hsin
   Chen, Shaochen
TI Integrated Two-Photon Polymerization With Nanoimprinting for Direct
   Digital Nanomanufacturing
SO JOURNAL OF MANUFACTURING SCIENCE AND ENGINEERING-TRANSACTIONS OF THE
   ASME
LA English
DT Article
ID LITHOGRAPHY; FABRICATION; IMPRINT
AB In this work, we demonstrate the plausibility of integrating two-photon polymerization (TPP) with nanoimprinting for direct, digital nanomanufacturing. TPP offers manufacturing of nanomolds at a low cost, while the nanoimprinting process using the nanomolds enables massively parallel printing of nanostructures. A Ti:sapphire femtosecond laser (800 nm wavelength, 100 fs pulse width, at a repetition rate of 80 MHz) was used to induce TPP in dipentaerythritol pentaacrylate to fabricate the nanoimprinting mold with 400 nm wide line array on a glass substrate. The mold surface was silanized by tridecafuoro-1,1,2,2-tetrahydrooctyl-1 trichlorosilane to facilitate the detachment of the mold from the imprinted material. This mold was then used to imprint poly(ethylene glycol) diacrylate (PEGDA). PEGDA is an important biomaterial for many applications such as tissue scaffolds for cell growth. A spectrophotometer and a scanning electron microscope were used to characterize the materials and nanostructures. [DOI: 10.1115/1.4001661]
C1 [Zhang, Wande] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Han, Li-Hsin; Chen, Shaochen] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.
RP Zhang, WD (reprint author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
EM scchen@mail.utexas.edu
OI Han, Li-Hsin/0000-0002-0135-2863
FU Office of Naval Research [N00014-07-1-0609]; National Science Foundation
FX This work is supported by grants from the Office of Naval Research
   (Grant No. N00014-07-1-0609) and the National Science Foundation to S.
   C.
CR Ahn SW, 2005, NANOTECHNOLOGY, V16, P1874, DOI 10.1088/0957-4484/16/9/076
   Bailey T, 2000, J VAC SCI TECHNOL B, V18, P3572, DOI 10.1116/1.1324618
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Fozdar DY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/21/215303
   HAN LH, 2008, ASME, V130
   Khang DY, 2004, LANGMUIR, V20, P2445, DOI 10.1021/la0358668
   Kim SH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/5/055306
   Konijn M, 2005, MICROELECTRON ENG, V78-79, P653, DOI 10.1016/j.mee.2004.12.081
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Murooka K, 2003, J VAC SCI TECHNOL B, V21, P2668, DOI 10.1116/1.1627803
   Pina-Hernandez C, 2008, J VAC SCI TECHNOL B, V26, P2426, DOI 10.1116/1.2987966
   Qiu J., 2009, P SPIE, V7203
   Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y
   Rolland JP, 2004, ANGEW CHEM INT EDIT, V43, P5796, DOI 10.1002/anie.200461122
   Serbin J, 2003, OPT LETT, V28, P301, DOI 10.1364/OL.28.000301
   STEWART MD, 2005, J MICROLITH MICROFAB, V4, P1
   Wu SM, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285312
   Xing JF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2717532
NR 20
TC 8
Z9 8
U1 1
U2 17
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1087-1357
J9 J MANUF SCI E-T ASME
JI J. Manuf. Sci. Eng.-Trans. ASME
PD JUN
PY 2010
VL 132
IS 3
AR 030907
DI 10.1115/1.4001661
PG 5
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 612HJ
UT WOS:000278887100007
DA 2018-10-20
ER

PT J
AU Madhwal, D
   Rait, SS
   Kumar, A
   Verma, A
   Tada, K
   Onoda, M
   Bhatnagar, PK
   Mathur, PC
AF Madhwal, Devinder
   Rait, S. S.
   Kumar, A.
   Verma, A.
   Tada, K.
   Onoda, M.
   Bhatnagar, P. K.
   Mathur, P. C.
TI Development and characterization of an efficient bio-white polymer
   light-emitting diode with red and green phosphorescent dyes as dopants
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID LAYER; DEVICES; EMISSION
AB An efficient white polymer light-emitting diode (WPLED) with stable Commission Internationale de l',clairage (CIE) coordinates is fabricated. A blue electroluminescence (EL)-emitting conducting polymer [poly(9,9-di-n-hexyl-fluorenyl-2,7-diyl)] is used as a host for red [Bis(1-phenyl-isoquinoline)(acetylacetonate)iridium(III)] and green [iridium(III)tris(2-(4-tolyl)pyridinato-N,C-2)] phosphorescent dyes. Although efficient triplet energy transfer is not possible in the green phosphorescent dye, the self-trapping mechanism is utilized for the emission of EL in the green region while an efficient triplet exciton energy transfer from the host to the red dye is utilized for EL in the red wavelength region. Concentrations of the three constituents are optimized to obtain pure white light of appropriate CIE coordinates. An efficient electron-blocking layer based on a biomaterial (salmon-DNA) is also incorporated in the WPLED to improve the device performance. The WPLED shows three distinguished peaks for the primary colors and achieved a maximum luminance and luminous efficiency of 350 cd/m(2) and 0.86 cd/A, respectively.
C1 [Madhwal, Devinder; Rait, S. S.; Kumar, A.; Verma, A.; Bhatnagar, P. K.; Mathur, P. C.] Univ Delhi, Dept Elect Sci, New Delhi 110021, India.
   [Tada, K.; Onoda, M.] Univ Hyogo, Dept Elect Engn & Comp Sci, Himeji, Hyogo, Japan.
RP Madhwal, D (reprint author), Univ Delhi, Dept Elect Sci, South Campus,Benito Juarez Rd, New Delhi 110021, India.
EM devindermadhwal@gmail.com
FU Department of Science and Technology (DST), Government of India
FX Financial support from Department of Science and Technology (DST),
   Government of India is highly acknowledged. The authors also wish to
   thank Dr. Kamalasanan, NPL, New Delhi, for providing some facilities for
   measurements.
CR Chen FC, 2003, APPL PHYS LETT, V82, P1006, DOI 10.1063/1.1544658
   Fischer A, 2006, J PHYS D APPL PHYS, V39, P917, DOI 10.1088/0022-3727/39/5/004
   GAO ZQ, 2000, SYNTHETIC MET, V39, P111
   Guo FW, 2006, OPT MATER, V28, P966, DOI 10.1016/j.optmat.2005.05.006
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   Huang F, 2008, J MATER CHEM, V18, P4495, DOI 10.1039/b804977g
   Ko YW, 2003, THIN SOLID FILMS, V426, P246, DOI 10.1016/S0040-6090(03)00007-5
   Kumar A, 2005, J APPL PHYS, V98, DOI 10.1063/1.1968445
   Kumar A, 2005, J MATER SCI, V40, P3849, DOI 10.1007/s10853-005-2556-9
   Lee CL, 2005, CURR APPL PHYS, V5, P309, DOI 10.1016/j.cap.2003.11.092
   Lei GT, 2006, SEMICOND SCI TECH, V21, P1455, DOI 10.1088/0268-1242/21/10/016
   Li G, 2003, APPL PHYS LETT, V83, P5359, DOI 10.1063/1.1635658
   Lyu YY, 2009, ADV FUNCT MATER, V19, P420, DOI 10.1002/adfm.200801319
   Madhwal D, 2010, J LUMIN, V130, P331, DOI 10.1016/j.jlumin.2009.09.012
   Niu JH, 2005, J PHYS D APPL PHYS, V38, P1136, DOI 10.1088/0022-3727/38/8/006
   XIAOMING WU, 2008, CHINESE PHYS LETT, V25, P294
   Yang SH, 2006, J APPL PHYS, V100, DOI 10.1063/1.2360153
   Yang XH, 2004, ADV MATER, V16, P161, DOI 10.1002/adma.200305621
   Yoshihara H, 2005, CURR APPL PHYS, V5, P27, DOI 10.1016/j.cap.2003.11.074
NR 19
TC 4
Z9 4
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD JUN
PY 2010
VL 45
IS 12
BP 3300
EP 3303
DI 10.1007/s10853-010-4343-5
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 582PD
UT WOS:000276609000022
DA 2018-10-20
ER

PT J
AU Fatimi, A
   Tassin, JF
   Axelos, MAV
   Weiss, P
AF Fatimi, Ahmed
   Tassin, Jean-Francois
   Axelos, Monique A. V.
   Weiss, Pierre
TI The stability mechanisms of an injectable calcium phosphate ceramic
   suspension
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; COLLOIDAL SUSPENSIONS; HYDROXYPROPYL
   METHYLCELLULOSE; STEAM STERILIZATION; AQUEOUS-SOLUTIONS; THERMAL
   GELATION; BONE INGROWTH; SEDIMENTATION; HYDROXYPROPYLMETHYLCELLULOSE;
   CELLULOSE
AB Calcium phosphate ceramics are widely used as bone substitutes in dentistry and orthopedic applications. For minimally invasive surgery an injectable calcium phosphate ceramic suspension (ICPCS) was developed. It consists in a biopolymer (hydroxypropylmethylcellulose: HPMC) as matrix and bioactive calcium phosphate ceramics (biphasic calcium phosphate: BCP) as fillers. The stability of the suspension is essential to this generation of "ready to use" injectable biomaterial. But, during storage, the particles settle down. The engineering sciences have long been interested in models describing the settling (or sedimentation) of particles in viscous fluids. Our work is dedicated to the comprehension of the effect of the formulation on the stability of calcium phosphate suspension before and after steam sterilization. The rheological characterization revealed the macromolecular behavior of the suspending medium. The investigations of settling kinetics showed the influence of the BCP particle size and the HPMC concentration on the settling velocity and sediment compactness before and after sterilization. To decrease the sedimentation process, the granule size has to be smaller and the polymer concentration has to increase. A much lower sedimentation velocity, as compared to Stokes law, is observed and interpreted in terms of interactions between the polymer network in solution and the particles. This experimentation highlights the granules spacer property of hydrophilic macromolecules that is a key issue for interconnection control, one of the better ways to improve osteoconduction and bioactivity.
C1 [Fatimi, Ahmed; Weiss, Pierre] INSERM U791, LIOAD, F-44042 Nantes 1, France.
   [Fatimi, Ahmed; Weiss, Pierre] Univ Nantes, LIOAD, F-44042 Nantes 1, France.
   [Tassin, Jean-Francois] Univ Maine, LPCI, UMR 6120, CNRS, F-72085 Le Mans 9, France.
   [Axelos, Monique A. V.] INRA, Biopolymeres Interact Assemblages BIA UR1268, F-44316 Nantes 3, France.
RP Weiss, P (reprint author), INSERM U791, LIOAD, 1 Pl Alexis Ricordeau,BP 84215, F-44042 Nantes 1, France.
EM pierre.weiss@univ-nantes.fr
RI Fatimi, Ahmed/F-2936-2012; Weiss, Pierre/P-1372-2014
OI Weiss, Pierre/0000-0002-6159-8590
FU Region Pays de la Loire, France
FX This present work was supported by the regional program BIOREGOS (Region
   Pays de la Loire, France). The help of Paul Pilet (LIOAD INSERM U791,
   Nantes) for the SEM analysis, Jean-Michel Bouler (LIOAD INSERM U791,
   Nantes) for BCP preparation, and Stephane Grolleau (CNRS IMN, Nantes)
   for density measurements is acknowledged with gratitude. We thank
   Colorcon (R) for providing the Methocel (TM) E4M.
CR Allain C, 1996, J COLLOID INTERF SCI, V178, P411, DOI 10.1006/jcis.1996.0135
   ALLAIN C, 1995, PHYS REV LETT, V74, P1478, DOI 10.1103/PhysRevLett.74.1478
   ALNAAFA MA, 1992, AICHE J, V38, P1618, DOI 10.1002/aic.690381012
   AUZERAIS FM, 1988, J FLUID MECH, V195, P437, DOI 10.1017/S0022112088002472
   Balastre M, 2002, COLLOID SURFACE A, V211, P145, DOI 10.1016/S0927-7757(02)00240-6
   Barros RRM, 2006, J PERIODONTOL, V77, P1280, DOI 10.1902/jop.2006.050161
   Bohic S, 2001, J MATER SCI-MATER M, V12, P201, DOI 10.1023/A:1008902829840
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Bourges X, 2001, J BIOMAT SCI-POLYM E, V12, P573, DOI 10.1163/156856201316883412
   BRADY JF, 1988, PHYS FLUIDS, V31, P717, DOI 10.1063/1.866808
   BUSCALL R, 1987, J CHEM SOC FARAD T 1, V83, P873, DOI 10.1039/f19878300873
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   Chen JF, 2006, J COLLOID INTERF SCI, V301, P549, DOI 10.1016/j.jcis.2006.05.029
   Clasen C, 2001, PROG POLYM SCI, V26, P1839, DOI 10.1016/S0079-6700(01)00024-7
   CROSS MM, 1965, J COLL SCI IMP U TOK, V20, P417, DOI 10.1016/0095-8522(65)90022-X
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DAVIS KE, 1989, PHYS FLUIDS A-FLUID, V1, P82, DOI 10.1063/1.857526
   Fatimi A, 2008, KEY ENG MATER, V361-363, P365, DOI 10.4028/www.scientific.net/KEM.361-363.365
   Fatimi A, 2008, MACROMOL SYMP, V266, P12, DOI 10.1002/masy.200850603
   Fatimi A, 2008, BIOMATERIALS, V29, P533, DOI 10.1016/j.biomaterials.2007.10.032
   Fatimi A, 2009, ACTA BIOMATER, V5, P3423, DOI 10.1016/j.actbio.2009.05.030
   Gallardo V, 2005, EUR J PHARM SCI, V26, P170, DOI 10.1016/j.ejps.2005.05.008
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P308
   Kryuchkov YN, 2005, THEOR FOUND CHEM ENG, V39, P522, DOI 10.1007/s11236-005-0111-7
   KYNCH GJ, 1952, T FARADAY SOC, V48, P166, DOI 10.1039/tf9524800166
   LEONHARDT J, 1985, RADIAT PHYS CHEM, V25, P899
   Li X, 2009, ACTA BIOMATER, V5, P508, DOI 10.1016/j.actbio.2008.06.010
   Novales B, 2003, COLLOID SURFACE A, V221, P81, DOI 10.1016/S0927-7757(03)00102-X
   Park PJ, 2003, J AGR FOOD CHEM, V51, P4624, DOI 10.1021/jf034039+
   Pekel N, 2004, CARBOHYD POLYM, V55, P139, DOI 10.1016/j.carbpol.2003.08.015
   Richardson J.F., 1954, T I CHEM ENG-LOND, V32, P35
   Roy J, 2006, B MATER SCI, V29, P85
   SARKAR N, 1979, J APPL POLYM SCI, V24, P1073, DOI 10.1002/app.1979.070240420
   SARKAR N, 1995, CARBOHYD POLYM, V26, P195, DOI 10.1016/0144-8617(94)00107-5
   SARKAR N, 1995, CARBOHYD POLYM, V27, P177, DOI 10.1016/0144-8617(95)00061-B
   Shojaei A, 2006, CHEM ENG SCI, V61, P7565, DOI 10.1016/j.ces.2006.08.050
   van Doornmalen J, 2008, AM J INFECT CONTROL, V36, P86, DOI 10.1016/j.ajic.2007.02.002
   Vesaratchanon JS, 2008, J COLLOID INTERF SCI, V322, P180, DOI 10.1016/j.jcis.2008.02.067
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
NR 41
TC 12
Z9 12
U1 0
U2 17
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2010
VL 21
IS 6
BP 1799
EP 1809
DI 10.1007/s10856-010-4047-z
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 607RX
UT WOS:000278525300004
PM 20229185
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Guo, DG
   Xu, KW
   Liu, YX
AF Guo Dagang
   Xu Kewei
   Liu Yaxiong
TI Physicochemical properties and cytotoxicities of Sr-containing biphasic
   calcium phosphate bone scaffolds
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POROUS HYDROXYAPATITE; CANCELLOUS BONE; IN-VITRO; MECHANICAL-PROPERTIES;
   TRICALCIUM PHOSPHATE; CERAMICS; CEMENT; MACROPOROSITY; SUBSTITUTE;
   INGROWTH
AB This study demonstrates a new biomaterial system composed of Sr-containing hydroxyapatite (Sr-HA) and Sr-containing tricalcium phosphate (Sr-TCP), termed herein Sr-containing biphasic calcium phosphate (Sr-BCP). Furthermore, a series of new Sr-BCP porous scaffolds with tunable structure and properties has also been developed. These Sr-BCP scaffolds were obtained by in situ sintering of a series of composites formed by casting various Sr-containing calcium phosphate cement (Sr-CPC) into different rapid prototyping (RP) porous phenol formaldehyde resins, which acted as the negative moulds for controlling pore structures of the final scaffolds. Results show that the porous Sr-BCP scaffolds are composed of Sr-HA and Sr-TCP. The phase composition and the macro-structure of the Sr-BCP scaffold could be adjusted by controlling the processing parameters of the Sr-CPC pastes and the structure parameters of the RP negative mould, respectively. It is also found that both the compressive strength (CS) and the dissolving rate of the Sr-BCP scaffold significantly vary with their phase composition and macropore percentage. In particular, the compressive strength achieves a maximum CS level of 9.20 +/- A 1.30 MPa for the Sr-BCP scaffold with a Sr-HA/Sr-TCP weight ratio of 78:22, a macropore percentage of 30% (400-550 mu m in size) and a total-porosity of 63.70%, significantly higher than that of the Sr-free BCP scaffold with similar porosity. All the extracts of the Sr-BCP scaffold exhibit no cytotoxicity. The current study shows that the incorporation of Sr plays an important role in positively improving the physicochemical properties of the BCP scaffold without introducing obvious cytotoxicity. It also reveals a potential clinical application for this material system as bone tissue engineering (BTE) scaffold.
C1 [Guo Dagang; Xu Kewei] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Mat Sci & Engn, Xian 710049, Peoples R China.
   [Liu Yaxiong] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Sch Mech Engn, Xian 710049, Peoples R China.
RP Guo, DG (reprint author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Sch Mat Sci & Engn, Xian 710049, Peoples R China.
EM guodagang@mail.xjtu.edu.cn
FU National Natural Science Foundation of China [50702043]; Foundation of
   Ministry of Education of China [20070698092]; Chinese Ministry of
   Education [2301G107aaa]
FX This work was supported by the National Natural Science Foundation of
   China (No: 50702043), Ph.D. Program Foundation of Ministry of Education
   of China (20070698092) and Program for New Century Excellent Talents in
   Universities (Chinese Ministry of Education, 2301G107aaa). The authors
   would like to thank Mr. Wang Wei, a graduate student of the Fourth
   Military Medical University, for his help to perform the cytotoxicity
   test. The authors also appreciate the help of Dr. Chenjie Xu and Ms.
   Luye Mu (Harvard-MIT Division of Health Science & Technology) for
   correcting grammar and language.
CR Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   AOKI H, 1994, MED APPL HYDROXYAPAT, P13
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chen D, 2001, CHIN J BIOMED ENG, V20, P278
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Curran JM, 2005, BIOMATERIALS, V26, P5313, DOI [10.1016/j.biomaterials.2005.01.065, 10.1016/.jbiomaterials.2005.01.065]
   DACILSI G, 1989, J BIOMED MATER RES, V23, P883
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Dietmar W.H., 2000, BIOMATERIALS, V21, P2529
   DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Fu Y.F., 2001, CHIN J STOMA MAT APP, V19, P178
   Galois L, 1996, ACTUALITES BIOMATERI, VIII, P361
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GB/T 16175-1996, 2003, 161751996 GBT, P6
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   GOLDBERG VM, 1994, ORTHOPEDICS, V17, P809
   Guo DG, 2008, J BIOMED MATER RES A, V86A, P947, DOI 10.1002/jbm.a.31687
   Guo DG, 2009, J BIOMED MATER RES A, V88A, P43, DOI 10.1002/jbm.a.31844
   Guo DG, 2005, J INORG MATER, V20, P1159
   Guo DG, 2005, RARE METAL MAT ENG, V34, P799
   Guo DG, 2005, BIOMATERIALS, V26, P4073, DOI 10.1016/j.biomaterials.2004.10.032
   Guo DG, 2005, MAT SCI ENG B-SOLID, V116, P175, DOI 10.1016/j.mseb.2004.09.032
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Karen JLB, 2000, BIOMATERIALS, V21, P2347
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Leroux L, 2001, J MATER RES, V16, P171, DOI 10.1557/JMR.2001.0028
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   [卢晓风 Lu Xiaofeng], 2002, [生物医学工程学杂志, Journal of Biomedical Engineering], V19, P361
   Luo Feng, 2006, Journal of the Chinese Ceramic Society, V34, P183
   Padilla S, 2002, J MATER SCI-MATER M, V13, P1193, DOI 10.1023/A:1021162626006
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   RAMAY HR, 2003, BIOMATERIALS, V24, P3292
   ROBINSON BP, 1995, OTOLARYNG HEAD NECK, V112, P707
   ROGER F, 1994, CERAM INT, V20, P327
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   Takagi S, 2001, J MATER SCI-MATER M, V12, P135, DOI 10.1023/A:1008917910468
   UCHIDA A, 1985, J ORTHOP RES, V3, P65, DOI 10.1002/jor.1100030108
   Woesz A, 2005, MAT SCI ENG C-BIO S, V25, P181, DOI 10.1016/j.msec.2005.01.014
   Yeni YN, 2001, J BIOMECH, V34, P1649, DOI 10.1016/S0021-9290(01)00155-5
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
NR 49
TC 7
Z9 7
U1 1
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2010
VL 21
IS 6
BP 1927
EP 1936
DI 10.1007/s10856-010-4044-2
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 607RX
UT WOS:000278525300018
PM 20217190
DA 2018-10-20
ER

PT J
AU Voskerician, G
   Jin, J
   White, MF
   Williams, CP
   Rosen, MJ
AF Voskerician, Gabriela
   Jin, Judy
   White, Michael F.
   Williams, Christina P.
   Rosen, Michael J.
TI Effect of biomaterial design criteria on the performance of surgical
   meshes for abdominal hernia repair: a pre-clinical evaluation in a
   chronic rat model
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POLYPROPYLENE-MESH; VENTRAL HERNIA
AB Despite the recognized advantage of surgical meshes in abdominal hernia repair, reports of long term complications after implantation are increasing. 25 chronic hernia rats underwent incisional repair (n = 5/mesh group) with compressed poly(tetra-fluoro-ethylene) (cPTFE), expanded poly(tetra-fluoro-ethylene) (ePTFE), polypropylene (PP), poly(ethylene-terephtalate) + collagen (PET + C), and porcine intestinal submucosa (SIS). At 30 days, the extent and strength of intra-abdominal adhesions was evaluated, along with tissue-mesh integration, material shrinkage, and inflammatory response. The extent and tenacity of adhesions were reduced in PET + C and SIS, while tissue contraction was largely reduced in the presence of cPTFE. The tissue integration was not affected by composition or material construction. The host tissue response was elevated and arrested in a chronic imflammatory phase in the presence of PET + C and SIS, and resolved in the case of cPTFE. The different composition and material construction did not affect significantly the overall performance of the evaluated surgical meshes, apart from PP.
C1 [Voskerician, Gabriela; White, Michael F.] Spiddal Co, Proxy Biomed Ltd, Galway, Ireland.
   [Jin, Judy; Williams, Christina P.; Rosen, Michael J.] Univ Hosp Case Med Ctr, Dept Surg, Case Sch Med, Case Hernia Inst, Cleveland, OH USA.
RP Voskerician, G (reprint author), Spiddal Co, Proxy Biomed Ltd, Galway, Ireland.
EM gxv4@case.edu
CR Agrawal A, 2006, Hernia, V10, P79, DOI 10.1007/s10029-005-0024-8
   AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022
   COOPER SLV, 2004, INTRO MAT MED, P67
   Greca FH, 2008, HERNIA, V12, P45, DOI 10.1007/s10029-007-0276-6
   Greca F H, 2001, Hernia, V5, P59
   Junge K, 2002, WORLD J SURG, V26, P1472, DOI 10.1007/s00268-002-6444-z
   Klinge U, 2001, BIOMATERIALS, V22, P1415, DOI 10.1016/S0142-9612(00)00299-4
   Klosterhalfen B, 1998, BIOMATERIALS, V19, P2235, DOI 10.1016/S0142-9612(98)00115-X
   Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020
   Pandit Abhay S, 2004, Technol Health Care, V12, P51
   Pascual G, 2008, SURGERY, V144, P427, DOI 10.1016/j.surg.2008.04.005
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Scheidbach H, 2004, EUR SURG RES, V36, P313, DOI 10.1159/000079917
   Schumpelick V, 2004, LANGENBECK ARCH SURG, V389, P1, DOI 10.1007/s00423-003-0352-z
   Voskerician G., 2006, WILEY ENCY BIOMEDICA
   Weyhe D, 2007, WORLD J SURG, V31, P234, DOI 10.1007/s00268-006-0123-4
   Williams David, 2003, Med Device Technol, V14, P10
NR 19
TC 12
Z9 12
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2010
VL 21
IS 6
BP 1989
EP 1995
DI 10.1007/s10856-010-4037-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 607RX
UT WOS:000278525300024
PM 20217192
DA 2018-10-20
ER

PT J
AU Sommar, P
   Pettersson, S
   Ness, C
   Johnson, H
   Kratz, G
   Junker, JPE
AF Sommar, Pehr
   Pettersson, Sofia
   Ness, Charlotte
   Johnson, Hans
   Kratz, Gunnar
   Junker, Johan P. E.
TI Engineering three-dimensional cartilage- and bone-like tissues using
   human dermal fibroblasts and macroporous gelatine microcarriers
SO JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY
LA English
DT Article
DE Dermal fibroblast; Chondrogenesis; Osteogenesis; Microcarrier; Tissue
   engineering; Regenerative medicine
ID MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; IN-VITRO; STROMAL CELLS;
   OSTEOBLASTIC DIFFERENTIATION; BIODEGRADABLE SCAFFOLD;
   ARTICULAR-CARTILAGE; CONNECTIVE TISSUES; DEMINERALIZED BONE; ALCIAN BLUE
AB The creation of tissue-engineered cartilage and bone, using cells from an easily available source seeded on a suitable biomaterial, may have a vast impact on regenerative medicine. While various types of adult stem cells have shown promising results, their use is accompanied by difficulties associated with harvest and culture. The proposed inherent plasticity of dermally derived human fibroblasts may render them useful in tissue-engineering applications. In the present study, human dermal fibroblasts cultured on macroporous gelatine microcarriers encapsulated in platelet-rich plasma into three-dimensional constructs were differentiated towards chondrogenic and osteogenic phenotypes using specific induction media. The effect of flow-induced shear stress on osteogenic differentiation of fibroblasts was also evaluated. The generated tissue constructs were analysed after 4, 8 and 12 weeks using routine and immunohistochemical stainings as well as an enzyme activity assay. The chondrogenic-induced tissue constructs were composed of glycosaminoglycan-rich extracellular matrix, which stained positive for aggrecan. The osteogenic-induced tissue constructs were composed of mineralised extracellular matrix containing osteocalcin and osteonectin, with cells showing an increased alkaline phosphatase activity. Increased osteogenic differentiation was seen when applying flow-induced shear stress to the culture. Un-induced fibroblast controls did not form cartilage- or bone-like tissues. Our findings suggest that primary human dermal fibroblasts can be used to form cartilage- and bone-like tissues in vitro when cultured in specific induction media. (C) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Junker, Johan P. E.] Linkoping Univ, Ctr Clin & Expt Res, Dept Clin & Expt Med,Fac Hlth Sci, Lab Reconstruct Plast Surg,Div Plast & Hand Surg, SE-58185 Linkoping, Sweden.
   [Ness, Charlotte; Johnson, Hans] Haukeland Hosp, Burn Ctr, N-5021 Bergen, Norway.
   [Ness, Charlotte; Johnson, Hans] Haukeland Hosp, Dept Surg, Sect Plast Surg, N-5021 Bergen, Norway.
RP Junker, JPE (reprint author), Linkoping Univ, Ctr Clin & Expt Res, Dept Clin & Expt Med,Fac Hlth Sci, Lab Reconstruct Plast Surg,Div Plast & Hand Surg, SE-58185 Linkoping, Sweden.
EM johan.junker@ibk.liu.se
OI Junker, Johan/0000-0003-3708-1978
CR Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008
   Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x
   Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337
   BEISER I H, 1990, Journal of Foot Surgery, V29, P595
   BILLS CE, 1971, JOHNS HOPKINS MED J, V128, P194
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Del Guerra S, 2001, BIOTECHNOL BIOENG, V75, P741, DOI 10.1002/bit.10053
   Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249
   Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031
   French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0
   GOLDSTEIN DJ, 1974, HISTOCHEM J, V6, P175, DOI 10.1007/BF01011805
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Huss FRM, 2007, J PLAST RECONSTR AES, V60, P543, DOI 10.1016/j.bjps.2005.10.031
   Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Kanno T, 2005, J ORAL MAXIL SURG, V63, P362, DOI 10.1016/j.joms.2004.07.016
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309, DOI 10.1177/12.4.309
   Liu JY, 2004, WOUND REPAIR REGEN, V12, P148, DOI 10.1111/j.1067-1927.2004.012205.x
   Magnusson P, 2002, CALCIFIED TISSUE INT, V71, P508, DOI 10.1002/s00223-001-1137-4
   Malda J, 2003, BIOMATERIALS, V24, P5153, DOI 10.1016/S0142-9612(03)00428-9
   MASON R M, 1971, Histochemical Journal, V3, P421, DOI 10.1007/BF01014780
   Masuoka K, 2006, J BIOMED MATER RES B, V79B, P25, DOI 10.1002/jbm.30507
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Melero-Martin JM, 2006, BIOMATERIALS, V27, P2970, DOI 10.1016/j.biomaterials.2006.01.023
   Mizuno S, 1996, EXP CELL RES, V227, P89, DOI 10.1006/excr.1996.0253
   Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5
   OHLSON S, 1994, CYTOTECHNOLOGY, V14, P67, DOI 10.1007/BF00772197
   Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v
   Phillips JE, 2007, TISSUE ENG, V13, P2029, DOI 10.1089/ten.2006.0041
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rutherford RB, 2002, TISSUE ENG, V8, P441, DOI 10.1089/107632702760184709
   Sledge SL, 2001, CLIN SPORT MED, V20, P365, DOI 10.1016/S0278-5919(05)70311-2
   Stover NP, 2005, ARCH NEUROL-CHICAGO, V62, P1833, DOI 10.1001/archneur.62.12.1833
   Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259
   Waldman SD, 2004, TISSUE ENG, V10, P1323, DOI 10.1089/1076327042500210
   Warejcka DJ, 1996, J SURG RES, V62, P233, DOI 10.1006/jsre.1996.0201
   Wendt D, 2006, BIORHEOLOGY, V43, P481
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205
   Young HE, 2001, ANAT REC, V264, P51, DOI 10.1002/ar.1128
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 48
TC 30
Z9 33
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-6815
J9 J PLAST RECONSTR AES
JI J. Plast. Reconstr. Aesthet. Surg.
PD JUN
PY 2010
VL 63
IS 6
BP 1036
EP 1046
DI 10.1016/j.bjps.2009.02.072
PG 11
WC Surgery
SC Surgery
GA 592DY
UT WOS:000277356900025
PM 19329368
DA 2018-10-20
ER

PT J
AU Ban, SJ
   Suehiro, Y
   Nakanishi, H
   Nawa, M
AF Ban, Seiji
   Suehiro, Yasuhiko
   Nakanishi, Hideo
   Nawa, Masahiro
TI Fracture toughness of dental zirconia before and after autoclaving
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Fracture toughness; Zirconia; Autoclaving; SEVNB; Low temperature aging
   degradation; Dental ceramics
ID BIAXIAL FLEXURE STRENGTH; CE-TZP/AL2O3 NANOCOMPOSITE;
   MECHANICAL-PROPERTIES; HEAT-TREATMENT; TRANSFORMATION; POLYCRYSTALS;
   BIOMATERIAL; CERAMICS; ALUMINA; PHASE
AB The purpose of this study was to evaluate the low temperature aging degradation (LTAD) of two types of zirconia through the determination of fracture toughness before and after autoclaving. The fracture toughness of yttria stabilized tetragonal zirconia polycrystals (Y-TZP) and zirconia/alumina nanocomposite stabilized with cerium oxide (Ce-TZP/Al2O3 nanocomposite, so called NANOZR) were determined by Single Edge V-Notch Beam (SEVNB) method before and after autoclaving at 134 C for 5 h. The fracture surfaces were characterized by micro-X-ray diffractometry and micro-Raman spectroscopy. Mean fracture toughness of Y-TZP slightly decreased from 6.31 to 5.79 MPa.m(1/2) with the autoclaving (p < 0.01). On the other hand, mean fracture toughness of NANOZR showed no change as 11.03 MPa.m(1/2) (p > 0.1) and was 1.75-1.91 times larger than that of Y-TZP. It seems to be caused by that NANOZR is susceptible to stress-induced transformation from tetragonal to monoclinic, but quite stable against LTAD. (C)2010 The Ceramic Society of Japan. All rights reserved.
C1 [Ban, Seiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 8908544, Japan.
   [Suehiro, Yasuhiko; Nakanishi, Hideo; Nawa, Masahiro] Panasonic Elect Works, Kadoma, Osaka 5718686, Japan.
RP Ban, SJ (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.
EM sban@dent.kagoshima-u.ac.jp
FU Japan Society for the Promotion of Science
FX The present study was supported by the Grant-in-Aid for General Science
   Research from Japan Society for the Promotion of Science.
CR [Anonymous], 133562008 ISO
   [Anonymous], 68722008 ISO
   Ban S, 2007, KEY ENG MATER, V330-332, P353, DOI 10.4028/www.scientific.net/KEM.330-332.353
   Ban S, 2006, KEY ENG MAT, V309-311, P1219, DOI 10.4028/www.scientific.net/KEM.309-311.1219
   Ban S, 2008, J BIOMED MATER RES B, V87B, P492, DOI 10.1002/jbm.b.31131
   Ban S, 2008, JPN DENT SCI REV, V44, P3, DOI 10.1016/j.jdsr.2008.04.001
   BASU D, 1995, CERAM INT, V21, P277, DOI 10.1016/0272-8842(95)99794-C
   Benzaid R, 2008, BIOMATERIALS, V29, P3636, DOI 10.1016/j.biomaterials.2008.05.021
   CHENG Y, 1990, J MATER SCI LETT, V9, P24, DOI 10.1007/BF00722858
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   El Attaoui H, 2007, J EUR CERAM SOC, V27, P483, DOI 10.1016/j.jeurceramsoc.2006.04.108
   GARVIE RC, 1975, NATURE, V703, P258
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   Kim BK, 1997, J MATER SCI LETT, V16, P669, DOI 10.1023/A:1018587821260
   Lin JD, 2003, MATER CHEM PHYS, V77, P808, DOI 10.1016/S0254-0584(02)00161-X
   LU HY, 1987, J AM CERAM SOC, V70, P537, DOI 10.1111/j.1151-2916.1987.tb05701.x
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   Niihara K., 1991, J CERAM SOC JPN, V99, P974, DOI DOI 10.2109/JCERSJ.99.974
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sato H, 2008, DENT MATER J, V27, P408, DOI 10.4012/dmj.27.408
   SATO T, 1985, AM CERAM SOC BULL, V64, P1382
   SWAIN MV, 1986, J AM CERAM SOC, V69, P511, DOI 10.1111/j.1151-2916.1986.tb04785.x
   Tanaka K, 2002, J BIOMED MATER RES, V63, P262, DOI 10.1002/jbm.10182
   TORAYA H, 1984, J AM CERAM SOC, V67, pC119
   WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x
NR 25
TC 12
Z9 12
U1 0
U2 10
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JUN
PY 2010
VL 118
IS 1378
BP 406
EP 409
DI 10.2109/jcersj2.118.406
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 612NL
UT WOS:000278905900004
OA Bronze
DA 2018-10-20
ER

PT J
AU Murata, M
   Akazawa, T
   Takahata, M
   Ito, M
   Tazaki, J
   Hino, J
   Nakamura, K
   Iwasaki, N
   Shibata, T
   Arisue, M
AF Murata, Masaru
   Akazawa, Toshiyuki
   Takahata, Masahiko
   Ito, Manabu
   Tazaki, Junichi
   Hino, Jun
   Nakamura, Katsuo
   Iwasaki, Norimasa
   Shibata, Takanori
   Arisue, Makoto
TI Bone induction of human tooth and bone crushed by newly developed
   automatic mill
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Human; Dentin; Bone; Demineralization; Bone induction; Crush
ID DENTIN; MATRIX
AB A novel automatic mill of teeth and bone has been developed for bone engineering. A human frozen-tooth and/or a human frozen-bone block were put into the Zirconium oxide (ZrO2) ceramics vessel of the machine, and crushed for 1 min with 20 salineice blocks (1 x 1 x 1 cm(3)/block) at 12000 rpm of ZrO2 blade. The crushed granules were demineralized completely in 2% HNO3 solution for 20 min, and rinsed in cold saline. We named each biomaterial after the acid treatment and washing, demineralized dentin matrices (DDM), demineralized bone matrices (DBM). Five wisdom teeth (total wet volume: 10.0 g) were crushed, decalcified, and lyophilized. The distribution of freeze-dried DDM granules was fine granules (0.5-1.0 mm: 0.27 g), moderate (1.0-2.0 mm: 0.46 g), and large (2.0-5.0 mm: 0.64 g). The fine granules of human DDM or DBM were implanted into the subcutaneous tissue of 4 week-old nude mice, and their tissue-inductive properties were estimated at 4 weeks after implantation histologically. The explanted samples were demineralized, embedded in paraffin, and sectioned. The specimens were stained with hematoxylin and eosin. We confirmed that DDM induced bone and cartilage independently, and DBM induced cartilage, bone and marrow at 4 weeks in the back skin of nude mice. These results indicated that our material preparation system by the novel mill with a vessel and a blade of ZrO2 under ice-cooling maintained the bone-inducing activity of human dentin and bone. (C)2010 The Ceramic Society of Japan All rights reserved.
C1 [Murata, Masaru; Tazaki, Junichi; Hino, Jun; Shibata, Takanori; Arisue, Makoto] Hlth Sci Univ Hokkaido, Sch Dent, Tobetsu, Hokkaido 0610293, Japan.
   [Akazawa, Toshiyuki; Nakamura, Katsuo] Hokkaido Ind Res Inst, Kita Ku, Sapporo, Hokkaido 0600819, Japan.
   [Takahata, Masahiko; Ito, Manabu; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0608586, Japan.
RP Murata, M (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, 1757 Kanazawa, Tobetsu, Hokkaido 0610293, Japan.
EM murata@hoku-iryo-u.ac.jp
RI Iwasaki, Norimasa/D-6448-2012; Takahata, Masahiko/E-1929-2012
FU METI [20045]; JST [2006-7]; Hokkaido, Japan [2006-8]
FX This work was supported by grants of 20045 METI, 2006-7 JST, and 2006-8
   Hokkaido, Japan. We would like to thank Mr. Kumagai (Manager, NOASTEC),
   and Dr. Takoshima (Coordinator, JST) very much for the advice and
   manegements of our research and development.
CR BANG G, 1967, ARCH SURG-CHICAGO, V94, P781
   BUTLER WT, 1977, J DENT RES, V56, P228, DOI 10.1177/00220345770560030601
   Ito K, 2007, J HARD TISSUE BIOL, V16, P199
   KAWAI T, 1989, J DENT RES, V68, P1069, DOI 10.1177/00220345890680060301
   Murata M, 2003, J HARD TISSUE BIOL, V11, P110
   Murata M, 2005, ARCH BIOCERAM RES, V5, P178
   Murata M, 2008, KEY ENG MATER, V361-363, P1327, DOI 10.4028/www.scientific.net/KEM.361-363.1327
   REDDI AH, 1973, P SOC EXP BIOL MED, V143, P634
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   YEOMANS JD, 1967, ARCH ORAL BIOL, V12, P999, DOI 10.1016/0003-9969(67)90095-7
NR 10
TC 16
Z9 17
U1 0
U2 5
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JUN
PY 2010
VL 118
IS 1378
BP 434
EP 437
DI 10.2109/jcersj2.118.434
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 612NL
UT WOS:000278905900010
OA Bronze
DA 2018-10-20
ER

PT J
AU Tanaka, Y
   Yoshida, M
   Nakamura, M
   Nagai, A
   Hashimoto, K
   Toda, Y
   Yamashita, K
AF Tanaka, Yumi
   Yoshida, Masato
   Nakamura, Miho
   Nagai, Akiko
   Hashimoto, Kazuaki
   Toda, Yoshitomo
   Yamashita, Kimihiro
TI Biocompatibility and water durability of alumina-zirconia ceramics
   blended with microsized HA particles
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Alumina-zirconia ceramics; Biomaterial; Composite; Hydroxyapatite; Low
   temperature degradation (LTD)
ID COMPOSITES
AB To improve the bioactivity of alumina containing yttria stabilized zirconia (Al-YSZ), composite ceramics consisting of Al-YSZ and 0-10 wt % of hydroxyapatite (HA) were prepared. The XRD patterns of sintered disks with an HA content above 3 wt % had monoclinic and cubic YSZ phases and a beta-tricalcium phosphate phase. Although the Vickers hardness decreased as the HA content increased, all the prepared ceramics had the same or greater hardness (1000-1300 Hv with a load of 0.49 N) compared to typical YSZ ceramics (900-1000 Hv) commonly used in clinics. Furthermore, the bonelike apatite formation ability in simulated body fluid, which was examined as a screening of bioactivity, suggested that all the surfaces of Al-YSZ ceramics blending with a small amount of HA may possess the ability to connect bone. After the accelerated low temperature degradation (LTD) test performed in normal saline at 120 degrees C for five days using composite ceramics with the HA content of 0, 1, 3, and 10 wt %, the tetragonal zirconia phase of all composite ceramics were partially transformed into the monoclinic phase with a transition ratio of ca. 16-18 mol % (for HA = 0 and 10 wt To) and ca. 4-5 mol (for HA = 1 and 3 wt %). Blending microsized HA powder in Al-YSZ ceramics has both positive and negative effects on the LTD durability of Al-YSZ ceramics. An advantage is that calcium ion substitution in YSZ seems to stabilize the tetragonal (or cubic) zirconia phases, but the increased surface area exposed to the solution is a disadvantage. (C)2010 The Ceramic Society of Japan All rights reserved.
C1 [Tanaka, Yumi; Yoshida, Masato; Nakamura, Miho; Nagai, Akiko; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Dept Inorgan Mat, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Tanaka, Yumi] Kyushu Univ, Fac Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan.
   [Yoshida, Masato; Hashimoto, Kazuaki; Toda, Yoshitomo] Chiba Inst Technol, Fac Engn, Dept Life & Environm Sci, Chiba 2750016, Japan.
RP Tanaka, Y (reprint author), Tokyo Med & Dent Univ, Dept Inorgan Mat, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM yutanaka@cstf.kyushu-u.ac.jp
RI Nakamura, Miho/T-3166-2017
CR GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V703, P258
   Inuzuka M, 2004, SOLID STATE IONICS, V172, P509, DOI 10.1016/j.ssi.2004.01.054
   Ito A, 2002, J BIOMED MATER RES, V60, P224, DOI 10.1002/jbm.10068
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   PCONI C, 1999, BIOMATERIALS, V20, P1
   Rao RR, 2002, MAT SCI ENG C-BIO S, V20, P187
   TANAKA Y, 2008, CERAM ENG SCI P, V29, P239
   TSUKUMA K, 1985, J AM CERAM SOC, V68, pC4
   UCHIDA M, 2002, J BIOMEDICAL MAT RES, V60, P227
NR 10
TC 0
Z9 0
U1 0
U2 7
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JUN
PY 2010
VL 118
IS 1378
BP 498
EP 501
DI 10.2109/jcersj2.118.498
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 612NL
UT WOS:000278905900023
OA Bronze
DA 2018-10-20
ER

PT J
AU Seib, FP
   Lanfer, B
   Bornhauser, M
   Werner, C
AF Seib, F. Philipp
   Lanfer, Babette
   Bornhaeuser, Martin
   Werner, Carsten
TI Biological activity of extracellular matrix-associated BMP-2
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE extracellular matrix; bone morphogenetic protein; osteogenesis;
   physisorption
ID BONE MORPHOGENETIC PROTEINS; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS;
   COLLAGEN; PHARMACOKINETICS; DIFFERENTIATION; RHBMP-2
AB The critical requirement for matrix-associated bone morphogenetic proteins (BMPs) during induction of bone formation in vivo has long been recognized. However, the role of extracellular matrix (ECM) physisorbed BMPs in inducing the differentiation of resident mesenchymal stem cells into osteoblasts has been ill-defined. We therefore used BMP-responsive C2C12s to study the biological activity of collagen type I physisorbed BMP-2. Fibrillar collagen type I scaffolds were loaded with 75 ng BMP-2/mu g collagen. Under cell culture conditions, 40% of loaded I-125-labelled BMP-2 was released within 24 h, whereas the remaining BMP-2 was stably physisorbed for >7 days. Using these systems suggested that physisorbed BMP-2 is more active than diffusible BMP-2. Thus, the current clinical practice of immobilizing BMPs on collagen type I scaffolds not only prolongs local delivery of the morphogen but could also enhance biological activity at the cellular level. Copyright (C) 2009 John Wiley & Sons, Ltd.
C1 [Seib, F. Philipp; Lanfer, Babette; Werner, Carsten] Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res, D-01069 Dresden, Germany.
   [Seib, F. Philipp; Bornhaeuser, Martin] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany.
RP Werner, C (reprint author), Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res, Hohe Str 6, D-01069 Dresden, Germany.
EM werner@ipfdd.de
RI Bornhauser, Martin/F-8101-2010; Werner, Carsten/F-8127-2010; Umlauf,
   Ursula/D-3356-2014
OI Werner, Carsten/0000-0003-0189-3448; Seib, Philipp/0000-0002-1955-1975
FU Deutsche Forschungsgemeinschaft, Collaborative Research Centre, Dresden
   [SFB 655]
FX The authors would like to thank Martian Franke for excellent technical
   assistance and Laurel Rohde for careful reading of the manuscript. This
   work was supported by the Deutsche Forschungsgemeinschaft,
   'Collaborative Research Centre: cells into tissues-stem cell and
   progenitor commitment and interactions during tissue formation' (SFB
   655, Dresden).
CR Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   PARALKAR VM, 1990, J BIOL CHEM, V265, P17281
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   Seib FP, 2009, TISSUE ENG PT A, V15, P3161, DOI [10.1089/ten.tea.2008.0600, 10.1089/ten.TEA.2008.0600]
   Seib FP, 2009, EUR J CELL BIOL, V88, P257, DOI 10.1016/j.ejcb.2009.01.003
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
NR 13
TC 10
Z9 10
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2010
VL 4
IS 4
BP 324
EP 327
DI 10.1002/term.240
PG 4
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 610LP
UT WOS:000278734500009
PM 20014079
DA 2018-10-20
ER

PT J
AU Nogueira, GM
   Swiston, AJ
   Beppu, MM
   Rubner, MF
AF Nogueira, Grinia M.
   Swiston, Albert J.
   Beppu, Marisa M.
   Rubner, Michael F.
TI Layer-by-Layer Deposited Chitosan/Silk Fibroin Thin Films with
   Anisotropic Nanofiber Alignment
SO LANGMUIR
LA English
DT Article
ID BOMBYX-MORI SILK; MECHANICAL-PROPERTIES; BIOMATERIAL COATINGS; SURFACES;
   SCAFFOLDS; HYDROGELS; BEHAVIOR; RELEASE; CELLS
AB Chitosan/silk fibroin multilayer thin films were assembled using layer-by-layer deposition. The resultant multilayer Films contained nanofibers aligned parallel to the dipping direction. Fiber deposition and orientation was enabled uniquely by a judicious choice of solvent and drying conditions and layer-by-layer assembly with chitosan. The deposition of oriented nanotibers was found to be the result of a unique combination of layer-by-layer and Langmuir-Blodgett type processing. Fiber orientation was confirmed by fast Fourier transform (FFT) analysis of optical micrographs and atomic force microscopy (AFM). Bidirectional fiber alignment was realized by rotating the substrate between multilayer deposition steps. Infrared spectroscopy revealed that the silk fibroin adopted the silk II secondary structure in the deposited films. We anticipate that these anisotropic films are able to combine the biocompatibility of a natural polymer system with the mechanical strength or SF, two properties useful in many biological applications including scaffolds suitable for guiding cell attachment and spreading.
C1 [Swiston, Albert J.; Rubner, Michael F.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Nogueira, Grinia M.; Beppu, Marisa M.] Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
RP Rubner, MF (reprint author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
EM rubner@mit.edu
RI BEPPU, MARISA/E-1057-2012
FU CAPES-Brazil; National Science Foundation [DMR-0819762]
FX The authors thank Prof. Robert Cohen, Dr. Adam Nolte, Erik Williamson,
   and Zekeriyya Gemici for valuable discussions. We acknowledge
   CAPES-Brazil for funding. This work was supported in part by the MRSEC
   Program of the National Science Foundation under Award DMR-0819762. This
   material is based upon work supported under a National Science
   Foundation Graduate Research Fellowship.
CR Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Berg MC, 2003, LANGMUIR, V19, P2231, DOI 10.1021/la0266076
   Cai K, 2007, J BIOMED MATER RES A, V82A, P927, DOI 10.1002/jbm.a.31233
   Cebeci FC, 2006, LANGMUIR, V22, P2856, DOI 10.1021/la053182p
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Croll TI, 2006, BIOMACROMOLECULES, V7, P1610, DOI 10.1021/bm060044l
   DECHER G, 2003, MUTILAYER THIN FILMS
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   FORSEN S, 1997, CALCIUM BIOL SYSTEMS
   HAPPEY F, 1967, BIOPOLYMERS, V5, P749, DOI 10.1002/bip.1967.360050808
   Hossain KS, 2003, J PHYS CHEM B, V107, P8066, DOI 10.1021/jp0224490i
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hwang W, 2009, LANGMUIR, V25, P12682, DOI 10.1021/la9015993
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jiang XP, 2002, LANGMUIR, V18, P2607, DOI 10.1021/la011098d
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Mandal BB, 2009, EUR J PHARM SCI, V37, P160, DOI 10.1016/j.ejps.2009.02.005
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MULLER WS, 1993, LANGMUIR, V9, P1857, DOI 10.1021/la00031a038
   Nelson DLC M. M., 2000, LEHNINGER PRINCIPLES, V3
   Nogueira GM, 2008, KEY ENG MATER, V361-363, P503, DOI 10.4028/www.scientific.net/KEM.361-363.503
   Payne GF, 2007, SOFT MATTER, V3, P521, DOI 10.1039/b613872a
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Shulha H, 2006, POLYMER, V47, P5821, DOI 10.1016/j.polymer.2006.06.002
   Sionkowska A, 2006, POLYM DEGRAD STABIL, V91, P3026, DOI 10.1016/j.polymdegradstab.2006.08.009
   Su B, 2009, LANGMUIR, V25, P3640, DOI 10.1021/la803948m
   Swiston AJ, 2008, NANO LETT, V8, P4446, DOI 10.1021/nl802404h
   Taketani I, 2005, APPL SURF SCI, V244, P623, DOI 10.1016/j.apsusc.2004.09.167
   Tanaka T, 1999, POLYM INT, V48, P811, DOI 10.1002/(SICI)1097-0126(199909)48:9<811::AID-PI221>3.0.CO;2-V
   Valluzzi R, 1997, BIOPOLYMERS, V42, P705, DOI 10.1002/(SICI)1097-0282(199711)42:6<705::AID-BIP8>3.0.CO;2-Y
   VALLUZZI R, 1999, INT J BIOL MACROMOL, V24, P6
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wu Z, 2007, SMALL, V3, P1467, DOI 10.1002/smll.200700084
   Yamada K, 2003, THIN SOLID FILMS, V440, P208, DOI 10.1016/S0040-6090(03)00460-7
   Zhai L, 2006, NANO LETT, V6, P1213, DOI 10.1021/nl060644q
   Zhang YJ, 2003, MACROMOLECULES, V36, P4238, DOI 10.1021/ma0342729
   Zhu T, 1999, LANGMUIR, V15, P5197, DOI 10.1021/la990081g
NR 51
TC 30
Z9 30
U1 5
U2 71
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 1
PY 2010
VL 26
IS 11
BP 8953
EP 8958
DI 10.1021/la904741h
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 599QL
UT WOS:000277928100172
PM 20158176
DA 2018-10-20
ER

PT J
AU Paulino, AT
   Guilherme, MR
   Mattoso, LHC
   Tambourgi, EB
AF Paulino, Alexandre T.
   Guilherme, Marcos R.
   Mattoso, Luiz H. C.
   Tambourgi, Elias B.
TI Smart Hydrogels Based on Modified Gum Arabic as a Potential Device for
   Magnetic Biomaterial
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE gum arabic; magnetic polymers; polysaccharides; smart hydrogels
ID PULSATILE DRUG-RELEASE; GLYCIDYL METHACRYLATE;
   POLY(N-ISOPROPYLACRYLAMIDE); BIOCOMPATIBILITY; NANOCOMPOSITES;
   NANOPARTICLES; NANOSPHERES; DELIVERY; CHITOSAN; DEXTRAN
AB By means of a conventional cross-linking/co-polymerization reaction of modified gum arabic (M-GA), acrylamide (AAm), and potassium acrylate (KAAc) in the presence of magnetite (Fe(3)O(4)) nanoparticles, a magnetic field-sensitive M-GA-based hydrogel (smart hydrogel) was synthesized to investigate its potential as a magnetic biomaterial and as a intelligent hydrogel. Characterizations through FT-IR, NMR, XRD, Mossbauer, SEM, and EDX inferred that the smart hydrogel was efficiently formed. Theoretically, the smart hydrogel obtained in this work may effectively be applied as biomaterial either on remote controlled release or tissue engineering or even in other areas of science and technology.
C1 [Paulino, Alexandre T.; Guilherme, Marcos R.; Tambourgi, Elias B.] Univ Estadual Campinas, Fac Engn Quim, Dept Engn Sistemas Quim, BR-13083852 Campinas, SP, Brazil.
   [Mattoso, Luiz H. C.] Embrapa Instrumentacao Agropecuaria, Lab Nacl Nanotecnol Agronegocio, BR-13560970 Sao Carlos, SP, Brazil.
RP Paulino, AT (reprint author), Univ Estadual Campinas, Fac Engn Quim, Dept Engn Sistemas Quim, Av Albert Einstein 500, BR-13083852 Campinas, SP, Brazil.
EM atpaulino10@gmail.com
RI Paulino, Alexandre/B-8075-2013; Guilherme, Marcos/J-6008-2012;
   Tambourgi, Elias/E-1863-2012; AgroNano, Rede/F-5675-2017; Mattoso, Luiz
   H C/D-2794-2016
OI Paulino, Alexandre/0000-0001-7076-2797; Tambourgi,
   Elias/0000-0002-4734-9723; Mattoso, Luiz H C/0000-0001-7586-1014;
   Guilherme, Marcos/0000-0002-4260-5660
FU State of Sao Paulo Research Foundation (FAPESP-Brazil) [2008/00285-7];
   FAPESP-Brazil; CAPES-Brazil; National Council for Scientific and
   Technological Development (CNPq-Brazil)
FX A. T. Paulino and E. B. Tambourgi thank the State of Sao Paulo Research
   Foundation (FAPESP-Brazil) for the post-doctorate fellowship (Process
   No. 2008/00285-7). M.R. Guilherme and L.H.C. Mattoso thank
   FAPESP-Brazil, the Coordination for Improvement of Higher Level
   Personnel (CAPES-Brazil), and the National Council for Scientific and
   Technological Development (CNPq-Brazil) for their financial support.
CR Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Bussemer T, 2001, CRIT REV THER DRUG, V18, P433
   Ding GW, 2007, INT J PHARMACEUT, V328, P78, DOI 10.1016/j.ijpharm.2006.07.042
   Gu Z, 2009, NANO LETT, V9, P4533, DOI 10.1021/nl902935b
   Huang SH, 2003, BIOTECHNOL PROGR, V19, P1095, DOI 10.1021/bp025587v
   Kato N, 1997, J INTEL MAT SYST STR, V8, P588, DOI 10.1177/1045389X9700800703
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Lau KT, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/7/070201
   Li JF, 2008, J AGR FOOD CHEM, V56, P1336, DOI [10.1021/jf072530l, 10.1021/jf0725301]
   Liang YY, 2007, CHEMPHYSCHEM, V8, P2367, DOI 10.1002/cphc.200700359
   Liu TY, 2008, J CONTROL RELEASE, V126, P228, DOI 10.1016/j.jconrel.2007.12.006
   Liu XQ, 2007, IEEE T MAGN, V43, P2462, DOI 10.1109/TMAG.2007.894004
   MASSART R, 1987, J CHIM PHYS PCB, V84, P967, DOI 10.1051/jcp/1987840967
   Meenach SA, 2009, J BIOMED MATER RES A, V91A, P903, DOI 10.1002/jbm.a.32322
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Reis AV, 2009, J ORG CHEM, V74, P3750, DOI 10.1021/jo900033c
   Satarkar NS, 2008, J CONTROL RELEASE, V130, P246, DOI 10.1016/j.jconrel.2008.06.008
   Satarkar NS, 2009, LAB CHIP, V9, P1773, DOI 10.1039/b822694f
   Straley KS, 2009, ADV MATER, V21, P4148, DOI 10.1002/adma.200901865
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P3411, DOI 10.1021/ma961764v
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Youan BBC, 2004, J CONTROL RELEASE, V98, P337, DOI 10.1016/j.jconrel.2004.05.015
   Zhang YX, 2005, POLYMER, V46, P7695, DOI 10.1016/j.polymer.2005.05.121
   Zhao YL, 2009, LANGMUIR, V25, P8442, DOI 10.1021/la804316u
NR 27
TC 30
Z9 31
U1 0
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYS
JI Macromol. Chem. Phys.
PD JUN 1
PY 2010
VL 211
IS 11
BP 1196
EP 1205
DI 10.1002/macp.200900657
PG 10
WC Polymer Science
SC Polymer Science
GA 614ZV
UT WOS:000279099400002
DA 2018-10-20
ER

PT J
AU Yu, JQ
   Yang, Y
   Liu, AQ
   Chin, LK
   Zhang, XM
AF Yu, J. Q.
   Yang, Y.
   Liu, A. Q.
   Chin, L. K.
   Zhang, X. M.
TI Microfluidic droplet grating for reconfigurable optical diffraction
SO OPTICS LETTERS
LA English
DT Article
ID KINETICS; BUBBLES; DEVICE; FLOW
AB This Letter presents a reconfigurable optical diffraction grating using multiphase droplets on a microfluidic chip. The uniform and evenly spaced circular droplets are generated by continuously dispersing two immiscible liquids into a T junction to produce plugs, which are then transformed into a circular shape at a sudden expansion of the microchannel. In experiments, the droplet grating shows a detection limit of similar to 6.3 x 10(-5) when used as an optofluidic refractometer and produces different colors as a color filter. Such a grating has the advantages of high stability and wide tunability in droplet size, grating period, and refractive index, making it promising for biochemical and biomaterial applications. (C) 2010 Optical Society of America
C1 [Yu, J. Q.; Yang, Y.; Liu, A. Q.; Chin, L. K.] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore.
   [Zhang, X. M.] Hong Kong Polytech Univ, Dept Appl Phys, Hong Kong, Hong Kong, Peoples R China.
RP Liu, AQ (reprint author), Nanyang Technol Univ, Sch Elect & Elect Engn, Nanyang Ave, Singapore 639798, Singapore.
EM eaqliu@ntu.edu.sg
RI Yang, Yi/I-2295-2012; Zhang, Xuming/K-4900-2013
OI Zhang, Xuming/0000-0002-9326-5547
CR Bringer MR, 2004, PHILOS T ROY SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364
   Chin LK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3009560
   Cubaud T, 2006, FLUID DYN RES, V38, P772, DOI 10.1016/j.fluiddyn.2005.12.004
   FARIA JAB, 1991, MICROW OPT TECHN LET, V4, P350, DOI 10.1002/mop.4650040906
   Ganan-Calvo AM, 2004, APPL PHYS LETT, V84, P4989, DOI 10.1063/1.1762992
   Garstecki P, 2006, LAB CHIP, V6, P693
   Garstecki P, 2004, APPL PHYS LETT, V85, P2649, DOI 10.1063/1.1796526
   Hashimoto M, 2006, SMALL, V2, P1292, DOI 10.1002/smll.200600211
   Hecht E., 2001, OPTICS
   Kelly BT, 2007, CHEM COMMUN, P1773, DOI 10.1039/b616252e
   Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060
   Shui LL, 2009, SOFT MATTER, V5, P2708, DOI 10.1039/b908498c
   Song H, 2003, J AM CHEM SOC, V125, P14613, DOI 10.1021/ja0354566
   Xu JH, 2006, LANGMUIR, V22, P7943, DOI 10.1021/la0605743
NR 14
TC 26
Z9 28
U1 2
U2 25
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 0146-9592
J9 OPT LETT
JI Opt. Lett.
PD JUN 1
PY 2010
VL 35
IS 11
BP 1890
EP 1892
DI 10.1364/OL.35.001890
PG 3
WC Optics
SC Optics
GA 603TG
UT WOS:000278230400056
PM 20517452
OA Green Published
DA 2018-10-20
ER

PT J
AU Menzies, KL
   Jones, L
AF Menzies, Kara L.
   Jones, Lyndon
TI The Impact of Contact Angle on the Biocompatibility of Biomaterials
SO OPTOMETRY AND VISION SCIENCE
LA English
DT Review
DE biomaterials; biocompatibility; wettability; contact angle; hydrophilic;
   hydrophobic
ID METHACRYLATE) INTRAOCULAR LENSES; BLOOD MATERIAL INTERACTIONS;
   SELF-ASSEMBLED MONOLAYERS; CAPTIVE-BUBBLE TECHNIQUES; SILICONE-HYDROGEL;
   STAPHYLOCOCCUS-EPIDERMIDIS; POLY(METHYL METHACRYLATE); CELL-ADHESION;
   POLYMER SURFACES; IN-VIVO
AB Biomaterials may be defined as artificial materials that can mimic, store, or come into close contact with living biological cells or fluids and are becoming increasingly popular in the medical, biomedical, optometric, dental, and pharmaceutical industries. Within the ophthalmic industry, the best example of a biomaterial is a contact lens, which is worn by similar to 125 million people worldwide. For biomaterials to be biocompatible, they cannot illicit any type of unfavorable response when exposed to the tissue they contact. A characteristic that significantly influences this response is that related to surface wettability, which is often determined by measuring the contact angle of the material. This article reviews the impact of contact angle on the biocompatibility of tissue engineering substrates, blood-contacting devices, dental implants, intraocular lenses, and contact lens materials. (Optom Vis Sci 2010; 87: 387-399)
C1 [Menzies, Kara L.; Jones, Lyndon] Univ Waterloo, Sch Optometry, Waterloo, ON N2L 3G1, Canada.
RP Menzies, KL (reprint author), Univ Waterloo, Sch Optometry, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM klmenzie@uwaterloo.ca
OI Jones, Lyndon/0000-0002-7409-7349
CR Abdelaziz Khalid M, 2005, J Prosthodont, V14, P104, DOI 10.1111/j.1532-849X.2005.00019.x
   Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1
   Aguilar-Mendoza JA, 2008, DENT MATER, V24, P994, DOI 10.1016/j.dental.2007.11.013
   Amon M, 1996, J CATARACT REFR SURG, V22, P825, DOI 10.1016/S0886-3350(96)80169-6
   AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   Anguita-Alonso Paloma, 2005, Expert Rev Anti Infect Ther, V3, P797, DOI 10.1586/14787210.3.5.797
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Barr J, 2004, CONTACT LENS SPECTRU, V20, P26
   Black J, 1999, BIOL PERFORMANCE MAT
   Brown SL, 2000, AM J ROENTGENOL, V175, P1057, DOI 10.2214/ajr.175.4.1751057
   Bruce AS, 2001, BIOMATERIALS, V22, P3249, DOI 10.1016/S0142-9612(01)00162-4
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Calvet JL, 2008, J MATER SCI-MATER M, V19, P1631, DOI 10.1007/s10856-008-3381-x
   Carney FP, 1998, CLIN EXP OPTOM, V81, P51
   Cheng L, 2004, CURR EYE RES, V28, P93, DOI 10.1076/ceyr.28.2.93.26231
   Cheung SW, 2007, CLIN EXP OPTOM, V90, P124, DOI 10.1111/j.1444-0938.2006.00107.x
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Deppisch R, 1998, SEP PURIF TECHNOL, V14, P241, DOI 10.1016/S1383-5866(98)00079-3
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DOANE MG, 1989, OPTOMETRY VISION SCI, V66, P383, DOI 10.1097/00006324-198906000-00008
   Drelich J, 1996, J COLLOID INTERF SCI, V179, P37, DOI 10.1006/jcis.1996.0186
   Dumbleton KA, 2001, OPTOMETRY VISION SCI, V78, P147, DOI 10.1097/00006324-200103000-00006
   Dumbleton KA, 2008, EYE CONTACT LENS, V34, P215, DOI 10.1097/ICL.0b013e31816499dc
   FATT I, 1984, AM J OPTOM PHYS OPT, V61, P419
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   French K., 2005, OPTICIAN, V230, P20
   Garrett Q, 2000, INVEST OPHTH VIS SCI, V41, P1687
   GELLATLY KW, 1988, AM J OPTOM PHYS OPT, V65, P937
   Gonzalez-Meijome JM, 2006, J BIOMED MATER RES B, V76B, P412, DOI 10.1002/jbm.b.30387
   Goswami S, 2008, LANGMUIR, V24, P8627, DOI 10.1021/la800799a
   GUILLON M, 1989, OPHTHAL PHYSL OPT, V9, P355, DOI 10.1016/0275-5408(89)90249-4
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Guryca Vilem, 2007, Cont Lens Anterior Eye, V30, P215, DOI 10.1016/j.clae.2007.02.010
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   HALVERSON GE, 1988, Patent No. 4763791
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Henriques M, 2005, OPTOMETRY VISION SCI, V82, P446, DOI 10.1097/01.opx.0000168585.53845.64
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   HOLLY FJ, 1975, J BIOMED MATER RES, V9, P315, DOI 10.1002/jbm.820090307
   Hoque E, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2566333
   Johnson R. E., 1993, WETTABILITY, P2
   Jones L, 2006, OPTICIAN, V232, P28
   Jones L, 2007, CONTACT LENS SPECTRU, V22, P21
   Jones L, 2007, CONTACT LENS SPECTRU, V22, P23
   Jones Lyndon, 2003, Eye Contact Lens, V29, pS75
   KEIR N, 2008, CONT LENS ANTERIOR E, V6, P292
   Kess RS, 2000, J PROSTHET DENT, V84, P98, DOI 10.1067/mpr.2000.106720
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Kodjikian L, 2004, BIO-MED MATER ENG, V14, P395
   Krishnan A, 2005, COLLOID SURFACE B, V43, P95, DOI 10.1016/j.colsurfb.2005.04.003
   Kunzler JF, 1999, CONTACT LENS SPECTRU, V14, P9
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   LEVER OW, 1995, INT CONTACT LENS CLI, V22, P5
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lopez-Alemany A, 2002, J BIOMED MATER RES, V63, P319, DOI 10.1002/jbm.10186
   Lorentz H, 2007, OPTOMETRY VISION SCI, V84, P946, DOI 10.1097/OPX.0b013e318157a6c1
   Maldonado-Codina C, 2007, J BIOMED MATER RES A, V83A, P496, DOI 10.1002/jbm.a.31260
   Maldonado-Codina C, 2006, OPHTHAL PHYSL OPT, V26, P408, DOI 10.1111/j.1475-1313.2006.00394.x
   Mercuri LG, 2006, J ORAL MAXIL SURG, V64, P1303, DOI 10.1016/j.joms.2006.04.004
   Mester U, 1998, J CATARACT REFR SURG, V24, P380, DOI 10.1016/S0886-3350(98)80327-1
   Michalakis Konstantinos X, 2007, J Prosthodont, V16, P238, DOI 10.1111/j.1532-849X.2007.00205.x
   Morgan Philip B, 2002, Clin Exp Optom, V85, P183
   Nichols JJ, 2005, INVEST OPHTH VIS SCI, V46, P2353, DOI 10.1167/iovs.05-0094
   Nichols JJ, 2003, INVEST OPHTH VIS SCI, V44, P68, DOI 10.1167/iovs.02-0377
   Nicolson P. C., 1998, Patent No. [US5760100, 5760100]
   Nicolson Paul C, 2003, Eye Contact Lens, V29, pS30
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Nishio R, 2006, TISSUE ENG, V12, P2565, DOI 10.1089/ten.2006.12.2565
   Norman JJ, 2005, TISSUE ENG, V11, P378, DOI 10.1089/ten.2005.11.378
   Ohnishi Y, 2001, J CATARACT REFR SURG, V27, P2036, DOI 10.1016/S0886-3350(01)00961-0
   Okada A, 2008, DENT MATER J, V27, P565, DOI 10.4012/dmj.27.565
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   Pande MV, 1996, J CATARACT REFR SURG, V22, P811, DOI 10.1016/S0886-3350(96)80167-2
   PEARCE JL, 1992, CURR OPIN OPHTHALMOL, V3, P29, DOI 10.1097/00055735-199202000-00004
   PEARCE JL, 1990, CURR OPIN OPHTHALMOL, V1, P42, DOI 10.1097/00055735-199002000-00010
   PETHICA B. A., 1961, EXPTL CELL RES SUPPL, V8, P123, DOI 10.1016/0014-4827(61)90344-5
   Petrucci R. H., 2002, GEN CHEM PRINCIPLES
   PORT MJ, 1999, OPTOM TODAY, V39, P27
   Pritchard Nicola, 1996, CLAO Journal, V22, P53
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P1
   READ M, 2008, CLAO J, V31, P253
   Rosen E, 1994, Curr Opin Ophthalmol, V5, P40
   Samoilova NA, 2007, J BIOMED MATER RES A, V82A, P589, DOI 10.1002/jbm.a.31178
   Santos Livia, 2007, Cont Lens Anterior Eye, V30, P183, DOI 10.1016/j.clae.2006.12.007
   Schroeder AC, 2009, GRAEF ARCH CLIN EXP, V247, P1277, DOI 10.1007/s00417-009-1130-6
   Shang J, 2008, J COLLOID INTERF SCI, V328, P299, DOI 10.1016/j.jcis.2008.09.039
   Spijker HT, 2003, BIOMATERIALS, V24, P4717, DOI 10.1016/S0142-9612(03)00380-6
   STEFFEN RB, 2004, CONTACT LENS SPECT S, V13, P1
   Tang HY, 2009, J BIOMED MATER RES A, V88A, P454, DOI 10.1002/jbm.a.31788
   Tapia G, 2006, ADV CHRONIC KIDNEY D, V13, P215, DOI 10.1053/j.ackd.2006.04.002
   Taylor M, 2007, LANGMUIR, V23, P6875, DOI 10.1021/la070100j
   Teichroeb JH, 2008, OPTOMETRY VISION SCI, V85, P1151, DOI 10.1097/OPX.0b013e31818e8ad6
   Tighe B., 2000, SILICONE HYDROGELS R, P1
   Tighe B., 2004, SILICONE HYDROGELS C, P1
   Tognetto D, 2003, GRAEF ARCH CLIN EXP, V241, P625, DOI 10.1007/s00417-003-0711-z
   Tonge S, 2001, CURR EYE RES, V23, P51, DOI 10.1076/ceyr.23.1.51.5418
   TRIPATHI RC, 1980, OPHTHALMOLOGY, V87, P365
   Tzoneva R, 2007, BBA-GEN SUBJECTS, V1770, P1538, DOI 10.1016/j.bbagen.2007.07.008
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Underwood PA, 2002, INT J BIOCHEM CELL B, V34, P55, DOI 10.1016/S1357-2725(01)00100-5
   Vermeltfoort PBJ, 2004, J BIOMED MATER RES B, V71B, P336, DOI 10.1002/jbm.b.30100
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wan GJ, 2007, MAT SCI ENG C-BIO S, V27, P928, DOI 10.1016/j.msec.2006.11.005
   Yang P, 2006, NUCL INSTRUM METH B, V242, P22, DOI 10.1016/j.nimb.2005.08.081
   Yao K, 2006, J BIOMED MATER RES A, V78A, P684, DOI 10.1002/jbm.a.30741
   ZHANG W, 1990, DESALINATION, V79, P1, DOI 10.1016/0011-9164(90)80067-L
NR 117
TC 103
Z9 105
U1 6
U2 118
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1040-5488
J9 OPTOMETRY VISION SCI
JI Optom. Vis. Sci.
PD JUN
PY 2010
VL 87
IS 6
BP 387
EP 399
DI 10.1097/OPX.0b013e3181da863e
PG 13
WC Ophthalmology
SC Ophthalmology
GA 622EC
UT WOS:000279642200003
PM 20375749
DA 2018-10-20
ER

PT J
AU Jang, ES
   Park, JW
   Kweon, H
   Lee, KG
   Kang, SW
   Baek, DH
   Choi, JY
   Kim, SG
AF Jang, Eun-Sik
   Park, Jun-Woo
   Kweon, HaeYong
   Lee, Kwang-Gill
   Kang, Seok-Woo
   Baek, Dong-Heon
   Choi, Je-Yong
   Kim, Seong-Gon
TI Restoration of peri-implant defects in immediate implant installations
   by Choukroun platelet-rich fibrin and silk fibroin powder combination
   graft
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
ID IN-VITRO; BONE DEFECTS; PLASMA; SCAFFOLDS; GROWTH; OSSEOINTEGRATION;
   BIOMATERIALS; TITANIUM; SURGERY; REPAIR
AB Objective. The objective of this study was to determine the capability of silk fibroin powder as a biomaterial template for the restoration of peri-implant defects when mixed with Choukroun platelet-rich fibrin (PRF) in vivo.
   Study design. Ten New Zealand white rabbits were used for this study. Using a trephine bur (diameter 7.0 mm), 2 monocortical defects were prepared. Subsequently, 2 dental implants were installed into the tibia (diameter 3.0 mm, length 10.0 mm). In the experimental group, the peri-implant defect was filled with a combination graft of silk fibroin powder and Choukroun PRF. The control was left in an unfilled state. The animals were killed at 8 weeks. Subsequently, a removal torque test and a histomorphometric analysis were done.
   Results. The removal torque for the experimental group was 30.34 +/- 5.06 N.cm, whereas it was 21.86 +/- 3.39 N.cm for the control. The difference between the 2 groups was statistically significant (P = .010). Mean new bone formation was 51.93 +/- 27.90% in the experimental group and 11.67 +/- 15.12% in the control (P = .003). Mean bone-to-implant contact was 43.07 +/- 21.96% in the experimental group and 15.37 +/- 23.84% in the control (P = .002).
   Conclusion. A peri-implant defect can be successfully repaired by the application of Choukroun PRF and silk fibroin powder. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 831-836)
C1 [Kim, Seong-Gon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung 210702, Gangwondo, South Korea.
   [Jang, Eun-Sik; Park, Jun-Woo] Hallym Univ, Dept Oral & Maxillofacial Surg, Chunchon, South Korea.
   [Baek, Dong-Heon] Dankook Univ, Dept Oral Microbiol & Immunol, Seoul, South Korea.
   [Choi, Je-Yong] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Taegu, South Korea.
RP Kim, SG (reprint author), Gangneung Wonju Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Kangnung 210702, Gangwondo, South Korea.
EM epker@chollian.net
OI Kim, Seong-Gon/0000-0001-5088-2732
FU Rural Development Administration. [200810FTH010103002,
   200810FTH010102001]
FX Supported by the BioGreen21 Program (grant nos. 200810FTH010103002 and
   200810FTH010102001) of the Rural Development Administration.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Casati MZ, 2007, INT J ORAL MAX SURG, V36, P132, DOI 10.1016/j.ijom.2006.06.004
   Chiapasco M, 2009, CLIN ORAL IMPLAN RES, V20, P113, DOI 10.1111/j.1600-0501.2009.01781.x
   Clausen C, 2006, CELLS TISSUES ORGANS, V184, P68, DOI 10.1159/000098948
   Cranin A N, 2001, J Oral Implantol, V27, P43, DOI 10.1563/1548-1336(2001)027<0043:ABRAUT>2.3.CO;2
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Ferreira CF, 2005, CLIN ORAL IMPLAN RES, V16, P456, DOI 10.1111/j.1600-0501.2005.01145.x
   Fiorellini Joseph P, 2003, Ann Periodontol, V8, P321, DOI 10.1902/annals.2003.8.1.321
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Huys L W, 2001, Implant Dent, V10, P93
   Hwang KG, 2008, J PERIODONTOL, V79, P941, DOI [10.1902/jop.2008.070408, 10.1902/jop.2008.070408 ]
   Ivanoff CJ, 1996, INT J ORAL MAX SURG, V25, P229, DOI 10.1016/S0901-5027(96)80036-1
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jung RE, 2005, CLIN ORAL IMPLAN RES, V16, P676, DOI 10.1111/j.1600-0501.2005.01183.x
   Kania RE, 1998, J BIOMED MATER RES, V43, P38, DOI 10.1002/(SICI)1097-4636(199821)43:1<38::AID-JBM4>3.0.CO;2-N
   Kassolis JD, 2000, J PERIODONTOL, V71, P1654, DOI 10.1902/jop.2000.71.10.1654
   Kawai M, 2009, PEDIATR NEPHROL, V24, P1277, DOI 10.1007/s00467-008-1040-6
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Mannai C, 2006, J ORAL MAXIL SURG, V64, P1420, DOI 10.1016/j.joms.2006.05.028
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park YS, 2005, CLIN ORAL IMPLAN RES, V16, P156, DOI 10.1111/j.1600-0501.2004.01083.x
   Pietrabissa R, 2000, CLIN ORAL IMPLAN RES, V11, P448, DOI 10.1034/j.1600-0501.2000.011005448.x
   Postlethwait RW, 1969, REPAIR REGENERATION, P263
   Rosenquist B, 1996, Int J Oral Maxillofac Implants, V11, P205
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schaaf H, 2008, ORAL SURG ORAL MED O, V106, P673, DOI 10.1016/j.tripleo.2008.04.004
   SENNERBY L, 1992, International Journal of Oral and Maxillofacial Implants, V7, P62
   Sennerby L, 2001, CLIN ORAL IMPLAN RES, V12, P91, DOI 10.1034/j.1600-0501.2001.012001091.x
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sykaras N, 2004, INT J ORAL MAX IMPL, V19, P667
   Turunen T, 1998, J MATER SCI-MATER M, V9, P403, DOI 10.1023/A:1013235630347
   Uebersax L, 2006, TISSUE ENG, V12, P3417, DOI 10.1089/ten.2006.12.3417
   Verardi Simone, 2007, Pract Proced Aesthet Dent, V19, P111
   Whitman DH, 1997, J ORAL MAXIL SURG, V55, P1294, DOI 10.1016/S0278-2391(97)90187-7
   Wilson TG, 1998, INT J ORAL MAX IMPL, V13, P333
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
NR 46
TC 43
Z9 48
U1 0
U2 12
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD JUN
PY 2010
VL 109
IS 6
BP 831
EP 836
DI 10.1016/j.tripleo.2009.10.038
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 592UH
UT WOS:000277405500011
PM 20163973
DA 2018-10-20
ER

PT J
AU Mladenovic, Z
   Sahlin-Platt, A
   Bengtsson, A
   Ransjo, M
   Shchukarev, A
AF Mladenovic, Z.
   Sahlin-Platt, A.
   Bengtsson, A.
   Ransjo, M.
   Shchukarev, A.
TI Surface characterization of bone graft substitute materials conditioned
   in cell culture medium
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 13th European Conference on Applications of Surface and Interface
   Analysis
CY OCT 18-23, 2009
CL Antalya, TURKEY
DE XPS; solid-liquid interface; bone graft substitute; biomaterial;
   Bio-Oss; Algipore; Bioglass 45S5
ID IN-VITRO; XPS; HYDROXYAPATITE; INTERFACE; GLASSES
AB Biomaterials are widely used in clinical practice as bone graft substitutes for treating patients with bone defects. A molecular level understanding of the chemical processes at the interface between the biomaterial and the biological environment is crucial to succeed in tissue regeneration and to predict the treatment outcome. In this study, we used three different bone graft substitute materials (BioGlass 45S5 - synthetic, Bio-Oss - bovine derived and Algipore - derived from algae) which were incubated in an a-minimum essential medium (alpha-MEM) during 1, 3 and 7 days. Initial surface composition of the biomaterials and the chemistry of their solid-solution interface were monitored by XPS with a fast-frozen samples technique. The XPS analysis showed that the equilibrium at the solid-solution interface is reached within 24 h. The Na/Cl atomic ratio at equilibrium indicates a negatively charged surface for Bio-Oss. In contrast, the other two materials gained a positive surface charge, which resulted in pronounced adsorption of amino acids at the interface from the medium. The surface chemical reconstruction and charge generation mechanism responsible for this effect are discussed with regard to bulk composition of the materials and possible proliferation and differentiation cell patterns that could be expected at the interface. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Bengtsson, A.; Shchukarev, A.] Umea Univ, Dept Chem, SE-90187 Umea, Sweden.
   [Mladenovic, Z.; Sahlin-Platt, A.; Ransjo, M.] Umea Univ, Dept Odontol, SE-90187 Umea, Sweden.
RP Shchukarev, A (reprint author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.
EM andrei.shchukarev@chem.umu.se
CR Bengtsson A, 2009, GEOCHIM COSMOCHIM AC, V73, P257, DOI 10.1016/j.gca.2008.09.034
   Cerruti M, 2005, J PHYS CHEM B, V109, P14496, DOI 10.1021/jp050705t
   HENCH L, 1993, INTRO BIOCERAMICS
   Kokubo T, 2009, J EUR CERAM SOC, V29, P1267, DOI 10.1016/j.jeurceramsoc.2008.08.004
   Lee KY, 2006, BIOMED MATER, V1, pR31, DOI 10.1088/1748-6041/1/2/R01
   Litvin A L, 2000, J Mater Sci Mater Med, V11, P91, DOI 10.1023/A:1008940916759
   Mahmood TA, 2000, J MATER SCI-MATER M, V11, P19, DOI 10.1023/A:1008929500904
   Ramstedt M, 2004, SURF INTERFACE ANAL, V36, P1074, DOI 10.1002/sia.1844
   Serra J, 2003, J NON-CRYST SOLIDS, V332, P20, DOI 10.1016/j.jnoncrysol.2003.09.013
   Shchukarev A, 2006, ADV COLLOID INTERFAC, V122, P149, DOI 10.1016/j.cis.2006.06.015
   Shchukarev A, 2005, SURF SCI, V584, P106, DOI 10.1016/j.susc.2005.01.060
   Shchukarev AV, 2004, CENT EUR J CHEM, V2, P347, DOI 10.2478/BF02475578
   Verne E, 2009, J MATER SCI-MATER M, V20, P75, DOI 10.1007/s10856-008-3537-8
   Zhu PX, 2004, BIOMATERIALS, V25, P3915, DOI 10.1016/j.biomaterials.2003.10.022
NR 14
TC 14
Z9 14
U1 0
U2 14
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUN-JUL
PY 2010
VL 42
IS 6-7
SI SI
BP 452
EP 456
DI 10.1002/sia.3337
PG 5
WC Chemistry, Physical
SC Chemistry
GA 641SJ
UT WOS:000281149700004
DA 2018-10-20
ER

PT J
AU Krasicka-Cydzik, E
   Kowalski, K
   Kaczmarek, A
   Glazowska, I
   Heltowski, KB
AF Krasicka-Cydzik, Elzbieta
   Kowalski, Kazimierz
   Kaczmarek, Agnieszka
   Glazowska, Izabela
   Heltowski, Krzysztof Bialas
TI Competition between phosphates and fluorides at anodic formation of
   titania nanotubes on titanium
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 13th European Conference on Applications of Surface and Interface
   Analysis
CY OCT 18-23, 2009
CL Antalya, TURKEY
DE porous titanium oxide; self-organization; anodic oxidation; phosphates;
   fluorides; competition
ID TIO2 NANOTUBES; ELECTROLYTES; OXIDATION; FILMS; SURFACES; ARRAYS; ACID
AB The influence of phosphate (and its concentration) on the electrochemical properties of anodic porous oxide films formed on titanium surfaces in fluoride containing electrolyte was investigated by performing electrochemical measurements [potentiodynamic/potentiostatic polarization, open circuit potential(OCP), and capacitance measurements] for a titanium/oxide film/solution interface system in SBF solution. In previous work we demonstrated, that during anodizing titanium and titanium-based implant materials in 2M phosphoric acid solution the highly bioactive phosphate gel-like layer can be formed over compact titania which can significantly stimulate apatite formation. In the present work, we report that anodizing titanium in the same solution with the addition of fluorides leads to formation of titanium oxide nanotubes rich in both phosphates and fluorides which makes the method highly suitable for additional promoting of apatite deposition into titania nanotubes. To study the effect of phosphates concentration, layers of titania nanotubes were produced in electrolytes of different phosphoric acid concentration. Their behavior as the future coatings on titanium for biomaterial applications was characterized by capacitance tests in simulated body fluids and by Scanning Electron Microscopy/Energy Dispersive Spectroscopy (SEM/EDS) observations. Judging on the results of XPS analysis, the competition between fluorides and phosphates is observed during anodizing, and the higher concentration of the latter is responsible for higher bioactivity of nanotubes formed in 2M H(3)PO(4) + 0.4% wt hydrofluoric acid (HF). Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Krasicka-Cydzik, Elzbieta; Kaczmarek, Agnieszka; Glazowska, Izabela; Heltowski, Krzysztof Bialas] Univ Zielona Gora Licealna 9, Dept Mech Engn, PL-65417 Zielona Gora, Poland.
   [Kowalski, Kazimierz] AGH Univ Sci & Technol, Fac Met Engn & Ind Comp Sci, Dept Surface Engn & Mat Characterizat, PL-30059 Krakow, Poland.
RP Krasicka-Cydzik, E (reprint author), Univ Zielona Gora Licealna 9, Dept Mech Engn, PL-65417 Zielona Gora, Poland.
EM e.krasicka@ibem.uz.zgora.pl
CR Beranek R, 2003, ELECTROCHEM SOLID ST, V6, pB12, DOI 10.1149/1.1545192
   CHARLOT G, 1956, REACTIONS CHIMIQUES
   Ghicov A, 2005, ELECTROCHEM COMMUN, V7, P505, DOI 10.1016/j.elecom.2005.03.007
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   HEUSLER KE, 1989, CORROS SCI, V29, P131, DOI 10.1016/0010-938X(89)90025-5
   JASSENSKY O, 1998, APPL PHYS LETT, V72, P1173
   Kodama A, 2009, ACTA BIOMATER, V5, P2322, DOI 10.1016/j.actbio.2009.02.032
   Kong DS, 2008, LANGMUIR, V24, P5324, DOI 10.1021/la703258e
   Krasicka-Cydzik E, 2004, CORROS SCI, V46, P2487, DOI 10.1016/j.corsci.2004.01.012
   Krasicka-Cydzik E, 2006, PASSIVATION METALS S, P193
   Krasicka-Cydzik E., 2003, FORMATION THIN ANODI
   KRASICKACYDZIK E, 2008, ENG BIOMATERIALS, V11, P77
   KRASICKACYDZIK E, 2009, Patent No. 203453
   MACAK JM, 2005, ELECTROCHIM ACTA, V50, P629
   Qiu JJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295604
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Wang DA, 2008, MATER LETT, V62, P1819, DOI 10.1016/j.matlet.2007.10.011
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yasuda K, 2007, ELECTROCHIM ACTA, V52, P4053, DOI 10.1016/j.electacta.2006.11.023
   Zhao JL, 2005, SOLID STATE COMMUN, V134, P705, DOI 10.1016/j.ssc.2005.02.028
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
NR 21
TC 4
Z9 4
U1 0
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD JUN-JUL
PY 2010
VL 42
IS 6-7
SI SI
BP 471
EP 474
DI 10.1002/sia.3306
PG 4
WC Chemistry, Physical
SC Chemistry
GA 641SJ
UT WOS:000281149700008
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Artificial muscle-like biomaterial developed
SO TCE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0302-0797
J9 TCE-THE CHEM ENG
JI TCE
PD JUN
PY 2010
IS 828
BP 16
EP 16
PG 1
WC Engineering, Chemical
SC Engineering
GA 613ZL
UT WOS:000279024000040
DA 2018-10-20
ER

PT J
AU Seif-Naraghi, SB
   Salvatore, MA
   Schup-Magoffin, PJ
   Hu, DP
   Christman, KL
AF Seif-Naraghi, Sonya B.
   Salvatore, Michael A.
   Schup-Magoffin, Pam J.
   Hu, Diane P.
   Christman, Karen L.
TI Design and Characterization of an Injectable Pericardial Matrix Gel: A
   Potentially Autologous Scaffold for Cardiac Tissue Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ASSEMBLING PEPTIDE NANOFIBERS; EXTRACELLULAR-MATRIX;
   MYOCARDIAL-INFARCTION; ENDOTHELIAL-CELLS; PROGENITOR CELLS; STEM-CELLS;
   DEGRADATION-PRODUCTS; SKELETAL MYOBLASTS; HEART-FAILURE; REGENERATION
AB Following ischemic injury in the heart, little to no repair occurs, causing a progressive degeneration of cardiac function that leads to congestive heart failure. Cardiac tissue engineering strategies have focused on designing a variety of injectable scaffolds that range in composition from single-component materials to complex extracellular matrix (ECM)-derived materials. In this study, the pericardial ECM, a commonly used biomaterial, was investigated for use as an injectable scaffold for cardiac repair. It was determined that a solubilized form of decellularized porcine pericardium could be injected and induced to gel in vivo, prompting investigation with human pericardium, which has the decided advantage of offering an autologous therapy. Characterization showed that the matrix gels retained components of the native pericardial ECM, with extant protein and glycosaminoglycan content identified. The results of an in vitro migration assay indicate that the porcine pericardial matrix is a stronger chemoattractant for relevant cell types, but in vivo results showed that the two materials caused statistically similar amounts of neovascularization, demonstrating feasibility as injectable treatments. Potential stem cell mobilization was supported by the presence of c-Kit+ cells within the matrix injection regions. With this work, the pericardium is identified as a novel source for an autologous scaffold for treating myocardial infarction.
C1 [Seif-Naraghi, Sonya B.; Salvatore, Michael A.; Schup-Magoffin, Pam J.; Hu, Diane P.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM christman@bioeng.ucsd.edu
FU NIH Roadmap for Medical Research [1-DP2-OD004309-01]; NSF
FX The authors would like to acknowledge Dr. Michael Madani and Dr. Kirk
   Knowlton for their help in procuring human tissue samples, Dr. Majid
   Ghassemian for assistance with mass spectroscopy data, Carolina Rogers
   for her guidance and cooperation in the harvesting of porcine specimens,
   Cynthia Cam for assistance with biochemical assays, and Dana Rutherford
   for assistance with immunohistochemistry. This research was supported in
   part by the NIH Director's New Innovator Award Program, part of the NIH
   Roadmap for Medical Research, through grant number 1-DP2-OD004309-01.
   S.B.S.-N. would like to thank the NSF for a Graduate Research
   Fellowship.
CR Akahane T, 2004, EXP CELL RES, V301, P158, DOI 10.1016/j.yexcr.2004.08.002
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baharuddin A, 2002, CLIN NEUROL NEUROSUR, V104, P342, DOI 10.1016/S0303-8467(02)00029-X
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Brennan EP, 2006, TISSUE ENG, V12, P2949, DOI 10.1089/ten.2006.12.2949
   Brennan EP, 2008, J TISSUE ENG REGEN M, V2, P491, DOI 10.1002/term.123
   Brown L, 2005, AM J PHYSIOL-HEART C, V289, pH973, DOI 10.1152/ajpheart.00443.2005
   CHAUVAUD S, 1991, J THORAC CARDIOV SUR, V102, P171
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Colombo A, 2009, EUROINTERVENTION, V5, P394, DOI 10.4244/V5I3A61
   DAVID TE, 1987, J THORAC CARDIOV SUR, V94, P710
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Di Luozzo G, 2005, ATHEROSCLEROSIS, V178, P271, DOI 10.1016/j.atherosclerosis.2004.09.017
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   DURAN CMG, 1995, J THORAC CARDIOV SUR, V110, P511, DOI 10.1016/S0022-5223(95)70248-2
   EITAN Y, 2009, TISSUE EN C IN PRESS
   Etzion Sharon, 2002, Circulation, V106, pI
   FRANCESCO R, 2004, J CELL PHYSL, V199, P174, DOI DOI 10.1002/JCP.10471
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   FUSTER V, 2001, HURSTS HEART
   Garlick RB, 1997, JPN CIRC J, V61, P682, DOI 10.1253/jcj.61.682
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   HVASS U, 1998, ANN THORAC SURG, V66, P134
   ISODA M, 1988, Journal of Dermatology (Tokyo), V15, P83
   Johnston N, 2007, LARYNGOSCOPE, V117, P1036, DOI 10.1097/M1LG.0b013e31804154c3
   Kao Race L, 2009, Asian Cardiovasc Thorac Ann, V17, P89, DOI 10.1177/0218492309104144
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Kubo H, 2008, CIRCULATION, V118, P649, DOI 10.1161/CIRCULATIONAHA.107.761031
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Lai PH, 2006, TISSUE ENG, V12, P2499, DOI 10.1089/ten.2006.12.2499
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Landsman Adam, 2009, Clin Podiatr Med Surg, V26, P525, DOI 10.1016/j.cpm.2009.08.012
   Lau YT, 1996, BIOCHEM BIOPH RES CO, V221, P670, DOI 10.1006/bbrc.1996.0654
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755
   Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Martinez Eliana C, 2009, Expert Rev Cardiovasc Ther, V7, P921, DOI 10.1586/erc.09.81
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   MOORE AR, 1989, INT J TISSUE REACT, V11, P301
   MUNDY GR, 1981, J CLIN INVEST, V68, P1102, DOI 10.1172/JCI110334
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   OBRIEN MF, 1995, ANN THORAC SURG, V60, pS410, DOI 10.1016/0003-4975(95)00267-O
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Rahimtoola SH, 2003, J AM COLL CARDIOL, V41, P893, DOI 10.1016/S0735-1097(02)02965-0
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   ROBERTS NB, 1978, BIOCHEM J, V169, P607, DOI 10.1042/bj1690607
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Braga-Vilela AS, 2008, J MEMBRANE BIOL, V221, P15, DOI 10.1007/s00232-007-9081-5
   SANANTONIO JD, 1993, ARTERIOSCLER THROMB, V13, P748, DOI 10.1161/01.ATV.13.5.748
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   WAINWRIGHT JM, 2009, TISSUE EN C IN PRESS
NR 69
TC 93
Z9 97
U1 4
U2 20
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2010
VL 16
IS 6
BP 2017
EP 2027
DI 10.1089/ten.tea.2009.0768
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 602UQ
UT WOS:000278164800020
PM 20100033
OA Green Published
DA 2018-10-20
ER

PT J
AU Sengupta, D
   Heilshorn, SC
AF Sengupta, Debanti
   Heilshorn, Sarah C.
TI Protein-Engineered Biomaterials: Highly Tunable Tissue Engineering
   Scaffolds
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI;
   EXTRACELLULAR-MATRIX; CODON OPTIMIZATION; MAMMALIAN-CELLS;
   CROSS-LINKING; PHYSICAL-PROPERTIES; SYNTHETIC PEPTIDE; GENE-EXPRESSION
AB A common goal in tissue engineering is to attain the ability to tailor specific cell-scaffold interactions and thereby gain control over cell behavior. The tunable nature of protein-engineered biomaterials enables independent tailoring of a range of biomaterial properties, creating an attractive alternative to synthetic polymeric scaffolds or harvested natural scaffolds. Protein-engineered biomaterials are comprised of modular peptide domains with various functionalities that are encoded into a DNA plasmid, transfected into an organism of choice, and expressed and purified to yield a biopolymer with exact molecular-level sequence specification. Because of the modular design strategy of protein-engineered biomaterials, these scaffolds can be easily modified to enable optimization for specific tissue engineering applications. By including multiple peptide domains with different functionalities in a single, modular biomaterial, the scaffolds can be designed to mimic the diverse properties of the natural extracellular matrix, including cell adhesion, cell signaling, elasticity, and biodegradability. Recently, the field of protein-engineered biomaterials has expanded to include functional modules that are not normally present in the extracellular matrix, thus expanding the scope and functionality of these materials. For example, these modules can include noncanonical amino acids, inorganic-binding domains, and DNA-binding sequences. The modularity, tunability, and sequence specificity of protein-engineered biomaterials make them attractive candidates for use as substrates for a variety of tissue engineering applications.
C1 [Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   [Sengupta, Debanti] Stanford Univ, Dept Chem, Stanford, CA 94305 USA.
RP Heilshorn, SC (reprint author), Stanford Univ, Dept Mat Sci & Engn, 476 Lomita Mall,McCullough 246, Stanford, CA 94305 USA.
EM heilshorn@stanford.edu
FU National Science Foundation-Emerging Frontiers in Research and
   Innovation [0709786 EFRI-CBE]
FX We acknowledge funding support from the National Science
   Foundation-Emerging Frontiers in Research and Innovation (0709786
   EFRI-CBE). We thank Professor Shantikumar Nair, Amrita Center for
   Nanosciences, Cochin, India, for helpful discussions.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Andersen DC, 2002, CURR OPIN BIOTECH, V13, P117, DOI 10.1016/S0958-1669(02)00300-2
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Boontheekul T, 2007, TISSUE ENG, V13, P1431, DOI 10.1089/ten.2006.0356
   BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398
   Carrico IS, 2007, J AM CHEM SOC, V129, P4874, DOI 10.1021/ja070200b
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299
   Chow DC, 2006, BIOTECHNOL PROGR, V22, P638, DOI 10.1021/bp0503742
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Dai HX, 2005, J AM CHEM SOC, V127, P15637, DOI 10.1021/ja055499h
   Davis NE, 2009, BIOMACROMOLECULES, V10, P1125, DOI 10.1021/bm801348g
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EyreWalker A, 1996, J MOL EVOL, V42, P73, DOI 10.1007/BF02198830
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467
   Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Griswold KE, 2003, PROTEIN EXPRES PURIF, V27, P134, DOI 10.1016/S1046-5928(02)00578-8
   Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   HITZEMAN RA, 1981, NATURE, V293, P717, DOI 10.1038/293717a0
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hollister SJ, 2006, NAT MATER, V5, P590, DOI 10.1038/nmat1683
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HOSEIN B, 1991, P NATL ACAD SCI USA, V88, P3647, DOI 10.1073/pnas.88.9.3647
   Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b
   Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3
   Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160
   Kwon I, 2003, J AM CHEM SOC, V125, P7512, DOI 10.1021/ja0350076
   Landrain TE, 2009, CURR OPIN BIOTECH, V20, P272, DOI 10.1016/j.copbio.2009.06.003
   Lee SC, 2010, BIOMED MICRODEVICES, V12, P283, DOI 10.1007/s10544-009-9383-8
   Li LT, 2001, CHEM BIOL, V8, P47, DOI 10.1016/S1074-5521(00)00055-7
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Link AJ, 2003, CURR OPIN BIOTECH, V14, P603, DOI 10.1016/j.copbio.2003.10.011
   Liu CY, 2003, NEUROSURGERY, V52, P1154, DOI 10.1227/01.NEU.0000057747.93237.8F
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308
   Nagaoka M, 2002, BIOTECHNOL LETT, V24, P1857, DOI 10.1023/A:1020905532227
   Nagata T, 1999, BIOCHEM BIOPH RES CO, V261, P445, DOI 10.1006/bbrc.1999.1050
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   Nowatzki PJ, 2004, BIOMATERIALS, V25, P1261, DOI 10.1016/S0142-9612(03)000365-5
   Ogiwara K, 2005, BIOTECHNOL LETT, V27, P1633, DOI 10.1007/s10529-005-2605-0
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106
   Sidhu SS, 2003, CURR OPIN CHEM BIOL, V7, P97, DOI 10.1016/S1367-5931(02)00011-x
   SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4
   Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Straley Karin S, 2009, Front Neuroeng, V2, P9, DOI 10.3389/neuro.16.009.2009
   Straley KS, 2009, ADV MATER, V21, P4148, DOI 10.1002/adma.200901865
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Tang Y, 2001, J AM CHEM SOC, V123, P11089, DOI 10.1021/ja016652k
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   THOMPSON MT, 1990, BIOMACROMOLECULES, V7, P2006
   Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987
   Trabbic-Carlson K, 2004, PROTEIN SCI, V13, P3274, DOI 10.1110/ps.04931604
   URRY DW, 1998, POLYM TISSUE ENG SHO, P19
   van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j
   Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5
   Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Wu XQ, 2004, BIOCHEM BIOPH RES CO, V313, P89, DOI 10.1016/j.bbrc.2003.11.091
   Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Yoder NC, 2002, CHEM SOC REV, V31, P335, DOI 10.1039/b201097f
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 88
TC 78
Z9 79
U1 0
U2 51
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD JUN
PY 2010
VL 16
IS 3
BP 285
EP 293
DI 10.1089/ten.teb.2009.0591
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 609FB
UT WOS:000278640000002
PM 20141386
DA 2018-10-20
ER

PT J
AU Logeart-Avramoglou, D
   Oudina, K
   Bourguignon, M
   Delpierre, L
   Nicola, MA
   Bensidhoum, M
   Arnaud, E
   Petite, H
AF Logeart-Avramoglou, Delphine
   Oudina, Karim
   Bourguignon, Marianne
   Delpierre, Laetitia
   Nicola, Marie-Anne
   Bensidhoum, Morad
   Arnaud, Eric
   Petite, Herve
TI In Vitro and In Vivo Bioluminescent Quantification of Viable Stem Cells
   in Engineered Constructs
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID PORCINE HEPATOCYTES; BONE-MARROW; SURVIVAL; IMMUNOSUPPRESSION;
   PROLIFERATION; ENGRAFTMENT; APOPTOSIS; NUMBER; GROWTH; ASSAYS
AB Bioluminescent quantification of viable cells inside three-dimensional porous scaffolds was performed in vitro and in vivo. The assay quantified the bioluminescence of murine stem (C3H10T1/2) cells tagged with the luciferase gene reporter and distributed inside scaffolds of either soft, translucent, AN69 polymeric hydrogel or hard, opaque, coral ceramic materials. Quantitative evaluation of bioluminescence emitted from tagged cells adhering to these scaffolds was performed in situ using either cell lysates and a luminometer or intact cells and a bioluminescence imaging system. Despite attenuation of the signal when compared to cells alone, the bioluminescence correlated with the number of cells (up to 1.5 x 10(5)) present on each material scaffold tested, both in vitro and noninvasively in vivo (subcutaneous implants in the mouse model). The noninvasive bioluminescence measurement technique proved to be comparable to the cell-destructive bioluminescence measurement technique. Monitoring the kinetics of luciferase expression via bioluminescence enabled real-time assessment of cell survival and proliferation on the scaffolds tested over prolonged (up to 59 days) periods of time. This novel, sensitive, easy, fast-to-implement, quantitative bioluminescence assay has great, though untapped, potential for screening and determining noninvasively the presence of viable cells on biomaterial constructs in the tissue engineering and tissue regeneration fields.
C1 [Logeart-Avramoglou, Delphine; Oudina, Karim; Bourguignon, Marianne; Delpierre, Laetitia; Bensidhoum, Morad; Petite, Herve] Univ Paris 07, CNRS, UMR 7052, Lab Bioengn & Biomech Bone & Joints B2OA,Fac Med, Paris, France.
   [Nicola, Marie-Anne] PFID Pasteur Inst, Paris, France.
   [Arnaud, Eric] Necker Enfants Malad Hosp, Dept Pediat Neurosurg, Paris, France.
RP Logeart-Avramoglou, D (reprint author), Univ Paris 07, CNRS, UMR 7052, Lab Bioengn & Biomech Bone & Joints B2OA,Fac Med, 10 Ave Verdun, Paris, France.
EM delphine.logeart@paris7.jussieu.fr
RI Bourguignon, Marianne/O-5854-2017; Petite, Herve/E-3478-2016
OI Bourguignon, Marianne/0000-0001-9824-1248; Petite,
   Herve/0000-0003-1694-5060; Logeart-Avramoglou,
   Delphine/0000-0002-2052-9425; Bensidhoum, Morad/0000-0002-6621-6010
FU Centre National de la Recherche Scientifique; Gueules Cassees
   Foundation; French National Research Agency (ANR) [ANR-07-RIB-011]
FX The authors gratefully acknowledge Dr. Jiri Honiger (Service de
   chirurgie orthope dique, Saint-Antoine Hospital) for donating the AN69
   polymer scaffolds and Inoteb, Inc. for donating the coral scaffolds used
   in the present study. We would also like to thank the Plate-forme
   d'Imagerie Dynamique at the Pasteur Institute, Paris, France, for their
   assistance with bioluminescent imaging and Pr. Rena Bizios for her
   valuable critical reading of the manuscript. This project was supported
   by the Centre National de la Recherche Scientifique, the Gueules Cassees
   Foundation, and the French National Research Agency (ANR) through
   project MYOCELLOS n degrees ANR-07-RIB-011.
CR BALLADUR P, 1995, SURGERY, V117, P189, DOI 10.1016/S0039-6060(05)80084-4
   Benoist SP, 2001, SURGERY, V129, P606, DOI 10.1067/msy.2001.112961
   Bensidhoum M, 2004, BLOOD, V103, P3313, DOI 10.1182/blood-2003-04-1121
   BLAND JM, 1986, LANCET, V1, P307
   Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4
   Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   DUVAL D, 1990, J IMMUNOL METHODS, V134, P177, DOI 10.1016/0022-1759(90)90379-A
   Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Honiger J, 2000, BIOMATERIALS, V21, P1269, DOI 10.1016/S0142-9612(00)00012-0
   Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5
   Khattak SF, 2007, BIOTECHNOL BIOENG, V96, P156, DOI 10.1002/bit.21151
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maury F, 1997, J MATER SCI-MATER M, V8, P571, DOI 10.1023/A:1018502915904
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Nikolaychik VV, 1996, J BIOMAT SCI-POLYM E, V7, P881, DOI 10.1163/156856296X00057
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105
   Roman I, 2007, BIOMATERIALS, V28, P2718, DOI 10.1016/j.biomaterials.2007.02.011
   Schenborn E, 1999, MOL BIOTECHNOL, V13, P29, DOI 10.1385/MB:13:1:29
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Terai H, 2002, MAT SCI ENG C-BIO S, V20, P3, DOI 10.1016/S0928-4931(02)00006-1
   Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7
   Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688
   Van Damme A, 2006, STEM CELLS, V24, P896, DOI 10.1634/stemcells.2003-0106
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121
NR 30
TC 17
Z9 17
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUN
PY 2010
VL 16
IS 3
BP 447
EP 458
DI 10.1089/ten.tec.2009.0004
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 601SJ
UT WOS:000278083900013
PM 19624260
DA 2018-10-20
ER

PT J
AU Gandhiraman, RP
   Muniyappa, MK
   Dudek, M
   Coyle, C
   Volcke, C
   Killard, AJ
   Burham, P
   Daniels, S
   Barron, N
   Clynes, M
   Cameron, DC
AF Gandhiraman, Ram P.
   Muniyappa, Mohan Kumar
   Dudek, Magdalena
   Coyle, Conor
   Volcke, Cedric
   Killard, Anthony J.
   Burham, Paul
   Daniels, Stephen
   Barron, Niall
   Clynes, Martin
   Cameron, David C.
TI Interaction of Plasma Deposited HMDSO-Based Coatings with Fibrinogen and
   Human Blood Plasma: The Correlation between Bulk Plasma, Surface
   Characteristics and Biomolecule Interaction
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE biocompatibility; cell culture; plasma enhanced chemical vapour
   deposition (PECVD); protein adsorption; roughness; surfaces; surface
   modification; surface roughness; wettability
ID SELF-ASSEMBLED MONOLAYERS; STAINLESS-STEEL SUBSTRATE; PROTEIN
   ADSORPTION; IN-VITRO; TITANIUM-OXIDE; MODEL SURFACES; CARBON-FILMS;
   THIN-FILMS; ROUGHNESS; ADHESION
AB The success of a biomaterial depends on the nature of interaction and the progressive reaction between the biological components and the surface of the biomaterial. In order to control the interaction between the biomaterial and biological component, it is necessary to understand the factors that influence the protein adsorption and cell proliferation. Surface chemistry plays a crucial role in the success of any blood contacting biomaterial. Plasma enhanced chemical vapour deposition (PECVD) is an interesting commonly used technique for tailoring surface characteristics while retaining bulk material properties. Two different films, namely polymer-like and silica-like coatings, with varying surface characteristics have been deposited from hexamethyldisiloxane, by PECVD, on 316L stainless steel. A correlation between the bulk plasma, interfacial adhesion of the coating to 316L steel, surface characteristics and biomolecule interaction is presented in this work The interfacial adhesion strength analysis demonstrated that silica-like coatings have higher adhesion strength to 316L stainless steel than polymer-like coatings, caused due to the formation of a strong Fe-O-Si and Cr-O-Si bonds. It was observed that the effect of nanoscale surface roughness (dose to 6 nm) was less significant, and that the surface chemistry played a significant role in governing the fibrinogen adsorption. Highest fibrinogen adsorption on plain steel was due to the electrostatic interaction of the metal oxide layer with the protein Hydrophobicity of the polymer like film resulted in a higher fibrinogen binding than the silica-like films.
C1 [Gandhiraman, Ram P.; Dudek, Magdalena; Coyle, Conor; Volcke, Cedric; Killard, Anthony J.; Daniels, Stephen] Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland.
   [Muniyappa, Mohan Kumar; Barron, Niall; Clynes, Martin] Dublin City Univ, Natl Inst Cellular Biotechnol NICB, Dublin 9, Ireland.
   [Coyle, Conor; Daniels, Stephen] Dublin City Univ, Natl Ctr Plasma Sci & Technol, Dublin 9, Ireland.
   [Volcke, Cedric] Univ Namur FUNDP, Res Ctr Phys Matter & Radiat PMR, B-5000 Namur, Belgium.
   [Burham, Paul] Dublin City Univ, Archport Ltd, Dublin 9, Ireland.
   [Cameron, David C.] Lappeenranta Univ Technol, ASTRaL, FI-50101 Mikkeli, Finland.
RP Gandhiraman, RP (reprint author), Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland.
EM ramprasad.gandhiraman@dcu.ie
RI Cameron, David/E-7955-2010; Gandhiraman, Ram Prasad/B-7004-2013;
   Muniyappa, MohanKumar/B-9415-2013; Killard, Anthony/A-8676-2008
OI Cameron, David/0000-0002-8883-2113; Gandhiraman, Ram
   Prasad/0000-0001-8957-7938; Muniyappa, MohanKumar/0000-0003-1611-593X;
   barron, niall/0000-0003-4602-326X; Killard, Anthony/0000-0001-6953-3655;
   Daniels, Stephen/0000-0002-5987-9924
FU Belgian National Fund for Scientific Research (F. R. S.-F. N. R. S.)
FX Dr. Cedric Volcke is a postdoctoral researcher of the Belgian National
   Fund for Scientific Research (F. R. S.-F. N. R. S.).
CR ANDRADE JD, 1985, SURFACE INTERFACIAL
   Arnould C, 2009, J COLLOID INTERF SCI, V336, P497, DOI 10.1016/j.jcis.2009.03.092
   Bapin E, 2001, SURF COAT TECH, V142, P649, DOI 10.1016/S0257-8972(01)01072-6
   Benitez F, 2000, THIN SOLID FILMS, V377, P109, DOI 10.1016/S0040-6090(00)01393-6
   Bertrand N, 1998, J VAC SCI TECHNOL A, V16, P6, DOI 10.1116/1.581013
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Dudek MM, 2009, PLASMA PROCESS POLYM, V6, P620, DOI 10.1002/ppap.200900053
   ELWING H, 1988, J COLLOID INTERF SCI, V123, P306, DOI 10.1016/0021-9797(88)90249-4
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   Gandhiraman RP, 2009, SURF COAT TECH, V203, P3521, DOI 10.1016/j.surfcoat.2009.05.028
   GANDHIRAMAN RP, 2007, PLASMA PROCESS POLYM, V4, P369
   GANDHIRAMAN RP, 2005, SURF COAT TECH, V200, P1031
   Gengenbach TR, 1999, POLYMER, V40, P5079, DOI 10.1016/S0032-3861(98)00727-7
   Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   Groth T, 2002, J BIOMED MATER RES, V61, P290, DOI 10.1002/jbm.10191
   Haidopoulos M, 2007, J MICROSC-OXFORD, V228, P227, DOI 10.1111/j.1365-2818.2007.01843.x
   Hasebe T, 2007, DIAM RELAT MATER, V16, P1343, DOI 10.1016/j.diamond.2006.12.009
   Hegemann D, 1999, SURF COAT TECH, V116, P1033, DOI 10.1016/S0257-8972(99)00092-4
   Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   JOHNSON SD, 1992, J BIOMED MATER RES, V26, P915, DOI 10.1002/jbm.820260707
   Joshi O, 2006, COLLOID SURFACE B, V50, P26, DOI 10.1016/j.colsurfb.2006.03.021
   KAVANAUGH JS, 1993, BIOCHEMISTRY-US, V32, P2509, DOI 10.1021/bi00061a007
   Kochkar H, 1997, J CATAL, V171, P420, DOI 10.1006/jcat.1997.1820
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   LIN TJ, 1991, J ADHES SCI TECHNOL, V5, P893, DOI 10.1163/156856191X00288
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Peters AM, 2001, J VAC SCI TECHNOL A, V19, P2773, DOI 10.1116/1.1403720
   Ratner BD, 1996, INTRO MAT MED
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Rodil SE, 2003, DIAM RELAT MATER, V12, P931, DOI 10.1016/S0925-9635(02)00217-0
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Spiga S, 1998, THIN SOLID FILMS, V325, P36, DOI 10.1016/S0040-6090(98)00423-4
   THEIL JA, 1994, J VAC SCI TECHNOL A, V12, P4
   Theirich D, 2003, VACUUM, V71, P349, DOI 10.1016/S0042-207X(02)00763-7
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Vallee C, 2000, J NON-CRYST SOLIDS, V272, P163, DOI 10.1016/S0022-3093(00)00232-5
   Vautrin-Ul C, 2000, PROG ORG COAT, V38, P9, DOI 10.1016/S0300-9440(99)00077-6
   Villa R, 2002, MATER TRANS, V43, P2991, DOI 10.2320/matertrans.43.2991
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P65, DOI 10.1111/j.1749-6632.1977.tb41753.x
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wavhal DS, 2006, PLASMA PROCESS POLYM, V3, P276, DOI 10.1002/ppap.200500140
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Wen J. M., 2007, BIOMATERIALS, V28, P1620
   Windecker S, 2001, CIRCULATION, V104, P928, DOI 10.1161/hc3401.093146
   Yongoli C, 1999, J COLLOID INTERF SCI, V214, P38, DOI DOI 10.1006/JCIS.1999.6159
NR 52
TC 15
Z9 15
U1 2
U2 23
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD MAY 21
PY 2010
VL 7
IS 5
BP 411
EP 421
DI 10.1002/ppap.200900133
PG 11
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 606NC
UT WOS:000278431700010
DA 2018-10-20
ER

PT J
AU Mieszawska, AJ
   Kaplan, DL
AF Mieszawska, Aneta J.
   Kaplan, David L.
TI Smart biomaterials - regulating cell behavior through signaling
   molecules
SO BMC BIOLOGY
LA English
DT Editorial Material
ID GROWTH-FACTOR
AB Important advances in the field of tissue engineering are arising from increased interest in novel biomaterial designs with bioactive components that directly influence cell behavior. Following the recent work of Mitchell and co-workers published in BMC Biology, we review how spatial and temporal control of signaling molecules in a matrix material regulates cellular responses for tissue-specific applications.
C1 [Mieszawska, Aneta J.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Mieszawska, AJ (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM aneta.mieszawska@tufts.edu
CR Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   Gomez N, 2007, BIOMATERIALS, V28, P271, DOI 10.1016/j.biomaterials.2006.07.043
   Mitchell EA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-57
   Sahni A, 1999, J BIOL CHEM, V274, P14936, DOI 10.1074/jbc.274.21.14936
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 10
TC 39
Z9 40
U1 2
U2 15
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD MAY 19
PY 2010
VL 8
AR 59
DI 10.1186/1741-7007-8-59
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 601JK
UT WOS:000278054200001
PM 20529238
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Liu, Y
   Yin, R
   Yu, WD
AF Liu, Yang
   Yin, Rong
   Yu, Weidong
TI Preparation and characterization of keratin-K2Ti6O13 whisker composite
   film
SO AFRICAN JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Biomaterials; mechanical properties; microstructure
ID WOOL KERATIN; MATRIX COMPOSITES; MOLECULAR-WEIGHT; FIBERS
AB Wool is the most popular natural material. In the textile industries, a lot of waste wool fibres and their products induce actions which lead to the regeneration of wool keratin materials. However, the most significant limitations may be the poor fracture resistance of neat keratin materials. Traditionally, biopolymer was used to enhance the mechanical property of wool keratin material, but it limits the application of the keratin material as a biomaterial. In this article, it was firstly proposed that potassium hexatitanate (K2Ti6O13) whiskers be used to reinforce keratin film. The effects of coupling agent, whisker content, distribution and orientation on properties of composite were investigated by microscope and tensile testing. It was found that K2Ti6O13 whiskers can effectively improve the mechanical properties of keratin films.
C1 [Liu, Yang; Yu, Weidong] Donghua Univ, Text Mat & Technol Lab, Shanghai 201620, Peoples R China.
   [Yin, Rong] Donghua Univ, Coll Mech Engn, Shanghai 201620, Peoples R China.
   [Yu, Weidong] Jiaxing Univ, Coll Garment & Art Design, Jiaxing 314001, Zhejiang, Peoples R China.
RP Yu, WD (reprint author), Donghua Univ, Text Mat & Technol Lab, Shanghai 201620, Peoples R China.
EM wdyu@dhu.edu.cn
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Bledzki AK, 1996, J APPL POLYM SCI, V59, P1329, DOI 10.1002/(SICI)1097-4628(19960222)59:8<1329::AID-APP17>3.3.CO;2-5
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   BUNSELL AR, 1986, COMPOSITE MAT SERIES
   Chen YY, 1996, J MATER SCI, V31, P407, DOI 10.1007/BF01139158
   Cooper CA, 2002, COMPOS SCI TECHNOL, V62, P1105, DOI 10.1016/S0266-3538(02)00056-8
   Fraser RDB, 1980, LINN SOC S SER, V9, P67
   Gassan J, 1997, COMPOS PART A-APPL S, V28, P1001, DOI 10.1016/S1359-835X(97)00042-0
   Haydaruzzaman, 2010, J COMPOS MATER, V44, P401, DOI 10.1177/0021998309344647
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Liu LJ, 2008, FOOD BIOPROD PROCESS, V86, P1, DOI 10.1016/j.fbp.2007.10.007
   LIU M, 2005, P 2005 INT C ADV FIB, V1, P1011
   LIU M, 2005, P 2005 INT C ADV FIB, V2, P1011
   MORIMOTO S, 1962, GRAFT COPOLYMERIZATI, P2
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   PAUL DR, 2000, POLYMERBLENDS
   Pavlath AE, 1999, TEXT RES J, V69, P539, DOI 10.1177/004051759906900712
   Prabu SB, 2008, J MATER PROCESS TECH, V207, P53, DOI 10.1016/j.jmatprotec.2007.12.077
   SORENSEN NJ, 1995, MAT SCI ENG A-STRUCT, V197, P1, DOI 10.1016/0921-5093(94)09739-9
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   TANG YW, 2005, P 2005 INT C ADV FIB, V1, P928
   TANG YW, 2005, P 2005 INT C ADV FIB, V2, P928
   Tjong SC, 1999, POLYM COMPOSITE, V20, P748, DOI 10.1002/pc.10398
   Tonin C, 2006, BIOMACROMOLECULES, V7, P3499, DOI 10.1021/bm060597w
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yih P, 1996, J MATER SCI, V31, P399, DOI 10.1007/BF01139157
NR 27
TC 1
Z9 1
U1 0
U2 4
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1684-5315
J9 AFR J BIOTECHNOL
JI Afr. J. Biotechnol.
PD MAY 17
PY 2010
VL 9
IS 20
BP 2884
EP 2890
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 598PI
UT WOS:000277849800009
DA 2018-10-20
ER

PT J
AU Hui, ZY
   Zhang, XL
   Yu, JH
   Huang, J
   Liang, ZS
   Wang, DX
   Huang, HT
   Xu, PH
AF Hui, Zhongying
   Zhang, Xiaolan
   Yu, Jiahui
   Huang, Jin
   Liang, Zhongshi
   Wang, Daxin
   Huang, Haitao
   Xu, Peihu
TI Carbon Nanotube-Hybridized Supramolecular Hydrogel Based on
   PEO-b-PPO-b-PEO/alpha-Cyclodextrin as a Potential Biomaterial
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE supramolecular hydrogel; carbon nanotube; hybrid; biomaterial
ID ALPHA-CYCLODEXTRIN; DRUG-DELIVERY; INCLUSION COMPLEXATION; FABRICATION;
   BIOCOMPATIBILITY; POLYROTAXANES; COPOLYMERS; COMPOSITE; STRENGTH; SODIUM
AB In virtue of the potential biomedical application of carbon nanotube (CNT), the CNT was hybridized into a supramolecular hydrogel based on the selective inclusion of alpha-cyclodextrin (alpha-CD) onto poly(ethylene oxide) (PEO) segments of a triblock copolymer, i.e., PEO-block-poly(propylene oxide)-block-PEO. Different from the previous report, the content of alpha-CD, in contrast to that of ethylene oxide unit, was decreased to decrease the network density in hydrogel and hence improve the diffusion of encapsulated substances. As a result, the modulus Of the hydrogels climbed slightly after introducing CNT. Furthermore, as the essential properties for Wound dressing, the antimicrobial activity, the skin-adhesion, and water-retention of Such supramolecular hybrid hydrogels were also verified. On the other hand, the supramolecular hybrid hydrogels inherited the shear-thinning property and are Suitable as an injectable biomaterial. The cell viability assay confirmed the equivalent cytotoxicity of the supramolecular hybrid hydrogels to that of the native hydrogels without CNT. Consequently, Such CNT-hybridized supramolecular hydrogel shows a great potential in the biomedical application. (C) 2010 Wiley Periodicals, Inc. J Appl Polym Sci 116: 1894-1901, 2010
C1 [Hui, Zhongying; Zhang, Xiaolan; Huang, Jin; Huang, Haitao; Xu, Peihu] Wuhan Univ Technol, Coll Chem Engn, Wuhan 430070, Peoples R China.
   [Hui, Zhongying; Zhang, Xiaolan; Huang, Jin; Huang, Haitao; Xu, Peihu] Wuhan Univ Technol, Affiliated Hosp, Wuhan 430070, Peoples R China.
   [Hui, Zhongying; Yu, Jiahui; Huang, Jin; Liang, Zhongshi] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.
   [Wang, Daxin] Yangzhou Univ, Subei Hosp Jiangsu Prov, Yangzhou 225001, Peoples R China.
RP Huang, J (reprint author), Wuhan Univ Technol, Coll Chem Engn, Wuhan 430070, Peoples R China.
EM huangjin@iccas.ac.cn; daxinw@sina.com
RI Yu, Jiahui/A-8382-2015; zhang, xiaolan/K-5035-2015; Huang,
   Jin/E-4537-2011
FU Chinese Ministry of Science and Technology [2007CB936104, 2009CB930300];
   National Natural Science Foundation of China [20404014, 20504010];
   Shanghai Municipality Commission for Special Project of Manometer
   Science and Technology [0752nm022, 0852nm03700, 0952nm05300]; Shanghai
   Municipality Commission for Non-governmental International Corporation
   Project [09540709000]; Youth Chenguang Program of Science & Technology
   in Wuhan [200850731383]
FX Contract grant sponsor: The 973 Projects of Chinese Ministry of Science
   and Technology; contract grant numbers: 2007CB936104, 2009CB930300.;
   Contract grant sponsor: National Natural Science Foundation of China;
   contract grant numbers: 20404014, 20504010.; Contract grant sponsor:
   Shanghai Municipality Commission for Special Project of Manometer
   Science and Technology; contract grant numbers: 0752nm022, 0852nm03700,
   0952nm05300.; Contract grant sponsor: Shanghai Municipality Commission
   for Non-governmental International Corporation Project; contract grant
   number: 09540709000.; Contract grant sponsor: Youth Chenguang Program of
   Science & Technology in Wuhan; contract grant number: 200850731383.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Choi HS, 2005, CHEMPHYSCHEM, V6, P1081, DOI 10.1002/cphc.200400598
   Choi HS, 2002, MACROMOL BIOSCI, V2, P298, DOI 10.1002/1616-5195(200208)2:6<298::AID-MABI298>3.0.CO;2-#
   CIFERRI A, 2000, SUPRAMOLECULAR POLYM
   Dhar S, 2008, J AM CHEM SOC, V130, P11467, DOI 10.1021/ja803036e
   Fraczek A, 2008, ACTA BIOMATER, V4, P1593, DOI 10.1016/j.actbio.2008.05.018
   Guo MY, 2008, MACROMOLECULES, V41, P9744, DOI 10.1021/ma801975s
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   He LH, 2005, MACROMOLECULES, V38, P3845, DOI 10.1021/ma0475333
   Huang FH, 2005, PROG POLYM SCI, V30, P982, DOI 10.1016/j.progpolymsci.2005.07.003
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kurkuri MD, 2004, J CONTROL RELEASE, V96, P9, DOI 10.1016/j.jconrel.2003.12.025
   Kurkuri MD, 2002, POLYM-PLAST TECHNOL, V41, P469, DOI 10.1081/PPT-120004363
   Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li J, 2001, MACROMOLECULES, V34, P7236, DOI 10.1021/ma010742s
   Li J, 2008, ADV DRUG DELIVER REV, V60, P1000, DOI 10.1016/j.addr.2008.02.011
   Li XL, 2008, TRANSPLANTATION, V86, P10, DOI 10.1097/TP.0b013e31817c4b97
   Liu Z, 2007, ACS NANO, V1, P50, DOI 10.1021/nn700040t
   Lu FS, 2009, ADV MATER, V21, P139, DOI 10.1002/adma.200801491
   Ma D, 2008, J PHYS CHEM B, V112, P6315, DOI 10.1021/jp7115627
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Manakker F, 2008, MACROMOLECULES, V41, P1766
   Meng J, 2009, J BIOMED MATER RES A, V88A, P105, DOI 10.1002/jbm.a.31862
   Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j
   Porter AE, 2007, NAT NANOTECHNOL, V2, P713, DOI 10.1038/nnano.2007.347
   Sabadini E, 2003, LANGMUIR, V19, P9680, DOI 10.1021/la0353273
   Shvartzman-Cohen R, 2004, LANGMUIR, V20, P6085, DOI 10.1021/la049344j
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Veetil JV, 2007, BIOTECHNOL PROGR, V23, P517, DOI 10.1021/bp0602395
   Wang ZM, 2007, MACROMOLECULES, V40, P3402, DOI 10.1021/ma0702593
   Wei HL, 2005, J POLYM SCI POL CHEM, V43, P2941, DOI 10.1002/pola.20773
   Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   Yuan RX, 2008, J POLYM SCI POL PHYS, V46, P782, DOI 10.1002/polb.21412
   Zhang DH, 2006, J PHYS CHEM B, V110, P12910, DOI 10.1021/jp061628k
   Zhao SP, 2006, J PHYS CHEM B, V110, P12225, DOI 10.1021/jp057506u
   Zhao SP, 2006, J PHYS CHEM B, V110, P16503, DOI 10.1021/jp063005c
   ZHOU X, 2004, LANGMUIR, V20, P484
NR 39
TC 12
Z9 12
U1 0
U2 58
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAY 15
PY 2010
VL 116
IS 4
BP 1894
EP 1901
DI 10.1002/app.31729
PG 8
WC Polymer Science
SC Polymer Science
GA 567GY
UT WOS:000275434800006
DA 2018-10-20
ER

PT J
AU Liu, SH
   Chang, YH
   Chiang, MT
AF Liu, Shing-Hwa
   Chang, Yu-Han
   Chiang, Meng-Tsan
TI Chitosan Reduces Gluconeogenesis and Increases Glucose Uptake in
   Skeletal Muscle in Streptozotocin-Induced Diabetic Rats
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Chitosan; streptozotocin; glucose metabolism; liver; skeletal muscle
ID ACTIVATED PROTEIN-KINASE; MOLECULAR-WEIGHT CHITOSAN; PHOSPHOENOLPYRUVATE
   CARBOXYKINASE; PLASMA-MEMBRANE; BODY-WEIGHT; INSULIN; LEPTIN;
   EXPRESSION; MELLITUS; MICE
AB Chitosan is a natural and versatile biomaterial with a blood-glucose-lowering effect in diabetic animals, but the mechanism of action is still unknown. This study was designed to investigate the possible mechanisms involved in the hypoglycemic activity of chitosan in rats with streptozotocin (STZ)-induced diabetes. Male Sprague Dawley (SD) rats were divided into non-diabetic with cellulose (control), diabetic with cellulose (DM), and diabetic with low- (DM + LOS) and high-(DM + HCS) molecular-weight chitosan groups. After a 4 week feeding study, plasma glucose and fructosamine levels were increased while plasma leptin was decreased in the DM group when compared to the control group. These alternations caused by diabetes could be effectively reversed by both chitosan treatments. The increased gluconeogenesis-related signals including phosphoenolpyruvate carboxykinase (PEPCK) expression and phosphorylations of p38 and AMP-activated kinase (AMPK) in the livers of diabetic rats were attenuated by chitosans. Moreover, chitosan significantly increased muscle glucose uptake-related signals including Akt phosphorylation and glucose transporter-4 (GLUT4) translocation from the cytosol to membrane in the soleus muscles of diabetic rats. These results indicate that chitosan may possess a potential for alleviating type-1 diabetic hyperglycemia through the decrease in liver gluconeogenesis and increase in skeletal muscle glucose uptake and use.
C1 [Chang, Yu-Han; Chiang, Meng-Tsan] Natl Taiwan Ocean Univ, Dept Food Sci, Coll Life Sci, Chilung 202, Taiwan.
   [Liu, Shing-Hwa] Natl Taiwan Univ, Inst Toxicol, Coll Med, Taipei 100, Taiwan.
RP Chiang, MT (reprint author), Natl Taiwan Ocean Univ, Dept Food Sci, Coll Life Sci, Chilung 202, Taiwan.
EM a0071@mail.ntou.edu.tw
OI LIU, SHING-HWA/0000-0002-9976-1197
FU National Science Council of the Republic of China
   [NSC96-2628-B-019-003-MY3]
FX Received for review February 19, 2010. Revised manuscript received April
   7, 2010. Accepted April 8, 2010. This study was supported by Research
   Grant (NSC96-2628-B-019-003-MY3) from the National Science Council of
   the Republic of China.
CR Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001
   ANDERSEN PH, 1993, DIABETIC MED, V10, P699, DOI 10.1111/j.1464-5491.1993.tb00151.x
   Berasi SP, 2006, J BIOL CHEM, V281, P27167, DOI 10.1074/jbc.M602416200
   Cai Chunlin, 2009, Inflammation & Allergy Drug Targets, V8, P285
   Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200
   Chen RH, 2002, J APPL POLYM SCI, V84, P193, DOI 10.1002/app.10296
   Chen RH, 2001, J APPL PHYCOL, V13, P481, DOI 10.1023/A:1012580604417
   Cheong J, 1998, J BIOL CHEM, V273, P22714, DOI 10.1074/jbc.273.35.22714
   Chiang MT, 2000, BIOSCI BIOTECH BIOCH, V64, P965, DOI 10.1271/bbb.64.965
   Chinookoswong N, 1999, DIABETES, V48, P1487, DOI 10.2337/diabetes.48.7.1487
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585
   Hayashi K, 2002, BIOL PHARM BULL, V25, P188, DOI 10.1248/bpb.25.188
   Inoue E, 2006, BIOCHEM BIOPH RES CO, V351, P793, DOI 10.1016/j.bbrc.2006.10.124
   KAHN BB, 1992, J CLIN ENDOCR METAB, V74, P1101, DOI 10.1210/jc.74.5.1101
   Kashyap N, 2007, BIOMATERIALS, V28, P2051, DOI 10.1016/j.biomaterials.2007.01.007
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Klip A, 2009, APPL PHYSIOL NUTR ME, V34, P481, DOI 10.1139/H09-047
   Kondo Y, 2000, BIOL PHARM BULL, V23, P1458
   Koyama K, 1997, DIABETES, V46, P1276, DOI 10.2337/diabetes.46.8.1276
   Lee HW, 2003, BIOL PHARM BULL, V26, P1100
   Mhurchu CN, 2004, INT J OBESITY, V28, P1149, DOI 10.1038/sj.ijo.0802693
   Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a
   MURAT JC, 1974, CLIN CHEM, V20, P1576
   Newsholme EA, 2001, EXP CLIN ENDOCR DIAB, V109, pS122, DOI 10.1055/s-2001-18575
   Okamoto T, 2009, ARCH BIOCHEM BIOPHYS, V491, P46, DOI 10.1016/j.abb.2009.09.015
   Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7
   Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200
   Sato K, 2009, ACTA PHYSIOL, V197, P217, DOI 10.1111/j.1748-1716.2009.02011.x
   Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8
   Tai TS, 2000, DIABETES CARE, V23, P1703, DOI 10.2337/diacare.23.11.1703a
   van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413
   Varum KM, 2001, CARBOHYD POLYM, V46, P89, DOI 10.1016/S0144-8617(00)00288-5
   Wong Tin W, 2009, Recent Pat Drug Deliv Formul, V3, P8
   Yao HT, 2008, FOOD CHEM TOXICOL, V46, P1525, DOI 10.1016/j.fct.2007.12.012
   Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105
   Zeng LT, 2008, CARBOHYD POLYM, V71, P435, DOI 10.1016/j.carbpol.2007.06.016
NR 39
TC 39
Z9 42
U1 1
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 12
PY 2010
VL 58
IS 9
BP 5795
EP 5800
DI 10.1021/jf100662r
PG 6
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 590OW
UT WOS:000277237500082
PM 20397731
DA 2018-10-20
ER

PT J
AU Goebel, JW
   Pickardt, T
   Bedau, M
   Fuchs, M
   Lenk, C
   Paster, I
   Spranger, TM
   Stockter, U
   Bauer, U
   Cooper, DN
   Krawczak, M
AF Goebel, Juergen W.
   Pickardt, Thomas
   Bedau, Maren
   Fuchs, Michael
   Lenk, Christian
   Paster, Inga
   Spranger, Tarde M.
   Stockter, Ulrich
   Bauer, Ulrike
   Cooper, David N.
   Krawczak, Michael
TI Legal and ethical consequences of international biobanking from a
   national perspective: the German BMB-EUCoop project
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID EUROPE
AB The international transfer of human biomaterial and data has become a prerequisite for collaborative biomedical research to be successful. However, although a national legal framework for 'biobanking' has already been formulated in many countries, little is known about how an international exchange of data and samples might affect the legal position of national biobanks and their donors. The German Telematics Platform and the Competence Network 'Congenital Heart Defects' jointly instigated a project(BMB-EUCoop) to (i) identify and assess the legal risks ensuing for biobanks and their donors in the context of Europe-wide research collaborations, (ii) devise practical recommendations to minimize or avoid these risks, and (iii) provide generic informational text, contracts and agreements to facilitate their practical implementation. Four different countries were included in the study; namely, the UK, Netherlands, Austria and Switzerland. The results of the study indicate that the degree of similarity between legal systems in different countries varies according to the respective field of jurisdiction. Although personality and property rights have long been enshrined in virtually identical pieces of law, the applicable medical professional regulations were found to be somewhat heterogeneous. Furthermore, clear-cut differences were often found to be lacking between regulations that reflect either 'soft law' or the nationally binding 'hard law' that has emerged from it. In view of the potential ambiguities, the experts uniformly concluded that the rights and interests of national (in this case, German) biobanks and their donors would be best protected by explicitly addressing any uncertainties in formal contractual agreements. European Journal of Human Genetics (2010) 18, 522-525; doi:10.1038/ejhg.2009.214; published online 2 December 2009
C1 [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany.
   [Goebel, Juergen W.] RAe Goebel & Scheller, Bad Homburg, Germany.
   [Pickardt, Thomas; Bauer, Ulrike] Deutsch Herzzentrum Berlin, Kompetenznetz Angeborene Herzfehler, Berlin, Germany.
   [Bedau, Maren] Hogan & Hartson Raue LLP, Berlin, Germany.
   [Fuchs, Michael; Spranger, Tarde M.] Univ Bonn, Inst Wissensch & Eth, D-5300 Bonn, Germany.
   [Lenk, Christian] Univ Gottingen, Abt Eth & Geschichte Med, Gottingen, Germany.
   [Paster, Inga] Barlein & Partner GbR, RAe Ignor, Berlin, Germany.
   [Stockter, Ulrich] Unabhangiges Landeszentrum Datenschutz Schleswig, Kiel, Germany.
   [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff, S Glam, Wales.
RP Krawczak, M (reprint author), Univ Kiel, Inst Med Informat & Stat, Brunswiker Str 10, D-24105 Kiel, Germany.
EM krawczak@medinfo.uni-kiel.de
RI Krawczak, Michael/A-8964-2010; Cooper, David/H-4384-2011
OI Krawczak, Michael/0000-0003-2603-1502; Cooper, David/0000-0002-8943-8484
FU German Federal Ministry of Education and Research [V010-02]
FX We thank Johannes Drepper (TMF, Berlin) for his excellent administrative
   support, the members of the TMF Working Group 'Biobanks' for monitoring
   the project, and Tim Lu (Kiel) for helpful comments on the manuscript.
   This work was supported by the German Federal Ministry of Education and
   Research through TMF project grant V010-02 BMB EU-Coop.
CR Anderlik Mary, 2003, Am J Pharmacogenomics, V3, P203, DOI 10.2165/00129785-200303030-00006
   Artizzu F, 2008, MED HEALTH CARE PHIL, V11, P181, DOI 10.1007/s11019-007-9086-y
   Caulfield T, 2004, Med Law, V23, P39
   Clark G, 2006, J LAW MED, V14, P102
   Gibbons SMC, 2005, EUR J HEALTH LAW, V12, P103, DOI 10.1163/1571809054640659
   Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X
   Nys Herman, 2008, Rev Derecho Genoma Hum, P169
   RICHARDSON G, 2004, LAW HUM GENOME REV, V20, P147
   Simon J, 2007, EUR J HUM GENET, V15, P528, DOI 10.1038/sj.ejhg.5201810
   Winickoff DE, 2001, J BIOLAW BUS, V4, P11
   Yuille M, 2008, BRIEF BIOINFORM, V9, P14, DOI 10.1093/bib/bbm050
   Zika E, 2008, PHARMACOGENOMICS, V9, P773, DOI 10.2217/14622416.9.6.773
NR 12
TC 12
Z9 13
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAY 10
PY 2010
VL 18
IS 5
BP 522
EP 525
DI 10.1038/ejhg.2009.214
PG 4
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 586ZO
UT WOS:000276955500003
PM 19953124
OA Green Published
DA 2018-10-20
ER

PT J
AU Brammer, KS
   Oh, S
   Frandsen, CJ
   Varghese, S
   Jin, S
AF Brammer, Karla S.
   Oh, Seunghan
   Frandsen, Christine J.
   Varghese, Shyni
   Jin, Sungho
TI Nanotube surface triggers increased chondrocyte extracellular matrix
   production
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE TiO(2) nanotube; Nanotopography; Chondrocyte; Extracellular matrix
ID FORMATION IN-VITRO; ARTICULAR CHONDROCYTES; CELL FATE; CARTILAGE;
   TISSUE; CHONDROGENESIS; BONE; CYTOSKELETON; COMPOSITES; SCAFFOLDS
AB We have altered TiO(2) nanotube diameters from 30 to 100 nm by anodization and investigated the in vitro bovine cartilage chondrocyte (BCC) response to the different nanoscale dimensions. The nanotopography of the vertically aligned TiO(2) nanotube structures triggered enhanced overall production of extracellular matrix (ECM) components over flat Ti control surfaces without a nanostructure-based surface topography. Initial SEM observations revealed that BCCs produced dense ECM fibrils on nanotubular substrates, which were lacking on flat Ti. Biochemical examination confirmed that glycosaminoglycan (GAG) secretion in the culture media was also up-regulated on nanotube substrates, reaching the highest production on the 70 nm diameter nanotubes with 100% amplification in GAG secretion over flat Ti. PCR analysis revealed that aggrecan and collagen type II transcription levels were increased on nanotube surfaces with the 70 nm diameter nanotubes exhibiting the highest relative levels of both chondrogenic transcription levels. This study demonstrates that TiO(2) nanotube structures in the 70 nm diameter regime, already being an osseo-integrating biomaterial, have significant and favorable effects on the extracellular matrix production of chondrocytes that could have encouraging implications for material applications in cartilage/bone interface osteochondral treatments utilizing nanotechnology. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Jin, Sungho] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA.
   [Oh, Seunghan] Wonkwang Univ, Coll Dent, Dept Dent Biomat, Iksan, South Korea.
   [Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
RP Jin, S (reprint author), Univ Calif San Diego, Dept Mech & Aerosp Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM kbrammer@ucsd.edu; shoh@wku.ac.kr; cfrandsen@ucsd.edu;
   svarghese@ucsd.edu; jin@ucsd.edu
FU UC San Diego
FX The authors acknowledge the financial support of this work from Iwama
   Endowed Fund at UC San Diego. No competing financial interests exist.
CR Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bhardwaj T, 2001, J BIOMED MATER RES, V57, P190, DOI 10.1002/1097-4636(200111)57:2<190::AID-JBM1158>3.0.CO;2-J
   BJURSTEN LM, 2009, J BIOMED MATER RES, pA88
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 1999, CLIN PLAST SURG, V26, P629
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Ciolfi VJD, 2003, BIOMATERIALS, V24, P4761, DOI 10.1016/S0142-9612(03)00373-9
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fedewa MM, 1998, J ORTHOPAED RES, V16, P227, DOI 10.1002/jor.1100160210
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Galois L, 2004, BIORHEOLOGY, V41, P433
   Gong YH, 2008, J BIOMAT SCI-POLYM E, V19, P207, DOI 10.1163/156856208783432453
   Grande DA, 1999, CLIN ORTHOP RELAT R, pS176
   Hamilton DW, 2005, CELL BIOL INT, V29, P605, DOI 10.1016/j.cellbi.2005.03.013
   HUNTER W, 1995, CLIN ORTHOP RELAT R, V3, P1743
   Hwang NS, 2007, FEBS LETT, V581, P4172, DOI 10.1016/j.febslet.2007.07.049
   INGBER DE, 1993, J CELL SCI, V104, P613
   MANKIN HJ, 1994, NEW ENGL J MED, V331, P940, DOI 10.1056/NEJM199410063311410
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Martinez J, 2008, J PEPT SCI, V14, P10
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2005, BIOMATERIALS, V23, P2945
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Olmedilla MP, 2006, BIOMATERIALS, V27, P1003, DOI 10.1016/j.biomaterials.2005.07.030
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   RICHARD WJL, 2003, ARTHRITIS RES THER, V5, P235
   Savaiano JK, 2004, BIOMATERIALS, V25, P1205, DOI 10.1016/j.biomaterials.2003.08.012
   Sawtell RM, 1997, J MATER SCI-MATER M, V8, P667, DOI 10.1023/A:1018531722265
   SOLURSH M, 1982, DEV BIOL, V94, P259, DOI 10.1016/0012-1606(82)90090-2
   SOLURSH M, 1989, P 3 INT C CHEM BIOL, V29, P81
   Spiteri CG, 2006, J BIOMED MATER RES A, V78A, P676, DOI 10.1002/jbm.a.30746
   VACANTI CA, 1993, TRANSPLANT P, V25, P1019
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zhang K, 2002, J BIOMED MATER RES, V61, P551, DOI 10.1002/jbm.10227
NR 42
TC 26
Z9 26
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 10
PY 2010
VL 30
IS 4
BP 518
EP 525
DI 10.1016/j.msec.2010.01.013
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 591PC
UT WOS:000277312600003
DA 2018-10-20
ER

PT J
AU Lv, S
   Dudek, DM
   Cao, Y
   Balamurali, MM
   Gosline, J
   Li, HB
AF Lv, Shanshan
   Dudek, Daniel M.
   Cao, Yi
   Balamurali, M. M.
   Gosline, John
   Li, Hongbin
TI Designed biomaterials to mimic the mechanical properties of muscles
SO NATURE
LA English
DT Article
ID CARDIAC-MUSCLE; PROTEIN TITIN; ELASTIN; RESILIN; CONNECTIN/TITIN;
   MYOFIBRILS; MOLECULES; FILAMENTS; DOMAINS; TENSION
AB The passive elasticity of muscle is largely governed by the I-band part of the giantmuscle protein titin(1-4), a complex molecular spring composed of a series of individually folded immunoglobulin-like domains as well as largely unstructured unique sequences(5). These mechanical elements have distinct mechanical properties, and when combined, they provide the desired passive elastic properties of muscle(6-11), which are a unique combination of strength, extensibility and resilience. Single-molecule atomic force microscopy (AFM) studies demonstrated that the macroscopic behaviour of titin in intact myofibrils can be reconstituted by combining the mechanical properties of these mechanical elements measured at the single-molecule level(8). Here we report artificial elastomeric proteins that mimic the molecular architecture of titin through the combination of well-characterized protein domains GB1(12) and resilin(13). We show that these artificial elastomeric proteins can be photochemically crosslinked and cast into solid biomaterials. These biomaterials behave as rubber-like materials showing high resilience at low strain and as shock-absorber-like materials at high strain by effectively dissipating energy. These properties are comparable to the passive elastic properties of muscles within the physiological range of sarcomere length(14) and so these materials represent a new muscle-mimetic biomaterial. The mechanical properties of these biomaterials can be fine-tuned by adjusting the composition of the elastomeric proteins, providing the opportunity to develop biomaterials that are mimetic of different types of muscles. We anticipate that these biomaterials will find applications in tissue engineering(15) as scaffold and matrix for artificial muscles.
C1 [Lv, Shanshan; Cao, Yi; Balamurali, M. M.; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada.
   [Dudek, Daniel M.; Gosline, John] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z1, Canada.
RP Li, HB (reprint author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.
EM gosline@zoology.ubc.ca; hongbin@chem.ubc.ca
RI Cao, Yi/A-4200-2011; Li, Hongbin/G-2949-2012
OI Li, Hongbin/0000-0001-7813-1332; Lv, Shanshan/0000-0002-6068-3048
FU Canadian Institutes of Health Research; Canada Research Chairs program;
   Canada Foundation for Innovation; Michael Smith Foundation for Health
   Research; Natural Sciences and Engineering Research Council of Canada
FX We thank M. Lillie and R. Shadwick for discussions. This work is
   supported by the Canadian Institutes of Health Research, the Canada
   Research Chairs program, the Canada Foundation for Innovation, the
   Michael Smith Foundation for Health Research, and the Natural Sciences
   and Engineering Research Council of Canada. H. L. is a Michael Smith
   Foundation for Health Research Career Investigator.
CR Amin AFMS, 2006, INT J PLASTICITY, V22, P1610, DOI 10.1016/j.ijplas.2005.09.005
   ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Bochicchio B, 2005, MACROMOL BIOSCI, V5, P502, DOI 10.1002/mabi.200500007
   Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   DUDEK DM, 2009, ANN M SOC INT COMP B, pE50
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X
   Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339
   Higuchi H, 1996, ADV BIOPHYS, V33, P159
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00398
   Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098
   LILLIE MA, 1994, CONNECT TISSUE RES, V31, P23, DOI 10.3109/03008209409005632
   LINKE WA, 1994, BIOPHYS J, V67, P782, DOI 10.1016/S0006-3495(94)80538-7
   Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631
   Maruyama K, 1997, FASEB J, V11, P341
   Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4
   Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199
   Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198
   Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x
   Wang K, 1996, ADV BIOPHYS, V33, P123
   Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
NR 33
TC 246
Z9 248
U1 26
U2 331
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD MAY 6
PY 2010
VL 465
IS 7294
BP 69
EP 73
DI 10.1038/nature09024
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 591OW
UT WOS:000277311900032
PM 20445626
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Witte, F
AF Witte, Frank
TI The history of biodegradable magnesium implants: A review
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Degradable Metals for Biomedical Applications held at
   THERMEC 2009
CY AUG 25-29, 2009
CL Berlin, GERMANY
DE Magnesium; Corrosion; History; Bone; Cardiovascular
ID RATS; BONE
AB Today, more than 200 years after the first production of metallic magnesium by Sir Humphry Davy in 1808, biodegradable magnesium-based metal implants are currently breaking the paradigm in biomaterial science to develop only highly corrosion resistant metals. This groundbreaking approach to temporary metallic implants is one of the latest developments in biomaterials science that is being rediscovered. It is a challenging topic, and several secrets still remain that might revolutionize various biomedical implants currently in clinical use. Magnesium alloys were investigated as implant materials long ago. A very early clinical report was given in 1878 by the physician Edward C. Huse. He used magnesium wires as ligature for bleeding vessels. Magnesium alloys for clinical use were explored during the last two centuries mainly by surgeons with various clinical backgrounds, such as cardiovascular, musculoskeletal and general surgery. Nearly all patients benefited from the treatment with magnesium implants. Although most patients experienced subcutaneous gas cavities caused by rapid implant corrosion, most patients had no pain and almost no infections were observed during the postoperative follow-up. This review critically summarizes the in vitro and in vivo knowledge and experience that has been reported on the use of magnesium and its alloys to advance the field of biodegradable metals. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Hannover Med Sch, Dept Orthopaed Surg, Lab Biomech & Biomat, D-30625 Hannover, Germany.
RP Witte, F (reprint author), Hannover Med Sch, Dept Orthopaed Surg, Lab Biomech & Biomat, Anna von Borries Str 1-7, D-30625 Hannover, Germany.
EM witte.frank@mh-hannover.de
RI Duncan, Kirsty/H-1911-2011
OI Witte, Frank/0000-0001-9154-6217
CR Andrews EW, 1917, JAMA-J AM MED ASSOC, V28, P278
   BUFE W, 1939, DEUT Z CHIR, V252, P224
   Chlumsky V, 1907, MITT GRENZGEBIETEN M, V3, P416
   Chlumsky V, 1900, CENTRALBLATT CHIR, V27, P921
   FONTENIER G, 1975, MED BIOL ENG, V13, P683, DOI 10.1007/BF02477326
   FROMHERZ K, 1909, Z CHIR, P210
   Glass E, 1926, DEUT Z CHIR, V194, P352
   GOSSRAU G, 1935, FARBENINDUSTRIE AKT
   Groves E., 1913, BRIT J SURG, V1, P438
   HENSCHEN C, 1934, ZBL CHIR, V61, P828
   HOFFHEINZ S., 1928, DEUTSCHE ZEITSCHR CHIR, V208, P346
   HOPFNER E, 1903, ARCH KLIN CHIR, V70, P417
   HUMEROTHERY W, 1927, 1927 I MET
   Huse E.C., 1878, CHICAGO MED J EXAM, P172
   HUSSL H, 1981, CHIR PLAST, V6, P117, DOI 10.1007/BF00289636
   JORGENSEN R, 1986, Patent No. 4602632
   Kammer C., 2000, MAGNESIUM TASCHENBUC
   Lambotte A, 1909, PRESSE MED, V17, P321
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Lespinasse VD, 1910, J AMER MED ASSOC, V55, P1785, DOI 10.1001/jama.1910.04330210013005
   Maier O., 1940, DEUT Z CHIR, V253, P552
   McBride E. D., 1938, SOUTH MED J, V31, P508
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   McCord Carey P., 1942, INDUST MED [BELOIT], V11, P71
   NICOLE R, 1947, HEL CHIR ACTA S3, V14, P3
   NOGARA G, 1939, ARCH ITAL CHIR, V56, P459
   Payr E, 1905, ARCH KLIN CHIR, V77, P962
   Payr E, 1903, ZENTRALBLATT CHIR, V30, P233
   Payr E, 1900, ARCH KLIN CHIR, V62, P67
   Payr E, 1902, DTSCH Z CHIR, V63, P503
   PAYR E, 1905, ZENTRALBL CHIR, V49, P1335
   Payr E., 1901, CENTRALBLATT CHIR, V28, P513
   Payr E, 1901, CENTRALBLATT CHIRURG, V28, P31
   Rostock P, 1937, ARCH ORTHOP TRAUMA S, V38, P486
   Seelig M., 1924, ARCH SURG-CHICAGO, V8, P669
   Sonntag E, 1914, ERGEB CHIR ORTHOP, V8, P1
   STONE P, 1951, SURGERY, V30, P987
   Stroganov G. B., 1972, [No title captured], Patent No. [3687135, 3, 687, 135]
   TROITSKY VV, 1948, RASSASYVAYUSHCH META, V8, P41
   Verbrugge J., 1937, B MEM SOC NAT CIR, V59, P813
   Verbrugge J., 1934, PRESSE MED, V23, P460
   Verbrugge J, 1933, PRESSE MED, V55, P1112
   VORDEMANN S, 1939, RESORPTION MAGNESIUM
   WEXLER BC, 1980, ATHEROSCLEROSIS, V36, P575, DOI 10.1016/0021-9150(80)90250-6
   WILFLINGSEDER P, 1981, CHIR PLAST, V6, P105, DOI 10.1007/BF00289635
   Zierold AA, 1924, ARCH SURG-CHICAGO, V9, P365, DOI 10.1001/archsurg.1924.01120080133008
NR 46
TC 664
Z9 695
U1 18
U2 341
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2010
VL 6
IS 5
BP 1680
EP 1692
DI 10.1016/j.actbio.2010.02.028
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 598OL
UT WOS:000277847500002
PM 20172057
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Moravej, M
   Prima, F
   Fiset, M
   Mantovani, D
AF Moravej, M.
   Prima, F.
   Fiset, M.
   Mantovani, D.
TI Electroformed iron as new biomaterial for degradable stents: Development
   process and structure-properties relationship
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Degradable Metals for Biomedical Applications held at
   THERMEC 2009
CY AUG 25-29, 2009
CL Berlin, GERMANY
DE Degradable material; Coronary stents; Electroforming; Microstructure;
   Mechanical properties
ID ELECTRODEPOSITED COPPER; GROWTH; IMPLANTATION; MORPHOLOGY; LAYERS;
   ALLOY; FILMS; FOILS; METAL
AB An electroforming technique was developed for fabricating iron foils targeted for application as biodegradable cardiovascular stent material. The microstructure, mechanical properties and corrosion of electroformed iron (E-Fe) foils were evaluated and compared with those of pure iron made by casting and thermomechanical treatment (CTT-Fe), with 316L stainless steel (316L SS) and with other candidate metallic materials for biodegradable stents. Electron backscattered diffraction revealed an average grain size of 4 mu m for E-Fe, resulting in a high yield (360 MPa) and ultimate tensile strength (423 MPa) being superior to those of other metallic biodegradable stent materials. Annealing at 550 degrees C was found to improve the ductility of the E-Fe from 8% to 18%. The corrosion rate of E-Fe in Hanks' solution, measured by potentiodynamic polarization, was higher than that of CTT-Fe, which had been found to have a slow in vivo degradation. The results showed that E-Fe possesses fine-grain microstructure, suitable mechanical properties and moderate corrosion rate as a degradable stent material. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Moravej, M.; Mantovani, D.] Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, Quebec City, PQ G1V 0A6, Canada.
   [Moravej, M.; Mantovani, D.] Univ Laval, Univ Hosp Res Ctr, Quebec City, PQ G1V 0A6, Canada.
   [Prima, F.] Univ Paris 06, Ecole Natl Super Chim Paris, Met Phys Lab, Paris 6, France.
RP Mantovani, D (reprint author), Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, Pav Adrien Pouliot,1745-E,1065 Ave Med, Quebec City, PQ G1V 0A6, Canada.
EM Diego.Mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
CR ASTM, 2006, E8M04 ASTM INT
   *ASTM INT, 2006, E101903 ASTM INT
   *ASTM INT, 2006, G59972003 ASTM INT
   *ASTM INT, 2006, D197602 ASTM INT
   Bugayev K., 2001, IRON STEEL PRODUCTIO, P25
   Choi JH, 2000, J MATER SCI, V35, P4055, DOI 10.1023/A:1004834204320
   Colombo A, 2000, CIRCULATION, V102, P371
   DAZHIN VJ, 1970, MET SCI HEAT TREAT, V12, P81
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Dini J.W., 1993, ELECTRODEPOSITION MA, P141
   Ebrahimi F, 1998, SCRIPTA MATER, V39, P315, DOI 10.1016/S1359-6462(98)00164-X
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   GOW KV, 1979, SURF TECHNOL, V8, P333, DOI 10.1016/0376-4583(79)90033-5
   Hart T, 2007, MET FINISH, V105, P331
   HARTY SF, 1981, SURF TECHNOL, V12, P39, DOI 10.1016/0376-4583(81)90135-7
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P113, DOI 10.4028/www.scientific.net/AMR.15-17.113
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hill M., RELATIONSHIP CRYSTAL
   Jartych E, 2002, APPL SURF SCI, V193, P210, DOI 10.1016/S0169-4332(02)00474-9
   Jartych E, 2001, MATER CHEM PHYS, V72, P356, DOI 10.1016/S0254-0584(01)00330-3
   KIM I, 2000, TEXTURE MICROSTRUCT, V34, P159
   Krause A, 2006, THIN SOLID FILMS, V515, P1694, DOI 10.1016/j.tsf.2006.06.003
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   McGeough J. A., 2001, ANN CIRP, V50, P499
   Merchant HD, 2004, MATER CHARACT, V53, P335, DOI 10.1016/j.matchar.2004.07.013
   MERCHANT HD, 1995, J ELECTRON MATER, V24, P919, DOI 10.1007/BF02652962
   MOROZOV GI, 1974, MET SCI HEAT TREAT+, V16, P888, DOI 10.1007/BF00664264
   Myung NV, 2004, ELECTROCHIM ACTA, V49, P4397, DOI 10.1016/j.electacta.2004.04.031
   PAUNOVIC M, 2006, FUNDAMENTALS ELECTRO, P286
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   REDDY AKN, 1963, ACTA CRYSTALLOGR, V16, P844, DOI 10.1107/S0365110X63002218
   SCHLESINGER M, 2000, MODERN ELECTROPLATIN, P45
   SHADROW VG, 1993, CRYST RES TECHNOL, V28, P157, DOI 10.1002/crat.2170280205
   SMIALOWSKI M, 1962, HYDROGEN STEEL EFFEC, P381
   YOSHIMURA S, 1994, ELECTROCHIM ACTA, V39, P589, DOI 10.1016/0013-4686(94)80105-3
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 38
TC 71
Z9 72
U1 0
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2010
VL 6
IS 5
BP 1726
EP 1735
DI 10.1016/j.actbio.2010.01.010
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 598OL
UT WOS:000277847500007
PM 20085829
DA 2018-10-20
ER

PT J
AU Mueller, WD
   Nascimento, ML
   de Mele, MFL
AF Mueller, Wolf-Dieter
   Nascimento, M. Lucia
   Fernandez Lorenzo de Mele, Monica
TI Critical discussion of the results from different corrosion studies of
   Mg and Mg alloys for biomaterial applications
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Degradable Metals for Biomedical Applications held at
   THERMEC 2009
CY AUG 25-29, 2009
CL Berlin, GERMANY
DE Magnesium; Corrosion; Resorbable biomaterials
ID IN-VIVO CORROSION; BONE IMPLANT APPLICATION; SIMULATED BODY-FLUID;
   MAGNESIUM ALLOYS; PURE MAGNESIUM; BIO-CORROSION; DEGRADATION; BEHAVIOR;
   VITRO; ALBUMIN
AB The aim of this work was to collect and compare data from different published reports which focused on the description of the influence of different electrochemical setups for the assessment of magnesium corrosion. Based on this, a comparison with our own results, obtained for LAE 442 and AZ 31, was made and discussed. As the collection of data has shown, the reported inconsistencies between in vivo and electrochemical data depend greatly on the electrochemical medium used, on the alloy composition and on surface preparation. Nevertheless, these differences also exist when comparing different in vitro results using different methodologies and even different Mg alloys, and need therefore to be discussed more thoroughly in the future. The simulation of transport conditions of the in vivo interface should become a focus of research interest in order to gain a better understanding of the influence of connecting processes on the degradation of the biomaterials. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mueller, Wolf-Dieter] Charite, D-14197 Berlin, Germany.
   [Nascimento, M. Lucia] Tech Univ Berlin, Fachgebiet Werkstofftech, D-10623 Berlin, Germany.
   [Fernandez Lorenzo de Mele, Monica] INIFTA, La Plata, Buenos Aires, Argentina.
   [Fernandez Lorenzo de Mele, Monica] Univ La Plata, Fac Ingn, La Plata, Buenos Aires, Argentina.
RP Mueller, WD (reprint author), Charite, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
EM wolf-dieter.mueller@charite.de
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551
CR Amemiya S, 2006, ANAL BIOANAL CHEM, V386, P458, DOI 10.1007/s00216-006-0510-6
   Atrens A, 2007, ADV ENG MATER, V9, P292, DOI 10.1002/adem.200600275
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Hao L, 2004, COLLOID SURFACE B, V34, P87, DOI 10.1016/j.colsurfb.2003.12.008
   Jones D.A., 1992, PRINCIPLES PREVENTIO, P568
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Lamaka SV, 2008, ELECTROCHEM COMMUN, V10, P259, DOI 10.1016/j.elecom.2007.12.003
   Lim CS, 2007, J MECH MED BIOL, V7, P89, DOI 10.1142/S0219519407002169
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   MUELLER WD, 2009, THESIS HUMBOLDT BERL
   MUELLER WD, 2007, MAT RES, V10, P1
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Pietak A, 2008, J MATER SCI-MATER M, V19, P407, DOI 10.1007/s10856-007-3172-9
   Quach NC, 2008, CR CHIM, V11, P1043, DOI 10.1016/j.crci.2008.06.007
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Virtanen S, 2008, CORROS REV, V26, P147, DOI 10.1515/corrrev.2008.147
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang Y, 2008, MATER LETT, V62, P2185
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang YJ, 2005, CORROS SCI, V47, P2816, DOI 10.1016/j.corsci.2005.01.010
   Zhao MC, 2008, CORROS SCI, V50, P3168, DOI 10.1016/j.corsci.2008.08.023
NR 31
TC 125
Z9 133
U1 2
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2010
VL 6
IS 5
BP 1749
EP 1755
DI 10.1016/j.actbio.2009.12.048
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 598OL
UT WOS:000277847500010
PM 20051271
DA 2018-10-20
ER

PT J
AU Alvarez-Lopez, M
   Pereda, MD
   del Valle, JA
   Fernandez-Lorenzo, M
   Garcia-Alonso, MC
   Ruano, OA
   Escudero, ML
AF Alvarez-Lopez, M.
   Dolores Pereda, Maria
   del Valle, J. A.
   Fernandez-Lorenzo, M.
   Garcia-Alonso, M. C.
   Ruano, O. A.
   Escudero, M. L.
TI Corrosion behaviour of AZ31 magnesium alloy with different grain sizes
   in simulated biological fluids
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Degradable Metals for Biomedical Applications held at
   THERMEC 2009
CY AUG 25-29, 2009
CL Berlin, GERMANY
DE AZ31 Mg alloy; Grain size; Biomaterial; Corrosion; Electrochemical
   techniques
ID IN-VIVO CORROSION; IMPEDANCE SPECTROSCOPY; HANKS SOLUTION; MGAL ALLOYS;
   AZ91D; CHLORIDE; BIOCOMPATIBILITY; MORPHOLOGY; SURFACE; STENTS
AB The corrosion behaviour of AZ31 magnesium alloy with different grain sizes immersed in simulated body fluids was compared in chloride solution (8 g l(-1)) and in phosphate-buffer solution (PBS). The influence of immersion time was also analyzed. Electrochemical techniques such as open circuit potential, polarization curves, transient currents and electrochemical impedance spectroscopy, complemented with scanning electron microscopy and energy dispersive spectroscopy, were used. Immediately after the immersion in the corrosive media the corrosion resistance was similar for both grain sizes of the AZ31 alloy and higher in NaCl solutions than in PBS. However, this corrosion behaviour was reversed after longer periods of immersion due to the stabilizing of the corrosion products of MgO by P-containing compounds. These P-compounds contribute to a higher level of protection by hindering the aggressive action of chloride ions. The best corrosion behaviour of the AZ31 alloy was obtained for the finest grain alloy associated with the highest transfer resistance value, after long periods of immersion in PBS. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Alvarez-Lopez, M.; del Valle, J. A.; Garcia-Alonso, M. C.; Ruano, O. A.; Escudero, M. L.] CSIC, CENIM, Madrid 28040, Spain.
   [Dolores Pereda, Maria; Fernandez-Lorenzo, M.] Univ Nacl La Plata CONICET, Fac Ciencias Exactas, INIFTA, RA-1900 La Plata, Buenos Aires, Argentina.
   [Dolores Pereda, Maria; Fernandez-Lorenzo, M.] Univ Nacl La Plata, Fac Ingn, RA-1900 La Plata, Buenos Aires, Argentina.
RP Escudero, ML (reprint author), CSIC, CENIM, Avda Gregorio del Amo 8, Madrid 28040, Spain.
EM escudero@cenim.csic.es
RI Ruano, Oscar/H-1835-2015; Garcia-Alonso, Maria Cristina/K-3779-2014;
   Escudero, Maria Lorenza/L-7113-2014
OI Ruano, Oscar/0000-0001-6368-986X; Garcia-Alonso, Maria
   Cristina/0000-0003-0275-4626; Escudero, Maria
   Lorenza/0000-0002-2181-448X
CR Abbas G, 2005, APPL SURF SCI, V247, P347, DOI [10.1016/j.apsusc.2005.01.169, 10.1016/J.APSUSC.2005.01.169]
   Al-Abdullat Y, 2001, MATER TRANS, V42, P1777, DOI 10.2320/matertrans.42.1777
   Ambat R, 2000, CORROS SCI, V42, P1433, DOI 10.1016/S0010-938X(99)00143-2
   Baril G, 2001, J ELECTROCHEM SOC, V148, pB489, DOI 10.1149/1.1415722
   Breslin CB, 2000, CORROS SCI, V42, P1023, DOI 10.1016/S0010-938X(99)00128-6
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   del Valle JA, 2006, ACTA MATER, V54, P4247, DOI 10.1016/j.actamat.2006.05.018
   Dube D, 2001, MAT SCI ENG A-STRUCT, V299, P38, DOI 10.1016/S0921-5093(00)01414-3
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Li Y, 2006, ELECTROCHIM ACTA, V51, P2845, DOI 10.1016/j.electacta.2005.08.023
   Loos A, 2007, MACROMOL SYMP, V253, P103, DOI 10.1002/masy.200750715
   Lucey TD, 1977, METAL TOXICITY MAMMA
   LUNDER O, 1989, CORROSION, V45, P741, DOI 10.5006/1.3585029
   MAGOS L, 1996, TOXICOLOGY METALS
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   METIKOSHUKOVIC M, 1994, J APPL ELECTROCHEM, V24, P772, DOI 10.1007/BF00578093
   NISANCIOGLU K, 1990, P 47 ANN WORLD MAGN, P47
   Nordlien JH, 1997, J ELECTROCHEM SOC, V144, P461, DOI 10.1149/1.1837432
   Nordlien JH, 1996, J ELECTROCHEM SOC, V143, P2564, DOI 10.1149/1.1837048
   PEBERE N, 1990, ELECTROCHIM ACTA, V35, P555, DOI 10.1016/0013-4686(90)87043-2
   Perez-Prado MT, 2004, SCRIPTA MATER, V50, P661, DOI 10.1016/j.scriptamat.2003.11.014
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 1999, CORROS SCI, V41, P249
   Song GL, 1998, CORROS SCI, V40, P1769, DOI 10.1016/S0010-938X(98)00078-X
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   UZAN P, 2000, P 2 ISR INT C MAGN S, P385
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wu CS, 2007, APPL SURF SCI, V253, P3893, DOI 10.1016/j.apsusc.2006.08.020
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang YJ, 2005, CORROS SCI, V47, P2816, DOI 10.1016/j.corsci.2005.01.010
NR 36
TC 206
Z9 218
U1 6
U2 117
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2010
VL 6
IS 5
BP 1763
EP 1771
DI 10.1016/j.actbio.2009.04.041
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 598OL
UT WOS:000277847500012
PM 19446048
DA 2018-10-20
ER

PT J
AU Pereda, MD
   Alonso, C
   Burgos-Asperilla, L
   del Valle, JA
   Ruano, OA
   Perez, P
   de Mele, MAFL
AF Pereda, M. D.
   Alonso, C.
   Burgos-Asperilla, L.
   del Valle, J. A.
   Ruano, O. A.
   Perez, P.
   Fernandez Lorenzo de Mele, M. A.
TI Corrosion inhibition of powder metallurgy Mg by fluoride treatments
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Degradable Metals for Biomedical Applications held at
   THERMEC 2009
CY AUG 25-29, 2009
CL Berlin, GERMANY
DE Magnesium; Degradable implant; Magnesium fluoride; Powder metallurgy;
   SECM
ID IN-VIVO CORROSION; BONE IMPLANT APPLICATION; SIMULATED BODY-FLUIDS;
   RARE-EARTH ALLOY; MAGNESIUM ALLOYS; TREATED MAGNESIUM;
   AQUEOUS-SOLUTIONS; VITRO CORROSION; PURE MAGNESIUM; BEHAVIOR
AB Pure Mg has been proposed as a potential degradable biomaterial to avoid both the disadvantages of non-degradable internal fixation implants and the use of alloying elements that may be toxic. However, it shows excessively high corrosion rate and insufficient yield strength. The effects of reinforcing Mg by a powder metallurgy (PM) route and the application of biocompatible corrosion inhibitors (immersion in 0.1 and 1 M KF solution treatments, 0.1 M FST and 1 M FST, respectively) were analyzed in order to improve Mg mechanical and corrosion resistance, respectively. Open circuit potential measurements, polarization techniques (PT), scanning electrochemical microscopy (SECM) and electrochemical impedance spectroscopy (EIS) were performed to evaluate its corrosion behavior. SECM showed that the local current of attacked areas decreased during the F(-) treatments. The corrosion inhibitory action of 0.1 M FST and 1 M FST in phosphate buffered solution was assessed by PT and EIS. Under the experimental conditions assayed, 0.1 M FST revealed better performance. X-ray photoelectron spectroscopy, energy dispersive X-ray and X-ray diffraction analyses of Mg(PM) with 0.1 M FST showed the presence of KMgF(3) crystals on the surface while a MgF(2) film was detected for 1 M FST. After fluoride inhibition treatments, promising results were observed for Mg(PM) as degradable metallic biomaterial due to its higher yield strength and lower initial corrosion rate than untreated Mg, as well as a progressive loss of the protective characteristics of the F(-)-containing film which ensures the gradual degradation process. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Pereda, M. D.; Fernandez Lorenzo de Mele, M. A.] Univ Nacl La Plata, INIFTA CCT La Plata CONICET, Fac Ciencias Exactas, RA-1900 La Plata, Buenos Aires, Argentina.
   [Pereda, M. D.; Fernandez Lorenzo de Mele, M. A.] Univ Nacl La Plata, Fac Ingn, RA-1900 La Plata, Buenos Aires, Argentina.
   [Alonso, C.; Burgos-Asperilla, L.] Univ Autonoma Madrid, Dept Quim Fis Aplicada, E-28049 Madrid, Spain.
   [del Valle, J. A.; Ruano, O. A.; Perez, P.] CSIC, CENIM, Dept Met Fis, E-28040 Madrid, Spain.
RP de Mele, MAFL (reprint author), Univ Nacl La Plata, INIFTA CCT La Plata CONICET, Fac Ciencias Exactas, Casilla Correo 16,Sucursal 4, RA-1900 La Plata, Buenos Aires, Argentina.
EM mmele@inifta.unlp.edu.ar
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015; Ruano, Oscar/H-1835-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551; Ruano,
   Oscar/0000-0001-6368-986X; Perez Zubiaur, Pablo/0000-0002-4218-2573
CR Al-Abdullat Y, 2001, MATER TRANS, V42, P1777, DOI 10.2320/matertrans.42.1777
   ALONSO C, 2008, ES, V1595, P1
   ARMSTRONG R, 1962, PHILOS MAG, V7, P45, DOI 10.1080/14786436208201857
   Baril G, 2001, CORROS SCI, V43, P471, DOI 10.1016/S0010-938X(00)00095-0
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   COWAN KG, 1979, ELECTROCHIM ACTA, V24, P301, DOI 10.1016/0013-4686(79)85049-5
   del Valle JA, 2006, ACTA MATER, V54, P4247, DOI 10.1016/j.actamat.2006.05.018
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   GRUHL S, 2009, J ANAL ATOM SPECTROM, V24, P117
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   GULBRANDSEN E, 1993, CORROS SCI, V34, P1423, DOI 10.1016/0010-938X(93)90238-C
   GUTMANAS EY, 1990, PROG MATER SCI, V34, P261, DOI 10.1016/0079-6425(90)90003-R
   Hassel T, 2005, MAGNESIUM TECHNOLOGY 2005, P485
   Heakal FET, 2009, ELECTROCHIM ACTA, V54, P1545, DOI 10.1016/j.electacta.2008.09.055
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Inoue H, 2002, CORROS SCI, V44, P603, DOI 10.1016/S0010-938X(01)00092-0
   Lamaka SV, 2008, ELECTROCHEM COMMUN, V10, P259, DOI 10.1016/j.elecom.2007.12.003
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Li JZ, 2009, T NONFERR METAL SOC, V19, P50, DOI 10.1016/S1003-6326(08)60227-7
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Perez P, 2007, J MATER SCI, V42, P3969, DOI 10.1007/s10853-006-1301-3
   Pietrzak WS, 1996, BONE, V19, pS109, DOI 10.1016/S8756-3282(96)00139-1
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rettig R, 2009, J BIOMED MATER RES A, V88A, P359, DOI 10.1002/jbm.a.31887
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Towler MR, 2004, BIO-MED MATER ENG, V14, P565
   Verdier S, 2004, APPL SURF SCI, V235, P513, DOI 10.1016/j.apsusc.2004.03.250
   WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Yamamoto A, 2008, MATER TRANS, V49, P1042, DOI 10.2320/matertrans.MC200704
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 41
TC 68
Z9 72
U1 2
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2010
VL 6
IS 5
BP 1772
EP 1782
DI 10.1016/j.actbio.2009.11.004
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 598OL
UT WOS:000277847500013
PM 19913114
DA 2018-10-20
ER

PT J
AU Moravej, M
   Purnama, A
   Fiset, M
   Couet, J
   Mantovani, D
AF Moravej, M.
   Purnama, A.
   Fiset, M.
   Couet, J.
   Mantovani, D.
TI Electroformed pure iron as a new biomaterial for degradable stents: In
   vitro degradation and preliminary cell viability studies
SO ACTA BIOMATERIALIA
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Degradable Metals for Biomedical Applications held at
   THERMEC 2009
CY AUG 25-29, 2009
CL Berlin, GERMANY
DE Degradable materials; Electroforming; In vitro degradation; Cell
   viability
ID SIMULATED BODY-FLUID; MAGNESIUM ALLOYS; METALLIC BIOMATERIALS;
   BIOCOMPATIBILITY; CYTOTOXICITY
AB In the search for a metallic material showing moderate and uniform degradation for application as degradable cardiovascular stents, electroformed iron (E-Fe) was evaluated by in vitro degradation and cell viability tests. Static immersion and dynamic degradation were used to evaluate degradation rate and mechanism, while cell viability assay was used to assess cytotoxicity. The results were compared with those of iron fabricated by casting and thermomechanical treatment previously investigated as a stent material. Electroformed iron showed faster degradation than iron fabricated by casting (0.25 vs. 0.14 mm year(-1)), with a uniform degradation mechanism. Cell viability results showed that E-Fe did not result in a decrease in metabolic activity when exposed to primary rat smooth muscle cells. However, it caused a decrease in cell proliferation activity which could be beneficial for the inhibition of in-stent restenosis. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Moravej, M.; Purnama, A.; Fiset, M.; Mantovani, D.] Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1V 0A6, Canada.
   [Moravej, M.; Purnama, A.; Fiset, M.; Mantovani, D.] Univ Laval, Univ Hosp Res Ctr, Quebec City, PQ G1V 0A6, Canada.
   [Purnama, A.; Couet, J.] Univ Laval, Dept Med, Quebec Heart Inst, Laval Hosp Res Ctr, Quebec City, PQ G1K 7P4, Canada.
RP Mantovani, D (reprint author), Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1V 0A6, Canada.
EM Diego.Mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
CR Ashby DT, 2002, CATHETER CARDIO INTE, V56, P83, DOI 10.1002/ccd.10209
   *ASTM INT, 2001, G3199 ASTM INT
   Butany J, 2005, J CLIN PATHOL, V58, P795, DOI 10.1136/jcp.2004.024174
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Gu X., 2009, BIOMATERIALS, V9, P484
   GUA X, 2008, BIOMATERIALS, V30, P484
   Hanzi AC, 2009, ACTA BIOMATER, V5, P162, DOI 10.1016/j.actbio.2008.07.034
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P113, DOI 10.4028/www.scientific.net/AMR.15-17.113
   Hermawan H, 2007, ADV MATER RES-SWITZ, V15-17, P107, DOI 10.4028/www.scientific.net/AMR.15-17.107
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   KANANI N, 2004, ELECTROPLATING BASIC, P169
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   KIAMA M, 1972, B CHEM SOC JPN, V45, P1923
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Loos A, 2007, MACROMOL SYMP, V253, P103, DOI 10.1002/masy.200750715
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Merchant HD, 2004, MATER CHARACT, V53, P335, DOI 10.1016/j.matchar.2004.07.013
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Ngamwongsatit P, 2008, J MICROBIOL METH, V73, P211, DOI 10.1016/j.mimet.2008.03.002
   OLOWE AA, 1989, HYPERFINE INTERACT, V46, P429, DOI 10.1007/BF02398227
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Seiler HG, 1988, HDB TOXICITY INORGAN
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song YW, 2009, MAT SCI ENG C-BIO S, V29, P1039, DOI 10.1016/j.msec.2008.08.026
   STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Waksman R, 2007, CATHETER CARDIO INTE, V70, P407, DOI 10.1002/ccd.21176
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 33
TC 84
Z9 87
U1 3
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2010
VL 6
IS 5
BP 1843
EP 1851
DI 10.1016/j.actbio.2010.01.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 598OL
UT WOS:000277847500021
PM 20080213
DA 2018-10-20
ER

PT J
AU Kasoju, N
   Bora, U
AF Kasoju, Naresh
   Bora, Utpal
TI Antheraea assama Silk Fibroin-Based Functional Scaffold with Enhanced
   Blood Compatibility for Tissue Engineering Applications
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID ANTICOAGULANT ACTIVITY; BIOMATERIAL SURFACES; POLYMERIC MATERIALS;
   PROTEIN ADSORPTION; NONWOVEN SCAFFOLD; IN-VITRO; PERSPECTIVE; SULFATION;
   ADHESION; SCIENCE
AB The architecture and surface chemistry of a scaffold determine its utility in tissue engineering (TE). Conventional techniques have limitations in fabricating a scaffold with control over both architecture and surface chemistry. To ameliorate this, in this report, we demonstrate the fabrication of an Antheraea assama silk fibroin (AASF)-based functional scaffold. AASF is a non-mulberry variety having superior qualities to mulberry SF and is largely unexplored in the context of TE. First, a 3D scaffold with biomimetic architecture is fabricated. The scaffold is subsequently made blood compatible by modifying the surface chemistry through a simple sulfation reaction. EDX and FTIR analysis demonstrate the successful sulfation of the scaffold. SEM observations reveal that sulfation has no any effect on the scaffold architecture. TGA reveals that it has increased thermal stability. The sulfation reaction significantly improves the overall hydrophilicity of the scaffold, as is evident from the increase in water holding capacity; this possibly enhances the blood compatibility. The enhancement in blood compatibility of the sulfated scaffold is determined from in vitro haemolysis, protein adsorption and platelet adhesion studies. The sulfated scaffold is non-toxic and supports cell adhesion and growth, as revealed by indirect and direct contact-based in vitro cytotoxicity assays. This study reveals that the AASF-based functional scaffold, which has biomimetic architecture and blood-compatible surface chemistry, could be suitable for TE applications.
C1 [Kasoju, Naresh; Bora, Utpal] Indian Inst Technol Guwahati, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
RP Kasoju, N (reprint author), Indian Inst Technol Guwahati, Dept Biotechnol, Biomat & Tissue Engn Lab, Gauhati 781039, Assam, India.
EM ubora@iitg.ernet.in
RI Kasoju, Naresh/A-5295-2009
OI Kasoju, Naresh/0000-0002-8700-0729
FU IITG; MHRD
FX We thank the Department of Biotechnology, Government of India for
   financial support (project number: BT/PR7984/MED/14/1214/2006). We thank
   the Silk Mark Organization of India, Guwahati Chapter for providing
   silk-cocoons and NCCS, Pune for providing cell lines. NK thanks IITG and
   MHRD for a senior research fellowship.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Atala A, 2007, J TISSUE ENG REGEN M, V1, P83, DOI 10.1002/term.18
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Daar AS, 2007, J TISSUE ENG REGEN M, V1, P179, DOI 10.1002/term.20
   Eisenbarth E, 2007, ADV ENG MATER, V9, P1051, DOI 10.1002/adem.200700287
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hazarika LK, 1998, BIORESOURCE TECHNOL, V64, P67, DOI 10.1016/S0960-8524(97)00158-2
   Jandt KD, 2007, ADV ENG MATER, V9, P1035, DOI 10.1002/adem.200700284
   Kasoju N, 2009, MATER LETT, V63, P2466, DOI 10.1016/j.matlet.2009.08.037
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li M, 2008, POLYM ADVAN TECHNOL, V19, P207, DOI 10.1002/pat.998
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Lv JA, 2008, APPL SURF SCI, V255, P498, DOI 10.1016/j.apsusc.2008.06.149
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NAIR RR, 1998, ARTIF ORGANS, V12, P26
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   PISKIN E, 1992, Clinical Materials, V11, P3, DOI 10.1016/0267-6605(92)90023-M
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   Rao GHR, 1999, B MATER SCI, V22, P633, DOI 10.1007/BF02749979
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Satish CS, 2007, INDIAN J PHARM EDUC, V41, P195
   Sharma CP, 2001, J BIOMATER APPL, V15, P359, DOI 10.1106/YY8L-M4DD-AGW1-QAGU
   Taddei P, 2007, BIOMACROMOLECULES, V8, P1200, DOI 10.1021/bm061017y
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Tamada Y, 2003, J APPL POLYM SCI, V87, P2377, DOI 10.1002/app.12022
   Teo WE, 2009, COMPOS SCI TECHNOL, V69, P1804, DOI 10.1016/j.compscitech.2009.04.015
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
NR 39
TC 18
Z9 18
U1 0
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD MAY
PY 2010
VL 12
IS 5
SI SI
BP B139
EP B147
DI 10.1002/adem.200980055
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 613AM
UT WOS:000278948100015
DA 2018-10-20
ER

PT J
AU Stephens, JH
   Rieger, NA
   Farmer, KC
   Bell, SW
   Hooper, JE
   Hewett, PJ
AF Stephens, Jacqueline H.
   Rieger, Nicholas A.
   Farmer, K. Chip
   Bell, Stephen W.
   Hooper, Judy E.
   Hewett, Peter J.
TI Implantation of ethylene vinyl alcohol copolymer for faecal incontinence
   management
SO ANZ JOURNAL OF SURGERY
LA English
DT Article
DE anal sphincter; ethylene vinyl alcohol copolymer (substance name);
   faecal incontinence; phase 1 clinical trial; pilot study
ID QUALITY-OF-LIFE; INJECTABLE SILICONE BIOMATERIAL; ANAL-SPHINCTER
   DYSFUNCTION; MULTICENTER TRIAL; INJECTION; ENTERYX; SEVERITY; SYMPTOMS;
   SAFETY; GERD
AB Purpose:
   The primary objectives of this trial were to evaluate the safety and feasibility of treatment and to gain a preliminary indication of the effectiveness of ethylene vinyl alcohol injections into the anal sphincters of faecally incontinent patients.
   Methods:
   Between April 2004 and February 2006, we conducted a prospective, single-arm, procedure optimization study of ethylene vinyl alcohol injections in 21 subjects with well-characterized faecal incontinence and an intact external anal sphincter at two Australian hospitals.
   Results:
   There was a significant decrease in the Cleveland Clinic Florida Faecal Incontinence Score (CCFFIS) (P = 0.0005) and the Faecal Incontinence Severity Index score (P = 0.005) after treatment. At 12 months post-treatment, the mean CCFFIS had decreased by 37% (P = 0.0021), and 47% of subjects had a >= 50% improvement in CCFFIS. There were significant improvements in embarrassment (P = 0.0455) and coping/behaviour (P = 0.0056) domains of the Faecal Incontinence Quality of Life. At 12 months, the mean anal canal length had increased by 29% (P = 0.066), with 40% of patients demonstrating increases of 50% or more. There were no further improvements following retreatment.
   Conclusions:
   Ethylene vinyl alcohol injection into the anal intersphincteric plane is feasible and well tolerated. Improvement in faecal incontinence compared with baseline was seen. Retreating initial non-responders was not successful.
C1 [Stephens, Jacqueline H.; Rieger, Nicholas A.; Hewett, Peter J.] Queen Elizabeth Hosp, Colorectal Unit, Div Surg, Woodville, SA 5011, Australia.
   [Rieger, Nicholas A.; Hewett, Peter J.] Univ Adelaide, Discipline Surg, Queen Elizabeth Hosp, Woodville, SA 5011, Australia.
   [Farmer, K. Chip; Bell, Stephen W.; Hooper, Judy E.] Cabrini Hosp Malvern, Melbourne Gastrointestinal Invest Unit, Malvern, Vic, Australia.
RP Rieger, NA (reprint author), Queen Elizabeth Hosp, Colorectal Unit, Div Surg, 28 Woodville Rd, Woodville, SA 5011, Australia.
EM nicholas.rieger@adelaide.edu.au
OI Stephens, Jacqueline/0000-0002-7278-1374
FU Boston Scientific Corporate, Natick, Massachusetts, USA
FX Source of support: This study was sponsored by Boston Scientific
   Corporate, Natick, Massachusetts, USA.
CR Bharucha AE, 2003, GASTROENTEROLOGY, V124, P1672, DOI 10.1016/S0016-5085(03)00329-9
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   Efron JE, 2003, DIS COLON RECTUM, V46, P1616
   Johnson DA, 2003, AM J GASTROENTEROL, V98, P1921, DOI 10.1016/S0002-9270(03)01142-0
   Johnson DA, 2003, AM J GASTROENTEROL, V98, P250, DOI 10.1016/S0002-9270(02)06013-6
   Kenefick NJ, 2006, GUT, V55, P1824
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kumar D, 1998, BRIT J SURG, V85, P978
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   OKEEFE EA, 1995, J GERONTOL A-BIOL, V50, pM184, DOI 10.1093/gerona/50A.4.M184
   Rockwood TH, 2004, GASTROENTEROLOGY, V126, pS106, DOI 10.1053/j.gastro.2003.10.057
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P16, DOI DOI 10.1007/BF02237236]
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   Schumacher B, 2005, J CLIN GASTROENTEROL, V39, P212, DOI 10.1097/01.mcg.0000152751.10268.fa
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
NR 25
TC 2
Z9 2
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1445-1433
J9 ANZ J SURG
JI ANZ J. Surg.
PD MAY
PY 2010
VL 80
IS 5
BP 324
EP 330
DI 10.1111/j.1445-2197.2010.05277.x
PG 7
WC Surgery
SC Surgery
GA 592SV
UT WOS:000277401300009
PM 20557505
DA 2018-10-20
ER

PT J
AU Vavken, P
   Arrich, F
   Pilz, M
   Dorotka, R
AF Vavken, Patrick
   Arrich, Ferdi
   Pilz, Magdalena
   Dorotka, Ronald
TI An in vitro model of biomaterial-augmented microfracture including
   chondrocyte-progenitor cell interaction
SO ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
LA English
DT Article
DE Tissue engineering; Biomaterial; Microfracture; Cartilage repair;
   Differentiation
ID MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; UMBILICAL-CORD
   BLOOD; HUMAN BONE-MARROW; CHONDRAL DEFECTS; COLLAGEN MATRIX; CARTILAGE
   REPAIR; ADIPOSE-TISSUE; KNEE; CHONDROGENESIS
AB Biomaterials, acting as scaffolds for cell migration and differentiation, may be used to improve outcomes after microfracture. Three mechanisms determine the success of such procedures and are tested herein: the general capacity of adult femoral mesenchymal progenitor cells (MPC) to differentiate into cartilage, their capacity to do so in a biomaterial, and finally potential interactions between MPC and autologous chondrocytes.
   Human adult chondrocytes and MPC were obtained with informed consent and cultured individually or in co-culture on a collagenous biomaterial. Differentiation potential of MPC was assessed using PCR and proliferation and biosynthesis were compared to test for differences between individual cultures and co-cultures. Finally, potential interaction between chondrocytes and MPC was assessed by comparing the observed levels of proliferation and biosynthesis with those expected in independent growth.
   We found that adult femoral marrow-derived MPC have the potential to differentiate into multiple lineages, and, seeded in a biomaterial, show similar differentiation when compared with autologous chondrocytes. Finally, there was a strong indication for an interaction between MPC and chondrocytes in biosynthetic activity, which was twice as high as would be expected in independent cell activity. Proliferation rates were unaffected.
   Our study showed that biomaterial-augmented microfracture is a viable option in cartilage repair from a biological perspective because adult femoral MPC have a strong capacity to differentiate into chondrocytes, which is further enhanced by the surrounding cartilage. Failure in in vivo studies must be explained by other factors of the intra-articular environment, such as cytokines or biomechanics.
C1 [Vavken, Patrick] Harvard Univ, Sports Med Res Lab, Dept Orthoped Surg, Childrens Hosp Boston,Med Sch, Boston, MA 02115 USA.
   [Vavken, Patrick; Arrich, Ferdi; Pilz, Magdalena; Dorotka, Ronald] Med Univ Vienna, Dept Orthopaed Surg, Vienna, Austria.
RP Vavken, P (reprint author), Harvard Univ, Sports Med Res Lab, Dept Orthoped Surg, Childrens Hosp Boston,Med Sch, 300 Longwood Ave Enders 1016, Boston, MA 02115 USA.
EM patrick.vavken@childrens.harvard.edu
FU Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der
   Bundeshauptstadt Wien
FX This study was financially supported by the
   Medizinisch-Wissenschaftlicher Fonds des Burgermeisters der
   Bundeshauptstadt Wien.
CR Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516
   Briggs TWR, 2003, J BONE JOINT SURG BR, V85B, P1077, DOI 10.1302/0301-620X.85B7.13672
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Csaki C, 2009, HISTOCHEM CELL BIOL, V131, P251, DOI 10.1007/s00418-008-0524-6
   DeGroot J, 1999, ARTHRITIS RHEUM, V42, P1003, DOI 10.1002/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO;2-K
   Dorotka R, 2005, OSTEOARTHR CARTILAGE, V13, P655, DOI 10.1016/j.joca.2005.04.001
   Dorotka R, 2005, BIOMATERIALS, V26, P3617, DOI 10.1016/j.biomaterials.2004.09.034
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Henderson I, 2007, CLIN ORTHOP RELAT R, P253, DOI 10.1097/01.blo.0000238829.42563.56
   Hickery MS, 2003, J BIOL CHEM, V278, P53063, DOI 10.1074/jbc.M209632200
   Huibregtse BA, 2000, J ORTHOPAED RES, V18, P18, DOI 10.1002/jor.1100180104
   Jakob M, 2004, RHEUMATOLOGY, V43, P852, DOI 10.1093/rheumatology/keh197
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Maleski MP, 1996, EXP CELL RES, V225, P55, DOI 10.1006/excr.1996.0156
   MARIJNISSEN WJ, 2000, BIOMATERIALS, V21, P771
   Murray MM, 2004, AM J SPORT MED, V32, P1484, DOI 10.1177/0363546504263700
   Nehrer S, 1998, BIOMATERIALS, V19, P2313, DOI 10.1016/S0142-9612(98)00143-4
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356
   Rosowski M, 2006, ARTIF ORGANS, V30, P775, DOI 10.1111/j.1525-1594.2006.00300.x
   Schulze-Tanzil G, 2009, HISTOCHEM CELL BIOL, V131, P219, DOI 10.1007/s00418-008-0516-6
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Tallheden T, 2003, J BONE JOINT SURG AM, V85A, P93, DOI 10.2106/00004623-200300002-00012
   Tsuchiya K, 2004, MAT SCI ENG C-BIO S, V24, P391, DOI 10.1016/j.msec.2003.12.014
   Vavken P, 2008, Z ORTHOP UNFALLCHIR, V146, P26, DOI 10.1055/s-2007-989435
   Vavken P, 2008, CLIN ORTHOP RELAT R, V466, P985, DOI 10.1007/s11999-007-0098-y
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zhang X, 2008, BIOMATERIALS, V29, P4616, DOI 10.1016/j.biomaterials.2008.07.051
NR 32
TC 5
Z9 8
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0936-8051
J9 ARCH ORTHOP TRAUM SU
JI Arch. Orthop. Trauma Surg.
PD MAY
PY 2010
VL 130
IS 5
BP 711
EP 716
DI 10.1007/s00402-010-1079-2
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 567PP
UT WOS:000275459400020
PM 20213450
DA 2018-10-20
ER

PT J
AU Betz, MW
   Yeatts, AB
   Richbourg, WJ
   Caccamese, JF
   Coletti, DP
   Falco, EE
   Fisher, JP
AF Betz, Martha W.
   Yeatts, Andrew B.
   Richbourg, William J.
   Caccamese, John F.
   Coletti, Domenick P.
   Falco, Erin E.
   Fisher, John P.
TI Macroporous Hydrogels Upregulate Osteogenic Signal Expression and
   Promote Bone Regeneration
SO BIOMACROMOLECULES
LA English
DT Article
ID POLY(PROPYLENE FUMARATE) SCAFFOLDS; MESENCHYMAL STEM-CELLS;
   CALCIUM-PHOSPHATE CERAMICS; POLYMER SCAFFOLDS; ORBITAL RECONSTRUCTIONS;
   TISSUE-RESPONSE; IN-VITRO; FRACTURES; DELIVERY; DIFFERENTIATION
AB The objective of this work was to investigate the effects of macroporous hydrogel architecture on the osteogenic signal expression and differentiation of human mesenchymal stem cells (hMSCs). In particular, we have proposed a tissue engineering approach for orbital bone repair based on a cyclic acetal biomaterial formed from 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) and poly(ethylene glycol) diacrylate (PEGDA). The El-ID monomer and PEGDA polymer may be fabricated into macroporous hydrogels by radical polymerization and subsequent porogen leaching, a novel technique for hydrophilic gels. We hypothesized that EH-PEG hydrogel macroporosity facilitates intercellular signaling among hMSCs. To investigate this phenomenon, hMSCs were loaded into El-I-PEG hydrogels with varying pore size and porosity. The viability of hMSCs, the expression of bone morphogenetic protein-2 (BMP-2), BMP receptor type 1A, and BMP receptor type 2 by hMSCs, and the differentiation of hMSCs were then assessed. Results demonstrate that macroporous El-I-PEG hydrogels support hMSCs and that this macroporous environment promotes a dramatic increase in BMP-2 expression by hMSCs. This upregulation of BMP-2 expression is associated by a more rapid hMSC differentiation, as measured by alkaline phosphatase expression. Altering hMSC interactions with the EH-PEG hydrogel surface, by the addition of fibronectin, did not appear to augment BMP-2 expression. We therefore speculate that EH-PEG hydrogel macroporosity facilitates autocrine and paracrine signaling by localizing endogenously expressed factors within the hydrogel's pores and thus promotes hMSC osteoblastic differentiation and bone regeneration.
C1 [Betz, Martha W.; Yeatts, Andrew B.; Richbourg, William J.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Caccamese, John F.; Coletti, Domenick P.; Fisher, John P.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Falco, Erin E.; Fisher, John P.] Univ Maryland, Sch Dent, Dept Oral & Maxillofacial Surg, Baltimore, MD 21201 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg 225, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012; Yeatts, Andrew/H-9344-2012
FU National Science Foundation [0448684]; State of Maryland
FX This work was supported by the National Science Foundation (CAREER Award
   to J.P.F., no. 0448684) and the State of Maryland, Maryland Stem Cell
   Research Fund.
CR Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640
   Betz MW, 2009, J BIOMED MATER RES A, V90A, P819, DOI 10.1002/jbm.a.32131
   Burnstine Michael A, 2003, Curr Opin Ophthalmol, V14, P236, DOI 10.1097/00055735-200310000-00002
   CALLISTER WD, 2005, FUNDAMENTALS MAT SCI, P1
   Chan ZSH, 2005, NEURAL PROCESS LETT, V21, P207, DOI 10.1007/s11063-005-1084-6
   CHEN C, 2010, P SPIE, V7566
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Donati L, 1997, INT SURG, V82, P325
   Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eski M, 2006, J CRANIOFAC SURG, V17, P1059, DOI 10.1097/01.scs.0000235111.92988.b2
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2004, J BIOMED MATER RES A, V68A, P428, DOI 10.1002/jbm.a.20073
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Fonseca RJ, 2000, ORAL MAXILLOFACIAL S, V3, P205
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Guo LK, 2008, J BIOMED MATER RES A, V87A, P903, DOI 10.1002/jbm.a.31834
   Haug RH, 1999, J ORAL MAXIL SURG, V57, P564, DOI 10.1016/S0278-2391(99)90076-9
   Hsu YY, 1997, J BIOMED MATER RES, V35, P107, DOI 10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Lee DH, 2006, TISSUE ENG, V12, P1577, DOI 10.1089/ten.2006.12.1577
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Manolidis S, 2002, J CRANIOFAC SURG, V13, P726, DOI 10.1097/01.SCS
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207
   Rinna C, 2005, J CRANIOFAC SURG, V16, P968, DOI 10.1097/01.scs.0000186308.16795.8b
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016
   Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Simon JL, 2003, J BIOMED MATER RES A, V66A, P275, DOI 10.1002/jbm.a.10569
   Singhatanadgit W, 2008, CELL BIOL INT, V32, P1362, DOI 10.1016/j.cellbi.2008.08.005
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 46
TC 47
Z9 49
U1 2
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2010
VL 11
IS 5
BP 1160
EP 1168
DI 10.1021/bm100061z
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 592DO
UT WOS:000277355800003
PM 20345129
DA 2018-10-20
ER

PT J
AU Sakai, S
   Matsuyama, T
   Hirose, K
   Kawakami, K
AF Sakai, Shinji
   Matsuyama, Tomohiro
   Hirose, Keisuke
   Kawakami, Koei
TI In Situ Simultaneous Protein-Polysaccharide Bioconjugation and
   Hydrogelation Using Horseradish Peroxidase
SO BIOMACROMOLECULES
LA English
DT Article
ID ALGINATE; MICROCAPSULES; GELATION; DEXTRAN; RELEASE;
   CARBOXYMETHYLCELLULOSE; BIOMATERIAL; ADHESION; MATRICES; H2O2
AB We propose the peroxidase-catalyzed simultaneous conjugation and hydrogelation of polysaccharide and protein derivatives, each possessing phenolic hydroxyl (Ph) moieties, as a novel route for obtaining protein polysaccharide conjugate hydrogels. We used alginate, gelatin, and albumin derivatives bearing Ph moieties (Alg-Ph, Gela-Ph, and Alb-Ph) to demonstrate the feasibility. The gelation time of conjugate gels decreased with decreasing H(2)O(2) concentration and with increasing horseradish peroxidase concentration. Gelation time was controllable from a few seconds to 6 min. The repulsion force detected at 40% compression of a conjugate gel obtained from a mixture of Alg-Ph and Gela-Ph at 1.0% (w/v), respectively, was more than 2.8 times larger than that detected for gels produced from 3.0% (w/v) Gela-Ph or 2.0% (w/v) Alg-Ph alone. Cell adhesiveness of gels was tunable by changing the type of protein derivative. A gel from Gela-Ph and Alg-Ph showed higher cell adhesiveness than Alg-Ph gel, but a gel produced from Alb-Ph and Alg-Ph showed a lower cell adhesiveness than Alg-Ph gel. The conjugate gel was degradable by degrading alginate molecules using the nonproteolytic enzyme alginate lyase. The tunable gelation, mechanical properties, and cell adhesiveness of polysaccharide protein conjugate hydrogels obtained through peroxidase-catalyzed gelation indicates great potential for a wide range of applications, such as scaffolds for tissue engineering and carriers for drug delivery system.
C1 [Sakai, Shinji] Osaka Univ, Div Chem Engn, Dept Mat Engn, Grad Sch Engn Sci, Osaka 5608531, Japan.
   [Matsuyama, Tomohiro; Hirose, Keisuke; Kawakami, Koei] Kyushu Univ, Fac Engn, Dept Chem Engn, Nishi Ku, Fukuoka 8190395, Japan.
RP Sakai, S (reprint author), Osaka Univ, Div Chem Engn, Dept Mat Engn, Grad Sch Engn Sci, 1-3 Machikaneyama Cho, Osaka 5608531, Japan.
EM sakai@cheng.es.osaka-u.ac.jp
RI Sakai, Shinji/F-9463-2016
OI Sakai, Shinji/0000-0002-1041-4798
FU Ministry of Education, Culture, Science, Sports and Technology of Japan
   [1956222]
FX This work was supported by a Grant-in-Aid for Exploratory Research (no.
   1956222, 2009) and a Grant-in-Aid for the Global COE Program, "Science
   for Future Molecular Systems", from the Ministry of Education, Culture,
   Science, Sports and Technology of Japan.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Begum S, 2003, BIOSCI BIOTECH BIOCH, V67, P1897, DOI 10.1271/bbb.67.1897
   Chen TH, 2002, BIOPOLYMERS, V64, P292, DOI 10.1002/bip.10196
   Diederix REM, 2003, INORG CHEM, V42, P7249, DOI 10.1021/ic0343861
   Fan LH, 2005, J APPL POLYM SCI, V96, P1625, DOI 10.1002/app.21610
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   HIRABAYASHI TN, 2009, BIOMATERIALS, V30, P4581
   Ito A, 2003, J BIOSCI BIOENG, V95, P196, DOI 10.1016/S1389-1723(03)80129-9
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   KATO A, 1990, AGR BIOL CHEM TOKYO, V54, P107, DOI 10.1080/00021369.1990.10869907
   Kato K, 2005, LANGMUIR, V21, P7071, DOI 10.1021/la050893e
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Lee F, 2008, SOFT MATTER, V4, P880, DOI 10.1039/b719557e
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu YX, 2009, BIOMATERIALS, V30, P196, DOI 10.1016/j.biomaterials.2008.09.041
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Ogushi Y, 2007, J BIOSCI BIOENG, V104, P30, DOI 10.1263/jbb.104.30
   Ogushi Y, 2009, MACROMOL BIOSCI, V9, P262, DOI 10.1002/mabi.200800263
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sakai S, 2010, ACTA BIOMATER, V6, P1446, DOI 10.1016/j.actbio.2009.10.004
   Sakai S, 2008, BIOTECHNOL BIOENG, V99, P235, DOI 10.1002/bit.21624
   Sakai S, 2007, BIOMACROMOLECULES, V8, P2622, DOI 10.1021/bm070300+
   Sakai S, 2007, ACTA BIOMATER, V3, P495, DOI 10.1016/j.actbio.2006.12.002
   Sakai S, 2009, BIOMATERIALS, V30, P5937, DOI 10.1016/j.biomaterials.2009.07.031
   Sakai S, 2009, J MATER CHEM, V19, P230, DOI 10.1039/b812086b
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   vanDeurzen MPJ, 1997, TETRAHEDRON, V53, P13183, DOI 10.1016/S0040-4020(97)00477-8
   Westhaus E, 2001, BIOMATERIALS, V22, P453, DOI 10.1016/S0142-9612(00)00200-3
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xiao CB, 2001, J MACROMOL SCI PURE, V38, P317, DOI 10.1081/MA-100103352
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
NR 35
TC 28
Z9 29
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2010
VL 11
IS 5
BP 1370
EP 1375
DI 10.1021/bm1001608
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 592DO
UT WOS:000277355800031
PM 20402496
DA 2018-10-20
ER

PT J
AU Wu, CT
   Zhang, YF
   Zhu, YF
   Friis, T
   Xiao, Y
AF Wu, Chengtie
   Zhang, Yufeng
   Zhu, Yufang
   Friis, Thor
   Xiao, Yin
TI Structure property relationships of silk-modified mesoporous bioglass
   scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Mesopore bioglass; Scaffold; Silk; Drug delivery; Cytocompatibility
ID CONTROLLED DRUG-RELEASE; IN-VITRO BIOACTIVITY; BIOLOGICAL-PROPERTIES;
   FIBROIN SCAFFOLDS; HUMAN OSTEOBLASTS; BONE; TITANIUM; CERAMICS; GLASSES;
   FILMS
AB Porous mesopore-bioglass (MBG) scaffolds have been proposed as a new class of bone regeneration materials due to their apatite-formation and drug-delivery properties; however, the material's inherent brittleness and high degradation and surface instability are major disadvantages, which compromise its mechanical strength and cytocompatibility as a biological scaffold. Silk, on the other hand, is a native biomaterial and is well characterized with respect to biocompatibility and tensile strength. In this study we set out to investigate what effects blending silk with MBG had on the physiochemical, drug-delivery and biological properties of MBG scaffolds with a view to bone tissue engineering applications. Transmission electron microscopy (TEM), scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR) were the methods used to analyze the inner microstructure, pore size and morphology, and composition of MBG scaffolds, before and after addition of silk. The effect of silk modification on the mechanical property of MBG scaffolds was determined by testing the compressive strength of the scaffolds and also compressive strength after degradation over time. The drug-delivery potential was evaluated by the release of dexamethasone (DEX) from the scaffolds. Finally, the cytocompatibility of silk-modified scaffolds was investigated by the attachment, morphology, proliferation, differentiation and bone-relative gene expression of bone marrow stromal cells (BMSCs). The results showed that silk modification improved the uniformity and continuity of pore network of MBG scaffolds, and maintained high porosity (94%) and large-pore size (200-400 mu m). There was a significant improvement in mechanical strength, mechanical stability, and control of burst release of DEX in silk-modified MBG scaffolds. Silk modification also appeared to provide a better environment for BMSC attachment, spreading, proliferation, and osteogenic differentiation on MBG scaffolds. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Wu, Chengtie; Zhang, Yufeng; Friis, Thor; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Zhang, Yufeng] Wuhan Univ, Minist Educ Key Lab Oral Biomed Engn, Sch Stormatol, Wuhan 430079, Peoples R China.
   [Zhu, Yufang] Natl Inst Mat Sci, ICYS Sengen, Tsukuba, Ibaraki 3050047, Japan.
RP Xiao, Y (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
EM yin.xiao@qut.edu.au
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827; Xiao, Yin/0000-0003-1785-3491
FU Queensland University of Technology [241402-0120/07, 241402-0126/07];
   NHMRC Exchange Fellowship and National Natural Science Foundation of
   China [30700948]
FX The authors would like to acknowledge the Vice-chancellor Fellowship
   (241402-0120/07) and Blue Box (241402-0126/07) of Queensland University
   of Technology (Dr Wu), NHMRC Exchange Fellowship and National Natural
   Science Foundation of China (30700948, Dr Zhang) for funding this
   research. We would like to thank Mr. Bill Kwiecien for assisting with
   the atomic emission spectrometer measurements.
CR Bertoldi C, 2008, BIOMATERIALS, V29, P1817, DOI 10.1016/j.biomaterials.2007.12.034
   Cai K, 2007, J BIOMED MATER RES A, V82A, P927, DOI 10.1002/jbm.a.31233
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Gibson LJ, 1999, CELLULAR SOLIDS STRU, P429
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   John A, 2003, J BIOMATER APPL, V18, P63, DOI 10.1177/088532803032826
   Jongpoiboonkit L, 2009, ADV MATER, V21, P1960, DOI 10.1002/adma.200801808
   Kang SW, 2008, J BIOMED MATER RES A, V85A, P747, DOI 10.1002/jbm.a.31572
   Kim HW, 2005, J MATER SCI-MATER M, V16, P189, DOI 10.1007/s10856-005-6679-y
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P240, DOI 10.1002/jbm.b.30038
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Li J, 2009, TISSUE ENG PT A, V15, P2481, DOI 10.1089/ten.TEA.2008.0463
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654
   Simmons A, 2008, BIOMATERIALS, V29, P2987, DOI 10.1016/j.biomaterials.2008.04.007
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wu CT, 2008, J BIOMED MATER RES A, V86A, P402, DOI 10.1002/jbm.a.31623
   Wu CT, 2008, ACTA BIOMATER, V4, P343, DOI 10.1016/j.actbio.2007.08.010
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Wu CT, 2007, J MATER SCI-MATER M, V18, P857, DOI [10.1007/s10856-006-0083-0, 10.1007/S10856-006-0083-0]
   Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598
   Zhang F, 2008, BIOMATERIALS, V29, P4751, DOI 10.1016/j.biomaterials.2008.08.043
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 35
TC 108
Z9 110
U1 6
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 13
BP 3429
EP 3438
DI 10.1016/j.biomaterials.2010.01.061
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 577WG
UT WOS:000276254100001
PM 20122721
DA 2018-10-20
ER

PT J
AU Chen, QZ
   Ishii, H
   Thouas, GA
   Lyon, AR
   Wright, JS
   Blaker, JJ
   Chrzanowski, W
   Boccaccini, AR
   Ali, NN
   Knowles, JC
   Harding, SE
AF Chen, Qi-Zhi
   Ishii, Hikaru
   Thouas, George A.
   Lyon, Alexander R.
   Wright, Jamie S.
   Blaker, Jonny J.
   Chrzanowski, Wojciech
   Boccaccini, Aldo R.
   Ali, Nadire N.
   Knowles, Jonathan C.
   Harding, Sian E.
TI An elastomeric patch derived from poly(glycerol sebacate) for delivery
   of embryonic stem cells to the heart
SO BIOMATERIALS
LA English
DT Article
DE Poly(glycerol sebacate); Embryonic stem cell; In vitro; In vivo; Heart
ID IN-VIVO; MYOCARDIAL TISSUE; INFARCTION; SCAFFOLDS; DEVICE; VITRO
AB We hypothesize that a combinatorial approach of ventricle constraint and stem cell therapy would offer a greater benefit for the treatment of heart failure than either strategy alone. A heart patch would serve two therapeutic purposes: biomechanical support and cell delivery. In this study, we describe a hybrid heart patch engineered from a synthetic elastomer, poly(glycerol sebacate) (PGS), supplemented with cardiomyocytes differentiated from human embryonic stem cells (hESCs). In line with two therapeutically relevant considerations, i.e. biocompatibility and cell delivery efficiency, the PGS was (a) preconditioned in culture medium for 6 days, and (b) prepared without gelatin coatings to facilitate detachment and delivery of cardiomyocytes following patch implantation. Following pre-conditioning under physiological conditions, the PGS patch material without gelatin coating was found to satisfactorily support cardiomyocyte viability and attachment, with active cell beating for periods of longer than 3 months until interrupted. Dynamic culture studies revealed that cells detached more efficiently from the uncoated surface of PGS than from gelatin-coated PGS. No significant differences were detected between the beating rates of human embryonic stem cell-derived cardiomyocytes on tissue culture plate and the pre-conditioned and gelatin-uncoated PGS. PGS patches sutured over the left ventricle of rats in vivo remained intact over a 2 week period without any deleterious effects on ventricular function. We conclude that PGS is a suitable biomaterial for stem cell-based regeneration strategies to restore cardiomyocyte function, and the hybrid heart patch engineered under optimal conditions would be a promising support device for the cardiac repair. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Chen, Qi-Zhi] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Ishii, Hikaru; Lyon, Alexander R.; Wright, Jamie S.; Ali, Nadire N.; Harding, Sian E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.
   [Thouas, George A.] Monash Univ, Div Biol Engn, Clayton, Vic 3800, Australia.
   [Blaker, Jonny J.] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Polymer & Composite Engn Grp, London SW7 2AZ, England.
   [Chrzanowski, Wojciech; Knowles, Jonathan C.] UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   [Boccaccini, Aldo R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
RP Chen, QZ (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM qizhi.chen@eng.monash.edu.au; sian.harding@imperial.ac.uk
RI Chrzanowski, Wojciech/B-5478-2010; Boccaccini, Aldo/C-7905-2013;
   Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446; Blaker,
   Jonny/0000-0003-1112-8619
FU UK Biotechnology and Biological Sciences Research Council (BBSRC)
   [BB/D011027/1]; Faculty of Engineering at Monash University;
   Biotechnology and Biological Sciences Research Council [BB/D011027/1];
   Medical Research Council [G0500373]
FX The authors would like to acknowledge financial support from the UK
   Biotechnology and Biological Sciences Research Council (BBSRC) (grant
   number BB/D011027/1). QZC would also like to acknowledge financial
   support from New Staff Research Grants and Small Research Grants of the
   Faculty of Engineering at Monash University.
CR Brito-Martins M, 2008, BRIT J PHARMACOL, V153, P751, DOI 10.1038/sj.bjp.0707619
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Das M, 2004, BIOMATERIALS, V25, P5643, DOI 10.1016/j.biomaterials.2004.01.020
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Eschenhagen T, 2005, J BIOTECHNOL, V118, pS65
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Luo E, 2006, SWISS MED WKLY, V136, P86
   Mann DL, 1998, CIRCULATION, V98, P2367, DOI 10.1161/01.CIR.98.22.2367
   Martin C, 1996, BIOMATERIALS, V17, P2373, DOI 10.1016/S0142-9612(96)00075-0
   Radisic M, 2005, J SERB CHEM SOC, V70, P541, DOI 10.2298/JSC0503541R
   Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X
   Walsh RG, 2005, HEART FAIL REV, V10, P101, DOI 10.1007/s10741-005-4637-x
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 18
TC 92
Z9 95
U1 3
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 14
BP 3885
EP 3893
DI 10.1016/j.biomaterials.2010.01.108
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 581RF
UT WOS:000276541300015
PM 20153041
DA 2018-10-20
ER

PT J
AU Gentleman, E
   Fredholm, YC
   Jell, G
   Lotfibakhshaiesh, N
   O'Donnell, MD
   Hill, RG
   Stevens, MM
AF Gentleman, Eileen
   Fredholm, Yann C.
   Jell, Gavin
   Lotfibakhshaiesh, Nasrin
   O'Donnell, Matthew D.
   Hill, Robert G.
   Stevens, Molly M.
TI The effects of strontium-substituted bioactive glasses on osteoblasts
   and osteoclasts in vitro
SO BIOMATERIALS
LA English
DT Article
DE Bioactive glass; Osteoblast; Osteoclast; Bone regeneration; Osteoporosis
ID CALCIUM-SENSING RECEPTOR; POSTMENOPAUSAL OSTEOPOROSIS; OSTEOGENIC
   SUPPLEMENTS; FETAL OSTEOBLASTS; BONE-RESORPTION; RANELATE;
   DIFFERENTIATION; FRACTURES; 45S5; BISPHOSPHONATES
AB Bioactive glasses (BC) which contain strontium have the potential to combine the known bone regenerative properties of BC with the anabolic and anti-catabolic effects of strontium cations. Here we created a BC series (SiO2-P2O5-Na2O-CaO) in which 0-100% of the calcium was substituted by strontium and tested their effects on osteoblasts and osteoclasts in vitro. We show that ions released from strontium-substituted BC enhance metabolic activity in osteoblasts. They also inhibit osteoclast activity by both reducing tartrate resistant acid phosphatase activity and inhibiting resorption of calcium phosphate films in a dose-dependent manner. Additionally, osteoblasts cultured in contact with BC show increased proliferation and alkaline phosphatase activity with increasing strontium substitution, while osteoclasts adopt typical resorption morphologies. These results suggest that similarly to the osteoporosis drug strontium ranelate, strontium-substituted BC may promote an anabolic effect on osteoblasts and an anti-catabolic effect on osteoclasts. These effects, when combined with the advantages of BC such as controlled ion release and delivery versatility, may make strontium-substituted BC an effective biomaterial choice for a range of bone regeneration therapies. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Gentleman, Eileen; Fredholm, Yann C.; Jell, Gavin; Lotfibakhshaiesh, Nasrin; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Gentleman, Eileen; Jell, Gavin; Lotfibakhshaiesh, Nasrin; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
   [O'Donnell, Matthew D.] BioCeram Therapeut Ltd, London SW7 2BP, England.
   [Hill, Robert G.] Queen Mary Univ London, Barts & London Sch Med & Dent, London E1 4NS, England.
RP Stevens, MM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
EM m.stevens@imperial.ac.uk
RI Jell, Gavin/C-4893-2009; O'Donnell, Matthew/A-6831-2011; Jell,
   Gavin/B-7855-2010
OI Gentleman, Eileen/0000-0003-0447-5137
FU UK Department of Trade and Industry
FX The authors wish to thank Dr. Morgan Mager for assistance with image
   processing, Ms. Sabrina Skeete for laboratory assistance and Mr. Nick
   Walters for help with ICP-OES. The authors acknowledge funding from the
   UK Department of Trade and Industry (now the Technology Strategy Board).
CR Baron R, 2002, EUR J PHARMACOL, V450, P11, DOI 10.1016/S0014-2999(02)02040-X
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Brennan TC, 2009, BRIT J PHARMACOL, V157, P1291, DOI 10.1111/j.1476-5381.2009.00305.x
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   Durie BGM, 2005, NEW ENGL J MED, V353, P99
   FREDHOLM Y, 2008, P 8 WORLD BIOM C 28
   Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x
   Gil-Albarova J, 2005, BIOMATERIALS, V26, P4374, DOI 10.1016/j.biomaterials.2004.11.006
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hurtel-Lemaire AS, 2009, J BIOL CHEM, V284, P575, DOI 10.1074/jbc.M801668200
   Jell G, 2008, J BIOMED MATER RES A, V86A, P31, DOI 10.1002/jbm.a.31542
   Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Jones JR, 2007, ELEMENTS, V3, P393, DOI 10.2113/GSELEMENTS.3.6.393
   Kaufmann EABE, 2000, TISSUE ENG, V6, P19, DOI 10.1089/107632700320856
   Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835
   MARIE PJ, 1993, J BONE MINER RES, V8, P607
   Mentaverri R, 2006, FASEB J, V20, P2562, DOI 10.1096/fj.06-6304fje
   Merolli A, 2000, J MATER SCI-MATER M, V11, P219, DOI 10.1023/A:1008912125171
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Pi M, 2004, J BONE MINER RES, V19, P862, DOI 10.1359/JBMR.040114
   Recker RR, 2009, J BONE MINER RES, V24, P1358, DOI [10.1359/jbmr.090315, 10.1359/JBMR.090315]
   Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461
   Russell RGG, 2007, PEDIATRICS, V119, pS150, DOI 10.1542/peds.2006-2023H
   Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Shapoff C A, 1997, Compend Contin Educ Dent, V18, P352
   Takahashi N, 2003, J BONE MINER RES, V18, P1082, DOI 10.1359/jbmr.2003.18.6.1082
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019
   Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
NR 35
TC 264
Z9 268
U1 11
U2 144
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 14
BP 3949
EP 3956
DI 10.1016/j.biomaterials.2010.01.121
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 581RF
UT WOS:000276541300022
PM 20170952
OA Green Published
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Thevenot, PT
   Nair, AM
   Shen, JH
   Lotfi, P
   Ko, CY
   Tang, LP
AF Thevenot, Paul T.
   Nair, Ashwin M.
   Shen, Jinhui
   Lotfi, Parisa
   Ko, Cheng-Yu
   Tang, Liping
TI The effect of incorporation of SDF-1 alpha into PLGA scaffolds on stem
   cell recruitment and the inflammatory response
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cell; Hematopoietic stem cells; Inflammation;
   Angiogenesis; Scaffold; Biocompatibility
ID ENDOTHELIAL PROGENITOR CELLS; FOREIGN-BODY REACTION; BONE-MARROW;
   MAST-CELLS; ENHANCED ANGIOGENESIS; MYOCARDIAL-INFARCTION; TISSUE
   REGENERATION; CONTROLLED-RELEASE; IN-VITRO; MIGRATION
AB Despite significant advances in the understanding of tissue responses to biomaterials, most implants are still plagued by inflammatory responses which can lead to fibrotic encapsulation. This is of dire consequence in tissue engineering, where seeded cells and bioactive components are separated from the native tissue, limiting the regenerative potential of the design. Additionally, these interactions prevent desired tissue integration and angiogenesis, preventing functionality of the design. Recent evidence supports that mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC) can have beneficial effects which alter the inflammatory responses and improve healing. The purpose of this study was to examine whether stem cells could be targeted to the site of biomaterial implantation and whether increasing local stern cell responses could improve the tissue response to PLGA scaffold implants. Through incorporation of SDF-1 alpha, through factor adsorption and mini-osmotic pump delivery, the host-derived stem cell response can be improved resulting in 3X increase in stem cell populations at the interface for up to 2 weeks. These interactions were found to significantly alter the acute mast cell responses, reducing the number of mast cells and degranulated mast cells near the scaffold implants. This led to subsequent downstream reduction in the inflammatory cell responses, and through altered mast cell activation and stern cell participation, increased angiogenesis and decreased fibrotic responses to the scaffold implants. These results support that enhanced recruitment of autologous stem cells can improve the tissue responses to biomaterial implants through modifying/bypassing inflammatory cell responses and jumpstarting stem cell participation in healing at the implant interface. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Thevenot, Paul T.; Nair, Ashwin M.; Shen, Jinhui; Lotfi, Parisa; Ko, Cheng-Yu; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIH [RO1 E8007271]
FX This work was supported by NIH grant RO1 E8007271.
CR Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF
   Abramoff MD, 2004, BIOPHOTON INT, V11, P36
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Belot MP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1410, DOI 10.1152/ajpendo.00286.2006
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Chen L., 2008, PLOS ONE
   Copland IB, 2009, STEM CELLS, V27, P467, DOI 10.1634/stemcells.2008-0520
   Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503
   El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860
   Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803
   Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504
   Godot V, 2007, J ALLERGY CLIN IMMUN, V120, P827, DOI 10.1016/j.jaci.2007.05.046
   Greco KV, 2006, EUR J PHARMACOL, V551, P131, DOI 10.1016/j.ejphar.2006.08.090
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354
   Hohlbaum AM, 2002, CLIN IMMUNOL, V103, P1, DOI 10.1006/clim.2001.5165
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   LANDGRAEBER S, BIOMATERIALS, V29, P3444
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lin TJ, 2000, J IMMUNOL, V165, P211, DOI 10.4049/jimmunol.165.1.211
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mountziaris PM, 2008, TISSUE ENG PT B-REV, V14, P179, DOI 10.1089/ten.teb.2008.0038
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   NAIR A, 2009, TISSUE ENG C
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Pietrzak A, 2009, IMMUNOL LETT, V123, P46, DOI 10.1016/j.imlet.2009.02.003
   Reimold AM, 2003, AM J MED SCI, V325, P75, DOI 10.1097/00000441-200302000-00005
   Sales V. L., 2006, CIRCULATION, V114, P1193
   Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942
   Seitz S, 2007, TISSUE ENG, V13, P1059, DOI 10.1089/ten.2006.0334
   Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200
   Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood2004-09-3507
   Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221
   Vranken I, 2008, BIOMATERIALS, V29, P797, DOI 10.1016/j.biomaterials.2007.10.041
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Xie YS, 2009, WOUND REPAIR REGEN, V17, P326, DOI 10.1111/j.1524-475X.2009.00480.x
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
NR 47
TC 145
Z9 151
U1 2
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 14
BP 3997
EP 4008
DI 10.1016/j.biomaterials.2010.01.144
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 581RF
UT WOS:000276541300027
PM 20185171
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shi, M
   Kretlow, JD
   Nguyen, A
   Young, S
   Baggett, LS
   Wong, ME
   Kasper, FK
   Mikos, AG
AF Shi, Meng
   Kretlow, James D.
   Nguyen, Anson
   Young, Simon
   Baggett, L. Scott
   Wong, Mark E.
   Kasper, F. Kurtis
   Mikos, Antonios G.
TI Antibiotic-releasing porous polymethylmethacrylate constructs for
   osseous space maintenance and infection control
SO BIOMATERIALS
LA English
DT Article
DE Bone tissue engineering; Scaffolds; Biodegradable microspheres;
   Polymethylmethacrylate; Carboxymethylcellulose; Colistin
ID NEGATIVE BACTERIAL-INFECTIONS; OF-THE-ART; BONE-CEMENT; ACRYLIC CEMENT;
   GUNSHOT WOUNDS; MANDIBULAR RECONSTRUCTION; POLYMER SCAFFOLDS;
   CALCIUM-PHOSPHATE; DISK DIFFUSION; FIBROUS TISSUE
AB The use of a strategy involving space maintenance as the initial step of a two-stage regenerative medicine approach toward reconstructing significant bony or composite tissue defects in the craniofacial area, preserves the void volume of bony defects and could promote soft tissue healing prior to the subsequent definitive repair. One of the complications with a biomaterial-based space maintenance approach is local infection, which requires early, effective eradication, ideally through local antibiotic delivery. The purpose of this study is to develop a dual function implant material for maintaining osseous space and releasing an antibiotic to eliminate local infection in bony defects. Colistin, a polymyxin antibiotic, was chosen specifically to address infections with Acinetobacter species, the most common pathogen associated with combat-related traumatic craniofacial injuries. Porous polymethylmethacrylate (PMMA) constructs incorporating poly(lactic-co-glycolic acid) (PLGA) microspheres were fabricated by mixing a clinically used bone cement formulation of PMMA powder and methylmethacrylate liquid with a carboxymethylcellulose (CMC) hydrogel (40 or 50 wt%) to impart porosity and PLGA microspheres (10 or 15 wt%) loaded with colistin to control drug release. The PMMA/CMC/PLGA construct featured mild setting temperature, controllable surface/bulk porosity by incorporation of the CMC hydrogel, reasonably strong compressive properties, and continuous drug release over a period of 5 weeks with total drug release of 68.1-88.3%, depending on the weight percentage of CMC and PLGA incorporation. The concentration of released colistin was well above its reported minimum inhibitory concentration against susceptible species for 5 weeks. This study provides information on the composition parameters that enable viable porosity characteristics/drug release kinetics of the PMMA/CMC/PLGA construct for the initial space maintenance as part of a two-stage regenerative medicine approach. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Shi, Meng; Kretlow, James D.; Young, Simon; Kasper, F. Kurtis; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   [Nguyen, Anson] Univ Texas Med Branch, Sch Med, Galveston, TX USA.
   [Young, Simon; Wong, Mark E.] Univ Texas Hlth Sci Ctr Houston, Dept Oral & Maxillofacial Surg, Houston, TX USA.
   [Baggett, L. Scott] Rice Univ, Dept Stat, Houston, TX 77251 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, MS 142,POB 1892, Houston, TX 77251 USA.
EM mikos@rice.edu
RI Kasper, Fred/H-5719-2011
OI Young, Simon/0000-0002-8198-7083
FU Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0032];
   Baylor College of Medicine [NIH T32 GM07330]; Rice Institute of
   Biosciences and Bioengineering [NIH T32 GM008362]; Gulf Coast Consortia
   (NIH) [5 T90 DK070121-04]
FX This work was supported by a grant from the Armed Forces Institute of
   Regenerative Medicine (W81XWH-08-2-0032). JDK acknowledges support from
   the Baylor College of Medicine Medical Scientist Training Program (NIH
   T32 GM07330), Rice Institute of Biosciences and Bioengineering's
   Biotechnology Training Grant (NIH T32 GM008362), and a training
   fellowship from the Keck Center Nanobiology Training Program of the Gulf
   Coast Consortia (NIH Grant No. 5 T90 DK070121-04). The authors also
   thank Dr. Nagi Demian for stimulating discussions and technical
   assistance.
CR Akhlaghi F, 1997, J ORAL MAXIL SURG, V55, P927, DOI 10.1016/S0278-2391(97)90060-4
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Barralet JE, 2002, J BIOMED MATER RES, V63, P1, DOI 10.1002/jbm.1074
   Behnia H, 1997, J CRANIO MAXILL SURG, V25, P220, DOI 10.1016/S1010-5182(97)80079-0
   BENOIST M, 1978, J MAXILLOFAC SURG, V6, P40, DOI 10.1016/S0301-0503(78)80067-8
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   Boger A, 2008, J BIOMAT SCI-POLYM E, V19, P1125, DOI 10.1163/156856208785540154
   Bruens ML, 2003, J CRANIOFAC SURG, V14, P63, DOI 10.1097/00001665-200301000-00011
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Crane DP, 2009, J ORTHOP RES, V27, P1008, DOI 10.1002/jor.20847
   DEWIJN JR, 1976, J BIOMED MATER RES, V10, P625, DOI 10.1002/jbm.820100419
   Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Frutos P, 2002, BIOMATERIALS, V23, P3787, DOI 10.1016/S0142-9612(02)00028-5
   Galani I, 2008, INT J ANTIMICROB AG, V31, P434, DOI 10.1016/j.ijantimicag.2008.01.011
   Goodger NM, 2005, J ORAL MAXIL SURG, V63, P1048, DOI 10.1016/j.joms.2005.03.024
   GRUSS JS, 1991, PLAST RECONSTR SURG, V87, P436, DOI 10.1097/00006534-199103000-00008
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hartman EHM, 2004, BIOMATERIALS, V25, P5831, DOI 10.1016/j.biomaterials.2004.01.039
   Hospenthal DR, 2009, J TRAUMA, V66, pS120, DOI 10.1097/TA.0b013e31819cdd96
   International Standard, 2002, ISO5833
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   KARAGEORGOPOULO.DE, 2008, LANCET INFECT DIS, V12, P751
   KIHTIR T, 1993, J TRAUMA, V35, P569, DOI 10.1097/00005373-199310000-00012
   Kline T, 2001, J PEPT RES, V57, P175, DOI 10.1111/j.1399-3011.2001.00835.x
   Koshima I, 2004, PLAST RECONSTR SURG, V113, P101, DOI 10.1097/01.PRS.0000090725.89401.DE
   KRETLOW JD, 2009, ADV MATER, V2, P3368
   KRETLOW JD, TISSUE ENG C UNPUB
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Li J, 2001, ANTIMICROB AGENTS CH, V45, P781, DOI 10.1128/AAC.45.3.781-785.2001
   Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   LIU JK, 2004, NEUROSURG FOCUS
   Lo-Ten-Foe JR, 2007, ANTIMICROB AGENTS CH, V51, P3726, DOI 10.1128/AAC.01406-06
   Mader JT, 1997, ANTIMICROB AGENTS CH, V41, P415, DOI 10.1128/AAC.41.2.415
   MESTIRI M, 1995, J CONTROL RELEASE, V33, P107, DOI 10.1016/0168-3659(94)00077-8
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Naraharisetti PK, 2005, J CONTROL RELEASE, V102, P345, DOI 10.1016/j.jconrel.2004.10.016
   Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003
   Rodriguez ED, 2006, J CRANIOFAC SURG, V17, P883, DOI 10.1097/01.scs.0000221522.03164.33
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170
   Sebeny PJ, 2008, CLIN INFECT DIS, V47, P444, DOI 10.1086/590568
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Stevens CM, 2005, J ORTHOP RES, V23, P27, DOI 10.1016/j.orthres.2004.03.003
   Suominen E, 2001, CLIN PLAST SURG, V28, P323
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   THORNE CH, 1992, CLIN PLAST SURG, V19, P233
   VAANDRAGER JM, 1983, BIOMATERIALS, V4, P128, DOI 10.1016/0142-9612(83)90053-4
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   VANMULLEM PJ, 1990, BIOMATERIALS, V11, P299, DOI 10.1016/0142-9612(90)90105-Y
   VANMULLEM PJ, 1988, ANN PLAS SURG, V21, P576, DOI 10.1097/00000637-198812000-00015
   Virto MR, 2003, BIOMATERIALS, V24, P79, DOI 10.1016/S0142-9612(02)00254-5
   Wang GH, 2004, INT J PHARM, V273, P203, DOI 10.1016/j.ijpharm.2004.01.010
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Young S, 2008, J BIOMED MATER RES A, V86A, P182, DOI 10.1002/jbm.a.31639
   Yun HC, 2008, J TRAUMA, V64, pS163, DOI 10.1097/TA.0b013e318160868c
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 60
TC 69
Z9 69
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 14
BP 4146
EP 4156
DI 10.1016/j.biomaterials.2010.01.112
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 581RF
UT WOS:000276541300044
PM 20153893
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yen, CM
   Chan, CC
   Lin, SJ
AF Yen, Chien-Mei
   Chan, Chih-Chieh
   Lin, Sung-Jan
TI High-throughput reconstitution of epithelial-mesenchymal interaction in
   folliculoid microtissues by biomaterial-facilitated self-assembly of
   dissociated heterotypic adult cells
SO BIOMATERIALS
LA English
DT Article
DE Hair follicle regeneration; Epithelial organ; Collective movement;
   Aggregation; Organ germ
ID HAIR FOLLICLE DEVELOPMENT; DERMAL PAPILLA CELLS; EMBRYONIC RAT SKIN;
   STEM-CELLS; BRANCHING MORPHOGENESIS; SUBSTRATUM ADHESIVITY; MELANOCYTE
   SPHEROIDS; COMPLEX TISSUES; REGENERATION; MECHANISMS
AB The aim of this study was to develop a method for efficient production of folliculoid keratinocyte-dermal papilla (DP) microtissues to facilitate epithelial-mesenchymal interaction. The behavior of DP cells and adult keratinocytes from hairless skin on poly(ethylene-co-vinyl alcohol) (EVAL) surface was investigated. Keratinocytes, poorly adherent both to substrate and between homotypic cells, become suspended disperse cells after homotypic cell seeding. Seeded simultaneously, keratinocytes and DP cells are able to aggregate into spheroidal microtissues. Dynamical analysis shows that DP cells act as a carrier in the process due to the heterotypic intercellular adhesion. DP cells attach faster to EVAL and start to aggregate. Keratinocytes adhere to DP cells and are then carried by DP cells to form initial hybrid aggregates. Due to the high motility of DP cells, these hybrid aggregates move collectively as clusters and merge into larger spheroids which subsequently detach from the substratum and can be easily collected. Compared with random cell distribution in spheroids generated in hanging drops, these hybrid spheroids have a preferential compartmented core-shell structure: an aggregated DP cell core surrounded by a keratinocyte shell. In addition to ameliorated DP signature gene expression, keratinocytes show down-regulated epidermal terminal differentiation and enhanced follicular differentiation. Functionally, these microtissues are able to grow hairs in vivo. This work sheds light on the complex effects and dynamics of cell-cell and cell-substratum interaction in the patterning of heterotypic cells into tissue forms and is of potential to be applied to mass generation of other epithelial organ primordia in vitro. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Yen, Chien-Mei; Chan, Chih-Chieh; Lin, Sung-Jan] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 100, Taiwan.
   [Yen, Chien-Mei; Chan, Chih-Chieh; Lin, Sung-Jan] Natl Taiwan Univ, Coll Engn, Taipei 100, Taiwan.
   [Chan, Chih-Chieh; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100, Taiwan.
RP Lin, SJ (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med, 1 Sec 1,Jen Ai Rd, Taipei 100, Taiwan.
EM drsjlin@ntu.edu.tw
OI Lin, Sung-Jan/0000-0003-1325-3464
FU National Science Council, Taiwan [NSC98-2627-B-002-005]; National Taiwan
   University Hospital [99S-1277, VN99-13]
FX The authors thank Cheng-Ming Chuong (University of Southern California)
   for critical reading of this manuscript. We are grateful to Junetai Wu,
   Hsien-Ching Chiu and Tai-Horng Young (National Taiwan University) for
   their valuable discussions and encouragement. We also thank Mr. Ji-Ying
   Huang for his assistance in time-lapse microscopy. The experiments and
   data analysis of time-lapse microscopy were performed in part through
   the use of the Cell Imaging Center in the Second Core Laboratory of
   National Taiwan University Hospital. This work is partly supported by
   research grants from National Science Council, Taiwan
   (NSC98-2627-B-002-005) and National Taiwan University Hospital
   (99S-1277, VN99-13).
CR Atala A, 2005, EXPERT OPIN BIOL TH, V5, P879, DOI 10.1517/14712598.5.7.879
   Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Ehama R, 2007, J INVEST DERMATOL, V127, P2106, DOI 10.1038/sj.jid.5700823
   Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/i.devcel.2008.03.003
   Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Havlickova B, 2009, J INVEST DERMATOL, V129, P972, DOI 10.1038/jid.2008.315
   Hogan BLM, 1998, CURR OPIN GENET DEV, V8, P481, DOI 10.1016/S0959-437X(98)80121-4
   Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039
   IHARA S, 1991, CELL TISSUE RES, V266, P65, DOI 10.1007/BF00678712
   Ingber DE, 2007, DEVELOPMENT, V134, P2541, DOI 10.1242/dev.003707
   Ishida-Yamamoto A, 2002, HISTOL HISTOPATHOL, V17, P331, DOI 10.14670/HH-17.331
   Kang IK, 2004, BIOMATERIALS, V25, P4225, DOI 10.1016/j.biomaterials.2003.11.004
   Kelm JM, 2004, TRENDS BIOTECHNOL, V22, P195, DOI 10.1016/j.tibtech.2004.02.002
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336
   Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361
   Lee LF, 2009, J INVEST DERMATOL, V129, P815, DOI 10.1038/jid.2008.434
   Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI [10.1089/ten.teb.2008.0575, 10.1089/ten.TEB.2008.0575]
   Lichti U, 1993, J INVEST DERMATOL, V101, P124
   Lin SJ, 2006, BIOMATERIALS, V27, P1462, DOI 10.1016/j.biomaterials.2005.08.031
   Lin SJ, 2005, BIOMATERIALS, V26, P1413, DOI 10.1016/j.biomaterials.2004.05.002
   Lin SJ, 2006, BIOMATERIALS, V27, P5079, DOI 10.1016/j.biomaterials.2006.05.035
   McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x
   Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x
   Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012
   Neelamegham S, 1997, BIOPHYS J, V72, P51, DOI 10.1016/S0006-3495(97)78646-6
   Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466
   OHYAMA M, 2009, EXP DERMATOL
   OLIVER R F, 1970, Journal of Embryology and Experimental Morphology, V23, P219
   Osada A, 2007, TISSUE ENG, V13, P975, DOI 10.1089/ten.2006.0304
   Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021
   Philpott MP, 1998, MOL BASIS EPITHELIAL, P75
   Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7
   Powers MJ, 1997, BIOTECHNOL BIOENG, V53, P415, DOI 10.1002/(SICI)1097-0290(19970220)53:4<415::AID-BIT10>3.0.CO;2-F
   Qiao JZ, 2008, REGEN MED, V3, P683, DOI 10.2217/17460751.3.5.683
   Rao KS, 1996, CELL BIOL INT, V20, P261
   Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331
   REYNOLDS AJ, 1992, DEVELOPMENT, V115, P587
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Rivron NC, 2009, BIOMATERIALS, V30, P4851, DOI 10.1016/j.biomaterials.2009.06.037
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002
   STEINBERG MS, 1962, SCIENCE, V137, P762, DOI 10.1126/science.137.3532.762
   STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206
   Stenn KS, 2005, CURR OPIN BIOTECH, V16, P493, DOI 10.1016/j.copbio.2005.08.002
   Takeda A, 1998, SCAND J PLAST RECONS, V32, P359, DOI 10.1080/02844319850158435
   Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123
   Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616
   YANG CC, 2009, J DERMATOL SCI
   Young TH, 2008, BIOMATERIALS, V29, P3521, DOI 10.1016/j.biomaterials.2008.05.013
   Young TH, 2009, BIOMATERIALS, V30, P5031, DOI 10.1016/j.biomaterials.2009.05.065
   Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x
NR 57
TC 35
Z9 36
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 15
BP 4341
EP 4352
DI 10.1016/j.biomaterials.2010.02.014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 586SH
UT WOS:000276932600011
PM 20206989
DA 2018-10-20
ER

PT J
AU Shin, SJ
   Tuinstra, HM
   Salvay, DM
   Shea, LD
AF Shin, Seungjin
   Tuinstra, Hannah M.
   Salvay, David M.
   Shea, Lonnie D.
TI Phosphatidylserine immobilization of lentivirus for localized gene
   transfer
SO BIOMATERIALS
LA English
DT Article
DE Lentivirus; Phosphatidylserine; Poly(lactide-co-glycolide); Regenerative
   medicine
ID SPINAL-CORD; DNA DELIVERY; TRANSGENE EXPRESSION; NERVOUS-SYSTEM;
   IN-VIVO; SCAFFOLDS; REGENERATION; THERAPY; VECTOR; LESION
AB Localized and efficient gene transfer can be promoted by exploiting the interaction between the vector and biomaterial. Regulation of the vector-material interaction was investigated by capitalizing on the binding between lentivirus and phosphatidylserine (PS), a component of the plasma membrane. PS was incorporated into microspheres composed of the copolymers of lactide and glycolide (PLG) using an emulsion process. Increasing the weight ratio of PS to PLC led to a greater incorporation of PS. Lentivirus, but not adenovirus, associated with PS-PLC microspheres, and binding was specific to PS relative to PLC alone or PLC modified with phosphatidylcholine. Immobilized lentivirus produced large numbers of transduced cells, and increased transgene expression relative to virus alone. Microspheres were subsequently formed into porous tissue engineering scaffolds, with retention of lentivirus binding. Lentivirus immobilization resulted in long-term and localized expression within a subcutaneously implanted scaffold. Microspheres were also formed into multiple channel bridges for implantation into the spinal cord. Lentivirus delivery from the bridge produced maximal expression at the implant and a gradient of expression rostrally and caudally. This specific binding of lentiviral vectors to biomaterial scaffolds may provide a versatile tool for numerous applications in regenerative medicine or within model systems that investigate tissue development. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Shin, Seungjin; Tuinstra, Hannah M.; Salvay, David M.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIH [R01 EB005678, RO1 EB003806]
FX Financial support for this research was provided by grants from NIH (R01
   EB005678 and RO1 EB003806).
CR BONDI A, 1982, HISTOCHEMISTRY, V76, P153, DOI 10.1007/BF00501918
   Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x
   Carneiro FA, 2002, J VIROL, V76, P3756, DOI 10.1128/JVI.76.8.3756-3764.2002
   Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Dull T, 1998, J VIROL, V72, P8463
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Guo T, 2006, BIOMATERIALS, V27, P1095, DOI 10.1016/j.biomaterials.2005.08.015
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006
   Hu WW, 2008, J GENE MED, V10, P1102, DOI 10.1002/jgm.1233
   Itaka K, 2007, MOL THER, V15, P1655, DOI 10.1038/sj.mt.6300218
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Kasparov S, 2007, NAT METHODS, V4, P379, DOI 10.1038/nmeth0507-379a
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   SHIN S, 2009, J BIOMED MAT RES A
   STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
NR 27
TC 25
Z9 27
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 15
BP 4353
EP 4359
DI 10.1016/j.biomaterials.2010.02.013
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 586SH
UT WOS:000276932600012
PM 20206382
OA Green Accepted
DA 2018-10-20
ER

PT J
AU King, VR
   Alovskaya, A
   Wei, DYT
   Brown, RA
   Priestley, JV
AF King, Von R.
   Alovskaya, Alla
   Wei, Diana Y. T.
   Brown, Robert A.
   Priestley, John V.
TI The use of injectable forms of fibrin and fibronectin to support axonal
   ingrowth after spinal cord injury
SO BIOMATERIALS
LA English
DT Article
DE Fibrin; Fibronectin; Spinal surgery; Nerve tissue engineering
ID MESENCHYMAL STEM-CELLS; ADULT-RAT; FUNCTIONAL RECOVERY; PLASMA
   FIBRONECTIN; BRAIN-INJURY; REGENERATION; IMPLANTS; GUIDANCE; GROWTH;
   REPAIR
AB Many studies have described biomaterial devices (conduits and scaffolds) that can be implanted into experimental lesions and which support axonal growth. However, a disadvantage of such pre-formed devices is that tissue needs to be excised to allow their insertion. In this study we have therefore examined four biomaterials that can be injected into an injury site and which gel in situ; namely collagen, viscous fibronectin, fibrin, and fibrin + fibronectin (FB/FN). The materials were tested in an experimental knife-cut cavity in the rat spinal cord, and evaluated at 1 week and 4 weeks survival for their biocompatibility, neuroprotective efficacy, and permissiveness for axonal growth. At one week, all four materials showed good integration with the host spinal cord and supported some degree of axonal ingrowth, which was associated with infiltration of Schwann cells and deposition of laminin. However axon growth in the collagen implants was uneven because implants contained dense inclusions which were not penetrated by axons. At 4 weeks, axon growth was greatest in the fibronectin and FB/FN implants, however the fibronectin implants had large cavities at the interface between the implant and host spinal cord. The fibronectin implants also had fewer surviving neurons in the intact spinal cord adjoining the implant site. The FB/FN mixture thus had the best combination of properties in that it was easy to handle, integrated with the host spinal cord tissue, and supported robust growth of axons. It therefore has promise as an injectable biomaterial for filling cavities at spinal cord injury sites. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [King, Von R.; Wei, Diana Y. T.; Priestley, John V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Neurosci & Trauma, London E1 2AT, England.
   [Alovskaya, Alla; Brown, Robert A.] Univ Coll London, Inst Orthopaed, Tissue Repair & Engn Ctr, Stanmore HA7 4LP, Middx, England.
RP Priestley, JV (reprint author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Neurosci & Trauma, 4 Newark St, London E1 2AT, England.
EM j.v.priestley@qmul.ac.uk
FU Biotechnology and Biological Sciences Research Council (BBSRC, UK);
   Biotechnology and Biological Sciences Research Council [BB/C513893/1]
FX This work was supported by a grant from the Biotechnology and Biological
   Sciences Research Council (BBSRC, UK).
CR Brodbelt AR, 2003, J CLIN NEUROSCI, V10, P401, DOI 10.1016/S0967-5868(02)00326-0
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   DELATORRE JC, 1984, EXP NEUROL, V84, P188, DOI 10.1016/0014-4886(84)90015-3
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   GOLDSMITH HS, 1992, BRAIN RES, V589, P217, DOI 10.1016/0006-8993(92)91280-R
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hejcl A, 2010, STEM CELLS DEV
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Jeon O, 2005, J CONTROL RELEASE, V105, P249, DOI 10.1016/j.jconrel.2005.03.023
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Khatun F, 2007, TISSUE ENG, V13, P1697
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Milner R, 1997, DEV BIOL, V185, P215, DOI 10.1006/dbio.1997.8547
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Petter-Puchner AH, 2007, EXP TOXICOL PATHOL, V58, P237, DOI 10.1016/j.etp.2006.07.004
   Rosenzweig ES, 2004, CURR OPIN NEUROL, V17, P121, DOI 10.1097/01.wco.0000124700.48483.5d
   Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041
   Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471
   Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Wirth ED, 2001, J NEUROTRAUM, V18, P911, DOI 10.1089/089771501750451839
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Woerly S, 2000, NEUROSURG REV, V23, P59
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhao LR, 2005, BRAIN RES, V1054, P1, DOI 10.1016/j.brainres.2005.04.056
NR 33
TC 60
Z9 63
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2010
VL 31
IS 15
BP 4447
EP 4456
DI 10.1016/j.biomaterials.2010.02.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 586SH
UT WOS:000276932600023
PM 20206381
DA 2018-10-20
ER

PT J
AU Ittah, S
   Barak, N
   Gat, U
AF Ittah, Shmulik
   Barak, Noaa
   Gat, Uri
TI A Proposed Model for Drag line Spider Silk Self-Assembly: Insights from
   the Effect of the Repetitive Domain Size on Fiber Progenies
SO BIOPOLYMERS
LA English
DT Article
DE spider dragline silk; self-assembly; synthetic protein; baculovirus;
   nano fibrils
ID CONSERVED C-TERMINI; EUPROSTHENOPS-AUSTRALIS; PROTEINS; GENE;
   EXPRESSION; SEQUENCE; ORIENTATION; SPIDROINS
AB Dragline spider silk has been intensively studied for its superior qualities as a biomaterial. In previous studies, we made use of the baculovirus mediated expression system for the production of a recombinant Araneus diadematus spider silk dragline ADF4 protein and its self-assembly into intricate fibers in host insect cells. In this study, our aim was to explore the function of the major repetitive domain of the dragline spider silk. Thus, we generated an array of synthetic proteins, each containing a different number of identical repeats up to the largest recombinantly expressed spider silk to date. Study of the self-assembly properties of these proteins showed that depending on the increasing number of repeats they give rise to different assembly phenotypes, from a fully soluble protein to bona fide fibers with superior qualities. The different assembly forms, the corresponding chemical resistance properties obtained as well as ultrastructural studies, revealed novel insights concerning the structure and intermolecular interactions of the repetitive and nonrepetitive domains. Based on these observations and current knowledge in the field, we hereby present a comprehensive hypothetical model for the mechanism of dragline silk self-assembly and fiber formation. (C) 2009 Wiley Periodicals, Inc. Biopolymers 93: 458-468, 2010.
C1 [Ittah, Shmulik; Barak, Noaa; Gat, Uri] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.
RP Gat, U (reprint author), Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Alexander Silberman Inst Life Sci, Edmond Safra Campus Givat Ram, IL-91904 Jerusalem, Israel.
EM gatu@vms.huji.ac.il
CR Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   BECK L, 1974, Zeitschrift fuer Tierpsychologie, V35, P173
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   CRAIG CL, 2003, SPIDERWEBS SILK
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hinman M., 1992, Results and Problems in Cell Differentiation, V19, P227
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Ittah S, 2007, BIOMACROMOLECULES, V8, P2768, DOI 10.1021/bm7004559
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Sponner A, 2004, BIOMACROMOLECULES, V5, P840, DOI 10.1021/bm034378b
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Winkler S, 2000, J Biotechnol, V74, P85
NR 38
TC 13
Z9 13
U1 4
U2 23
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD MAY
PY 2010
VL 93
IS 5
BP 458
EP 468
DI 10.1002/bip.21362
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 574QQ
UT WOS:000276007700007
PM 20014164
DA 2018-10-20
ER

PT J
AU Suck, K
   Roeker, S
   Diederichs, S
   Anton, F
   Sanz-Herrera, JA
   Ochoa, I
   Doblare, M
   Scheper, T
   van Griensven, M
   Kasper, C
AF Suck, Kirstin
   Roeker, Stefanie
   Diederichs, Solvig
   Anton, Fabienne
   Sanz-Herrera, Jose A.
   Ochoa, Ignacio
   Doblare, Manuel
   Scheper, Thomas
   van Griensven, Martijn
   Kasper, Cornelia
TI A Rotating Bed System Bioreactor Enables Cultivation of Primary
   Osteoblasts on Well-Characterized Sponceram (R) Regarding Structural and
   Flow Properties
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE Sponceram (R); rotating bed system; primary osteoblasts; biomechanics;
   Young's modulus
ID TISSUE-ENGINEERING APPLICATIONS; FOCAL ADHESIONS; FLUID-FLOW; BONE;
   SCAFFOLDS; CELL; DESIGN; BIOMECHANICS; BIOMATERIAL; PERMEABILITY
AB The development of bone tissue engineering depends on the availability of suitable biomaterials, a well-defined and controlled bioreactor system, and on the use of adequate cells. The biomaterial must fulfill chemical, biological, and mechanical requirements. Besides biocompatibility, the structural and flow characteristics of the biomaterial are of utmost importance for a successful dynamic cultivation of osteoblasts, since fluid percolation within the microstructure must be assured to supply to cells nutrients and waste removal. Therefore, the biomaterial must consist of a three-dimensional structure, exhibit high porosity and present an interconnected porous network. Sponceram (R), a ZrO(2) based porous ceramic, is characterized in the presented work with regard to its microstructural design. Intrinsic permeability is obtained through a standard Darcy's experiment, while Young's modulus is derived from a two plates stress strain test in the linear range. Furthermore, the material is applied for the dynamic cultivation of primary osteoblasts in a newly developed rotating bed bioreactor. (C) 2010 American Institute of Chemical Engineers Biotechnol. Prog., 26: 671-678, 2010
C1 [Suck, Kirstin; Roeker, Stefanie; Diederichs, Solvig; Anton, Fabienne; Scheper, Thomas; Kasper, Cornelia] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany.
   [Sanz-Herrera, Jose A.; Ochoa, Ignacio; Doblare, Manuel] Univ Zaragoza, GEMM Dpto Ingn Mecan, Zaragoza 50018, Spain.
   [van Griensven, Martijn] Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
RP Kasper, C (reprint author), Leibniz Univ Hannover, Inst Tech Chem, Callinstr 5, D-30167 Hannover, Germany.
EM kasper@iftc.uni-hannover.de
RI Scheper, Thomas/H-8143-2013; Sanz-Herrera, Jose/E-6598-2010; Diederichs,
   Solvig/T-9240-2017; van Griensven, Martijn/F-5808-2012; Ochoa,
   Ignacio/G-8776-2015
OI Sanz-Herrera, Jose/0000-0001-8371-3820; Diederichs,
   Solvig/0000-0002-2527-9517; van Griensven, Martijn/0000-0001-5104-9881;
   Ochoa, Ignacio/0000-0003-2410-5678; /0000-0001-8741-6452
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   Anton F, 2008, BIOTECHNOL PROGR, V24, P140, DOI 10.1021/bp070241b
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   BEAUDOIN AJ, 1991, J BIOMECH, V24, P127, DOI 10.1016/0021-9290(91)90357-S
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   Brigido-Diego R, 2007, J BIOMED MATER RES B, V81B, P448, DOI DOI 10.1002/JBM.B.30683
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   CHAPLIN AJ, 1975, HISTOCHEM J, V5, P451
   Chor MV, 2007, MEAS SCI TECHNOL, V18, P208, DOI 10.1088/0957-0233/18/1/026
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   El Haj A, 2004, MED BIOL ENG COMPUT, V42, P2, DOI 10.1007/BF02351003
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Guilak F, 2002, ANN NY ACAD SCI, V961, P193, DOI 10.1111/j.1749-6632.2002.tb03080.x
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Qiu QQ, 1999, BIOMATERIALS, V20, P989, DOI 10.1016/S0142-9612(98)00183-5
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Sanz-Herrera JA, 2007, TISSUE ENG, V13, P1693
   Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Shimko DA, 2007, J BIOMED MATER RES B, V80B, P360, DOI 10.1002/jbm.b.30605
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Suck K, 2007, J BIOMED MATER RES A, V80A, P268, DOI 10.1002/jbm.a.30965
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   Swider P, 2007, J BIOMECH, V40, P2112, DOI 10.1016/j.jbiomech.2006.10.002
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
NR 49
TC 7
Z9 7
U1 0
U2 6
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 8756-7938
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD MAY-JUN
PY 2010
VL 26
IS 3
BP 671
EP 678
DI 10.1002/btpr.386
PG 8
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 615HG
UT WOS:000279124800009
PM 20196152
DA 2018-10-20
ER

PT J
AU Maimoun, L
   Brennan, TC
   Badoud, I
   Dubois-Ferriere, V
   Rizzoli, R
   Ammann, P
AF Maimoun, Laurent
   Brennan, Tara C.
   Badoud, Isabelle
   Dubois-Ferriere, Victor
   Rizzoli, Rene
   Ammann, Patrick
TI Strontium ranelate improves implant osseointegration
SO BONE
LA English
DT Article
DE Rodent; Implants; Osseointegration; Strontium ranelate
ID RESORPTION IN-VITRO; MAINTAINING BONE-FORMATION; TOTAL HIP-ARTHROPLASTY;
   OSTEOCLAST FORMATION; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE;
   CONTROLLED TRIAL; DOUBLE-BLIND; OSTEOPOROSIS; FRACTURES
AB Introduction: Endosseous implantation is a frequent procedure in orthopaedics and dentistry, particularly in the aging population. The incidence of implant failure, however, is high in situations where the bone at the site of implantation is not of optimal quality and quantity. Alterations of bone turnover and changes in intrinsic bone tissue quality have potentially negative effects on optimal osseointegration. Strontium ranelate, which acts on both resorption and formation, and improves biomaterial properties, is hypothesized to improve osseointegration and this hypothesis was tested here.
   Materials and methods: Titanium implants were inserted into the proximal tibias of thirty 6-month-old Sprague-Dawley female rats. During the 8 weeks following implantation, animals received orally strontium ranelate (SrRan) 5 days a week (625 mg/kg/day) or saline vehicle. Pull-out strength, mu CT and nanoindentation were assessed on the implanted tibias.
   Results: SrRan significantly increased pull-out strength compared to controls (+ 34%). This was associated with a significant improvement of bone microarchitecture around the implant (BV/TV + 36%; Tb.Th + 13%; Conn.D + 23%) with a more plate-shape structure and an increase in bone-to-implant contact (+ 19%). Finally, strontium ranelate had a significant beneficial effect on parameters of bone biomaterial properties at both cortical (modulus + 11.6%; hardness + 13%) and trabecular areas (modulus + 7%; hardness + 16.5%).
   Conclusions: SrRan is an antiosteoporotic agent that increased mechanical fixation of the implant. The improvement of pull-out strength was associated with an improvement of implant osseointegration with both a positive effect on bone microarchitecture and on bone biomaterial properties in the vicinity of the implant. These current results may support potential benefits of strontium ranelate in orthopaedic and dental surgery to enhance osseointegration. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Ammann, Patrick] Univ Hosp Geneva, Dept Rehabil & Geriatr, Serv Bone Dis, WHO,Collaborating Ctr Osteoporosis Prevent, CH-1211 Geneva 14, Switzerland.
   Univ Hosp Geneva, Fac Med, CH-1211 Geneva, Switzerland.
RP Ammann, P (reprint author), Univ Hosp Geneva, Dept Rehabil & Geriatr, Serv Bone Dis, WHO,Collaborating Ctr Osteoporosis Prevent, CH-1211 Geneva 14, Switzerland.
EM laurent.maimoun@laposte.net; Tara.Brennan@unige.ch;
   Isabelle.Badoud@unige.ch; victor.Dubois-Ferriere@unige.ch;
   Rene.Rizzoli@unige.ch; Patrick.Ammann@unige.ch
OI Speranza, Tara/0000-0001-5472-4969
FU Servier
FX This study was supported by a grant from Servier.
CR AMMANN P, 2004, J BONE MINER RES, V20, P548
   Ammann P, 2007, J BONE MINER RES, V22, P1419, DOI 10.1359/jbmr.070607
   Arabmotlagh M, 2006, J ORTHOP RES, V24, P1336, DOI 10.1002/jor.20162
   Bain SD, 2009, OSTEOPOROSIS INT, V20, P1417, DOI 10.1007/s00198-008-0815-8
   Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   Baron R, 2002, EUR J PHARMACOL, V450, P11, DOI 10.1016/S0014-2999(02)02040-X
   BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   Bhandari M, 2005, J BONE JOINT SURG AM, V87A, P293, DOI 10.2106/JBJS.D.01772
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Brennan TC, 2009, BRIT J PHARMACOL, V157, P1291, DOI 10.1111/j.1476-5381.2009.00305.x
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Dayer R, 2006, J BONE MINER RES, V21, P258, DOI 10.1359/JBMR.051009
   DAYER R, 2009, OSTEOPOROS INT
   Dayer R, 2007, J BONE MINER RES, V22, P1526, DOI 10.1359/JBMR.070610
   Delannoy P, 2002, METABOLISM, V51, P906, DOI 10.1053/meta.2002.33360
   Friedman R J, 1994, Instr Course Lect, V43, P233
   Hengsberger S, 2005, BONE, V36, P134, DOI [10.1016/j.bone.2004.09.013, 10.1016/j.bones.2004.09.013]
   Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006
   Hott M, 2003, BONE, V33, P115, DOI 10.1016/S8756-3282(03)00115-7
   HOWIE DW, 1993, ORTHOP CLIN N AM, V24, P571
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Hurtel-Lemaire AS, 2009, J BIOL CHEM, V284, P575, DOI 10.1074/jbc.M801668200
   JACOBS JJ, 1993, ORTHOP CLIN N AM, V24, P583
   Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493
   MALCHAU H, 1993, ACTA ORTHOP SCAND, V64, P497, DOI 10.3109/17453679308993679
   MARIE PJ, 1993, J BONE MINER RES, V8, P607
   Meunier PJ, 2002, J CLIN ENDOCR METAB, V87, P2060, DOI 10.1210/jc.87.5.2060
   Meunier PJ, 2004, NEW ENGL J MED, V350, P2002
   Meunier PJ, 2009, OSTEOPOROS INT
   Neale SD, 1999, J ORTHOPAED RES, V17, P686, DOI 10.1002/jor.1100170510
   Neale SD, 2000, J ARTHROPLASTY, V15, P654, DOI 10.1054/arth.2000.6622
   Nunley RM, 2009, CLIN ORTHOP RELAT R, V467, P56, DOI 10.1007/s11999-008-0558-z
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   Shanbhag AS, 2006, J AM ACAD ORTHOP SUR, V14, P215, DOI 10.5435/00124635-200604000-00003
   Skripitz R, 2001, CLIN ORTHOP RELAT R, P427
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Takahashi N, 2003, J BONE MINER RES, V18, P1082, DOI 10.1359/jbmr.2003.18.6.1082
   Wilkinson JM, 2001, J BONE MINER RES, V16, P556, DOI 10.1359/jbmr.2001.16.3.556
NR 39
TC 87
Z9 90
U1 0
U2 35
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAY
PY 2010
VL 46
IS 5
BP 1436
EP 1441
DI 10.1016/j.bone.2010.01.379
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 586VC
UT WOS:000276941000028
PM 20116464
DA 2018-10-20
ER

PT J
AU Pavcnik, D
   Takulve, K
   Uchida, BT
   Arnol, MP
   VanAlstine, W
   Keller, F
   Rosch, J
AF Pavcnik, Dusan
   Takulve, Kurt
   Uchida, Barry T.
   Arnol, Maja Pavcnik
   VanAlstine, William
   Keller, Frederick
   Rosch, Josef
TI Biodisk: A New Device for Closure of Patent Foramen Ovale: A Feasibility
   Study in Swine
SO CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
LA English
DT Article
DE patent foramen ovale; transcatheter closure; small intestinal submucosa;
   biomaterial; embolism; heart septal defects
ID PRESUMED PARADOXICAL EMBOLISM; ATRIAL SEPTAL-DEFECT; TRANSCATHETER
   CLOSURE; PERCUTANEOUS CLOSURE; OCCLUDER; AMPLATZER; MATRIX
AB Purpose: To evaluate the feasibility, effectiveness, and safety of a porcine small intestinal submucosa (SIS)-covered Biodisk (BD) for the closure of patent foramen ovale (PFO) in swine. Methods: Twelve piglets (9-30 kg) with PFO ranging in size from 6 to 12 mm were used for the in vivo testing. The BD device consisted of two basic nitinol wire components covered with platinum coil, a flexible SIS-covered ring, and an anchor. The BD was advanced through an 8-Fr sheath from the femoral vein. Nine acute animals were used to test the BD for deployment, stability, immediate shunt closure, and device repositioning before or after its detachment. To assess retrievability, four devices were deployed and intentionally embolized into the RA (n = 2) and LA (n = 2). The effectiveness of the device was evaluated by angiocardiography. EKG was recorded before and after PFO closure for 3 hr. From the 12 animals, nine were acute and three were followed; one for 6 weeks, one for 12 weeks, and one for 16 weeks. Results: Successful device implantation was achieved in all animals with no shunting of contrast media observed during follow-up in. One animal needed to have device repositioned for complete PFO occlusion because of suboptimal placement at the first attempt. The device was easily placed and retrieved before detachment in all nine animals in the acute study. None of the BDs spontaneously embolized during release or on follow-up. EKG did not demonstrate arrhythmias during or after treatment. Four intentionally embolized BDs were easily retrieved with an Amplatz goose neck snare. Macroscopic and histologic evaluation of the three long-term animals showed that devices were well incorporated in the atrial septum with complete shunt closure. The SIS showed progressive remodeling with the host cells. There was also progressive endothelization of the BD device. Conclusion: The BD device deployment is feasible, safe, and effective. Long-term studies are needed to evaluate its long-term effectiveness. (C) 2010 Wiley-Liss, Inc.
C1 [Pavcnik, Dusan; Uchida, Barry T.; Keller, Frederick; Rosch, Josef] Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR 97201 USA.
   [Takulve, Kurt] Cook Med Inc, Bloomington, IN USA.
   [Arnol, Maja Pavcnik] Univ Med Ctr Ljubljana, Dept Pediat Surg & Intens Care, Ljubljana, Slovenia.
   [VanAlstine, William] Purdue Univ, Anim Dis Diagnost Lab, W Lafayette, IN 47907 USA.
RP Pavcnik, D (reprint author), Oregon Hlth & Sci Univ, Dotter Intervent Inst, L342,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.
EM pavcnikd@ohsu.edu
FU Cook Medical
FX Supported in part by a grant from Cook Medical.
CR Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X
   Hara H, 2005, J AM COLL CARDIOL, V46, P1768, DOI 10.1016/j.jacc.2005.08.038
   Jux C, 2006, J AM COLL CARDIOL, V48, P161, DOI 10.1016/j.jacc.2006.02.057
   Jux Christian, 2003, J Interv Cardiol, V16, P149, DOI 10.1046/j.1540-8183.2003.08027.x
   KING TD, 1974, SURGERY, V75, P383
   Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030
   Luermans JGLM, 2008, CATHETER CARDIO INTE, V71, P822, DOI 10.1002/ccd.21458
   Majunke Nicolas, 2007, J Interv Cardiol, V20, P517, DOI 10.1111/j.1540-8183.2007.00303.x
   Narayanaswamy M, 2000, J VASC INTERV RADIOL, V11, P5, DOI 10.1016/S1051-0443(07)61271-8
   PAVENIK D, 1993, CARDIOVASC INTERVENT, V16, P308
   Rao PS, 2003, CATHETER BASED DEVIC, P3
   Reiffenstein I, 2008, EXPERT REV MED DEVIC, V5, P419, DOI 10.1586/17434440.5.4.419
   Sievert H, 2009, CATHETER CARDIO INTE, V73, P368, DOI 10.1002/ccd.21809
   Sigler M, 2007, HEART, V93, P444, DOI 10.1136/hrt.2006.098103
   Silvestry FE, 2008, CATHETER CARDIO INTE, V71, P383, DOI 10.1002/ccd.21364
   Spies C, 2008, CATHETER CARDIO INTE, V71, P390, DOI 10.1002/ccd.21383
   Spies C, 2008, J INVASIVE CARDIOL, V20, P442
   Spies C, 2008, CATHETER CARDIO INTE, V72, P966, DOI 10.1002/ccd.21737
   Taaffe M, 2008, AM J CARDIOL, V101, P1353, DOI 10.1016/j.amjcard.2007.12.040
   WINDECKER S, 2003, CATHETER BASED DEVIC, P111
NR 21
TC 6
Z9 6
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1522-1946
J9 CATHETER CARDIO INTE
JI Catheter. Cardiovasc. Interv.
PD MAY 1
PY 2010
VL 75
IS 6
BP 861
EP 867
DI 10.1002/ccd.22429
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 592RC
UT WOS:000277396200012
PM 20432391
DA 2018-10-20
ER

PT J
AU Joshy, MIA
   Elayaraja, K
   Suganthi, RV
   Kalkura, SN
AF Joshy, M. I. Ahymah
   Elayaraja, K.
   Suganthi, R. V.
   Kalkura, S. Narayana
TI Mineralization of oriented nano hydroxyapatite in photopolymerized
   polyacrylamide gel matrix
SO CRYSTAL RESEARCH AND TECHNOLOGY
LA English
DT Article
DE biomaterials; dissolution; biocompatibility; hydroxyapatite
ID IN-VITRO BIOACTIVITY; CALCIUM-PHOSPHATE; NANOCOMPOSITE; ADSORPTION;
   APATITE; GROWTH; BONE
AB Polyacrylamide hydrogel is a biomaterial and nondegradable water based polymer which is used as tissue filler. Mineralization of hydroxyapatite (HAp) in a UV polymerized acrylamide gel matrix was investigated by varying the concentration of precursors and pH in the range 8, 9 and 10. During polymerization, diammonium hydrogen phosphate ions were impregnated in the gel matrix and subsequently, immersed in the calcium nitrate solution. Thin laminated macroporous structures, embedded with nanospheres and ribbons of HAp were mineralized. The HAp was found to be oriented along c-axis, which could lead to the preferential binding of the acidic proteins on it's surface. In addition, there was an enlargement of pore sizes with an increase in pH. The laminated structures showed resorbable nature whereas, flake like structures obtained at higher concentrations were found to be bioactive. This composite could be an alternative to the use of silicone gel, to avoid long term risk of fibrosis and migration when implanted. (C) 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
C1 [Joshy, M. I. Ahymah; Elayaraja, K.; Suganthi, R. V.; Kalkura, S. Narayana] Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
RP Kalkura, SN (reprint author), Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
EM kalkura@annauniv.edu
RI Kolanthai, Elayaraja/D-3041-2015
OI Kolanthai, Elayaraja/0000-0003-2615-6866
FU DST, New Delhi [SR/SO/HS-05/2005]; AICTE, New Delhi
   [8023/BOR/RID/PRS-63/2008-2009]
FX One of the authors (M.I.A.J) acknowledges AICTE India for awarding
   National Doctoral Fellowship. The study was funded by a grant from DST,
   New Delhi through research project no. SR/SO/HS-05/2005 and AICTE, New
   Delhi through project no. 8023/BOR/RID/PRS-63/2008-2009. The authors
   wish to thank Prof. M. Palanichamy, Department of Chemistry, Anna
   University, Chennai for useful discussions.
CR Bhowmik R, 2009, INT J NANOTECHNOL, V6, P511, DOI 10.1504/IJNT.2009.024642
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Chen JD, 2007, BIOMATERIALS, V28, P2275, DOI 10.1016/j.biomaterials.2007.01.033
   CHRISTENSEN LH, 2008, DERMATOL SURG, V1, P368
   Cortes D, 2005, J MATER SCI, V40, P3509, DOI 10.1007/s10853-005-2856-0
   Das P, 2005, J CRYST GROWTH, V280, P587, DOI 10.1016/j.jcrysgro.2005.04.029
   Furuichi K, 2006, SCI TECHNOL ADV MAT, V7, P219, DOI 10.1016/j.stam.2005.10.008
   He QJ, 2007, CRYST RES TECHNOL, V42, P460, DOI 10.1002/crat.2006610848
   Iijima M, 1998, J CRYST GROWTH, V194, P125, DOI 10.1016/S0022-0248(98)00605-8
   Imai H, 2003, CHEM COMMUN, P1952, DOI 10.1039/b304367c
   Kandori K, 2000, PHYS CHEM CHEM PHYS, V2, P2015, DOI 10.1039/a909396f
   Kandori K, 2007, COLLOID SURFACE B, V58, P98, DOI 10.1016/j.colsurfb.2007.02.014
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumbar Sangamesh Q., 2008, Recent Patents on Biomedical Engineering, V1, P68
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   MCQUIRE RG, 2004, J MATER CHEM, V14, P2277
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Pereira Marivalda de Magalhães, 2003, Mat. Res., V6, P311, DOI 10.1590/S1516-14392003000300002
   QIAO MDQ, 2005, AESTHET PLAST SURG, V24, P156
   REGI MV, 2004, PROG SOLID STATE CHE, V32, P1
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   SCRANTON AC, 2001, TRENDS PHOTOCHEM PHO, V7, P169
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Vani R, 2009, J MATER SCI-MATER M, V20, P43, DOI 10.1007/s10856-008-3480-8
   Zhang L, 2005, J MATER SCI, V40, P107, DOI 10.1007/s10853-005-5693-2
NR 25
TC 6
Z9 6
U1 1
U2 23
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0232-1300
EI 1521-4079
J9 CRYST RES TECHNOL
JI Cryst. Res. Technol.
PD MAY
PY 2010
VL 45
IS 5
BP 551
EP 556
DI 10.1002/crat.200900734
PG 6
WC Crystallography
SC Crystallography
GA 594ZH
UT WOS:000277579900015
DA 2018-10-20
ER

PT J
AU Bayrak, O
   Yetim, AF
   Alsaran, A
   Celik, A
AF Bayrak, Oe
   Yetim, A. F.
   Alsaran, A.
   Celik, A.
TI Fatigue life determination of plasma nitrided medical grade CoCrMo alloy
SO FATIGUE & FRACTURE OF ENGINEERING MATERIALS & STRUCTURES
LA English
DT Article
DE biomaterial; CoCrMo; fatigue; plasma nitriding
ID TRIBOLOGICAL PROPERTIES; SURGICAL IMPLANTS; BEHAVIOR; STEEL; STRENGTH;
   TITANIUM; GROWTH; PHASE
AB In this paper, the fatigue behaviour of plasma nitrided medical grade forged CoCrMo alloy was studied. Since metallic biomaterials are used for implant applications where high and/or cyclic stresses along with corrosive effects of human body are of concern, enhancing mechanical and surface properties of implant alloys is crucial. Plasma nitriding was implemented at three different temperatures as 600, 700 and 800 degrees C for time intervals of 1 and 4 h. S-N curves of untreated and nitrided specimens were obtained via axial tension compression fatigue tests. It was found that plasma nitriding treatment reduces the fatigue resistance of forged CoCrMo alloy by the ratios of 7-23% depending on the surface roughness, phase structure and hardness of the modified layer which are determined by the treatment parameters.
C1 [Bayrak, Oe; Alsaran, A.; Celik, A.] Ataturk Univ, Fac Engn, Dept Mech Engn, TR-25240 Erzurum, Turkey.
   [Yetim, A. F.] Ataturk Univ, Fac Engn, Dept Met Engn, TR-25240 Erzurum, Turkey.
RP Bayrak, O (reprint author), Ataturk Univ, Fac Engn, Dept Mech Engn, TR-25240 Erzurum, Turkey.
EM ozgubayrak@atauni.edu.tr
RI Bayrak, Ozgu/C-7754-2011
OI Bayrak, Ozgu/0000-0002-9031-4980
FU TUBITAK (The Scientific and Technical Research Council of Turkey)
   [106M066]
FX This research is a part of the TUBITAK (The Scientific and Technical
   Research Council of Turkey) project supported by grant no. 106M066. The
   authors would also like to thank Dr. Mustafa Toparli and Dr. Osman Culha
   from Dokuz Eylul University for ultra micro hardness tests.
CR Alsaran A, 2002, MATER CHARACT, V48, P323, DOI 10.1016/S1044-5803(02)00275-9
   Alsaran A, 2001, MATER CHARACT, V47, P207, DOI 10.1016/S1044-5803(01)00169-3
   Aouadi SM, 2001, SURF COAT TECH, V140, P269, DOI 10.1016/S0257-8972(01)01121-5
   Celik A, 2008, SURF COAT TECH, V202, P2433, DOI 10.1016/j.surfcoat.2007.08.030
   CELIK A, 1995, SURF COAT TECH, V72, P169, DOI 10.1016/0257-8972(94)02348-4
   Celik A, 1996, SURF COAT TECH, V80, P283, DOI 10.1016/0257-8972(95)02471-9
   Fang JS, 2004, J VAC SCI TECHNOL A, V22, P698, DOI 10.1116/1.1722656
   INAL OT, 1989, ION NITRIDING ION CA, P57
   Joubert JM, 2008, PROG MATER SCI, V53, P528, DOI 10.1016/j.pmatsci.2007.04.001
   Morita T, 1997, FATIGUE FRACT ENG M, V20, P85, DOI 10.1111/j.1460-2695.1997.tb00404.x
   Niinomi M, 2007, INT J FATIGUE, V29, P992, DOI 10.1016/j.ijfatigue.2006.09.021
   Schijve J., 2009, FATIGUE STRUCTURES M
   SHIBATA H, 1994, INT J FATIGUE, V16, P370, DOI 10.1016/0142-1123(94)90448-0
   SRIDHAR N, 1992, ASM HDB CORROSION, V13
   VOORWALD HJC, 2008, FATIGUE FRACT ENG M, V32, P97
   Wei RH, 2004, SURF COAT TECH, V186, P305, DOI 10.1016/j.surfcoat.2004.02.052
   Wu ZJ, 2008, J PHYS CHEM SOLIDS, V69, P2723, DOI 10.1016/j.jpcs.2008.06.147
   Yamabe J, 2006, FATIGUE FRACT ENG M, V29, P403, DOI 10.1111/j.1460-2695.2006.01017.x
   Yetim AF, 2008, SURF COAT TECH, V202, P2428, DOI 10.1016/j.surfcoat.2007.08.027
   Yildiz F, 2008, SURF COAT TECH, V202, P2471, DOI 10.1016/j.surfcoat.2007.08.004
   ZHUANG LZ, 1989, MAT SCI ENG A-STRUCT, V108, P247, DOI 10.1016/0921-5093(89)90427-9
   ZHUANG LZ, 1989, METALL TRANS A, V20, P99, DOI 10.1007/BF02647497
NR 22
TC 4
Z9 4
U1 0
U2 7
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 8756-758X
J9 FATIGUE FRACT ENG M
JI Fatigue Fract. Eng. Mater. Struct.
PD MAY
PY 2010
VL 33
IS 5
BP 303
EP 309
DI 10.1111/j.1460-2695.2010.01442.x
PG 7
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 580RD
UT WOS:000276466200005
DA 2018-10-20
ER

PT J
AU Dudding, TC
   Pares, D
   Vaizey, CJ
   Kamm, MA
AF Dudding, Thomas C.
   Pares, David
   Vaizey, Carolynne J.
   Kamm, Michael A.
TI Sacral nerve stimulation for the treatment of faecal incontinence
   related to dysfunction of the internal anal sphincter
SO INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
LA English
DT Article
DE Sacral nerve stimulation; Faecal incontinence; Anal sphincter;
   Neuromodulation
ID QUALITY-OF-LIFE; INJECTABLE SILICONE BIOMATERIAL; SHORT FORM-36;
   MANAGEMENT; DAMAGE; NEUROMODULATION; INSTRUMENT
AB In patients with faecal incontinence related to isolated internal anal sphincter (IAS) disruption, conservative management is the mainstay of treatment. Surgical repair of the internal sphincter is not successful. This study evaluated the use of sacral nerve stimulation (SNS) in those with faecal incontinence and IAS disruption in whom medical and behavioural treatments had failed.
   Nine patients (seven women, median age 44 years, range 39-62 years), with a history of obstetric or iatrogenic anal sphincter trauma, underwent a trial of SNS. All had passive faecal incontinence, low resting anal sphincter pressure and full thickness IAS muscle disruption of greater than 30A degrees radial extent. The effect of SNS on symptoms was measured by a bowel habit diary and validated questionnaires used to assess impact on quality of life.
   Eight (89%) patients benefited from temporary stimulation and proceeded to permanent device implantation. Follow-up was at a mean of 46 months (range 2-81). Faecal incontinence decreased from a mean (SD) of 9.9 (10.9) to 1.0 (2.4) episodes per week (p = 0.031), and soiling decreased from 6.1 (1.6) to 1.7 (2.4) episodes per week (p = 0.031), with chronic stimulation. At latest follow-up, three patients had no incontinence, three patients had episodes of minor soiling only, one patient had > 75% reduction of incontinent episodes, and two patients remained incontinent.
   Sacral nerve stimulation is effective in treating faecal incontinence related to a structurally and functionally abnormal internal anal sphincter. Treatment should not be refused on the basis of IAS disruption.
C1 [Dudding, Thomas C.; Pares, David; Vaizey, Carolynne J.; Kamm, Michael A.] St Marks Hosp, Physiol Unit, Harrow HA1 3UJ, Middx, England.
RP Vaizey, CJ (reprint author), St Marks Hosp, Physiol Unit, Watford Rd, Harrow HA1 3UJ, Middx, England.
EM carolynne.vaizey@nwlh.nhs.uk
OI Pares, David/0000-0001-8233-4888
FU Medtronic
FX This institution has previously received financial support from
   Medtronic for studies related to sacral nerve stimulation. The design,
   performance, analysis and reporting of this study have been conducted
   without the influence of Medtronic.
CR ADAMS EJ, 2001, 29 ROYAL COLL OBST G
   Altomare DF, 2004, INT J COLORECTAL DIS, V19, P203, DOI 10.1007/s00384-003-0523-y
   Bordeianou L, 2008, COLORECTAL DIS, V10, P273, DOI 10.1111/j.1463-1318.2007.01288.x
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Dudding TC, 2008, BRIT J SURG, V95, P1155, DOI 10.1002/bjs.6237
   Dudding TC, 2008, ANN SURG, V247, P224, DOI 10.1097/SLA.0b013e318142cdf4
   Enck P, 2004, DIGESTION, V69, P102, DOI 10.1159/000077876
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1995, EUR J GASTROEN HEPAT, V7, P65
   ENGEL AF, 1994, BRIT J SURG, V81, P1069, DOI 10.1002/bjs.1800810749
   FELTBERSMA RJF, 1995, DIS COLON RECTUM, V38, P249, DOI 10.1007/BF02055596
   FRENCKNER B, 1975, GUT, V16, P638, DOI 10.1136/gut.16.8.638
   Ganio E, 2001, DIS COLON RECTUM, V44, P965, DOI 10.1007/BF02235484
   Huang JC, 1997, NEUROSURGERY, V41, P411, DOI 10.1097/00006123-199708000-00015
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Jarrett MED, 2004, BRIT J SURG, V91, P755, DOI 10.1002/bjs.4545
   Jarrett MED, 2008, DIS COLON RECTUM, V51, P531, DOI 10.1007/s10350-008-9199-2
   JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437
   KAMM MA, 1994, LANCET, V344, P730, DOI 10.1016/S0140-6736(94)92213-6
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Matzel KE, 2004, LANCET, V363, P1270, DOI 10.1016/S0140-6736(04)15999-0
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   Mundy L, 2004, BRIT J SURG, V91, P665, DOI 10.1002/bjs.4587
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010
   Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x
   Oberwalder M, 2003, BRIT J SURG, V90, P1333, DOI 10.1002/bjs.4369
   Paick JS, 2007, EUR J OBSTET GYN R B, V130, P18, DOI 10.1016/j.ejogrb.2006.05.018
   Rao SSC, 2004, GASTROENTEROLOGY, V126, pS14, DOI 10.1053/j.gastro.2003.10.013
   Rasmussen OO, 2004, DIS COLON RECTUM, V47, P1158, DOI 10.1007/s10350-004-0553-8
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120
   SHELDON R, 2004, COLORECTAL DIS S1, V6, P23
   Spinelli M, 2003, EUR UROL, V43, P70, DOI 10.1016/S0302-2838(02)00442-6
   Stamatiadis Apostolos, 2002, Gastroenterol Nurs, V25, P55, DOI 10.1097/00001610-200203000-00005
   SULTAN AH, 1993, NEW ENGL J MED, V329, P1905, DOI 10.1056/NEJM199312233292601
   Uludag O, 2004, DIS COLON RECTUM, V47, P1350, DOI 10.1007/s10350-004-0589-9
NR 39
TC 20
Z9 20
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0179-1958
J9 INT J COLORECTAL DIS
JI Int. J. Colorectal Dis.
PD MAY
PY 2010
VL 25
IS 5
BP 625
EP 630
DI 10.1007/s00384-010-0880-2
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 575EP
UT WOS:000276050000012
PM 20127098
DA 2018-10-20
ER

PT J
AU Hermann, BG
   Blok, K
   Patel, MK
AF Hermann, Barbara G.
   Blok, Kornelis
   Patel, Martin K.
TI Twisting biomaterials around your little finger: environmental impacts
   of bio-based wrappings
SO INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT
LA English
DT Article
DE Biomaterial; Biopolymer; Cellulose; Film; LCA; Life cycle assessment;
   Packaging; Paper; Plastic; Polyester; Polyethylene; Polylactic acid;
   Polypropylene
ID LIFE-CYCLE ASSESSMENT; LCA; CONSUMPTION
AB Packaging uses nearly 40% of all polymers, a substantial share of which is used for sensitive merchandise such as moisture-sensitive food. To find out if bio-based materials are environmentally advantageous for this demanding application, we compared laminated, printed film across the whole life cycle.
   We compared bio-based materials (paper, polylactic acid, bio-based polyethylene, and a bio-based polyester) as well as conventional ones (polypropylene, polyethylene). Data stemmed from 13 companies that produce raw materials, films and/or laminates and which co-operated with us in a project commissioned by a large food producer. The functional unit chosen for this study is 1 m(2) of packaging film. This is (mostly) laminated, printed film that is delivered on reels to the food industry, where the laminate is cut, sealed and filled. The impact assessment is presented for non-renewable energy use, total energy use, global warming potential, depletion of abiotic resources, photo-oxidant formation, acidification, eutrophication, water use, and land use.
   For Inner Packs that get in direct contact with food and therefore require certain barrier properties, the environmental performance of many laminates is not better than the reference, petrochemical material. However, our study shows that paper/polypropylene laminates perform equally well as the current material (polypropylene) if the material is landfilled, and better if incinerated with energy recovery. For Outer Packs, bio-based polyethylene film shows a particularly low environmental impact. Paper/bio-based polyester laminates also offer significant savings compared with the current material. For Inner as well as Outer Packs, laminates including polylactic acid offer environmental advantages when accounting for wind credits or when assuming a future technology level for polymer or film production.
   Increased technology maturity of PLA and cellulose in the film production stage offers significant environmental improvement with respect to global warming potential compared with today's technology. Though large, the uncertainty regarding the degree of degradation of paper, cellulose, PLA and bio-based polyester, is not decisive for the conclusions.
   Generally, laminates and films (partly) consisting of bio-based polymers offer opportunities for significantly reducing environmental impacts of food packaging. Large variations in land-use are possible depending on the type of bio-based material that is used. The environmental advantages differ depending on the polymer and the final product (Inner vs. Outer Pack). Lack of experience and investment in converting bio-based polymers into final products and comparatively unfavourable material properties result in lower environmental advantages for some novel bio-based materials than one may expect. However, a) already today, the options with the lowest global warming potential are partly or fully bio-based and b) bio-based materials will benefit more from technological progress than conventional materials, potentially making certain bio-based laminates highly attractive options for the future. Overall, Outer Packs are more promising than Inner Packs when introducing bio-based wrappings to replace the current petrochemical material because a) the opportunities are clearer for this application and b) the product specifications (required barrier properties) are less demanding. Starting with the Outer Packs would also allow bio-based polymer producers and processors to invest and learn, thus offering the opportunity to reduce the environmental impact even further.
C1 [Hermann, Barbara G.; Blok, Kornelis; Patel, Martin K.] Univ Utrecht, Copernicus Inst, NL-3584 CS Utrecht, Netherlands.
RP Hermann, BG (reprint author), Univ Utrecht, Copernicus Inst, Heidelberglaan 2, NL-3584 CS Utrecht, Netherlands.
EM b.g.hermann@uu.nl
RI Blok, Kornelis/D-9532-2014
CR Bohlmann GM, 2004, ENVIRON PROG, V23, P342, DOI 10.1002/ep.10053
   Boustead I, 1999, ECOPROFILES PLASTICS
   Canals LMI, 2007, INT J LIFE CYCLE ASS, V12, P5, DOI 10.1065/lca2006.05.250
   CANALS LM, 2003, CONTRIBUTIONS LCA ME, P117
   Dreyer LC, 2003, INT J LIFE CYCLE ASS, V8, P191, DOI 10.1065/lca2003.06.115
   *EUR, 2008, MUN WAST TREATM TYP
   Guinee J. B., 2001, LIFE CYCLE ASSESSMEN
   Gustafsson LM, 2007, INT J LIFE CYCLE ASS, V12, P151, DOI 10.1065/lca2006.11.280
   Hermann BG, 2007, ENVIRON SCI TECHNOL, V41, P7915, DOI 10.1021/es062559q
   HERMANN BG, 2007, CONFIDENTIAL REPORT
   International Energy Agency (IEA), 2003, EN BAL OECD COUNTR 2
   Iovino R, 2008, POLYM DEGRAD STABIL, V93, P147, DOI 10.1016/j.polymdegradstab.2007.10.011
   Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505
   KAB H, 2002, BIO RESTABFALL BEHAN, P149
   Kale G, 2007, PACKAG TECHNOL SCI, V20, P49, DOI 10.1002/pts.742
   Kim S, 2005, BIOMASS BIOENERG, V29, P426, DOI 10.1016/j.biombioe.2005.06.004
   Kim S, 2005, INT J LIFE CYCLE ASS, V10, P200, DOI 10.1065/lca2004.08.171
   Kloverpris J, 2008, INT J LIFE CYCLE ASS, V13, P13, DOI 10.1065/lca2007.10.364
   Canals LMI, 2009, INT J LIFE CYCLE ASS, V14, P28, DOI 10.1007/s11367-008-0030-z
   Patel M, 2006, MEDIUM LONG TERM OPP
   Pfister S, 2009, ENVIRON SCI TECHNOL, V43, P4098, DOI 10.1021/es802423e
   PlasticsEurope, 2008, COMP FACTS PLAST AN
   Schmidtbauer J., 1997, LENZINGER BERICHTE, V76, P27
   Schuessler G, 2008, Z PSYCHOSOM MED PSYC, V54, P89, DOI 10.13109/zptm.2008.54.1.89
   SimaPro, 2007, INV DAT
   Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5
   Vink ETH, 2007, IND BIOTECHNOL, V3, P58, DOI DOI 10.1089/IND.2007.3.058
NR 27
TC 20
Z9 21
U1 1
U2 33
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0948-3349
J9 INT J LIFE CYCLE ASS
JI Int. J. Life Cycle Assess.
PD MAY
PY 2010
VL 15
IS 4
BP 346
EP 358
DI 10.1007/s11367-010-0155-8
PG 13
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 584BM
UT WOS:000276725000005
OA Other Gold
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Novel nano-composite biomaterial for osteochondral tissue engineering:
   pilot clinical study Abstracts
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD MAY-AUG
PY 2010
VL 8
IS 2
BP 103
EP 132
PG 30
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 643EK
UT WOS:000281278200007
DA 2018-10-20
ER

PT J
AU Johnson, PA
   Luk, A
   Demtchouk, A
   Pate, H
   Sung, HJ
   Treiser, MD
   Gordonov, S
   Sheihet, L
   Bolikal, D
   Kohn, J
   Moghe, PV
AF Johnson, Patrick A.
   Luk, Arnold
   Demtchouk, Aleksey
   Pate, Hiral
   Sung, Hak-Joon
   Treiser, Matthew D.
   Gordonov, Simon
   Sheihet, Larisa
   Bolikal, Das
   Kohn, Joachim
   Moghe, Prabhas V.
TI Interplay of anionic charge, poly(ethylene glycol), and iodinated
   tyrosine incorporation within tyrosine-derived polycarbonates: Effects
   on vascular smooth muscle cell adhesion, proliferation, and motility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell adhesion and motility; tyrosine-derived polycarbonates; smooth
   muscle cells; vascular biomaterials; iodination; poly(ethylene glycol)
ID POLYMER SURFACES; BIOMATERIALS; PEG; GLYCOPROTEINS; MICROARRAYS;
   ADSORPTION; FIBRINOGEN; MODEL; FILMS; ACID)
AB Regulation of smooth muscle cell adhesion, proliferation, and motility on biomaterials is critical to the performance of blood-contacting implants and vascular tissue engineering scaffolds. The goal of this study was to examine the underlying substrate-smooth muscle cell response relations, using a selection of polymers representative of an expansive library of multifunctional, tyrosine-derived poly-carbonates. Three chemical components within the polymer structure were selectively varied through copolymerization: (1) the content of iodinated tyrosine to achieve X-ray visibility; (2) the content of poly(ethylene glycol) (PEG) to decrease protein adsorption and cell adhesivity; and (3) the content of desaminotyrosyl-tyrosine (DT), which regulates the rate of polymer degradation. Using quartz crystal microbalance with dissipation, we quantified differential serum protein adsorption behavior because of the chemical components DT, iodinated tyrosine, and PEG: increased PEG content within the polymer structure progressively decreased protein adsorption but the simultaneous presence of both DT and iodinated tyrosine reversed the effects of PEG. The complex interplay of these components was next tested on the adhesion, proliferation, and motility behavior cultured human aortic smooth muscle cells. The incorporation of PEG into the polymer reduced cell attachment, which was reversed in the presence of iodinated tyrosine. Further, we found that as little as 10% DT content was sufficient to negate the PEG effect in polymers containing iodinated tyrosine, whereas in non-iodinated polymers, the PEG effect on cell attachment was reversed. Cross-functional analysis of motility and proliferation revealed divergent substrate chemistry related cell response regimes. For instance, within the series of polymers containing both iodinated tyrosine and 10% of DT, increasing PEG levels lowered smooth muscle cell motility without a change in the rate of cell proliferation. In contrast, for non-iodinated tyrosine and 10% of DT, increasing PEG levels increased cell proliferation significantly while reducing cell motility. Clearly, the polycarbonate polymer library offers a sensitive platform to modulate cell adhesion, proliferation, and motility responses, which, in turn, may have implications for controlling vascular remodeling in vivo. Additionally, our data suggests unique biorelevant properties following the incorporation of iodinated subunits in a polymeric biomaterial as a potential platform for X-ray visible devices. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 505-514, 2010
C1 [Johnson, Patrick A.; Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
   [Johnson, Patrick A.; Luk, Arnold; Sung, Hak-Joon; Sheihet, Larisa; Bolikal, Das; Kohn, Joachim] Rutgers State Univ, Dept Chem & Chem Biol, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
   [Luk, Arnold; Demtchouk, Aleksey; Pate, Hiral; Treiser, Matthew D.; Gordonov, Simon; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
EM moghe@rci.rutgers.edu
FU NIH [P41 EB001046]
FX Contract grant sponsor: NIH; contract grant number: P41 EB001046
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Cabral JT, 2004, LANGMUIR, V20, P10020, DOI 10.1021/la049501e
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Duan WL, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-16
   Edelman ER, 1999, CIRC RES, V85, P1115
   France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d
   Ghosh D, 2004, J PROTEOME RES, V3, P841, DOI 10.1021/pr049937f
   Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Kim G, 1998, MACROMOLECULES, V31, P2569, DOI 10.1021/ma971349i
   KOHN J, 2005, Patent No. 6852308
   Kohn J, 2005, EXPERT REV MED DEVIC, V2, P667, DOI 10.1586/17434440.2.6.667
   LOU B, 2008, ARTERIOSCLER THROMB, V28, P651
   Macario DK, 2008, J BIOMED MATER RES B, V86B, P237, DOI 10.1002/jbm.b.31011
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Sharma RI, 2004, J BIOMED MATER RES A, V69A, P114, DOI 10.1002/jbm.a.20125
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346
   Tourniaire G, 2006, CHEM COMMUN, P2118, DOI 10.1039/b602009g
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Weber N, 2005, J BIOMED MATER RES A, V72A, P420, DOI 10.1002/jbm.a.30272
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
   Zhang R, 2008, CHEM COMMUN, P1317, DOI 10.1039/b717932d
NR 31
TC 12
Z9 12
U1 0
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2010
VL 93A
IS 2
BP 505
EP 514
DI 10.1002/jbm.a.32544
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579ET
UT WOS:000276351300011
PM 19585568
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Buchanan, LA
   EI-Ghannam, A
AF Buchanan, Laura A.
   EI-Ghannam, Ahmed
TI Effect of bioactive glass crystallization on the conformation and
   bioactivity of adsorbed proteins
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE protein adsorption; FTIR; conformation; bioactive glass; cell adhesion
ID BOVINE SERUM-ALBUMIN; TRANSFORM-INFRARED-SPECTROSCOPY; FOURIER
   SELF-DECONVOLUTION; SECONDARY STRUCTURE; AMIDE-I; BRUSHITE
   TRANSFORMATION; FTIR SPECTROSCOPY; ADSORPTION; ADHESION; AGGREGATION
AB Protein adsorption onto the surface of a biomaterial mediates cell adhesion and enhances tissue-implant integration. In a previous study, we demonstrated that crystallization of bioactive glass (BC) significantly increased the negative zeta potential and decreased serum protein adsorption onto the material surface. In this study, the conformation of protein adsorbed onto the surface of amorphous bioactive glass (ABG) and crystallized bioactive glass (CBG) was analyzed and correlated to bone marrow mesenchymal stem cell adhesion and spreading. ABG, and CBG were immersed in three different protein solutions containing 10% fetal bovine serum, bovine serum albumin (BSA), and fibronectin (FN) for 4 h at 37 degrees C. Grazing angle Fourier transform infrared spectroscopy (GA-FTIR) demonstrated that the ratio of (amide I)/(amide II) functional groups of all proteins adsorbed onto ABG was greater than that for proteins adsorbed onto CBG. The Gaussian curve fitting analysis suggests that the significant expression of amide I, rich in charged and flexible unordered secondary structure of adsorbed FN, stimulated bone cell adhesion and spreading on the surface of ABG. CBG enforces protein conformation that exposes amide II, rich in neutral and stable beta-sheet structure and alpha-helix, which limited cell adhesion and spreading. Although ABG adsorbed significantly higher quantity of BSA than FN, GA-FTIR analyses showed that the ratio of amide I/amide II was significantly higher for adsorbed FN. Therefore, the intensity of amide 1 or amide II bands cannot be taken as a measure of the quantity of adsorbed protein. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 537-546, 2010
C1 [EI-Ghannam, Ahmed] Univ N Carolina, Dept Mech Engn & Engn Sci, Charlotte, NC 28223 USA.
   [Buchanan, Laura A.] Univ Louisville, Dept Med, Louisville, KY 40292 USA.
RP EI-Ghannam, A (reprint author), Univ N Carolina, Dept Mech Engn & Engn Sci, DCH 177,9201 Univ City Blvd, Charlotte, NC 28223 USA.
EM arelgha@uncc.edu
FU Sigma Xi Grant-in-Aid of Research
FX Contract grant sponsor: Sigma Xi Grant-in-Aid of Research
CR Andreeva AE, 2001, J MOL STRUCT, V565, P177, DOI 10.1016/S0022-2860(00)00893-0
   Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   CAMERON DG, 1984, J TEST EVAL, V12, P78
   Champe P. C., 2005, LIPPINCOTTS ILLUSTRA
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407
   Dong AC, 2000, J BIOL CHEM, V275, P27689
   DOUSSEAU F, 1990, BIOCHEMISTRY-US, V29, P8771, DOI 10.1021/bi00489a038
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   El-Ghannam A, 2001, J BIOMED MATER RES, V55, P387, DOI 10.1002/1097-4636(20010605)55:3<387::AID-JBM1027>3.0.CO;2-V
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   GRANER F, 1993, J THEOR BIOL, V164, P455, DOI 10.1006/jtbi.1993.1167
   Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2
   Heredia P, 2003, BIOCHEMISTRY-US, V42, P11831, DOI 10.1021/bi034582j
   JAKOBSEN RJ, 1986, BIOPOLYMERS, V25, P639, DOI 10.1002/bip.360250409
   KATO K, 1987, APPL SPECTROSC, V41, P861, DOI 10.1366/0003702874448049
   KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634
   LAUFFENBURGER DA, 1991, ANNU REV BIOPHYS BIO, V20, P387, DOI 10.1146/annurev.bb.20.060191.002131
   MARCELJA S, 1992, BIOPHYS J, V61, P1117, DOI 10.1016/S0006-3495(92)81921-5
   Militello V, 2004, BIOPHYS CHEM, V107, P175, DOI 10.1016/j.bpc.2003.09.004
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Servagent-Noinville S, 2000, J COLLOID INTERF SCI, V221, P273, DOI 10.1006/jcis.1999.6576
   Smith B.C., 1996, FUNDAMENTALS FOURIER
   Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200
   SUSI H, 1986, METHOD ENZYMOL, V130, P290
   SUSI H, 1988, APPL SPECTROSC, V42, P819, DOI 10.1366/0003702884428905
   Vedantham G, 2000, ANAL BIOCHEM, V285, P33, DOI 10.1006/abio.2000.4744
   Venyaminov S. Y., 1996, CIRCULAR DICHROISM C, P69
   WASACZ FM, 1987, BIOCHEMISTRY-US, V26, P1464, DOI 10.1021/bi00379a038
   Xie J, 2002, BIOMATERIALS, V23, P3609, DOI 10.1016/S0142-9612(02)00090-X
   Xie J, 2001, J BIOMED MATER RES, V57, P357, DOI 10.1002/1097-4636(20011205)57:3<357::AID-JBM1178>3.0.CO;2-1
   YANG WJ, 1985, APPL SPECTROSC, V39, P282, DOI 10.1366/0003702854248917
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858
NR 39
TC 20
Z9 20
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2010
VL 93A
IS 2
BP 537
EP 546
DI 10.1002/jbm.a.32561
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579ET
UT WOS:000276351300014
PM 19585571
DA 2018-10-20
ER

PT J
AU Elvin, CM
   Danon, SJ
   Brownlee, AG
   White, JF
   Hickey, M
   Liyou, NE
   Edwards, GA
   Ramshaw, JAM
   Werkmeister, JA
AF Elvin, C. M.
   Danon, S. J.
   Brownlee, A. G.
   White, J. F.
   Hickey, M.
   Liyou, N. E.
   Edwards, G. A.
   Ramshaw, J. A. M.
   Werkmeister, J. A.
TI Evaluation of photo-crosslinked fibrinogen as a rapid and strong tissue
   adhesive
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tissue sealant; photochemical crosslinking; dityrosine; ruthenium; wound
   healing; degradation
ID DEGRADATION; MIGRATION; COMPONENT; SCAFFOLD; SEALANT; BINDING; MODEL;
   SKIN
AB Tissue adhesives and sealants are commonly used in surgery either as an adjunct to, or replacement for, sutures. Previously, we have shown that fibrinogen can be crosslinked rapidly to give a high-strength bond in the presence of a ruthenium(II) complex, a persulfate and irradiation with visible light, and that the crosslinked fibrinogen is nontoxic to cells in vitro. This approach addresses limitations to current fibrin sealants that typically have relatively slow curing times and low bond strengths. In the present study, we have evaluated the efficacy and safety of this new biological scaffold sealant in various animal models. When placed as solid implants into rats, the crosslinked fibrinogen persisted for at least 8 weeks but was fully resorbed by 18 weeks with minimal inflammatory responses. When used as a tissue adhesive for repair of skin incisions in rats or as an arterial haemostat in pig, the photo-crosslinked fibrinogen sealed tissue or arrested bleeding within 20 s of application. For the skin incisions, the fibrinogen sealant promoted rapid tissue vascularization and cellular infiltration with no adverse foreign body cell generation. New collagen deposition occurred and with time the matrix had remodelled to acquire large mature collagen fiber bundles which were accompanied by maximum regenerated tensile strength. This biomaterial system may find useful applications in surgical procedures where rapid curing and/or high strength tissue sealing is required. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 687-695, 2010
C1 [White, J. F.; Ramshaw, J. A. M.; Werkmeister, J. A.] CSIRO Mol & Hlth Technol, Clayton, Vic 3169, Australia.
   [Elvin, C. M.; Brownlee, A. G.; Liyou, N. E.] CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4072, Australia.
   [Danon, S. J.] CSIRO Mol & Hlth Technol, N Ryde, NSW 2111, Australia.
   [Hickey, M.] CSIRO Mat Sci & Engn, Clayton, Vic 3169, Australia.
   [Edwards, G. A.] Univ Melbourne, Dept Vet Sci, Werribee, Vic 3030, Australia.
RP Werkmeister, JA (reprint author), CSIRO Mol & Hlth Technol, Clayton, Vic 3169, Australia.
EM Jerome.werkmeister@csiro.au
RI White, Jacinta/D-6961-2013; elvin, chris/H-2333-2013; Ramshaw,
   John/A-9411-2011; Hickey, Mark/C-2376-2017
OI White, Jacinta/0000-0002-4855-0170; 
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Bar L, 2005, BLOOD COAGUL FIBRIN, V16, P111, DOI 10.1097/01.mbc.0000161564.74387.12
   BERGEL S, 1909, DEUT MED WOCHENSCHR, V35, P633
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Cronkite EP, 1944, J AMER MED ASSOC, V124, P976, DOI 10.1001/jama.1944.02850140022006
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   ELVIN CM, Patent No. 2007092998
   ELVIN CM, Patent No. 2007904359
   Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Gross TJ, 1997, THROMB HAEMOSTASIS, V77, P894
   Kjaergard HK, 2000, THROMB RES, V98, P221, DOI 10.1016/S0049-3848(99)00234-0
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Lee Meng-G Martin, 2005, Surg Innov, V12, P203, DOI 10.1177/155335060501200304
   Makogonenko E, 2007, BIOCHEMISTRY-US, V46, P5418, DOI 10.1021/bi7001373
   McManus MC, 2007, J BIOMED MATER RES A, V81A, P299, DOI 10.1002/jbm.a.30989
   MIRSHAHI M, 1991, J LAB CLIN MED, V117, P274
   MIURA S, 1995, JPN J CLIN ONCOL, V25, P61
   Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200
   Quinn JV, 2005, TISSUE ADHESIVES CLI, P1
   Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822
   Sierra DH, 2002, J BIOMED MATER RES, V59, P1
   SPOTNITZ WD, 2005, TISSUE ADHESIVES CLI, P1
   Underwood S, 2001, BIOTECHNOL BIOENG, V73, P295, DOI 10.1002/bit.1062
   VOGEL HG, 1976, J MED, V7, P177
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
NR 27
TC 19
Z9 20
U1 3
U2 28
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2010
VL 93A
IS 2
BP 687
EP 695
DI 10.1002/jbm.a.32572
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579ET
UT WOS:000276351300029
PM 19610050
DA 2018-10-20
ER

PT J
AU Henderson, PW
   Kadouch, DJM
   Singh, SP
   Zawaneh, PN
   Weiser, J
   Yazdi, S
   Weinstein, A
   Krotscheck, U
   Wechsler, B
   Putnam, D
   Spector, JA
AF Henderson, Peter W.
   Kadouch, Daniel J. M.
   Singh, Sunil P.
   Zawaneh, Peter N.
   Weiser, Jennifer
   Yazdi, Sara
   Weinstein, Andrew
   Krotscheck, Ursula
   Wechsler, Bennett
   Putnam, David
   Spector, Jason A.
TI A rapidly resorbable hemostatic biomaterial based on dihydroxyacetone
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE topical hemostatic; dihydroxyacetone; MPEG; resorbable; hemostasis
ID PARVOVIRUS B19 INFECTION; OXIDIZED CELLULOSE; RAT; AGENTS; COLLAGEN;
   SURGERY; LIVER; MODEL; INTERMEDIATE; TRANSMISSION
AB We have developed a rapid acting, rapidly resorbable, non-toxic, topical hemostatic agent comprised of a PEGylated, polymerized sequence of dihydroxyacetone (MPEG-pDHA) that is highly effective in vivo. Twenty-eight Sprague-Dawley rats underwent left lateral hepatectomy. To the cut edge of the liver, rats received MPEG-pDHA (50 mg), normal saline (0.5 mL), or Instat (TM) (50 mg), a commercially available hemostatic compound. Bleeding time and total blood loss were quantified. Coagulation studies and scanning electron microscopy were performed on phlebotomized blood combined with MPEG-pDHA. Rats treated with MPEG-pDHA had significantly decreased bleeding time (97 s) and total blood loss (1.35 g) compared to normal saline (464 s and 3.83 g, p < 0.05 for each), and a significantly shorter bleeding time compared to Instat (165 s, p < 0.05). Histology confirmed that all MPEG-pDHA was metabolized within 3 weeks. The addition of MPEG-pDHA to whole blood did not significantly affect prothrombin time (12.0 s vs. 13.2 s, p = 0.130), partial thromboplastin time (27.0 s vs. 21.8 s, p = 0.118), or thrombin clotting time. MPEG-pDHA is an effective and rapidly resorbable hemostatic agent that may find broad hemostatic application in a wide range of surgical procedures. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 776-782, 2010
C1 [Henderson, Peter W.; Singh, Sunil P.; Weinstein, Andrew; Wechsler, Bennett; Spector, Jason A.] Weill Cornell Med Coll, Lab Bioregenerat Med & Surg, Div Plast & Reconstruct Surg, New York, NY USA.
   [Kadouch, Daniel J. M.] Vrije Univ Amsterdam Med Ctr, Dept Plast & Reconstruct Surg, Amsterdam, Netherlands.
   [Zawaneh, Peter N.; Yazdi, Sara; Putnam, David] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA.
   [Weiser, Jennifer; Putnam, David] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.
   [Krotscheck, Ursula] Cornell Univ, Dept Clin Sci, Ithaca, NY USA.
RP Spector, JA (reprint author), Weill Cornell Med Coll, Lab Bioregenerat Med & Surg, Div Plast & Reconstruct Surg, New York, NY USA.
EM jas2037@med.cornell.edu
RI Henderson, Peter/O-1053-2017
OI Henderson, Peter/0000-0002-8392-7180; Putnam, David/0000-0002-0794-4915
FU Plastic Surgery Education Foundation [CBRG72-08]; Wallace H. Coulter
   Foundation
FX Contract grant sponsor: The Plastic Surgery Education Foundation;
   contract grant number: CBRG72-08; Contract grant sponsor: Phase 1 and
   Phase 2 grant from the Wallace H. Coulter Foundation
CR Antisdel JL, 2008, LARYNGOSCOPE, V118, P1265, DOI 10.1097/MLG.0b013e31816c7bc9
   Baruch Y, 2002, J HEPATOL, V37, P471, DOI 10.1016/S0168-8278(02)00215-5
   BENGMARK S, 1980, THROMB HAEMOSTASIS, V43, P203
   Berger A, 2001, BREAST CANCER RES TR, V67, P9, DOI 10.1023/A:1010671209279
   ERETH MH, 2008, NEUROSURGERY, V63
   ESMANN V, 1968, ACTA CHEM SCAND, V22, P2281, DOI 10.3891/acta.chem.scand.22-2281
   Hino M, 2000, BRIT J HAEMATOL, V108, P194, DOI 10.1046/j.1365-2141.2000.01818.x
   Kawamura M, 2002, ANN THORAC SURG, V73, P1098, DOI 10.1016/S0003-4975(02)03415-X
   Liening DA, 1997, OTOLARYNG HEAD NECK, V116, P454, DOI 10.1016/S0194-5998(97)70294-8
   Martins PNA, 2007, LIVER INT, V27, P384, DOI 10.1111/j.1478-3231.2006.01414.x
   Msezane LP, 2008, J ENDOUROL, V22, P403, DOI 10.1089/end.2007.9844
   Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005
   National Research Council, 1996, GUID CAR US LAB AN
   RACCUIA JS, 1992, AM J SURG, V163, P234, DOI 10.1016/0002-9610(92)90108-4
   Sani S, 2008, J NEUROSURG, V109, P149, DOI 10.3171/JNS/2008/109/7/0149
   Schonauer C, 2004, EUR SPINE J, V13, pS89, DOI 10.1007/s00586-004-0727-z
   SHARP PE, 1998, LAB RAT, P16
   SINGH SP, 2008, J AM COLL SURGEONS, V127, pS64
   Sirlak M, 2003, J THORAC CARDIOV SUR, V126, P666, DOI 10.1016/S0022-5223(03)00042-4
   Spotnitz William D, 2005, J Long Term Eff Med Implants, V15, P245, DOI 10.1615/JLongTermEffMedImplants.v15.i3.20
   STRYER L, 1995, BIOCHEMISTRY-US, P470
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   TRIPLETT DA, 1981, THROMBIN CLOTTING TI, P38
   Tuthill DD, 2001, J SURG RES, V95, P126, DOI 10.1006/jsre.2000.6027
   Zawaneh PN, 2006, BIOMACROMOLECULES, V7, P3245, DOI 10.1021/bm0605457
   ZAWANEH PN, P NATL ACAD IN PRESS
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P3239, DOI 10.1021/bm060544e
   ZOUCAS E, 1984, J SURG RES, V37, P145, DOI 10.1016/0022-4804(84)90175-6
NR 28
TC 15
Z9 16
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2010
VL 93A
IS 2
BP 776
EP 782
DI 10.1002/jbm.a.32586
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579ET
UT WOS:000276351300038
PM 19653301
DA 2018-10-20
ER

PT J
AU Liang, L
   Xu, XD
   Chen, CS
   Fang, JH
   Jiang, FG
   Zhang, XZ
   Zhuo, RX
AF Liang, Liang
   Xu, Xiao-Ding
   Chen, Chang-Sheng
   Fang, Jia-Hua
   Jiang, Fa-Gang
   Zhang, Xian-Zheng
   Zhuo, Ren-Xi
TI Evaluation of the Biocompatibility of Novel Peptide Hydrogel in Rabbit
   Eye
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE peptide; self-assembly; hydrogel; biocompatibility
ID OCULAR DRUG-DELIVERY; SUPRAMOLECULAR HYDROGELS; POLY(ORTHO ESTER);
   CONTROLLED-RELEASE; ACID; BIOMATERIAL; SURGERY; SYSTEM
AB A peptide containing a RGD (arginine-glycine-aspartic acid) sequence as well as a hydrophobic N-fluorenyl-9-methoxycarbonyl (FMOC) tail was prepared via a standard FMOC solid-phase peptide synthesis technique. The supramolecular self-assembly of such peptide through pi-pi stacking from FMOC tail can transfer the peptide aqueous solution into a three-dimensional hydrogel. The biocompatibility of the peptide hydrogel was evaluated via clinical follow-up and histological analysis. The data obtained demonstrated that the peptide hydrogel exhibited good biocompatibility when injected to the subconjunctival space and anterior chamber of rabbit, indicating a potential application in ophthalmology as an implantable drug delivery system for the treatment to ocular anterior segment diseases such as glaucoma, iridocyclitis, and keratopathy. (C) 2010 Wiley Periodicals. Inc J Filmed Mater Res Part B Appl Biomater 93B 324-332, 2010
C1 [Liang, Liang; Fang, Jia-Hua; Jiang, Fa-Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ophthalmol, Wuhan 430022, Peoples R China.
   [Xu, Xiao-Ding; Chen, Chang-Sheng; Zhang, Xian-Zheng; Zhuo, Ren-Xi] Wuhan Univ, Minist Educ, Key Lab Biomed Polymers, Wuhan 430072, Peoples R China.
   [Xu, Xiao-Ding; Chen, Chang-Sheng; Zhang, Xian-Zheng; Zhuo, Ren-Xi] Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
RP Jiang, FG (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ophthalmol, Wuhan 430022, Peoples R China.
FU National Natural Science Foundation of China [30772382, 20774069,
   50633020]; National Key Basic Research Program of China [2005CB623903]
FX Contract grant sponsor National Natural Science Foundation of China.
   Contract grant numbers 30772382, 20774069, and 50633020; Contract grant
   sponsor National Key Basic Research Program of China. Contract grant
   number 2005CB623903
CR BAE YH, 1993, ADV DRUG DELIVER REV, V11, P109, DOI 10.1016/0169-409X(93)90029-4
   Cao YX, 2007, J CONTROL RELEASE, V120, P186, DOI 10.1016/j.jconrel.2007.05.009
   Einmahl S, 2002, INVEST OPHTH VIS SCI, V43, P1533
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 2003, J BIOMED MATER RES A, V67A, P44, DOI 10.1002/jbm.a.10597
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Harada N., 1969, CIRCULAR DICHROISM P, V91, P5896
   Heller J, 2005, ADV DRUG DELIVER REV, V57, P2053, DOI 10.1016/j.addr.2005.09.007
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Kaluzny JJ, 2007, J BIOMED MATER RES B, V81B, P403, DOI 10.1002/jbm.b.30677
   Kim J, 2008, INT J PHARMACEUT, V353, P205, DOI 10.1016/j.ijpharm.2007.11.049
   Kiyonaka S, 2002, J AM CHEM SOC, V124, P10954, DOI 10.1021/ja027277e
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Ng SY, 2000, J CONTROL RELEASE, V65, P367, DOI 10.1016/S0168-3659(99)00218-7
   Okano T., 1998, BIORELATED POLYM GEL
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rainer G, 2007, OPHTHALMOLOGY, V114, P1089, DOI 10.1016/j.ophtha.2006.08.048
   Rathore R, 2003, J AM CHEM SOC, V125, P8712, DOI 10.1021/ja035518s
   Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021
   Sethuraman S, 2006, J BIOMED MATER RES A, V77A, P679, DOI 10.1002/jbm.a.30620
   Suzuki M, 2005, ORG BIOMOL CHEM, V3, P3073, DOI 10.1039/b507540h
   TRIECH P, 1997, CHEM REV, V97, P3133
   Wang Y, 2004, BIOMATERIALS, V25, P4279, DOI 10.1016/j.biomaterials.2003.10.075
   Yang ZM, 2005, CHEM COMMUN, P4414, DOI 10.1039/b507314f
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
NR 27
TC 26
Z9 30
U1 1
U2 30
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2010
VL 93B
IS 2
BP 324
EP 332
DI 10.1002/jbm.b.31562
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 583YG
UT WOS:000276715800005
PM 20225215
DA 2018-10-20
ER

PT J
AU Dashti, A
   Ready, D
   Salih, V
   Knowles, JC
   Barralet, JE
   Wilson, M
   Donos, N
   Nazhat, SN
AF Dashti, A.
   Ready, D.
   Salih, V.
   Knowles, J. C.
   Barralet, J. E.
   Wilson, M.
   Donos, N.
   Nazhat, S. N.
TI In Vitro antibacterial efficacy of tetracycline hydrochloride adsorbed
   onto Bio-Oss (R) bone graft
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Bio-Oss (R); bone graft; antibiotics; local delivery; antimicrobial;
   periodontal disease; peri-implantitis; infection
ID GINGIVAL CREVICE FLUID; PERI-IMPLANTITIS; BOVINE BONE; ANTIMICROBIAL
   THERAPY; SUBGINGIVAL ORGANISMS; PERIODONTAL POCKETS; LOCAL-DELIVERY;
   HYDROXYAPATITE; REGENERATION; DEFECTS
AB Local delivery of antibiotics may provide the advantage of reducing the potential side effects associated with their systemic administration This study assessed, in vitro, the antimicrobial efficacy of tetracycline hydrochloride ITCH) adsorbed onto Bio-Oss (R) bone grafts against a range of pathogenic bacteria Various levels of TCH were adsorbed onto Bio-Oss (R) granules by immersing in TCH aqueous solutions of different initial concentrations for 48 h at room temperature TCH release was assessed in phosphate buffered saline at 37 degrees C, and its antimicrobial efficacy, up to 96 h, was tested against two Gram-negative bacteria associated with periodontal diseases Aggregatibacter (formerly Actinobacillus) actinomycetemcomitans, and Porphyromonas gingivalis, and one Gram-positive bacterium associated with soft-tissue and bone infections Staphylococcus aureus The range of TCH concentrations studied was also assessed for cytotoxicity against osteoblast-like human osteosarcoma cell lines. The amount of TCH adsorbed and released from Bio-Oss (R) was concentration dependent All TCH adsorbed Bio-Oss (R) resulted in a reduction of A actinomycetemcomitans, P gingivalis, and S aureus and higher concentrations were generally more effective in reducing or eliminating bacterial growth The proliferation of HOS cells was not substantially reduced except for the maximum concentration of TCH In addition to its osteoconductive role, TCH adsorbed Bio-Oss (R) could also be functional in negating systemically antibiotic prophylactic treatment in the prevention of implant or biomaterial related infections (C) 2010 Wiley Periodicals, Inc J Biomed Mater Res Part B Appl Biomater 93B 394-400, 2010
C1 [Salih, V.; Knowles, J. C.; Nazhat, S. N.] UCL, UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   [Dashti, A.; Donos, N.] UCL, UCL Eastman Dent Inst, Dept Periodontol, London WC1X 8LD, England.
   [Ready, D.] UCL, UCLH NHS Fdn Trust, Eastman Dent Hosp, London WC1X 8LD, England.
   [Barralet, J. E.] McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   [Wilson, M.] UCL, UCL Eastman Dent Inst, Div Microbial Dis, London WC1X 8LD, England.
   [Nazhat, S. N.] McGill Univ, Fac Engn, Dept Min & Mat Engn, Montreal, PQ H3A 2B2, Canada.
RP Nazhat, SN (reprint author), UCL, UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
RI Knowles, Jonathan Campbell/B-9019-2008; barralet, jake/A-5820-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446; barralet,
   jake/0000-0003-3543-6042
FU UK EPSRC; Geistlich Biomaterials (Geistlich Pharma AG Wolhusen,
   Switzerland); UCLH/UCL (Department of Health's NIHR Biomedical Research
   Centres Funding Scheme, UK)
FX Contract grant sponsors UK EPSRC and Geistlich Biomaterials (Geistlich
   Pharma AG Wolhusen, Switzerland), UCLH/UCL (Department of Health's NIHR
   Biomedical Research Centres Funding Scheme, UK)
CR ALALI W, 1989, J PERIODONTOL, V60, P582, DOI 10.1902/jop.1989.60.10.582
   ALBERT A, 1956, NATURE, V177, P433, DOI 10.1038/177433a0
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   BAYSTON R, 1999, DENT PLAQUES REVISIT
   Becker W, 2003, PERIODONTOL 2000, V33, P26, DOI 10.1046/j.0906-6713.2003.03303.x
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   Buchter A, 2004, BRIT J ORAL MAX SURG, V42, P439, DOI 10.1016/j.bjoms.2004.06.005
   Chung CP, 1997, J PERIODONTAL RES, V32, P172, DOI 10.1111/j.1600-0765.1997.tb01400.x
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   DAVIES AK, 1985, J DENT RES, V64, P936, DOI 10.1177/00220345850640061701
   DELEU J, 1964, NATURE, V204, P1103, DOI 10.1038/2041103b0
   Donos N, 2004, CLIN ORAL IMPLAN RES, V15, P101, DOI 10.1111/j.1600-0501.2004.00986.x
   DRURY GI, 1991, J PERIODONTOL, V62, P652, DOI 10.1902/jop.1991.62.11.652
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Gomes PS, 2008, ACTA BIOMATER, V4, P630, DOI 10.1016/j.actbio.2007.12.006
   Gomes PS, 2007, ARCH ORAL BIOL, V52, P251, DOI 10.1016/j.archoralbio.2006.10.005
   GOODSON JM, 1983, J PERIODONTOL, V54, P575, DOI 10.1902/jop.1983.54.10.575
   GORDON JM, 1981, J PERIODONTOL, V52, P609, DOI 10.1902/jop.1981.52.10.609
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   HARTMANN A, 1995, MUTAT RES LETT, V348, P7, DOI 10.1016/0165-7992(95)90014-4
   Huang WC, 2008, CHINESE CHEM LETT, V19, P19, DOI 10.1016/j.cclet.2007.10.048
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x
   MISRA DN, 1991, CALCIFIED TISSUE INT, V48, P362, DOI 10.1007/BF02556156
   Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x
   Mombelli A, 2001, CLIN ORAL IMPLAN RES, V12, P287, DOI 10.1034/j.1600-0501.2001.012004287.x
   Murugan R, 2004, BIOMATERIALS, V25, P3073, DOI 10.1016/j.biomaterials.2003.09.089
   *NAT COMM CLIN LAB, 2003, M11A5 NCCLS
   *NAT COMM CLIN LAB, 2003, M07A6 NCCLS
   Needleman IG, 1998, J PERIODONTOL, V69, P578, DOI 10.1902/jop.1998.69.5.578
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Oyane A, 2006, BIOMATERIALS, V27, P3295, DOI 10.1016/j.biomaterials.2006.01.029
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, P87
   PERRIN DD, 1965, NATURE, V208, P787, DOI 10.1038/208787a0
   Persson GR, 2006, CLIN ORAL IMPLAN RES, V17, P386, DOI 10.1111/j.1600-0501.2006.01269.x
   Queiroz AC, 2001, BIOMATERIALS, V22, P1393, DOI 10.1016/S0142-9612(00)00296-9
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Renvert S, 2006, J CLIN PERIODONTOL, V33, P362, DOI 10.1111/j.1600-051X.2006.00919.x
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Saito T, 2002, J BIOMED MATER RES, V63, P245, DOI 10.1002/jbm.10179
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Schwartz Z, 2000, J PERIODONTOL, V71, P586, DOI 10.1902/jop.2000.71.4.586
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   Sculean A, 2004, Clin Oral Investig, V8, P70
   SLOTS J, 1990, J CLIN PERIODONTOL, V17, P479
   SOMERMAN MJ, 1988, J PERIODONTAL RES, V23, P154, DOI 10.1111/j.1600-0765.1988.tb01349.x
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   TONETTI M, 1990, J PERIODONTAL RES, V25, P243, DOI 10.1111/j.1600-0765.1990.tb00911.x
   WALKER CB, 1981, J PERIODONTOL, V52, P613, DOI 10.1902/jop.1981.52.10.613
   Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011
   Winkler H, 2000, J ANTIMICROB CHEMOTH, V46, P423, DOI 10.1093/jac/46.3.423
   Young AM, 2008, ACTA BIOMATER, V4, P1081, DOI 10.1016/j.actbio.2007.12.009
   Zitzmann NU, 2004, J CLIN PERIODONTOL, V31, P845, DOI 10.1111/j.1600-051X.2004.00567.x
NR 55
TC 16
Z9 16
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2010
VL 93B
IS 2
BP 394
EP 400
DI 10.1002/jbm.b.31594
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 583YG
UT WOS:000276715800013
PM 20119947
DA 2018-10-20
ER

PT J
AU Yun, JI
   Wikesjo, UME
   Borke, JL
   Bisch, FC
   Lewis, JE
   Herold, RW
   Swiec, GD
   Wood, JC
   McPherson, JC
AF Yun, Jonathan I.
   Wikesjoe, Ulf M. E.
   Borke, James L.
   Bisch, Frederick C.
   Lewis, Jill E.
   Herold, Robert W.
   Swiec, Gary D.
   Wood, Joseph C.
   McPherson, James C., III
TI Effect of systemic parathyroid hormone (1-34) and a beta-tricalcium
   phosphate biomaterial on local bone formation in a critical-size rat
   calvarial defect model
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE beta-tricalcium phosphate; guided bone regeneration; parathyroid
   hormone; rat calvaria model; tissue engineering
ID MORPHOGENETIC PROTEIN-4; REGENERATION; APOPTOSIS; SURGERY; MATRIX; DRUG
AB P>Objective
   The objective of this study was to evaluate local bone formation following systemic administration of parathyroid hormone (1-34) (PTH), a surgically implanted synthetic beta-tricalcium phosphate (beta-TCP) bone biomaterial serving as a matrix to support new bone formation.
   Materials and Methods
   Critical-size, 8 mm, calvarial through-and-through osteotomy defects were surgically created in 100 adult male Sprague-Dawley rats. The animals were randomized into five groups of 20 animals each to receive one of the following treatments: PTH (15 mu g PTH/kg/day; subcutaneously), PTH/beta-TCP, beta-TCP, or particulate human demineralized freeze-dried bone (DFDB), and sham-surgery controls. Ten animals/group were euthanized at 4 and 8 weeks post-surgery for radiographic and histometric analysis.
   Results
   The histometric analysis showed that systemic PTH significantly enhanced local bone formation, bone fill averaging (+/- SE) 32.2 +/- 4.0% compared with PTH/beta-TCP (15.7 +/- 2.4%), beta-TCP (12.5 +/- 2.3%), DFDB (14.5 +/- 2.3%), and sham-surgery control (10.0 +/- 1.5%) at 4 weeks (p < 0.014). Systemic PTH showed significantly enhanced bone formation (41.5 +/- 4.0%) compared with PTH/beta-TCP (22.4 +/- 3.0%), beta-TCP (21.3 +/- 4.4%), and with the sham-surgery control (23.8 +/- 4.2%) at 8 weeks (p < 0.025). The DFDB group showed significantly increased bone formation from 4 (14.5 +/- 2.3%) to 8 weeks (32.0 +/- 3.2%) (p < 0.006). The PTH/beta-TCP and beta-TCP groups both showed limited biomaterials resorption. The radiographic analysis was not diagnostic to distinguish local bone formation from the radiopaque beta-TCP biomaterial.
   Conclusions
   Systemic administration of PTH significantly stimulates local bone formation. Bone formation was significantly limited by the beta-TCP biomaterial.
C1 [Yun, Jonathan I.; Bisch, Frederick C.; Herold, Robert W.] US Army, Adv Educ Program Periodont, Ft Gordon, GA USA.
   [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, LAPCR, Dept Periodont, Augusta, GA 30912 USA.
   [Wikesjoe, Ulf M. E.] Med Coll Georgia, Sch Dent, LAPCR, Dept Oral Biol, Augusta, GA 30912 USA.
   [Swiec, Gary D.] USA, DENTAC, Ft George G Meade, MD USA.
   [Wood, Joseph C.; McPherson, James C., III] US Army, Dept Clin Invest, Ft Gordon, GA USA.
RP Yun, JI (reprint author), 851 Ted A Crozier Sr,Blvd Apt 711, Clarksville, TN 37043 USA.
EM jonathan.yun@us.army.mil
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
FU USA DENTAC, Fort Gordon, GA
FX The study was funded in its entirety by the USA DENTAC, Fort Gordon, GA.
CR Ahn SH, 2003, J PERIODONTOL, V74, P787, DOI 10.1902/jop.2003.74.6.787
   Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115
   Andreassen TT, 2004, J CRANIOFAC SURG, V15, P424, DOI 10.1097/00001665-200405000-00014
   Cosman Felicia, 2005, Curr Osteoporos Rep, V3, P143, DOI 10.1007/s11914-996-0017-2
   Deal C, 2003, CLEV CLIN J MED, V70, P585, DOI 10.3949/ccjm.70.7.585
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   ISAKSSON S, 1992, J CRANIO MAXILL SURG, V20, P73, DOI 10.1016/S1010-5182(05)80471-8
   Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610
   Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x
   Kuemmerle JF, 2005, AM J PHYSIOL-GASTR L, V288, pG101, DOI 10.1152/ajpgi.00032.2004
   Lim SC, 2000, PATHOL INT, V50, P594, DOI 10.1046/j.1440-1827.2000.01089.x
   Madore GR, 2004, J AM ACAD ORTHOP SUR, V12, P67, DOI 10.5435/00124635-200403000-00001
   Marx J, 2004, SCIENCE, V305, P1420, DOI 10.1126/science.305.5689.1420
   Matzenbacher SA, 2003, J PERIODONTOL, V74, P1641, DOI 10.1902/jop.2003.74.11.1641
   Pang EK, 2004, J PERIODONTOL, V75, P1364, DOI 10.1902/jop.2004.75.10.1364
   Poehling S, 2006, J PERIODONTOL, V77, P1582, DOI 10.1902/jop.2006.050328
   Precheur Harry V, 2007, Dent Clin North Am, V51, P729
   PROLO DJ, 1982, CLIN ORTHOP RELAT R, V168, P230
   Pryor ME, 2006, J CLIN PERIODONTOL, V33, P455, DOI 10.1111/j.1600-051X.2006.00921.x
   Quattrocchi E, 2004, CLIN THER, V26, P841, DOI 10.1016/S0149-2918(04)90128-2
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299
   Shiratori K, 2005, BIOMED RES-TOKYO, V26, P51, DOI 10.2220/biomedres.26.51
   Skripitz R, 2000, J BONE JOINT SURG BR, V82B, P138, DOI 10.1302/0301-620X.82B1.9729
   Skripitz R, 2004, ACTA ORTHOP SCAND, V75, P654, DOI 10.1080/00016470410004012
   Zellin G, 1997, J BIOMED MATER RES, V35, P181
   Zijderveld SA, 2005, INT J ORAL MAX IMPL, V20, P432
NR 27
TC 34
Z9 34
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD MAY
PY 2010
VL 37
IS 5
BP 419
EP 426
DI 10.1111/j.1600-051X.2010.01547.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 580ZP
UT WOS:000276490000003
PM 20236187
DA 2018-10-20
ER

PT J
AU D'Sa, RA
   Burke, GA
   Meenan, BJ
AF D'Sa, Raechelle A.
   Burke, George A.
   Meenan, Brian J.
TI Lens epithelial cell response to atmospheric pressure plasma modified
   poly(methylmethacrylate) surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DIELECTRIC BARRIER DISCHARGE; POSTERIOR CAPSULAR OPACIFICATION;
   INTRAOCULAR LENSES; POLY(METHYL METHACRYLATE); TYROSINE PHOSPHORYLATION;
   POLY(ETHYLENE GLYCOL); OPERATING PARAMETERS; POLYMER SURFACE; IN-VITRO;
   ADHESION
AB Selective control of cellular response to polymeric biomaterials is an important consideration for many ocular implant applications. In particular, there is often a need to have one surface of an ophthalmic implant capable of promoting cell attachment while the other needs to be resistant to this effect. In this study, an atmospheric pressure dielectric barrier discharge (DBD) has been used to modify the surface region of poly(methyl methacrylate) (PMMA), a well established ocular biomaterial, with the aim of promoting a controlled response to human lens epithelial cells (LEC) cultured thereon. The DBD plasma discharge environment has also been employed to chemically graft a layer of poly(ethylene glycol) methyl ether methacrylate (PEGMA) onto the PMMA and the response to LEC likewise determined. Two different molecular weights of PEGMA, namely 1000 and 2000 MW were used in these experiments. The LEC response to DBD treated polystyrene (PS) samples has also been examined as a positive control and to help to further elucidate the nature of the modified surfaces. The LEC adhered and proliferated readily on the DBD treated PMMA and PS surfaces when compared to the pristine polymer samples which showed little or no cell response. The PMMA and PS surfaces that had been DBD grafted with the PEGMA(1000) layer were found to have some adhered cells. However, on closer inspection, these cells were clearly on the verge of detaching. In the case of the PEGMA(2000) grafted surfaces no cells were observed indicating that the higher molecular weight PEGMA has been able to attain a surface conformation that is capable of resisting cell attachment in vitro.
C1 [D'Sa, Raechelle A.; Burke, George A.; Meenan, Brian J.] Univ Ulster, Sch Engn, NIBEC, Newtownabbey BT37 0QB, Antrim, North Ireland.
RP Meenan, BJ (reprint author), Univ Ulster, Sch Engn, NIBEC, Shore Rd, Newtownabbey BT37 0QB, Antrim, North Ireland.
EM bj.meenan@ulster.ac.uk
FU University of Ulster
FX The authors wish to thank Dr. G. Mahon, Department of Ophthalmology,
   Queen's University Belfast, UK for provision of the lens epithelial cell
   line. R. A. D. acknowledges the University of Ulster for the award of a
   Vice-chancellors postgraduate studentship.
CR ANDRADE J D, 1991, Journal of Biomaterials Science Polymer Edition, V2, P161
   Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549
   Borcia G, 2004, APPL SURF SCI, V225, P186, DOI 10.1016/j.apsusc.2003.10.002
   Borcia G, 2004, APPL SURF SCI, V221, P203, DOI 10.1016/S0169-4332(03)00879-1
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui NY, 2007, APPL SURF SCI, V253, P3865, DOI 10.1016/j.apsusc.2006.08.008
   Doan Kim T, 2002, Curr Opin Ophthalmol, V13, P24, DOI 10.1097/00055735-200202000-00006
   DSA RA, 2010, LANGMUIR, V24, P1894
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Evans MDM, 2004, J BIOMED MATER RES A, V69A, P469, DOI 10.1002/jbm.a.30017
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Hicks CR, 1997, SURV OPHTHALMOL, V42, P175, DOI 10.1016/S0039-6257(97)00024-6
   Ilhan-Sarac Ozge, 2005, Curr Opin Ophthalmol, V16, P246, DOI 10.1097/01.icu.0000172829.33770.d3
   Kato K, 2003, PROG POLYM SCI, V28, P209, DOI 10.1016/S0079-6700(02)00032-1
   Kim MK, 2001, J CATARACT REFR SURG, V27, P766, DOI 10.1016/S0886-3350(00)00701-X
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Liu CZ, 2006, APPL SURF SCI, V252, P2297, DOI 10.1016/j.apsusc.2005.04.016
   Liu CZ, 2005, SURF SCI, V575, P273, DOI 10.1016/j.susc.2004.11.026
   Liu HZ, 2004, SURF COAT TECH, V185, P311, DOI 10.1016/j.surfcoat.2004.01.024
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Matsushima H, 2008, EXPERT REV MED DEVIC, V5, P197, DOI 10.1586/17434440.5.2.197
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Mitchell SA, 2005, J COLLOID INTERF SCI, V281, P122, DOI 10.1016/j.jcis.2004.08.049
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Nishi O, 1999, J CATARACT REFR SURG, V25, P106, DOI 10.1016/S0886-3350(99)80020-0
   NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398
   Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009
   Schauersberger J, 2001, J CATARACT REFR SURG, V27, P850, DOI 10.1016/S0886-3350(00)00861-0
   SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738
   Spalton DJ, 1999, EYE, V13, P489
   Tognetto D, 2003, OPHTHALMOLOGY, V110, P1935, DOI 10.1016/S0161-6420(03)00736-X
   Upadhyay DJ, 2005, J PHYS D APPL PHYS, V38, P922, DOI 10.1088/0022-3727/38/6/022
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   Wang P, 2002, J MEMBRANE SCI, V195, P103, DOI 10.1016/S0376-7388(01)00548-8
   Weber GF, 2006, DEV BIOL, V295, P714, DOI 10.1016/j.ydbio.2006.03.056
   Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8
   Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200
   Yan Q, 2005, GRAEF ARCH CLIN EXP, V243, P1253, DOI 10.1007/s00417-005-1181-2
   Yuen C, 2006, CLIN EXP OPHTHALMOL, V34, P568, DOI 10.1111/j.1442-9071.2006.1278.x
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 45
TC 14
Z9 15
U1 3
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2010
VL 21
IS 5
BP 1703
EP 1712
DI 10.1007/s10856-010-4030-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 595ID
UT WOS:000277603000034
PM 20195888
DA 2018-10-20
ER

PT J
AU Andersen, TE
   Kingshott, P
   Palarasah, Y
   Benter, M
   Alei, M
   Kolmos, HJ
AF Andersen, Thomas Emil
   Kingshott, Peter
   Palarasah, Yaseelan
   Benter, Maike
   Alei, Mojagan
   Kolmos, Hans Jorn
TI A flow chamber assay for quantitative evaluation of bacterial surface
   colonization used to investigate the influence of temperature and
   surface hydrophilicity on the biofilm forming capacity of uropathogenic
   Escherichia coli
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE E. coli; Biofilm; Biomaterial-associated infection; Quantitative biofilm
   assay; Clinical isolates; Surface chemistry
ID MICROBIAL ADHESION; FIBRONECTIN-BINDING; ADHERENCE; STAPHYLOCOCCI;
   INHIBITION; CURLI; QUANTIFICATION; BIOMATERIAL; INFECTIONS; EXPRESSION
AB We have established a simple flow chamber-based procedure which provides an accurate and reproducible way to measure the amount of biofilm formed on an implantable biomaterial surface. The method enables the side-by-side evaluation of different materials under hydrodynamic flow conditions similar to those found on an implanted device. We have used the method to evaluate the biofilm forming capacity of clinically isolated Escherichia coli on silicone rubber and on silicone rubber containing a hydrophilic coating. It was found that the surface chemistry influenced the colonization of the isolates very differently. In addition, the temperature was found to have a considerable influence upon the adhesion and biofilm forming capacity of some of the isolates, and that the influence of surface chemistry depended on temperature. Our results suggest that the step from using E. coli laboratory strains to clinical isolates entails a significant rise in complexity and yields results that cannot be generalized. The results should be valuable information for researchers working with pre-clinical evaluation of device-associated E. coli infections. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Andersen, Thomas Emil; Kolmos, Hans Jorn] Univ So Denmark, Res Unit Clin Microbiol, DK-5000 Odense C, Denmark.
   [Kingshott, Peter] Aarhus Univ, Fac Sci, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark.
   [Palarasah, Yaseelan] Univ So Denmark, Res Unit Immunol & Microbiol, DK-5000 Odense C, Denmark.
   [Andersen, Thomas Emil; Benter, Maike; Alei, Mojagan] Nanon AS, DK-2605 Brondby, Denmark.
RP Andersen, TE (reprint author), Univ So Denmark, Res Unit Clin Microbiol, DK-5000 Odense C, Denmark.
EM thandersen@health.sdu.dk
RI Usher, Kayley/F-7342-2011
OI Kingshott, Peter/0000-0001-5882-5804; Andersen, Thomas
   Emil/0000-0001-9453-1141
FU Danish Agency for Science Technology and Innovation
FX We wish to thank the Danish Agency for Science Technology and Innovation
   for financial support.
CR ANDERSEN TE, BIOMATERIALS UNPUB
   Bakker DP, 2003, APPL ENVIRON MICROB, V69, P6280, DOI 10.1128/AEM.69.10.6280-6287.2003
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BRIDGETT MJ, 1993, BIOMATERIALS, V14, P184, DOI 10.1016/0142-9612(93)90021-S
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   Cagavi F, 2004, ACTA NEUROCHIR, V146, P603, DOI 10.1007/s00701-004-0262-z
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2
   Fallis Wendy M, 2005, Crit Care Nurse, V25, P44
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Fundeanu I, 2008, COLLOID SURFACE B, V64, P297, DOI 10.1016/j.colsurfb.2008.02.005
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X
   Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x
   Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409
   JANSEN B, 1993, GASTROINTEST ENDOSC, V39, P670, DOI 10.1016/S0016-5107(93)70220-5
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   Millsap KW, 1999, FEMS IMMUNOL MED MIC, V26, P69, DOI 10.1016/S0928-8244(99)00124-8
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Nejadnik MR, 2008, APPL ENVIRON MICROB, V74, P916, DOI 10.1128/AEM.01557-07
   OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0
   PITT WG, 1993, BIOMATERIALS, V14, P605, DOI 10.1016/0142-9612(93)90179-6
   Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x
   Reisner A, 2006, J BACTERIOL, V188, P3572, DOI 10.1128/JB.188.10.3572-3581.2006
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   ROOSJEN A, 2003, MICROBIOLOGY, V149, P1
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
   Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x
   Stickler DJ, 2006, J APPL MICROBIOL, V100, P1028, DOI 10.1111/j.1365-2672.2006.02840.x
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005
   Velraeds MMC, 1997, UROLOGY, V49, P790, DOI 10.1016/S0090-4295(97)00065-4
   WINTHERJENSEN B, 2003, Patent No. 6628084
NR 39
TC 15
Z9 18
U1 3
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD MAY
PY 2010
VL 81
IS 2
BP 135
EP 140
DI 10.1016/j.mimet.2010.02.009
PG 6
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 599YJ
UT WOS:000277949900008
PM 20188127
DA 2018-10-20
ER

PT J
AU Klemuk, SA
   Lu, XY
   Hoffman, HT
   Titze, IR
AF Klemuk, Sarah A.
   Lu, Xiaoying
   Hoffman, Henry T.
   Titze, Ingo R.
TI Phonation Threshold Pressure Predictions Using Viscoelastic Properties
   Up to 1,400 Hz of Injectables Intended for Reinke's Space
SO LARYNGOSCOPE
LA English
DT Article
DE Reinke's space; phonation threshold pressure; viscoelasticity
ID CROSS-LINKED HYALURONAN; VOCAL FOLD AUGMENTATION; RHEOMETER; INJECTION;
   BIOMATERIALS; FREQUENCIES; DEPENDENCE; PARALYSIS; HYDRATION; COLLAGEN
AB Objectives/Hypothesis: Viscoelastic properties of numerous vocal fold injectables have been reported but not at speaking frequencies. For materials intended for Reinke's space, ramifications of property values are of great concern because of their impact on ease of voice onset. Our objectives were: 1) to measure viscoelastic properties of a new nonresorbing carbomer and well-known vocal fold injectables at vocalization frequencies using established and new instrumentation, and 2) to predict phonation threshold pressures using a computer model with intended placement in Reinke's space.
   Study Design: Rheology and phonation threshold pressure calculations.
   Methods: Injectables were evaluated with a traditional rotational rheometer and a new piezo-rotary vibrator. Using these data at vocalization frequencies, phonation threshold pressures (PTP) were calculated for each biomaterial, assuming a low dimensional model with supraglottic coupling and adjusted vocal fold length and thickness at each frequency. Results were normalized to a nominal PTP value.
   Results: Viscoelastic data were acquired at vocalization frequencies as high as 363 to 1,400 Hz for six new carbomer hydrogels, Hylan B, and Extracel intended for vocal fold Reinke's space injection and for Cymetra (lateral injection). Reliability was confirmed with good data overlap when measuring with either rheometer. PTP predictions ranged from 0.001 to 16 times the nominal PTP value of 0.283 kPa.
   Conclusions: Accurate viscoelastic measurements of vocal fold injectables are now possible at physiologic frequencies. Hylan B, Extracel, and the new carbomer hydrogels should generate easy vocal onset and sustainable vocalization based on their rheologic properties if injected into Reinke's space. Applications may vary depending on desired longevity of implant.
C1 [Klemuk, Sarah A.; Lu, Xiaoying; Titze, Ingo R.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA 52242 USA.
   [Hoffman, Henry T.] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.
   [Titze, Ingo R.] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA.
RP Klemuk, SA (reprint author), Univ Iowa, Dept Commun Sci & Disorders, 334B SHC, Iowa City, IA 52242 USA.
EM sarah-klemuk@uiowa.edu
OI Hoffman, Henry/0000-0003-4486-855X
FU National Institute on Deafness and Other Communication Disorders, NIH
   [DC004224, DC008047]
FX This work was performed at The University of Iowa, Iowa City, Iowa, and
   was supported by NIH Grant No. DC004224 and No. DC008047 from the
   National Institute on Deafness and Other Communication Disorders.
   Cymetra samples were provided by Life Cell Corp. as per study review
   board request. Carbomer samples and nominal funding for labor were
   provided by Cytophil, Inc. as part of a preclinical trials contract with
   The University of Iowa. Cytophil, Inc. was not involved in developing
   the purpose, experimental design, analysis, results, or discussion of
   the study. The authors have no other funding, financial relationships,
   or conflicts of interest to disclose.
CR Bock JM, 2007, LARYNGOSCOPE, V117, P2251, DOI 10.1097/MLG.0b013e3181462a16
   Caton T, 2007, LARYNGOSCOPE, V117, P516, DOI 10.1097/MLG.0b013e31802e9291
   Ceulemans J, 2002, EUR J PHARM BIOPHARM, V54, P41, DOI 10.1016/S0939-6411(02)00036-X
   Chan RW, 2008, J ACOUST SOC AM, V124, P1207, DOI 10.1121/1.2946715
   Chan RW, 2006, J ACOUST SOC AM, V119, P2351, DOI 10.1121/1.2173516
   Chan RW, 1998, LARYNGOSCOPE, V108, P725, DOI 10.1097/00005537-199805000-00019
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Chang A, 2004, J VOICE, V18, P454, DOI 10.1016/j.jvoice.2004.01.004
   Courey MS, 2001, LARYNGOSCOPE, V111, P747, DOI 10.1097/00005537-200105000-00001
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Hertegard S, 2004, ACTA OTO-LARYNGOL, V124, P1208, DOI 10.1080/00016480410017701
   HUANG LL, 1995, DRUG DEV IND PHARM, V21, P1487, DOI 10.3109/03639049509069240
   Islam MT, 2004, PHARM RES, V21, P1192, DOI 10.1023/B:PHAM.0000033006.11619.07
   Jahan-Parwar B, 2008, ANN OTO RHINOL LARYN, V117, P703, DOI 10.1177/000348940811700913
   Kirschenmann L, 2002, RHEOL ACTA, V41, P362, DOI 10.1007/s00397-002-0229-z
   Klemuk SA, 2004, LARYNGOSCOPE, V114, P1597, DOI 10.1097/00005537-200409000-00018
   Klemuk SA, 2009, J RHEOL, V53, P765, DOI 10.1122/1.3119056
   Manna F, 1999, J EUR ACAD DERMATOL, V13, P183
   Milstein CF, 2005, LARYNGOSCOPE, V115, P1691, DOI 10.1097/01.mlg.0000173163.07828.30
   Morrison F, 2001, UNDERSTANDING RHEOLO
   Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001
   Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007
   Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299
   Titze I. R., 2000, PRINCIPLES VOICE PRO
   Titze I. R., 2006, MYOELASTIC AERODYNAM
   TITZE IR, 1992, J ACOUST SOC AM, V91, P2926, DOI 10.1121/1.402928
   TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910
   TITZE IR, 2003, J SPEECH LANG HEAR R, V46, P922
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
   VERDOLINI K, 1994, J SPEECH HEAR RES, V37, P1001, DOI 10.1044/jshr.3705.1001
   VERDOLINIMARSTON K, 1990, J VOICE, V4, P142, DOI 10.1016/S0892-1997(05)80139-0
   WEXLER DB, 1989, ANN OTO RHINOL LARYN, V98, P668, DOI 10.1177/000348948909800902
NR 32
TC 9
Z9 9
U1 1
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0023-852X
J9 LARYNGOSCOPE
JI Laryngoscope
PD MAY
PY 2010
VL 120
IS 5
BP 995
EP 1001
DI 10.1002/lary.20877
PG 7
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA 594LW
UT WOS:000277540200024
PM 20422697
DA 2018-10-20
ER

PT J
AU Mour, M
   Das, D
   Winkler, T
   Hoenig, E
   Mielke, G
   Morlock, MM
   Schilling, AF
AF Mour, Meenakshi
   Das, Debarun
   Winkler, Thomas
   Hoenig, Elisa
   Mielke, Gabriela
   Morlock, Michael M.
   Schilling, Arndt F.
TI Advances in Porous Biomaterials for Dental and Orthopaedic Applications
SO MATERIALS
LA English
DT Review
DE biomaterial; porosity; tissue engineering; bone; teeth
ID BMP-INDUCED OSTEOGENESIS; ECTOPIC BONE-FORMATION; TOTAL
   HIP-ARTHROPLASTY; FORMATION IN-VITRO; TITANIUM IMPLANTS;
   ELECTRODISCHARGE COMPACTION; MECHANICAL-PROPERTIES; SYNTHETIC
   HYDROXYAPATITE; SURFACE CHARACTERISTICS; FABRICATION TECHNIQUES
AB The connective hard tissues bone and teeth are highly porous on a micrometer scale, but show high values of compression strength at a relatively low weight. The fabrication of porous materials has been actively researched and different processes have been developed that vary in preparation complexity and also in the type of porous material that they produce. Methodologies are available for determination of pore properties. The purpose of the paper is to give an overview of these methods, the role of porosity in natural porous materials and the effect of pore properties on the living tissues. The minimum pore size required to allow the ingrowth of mineralized tissue seems to be in the order of 50 mu m: larger pore sizes seem to improve speed and depth of penetration of mineralized tissues into the biomaterial, but on the other hand impair the mechanical properties. The optimal pore size is therefore dependent on the application and the used material.
C1 [Winkler, Thomas; Hoenig, Elisa; Mielke, Gabriela; Morlock, Michael M.; Schilling, Arndt F.] Hamburg Univ Technol, Biomech Sect, D-21073 Hamburg, Germany.
   [Mour, Meenakshi; Das, Debarun] Natl Inst Technol, Dept Mech Engn, Durgapur 713209, India.
RP Schilling, AF (reprint author), Hamburg Univ Technol, Biomech Sect, D-21073 Hamburg, Germany.
EM meenakshi.mour@gmail.com; debarun.das88@gmail.com;
   thomas.winkler@tuhh.de; elisa.hoenig@tuhh.de; gabriela.mielke@tuhh.de;
   morlock@tuhh.de; a.schilling@tuhh.de
OI Morlock, Michael/0000-0002-5330-2454
FU German Research Community (DFG) [EI467/3-1]; Kurt-Eberhard-Bode-Trust,
   Stifterverband fur die Deutsche Wissenschaft, Essen, Germany
FX Elisa Hoenig was supported by a grant of the German Research Community
   (DFG) EI467/3-1. Arndt F. Schilling is supported by an unrestricted
   grant of the Kurt-Eberhard-Bode-Trust, Stifterverband fur die Deutsche
   Wissenschaft, Essen, Germany.
CR ADELL R, 1970, Scandinavian Journal of Plastic and Reconstructive Surgery, V4, P19
   Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Akin FA, 2001, J BIOMED MATER RES, V57, P588, DOI 10.1002/1097-4636(20011215)57:4<588::AID-JBM1206>3.0.CO;2-Y
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   Blackwood DJ, 2003, CORROS REV, V21, P97
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Burdick JA, 2003, BIOMATERIALS, V24, P1613, DOI 10.1016/S0142-9612(02)00538-0
   Burdick JA, 2002, J BIOMED MATER RES, V63, P484, DOI 10.1002/jbm.10298
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   Chang YS, 1998, J ARTHROPLASTY, V13, P816, DOI 10.1016/S0883-5403(98)90037-7
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen FL, 2002, J ORAL MAXIL SURG, V60, P1155, DOI 10.1053/joms.2002.34991
   Clerc CO, 1997, J BIOMED MATER RES, V38, P229, DOI 10.1002/(SICI)1097-4636(199723)38:3<229::AID-JBM7>3.0.CO;2-R
   COOK SD, 1988, J BIOMED MATER RES, V22, P287, DOI 10.1002/jbm.820220404
   Cooper DML, 2004, CALCIFIED TISSUE INT, V74, P437, DOI 10.1007/s00223-003-0071-z
   Crowninshield R D, 1986, Instr Course Lect, V35, P144
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   Curtis A., 2001, MATER TODAY, V4, P22, DOI DOI 10.1016/S1369-7021(01)80035-3)
   D'Lima DD, 1998, J ARTHROPLASTY, V13, P928, DOI 10.1016/S0883-5403(98)90201-7
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Damien E, 2003, J BIOMED MATER RES A, V66A, P241, DOI 10.1002/jbm.a.10564
   DAVID HK, 1990, J BIOMED MATER RES, V24, P1483
   Davis NG, 2001, J MATER RES, V16, P1508, DOI 10.1557/JMR.2001.0210
   De Santis R, 2002, INTEGRATED BIOMATERIALS SCIENCE, P589
   DEFIGUEIREDO MM, 2008, J DENT, V36, P588
   Demirel MC, 2007, J BIOMED MATER RES B, V81B, P219, DOI 10.1002/jbm.b.30656
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUCHEYNE P, 1983, BIOMATERIALS, V4, P185, DOI 10.1016/0142-9612(83)90008-X
   Ducheyne P., 1986, CLIN MATER, V1, P59
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V69A, P490, DOI 10.1002/jbm.a.30022
   EPPLE M, 2003, MICROSC MICROANAL S3, V9, P450
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Geirsson J, 2004, DENT MATER, V20, P987, DOI 10.1016/j.dental.2004.07.003
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Gong WL, 2001, J BIOMED MATER RES, V54, P320, DOI 10.1002/1097-4636(20010305)54:3<320::AID-JBM20>3.0.CO;2-E
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Groza JR, 2000, MAT SCI ENG A-STRUCT, V287, P171, DOI 10.1016/S0921-5093(00)00771-1
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Hardt CRE, 2002, CLIN ORAL IMPLAN RES, V13, P488, DOI 10.1034/j.1600-0501.2002.130507.x
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Harvey EJ, 1999, J BONE JOINT SURG AM, V81A, P93, DOI 10.2106/00004623-199901000-00013
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Heinl P, 2007, ADV ENG MATER, V9, P360, DOI 10.1002/adem.200700025
   HILLMAN P, 1991, CASE NEW PARADIGMS C
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   Holand W, 2009, J EUR CERAM SOC, V29, P1291, DOI 10.1016/j.jeurceramsoc.2008.08.023
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Huysmans MCDNJM, 1996, DENT MATER, V12, P116, DOI 10.1016/S0109-5641(96)80078-9
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   Itala AI, 2001, J BIOMED MATER RES, V58, P679, DOI 10.1002/jbm.1069
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   JAMES SP, 1992, J BIOMED MATER RES, V26, P651, DOI 10.1002/jbm.820260507
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO;2-1
   JOSHUA LS, 2003, J BIOMED MATER RES A, V66, P275
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   Kaplan F.S., 1994, FORM FUNCTION BONE, P128
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KARAGIANES MT, 1973, ARTIF CELL BLOOD SUB, V1, P171
   Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307
   KENZO A, 1985, J BIOMED MATER RES, V19, P699
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KLAWITTER JJ, 1977, J DENT RES, V56, P768, DOI 10.1177/00220345770560071101
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   Kon M, 2004, J BIOMED MATER RES B, V68B, P88, DOI 10.1002/jbm.b.20004
   KORNER C, 2002, HDB CELLULAR METALS, P8
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LANGTON CM, 1990, CLIN PHYS PHYSIOL M, V11, P243, DOI 10.1088/0143-0815/11/3/007
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lee WH, 2000, J MATER SCI, V35, P593, DOI 10.1023/A:1004768125476
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   Li BY, 2000, INTERMETALLICS, V8, P881, DOI 10.1016/S0966-9795(00)00024-8
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Li JP, 2002, KEY ENG MAT, V218-2, P51, DOI 10.4028/www.scientific.net/KEM.218-220.51
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Lifland M. I., 1993, Clinical Materials, V14, P13, DOI 10.1016/0267-6605(93)90042-6
   LIFLAND MI, 1994, CLIN MATER, V17, P203, DOI 10.1016/0267-6605(94)90037-X
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lin LL, 2007, J RARE EARTH, V25, P379
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   MANLEY MT, 1987, CLIN ORTHOP RELAT R, P293
   Markaki AE, 2004, BIOMATERIALS, V25, P4805, DOI 10.1016/j.biomaterials.2003.11.041
   Maspero FA, 2002, J BIOMED MATER RES, V62, P89, DOI 10.1002/jbm.10212
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MCCABE JF, 1987, DENT MATER, V3, P9, DOI 10.1016/S0109-5641(87)80053-2
   Miranda P, 2006, ACTA BIOMATER, V2, P457, DOI 10.1016/j.actbio.2006.02.004
   Miyao R., 2000, J JAPAN SOC POWDER M, V47, P1239
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   OKAZAKI K, 1991, J BIOMED MATER RES, V25, P1417, DOI 10.1002/jbm.820251202
   OKUNO O, 2007, CORROSION RESISTANCE, P105
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Paulus JA, 1997, BIOMATERIALS, V18, P1609, DOI 10.1016/S0142-9612(97)00102-6
   Qiu J, 1997, BIOMATERIALS, V18, P153, DOI 10.1016/S0142-9612(96)00097-X
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001
   Rausch G, 2002, HDB CELLULAR METALS, P21
   Reclaru L, 2005, BIOMATERIALS, V26, P4747, DOI 10.1016/j.biomaterials.2005.01.004
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Salito A, 1998, SULZER TECH REV, V1, P34
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   Schneider J.A., 1996, CERAM T, V79, P143
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Simancik F., 2002, HDB CELLULAR METALS, P1
   SIVAKUMAR M, 1993, J MATER SCI, V28, P6081, DOI 10.1007/BF00365025
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   STAINES M, 1981, J MATER SCI, V16, P2551, DOI 10.1007/BF01113595
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Sul YT, 2002, CLIN ORAL IMPLAN RES, V13, P252, DOI 10.1034/j.1600-0501.2002.130304.x
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   Sunnegardh-Gronberg K, 2002, EUR J ORAL SCI, V110, P175, DOI 10.1034/j.1600-0722.2002.11226.x
   Sunnegardh-Gronberg Karin, 2003, Clin Oral Investig, V7, P27
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tache A, 2004, INT J ORAL MAX IMPL, V19, P19
   TARVAINEN T, 1986, ANN BIOMED ENG, V14, P417, DOI 10.1007/BF02367362
   TOM JW, 1991, J AEROSOL SCI, V22, P555, DOI 10.1016/0021-8502(91)90013-8
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Vadgama P, 2005, SURFACES INTERFACES, P200
   VIETH WR, 1991, DIFFUSION POLYM PRIN
   VRIJHOEF MMA, 1987, J DENT RES, V66, P1456, DOI 10.1177/00220345870660090901
   WEBER JN, 1972, MATER RES BULL, V7, P1005, DOI 10.1016/0025-5408(72)90092-X
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   WOLFARTH D, 1994, J BIOMED MATER RES, V28, P417, DOI 10.1002/jbm.820280403
   Wolfe MS, 2002, J BIOMED MATER RES, V61, P159, DOI 10.1002/jbm.10058
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang J, 2007, J BIOMECH, V40, P2377, DOI 10.1016/j.jbiomech.2006.11.019
   Yang SF, 2008, MATER DESIGN, V29, P1802, DOI 10.1016/j.matdes.2008.03.024
   Yang WE, 2009, J ALLOY COMPD, V479, P642, DOI 10.1016/j.jallcom.2009.01.021
   Yeo LY, 2005, BIOMATERIALS, V26, P6122, DOI 10.1016/j.biomaterials.2005.03.033
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   YUE S, 1984, J BIOMED MATER RES, V18, P1043, DOI 10.1002/jbm.820180908
   Zandinejad AA, 2006, DENT MATER, V22, P382, DOI 10.1016/j.dental.2005.04.027
   Zhang C, 2001, J BIOMED MATER RES, V54, P407, DOI 10.1002/1097-4636(20010305)54:3<407::AID-JBM140>3.3.CO;2-3
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang X, 2001, Biomed Sci Instrum, V37, P463
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 170
TC 57
Z9 57
U1 0
U2 50
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2010
VL 3
IS 5
BP 2947
EP 2974
DI 10.3390/ma3052947
PG 28
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LJ
UT WOS:000298241200001
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU diZerega, GS
   Traylor, MM
   Alphonso, LS
   Falcone, SJ
AF diZerega, Gere S.
   Traylor, Melissa M.
   Alphonso, Lisa S.
   Falcone, Samuel J.
TI Use of Temporary Implantable Biomaterials to Reduce Leg Pain and Back
   Pain in Patients with Sciatica and Lumbar Disc Herniation
SO MATERIALS
LA English
DT Review
DE biomaterial; viscoelastic gel; back pain; sciatica; lumbar surgery;
   fibrosis; cytokines; disc herniation; oxiplex; healon
ID TUMOR-NECROSIS-FACTOR; DORSAL-ROOT GANGLION; AUTOLOGOUS NUCLEUS
   PULPOSUS; HUMAN INTERVERTEBRAL DISC; SPINAL NERVE ROOTS; PREVENTING
   PERIDURAL FIBROSIS; RANDOMIZED CONTROLLED-TRIAL; FACTOR-ALPHA;
   FOLLOW-UP; GAMMA-INTERFERON
AB The principle etiology of leg pain (sciatica) from lumbar disc herniation is mechanical compression of the nerve root. Sciatica is reduced by decompression of the herniated disc, i.e., removing mechanical compression of the nerve root. Decompression surgery typically reduces sciatica more than lumbar back pain (LBP). Decompression surgery reduces mechanical compression of the nerve root. However, decompression surgery does not directly reduce sensitization of the sensory nerves in the epidural space and disc. In addition, sensory nerves in the annulus fibrosus and epidural space are not protected from topical interaction with pain mediators induced by decompression surgery. The secondary etiology of sciatica from lumbar disc herniation is sensitization of the nerve root. Sensitization of the nerve root results from a) mechanical compression, b) exposure to cellular pain mediators, and/or c) exposure to biochemical pain mediators. Although decompression surgery reduces nerve root compression, sensory nerve sensitization often persists. These observations are consistent with continued exposure of tissue in the epidural space, including the nerve root, to increased cellular and biochemical pain mediators following surgery. A potential contributor to lumbar back pain (LBP) is stimulation of sensory nerves in the annulus fibrosus by a) cellular pain mediators and/or b) biochemical pain mediators that accompany annular tears or disruption. Sensory fibers located in the outer one-third of the annulus fibrosus increase in number and depth as a result of disc herniation. The nucleus pulposus is comprised of material that can produce an autoimmune stimulation of the sensory nerves located in the annulus and epidural space leading to LBP. The sensory nerves of the annulus fibrosus and epidural space may be sensitized by topical exposure to cellular and biochemical pain mediators induced by lumbar surgery. Annulotomy or annular rupture allows the nucleus pulposus topical access to sensory nerve fibers, thereby leading to LBP. Coverage of the annulus and adjacent structures in the epidural space by absorbable viscoelastic gels appears to reduce LBP following surgery by protecting sensory fibers from cellular and biochemical pain mediators.
C1 [diZerega, Gere S.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.
   [Traylor, Melissa M.; Alphonso, Lisa S.; Falcone, Samuel J.] FzioMed Inc, Los Angeles, CA 90033 USA.
RP diZerega, GS (reprint author), Univ So Calif, Keck Sch Med, 1321 N Mission Rd, Los Angeles, CA 90033 USA.
EM dizerega@usc.edu; mtraylor@fziomed.com; lalphonso@fziomed.com;
   sfalcone@fziomed.com
CR Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53
   Akeson Wayne H, 2005, Spine J, V5, P180, DOI 10.1016/j.spinee.2004.06.019
   ANDERSON DG, 2003, SEMIN SPINE SURG, V15, P352
   Aoki Y, 2004, LIFE SCI, V74, P2627, DOI 10.1016/j.lfs.2004.01.008
   Aoki Y, 2002, SPINE, V27, P1614, DOI 10.1097/01.BRS.0000018781.70615.87
   AOKI Y, 2005, INT J SPINE SURG, V2, P1
   Aoki Y, 2007, SPINE, V32, P857, DOI 10.1097/01.brs.0000259810.48681.90
   Asch HL, 2002, J NEUROSURG, V96, P34, DOI 10.3171/spi.2002.96.1.0034
   ASHTON IK, 1994, J ORTHOPAED RES, V12, P186, DOI 10.1002/jor.1100120206
   Assietti R, 2008, SPINE, V33, P1762, DOI 10.1097/BRS.0b013e31817e30fb
   ATHA DH, 1981, J BIOL CHEM, V256, P2108
   Atlas SJ, 2005, SPINE, V30, P927, DOI 10.1097/01.brs.0000158954.68522.2a
   Atlas SJ, 2001, SPINE, V26, P1179, DOI 10.1097/00007632-200105150-00017
   AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x
   BAKER AG, 1969, AM J SURG, V117, P690, DOI 10.1016/0002-9610(69)90407-3
   BENNETT GJ, 1993, MUSCLE NERVE, V16, P1040, DOI 10.1002/mus.880161007
   BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0
   BOGDUK N, 1981, J ANAT, V132, P39
   Bogduk N, 1997, CLIN J PAIN, V13, P285, DOI 10.1097/00002508-199712000-00003
   Brisby H, 2006, J BONE JOINT SURG AM, V88A, P68, DOI 10.2106/JBJS.E.01282
   Brown MF, 1997, J BONE JOINT SURG BR, V79B, P147, DOI 10.1302/0301-620X.79B1.6814
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511
   CARLSSON CA, 1967, EXPERIENTIA, V23, P125, DOI 10.1007/BF02135957
   CARLTON SM, 1994, PAIN, V56, P155, DOI 10.1016/0304-3959(94)90090-6
   Cavanaugh JM, 1997, CLIN ORTHOP RELAT R, P166
   Cohen SP, 2005, REGION ANESTH PAIN M, V30, P163, DOI 10.1016/j.rapm.2004.10.006
   Coppes MH, 1997, SPINE, V22, P2342, DOI 10.1097/00007632-199710150-00005
   COPPES MH, 1990, LANCET, V336, P189, DOI 10.1016/0140-6736(90)91723-N
   Coskun E, 2000, EUR SPINE J, V9, P218, DOI 10.1007/s005860000144
   DAYER JM, 1977, SCIENCE, V195, P181, DOI 10.1126/science.188134
   DINARELLO CA, 1987, IMMUNOL LETT, V16, P227, DOI 10.1016/0165-2478(87)90151-9
   Dizerega GS, 2007, J BIOMED MATER RES B, V81B, P239, DOI 10.1002/jbm.b.30659
   Doita M, 1996, SPINE, V21, P235, DOI 10.1097/00007632-199601150-00015
   Doita M, 2001, SPINE, V26, P1522, DOI 10.1097/00007632-200107150-00004
   DUNCAN MR, 1985, J EXP MED, V162, P516, DOI 10.1084/jem.162.2.516
   DVORAK J, 1988, SPINE, V13, P1418, DOI 10.1097/00007632-198812000-00015
   ECHLIN F, 1949, J NEUROSURG, V6, P530, DOI 10.3171/jns.1949.6.6.0530
   Edgar MA, 2007, J BONE JOINT SURG BR, V89B, P1135, DOI 10.1302/0301-620X.89B9.18939
   ELVES MW, 1975, ORTHOP CLIN N AM, V6, P59
   Emmez H, 2008, NEUROSURGERY, V62, P1351, DOI [10.1227/01.neu.0000333307.02802.04, 10.1227/01.NEU.0000317272.86593.E3]
   ESSICK CR, 1920, CARNEGIE CONTR EMBRY, V42, P379
   Falcone SJ, 2006, ACS SYM SER, V934, P155
   Falcone SJ, 2006, J BIOMED MATER RES A, V76A, P721, DOI 10.1002/jbm.a.30623
   FRANSEN PA, 2008, SPINE J, V8, pS56
   Fransen Patrick, 2008, Ann Surg Innov Res, V2, P2, DOI 10.1186/1750-1164-2-2
   FRANSON RC, 1992, SPINE, V17, pS129, DOI 10.1097/00007632-199206001-00011
   Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Garfin S R, 1988, J Spinal Disord, V1, P116
   GARFIN SR, 1995, SPINE, V20, P1810, DOI 10.1097/00007632-199508150-00012
   GERTZBEIN SD, 1975, ORTHOP CLIN N AM, V6, P67
   GILLERY P, 1992, EUR J CELL BIOL, V57, P244
   GILLETTE RG, 1994, PAIN, V56, P31, DOI 10.1016/0304-3959(94)90147-3
   GOLDRING MB, 1986, J BIOL CHEM, V261, P9049
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRANSTEIN RD, 1990, J INVEST DERMATOL, V95, pS75, DOI 10.1111/1523-1747.ep12874789
   GRONBLAD M, 1994, SPINE, V19, P2744
   HARGREAVES KM, 1994, ORAL SURG ORAL MED O, V78, P503, DOI 10.1016/0030-4220(94)90045-0
   Haro H, 2002, J ORTHOPAED RES, V20, P409, DOI 10.1016/S0736-0266(01)00150-4
   HARRISON RG, 1993, PROTEIN PURIFICATION, P115
   HE Y, 1995, SPINE, V20, P557, DOI 10.1097/00007632-199503010-00010
   HERLIHY W F, 1949, N Z Med J, V48, P214
   HIRSCH CARL, 1963, ACTA ORTHOPAED SCAND, V33, P1, DOI 10.3109/17453676308999829
   Hyodo H, 2005, EUR SPINE J, V14, P573, DOI 10.1007/s00586-004-0844-8
   Ido K, 2001, SPINAL CORD, V39, P269, DOI 10.1038/sj.sc.3101157
   Igarashi A, 2004, SPINE, V29, P2091, DOI 10.1097/01.brs.0000141265.55411.30
   Igarashi T, 2000, SPINE, V25, P2975, DOI 10.1097/00007632-200012010-00003
   Inoue G, 2006, SPINE, V31, P1433, DOI 10.1097/01.brs.0000219946.25103.db
   JACKSON HC, 1966, J BONE JOINT SURG AM, VA 48, P1272, DOI 10.2106/00004623-196648070-00002
   Jaffe HA, 1999, EXP LUNG RES, V25, P199
   Jou IM, 2007, SPINE, V32, P2111, DOI 10.1097/BRS.0b013e3181453fa5
   Kato Tsuyoshi, 2005, Spine J, V5, P479, DOI 10.1016/j.spinee.2005.01.010
   KAWAKAMI M, 1994, SPINE, V19, P1795, DOI 10.1097/00007632-199408150-00002
   KAWAKAMI M, 1994, SPINE, V19, P1780, DOI 10.1097/00007632-199408150-00001
   Kayama S, 1998, SPINE, V23, P2155, DOI 10.1097/00007632-199810150-00002
   Kayama S, 1996, SPINE, V21, P2539, DOI 10.1097/00007632-199611150-00002
   Kim KD, 2003, SPINE, V28, P1080, DOI 10.1097/00007632-200305150-00023
   Kim KD, 2004, NEUROSURG FOCUS, V17, P1
   Kobayashi S, 2004, J ORTHOP RES, V22, P170, DOI 10.1016/S0736-0266(03)00131-1
   Koes BW, 2007, BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223428495.BE
   Koes BW, 2007, LANCET, V370, P1595, DOI 10.1016/S0140-6736(07)61670-5
   Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2
   Korecki CL, 2008, SPINE, V33, P235, DOI 10.1097/BRS.0b013e3181624504
   Korhonen T, 2006, SPINE, V31, P2759, DOI 10.1097/01.brs.0000245873.23876.1e
   Kosharskyy B, 2007, ANASTH INTENSIV NOTF, V42, P262, DOI 10.1055/s-2007-980027
   Kurt G, 2009, NEUROCIRUGIA, V20, P360
   KUSLICH SD, 1991, ORTHOP CLIN N AM, V22, P181
   LAGUNOFF D, 1972, BIOCHEM PHARMACOL, V21, P1889, DOI 10.1016/0006-2952(72)90001-9
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEWIS PJ, 1987, J NEUROSURG, V67, P49, DOI 10.3171/jns.1987.67.1.0049
   Liu LS, 2002, J BIOMED MATER RES, V63, P326, DOI 10.1002/jbm.10211
   Lotz JC, 2006, J BONE JOINT SURG AM, V88A, P76, DOI 10.2106/JBJS.E.01448
   Loupasis GA, 1999, SPINE, V24, P2313, DOI 10.1097/00007632-199911150-00005
   Madsen F, 1998, J CONTROL RELEASE, V50, P167, DOI 10.1016/S0168-3659(97)00138-7
   MALINSKY JII, 1959, ACTA ANAT, V38, P96
   Massie Jennifer B, 2005, Spine J, V5, P494, DOI 10.1016/j.spinee.2004.12.003
   MCCARRON RF, 1987, SPINE, V12, P760, DOI 10.1097/00007632-198710000-00009
   MELIN M, 1989, CELL MOL BIOL, V35, P97
   MELLER ST, 1992, PAIN, V51, P317, DOI 10.1016/0304-3959(92)90216-X
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   MONETA GB, 1994, SPINE, V19, P1968, DOI 10.1097/00007632-199409000-00018
   MOONEY V, 1987, SPINE, V12, P754, DOI 10.1097/00007632-198710000-00008
   Morinaga T, 1996, SPINE, V21, P1848, DOI 10.1097/00007632-199608150-00002
   MORTAZAVI SA, 1995, INT J PHARM, V116, P223, DOI 10.1016/0378-5173(94)00299-K
   Mulleman D, 2006, JOINT BONE SPINE, V73, P270, DOI 10.1016/j.jbspin.2005.03.004
   Mulleman D, 2006, JOINT BONE SPINE, V73, P151, DOI 10.1016/j.jbspin.2005.03.003
   Murata Y, 2005, SPINE, V30, P1712, DOI 10.1097/01.brs.0000172231.11296.13
   NACHEMSON A L, 1976, Spine, V1, P59, DOI 10.1097/00007632-197603000-00009
   NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020
   Nakamura S, 1996, SPINE, V21, P917, DOI 10.1097/00007632-199604150-00003
   Nerlich AG, 2002, SPINE, V27, P2484, DOI 10.1097/01.BRS.0000031266.31284.75
   NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5
   NGUYEN KD, 1994, INVEST OPHTH VIS SCI, V35, P3064
   NORTH RB, 1991, NEUROSURGERY, V28, P685, DOI 10.1227/00006123-199105000-00008
   ODonnell JL, 1996, SPINE, V21, P1653, DOI 10.1097/00007632-199607150-00007
   Ohtori S, 2006, SPINE, V31, P1026, DOI 10.1097/01.brs.0000215027.87102.7c
   Ohtori S, 2006, SPINE, V31, P2987, DOI 10.1097/01.brs.0000250306.12996.fa
   Olmarker K, 1996, SPINE, V21, P411, DOI 10.1097/00007632-199602150-00002
   Olmarker K, 1998, SPINE, V23, P2538, DOI 10.1097/00007632-199812010-00008
   OLMARKER K, 1991, ORTHOP CLIN N AM, V22, P223
   OLMARKER K, 1993, SPINE, V18, P1425
   OLMARKER K, 1995, SPINE, V20, P665, DOI 10.1097/00007632-199503150-00006
   Olmarker K, 2002, SPINE, V27, P1312, DOI 10.1097/00007632-200206150-00013
   Olmarker K, 2001, SPINE, V26, P863, DOI 10.1097/00007632-200104150-00007
   Olmarker K, 2004, LUMBAR SPINE, P11
   OLMARKER K, 1998, PAIN, V78, P99
   Omoigui S, 2007, MED HYPOTHESES, V69, P70, DOI 10.1016/j.mehy.2006.11.028
   Onda A, 2002, SPINE, V27, P1618, DOI 10.1097/01.BRS.0000018786.06286.62
   Osterman H, 2006, SPINE, V31, P2409
   Ozawa T, 2006, SPINE, V31, P2418, DOI 10.1097/01.brs.0000239159.74211.9c
   PALEG LG, 1984, PLANT PHYSIOL, V75, P974, DOI 10.1104/pp.75.4.974
   Palmgren T, 1996, SPINE, V21, P1301, DOI 10.1097/00007632-199606010-00004
   Palmgren T, 1999, SPINE, V24, P2075, DOI 10.1097/00007632-199910150-00002
   Pearson AM, 2008, SPINE, V33, P428, DOI 10.1097/BRS.0b013e31816469de
   Peng BG, 2007, PAIN, V127, P11, DOI 10.1016/j.pain.2006.06.034
   Peng BG, 2006, SPINE, V31, P560, DOI 10.1097/01.brs.0000201324.45537.46
   Peul WC, 2008, PAIN, V138, P180, DOI 10.1016/j.pain.2007.12.014
   Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039
   Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x
   RHYNE AL, 2009, SPINE UNPUB
   Roberts S, 1995, SPINE, V20, P2645, DOI 10.1097/00007632-199512150-00005
   Rodgers Kathleen E, 2003, Spine J, V3, P277, DOI 10.1016/S1529-9430(03)00035-4
   ROSSI S, 1995, BIOMATERIALS, V16, P1073, DOI 10.1016/0142-9612(95)98903-R
   ROTSHENKER S, 1992, J NEUROIMMUNOL, V39, P75, DOI 10.1016/0165-5728(92)90176-L
   Rutkowski MA, 2002, DRUG NEWS PERSPECT, V15, P626, DOI 10.1358/dnp.2002.15.10.740239
   SAAL JS, 1990, SPINE, V15, P674, DOI 10.1097/00007632-199007000-00011
   Sakuma Y, 2007, EUR SPINE J, V16, P1273, DOI 10.1007/s00586-007-0365-3
   Sandoval MA, 2008, EUR SPINE J, V17, P451, DOI 10.1007/s00586-007-0580-y
   Saxler G, 2008, EUR SPINE J, V17, P1362, DOI 10.1007/s00586-008-0741-7
   Schimizzi Aimee L, 2006, Spine J, V6, P550, DOI 10.1016/j.spinee.2005.12.005
   Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9
   Sekiguchi M, 2004, SPINE, V29, P1105, DOI 10.1097/00007632-200405150-00011
   Sekine M, 2001, SPINE, V26, P1516, DOI 10.1097/00007632-200107150-00003
   Silvers HR, 1997, BRIT J NEUROSURG, V11, P16
   SILVERS HR, 1994, SPINE, V19, P2387, DOI 10.1097/00007632-199411000-00002
   Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008
   SIMONS J, 2004, C NEUR SURG SAN FRAN
   Slipman CW, 2002, PAIN MED, V3, P200, DOI 10.1046/j.1526-4637.2002.02033.x
   SMYTH MJ, 1958, J BONE JOINT SURG AM, V40, P1401, DOI 10.2106/00004623-195840060-00016
   SONGER MN, 1990, SPINE, V15, P550, DOI 10.1097/00007632-199006000-00022
   SONGER MN, 1995, SPINE, V20, P571, DOI 10.1097/00007632-199503010-00012
   SPANGFORT EV, 1972, ACTA ORTHOP SCAND, P1
   Suseki K, 1996, NEUROSCI LETT, V221, P41, DOI 10.1016/S0304-3940(96)13282-1
   TAHMOUSH AJ, 1981, PAIN, V10, P187, DOI 10.1016/0304-3959(81)90194-9
   Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011
   Takahashi K, 2008, EUR SPINE J, V17, pS428, DOI 10.1007/s00586-008-0752-4
   Takahashi N, 2003, SPINE, V28, P435, DOI 10.1097/00007632-200303010-00005
   Takebayashi T, 2001, SPINE, V26, P940, DOI 10.1097/00007632-200104150-00018
   Takebayashi T, 2006, J BONE JOINT SURG BR, V88B, P554, DOI 10.1302/0301-620X.8884.17194
   TAKENAKA Y, 1986, J RHEUMATOL, V13, P397
   Tatsui CE, 2006, J NEUROSURG-SPINE, V4, P51, DOI 10.3171/spi.2006.4.1.51
   Tobinick EL, 2003, SWISS MED WKLY, V133, P170
   Toyone T, 2004, J BONE JOINT SURG AM, V86A, P893, DOI 10.2106/00004623-200405000-00001
   Tredget EE, 2000, J INTERF CYTOK RES, V20, P143, DOI 10.1089/107999000312540
   Vogelsang JP, 1999, EUR SPINE J, V8, P475, DOI 10.1007/s005860050208
   Walsh AJL, 2007, SPINE J, V7, P601, DOI 10.1016/j.spinee.2006.10.012
   WARNER SJC, 1989, J IMMUNOL, V142, P100
   Waxman S.G., 1999, PAIN S, V6, P133
   Waxman SG, 1999, MUSCLE NERVE, V22, P1177, DOI 10.1002/(SICI)1097-4598(199909)22:9<1177::AID-MUS3>3.3.CO;2-G
   WEBER H, 1983, SPINE, V8, P131, DOI 10.1097/00007632-198303000-00003
   Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20
   Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0
   WEINSTEIN J, 1988, SPINE, V13, P1344, DOI 10.1097/00007632-198812000-00002
   Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451
   WIBERG GUNNAR, 1949, ACTA ORTHOPAED SCAND, V19, P211
   Winkelstein BA, 2002, BRAIN RES, V956, P294, DOI 10.1016/S0006-8993(02)03560-6
   Winkelstein BA, 2002, SPINE, V27, P27, DOI 10.1097/00007632-200201010-00009
   Wu G, 2001, J Neurosci, V21, pRC140
   Yabuki S, 1998, SPINE, V23, P2517, DOI 10.1097/00007632-199812010-00006
   Yabuki S, 1998, SPINE, V23, P2383, DOI 10.1097/00007632-199811150-00004
   Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680
   YOSHIZAWA H, 1980, J PATHOL, V132, P95, DOI 10.1002/path.1711320202
   Zanella JM, 2008, SPINE, V33, P227, DOI 10.1097/BRS.0b013e318162340a
   Ziesche R, 2000, WIEN KLIN WOCHENSCHR, V112, P785
   Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6
   ZUKI Z, 2006, USE ANTIADHESION GEL
NR 197
TC 4
Z9 4
U1 2
U2 9
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2010
VL 3
IS 5
BP 3331
EP 3368
DI 10.3390/ma3053331
PG 38
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LJ
UT WOS:000298241200011
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lee, EH
   Kim, JY
   Kweon, HY
   Jo, YY
   Min, SK
   Park, YW
   Choi, JY
   Kim, SG
AF Lee, Eui-Hee
   Kim, Jwa-Young
   Kweon, Hae Yong
   Jo, You-Young
   Min, Soo-Kee
   Park, Young-Wook
   Choi, Je-Yong
   Kim, Seong-Gon
TI A combination graft of low-molecular-weight silk fibroin with Choukroun
   platelet-rich fibrin for rabbit calvarial defect
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND
   ENDODONTOLOGY
LA English
DT Article
ID ALLOPLASTIC BONE SUBSTITUTES; SPIDER SILK; IN-VITRO; TISSUE;
   BIOMATERIAL; TOMOGRAPHY; SCAFFOLDS; SUTURES; PLASMA
AB Objective. The objective of this study was to determine the capabilities of silk fibroin as a biomaterial template for bone formation when mixed with Choukroun platelet-rich fibrin (PRF) in vivo.
   Study design. Ten New Zealand white rabbits were used for this study and bilateral round shaped defects were formed in the parietal bone (diameter 9.0 mm). The silk fibroin was digested by acid and made into powder (molecular weight <1.0 kDa). The right side (experimental group) received the silk fibroin plus platelet-rich fibroin and the left side (control group) did not receive a graft. Animals were killed at 6 weeks and 12 weeks. The specimens were examined by microscopic computerized tomography (mu-CT). Subsequently, they underwent decalcification and were stained for histologic analysis.
   Results. There was no significant difference between groups at 6 weeks after operation. In the mu-CT results, however, tissue mineral content in the experimental group at 12 weeks after operation was 132.09 +/- 4.41 and that in the control group was 126.42 +/- 6.62 (P = .011). Tissue mineral density in the experimental group was 2,088.88 +/- 648.34, and that in the control group was 2,029.72 +/- 668.22 (P = .013). The results of the histomorphometric analysis were in accordance with the mu-CT results. The total new bone was 49.86 +/- 7.49% in the control group at 12 weeks after the operation and 59.83 +/- 10.92% in the experimental group (P = .021).
   Conclusion. A combined application of Choukroun PRF with acid-digested silk fibroin showed more rapid bone healing than unfilled control. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: e33-e38)
C1 [Kim, Seong-Gon] Gangneung Wonju Natl Univ, Dept Oral & Maxillofacial Surg, Coll Dent, Kangnung 210702, Gangwondo, South Korea.
   [Lee, Eui-Hee; Kim, Jwa-Young] Hallym Univ, Dept Oral & Maxillofacial Surg, Sacred Heart Hosp, Chunchon, South Korea.
   [Min, Soo-Kee] Hallym Univ, Dept Pathol, Sacred Heart Hosp, Chunchon, South Korea.
   [Choi, Je-Yong] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Taegu, South Korea.
RP Kim, SG (reprint author), Gangneung Wonju Natl Univ, Dept Oral & Maxillofacial Surg, Coll Dent, Kangnung 210702, Gangwondo, South Korea.
EM epker@chollian.net
FU BioGreen21 Program [200810FTH010103002, 200810FTH010102001]; Rural
   Development Administration
FX Supported by the BioGreen21 Program (grant nos. 200810FTH010103002 and
   200810FTH010102001), Rural Development Administration.
CR Bai JM, 2006, BIOMED MICRODEVICES, V8, P317, DOI 10.1007/s10544-006-9820-x
   Buchman SR, 1998, J CRANIOFAC SURG, V9, P48, DOI 10.1097/00001665-199801000-00011
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Carmagnola D, 2002, J CLIN PERIODONTOL, V29, P377, DOI 10.1034/j.1600-051X.2002.290501.x
   Craig CL, 2003, COMP BIOCHEM PHYS B, V135, P721, DOI 10.1016/S1096-4959(03)00114-3
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   DOHAN MD, 2006, ORAL SURG ORAL MED O, V101, pE37
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Haddad AJ, 2006, J CRANIOFAC SURG, V17, P926, DOI 10.1097/01.scs.0000230615.49270.d1
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jung RE, 2005, CLIN ORAL IMPLAN RES, V16, P676, DOI 10.1111/j.1600-0501.2005.01183.x
   Kania RE, 1998, J BIOMED MATER RES, V43, P38, DOI 10.1002/(SICI)1097-4636(199821)43:1<38::AID-JBM4>3.0.CO;2-N
   KAPLAN DL, 1992, MATER RES SOC S P, V255, P19
   Kim SG, 2002, J ORAL MAXIL SURG, V60, P1018, DOI 10.1053/joms.2002.34413
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   LORENA M, 2005, BONE, V37, P688
   Mannaioni PF, 1997, INFLAMM RES, V46, P4, DOI 10.1007/PL00000158
   Moghadam HG, 2004, J ORAL MAXIL SURG, V62, P202, DOI 10.1016/j.joms.2003.10.002
   Mueller AA, 2005, PEDIATR NEUROSURG, V41, P285, DOI 10.1159/000088730
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Nair MK, 2007, ORAL SURG ORAL MED O, V103, P267, DOI 10.1016/j.tripleo.2006.02.006
   Postlethwait RW, 1969, REPAIR REGENERATION, P263
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   SOFFER E, 1998, ORAL SURG ORAL MED O, V85, P638
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   TAYAPONGSAK P, 1994, J ORAL MAXIL SURG, V52, P161, DOI 10.1016/0278-2391(94)90401-4
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
NR 31
TC 27
Z9 33
U1 0
U2 13
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1079-2104
J9 ORAL SURG ORAL MED O
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.
PD MAY
PY 2010
VL 109
IS 5
BP E33
EP E38
DI 10.1016/j.tripleo.2009.12.043
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 586QD
UT WOS:000276925400033
PM 20149696
DA 2018-10-20
ER

PT J
AU Frantzides, CT
   Carlson, MA
   Loizides, S
   Papafili, A
   Luu, M
   Roberts, J
   Zeni, T
   Frantzides, A
AF Frantzides, Constantine T.
   Carlson, Mark A.
   Loizides, Sofronis
   Papafili, Anastasia
   Luu, Mihn
   Roberts, Jacob
   Zeni, Tallal
   Frantzides, Alexander
TI Hiatal hernia repair with mesh: a survey of SAGES members
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Hiatal hernia repair; Hiatal herniorrhaphy; Mesh; Recurrence;
   Gastroesophageal reflux disease; Paraesophageal hernia; Stricture;
   Erosion; Prosthetic; Biomaterial
ID LAPAROSCOPIC ANTIREFLUX SURGERY; GASTROESOPHAGEAL-REFLUX DISEASE;
   ACELLULAR DERMAL MATRIX; PARAESOPHAGEAL HERNIA; BIOLOGIC PROSTHESIS;
   POLYPROPYLENE MESH; FOLLOW-UP; FUNDOPLICATION; RECURRENCE; COMPLICATIONS
AB Primary repair of large hiatal hernia is associated with a high recurrence rate. The use of mesh may reduce this recurrence rate. The indication for mesh use, the type of mesh to use, and the placement technique are controversial. A survey of surgeon practice was undertaken to obtain a better understanding of the controversies surrounding this clinical problem.
   A questionnaire on the technique and results of mesh hiatal herniorrhaphy was sent to 1,192 members of the Society of Gastrointestinal and Endoscopic Surgeons (SAGES).
   There were 275 responses; 261 of these were analyzed. A total of 5,486 hiatal hernia repairs with mesh were reported; 77% and 23% were performed laparoscopically vs open, respectively. The most common indication for mesh usage was an increased size hiatal defect (46% of respondents). The most common mesh types were biomaterial (28%), polytetrafluoroethylene (25%), and polypropylene (21%). Suture anchorage was the most common fixation technique (56% of respondents). The findings showed a failure rate of 3%, a stricture rate of 0.2%, and an erosion rate of 0.3%. Biomaterial tended to be associated with failure, whereas nonabsorbable mesh tended to be associated with stricture and erosion.
   The use of mesh during hiatal hernia repair resulted in a reported recurrence rate which appeared to be lower than that obtained historically without mesh. No one mesh type was clearly superior in terms of avoiding failure and complication.
C1 [Carlson, Mark A.] Univ Nebraska Med Ctr, Dept Surg, Omaha VA Med Ctr, Omaha, NE 68105 USA.
   [Frantzides, Constantine T.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA.
   [Frantzides, Constantine T.; Loizides, Sofronis; Papafili, Anastasia; Luu, Mihn; Roberts, Jacob; Zeni, Tallal; Frantzides, Alexander] Chicago Inst Minimally Invas Surg, Skokie, IL USA.
   [Loizides, Sofronis; Papafili, Anastasia] Royal Free Hosp, London NW3 2QG, England.
   [Zeni, Tallal] Michigan Bariatr Inst, Livonia, MI USA.
   [Zeni, Tallal] St Mary Mercy Hosp, Livonia, MI USA.
RP Carlson, MA (reprint author), Univ Nebraska Med Ctr, Dept Surg, Omaha VA Med Ctr, 4101 Woolworth Ave, Omaha, NE 68105 USA.
EM macarlso@unmc.edu
FU Omaha VA Medical Center; Chicago Institute of Minimally Invasive Surgery
FX This study was supported with the resources and facilities of the Omaha
   VA Medical Center and the Chicago Institute of Minimally Invasive
   Surgery. The authors acknowledge Valerie K. Shostrom of the Department
   of Biostatistics at the University of Nebraska Medical Center for
   assistance with statistical testing.
CR Akolekar D, 2008, HERNIA, V12, P39, DOI 10.1007/s10029-007-0275-7
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Basso N, 2000, SURG ENDOSC-ULTRAS, V14, P164, DOI 10.1007/s004649900092
   Blatnik J, 2008, AM J SURG, V196, P47, DOI 10.1016/j.amjsurg.2007.06.035
   Carlson MA, 1998, J AM COLL SURGEONS, V187, P227, DOI 10.1016/S1072-7515(98)00162-8
   Champion JK, 2003, SURG ENDOSC, V17, P551, DOI 10.1007/s00464-002-8817-7
   Cobb William S, 2005, Surg Innov, V12, P63, DOI 10.1177/155335060501200109
   Davis SS, 2008, SURG CLIN N AM, V88, P959, DOI 10.1016/j.suc.2008.05.005
   Desai KM, 2006, SURG ENDOSC, V20, P1693, DOI 10.1007/s00464-006-0680-5
   Diaz S, 2003, J GASTROINTEST SURG, V7, P59, DOI 10.1016/S1091-255X(02)00151-8
   ECRI Institute, 2004, HLTH DEVICES, V33, P293
   ELLIS FH, 1986, ARCH SURG-CHICAGO, V121, P416
   Ferri LE, 2005, SURG ENDOSC, V19, P4, DOI 10.1007/s00464-004-8903-0
   Foda M, 2009, HERNIA, V13, P323, DOI 10.1007/s10029-008-0441-6
   Frantzides CT, 2002, ARCH SURG-CHICAGO, V137, P649, DOI 10.1001/archsurg.137.6.649
   Frantzides CT, 2009, ATLAS MINIMALLY INVA
   Fumagalli U, 2008, SURG LAPARO ENDO PER, V18, P433, DOI 10.1097/SLE.0b013e3181802ca7
   Granderath FA, 2008, WORLD J SURG, V32, P999, DOI 10.1007/s00268-008-9558-0
   Granderath FA, 2007, SURG ENDOSC, V21, P542, DOI 10.1007/s00464-006-9041-7
   Granderath FA, 2006, SURG ENDOSC, V20, P367, DOI 10.1007/s00464-005-0467-0
   Granderath FA, 2005, ARCH SURG-CHICAGO, V140, P40, DOI 10.1001/archsurg.140.1.40
   Granderath FA, 2002, J GASTROINTEST SURG, V6, P347, DOI 10.1016/S1091-255X(01)00025-7
   Griffith P Sahle, 2008, Int J Surg, V6, P106, DOI 10.1016/j.ijsu.2007.12.004
   Gryska P V, 2005, Hernia, V9, P150, DOI 10.1007/s10029-004-0312-8
   Hashemi M, 2000, J AM COLL SURGEONS, V190, P553, DOI 10.1016/S1072-7515(00)00260-X
   HILL LD, 1968, ARCH SURG-CHICAGO, V96, P735
   Jacobs M, 2007, SURG LAPARO ENDO PER, V17, P365, DOI 10.1097/SLE.0b013e318123fc49
   Johnson JM, 2006, SURG ENDOSC, V20, P362, DOI 10.1007/s00464-005-0357-5
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   Kelty CJ, 2007, ANN ROY COLL SURG, V89, P479
   Kemppainen E, 2000, Surg Endosc, V14, P593
   Klosterhalfen B, 2005, EXPERT REV MED DEVIC, V2, P103, DOI 10.1586/17434440.2.1.103
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   Lee YK, 2008, J GASTROINTEST SURG, V12, P811, DOI 10.1007/s11605-007-0463-x
   Losanoff J E, 2002, Hernia, V6, P144
   Muller-Stich BP, 2006, AM J SURG, V191, P139, DOI 10.1016/j.amjsurg.2005.08.006
   Muller-Stich BP, 2006, SURG ENDOSC, V20, P380, DOI 10.1007/s00464-004-2272-6
   Nason KS, 2008, J GASTROINTEST SURG, V12, P2066, DOI 10.1007/s11605-008-0712-7
   Oelschlager BK, 2006, ANN SURG, V244, P481, DOI 10.1097/01.sla.0000237759.42831.03
   Rice TW, 2007, ANN SURG, V246, P1116, DOI 10.1097/SLA.0b013e31815c299c
   Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y
   Rumstadt B, 2008, ENDOSCOPY, V40, pE70, DOI 10.1055/s-2007-995332
   *SAGES, 2009, ADV PROGR 2009 SAGES
   Smith GS, 2004, DIS ESOPHAGUS, V17, P279, DOI 10.1111/j.1442-2050.2004.00426.x
   Stadlhuber RJ, 2008, SURG ENDOSC, V23, P1219
   STIRLING MC, 1986, J THORAC CARDIOV SUR, V92, P667
   Targarona EM, 2004, ARCH SURG-CHICAGO, V139, P1286, DOI 10.1001/archsurg.139.12.1286
   Tatum RP, 2008, J GASTROINTEST SURG, V12, P953, DOI 10.1007/s11605-007-0316-7
   Thijssens K, 2002, LANCET, V360, P1586, DOI 10.1016/S0140-6736(02)11530-3
   Turkcapar A, 2007, WORLD J SURG, V31, P2169
   Willekes CL, 1997, ANN SURG, V225, P31, DOI 10.1097/00000658-199701000-00004
   Zaninotto G, 2007, J GASTROINTEST SURG, V11, P1138, DOI 10.1007/s11605-007-0195-y
NR 52
TC 52
Z9 57
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD MAY
PY 2010
VL 24
IS 5
BP 1017
EP 1024
DI 10.1007/s00464-009-0718-6
PG 8
WC Surgery
SC Surgery
GA 589LF
UT WOS:000277148500007
PM 19997755
DA 2018-10-20
ER

PT J
AU Nie, FL
   Zheng, YF
   Cheng, Y
   Wei, SC
   Valiev, RZ
AF Nie, F. L.
   Zheng, Y. F.
   Cheng, Y.
   Wei, S. C.
   Valiev, R. Z.
TI In vitro corrosion and cytotoxicity on microcrystalline, nanocrystalline
   and amorphous NiTi alloy fabricated by high pressure torsion
SO MATERIALS LETTERS
LA English
DT Article
DE Ni50.2Ti49.8 alloy; Nanocrystalline; Amorphous; Metals and alloys;
   Corrosion and ion release; Cytotoxicity
ID BIOCOMPATIBILITY
AB Bulk nanocrystalline and amorphous Ni50.2Ti49.8 alloy samples were successfully prepared from commercial microcrystalline Ni50.2Ti49.8 alloy discs by high pressure torsion (HPT) technique. Then their corrosion resistance, surface wettability and cytotoxicity were further studied from the viewpoint of biomaterials. In both Hank's solution and artificial saliva, bulk nanocrystalline and amorphous Ni50.2Ti49.8 alloys showed significantly higher pitting corrosion potentials than that of microcrystalline Ni50.2Ti49.8 alloy. Meanwhile, the amount of Ni ion release after immersion in Hank's solution was minor, far below the threatening threshold of daily diet. Murine fibroblast and osteoblast cell lines were indirectly co-cultured with experimental sample extracts, indicating no cytotoxicity. Amongst all samples, the nanocrystalline Ni50.2Ti49.8 shows promising as best biomaterial candidate for its good combination of mechanical property, corrosion resistance and cytocompatibility. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Nie, F. L.; Zheng, Y. F.] Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
   [Nie, F. L.; Zheng, Y. F.] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Zheng, Y. F.; Cheng, Y.; Wei, S. C.] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
   [Wei, S. C.] Peking Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100081, Peoples R China.
   [Valiev, R. Z.] Ufa State Aviat Tech Univ, Inst Phys Adv Mat, Ufa, Russia.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Adv Mat & Nanotechnol, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National Natural Science Foundation of China [30770580]; National Key
   Scientific Program-Nanoscience and Nanotechnology [2007CB936103]
FX This work was supported by the National Natural Science Foundation of
   China (No. 30770580), the National Key Scientific Program-Nanoscience
   and Nanotechnology (No. 2007CB936103).
CR COOGAN TP, 1989, CRC CR REV TOXICOL, V19, P341, DOI 10.3109/10408448909029327
   DUERIG T, 1999, MAT SCI ENG A-STRUCT, V149, P273, DOI DOI 10.1016/S0921-5093(99)00294-4
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Huang HH, 2003, BIOMATERIALS, V24, P3585, DOI 10.1016/S0142-9612(03)00188-1
   INOUE A, 2001, MAT SCI ENG A-STRUCT, V1, P304
   Kim TN, 2007, BIOMED MATER, V2, pS117, DOI 10.1088/1748-6041/2/3/S06
   Liu XM, 2009, J NANOSCI NANOTECHNO, V9, P3449, DOI 10.1166/jnn.2009.NS15
   Lu K, 1996, MAT SCI ENG R, V16, P161, DOI 10.1016/0927-796X(95)00187-5
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
NR 10
TC 28
Z9 29
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD APR 30
PY 2010
VL 64
IS 8
BP 983
EP 986
DI 10.1016/j.matlet.2010.01.081
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 576IS
UT WOS:000276138400028
DA 2018-10-20
ER

PT J
AU Wong, MS
   Sun, DS
   Chang, HH
AF Wong, Ming-Show
   Sun, Der-Shan
   Chang, Hsin-Hou
TI Bactericidal Performance of Visible-Light Responsive Titania
   Photocatalyst with Silver Nanostructures
SO PLOS ONE
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; ESCHERICHIA-COLI; BIOMATERIAL SYSTEM;
   MAGNETIC CORE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY;
   DISINFECTION; INACTIVATION; SHELL; ANTIBIOTICS
AB Background: Titania dioxide (TiO2) photocatalyst is primarily induced by ultraviolet light irradiation. Visible-light responsive anion-doped TiO2 photocatalysts contain higher quantum efficiency under sunlight and can be used safely in indoor settings without exposing to biohazardous ultraviolet light. The antibacterial efficiency, however, remains to be further improved.
   Methodology/Principal Findings: Using thermal reduction method, here we synthesized silver-nanostructures coated TiO2 thin films that contain a high visible-light responsive antibacterial property. Among our tested titania substrates including TiO2, carbon-doped TiO2 [TiO2 (C)] and nitrogen-doped TiO2 [TiO2 (N)], TiO2 (N) showed the best performance after silver coating. The synergistic antibacterial effect results approximately 5 log reductions of surviving bacteria of Escherichia coli, Streptococcus pyogenes, Staphylococcus aureus and Acinetobacter baumannii. Scanning electron microscope analysis indicated that crystalline silver formed unique wire-like nanostructures on TiO2 (N) substrates, while formed relatively straight and thicker rod-shaped precipitates on the other two titania materials.
   Conclusion/Significance: Our results suggested that proper forms of silver on various titania materials could further influence the bactericidal property.
C1 [Wong, Ming-Show] Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan.
   [Wong, Ming-Show; Chang, Hsin-Hou] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan.
   [Sun, Der-Shan; Chang, Hsin-Hou] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.
   [Chang, Hsin-Hou] Tzu Chi Univ, Ctr Vasc Med, Hualien, Taiwan.
RP Wong, MS (reprint author), Natl Dong Hwa Univ, Dept Mat Sci & Engn, Hualien, Taiwan.
EM hhchang@mail.tcu.edu.tw
RI Dom, Rekha/B-7113-2012
FU National Science Council of Taiwan ROC [95-2314-B-320-009-MY3,
   95-2120-M-259-003, 96-2221-E-259-010-MY3]; Ministry of Economic Affairs
   of Taiwan ROC [98-EC-17-A-19-S2-0111]
FX This work was supported by National Science Council of Taiwan ROC under
   grant no. 95-2314-B-320-009-MY3, 95-2120-M-259-003 and
   96-2221-E-259-010-MY3, and Ministry of Economic Affairs of Taiwan ROC
   under grant no. 98-EC-17-A-19-S2-0111. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ASAHI R, 2001, SCIENCE, V269, P293
   BERNARD BK, 1990, J TOXICOL ENV HEALTH, V29, P417, DOI 10.1080/15287399009531402
   Butkus MA, 2004, APPL ENVIRON MICROB, V70, P2848, DOI 10.1128/AEM.70.5.2848-2853.2004
   Chang CW, 2007, J BIOMED SCI, V14, P419, DOI 10.1007/s11373-007-9154-6
   Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2
   Cheng CL, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-7
   Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Elechiguerra JL, 2005, J NANOBIOTECHNOL, V3, P1, DOI DOI 10.1186/1477-3155-3-6
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269
   Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400
   Hu C, 2007, LANGMUIR, V23, P4982, DOI 10.1021/la063626x
   Iroha IR, 2007, SCI RES ESSAYS, V2, P338
   Kau JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004167
   Kisch H, 2002, CHEMPHYSCHEM, V3, P399, DOI 10.1002/1439-7641(20020517)3:5<399::AID-CPHC399>3.0.CO;2-H
   Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082
   Li Q, 2007, ENVIRON SCI TECHNOL, V41, P5050, DOI 10.1021/es062753c
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Matsui Y, 2004, MICROBIOL IMMUNOL, V48, P489, DOI 10.1111/j.1348-0421.2004.tb03541.x
   Mitoraj D, 2007, PHOTOCH PHOTOBIO SCI, V6, P642, DOI 10.1039/b617043a
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Panyala NR, 2008, J APPL BIOMED, V6, P117
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rengifo-Herrera JA, 2008, APPL CATAL B-ENVIRON, V84, P448, DOI 10.1016/j.apcatb.2008.04.030
   Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001
   Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sun DS, 2005, J BIOMED SCI, V12, P321, DOI 10.1007/s11373-005-0979-6
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002
   Wong MS, 2008, J MOL CATAL A-CHEM, V279, P20, DOI 10.1016/j.molcata.2007.09.024
   Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05
   Yang GX, 2004, PLANT PHYSIOL BIOCH, V42, P1, DOI 10.1016/j.plaphy.2003.10.001
   Yang TS, 2004, SURF SCI, V548, P75, DOI 10.1016/j.susc.2003.10.044
   Yao Y, 2008, J BIOMED MATER RES B, V85B, P453, DOI 10.1002/jbm.b.30965
   Yu JC, 2005, ENVIRON SCI TECHNOL, V39, P1175, DOI 10.1021/es035374h
NR 45
TC 26
Z9 26
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 29
PY 2010
VL 5
IS 4
AR e10394
DI 10.1371/journal.pone.0010394
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 590PU
UT WOS:000277240100010
PM 20454454
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Narayan, RJ
AF Narayan, Roger J.
TI The next generation of biomaterial development PREFACE
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Editorial Material
ID DRUG-ELUTING STENTS; SCAFFOLD FABRICATION; MEDICAL DEVICES; TISSUE;
   CERAMICS; SAFETY
C1 [Narayan, Roger J.] Univ N Carolina, Joint Dept Biomed Engn, Raleigh, NC USA.
   [Narayan, Roger J.] N Carolina State Univ, Raleigh, NC 27695 USA.
RP Narayan, RJ (reprint author), Univ N Carolina, Joint Dept Biomed Engn, Raleigh, NC USA.
EM roger_narayan@msn.com
RI Narayan, Roger/J-2789-2013
OI Narayan, Roger/0000-0002-4876-9869
CR Apple DJ, 1996, SURV OPHTHALMOL, V40, P279, DOI 10.1016/S0039-6257(96)82003-0
   BLACK MM, 1982, PHYS TECHNOL, V13, P50, DOI 10.1088/0305-4624/13/2/302
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Burg T, 2010, PHILOS T R SOC A, V368, P1839, DOI 10.1098/rsta.2010.0002
   Cox ED, 2009, TRANSFUSION, V49, p248S, DOI 10.1111/j.1537-2995.2008.01988.x
   Dahotre NB, 2010, PHILOS T R SOC A, V368, P1863, DOI 10.1098/rsta.2010.0003
   DHERT WJA, 1994, MED PROG TECHNOL, V20, P143
   Doraiswamy A, 2006, ACTA BIOMATER, V2, P267, DOI 10.1016/j.actbio.2006.01.004
   DORAISWAMY A, 2008, J BIOMED MATER RES B, V89, P28
   Doraiswamy A, 2010, PHILOS T R SOC A, V368, P1891, DOI 10.1098/rsta.2010.0004
   DUCHEYNE P, 1994, J BONE JOINT SURG BR, V76B, P861
   EYRONLEWIS NJ, 1992, BRIT MED J, V305, P1534
   Fritsch A, 2010, PHILOS T R SOC A, V368, P1913, DOI 10.1098/rsta.2010.0005
   Giocondi JL, 2010, PHILOS T R SOC A, V368, P1937, DOI 10.1098/rsta.2010.0006
   Halsted WS, 1913, J AMER MED ASSOC, V60, P1119, DOI 10.1001/jama.1913.04340150001001
   Hansmann C, 1886, VERH DTSCH GES CHIR, V15, P134
   Hassan W, 2008, ANN SAUDI MED, V28, P114
   He YJ, 2006, INT J ADV MANUF TECH, V28, P504, DOI 10.1007/s00170-004-2406-y
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Katti KS, 2010, PHILOS T R SOC A, V368, P1963, DOI 10.1098/rsta.2010.0008
   Ko HF, 2010, PHILOS T R SOC A, V368, P1981, DOI 10.1098/rsta.2010.0009
   Kolff WJ, 2002, NAT MED, V8, P1063, DOI 10.1038/nm771
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Kukreja N, 2008, PHARMACOL RES, V57, P171, DOI 10.1016/.i.phrs.2008.01.012
   Lee K. K., 2009, NANOMEDICINE SYSTEMS, P1
   Lister J., 1867, LANCET, V90, P353, DOI DOI 10.1016/S0140-6736(02)51827-4
   Madurantakam PA, 2009, NANOMEDICINE-UK, V4, P193, DOI 10.2217/17435889.4.2.193
   Murr LE, 2010, PHILOS T R SOC A, V368, P1999, DOI 10.1098/rsta.2010.0010
   Narayan RJ, 2004, JOM-US, V56, P38, DOI 10.1007/s11837-004-0289-x
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P2033, DOI 10.1098/rsta.2010.0011
   Ovsianikov A, 2007, APPL SURF SCI, V253, P6603, DOI 10.1016/j.apsusc.2007.01.062
   PARK J, 2007, BIOMATERIALS INTRO, P2
   PARK JB, 2003, BIOMATERIALS PRINCIP, pR3
   Petit R., 1999, EUR J ORTHOP SURG TR, V9, P71, DOI DOI 10.1007/BF01695730
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Rodriguez G, 2007, CAN J PLANT PATHOL, V29, P79, DOI 10.1080/07060660709507440
   Venable CS, 1937, ANN SURG, V105, P917, DOI 10.1097/00000658-193706000-00006
   Venugopal J, 2010, PHILOS T R SOC A, V368, P2065, DOI 10.1098/rsta.2010.0012
   Verma D, 2010, PHILOS T R SOC A, V368, P2083, DOI 10.1098/rsta.2010.0013
   Wegst UGK, 2010, PHILOS T R SOC A, V368, P2099, DOI 10.1098/rsta.2010.0014
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT, P40
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
NR 42
TC 24
Z9 24
U1 1
U2 13
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD APR 28
PY 2010
VL 368
IS 1917
BP 1831
EP 1837
DI 10.1098/rsta.2010.0001
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 572ER
UT WOS:000275810800001
PM 20308105
OA Bronze
DA 2018-10-20
ER

PT J
AU Fritsch, A
   Hellmich, C
   Dormieux, L
AF Fritsch, Andreas
   Hellmich, Christian
   Dormieux, Luc
TI The role of disc-type crystal shape for micromechanical predictions of
   elasticity and strength of hydroxyapatite biomaterials
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE micromechanics; hydroxyapatite; disc; needle; strength; elasticity
ID CONTINUUM MICROMECHANICS; MECHANICAL-PROPERTIES; COMPOSITE-MATERIALS;
   BONE; SCAFFOLDS; MODEL; BEHAVIOR; STRESS; MATRIX; GLASS
AB The successful design of ceramic bone biomaterials is challenged by two competing requirements: on the one hand, such materials need to be stiff and strong, which would suggest a low porosity (of pore sizes in the 10-100 mm range) to be targeted; on the other hand, bone biomaterials need to be bioactive (in particular vascularized), which suggests a high porosity of such materials. Conclusively, reliable information on how porosity drives the stiffness and strength properties of ceramic bone biomaterials (tissue engineering scaffolds) is of great interest. In this context, mathematical models are increasingly being introduced into the field. Recently, self-consistent continuum micromechanics formulations have turned out as expressedly efficient and reliable tools to predict hydroxyapatite biomaterials' stiffness and strength, as a function of the biomaterial-specific porosity, and of the 'universal' properties of the individual hydroxyapatite crystals: their stiffness, strength and shape. However, the precise crystal shape can be suitably approximated by specific ellipsoidal shapes: while it was shown earlier that spherical shapes do not lead to satisfactory results, and that acicular shapes are an appropriate choice, we here concentrate on disc-type crystal shape as, besides needles, plates are often reported in micrographs of hydroxyapatite biomaterials. Disc-based model predictions of a substantial set of experimental data on stiffness and strength of hydroxyapatite biomaterials almost attain the quality of the very satisfactory needle-based models. This suggests that, as long as the crystal shape is clearly non-spherical, its precise shape is of secondary importance if stiffness and strength of hydroxyapatite biomaterials are predicted on the basis of continuum micromechanics, from their micromorphology and porosity.
C1 [Fritsch, Andreas; Hellmich, Christian] Vienna Univ Technol TU Wien, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
   [Dormieux, Luc] Ecole Ponts Paris Tech, F-77455 Marne La Vallee, France.
RP Hellmich, C (reprint author), Vienna Univ Technol TU Wien, Inst Mech Mat & Struct, A-1040 Vienna, Austria.
EM christian.hellmich@tuwien.ac.at
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   ASHMAN RB, 1987, J BIOMECH, V20, P979, DOI 10.1016/0021-9290(87)90327-7
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   BENVENISTE Y, 1987, MECH MATER, V6, P147, DOI 10.1016/0167-6636(87)90005-6
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Carcione J. M., 2001, WAVE FIELDS REAL MED
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   COWIN SC, 1992, J MECH PHYS SOLIDS, V40, P1459, DOI 10.1016/0022-5096(92)90029-2
   Cowin SC, 2003, TRANSPORT POROUS MED, V50, P35, DOI 10.1023/A:1020626717067
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   ESHELBY JD, 1957, P ROY SOC LOND A MAT, V241, P396
   Fritsch A, 2006, CR MECANIQUE, V334, P151, DOI 10.1016/j.crme.2006.01.008
   Fritsch A, 2007, J MATER SCI, V42, P8824, DOI 10.1007/s10853-007-1859-4
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   Fritsch A, 2009, J BIOMED MATER RES A, V88A, P149, DOI 10.1002/jbm.a.31727
   GILMORE RS, 1982, J MATER SCI, V17, P1131, DOI 10.1007/BF00543533
   HASHIN Z, 1983, J APPL MECH-T ASME, V50, P481, DOI 10.1115/1.3167081
   Hellmich C, 2004, EUR J MECH A-SOLID, V23, P783, DOI 10.1016/j.euromechsol.2004.05.004
   Hellmich C, 2002, J ENG MECH-ASCE, V128, P898, DOI 10.1061/(ASCE)0733-9399(2002)128:8(898)
   Helnwein P, 2001, COMPUT METHOD APPL M, V190, P2753, DOI 10.1016/S0045-7825(00)00263-2
   HERSHEY AV, 1954, J APPL MECH-T ASME, V21, P236
   HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X
   Hofstetter K., 2006, Computer Assisted Mechanics and Engineering Sciences, V13, P523
   Hofstetter K, 2005, EUR J MECH A-SOLID, V24, P1030, DOI 10.1016/j.euromechsol.2005.05.006
   KATZ JL, 1971, J BIOMECH, V4, P221, DOI 10.1016/0021-9290(71)90007-8
   Kolsky H, 1953, STRESS WAVES SOLIDS
   KRONER E, 1958, Z PHYS, V151, P504, DOI 10.1007/BF01337948
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   LAWS N, 1977, J ELASTICITY, V7, P91, DOI 10.1007/BF00041133
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Malasoma A, 2008, ADV APPL CERAM, V107, P277, DOI 10.1179/174367508X306488
   MARTIN RI, 1995, J MATER SCI-MATER M, V6, P138, DOI 10.1007/BF00120289
   MAYR E, 1997, THIS IS BIOL SCI LIV
   MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3
   Peelen J. G. J., 1978, Ceramurgia International, V4, P71, DOI 10.1016/0390-5519(78)90122-9
   Pereira MM, 2005, ADV APPL CERAM, V104, P35, DOI 10.1179/174367605225011034
   SALENCON J, 2001, HDB CONTINUUM MECH G
   Scheiner S, 2009, BIOMATERIALS, V30, P2411, DOI 10.1016/j.biomaterials.2008.12.048
   Schreiber E., 1973, ELASTIC CONSTANTS TH
   SHAREEF MY, 1993, BIOMATERIALS, V14, P69, DOI 10.1016/0142-9612(93)90078-G
   SUQUET P, 1997, CONTINUUM MICROMECHA
   Zaoui A, 2002, J ENG MECH-ASCE, V128, P808, DOI 10.1061/(ASCE)0733-9399(2002)128:8(808)
NR 44
TC 18
Z9 18
U1 2
U2 5
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
EI 1471-2962
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD APR 28
PY 2010
VL 368
IS 1917
BP 1913
EP 1935
DI 10.1098/rsta.2010.0005
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 572ER
UT WOS:000275810800005
PM 20308109
OA Bronze
DA 2018-10-20
ER

PT J
AU Ko, HF
   Sfeir, C
   Kumta, PN
AF Ko, Hsu-Feng
   Sfeir, Charles
   Kumta, Prashant N.
TI Novel synthesis strategies for natural polymer and composite
   biomaterials as potential scaffolds for tissue engineering
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE natural polymers; composite scaffolds; cellulose; chitosan; alginate;
   agarose
ID POROUS ALGINATE SCAFFOLDS; GENE DELIVERY-SYSTEM; IN-VITRO; BACTERIAL
   CELLULOSE; CHITOSAN; BONE; HYDROGELS; CARTILAGE; MICROSPHERES; RELEASE
AB Recent developments in tissue engineering approaches frequently revolve around the use of three-dimensional scaffolds to function as the template for cellular activities to repair, rebuild and regenerate damaged or lost tissues. While there are several biomaterials to select as three-dimensional scaffolds, it is generally agreed that a biomaterial to be used in tissue engineering needs to possess certain material characteristics such as biocompatibility, suitable surface chemistry, interconnected porosity, desired mechanical properties and biodegradability. The use of naturally derived polymers as three-dimensional scaffolds has been gaining widespread attention owing to their favourable attributes of biocompatibility, low cost and ease of processing. This paper discusses the synthesis of various polysaccharide-based, naturally derived polymers, and the potential of using these biomaterials to serve as tissue engineering three-dimensional scaffolds is also evaluated.
   In this study, naturally derived polymers, specifically cellulose, chitosan, alginate and agarose, and their composites, are examined. Single-component scaffolds of plain cellulose, plain chitosan and plain alginate as well as composite scaffolds of cellulose-alginate, cellulose-agarose, cellulose-chitosan, chitosan-alginate and chitosan-agarose are synthesized, and their suitability as tissue engineering scaffolds is assessed. It is shown that naturally derived polymers in the form of hydrogels can be synthesized, and the lyophilization technique is used to synthesize various composites comprising these natural polymers. The composite scaffolds appear to be sponge-like after lyophilization. Scanning electron microscopy is used to demonstrate the formation of an interconnected porous network within the polymeric scaffold following lyophilization. It is also established that HeLa cells attach and proliferate well on scaffolds of cellulose, chitosan or alginate. The synthesis protocols reported in this study can therefore be used to manufacture naturally derived polymer-based scaffolds as potential biomaterials for various tissue engineering applications.
C1 [Ko, Hsu-Feng; Sfeir, Charles; Kumta, Prashant N.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Ko, Hsu-Feng; Sfeir, Charles; Kumta, Prashant N.] Univ Pittsburgh, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA.
   [Sfeir, Charles; Kumta, Prashant N.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Dept Chem & Petr Engn Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA.
RP Kumta, PN (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
EM pkumta@pitt.edu
FU NSF [NIRT-CTS-0210238, NIH-NIBIB 1R01EB002706-01, NIH-NIDCR
   5R01DE016123]; Edward R. Weidlein Chair Professorship; NSF-ERC
FX The authors would like to acknowledge the following grants for providing
   the monetary support of this research: the Pittsburgh Tissue Engineering
   Initiative, NSF NIRT-CTS-0210238, NIH-NIBIB 1R01EB002706-01 and
   NIH-NIDCR 5R01DE016123. The authors would also like to thank Marc Rubin,
   formerly from the Center for Biologic Imaging (University of
   Pittsburgh), for help with the capture of some of the SEM images
   reported in this paper. P.N.K. also acknowledges the partial support of
   the Edward R. Weidlein Chair Professorship funds for supporting this
   research. The authors also acknowledge NSF-ERC funds for partial support
   of this research.
CR AHSAN T, 2008, TRANSLATIONAL APPROA, P3
   ANBERGEN U, 1990, POLYMER, V31, P1854, DOI 10.1016/0032-3861(90)90006-K
   Aufderheide AC, 2005, TISSUE ENG, V11, P1095, DOI 10.1089/ten.2005.11.1095
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   BONFIGLIO M, 1972, CLIN ORTHOP RELAT R, P19
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Capitani D, 2000, MACROMOLECULES, V33, P430, DOI 10.1021/ma9914117
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   EHRENFREUNDKLEI.T, 2006, SCAFFOLDING TISSUE E, P27
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Esposito A, 2005, BIOMATERIALS, V26, P4101, DOI 10.1016/j.biomaterials.2004.10.023
   Esposito F, 1996, J APPL POLYM SCI, V60, P2403
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Guo JH, 1998, PHARM SCI TECHNOL TO, V1, P254, DOI 10.1016/S1461-5347(98)00072-8
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Higashi T, 2004, J BIOSCI BIOENG, V97, P191, DOI 10.1263/jbb.97.191
   Hu JC, 2005, BIOMATERIALS, V26, P2001, DOI 10.1016/j.biomaterials.2004.06.008
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Issa Mohamed M, 2005, Drug Discov Today Technol, V2, P1, DOI 10.1016/j.ddtec.2005.05.008
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   Li JJ, 2002, J PHARM SCI-US, V91, P1669, DOI 10.1002/jps.10157
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Ma PX, 2006, SCAFFOLDING TISSUE E, P13
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Roy K, 1999, NAT MED, V5, P387
   Ruel-Gariepy E, 2000, INT J PHARM, V203, P89, DOI 10.1016/S0378-5173(00)00428-2
   Sannino A, 2003, J BIOMED MATER RES A, V67A, P1016, DOI 10.1002/jbm.a.10149
   SEBERT P, 1994, INT J PHARM, V106, P103, DOI 10.1016/0378-5173(94)90307-7
   Sivakumar M, 2003, J BIOMED MATER RES A, V65A, P222, DOI 10.1002/jbm.a.10495
   Sone T, 2002, J BIOSCI BIOENG, V94, P87, DOI 10.1263/jbb.94.87
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   VARGHESE S, 2006, ADV POLYM SCI, V203, P95
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Xu XL, 2005, J BIOMED MATER RES B, V75B, P289, DOI 10.1002/jbm.b.30299
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 49
TC 41
Z9 45
U1 6
U2 48
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD APR 28
PY 2010
VL 368
IS 1917
BP 1981
EP 1997
DI 10.1098/rsta.2010.0009
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 572ER
UT WOS:000275810800008
PM 20308112
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Lovell, CS
   de Oca, HM
   Farrar, D
   Ries, ME
   Ward, IM
AF Lovell, C. S.
   de Oca, H. Montes
   Farrar, D.
   Ries, M. E.
   Ward, I. M.
TI Analysis and modeling of the mechanical properties of novel thermotropic
   polymer biomaterials
SO POLYMER
LA English
DT Article
DE Biomaterial; Liquid crystalline polymers; Aggregate model
ID LIQUID-CRYSTALLINE COPOLYESTERS; X-RAY-DIFFRACTION; BIODEGRADABLE
   POLYMERS; MOLECULAR-ORIENTATION; HYDROXYBENZOIC ACID; TEREPHTHALIC ACID;
   LACTIDE MOIETIES; FIBERS; DEGRADATION; POLYESTERS
AB A series of random aromatic-aliphatic thermotropic copolyesters comprising p-hydroxybenzoic acid (NBA), vanillic acid (VA), 4,4'-sulfonyl bis(2-methylphenol) (dBPS) and three aliphatic diacids (Spacer), developed for potential applications in orthopaedic medicine, have been characterized in the context of their structure and mechanical properties. Each of the three polymers comprised the following molar percentages of monomer units 50/25/12.5/12.5 (HBA/VA/dBPS/Spacer). Oriented fibres prepared from the materials via melt-spinning have been analyzed using X-ray diffraction to evaluate order parameters describing the degree of molecular orientation and mechanical measurements to determine their tensile properties. In addition, measurements of the bulk isotropic and shear moduli of one polymer composition have also been performed. To obtain an understanding of the material properties the aggregate model due to Ward has been applied to the orientation dependence of the measured elastic moduli and the development of mechanical anisotropy. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lovell, C. S.; Ries, M. E.; Ward, I. M.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.
   [de Oca, H. Montes; Farrar, D.] Smith & Nephew Res Ctr, York YO10 5DF, N Yorkshire, England.
RP Ward, IM (reprint author), Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England.
EM cs.lovell@me.com; horacio.montesdeoca@smith-nephew.com;
   david.farrar@smith-nephew.com; m.e.ries@leeds.ac.uk;
   i.m.ward@leeds.ac.uk
FU Yorkshire Forward (Yorkshire & Humber Regional Development Agency);
   European Union; EPSRC; Engineering and Physical Sciences Research
   Council [EP/I019103/1, EP/G032483/1, EP/J017620/1]
FX The authors wish to thank Prof. J.W. Goodby, Dr. I.M. Saez and Dr. A.D.
   Wilson within the Liquid Crystals Group at the University of York for
   their work on the synthesis of the materials studied in this work. This
   project received funding from Yorkshire Forward (Yorkshire & Humber
   Regional Development Agency). Project part financed by the European
   Union European Regional Development Fund. C.S. Lovell would like to
   thank the EPSRC and Smith & Nephew (R) for their sponsorship through an
   EPSRC CASE Award.
CR BISWAS A, 1988, MACROMOLECULES, V21, P3146, DOI 10.1021/ma00189a004
   BISWAS A, 1987, MACROMOLECULES, V20, P2997, DOI 10.1021/ma00178a008
   BLACKWELL J, 1982, POLYMER, V23, P671, DOI 10.1016/0032-3861(82)90049-0
   BLACKWELL J, 1985, MACROMOLECULES, V18, P2126, DOI 10.1021/ma00153a010
   BLUMSTEIN A, 1990, J APPL POLYM SCI, V41, P995, DOI 10.1002/app.1990.070410511
   BOWER D, 1981, J POLYM SCI POL LETT, V19, P83
   Chen YW, 2004, BIOMACROMOLECULES, V5, P11, DOI 10.1021/bm034388c
   Chen YW, 2003, POLYMER, V44, P5513, DOI 10.1016/S0032-3861(03)00571-8
   Choy C., 1998, MECH THERMOPHYSICAL, P448
   De Oca HM, 2007, J POLYM SCI POL PHYS, V45, P892, DOI 10.1002/polb.21131
   de Oca HM, 2006, POLYMER, V47, P7070, DOI 10.1016/j.polymer.2006.07.045
   de Oca HM, 2004, POLYMER, V45, P7261, DOI 10.1016/j.polymer.2004.08.028
   DEAS HD, 1952, ACTA CRYSTALLOGR, V5, P542, DOI 10.1107/S0365110X52001507
   DEOCA HM, LIQUID CRYSTAL UNPUB
   DEOCA HM, 2005, PRODUCTION PROPERTIE
   Donald A. M., 1992, CAMBRIDGE SOLID STAT
   Duckett R., 1997, STRUCTURE PROPERTIES, P377
   FRANCK A, EVALUATION CORRECT M
   Gomes ME, 2004, INT MATER REV, V49, P261, DOI 10.1179/095066004225021918
   Green DI, 1997, POLYMER, V38, P5355, DOI 10.1016/S0032-3861(97)00081-5
   GREEN DI, 1990, POLYMER, V31, P579, DOI 10.1016/0032-3861(90)90272-Z
   Haderlein G, 1997, POLYM ADVAN TECHNOL, V8, P568
   Haderlein G, 1999, MACROMOL CHEM PHYSIC, V200, P2080, DOI 10.1002/(SICI)1521-3935(19990901)200:9<2080::AID-MACP2080>3.0.CO;2-Y
   Kricheldorf HR, 1997, MACROMOL CHEM PHYS, V198, P3753, DOI 10.1002/macp.1997.021981134
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mitchell G. R., 1988, DEV CRYSTALLINE POLY, V3, P115
   MITCHELL GR, 1982, COLLOID POLYM SCI, V260, P754, DOI 10.1007/BF01452065
   MITCHELL GR, 1983, POLYMER, V24, P1513, DOI 10.1016/0032-3861(83)90164-7
   Nagata M, 2000, J APPL POLYM SCI, V78, P2474, DOI 10.1002/1097-4628(20001227)78:14<2474::AID-APP60>3.0.CO;2-1
   Nagata M, 2001, J POLYM SCI POL CHEM, V39, P3043, DOI 10.1002/pola.1285
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SWEENEY J, 1992, POLYMER, V33, P4901, DOI 10.1016/0032-3861(92)90039-Y
   TROUGHTON MJ, 1989, POLYMER, V30, P58, DOI 10.1016/0032-3861(89)90383-2
   UNWIN AP, 1985, POLYMER, V26, P1605, DOI 10.1016/0032-3861(85)90271-X
   WANG XJ, 2004, LIQUID CRYSTALLINE P
   Ward I. M., 2004, INTRO MECH PROPERTIE
   WARD IM, 1962, P PHYS SOC LOND, V80, P1176, DOI 10.1088/0370-1328/80/5/319
   ZHANG H, 1992, POLYMER, V33, P2651, DOI 10.1016/0032-3861(92)90434-X
NR 38
TC 8
Z9 8
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD APR 20
PY 2010
VL 51
IS 9
BP 2013
EP 2020
DI 10.1016/j.polymer.2010.02.047
PG 8
WC Polymer Science
SC Polymer Science
GA 588FY
UT WOS:000277054700019
DA 2018-10-20
ER

PT J
AU Ge, C
   Lu, M
   Zhang, W
   Cunningham, BT
AF Ge, Chun
   Lu, Meng
   Zhang, Wei
   Cunningham, Brian T.
TI Distributed feedback laser biosensor incorporating a titanium dioxide
   nanorod surface
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID LABEL-FREE; RING-RESONATOR
AB A dielectric nanorod structure is used to enhance the label-free detection sensitivity of a vertically-emitting distributed feedback laser biosensor (DFBLB). The device is comprised of a replica molded plastic grating that is subsequently coated with a dye-doped polymer layer and a TiO2 nanorod layer produced by the glancing angle deposition technique. The DFBLB emission wavelength is modulated by the adsorption of biomolecules, whose greater dielectric permittivity with respect to the surrounding liquid media will increase the laser wavelength in proportion to the density of surface-adsorbed biomaterial. The nanorod layer provides greater surface area than a solid dielectric thin film, resulting in the ability to incorporate a greater number of molecules. The detection of a monolayer of protein polymer poly (Lys, Phe) is used to demonstrate that a 90 nm TiO2 nanorod structure improves the detection sensitivity by a factor of 6.6 compared to an identical sensor with a nonporous TiO2 surface. (C) 2010 American Institute of Physics. [doi:10.1063/1.3394259]
C1 [Ge, Chun; Lu, Meng; Cunningham, Brian T.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
   [Zhang, Wei] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Cunningham, Brian T.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
RP Cunningham, BT (reprint author), Univ Illinois, Dept Elect & Comp Engn, 1406 W Green St, Urbana, IL 61801 USA.
EM bcunning@illinois.edu
FU U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine &
   Advanced Technology Research Center (TATRC) [W81XWH0810701]
FX This project was made possible by a cooperative agreement that was
   awarded and administered by the U.S. Army Medical Research & Materiel
   Command (USAMRMC) and the Telemedicine & Advanced Technology Research
   Center (TATRC), under Contract No. W81XWH0810701.
CR Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002
   Balslev S, 2005, J MICROMECH MICROENG, V15, P2456, DOI 10.1088/0960-1317/15/12/030
   Block ID, 2008, IEEE SENS J, V8, P274, DOI 10.1109/JSEN.2008.917127
   Chen Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2757600
   Cunningham A. J., 1998, INTRO BIOANALYTICAL
   Cunningham BT, 2006, EXPERT REV PROTEOMIC, V3, P271, DOI 10.1586/14789450.3.3.271
   Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604
   HENRY CH, 1985, IEEE J QUANTUM ELECT, V21, P151, DOI 10.1109/JQE.1985.1072620
   KAZARINOV RF, 1985, IEEE J QUANTUM ELECT, V21, P144, DOI 10.1109/JQE.1985.1072627
   Lu M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2913007
   LU M, 2008, APPL PHYS LETT, V92, P63505
   Narayanaswamy R., 2004, OPTICAL SENSORS IND
   ROBBIE K, 1995, J VAC SCI TECHNOL A, V13, P1032, DOI 10.1116/1.579579
   Suter JD, 2008, BIOSENS BIOELECTRON, V23, P1003, DOI 10.1016/j.bios.2007.10.005
   TEMKIN H, 1985, APPL PHYS LETT, V46, P105, DOI 10.1063/1.95700
   Washburn AL, 2009, ANAL CHEM, V81, P9499, DOI 10.1021/ac902006p
   White IM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2387112
   Zhang W, 2008, SENSOR ACTUAT B-CHEM, V131, P279, DOI 10.1016/j.snb.2007.11.017
   Zhang W, 2008, SMALL, V4, P2199, DOI 10.1002/smll.200800367
   Zhu HY, 2007, OPT EXPRESS, V15, P9139, DOI 10.1364/OE.15.009139
NR 20
TC 23
Z9 24
U1 0
U2 16
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD APR 19
PY 2010
VL 96
IS 16
AR 163702
DI 10.1063/1.3394259
PG 3
WC Physics, Applied
SC Physics
GA 587UY
UT WOS:000277020600069
DA 2018-10-20
ER

PT J
AU Zhang, JD
   Ding, Q
   Wang, R
   Gong, JY
   Yang, CZ
AF Zhang, Jingdong
   Ding, Qiang
   Wang, Rui
   Gong, Jianyu
   Yang, Changzhu
TI Liquid phase deposition of mesoporous TiO2/DNA hybrid film:
   Characterization and photoelectrochemical investigation
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE DNA; TiO2; Liquid phase deposition; Hybrid film; Photoelectrochemistry
ID TITANIUM-DIOXIDE; THIN-FILMS; ELECTROCHEMICAL PROPERTIES;
   CHARGE-TRANSFER; DNA-DAMAGE; ELECTRODES; HYBRIDIZATION; KINETICS;
   SENSOR; PH
AB A photoelectroactive TiO2/DNA hybrid film was synthesized via the liquid phase deposition (LPD) process. Scanning electron microscopic (SEM) characterization showed that the compact TiO2 film was changed to a mesoporous structure when DNA was present in the deposition solution, which might be the result of TiO2 particles growing along the backbones of the double-helical structure of DNA molecules. Although UV absorption spectra and cyclic voltammograms indicated that the deposited TiO2 on the substrate surface was decreased in the presence of DNA, an enhanced photocurrent response was observed. The electrochemical impedance and cyclic voltammetric measurements using K-3[Fe(CN)(6)] as a redox probe suggested that the mesoporous film provided a relatively more efficient electron transfer interface, which could improve the photoelectron transfer rate from the semiconducting film to the electrode and reduce the recombination of photoelectrons and holes. This results in an enhanced photocurrent. Even after long-term and continuous UV irradiation, the mesoporous film exhibited a promoted photoelectrochemical response. The promoted photoelectrocatalytic degradation of methylene blue was obtained on the TiO2/DNA composite film, which is consistent with the enhanced photocurrent, and this demonstrates that DNA behaved as a useful biomaterial for the synthesis of a photoelectroactive hybrid film with improved performance. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Zhang, Jingdong; Wang, Rui] Huazhong Univ Sci & Technol, Coll Chem & Chem Engn, Wuhan 430074, Peoples R China.
   [Ding, Qiang; Gong, Jianyu; Yang, Changzhu] Huazhong Univ Sci & Technol, Coll Environm Sci & Engn, Wuhan 430074, Peoples R China.
RP Zhang, JD (reprint author), Huazhong Univ Sci & Technol, Coll Chem & Chem Engn, Luoyu Rd 1037, Wuhan 430074, Peoples R China.
EM zhangjd@mail.hust.edu.cn
RI gong, jianyu/C-6448-2015
OI gong, jianyu/0000-0002-0446-334X
FU National Natural Science Foundation of China [20977037]
FX This work was supported by the National Natural Science Foundation of
   China (No. 20977037). The authors thank the Analytical and Testing
   Center of Huazhong University of Science and Technology for the use of
   the SEM equipment.
CR Bandyopadhyay A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2781472
   Chen GF, 2007, J BIOTECHNOL, V127, P653, DOI 10.1016/j.jbiotec.2006.07.029
   Dovbeshko GI, 2000, TALANTA, V53, P233, DOI 10.1016/S0039-9140(00)00462-8
   Fabregat-Santiago F, 2003, J PHYS CHEM B, V107, P758, DOI 10.1021/jp0265182
   Gao ZQ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni125
   Gutierrez-Tauste D, 2007, J PHOTOCH PHOTOBIO A, V187, P45, DOI 10.1016/j.jphotochem.2006.09.011
   Haruna KI, 2008, ORG BIOMOL CHEM, V6, P1613, DOI 10.1039/b800295a
   Houlton A, 2009, CHEM COMMUN, P1797, DOI 10.1039/b818456a
   Jiang GD, 2009, SENSOR ACTUAT B-CHEM, V138, P607, DOI 10.1016/j.snb.2009.03.019
   Jiang L, 2005, ADV MATER, V17, P2066, DOI 10.1002/adma.200402004
   Li SN, 2005, J AM CHEM SOC, V127, P14, DOI 10.1021/ja0446045
   Liang MM, 2007, ENVIRON SCI TECHNOL, V41, P658, DOI 10.1021/es0617688
   Lu W, 2008, BIOSENS BIOELECTRON, V23, P1534, DOI 10.1016/j.bios.2008.01.011
   Ma B, 2007, J ELECTROCHEM SOC, V154, pD557, DOI 10.1149/1.2769828
   Marken F, 2004, ELECTROCHEM COMMUN, V6, P1153, DOI 10.1016/j.elecom.2004.09.006
   Monreal-Romero HA, 2005, NANOTECHNOLOGY, V16, P1272, DOI 10.1088/0957-4484/16/8/048
   Oliva FY, 2002, J ELECTROANAL CHEM, V534, P19, DOI 10.1016/S0022-0728(02)01099-9
   Rajh T, 2004, NANO LETT, V4, P1017, DOI 10.1021/nl049684p
   SABATANI E, 1987, J PHYS CHEM-US, V91, P6663, DOI 10.1021/j100311a021
   Sharma J, 2008, ANGEW CHEM INT EDIT, V47, P5157, DOI 10.1002/anie.200801485
   Suzuki H, 2008, ENVIRON SCI TECHNOL, V42, P8076, DOI 10.1021/es800948d
   Takada T, 2007, ANGEW CHEM INT EDIT, V46, P6681, DOI 10.1002/anie.200701525
   Tatemichi M, 2007, J AM CHEM SOC, V129, P10906, DOI 10.1021/ja071890m
   Tokudome H, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135392
   Toyooka T, 2009, SCI TOTAL ENVIRON, V407, P2143, DOI 10.1016/j.scitotenv.2008.12.011
   Wu AG, 2008, NANO, V3, P27, DOI 10.1142/S1793292008000836
   Yang P, 2007, J AM CHEM SOC, V129, P1541, DOI 10.1021/ja063716o
   Yu JG, 2003, J PHYS CHEM B, V107, P13871, DOI 10.1021/jp036158y
   Zhang JD, 2008, J APPL ELECTROCHEM, V38, P1421, DOI 10.1007/s10800-008-9582-7
   Zhang JD, 2008, ELECTROCHEM COMMUN, V10, P1038, DOI 10.1016/j.elecom.2008.04.039
NR 30
TC 13
Z9 13
U1 3
U2 45
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD APR 15
PY 2010
VL 55
IS 11
BP 3614
EP 3620
DI 10.1016/j.electacta.2010.01.116
PG 7
WC Electrochemistry
SC Electrochemistry
GA 586TK
UT WOS:000276935900003
DA 2018-10-20
ER

PT J
AU Aran, B
   Sankir, M
   Vargun, E
   Sankir, ND
   Usanmaz, A
AF Aran, Bengi
   Sankir, Mehmet
   Vargun, Elif
   Sankir, Nurdan D.
   Usanmaz, Ali
TI Tailoring the Swelling and Glass-Transition Temperature of
   Acrylonitrile/Hydroxyethyl Acrylate Copolymers
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE copolymerization; emulsion polymerization; films; hydrogels; hydrophilic
   polymers
ID THERMAL-DEGRADATION; METHYL ACRYLATE; BUTYL ACRYLATE; POLYACRYLONITRILE;
   HYDROGELS; METHACRYLATE; TERPOLYMERS; BEHAVIOR; FIBER; ACID
AB Novel polyacrylonitrile (PAN)-co-poly(hydroxyethyl acrylate) (PHEA) copolymers at three different compositions (8,12, and 16 mol % PHEA) and their homopolymers were synthesized systematically by emulsion polymerization. Their chemical structures and compositions were elucidated by Fourier transform infrared, (1)H-NMR, and (13)C-NMR spectroscopy. Intrinsic viscosity measurements revealed that the molecular weights of the copolymers were quite enough to form ductile films. The influence of the molar fraction of hydroxyethl acrylate on the glass-transition temperature (T(g)) and mechanical properties was demonstrated by differential scanning calorimetry and tensile test results, respectively. Additionally, thermogravimetric analysis of copolymers was performed to investigate the degradation mechanism. The swelling behaviors and densities of the free-standing copolymer films were also evaluated. This study showed that one can tailor the hydrogel properties, mechanical properties, and T(g)'s of copolymers by changing the monomer feed ratios. On the basis of our findings, PAN-co-PHEA copolymer films could be useful for various biomaterial applications requiring good mechanical properties, such as ophthalmic and tissue engineering and also drug and hormone delivery. (C) 2009 Wiley Periodicals, Inc. J AppI Polyrn Sci 116: 628-635, 2010
C1 [Aran, Bengi; Sankir, Mehmet; Sankir, Nurdan D.] TOBB Univ Econ & Technol, Nanotechnol & Membrane Sci Res Lab, TR-06560 Ankara, Turkey.
   [Aran, Bengi; Vargun, Elif; Usanmaz, Ali] Middle E Tech Univ, Dept Chem, TR-06531 Ankara, Turkey.
RP Sankir, M (reprint author), TOBB Univ Econ & Technol, Nanotechnol & Membrane Sci Res Lab, Sogutozu Caddesi 43, TR-06560 Ankara, Turkey.
EM msankir@etu.edu.tr
FU Scientific and Technological Research Council of Turkey [108T099]
FX Contract grant sponsor: Scientific and Technological Research Council of
   Turkey; contract grant number: 108T099.
CR Bortner MJ, 2004, J APPL POLYM SCI, V93, P2856, DOI 10.1002/app.20833
   BRAR AS, 1992, EUR POLYM J, V28, P803, DOI 10.1016/0014-3057(92)90087-I
   Bunia I, 2000, POLYM DEGRAD STABIL, V70, P205, DOI 10.1016/S0141-3910(00)00114-2
   Cascone MG, 1999, J MATER SCI-MATER M, V10, P301, DOI 10.1023/A:1008961614439
   Ferrer GG, 2005, COLLOID POLYM SCI, V283, P681, DOI 10.1007/s00396-004-1208-y
   Godshall D, 2003, POLYMER, V44, P4221, DOI 10.1016/S0032-3861(03)00369-0
   Tejedor JAG, 2007, J NON-CRYST SOLIDS, V353, P276, DOI 10.1016/j.jnoncrysol.2006.11.003
   Hou C, 2006, J APPL POLYM SCI, V100, P4679, DOI 10.1002/app.22854
   JOSEPH R, 1993, J APPL POLYM SCI, V50, P173, DOI 10.1002/app.1993.070500119
   Krusic MK, 2006, POLYMER, V47, P148, DOI 10.1016/j.polymer.2005.11.002
   Lee WF, 2001, J APPL POLYM SCI, V81, P1360, DOI 10.1002/app.1561
   Lin CH, 2009, COLLOID SURFACE B, V71, P36, DOI 10.1016/j.colsurfb.2009.01.002
   McManus NT, 1998, POLYM BULL, V41, P661, DOI 10.1007/s002890050415
   Mun GA, 2007, MACROMOL CHEM PHYSIC, V208, P979, DOI 10.1002/macp.200600555
   Niu GG, 2009, ACTA BIOMATER, V5, P1056, DOI 10.1016/j.actbio.2008.10.015
   Pawde SM, 2008, J APPL POLYM SCI, V109, P3431, DOI 10.1002/app.28454
   Penzel E, 1997, POLYMER, V38, P325, DOI 10.1016/S0032-3861(96)00521-6
   Rahaman MSA, 2007, POLYM DEGRAD STABIL, V92, P1421, DOI 10.1016/j.polymdegradstab.2007.03.023
   Rangarajan P, 2002, POLYMER, V43, P2699, DOI 10.1016/S0032-3861(02)00077-0
   Rangarajan P, 2002, J APPL POLYM SCI, V85, P69, DOI 10.1002/app.10655
   Ray S, 2007, J APPL POLYM SCI, V103, P728, DOI 10.1002/app.25017
   Reddy GVR, 2002, DES MONOMERS POLYM, V5, P97, DOI 10.1163/156855502760151616
   TROCHIMCZUK A, 1990, EUR POLYM J, V26, P959, DOI 10.1016/0014-3057(90)90108-G
   Wu G, 2007, MATER CHEM PHYS, V104, P284, DOI 10.1016/j.matchemphys.2007.03.013
   Xue TJ, 1997, POLYM DEGRAD STABIL, V58, P193, DOI 10.1016/S0141-3910(97)00048-7
NR 25
TC 8
Z9 10
U1 1
U2 17
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 15
PY 2010
VL 116
IS 2
BP 628
EP 635
DI 10.1002/app.30854
PG 8
WC Polymer Science
SC Polymer Science
GA 557CP
UT WOS:000274646300002
DA 2018-10-20
ER

PT J
AU Chen, DY
   Xu, QF
   Xia, XW
   Ge, JF
   Lu, JM
   Li, NJ
AF Chen, Dongyun
   Xu, Qingfeng
   Xia, Xuewei
   Ge, Jianfeng
   Lu, Jianmei
   Li, Najun
TI A novel pH-sensitive polymeric fluorescent probe: Synthesis,
   characterization and optical properties
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Polymer; Chemical synthesis; Biomaterial; Optical properties
ID TRANSFER RADICAL POLYMERIZATION; SILICA NANOPARTICLES; ATRP;
   TEMPERATURE; POLY(N,N-DIMETHYLACRYLAMIDE); RNA
AB A novel initiator containing proflavine derivative moiety, 3,6-dibromo-isobutyramide acridine (DIA), was synthesized and initiated the atom transfer radical polymerization (ATRP) of methyl methacrylate (MMA). A water-soluble monomer, N,N-dimethylacrylamide (DMAA) was also initiated by DIA for comparison. The obtained fluorescent polymers, PMMA-DIA and PDMAA-DIA, were characterized by (1)H NMR, GPC and TGA. The emission spectra of the fluorescent polymers exhibit obvious changes in color and fluorescence intensity along with pH varied in range of 3.0-9.0. In addition, the obtained polymers present good film-forming capacity and the films also have a high quantum yield and pH response. Both oil-soluble PMMA-DIA and water-soluble PDMAA-DIA have steady optical and chemical properties by containing proflavine moiety in the main chain. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chen, Dongyun; Xu, Qingfeng; Xia, Xuewei; Ge, Jianfeng; Lu, Jianmei; Li, Najun] Soochow Univ, Coll Chem Chem Engn & Mat Sci, Key Lab Organ Synth Jiangsu Prov, Suzhou 215123, Jiangsu, Peoples R China.
RP Lu, JM (reprint author), Soochow Univ, Coll Chem Chem Engn & Mat Sci, Key Lab Organ Synth Jiangsu Prov, Suzhou 215123, Jiangsu, Peoples R China.
EM lujm@suda.edu.cn; linajun@sina.com
RI Lu, Jian-Mei/H-1186-2012; CHEN, DONGYUN/K-3095-2018
OI Lu, Jian-Mei/0000-0003-2302-3275; CHEN, DONGYUN/0000-0003-0083-1843
FU National Natural Science Foundation of China [20571054, 20876101];
   Ministry of Education [20070285003]; Department of Education of Jiangsu
   Province [08KJA430004]
FX This work is supported by the National Natural Science Foundation of
   China (20571054 and 20876101), Project of Ministry of Education
   (20070285003) and Major project of Department of Education of Jiangsu
   Province (08KJA430004).
CR AOKI T, 1994, MACROMOLECULES, V27, P947, DOI 10.1021/ma00082a010
   Biver T, 2006, ARCH BIOCHEM BIOPHYS, V452, P93, DOI 10.1016/j.abb.2006.06.021
   Burns A, 2006, CHEM SOC REV, V35, P1028, DOI 10.1039/b600562b
   Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X
   DeJong ES, 2003, BIOCHEMISTRY-US, V42, P8035, DOI 10.1021/bi0345252z
   Gunnlaugsson T, 2001, J AM CHEM SOC, V123, P12866, DOI 10.1021/ja004316i
   Jin ZN, 2008, EUR POLYM J, V44, P1752, DOI 10.1016/j.eurpolymj.2008.03.025
   JIN ZN, 2007, E-POLYMERS, V8, P62901
   Kamigaito M, 2001, CHEM REV, V101, P3689, DOI 10.1021/cr9901182
   KATAOKA K, 1994, MACROMOLECULES, V27, P1061, DOI 10.1021/ma00082a028
   Kim S, 2006, CHEM COMMUN, P2071, DOI 10.1039/b600926c
   KINGSBURY AE, 1995, MOL BRAIN RES, V28, P311, DOI 10.1016/0169-328X(94)00219-5
   Kizhakkedathu JN, 2003, MACROMOLECULES, V36, P591, DOI 10.1021/ma021337j
   Li NJ, 2009, POLYMER, V50, P428, DOI 10.1016/j.polymer.2008.11.031
   Lu JM, 2007, J POLYM SCI POL CHEM, V45, P3894, DOI 10.1002/pola.22139
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Rademacher JT, 2000, MACROMOLECULES, V33, P284, DOI 10.1021/ma991550o
   Rutkaite R, 2008, POLYMER, V49, P1800, DOI 10.1016/j.polymer.2008.02.007
   Schwarze T, 2007, ANGEW CHEM INT EDIT, V46, P1671, DOI 10.1002/anie.200603992
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   Wei XL, 1996, J AM CHEM SOC, V118, P2545, DOI 10.1021/ja952277i
   WEISSLEDER R, 1999, NAT BIOTECHNOL   APR, P17
   Wheate NJ, 2008, J INORG BIOCHEM, V102, P2060, DOI 10.1016/j.jinorgbio.2008.06.005
   WINNIK FM, 1993, CHEM REV, V93, P587, DOI 10.1021/cr00018a001
   Wu YK, 2007, J ORG CHEM, V72, P62, DOI 10.1021/jo061634c
   Xiao HB, 2009, DYES PIGMENTS, V83, P334, DOI 10.1016/j.dyepig.2009.05.012
   Xu QF, 2008, EUR POLYM J, V44, P1874, DOI 10.1016/j.eurpolymj.2008.01.004
   Yoon HJ, 2008, J AM CHEM SOC, V130, P11590, DOI 10.1021/ja804076q
   Yuan X, 2005, POLYMER, V46, P9186, DOI 10.1016/j.polymer.2005.07.06
   Zhang L, 2007, EUR POLYM J, V43, P2718, DOI 10.1016/j.eurpolymj.2007.02.032
NR 30
TC 4
Z9 4
U1 3
U2 23
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD APR 15
PY 2010
VL 120
IS 2-3
BP 614
EP 618
DI 10.1016/j.matchemphys.2009.12.018
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 587IN
UT WOS:000276984600066
DA 2018-10-20
ER

PT J
AU Kaewtatip, K
   Menut, P
   Auvergne, R
   Tanrattanakul, V
   Morel, MH
   Guilbert, S
AF Kaewtatip, Kaewta
   Menut, Paul
   Auvergne, Remi
   Tanrattanakul, Varaporn
   Morel, Marie-Helene
   Guilbert, Stephane
TI Interactions of Kraft Lignin and Wheat Gluten during Biomaterial
   Processing: Evidence for the Role of Phenolic Groups
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Polyphenol; protein; mixing; wheat gluten; Kraft lignin; esterification;
   cross-linking
ID ANTIOXIDANT ACTIVITY; PROTEIN; DERIVATIVES; GLYCEROL; POLYPROPYLENE;
   BIOPLASTICS; REACTIVITY; EXTRUSION; ESTERS; HEAT
AB The chemical interactions between Kraft lignin and wheat gluten under processing conditions were investigated by determining the extent of the protein network formation. To clarify the role of different chemical functions found in lignin, the effect of Kraft lignin was compared with that of an esterified lignin, in which hydroxyl groups had been suppressed by esterification, and with a series of simple aromatics and phenolic structures with different functionalities (conjugated double bonds, hydroxyl, carboxylic acid, and aldehyde). The protein solubility was determined by using the Kjeldahl method. The role of the hydroxyl function was assessed by the significantly lower effect of esterified lignin. The importance of the phenolic radical scavenging structure is evidenced by the effect of guaiacol, which results in a behavior similar to that of the Kraft lignin. In addition, the significant effect of conjugated double bonds on gluten reactivity, through nucleophilic addition, was demonstrated.
C1 [Kaewtatip, Kaewta; Menut, Paul; Auvergne, Remi; Morel, Marie-Helene; Guilbert, Stephane] INRA, Montpellier SupAgro,CIRAD, UMR IATE, UMII, F-34060 Montpellier 1, France.
   [Kaewtatip, Kaewta; Tanrattanakul, Varaporn] Prince Songkla Univ, Dept Mat Sci & Technol, Bioplast Res Unit, Fac Sci, Hat Yai 90112, Songkhla, Thailand.
RP Menut, P (reprint author), INRA, Montpellier SupAgro,CIRAD, UMR IATE, UMII, 2 Pl Viala, F-34060 Montpellier 1, France.
EM paul.menut@supagro.inra.fr
RI Menut, Paul/D-5226-2009
OI Menut, Paul/0000-0002-6455-8447; GUILBERT, Stephane/0000-0002-8964-670X
FU Graduate School and Faculty of Science, Prince of Songkla University;
   French embassy in Thailand; Montpellier SupAgro - INRA
FX Received for review December 3, 2009. Revised manuscript received
   February 21, 2010. Accepted February 25, 2010. We thank the Graduate
   School and Faculty of Science, Prince of Songkla University, the French
   embassy in Thailand, and Montpellier SupAgro - INRA for financial
   support.
CR Auvergne R, 2008, BIOMACROMOLECULES, V9, P664, DOI 10.1021/bm7009834
   Balakshin MY, 2003, J AGR FOOD CHEM, V51, P6116, DOI 10.1021/jf034372d
   Baptista C, 2006, CHEM ENG J, V121, P153, DOI 10.1016/j.cej.2006.05.002
   Brand-Williams W., 1995, Lebensmittel-Wissenschaft and Technologie, V28, P25, DOI 10.1016/S0023-6438(95)80008-5
   BRAUNS FE, 1945, IND ENG CHEM, V37, P70, DOI 10.1021/ie50421a015
   Brodin I, 2010, J ANAL APPL PYROL, V87, P70, DOI 10.1016/j.jaap.2009.10.005
   BUTTERFIELD DA, 2002, J NUTR BIOCH, V13, P273
   Chakar FS, 2004, IND CROP PROD, V20, P131, DOI 10.1016/j.indcrop.2004.04.016
   Chen C., 1992, METHODS LIGNIN CHEM
   Cheng JC, 2007, FOOD CHEM, V104, P132, DOI 10.1016/j.foodchem.2006.11.012
   Cuq B, 1998, CEREAL CHEM, V75, P1, DOI 10.1094/CCHEM.1998.75.1.1
   de Heer MI, 2000, J AM CHEM SOC, V122, P2355, DOI 10.1021/ja9937674
   Dizhbite T, 2004, BIORESOURCE TECHNOL, V95, P309, DOI 10.1016/j.biortech.2004.02.024
   GLASSER WG, 1993, HOLZFORSCHUNG, V47, P225, DOI 10.1515/hfsg.1993.47.3.225
   GRAF E, 1992, FREE RADICAL BIO MED, V13, P435, DOI 10.1016/0891-5849(92)90184-I
   Gregorova A, 2007, J APPL POLYM SCI, V106, P1626, DOI 10.1002/app.26687
   Hoseney R.C, 1998, PRINCIPLES CEREAL SC
   Jerez A, 2005, BIOCHEM ENG J, V26, P131, DOI 10.1016/j.bej.2005.04.010
   Kunanopparat T, 2008, COMPOS PART A-APPL S, V39, P777, DOI 10.1016/j.compositesa.2008.02.001
   Kunanopparat T, 2009, J AGR FOOD CHEM, V57, P8526, DOI 10.1021/jf901183z
   Lewis HF, 1943, IND ENG CHEM, V35, P1113, DOI 10.1021/ie50406a020
   Mansouri N.E., 2006, IND CROP PROD, V24, P8, DOI DOI 10.1016/J.INDCR0P.2005.10.002
   MANSSON P, 1983, HOLZFORSCHUNG, V37, P143, DOI 10.1515/hfsg.1983.37.3.143
   Micard V, 2001, POLYMER, V42, P477, DOI 10.1016/S0032-3861(00)00358-X
   MORCK R, 1985, HOLZFORSCHUNG, V39, P109, DOI 10.1515/hfsg.1985.39.2.109
   *NF EN ISO, 20483 NF EN ISO
   Pan XJ, 2006, J AGR FOOD CHEM, V54, P5806, DOI 10.1021/jf0605392
   Pommet M, 2003, MACROMOL SYMP, V197, P207, DOI 10.1002/masy.200350719
   Pommet M, 2005, J CEREAL SCI, V42, P81, DOI 10.1016/j.jcs.2005.02.005
   Pouplin M, 1999, J AGR FOOD CHEM, V47, P538, DOI 10.1021/jf980697w
   Pouteau C, 2003, POLYM DEGRAD STABIL, V81, P9, DOI 10.1016/S0141-3910(03)00057-0
   Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4
   Redl A, 2003, J CEREAL SCI, V38, P105, DOI 10.1016/S0733-5210(03)00003-1
   Redl A, 1999, CEREAL CHEM, V76, P361, DOI 10.1094/CCHEM.1999.76.3.361
   SCHOFIELD JD, 1983, J CEREAL SCI, V1, P241, DOI 10.1016/S0733-5210(83)80012-5
   Song YH, 2008, BIORESOURCE TECHNOL, V99, P7665, DOI 10.1016/j.biortech.2008.01.075
   Tejado A, 2007, BIORESOURCE TECHNOL, V98, P1655, DOI 10.1016/j.biortech.2006.05.042
   Thielemans W, 2005, BIOMACROMOLECULES, V6, P1895, DOI 10.1021/bm0500345
   Ugartondo V, 2008, BIORESOURCE TECHNOL, V99, P6683, DOI 10.1016/j.biortech.2007.11.038
   Villar JC, 1997, J WOOD CHEM TECHNOL, V17, P259, DOI 10.1080/02773819708003131
   Vinardell MP, 2008, IND CROP PROD, V27, P220, DOI 10.1016/j.indcrop.2007.07.011
   Zang LY, 2000, AM J PHYSIOL-CELL PH, V279, P954
NR 42
TC 17
Z9 18
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD APR 14
PY 2010
VL 58
IS 7
BP 4185
EP 4192
DI 10.1021/jf9042776
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 577OG
UT WOS:000276232700044
PM 20205449
DA 2018-10-20
ER

PT J
AU Matos, M
   Terra, J
   Ellis, DE
AF Matos, M.
   Terra, J.
   Ellis, D. E.
TI Mechanism of Zn stabilization in hydroxyapatite and hydrated (001)
   surfaces of hydroxyapatite
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Article
ID DISCRETE VARIATIONAL METHOD; TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET;
   ALKALINE-PHOSPHATASE; OSTEOBLAST ADHESION; POTENTIAL MODEL;
   BONE-FORMATION; ZINC; HYDROXYLAPATITE; INCREASES
AB A basic understanding of Zn incorporation on bulk and hydrated (0 0 1) surfaces of hydroxyapatite (HA) is attained through electronic structure calculations which use a combined first principles density functional (DFT) and extended Huckel tight binding (EHTB) methodology. A Zn substituted hydroxyapatite relaxed structure is obtained through a periodic cell DFT geometry optimization method. Electronic structure properties are calculated by using both cluster DFT and periodic cell EHTB methods. Bond order calculations show that Zn preference for the Ca2 vacancy, near the OH channel and with greater structural flexibility, is associated with the formation of a four-fold (bulk) and nearly four-fold (surface) coordination, as in ZnO. When occupying the octahedral Ca1 vacancy, Zn remains six-fold in the bulk, but coordination decreases to five-fold in the surface. In the bulk and surface, Zn2 is found to be more covalent than Zn1, due to a decrease in bond lengths at the four-fold site, which approach the 1.99 angstrom ZnO value. Zn is however considerably less bound in the biomaterial than in the oxide, where calculated bond orders are twice as large as in HA. Surface phosphate groups (PO4) and hydroxide ions behave as compact individual units as in the bulk; no evidence is found for the presence of HPO4. Ca-O bond orders decrease at the surface, with a consequent increase in ionicity. Comparison between DFT and EHTB results show that the latter method gives a good qualitative account of charge and bonding in these systems.
C1 [Matos, M.] Pontificia Univ Catolica Rio de Janeiro, Dept Fis, BR-22453900 Rio de Janeiro, Brazil.
   [Terra, J.] Ctr Brasileiro Pesquisas Fis, BR-22290180 Rio De Janeiro, Brazil.
   [Ellis, D. E.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Ellis, D. E.] Northwestern Univ, Mat Res Ctr, Evanston, IL 60208 USA.
RP Matos, M (reprint author), Pontificia Univ Catolica Rio de Janeiro, Dept Fis, Caixa Postal 38071, BR-22453900 Rio de Janeiro, Brazil.
EM maria.matos@fis.puc-rio.br
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BOCHMANN M, 1993, INORG CHEM, V32, P532, DOI 10.1021/ic00057a008
   BRANDAONETO J, 1995, NUTR RES, V15, P335, DOI 10.1016/0271-5317(95)00003-8
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   de Leeuw NH, 2004, PHYS CHEM CHEM PHYS, V6, P1860, DOI 10.1039/b313242k
   Ellis DE, 1970, PHYS REV B-SOLID ST, V2, P2887, DOI 10.1103/PhysRevB.2.2887
   Ellis DE, 1999, ADV QUANTUM CHEM, V34, P51, DOI 10.1016/S0065-3276(08)60531-6
   ELLIS DE, 1985, HDB PHYSICS CHEM ACT, P1
   Fujii E, 2006, ACTA BIOMATER, V2, P69, DOI 10.1016/j.actbio.2005.09.002
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   HOFFMANN R, 1963, J CHEM PHYS, V39, P1397, DOI 10.1063/1.1734456
   HOFFMANN R, 1989, SOLIDS SURFACES
   Jallot E, 2005, COLLOID SURFACE B, V42, P205, DOI 10.1016/j.colsurfb.2005.03.001
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169
   KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558
   Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0
   LANDRUM GA, 2001, BIND VER 3 0 BIND DI
   LANDRUM GA, 2001, VIEWKEL VER 3 0 VIEW
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Ma XY, 2008, BIOMATERIALS, V29, P257, DOI 10.1016/j.biomaterials.2007.10.001
   Matos M, 1999, J MOL STRUC-THEOCHEM, V464, P129, DOI 10.1016/S0166-1280(98)00542-9
   Matsos M, 2009, INT J QUANTUM CHEM, V109, P849, DOI 10.1002/qua.21887
   Matsunaga K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940337
   Mkhonto D, 2002, J MATER CHEM, V12, P2633, DOI 10.1039/b204111a
   Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666
   Peretz A, 2001, J TRACE ELEM MED BIO, V15, P175, DOI 10.1016/S0946-672X(01)80063-8
   ROSEN A, 1975, J CHEM PHYS, V62, P3039, DOI 10.1063/1.430892
   Rulis P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245410
   Schramm D. U., 2001, Physical Review B (Condensed Matter), V63, p024107/1, DOI 10.1103/PhysRevB.63.024107
   SUMMERVILLE RH, 1976, J AM CHEM SOC, V98, P7240, DOI 10.1021/ja00439a023
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   TERRA J, 2002, PHILOS MAG A, V77, P2357
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   YAMAGUCHI M, 1986, BIOCHEM PHARMACOL, V35, P773, DOI 10.1016/0006-2952(86)90245-5
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
NR 39
TC 5
Z9 5
U1 6
U2 34
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
EI 1361-648X
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD APR 14
PY 2010
VL 22
IS 14
AR 145502
DI 10.1088/0953-8984/22/14/145502
PG 7
WC Physics, Condensed Matter
SC Physics
GA 574CZ
UT WOS:000275967400011
PM 21389531
DA 2018-10-20
ER

PT J
AU Zheng, Q
   Zhao, XJ
AF Zheng, Qing
   Zhao, Xiaojun
TI Research of mechanical strength enhanced fibrin-PLGA hybrid scaffold
   with its effect on proliferation of rMSC
SO E-POLYMERS
LA English
DT Article
DE Fibrin; PLGA fiber; Mechanical strength; Three-dimensional scaffold;
   Mesenchymal stem cell
ID MARROW STROMAL CELLS; DEFECT REPAIR; TISSUE; CARTILAGE; MUSCLE; BONE;
   TRANSPLANTS; EXPRESSION; SEALANTS; MODEL
AB As a tissue engineering biomaterial, fibrin possesses outstanding biodegradable and biocompatible features except for its weak mechanical strength which limits its ranges of further application. In this study, hybrid scaffold was obtained by mixed fibrinogen and thrombin solution homogeneously in the presence of various amounts (0, 1, 2, and 4 mg, respectively) of non-woven fabric of PLGA fiber through traditional freeze-dried method to improve the mechanical strength while keeping its biological characters. The observation by scanning electron microscopy (SEM) showed that all the fibrin sponges have porous and interconnected pore structure, irrespective of the amount of PLGA fiber incorporated. In the measurement of the scaffold shrinkage, the percent of shrinkage of fibrin sponge incorporating PLGA fiber decreased when the amount of PLGA fiber incorporated increased compared with the fibrin sponge without PLGA fiber. The compression test suggested that compression modulus of PLGA fiber incorporated fibrin sponge significantly increased against the fibrin sponge without PLGA fiber; the incorporation of PLGA fiber enabled the mechanical strength of fibrin sponge to be effectively enhanced. Rat mesenchymal stem cells (rMSCs), which is of high potential to induce tissue regeneration, was selected to seed and culture in the fibrin scaffolds with or without PLGA fiber, and the number of rMSC was tested by DNA assay and calculated to examine which sponge was more favourable for rMSC to proliferate. The results reveal that the incorporation of PLGA fiber reinforced the fibrin scaffolds and maintained their intraspace. MSCs proliferated in fibrin scaffold with PLGA fiber was obviously on average more than that without PLGA fiber in vitro.
C1 [Zheng, Qing; Zhao, Xiaojun] Sichuan Univ, Inst Nanobiomed Technol & Membrane Biol, Chengdu, Sichuan, Peoples R China.
RP Zhao, XJ (reprint author), Sichuan Univ, Inst Nanobiomed Technol & Membrane Biol, 1 Ke Yuan 4th St, Chengdu, Sichuan, Peoples R China.
EM xiaojunz@mit.edu
CR Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Deng WW, 2003, AM J PHYSIOL-CELL PH, V285, pC1322, DOI 10.1152/ajpcell.00141.2003
   GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139
   Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030
   Hunter CJ, 2004, TISSUE ENG, V10, P736, DOI 10.1089/1076327041348310
   Jackson MR, 2001, AM J SURG, V182, P1
   Javazon EH, 2001, STEM CELLS, V19, P219, DOI 10.1634/stemcells.19-3-219
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   Mankad PS, 2001, AM J SURG, V182, p21S, DOI 10.1016/S0002-9610(01)00773-5
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8
   Schwarz EJ, 1999, HUM GENE THER, V10, P2539, DOI 10.1089/10430349950016870
   Takahashi Y, 2003, TISSUE ENG, V9, P931, DOI 10.1089/107632703322495574
   Xu JW, 2004, PLAST RECONSTR SURG, V113, P1361, DOI 10.1097/01.PRS.000011594.52661.29
NR 19
TC 0
Z9 0
U1 0
U2 10
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD APR 13
PY 2010
AR 045
PG 9
WC Polymer Science
SC Polymer Science
GA 584HS
UT WOS:000276742700003
DA 2018-10-20
ER

PT J
AU Duan, KR
   Chen, HL
   Huang, J
   Yu, JH
   Liu, SY
   Wang, DX
   Li, YP
AF Duan, Kongrong
   Chen, Honglin
   Huang, Jin
   Yu, Jiahui
   Liu, Shiyuan
   Wang, Daxin
   Li, Yaping
TI One-step synthesis of amino-reserved chitosan-graft-polycaprolactone as
   a promising substance of biomaterial
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan-graft-polycaprolactone; One-step synthesis; Biomaterials;
   Methanesulfonic acid; Brush-like polycations
ID MODIFIED GLYCOL CHITOSAN; EPSILON-CAPROLACTONE; ORGANIC CATALYST;
   L-LACTIDE; COPOLYMERS; NANOPARTICLES; MEMBRANE; DELIVERY; SCAFFOLD;
   RELEASE
AB One-step approach was developed to synthesize amino-reserved chitosan-graft-polycaprolactone (CS-g-PCL) by grafting epsilon-CL oligomers onto the hydroxyl groups of CS via ring-opening polymerization by using methanesulfonic acid as solvent and catalyst. The controllable grafting content of PCL within CS-g-PCL provided the possibility to manipulate the biodegradation rate, hydrophilicity, and hence the cytotoxicity of CS-g-PCL. As a result, the specimen synthesized from the feed molar ratio of glucosamine units in CS vs. epsilon-CL as 1:12 showed equivalent cytotoxicity to the neat CS and PCL against KB cell line, and the cell viability was almost close to 100%. In addition, CS-g-PCL exhibited good solubility in organic solvents, facilitating formation of PCL/CS-g-PCL blend nanofibers via electrospinning with the use of DMF/CHCl(3) as solvent. Owing to the enhanced cellular attachment results from cationic amino groups, it is promising that these copolymers are ideal substances for developing drug carriers and tissue engineering scaffolds. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Duan, Kongrong; Chen, Honglin; Huang, Jin; Yu, Jiahui] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.
   [Liu, Shiyuan] Changzheng Hosp, Dept Diagnost Imaging, Shanghai 200003, Peoples R China.
   [Wang, Daxin] Yangzhou Univ, Subei Hosp Jiangsu Prov, Yangzhou 225001, Peoples R China.
   [Li, Yaping] Chinese Acad Sci, Ctr Drug Delivery Syst, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.
RP Yu, JH (reprint author), E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.
EM jhyu@sist.ecnu.edu.cn
RI Yu, Jiahui/A-8382-2015
FU Chinese Ministry of Science and Technology [2007CB936104, 2009CB930300];
   Shanghai Municipality Commission for Special Project of Nanometer
   Science and Technology [0852nm03700, 0952nm05300]; Shanghai Municipality
   Commission for Non-governmental International Corporation Project
   [09540709000]
FX This work was supported by the 973 Projects of Chinese Ministry of
   Science and Technology (2007CB936104 and 2009CB930300), Shanghai
   Municipality Commission for Special Project of Nanometer Science and
   Technology (0852nm03700 and 0952nm05300), and Shanghai Municipality
   Commission for Non-governmental International Corporation Project
   (09540709000).
CR Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Don TM, 2002, J APPL POLYM SCI, V86, P3057, DOI 10.1002/app.11329
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Feng H, 2007, CARBOHYD POLYM, V70, P258, DOI 10.1016/j.carbpol.2007.04.004
   Feng H, 2006, J POLYM SCI POL CHEM, V44, P5353, DOI 10.1002/pola.21625
   Fujioka M, 2004, MACROMOL RAPID COMM, V25, P1776, DOI 10.1002/marc.200400288
   Guan XP, 2007, J POLYM SCI POL CHEM, V45, P2556, DOI 10.1002/pola-22015
   Jenkins DW, 2002, MACROMOLECULES, V35, P3413, DOI 10.1021/ma011336b
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Leane MM, 2004, INT J PHARM, V271, P241, DOI 10.1016/j.ijpharm.2003.11.023
   Liu L, 2004, EUR POLYM J, V40, P2739, DOI 10.1016/j.eurpolymj.2004.07.016
   Liu L, 2005, BIOPOLYMERS, V78, P163, DOI 10.1002/bip.20261
   Liu L, 2009, CARBOHYD POLYM, V75, P401, DOI 10.1016/j.carbpol.2008.07.038
   Liu Y, 2004, CARBOHYD RES, V339, P845, DOI 10.1016/j.carres.2003.09.013
   Luckachan GE, 2006, CARBOHYD POLYM, V64, P254, DOI 10.1016/j.carbpol.2005.11.035
   Min KH, 2008, J CONTROL RELEASE, V127, P208, DOI 10.1016/j.jconrel.2008.01.013
   Muzzarelli R. A. A., 1997, CHITIN HDB, P109
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109
   Sashiwa H, 2002, BIOMACROMOLECULES, V3, P1126, DOI 10.1021/bm0200480
   Shantha KL, 2002, CARBOHYD POLYM, V48, P247, DOI 10.1016/S0144-8617(01)00244-2
   Skotak M, 2008, BIOMACROMOLECULES, V9, P1902, DOI 10.1021/bm800158c
   Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1
   Tan PS, 2007, MAT SCI ENG C-BIO S, V27, P304, DOI 10.1016/j.msec.2006.03.010
   Velde K., 2004, CARBOHYD POLYM, V58, P409
   Wang YW, 2007, BIOMATERIALS, V28, P4619, DOI 10.1016/j.biomaterials.2007.07.006
   Williamson MR, 2004, BIOMATERIALS, V25, P459, DOI 10.1016/S0142-9612(03)00536-2
   Yagi K, 1997, BIOL PHARM BULL, V20, P1290
   Yoo HS, 2005, J CONTROL RELEASE, V103, P235, DOI 10.1016/j.jconrel.2004.11.033
   Yu HJ, 2006, BIOPOLYMERS, V83, P233, DOI 10.1002/bip.20551
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhou YS, 2008, BIOMACROMOLECULES, V9, P349, DOI 10.1021/bm7009015
NR 32
TC 29
Z9 32
U1 1
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 12
PY 2010
VL 80
IS 2
BP 498
EP 503
DI 10.1016/j.carbpol.2009.12.013
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 586OR
UT WOS:000276920500029
DA 2018-10-20
ER

PT J
AU Katz, JS
   Burdick, JA
AF Katz, Joshua S.
   Burdick, Jason A.
TI Light-Responsive Biomaterials: Development and Applications
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE biomaterials; drug delivery; light-responsive; polymers; tissue
   engineering
ID PHASE-TRANSITION; VISIBLE-LIGHT; BIOMEDICAL APPLICATIONS; IMMUNOLOGICAL
   SYNAPSE; DIBLOCK COPOLYMERS; POLYMER MICELLES; CONTENT RELEASE;
   DRUG-DELIVERY; GOLD NANORODS; HYDROGELS
AB Novel biomaterials are beneficial to the growing fields of drug delivery, cell biology, microdevices, and tissue engineering. With recent advances in chemistry and materials science, light is becoming an attractive option as a method to control biomaterial behavior and properties. In this Feature Article, we explore some of the early and recent advances in the design of light-responsive biomaterials. Particular attention is paid to macromolecular assemblies for drug delivery, multi-component surface patterning for advanced cell assays, and polymer networks that undergo chemical or shape changes upon light exposure. We conclude with some remarks about future directions of the field.
C1 [Katz, Joshua S.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 210 S 33rd St,240 Skirkanich Hall, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu
RI Katz, Joshua/R-5980-2017
OI Katz, Joshua/0000-0002-0046-4062
FU National Science Foundation; MRSEC [DMR05-20020]; CAREER
FX The authors acknowledge funding through a National Science Foundation
   graduate research fellowship (J.S.K.), MRSEC grant (DMR05-20020), and
   CAREER Award (JAB).
CR Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012
   Alvarez M, 2008, ADV MATER, V20, P4563, DOI 10.1002/adma.200800746
   Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   ANDERSON VC, 1992, BIOCHIM BIOPHYS ACTA, V1109, P33, DOI 10.1016/0005-2736(92)90183-M
   Aujard I, 2006, CHEM-EUR J, V12, P6865, DOI 10.1002/chem.200501393
   Babin J, 2009, ANGEW CHEM INT EDIT, V48, P3329, DOI 10.1002/anie.200900255
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bikram M, 2007, J CONTROL RELEASE, V123, P219, DOI 10.1016/j.jconrel.2007.08.013
   Bisby RH, 2000, PHOTOCHEM PHOTOBIOL, V72, P57, DOI 10.1562/0031-8655(2000)072<0057:AUODIP>2.0.CO;2
   Blanazs A, 2009, MACROMOL RAPID COMM, V30, P267, DOI 10.1002/marc.200800713
   Blawas AS, 1998, LANGMUIR, V14, P4243, DOI 10.1021/la971231v
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Budhlall BM, 2008, LANGMUIR, V24, P11959, DOI 10.1021/la8019556
   Chandra B, 2006, ORG BIOMOL CHEM, V4, P1730, DOI 10.1039/b518359f
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Discher DE, 2007, PROG POLYM SCI, V32, P838, DOI 10.1016/j.progpolymsci.2007.05.011
   Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838
   Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103
   Doh J, 2004, J AM CHEM SOC, V126, P9170, DOI 10.1021/ja048261m
   Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386
   Eastoe J, 2002, LANGMUIR, V18, P7837, DOI 10.1021/la0257384
   Edahiro J, 2005, BIOMACROMOLECULES, V6, P970, DOI 10.1021/bm0493382
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ericson J, 1998, DEVELOPMENT, V125, P1005
   Fujigaya T, 2008, ADV MATER, V20, P3610, DOI 10.1002/adma.200800494
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Ghoroghchian PP, 2005, P NATL ACAD SCI USA, V102, P2922, DOI 10.1073/pnas.0409394102
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Goodwin AP, 2005, J AM CHEM SOC, V127, P9952, DOI 10.1021/ja0523035
   Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hahn MS, 2005, ADV MATER, V17, P2939, DOI 10.1002/adma.200500184
   Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818
   Holden MA, 2003, J AM CHEM SOC, V125, P8074, DOI 10.1021/ja035390e
   Hribar KC, 2009, SMALL, V5, P1830, DOI 10.1002/smll.200900395
   Jiang JQ, 2005, J AM CHEM SOC, V127, P8290, DOI 10.1021/ja0521019
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Jiang YG, 2007, LANGMUIR, V23, P4029, DOI 10.1021/la063305l
   Katz JS, 2006, LANGMUIR, V22, P353, DOI 10.1021/la0523098
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee HI, 2007, ANGEW CHEM INT EDIT, V46, P2453, DOI 10.1002/anie.200604278
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Lepage M, 2007, PHYS MED BIOL, V52, pN249, DOI 10.1088/0031-9155/52/10/N04
   Levine DH, 2008, METHODS, V46, P25, DOI 10.1016/j.ymeth.2008.05.006
   Li MH, 2009, SOFT MATTER, V5, P927, DOI 10.1039/b815725a
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lin L, 2009, MACROMOL RAPID COMM, V30, P1089, DOI 10.1002/marc.200900105
   Liu YC, 2009, LANGMUIR, V25, P5713, DOI 10.1021/la803588d
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Luo Y, 2004, BIOMACROMOLECULES, V5, P2315, DOI 10.1021/bm0495811
   Mabrouk E, 2009, P NATL ACAD SCI USA, V106, P7294, DOI 10.1073/pnas.0813157106
   MAMADA A, 1990, MACROMOLECULES, V23, P1517, DOI 10.1021/ma00207a046
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Myung D, 2007, BIOMED MICRODEVICES, V9, P911, DOI 10.1007/s10544-006-9040-4
   Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017
   Ortega AM, 2008, J APPL POLYM SCI, V110, P1559, DOI 10.1002/app.28732
   Paasonen L, 2007, J CONTROL RELEASE, V122, P86, DOI 10.1016/j.jconrel.2007.06.009
   Robbins GP, 2009, J AM CHEM SOC, V131, P3872, DOI 10.1021/ja808586q
   Sandberg S. A., 1995, J AM CHEM SOC, V117, P12050
   Sau TK, 2004, LANGMUIR, V20, P6414, DOI 10.1021/la049463z
   Sershen SR, 2000, J BIOMED MATER RES, V51, P293, DOI 10.1002/1097-4636(20000905)51:3<293::AID-JBM1>3.0.CO;2-T
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sorribas H, 2002, BIOMATERIALS, V23, P893, DOI 10.1016/S0142-9612(01)00199-5
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   Takahashi H, 2006, LANGMUIR, V22, P2, DOI 10.1021/la0520029
   Tatsuma T, 2007, ADV MATER, V19, P1249, DOI 10.1002/adma.200602386
   TAZUKE S, 1987, J PHYS CHEM-US, V91, P249, DOI 10.1021/j100286a001
   Thierry B, 2009, CHEM COMMUN, P1724, DOI 10.1039/b820137d
   Tien J, 2002, P NATL ACAD SCI USA, V99, P1758, DOI 10.1073/pnas.042493399
   Tong R, 2009, MRS BULL, V34, P422, DOI 10.1557/mrs2009.118
   Troutman TS, 2009, ADV MATER, V21, P2334, DOI 10.1002/adma.200900018
   VANDALEN EC, 2008, COCHRANE DATABASE SY
   Wang G, 2004, MACROMOLECULES, V37, P8911, DOI 10.1021/ma048416a
   Wang Y, 2009, ADV MATER, V21, P2849, DOI 10.1002/adma.200803276
   Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wu GH, 2008, J AM CHEM SOC, V130, P8175, DOI 10.1021/ja802656d
   Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101
   XIE Z, 2009, ADV ENG MATER, V11, P87
   Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899
NR 85
TC 127
Z9 131
U1 4
U2 124
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR 8
PY 2010
VL 10
IS 4
BP 339
EP 348
DI 10.1002/mabi.200900297
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 584SL
UT WOS:000276772900001
PM 20014197
DA 2018-10-20
ER

PT J
AU Lawrence, BD
   Wharram, S
   Kluge, JA
   Leisk, GG
   Omenetto, FG
   Rosenblatt, MI
   Kaplan, DL
AF Lawrence, Brian D.
   Wharram, Scott
   Kluge, Jonathan A.
   Leisk, Gary G.
   Omenetto, Fiorenzo G.
   Rosenblatt, Mark I.
   Kaplan, David L.
TI Effect of Hydration on Silk Film Material Properties
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE films; mechanical properties; swelling; thermogravimetric analysis (TGA)
ID CONFORMATION TRANSITION KINETICS; FIBROIN MEMBRANE; IN-VIVO;
   INFRARED-SPECTROSCOPY; THERMAL-PROPERTIES; BIOMATERIAL; PROTEIN; WATER;
   DEGRADATION; SCAFFOLDS
AB Effects of hydration on silk fibroin film properties were investigated for water-annealed and MeOH-treated samples. Hydration increased thickness by 60% for MeOH-immersed films, while water-annealed samples remained constant. MeOH-immersed films showed an 80% mass loss due to water, while water-annealed lost only 40%. O(2) permeability was higher in MeOH-immersed films with Dk values of 10(-10) (mL O(2).cm) (cm(-1).s(-1) mmHg(-1)), while those of water-annealed films reached only one fifth of this value. All films showed a decrease in Young's modulus and increased plastic deformation by two orders of magnitude when submerged in saline solution. FT-IR showed that beta-sheet content in water-annealed films increased with increasing water vapor pressure, while MeOH-immersed films showed no change.
C1 [Lawrence, Brian D.; Kluge, Jonathan A.; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, Medford, MA 02155 USA.
   [Lawrence, Brian D.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   [Wharram, Scott] Univ Massachusetts, Dept Plast Engn, Lowell, MA 01854 USA.
   [Leisk, Gary G.] Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
   [Omenetto, Fiorenzo G.] Cornell Univ, Weill Med Coll, Dept Ophthalmol, New York, NY 10065 USA.
   [Rosenblatt, Mark I.] Weill Cornell Med Coll, Margaret M Dyson Vis Res Inst, New York, NY 10021 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Ctr Sci & Technol, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH P41 Tissue Engineering Resource Center; US Army Research Laboratory;
   US Army Research Office [W911NF-07-1-0618]; DARPA-DSO
FX The authors thank the NIH P41 Tissue Engineering Resource Center for
   support for this work. In addition, this material is based upon work
   supported in part by the US Army Research Laboratory and the US Army
   Research Office under contract number W911NF-07-1-0618 and by the
   DARPA-DSO.
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   LAWRENCE B, 2008, 2008 C QUANT EL LAS
   LAWRENCE BD, J MAT SCI IN PRESS
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   LIN HJ, 2004, BIOMACROMOLECULES, V5, P711
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   SHEAR WA, 1989, SCIENCE, V246, P479, DOI 10.1126/science.246.4929.479
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799
NR 36
TC 54
Z9 55
U1 2
U2 58
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR 8
PY 2010
VL 10
IS 4
BP 393
EP 403
DI 10.1002/mabi.200900294
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 584SL
UT WOS:000276772900008
PM 20112237
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akasaka, T
   Yokoyama, A
   Matsuoka, M
   Hashimoto, T
   Watari, F
AF Akasaka, Tsukasa
   Yokoyama, Atsuro
   Matsuoka, Makoto
   Hashimoto, Takeshi
   Watari, Fumio
TI Thin films of single-walled carbon nanotubes promote human osteoblastic
   cells (Saos-2) proliferation in low serum concentrations
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Carbon nanotubes; Thin film; Cell proliferation; Serum; Osteoblastic
   cells; Protein adsorption
ID IN-VITRO; FIBRONECTIN ADSORPTION; NEURONAL GROWTH; BOVINE SERUM;
   STEM-CELLS; TISSUE; BONE; SCAFFOLDS; SURFACES; ROUGHNESS
AB One strategy used for the regeneration of bone is the development of cell culture substrates and scaffolds that can control osteoblast proliferation and differentiation. In recent investigations, carbon nanotubes (CNTs) have been utilized as scaffolds for osteoblastic cell cultures; however, there are only a few reports describing the proliferation of osteoblastic cells on thin CNT films; in particular, the effects of serum concentration on cell proliferation have not been studied. In the present study, we prepared culture dishes with homogeneous thin or thick films of non-modified CNTs and examined the effect of serum concentrations on human osteoblastic cells (Saos-2) proliferation in these culture dishes. We demonstrated that the ratio of cell proliferation was strongly affected by the concentration of serum. Interestingly, single-walled carbon nanotube (SWNT) thin films were found to be the most effective substrate for the proliferation of Saos-2 cells in low concentrations of serum. Thus, thin SWNT films may be used as an effective biomaterial for the culture of Saos-2 cells in low serum concentrations. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Akasaka, Tsukasa; Yokoyama, Atsuro; Matsuoka, Makoto; Watari, Fumio] Hokkaido Univ, Grad Sch Dent Med, Kita Ku, Sapporo, Hokkaido 0608586, Japan.
   [Hashimoto, Takeshi] Meijo Nano Carbon Co Ltd, Naka Ku, Nagoya, Aichi 4600002, Japan.
RP Akasaka, T (reprint author), Hokkaido Univ, Grad Sch Dent Med, Kita Ku, Kita 13 Nishi 7, Sapporo, Hokkaido 0608586, Japan.
EM akasaka@den.hokudai.ac.jp
RI Yokoyama, Atsuro/F-6418-2012; Akasaka, Tsukasa/A-5271-2012
FU Japan Science and Technology Agency (JST); Ministry of Health, Labour
   and Welfare of Japan [H18-kagaku-006]
FX The authors would like to thank Dr. Jin Shigeki from the Creative
   Research Initiative "SOUSEI" at Hokkaido University for acquiring AFM
   images in data processing. This work was partly funded by "Collaborative
   Development of Innovative Seeds, Potentiality Verification Stage" of the
   Japan Science and Technology Agency (JST) and by the Health and Labour
   Science Research Grants in 2006 (H18-kagaku-006) from the Ministry of
   Health, Labour and Welfare of Japan.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Akasaka T, 2006, MAT SCI ENG C-BIO S, V26, P675, DOI 10.1016/j.msec.2005.03.009
   Akasaka T, 2009, BIO-MED MATER ENG, V19, P147, DOI 10.3233/BME-2009-0574
   Aoki N, 2007, DENT MATER J, V26, P178, DOI 10.4012/dmj.26.178
   Aoki N, 2005, J BIOMED NANOTECHNOL, V1, P402, DOI 10.1166/jbn.2005.048
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Brown S, 2008, SMALL, V4, P416, DOI 10.1002/smll.200700940
   Casey A, 2007, CARBON, V45, P34, DOI 10.1016/j.carbon.2006.08.009
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209
   GOWEN M, 1985, J CLIN INVEST, V75, P1223, DOI 10.1172/JCI111819
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Guehennec L., 2008, ACTA BIOMATER, V4, P535, DOI DOI 10.1016/J.ACTBIO.2007.12.002
   Gulden M, 2006, TOXICOL IN VITRO, V20, P1114, DOI 10.1016/j.tiv.2006.02.002
   Guo L, 2008, SMALL, V4, P721, DOI 10.1002/smll.200700754
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jia D, 2000, BONE, V27, P785, DOI 10.1016/S8756-3282(00)00400-2
   Kalbacova M, 2007, CARBON, V45, P2266, DOI 10.1016/j.carbon.2007.06.025
   Kalbacova M, 2006, PHYS STATUS SOLIDI B, V243, P3514, DOI 10.1002/pssb.200669167
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li XM, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015005
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   Lopez-Hernandez FJ, 2003, BIOCHEM PHARMACOL, V65, P2021, DOI 10.1016/S0006-2952(03)00195-3
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Melican D, 2005, THERIOGENOLOGY, V63, P1549, DOI 10.1016/j.theriogenology.2004.05.029
   Meng J, 2006, J BIOMED MATER RES A, V79A, P298, DOI 10.1002/jbm.a.30787
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Mwenifumbo S, 2007, J MATER CHEM, V17, P1894, DOI 10.1039/b617708e
   Nepal D, 2007, SMALL, V3, P1259, DOI 10.1002/smll.200600511
   Plesner A, 2003, J IMMUNOL METHODS, V279, P287, DOI 10.1016/S0022-1759(03)00234-5
   Sato Y, 2005, MOL BIOSYST, V1, P176, DOI 10.1039/b502429c
   Seto J, 2001, CELL BIOL INT, V25, P893, DOI 10.1006/cbir.2000.0757
   Shen JW, 2008, BIOMATERIALS, V29, P3847, DOI 10.1016/j.biomaterials.2008.06.013
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Stalder AF, 2006, COLLOID SURFACE A, V286, P92, DOI 10.1016/j.colsurfa.2006.03.008
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Valenti LE, 2007, J COLLOID INTERF SCI, V307, P349, DOI 10.1016/j.jcis.2006.11.046
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Wirth C, 2008, MAT SCI ENG C-BIO S, V28, P990, DOI 10.1016/j.msec.2007.10.085
   Xu JL, 2009, MAT SCI ENG C-BIO S, V29, P44, DOI 10.1016/j.msec.2008.05.009
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhang XK, 2008, CARBON, V46, P453, DOI 10.1016/j.carbon.2007.12.015
   Zhao XL, 2003, CHEM PHYS LETT, V373, P266, DOI 10.1016/S0009-2614(03)00610-9
   Zhu Y, 2006, NANOTECHNOLOGY, V17, P4668, DOI 10.1088/0957-4484/17/18/024
NR 49
TC 48
Z9 50
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 6
PY 2010
VL 30
IS 3
BP 391
EP 399
DI 10.1016/j.msec.2009.12.006
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 582II
UT WOS:000276590000010
DA 2018-10-20
ER

PT J
AU Lu, Q
   Hu, X
   Wang, XQ
   Kluge, JA
   Lu, SZ
   Cebe, P
   Kaplan, DL
AF Lu, Qiang
   Hu, Xiao
   Wang, Xiaoqin
   Kluge, Jonathan A.
   Lu, Shenzhou
   Cebe, Peggy
   Kaplan, David L.
TI Water-insoluble silk films with silk I structure
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk I; Silk II; Water-insoluble; Films
ID BOMBYX-MORI SILK; MECHANICAL-PROPERTIES; POLY(ETHYLENE OXIDE); FIBROIN
   SOLUTION; SCAFFOLDS; BIOMATERIAL; MICROSPHERES; VITRO; VIVO; PH
AB Water-insoluble regenerated silk materials are normally produced by increasing the beta-sheet content (silk II). In the present study water-insoluble silk films were prepared by controlling the very slow drying of Bombyx mod silk solutions, resulting in the formation of stable films with a predominant silk I instead of silk II structure. Wide angle X-ray scattering indicated that the silk films stabilized by slow drying were mainly composed of silk I rather than silk II, while water- and methanol-annealed silk films had a higher silk II content. The silk films prepared by slow drying had a globule-like structure at the core surrounded by nano-filaments. The core region was composed of silk I and silk II, surrounded by hydrophilic nano-filaments containing random turns and a-helix secondary structures. The insoluble silk films prepared by slow drying had unique thermal, mechanical and degradative properties. Differential scanning calorimetry results revealed that silk I crystals had stable thermal properties up to 250 degrees C, without crystallization above the T(g), but degraded at lower temperatures than silk II structure. Compared with water- and methanol-annealed films the films prepared by slow drying had better mechanical ductility and were more rapidly enzymatically degraded, reflecting the differences in secondary structure achieved via differences in post processing of the cast silk films. Importantly, the silk I structure, a key intermediate secondary structure for the formation of mechanically robust natural silk fibers, was successfully generated by the present approach of very slow drying, mimicking the natural process. The results also point to a new mode of generating new types of silk biomaterials with enhanced mechanical properties and increased degradation rates, while maintaining water insolubility, along with a low beta-sheet content. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lu, Qiang; Hu, Xiao; Wang, Xiaoqin; Kluge, Jonathan A.; Lu, Shenzhou; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Lu, Shenzhou] Soochow Univ, Natl Engn Lab Modern Silk, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
   [Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Lu, Shenzhou/P-6519-2015; Hu, Xiao/F-2403-2012
OI Lu, Shenzhou/0000-0003-4188-2057; Hu, Xiao/0000-0002-2579-2820; Cebe,
   Peggy/0000-0002-8721-644X
FU NSF; AFOSR; NIH
FX The authors thank the NSF, the AFOSR and the NIH for support of this
   research.
CR Anderson JP, 1998, BIOPOLYMERS, V45, P307
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Chen C, 2006, POLYMER, V47, P6322, DOI 10.1016/j.polymer.2006.07.009
   DEMURA M, 1989, BIOSENSORS, V4, P361, DOI 10.1016/0265-928X(89)80002-1
   Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KRATKY O, 1950, NATURE, V165, P319, DOI 10.1038/165319a0
   LI Z, 2005, J PHYS CHEM B, V109, P16937
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Lu Q., 2008, J BIOMED MATER RES A, V84, P198
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Pyda M, 2008, MACROMOLECULES, V41, P4786, DOI 10.1021/ma8003357
   Sohn S, 2004, BIOMACROMOLECULES, V5, P751, DOI 10.1021/bm034393
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
NR 30
TC 238
Z9 244
U1 27
U2 182
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2010
VL 6
IS 4
BP 1380
EP 1387
DI 10.1016/j.actbio.2009.10.041
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 574SM
UT WOS:000276013500019
PM 19874919
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Zhu, XD
   Zhang, HJ
   Fan, HS
   Li, W
   Zhang, XD
AF Zhu, X. D.
   Zhang, H. J.
   Fan, H. S.
   Li, Wei
   Zhang, X. D.
TI Effect of phase composition and microstructure of calcium phosphate
   ceramic particles on protein adsorption
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Calcium phosphate ceramics; Phase composition; Microstructure; Protein
   adsorption
ID ATOMIC-FORCE MICROSCOPY; BOVINE SERUM-ALBUMIN; CONFORMATIONAL-CHANGES;
   IN-VITRO; CELL ATTACHMENT; BONE; HYDROXYAPATITE; FIBRINOGEN; COLLAGEN;
   SURFACE
AB The biological performance of biomaterials is strongly influenced by their protein adsorption characteristics, which are related to the structures and properties of both the biomaterial and the protein. In the present study two groups of hydroxyapatite (HA) and biphasic calcium phosphate (BCP) ceramic powders were fabricated by different drying processes. The roles of the phase composition and microstructure of the powders in the adsorption of various model proteins were evaluated. The experimental results showed that BCP always had a higher ability to adsorb fibrinogen, insulin or type I collagen (Col-I) than HA. The microporosity and micropore size of the CaP particles also had a strong impact on their protein adsorption characteristics. HA and BCP particles with higher microporosities and/or more micropores >20 nm in diameter could adsorb more fibrinogen or insulin. However, amounts of adsorbed Col-I were largely unaffected by the microstructure of HA and BCP particles. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhu, X. D.; Zhang, H. J.; Fan, H. S.; Zhang, X. D.] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Li, Wei] Sichuan Univ, Key Lab Oral Biomed Engn, Minist Educ, Chengdu 610041, Peoples R China.
RP Fan, HS (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM zxd7303@163.com; hsfan@scu.edu.cn
RI Zhang, Huijie/N-9869-2014
OI , Jay/0000-0001-9676-4264
FU National Natural Science Foundation of China [50802060]; National Basic
   Research Program of China [G2005cb623901]
FX The authors are grateful for financial support from the National Natural
   Science Foundation of China (Contract Grant No. 50802060) and the
   National Basic Research Program of China (Contract Grant No.
   G2005cb623901).
CR BAO CY, 2005, ASBM6 ADV BIOMATER, V6, P281
   Barroug A, 2004, J ORTHOPAED RES, V22, P703, DOI 10.1016/j.orthres.2003.10.016
   BERNACHEASSOLAN.D, 1991, BIOMATERIALS DEGRADA, P111
   Blacher S, 2003, BIOMATERIALS, V24, P1033, DOI 10.1016/S0142-9612(02)00423-4
   Buijs J, 1999, ANAL CHEM, V71, P3219, DOI 10.1021/ac9809433
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   COOPER DR, 1957, BIOCHIM BIOPHYS ACTA, V26, P317, DOI 10.1016/0006-3002(57)90012-4
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Dee K.C., 2002, INTRO TISSUE BIOMATE, P37
   Dewez JL, 1997, J COLLOID INTERF SCI, V191, P1, DOI 10.1006/jcis.1997.4908
   FAN HS, 2006, BIOCERAMICS, V18, P1299
   Fuss C, 2001, J VASC INTERV RADIOL, V12, P677, DOI 10.1016/S1051-0443(07)61437-7
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   *ISO, 137793 ISO
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kandori K, 2004, J COLLOID INTERF SCI, V273, P406, DOI 10.1016/j.jcis.2004.01.069
   KAWASAKI T, 1990, J CHROMATOGR, V515, P125, DOI 10.1016/S0021-9673(01)89307-9
   Kobayashi M, 1999, J DENT RES, V78, P1624, DOI 10.1177/00220345990780100701
   Kweh SWK, 1999, J MATER PROCESS TECH, V90, P373
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Lopez MSP, 2009, BIOSENS BIOELECTRON, V24, P2574, DOI 10.1016/j.bios.2009.01.002
   Mansur HS, 2001, ADSORPTION, V7, P105, DOI 10.1023/A:1011687706161
   Marchin KL, 2003, LANGMUIR, V19, P9883, DOI 10.1021/la035127r
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   NAKUMURA S, 1990, THERMOCHIM ACTA, V165, P57
   PENNERS G, 1981, J COLLOID INTERF SCI, V80, P437, DOI 10.1016/0021-9797(81)90202-2
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   SILBERBERG A, 1981, BIORHEOLOGY, V18, P589
   Suh CW, 2004, J BIOTECHNOL, V112, P267, DOI 10.1016/j.jbiotec.2004.05.005
   Sun RX, 2009, MAT SCI ENG C-BIO S, V29, P1088, DOI 10.1016/j.msec.2008.08.010
   Tahara Y, 2001, J Orthop Sci, V6, P556, DOI 10.1007/s007760100012
   TANG LP, 1994, CELL MATER, V4, P429
   Tsapikouni TS, 2007, COLLOID SURFACE B, V57, P89, DOI 10.1016/j.colsurfb.2007.01.011
   Tsapikouni TS, 2008, MATER SCI ENG B-ADV, V152, P2, DOI 10.1016/j.mseb.2008.06.007
   Wang AJ, 2009, POWDER TECHNOL, V191, P1, DOI 10.1016/j.powtec.2008.10.020
   WASSELL DTH, 1995, BIOMATERIALS, V16, P697, DOI 10.1016/0142-9612(95)99697-K
   Wintersteiner O, 1933, J BIOL CHEM, V99, P741
   Woodcock SE, 2005, J COLLOID INTERF SCI, V292, P99, DOI 10.1016/j.jcis.2005.05.059
   Yang YZ, 2003, COLLOID SURFACE B, V30, P291, DOI 10.1016/S0927-7765(03)00116-4
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
   Zhu XD, 2009, ACTA BIOMATER, V5, P1311, DOI 10.1016/j.actbio.2008.11.024
   Zhu XD, 2006, BIOCERAMICS, V18, P73
NR 52
TC 46
Z9 47
U1 4
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2010
VL 6
IS 4
BP 1536
EP 1541
DI 10.1016/j.actbio.2009.10.032
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 574SM
UT WOS:000276013500037
PM 19857608
DA 2018-10-20
ER

PT J
AU Mabilleau, G
   Filmon, R
   Petrov, PK
   Basle, MF
   Sabokbar, A
   Chappard, D
AF Mabilleau, G.
   Filmon, R.
   Petrov, P. K.
   Basle, M. F.
   Sabokbar, A.
   Chappard, D.
TI Cobalt, chromium and nickel affect hydroxyapatite crystal growth in
   vitro
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Metal; Mineralization; Hydroxyapatite; Crystal size; Crystallinity
ID BONE-MINERAL DENSITY; HIP RESURFACING ARTHROPLASTY; OSTEOBLAST-LIKE
   CELLS; METAL-IONS; OSTEOCLASTOGENESIS; OSTEONECROSIS; METHACRYLATE;
   PHOSPHATASE; STRONTIUM; ALUMINUM
AB Metals are widely used in orthopaedics and recent studies have reported that patients with metal implants have a significant increase of metal levels in serum and synovial fluid. Femoral neck fracture occurred in some patients with metal-on-metal implants for unknown reasons. Recently, bone quality has emerged as an important factor of bone strength and few studies have investigated the effects of metal ions on hydroxyapatite properties. In the present study, we investigated the effects of Co(2+), Cr(3+) and Ni(2+) on hydroxyapatite (HA) growth in vitro, using carboxymethylated poly(2-hydroxyethyl methacrylate) (pHEMA) as a biomaterial for calcification. We have demonstrated that metal ions reduced the quantity of mineral formed at the surface of the polymer and decreased the ratio Ca/P by 1.12-, 1.05- and 1.08-fold for Cr(2+), Ci(3+) and Ni(2+) respectively. Furthermore, the size of calcospherites was significantly increased in the metal-doped HA compared to the controls, indicating a possible effect of metal ions on the crystal lattice. Indeed, the presence of metal ions increased the crystal size as well as the crystallinity of HA and reduce the lattice parameter c of the HA framework. The information obtained from this work suggests that the quality of the mineral around metallic implants could be altered. However, further investigation should be conducted to further elucidate the effects of metal incorporation on bone mineral and the functional consequences. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mabilleau, G.; Sabokbar, A.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.
   [Filmon, R.; Basle, M. F.; Chappard, D.] Univ Angers, INSERM, U922, LHEA,Fac Med, Angers, France.
   [Petrov, P. K.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
RP Mabilleau, G (reprint author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.
EM guillaume.mabilleau@ndorms.ox.ac.uk
RI Mabilleau, Guillaume/M-8261-2018
OI Mabilleau, Guillaume/0000-0003-1445-329X
FU Furlong Charitable Research Foundation; Contrat Region Pays de la Loire
   BIOREGOS2; INSERM
FX This work was supported by grants from the Furlong Charitable Research
   Foundation, Contrat Region Pays de la Loire BIOREGOS2 and INSERM.
CR Boskey A, 2003, OSTEOPOROSIS INT, V14, pS16, DOI 10.1007/s00198-003-1468-2
   Brodner W, 1997, J BONE JOINT SURG BR, V79B, P316, DOI 10.1302/0301-620X.79B2.7326
   Chantawong V, 2003, WATER AIR SOIL POLL, V148, P111, DOI 10.1023/A:1025401927023
   Chappard D, 1999, INT J ORAL MAX IMPL, V14, P189
   Chen LC, 2009, INHAL TOXICOL, V21, P1, DOI 10.1080/08958370802105405 
   Christopher J. G., 2002, ENVIRON SCI TECHNOL, V36, P3010
   COLLERY P, 2008, METAL IONS BIOL
   Damborg F, 2008, ACTA ORTHOP, V79, P494, DOI 10.1080/17453670710015481
   de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672
   Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2
   Farlay D, 2005, J BONE MINER RES, V20, P1569, DOI 10.1359/JBMR.050405
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Filmon R, 2002, BIOMATERIALS, V23, P3053, DOI 10.1016/S0142-9612(02)00069-8
   Filmon R, 1997, J HISTOTECHNOL, V20, P343
   Filmon R., 1996, Cells and Materials, V6, P11
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Fleury C, 2006, BIOMATERIALS, V27, P3351, DOI 10.1016/j.biomaterials.2006.01.035
   Guggenbuhl P, 2008, METABOLISM, V57, P903, DOI 10.1016/j.metabol.2008.02.004
   Jacobs JJ, 1996, CLIN ORTHOP RELAT R, pS256
   Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032
   Li MG, 2007, J ARTHROPLASTY, V22, P689, DOI 10.1016/j.arth.2006.05.035
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Lian YY, 2008, J ORTHOP RES, V26, P453, DOI 10.1002/jor.20503
   Libouban H, 2009, J RAMAN SPECTROSC, V40, P1234, DOI 10.1002/jrs.2272
   Little CP, 2005, J BONE JOINT SURG BR, V87B, P320, DOI 10.1302/0301-620X.87B3.15330
   Mabilleau G, 2007, BONE, V40, pS278
   Mabilleau G, 2007, CALCIFIED TISSUE INT, V80, pS92
   Mabilleau G, 2008, BIOMATERIALS, V29, P1593, DOI 10.1016/j.biomaterials.2007.12.01
   Mabilleau G, 2008, ACTA ORTHOP, V79, P734, DOI 10.1080/17453670810016795
   Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   Nichols KG, 1997, J BIOMED MATER RES, V35, P265
   PASCHALIS EP, 2001, SIZE MATTERS
   Perrone J, 2001, J COLLOID INTERF SCI, V239, P303, DOI 10.1006/jcis.2001.7583
   Rousselle AV, 2002, HISTOL HISTOPATHOL, V17, P1025, DOI 10.14670/HH-17.1025
   Rowatt E, 1997, J INORG BIOCHEM, V68, P235, DOI 10.1016/S0162-0134(97)00088-3
   Savarino L, 2002, J BIOMED MATER RES, V63, P467, DOI 10.1002/jbm.10299
   Saxena S, 2006, ENVIRON INT, V32, P199, DOI 10.1016/j.envint.2005.08.011
   Schmidt A, 2007, EUR J HAEMATOL, V78, P500, DOI 10.1111/j.1600-0609.2007.00852.x
   Shimmin AJ, 2005, J BONE JOINT SURG BR, V87B, P463, DOI 10.1302/0301-620X.87B4
   STULBERG SD, 1994, ORTHOPEDICS, V17, P869
   YAMADA S, 1994, J BIOMED MATER RES, V28, P1357, DOI 10.1002/jbm.820281114
   Zaffe D, 2004, BIOMATERIALS, V25, P3837, DOI 10.1016/j.biomaterials.2003.10.020
NR 43
TC 31
Z9 32
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2010
VL 6
IS 4
BP 1555
EP 1560
DI 10.1016/j.actbio.2009.10.035
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 574SM
UT WOS:000276013500040
PM 19861179
DA 2018-10-20
ER

PT J
AU Asamura, S
   Mochizuki, Y
   Yamamoto, M
   Tabata, Y
   Isogai, N
AF Asamura, Shinichi
   Mochizuki, Yuichi
   Yamamoto, Masaya
   Tabata, Yasuhiko
   Isogai, Noritaka
TI Bone Regeneration Using a Bone Morphogenetic Protein-2 Saturated
   Slow-Release Gelatin Hydrogel Sheet Evaluation in a Canine Orbital Floor
   Fracture Model
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE gelatin hydrogel; biodegradable polymer; BMP-2; orbital floor fracture;
   bone structural analysis
ID FIBROBLAST-GROWTH-FACTOR; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS;
   RECONSTRUCTION; IMPLANTS; COLLAGEN; PHARMACOKINETICS; SUBSTITUTE;
   RHBMP-2; POLYMER
AB Bone regeneration methods using bone inductive cytokines show promise, however, due to early diffusion and absorption of single applications of these cytokines, the bone inductive effects are limited. In this study, such a system was applied, using gelatin hydrogel as a carrier to slowly release (bone morphogenetic proteins) BMP-2 over a relatively long period in vivo. By coupling this slow-release system with a biodegradable copolymer, this composite was evaluated by grafting into bone defect sites of a canine orbital floor fracture model. Radio-iodinated BMP-2 incorporated into the gelatin hydrogel carrier and subcutaneously implanted into nude mice showed a similar slow release (approximately, 60% at 3 days and 80% at 14 days) as the radiolabeled hydrogel carrier alone. In contrast, greater than 90% of fluid-injected BMP-2 was lost in the injection site within the first 8 hours. Using a dog model of orbital floor fracture, a complex of BMP-2-saturated gelatin hydrogel and a polylactide-based biodegradable copolymer was implanted into the orbital bone defect. Bone structural analysis, using radiography, histologic examination, and microfocus CT, showed greatly enhanced new bone formation and defect healing at 5 weeks in comparison to implanted biodegradable copolymer directly saturated with the same amount of BMP-2 (no slow-release hydrogel carrier). A trabecular structure resembling that normal bone tissue was restored in the new bone tissue generated by the slow-release constructs. Thus study demonstrates the potential of slow-release BMP-2 for bone healing of difficult defects.
C1 [Asamura, Shinichi; Mochizuki, Yuichi; Isogai, Noritaka] Kinki Univ, Sch Med, Dept Plast & Reconstruct Surg, Osaka 5898511, Japan.
   [Yamamoto, Masaya; Tabata, Yasuhiko] Kyoto Univ, Dept Biomat, Field Tissue Engn, Kyoto, Japan.
RP Asamura, S (reprint author), Kinki Univ, Sch Med, Dept Plast & Reconstruct Surg, 377-2 Ohono Higashi, Osaka 5898511, Japan.
EM fibringlue@aol.com
CR Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529
   BORGHOUTS JMHM, 1978, BRIT J PLAST SURG, V31, P254, DOI 10.1016/0007-1226(78)90096-6
   Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   CORDEWENER FW, 1996, J ORAL MAXILLOFAC SU, V54, P59
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   GERHART TN, 1991, T ORTHOP RES SOC, V16, P172
   Gilhotra JS, 2002, CLIN EXP OPHTHALMOL, V30, P352, DOI 10.1046/j.1442-9071.2002.t01-1-00555.x
   GORDON RM, 1966, ARCH OPHTHALMOL-CHIC, V76, P662
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527
   Jacono A A, 2000, Facial Plast Surg, V16, P63, DOI 10.1055/s-2000-7327
   KITAZATO A, 2005, KASEN KOENSHU COLLEC, V62, P107
   KOMIYAMA K, 2000, KITASATO MED, V30, P422
   Krishnan V, 1997, J ORAL MAXIL SURG, V55, P327, DOI 10.1016/S0278-2391(97)90117-8
   Potter JK, 2004, J ORAL MAXIL SURG, V62, P1280, DOI 10.1016/j.joms.2004.04.018
   Reddi S P, 1999, J Craniomaxillofac Trauma, V5, P7
   Romano J J, 1993, J Craniofac Surg, V4, P142, DOI 10.1097/00001665-199307000-00007
   Saito N, 2001, NAT BIOTECHNOL, V19, P332, DOI 10.1038/86715
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   Sciadini MF, 2000, J ORTHOPAED RES, V18, P289, DOI 10.1002/jor.1100180218
   Siritongtaworn Preecha, 2001, Journal of the Medical Association of Thailand, V84, pS485
   SMITH B, 1957, Am J Ophthalmol, V44, P733
   Spector JA, 2001, PLAST RECONSTR SURG, V107, P124, DOI 10.1097/00006534-200101000-00018
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   Tabata Y, 1999, J NEUROSURG, V91, P851, DOI 10.3171/jns.1999.91.5.0851
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   UCHIYAMA Y, 1994, J JPN SOC BONE MORPH, V4, P83
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Utida A, 1990, J BONE JOINT SURG BR, V72, P298
   Villarreal PM, 2002, PLAST RECONSTR SURG, V109, P877, DOI 10.1097/00006534-200203000-00007
   WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yamada K, 2002, J NEUROSURG, V96, P731, DOI 10.3171/jns.2002.96.4.0731
   Yamada K, 1997, J NEUROSURG, V86, P871, DOI 10.3171/jns.1997.86.5.0871
   Yamada K, 1997, J NEUROSURG, V86, P1012, DOI 10.3171/jns.1997.86.6.1012
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 46
TC 32
Z9 37
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD APR
PY 2010
VL 64
IS 4
BP 496
EP 502
DI 10.1097/SAP.0b013e31819b6c52
PG 7
WC Surgery
SC Surgery
GA 574TE
UT WOS:000276015600026
PM 20224349
DA 2018-10-20
ER

PT J
AU Nancharaiah, YV
   Dodge, C
   Venugopalan, VP
   Narasimhan, SV
   Francis, AJ
AF Nancharaiah, Y. V.
   Dodge, C.
   Venugopalan, V. P.
   Narasimhan, S. V.
   Francis, A. J.
TI Immobilization of Cr(VI) and Its Reduction to Cr(III) Phosphate by
   Granular Biofilms Comprising a Mixture of Microbes
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID SEQUENCING BATCH REACTOR; CHROMATE REDUCTION; HEXAVALENT CHROMIUM;
   AEROBIC GRANULATION; BACTERIAL REDUCTION; SOLUBLE CHROMATE; SLUDGE;
   REMOVAL; BIOMATERIAL; BIOSORPTION
AB We assessed the potential of mixed microbial consortia, in the form of granular biofilms, to reduce chromate and remove it from synthetic minimal medium. In batch experiments, acetate-fed granular biofilms incubated aerobically reduced 0.2 mM Cr(VI) from a minimal medium at 0.15 mM day(-1) g(-1), with reduction of 0.17 mM day(-1) g(-1) under anaerobic conditions. There was negligible removal of Cr(VI) (i) without granular biofilms, (ii) with lyophilized granular biofilms, and (iii) with granules in the absence of an electron donor. Analyses by X-ray absorption near edge spectroscopy (XANES) of the granular biofilms revealed the conversion of soluble Cr(VI) to Cr(III). Extended X-ray absorption fine-structure (EXAFS) analysis of the Cr-laden granular biofilms demonstrated similarity to Cr(III) phosphate, indicating that Cr(III) was immobilized with phosphate on the biomass subsequent to microbial reduction. The sustained reduction of Cr(VI) by granular biofilms was confirmed in fed-batch experiments. Our study demonstrates the promise of granular-biofilm-based systems in treating Cr(VI)-containing effluents and wastewater.
C1 [Nancharaiah, Y. V.; Dodge, C.; Francis, A. J.] Brookhaven Natl Lab, Dept Environm Sci, Upton, NY 11973 USA.
   [Nancharaiah, Y. V.; Venugopalan, V. P.; Narasimhan, S. V.] Bhabha Atom Res Ctr Facil, Water & Steam Chem Div, Kalpakkam 603102, Tamil Nadu, India.
RP Francis, AJ (reprint author), Brookhaven Natl Lab, Dept Environm Sci, Bldg 490A, Upton, NY 11973 USA.
EM francis1@bnl.gov
OI Yarlagadda, Nancharaiah/0000-0002-6443-7661
FU Department of Atomic Energy, Government of India; Environmental
   Remediation Sciences Division, Office of Biological and Environmental
   Research, Office of Science, U.S. Department of Energy
   [DE-AC02-98CH10886]; Indo-US Visiting Research Professorship Award
FX This research was supported by the Department of Atomic Energy,
   Government of India, and in part by the Environmental Remediation
   Sciences Division, Office of Biological and Environmental Research,
   Office of Science, U.S. Department of Energy under contract no.
   DE-AC02-98CH10886. Y.V.N. gratefully acknowledges the American Society
   for Microbiology for the Indo-US Visiting Research Professorship Award.
CR Ackerley DF, 2004, ENVIRON MICROBIOL, V6, P851, DOI 10.1111/j.1462-2920.2004.00639.x
   Al Hasin A, 2010, ENVIRON SCI TECHNOL, V44, P400, DOI 10.1021/es901723c
   APHA AWWA WEF, 1995, STAND METH EX WAT WA
   Barak Y, 2006, APPL ENVIRON MICROB, V72, P7074, DOI 10.1128/AEM.01334-06
   Beun JJ, 1999, WATER RES, V33, P2283, DOI 10.1016/S0043-1354(98)00463-1
   Cervantes C, 2001, FEMS MICROBIOL REV, V25, P335, DOI 10.1016/S0168-6445(01)00057-2
   Chardin B, 2003, APPL MICROBIOL BIOT, V63, P315, DOI 10.1007/s00253-003-1390-8
   Chung J, 2006, WATER RES, V40, P1634, DOI 10.1016/j.watres.2006.01.049
   de Kreuk M, 2005, BIOTECHNOL BIOENG, V90, P761, DOI 10.1002/bit.20470
   Fein JB, 2002, GEOMICROBIOL J, V19, P369, DOI 10.1080/01490450290098423
   FERRIS FG, 1989, APPL ENVIRON MICROB, V55, P1249
   Francis AJ, 2007, J ALLOY COMPD, V444, P500, DOI 10.1016/j.jallcom.2007.01.132
   Francis AJ, 1998, J ALLOY COMPD, V271, P78, DOI 10.1016/S0925-8388(98)00028-0
   Ganguli A, 2002, APPL MICROBIOL BIOT, V58, P416, DOI 10.1007/s00253-001-0871-x
   Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774
   Horton RN, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-5
   Inizan M, 2005, WATER SCI TECHNOL, V52, P335
   Kemner KM, 2004, SCIENCE, V306, P686, DOI 10.1126/science.1103524
   Liu Y, 2002, LETT APPL MICROBIOL, V35, P548, DOI 10.1046/j.1472-765X.2002.01227.x
   LOSI ME, 1994, REV ENVIRON CONTAM T, V136, P91
   LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403
   McLean J, 2001, APPL ENVIRON MICROB, V67, P1076, DOI 10.1128/AEM.67.3.1076-1084.2001
   Morales DK, 2007, J APPL MICROBIOL, V103, P2704, DOI 10.1111/j.1365-2672.2007.03510.x
   Morgenroth E, 1997, WATER RES, V31, P3191, DOI 10.1016/S0043-1354(97)00216-9
   Nancharaiah YV, 2006, CURR SCI INDIA, V91, P503
   Nancharaiah YV, 2008, CHEMOSPHERE, V71, P30, DOI 10.1016/j.chemosphere.2007.10.062
   Nancharaiah YV, 2006, WATER RES, V40, P1539, DOI 10.1016/j.watres.2006.02.006
   Neal AL, 2002, APPL SURF SCI, V202, P150, DOI 10.1016/S0169-4332(02)00550-0
   Nicolella C, 2000, TRENDS BIOTECHNOL, V18, P312, DOI 10.1016/S0167-7799(00)01461-X
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   Pattanapipitpaisal P, 2001, BIOTECHNOL LETT, V23, P61, DOI 10.1023/A:1026750810580
   Priester JH, 2006, APPL ENVIRON MICROB, V72, P1988, DOI 10.1128/AEM.72.3.1988-1996.2006
   Ramirez-Diaz MI, 2008, BIOMETALS, V21, P321, DOI 10.1007/s10534-007-9121-8
   Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719
   Rege MA, 1997, BIOTECHNOL LETT, V19, P691, DOI 10.1023/A:1018355318821
   Smith WL, 2000, J APPL MICROBIOL, V88, P983, DOI 10.1046/j.1365-2672.2000.01066.x
   Stasinakis AS, 2004, CHEMOSPHERE, V57, P1069, DOI 10.1016/j.chemosphere.2004.08.020
   WANG YT, 1995, J IND MICROBIOL, V14, P159, DOI 10.1007/BF01569898
   Wani R, 2007, APPL MICROBIOL BIOT, V75, P627, DOI 10.1007/s00253-007-0862-7
   Xu H, 2006, BIORESOURCE TECHNOL, V97, P359, DOI 10.1016/j.biortech.2005.03.011
NR 40
TC 41
Z9 42
U1 0
U2 33
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD APR
PY 2010
VL 76
IS 8
BP 2433
EP 2438
DI 10.1128/AEM.02792-09
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 578FX
UT WOS:000276280100008
PM 20173073
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Gordon, SH
   Mohamed, A
   Harry-O'Kuru, RE
   Imam, SH
AF Gordon, S. H.
   Mohamed, A.
   Harry-O'Kuru, R. E.
   Imam, S. H.
TI A Chemometric Method for Correcting Fourier Transform Infrared Spectra
   of Biomaterials for Interference from Water in KBr Discs
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE Biomaterial; Infrared spectrometric method; Water interference; KBr
   disc; KBr pellet; r-matrix method; Chemometrics; KBr water correction
   method
ID POTASSIUM-BROMIDE; SPECTROSCOPY; PROTEIN; SPECTROPHOTOMETRY; COMPONENTS;
   PELLETS
AB Mid-infrared (mid-IR) analysis of solid biomaterials by the familiar KBr disc technique is all too often frustrated by water interference in the very important protein (amide) and carbohydrate (hydroxyl) regions of their spectra. A method was therefore devised that overcomes the difficulty and corrects IR spectra of solid biomaterials in KBr discs by mathematically eliminating the interference that arises from water molecules absorbed and bound in the KBr crystal lattice. The derivation of a linear system of chemometric equations that solves the water interference problem in a rigorous objective way is presented. Infrared spectra that result after correction by the method can be used reliably for quantitative analysis as well as structure identification. A major advantage is realized in quantitative analysis as the technique permits cryogenic pulverization of the biomaterial in KW to prevent change in chemical structure and minimize the particle size to closely approach the solid solution condition required by the Beer Lambert law. Extensive pulverization, which produces large water absorption bands that overlap and obscure the amide and hydroxyl regions of interest, is no longer problematic. The method is illustrated by removing strong water interference to extract the spectra of corn starch and gluten in pressed KBr discs. Results of the new method are compared with attenuated total reflection (ATR) spectra of gluten corrected using the conventional advanced ATR correction algorithm.
C1 [Gordon, S. H.; Mohamed, A.; Harry-O'Kuru, R. E.] ARS, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA.
   [Imam, S. H.] ARS, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
RP Gordon, SH (reprint author), ARS, Natl Ctr Agr Utilizat Res, USDA, 1815 N Univ St, Peoria, IL 61604 USA.
EM sherald.gordon@ars.usda.gov
CR ATAMAN OY, 1977, APPL SPECTROSC REV, V13, P1
   BORKA L, 1975, ANAL CHEM, V47, P1212, DOI 10.1021/ac60357a078
   BROWNING RS, 1955, ANAL CHEM, V27, P7, DOI 10.1021/ac60097a003
   Costantino HR, 1997, PHARM SCI, V3, P121
   FALK M, 1966, CAN J CHEMISTRY, V44, P1699, DOI 10.1139/v66-255
   FALK M, 1991, CAN J APPL SPECTROSC, V36, P22
   FRASER RDB, 1973, PHYSICAL PRINCIPLE C, V21, P301
   FRIEDEL RA, 1971, ANAL CHEM, V43, P761, DOI 10.1021/ac60301a047
   Gordon SH, 2005, J APPL POLYM SCI, V97, P813, DOI [10.1002/app.21775, 10.1002/app.21755]
   Gordon SH, 2000, J POLYM ENVIRON, V8, P125, DOI 10.1023/A:1014825816031
   INGEBRIGTSON DN, 1954, ANAL CHEM, V26, P1765, DOI 10.1021/ac60095a023
   JOHNSON LW, 1981, INTRO LINEAR ALGEBRA, P264
   Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f
   MALHOTRA VM, 1989, APPL SPECTROSC, V43, P638, DOI 10.1366/0003702894202643
   Manning MC, 2005, EXPERT REV PROTEOMIC, V2, P731, DOI 10.1586/14789450.2.5.731
   Meyer JD, 2004, J PHARM SCI-US, V93, P496, DOI 10.1002/jps.10562
   MILKEY RG, 1958, ANAL CHEM, V30, P1931, DOI 10.1021/ac60144a014
   MU R, 1987, THESIS SIU CARBONDAL
   NORRIS WP, 1972, APPL SPECTROSC, V26, P247, DOI 10.1366/000370272774352236
   Nunn S., 2003, 01153 THERM CORP
   PRICE WC, 1958, PROC R SOC LON SER-A, V247, P467, DOI 10.1098/rspa.1958.0203
   ROSENKRANTZ H, 1957, Methods Biochem Anal, V5, P407
   SCHIEDT U, 1952, Z NATURFORSCH B, V7, P270
   SCHWOCHAU K, 1962, Z NATURFORSCH PT B, VB 17, P582
   SINHA S, 2008, THESIS U KANSAS LAWR
   STEVENSON FJ, 1974, SOIL SCI, V117, P34, DOI 10.1097/00010694-197401000-00005
   STIMSON MM, 1952, J AM CHEM SOC, V74, P1805, DOI 10.1021/ja01127a054
   SUSI H, 1986, METHOD ENZYMOL, V130, P290
   THOMPSON WK, 1964, J CHEM SOC, P3658, DOI 10.1039/jr9640003658
   van de Weert M, 2001, ANAL BIOCHEM, V297, P160, DOI 10.1006/abio.2001.5337
   WALTER HU, 1971, Z PHYS CHEM NEUE FOL, V75, P287, DOI 10.1524/zpch.1971.75.5_6.287
NR 31
TC 6
Z9 6
U1 3
U2 25
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-7028
EI 1943-3530
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD APR
PY 2010
VL 64
IS 4
BP 448
EP 457
DI 10.1366/000370210791114301
PG 10
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA 587OD
UT WOS:000277001200014
PM 20412631
DA 2018-10-20
ER

PT J
AU Xue, XQ
   Wang, J
   Zhu, Y
   Tu, QF
   Huang, N
AF Xue, Xiaoqing
   Wang, Jin
   Zhu, Ying
   Tu, Qiufen
   Huang, Nan
TI Biocompatibility of pure titanium modified by human endothelial
   cell-derived extracellular matrix
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Endothelial cell-derived extracellular matrix; Biocompatibility;
   Endothelial cell; Platelet adhesion; Titanium
ID BASEMENT-MEMBRANE; ACTIN CYTOSKELETON; PLATELET-ADHESION; LAMININ;
   DIFFERENTIATION; MORPHOGENESIS; FIBRONECTIN; ACTIVATION; PROTEINS
AB Extracellular matrix (ECM) used to modify biomaterial surface is a promising method for improving cardiovascular material hemocompatibility. In the present work, human umbilical vein endothelial cells (HUVECs) are cultured and native ECM is obtained on pure titanium surface. Fourier infrared spectrum (FTIR) test proves the existence of amide I and amide II band on the modified titanium surface. X-ray photoelectron spectroscopy (XPS) further confirms the chemical composition and binding types of the ECM proteins on the titanium substrate. The results of light microscopy and atomic force microscopy (AFM) exhibit the morphology of HUVEC derived ECM. There are higher water contact angles on the ECM modified samples. Furthermore, some ECM components, including fibronectin (FN), laminin (LN) and type IV collagen (IV-COL) are presented on ECM-covered titanium surface by immunofluorescence staining. The biological behavior of cultured HUVECs and adherent platelets on different samples are investigated by in vitro HUVECs culture and platelet adhesion. Cells exhibit better morphology and their proliferation ability greatly improve on the ECM-covered titanium. At the same time, the platelet adhesion and spreading are inhibited on ECM-covered titanium surface. These investigations demonstrate that ECM produced by HUVECs cannot only improve adhesion and proliferation ability of endothelial cell but also inhibit adhesion and activation of platelets. Thus, the approach described here may provide a basis for preparation of modified surface in cardiovascular implants application. (C) 2010 Elsevier B. V. All rights reserved.
C1 [Xue, Xiaoqing; Wang, Jin; Zhu, Ying; Tu, Qiufen; Huang, Nan] SW Jiaotong Univ, Key Lab Adv Technol, Mat Educ Minist, Chengdu 610031, Peoples R China.
RP Wang, J (reprint author), SW Jiaotong Univ, Key Lab Adv Technol, Mat Educ Minist, Chengdu 610031, Peoples R China.
EM jinxxwang@263.net
FU Ministry of Scientific and Technical Project of China [2005CB623904];
   National Natural Science Foundation of China [50673081]; Ministry of
   Education of China [NCET-07-0715]
FX This work was supported by Key Basic Research Project No. 2005CB623904
   supported by Ministry of Scientific and Technical Project of China,
   Project 50673081 supported by National Natural Science Foundation of
   China, and program for New Century Excellent University Talent
   (NCET-07-0715) supported by Ministry of Education of China.
CR Amiji MM, 1998, COLLOID SURFACE B, V10, P263, DOI 10.1016/S0927-7765(98)00005-8
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BRUNI S, 2005, ACTA MAT, V1, P23
   Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3
   Ge SN, 2007, KEY ENG MATER, V342-343, P305, DOI 10.4028/www.scientific.net/KEM.342-343.305
   HAHN E, 1980, GUT, V21, P63, DOI 10.1136/gut.21.1.63
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Haudenschild DR, 2008, BIORHEOLOGY, V45, P219, DOI 10.3233/BIR-2008-0499
   HOUDIJK WPM, 1986, ARTERIOSCLEROSIS, V6, P24, DOI 10.1161/01.ATV.6.1.24
   Ji Yan, 2001, CHEM IND ENG, V18, P44
   JIANG DY, 2005, CHIN J CLIN REHABIL, V9, P35
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Kumari TV, 2002, BIO-MED MATER ENG, V12, P329
   LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455
   Li Cheng, 2004, Hemodial Int, V8, P360, DOI 10.1111/j.1492-7535.2004.80412.x
   Li Q. L., 2008, J BIOMED MATER RES A, V89A, P575, DOI [10.1002/jbm.a.31999, DOI 10.1002/JBM.A.31999]
   Li QL, 2009, J BIOACT COMPAT POL, V24, P129, DOI 10.1177/0883911508101553
   MARK AR, 2001, THESIS CASE W RESERV
   Matsubara T, 2004, BIOCHEM BIOPH RES CO, V313, P503, DOI 10.1016/j.bbrc.2003.11.143
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   SAGNELLA SM, 2003, THESIS CASE W RESERV
   SCHMOLLER KM, 2008, PHYS REV LETT, V101, P102
   Svoboda KKH, 1999, ANAT REC, V254, P348, DOI 10.1002/(SICI)1097-0185(19990301)254:3<348::AID-AR5>3.0.CO;2-5
   Takemoto S, 2001, J SOL-GEL SCI TECHN, V21, P97, DOI 10.1023/A:1011269802356
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   VONGCHAN P, 2002, CARBOHYD RES, V337, P1233
   WIJELATH ES, 2006, CIRC RES, V99, P1
   Woods AM, 2004, BIOMATERIALS, V25, P515, DOI 10.1016/S0142-9612(03)00552-0
   Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110
   YAMANE T, 2004, INT C SER, V1262, P407
   YOUNG WC, 1985, J CELL SCI, V73, P19
NR 33
TC 15
Z9 17
U1 3
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 1
PY 2010
VL 256
IS 12
BP 3866
EP 3873
DI 10.1016/j.apsusc.2010.01.042
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 564RM
UT WOS:000275234000028
DA 2018-10-20
ER

PT J
AU Hedhammar, M
   Bramfeldt, H
   Baris, T
   Widhe, M
   Askarieh, G
   Nordling, K
   von Aulock, S
   Johansson, J
AF Hedhammar, My
   Bramfeldt, Hanna
   Baris, Teodora
   Widhe, Mona
   Askarieh, Glareh
   Nordling, Kerstin
   von Aulock, Sonja
   Johansson, Jan
TI Sterilized Recombinant Spider Silk Fibers of Low Pyrogenicity
SO BIOMACROMOLECULES
LA English
DT Article
ID ENDOTOXIN REMOVAL; ESCHERICHIA-COLI; CHROMATOGRAPHIC REMOVAL;
   AFFINITY-CHROMATOGRAPHY; PROTEIN SOLUTIONS; LIPOPOLYSACCHARIDE;
   BIOMATERIAL; EFFICIENCY; PROTOCOL; RELEASE
AB We have recently shown that it is possible to recombinantly produce a miniature spider silk protein, 4RepCT, that spontaneously self-assembles into mechanically stable macroscopic fibers (Stark, M.; Grip, S.; Rising, A.; Hedhammar, M.; Engstrom, W.; Hjalm, G.; Johansson, J. Macroscopic fibers self-assembled from recombinant miniature spider silk proteins. Biomacromolecules 2007, 8 (5), 1695-1701). When produced as a soluble fusion protein (with thioredoxin) in Escherichia con, the spider silk protein can be subjected to several purification steps without aggregating. Here, combined purification and endotoxin removal is achieved using a simple cell wash procedure, protein affinity purification, and LIDS depletion. No toxic chemicals were included in the process and the protein retained its ability to self-assemble into fibers. With this method, fibers with pyrogenicity corresponding to less than 1 EU/mg could be recovered. Moreover, the fibers could be sterilized through autoclaving with retained morphology, structure, and mechanical properties. This implies that this recombinant silk is suitable for usage as biomaterial, which is further supported by data showing that the fibers allow growth of human primary fibroblasts.
C1 [Hedhammar, My; Bramfeldt, Hanna; Widhe, Mona; Nordling, Kerstin; Johansson, Jan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala Biomed Ctr, SE-75123 Uppsala, Sweden.
   [Baris, Teodora; von Aulock, Sonja] Univ Konstanz, D-78464 Constance, Germany.
   [Askarieh, Glareh] Univ Oslo, Dept Chem, N-0315 Oslo, Norway.
RP Hedhammar, M (reprint author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala Biomed Ctr, SE-75123 Uppsala, Sweden.
EM my.hedhammar@afb.slu.se
FU European Commission [G5RD-CT-200200738]; Swedish Research Council,
   Formas and Vinnova
FX We thank Bjorn Atthoff for help with scanning electron microscopy and
   Marie Svensson for help with the LAL assay. This study was supported by
   a European Commission grant ("Spidernian" Contract No.
   G5RD-CT-200200738), the Swedish Research Council, Formas and Vinnova.
CR Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   DEPAMPHILIS ML, 1971, J BACTERIOL, V105, P1184
   Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Han SO, 2006, J APPL POLYM SCI, V100, P4972, DOI 10.1002/app.23300
   Hartung Thomas, 1996, In Vitro Toxicology, V9, P353
   Hasiwa M, 2007, BIOMATERIALS, V28, P1367, DOI 10.1016/j.biomaterials.2006.11.016
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hirayama C, 2002, J CHROMATOGR B, V781, P419, DOI 10.1016/S1570-0232(02)00430-0
   Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010
   Kang Y, 1998, J CHROMATOGR A, V809, P13, DOI 10.1016/S0021-9673(98)00137-X
   LEIVE L, 1968, J BIOL CHEM, V243, P6384
   LEIVE L, 1965, BIOCHEM BIOPH RES CO, V21, P290, DOI 10.1016/0006-291X(65)90191-9
   LEIVE L, 1974, ANN NY ACAD SCI, V235, P109, DOI 10.1111/j.1749-6632.1974.tb43261.x
   LEVY SB, 1968, P NATL ACAD SCI USA, V61, P1435, DOI 10.1073/pnas.61.4.1435
   Lin MF, 2005, J CHROMATOGR B, V816, P167, DOI 10.1016/j.jchromb.2004.11.029
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   McAllister LA, 2007, BIOCONJUGATE CHEM, V18, P559, DOI 10.1021/bc0602984
   NEWTON BA, 1956, BACTERIOL REV, V20, P14
   Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6
   Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027
   Sheu HS, 2004, INT J BIOL MACROMOL, V34, P325, DOI 10.1016/j.ijbiomac.2004.09.004
   SHINTANI H, 1995, J BIOMATER APPL, V10, P23, DOI 10.1177/088532829501000102
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   STECK S, 2007, BIOTECHNOL BAVARIA P, P58
   Svensson M, 2005, BIOPROC BIOSYST ENG, V27, P91, DOI 10.1007/s00449-004-0377-x
   Tessarolo F, 2006, INT J HYG ENVIR HEAL, V209, P557, DOI 10.1016/j.ijheh.2006.05.001
   Vollrath F, 2002, IN VIVO, V16, P229
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
NR 31
TC 34
Z9 37
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2010
VL 11
IS 4
BP 953
EP 959
DI 10.1021/bm9014039
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 581WW
UT WOS:000276557300016
PM 20235574
DA 2018-10-20
ER

PT J
AU Kim, YS
   Kadla, JF
AF Kim, Yong Sik
   Kadla, John F.
TI Preparation of a Thermoresponsive Lignin-Based Biomaterial through Atom
   Transfer Radical Polymerization
SO BIOMACROMOLECULES
LA English
DT Article
ID GRAFT-COPOLYMERIZATION; N-ISOPROPYLACRYLAMIDE; METHYL-METHACRYLATE;
   KRAFT LIGNIN; BLENDS; CELLULOSE; ALCOHOLS; STYRENE; GELS
AB Copolymerization of N-isopropylacrylamide (NIPAM) with technical hardwood kraft lignin (HWKL) was achieved by atom transfer radical polymerization (ATRP) using a selectively modified lignin-based macroinitiator. The degree of polymerization (DP) of polyNIPAM graft side chains was affected by varying the ratio of the DMF/water solvent system from 5:0 to 0:5, and an estimated DP(NIPAM) of >40 was obtained using a ratio of 1:4 (v/v). The thermal decomposition temperature of the lignin-g-polyNIPAM copolymers significantly increased with increasing DP(NIPAM). Likewise, the solubility of the lignin-g-polyNIPAM copolymers in water changed depending on copolymer structure. In both the water-soluble and suspended copolymers, at temperatures above 32 degrees C, the g-polyNIPAM component underwent the typical hydrophilic-to-hydrophobic transition, resulting in the precipitation of the copolymer.
C1 [Kim, Yong Sik; Kadla, John F.] Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1W5, Canada.
RP Kadla, JF (reprint author), Univ British Columbia, Fac Forestry, Vancouver, BC V6T 1W5, Canada.
EM john.kadla@ubc.ca
FU Natural Science and Engineering Research Council of Canada
FX The authors thank the Natural Science and Engineering Research Council
   of Canada for financial support.
CR Alder E., 1977, WOOD SCI TECHNOL, V11, P169, DOI DOI 10.1007/BF00365615
   Binh NTT, 2009, COMPOS INTERFACE, V16, P923, DOI 10.1163/092764409X12477479344485
   Bokias G, 2001, MACROMOLECULES, V34, P4958, DOI 10.1021/ma010154e
   Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b
   CHEN RL, 1986, J APPL POLYM SCI, V32, P4815, DOI 10.1002/app.1986.070320504
   Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X
   Fischer H, 1999, J POLYM SCI POL CHEM, V37, P1885, DOI 10.1002/(SICI)1099-0518(19990701)37:13<1885::AID-POLA1>3.0.CO;2-1
   FREUDENBERG K, 1965, SCIENCE, V148, P595, DOI 10.1126/science.148.3670.595
   Glasser WG, 1989, ACS S SERIES, V397
   GLASSER WG, 1989, ACS S SERIES, V385
   Griffith WL, 2008, SEP SCI TECHNOL, V43, P2396, DOI 10.1080/01496390802148571
   Gupta KC, 2003, BIOMACROMOLECULES, V4, P758, DOI 10.1021/bm020135s
   HUANG YF, 1992, J APPL POLYM SCI, V45, P71, DOI 10.1002/app.1992.070450108
   Ifuku S, 2008, BIOMACROMOLECULES, V9, P3308, DOI 10.1021/bm800911w
   Kadla JF, 2003, MACROMOLECULES, V36, P7803, DOI 10.1021/ma0348371d
   KENNEDY JF, 1992, LIGNOCELLULOSIC SCI
   Kubo S, 2004, MACROMOLECULES, V37, P6904, DOI 10.1021/ma0490552
   Kubo S, 2003, BIOMACROMOLECULES, V4, P561, DOI 10.1021/bm025727p
   Lapierre C, 2000, J AGR FOOD CHEM, V48, P2326, DOI 10.1021/jf991398p
   Mai C, 2000, ENZYME MICROB TECH, V27, P167, DOI 10.1016/S0141-0229(00)00214-3
   Masci G, 2004, MACROMOL RAPID COMM, V25, P559, DOI 10.1002/marc.200300140
   Matyjaszewski K, 1997, J AM CHEM SOC, V119, P674, DOI 10.1021/ja963361g
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   MEISTER JJ, 1984, J APPL POLYM SCI, V29, P3457, DOI 10.1002/app.1984.070291122
   Nahmany M, 2004, ORG BIOMOL CHEM, V2, P1563, DOI 10.1039/b403161j
   Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925
   Qin DQ, 2000, POLYMER, V41, P7347, DOI 10.1016/S0032-3861(00)00105-1
   Sarkanen K.V., 1971, LIGNINS OCCURRENCE F
   Shen D, 2006, CELLULOSE, V13, P235, DOI 10.1007/s10570-005-9044-x
   Shen DW, 2004, POLYMER, V45, P7091, DOI 10.1016/j.polymer.2004.08.042
   Tsarevsky NV, 2002, MACROMOLECULES, V35, P6142, DOI 10.1021/ma020560d
   Uraki Y, 2004, CARBOHYD POLYM, V58, P123, DOI 10.1016/j.carbpol.2004.05.019
   VENGAL CJ, 2005, TRENDS BIOMATER ARTI, V18, P237
NR 33
TC 100
Z9 109
U1 6
U2 99
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2010
VL 11
IS 4
BP 981
EP 988
DI 10.1021/bm901455p
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 581WW
UT WOS:000276557300020
PM 20187613
DA 2018-10-20
ER

PT J
AU Peng, YY
   Yoshizumi, A
   Danon, SJ
   Glattauer, V
   Prokopenko, O
   Mirochnitchenko, O
   Yu, ZX
   Inouye, M
   Werkmeister, JA
   Brodsky, B
   Ramshawa, JAM
AF Peng, Yong Y.
   Yoshizumi, Ayumi
   Danon, Stephen J.
   Glattauer, Veronica
   Prokopenko, Olga
   Mirochnitchenko, Oleg
   Yu, Zhuoxin
   Inouye, Masayori
   Werkmeister, Jerome A.
   Brodsky, Barbara
   Ramshawa, John A. M.
TI A Streptococcus pyogenes derived collagen-like protein as a
   non-cytotoxic and non-immunogenic cross-linkable biomaterial
SO BIOMATERIALS
LA English
DT Article
DE Recombinant protein; Cell viability; Fibroblast; Immune response;
   Cross-linking
ID GROUP-A STREPTOCOCCUS; TRIPLE-HELIX; I COLLAGEN; EXTRACELLULAR-MATRIX;
   BACILLUS-ANTHRACIS; SURFACE PROTEIN; SCL2 PROTEINS; III COLLAGEN; CELL;
   IDENTIFICATION
AB A range of bacteria have been shown to contain collagen-like sequences that form triple-helical structures. Some of these proteins have been shown to form triple-helical motifs that are stable around body temperature without the inclusion of hydroxyproline or other secondary modifications to the protein sequence. This makes these collagen-like proteins particularly suitable for recombinant production as only a single gene product and no additional enzyme needs to be expressed. In the present study, we have examined the cytotoxicity and immunogenicity of the collagen-like domain from Streptococcus pyogenes Scl2 protein. These data show that the purified, recombinant collagen-like protein is not cytotoxic to fibroblasts and does not elicit an immune response in SJL/J and Arc mice. The freeze dried protein can be stabilised by glutaraldehyde cross-linking giving a material that is stable at >37 degrees C and which supports cell attachment while not causing loss of viability. These data suggest that bacterial collagen-like proteins, which can be modified to include specific functional domains, could be a useful material for medical applications and as a scaffold for tissue engineering. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
C1 [Peng, Yong Y.; Glattauer, Veronica; Werkmeister, Jerome A.; Ramshawa, John A. M.] CSIRO Mol & Hlth Technol, Clayton, Vic 3169, Australia.
   [Yoshizumi, Ayumi; Prokopenko, Olga; Mirochnitchenko, Oleg; Yu, Zhuoxin; Inouye, Masayori; Brodsky, Barbara] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.
   [Danon, Stephen J.] CSIRO Food Sci & Nutr, N Ryde, NSW 2113, Australia.
RP Ramshawa, JAM (reprint author), CSIRO Mol & Hlth Technol, Bayview Ave, Clayton, Vic 3169, Australia.
EM john.ramshaw@csiro.au
RI Glattauer, veronica/A-9435-2018; Ramshaw, John/A-9411-2011; Yu,
   Zhuoxin/L-1512-2013
FU NIH [R21 EB007198]
FX The authors wish to thank Dr Wendy Tian for help with I)SC
   determinations and Teresita Silva for assistance with protein
   preparations. This work was supported in part by NIH grant R21 EB007198
   (B.B.)
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   ADELMANN BC, 1972, IMMUNOLOGY, V23, P723
   Borenfreunds E, 1984, J TISSUE CULTURE MET, V9, P7
   Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005
   Brodsky B, 1995, FASEB J, V9, P1537
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x
   Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200
   Egles C, 2008, J INVEST DERMATOL, V128, P1830, DOI 10.1038/sj.jid.5701240
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Han RL, 2006, APPL MICROBIOL BIOT, V72, P109, DOI 10.1007/s00253-006-0387-5
   Hoe NP, 2007, FEMS MICROBIOL LETT, V277, P142, DOI 10.1111/j.1574-6968.2007.00955.x
   Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Myllyharju Johanna, 2009, V522, P51, DOI 10.1007/978-1-59745-413-1_3
   Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   Peng YY, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015006
   PENG YY, 2009, J BIOMED MAT RES A
   Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984
   Ramshaw JAM, 1996, BIOTECHNOL GENET ENG, V13, P335, DOI 10.1080/02648725.1996.10647934
   RAMSHAW JAM, 2000, HDB BIOMATERIALS ENG, P717
   Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000
   Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200
   Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024
   ROSENBLO.J, 1973, ARCH BIOCHEM BIOPHYS, V158, P478, DOI 10.1016/0003-9861(73)90539-0
   Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003
   SUNDARRAJ N, 1982, BIOCHEM BIOPH RES CO, V106, P48, DOI 10.1016/0006-291X(82)92056-3
   Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200
   Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Vaughan PR, 1998, DNA CELL BIOL, V17, P511, DOI 10.1089/dna.1998.17.511
   Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200
   WERKMEISTER J A, 1990, Clinical Materials, V6, P13, DOI 10.1016/0267-6605(90)90040-3
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
   Werkmeister JA, 2000, HDB BIOMATERIALS ENG, P739
   Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419
   XU C, BIOMACROMOL IN PRESS
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
NR 46
TC 36
Z9 37
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2010
VL 31
IS 10
BP 2755
EP 2761
DI 10.1016/j.biomaterials.2009.12.040
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571TD
UT WOS:000275777800006
PM 20056274
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shachaf, Y
   Gonen-Wadmany, M
   Seliktar, D
AF Shachaf, Yonatan
   Gonen-Wadmany, Maya
   Seliktar, Dror
TI The biocompatibility of Pluronic (R) F127 fibrinogen-based hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Fibrinogen; Fibroblast; Hydrogel; Polyethylene oxide; Pluronic; Scaffold
ID CELL ADHESIVE; TISSUE REGENERATION; SCAFFOLDS; MEDICINE; PROTEOLYSIS;
   MIGRATION; POLYMERS; DESIGN; GROWTH; REPAIR
AB Our research is focused on the design of hydrogel biomaterials that can be used for 3-D cell encapsulation and tissue engineering. In this study, our goal was to engineer a temperature-responsive biomaterial to possess bioactive properties using polymer and protein chemistry, and at the same time provide the biomaterial with susceptibility to cell-mediated remodeling. Toward this goal, we developed a biomimetic material that can harness the bioactive properties of fibrinogen and the unique structural properties of Pluronic (R) F127. Pluronic (R) F127 is a synthetic block copolymer that exhibits reverse thermal gelation (RTG) in response to small changes in ambient temperature. We conjugated fibrinogen to Pluronic (R) F127 to create a biosynthetic precursor with tunable physicochemical properties based on the relationship between the two constituents. A hydrogel matrix was formed from the fibrinogen-F127 adducts by free-radical polymerization using light activation (photo-polymerization). These materials displayed a reversible temperature-induced physical sol-gel transition and an irreversible light-activated chemical cross-linking. The Susceptibility of this hydrogel biomaterial to protease degradation and consequent cell-mediated remodeling was controlled by the Pluronic (R) F127 constituent. The protein-based material also conveyed inductive signals to cells through bioactive sites on the fibrinogen backbone, as well as through structural properties such as the matrix modulus. We apply these materials as a tissue engineering hydrogel scaffold for 3-D in vitro culture of dermal fibroblasts in order to gain a better understanding of how the material bicactivity and matrix properties can independently affect cell Morphology and remodeling. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Shachaf, Yonatan; Gonen-Wadmany, Maya; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Technion, Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Technion, Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Cohn D, 2005, BIOMACROMOLECULES, V6, P1168, DOI 10.1021/bm0495250
   Cohn D, 2003, BIOMATERIALS, V24, P3707, DOI 10.1016/S0142-9612(03)00245-X
   Cohn D, 2007, POLYM ADVAN TECHNOL, V18, P731, DOI 10.1002/pat.961
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Nagarajan R, 1996, J COLLOID INTERF SCI, V184, P489, DOI 10.1006/jcis.1996.0644
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sharma PK, 2004, INT J PHARM, V278, P361, DOI 10.1016/j.ijpharm.2004.03.029
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 27
TC 56
Z9 56
U1 7
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2010
VL 31
IS 10
BP 2836
EP 2847
DI 10.1016/j.biomaterials.2009.12.050
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571TD
UT WOS:000275777800015
PM 20092890
DA 2018-10-20
ER

PT J
AU Minuth, WW
   Denk, L
   Glashauser, A
AF Minuth, Will W.
   Denk, Lucia
   Glashauser, Anne
TI A modular culture system for the generation of multiple specialized
   tissues
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Tissue carrier; Container; Perfusion culture; Gradient
   perfusion culture; Differentiation
ID IN-VITRO MODEL; LONG-TERM CULTURE; ORGANOTYPIC PERFUSION CULTURE;
   DEPENDENT NEURONAL PLASTICITY; COLLECTING DUCT EPITHELIA; BASAL MEDIUM
   GRADIENT; BLOOD-RETINA BARRIER; CELL-CULTURE; STEM-CELLS; ARTIFICIAL
   INTERSTITIUM
AB Numerous factors influence cell functions and tissue development in culture. A modular culture system has been developed to allow the control of many of these important environmental parameters. Optimal adhesion of cells is obtained by selecting an individual biomaterial. Selected specimens are mounted in a tissue carrier in order to protect it against damage during handling and after seeding cells, the carriers can be used in a series of compatible perfusion culture containers. This technique allows the simple bathing of growing tissue under continuous medium transport and the exposure of epithelia to a gradient with different fluids at the luminal and basal sides. A further container is made of transparent material to observe microscopically the developing tissue. In addition, a special model features a flexible silicone lid to apply force to mimic the mechanical load required for developing connective and muscular tissue. Perfusion culture of stem/progenitor cells at the interface of an artificial interstitium made by a polyester fleece results in the spatial development of tubules. During long term culture over weeks the growing tissue is continuously exposed to fresh nutrition and respiratory gas. The medium is transported in a constant flow or in pulses, preventing unstirred layers of fluid. A variety of applications of this modular system, described in this paper, demonstrates that the biological profile of cells and tissues can be strongly improved when perfusion culture with a permanent provision of fresh medium is applied. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Minuth, Will W.; Denk, Lucia; Glashauser, Anne] Univ Regensburg, Dept Mol & Cellular Anat, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Mol & Cellular Anat, Univ Str 31, D-93053 Regensburg, Germany.
EM will.minuth@vkl.uni-regensburg.de
CR AIGNER J, 1995, EPITHELIAL CELL BIOL, V3, P121
   AIGNER J, 1994, EPITHELIAL CELL BIOL, V2, P70
   ANDERS JO, 2009, J BONE JOINT SURG BR, V3, P409
   Bakowsky U, 2005, CURR RES APPL, P157
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Bhadriraju K, 2000, BIOMATERIALS, V21, P267, DOI 10.1016/S0142-9612(99)00175-1
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035
   BLATTMANN A, 2008, BIOMATERIALS, V18, P2749
   Blochl A, 1996, J BIOL CHEM, V271, P21100
   Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446
   BUJIA J, 1994, LARYNGO RHINO OTOL, V73, P577, DOI 10.1055/s-2007-997199
   BUJIA J, 1995, ACTA OTO-LARYNGOL, V115, P307, DOI 10.3109/00016489509139316
   Camps J, 2002, CONNECT TISSUE RES, V43, P396, DOI 10.1080/03008200290001069
   Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279
   Capitan Guarnizo A, 2002, ACTA OTORRINOLARINGO, V53, P631
   Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082
   CHEN DC, 2006, CELLS TISSUES ORGANS, V3, P154
   Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17
   COURNILHENRIONN.C, 2008, BIORHEOLOGY, V3, P513
   DAWSON JI, 2008, BIOMATERIALS, V21, P3105
   DEMERCI M, 2008, DENT MATER, V24, P362
   DETSCH R, 2008, J MATER SCI-MATER M, V4, P1491
   DIMOVA S, 2005, INT J PHARMACEUT, V1, P157
   Dreesmann L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034119
   DU Y, 2008, BIOMATERIALS, V3, P290
   Duda GN, 2004, J BIOMED MATER RES B, V68B, P21, DOI 10.1002/jbm.b.10075
   Duda GN, 2000, J BIOMED MATER RES, V53, P673, DOI 10.1002/1097-4636(2000)53:6<673::AID-JBM9>3.0.CO;2-V
   ELBERG G, 2008, CELL TISSUE RES, V2, P495
   FIEGEL HC, TISSUE ENG, V1, P165
   Flieger A, 2008, J TOXICOL ENV HEAL A, V71, P930, DOI 10.1080/15287390801988939
   Framme C, 2002, OPHTHALMOLOGICA, V216, P320, DOI 10.1159/000066184
   Frerich B, 2008, INT J ORAL MAX SURG, V37, P459, DOI 10.1016/j.ijom.2008.01.014
   Frerich Bernhard, 2006, Head Face Med, V2, P26, DOI 10.1186/1746-160X-2-26
   Fuss M, 2000, ANN ANAT, V182, P303
   Galler K, 2005, J ENDODONT, V31, P396, DOI 10.1097/01.don.0000145428.26880.e5
   GELINSKY M, MAT WERKST, P229
   Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004
   GLAUM R, 2009, J BIOMED MAT RES A
   Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K
   Gueven N, 1996, EUR RESPIR J, V9, P968, DOI 10.1183/09031936.96.09050968
   Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1
   Hamilton RD, 2007, J ANAT, V211, P707, DOI 10.1111/j.1469-7580.2007.00812.x
   Hammer M, 2008, GRAEF ARCH CLIN EXP, V246, P979, DOI 10.1007/s00417-008-0789-4
   HAYASHI M, 2009, MOL CELL BIOCHEM, V1, P1
   Heber S, 2007, TISSUE ENG, V13, P281, DOI 10.1089/ten.2006.0199
   HEINEMANN C, 2009, BIOMACROMOLECULES, V5, P1305
   HEINEMANN C, 2008, BIOMACROMOLECULES, V10, P2913
   HERTER P, 1993, J MICROSC-OXFORD, V171, P107, DOI 10.1111/j.1365-2818.1993.tb03364.x
   HOENER MC, 2000, EUR J NEUROSCI, V9, P3096
   HU K, 2007, BIOTECHNOL J, V8, P992
   HUTMACHER D, INT J ORAL MAXILLOFA, V5, P667
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Jian GE, 2007, FRONT MED-PRC, V1, P6
   Kloth S, 1998, IN VITRO CELL DEV-AN, V34, P515
   Kloth S, 2000, TOXICOL IN VITRO, V14, P265, DOI 10.1016/S0887-2333(00)00010-2
   KLOTH S, 1995, FASEB J, V9, P963
   Kloth S, 1998, KIDNEY INT, V53, P970, DOI 10.1111/j.1523-1755.1998.00854.x
   KLOTH S, 1994, EUR J CELL BIOL, V1, P84
   KLOTH S, 2000, MICROVASC RES, V1, P190
   Kloth S, 1999, BIOFORUM INT, V3, P70
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   Kobuch K, 2008, EXP EYE RES, V86, P661, DOI 10.1016/j.exer.2008.01.011
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   Kremer M, 2001, LANGENBECK ARCH SURG, V386, P357, DOI 10.1007/s004230100227
   LAUER G, 2009, FUNDAMENTALS TISSUE, P375
   Lehmann P, 1997, Mund Kiefer Gesichtschir, V1, P26
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Leukers B, 2005, MATERIALWISS WERKST, V36, P781, DOI 10.1002/mawe.200500968
   LOPEZ JI, 2008, ONCOGENE, V55, P6981
   Maier KL, 2008, INHAL TOXICOL, V20, P319, DOI [10.1080/08958370701866313, 10.1080/08958370701866313 ]
   Masungi C, 2004, J PHARM SCI-US, V93, P2507, DOI 10.1002/jps.20149
   MASUNGI C, 2009, PHARMAZIE, V1, P36
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   MINUTH WW, 1990, CYTOTECHNOLOGY, V4, P181, DOI 10.1007/BF00365099
   MINUTH WW, 1992, KIDNEY INT, V41, P215, DOI 10.1038/ki.1992.30
   Minuth WW, 2005, BIO-MED MATER ENG, V15, P51
   Minuth WW, 2005, BIOMATERIALS, V26, P6588, DOI 10.1016/j.biomaterials.2005.04.029
   Minuth WW, 1997, EXP NEPHROL, V5, P10
   Minuth WW, 2004, CELL PHYSIOL BIOCHEM, V14, P387, DOI 10.1159/000080348
   Minuth WW, 2004, TISSUE ENG, V10, P285, DOI 10.1089/107632704322791925
   MINUTH WW, 1992, EUR J CELL BIOL, V57, P132
   Minuth WW, 2001, J BIOMAT SCI-POLYM E, V12, P353, DOI 10.1163/156856201750180861
   Minuth WW, 1997, EXP NEPHROL, V5, P414
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   Minuth WW, 2008, J EPITHEL BIOL PHARM, V11, P24
   MINUTH WW, 1993, KIDNEY INT, V3, P537
   Minuth WW, 2008, TRANSPLANTATIONSMEDI, V20, P42
   MINUTH WW, 2007, CENTRAL EUROPEAN J B, V2, P3307
   MINUTH WW, 2003, MUNICH MED KLIN, P31
   MINUTH WW, 2009, LANGMUIR, V8, P4621
   MINUTH WW, 1990, 3923279 DEPS
   MINUTH WW, 2007, BIOMATERIALS, V30, P4418
   Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334
   POTTER W, 2008, FRONT BIOSCI, P806
   Prem Caroline, 2000, Methods in Cell Science, V22, P125, DOI 10.1023/A:1009826424171
   Ramsauer M, 1998, J CEREBR BLOOD F MET, V18, P1270, DOI 10.1097/00004647-199811000-00014
   RECUM HA, 1995, BIOMATERIALS, V6, P441
   Reischl J, 1999, CELL TISSUE RES, V296, P371, DOI 10.1007/s004410051297
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Ropke E, 2007, LARYNGO RHINO OTOL, V86, P37, DOI 10.1055/s-2006-945025
   ROESSGER A, 2009, BIOMATERIALS
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Rotter N, 1999, J MATER SCI-MATER M, V10, P689, DOI 10.1023/A:1008912514271
   Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283
   Saikia P, 2006, INVEST OPHTH VIS SCI, V47, P4998, DOI 10.1167/05-1665
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Schmalz G, 1996, J ENDODONT, V22, P249, DOI 10.1016/S0099-2399(06)80142-1
   Schmalz G, 1999, J ENDODONT, V25, P24, DOI 10.1016/S0099-2399(99)80394-X
   Schmalz G, 2002, J ENDODONT, V28, P188, DOI 10.1097/00004770-200203000-00011
   Schmalz G, 2001, J ENDODONT, V27, P96, DOI 10.1097/00004770-200102000-00009
   Schultz O, 1997, ARTHRITIS RHEUM, V40, P1420, DOI 10.1002/art.1780400809
   Schumacher K, 2002, BIOMATERIALS, V23, P805, DOI 10.1016/S0142-9612(01)00186-7
   Schumacher K, 1999, IN VITRO CELL DEV, V8, P465
   Schumacher K, 2007, TISSUE ENG, V13, P197, DOI 10.1089/ten.2006.0046
   Schunemann Holger J, 2002, BMC Pulm Med, V2, P3, DOI 10.1186/1471-2466-2-3
   SEITZ S, 2007, TISSUE ENG, V5, P1059
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Spiegel D, 2002, GRAEF ARCH CLIN EXP, V240, P111, DOI 10.1007/s00417-001-0407-1
   Steiner P, 1997, DIFFERENTIATION, V62, P193
   STERNBERG K, 2004, UROLOGE, V10, P1200
   Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925
   Steuer H, 2004, BRAIN RES PROTOC, V13, P26, DOI 10.1016/j.brainresprot.2003.12.002
   STODDART MJ, 2009, REGEN MED, V1, P81
   Strehl R, 2004, TISSUE ENG, V10, P1196, DOI 10.1089/1076327041887853
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   TIEMANN U, 2005, PROSTAG OTH LIPID M, V1, P35
   Tippe A, 2002, AEROSOL SCI, V33, P2007
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   ULKER HE, 2009, EUR J DENT, V2, P120
   Vajrabhaya L, 2009, ORAL SURG ORAL MED O, V3, pe86
   VIERO C, 2008, CELL CALCIUM, V1, P59
   VOLKMER E, 2008, TISSUE ENG PART A, V8, P1331
   WANG Y, 2003, TISSUE ENG, V6, P1205
   Weinberg N, 2007, DIABETES, V56, P1299, DOI 10.2337/db06-1654
   Xia L, 2009, BIOMATERIALS, V30, P5927, DOI 10.1016/j.biomaterials.2009.07.022
   Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031
   ZHENG W, 2007, BIOL REPROD, V6, P1091
NR 144
TC 6
Z9 7
U1 3
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2010
VL 31
IS 11
BP 2945
EP 2954
DI 10.1016/j.biomaterials.2009.12.048
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 573WR
UT WOS:000275946500001
PM 20096452
DA 2018-10-20
ER

PT J
AU Zaveri, TD
   Dolgova, NV
   Chu, BH
   Lee, JY
   Wong, JE
   Lele, TP
   Ren, F
   Keselowsky, BG
AF Zaveri, Toral D.
   Dolgova, Natalia V.
   Chu, Byung Hwan
   Lee, Jiyeon
   Wong, Joey
   Lele, Tanmay P.
   Ren, Fan
   Keselowsky, Benjamin G.
TI Contributions of surface topography and cytotoxicity to the macrophage
   response to zinc oxide nanorods
SO BIOMATERIALS
LA English
DT Article
DE Nanotopography; Nanotechnology; Foreign body response; Macrophage; Cell
   adhesion
ID CORTICAL NEURONAL DEATH; INTEGRIN BINDING; CELL-ADHESION; FLUORESCENCE
   DETECTION; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; MAMMALIAN-CELLS; ZNO;
   BIOMATERIALS; APOPTOSIS
AB Macrophages associated with implanted biomaterials are primary mediators of chronic inflammation and foreign body reaction to the implant. Hence, various approaches have been investigated to modulate macrophage interactions with biomaterial surfaces to mitigate inflammatory responses. Nanostructured materials possess unique surface properties, and nanotopography has been reported to modulate cell adhesion and viability in a cell type-dependent manner. Zinc oxide (ZnO) has been investigated in a number of biomedical applications and surfaces presenting well-controlled nanorod structures of ZnO have recently been developed. In order to investigate the influence of nanotopography on macrophage adhesive response, we evaluated macrophage adhesion and viability on ZnO nanorods, compared to a relatively flat sputtered ZnO controls and using glass substrates for reference. We found that although macrophages are capable of initially adhering to and spreading on ZnO nanorod substrates, the number of adherent macrophages on ZnO nanorods was reduced compared to ZnO flat substrate and glass. Additionally adherent macrophage number on ZnO flat substrate was reduced as compared to glass. While these data suggest nanotopography may modulate macrophage adhesion, reduced cell viability on both sputtered and nanorod ZnO substrate indicates appreciable toxicity associated with ZnO. Cell death was apparently not apoptotic, given the lack of activated caspase-3 immunostaining. A decrease in viable macrophage numbers when ZnO substrates were present in the same media verified the role of ZnO substrate dissolution, and dissolved levels of Zn in culture media were quantified. In order to determine long-term physiological responses, ZnO nanorod-coated and sputtered ZnO-coated polyethylene terephthalate (PET) discs were implanted subcutaneously in mice for 14 d. Upon implantation, both ZnO-coated discs resulted in a discontinuous cellular fibrous capsule indicative of unresolved inflammation, in contrast to uncoated PET discs, which resulted in typical foreign body capsule formation. In conclusion, although ZnO substrates presenting nanorod topography have previously been shown to modulate cellular adhesion in a topography-dependent fashion for specific cell types, this work demonstrates that for primary murine macrophages, cell adhesion and viability correlate to both nanotopography and toxicity of dissolved Zn, parameters which are likely interdependent. Published by Elsevier Ltd.
C1 [Zaveri, Toral D.; Dolgova, Natalia V.; Keselowsky, Benjamin G.] Univ Florida, Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
   [Chu, Byung Hwan; Lee, Jiyeon; Wong, Joey; Lele, Tanmay P.; Ren, Fan] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
RP Keselowsky, BG (reprint author), Univ Florida, Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
EM bkeselowsky@bme.ufl.edu
OI Zaveri, Toral/0000-0003-0059-9212
FU Arthritis Foundation
FX The authors acknowledge support for this work from the Arthritis
   Foundation in the form of an Arthritis investigator Award to BGK.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2009, BIOMATERIALS, V30, P4168, DOI 10.1016/j.biomaterials.2009.04.032
   Agren M S, 2004, J Wound Care, V13, P367
   Agren MS, 1999, ARCH DERMATOL, V135, P1273, DOI 10.1001/archderm.135.10.1273-a
   Al-Hilli SM, 2007, J APPL PHYS, V102, DOI 10.1063/1.2798582
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bodrumlu E, 2008, AUST ENDOD J, V34, P30, DOI 10.1111/j.1747-4477.2007.00085.x
   Bridges AW, 2008, BIOMATERIALS, V29, P4605, DOI 10.1016/j.biomaterials.2008.08.015
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chu BH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3033407
   CHU P, 2001, CLIN EXP DERMATOL, V25, P16
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   COLYAR M, 2006, ADV NURSE PRACT, V14
   Cunnick J, 2006, J IMMUNOL METHODS, V311, P96, DOI 10.1016/j.jim.2006.01.017
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dorfman A, 2006, LANGMUIR, V22, P4890, DOI 10.1021/la053270+
   Dorfman A, 2006, ADV MATER, V18, P2685, DOI 10.1002/adma.200502616
   Dunn AC, 2007, TRIBOL LETT, V27, P233, DOI 10.1007/s11249-007-9230-0
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gojova A, 2007, ENVIRON HEALTH PERSP, V115, P403, DOI 10.1289/ehp.8497
   Greene LE, 2003, ANGEW CHEM INT EDIT, V42, P3031, DOI 10.1002/anie.200351461
   Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949
   Jeng HA, 2006, J ENVIRON SCI HEAL A, V41, P2699, DOI 10.1080/10934520600966177
   Kang BS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2825574
   Kang BS, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1883330
   Kao WJ, 1999, J MATER SCI-MATER M, V10, P601, DOI 10.1023/A:1008971222932
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kietzmann M, 1999, VET DERMATOL, V10, P83, DOI 10.1046/j.1365-3164.1999.00155.x
   Kim JY, 2009, J BIOMED MATER RES A, V88A, P419, DOI 10.1002/jbm.a.31799
   Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Lee J, 2009, BIOMATERIALS, V30, P4488, DOI 10.1016/j.biomaterials.2009.05.028
   Moriarty P, 2001, REP PROG PHYS, V64, P297, DOI 10.1088/0034-4885/64/3/201
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nohynek GJ, 2007, CRIT REV TOXICOL, V37, P251, DOI 10.1080/10408440601177780
   Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324
   Ren WP, 2008, J BIOMED MATER RES A, V85A, P1043, DOI 10.1002/jbm.a.31665
   SCHEDLE A, 1995, J DENT RES, V74, P1513, DOI 10.1177/00220345950740081301
   Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000
   STANLEY ER, 1997, MURINE BONE MARROW D, P301
   Sun XW, 1999, J APPL PHYS, V86, P408, DOI 10.1063/1.370744
   TARNOW P, 1994, SCAND J PLAST RECONS, V28, P255, DOI 10.3109/02844319409022008
   TOMIDA M, 1984, J BIOL CHEM, V259, P978
   WATAHA JC, 1995, DENT MATER, V11, P239, DOI 10.1016/0109-5641(95)80056-5
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202
NR 57
TC 84
Z9 85
U1 1
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2010
VL 31
IS 11
BP 2999
EP 3007
DI 10.1016/j.biomaterials.2009.12.055
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 573WR
UT WOS:000275946500006
PM 20074795
DA 2018-10-20
ER

PT J
AU You, ZW
   Cao, HP
   Gao, J
   Shin, PH
   Day, BW
   Wang, YD
AF You, Zhengwei
   Cao, Haiping
   Gao, Jin
   Shin, Paul H.
   Day, Billy W.
   Wang, Yadong
TI A functionalizable polyester with free hydroxyl groups and tunable
   physiochemical and biological properties
SO BIOMATERIALS
LA English
DT Article
DE Functionalizable polyester; Elastomer
ID RING-OPENING POLYMERIZATION; POLY(GLYCEROL SEBACATE); BIODEGRADABLE
   POLYMERS; ALIPHATIC POLYESTERS; MECHANICAL-PROPERTIES; GLYCIDYL ESTERS;
   PENDANT GROUPS; DRUG-DELIVERY; IN-VITRO; TISSUE
AB Polyesters with free functional groups allow facile modifications with biomolecules, which can lead to versatile biomaterials that afford controlled interactions with cells and tissues. Efficient synthesis of functionalizable polyesters (Functionalizable polymer is defined as a polymer with functional groups that readily react with biomolecules and functionalized biomaterial as one already modified with biomolecules.) is still a challenge that greatly limits the availability and widespread applications of biofunctionalized synthetic polymers. Here we report a simple route to prepare a functionalizable polyester, poly(sebacoyl diglyceride) (PSeD) bearing free hydroxyl groups. The key synthetic step is an epoxide ring-opening polymerization, instead of the traditional polycondensation that produces poly(glycerol sebacate) (PGS) (Wang YD, Ameer GA, Sheppard BJ, Langer R. A tough biodegradable elastomer. Nat Biotechnol 2002;20(6):602-6). PSeD has a more defined structure with mostly linear backbone, more free hydroxyl groups, higher molecular weight, and lower polydispersity than PGS. Crosslinking PSeD with sebacic acid yields a polymer five times tougher and more elastic than cured PGS. PSeD exhibits good cytocompatibility in vitro. Furthermore, functionalization by glycine proceeds with high efficiency. This versatile synthetic platform can offer a large family of biodegradable, functionalized polymers with tunable physiochemical and biological properties useful for a wide range of biomedical applications. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [You, Zhengwei; Gao, Jin; Shin, Paul H.; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [You, Zhengwei; Gao, Jin; Shin, Paul H.; Wang, Yadong] Univ Pittsburgh, McGowan Inst, Pittsburgh, PA 15219 USA.
   [Cao, Haiping; Day, Billy W.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15213 USA.
   [Day, Billy W.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15213 USA.
RP Wang, YD (reprint author), Univ Pittsburgh, Dept Bioengn, 300 Technol Dr, Pittsburgh, PA 15219 USA.
EM yaw20@pitt.edu
OI Wang, Yadong/0000-0003-2067-382X; Gao, Jin/0000-0002-6200-4141
FU NHLBI [R01HL 089658]
FX The authors are grateful for the financial support from NHLBI R01HL
   089658.
CR Albertsson A.-C., 2002, ADV POLYM SCI, P1
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001
   Deng C, 2007, J POLYM SCI POL CHEM, V45, P3218, DOI 10.1002/pola.22071
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gao J, 2008, J BIOMED MATER RES A, V85A, P1120, DOI 10.1002/jbm.a.32028
   Gao J, 2007, J BIOMED MATER RES A, V83A, P1070, DOI 10.1002/jbm.a.31434
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   Gerhardt WW, 2006, BIOMACROMOLECULES, V7, P1735, DOI 10.1021/bm060024j
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747
   Hao QH, 2005, BIOMACROMOLECULES, V6, P3474, DOI 10.1021/bm050317x
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Jerome C, 2008, ADV DRUG DELIVER REV, V60, P1056, DOI 10.1016/j.addr.2008.02.008
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kallinteri P, 2005, BIOMACROMOLECULES, V6, P1885, DOI 10.1021/bm049200j
   Kester EB, 1943, J ORG CHEM, V8, P550, DOI 10.1021/jo01194a010
   Kline BJ, 1998, J AM CHEM SOC, V120, P9475, DOI 10.1021/ja9808907
   Kumar A, 2003, MACROMOLECULES, V36, P8219, DOI 10.1021/ma0351827
   Kwon GS, 1996, ADV DRUG DELIVER REV, V21, P107, DOI 10.1016/S0169-409X(96)00401-2
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V920, P260
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lecomte P, 2006, MACROMOL SYMP, V240, P157, DOI 10.1002/masy.200650820
   LEE MC, 1992, J BIOMECH, V25, P925, DOI 10.1016/0021-9290(92)90232-P
   Leemhuis M, 2006, MACROMOLECULES, V39, P3500, DOI 10.1021/ma052128c
   Liu QY, 2007, J APPL POLYM SCI, V104, P1131, DOI 10.1002/app.25606
   Liu QY, 2005, J APPL POLYM SCI, V98, P2033, DOI 10.1002/app.22397
   LIU QY, 2009, BIOMEDICAL MAT, V4, P9
   MAERKER G, 1961, J ORG CHEM, V26, P2681, DOI 10.1021/jo01066a018
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   NISHIKUBO T, 1993, PROG POLYM SCI, V18, P963, DOI 10.1016/0079-6700(93)90023-6
   Noga DE, 2008, BIOMACROMOLECULES, V9, P2056, DOI 10.1021/bm800292Z
   Parrish B., 2006, ACS SYM SER, V939, P248, DOI [10.102Ubk-2006-0939.ch016, DOI 10.102UBK-2006-0939.CH016]
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   POIRIER Y, 1995, BIO-TECHNOL, V13, P142, DOI 10.1038/nbt0295-142
   Ponsart S, 2000, BIOMACROMOLECULES, V1, P275, DOI 10.1021/bm005521t
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Sales VL, 2007, CIRCULATION, V116, P155
   Studer P, 2008, EUR POLYM J, V44, P1714, DOI 10.1016/j.eurpolymj.2008.04.003
   Taniguchi I, 2006, POLYM INT, V55, P1385, DOI 10.1002/pi.2139
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Williams CK, 2007, CHEM SOC REV, V36, P1573, DOI 10.1039/b614342n
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
   Zhang SP, 2003, BIOMACROMOLECULES, V4, P437, DOI 10.1021/bm0201183
   Zimmermann WH, 2008, NAT MATER, V7, P932, DOI 10.1038/nmat2328
NR 62
TC 65
Z9 70
U1 7
U2 88
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2010
VL 31
IS 12
BP 3129
EP 3138
DI 10.1016/j.biomaterials.2010.01.023
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 576EB
UT WOS:000276126000002
PM 20149441
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hozumi, K
   Otagiri, D
   Yamada, Y
   Sasaki, A
   Fujimori, C
   Wakai, Y
   Uchida, T
   Katagiri, F
   Kikkawa, Y
   Nomizu, M
AF Hozumi, Kentaro
   Otagiri, Dai
   Yamada, Yuji
   Sasaki, Ayano
   Fujimori, Chikara
   Wakai, Yuki
   Uchida, Tatsuya
   Katagiri, Fumihiko
   Kikkawa, Yamato
   Nomizu, Motoyoshi
TI Cell surface receptor-specific scaffold requirements for adhesion to
   laminin-derived peptide-chitosan membranes
SO BIOMATERIALS
LA English
DT Article
DE Scaffold; Peptide; Chitin/chitosan; Integrin; ECM (extracellular
   matrix); Cell adhesion
ID CHAIN-G-DOMAIN; ALPHA-1 CHAIN; REGENERATIVE MEDICINE;
   BIOLOGICAL-ACTIVITIES; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES; BINDING
   SEQUENCES; TISSUE; IDENTIFICATION; SYSTEMS
AB Scaffolds are used for bioengineering to regulate cellular functions. Previously, we developed laminin-derived peptide-conjugated chitosan membranes for cell engineering. Here, we determined whether changes in the chitosan scaffold altered the cellular response. When an alpha v beta 3 integrin-binding peptide A99a (ALRGDN) was conjugated on chitosan membranes of varying density (1.5-1500 ng/mm(2)), cell adhesion was altered depending on the amount of chitosan. 3 or 30 ng/mm(2) of the A99a-chitosan membrane effectively promoted cell attachment, cell spreading with well-organized actin stress fibers, phosphorylation of FAK Tyr397, and neurite outgrowth. In contrast, syndecan-binding peptide AG73 (RKRLQVQLSIRT) conjugated chitosan membranes density (1.5-1500 ng/mm(2)) promoted similar biological activities at all of the concentrations tested. These results suggest that integrin-mediated cell adhesion is sensitive to the scaffold condition. To improve the function of integrin-mediated biological activities on a large amount of scaffold, we designed an A99a/AG73 mixed peptide-chitosan membrane. The mixed peptide-chitosan membrane promoted the strongest biological activities at 150-1500 ng/mm(2) of chitosan membrane. We conclude that the A99a/AG73 mixed peptide-chitosan membrane effectively interacts with both integrins and syndecans and is a useful multi-functional biomaterial. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Hozumi, Kentaro; Otagiri, Dai; Yamada, Yuji; Sasaki, Ayano; Fujimori, Chikara; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan.
   [Wakai, Yuki; Uchida, Tatsuya] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Environm Chem Lab, Tokyo 1920392, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
RI Kikkawa, Yamato/D-1503-2010
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [17390024, 17014081, 21750174]
FX This work was supported by Grants-in-Aid for Scientific Research from
   the Ministry of Education, Cultures, Sports, Science and Technology of
   Japan (17390024, 17014081, and 21750174).
CR Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Cardenas G, 2008, J MATER SCI-MATER M, V19, P2397, DOI 10.1007/s10856-007-3275-3
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802
   Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x
   McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
NR 35
TC 30
Z9 30
U1 2
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2010
VL 31
IS 12
BP 3237
EP 3243
DI 10.1016/j.biomaterials.2010.01.043
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 576EB
UT WOS:000276126000013
PM 20122724
DA 2018-10-20
ER

PT J
AU Hashizume, R
   Fujimoto, KL
   Hong, Y
   Amoroso, NJ
   Tobita, K
   Miki, T
   Keller, BB
   Sacks, MS
   Wagner, WR
AF Hashizume, Ryotaro
   Fujimoto, Kazuro L.
   Hong, Yi
   Amoroso, Nicholas J.
   Tobita, Kimimasa
   Miki, Toshio
   Keller, Bradley B.
   Sacks, Michael S.
   Wagner, William R.
TI Morphological and mechanical characteristics of the reconstructed rat
   abdominal wall following use of a wet electrospun biodegradable
   polyurethane elastomer scaffold
SO BIOMATERIALS
LA English
DT Article
DE Abdomen; Animal model; Biodegradation; Elastomer; Mechanical properties
ID ACELLULAR DERMAL MATRIX; VENTRAL HERNIA REPAIR; SMOOTH-MUSCLE;
   POLYPROPYLENE MESHES; PROSTHETIC MESHES; DEFECTS; MANAGEMENT; MODEL;
   FABRICATION; LIGHTWEIGHT
AB Although a variety of materials are currently used for abdominal wall repair, general complications encountered include herniation, infection, and mechanical mismatch with native tissue. An approach wherein a degradable synthetic material is ultimately replaced by tissue mechanically approximating the native state could obviate these complications. We report here on the generation of biodegradable scaffolds for abdominal wall replacement using a wet electrospinning technique in which fibers of a biodegradable elastomer, poly(ester urethane)urea (PEUU), were concurrently deposited with electrosprayed serum-based culture medium. Wet electrospun PEUU (wet ePEUU) was found to exhibit markedly different mechanical behavior and to possess an altered microstructure relative to dry processed ePEUU. In a rat model for abdominal wall replacement, wet ePEUU scaffolds (1 x 2.5 cm) provided a healing result that developed toward approximating physiologic mechanical behavior at 8 weeks. An extensive cellular infiltrate possessing contractile smooth muscle markers was observed together with extensive extracellular matrix (collagens, elastin) elaboration. Control implants of dry ePEUU and expanded polytetrafluoroethylene did not experience substantial cellular infiltration and did not take on the native mechanical anisotropy of the rat abdominal wall. These results illustrate the markedly different in vivo behavior observed with this newly reported wet electrospinning process, offering a potentially useful refinement of an increasingly common biomaterial processing technique. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Hashizume, Ryotaro; Fujimoto, Kazuro L.; Hong, Yi; Amoroso, Nicholas J.; Miki, Toshio; Sacks, Michael S.; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Hashizume, Ryotaro; Fujimoto, Kazuro L.; Hong, Yi; Miki, Toshio; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
   [Amoroso, Nicholas J.; Sacks, Michael S.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Tobita, Kimimasa; Keller, Bradley B.] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI Sacks, Michael/F-3703-2011; Amoroso, Nicholas/G-8093-2011
OI Amoroso, Nicholas/0000-0003-4659-5604; Miki, Toshio/0000-0001-5546-6770
FU Armed Forces Institute for Regenerative Medicine (AFIRM)
   [W81XWH-08-2-0032]; NIH [R01 HL-068816]
FX This study was supported by the Armed Forces Institute for Regenerative
   Medicine (AFIRM) (grant# W81XWH-08-2-0032). The authors thank Jennifer
   Debarr and Amanda Farkas for their help with tissue histological
   assessment, Li Liu and Crescenzio F. Minervini for their technical
   assistance, and Joseph Tinney for animal care. NJA and MSS were
   supported by NIH R01 HL-068816.
CR Becker S, 2009, PLAST RECONSTR SURG, V123, P1, DOI 10.1097/PRS.0b013e3181904bff
   Bellon JM, 2009, J BIOMED MATER RES B, V89B, P448, DOI 10.1002/jbm.b.31234
   Bellon JM, 2007, AM J SURG, V194, P68, DOI 10.1016/j.amjsurg.2006.11.016
   Bellon JM, 2007, J LAPAROENDOSC ADV S, V17, P160, DOI 10.1089/lap.2006.0028
   Bir SC, 2009, J VASC SURG, V50, P870, DOI 10.1016/j.jvs.2009.06.016
   Campanelli G, 2004, Hernia, V8, P190
   Campanelli G, 2008, WORLD J EMERG SURG, V3, DOI 10.1186/1749-7922-3-33
   Candage R, 2008, SURGERY, V144, P703, DOI 10.1016/j.surg.2008.06.018
   Catena F, 2007, Hernia, V11, P57, DOI 10.1007/s10029-006-0171-6
   Cobb William S, 2005, Surg Innov, V12, P63, DOI 10.1177/155335060501200109
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   D'Addario SF, 2002, J CUTAN PATHOL, V29, P426, DOI 10.1034/j.1600-0560.2002.290707.x
   De Santis Luigi, 2003, Acta Biomed, V74 Suppl 2, P34
   DuBay DA, 2005, SURGERY, V137, P463, DOI 10.1016/j.surg.2004.12.016
   Dubay DA, 2007, ANN SURG, V245, P140, DOI 10.1097/01.sla.0000251267.11012.85
   Dubay DA, 2006, SURGERY, V140, P14, DOI 10.1016/j.surg.2006.01.007
   El-Kurdi MS, 2008, BIOMATERIALS, V29, P3213, DOI 10.1016/j.biomaterials.2008.04.009
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Horan RL, 2009, HERNIA, V13, P189, DOI 10.1007/s10029-008-0459-9
   Jernigan TW, 2003, ANN SURG, V238, P349, DOI 10.1097/01.sla.0000086544.42647.84
   Lai PH, 2005, J SURG RES, V127, P85, DOI 10.1016/j.jss.2005.03.016
   Lipman J, 2008, AM J SURG, V195, P84, DOI 10.1016/j.amjsurg.2007.02.017
   Morris-Stiff GJ, 1998, J AM COLL SURGEONS, V186, P352, DOI 10.1016/S1072-7515(98)00002-7
   Natale F, 2006, CURR OPIN UROL, V16, P407, DOI 10.1097/01.mou.0000250280.29743.54
   O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833
   Ott R, 2007, LANGENBECK ARCH SURG, V392, P473, DOI 10.1007/s00423-006-0080-2
   Patton JH, 2007, AM J SURG, V193, P360, DOI 10.1016/j.amjsurg.2006.09.021
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   Saettele T M, 2007, Hernia, V11, P279, DOI 10.1007/s10029-006-0186-z
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Sergent F, 2009, EUR J OBSTET GYN R B, V147, P106, DOI 10.1016/j.ejogrb.2009.07.019
   Sriussadaporn S, 2006, ASIAN J SURG, V29, P1, DOI 10.1016/S1015-9584(09)60284-0
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Stankus JJ, 2008, J BIOMAT SCI-POLYM E, V19, P635, DOI 10.1163/156856208784089599
   Stankus JJ, 2007, BIOMATERIALS, V28, P2738, DOI 10.1016/j.biomaterials.2007.02.012
   Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029
   Vertrees A, 2008, J AM COLL SURGEONS, V207, P801, DOI 10.1016/j.jamcollsurg.2008.08.014
   Welty G, 2001, Hernia, V5, P142
   Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0
   Yokoyama Y, 2009, MATER LETT, V63, P754, DOI 10.1016/j.matlet.2008.12.042
NR 43
TC 46
Z9 48
U1 7
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2010
VL 31
IS 12
BP 3253
EP 3265
DI 10.1016/j.biomaterials.2010.01.051
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 576EB
UT WOS:000276126000015
PM 20138661
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ghanaati, SM
   Thimm, BW
   Unger, RE
   Orth, C
   Kohler, T
   Barbeck, M
   Muller, R
   Kirkpatrick, CJ
AF Ghanaati, Shahram M.
   Thimm, Benjamin W.
   Unger, Ronald E.
   Orth, Carina
   Kohler, Thomas
   Barbeck, Mike
   Mueller, Ralph
   Kirkpatrick, C. James
TI Collagen-embedded hydroxylapatite-beta-tricalcium phosphate-silicon
   dioxide bone substitute granules assist rapid vascularization and
   promote cell growth
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID FOREIGN-BODY REACTION; IN-VIVO; ENDOTHELIAL-CELLS; OSTEOBLAST PHENOTYPE;
   CONNECTIVE TISSUE; ADSORBED PROTEINS; BIOACTIVE GLASS; HYDROXYAPATITE;
   DIFFERENTIATION; BIOMATERIALS
AB In the present study we assessed the biocompatibility in vitro and in vivo of a low-temperature sol-gel-manufactured SiO2-based bone graft substitute. Human primary osteoblasts and the osteoblastic cell line, MG63, cultured on the SiO2 biomatrix in monoculture retained their osteoblastic morphology and cellular functionality in vitro. The effect of the biomaterial in vivo and its vascularization potential was tested subcutaneously in Wistar rats and demonstrated both rapid vascularization and good integration within the peri-implant tissue. Scaffold degradation was progressive during the first month after implantation, with tartrate-resistant acid phosphatase-positive macrophages being present and promoting scaffold degradation from an early stage. This manuscript describes successful osteoblastic growth promotion in vitro and a promising biomaterial integration and vasculogenesis in vivo for a possible therapeutic application of this biomatrix in future clinical studies.
C1 [Ghanaati, Shahram M.; Thimm, Benjamin W.; Unger, Ronald E.; Orth, Carina; Barbeck, Mike; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   [Thimm, Benjamin W.; Kohler, Thomas; Mueller, Ralph] ETH, Inst Biomech, CH-8093 Zurich, Switzerland.
RP Ghanaati, SM (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM ghanaati@uni-mainz.de
RI Thimm, Benjamin/G-7410-2012; Muller, Ralph/A-1198-2008
OI Muller, Ralph/0000-0002-5811-7725; Barbeck, Mike/0000-0002-3001-1347
FU BMBF [0313405C]
FX This work was supported by a BMBF grant no 0313405C. The authors thank
   DOT GmbH, Rostock, Germany, for their generous supply of BONITmatrix
   (R)-collagen scaffolds. Thanks also go to Mrs A Sartoris, Mrs B Pavic,
   Mr B Bondar and Mr R Tsaryk, for technical assistance. They are also
   grateful to Ms M Muller and Ms K Molter for their documentation of the
   scanning electron microscope micrographs.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JS, 1987, SURGERY, V101, P577
   Arrington E D, 1996, Clin Orthop Relat Res, P300, DOI 10.1097/00003086-199608000-00037
   ASAHINA I, 1999, BONE ENG, P526
   BECKER P, 2004, BIOMATERIALIEN, P10
   Bienengraber V, 2004, MATERIALWISS WERKST, V35, P234, DOI 10.1002/mawe.200400733
   BOTTCHER R, 2004, BONITMATRIX ALS OPTI
   CANNON GJ, 1992, J CELL SCI, V101, P907
   Carmeliet G, 1997, J BONE MINER RES, V12, P786, DOI 10.1359/jbmr.1997.12.5.786
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   CLEZARDIN P, 1988, EUR J BIOCHEM, V175, P275, DOI 10.1111/j.1432-1033.1988.tb14194.x
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DUMITRIU S, 2001, POLYM BIOMATERIALS R, P430
   Erbe EM, 2001, EUR SPINE J, V10, pS141, DOI 10.1007/s005860100287
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   GERBER T, 2001, OSTEOLOGIE, V10, P175
   Ghanaati S, 2008, TISSUE ENG PT A, V14, P917
   GHANAATI S, 2009, J REGENERATIVE MED, V4, P182
   GHANAATI S, 2008, BIOMATERIALIEN, V9, P90
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Henkel K-O, 2004, Mund Kiefer Gesichtschir, V8, P277, DOI 10.1007/s10006-004-0561-9
   HENKEL KO, 2004, OSTEOLOGIE, V13, P57
   HOPP M, 2005, IMPLANTOLOGIE, V13, P301
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   JAY SM, 2009, J BIOMED MAT RES A
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Kanaan RA, 2006, MED SCI MONITOR, V12, pRA164
   KASPERK C, 1988, INT J ORAL MAX SURG, V17, P319
   LEHNINGER A, 1987, PRINZIPIEN BIOCH, P298
   LI P, 1994, J BIOMED MATER RES, V7, P28
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877
   McAndrew M P, 1988, J Orthop Trauma, V2, P333, DOI 10.1097/00005131-198802040-00011
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003
   MOVAT HZ, 1955, ARCH PATHOL, V60, P289
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   NYSTROM E, 1995, INT J ORAL MAX SURG, V24, P20, DOI 10.1016/S0901-5027(05)80851-3
   Parikh S N, 2002, J Postgrad Med, V48, P142
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   RATNER B, 1997, BIOMATERIALS SCI INT, P170
   RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85
   ROMBERG RW, 1985, J BIOL CHEM, V260, P2728
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Sun JS, 1997, BIOMATERIALS, V18, P683, DOI 10.1016/S0142-9612(96)00183-4
   SWEAT F, 1964, ARCH PATHOL, V78, P69
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   TERMINE JD, 1988, CIBA F SYMP, V136, P178
   Thimm BW, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015007
   Traykova T, 2004, KEY ENG MAT, V254-2, P679, DOI 10.4028/www.scientific.net/KEM.254-256.679
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   von Wilmowsky C, 2008, J BIOMED MATER RES A, V87A, P896, DOI 10.1002/jbm.a.31822
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xu WG, 2009, J BIOMED MATER RES B, V91B, P692, DOI 10.1002/jbm.b.31445
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   ZHU XD, 2009, ACTA BIOMATER
NR 63
TC 25
Z9 25
U1 0
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2010
VL 5
IS 2
AR 025004
DI 10.1088/1748-6041/5/2/025004
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 575DY
UT WOS:000276048000006
PM 20208127
DA 2018-10-20
ER

PT J
AU Li, XM
   Fan, YB
   Watari, F
AF Li, Xiaoming
   Fan, Yubo
   Watari, Fumio
TI Current investigations into carbon nanotubes for biomedical application
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID CHITIN FIBERS; CALCIUM-PHOSPHATE; NEURONAL GROWTH; GENE-THERAPY;
   PULMONARY TOXICITY; IN-VITRO; TISSUE; CELLS; BONE; SCAFFOLDS
AB The nano-dimensionality of nature has logically given rise to the interest in using nanomaterials in the biomedical field. Currently, a lot of investigations into carbon nanotubes (CNTs), as one of the typical nanomaterials, are being made for biomedical application. In this review, five parts, such as cellular functions induced by CNTs, apatite formation on CNTs, CNT-based tissue engineering scaffold, functionalized CNTs for the delivery of genes and drugs and CNT-based biosensors, are stated, which might indicate that CNTs, with a range of unique properties, appear suited as a biomaterial and may become a useful tool for tissue engineering. However, everything has two parts and CNTs is not an exception. There are still concerns about cytotoxicity and biodegradation of CNTs. Chemical fictionalization may be one of the effective ways to improve the 'disadvantages' and utilize the 'advantages' of CNTs. One of their 'disadvantages', unbiodegradable property, may be utilized by creating monitors in in vivo-engineered tissues or nanosized CNT-based biosensors. Other promising research points, for example proteins adsorbed on CNTs, use of CNTs in combination with other biomaterials to achieve the goals of tissue engineering, mineralization of CNTs and standard toxicological tests for CNTs, are also described in the conclusion and perspectives part.
C1 [Li, Xiaoming; Fan, Yubo] Beihang Univ, Key Lab Biomech & Mechanobiol, Minist Educ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
   [Watari, Fumio] Hokkaido Univ, Grad Sch Dent Med, Dept Biomed Mat & Engn, Sapporo, Hokkaido 0608586, Japan.
RP Li, XM (reprint author), Beihang Univ, Key Lab Biomech & Mechanobiol, Minist Educ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China.
EM x.m.li@hotmail.com
FU National Natural Science Foundation of China (NSFC) [10925208]; Beihang
   University [211104]
FX The authors acknowledge the financial support from the National Natural
   Science Foundation of China (NSFC, 10925208) and Beihang University
   (211104).
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Akasaka T, 2006, MAT SCI ENG C-BIO S, V26, P675, DOI 10.1016/j.msec.2005.03.009
   Akasaka T, 2005, CHEM LETT, V34, P826, DOI 10.1246/cl.2005.826
   Allen BL, 2008, NANO LETT, V8, P3899, DOI 10.1021/nl802315h
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Aoki N, 2006, CHEM LETT, V35, P508, DOI 10.1246/cl.2006.508
   Baker SE, 2002, NANO LETT, V2, P1413, DOI 10.1021/nl025729f
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Bianco A, 2005, J AM CHEM SOC, V127, P58, DOI 10.1021/ja044293y
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s
   Chen X, 2004, ANGEW CHEM INT EDIT, V43, P6111, DOI 10.1002/anie.200460620
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Cui DX, 2007, J NANOSCI NANOTECHNO, V7, P1298, DOI 10.1166/jnn.2007.654
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Davis JJ, 1997, J ELECTROANAL CHEM, V440, P279, DOI 10.1016/S0022-0728(97)00425-7
   Davis JJ, 1998, INORG CHIM ACTA, V272, P261, DOI 10.1016/S0020-1693(97)05926-4
   Davis JJ, 2003, CHEM-EUR J, V9, P3732, DOI 10.1002/chem.200304872
   Dumortier H, 2006, NANO LETT, V6, P1522, DOI 10.1021/nl061160x
   Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031
   Firkowska I, 2006, LANGMUIR, V22, P5427, DOI 10.1021/la053067e
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Gao M, 2003, ELECTROANAL, V15, P1089, DOI 10.1002/elan.200390131
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hrapovic S, 2004, ANAL CHEM, V76, P1083, DOI 10.1021/ac035143t
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k
   Labhasetwar V, 2005, J BIOMED NANOTECHNOL, V1, P373, DOI 10.1166/jbn.2005.058
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Li XM, 2009, J BIOMED MATER RES A, V91A, P132, DOI 10.1002/jbm.a.32203
   Li XM, 2009, J BIOMED MATER RES B, V90B, P503, DOI 10.1002/jbm.b.31311
   Li XM, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015005
   Li XM, 2008, BONE, V43, pS111, DOI 10.1016/j.bone.2008.07.134
   Li XM, 2008, BONE, V43, pS94, DOI 10.1016/j.bone.2008.07.185
   Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062
   Li XM, 2006, J BIOMED MATER RES B, V77B, P219, DOI 10.1002/jbm.b.30425
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   Li XM, 2005, MATER SCI FORUM, V475-479, P2387, DOI 10.4028/www.scientific.net/MSF.475-479.2387
   Li XM, 2005, POLYM BULL, V54, P47, DOI 10.1007/s00289-005-0364-7
   Li XM, 2005, POLYM INT, V54, P1034, DOI [10.1002/pi.1804, 10.1002/pi.l804]
   Li Y, 2008, BIOMATERIALS, V29, P2025, DOI 10.1016/j.biomaterials.2008.01.009
   Liao S, 2007, ACTA BIOMATER, V3, P669, DOI [10.1016/j.actbio.2007.03.007, 10.1016/j.aetbio.2007.03.007]
   Lin YH, 2004, NANO LETT, V4, P191, DOI 10.1021/nl0347233
   LIU XH, 2010, J BIOMED MATER RES B
   Lu Q, 2004, NANO LETT, V4, P2473, DOI 10.1021/nl048326j
   Lucente-Schultz RM, 2009, J AM CHEM SOC, V131, P3934, DOI 10.1021/ja805721p
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mwenifumbo S, 2007, J MATER CHEM, V17, P1894, DOI 10.1039/b617708e
   Nabel GJ, 2004, NAT MED, V10, P135, DOI 10.1038/nm990
   Nguyen CV, 2002, NANO LETT, V2, P1079, DOI 10.1021/nl025689f
   Niidome T, 2002, GENE THER, V9, P1647, DOI 10.1038/sj.gt.3301923
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Park GE, 2005, J BIOMED NANOTECHNOL, V1, P18, DOI 10.1166/jbn.2005.003
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Rubianes MD, 2003, ELECTROCHEM COMMUN, V5, P689, DOI 10.1016/S1388-2481(03)00168-1
   Schmidt-Wolf GD, 2003, TRENDS MOL MED, V9, P67, DOI 10.1016/S1471-4914(03)00005-4
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Strano MS, 2004, NANO LETT, V4, P543, DOI 10.1021/nl034937k
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Terada M, 2009, DENT MATER J, V28, P82, DOI 10.4012/dmj.28.82
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Thordarson P, 2006, APPL MICROBIOL BIOT, V73, P243, DOI 10.1007/s00253-006-0574-4
   Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113
   Wang J, 2003, ANALYST, V128, P1382, DOI 10.1039/b309928h
   Wang J, 2003, J AM CHEM SOC, V125, P2408, DOI 10.1021/ja028951v
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Wei W, 2007, J NANOSCI NANOTECHNO, V7, P1284, DOI 10.1166/jnn.2007.655
   Yang WR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/412001
   Ye JS, 2004, ELECTROCHEM COMMUN, V6, P66, DOI 10.1016/j.elecom.2003.10.013
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877
   Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911
NR 86
TC 84
Z9 87
U1 4
U2 84
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2010
VL 5
IS 2
AR 022001
DI 10.1088/1748-6041/5/2/022001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 575DY
UT WOS:000276048000002
PM 20339169
DA 2018-10-20
ER

PT J
AU Ma, YX
   Zheng, YD
   Huang, XS
   Xi, TF
   Lin, XD
   Han, DF
   Song, WH
AF Ma, Yanxuan
   Zheng, Yudong
   Huang, Xiaoshan
   Xi, Tingfei
   Lin, Xiaodan
   Han, Dongfei
   Song, Wenhui
TI Mineralization behavior and interface properties of BG-PVA/bone
   composite implants in simulated body fluid
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID POLYVINYL-ALCOHOL-HYDROGEL; ARTIFICIAL ARTICULAR-CARTILAGE;
   PVA-HYDROGEL; IN-VIVO; MENISCUS; LUBRICATION; REPLACEMENT; THICKNESS;
   FRICTION; BIOGLASS
AB Due to the non-bioactivity and poor conjunction performance of present cartilage prostheses, the main work here is to develop the bioactive glass-polyvinyl alcohol hydrogel articular cartilage/bone (BG-PVA/bone) composite implants. The essential criterion for a biomaterial to bond with living bone is well-matched mechanical properties as well as biocompatibility and bioactivity. In vitro studies on the formation of a surface layer of carbonate hydroxyl apatite (HCA) and the corresponding variation of the properties of biomaterials are imperative for their clinical application. In this paper, the mineralization behavior and variation of the interface properties of BG-PVA/bone composites were studied in vitro by using simulated body fluid (SBF). The mineralization and HCA layer formed on the interface between the BG-PVA hydrogel and bone in SBF could provide the composites with bioactivity and firmer combination. The compression property, shear strength and interface morphology of BG-PVA/bone composite implants varying with the immersion time in SBF were characterized. Also, the influence laws of the immersion time, content of BG in the composites and aperture of bones to the mineralization behavior and interface properties were investigated. The good mineralization behavior and enhanced conjunction performance of BG-PVA/bone composites demonstrated that this kind of composite implant might be more appropriate cartilage replacements.
C1 [Ma, Yanxuan; Zheng, Yudong; Huang, Xiaoshan; Xi, Tingfei; Han, Dongfei] Beijing Univ Sci & Technol, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Lin, Xiaodan] S China Univ Technol, Coll Mat Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China.
   [Song, Wenhui] Brunel Univ, Sch Engn & Design, Wolfson Ctr Mat Proc, London UB8 3PH, England.
RP Zheng, YD (reprint author), Beijing Univ Sci & Technol, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
EM zhengyudong@mater.ustb.edu.cn; wenhui.song@brunel.ac.uk
RI Song, Wenhui/M-9661-2013
OI Song, Wenhui/0000-0001-8406-472X
FU National Natural Science Foundation of China [50773004]; National
   Exemplary Center for Experimental Teaching of China
FX This study was financially supported by National Natural Science
   Foundation of China Project (grant no 50773004) and National Exemplary
   Center for Experimental Teaching of China.
CR Auger D D, 1995, Proc Inst Mech Eng H, V209, P73, DOI 10.1243/PIME_PROC_1995_209_323_02
   Balamurugan A, 2006, MATER LETT, V60, P3752, DOI 10.1016/j.matlet.2006.03.102
   Balamurugan A, 2007, ACTA BIOMATER, V3, P255, DOI 10.1016/j.actbio.2006.09.005
   BAO QB, 1991, Patent No. 5047055
   BURILLO G, 1980, MAKROMOL CHEM-RAPID, V1, P545
   CARAVIA L, 1995, WEAR, V181, P236, DOI 10.1016/0043-1648(95)90029-2
   Choi J, 2007, BIOMATERIALS, V28, P772, DOI 10.1016/j.biomaterials.2006.09.049
   Cui L, 2009, BIOMATERIALS, V30, P2683, DOI 10.1016/j.biomaterials.2009.01.045
   Gu ZQ, 1999, BIO-MED MATER ENG, V9, P347
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Jin ZM, 1998, P I MECH ENG H, V212, P157, DOI 10.1243/0954411981533935
   Kaneshiro N, 2006, BIOCHEM BIOPH RES CO, V349, P723, DOI 10.1016/j.bbrc.2006.08.096
   Klein TJ, 2007, J BIOMECH, V40, P182, DOI 10.1016/j.jbiomech.2005.11.002
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kobayashi M, 2003, KNEE, V10, P47, DOI 10.1016/S0968-0160(02)00152-7
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T., 1990, BIOMED MAT RES, V24, P721, DOI DOI 10.1002/JBM.820240607
   Li YL, 2004, POLYMER, V45, P8779, DOI 10.1016/j.polymer.2004.10.077
   Oka M, 2001, J Orthop Sci, V6, P448, DOI 10.1007/s007760170014
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Quigley FP, 2002, P I MECH ENG H, V216, P77, DOI 10.1243/0954411021536306
   Saranti A, 2006, J NON-CRYST SOLIDS, V352, P390, DOI 10.1016/j.jnoncrysol.2006.01.042
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   THOMAS BH, 2008, J MECH BEHAV BIOMED, V6, P588
   Unsworth A, 1995, Proc Inst Mech Eng H, V209, P59, DOI 10.1243/PIME_PROC_1995_209_317_02
   Wu G, 2008, MATER CHEM PHYS, V107, P364, DOI 10.1016/j.matchemphys.2007.07.028
   Xu H, 2007, BIOMED MATER, V2, P62, DOI 10.1088/1748-6041/2/2/002
   YAO JQ, 1994, P I MECH ENG H, V208, P206, DOI 10.1243/PIME_PROC_1994_208_290_02
   ZHENG Y, 2006, Patent No. 2006101649522
   Zheng Y., 2009, BIOMED MATER, V4, P7
   Zheng YD, 2003, CHEM J CHINESE U, V24, P1325
   Zheng YD, 2009, J APPL POLYM SCI, V113, P736, DOI 10.1002/app.29326
NR 33
TC 7
Z9 9
U1 0
U2 23
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2010
VL 5
IS 2
AR 025003
DI 10.1088/1748-6041/5/2/025003
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 575DY
UT WOS:000276048000005
PM 20208130
DA 2018-10-20
ER

PT J
AU Vlad, MD
   Valle, LJ
   Poeata, I
   Lopez, J
   Torres, R
   Barraco, M
   Fernandez, E
AF Vlad, M. D.
   Valle, L. J.
   Poeata, I.
   Lopez, J.
   Torres, R.
   Barraco, M.
   Fernandez, E.
TI Biphasic calcium sulfate dihydrate/iron-modified alpha-tricalcium
   phosphate bone cement for spinal applications: in vitro study
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; CELL-LINE MG-63; OSTEOCALCIN SECRETION;
   CLINICAL-APPLICATIONS; OSTEOBLAST ADHESION; GRAFT SUBSTITUTE;
   DIFFERENTIATION; VERTEBROPLASTY; HYDROXYAPATITE; PROLIFERATION
AB In this study, the cytocompatibility of new 'iron-modified/alpha-tricalcium phosphate (IM/alpha-TCP) and calcium sulfate dihydrate (CSD)' bone cement (IM/alpha-TCP/CSD-BC) intended for spinal applications has been approached. The objective was to investigate by direct-contact osteoblast-like cell cultures ( from 1 to 14 days) the in vitro cell adhesion, proliferation, morphology and cytoskeleton organization of MG-63 cells seeded onto the new cements. The results were as follows: ( a) quantitative MTT-assay and scanning electron microscopy (SEM) showed that cell adhesion, proliferation and viability were not affected with time by the presence of iron in the cements; (b) double immunofluorescent labeling of F-actin and alpha-tubulin showed a dynamic interaction between the cell and its porous substrates sustaining the locomotion phenomenon on the cements' surface, which favored the colonization, and confirming the biocompatibility of the experimental cements; ( c) SEM-cell morphology and cytoskeleton observations also evidenced that MG-63 cells were able to adhere, to spread and to attain normal morphology on the new IM/alpha-TCP/CSD-BC which offered favorable substratum properties for osteoblast-like cells proliferation and differentiation in vitro. The results showed that these new iron-modified cement-like biomaterials have cytocompatible features of interest not only as possible spinal cancellous bone replacement biomaterial but also as bone tissue engineering scaffolds.
C1 [Vlad, M. D.; Lopez, J.; Torres, R.; Barraco, M.; Fernandez, E.] Tech Univ Catalonia UPC, IRGASC, Div Biomat & Bioengn, E-08028 Barcelona, Spain.
   [Vlad, M. D.; Poeata, I.] Gr T Popa Univ Med & Pharm, Fac Med Bioengn, Iasi 700454, Romania.
   [Valle, L. J.] UPC, ESAB, Ctr Mol Biotechnol CEBIM, Dept Agri Food Engn & Biotechnol, E-08860 Castelldefels, Spain.
RP Fernandez, E (reprint author), Tech Univ Catalonia UPC, IRGASC, Div Biomat & Bioengn, Avda Diagonal 647, E-08028 Barcelona, Spain.
EM enrique.fernandez@upc.edu
RI Torres, Ricardo/I-4858-2014
OI Torres, Ricardo/0000-0001-8030-5522
CR Alberts B., 2002, MOL BIOL CELL, p907 982
   Annaz B, 2004, J MICROSC-OXFORD, V215, P100, DOI 10.1111/j.0022-2720.2004.01354.x
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arcos D, 2003, J BIOMED MATER RES A, V65A, P71, DOI 10.1002/jbm.a.10445
   Baroud G, 2004, BIO-MED MATER ENG, V14, P487
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 2005, BIOMATERIALS, V26, P1553, DOI 10.1016/j.biomaterials.2004.05.010
   BOHNER M, 2001, EUR SPINE J, V10, P114
   BOHNER M, 2000, INJURY, V31, pD37, DOI DOI 10.1016/S0020-1383(00)80022-4
   BOYAN BD, 1989, J BIOL CHEM, V264, P11879
   Brown W.E., 1986, CEMENTS RES PROGR, P351
   BROWN WE, 1985, Patent No. 4518430
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Chang YL, 1999, INT J ORAL MAX IMPL, V14, P239
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013
   COTRAN R, 2004, PATHOLOGIC BASIS DIS, P14
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Fernandez E, 2005, J MATER SCI, V40, P3677, DOI 10.1007/s10853-005-0614-y
   Fernandez E, 2005, BIOMATERIALS, V26, P3395, DOI 10.1016/j.biomaterials.2004.09.023
   Fernandez E, 1998, J BIOMED MATER RES, V41, P560, DOI 10.1002/(SICI)1097-4636(19980915)41:4<560::AID-JBM7>3.0.CO;2-A
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P177, DOI 10.1023/A:1008989525461
   FERNANDEZ E, 2006, WILEY ENCY BIOMEDICA, P1, DOI DOI 10.1002/9780471740360.EBS1367
   FERNIE S, 1998, CENTREPIECE, V3, P6
   FRANCESCHI RT, 1985, J CELL PHYSIOL, V123, P401, DOI 10.1002/jcp.1041230316
   Frank J W, 1985, Am J Prev Med, V1, P25
   Gisep A, 2003, J BIOMED MATER RES A, V66A, P532, DOI 10.1002/jbm.a.10593
   Gitelis S, 2001, ORTHOPEDICS, V24, P162
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Heini PF, 2001, EUR SPINE J, V10, pS203, DOI 10.1007/s005860100308
   HENZE MW, 2004, CELL, V117, P285
   HIRST LS, 2004, PHYS REV LETT, V93, P1
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Ignjatovic N, 2006, MICROSC RES TECHNIQ, V69, P976, DOI 10.1002/jemt.20374
   Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   KOHRI M, 1993, BIOMATERIALS, V14, P299, DOI 10.1016/0142-9612(93)90122-I
   LAJEUNESSE D, 1990, J BONE MINER RES, V5, P915
   LAJEUNESSE D, 1991, BONE MINER, V14, P237, DOI 10.1016/0169-6009(91)90025-U
   Lefaix H, 2008, J MATER SCI-MATER M, V19, P1861, DOI 10.1007/s10856-007-3248-6
   LEMAITRE J, 1995, INNOV TECH BIOL MED, V16, P109
   Lemaitre J, 1987, SIL IND CERAM SCI TE, V52, P141
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   Lewis G, 2007, J BIOMED MATER RES B, V81B, P371, DOI 10.1002/jbm.b.30674
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Nelson CL, 2002, J ORTHOPAED RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Parikh SN, 2002, ORTHOPEDICS, V25, P1301
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   Saldanha KJ, 2008, EUR CELLS MATER, V16, P17, DOI 10.22203/eCM.v016a03
   Simon CG, 2004, J BIOMED MATER RES A, V68A, P628, DOI 10.1002/jbm.a.20008
   Stamenovic D, 2006, NAT MATER, V5, P597, DOI 10.1038/nmat1700
   Suzuki T, 1999, J BIOSCI BIOENG, V87, P320, DOI 10.1016/S1389-1723(99)80039-5
   Takegami K, 1998, J BIOMED MATER RES, V43, P210, DOI 10.1002/(SICI)1097-4636(199822)43:2<210::AID-JBM16>3.0.CO;2-L
   Tyllianakis M, 2002, ORTHOPEDICS, V25, P311
   Vlad MD, 2010, ACTA BIOMATER, V6, P607, DOI 10.1016/j.actbio.2009.07.010
   Vlad MD, 2008, SPINE, V33, P2290, DOI 10.1097/BRS.0b013e31817eccab
   Yamaguchi T, 2001, AM J PHYSIOL-CELL PH, V280, pC382
   Yang XF, 2009, MATER LETT, V63, P629, DOI 10.1016/j.matlet.2008.12.004
   Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 71
TC 6
Z9 7
U1 0
U2 23
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2010
VL 5
IS 2
AR 025006
DI 10.1088/1748-6041/5/2/025006
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 575DY
UT WOS:000276048000008
PM 20308776
DA 2018-10-20
ER

PT J
AU Khataee, AR
   Dehghan, G
   Ebadi, A
   Zarei, M
   Pourhassan, M
AF Khataee, A. R.
   Dehghan, G.
   Ebadi, A.
   Zarei, M.
   Pourhassan, M.
TI Biological treatment of a dye solution by Macroalgae Chara sp.: Effect
   of operational parameters, intermediates identification and artificial
   neural network modeling
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Biodegradation; Macroalgae; Malachite Green; Modeling; Decolorization
ID MALACHITE-GREEN; AZO-DYE; FRESH-WATER; DECOLORIZATION; REMOVAL;
   BIOSORPTION; EFFLUENTS; ALGAE; BLUE; BIODEGRADATION
AB The potential of a macroalgae Chara sp. was investigated as a viable biomaterial for biological treatment of Malachite Green (MG) solution. The effects of operational parameters such as temperature, pH, initial dye concentration, reaction time and amount of algae on biological decolorization efficiency were studied. Biological treatment of MG solution by live and dead algae was compared. The reusability and efficiency of the live algae in long-term repetitive operations were also examined. The batch experiments results revealed the ability of algal species in biological degradation of the dye. The biological degradation compounds formed in this process were analyzed by UV-Vis, FT-IR and GC-Mass techniques. The degradation pathway of MG was proposed based on the identified compounds. In addition, an artificial neural network model was developed to predict the biological degradation efficiency. The findings indicated that ANN provides reasonable predictive performance (R-2 = 0.970). The influence of each parameter on the variable studied was assessed, reaction time being the most significant factor, followed by temperature of the solution. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Khataee, A. R.; Ebadi, A.; Zarei, M.] Univ Tabriz, Fac Chem, Dept Appl Chem, Tabriz, Iran.
   [Dehghan, G.; Ebadi, A.; Pourhassan, M.] Univ Tabriz, Fac Sci, Dept Biol, Tabriz, Iran.
RP Khataee, AR (reprint author), Univ Tabriz, Fac Chem, Dept Appl Chem, Tabriz, Iran.
EM a_khataee@tabrizu.ac.ir
RI Khataee, Alireza/E-2874-2015
OI Khataee, Alireza/0000-0002-4673-0223; Pourhassan shamchi,
   Minoo/0000-0003-1764-0453
FU University of Tabriz, Iran
FX The authors thank the University of Tabriz, Iran for financial supports.
CR Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2000, PROCESS BIOCHEM, V36, P431, DOI 10.1016/S0032-9592(00)00233-8
   Aleboyeh A, 2008, DYES PIGMENTS, V77, P288, DOI 10.1016/j.dyepig.2007.05.014
   Banat IM, 1996, BIORESOURCE TECHNOL, V58, P217, DOI 10.1016/S0960-8524(96)00113-7
   Bekci Z, 2009, J HAZARD MATER, V161, P1454, DOI 10.1016/j.jhazmat.2008.04.125
   Chang JS, 2000, BIORESOURCE TECHNOL, V75, P107, DOI 10.1016/S0960-8524(00)00049-3
   Chen KC, 2003, J BIOTECHNOL, V101, P57, DOI 10.1016/S0168-1656(02)00303-6
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Daneshvar N, 2007, J HAZARD MATER, V143, P214, DOI 10.1016/j.jhazmat.2006.09.016
   Daneshvar N, 2007, BIORESOURCE TECHNOL, V98, P1176, DOI 10.1016/j.biortech.2006.05.025
   Daneshvar N, 2004, J PHOTOCH PHOTOBIO A, V162, P317, DOI 10.1016/s1010-6030(03)00378-2
   Despange F., 1998, ANALYST, V123, P157
   Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155
   Donmez GC, 1999, PROCESS BIOCHEM, V34, P885
   Ertugrul S, 2009, ECOL ENG, V35, P128, DOI 10.1016/j.ecoleng.2008.09.015
   Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017
   Jadhav JP, 2006, YEAST, V23, P315, DOI 10.1002/yea.1356
   JINQUI L, 1992, Environmental Pollution, V75, P273, DOI 10.1016/0269-7491(92)90127-V
   Kannan C, 2008, J HAZARD MATER, V157, P137, DOI 10.1016/j.jhazmat.2007.12.116
   Kaushik P, 2009, ENVIRON INT, V35, P127, DOI 10.1016/j.envint.2008.05.010
   Khatace A. R., 2009, Chinese Journal of Applied and Environmental Biology, V15, P110, DOI 10.3724/SP.J.1145.2009.00110
   Khataee AR, 2009, ENVIRON TECHNOL, V30, P1155, DOI 10.1080/09593330903133911
   Khataee AR, 2009, J HAZARD MATER, V161, P1225, DOI 10.1016/j.jhazmat.2008.04.075
   Kivaisi AK, 2001, ECOL ENG, V16, P545, DOI 10.1016/S0925-8574(00)00113-0
   Kumar KV, 2005, PROCESS BIOCHEM, V40, P2865, DOI 10.1016/j.procbio.2005.01.007
   Kumar KV, 2006, DYES PIGMENTS, V69, P74
   Mohan SV, 2002, WASTE MANAGE, V22, P575
   Parshetti G, 2006, ACTA CHIM SLOV, V53, P492
   Peta A., 2009, SCI TOTAL ENVIRON, V407, P1164
   Couto SR, 2009, BIOTECHNOL ADV, V27, P227, DOI 10.1016/j.biotechadv.2008.12.001
   Vashishta B.R., 2005, BOT DEGREE STUDENTS
   Velis CA, 2009, BIORESOURCE TECHNOL, V100, P2747, DOI 10.1016/j.biortech.2008.12.026
   WALSH GE, 1980, ENVIRON POLLUT A, V21, P169, DOI 10.1016/0143-1471(80)90161-0
   Zarei M, 2009, ELECTROCHIM ACTA, V54, P6651, DOI 10.1016/j.electacta.2009.06.060
NR 34
TC 96
Z9 98
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD APR
PY 2010
VL 101
IS 7
BP 2252
EP 2258
DI 10.1016/j.biortech.2009.11.079
PG 7
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 556RV
UT WOS:000274609900027
PM 20022487
DA 2018-10-20
ER

PT J
AU Keogh, MB
   O'Brien, FJ
   Daly, JS
AF Keogh, Michael B.
   O'Brien, Fergal J.
   Daly, Jacqueline S.
TI A novel collagen scaffold supports human osteogenesis-applications for
   bone tissue engineering
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Bone tissue engineering; Osteoblast; Collagen; Scaffold; Transforming
   growth factor-beta(1); Human
ID IN-VITRO; OSTEOBLASTIC DIFFERENTIATION; GLYCOSAMINOGLYCAN SCAFFOLD;
   MECHANICAL STIMULATION; GENE-EXPRESSION; STROMAL CELLS; PORE-SIZE; HFOB
   1.19; PROLIFERATION; CONTRACTION
AB Collagen glycosaminoglycan (CG) scaffolds have been clinically approved as an application for skin regeneration. The goal of this study has been to examine whether a CG scaffold is a suitable biomaterial for generating human bone tissue. Specifically, we have asked the following questions: (1) can the scaffold support human osteoblast growth and differentiation and (2) how might recombinant human transforming growth factor-beta (TGF-beta(1)) enhance long-term in vitro bone formation? We show human osteoblast attachment, infiltration and uniform distribution throughout the construct, reaching the centre within 14 days of seeding. We have identified the fully differentiated osteoblast phenotype categorised by the temporal expression of alkaline phosphatase, collagen type 1, osteonectin, bone sialo protein, biglycan and osteocalcin. Mineralised bone formation has been identified at 35 days post-seeding by using von Kossa and Alizarin S Red staining. Both gene expression and mineral staining suggest the benefit of introducing an initial high treatment of TGF-beta(1) (10 ng/ml) followed by a low continuous treatment (0.2 ng/ml) to enhance human osteogenesis on the scaffold. Osteogenesis coincides with a reduction in scaffold size and shape (up to 70% that of original). A notable finding is core degradation at the centre of the tissue-engineered construct after 49 days of culture. This is not observed at earlier time points. Therefore, a maximum of 35 days in culture is appropriate for in vitro studies of these scaffolds. We conclude that the CG scaffold shows excellent potential as a biomaterial for human bone tissue engineering.
C1 [Keogh, Michael B.; O'Brien, Fergal J.; Daly, Jacqueline S.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland.
   [Keogh, Michael B.; Daly, Jacqueline S.] Royal Coll Surgeons Ireland, Div Biol, Dublin 2, Ireland.
RP Keogh, MB (reprint author), Royal Coll Surgeons Ireland, Dept Anat, 123 St Stephens Green, Dublin 2, Ireland.
EM mkeogh@rcsi.ie
RI O'Brien, Fergal/F-9485-2011; Daly, Jacqueline/D-6687-2012
OI O'Brien, Fergal/0000-0003-2030-8005; Keogh, Michael/0000-0001-7149-1191
FU RCSI Research Committee; President of Ireland Young Researcher Award
   (PIYRA)
FX The authors acknowledge the RCSI Research Committee and President of
   Ireland Young Researcher Award (PIYRA) for funding.
CR BILEZIKIAN JP, 2001, PRINCIPLES BONE BIOL
   Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Dhurjati R, 2006, TISSUE ENG, V12, P3045, DOI 10.1089/ten.2006.12.3045
   Donahue HJ, 2000, AM J PHYSIOL-CELL PH, V278, pC315
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Freyman TM, 2001, BIOMATERIALS, V22, P2883, DOI 10.1016/S0142-9612(01)00034-5
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   Jaasma MJ, 2008, TISSUE ENG PT A, V14, P1213, DOI [10.1089/ten.tea.2007.0321, 10.1089/tea.2007.0321]
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lieb E, 2004, TISSUE ENG, V10, P1414, DOI 10.1089/1076327042500201
   McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259
   Sun HL, 2006, BIOMATERIALS, V27, P5651, DOI 10.1016/j.biomaterials.2006.07.027
   Ter Brugge PJ, 2002, TISSUE ENG, V8, P321, DOI 10.1089/107632702753725076
   TIERNEY CM, 2008, J BIOMED MATER RES A, V2, P202
   Yannas I., 2001, TISSUE ORGAN REGENER
   Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6
NR 29
TC 35
Z9 41
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD APR
PY 2010
VL 340
IS 1
BP 169
EP 177
DI 10.1007/s00441-010-0939-y
PG 9
WC Cell Biology
SC Cell Biology
GA 576QF
UT WOS:000276160000016
PM 20198386
DA 2018-10-20
ER

PT J
AU Wu, RQ
   Li, ZX
   Yang, JP
   Xing, XH
   Shao, DY
   Xing, KL
AF Wu, Rui-Qin
   Li, Zhi-Xi
   Yang, Jia-Ping
   Xing, Xiao-Hui
   Shao, Dong-Yan
   Xing, Kang-Lin
TI Mutagenesis induced by high hydrostatic pressure treatment: a useful
   method to improve the bacterial cellulose yield of a Gluconoacetobacter
   xylinus strain
SO CELLULOSE
LA English
DT Article
DE Gluconoacetobacter xylinus; High hydrostatic pressure; Mutagenesis;
   Bacterial cellulose
ID ACETOBACTER-XYLINUM; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; MUTANTS;
   GROWTH; ENZYME; TEMPERATURE; BLOOD; MILK
AB Bacterial cellulose (BC) is a new biomaterial which has wide application potential in various industries. BC industrialization requires bacterial strains with high BC productivity. The objective of this study is to increase the BC yield of a Gluconoacetobacter xylinus strain through mutagenesis induced by high hydrostatic pressure (HHP) treatment. In this study, the parental strain in its exponential phase was treated at 250 MPa and 25 degrees C for 15 min to induce mutagenesis using a HHP machine. The HHP-treated strains were incubated in glucose agar plate at 30 degrees C for 4 days. After the incubation, 50 larger colonies in these plates were randomly selected and cultivated to produce BC membrane in a tailor-made glass vessel, and wet weights of the BC membranes were tested. Compared with the parental strain, 29 mutants showed higher BC yields, of which eight mutants with BC yield >130.00 g/L were initially screened and were then cultivated for five generations to test their genetic stabilities for BC production. Among the eight mutants, M(438), a mutant which showed the highest average BC yield (158.56 g/L) and lowest coefficient of variation (2.4%) for five generations, was finally screened as objective mutant. HHP treatment can serve as an effective method to cause mutagenesis in BC-producing bacteria. The HHP-treated strains with significantly higher BC yield than parental strain can be screened from the HHP-induced mutants.
C1 [Wu, Rui-Qin; Li, Zhi-Xi; Yang, Jia-Ping; Xing, Xiao-Hui; Shao, Dong-Yan] NW A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.
   [Xing, Kang-Lin] Henan Univ Technol, Coll Mech & Elect Engn, Zhengzhou 450000, Henan, Peoples R China.
RP Li, ZX (reprint author), NW A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.
EM lzx580721@yahoo.com.cn
FU Provincial Key Project for Science and Technology Development, Shaanxi,
   China [2005K03-G03]
FX This research was financially supported by the Provincial Key Project
   for Science and Technology Development (grant number: 2005K03-G03),
   Shaanxi, China. The technical support of Dr. Xuchang Duan, associate
   professor of the College of Food Science and Engineering, Northwest A&F
   University, is also gratefully acknowledged.
CR ALONI Y, 1983, J BIOL CHEM, V258, P4419
   Anicuta S. G., 2007, NUCL INSTRUM METH B, V265, P434
   BENZIMAN M, 1972, J BACTERIOL, V111, P325
   Budhiono A., 1999, CARBOHYD POLYM, V40, P37
   [车黎猛 CHE Limeng], 2006, [食品科学, Food Science], V27, P109
   DeWulf P, 1996, J CHEM TECHNOL BIOT, V67, P376, DOI 10.1002/(SICI)1097-4660(199612)67:4<376::AID-JCTB569>3.0.CO;2-J
   Gao X, 2001, ACTA BIOCH BIOPH SIN, V33, P77
   Gervilla R, 1997, J FOOD PROTECT, V60, P33, DOI 10.4315/0362-028X-60.1.33
   GROMET Z, 1957, BIOCHEM J, V67, P679, DOI 10.1042/bj0670679
   Guo YX, 2009, FOOD CHEM, V114, P328, DOI 10.1016/j.foodchem.2008.09.041
   Hayman MM, 2007, INT J FOOD MICROBIOL, V115, P220, DOI 10.1016/j.ijfoodmicro.2006.10.019
   HOFHERR LA, 1983, J DAIRY SCI, V66, P2482, DOI 10.3168/jds.S0022-0302(83)82115-8
   Hong F, 2008, CARBOHYD POLYM, V72, P545, DOI 10.1016/j.carbpol.2007.09.015
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Keshk S, 2006, ENZYME MICROB TECH, V40, P4, DOI 10.1016/j.enzmictec.2006.07.037
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lauro FM, 2008, J BACTERIOL, V190, P1699, DOI 10.1128/JB.01176-07
   Liu F-z, 2008, LIQUOR MAKING SCI TE, V3, P51
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   Nguyen VT, 2008, FOOD MICROBIOL, V25, P471, DOI 10.1016/j.fm.2008.01.004
   ODONOVAN GA, 1965, J BACTERIOL, V90, P611
   REYES DS, 2009, INNOV FOOD SCI EMERG, V10, P135
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   VALLA S, 1989, MOL GEN GENET, V217, P26, DOI 10.1007/BF00330938
   Vandamme EJ, 1998, POLYM DEGRAD STABIL, V59, P93, DOI 10.1016/S0141-3910(97)00185-7
   Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341
   [王岁楼 Wang Suilou], 2006, [工业微生物, Industrial Microbiology], V36, P31
   Wang X, 2008, T ASABE, V51, P55
   Wu R. Q., 2008, CHINA BREW, V10, P37
   Wu R. Q., 2008, CHIN J BIOTECHNOL, V24, P1068
   Yu X. B., 1999, J CELLUL SCI TECHNOL, V7, P63
NR 31
TC 17
Z9 24
U1 1
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD APR
PY 2010
VL 17
IS 2
BP 399
EP 405
DI 10.1007/s10570-009-9388-8
PG 7
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 595TT
UT WOS:000277636800017
DA 2018-10-20
ER

PT J
AU Jeni, K
   Yapa, M
   Rattanadecho, P
AF Jeni, Kusturee
   Yapa, Mudtapha
   Rattanadecho, Phadungsak
TI Design and analysis of the commercialized drier processing using a
   combined unsymmetrical double-feed microwave and vacuum system (case
   study: tea leaves)
SO CHEMICAL ENGINEERING AND PROCESSING
LA English
DT Article
DE Microwave vacuum drying; Tea leaves; Heat and mass transfer; Quality
ID BELT DRIER; CRANBERRIES
AB Combined microwave (MW) and vacuum drying of biomaterials has a promising potential for high-quality dehydrated products. A better knowledge of the drying kinetics of biomaterial products could improve the design and operation of efficient dehydration systems. The experiments were carried out on commercialized biomaterials drier using a combined unsymmetrical double-feed microwave and vacuum system. Three kilograms of tea leaves were applied with the microwave power of 800 (single-feed magnetron) and 1600W (unsymmetrical double-feed magnetrons) operating at 2450 MHz frequency. Rotation rates of the rotary drum were held constant at 10 rpm. Vacuum pressure was controlled at the constant pressure of 385 Torr and 535 Torr, respectively In this study, the system can be operated either in continuous or pulse mode in each experiments Experiments show that in the case of high power level and continuous operating mode causes greater damage to the structure of tea leaves sample Microwave drying with pulse operating mode at 385 Torr ensured the shortest drying time and the best overall quality of dried tea leaves, and thus was chosen as the most appropriate technique for tea leaves drying (C) 2010 Elsevier B.V All rights reserved.
C1 [Jeni, Kusturee; Yapa, Mudtapha; Rattanadecho, Phadungsak] Thammasat Univ, Dept Mech Engn, Fac Engn, Res Ctr Microwave Utilizat Engn, Pathum Thani 12120, Thailand.
RP Rattanadecho, P (reprint author), Thammasat Univ, Dept Mech Engn, Fac Engn, Res Ctr Microwave Utilizat Engn, Rangsit Campus, Pathum Thani 12120, Thailand.
FU Thailand Research Fund (TRF); Commission on Higher Education (CHE),
   Thailand
FX The authors would like to express their appreciation to the Thailand
   Research Fund (TRF) and Commission on Higher Education (CHE), Thailand
   for providing financial support for this study.
CR Association of Official Analytical Chemists (AOAC), 1995, OFF METH AN AOAC INT
   AYAPPA KG, 1991, AICHE J, V37, P313, DOI 10.1002/aic.690370302
   Chan T. V. Chow Ting, 2000, UNDERSTANDING MICROW
   Cui Z. W., 2004, DRYING TECHNOLOGY, V22, P561
   Cui ZW, 2003, DRY TECHNOL, V21, P1173, DOI 10.1081/DRT-120023174
   Curet S, 2008, CHEM ENG PROCESS, V47, P1656, DOI 10.1016/j.cep.2007.09.011
   Datta A. K., 2001, HDB MICROWAVE TECHNO
   DECAREAU RV, 1985, MICROWAVE FOOD PROCE
   Drouzas AE, 1996, J FOOD ENG, V28, P203, DOI 10.1016/0260-8774(95)00040-2
   Drouzas AE, 1999, J FOOD ENG, V39, P117, DOI 10.1016/S0260-8774(98)00133-2
   Kaensup W, 2002, DRY TECHNOL, V20, P2067, DOI 10.1081/DRT-120015585
   Lin T. M., 1999, Journal of Aquatic Food Product Technology, V8, P41, DOI 10.1300/J030v08n04_05
   Metaxas A. A., 1983, IND MICROWAVE HEATIN
   Perre P, 1997, AICHE J, V43, P2579, DOI 10.1002/aic.690431019
   RATANADECHO P, 2002, IEEE T MICROW THEORY, V50, P1487
   RATANADECHO P, 2002, ASME, V124, P151
   Rattanadecho P, 2007, J MANUF SCI E-T ASME, V129, P157, DOI 10.1115/1.2386166
   Rattanadecho P, 2008, MAT SCI ENG A-STRUCT, V472, P299, DOI 10.1016/j.msea.2007.03.035
   RISMAN PO, 1987, J MICROWAVE POWER EE, V22, P193
   Schiffmann R. F., 1995, HDB IND DRYING
   Sunjka PS, 2004, DRY TECHNOL, V22, P1217, DOI [10.1081/DRT-120038588, 10.1081/drt-120038588]
   Vongpradubchai S, 2009, CHEM ENG PROCESS, V48, P997, DOI 10.1016/j.cep.2009.01.008
   WADSWORTH JI, 1990, T ASAE, V33, P199
   Yongsawatdigul J, 1996, J FOOD PROCESS PRES, V20, P121, DOI 10.1111/j.1745-4549.1996.tb00850.x
   Yongsawatdigul J, 1996, J FOOD PROCESS PRES, V20, P145, DOI 10.1111/j.1745-4549.1996.tb00851.x
NR 25
TC 15
Z9 17
U1 0
U2 13
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0255-2701
J9 CHEM ENG PROCESS
JI Chem. Eng. Process.
PD APR
PY 2010
VL 49
IS 4
BP 389
EP 395
DI 10.1016/j.cep.2010.03.003
PG 7
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA 606HP
UT WOS:000278413900009
DA 2018-10-20
ER

PT J
AU Araujo, MG
   Liljenberg, B
   Lindhe, J
AF Araujo, Mauricio G.
   Liljenberg, Birgitta
   Lindhe, Jan
TI beta-tricalcium phosphate in the early phase of socket healing: an
   experimental study in the dog
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; bone formation; extraction socket; grafting
ID INTRA-BONY DEFECTS; TOOTH EXTRACTION; HISTOMORPHOMETRIC OBSERVATIONS;
   OSTEOPONTIN; TISSUE; RAT; AUGMENTATION; SIALOPROTEIN; OSTEOCLASTS;
   EXPRESSION
AB Objectives
   The aim of this experiment was to analyze processes involved in the incorporation of beta-tricalcium phospate (TCP) particles in host tissue during healing following tooth extraction and grafting.
   Material and methods
   Five beagle dogs were used. Four premolars in the maxilla (3P3, 2P2) were hemi-sected, the distal roots were removed and the fresh extraction socket filled with TCP. The tooth extraction and grafting procedures were scheduled in such a way that biopsies representing 1 and 3 days, as well as 1, 2, and 4 weeks of healing could be obtained. Tissue elements such as cells, fibers, vessels, leukocytes and mineralized bone were determined. In deparaffinized sections structures and cells that expressed Tratarate resistant acid phosphate, alkaline phosphatase, and osteopontin were identified by the use of markers.
   Results
   The porosities of the TCP particles were initially filled with erythrocytes that subsequently were replaced with mineralized bone. Some of the graft material was invaded by mesenchymal and inflammatory cells and disintegrated. Thus, small membrane bound granules appeared in the granulation tissue and the provisional matrix. In the process of hard tissue formation, partly mineralized (modified) TCP particles became surrounded by ridges of woven bone.
   Conclusions
   It was demonstrated that the early healing of an extraction socket that had been grafted with beta-TCP involved (i) the formation of a coagulum that was (ii) replaced with granulation tissue and a provisional matrix in which (iii) woven bone could form. In this process the biomaterial was apparently involved.
   To cite this article:Araujo MG, Liljenberg B, Lindhe J. beta-tricalcium phosphate in the early phase of socket healing: an experimental study in the dog. Clin. Oral Impl. Res. 21, 2010; 445-454.doi: 10.1111/j.1600-0501.2009.01876.x.
C1 [Araujo, Mauricio G.; Liljenberg, Birgitta; Lindhe, Jan] Univ Gothenburg, Inst Odontol, Sahlgrenska Acad, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim,15 Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2003, INT J ORAL MAX IMPL, V18, P242
   Bartee B K, 2001, J Oral Implantol, V27, P187, DOI 10.1563/1548-1336(2001)027<0187:ESRFAR>2.3.CO;2
   Bokan I, 2006, J CLIN PERIODONTOL, V33, P885, DOI 10.1111/j.1600-051X.2006.01010.x
   Brkovic BMB, 2008, J CAN DENT ASSOC, V74, P523
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   CHEN J, 1991, HISTOCHEM J, V23, P281, DOI 10.1007/BF01045047
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Dori F, 2008, J PERIODONTOL, V79, P660, DOI 10.1902/jop.2008.070473 
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Johnston R, 2007, SINGAPORE J TROP GEO, V28, P246, DOI 10.1111/j.1467-9493.2007.00297.x
   Jung UW, 2006, J PERIODONTOL, V77, P765, DOI 10.1902/jop.2006.050268
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   KONDO N, 2005, J BIOMATERIALS, V27, P4419
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   MARK MP, 1988, DIFFERENTIATION, V37, P123, DOI 10.1111/j.1432-0436.1988.tb00804.x
   MERRY K, 1993, J CELL SCI, V104, P1013
   NODA M, 2002, TXB PRINCIPLES BONE, V2, P239
   Ogose A, 2006, BIOMATERIALS, V27, P1542, DOI 10.1016/j.biomaterials.2005.08.034
   Ormianer Zeev, 2006, Implant Dent, V15, P395, DOI 10.1097/01.id.0000239316.82325.8c
   OZAWA M, 1995, J JPN SOC BIOMATER, V13, P17
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Pietrokovski Jaime, 2007, J Prosthodont, V16, P141, DOI 10.1111/j.1532-849X.2007.00165.x
   PINERO GJ, 1995, ARCH ORAL BIOL, V40, P145, DOI 10.1016/0003-9969(94)00144-Z
   REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473
   Ridgway HK, 2008, INT J PERIODONT REST, V28, P171
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Sculean A, 2007, J CLIN PERIODONTOL, V34, P507, DOI 10.1111/j.1600-051X.2007.01084.x
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 39
TC 33
Z9 34
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2010
VL 21
IS 4
BP 445
EP 454
DI 10.1111/j.1600-0501.2009.01876.x
PG 10
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 567JS
UT WOS:000275443500013
PM 20443798
DA 2018-10-20
ER

PT J
AU Luo, C
   Samaranayake, CB
   Plank, LD
   Bissett, IP
AF Luo, C.
   Samaranayake, C. B.
   Plank, L. D.
   Bissett, I. P.
TI Systematic review on the efficacy and safety of injectable bulking
   agents for passive faecal incontinence
SO COLORECTAL DISEASE
LA English
DT Review
DE Faecal incontinence; systematic review; PTQ; Durasphere; injectable
   bulking agents
ID ANAL-SPHINCTER DYSFUNCTION; SILICONE BIOMATERIAL; INJECTION; IMPLANTS;
   EPIDEMIOLOGY
AB Objective
   The aim of this study was to systematically review all published evidence to determine the efficacy and safety of injectable bulking agents for passive faecal incontinence (FI) in adults.
   Method
   Electronic searches were performed for MEDLINE, EMBASE, ISI Web of Knowledge and other relevant databases. Hand searching of relevant conference proceedings was undertaken. Studies were considered if they met the predefined inclusion criteria of more than ten adult patients and receiving an injectable bulking agent for passive FI with a validated means of assessing preoperative and postoperative incontinence.
   Results
   Thirteen case series studies and one randomized placebo-controlled trial (RCT) were included with a total of 420 patients. Two completed RCTs with placebo control were identified but results were unobtainable. Coaptite, Contigen, Durasphere, EVOH and PTQ injections were assessed with 24, 73, 83, 21 and 208 patients respectively. Most studies reported a statistically significant improvement in incontinence scores and quality of life. No statistically significant difference was found between the treatment and placebo arms in the RCT. No serious adverse events were reported.
   Conclusions
   Currently there is little evidence for the effectiveness of injectable bulking agents in managing passive FI. The inability to obtain results from two further RCTs concerned the reviewers and hindered their ability to make strong recommendations. The identified injectable bulking agents appear to be safe with only minor complications reported.
C1 [Luo, C.; Samaranayake, C. B.; Plank, L. D.; Bissett, I. P.] Univ Auckland, Dept Surg, Fac Med & Hlth Sci, Auckland, New Zealand.
RP Bissett, IP (reprint author), Univ Auckland, Dept Surg, Fac Med & Hlth Sci, Private Bag 92019, Auckland, New Zealand.
EM i.bissett@auckland.ac.nz
RI Bissett, Ian/A-4529-2016
OI Bissett, Ian/0000-0001-6530-2454; Plank, Lindsay/0000-0003-2737-0151
CR AIGNER F, 2007, COLORECTAL DIS S3, V9, P50
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   ALTOMARE DF, 2002, 7 INT M COL SAINT VI
   Andrews CN, 2005, NAT CLIN PRACT GASTR, V2, P516, DOI 10.1038/ncpgasthep0315
   BORRIE MJ, 1992, CAN MED ASSOC J, V147, P322
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Donovan J, 2002, INCONTINENCE
   EZIO G, 2004, DIS COLON RECTUM, V47, P565
   FARMER KC, 2005, COLORECTAL DIS S1, V7, P99
   Fisher RA, 1941, STAT METHODS RES WOR
   Gaj Fabio, 2007, Chir Ital, V59, P355
   *INT PROC ADV COMM, 2007, INJ BULK AG FAEC INC
   IRUKULLA S, 2006, COLORECTAL DIS S2, V8, P57
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   Jorge JM, 2004, DIS COLON RECTUM, V47, P612
   Lindsey I, 2004, DIS COLON RECTUM, V47, P612
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   *MED SERV ADV COMM, 2006, INT INJ SIL BIOM SEV
   Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010
   Nijhuis PH, 1998, DIS COLON RECTUM, V41, P624, DOI 10.1007/BF02235272
   RAO SS, 2004, GASTROENTEROLOGY S1, V126, P14
   SHARMA A, 2008, DIS COLON RECTUM, V51, P622
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Soffer EE, 2000, AM J GASTROENTEROL, V95, P1873
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2
   Taylor RS, 2006, EUR J PAIN, V10, P91, DOI 10.1016/j.ejpain.2005.02.004
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
NR 32
TC 21
Z9 21
U1 0
U2 4
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD APR
PY 2010
VL 12
IS 4
BP 296
EP 303
DI 10.1111/j.1463-1318.2009.01828.x
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 568IA
UT WOS:000275514700003
PM 19320664
DA 2018-10-20
ER

PT J
AU Zinelis, S
   Thomas, A
   Syres, K
   Silikas, N
   Eliades, G
AF Zinelis, S.
   Thomas, A.
   Syres, K.
   Silikas, N.
   Eliades, G.
TI Surface characterization of zirconia dental implants
SO DENTAL MATERIALS
LA English
DT Article
DE Zirconia dental implants; Surface analysis; XPS; Raman microanalysis;
   SEM/EDX; Optical profilometry
ID TETRAGONAL ZIRCONIA; TITANIUM IMPLANTS; IN-VIVO; OSSEOINTEGRATION;
   CERAMICS; OXIDE; BONE; BIOMATERIAL; DEGRADATION; ADHESION
AB Objectives. The aim of the study was to characterize the chemical composition, microstructure and roughness of two commercially available zirconia dental implants (WhiteSky and Zit-Z).
   Methods. The chemical composition of the cervical collar and threaded root parts of the implants (n = 2) were studied by XPS and HV-EDX. LV-SEM was used for morphological assessment, Raman microanalysis for microstructural characterization and optical profilometry for surface roughness measurements. XRD, HV-EDX and Raman microanalysis of bulk regions ( longitudinal sections) were used as reference.
   Results. XPS showed the presence of C, O, Zr and Y ( collar) plus Al ( root) at implant surfaces. More C (10-26 at%) and a lower Al/Zr ratio were found in WhiteSky (1.05 vs 1.26 in Zit-Z). Zr, Y and Al were detected in single, fully oxidized states. The same elements, plus Hf, were identified by HV-EDX at bulk and surface regions, with a Al/Zr ratio higher in WhiteSky (0.17 vs 0.09 in Zit-Z). Na, K and Cl contaminants were traced at implant root parts by both methods. XRD analysis of cross-sectioned specimens revealed the presence of monoclinic and tetragonal zirconia along with cubic yttria phases. Raman microanalysis showed that the monoclinic zirconia volume fraction was higher at root surfaces than the collar. No monoclinic phase was found at bulk regions. Significantly higher Sa and Sq values were recorded in WhiteSky than Zit-Z, whereas Zit-Z showed higher Rt value.
   Significance. The differences found between the implants in the extent of carbon contamination, residual alumina content, tetragonal to monoclinic ZrO(2) phase transformation and 3D-roughness parameters may contribute to a substantial differentiation in the cellular and tissue response. (C) 2009 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Eliades, G.] Univ Athens, Sch Dent, Dept Biomat, Athens 11527, Greece.
   [Thomas, A.; Syres, K.] Univ Manchester, Photon Sci Inst, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.
   [Silikas, N.] Univ Manchester, Biomat Unit, Manchester M13 9PL, Lancs, England.
RP Eliades, G (reprint author), Univ Athens, Sch Dent, Dept Biomat, 2 Thivon Str Goudi, Athens 11527, Greece.
RI Silikas, Nick/B-2990-2009
OI Silikas, Nick/0000-0003-4576-4584; Thomas, Andrew/0000-0002-1900-6686;
   Zinelis, Spiros/0000-0001-9188-7839
FU National and Kapodistrian University of Athens [ELKE 70/4/5768]; EPSRC
   [EP/E025722/1]; Engineering and Physical Sciences Research Council
   [EP/E025722/1]
FX The study was supported by the ELKE 70/4/5768 research fund from the
   National and Kapodistrian University of Athens. The support provided by
   Dr. E. Lancelot (Raman microanalysis), Dr. H. Stadler ( optical
   profilometry) and Dr. D. S.-L. Law (ESCA facility at NCESS) is
   gratefully acknowledged. The implant samples were generously provided by
   the manufacturers. The authors would like to acknowledge Daresbury NCESS
   facility and EPSRC grant ref EP/E025722/1.
CR Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   [Anonymous], 1997, 13356 ISO
   *ASTM, 1998, F187398 ASTM, P908
   Bianchi A E, 2004, J Appl Biomater Biomech, V2, P143
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   CLARKE DR, 1982, J AM CERAM SOC, V65, P284, DOI 10.1111/j.1151-2916.1982.tb10445.x
   Degidi M, 2006, J PERIODONTOL, V77, P73, DOI 10.1902/jop.2006.77.1.73
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   Fernandez-Fairen M, 2006, BIO-MED MATER ENG, V16, P415
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   Macdonald W, 2004, J BIOMED MATER RES B, V70B, P262, DOI 10.1002/jbm.b.30036
   MASSARO C, 2002, J MATER SCI-MATER M, V13, P538
   Munoz MC, 2006, SURF SCI REP, V61, P303, DOI 10.1016/j.surfrep.2006.03.002
   Pezzotti G, 2008, J AM CERAM SOC, V91, P1199, DOI 10.1111/j.1551-2916.2007.01507.x
   Piattelli A, 2003, BIOMATERIALS, V24, P4081, DOI 10.1016/S0142-9612(03)00300-4
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   THOMPSON I, 1990, BIOMATERIALS, V11, P505, DOI 10.1016/0142-9612(90)90066-Y
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
NR 29
TC 40
Z9 40
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2010
VL 26
IS 4
BP 295
EP 305
DI 10.1016/j.dental.2009.11.079
PG 11
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 559VV
UT WOS:000274857000003
PM 20018361
DA 2018-10-20
ER

PT J
AU Winkler, T
   Hoenig, E
   Huber, G
   Janssen, R
   Fritsch, D
   Gildenhaar, R
   Berger, G
   Morlock, MM
   Schilling, AF
AF Winkler, Thomas
   Hoenig, Elisa
   Huber, Gerd
   Janssen, Rolf
   Fritsch, Daniel
   Gildenhaar, Renate
   Berger, Georg
   Morlock, Michael M.
   Schilling, Arndt F.
TI Osteoclastic bioresorption of biomaterials: Two- and three-dimensional
   imaging and quantification
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Biomaterial; Three-dimensional; IFM; Osteoclast; Dentin; Calcium
   phosphate
ID IN-VITRO; BONE; SUBSTITUTE; RESORPTION; RESORBABILITY; EXPRESSION;
   OSTEOTOMY; CERAMICS
AB Purpose: Bioresorbable materials have been developed in the hope that the body will replace them with newly formed tissue. The first step of this remodeling process in bone is the bioresorption of the material by osteoclasts. The aim of this study was to analyze osteoclastic resorption of biomaterials in vitro using the commonly used two-dimensional methods of light-microscopy (LM) and scanning electron microscopy (SEM) in comparison with infinite focus microscopy (IFM), a recently developed imaging method allowing for three-dimensional surface analysis.
   Methods: Human hematopoietic stem cells were cultivated in the presence of the cytokines M-CSF and RANK-L for 4 weeks directly on dentin and a calcium phosphate cement. Osteoclast development was surveyed with standard techniques. After removal of the cells, resorption was characterized and quantified by LM, SEM and IFM.
   Results: Osteoclast cultures on the biomaterials presented the typical osteoclast-specific markers. On dentin samples LM, SEM as well as IFM allowed for discrimination of resorption. Quantification of the resorbed area showed a linear correlation between the results (LM vs. SEM: r=0.996, p=0.004; SEM vs. IFM: r=0.989, p=0.011; IFM vs. LM: r=0.995). It was not possible to demarcate resorption pits on GB14 using LM or SEM. With IFM, resorption on GB14 could be visualized and quantified two- and three-dimensionally.
   Conclusions: In this paper we introduce IFM as a technology for three-dimensional visualization and quantification of resorption of biomaterials. Better understanding of the bioresorption of biomaterials may help in the design of better materials and might therefore constitute an important step on the avenue to the development of artificial bone. (Int J Artif Organs 2010; 33: 198-203)
C1 [Winkler, Thomas; Hoenig, Elisa; Huber, Gerd; Morlock, Michael M.; Schilling, Arndt F.] Hamburg Univ Technol, Biomech Sect, D-21079 Hamburg, Germany.
   [Gildenhaar, Renate; Berger, Georg] Fed Inst Mat Res & Testing, Berlin, Germany.
   [Janssen, Rolf; Fritsch, Daniel] Hamburg Univ Technol, Inst Adv Ceram, Hamburg, Germany.
RP Schilling, AF (reprint author), Hamburg Univ Technol, Biomech Sect, Denickestr 15, D-21079 Hamburg, Germany.
EM a.schilling@tuhh.de
FU German Research Community (DFG) [EI467/3-1]; Kurt-Eberhard-Bode-Trust,
   Stifterverband fur die Deutsche Wissenschaft, Essen, Germany
FX Elisa Hoenig was supported by a grant of the German Research Community
   (DFG) EI467/3-1. Arndt F. Schilling is supported by an unrestricted
   grant of the Kurt-Eberhard-Bode-Trust, Stifterverband fur die Deutsche
   Wissenschaft, Essen, Germany.
CR Bocaege E, 2010, AM J PHYS ANTHROPOL, V141, P498, DOI 10.1002/ajpa.21233
   BOYDE A, 1990, J MICROSC-OXFORD, V158, P261, DOI 10.1111/j.1365-2818.1990.tb02999.x
   BOYDE A, 1986, J MICROSC-OXFORD, V143, P257, DOI 10.1111/j.1365-2818.1986.tb02782.x
   Craelius W, 2002, SCIENCE, V295, P1018, DOI 10.1126/science.295.5557.1018
   DEBARI K, 1995, CALCIFIED TISSUE INT, V56, P566, DOI 10.1007/BF00298591
   Dehoux E, 2005, REV CHIR ORTHOP, V91, P143, DOI 10.1016/S0035-1040(05)84292-8
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Hang JR, 2009, J ORAL MAXIL SURG, V67, P257, DOI 10.1016/j.joms.2008.08.009
   JONES SJ, 1986, ANAT EMBRYOL, V174, P265, DOI 10.1007/BF00824342
   Knabe C, 2008, J BIOMED MATER RES A, V84A, P856, DOI 10.1002/jbm.a.31383
   Knabe C, 2005, CLIN ORAL IMPLAN RES, V16, P119, DOI 10.1111/j.1600-0501.2004.01066.x
   Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9
   Kraal T, 2008, KNEE, V15, P201, DOI 10.1016/j.knee.2008.02.005
   Krenn A., 2007, IMAGING MICROSCOPY, V9, P38
   Li A, 2009, J BURN CARE RES, V30, P717, DOI 10.1097/BCR.0b013e3181abffca
   Markowitz K, 2010, ARCH ORAL BIOL, V55, P60, DOI 10.1016/j.archoralbio.2009.11.002
   Nieponice A, 2010, TISSUE ENG PT A, V16, P1215, DOI 10.1089/ten.TEA.2009.0427
   Rueger JM, 1998, ORTHOPADE, V27, P72
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   SCHILLING AF, 2006, EUR J TRAUMA, V32, P107
   Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963
   SWEDLOW DB, 1975, BIOMATER ARTIF CELL, V3, P121, DOI 10.3109/10731197509118617
   Tkachenko EV, 2009, BONE, V45, P487, DOI 10.1016/j.bone.2009.05.019
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 24
TC 6
Z9 6
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD APR
PY 2010
VL 33
IS 4
BP 198
EP 203
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 627MI
UT WOS:000280043400003
PM 20458689
DA 2018-10-20
ER

PT J
AU Brammer, KS
   Oh, S
   Frandsen, CJ
   Jin, S
AF Brammer, Karla S.
   Oh, Seunghan
   Frandsen, Christine J.
   Jin, Sungho
TI TiO2 nanotube structures for enhanced cell and biological functionality
SO JOM
LA English
DT Article
ID TITANIUM; SURFACES; BONE; IMPLANTS; GROWTH; NANOTOPOGRAPHY; BEHAVIOR;
   FATE
AB Nanostructures have pronounced effects on biological processes such as growth of cells and their functionality. Advances in biomaterial surface structure and design have resulted in improved tissue engineering. Nanotechnology can be utilized for optimization of titanium implants with a formation of vertically aligned TiO2 nanotube arrays on the implant surface. The anodic oxidation of the titanium implant surface to form a TiO2 nanotube array involves electrochemical processes and self assembly. In this paper, the mechanism of nanotube formation, nanotube bio-characteristics, and their emerging role in soft and hard tissue engineering as well as in regenerative medicine will be reviewed, and the beneficial effects of surface nanotubes on cell adhesion, proliferation, and functionality will be discussed in relation to potential orthopedics applications.
C1 [Brammer, Karla S.; Oh, Seunghan; Frandsen, Christine J.; Jin, Sungho] Univ Calif San Diego, Dept Mat Sci & Engn, La Jolla, CA 92093 USA.
   [Oh, Seunghan] Wonkwang Univ, Dept Dent Biomat, Coll Dent, Iksan, South Korea.
RP Brammer, KS (reprint author), Univ Calif San Diego, Dept Mat Sci & Engn, La Jolla, CA 92093 USA.
EM jin@ucsd.edu
CR Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Curtis ASG, 2006, NANOMEDICINE-UK, V1, P67, DOI 10.2217/17435889.1.1.67
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2009, NANOMEDICINE-UK, V4, P247, DOI [10.2217/nnm.09.1, 10.2217/NNM.09.1]
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   INGBER DE, 1993, J CELL SCI, V104, P613
   LINDER L, 1988, J BONE JOINT SURG BR, V70, P550
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   OH S, 2009, RECENT DEV ADV MED D, P199
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Prakasam HE, 2007, J PHYS CHEM C, V111, P7235, DOI 10.1021/jp070273h
   PRAKASH S, 2005, ADV INORG CHEM, V2, P2
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   SATOMI K, 1988, J PROSTHET DENT, V59, P339, DOI 10.1016/0022-3913(88)90187-4
   TAO J, 2008, NEW J CHEM, V32, P2159
NR 30
TC 15
Z9 15
U1 1
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
J9 JOM-US
JI JOM
PD APR
PY 2010
VL 62
IS 4
BP 50
EP 55
DI 10.1007/s11837-010-0059-x
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 584RL
UT WOS:000276770100009
DA 2018-10-20
ER

PT J
AU Patel, SS
   Owida, AA
   Morsi, YS
AF Patel, Shital S.
   Owida, Amal A.
   Morsi, Yos S.
TI RETRACTED: Microwave sterilization of bovine pericardium for heart valve
   applications (Retracted Article. See vol 13, pg 182, 2010)
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article; Retracted Publication
DE Bioprosthetic valve; Fixation; Sterilization; Microwaves; Bovine
   pericardium
ID FIXATION; CELLS; CALCIFICATION; DESTRUCTION; IRRADIATION; PREVENTION;
   RADIATION; TISSUE; ENERGY
AB It is widely recognised that the bioprosthetic valves widely used for heart valve replacements have some drawbacks, for example tearing and occurrence of infections, which can be attributed to the fixation and sterilization techniques currently available. These techniques adversely affect the physical properties, functionality, and lifespan of the leaflets. In the work discussed in this paper we examined a novel procedure of using high-frequency microwaves to fix and disinfect the pericardium, without causing any harmful affects. The test bacteria used were Escherichia coli and Staphylococcus aureus. The pericardium was exposed to microwaves at a frequency of 18 GHz for three consecutive replicates. The findings indicated that there was almost complete inactivation of the bacteria on the biomaterial without compromising the biocompatibility, which was studied using ovine fibroblasts. An effective fixation and sterilization procedure, that is quick and has no adverse effects is presented and discussed.
C1 [Patel, Shital S.; Owida, Amal A.] Swinburne Univ Technol, Fac Engn & Ind Sci, AD220, Hawthorn, Vic 3122, Australia.
   [Morsi, Yos S.] Swinburne Univ Technol, Fac Engn & Ind Sci, EN707C, Hawthorn, Vic 3122, Australia.
RP Patel, SS (reprint author), Swinburne Univ Technol, Fac Engn & Ind Sci, AD220, 533-545 Burwood Rd, Hawthorn, Vic 3122, Australia.
EM spatel@swin.edu.au
CR Acton A, 2005, DEV DYNAM, V233, P1464, DOI 10.1002/dvdy.20448
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   Avci B, 2006, BIOTECH HISTOCHEM, V81, P63, DOI 10.1080/10520290600783044
   Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4
   Bazinet RP, 2005, NEUROCHEM RES, V30, P597, DOI 10.1007/s11064-005-2746-5
   DARDANONI L, 1985, J BIOELECTRICITY, V4, P171, DOI 10.3109/15368378509040371
   Dincer AH, 2004, CRIT REV MICROBIOL, V30, P197, DOI 10.1080/10408410490468803
   DREYFUSS MS, 1980, APPL ENVIRON MICROB, V39, P13
   Dunsmuir RA, 2003, J CLIN MICROBIOL, V41, P4755, DOI 10.1128/JCM.41.10.4755-4757.2003
   Gedikli S., 2008, J APPL BIOL SCI, V2, P67
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   HEDDLESON RA, 1994, J FOOD PROTECT, V57, P1025, DOI 10.4315/0362-028X-57.11.1025
   HEDDLESON RA, 1994, J FOOD SCI, V59, P447, DOI 10.1111/j.1365-2621.1994.tb06987.x
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hyland G. J., 1998, Engineering Science and Education Journal, V7, P261, DOI 10.1049/esej:19980606
   Kozempel M, 2000, J FOOD PROCESS PRES, V24, P287, DOI 10.1111/j.1745-4549.2000.tb00420.x
   Morsi YS, 2004, INT J ARTIF ORGANS, V27, P445
   Ozawa H, 2004, J ENDOCRINOL, V183, P507, DOI 10.1677/joe.1.05656
   PATHAK YV, 1990, BIOMATERIALS, V11, P718, DOI 10.1016/0142-9612(90)90034-N
   PHILLIP S, 2008, WASHINGTON MANUAL CA, P212
   Shamis Y, 2008, INT J FOOD ENG, V4, DOI 10.2202/1556-3758.1360
   Shazman A., 2007, Food Chemistry, V103, P444, DOI 10.1016/j.foodchem.2006.08.024
   Stein PD, 2001, CHEST, V119, p220S, DOI 10.1378/chest.119.1_suppl.220S
   Sung HW, 1997, J BIOMED MATER RES, V37, P376, DOI 10.1002/(SICI)1097-4636(19971205)37:3<376::AID-JBM8>3.0.CO;2-I
   THUERY J, 1985, MICROWAVES IND SCI M
   Uchiyama K, 2005, J ORTHOP SCI, V10, P77, DOI 10.1007/s00776-004-0857-5
   Vasudev SC, 1999, J MATER SCI-MATER M, V10, P121, DOI 10.1023/A:1008925204988
   Woo IS, 2000, APPL ENVIRON MICROB, V66, P2243, DOI 10.1128/AEM.66.5.2243-2247.2000
NR 28
TC 2
Z9 2
U1 2
U2 11
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1434-7229
EI 1619-0904
J9 J ARTIF ORGANS
JI J. Artif. Organs
PD APR
PY 2010
VL 13
IS 1
BP 24
EP 30
DI 10.1007/s10047-010-0489-9
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 578AB
UT WOS:000276264500005
PM 20213454
DA 2018-10-20
ER

PT J
AU Bass, JD
   Belamie, E
   Grosso, D
   Boissiere, C
   Coradin, T
   Sanchez, C
AF Bass, John D.
   Belamie, Emmanuel
   Grosso, David
   Boissiere, Cedric
   Coradin, Thibaud
   Sanchez, Clement
TI Nanostructuration of titania films prepared by self-assembly to affect
   cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE adhesion; nanotopography; titanium oxide; sol-gel techniques;
   self-assembly
ID THIN-FILMS; SURFACE-CHEMISTRY; PROTEIN ADSORPTION; OSTEOBLASTIC CELLS;
   TOPOGRAPHY; ROUGHNESS; DIFFERENTIATION; PROLIFERATION; FIBRONECTIN;
   STABILITY
AB Nanostructured and dense titania films prepared by evaporation-induced self-assembly (EISA) are shown to Possess tunable topographical nanoscale features on the order 2-12 run. Thermal treatment (calcination) induces a transition from amorphous titania to crystalline anatase that modifies the chemical and Structural properties of the surfaces via the migration of matter. For nanostructured films, the nanoporous network changes from organized ellipsoidal pores, similar to 4 nm x 2 nm, to a grid-like structure with pores on the order of 12 nm, whereas dense films show a slight roughening of the surface. Cells seeded on templated films show measurable, statistically significant differences in morphology compared with cells seeded on dense films. Moreover, although crystallization of templated films results in Surfaces that promote less well-spread cells with higher circularities, the opposite trend is observed for dense films. As such, these results represent a new method to tailor interfaces for biomaterial applications, using EISA to control material patterning on the nanoscale. This self-assembly based approach allows the patterning on size scales that are inaccessible by most traditional techniques while offering the added pontential to package and control the release of bioactive molecules. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 96-106, 2010
C1 [Bass, John D.; Belamie, Emmanuel; Grosso, David; Boissiere, Cedric; Coradin, Thibaud; Sanchez, Clement] Univ Paris 06, UMR 7574, CNRS, Lab Chim Mat Condensee, F-75252 Paris 05, France.
RP Belamie, E (reprint author), CNRS UM2 ENSCM UM 1 Equipe MACS 8, Ecole Part Hautes Etud, Inst Charles Gerhardt Montpellier, UMR 5253, Rue Ecole Normale, F-34296 Montpellier 5, France.
EM emmanuel.belamie@enscm.fr
RI SANCHEZ, CLEMENT/B-7097-2014; Grosso, David/H-7133-2012; Coradin,
   Thibaud/L-8932-2013; Grosso, David/K-9500-2015
OI Sanchez, Clement/0000-0002-6426-4844
CR Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Bass JD, 2008, CHEM MATER, V20, P5550, DOI 10.1021/cm8010106
   Bass JD, 2008, J AM CHEM SOC, V130, P7882, DOI 10.1021/ja078140x
   Bass JD, 2007, CHEM MATER, V19, P4349, DOI 10.1021/cm071305g
   Boissiere C, 2005, LANGMUIR, V21, P12362, DOI 10.1021/la050981z
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Cohen M, 2004, CHEMBIOCHEM, V5, P1393, DOI 10.1002/cbic.200400162
   Crepaldi EL, 2003, ANGEW CHEM INT EDIT, V42, P347, DOI 10.1002/anie.200390113
   Curtis A S G, 2004, Eur Cell Mater, V8, P27
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904
   Grosso D, 2003, CHEM MATER, V15, P4562, DOI 10.1021/cm031060h
   Grosso D, 2004, ADV FUNCT MATER, V14, P309, DOI 10.1002/adfm.200305036
   Hadjiivanov KI, 1996, CHEM SOC REV, V25, P61, DOI 10.1039/cs9962500061
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Kuhlman W, 2007, BIOMACROMOLECULES, V8, P3206, DOI 10.1021/bm070237o
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lu Y, 2006, J BIOMED MATER RES A, V77A, P396, DOI 10.1002/jbm.a.30601
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Nebe B, 2004, MAT SCI ENG C-BIO S, V24, P619, DOI 10.1016/j.msec.2004.08.034
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Peterson A, 2007, APPL SURF SCI, V253, P5767, DOI 10.1016/j.apsusc.2006.12.094
   Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Sanchez C, 2008, CHEM MATER, V20, P682, DOI 10.1021/cm702100t
   Scotchford CA, 2003, BIOMATERIALS, V24, P1147, DOI 10.1016/S0142-9612(02)00488-X
   SLOWING H, 2007, ADV FUNCT MATER, V17, P1225
   Spoerke ED, 2008, J BIOMED MATER RES A, V84A, P402, DOI 10.1002/jbm.a.31317
   Steinberg T, 2007, NANO LETT, V7, P287, DOI 10.1021/nl06227z
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   VALLETREGI V, 2001, CHEM MATER, V13, P308
   Vitte J, 2004, Eur Cell Mater, V7, P52
   Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 42
TC 8
Z9 8
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 96
EP 106
DI 10.1002/jbm.a.32477
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800011
PM 19536826
DA 2018-10-20
ER

PT J
AU Spin-Neto, R
   de Freitas, RM
   Pavone, C
   Cardoso, MB
   Campana, SP
   Marcantonio, RAC
   Marcantonio, E
AF Spin-Neto, Rubens
   de Freitas, Rubens Moreno
   Pavone, Chaine
   Cardoso, Marcia Barreto
   Campana-Filho, Sergio Paulo
   Chierici Marcantonio, Rosemary Adriana
   Marcantonio, Elcio, Jr.
TI Histological evaluation of chitosan-based biomaterials used for the
   correction of critical size defects in rat's calvaria
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatible material; bone regeneration; chitosan
ID GUIDED BONE REGENERATION; BIOABSORBABLE PHYSICAL BARRIER;
   HISTOMORPHOMETRIC ANALYSIS; CHITIN DERIVATIVES; DELIVERY; DOGS;
   ACTIVATION; MEMBRANES; CARRIERS; RHBMP-2
AB Chitosan, a biopolymer obtained from chitin, and its derivates, such as chitosan hydrochloride, has been reported as wound healing accelerators and as possible bone substitutes for tissue engineering, and therefore these Substances could be relevant in dentistry and periodontology. The purpose of this investigation was to make a histological evaluation of chitosan and chitosan hydrochloride biomaterials (gels) used in the correction of critical size bone defects made in rat's calvaria. Bone defects of 8 mm in diameter were surgically created in the calviria of 50 Holtzman (Rattus norvegicus) rats and filled with blood clot (control), low molecular weight chitosan, high molecular weight chitosan, low molecular weight chitosan hydrochloride, and high molecular weight chitosan hydrochloride, numbering 10 animals, divided into two experimental periods (15 and 60 days), for each biomaterial. The histological evaluation was made based on the morphology of the new-formed tissues in defect's region, and the results indicated that there was no statistical difference between the groups when the new bone formation in the entire defect's area were compared (p > 0.05) and, except in the control groups, assorted degrees of inflammation Could be Seen. In Conclusion, chitosan and chitosan hydrochloride biomaterials used in this study were not able to promote new bone formation in critical size defects made in rat's calvaria. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 107-114, 2016
C1 [Spin-Neto, Rubens; de Freitas, Rubens Moreno; Pavone, Chaine; Cardoso, Marcia Barreto; Marcantonio, Elcio, Jr.] Sao Paulo State Univ, Dept Periodontol, Araraquara Dent Sch, Sao Paulo, Brazil.
   [Campana-Filho, Sergio Paulo; Chierici Marcantonio, Rosemary Adriana] Univ Sao Paulo, Dept Organ Chem, Sao Carlos Chem Inst, Sao Paulo, Brazil.
RP Spin-Neto, R (reprint author), Sao Paulo State Univ, Dept Periodontol, Araraquara Dent Sch, Sao Paulo, Brazil.
EM elciojr@foar.unesp.br
RI Campana-Filho, Sergio Paulo/I-5769-2012; Spin-Neto, Rubens/A-8620-2013;
   Marcantonio, Rosemary/C-2039-2012; Marcantonio, Elcio/A-4784-2008
OI Campana-Filho, Sergio Paulo/0000-0002-0980-0085; Spin-Neto,
   Rubens/0000-0002-9562-0610; Marcantonio, Rosemary/0000-0002-5052-7439;
   Marcantonio, Elcio/0000-0003-1294-2305; Marcantonio Junior,
   Elcio/0000-0002-9660-4524
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Asikainen AJ, 2007, J BIOMED MATER RES A, V83A, P530, DOI 10.1002/jbm.a.31225
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   Cancian DCJ, 2004, INT J ORAL MAX IMPL, V19, P73
   Cardoso AKMV, 2006, CELLS TISSUES ORGANS, V184, P128, DOI 10.1159/000099619
   Carvalho VAP, 2004, INT J ORAL MAX IMPL, V19, P679
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chesmel KD, 1998, J ORAL MAXIL SURG, V56, P857, DOI 10.1016/S0278-2391(98)90015-5
   Develioglu H, 2007, J BIOMED MATER RES A, V80A, P505, DOI 10.1002/jbm.a.31121
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Furlaneto FAC, 2007, CLIN ORAL IMPLAN RES, V18, P311, DOI 10.1111/j.1600-0501.2006.01331.x
   Furusawa T, 1997, Implant Dent, V6, P93, DOI 10.1097/00008505-199700620-00003
   Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   Inoda H, 2007, INT J ORAL MAX SURG, V36, P39, DOI 10.1016/j.ijom.2006.07.011
   Kamiyama K, 1999, BIOL PHARM BULL, V22, P179
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kosaka T, 1996, J VET MED SCI, V58, P963, DOI 10.1292/jvms.58.10_963
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Lin YF, 2007, J BIOMED MATER RES A, V81A, P900, DOI 10.1002/jbm.a.31149
   Issa JPM, 2008, MICRON, V39, P952, DOI 10.1016/j.micron.2007.11.001
   Issa JPM, 2008, MICRON, V39, P373, DOI 10.1016/j.micron.2007.03.008
   Mellonig JT, 1998, INT J PERIODONT REST, V18, P139
   Mellonig JT, 1998, INT J PERIODONT REST, V18, P129
   Miguel FB, 2006, J BIOMED MATER RES B, V78B, P334, DOI 10.1002/jbm.b.30492
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Mori T, 2005, J VET MED SCI, V67, P51, DOI 10.1292/jvms.67.51
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   PARADOSSI G, 1992, INT J BIOL MACROMOL, V14, P73, DOI 10.1016/0141-8130(92)90002-P
   Park JS, 2003, J CLIN PERIODONTOL, V30, P443, DOI 10.1034/j.1600-051X.2003.10283.x
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Park YK, 2000, J CONTROL RELEASE, V69, P97, DOI 10.1016/S0168-3659(00)00298-4
   Pryor ME, 2006, J CLIN PERIODONTOL, V33, P455, DOI 10.1111/j.1600-051X.2006.00921.x
   Senel S, 2000, INT J PHARM, V193, P197, DOI 10.1016/S0378-5173(99)00334-8
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shahidi F, 2005, ADV FOOD NUTR RES, V49, P93, DOI 10.1016/S1043-4526(05)49003-8
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Ueno H, 2001, BIOMATERIALS, V22, P1667, DOI 10.1016/S0142-9612(00)00328-8
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   WILLIAMS KR, 1987, BIOMATERIALS, V8, P254, DOI 10.1016/0142-9612(87)90112-8
   Zahraoui C, 1999, BONE, V25, p63S, DOI 10.1016/S8756-3282(99)00136-2
NR 49
TC 13
Z9 15
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 107
EP 114
DI 10.1002/jbm.a.32491
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800012
PM 19536827
DA 2018-10-20
ER

PT J
AU Esguerra, M
   Fink, H
   Laschke, MW
   Jeppsson, A
   Delbro, D
   Gatenholm, P
   Menger, MD
   Risberg, B
AF Esguerra, Maricris
   Fink, Helen
   Laschke, Matthias W.
   Jeppsson, Anders
   Delbro, Dick
   Gatenholm, Paul
   Menger, Michael D.
   Risberg, Bo
TI Intravital fluorescent microscopic evaluation of bacterial cellulose as
   scaffold for vascular grafts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bacterial cellulose; biomaterial; biocamptability; dorsal skinfold
   chamber; intravital fluorescence microscopy
ID IN-VIVO; SMOOTH-MUSCLE; BIODEGRADABLE POLYMER; EXTRACELLULAR-MATRIX;
   NEOVASCULARIZATION; MECHANISMS; PROSTHESES; BIOCOMPATIBILITY;
   PERMEABILITY; ARCHITECTURE
AB Although commonly used synthetic vascular grafts perform satisfactorily in large caliber blood vessels, they are prone to thrombosis in small diameter vessels. Therefore, small vessels might benefit from tissue engineered vascular grafts. This study evaluated bacterial cellulose (BC) as a potential biomaterial for biosynthetic blood vessels. We implanted the dorsal skinfold chambers in three groups of Syrian golden hamsters with BC (experimental group), polyglycolic acid, or expanded polytetrafluorethylane (control groups). Following implantation, we used intravital fluorescence microscopy, histology, and immunochemistry to analyze the biocompatibility, neovascularization, and incorporation of each material over a time period of 2 weeks. Biocompatibility was good in all groups, as indicated by the absence of leukocyte acti-vation upon implantation. All groups displayed angiogenic response in the host tissue, but that response was highest in the polyglycolic acid group. Histology revealed vascularized granulation tissue Surrounding all three biomaterials, with many proliferating cells and a lack of apoptotic cell death 2 weeks after implantation. In conclusion, BC offers good biocompatibility and material incorporation compared with commonly used materials in vascular surgery. Thus, BC represents a promising new biomaterial for tissue engineering of vascular grafts. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 140-149, 2010
C1 [Esguerra, Maricris; Fink, Helen; Risberg, Bo] Sahlgrens Univ Hosp, Vasc Engn Ctr, Gothenburg, Sweden.
   [Laschke, Matthias W.; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, D-6650 Homburg, Saarland, Germany.
   [Jeppsson, Anders] Sahlgrens Univ Hosp, Dept Cardiothorac Surg, Gothenburg, Sweden.
   [Delbro, Dick] Sahlgrens Univ Hosp, Dept Surg, Gothenburg, Sweden.
   [Delbro, Dick] Univ Karlstad, Sch Pure & Appl Nat Sci, Karlstad, Sweden.
   [Gatenholm, Paul] Chalmers, Dept Biol & Chem Engn, S-41296 Gothenburg, Sweden.
RP Risberg, B (reprint author), Sahlgrens Univ Hosp, Vasc Engn Ctr, Gothenburg, Sweden.
EM bo.risberg@surgery.gu.se
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   CLOWES AW, 1986, J VASC SURG, V3, P877, DOI 10.1067/mva.1986.avs0030877
   CLOWES AW, 1987, AM J SURG, V153, P501, DOI 10.1016/0002-9610(87)90802-6
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Heydarkhan-Hagvall S, 2006, TISSUE ENG, V12, P831, DOI 10.1089/ten.2006.12.831
   Higgins SP, 2003, J BIOMED MATER RES A, V67A, P295, DOI 10.1002/jbm.a.10599
   JONES DN, 1991, J VASC SURG, V14, P441, DOI 10.1016/0741-5214(91)90237-O
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kennedy JH, 1998, J THORAC CARDIOV SUR, V115, P545
   Lahtinen M, 2007, EUR J CARDIO-THORAC, V31, P383, DOI 10.1016/j.ejcts.2006.11.048
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   LEUNIG M, 1992, CANCER RES, V52, P6553
   MENGER MD, 1990, EUR J CARDIO-THORAC, V4, P191, DOI 10.1016/1010-7940(90)90003-I
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Salzmann DL, 1999, CARDIOVASC PATHOL, V8, P63, DOI 10.1016/S1054-8807(98)00003-9
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shinoka T, 2002, ARTIF ORGANS, V26, P402, DOI 10.1046/j.1525-1594.2002.07004.x
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   SHUMTIM D, 1999, ANN THORAC SURG, V68, P2305
   Sokolnicki AM, 2006, J MEMBRANE SCI, V272, P15, DOI 10.1016/j.memsci.2005.06.065
   Solan A, 2001, TRANSPLANT P, V33, P66, DOI 10.1016/S0041-1345(00)01909-6
   ZACHARIAS RK, 1987, J VASC SURG, V6, P429, DOI 10.1067/mva.1987.avs0060429
NR 31
TC 24
Z9 28
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 140
EP 149
DI 10.1002/jbm.a.32516
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800016
PM 19536832
DA 2018-10-20
ER

PT J
AU Jay, SM
   Skokos, EA
   Zeng, JM
   Knox, K
   Kyriakides, TR
AF Jay, Steven M.
   Skokos, Eleni A.
   Zeng, Jianmin
   Knox, Kristin
   Kyriakides, Themis R.
TI Macrophage fusion leading to foreign body giant cell formation persists
   under phagocytic stimulation by microspheres in vitro and in vivo in
   mouse models
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE foreign body giant cell; foreign body response; macrophage fusion;
   inflammation
ID BIOMATERIALS; ACTIVATION; ADHESION; DIFFERENTIATION; INFLAMMATION;
   MECHANISMS; INHIBITOR; RESPONSES; BEHAVIOR
AB The formation of surface-damaging foreign body giant cells (FBGC) from the fusion of macrophages is considered a hallmark of the foreign body response. Experimental evidence indicates that when macrophages ire unable to internalize foreign bodies via phagocytosis due to their large size, they acquire a fusogenic phenotype. The mechanism behind this transformation is unclear, and questions, Such as which phenotype takes precedence for co-stimulated macrophages engaged in the foreign body response and whether or not such phenotypic alteration is graded, remain unanswered. By recapitulating fusion ill vitro using Cell lines and primary mouse bone marrow-derived macrophages, we investigated whether concurrent exposure of macrophages to phagocytic and fusogenic stimuli would limit fusion. Induction of phagocytosis by addition of 3.0 mu m-diameter polystyrene microspheres to cells Under fusogenic conditions, at ratios of 1:10, 1:1, and 10:1 did not prevent fusion. To determine the effect of microsphere phagocytosis on fusion ill vivo, we first determined the kinetics of monocyte recruitment, surface adhesion, and fusion following intraperitoneal implantation) of a foreign body in a mouse model. Concomitant or subsequent injection of microspheres resulted in their significant accumulation at the biomaterial surface at 2 weeks, but FBGC were still detected. Our findings indicate that despite increasing the abundance of a phagocytic stimulus (microspheres), significant FBGC formation occurs. (E) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 189-199, 2010
C1 [Skokos, Eleni A.; Zeng, Jianmin; Kyriakides, Themis R.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA.
   [Jay, Steven M.; Knox, Kristin; Kyriakides, Themis R.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
   [Jay, Steven M.; Skokos, Eleni A.; Zeng, Jianmin; Kyriakides, Themis R.] Yale Univ, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA.
RP Kyriakides, TR (reprint author), Yale Univ, Dept Pathol, Amistad Bldg 301C,10 Amistad St, New Haven, CT 06520 USA.
EM themis.kyriakides@yale.edu
OI Jay, Steven/0000-0002-3827-5988
FU National Institutes of Health [GM 072194-01]
FX Contract grant sponsor: National Institutes of Health Grant; contract
   grant number: GM 072194-01
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 2002, CARDIOVASC PATHOL, V2, pS33
   Avital A, 2002, AM J RESP CELL MOL, V27, P511, DOI 10.1165/rcmb.2002-0028OC
   Boynton EL, 1995, CAN J SURG, V38, P507
   Chamberlain LM, 2009, J BIOMED MATER RES A, V88A, P858, DOI 10.1002/jbm.a.31930
   Fujikawa Yosuke, 2005, Mod Rheumatol, V15, P346
   Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101
   Gil CD, 2006, INFLAMM RES, V55, P99, DOI 10.1007/s00011-005-0059-4
   Godek Marisha L, 2004, Biomed Sci Instrum, V40, P7
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   LEAKE ES, 1975, J RETICULOENDOTH SOC, V17, P370
   Li HM, 2005, J EXP MED, V201, P1169, DOI 10.1081/jem.20011111
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Matsukawa A, 2006, FASEB J, V20, P302, DOI 10.1096/fj.04-1728fje
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2008, EXP MOL PATHOL, V84, P37, DOI 10.1016/j.yexmp.2007.10.005
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Mullerad J, 2000, CYTOKINE, V12, P1683, DOI 10.1006/cyto.2000.0775
   Nishimura M, 2005, J ORTHOP RES, V23, P979, DOI 10.1016/j.orthres.2005.01.004
   SEYMOUR L, 1991, CELL BIOL INT REP, V15, P277, DOI 10.1016/0309-1651(91)90166-G
   Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064
   TABATA Y, 1990, ADV POLYM SCI, V94, P107
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123
   Xing S, 2002, J BIOMED MATER RES, V61, P619, DOI 10.1002/jbm.10078
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 38
TC 20
Z9 20
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 189
EP 199
DI 10.1002/jbm.a.32513
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800021
PM 19536825
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Smith, RA
   Maghsoodpour, A
   Hallab, NJ
AF Smith, Richard A.
   Maghsoodpour, Anobel
   Hallab, Nadim James
TI In vivo response to cross-linked polyethylene and polycarbonate-urethane
   particles
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyethylene; polycarbonate-urethane; in vivo; particles; osteolysis
ID RELEVANT UHMWPE PARTICLES; OVINE ARTHROPLASTY MODEL; TOTAL-JOINT
   ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; WEAR PARTICLES; TITANIUM
   PARTICLES; BONE-RESORPTION; BIOMATERIAL PARTICLES; KNEE ARTHROPLASTY;
   CYTOKINE RESPONSE
AB This study Was undertaken to examine macrophage response to polycarbonate-urethane, a proposed alternative material to polyethylene in acetabular components of total hip arthroplasty. Polyethylene wear debris from total joint replacements has been linked to osteolysis and implant lifespan. It has been shown in vitro, that polyethylene particles cleaned of endotoxin generate less of all inflammatory cytokine response than endotoxin bound particles. Comparative particle induced effects on implant fixation were tested using endotoxin free cross-linked ultra-high molecular weight polyethylene (x-UHMWPE) and polycarbonate-urethane (PCU) particles with and without intraperitoneal injection (IP) of lipopolysaccharide (LPS) using a Ti-alloy femoral intramedullary nail rat model. MicroCT and mechanical testing assessment of peri-implant bone indicated significantly less bone and lower fixation strength, respectively, when the implant Was surrounded by xUHMWPE particles compared to PCU particles (with and without LPS IP). This indicates particles of PCU may be less disruptive to bone-implant fixation than X-UHMWPE ill vivo, Under both ITS free and challenged conditions. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 227-234, 2010
C1 [Smith, Richard A.] Univ Tennessee, Campbell Clin, Dept Orthopaed Surg, Memphis, TN 38163 USA.
   [Maghsoodpour, Anobel] Univ Tennessee, Ctr Hlth Sci, Dept Biomed Engn & Imaging, Memphis, TN 38163 USA.
   [Hallab, Nadim James] Rush Univ, Med Ctr, Dept Orthopaed Surg, Chicago, IL 60612 USA.
RP Smith, RA (reprint author), Univ Tennessee, Campbell Clin, Dept Orthopaed Surg, Memphis, TN 38163 USA.
EM rsmith@utmem.edu
FU Active Implants, Inc
FX Contract grant sponsor: Active Implants, Inc
CR Baumann B, 2005, J ORTHOP RES, V23, P1241, DOI 10.1016/j.orthres.2005.02.017
   Baumann B, 2004, ACTA ORTHOP SCAND, V75, P295, DOI 10.1080/00016470410001222
   Baumann B, 2006, BIOMED TECH, V51, P360, DOI 10.1515/BMT.2006.070
   CARAVIA L, 1993, WEAR, V160, P191, DOI 10.1016/0043-1648(93)90420-Q
   Cho DR, 2002, J ORTHOPAED RES, V20, P704, DOI 10.1016/S0736-0266(01)00179-6
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   Dowson D, 1991, Proc Inst Mech Eng H, V205, P59, DOI 10.1243/PIME_PROC_1991_205_269_02
   Espehaug B, 1997, J BONE JOINT SURG BR, V79B, P590, DOI 10.1302/0301-620X.79B4.7420
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Hiki N, 2003, J TRAUMA, V54, P584, DOI 10.1097/01.TA.0000060180.29719.57
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   Ingram J, 2002, BIO-MED MATER ENG, V12, P177
   Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P99, DOI 10.2106/JBJS.F.00102
   JENNINGS LM, 2002, ENG SURG, P13
   Khan M, 2005, BIOMATERIALS, V26, P633, DOI 10.1016/j.biomaterials.2004.02.064
   Khan M, 2005, BIOMATERIALS, V26, P621, DOI 10.1016/j.biomaterials.2004.02.065
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   KWON SY, 2000, 46 ANN M ORTH RES SO, P25
   Mariani BD, 1996, CLIN ORTHOP RELAT R, P11
   Matthews JB, 2000, BIO-MED MATER ENG, V10, P229
   Matthews JB, 2000, J BIOMED MATER RES, V52, P296, DOI 10.1002/1097-4636(200011)52:2<296::AID-JBM8>3.0.CO;2-9
   Miyoshi M, 2003, AM J PHYSIOL-REG I, V284, pR1092, DOI 10.1152/ajpregu.00700.2002
   Nalepka JL, 2006, CLIN ORTHOP RELAT R, P229, DOI 10.1097/01.blo.0000224050.94248.38
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Orishimo KF, 2003, J ARTHROPLASTY, V18, P546, DOI 10.1016/S0883-5403(03)00147-5
   Orishimo KF, 2003, J BONE JOINT SURG AM, V85A, P1095, DOI 10.2106/00004623-200306000-00018
   PINCHUK LS, 2006, TRIBOL INTERFACE ENG, V50, P175
   Pioletti DP, 2002, J BIOMED MATER RES, V61, P408, DOI 10.1002/jbm.10218
   Quan N, 2003, BRAIN RES BULL, V59, P447, DOI 10.1016/S0361-9230(02)00951-6
   Quigley FP, 2002, P I MECH ENG H, V216, P77, DOI 10.1243/0954411021536306
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   Ramachandran R, 2006, J BIOMED MATER RES A, V77A, P512, DOI 10.1002/jbm.a.30649
   Sabokbar A, 2003, J MATER SCI-MATER M, V14, P731, DOI 10.1023/A:1025088418878
   Sabokbar A, 2003, J ORTHOPAED RES, V21, P73, DOI 10.1016/S0736-0266(02)00106-7
   Schwartz CJ, 2007, WEAR, V262, P331, DOI 10.1016/j.wear.2006.05.018
   Shaju KA, 2005, J ARTHROPLASTY, V20, P903, DOI 10.1016/j.arth.2005.02.005
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   Skoglund B, 2002, J BONE JOINT SURG BR, V84B, P767, DOI 10.1302/0301-620X.84B5.11775
   SMITH RA, 2007, 6 COMB M ORTH RES SO, P21
   Smith SL, 2000, J BIOMED MATER RES, V53, P710, DOI 10.1002/1097-4636(2000)53:6<710::AID-JBM14>3.3.CO;2-I
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   Tobias PS, 1997, J PERIODONTAL RES, V32, P99, DOI 10.1111/j.1600-0765.1997.tb01388.x
   Tomazic-Jezic VJ, 2001, J BIOMED MATER RES, V55, P523, DOI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G
   Vermes C, 2001, J BONE JOINT SURG AM, V83A, P201, DOI 10.2106/00004623-200102000-00007
   von Knoch M, 2004, J ORTHOPAED RES, V22, P237, DOI 10.1016/j.orthres.2003.08.013
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Wiggins MJ, 2004, J BIOMED MATER RES A, V68A, P668, DOI 10.1002/jbm.a.20081
   Wooley PH, 1999, J BONE JOINT SURG AM, V81A, P616, DOI 10.2106/00004623-199905000-00003
   Xing ZQ, 2007, J BIOMED MATER RES B, V83B, P354, DOI 10.1002/jbm.b.30803
   Xing ZQ, 2006, J ORTHOP RES, V24, P959, DOI 10.1002/jor.20038
NR 54
TC 25
Z9 26
U1 2
U2 22
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 227
EP 234
DI 10.1002/jbm.a.32531
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800025
PM 19557792
DA 2018-10-20
ER

PT J
AU Ariganello, MB
   Labow, RS
   Lee, JM
AF Ariganello, Marianne B.
   Labow, Rosalind S.
   Lee, J. Michael
TI In vitro response of monocyte-derived macrophages to a decellularized
   pericardial biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage; decellularized bovine pericardium; acid phosphatase;
   collagen; biomaterials
ID BIOPROSTHETIC HEART-VALVES; EXTRACELLULAR-MATRIX; DIFFERENT MODES;
   CELL-LINES; TISSUE; DEGENERATION; PORCINE; BIODEGRADATION; INFLAMMATION;
   PROSTHESES
AB Decellularized tissue-derived heart valves are all example of biomaterials derived from natural scaffolds. These types of implants are increasing in popularity although their in vivo performance is still only poorly understood and has, at times, been catastrophic. It is apparent that better understanding is required before these biomaterials can be used safely. In this study, the human monocyte-derived macrophage (MDM) response to decellularized bovine pericardium (DBP) Was used as a model to predict the biological performance of these materials oil implaotation. Human monocytes differentiated on tissue Culture polystyrene (TCPS) for 14 days were trypsinized and reseeded onto DBP, TCPS, and polydimethylsiloxane (PDMS) for 48 h. The MDMs on DBP contained less intracellular and extracellular esterase activity compared with MDMs oil TCPS and PDMS, as well as less acid phosphatase activity than oil TCPS. As well, morphologically, MDMs oil DBP were less spread, less multinucleated and did not display many lamellipodia. Taken together, these data represent the first evidence of the MDM response to intact, native extracellular matrix, demonstrating that these cells reacted with all altered, possibly reduced foreign body response oil this natural scaffold compared with the two control surfaces. This in vitro MDM cell model may provide a novel method for predicting and elucidating the biological performance Of tissue-derived biomaterials, thereby directing a more rational design of biomaterials for tissue regeneration purposes. (C) 2009 Wiley Periodicals, Inc. J Biomed Matcr Res 93A: 280-288, 2010
C1 [Ariganello, Marianne B.; Labow, Rosalind S.; Lee, J. Michael] Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON, Canada.
   [Lee, J. Michael] Dalhousie Univ, Dept Appl Oral Sci, Halifax, NS, Canada.
RP Ariganello, MB (reprint author), Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.
EM marigane@dal.ca
FU Natural Science and Engineering Research Council (NSERC); Institute for
   Musculoskeletal Health and Arthritis (IMHA); Canadian Federation of
   University Women (CFUW); CIHR [STPD53877]
FX Contract grant sponsor: Natural Science and Engineering Research Council
   (NSERC); Contract grant sponsor: Institute for Musculoskeletal Health
   and Arthritis (IMHA); Contract grant sponsor: Canadian Federation of
   University Women (CFUW); Contract grant sponsor: CIHR Strategic Training
   Fellowship in Cell Signaling in Mucosal Inflammation and Pain; contract
   grant number: STPD53877
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Ariganello MB, 2009, J HEART VALVE DIS, V18, P187
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   DAHM M, 1995, ANN THORAC SURG, V60, pS348, DOI 10.1016/0003-4975(95)00291-R
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gowen BB, 2000, MATRIX BIOL, V19, P61, DOI 10.1016/S0945-053X(99)00052-9
   Grabenwoger M, 2000, J HEART VALVE DIS, V9, P104
   HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lepidi H, 2006, CLIN INFECT DIS, V42, P590, DOI 10.1086/500135
   Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Matheson LA, 2006, J BIOMED MATER RES A, V76A, P52, DOI 10.1002/jbm.a.30448
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Matthews JB, 2001, J MATER SCI-MATER M, V12, P249, DOI 10.1023/A:1008967200706
   Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320
   Ray R, 2002, CARDIOVASC PATHOL, V11, P177, DOI 10.1016/S1054-8807(02)00098-4
   RIDDLE JM, 1984, SCAN ELECTRON MICROS, P207
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Rieder E, 2006, BIOMATERIALS, V27, P5634, DOI 10.1016/j.biomaterials.2006.06.020
   Schmidt D, 2007, PHILOS T R SOC B, V362, P1505, DOI 10.1098/rstb.2007.2131
   Schmidt Doerthe, 2007, V140, P319
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967
   Thiene G, 2000, J HEART VALVE DIS, V9, P110
   Tsirogianni AK, 2006, INJURY, V37, pS5, DOI 10.1016/j.injury.2006.02.035
   Uphoff CC, 2000, LEUKEMIA LYMPHOMA, V39, P257, DOI 10.3109/10428190009065825
   Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004
   Zilla P, 2004, BIOTECHNOL APPL BIOC, V40, P57, DOI 10.1042/BA20030211
NR 35
TC 13
Z9 13
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 280
EP 288
DI 10.1002/jbm.a.32554
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800031
PM 19562747
DA 2018-10-20
ER

PT J
AU Rodriguez, AP
   Inoue, M
   Tanaka, T
   Miyake, M
   Sfer, AM
   Kishimoto, E
   Tsujigiwa, H
   Rivera, RS
   Nagatsuka, H
AF Rodriguez, Andrea P.
   Inoue, Miho
   Tanaka, Toshiyuki
   Miyake, Michihiro
   Sfer, Ana M.
   Kishimoto, Etsuo
   Tsujigiwa, Hidetsugu
   Rivera, Rosario S.
   Nagatsuka, Hitoshi
TI Effect of CaTiO3-CaCO3 prepared by alkoxide method on cell response
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbonate; cell culture; osteoblast; particles; calcium titanate
ID AMORPHOUS-CARBON FILMS; IN-VITRO; ION IMPLANTATION; TITANIUM; BONE;
   CALCIUM; ADHESION; TISSUE; GLASS; MINERALIZATION
AB In recent years, calcium titanate (CaTiO3) and carbon-containing materials have gained much attention in a number of biomedical material researches. To maximize the advantages of both materials, we developed a novel alkoxide method to get "calcium titanate with calcium carbonate" (CaTiO3-CaCO3). The objective was to evaluate the crystallinity and elemental composition of CaTiO3CaCO3 prepared by alkoxide method, CaTiO3-aC elaborated by modified thermal decomposition method, commercially-prepared CaTiO3, and the effect of these materials on the bone marrow stromal cell. Hydroxyapatite was used as positive control material. We examined the cellular proliferation, osteoblastic differentiation, and mineralization of KUSA/A1 cells cultured with the materials. The results showed that CaTiO3-CaCO3 and CaTiO3-aC contained evidence Of calcium carbonate enhancing cell proliferation, osteoblastic differentiation, and mineralization. On the contrary, the commercially-prepared CaTiO3 revealed absence of calcium carbonate with lower cell response than the other groups. The results indicated that calcium carbonate could play a key role in the cell response Of CaTiO3 material. In conclusion, our findings suggest that CaTiO3-CaCO3 could be considered in important candidate as a biomaterial for medical and dental applications. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 297-303, 2010
C1 [Rodriguez, Andrea P.; Inoue, Miho; Rivera, Rosario S.; Nagatsuka, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama, Japan.
   [Tanaka, Toshiyuki; Miyake, Michihiro] Okayama Univ, Grad Sch Environm Sci, Dept Mat & Energy Sci, Okayama, Japan.
   [Sfer, Ana M.] Tucuman Univ, Coll Exacts Sci & Technol, Dept Math Probabil & Stat, San Miguel De Tucuman, Argentina.
   [Kishimoto, Etsuo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Hlth, Okayama, Japan.
   [Tsujigiwa, Hidetsugu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Virol, Okayama, Japan.
RP Nagatsuka, H (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama, Japan.
EM jin@md.okayama-u.ac.jp
FU Grant-in-Aid for JSPS Postdoctoral Fellowship [1907217]; Ministry of
   Education, Culture, Sports, Science, and Technology [20592454]
FX Contract grant sponsor: Grant-in-Aid for JSPS Postdoctoral Fellowship
   for Foreign Research; contract grant number: 1907217; Contract grant
   sponsor: Grant-in-Aid for Scientific Researches from the Ministry of
   Education, Culture, Sports, Science, and Technology; contract grant
   number: 20592454
CR DERMERS C, 2002, BIOMED MAT ENG, V12, P15
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Fujishiro Y, 1998, J MATER SCI-MATER M, V9, P363, DOI 10.1023/A:1013201627622
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Holliday S, 2004, SURF COAT TECH, V188, P741, DOI 10.1016/j.surfcoat.2004.07.044
   Lee YK, 2004, J BIOMED MATER RES A, V69A, P188, DOI 10.1002/jbm.a.20137
   Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430
   Manso M, 2003, MAT SCI ENG C-BIO S, V23, P447, DOI 10.1016/S0928-4931(02)00319-3
   MCGEERUSSELL SM, 1958, J HISTOCHEM CYTOCHEM, V6, P22, DOI 10.1177/6.1.22
   Nagai N, 2008, J HARD TISSUE BIOL, V17, P47, DOI 10.2485/jhtb.17.47
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   Ohtsu N, 2004, MATER TRANS, V45, P1778, DOI 10.2320/matertrans.45.1778
   Ohtsu N, 2007, J BIOMED MATER RES A, V82A, P304, DOI 10.1002/jbm.a.31136
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Relic B, 2001, J IMMUNOL, V166, P2775, DOI 10.4049/jimmunol.166.4.2775
   Rodil SE, 2005, BIO-MED MATER ENG, V15, P101
   Rodriguez A.P., 2007, J HARD TISSUE BIOL, V16, P1
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   Silva GA, 2007, BIOMATERIALS, V28, P326, DOI 10.1016/j.biomaterials.2006.07.009
   UKEGAWA Y, 1992, J JPN ORTHOP ASSOC, V60, P688
   UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125
   Wang J, 2004, BIOMATERIALS, V25, P3163, DOI 10.1016/j.biomaterials.2003.10.010
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
NR 27
TC 5
Z9 5
U1 3
U2 18
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 297
EP 303
DI 10.1002/jbm.a.32551
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800033
PM 19562752
DA 2018-10-20
ER

PT J
AU Carvalho, J
   Moreira, S
   Maia, J
   Gama, FM
AF Carvalho, Joana
   Moreira, Susana
   Maia, Joao
   Gama, Francisco M.
TI Characterization of dextrin-based hydrogels: Rheology, biocompatibility,
   and degradation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE dextrin; hydrogels; biocompatibility; degradation kinetics
ID ETHYLENE GLYCOL) HYDROGELS; IN-VITRO; GLYCIDYL METHACRYLATE;
   ENZYMATIC-SYNTHESIS; HEMA HYDROGELS; GELATIN; RELEASE; GROWTH;
   DIALDEHYDE; MECHANISM
AB A new class of degradable dextrin-based hydrogels (dextrin-HEMA) was developed. The hydroxyethyl methacrylate ester (HEMA) hydroxyl groups were activated with N,N'-carbonydiimidazole (CDI), followed by their coupling to dextrin, yielding a derivatized material that call be polymerized in aqueous solution to form hydrogels. A comparative study of the stability of the dextrin-HEMA hydrogels and dextrin-vinyl acrylate (dextrin-VA, produced in previous work) revealed that only the firsts are effectively hydrolyzed under physiological conditions. A severe mass loss of dextrin-HEMA gels occurs over time, culminating in the complete dissolution of the gels. Rheologic analysis confirmed that physical structure ing is less pronounced when dextrin is modified with methacrylate side groups. The biocompatibility results revealed that the dextrin hydrogels have negligible cell toxicity, irrespective of the hydrogel type (HEMA and VA), allowing cell adhesion and proliferation. Gathering the biocompatibility and the ability to tailor the release profiles, we consider dextrin a promising biomaterial for biomedical applications, namely for controlled release. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A: 389-399, 2010
C1 [Carvalho, Joana; Moreira, Susana; Gama, Francisco M.] Univ Minho, Dept Biol Engn, IBB, P-4710057 Braga, Portugal.
   [Maia, Joao] Univ Minho, Inst Nanostruct Nanomodelling & Nanofabricat, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Gama, FM (reprint author), Univ Minho, Dept Biol Engn, IBB, Campus Gualtar, P-4710057 Braga, Portugal.
EM fmgama@deb.uminho.pt
RI Moreira, Susana/J-1905-2015; Gama, Miguel/I-3140-2015
OI Gama, Miguel/0000-0002-5655-0015; Carvalho, Joana/0000-0002-4027-735X;
   Maia, Joao/0000-0001-6285-566X; Moreira, Susana/0000-0002-8333-3016
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Autissier A, 2007, J BIOMED MATER RES A, V82A, P336, DOI 10.1002/jbm.a.30998
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   BERRIDGE MV, 1996, BIOCHEMICA, V4, P15
   Carvalho J, 2007, EUR POLYM J, V43, P3050, DOI 10.1016/j.eurpolymj.2007.02.046
   Carvalho JM, 2009, CARBOHYD POLYM, V75, P322, DOI 10.1016/j.carbpol.2008.07.033
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   De Groot CJ, 2001, BIOMATERIALS, V22, P1197, DOI 10.1016/S0142-9612(00)00266-0
   DISILVIO L, 1994, BIOMATERIALS, V15, P931, DOI 10.1016/0142-9612(94)90120-1
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ferreira L, 2004, J BIOMED MATER RES A, V68A, P584, DOI 10.1002/jm.a.20102
   Ferreira L, 2002, BIOMATERIALS, V23, P3957, DOI 10.1016/S0142-9612(02)00132-1
   Ferreira L, 2002, BIOMACROMOLECULES, V3, P333, DOI 10.1021/bm010150h
   Ferreira LS, 2003, ABSTR PAP AM CHEM S, V225, pU239
   FERRY JD, 1980, VISCOELASTIC PROPERT
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Ishihara M, 2001, WOUND REPAIR REGEN, V9, P513, DOI 10.1046/j.1524-475x.2001.00513.x
   Kane J.B., 1996, BIOMATERIALS SCI INT
   LEVY MC, 1991, J MICROENCAPSUL, V8, P335, DOI 10.3109/02652049109069560
   Mann P, 2005, N-S ARCH PHARMACOL, V371, pR87
   Martens P, 2002, POLYMER, V43, P6093, DOI 10.1016/S0032-3861(02)00561-X
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   MCCULLOCH I, 1998, TAILORED POLYM MAT C
   Meyvis TKL, 2000, MACROMOLECULES, V33, P4717, DOI 10.1021/ma992131u
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OKAY O, 1992, J APPL POLYM SCI, V46, P401, DOI 10.1002/app.1992.070460305
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 1996, BIOMATERIALS SCI INT
   Ramamurthi A, 2002, J BIOMED MATER RES, V60, P196
   Schacht E, 1997, REACT FUNCT POLYM, V33, P109, DOI 10.1016/S1381-5148(97)00047-3
   Stubbe BG, 2002, MACROMOLECULES, V35, P2501, DOI 10.1021/ma011408z
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Suggs LJ, 1998, J BIOMED MATER RES, V42, P312, DOI 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P3411, DOI 10.1021/ma961764v
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P4639, DOI 10.1021/ma9704018
   vanDijkWolthuis WNE, 1997, J PHARM SCI, V86, P413, DOI 10.1021/js9604220
   vanDijkWolthuis WNE, 1997, POLYMER, V38, P6235, DOI 10.1016/S0032-3861(97)00189-4
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   VYAVAHARE N, 1994, J POLYM SCI POL CHEM, V32, P1271, DOI 10.1002/pola.1994.080320708
   WALTHER DH, 1995, POLYM GELS NETW, V3, P29, DOI 10.1016/0966-7822(94)00006-S
   Wong WH, 1997, SYNTHETIC BIODEGRADA, P49
NR 47
TC 12
Z9 12
U1 0
U2 26
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2010
VL 93A
IS 1
BP 389
EP 399
DI 10.1002/jbm.a.32553
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563KV
UT WOS:000275131800043
PM 19569221
DA 2018-10-20
ER

PT J
AU Suckow, MA
   Hodde, JP
   Wolter, WR
   Wood, KV
   Hiles, MC
   Janis, AD
AF Suckow, Mark A.
   Hodde, Jason P.
   Wolter, William R.
   Wood, Karl V.
   Hiles, Michael C.
   Janis, Abram D.
TI Addition of Nimesulide to Small Intestinal Submucosa Biomaterial
   Inhibits Postsurgical Adhesiogenesis in Rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE SIS; nimesulide; adhesion; extracellular matrix; NSAID
ID PERITONEAL FIBRINOLYTIC-ACTIVITY; ANTI-INFLAMMATORY AGENT; ADHESION
   FORMATION; POSTOPERATIVE ADHESIONS; INTRAPERITONEAL ADHESIONS;
   INTRAABDOMINAL ADHESIONS; COX-2 INHIBITOR; TISSUE-REPAIR; PREVENTION;
   MODEL
AB Adhesion formation is a common complication in abdominal surgery with incidence as high as 93% and small bowel obstruction a common complication. Because the extracellular matrix material, small intestinal submucosa (SIS), is commonly used in various surgical procedures, methods to inhibit adhesiogenesis are of great interest. This study was undertaken to determine if incorporation of nimesulide (NM), a selective cyclooxygenase (COX)-2 inhibitor, could reduce the extent and tenacity of intraabdominal adhesion formation associated with SIS implantation. Female Sprague-Dawley rats underwent a cecal abrasion surgical procedure to induce adhesiogenesis. Rats were either left untreated or treated by direct application over the injured cecum with polypropylene mesh (PPM); SIS; SIS containing a low dose of NM; or SIS containing a high dose of NM. Rats were euthanized 21 days later, and adhesion extent and tenacity were evaluated using standard scales (0 = minimal adhesiogenesis; 4 = severe adhesiogenesis). Addition of NM to SIS resulted in a significant (p < 0.05) reduction in adhesion extent and in a similar reduction in adhesion tenacity for SIS containing a low dose of NM. Adhesions typically extended from the abraded cecal surface to the body wall and were characterized histologically by fibrous tissue adherent to the cecal wall. In conclusion, addition of the nonsteroidal anti-inflammatory, COX-2 selective drug, NM, to SIS attenuates adhesion extent and tenacity when compared with surgical placement of SIS or PPM alone. (C) 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 93B: 18-23, 2010
C1 [Suckow, Mark A.; Wolter, William R.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA.
   [Hodde, Jason P.; Hiles, Michael C.; Janis, Abram D.] Cook Biotech Inc, W Lafayette, IN 47906 USA.
   [Wood, Karl V.] Purdue Univ, Dept Chem, Campus Wide Mass Spectrometry Ctr, W Lafayette, IN 47907 USA.
RP Suckow, MA (reprint author), Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA.
EM suckow.1@nd.edu
RI Suckow, Mark/C-2696-2014
OI Suckow, Mark/0000-0001-7317-697X
CR Agrawal S, 2004, INT J PHARM, V274, P149, DOI 10.1016/j.ijpharm.2004.01.012
   Aldemir M, 2004, ACTA CHIR BELG, V104, P97
   Alpay Z, 2008, SEMIN REPROD MED, V26, P313, DOI 10.1055/s-0028-1082389
   ArRajab A, 1996, J SURG RES, V61, P143, DOI 10.1006/jsre.1996.0095
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Brown-Etris M, 2002, WOUNDS, V14, P150
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   COFER KF, 1994, FERTIL STERIL, V62, P1262
   Dijkstra FR, 2000, SCAND J GASTROENTE S, V232, P52
   Franklin M E Jr, 2002, Hernia, V6, P171
   Garrard CL, 1999, SURG ENDOSC-ULTRAS, V13, P10, DOI 10.1007/s004649900887
   GOLAN A, 1991, HUM REPROD, V6, P251, DOI 10.1093/oxfordjournals.humrep.a137316
   Golan A, 1990, ACTA OBSTET GYN SCAN, V69, P339, DOI 10.3109/00016349009036158
   GOLAN A, 1995, HUM REPROD, V10, P1797, DOI 10.1093/oxfordjournals.humrep.a136177
   Greene AK, 2005, ANN SURG, V242, P140, DOI 10.1097/01.sla.0000167847.53159.c1
   Guvenal T, 2001, HUM REPROD, V16, P1732, DOI 10.1093/humrep/16.8.1732
   Hellebrekers BWJ, 2005, FERTIL STERIL, V83, P122, DOI 10.1016/j.fertnstert.2004.06.060
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde JP, 2001, WOUNDS, V13, P195
   Holmdahl L, 1997, APMIS, V105, P25, DOI 10.1111/j.1699-0463.1997.tb00535.x
   Holmdahl L, 1997, Eur J Surg Suppl, P24
   Holmdahl L, 1997, Eur J Surg Suppl, P56
   HOLTZ G, 1982, FERTIL STERIL, V37, P582
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   IDELL S, 1992, AM J PHYSIOL, V263, pL487
   Jaffe JS, 2001, J INVEST SURG, V14, P259, DOI 10.1080/089419301753170039
   MACON A, 2000, P PAC COAST REPR SOC
   Marbet GA, 1998, EUR J CLIN PHARMACOL, V54, P383, DOI 10.1007/s002280050479
   Masferrer JL, 1999, ANN NY ACAD SCI, V889, P84, DOI 10.1111/j.1749-6632.1999.tb08726.x
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   MENZIES D, 1973, J ROY SOC MED, V126, P345
   MONTZ FJ, 1993, GYNECOL ONCOL, V48, P76, DOI 10.1006/gyno.1993.1012
   Muzii L, 1998, HUM REPROD, V13, P1486, DOI 10.1093/humrep/13.6.1486
   NISHIMURA K, 1984, J SURG RES, V36, P115, DOI 10.1016/0022-4804(84)90076-3
   Oncel M, 2001, J SURG RES, V101, P52, DOI 10.1006/jsre.2001.6245
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Reed KL, 2008, SEMIN REPROD MED, V26, P331, DOI 10.1055/s-0028-1082391
   Rosen M, 2002, SURGERY, V132, P480, DOI 10.1067/msy.2002.126505
   Saed GM, 2005, FERTIL STERIL, V83, P1216, DOI 10.1016/j.fertnstert.2004.11.037
   Saed GM, 2004, J AM ASSOC GYN LAP, V11, P307, DOI 10.1016/S1074-3804(05)60041-2
   Saed GM, 2003, FERTIL STERIL, V79, P1404, DOI 10.1016/S0015-0282(03)00257-7
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SIEGLER AM, 1980, FERTIL STERIL, V34, P46
   Singla AK, 2000, J PHARM PHARMACOL, V52, P467, DOI 10.1211/0022357001774255
   Soiderer EE, 2004, J SURG RES, V118, P161, DOI 10.1016/S0022-4804(03)00352-4
   Taveau JW, 2004, J INVEST SURG, V17, P81, DOI 10.1080/08941930490422456
   VIPOND MN, 1994, EUR J SURG, V160, P471
   WHAWELL SA, 1993, BRIT J SURG, V80, P107, DOI 10.1002/bjs.1800800134
   2007, SAFETY DATA NIMESULI
NR 50
TC 3
Z9 3
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2010
VL 93B
IS 1
BP 18
EP 23
DI 10.1002/jbm.b.31545
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571ZY
UT WOS:000275796700003
PM 20091905
DA 2018-10-20
ER

PT J
AU Kim, I
   Kim, HJ
   Kim, HM
AF Kim, InAe
   Kim, Hyun Jung
   Kim, Hyun-Man
TI Array of Amorphous Calcium Phosphate Particles Improves Cellular
   Activity on a Hydrophobic Surface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE amorphous CaP; array; hydrophobicity; osteoblast; biomaterial
ID OSTEOBLAST-LIKE CELLS; THIN-FILM; LOW-TEMPERATURE; ADHESION; APOPTOSIS;
   HYDROXYAPATITE; BIOMATERIALS; ROUGHNESS; MIGRATION; BONE
AB Poor interaction between cells and surfaces, especially hydrophobic surfaces, results in delayed proliferation and increased apoptosis due to low cell adhesion signaling. To improve cell adhesion, hydrophilic array of amorphous calcium phosphate (ACP) was fabricated on a surface. A phosphate-buffered solution containing calcium ions was prepared at low temperature to prevent spontaneous precipitation. Then, the ion solution was heated to generate nuclei of ACP nanoparticles. The ACP nanoparticles adhered to the hydrophobic polystyrene surface forming an array composed of ACP particles. Multiple treatments of these nuclei with fresh Cap ion solutions increased the diameter and decreased the solubility of ACP particles enough to mediate cellular adhesion. The particle density in the array was dependent on the ion concentration of the CaP ion solutions. The ACP array improved a wide variety of activities when osteoblastic MC3T3-E1 cells were cultured on the ACP array fabricated on a hydrophobic bacteriological dish surface, compared to those cultured without the ACP array in vitro. The use of ACP array resulted in a lower apoptosis and also increased the spreading of cells to form stress fibers and focal contacts. Cells cultured on the ACP array proliferated more than cells cultured on a hydrophobic surface without the ACP array. The ACP array increased the expression of markers of differentiation in osteoblast. These results indicate that an array of ACP can be used as a coating material for enhancing biocompatibility in tissue engineering or biomaterials rather than modifying the surface with organic molecules. 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomaler 93B: 113-121, 2010
C1 [Kim, Hyun-Man] Seoul Natl Univ, Sch Dent, Dept Oral Histol & Dev Biol, Lab Study Mol Biointerfaces, Seoul 110749, South Korea.
   Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
RP Kim, HM (reprint author), Seoul Natl Univ, Sch Dent, Dept Oral Histol & Dev Biol, Lab Study Mol Biointerfaces, Seoul 110749, South Korea.
EM hyunmkim@snu.ac.kr
CR Adams CS, 1999, J BONE MINER RES, V14, pS346
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   BAGAMBISA FB, 1990, BIOMATERIALS, V11, P50, DOI 10.1016/0142-9612(90)90052-R
   Ball M, 2008, J BIOMED MATER RES A, V86A, P637, DOI 10.1002/jbm.a.31652
   Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   Cao Yang, 2004, Methods Mol Biol, V238, P87
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Deng M, 2002, J MATER SCI-MATER M, V13, P1091, DOI 10.1023/A:1020361109859
   GREGOIRE M, 1990, J BIOMED MATER RES, V24, P165, DOI 10.1002/jbm.820240204
   Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693
   Hong JY, 2003, BIOMATERIALS, V24, P2977, DOI 10.1016/S0142-9612(02)00121-2
   Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X
   Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200
   Kim HM, 2000, BIOMATERIALS, V21, P1129, DOI 10.1016/S0142-9612(99)00265-3
   KIM HM, 1995, J BONE MINER RES, V10, P1589
   Lebowitz PF, 1997, CANCER RES, V57, P708
   Lee YJ, 2006, BIOMATERIALS, V27, P3738, DOI 10.1016/j.biomaterials.2006.02.032
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Margadant C, 2007, J CELL SCI, V120, P66, DOI 10.1242/jcs.03301
   Nelea V, 2002, J MATER SCI-MATER M, V13, P1167, DOI 10.1023/A:1021150207350
   Nguyen H, 1997, J DENT RES, V76, P2151
   ONEILL C, 1990, J CELL SCI, V95, P577
   Pan H, 2008, BIOMATERIALS, V29, P1583, DOI 10.1016/j.biomaterials.2007.12.005
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Stockton RA, 2001, MOL BIOL CELL, V12, P1937, DOI 10.1091/mbc.12.7.1937
   Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004
   Tanaka Y, 2002, J BIOL CHEM, V277, P21446, DOI 10.1074/jbc.M202238200
   Telford WG, 1999, CYTOMETRY, V37, P314, DOI 10.1002/(SICI)1097-0320(19991201)37:4<314::AID-CYTO9>3.0.CO;2-X
   Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823
   Vermeer AWP, 2001, BBA-GEN SUBJECTS, V1526, P61, DOI 10.1016/S0304-4165(01)00101-5
   Zilberman M, 2006, J BIOMED MATER RES A, V79A, P370, DOI 10.1002/jbm.a.30775
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 39
TC 6
Z9 7
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2010
VL 93B
IS 1
BP 113
EP 121
DI 10.1002/jbm.b.31565
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571ZY
UT WOS:000275796700013
PM 20119940
DA 2018-10-20
ER

PT J
AU Gilmore, BF
   Hamill, TM
   Jones, DS
   Gorman, SP
AF Gilmore, Brendan F.
   Hamill, Turlough M.
   Jones, David S.
   Gorman, Sean P.
TI Validation of the CDC Biofilm Reactor as a Dynamic Model for Assessment
   of Encrustation Formation on Urological Device Materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE urinary encrustation; CDC biofilm reactor; biomaterials; struvite;
   hydroxyapatite; Proteus mirabilis; urease
ID UREASE-INDUCED CRYSTALLIZATION; MAGNESIUM AMMONIUM PHOSPHATE; IN-VITRO;
   URETHRAL CATHETERS; HUMAN-URINE; BIOMATERIAL ENCRUSTATION; SYNTHETIC
   URINE; URETERAL STENTS; STONE FORMATION; STRUVITE
AB Contemporary medical science is reliant upon the rational selection and utilization of devices, and therefore, an increasing need has developed for in vitro systems aimed at replicating the conditions to which urological devices will be subjected to during their use in vivo. We report the development and validation of a novel continuous flow encrustation model based on the commercially available CDC biofilm reactor. Proteus mirabilis-induced encrustation formation on test biomaterial sections under varying experimental parameters was analyzed by X-ray diffraction, infrared- and Raman spectroscopy and by scanning electron microscopy. The model system produced encrusted deposits similar to those observed in archived clinical samples. Results obtained for the system are highly reproducible with encrustation being rapidly deposited on test biomaterial sections. This model will have utility in the rapid screening of encrustation behavior of biomaterials for use in urological applications. (C) 2010 Wiley Periodicals. Inc. J Biomed Mater Res Part B: Appl Biomater 93B: 128-140, 2010
C1 [Gilmore, Brendan F.; Hamill, Turlough M.; Jones, David S.; Gorman, Sean P.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Gilmore, BF (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
EM b.gilmore@qub.ac.uk
CR Bouropoulos NC, 2000, J CRYST GROWTH, V213, P381, DOI 10.1016/S0022-0248(00)00351-1
   Brosnahan J, 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD004013.PUB2
   Carmona P, 1997, BIOSPECTROSCOPY, V3, P331, DOI 10.1002/(SICI)1520-6343(1997)3:5<331::AID-BSPY2>3.0.CO;2-5
   Choong SKS, 2000, BJU INT, V86, P414, DOI 10.1046/j.1464-410X.2000.00861.x
   CLAPHAM L, 1990, J CRYST GROWTH, V104, P475, DOI 10.1016/0022-0248(90)90150-J
   Cox A J, 1987, Eng Med, V16, P37
   DAUDON M, 1983, KIDNEY INT, V23, P842, DOI 10.1038/ki.1983.104
   Desgrandchamps F, 1997, BRIT J UROL, V79, P24, DOI 10.1046/j.1464-410X.1997.02775.x
   DUMANSKI AJ, 1994, INFECT IMMUN, V62, P2998
   Ebisuno S, 1997, UROL RES, V25, P263, DOI 10.1007/BF00942096
   ELLIOT JS, 1958, J UROLOGY, V80, P269, DOI 10.1016/S0022-5347(17)66177-9
   FINLAYSON B, 1973, INVEST UROL, V10, P429
   FROST RL, 2005, SPECTROCHIM ACTA A, V62, P1
   Gepi-Attee S, 1997, P I MECH ENG H, V211, P475, DOI 10.1243/0954411981534592
   Getliffe KA, 2000, BJU INT, V85, P60, DOI 10.1046/j.1464-410x.2000.00343.x
   GLEESON MJ, 1989, T AM SOC ART INT ORG, V35, P495
   Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0
   GRASES F, 1996, CLIN CHIM ACTA, V244, P46
   GRENABO L, 1986, J UROLOGY, V135, P416, DOI 10.1016/S0022-5347(17)45655-2
   GRIFFITH DP, 1976, INVEST UROL, V13, P346
   Hamill TM, 2007, EXPERT REV MED DEVIC, V4, P215, DOI 10.1586/17434440.4.2.215
   HEDELIN H, 1991, BRIT J UROL, V67, P527, DOI 10.1111/j.1464-410X.1991.tb15200.x
   HEDELIN H, 1985, J UROLOGY, V133, P529, DOI 10.1016/S0022-5347(17)49047-1
   HESSE A, 1989, UROL INT, V44, P364, DOI 10.1159/000281541
   Jones DS, 2004, BIOMATERIALS, V25, P1421, DOI 10.1016/j.biomaterials.2003.08.01
   Jones DS, 2006, J BIOMED MATER RES B, V76B, P1, DOI 10.1002/jbm.b.30230
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   Le Corre KS, 2005, J CRYST GROWTH, V283, P514, DOI 10.1016/j.jcrysgro.2005.06.012
   Mathur S, 2006, UROL RES, V34, P173, DOI 10.1007/s00240-006-0036-6
   Morris NS, 1998, J HOSP INFECT, V39, P227, DOI 10.1016/S0195-6701(98)90262-6
   Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205
   ROBERTSON WG, 1976, SCI FDN UROLOGY, V1, P254
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Santin M, 1999, BIOMATERIALS, V20, P1245, DOI 10.1016/S0142-9612(99)00026-5
   SARANGAPANI S, 1995, J BIOMED MATER RES, V29, P1185, DOI 10.1002/jbm.820291005
   SCHMITZ W, 1993, CELL MATER, V3, P1
   Schulz A, 2008, AKTUEL UROL, V39, P53, DOI 10.1055/s-2007-980096
   SRINIVASAN V, 1972, J UROLOGY, V108, P473, DOI 10.1016/S0022-5347(17)60777-8
   Stickler DJ, 1996, BRIT J UROL, V78, P579, DOI 10.1046/j.1464-410X.1996.16915.x
   STICKLER DJ, 1994, CELL MATER, V4, P387
   Stickler DJ, 1999, METHOD ENZYMOL, V310, P494
   Takasaki E, 1996, Int J Urol, V3, P27
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
   WALL I, 1990, UROL RES, V18, P401, DOI 10.1007/BF00297373
NR 45
TC 16
Z9 17
U1 1
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2010
VL 93B
IS 1
BP 128
EP 140
DI 10.1002/jbm.b.31567
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571ZY
UT WOS:000275796700015
PM 20091909
DA 2018-10-20
ER

PT J
AU Bispo, VM
   Mansur, AAP
   Barbosa-Stancioli, EF
   Mansur, HS
AF Bispo, Viviane M.
   Mansur, Alexandra A. P.
   Barbosa-Stancioli, Edel F.
   Mansur, Herman S.
TI Biocompatibility of Nanostructured Chitosan/Poly(Vinyl Alcohol) Blends
   Chemically Cross linked with Genipin for Biomedical Applications
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Biomaterial; Nanostructured Hydrogels; Natural Cross linker; Chitosan;
   Poly(Vinyl Alcohol); Genipin
ID POLY(VINYL ALCOHOL); CHITOSAN HYDROGELS; CONTROLLED-RELEASE; ALUMINA
   SCAFFOLDS; FTIR SPECTROSCOPY; POLYMER SCAFFOLDS; GLUTARALDEHYDE;
   BIOMATERIALS; INTEGRATION; CHITIN
AB In the present research it is reported the development and characterization of novel polymer blends based on chitosan and poly(vinyl alcohol) (PVA). The hybrid polymeric network was synthesized and modified by chemical crosslinking using genipin for potential use in a variety of biomedical applications. The micro and nanostructures of the blended hydrogels and hybrids were characterized through Fourier Transform Infrared spectroscopy (FTIR) and swelling test analysis. Moreover, cytotoxicity and cell viability were also performed by MU assay with cell culture. The chemical crosslinking was achieved via the relative intensity of the band at 1650 cm(-1) which is mostly associated with the reaction of genipin carboxymethyl group with the amino group of chitosan forming amides. It was found that by increasing the chitosan content relative to PVA the swelling index of the blend has decreased, reflecting the reduction on the mobility of polymer network and the hydrophilic behavior of the blend. The tested hydrogels have clearly presented adequate cell viability, non-toxicity and suitable properties which can be tailored for potential use in bioengineering applications.
C1 [Bispo, Viviane M.; Mansur, Alexandra A. P.; Mansur, Herman S.] Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
   [Barbosa-Stancioli, Edel F.] Univ Fed Minas Gerais, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
OI Mansur, Alexandra/0000-0003-1526-2508; Mansur,
   Herman/0000-0002-3032-495X
FU FAPE-MIG/CNPq/CAPES
FX The authors acknowledge FAPE-MIG/CNPq/CAPES for financial support on
   this work. They are grateful to Professor Wander L. Vasconcelos
   (Laboratory of Ceramic Materials) for the FTIR spectroscopy and to
   Professor Dagoberto B. Santos and Patricia M. T. de Azevedo for SEM
   analysis. Authors also thank Professor Edel F Barbosa-Stancioli
   (Department of Microbiology-UFMG) for conducting MTT laboratory
   protocols.
CR Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bose S, 2002, J MATER SCI-MATER M, V13, P23, DOI 10.1023/A:1013622216071
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Clapper JD, 2007, POLYMER, V48, P6554, DOI 10.1016/j.polymer.2007.08.023
   COSTA ESC, 2007, AN 9 C BRAS POL CAMP, P86
   Costa ED, 2008, QUIM NOVA, V31, P1460, DOI 10.1590/S0100-40422008000600034
   Costa HS, 2008, J MATER SCI, V43, P510, DOI 10.1007/s10853-007-1849-6
   Costa HS, 2008, J MATER SCI, V43, P494, DOI 10.1007/s10853-007-1875-4
   Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   DUNN GA, 1995, J CELL SCI, V108, P1239
   Elizondo NJ, 2009, CARBOHYD POLYM, V75, P592, DOI 10.1016/j.carbpol.2008.08.020
   Gao JH, 2009, NANO TODAY, V4, P37, DOI 10.1016/j.nantod.2008.10.009
   GRUPTA KC, 2007, CARBOHYD RES, V342, P2244
   Hannah S, 2005, BIOMATERIALS, V26, P5492, DOI DOI 10.1016/J.BIOMATERIALS.2005.01.043
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   LIMA SI, 2005, THESIS U ESTADUAL CA
   Liu BS, 2004, J BIOMATER APPL, V19, P21, DOI 10.1177/0885328204042544
   Mansur HS, 2007, SOLID STATE PHENOMEN, V121-123, P855, DOI 10.4028/www.scientific.net/SSP.121-123.855
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Mansur HS, 2008, CHEM ENG J, V137, P72, DOI 10.1016/j.cej.2007.09.036
   Mansur HS, 2010, WIRES NANOMED NANOBI, V2, P113, DOI 10.1002/wnan.78
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.3.CO;2-P
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Park JH, 2008, PROG POLYM SCI, V33, P113, DOI 10.1016/j.progpolymsci.2007.09.003
   Peppas NA, 1997, EUR J PHARM BIOPHARM, V43, P51, DOI 10.1016/S0939-6411(96)00010-0
   Rao KSVK, 2006, CARBOHYD POLYM, V66, P333, DOI 10.1016/j.carbpol.2006.03.025
   Sahoo SK, 2007, NANOMED-NANOTECHNOL, V3, P20, DOI 10.1016/j.nano.2006.11.008
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Skoog D. A, 2002, PRINCIPIOS ANALISE I
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   Yeo YJ, 2005, J BIOMED MATER RES B, V72B, P86, DOI 10.1002/jbm.b.30121
   Zhang YY, 2007, COLLOID POLYM SCI, V285, P855, DOI 10.1007/s00396-006-1630-4
NR 42
TC 45
Z9 45
U1 2
U2 47
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2010
VL 6
IS 2
BP 166
EP 175
DI 10.1166/jbn.2010.1110
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 631QD
UT WOS:000280361800009
PM 20738071
DA 2018-10-20
ER

PT J
AU Avila, MY
   Navia, JL
AF Avila, Marcel Y.
   Navia, Jose L.
TI Effect of genipin collagen crosslinking on porcine corneas
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID IN-VITRO; AGENT GENIPIN; ULTRAVIOLET-A; UV-B; KERATOCONUS; RADIATION;
   KERATECTASIA; RIBOFLAVIN; GARDENIA; CELLS
AB PURPOSE: To evaluate the effect of genipin, a natural crosslinker, on porcine corneas
   SETTING: Department of Ophthalmology, Universidad Nacional de Colombia, Bogota, Colombia
   METHODS: Corneal strips (12.0 mm x 2 3 mm) were harvested from porcine eyes and treated by incubation with genipin at concentrations of 1.00%, 0.25%, and 010%. Parallel corneal strips from the same eye were used as untreated controls After treatment at 20 degrees C for 40 minutes, tensile strain measurements were performed in a biomaterial tester. Porcine button corneas were treated with genipin 0 25% for 15 minutes and then digested by bacterial collagenase. Treated and untreated corneas were evaluated by light microscopy.
   RESULTS: Young modulus and stiffness in treated corneas increased in a concentration-dependent manner Genipin increased resistance to corneal collagenase 5-fold in comparison with the controls. A decrease in the interlamellar space in treated corneas was also observed.
   CONCLUSIONS: Corneal collagen crosslinking induced with genipin produced a significant increase in biomechanical strength and resistance to bacterial collagenase This crosslinker could be useful in treating corneal ectasia and corneal infectious and noninfectious diseases involving corneal melting.
C1 [Avila, Marcel Y.; Navia, Jose L.] Univ Nacl Colombia, Sch Med, Dept Ophthalmol, Bogota, Colombia.
RP Avila, MY (reprint author), Univ Nacl Colombia, Fac Med, Dept Ophthalmol, Carrera 30 Calle 45, Bogota, Colombia.
OI AVILA, MARCEL/0000-0001-7734-8177
FU Department of Surgery, School of Medicine, Universidad Nacional de
   Colombia, Bogota
FX Funded by a grant from the Department of Surgery, School of Medicine,
   Universidad Nacional de Colombia, Bogota.
CR Dhaliwal JS, 2009, CORNEA, V28, P62, DOI 10.1097/ICO.0b013e31818225c3
   Dong XQ, 2005, EXP EYE RES, V80, P561, DOI 10.1016/j.exer.2004.11.007
   Hafezi F, 2007, J CATARACT REFR SURG, V33, P2035, DOI 10.1016/j.jcrs.2007.07.028
   Huang LLH, 1998, J BIOMED MATER RES, V42, P568, DOI 10.1002/(SICI)1097-4636(19981215)42:4<568::AID-JBM13>3.0.CO;2-7
   Inao M, 2004, J HEPATOL, V41, P584, DOI 10.1016/j.jhep.2004.06.033
   Kitano A, 2006, OPHTHAL RES, V38, P355, DOI 10.1159/000096231
   Kitano A, 2006, J CATARACT REFR SURG, V32, P1727, DOI 10.1016/j.jcrs.2006.05.015
   Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Mackool RJ, 2008, J CATARACT REFR SURG, V34, P879, DOI 10.1016/j.jcrs.2008.02.027
   Miguel NCD, 2003, MICRON, V34, P395, DOI 10.1016/S0968-4328(03)00081-7
   Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098
   Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039
   Rogers CS, 2004, EXP EYE RES, V78, P1007, DOI 10.1016/j.exer.2003.12.011
   Schmut O, 1999, OPHTHALMOLOGE, V96, P375, DOI 10.1007/s003470050421
   Somers P, 2008, J HEART VALVE DIS, V17, P682
   Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   Sung HW, 1999, J BIOMED MATER RES, V47, P116, DOI 10.1002/(SICI)1097-4636(199911)47:2<116::AID-JBM2>3.0.CO;2-J
   Tsai CC, 2000, J BIOMED MATER RES, V52, P58, DOI 10.1002/1097-4636(200010)52:1<58::AID-JBM8>3.0.CO;2-0
   Wollensak G, 2004, EYE, V18, P718, DOI 10.1038/sj.eye.6700751
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
   YAMANO T, 1990, FOOD CHEM TOXICOL, V28, P515, DOI 10.1016/0278-6915(90)90122-4
   ZHANG CY, CELL METAB, P417
   Zhou T, 2007, J CHROMATOGR B, V858, P296, DOI 10.1016/j.jehromb.2007.08.031
NR 28
TC 49
Z9 54
U1 0
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD APR
PY 2010
VL 36
IS 4
BP 659
EP 664
DI 10.1016/j.jcrs.2009.11.003
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 584WS
UT WOS:000276785200021
PM 20362860
DA 2018-10-20
ER

PT J
AU Yamada, M
   Ueno, T
   Minamikawa, H
   Sato, N
   Iwasa, F
   Hori, N
   Ogawa, T
AF Yamada, M.
   Ueno, T.
   Minamikawa, H.
   Sato, N.
   Iwasa, F.
   Hori, N.
   Ogawa, T.
TI N-acetyl Cysteine Alleviates Cytotoxicity of Bone Substitute
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE apoptosis; reactive oxygen species (ROS); anti-oxidant; bone
   regeneration; inorganic biomaterial
ID IN-VITRO; REACTIVE OXYGEN; CELL-DEATH; RESIN; ACETYLCYSTEINE;
   OSTEOBLASTS; DIFFERENTIATION; DEPROTEINATION; INTERLEUKIN-8;
   BIOMATERIALS
AB Lack of cytocompatibility in bone substitutes impairs healing in surrounding bone. Adverse biological events around biomaterials may be associated with oxidative stress. We hypothesized that a clinically used inorganic bone substitute is cytotoxic to osteoblasts due to oxidative stress and that N-acetyl cysteine (NAC), an antioxidant amino acid derivative, would detoxify such material. Only 20% of rat calvaria osteoblasts were viable when cultured on commercial deproteinized bovine bone particles for 24 hr, whereas this percentage doubled on bone substitute containing NAC. Intracellular ROS levels markedly increased on and under bone substitutes, which were reduced by prior addition of NAC to materials. NAC restored suppressed alkaline phosphatase activity in the bone substitute. Proinflammatory cytokine levels from human osteoblasts on the bone substitute decreased by one-third or more with addition of NAC. NAC alleviated cytotoxicity of the bone substitute to osteoblastic viability and function, implying enhanced bone regeneration around NAC-treated inorganic biomaterials.
C1 [Yamada, M.; Ueno, T.; Minamikawa, H.; Sato, N.; Iwasa, F.; Hori, N.; Ogawa, T.] Univ Calif Los Angeles, Sch Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent,LBIS, Los Angeles, CA 90024 USA.
   [Yamada, M.] Tokyo Dent Coll, Dept Removable Prosthodont & Gerodontol, Tokyo, Japan.
RP Yamada, M (reprint author), Univ Calif Los Angeles, Sch Dent, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Div Adv Prosthodont Biomat & Hosp Dent,LBIS, Los Angeles, CA 90024 USA.
EM masayamada@tdc.ac.jp
OI Yamada, Masahiro/0000-0002-6316-7866
FU Japan Medical Materials (JMM) Corporation; Nissenken Institute
FX This work was supported by the Japan Medical Materials (JMM) Corporation
   and the Nissenken Institute. The authors thank Associate Professor
   Jeremy Williams, Tokyo Dental College, for his assistance with the
   English of the manuscript.
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Alpar B, 2000, Clin Oral Investig, V4, P219, DOI 10.1007/s007840000079
   Att W, 2009, ACTA BIOMATER, V5, P391, DOI 10.1016/j.actbio.2008.07.021
   BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
   Bertazzo S, 2008, J INORG BIOCHEM, V102, P137, DOI 10.1016/j.jinorgbio.2007.07.031
   Carter DH, 2002, BONE, V31, P389, DOI 10.1016/S8756-3282(02)00840-2
   Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701
   Feinendegen LE, 2002, HUM EXP TOXICOL, V21, P85, DOI 10.1191/0960327102ht216oa
   Gillissen A, 1998, RESP MED, V92, P609, DOI 10.1016/S0954-6111(98)90506-6
   Gillissen A, 1997, LUNG, V175, P235, DOI 10.1007/PL00007570
   Huang FM, 2005, J ENDODONT, V31, P679, DOI 10.1097/01.don.0000155227.86046.a2
   Ignjatovic N, 2006, MICROSC RES TECHNIQ, V69, P976, DOI 10.1002/jemt.20374
   ISHIMI Y, 1990, J IMMUNOL, V145, P3297
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]
   Kojima N, 2008, DENT MATER, V24, P1686, DOI 10.1016/j.dental.2008.04.008
   Lenz R, 2009, J BIOMED MATER RES A, V89A, P370, DOI 10.1002/jbm.a.31996
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5
   Nadzam GS, 2000, ANN SURG, V231, P587, DOI 10.1097/00000658-200004000-00019
   Paranjpe A, 2007, FREE RADICAL BIO MED, V43, P1394, DOI 10.1016/j.freeradbiomed.2007.07.011
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   Rauner M, 2007, INT ARCH ALLERGY IMM, V143, P31, DOI 10.1159/000098223
   Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001
   Somanathan Rakesh V, 2006, Acta Medica (Hradec Kralove), V49, P87
   Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022
   Stefaniak AB, 2009, J PHYS CONF SER, V151, DOI 10.1088/1742-6596/151/1/012045
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   Tsaryk R, 2007, BIOMATERIALS, V28, P806, DOI 10.1016/j.biomaterials.2006.09.033
   Tsukimura N, 2009, BIOMATERIALS, V30, P3378, DOI 10.1016/j.biomaterials.2009.02.043
   Vermes C, 2001, J BONE JOINT SURG AM, V83A, P201, DOI 10.2106/00004623-200102000-00007
   Yamada M, 2008, J DENT RES, V87, P372, DOI 10.1177/154405910808700417
   Yamada M, 2009, ACTA BIOMATER, V5, P2963, DOI 10.1016/j.actbio.2009.04.027
   Yamada M, 2009, REDOX REP, V14, P13, DOI 10.1179/135100009X392430
   Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001
NR 36
TC 17
Z9 19
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 2010
VL 89
IS 4
BP 411
EP 416
DI 10.1177/0022034510363243
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 568ZZ
UT WOS:000275566800016
PM 20200411
OA Green Published
DA 2018-10-20
ER

PT J
AU Fleckman, P
   Underwood, R
   Usui, M
   Zhao, G
   Marshall, A
   Maginness, M
   Glaister, C
   Ratner, B
   Olerud, J
AF Fleckman, P.
   Underwood, R.
   Usui, M.
   Zhao, G.
   Marshall, A.
   Maginness, M.
   Glaister, C.
   Ratner, B.
   Olerud, J.
TI Cutaneous response to long term percutaneous porous/solid biomaterial
   implants in a mouse model
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Society-for-Investigative-Dermatology
CY MAY 05-08, 2010
CL Atlanta, GA
SP Soc Investtigat Dermatol
C1 [Fleckman, P.; Underwood, R.; Usui, M.; Zhao, G.; Olerud, J.] Univ Washington, Seattle, WA 98195 USA.
   [Marshall, A.; Maginness, M.; Glaister, C.; Ratner, B.] Healion, Seattle, WA USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD APR
PY 2010
VL 130
SU 1
MA 029
BP S5
EP S5
PG 1
WC Dermatology
SC Dermatology
GA 580ND
UT WOS:000276455100028
DA 2018-10-20
ER

PT J
AU Dong, CX
   Zhu, SJ
   Mizuno, M
   Hashimoto, M
AF Dong, C. X.
   Zhu, S. J.
   Mizuno, M.
   Hashimoto, M.
TI Compressive creep behavior of silane treated TiO2/high-density
   polyethylene
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID MECHANICAL-PROPERTIES; COMPOSITES; NANOCOMPOSITES; BIOACTIVITY;
   RESISTANCE
AB In biomaterial silane treated TiO2/high-density polyethylene(silane-TiO2/HDPE), silane connection structurally corresponds to acid phosphoprotein bond, which connects the noncalcified collagen fibril bands and the adjacent apatite crystals in natural bones. In order to explore the function and variation process of acid phosphoprotein under loading in natural bones, the microscopic variation mechanism of silane connection in silane-TiO2/HDPE was investigated through the compressive creep tests in air and saline solution. Through the analysis of creep rate curves under different stress loads, different creep mechanisms were proposed, in which silane connection plays a very important role. Through SEM observation of sample surfaces and the creep tests in saline solution, the important role of silane connection in creep process was further proved. That is, silane connection can not only support the loading stress but also hinder the failure process under loading effectively.
C1 [Dong, C. X.; Zhu, S. J.] Fukuoka Inst Technol, Dept Intelligent Mech Engn, Fukuoka 8110295, Japan.
   [Dong, C. X.] Beihua Univ, Coll Chem & Biol, Jilin 132013, Peoples R China.
   [Mizuno, M.; Hashimoto, M.] Japan Fine Ceram Ctr, Nagoya, Aichi 4568587, Japan.
RP Zhu, SJ (reprint author), Fukuoka Inst Technol, Dept Intelligent Mech Engn, Fukuoka 8110295, Japan.
EM zhu@fit.ac.jp
RI Hashimoto, Masami/J-7205-2013
CR Ascenzi MG, 2007, J BIOMECH, V40, P2619, DOI 10.1016/j.jbiomech.2007.01.014
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Guild FJ, 1998, J MATER SCI-MATER M, V9, P497, DOI 10.1023/A:1008831720198
   Hashimoto M, 2006, MATER RES BULL, V41, P515, DOI 10.1016/j.materresbull.2005.09.014
   Lietz S, 2007, MACROMOL MATER ENG, V292, P23, DOI 10.1002/mame.200600280
   Mohamed KR, 2008, MAT SCI ENG C-BIO S, V28, P1087, DOI 10.1016/j.msec.2007.04.040
   Othman N, 2006, POLYM DEGRAD STABIL, V91, P1761, DOI 10.1016/j.polymdegradstab.2005.11.022
   Pegoretti A, 2004, POLYMER, V45, P2751, DOI 10.1016/j.polymer.2004.02.015
   Takadama H, 2004, KEY ENG MAT, V254-2, P569, DOI 10.4028/www.scientific.net/KEM.254-256.569
   Tee DI, 2007, COMPOS SCI TECHNOL, V67, P2584, DOI 10.1016/j.compscitech.2006.12.007
   Xia HS, 2007, J APPL POLYM SCI, V103, P2992, DOI 10.1002/app.25462
   Yang JL, 2006, POLYMER, V47, P2791, DOI 10.1016/j.polymer.2006.02.065
   Zhang SM, 2005, CURR APPL PHYS, V5, P516, DOI 10.1016/j.cap.2005.01.023
   Zhang Z, 2004, POLYMER, V45, P3481, DOI 10.1016/j.polymer.2004.03.004
   Zhou T.H., 2007, COMPOS SCI TECHNOL, V7, P2297
NR 15
TC 3
Z9 4
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD APR
PY 2010
VL 45
IS 7
BP 1796
EP 1802
DI 10.1007/s10853-009-4161-9
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 550AA
UT WOS:000274096400010
DA 2018-10-20
ER

PT J
AU Liu, Y
   Mao, J
   Zhou, B
   Wei, W
   Gong, SQ
AF Liu, Yan
   Mao, Jing
   Zhou, Bin
   Wei, Wei
   Gong, Shiqiang
TI Peptide aptamers against titanium-based implants identified through
   phage display
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BINDING PEPTIDES; DENTAL IMPLANTS; SURFACE; HYDROXYAPATITE; CELLS; RGD;
   FUNCTIONALIZATION; POLYPEPTIDES; SELECTION; ADHESION
AB Commercially pure titanium (cp-Ti) is widely used in the field of long-term clinical oral implantology owing to its ability to allow close bone-implant apposition. The optimization of its function based on artificial proteins has become a key issue in the development of improved cp-Ti implants. Here, we set out to identify peptide aptamers with preferential adsorption towards titanium-based implants through the phage display methodology. Fifteen sequences were selected in the third round of biopanning. One sequence, ATWVSPY (named TBP1), had a 40% repetition rate and exhibited the strongest binding affinity to cp-Ti disks. Ten sequences were selected in the fourth round, among which the repetition rate is 80% for TBP1 and 20% for TBP2 (GVGLPHT). The peptide aptamers against cp-Ti disks can provide an alternative method of functional coating for biomaterial surfaces.
C1 [Liu, Yan; Mao, Jing; Zhou, Bin; Wei, Wei; Gong, Shiqiang] Huazhong Univ Sci & Technol, Dept Stomatol, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China.
RP Zhou, B (reprint author), Huazhong Univ Sci & Technol, Dept Stomatol, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China.
EM bzhou@tjh.tjmu.edu.cn
OI Gong, Shi-qiang/0000-0001-9796-4081
FU National Science Foundation of China [30700957]
FX This research was funded by National Science Foundation of China which
   was conferred to Dr. B. Zhou (NSFC No. 30700957). The authors are
   grateful to the Analytical and Testing Center, Huazhong University of
   Science and Technology in China for technical assistance.
CR Brown S, 2000, J MOL BIOL, V299, P725, DOI 10.1006/jmbi.2000.3682
   Donatan S, 2009, MAT SCI ENG C-BIO S, V29, P14, DOI 10.1016/j.msec.2008.05.003
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Gronewold TMA, 2009, ACTA BIOMATER, V5, P794, DOI 10.1016/j.actbio.2008.09.014
   Gungormus M, 2008, BIOMACROMOLECULES, V9, P966, DOI 10.1021/bm701037x
   Hsu SH, 2007, BIO-MED MATER ENG, V17, P53
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   KAWAHARA H, 1989, ORAL IMPLANTOLOGY BI, P169
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Mante Francis K, 2004, J Oral Implantol, V30, P343, DOI 10.1563/0.667.1
   Mante Mamle, 2003, J Oral Implantol, V29, P66, DOI 10.1563/1548-1336(2003)029<0066:AOHMSC>2.3.CO;2
   Matsui T, 2007, LANGMUIR, V23, P1615, DOI 10.1021/la061318t
   Nakamura HK, 2007, J DENT RES, V86, P147, DOI 10.1177/154405910708600208
   Oya K, 2009, BIOMATERIALS, V30, P1281, DOI 10.1016/j.biomaterials.2008.11.030
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   Sawyer AA, 2007, BIOMATERIALS, V28, P383, DOI 10.1016/j.biomaterials.2006.08.031
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Schuler M, 2006, NANOMEDICINE-UK, V1, P449, DOI 10.2217/17435889.1.4.449
   Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008
   Thai CK, 2004, BIOTECHNOL BIOENG, V87, P129, DOI 10.1002/bit.20149
NR 23
TC 14
Z9 14
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2010
VL 21
IS 4
BP 1103
EP 1107
DI 10.1007/s10856-009-3970-3
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 578EF
UT WOS:000276275600008
PM 20091097
DA 2018-10-20
ER

PT J
AU Zhang, ML
   Zhai, WY
   Chang, J
AF Zhang, Meili
   Zhai, Wanyin
   Chang, Jiang
TI Preparation and characterization of a novel willemite bioceramic
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOACTIVE GLASS DISSOLUTION; IN-VITRO BIOACTIVITY; HUMAN OSTEOBLASTS;
   GENE-EXPRESSION; IONIC PRODUCTS; BONE-FORMATION; ZINC; CERAMICS;
   PROLIFERATION; BEHAVIOR
AB Willemite (Zn(2)SiO(4)) ceramics were prepared by sintering the willemite green compacts. The effects of sintering temperature on the linear shrinkage, porosity and mechanical strength of the ceramics were examined. With the sintering temperature increased, the linear shrinkage of the ceramics increased and the porosity decreased. When sintered at 1,300A degrees C, willemite ceramics showed mechanical properties of the same order of magnitude as values for human cortical bone, as measured by bending strength (91.2 +/- A 4.2 MPa) and Young's modulus (37.5 +/- A 1.5 GPa). In addition, the adhesion and proliferation of rabbit bone marrow stromal cells (BMSCs) on willemite ceramics was investigated. The results showed that the ceramics supported cell adhesion and stimulated the proliferation. All these findings suggest that willemite ceramics possess suitable mechanical properties and favorable biocompatibility and might be a promising biomaterial for bone implant applications.
C1 [Zhang, Meili; Zhai, Wanyin; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Zhang, Meili] Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
FU Science and Technology Commission of Shanghai Municipality [08JC1420800,
   09JC1415500]; National Basic Research Program [2005CB522704]; Natural
   Science Foundation of China [30730034]
FX This work was supported by grants from Science and Technology Commission
   of Shanghai Municipality (Grant No.: 08JC1420800 and No.: 09JC1415500);
   the National Basic Research Program (973 Program) of P. R. China (Grant
   No.: 2005CB522704) and Natural Science Foundation of China (Grant No.:
   30730034).
CR Boyd D, 2009, J MATER SCI-MATER M, V20, P413, DOI 10.1007/s10856-008-3569-0
   BURCH RE, 1975, CLIN CHEM, V21, P501
   CARLISLE EM, 1972, FED PROC, V31, pA700
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Cui HT, 2005, CHEM MATER, V17, P5562, DOI 10.1021/cm051289s
   Du RL, 2006, J BIOMATER APPL, V20, P341, DOI 10.1177/0885328206054535
   Guo YP, 2006, J EUR CERAM SOC, V26, P1827, DOI 10.1016/j.jeurceramsoc.2005.09.008
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HSIEH HS, 1980, J NUTR, V110, P1581
   HURLEY L, 1981, PHYSIOL REV, V61, P249
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Josset Y, 2003, J BIOMED MATER RES A, V67A, P1205, DOI 10.1002/jbm.a.20035
   Kim JT, 2009, J MED FOOD, V12, P118, DOI 10.1089/jmf.2007.0647
   KNUDSEN FP, 1959, J AM CERAM SOC, V42, P376, DOI 10.1111/j.1151-2916.1959.tb13596.x
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   Lusvardi G, 2009, ACTA BIOMATER, V5, P419, DOI 10.1016/j.actbio.2008.07.007
   Miao SD, 2007, J MATER SCI-MATER M, V18, P2101, DOI 10.1007/s10856-007-3131-5
   Ni SY, 2007, CERAM INT, V33, P83, DOI 10.1016/j.ceramint.2005.07.021
   PARISI AF, 1969, AM J CLIN NUTR, V22, P1222
   Ramaswamy Y, 2008, ACTA BIOMATER, V4, P1487, DOI 10.1016/j.actbio.2008.04.014
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Sogo Y, 2004, MATER SCI TECH-LOND, V20, P1079, DOI 10.1179/026708304225019704
   SPLINTER RJ, 1971, J BIOMED MATER RES, V74, P1478
   Sun JY, 2009, ACTA BIOMATER, V5, P1284, DOI 10.1016/j.actbio.2008.10.011
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Wang HF, 2003, MATER CHEM PHYS, V82, P414, DOI 10.1016/S0254-0584(03)00262-1
   Wu C, 2007, J BIOMED MATER RES B, V83B, P153, DOI 10.1002/jbm.b.30779
   Wu CT, 2006, J BIOMATER APPL, V21, P119, DOI 10.1177/0885328206057953
   Wu CT, 2005, CERAM INT, V31, P27, DOI 10.1016/j.ceramint.2004.02.008
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yamaguchi M, 1998, J TRACE ELEM EXP MED, V11, P119
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   Yamaguchi M, 2008, MOL CELL BIOCHEM, V312, P157, DOI 10.1007/s11010-008-9731-7
   Yu B, 2003, CERAM INT, V29, P695, DOI 10.1016/S0272-8842(02)00219-5
NR 36
TC 18
Z9 18
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2010
VL 21
IS 4
BP 1169
EP 1173
DI 10.1007/s10856-010-3985-9
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 578EF
UT WOS:000276275600015
PM 20069346
DA 2018-10-20
ER

PT J
AU Chung, TW
   Chang, YL
AF Chung, Tze-Wen
   Chang, Yu-Lin
TI Silk fibroin/chitosan-hyaluronic acid versus silk fibroin scaffolds for
   tissue engineering: promoting cell proliferations in vitro
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL-CELLS; COLORIMETRIC ASSAY; ENHANCING
   GROWTH; BOMBYX-MORI; BONE; FIBROBLASTS; DIFFERENTIATION; BIOMATERIAL;
   RESPONSES
AB The feasibility of silk fibroin protein (SF) scaffolds for tissue engineering applications to promote cell proliferation has been demonstrated, as well as the ability to mimic natural extra-cellular matrix (ECM), SF/chitosan (CS), a polysaccharide, scaffolds for tissue engineering. However, the response of cells to SF/CS-hyaluronic acid (SF/CS-HA) scaffolds has not been examined, which this study attempts to do and then compares those results with those of SF scaffolds. SF/CS-HA microparticles were fabricated to produce scaffolds in order to examine the proliferations of human dermal fibroblasts (HDF) in the scaffolds. Positive zeta potentials and ATR-FTIR spectra confirmed the co-existence of SF and CS-HA in SF/CS-HA microparticles. HDF proliferated well and migrated into SF/CS-HA scaffolds for around 160 mu m in depth, as well as those in SF scaffolds after 7 days of cultivation, as observed using confocal microscopy. Interestingly, HDF grown in SF/CS-HA scaffolds had a markedly higher cell density than that in SF ones. Additionally, MTT assay revealed that the growth rates of HDF in SF/CS-HA scaffolds significantly exceeded (P < 0.01, n = 5) those in scaffolds of SF and SF/CS. The daily glucose consumptions and lactate formations, metabolic parameters, of HDF grown in SF/CS-HA and SF/CS scaffolds were significantly higher (P < 0.01, n = 3) than those in SF ones in most culturing days. Results of this study suggest that SF/CS-HA scaffolds have better cell responses for tissue engineering applications than SF ones.
C1 [Chung, Tze-Wen; Chang, Yu-Lin] Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Liu 640, Yun Lin, Taiwan.
RP Chung, TW (reprint author), Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Liu 640, Yun Lin, Taiwan.
EM twchung@yuntech.edu.tw
FU National Science Council of the Republic of China, Taiwan
   [NSC-96-2321-B-002043, NSC-97-2314-B-002-045, NSC-96-2221-E-224-077-MY3]
FX The authors would like to thank the National Science Council of the
   Republic of China, Taiwan, for financially supporting this research
   under Contract Nos; NSC-96-2321-B-002043, NSC-97-2314-B-002-045 and
   NSC-96-2221-E-224-077-MY3.
CR Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Chung TW, 2006, ARTIF ORGANS, V30, P35, DOI 10.1111/j.1525-1594.2006.00178.x
   Chung TW, 2005, J BIOMED MATER RES A, V72A, P213, DOI 10.1002/jbm.a.30225
   Chung TW, 2008, BIOMATERIALS, V29, P228, DOI 10.1016/j.biomaterials.2007.09.027
   Chung TW, 2009, J MATER SCI-MATER M, V20, P397, DOI 10.1007/s10856-008-3586-z
   Dechert TA, 2006, WOUND REPAIR REGEN, V14, P252, DOI 10.1111/j.1743-6109.2006.00119.x
   Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012
   ENGBERSBUIJTENH.P, 2008, J MATER SCI-MATER M, V19, P3545
   Fan HB, 2008, BIOMATERIALS, V29, P1017, DOI 10.1016/j.biomaterials.2007.10.048
   Garcia-Fuentes M, 2008, BIOMATERIALS, V29, P633, DOI 10.1016/j.biomaterials.2007.10.024
   Garside P, 2005, APPL SPECTROSC, V59, P1242, DOI 10.1366/000370205774430855
   GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   GOBIN AS, 2005, J BIOMED MATER RES A, V74, P324
   GROSSJENDROSKA M, 1992, INVEST OPHTH VIS SCI, V33, P3394
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
NR 37
TC 29
Z9 33
U1 1
U2 36
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2010
VL 21
IS 4
BP 1343
EP 1351
DI 10.1007/s10856-009-3876-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 578EF
UT WOS:000276275600034
PM 20135206
DA 2018-10-20
ER

PT J
AU Steinhaus, S
   Stark, Y
   Bruns, S
   Haile, Y
   Scheper, T
   Grothe, C
   Behrens, P
AF Steinhaus, Stephanie
   Stark, Yvonne
   Bruns, Stephanie
   Haile, Yohannes
   Scheper, Thomas
   Grothe, Claudia
   Behrens, Peter
TI Polysialic acid immobilized on silanized glass surfaces: a test case for
   its use as a biomaterial for nerve regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CELL-ADHESION MOLECULE; ESCHERICHIA-COLI K1; SCHWANN-CELLS; GUIDES;
   REPAIR; RECONSTRUCTION; ENDOSIALIDASE; MECHANISM; CHAMBERS; SYSTEMS
AB The immobilization of polysialic acid (polySia) on glass substrates has been investigated with regard to the applicability of this polysaccharide as a novel, biocompatible and bioresorbable material for tissue engineering, especially with regard to its use in nerve regeneration. PolySia, a homopolymer of alpha-2,8-linked sialic acid, is involved in post-translational modification of the neural cell adhesion molecule (NCAM). The degradation of polySia can be controlled which makes it an interesting material for coating and for scaffold construction in tissue engineering. Here, we describe the immobilization of polySia on glass surfaces via an epoxysilane linker. Whereas glass surfaces will not actually be used in nerve regeneration scaffolds, they provide a simple and efficient means for testing various methods for the investigation of immobilized polySia. The modified surfaces were investigated with contact angle measurements and the quantity of immobilized polySia was examined by the thiobarbituric acid assay and a specific polySia-ELISA. The interactions between the polySia-modified surface and immortalized Schwann cells were evaluated via cell adhesion and cell viability assays. The results show that polySia can be immobilized on glass surfaces via the epoxysilane linker and that surface-bound polySia has no toxic effects on Schwann cells. Therefore, as a key substance in the development of vertebrates and as a favourable substrate for the cultivation of Schwann cells, it offers interesting features for the use in nerve guidance tubes for treatment of peripheral nerve injuries.
C1 [Steinhaus, Stephanie; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Ctr Solid State Chem & New Mat, D-30167 Hannover, Germany.
   [Stark, Yvonne; Bruns, Stephanie; Scheper, Thomas] Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany.
   [Haile, Yohannes; Grothe, Claudia] Hannover Med Sch, Inst Neuroanat, D-30167 Hannover, Germany.
RP Behrens, P (reprint author), Leibniz Univ Hannover, Inst Inorgan Chem, Ctr Solid State Chem & New Mat, Callinstr 9, D-30167 Hannover, Germany.
EM Peter.Behrens@acb.uni-hannover.de
RI Scheper, Thomas/H-8143-2013
FU Deutsche Forschungsgemeinschaft [548]
FX This work was supported by Deutsche Forschungsgemeinschaft within the
   framework of the DFG research group 548. We thank Rita Gerardy-Schahn
   (Institute of Cellular Chemistry, Medical School Hannover) for fruitful
   discussions.
CR AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384
   Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8
   Ansselin AD, 1997, NEUROPATH APPL NEURO, V23, P387
   Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.3.CO;2-Y
   Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   FINNE J, 1985, J BIOL CHEM, V260, P1265
   FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0
   Franceschini I, 2001, GLYCOBIOLOGY, V11, P231, DOI 10.1093/glycob/11.3.231
   GRAVVANIS AI, 2003, EUR J PLAST SURG, V26, P111
   GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q
   Haastert K, 2007, CURR GENE THER, V7, P221, DOI 10.2174/156652307780859035
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   Haile Y, 2008, BIOMATERIALS, V29, P1880, DOI 10.1016/j.biomaterials.2007.12.030
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X
   Lietz M, 2006, BIOTECHNOL BIOENG, V93, P99, DOI 10.1002/bit.20688
   Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007
   Lundborg G, 1997, J HAND SURG-AM, V22A, P99, DOI 10.1016/S0363-5023(05)80188-1
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   LUNDBORG G, 2004, REV HANDCHIR MIKROCH, V36, P1
   MACKINNON S E, 1990, Journal of Reconstructive Microsurgery, V6, P117, DOI 10.1055/s-2007-1006810
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MATSUMOTO S, 1981, J MOL BIOL, V152, P501, DOI 10.1016/0022-2836(81)90255-2
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   MILLESI H, 1981, SURG CLIN N AM, V61, P321
   Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9
   OConnell AW, 1997, J NEUROCHEM, V68, P2538
   PAERELS GB, 1965, BIOCHEM J, V96, P787, DOI 10.1042/bj0960787
   Potyrailo RA, 1998, ANAL CHEM, V70, P3419, DOI 10.1021/ac9802325
   Rode B, 2008, J BIOTECHNOL, V135, P202, DOI 10.1016/j.jbiotec.2008.03.012
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   Sparmann M, 1998, ORTHOPADE, V27, P433
   Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874
   Valero-Cabre A, 2001, J NEUROSCI RES, V63, P214, DOI 10.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D
   ZHANG H, 1992, J NEUROSCI, V12, P3107
NR 39
TC 13
Z9 15
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2010
VL 21
IS 4
BP 1371
EP 1378
DI 10.1007/s10856-009-3981-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 578EF
UT WOS:000276275600037
PM 20119645
DA 2018-10-20
ER

PT J
AU Bae, SR
   Park, C
   Choi, JC
   Poo, H
   Kim, CJ
   Sung, MH
AF Bae, Sun-Ryang
   Park, Chung
   Choi, Jae-Chul
   Poo, Haryoung
   Kim, Chul-Joong
   Sung, Moon-Hee
TI Effects of Ultra High Molecular Weight Poly-gamma-glutamic Acid from
   Bacillus subtilis (chungkookjang) on Corneal Wound Healing
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Poly-gamma-glutamic acid (gamma-PGA); corneal wound healing; hyaluronic
   acid
ID SODIUM HYALURONATE; RABBIT; GLYCOSAMINOGLYCANS; BIOSYNTHESIS;
   EPITHELIUM; STIMULANT; COLLAGEN; CULTURES; HEALON; CELLS
AB Poly-gamma-glutamic acid (gamma-PGA) is a natural edible polypeptide in which glutamate is polymerized via gamma-amide linkages. First, we assessed the eye irritancy potential of gamma-PGA in rabbits. Additionally, we studied the effects of gamma-PGA on corneal wound healing, due to the anti-inflammatory properties and water retaining abilities of gamma-PGA. In this study, the effects of gamma-PGA on corneal wound healing after an alkali burn were evaluated. Thirty eyes wounded by alkali burning in 30 white rabbits were divided into three groups: group A was treated with 0.1% 5,000 kDa gamma-PGA for 2 days; group B was treated with 0.1% hyaluronic acid; and group C was not treated, as a control. The area of corneal epithelial defect was examined at 12, 24, 30, 36, 42, and 48 h after corneal alkali wounding to determine initial wound healing. We found that gamma-PGA promoted corneal wound healing, compared with controls, and showed similar effects to hyaluronic acid. These results indicate that gamma-PGA stimulates corneal wound healing by an anti-inflammatory effect and enhancing cell migration and cell proliferation. gamma-PGA is a promising biomaterial that may be a substitute for hyaluronic acid in corneal wound healing treatment.
C1 [Park, Chung; Choi, Jae-Chul; Sung, Moon-Hee] BioLeaders Corp, Taejon 305500, South Korea.
   [Bae, Sun-Ryang] Catholic Univ Korea, Coll Med, Seoul 150101, South Korea.
   [Poo, Haryoung] Korea Res Inst Biosci & Biotechnol, Viral Infect Dis Res Ctr, Taejon 305806, South Korea.
   [Kim, Chul-Joong] Chungnam Natl Univ, Coll Vet Med, Taejon 305764, South Korea.
   [Sung, Moon-Hee] Kookmin Univ, Dept Bio & Nanochem, Seoul 136702, South Korea.
RP Sung, MH (reprint author), BioLeaders Corp, Taejon 305500, South Korea.
EM smoonhee@kookmin.ac.kr
FU Seoul RBD Program [10580]; Kookmin University in Korea
FX This work was supported by the Seoul R&BD Program (10580) and the
   Research Program 2008 of Kookmin University in Korea.
CR AONO R, 1987, BIOCHEM J, V245, P467, DOI 10.1042/bj2450467
   ASHIUCHI M, 2002, BIOPOLYMERS, V7, P123
   BRAZZELL RK, 1991, INVEST OPHTH VIS SCI, V32, P336
   BUESCHER JM, 2007, CRIT REV BIOTECHNOL, V2, P1
   CHUNG JH, 1987, ACTA OPHTHALMOL, V65, P648
   CHUNG JH, 1989, EXP EYE RES, V48, P569, DOI 10.1016/0014-4835(89)90039-0
   Chung JH, 1998, OPHTHALMIC RES, V30, P96, DOI 10.1159/000055460
   CHUNG JH, 1987, ACTA OPHTHALMOL, V65, P529
   CHUNG JH, 1988, ACTA OPHTHALMOL S187, V66, P1
   CONRAD GW, 1977, J BIOL CHEM, V252, P6861
   DAHL IM, 1981, EXP EYE RES, V32, P419, DOI 10.1016/S0014-4835(81)80021-8
   DELUISE VP, 1984, ANN OPHTHALMOL, V16, P823
   Draize J. H., 1959, APPRAISAL SAFETY CHE, P46
   HIBBS MS, 1985, J BIOL CHEM, V260, P2493
   INOUE M, 1993, INVEST OPHTH VIS SCI, V34, P2313
   Kang SE, 2005, FOOD SCI BIOTECHNOL, V14, P704
   Kay JH, 1962, J SOC COSMET CHEM, V13, P281
   Kim TW, 2007, J IMMUNOL, V179, P775, DOI 10.4049/jimmunol.179.2.775
   Lee TY, 2009, CANCER IMMUNOL IMMUN, V58, P1783, DOI 10.1007/s00262-009-0689-4
   MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989
   Nakamura M, 1997, EXP EYE RES, V64, P1043, DOI 10.1006/exer.1997.0302
   NISHIDA T, 1991, EXP EYE RES, V53, P753, DOI 10.1016/0014-4835(91)90110-Z
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   PFISTER RR, 1988, INVEST OPHTH VIS SCI, V29, P955
   PFISTER RR, 1987, INVEST OPHTH VIS SCI, V28, P295
   REIM M, 1984, FORTSCHR OPHTHALMOL, V8, P323
   SARIC D, 1984, FORTSCHR OPHTHALMOL, V8, P588
   SCHULTZ GS, 1992, INVEST OPHTH VIS SCI, V33, P3325
   STUART JC, 1985, ANN OPHTHALMOL, V17, P190
   Sung MH, 2005, CHEM REC, V5, P352, DOI 10.1002/tcr.20061
   Toole B.P., 1976, NEURONAL RECOGNITION, P275
   WYSENBEEK YS, 1988, INVEST OPHTH VIS SCI, V29, P194
   YUE BYJT, 1978, INVEST OPHTH VIS SCI, V17, P523
NR 33
TC 20
Z9 21
U1 0
U2 18
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD APR
PY 2010
VL 20
IS 4
BP 803
EP 808
DI 10.4014/jmb.0911.11021
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 589JT
UT WOS:000277144200024
PM 20467257
DA 2018-10-20
ER

PT J
AU Coekeliler, D
   Goktas, H
   Tosun, PD
   Mutlu, S
AF Coekeliler, Dilek
   Goktas, Hilal
   Tosun, Pinar Deniz
   Mutlu, Selma
TI Infection Free Titanium Alloys by Stabile Thiol Based Nanocoating
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Advanced Nano Materials
CY 2008
CL Univ Aveiro, Aveiro, PORTUGAL
HO Univ Aveiro
DE Ti Alloys; Plasma Polymerization; Bacterial Anti-Fouling; Biomaterials;
   Cold Plasma
ID PLASMA POLYMERIZATION; ION-IMPLANTATION; FILMS
AB As biomedical materials, titanium and titanium alloys (Ti-6Al-4V) are superior to many materials in terms of mechanical properties and biocompatibility. However, they are still not sufficient for prolonged clinical use because the biocompatibility of these materials must be improved. In this study, the prevention of the attachment of test microorganism on the Ti alloy surfaces by thiol (-SH) and hydroxyl (-OH) functional group containing monomer in plasma based electron beam generator was reported in order to prepare anti-fouling surfaces. The precursor, 11-mercaptoundecanoic acid is used as plasma source to create nano-film with 30-60 nm approximately. The surface chemistry and topology of uncoated and coated samples are characterized by Fourier Transform Infrared Spectroscopy (FTIR) and Atomic Force Microscopy (AFM). Static contact angle measurements are performed to state the change of surface hydrophilicity. All coated samples are tested in-vitro environment with Staphylococcus epidermidis that is chosen as the test bacteria strain in view of its significance for the pathogenesis of medical-device-related infections. This test is repeated after certain period of times and samples are waited in dynamic fluid media in order to investigate the stability of nano-coating. Plasma polymerized 11-mercaptounclecanoic acid film (PP MUA) with 42 +/- 4 nm is found alternative, stabile and simple method to create bacterial anti-fouling surfaces. The static contact angle of the coated surface is 34 +/- 8 degrees whereas the uncoated surface is 57 +/- 5 degrees. For the coated surface, the presence of C-OH and C=O groups in infrared spectra defining the PP MUA is achieved by the plasma polymerization. The attachment of the model microorganism on the biomaterial surface prepared by PP MUA is reduced 85.3% if compared to unmodified control surface.
C1 [Coekeliler, Dilek; Tosun, Pinar Deniz] Baskent Univ, Dept Biomed Engn, TR-06810 Ankara, Turkey.
   [Goktas, Hilal] Canakkale Onsekiz Mart Univ, Dept Phys, TR-17100 Canakkale, Turkey.
   [Mutlu, Selma] Hacettepe Univ, Dept Chem Engn, TR-06532 Ankara, Turkey.
RP Coekeliler, D (reprint author), Baskent Univ, Dept Biomed Engn, Bagl Campus, TR-06810 Ankara, Turkey.
CR Biederman H, 2000, SURF COAT TECH, V125, P371, DOI 10.1016/S0257-8972(99)00578-2
   Bilek MMM, 2002, SURF COAT TECH, V156, P136, DOI 10.1016/S0257-8972(02)00078-6
   Cokeliler D, 2007, BIOMED MATER, V2, P39, DOI 10.1088/1748-6041/2/1/007
   Goktas H, 2002, IEEE T PLASMA SCI, V30, P1837, DOI 10.1109/TPS.2002.806620
   Hanawa T, 2002, SCI TECHNOL ADV MAT, V3, P289, DOI 10.1016/S1468-6996(02)00028-1
   Hartley P. G., 2000, Plasmas and Polymers, V5, P47, DOI 10.1023/A:1009508426115
   HINMAN PV, 1979, J APPL POLYM SCI, V23, P3651, DOI 10.1002/app.1979.070231220
   KONIG B, 1994, ANAL CHEM, V66, P341, DOI 10.1021/ac00075a005
   Mutlu S, 2008, THIN SOLID FILMS, V516, P1249, DOI 10.1016/j.tsf.2007.06.074
   Shervedani RK, 2005, SURF COAT TECH, V198, P123, DOI 10.1016/j.surfcoat.2004.10.025
   ULMAN A, 1991, J AM CHEM SOC, V113, P1499, DOI 10.1021/ja00005a004
   Yap E, 1998, J APPL PHYS, V83, P3404, DOI 10.1063/1.367108
   Yasuda H., 1985, PLASMA POLYM
NR 13
TC 6
Z9 6
U1 0
U2 3
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD APR
PY 2010
VL 10
IS 4
BP 2583
EP 2589
DI 10.1166/jnn.2010.1414
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 548RW
UT WOS:000273984900046
DA 2018-10-20
ER

PT J
AU Lanca, MC
   Brandt, M
   Neagu, ER
   Dias, CJ
   Marat-Mendes, JN
AF Lanca, M. C.
   Brandt, M.
   Neagu, E. R.
   Dias, C. J.
   Marat-Mendes, J. N.
TI Dielectric spectra of natural cork and derivatives
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Dielectric Spectroscopy and Its
   Applications
CY AUG 26-29, 2008
CL Lyon, FRANCE
DE Dielectric properties, relaxation, electric modulus
ID ELECTRICAL-CONDUCTIVITY
AB Cork is a cellular biomaterial that has unique characteristics that make it suitable for many types of applications. Since it is also an electrical insulator, the study of its electrical and dielectric properties can lead to new interesting applications. The moisture present in cork and derivatives has a very important role on the dielectric properties. In this work a composite made of both recycled cork and TetraPak (R) used containers was studied and compared with other cork products. The dielectric relaxation spectra of natural cork (as received), commercial cork agglomerate and of a composite cork/Tetrapak (R) was investigated in the temperature range of -50 to 120 degrees C and in the frequency range of 10(-1) Hz-2 MHz. For some samples of the composite a small amount of paraffin was added. The highest values for the imaginary part of the dielectric permittivity were found for the commercial material and the composite without paraffin. The lowest was found for the cork/TetraPak (R)/paraffin composite. The influence of humidity content was investigated for the composite with wax. Natural cork shows a peak around 80 degrees C (not seen in the derivative materials). The commercial agglomerate and the cork/TetraPak (R)/paraffin composite show a peak around 40-50 degrees C. In the composite this peak becomes smaller as humidity is removed. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Lanca, M. C.; Neagu, E. R.; Dias, C. J.; Marat-Mendes, J. N.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencia Mat, I3N,CENIMAT, P-2829516 Caparica, Portugal.
   [Brandt, M.] Hsch FH, D-06217 Merseburg, Germany.
   [Neagu, E. R.] Tech Univ Iasi, Dept Phys, Iasi 700050, Romania.
RP Lanca, MC (reprint author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencia Mat, I3N,CENIMAT, P-2829516 Caparica, Portugal.
EM carmo@dcm.fct.unl.pt
RI Dias, Carlos/J-4947-2013; Lanca, M. Carmo/A-4437-2013
OI Dias, Carlos/0000-0003-3042-5029; Lanca, M. Carmo/0000-0001-9258-4899
CR Gibson L. J, 1997, CELLULAR SOLIDS STRU
   JONSCHER AK, 1983, DIELECTRIC RELAXATIO
   Kremer F., 2002, BROADBAND DIELECTRIC
   Lanca MC, 2007, J NON-CRYST SOLIDS, V353, P4501, DOI 10.1016/j.jnoncrysol.2007.03.037
   Lanca MC, 2008, MATER SCI FORUM, V587-588, P613, DOI 10.4028/www.scientific.net/MSF.587-588.613
   Lanca MC, 2006, MATER SCI FORUM, V514-516, P940
   Marat-Mendes JN, 2003, FERROELECTRICS, V294, P123, DOI 10.1080/00150190390238757
   Neagu E, 2000, J APPL PHYS, V87, P2914, DOI 10.1063/1.372277
   Silva SP, 2005, INT MATER REV, V50, P345, DOI 10.1179/174328005X41168
   VANTURNHOUT J, 2000, DIELECTR NEWSL   NOV, P1
NR 10
TC 1
Z9 2
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD APR 1
PY 2010
VL 356
IS 11-17
BP 763
EP 767
DI 10.1016/j.jnoncrysol.2009.09.042
PG 5
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 583HU
UT WOS:000276665500049
DA 2018-10-20
ER

PT J
AU Brevi, BC
   Magri, AS
   Toma, L
   Sesenna, E
AF Brevi, Bruno C.
   Magri, Alice S.
   Toma, Livia
   Sesenna, Enrico
TI Cranioplasty for repair of a large bone defect with autologous and
   homologous bone in children
SO JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
DE Cranioplasty; Skull defect; Custom made implant; Biomaterial; Bone
   banking
AB Cranioplasty is a well-established reconstructive procedure for restoring craniocerebral protection and improving cosmetic defects. Most allograft materials are not suitable in pediatric patients owing to skull growth; thus, autologous bone is often preferred in the reconstruction of the pediatric skull because of its capacity to osseointegrate and grow with the pediatric skeleton.
   A 33-month-old boy with Ewing sarcoma of the right frontal bone underwent surgical treatment with tumor excision. The resected bone was reconstructed with full-thickness calvaria harvested from the right parietal region. The residual parietal gap was filled with homologous bone taken from the iliac wing.
   This reconstructive technique was chosen to guarantee normal development of the frontal region and tissue integration, while considering possible radiotherapy after the primary surgery. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Brevi, Bruno C.; Magri, Alice S.; Toma, Livia; Sesenna, Enrico] Univ & Hosp Parma, Head & Neck Dept, Maxillofacial Surg Operat Unit, Parma, Italy.
RP Magri, AS (reprint author), Univ & Hosp Parma, Head & Neck Dept, Maxillofacial Surg Operat Unit, Parma, Italy.
EM alicesaramagri@libero.it
CR Blum KS, 1997, PEDIATR NEUROSURG, V26, P33, DOI 10.1159/000121158
   Ducic Yadranko, 2002, J Oral Maxillofac Surg, V60, P272, DOI 10.1053/joms.2002.30575
   Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01.01290.8E
   Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2
   Kosaka M, 2003, J CRANIO MAXILL SURG, V31, P15, DOI 10.1016/S1010-5182(02)00162-2
   McComb JG, 2003, NEUROSURGERY, V52, P45, DOI DOI 10.1227/01.NEU.0000054220.01290.8E
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   Rajan GP, 2006, J TRAUMA, V60, P1322, DOI 10.1097/01.ta.0000195977.18035.40
   RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002
NR 10
TC 19
Z9 20
U1 1
U2 3
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0022-3468
J9 J PEDIATR SURG
JI J. Pediatr. Surg.
PD APR
PY 2010
VL 45
IS 4
BP E17
EP E20
DI 10.1016/j.jpedsurg.2010.01.011
PG 4
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 581LC
UT WOS:000276523500043
PM 20385265
DA 2018-10-20
ER

PT J
AU Chambrone, L
   Sukekava, F
   Araujo, MG
   Pustiglioni, FE
   Chambrone, LA
   Lima, LA
AF Chambrone, Leandro
   Sukekava, Flavia
   Araujo, Mauricio G.
   Pustiglioni, Francisco E.
   Chambrone, Luiz Armando
   Lima, Luiz A.
TI Root-Coverage Procedures for the Treatment of Localized Recession-Type
   Defects: A Cochrane Systematic Review
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Review
DE Connective tissue; gingival recession; gingival recession/surgery;
   gingival recession/therapy; systematic review; tooth root/surgery
ID CONNECTIVE-TISSUE GRAFT; CORONALLY ADVANCED FLAP; ACELLULAR DERMAL
   MATRIX; HUMAN GINGIVAL RECESSION; PERIODONTAL PLASTIC-SURGERY; MILLER
   CLASS-I; DRIED BONE ALLOGRAFT; DOUBLE PEDICLE GRAFT; QUALITY-OF-LIFE;
   POSITIONED FLAP
AB Background: The purpose of this review is to evaluate the effectiveness of different root-coverage procedures in the treatment of recession-type defects.
   Methods: The Cochrane Oral Health Group Trials Register, Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE were searched for entries up to October 2008. There were no restrictions regarding publication status or the language of publication. Only clinical randomized controlled trials (RCTs) with a duration >= 6 months that evaluated recession areas (Miller Class I or II >= 3 mm) that were treated by means of periodontal plastic surgery procedures were included.
   Results: Twenty-four RCTs provided data. Only one trial was considered to be at low risk of bias. The remaining trials were considered to be at high risk of bias. The results indicated a significantly greater reduction in gingival recession and gain in keratinized tissue for subepithelial connective tissue grafts (SCTGs) compared to guided tissue regeneration (GTR) with bioabsorbable membranes (GTR bms). A significantly greater gain in keratinized tissue was found for enamel matrix protein compared to a coronally advanced flap (0.40 mm) and for SCTGs compared to GTR bms plus bone substitutes. Limited data exist on the changes of esthetic conditions as related to the opinions and preferences of patients for specific procedures.
   Conclusions: SCTGs, coronally advanced flaps alone or associated with other biomaterial, and GTR may be used as root-coverage procedures for the treatment of localized recession-type defects. In cases where root coverage and gain in keratinized tissue are expected, the use of SCTGs seems to be more adequate. J Periodontol 2070;81:452-478.
C1 [Chambrone, Leandro; Sukekava, Flavia; Pustiglioni, Francisco E.; Lima, Luiz A.] Univ Sao Paulo, Sch Dent, Dept Stomatol, Div Periodont, BR-05508000 Sao Paulo, Brazil.
   [Sukekava, Flavia; Araujo, Mauricio G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
RP Chambrone, L (reprint author), Univ Sao Paulo, Sch Dent, Dept Stomatol, Div Periodont, Av Prof Lineu Prestes,2227 Cidade Univ, BR-05508000 Sao Paulo, Brazil.
EM chambrone@usp.br
RI Chambrone, Leandro/D-8038-2011; Lima, Luiz/A-2400-2009; Sukekava,
   Flavia/F-9134-2018
OI Lima, Luiz/0000-0002-3086-8738; Sukekava, Flavia/0000-0003-1331-5821
CR Aichelmann-Reidy ME, 2001, J PERIODONTOL, V72, P998, DOI 10.1902/jop.2001.72.8.998
   Amarante ES, 2000, J PERIODONTOL, V71, P989, DOI 10.1902/jop.2000.71.6.989
   BAER PN, 1981, J PERIODONTOL, V52, P206, DOI 10.1902/jop.1981.52.4.206
   Baldi C, 1999, J PERIODONTOL, V70, P1077, DOI 10.1902/jop.1999.70.9.1077
   Barros Raquel R M, 2005, J Esthet Restor Dent, V17, P156, DOI 10.1111/j.1708-8240.2005.tb00105.x
   Barros RRM, 2004, J PERIODONTOL, V75, P1350, DOI 10.1902/jop.2004.75.10.1350
   BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446
   Berlucchi I, 2005, J PERIODONTOL, V76, P899, DOI 10.1902/jop.2005.76.6.899
   Berlucchi I, 2002, INT J PERIODONT REST, V22, P583
   BERNIMOULIN J-P, 1975, Journal of Clinical Periodontology, V2, P1, DOI 10.1111/j.1600-051X.1975.tb01721.x
   Bittencourt S, 2006, J PERIODONTOL, V77, P174, DOI 10.1902/jop.2006.050114
   BJORN H, 1963, SVERIGES TANDLAKARFO, V22, P684
   Borghetti A, 1999, J PERIODONTOL, V70, P123, DOI 10.1902/jop.1999.70.2.123
   BORGHETTI A, 1994, J PERIODONTOL, V65, P1107, DOI 10.1902/jop.1994.65.12.1107
   Bouchard P, 1997, J PERIODONTOL, V68, P262, DOI 10.1902/jop.1997.68.3.262
   BOUCHARD P, 1994, J PERIODONTOL, V65, P929, DOI 10.1902/jop.1994.65.10.929
   Burkhardt R, 2005, J CLIN PERIODONTOL, V32, P287, DOI 10.1111/j.1600-051X.2005.00660.x
   Caffesse RG, 1995, PERIODONTOL 2000, V9, P7, DOI 10.1111/j.1600-0757.1995.tb00051.x
   Caffesse RG, 2000, J PERIODONTOL, V71, P568, DOI 10.1902/jop.2000.71.4.568
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x
   Camargo PM, 2001, PERIODONTOL 2000, V27, P72, DOI 10.1034/j.1600-0757.2001.027001072.x
   Castellanos A, 2006, J PERIODONTOL, V77, P7, DOI 10.1902/jop.2006.77.1.7
   Cetiner D, 2003, J PERIODONTOL, V74, P1196, DOI 10.1902/jop.2003.74.8.1196
   Chambrone L, 2008, J DENT, V36, P659, DOI 10.1016/j.jdent.2008.05.007
   Chambrone Leandro, 2003, J Can Dent Assoc, V69, P505
   Chambrone L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007161.pub2
   Chambrone L, 2009, J CAN DENT ASSOC, V75, P203
   Chambrone L, 2009, J AM DENT ASSOC, V140, P294, DOI 10.14219/jada.archive.2009.0158
   Chambrone LA, 2006, J PERIODONTOL, V77, P909, DOI 10.1902/jop.2006.050249
   Chambrone LA, 2009, AM J DENT, V22, P339
   CHECCHI L, 1993, J PERIODONTOL, V64, P1238, DOI 10.1902/jop.1993.64.12.1238
   Cheung WS, 2004, J PERIODONTOL, V75, P1678, DOI 10.1902/jop.2004.75.12.1678
   COHEN DW, 1968, J PERIODONTOL, V39, P65, DOI 10.1902/jop.1968.39.2.65
   Cordioli G, 2001, J PERIODONTOL, V72, P1470, DOI 10.1902/jop.2001.72.11.1470
   Cortes AD, 2004, J PERIODONTOL, V75, P1137
   da Silva RC, 2004, J PERIODONTOL, V75, P413, DOI 10.1902/jop.2004.75.3.413
   Daniel A, 1990, J Indian Dent Assoc, V61, P294
   Cortes AD, 2006, J CLIN PERIODONTOL, V33, P683, DOI 10.1111/j.1600-051X.2006.00969.x
   Del Pizzo M, 2005, J CLIN PERIODONTOL, V32, P1181, DOI 10.1111/j.1600-051X.2005.00831.x
   Dembowska E, 2007, ORAL SURG ORAL MED O, V104, pE1, DOI 10.1016/j.tripleo.2007.03.013
   Dodge JR, 2000, INT J PERIODONT REST, V20, P399
   Duval BT, 2000, J PERIODONTOL, V71, P1687, DOI 10.1902/jop.2000.71.11.1687
   Egger M, 1997, BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   Erley KJ, 2006, J PERIODONTOL, V77, P1148, DOI 10.1902/jop.2006.050252
   Esposito M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003875.pub2
   Fardal O, 2002, J PERIODONTOL, V73, P1060, DOI 10.1902/jop.2002.73.9.1060
   Felipe MEMC, 2007, J PERIODONTOL, V78, P1209, DOI 10.1902/jop.2007.060356
   FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q
   Glickman I, 1958, J PERIODONTOL, V29, P50
   GRUPE HE, 1966, J PERIODONTOL, V37, P491, DOI 10.1902/jop.1966.37.6.491
   Grupe HE, 1956, J PERIODONTOL, V27, P92
   Gupta R, 2006, INT J PERIODONT REST, V26, P271
   Hagewald S, 2002, J CLIN PERIODONTOL, V29, P35, DOI 10.1034/j.1600-051x.2002.290106.x
   Harris RJ, 2005, J PERIODONTOL, V76, P1758, DOI 10.1902/jop.2005.76.10.1758
   HARRIS RJ, 1992, J PERIODONTOL, V63, P477, DOI 10.1902/jop.1992.63.5.477
   Harris RJ, 2000, INT J PERIODONT REST, V20, P51
   Harris RJ, 2002, J PERIODONTOL, V73, P1054, DOI 10.1902/jop.2002.73.9.1054
   Harris RJ, 1997, J PERIODONTOL, V68, P779, DOI 10.1902/jop.1997.68.8.779
   Harvey P M, 1965, N Z Dent J, V61, P180
   Harvey P M, 1970, N Z Dent J, V66, P42
   Henderson RD, 2001, J PERIODONTOL, V72, P571, DOI 10.1902/jop.2001.72.5.571
   Higgins JPT, 2008, COCHRANE HDB SYSTEMA
   Hirsch A, 2005, J PERIODONTOL, V76, P1323, DOI 10.1902/jop.2005.76.8.1323
   Huang LH, 2005, J PERIODONTOL, V76, P1768, DOI 10.1902/jop.2005.76.10.1768
   Ito K, 2000, QUINTESSENCE INT, V31, P319
   JAHNKE PV, 1993, J PERIODONTOL, V64, P315, DOI 10.1902/jop.1993.64.4.315
   Jepsen K, 1998, J PERIODONTOL, V69, P383, DOI 10.1902/jop.1998.69.3.383
   Joly JC, 2007, J PERIODONTOL, V78, P1017, DOI 10.1902/jop.2007.060428
   Jornung J, 2007, J AM DENT ASSOC, V138, P1544, DOI 10.14219/jada.archive.2007.0103
   Karadottir H, 2002, J PERIODONTOL, V73, P536, DOI 10.1902/jop.2002.73.5.536
   Keceli HG, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2007.01181.x
   KENNEDY JE, 1985, J CLIN PERIODONTOL, V12, P667, DOI 10.1111/j.1600-051X.1985.tb00938.x
   KHOCHT A, 1993, J PERIODONTOL, V64, P900, DOI 10.1902/jop.1993.64.9.900
   Kimble KM, 2004, J PERIODONTOL, V75, P210, DOI 10.1902/jop.2004.75.2.210
   Lafzi A, 2007, CLIN ORAL INVEST, V11, P401, DOI 10.1007/s00784-007-0143-y
   LANEY JB, 1992, J PERIODONTOL, V63, P19, DOI 10.1902/jop.1992.63.1.19
   LANGER B, 1985, J PERIODONTOL, V56, P715, DOI 10.1902/jop.1985.56.12.715
   Leknes KN, 2005, J CLIN PERIODONTOL, V32, P518, DOI 10.1111/j.1600-051X.2005.00706.x
   Lins LHS, 2003, J PERIODONTOL, V74, P168, DOI 10.1902/jop.2003.74.2.168
   Mahajan A, 2007, J PERIODONTOL, V78, P2348, DOI 10.1902/jop.2007.070074
   Martins AG, 2004, J PERIODONTOL, V75, P586, DOI 10.1902/jop.2004.75.4.586
   Matarasso S, 1998, INT J PERIODONT REST, V18, P445
   MATTHEWS DC, 1993, J PERIODONTOL, V64, P990, DOI 10.1902/jop.1993.64.10.990
   McGuire MK, 2003, J PERIODONTOL, V74, P1110, DOI 10.1902/jop.2003.74.8.1110
   MCGUIRE MK, 1995, INT J PERIODONT REST, V15, P71
   Miller P D Jr, 1985, Int J Periodontics Restorative Dent, V5, P8
   MILLER PD, 1988, DENT CLIN N AM, V32, P287
   Modica F, 2000, J PERIODONTOL, V71, P1693, DOI 10.1902/jop.2000.71.11.1693
   Moses O, 2006, J PERIODONTOL, V77, P195, DOI 10.1902/jop.2006.050008
   Muller HP, 1998, J CLIN PERIODONTOL, V25, P424, DOI 10.1111/j.1600-051X.1998.tb02466.x
   Muller HP, 1999, J PERIODONTOL, V70, P743, DOI 10.1902/jop.1999.70.7.743
   NABERS JM, 1966, PERIODONTICS, V4, P243
   Needleman I, 2005, PERIODONTOL 2000, V37, P12, DOI 10.1111/j.1600-0757.2004.37100.x
   Needleman I, 2005, PERIODONTOL 2000, V37, P106, DOI 10.1111/j.1600-0757.2004.37101.x
   Needleman IG, 2002, J CLIN PERIODONTOL, V29, P6, DOI 10.1034/j.1600-051X.29.s3.15.x
   Nemcovsky CE, 2004, J PERIODONTOL, V75, P600, DOI 10.1902/jop.2004.75.4.600
   Ng SKS, 2006, COMMUNITY DENT ORAL, V34, P114, DOI 10.1111/j.1600-0528.2006.00267.x
   Novaes AB, 2001, J PERIODONTOL, V72, P1477, DOI 10.1902/jop.2001.72.11.1477
   Oates Thomas W, 2003, Ann Periodontol, V8, P303, DOI 10.1902/annals.2003.8.1.303
   Ozcelik O, 2007, J CLIN PERIODONTOL, V34, P788, DOI 10.1111/j.1600-051X.2007.01120.x
   Paolantonio M, 1997, J CLIN PERIODONTOL, V24, P51, DOI 10.1111/j.1600-051X.1997.tb01184.x
   Paolantonio M, 2002, J PERIODONTOL, V73, P1299, DOI 10.1902/jop.2002.73.11.1299
   Paolantonio M, 2002, J PERIODONTOL, V73, P53, DOI 10.1902/jop.2002.73.1.53
   Pilloni A, 2006, J PERIODONTOL, V77, P2031, DOI 10.1902/jop.2006.050390
   Pini-Prato G, 1999, J PERIODONTOL, V70, P1064, DOI 10.1902/jop.1999.70.9.1064
   Prato GP, 1996, J PERIODONTOL, V67, P1216, DOI 10.1902/jop.1996.67.11.1216
   Prato GP, 2000, J PERIODONTOL, V71, P188, DOI 10.1902/jop.2000.71.2.188
   PRATO GP, 1992, J PERIODONTOL, V63, P919, DOI 10.1902/jop.1992.63.11.919
   Prato GPP, 2005, J PERIODONTOL, V76, P713, DOI 10.1902/jop.2005.76.5.713
   Rahmani M E, 2006, J Contemp Dent Pract, V7, P63
   Ricci G, 1996, J Esthet Dent, V8, P66, DOI 10.1111/j.1708-8240.1996.tb00887.x
   Ricci G, 1996, INT J PERIODONT REST, V16, P539
   Richmond S, 2007, COMMUNITY DENT ORAL, V35, P89, DOI 10.1111/j.1600-0528.2007.00296.x
   Roccuzzo M, 2002, J CLIN PERIODONTOL, V29, P178, DOI 10.1034/j.1600-051X.29.s3.11.x
   Roccuzzo M, 1996, J PERIODONTOL, V67, P7, DOI 10.1902/jop.1996.67.1.7
   Romagna-Genon C, 2001, J PERIODONTOL, V72, P1258, DOI 10.1902/jop.2000.72.9.1258
   Rosetti EP, 2000, J PERIODONTOL, V71, P1441, DOI 10.1902/jop.2000.71.9.1441
   Sallum EA, 2003, AM J DENT, V16, P287
   SBORDONE L, 1998, PERIODONTAL CASE REP, V10, P8
   Scabbia A, 1998, J CLIN PERIODONTOL, V25, P1041, DOI 10.1111/j.1600-051X.1998.tb02411.x
   Silva CO, 2007, J PERIODONTOL, V78, P1702, DOI 10.1902/jop.2007.070068
   Spahr A, 2005, J PERIODONTOL, V76, P1871, DOI 10.1902/jop.2005.76.11.1871
   SULLIVAN HC, 1968, PERIODONTICS, V6, P152
   SUMNER CF, 1969, J PERIODONTOL, V40, P119, DOI 10.1902/jop.1969.40.2.119
   Susin C, 2004, J PERIODONTOL, V75, P1377, DOI 10.1902/jop.2004.75.10.1377
   Tal H, 2002, J PERIODONTOL, V73, P1405, DOI 10.1902/jop.2002.73.12.1405
   Tatakis DN, 2000, J PERIODONTOL, V71, P299, DOI 10.1902/jop.2000.71.2.299
   Thomson WM, 2006, J PERIODONTOL, V77, P947, DOI 10.1902/jop.2006.050319
   Tozum TF, 2005, J PERIODONTOL, V76, P1842, DOI 10.1902/jop.2005.76.11.1842
   Trabulsi M, 2004, J PERIODONTOL, V75, P1446, DOI 10.1902/jop.2004.75.11.1446
   TROMBELLI L, 1995, J PERIODONTOL, V66, P313, DOI 10.1902/jop.1995.66.5.313
   Trombelli L, 2005, J CLIN PERIODONTOL, V32, P16, DOI 10.1111/j.1600-051X.2004.00625.x
   TROMBELLI L, 1995, J PERIODONTOL, V66, P14, DOI 10.1902/jop.1995.66.1.14
   Trombelli L, 1996, J CLIN PERIODONTOL, V23, P861, DOI 10.1111/j.1600-051X.1996.tb00624.x
   Trombelli L, 1997, INT J PERIODONT REST, V17, P449
   Trombelli L, 1998, J PERIODONTOL, V69, P1271, DOI 10.1902/jop.1998.69.11.1271
   Wang HL, 2001, J PERIODONTOL, V72, P1301, DOI 10.1902/jop.2001.72.10.1301
   Wennstrom JL, 1996, J CLIN PERIODONTOL, V23, P770, DOI 10.1111/j.1600-051X.1996.tb00608.x
   Wilson TG, 2005, J PERIODONTOL, V76, P881, DOI 10.1902/jop.2005.76.6.881
   Woodyard JG, 2004, J PERIODONTOL, V75, P44, DOI 10.1902/jop.2004.75.1.44
   YONEYAMA T, 1988, J CLIN PERIODONTOL, V15, P581, DOI 10.1111/j.1600-051X.1988.tb02133.x
   Zucchelli G, 2003, J CLIN PERIODONTOL, V30, P862, DOI 10.1034/j.1600-051X.2003.00397.x
   Zucchelli G, 1998, J PERIODONTOL, V69, P138, DOI 10.1902/jop.1998.69.2.138
NR 143
TC 150
Z9 160
U1 3
U2 21
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD APR
PY 2010
VL 81
IS 4
BP 452
EP 478
DI 10.1902/jop.2010.090540
PG 27
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 665FO
UT WOS:000283020800003
PM 20367089
DA 2018-10-20
ER

PT J
AU Ehrenfest, DMD
   Del Corso, M
   Diss, A
   Mouhyi, J
   Charrier, JB
AF Ehrenfest, David M. Dohan
   Del Corso, Marco
   Diss, Antoine
   Mouhyi, Jaafar
   Charrier, Jean-Baptiste
TI Three-Dimensional Architecture and Cell Composition of a Choukroun's
   Platelet-Rich Fibrin Clot and Membrane
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Blood platelets; fibrin; leukocytes; scanning electron microscopy
ID IN-VITRO; GRAFTING MATERIAL; PRF; PLASMA; METRONIDAZOLE; OSTEOBLASTS;
   MORPHOLOGY; RELEVANCE; SURGERY; SEALANT
AB Background: Platelet-rich fibrin (PRF; Choukroun's technique) is a second-generation platelet concentrate for surgical use. This easy protocol allows the production of leukocyte- and platelet-rich fibrin clots and membranes starting from 10-ml blood samples. The purposes of this study were to determine the cell composition and three-dimensional organization of this autologous biomaterial and to evaluate the influence of different collection tubes (dry glass or glass-coated plastic tubes) and compression procedures (forcible or soft) on the final PRF-membrane architecture.
   Methods: After centrifugation, blood analyses were performed on the residual waste plasmatic layers after collecting PRF clots. The PRF clots and membranes were processed for examination by light microscopy and scanning electron microscopy.
   Results: Approximately 97% of the platelets and >50% of the leukocytes were concentrated in the PRF clot and showed a specific three-dimensional distribution, depending on the centrifugation forces. Platelets and fibrin formed large clusters of coagulation in the first millimeters of the membrane beyond the red blood cell base. The fibrin network was very mature and dense. Moreover, there was no significant difference in the PRF architecture between groups using the different tested collection tubes and compression techniques, even if these two parameters could have influenced the growth factor content and biologic matrix properties.
   Conclusions: The PRF protocol concentrated most platelets and leukocytes from a blood harvest into a single autologous fibrin biomaterial. This protocol offers reproducible results as long as the main production principles are respected. J Periodontol 2010;81:546-555.
C1 [Ehrenfest, David M. Dohan; Mouhyi, Jaafar] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, S-41390 Gothenburg, Sweden.
   [Ehrenfest, David M. Dohan; Del Corso, Marco; Diss, Antoine; Charrier, Jean-Baptiste] LoB5 Fdn Res, Paris, France.
   [Mouhyi, Jaafar] Univ So Calif, Dept Periodontol, Los Angeles, CA USA.
   [Charrier, Jean-Baptiste] Univ Paris Sud, Hop Bicetre, AP HP, Dept Ear Nose Throat Head & Neck Surg, F-94275 Le Kremlin Bicetre, France.
RP Ehrenfest, DMD (reprint author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Medicinaregatan 8B, S-41390 Gothenburg, Sweden.
EM lob5@mac.com
RI Dohan Ehrenfest, David/C-8866-2012
OI Del Corso, Marco/0000-0002-2882-8139
FU LoB5 Foundation for Research
FX This work was partially supported by a grant from the LoB5 Foundation
   for Research. The authors declare no competing financial interests
   related to this study.
CR Braccini F, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P255
   Buchta C, 2005, BIOMATERIALS, V26, P6233, DOI 10.1016/j.biomaterials.2005.04.014
   Charrier J B, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P313
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J, 2001, IMPLANTODONTIE, V42, P55
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808
   Del Corso M, 2009, J PERIODONTOL, V80, P1694, DOI 10.1902/jop.2009.090253
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P305, DOI 10.1016/j.tripleo.2006.10.009
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.016
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   GIBBLE JW, 1990, TRANSFUSION, V30, P741, DOI 10.1046/j.1537-2995.1990.30891020337.x
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Kawasaki J, 2004, ANESTH ANALG, V99, P1440, DOI 10.1213/01.ANE.0000134805.30532.59
   Man D, 2001, PLAST RECONSTR SURG, V107, P229, DOI 10.1097/00006534-200101000-00037
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Mazor Z, 2009, J PERIODONTOL, V80, P2056, DOI 10.1902/jop.2009.090252
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   SAADOUN AP, 2007, PRACT PROCED AESTHET, V19, P81
   Simonpieri A, 2009, IMPLANT DENT, V18, P220, DOI 10.1097/ID.0b013e31819b5e3f
   Simonpieri A, 2009, IMPLANT DENT, V18, P102, DOI 10.1097/ID.0b013e318198cf00
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   ZILLA P, 1984, SCAND J HAEMATOL, V33, P440
NR 30
TC 102
Z9 110
U1 1
U2 13
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD APR
PY 2010
VL 81
IS 4
BP 546
EP 555
DI 10.1902/jop.2009.090531
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 665FO
UT WOS:000283020800012
PM 20373539
DA 2018-10-20
ER

PT J
AU Shibli, JA
   Piattelli, A
   Iezzi, G
   Cardoso, LA
   Onuma, T
   de Carvalho, PSP
   d'Avila, S
   Ferrari, DS
   Mangano, C
   Zenobio, EG
AF Shibli, Jamil Awad
   Piattelli, Adriano
   Iezzi, Giovanna
   Cardoso, Luciana Ap.
   Onuma, Tatiana
   Perri de Carvalho, Paulo Sergio
   d'Avila, Susana
   Ferrari, Daniel S.
   Mangano, Carlo
   Zenobio, Elton Goncalves
TI Effect of Smoking on Early Bone Healing Around Oxidized Surfaces: A
   Prospective, Controlled Study in Human Jaws
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Dental implants; histology; osseointegration; smoking; wound healing
ID TITANIUM IMPLANTS; DENTAL IMPLANTS; ORAL IMPLANTS; FOLLOW-UP;
   ANGIOGENESIS; NICOTINE; RATS; VEGF; BIOMATERIAL; TOPOGRAPHY
AB Background: This prospective and controlled histologic study evaluates the impact of smoking on bone-to-implant contact, the bone density in the threaded area, and the bone density outside the threaded area around microimplants with anodized surface retrieved from human jaws.
   Methods: A total of 24 subjects (mean age 51.32 +/- 7.5 years) were divided in two groups: smokers (n = 13 subjects) and non-smokers (n = 11 subjects). Each subject received one microimplant with oxidized surface during conventional mandible or maxilla implant surgery. After 8 weeks, the microimplants and the surrounding tissue were removed and prepared for histomorphometric analysis.
   Results: Three microimplants placed in smokers showed no osseointegration. The newly formed bone showed early stages of maturation, mainly in the non-smokers. Marginal bone loss, gap, and fibrous tissue were present around implants retrieved from smokers. Histometric evaluation indicated that the mean bone-to-implant contact ranged between 25.97% +/- 9.02% and 40.01% +/- 12.98% for smokers and non-smokers, respectively (P <0.001). Smokers presented 28.17% +/- 10.32% of bone density in the threaded area, whereas non-smokers showed 46.34% +/- 19.12%. The mean of bone density outside the threaded area ranged between 18.76% and 25.11% for smokers and non-smokers, respectively (P>0.05).
   Conclusion: The present data obtained in human subjects confirm that smoking has a detrimental effect on early bone tissue response around oxidized implant surfaces. J Periodontol 2010;81:575-583.
C1 [Shibli, Jamil Awad] Univ Guarulhos, CEPE, Dent Res Div, Dept Periodontol & Implantol, BR-07011040 Guarulhos, SP, Brazil.
   [Piattelli, Adriano; Iezzi, Giovanna] Univ G dAnnunzio, Dept Oral Med & Pathol, Chieti, Italy.
   [Perri de Carvalho, Paulo Sergio] State Univ Sao Paulo UNESP, Dent Sch Aracatuba, Dept Oral Med & Pathol, Aracatuba, SP, Brazil.
   [Mangano, Carlo] Univ Varese, Insumbira, Italy.
   [Zenobio, Elton Goncalves] Pontificia Univ Catolica Minas Gerais, Dept Periodontol & Implantol, Belo Horizonte, MG, Brazil.
RP Shibli, JA (reprint author), Univ Guarulhos, CEPE, Dent Res Div, Dept Periodontol & Implantol, Praca Tereza Cristina 229, BR-07011040 Guarulhos, SP, Brazil.
EM jashibli@yahoo.com
RI Shibli, Jamil/A-1361-2014; de Carvalho, Paulo Sergio/H-4279-2012
OI Shibli, Jamil/0000-0003-1971-0195; 
CR Ammenheuser MM, 1997, ENVIRON MOL MUTAGEN, V30, P131, DOI 10.1002/(SICI)1098-2280(1997)30:2<131::AID-EM5>3.3.CO;2-3
   Astrand P, 2008, CLIN IMPLANT DENT R, V10, P207, DOI 10.1111/j.1708-8208.2007.00081.x
   Bain C A, 1993, Int J Oral Maxillofac Implants, V8, P609
   Balshe AA, 2008, INT J ORAL MAX IMPL, V23, P1117
   Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778
   Cesar-Neto JB, 2005, INT J ORAL MAX IMPL, V20, P713
   Cesar-Neto JB, 2005, J PERIODONTOL, V76, P1476, DOI 10.1902/jop.2005.76.9.1476
   Cooke JP, 2004, ANN MED, V36, P33, DOI 10.1080/07853890310017576
   Correa MG, 2009, CLIN ORAL IMPLAN RES, V20, P588, DOI 10.1111/j.1600-0501.2008.01695.x
   Dai J, 2007, J DENT RES, V86, P937, DOI 10.1177/154405910708601006
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   de Valk-de Roo GW, 1997, MATURITAS, V28, P153, DOI 10.1016/S0378-5122(97)00070-4
   DEBRUYN H, 1994, CLIN ORAL IMPLAN RES, V5, P260, DOI 10.1034/j.1600-0501.1994.050410.x
   DeLuca S, 2006, INT J PROSTHODONT, V19, P560
   Eckardt H, 2003, J ORTHOP RES, V21, P335, DOI 10.1016/S0736-0266(02)00159-6
   Huang YH, 2005, CLIN ORAL IMPLAN RES, V16, P105, DOI 10.1111/j.1600-0501.2004.01086.x
   Ivanoff CJ, 2003, INT J ORAL MAX IMPL, V18, P341
   Jungner M, 2005, CLIN ORAL IMPLAN RES, V16, P308, DOI 10.1111/j.1600-0501.2005.01101.x
   LAROCHE M, 1994, CLIN RHEUMATOL, V13, P611, DOI 10.1007/BF02243003
   Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016
   Misch C E, 1990, Int J Oral Implantol, V7, P9
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rawlinson A, 2003, J CLIN PERIODONTOL, V30, P42, DOI 10.1034/j.1600-051X.2003.300107.x
   Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P283, DOI 10.1111/j.1600-051X.2006.00907.x
   Saldanha JB, 2006, J ORAL MAXIL SURG, V64, P1359, DOI 10.1016/j.joms.2006.05.021
   Sennerby L, 1998, INT J PROSTHODONT, V11, P408
   SHIBLI JA, 2009, CLIN IMPLAN IN PRESS
   Shibli JA, 2007, IMPLANT DENT, V16, P252, DOI 10.1097/ID.0b013e3180de4d64
   Shibli JA, 2007, J BIOMED MATER RES B, V80B, P377, DOI 10.1002/jbm.b.30608
   Strietzel FP, 2007, J CLIN PERIODONTOL, V34, P523, DOI 10.1111/j.1600-051X.2007.01083.x
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   W-Dahl A, 2004, ACTA ORTHOP SCAND, V75, P347, DOI 10.1080/00016470410001303
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Yildiz D, 2004, TOXICON, V43, P619, DOI 10.1016/j.toxicon.2004.01.017
   Yuhara S, 1999, EUR J PHARMACOL, V383, P387, DOI 10.1016/S0014-2999(99)00551-8
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 38
TC 23
Z9 25
U1 2
U2 14
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD APR
PY 2010
VL 81
IS 4
BP 575
EP 583
DI 10.1902/jop.2010.090493
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 665FO
UT WOS:000283020800016
PM 20367100
DA 2018-10-20
ER

PT J
AU Wu, DF
   Zhang, YS
   Yuan, LJ
   Zhang, M
   Zhou, WD
AF Wu, Defeng
   Zhang, Yisheng
   Yuan, Lijuan
   Zhang, Ming
   Zhou, Weidong
TI Viscoelastic Interfacial Properties of Compatibilized
   Poly(epsilon-caprolactone)/Polylactide Blend
SO JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS
LA English
DT Article
DE blend; compatibilization; poly(epsilon-caprolactone) (PCL); polylactide
   (PLA); rheology
ID IMMISCIBLE POLYMER BLENDS; PHASE MORPHOLOGY ANALYSIS; BLOCK-COPOLYMER;
   BIODEGRADABLE BLENDS; ALIPHATIC POLYESTERS; PHYSICAL-PROPERTIES; STEADY
   SHEAR; BEHAVIOR; POLY(L-LACTIDE); MODEL
AB Poly(epsilon-caprolactone)/polylactide blend (PCL/PLA) is an interesting biomaterial because the two component polymers show good complementarity in their physical properties. However, PCL and PLA are incompatible thermodynamically and hence the interfacial properties act as the important roles controlling the final properties of their blends. Thus, in this work, the PCL/PLA blends were prepared by melt mixing using the block copolymers as compatibilizer for the studies of interfacial properties. Several rheological methods and viscoelastic models were used to establish the relations between improved phase morphologies and interfacial properties. The results show that the interfacial behaviors of the PCL/PLA blends highly depend on the interface-located copolymers. The presence of copolymers reduces the interfacial tension and emulsified the phase interface, leading to stabilization of the interface and retarding both the shape relaxation and the elastic interface relaxation. As a result, besides the relaxation of matrices (tau(m)) and the shape relaxation of the dispersed PLA phase (tau(F)), a new relaxation behavior (tau(beta)), which is attribute to the relaxation of Marangoni stresses tangential to the interface between dispersed PLA phase and matrix PCL, is observed on the compatibilized blends. In contrast to that of the diblock copolymers, the triblock copolymers show higher emulsifying level. However, both can improve the overall interfacial properties and enhance the mechanical strength of the PCL/PLA blends as a result. (C) 2010 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys 48: 756-765, 2010
C1 [Wu, Defeng; Zhang, Yisheng; Yuan, Lijuan; Zhang, Ming] Yangzhou Univ, Sch Chem & Chem Engn, Jiangsu 225002, Peoples R China.
   [Wu, Defeng; Zhang, Yisheng; Yuan, Lijuan; Zhang, Ming] Yangzhou Univ, Prov Key Lab Environm Mat & Engn, Jiangsu 225002, Peoples R China.
   [Zhou, Weidong] Yangzhou Univ, Testing Ctr, Jiangsu 225002, Peoples R China.
RP Wu, DF (reprint author), Yangzhou Univ, Sch Chem & Chem Engn, Jiangsu 225002, Peoples R China.
EM dfwu@yzu.edu.cn
RI Defeng, WU/K-8865-2012
FU National Natural Science Foundation of China [50803052]; Postdoctoral
   Science Foundation of China [20080441078, 200902532]
FX This work was supported by the research grants from the National Natural
   Science Foundation of China (50803052) and the Postdoctoral Science
   Foundation of China (20080441078, 200902532).
CR Aslan S, 2000, J MATER SCI, V35, P1615, DOI 10.1023/A:1004787326273
   Bousmina M, 1999, RHEOL ACTA, V38, P73, DOI 10.1007/s003970050157
   Bousmina M, 1999, RHEOL ACTA, V38, P251, DOI 10.1007/s003970050175
   BOUSMINA M, 1995, J RHEOL, V39, P499, DOI 10.1122/1.550709
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   Dai CA, 1997, MACROMOLECULES, V30, P6727, DOI 10.1021/ma960543m
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   Eastmond GC, 2000, ADV POLYM SCI, P59, DOI DOI 10.1007/3-540-48838-3_2
   ELEMANS PHM, 1990, J RHEOL, V34, P1311, DOI 10.1122/1.550087
   GRACE HP, 1982, CHEM ENG COMMUN, V14, P225, DOI 10.1080/00986448208911047
   GRAEBLING D, 1993, MACROMOLECULES, V26, P320, DOI 10.1021/ma00054a011
   GRAMESPACHER H, 1992, J RHEOL, V36, P1127, DOI 10.1122/1.550304
   GUPTA B, 2007, J PROG POLYM SCI, V32, P455
   Huo YL, 2007, RHEOL ACTA, V46, P507, DOI 10.1007/s00397-006-0158-3
   Jacobs U, 1999, J RHEOL, V43, P1495, DOI 10.1122/1.551056
   Kim CH, 2000, J APPL POLYM SCI, V77, P226, DOI 10.1002/(SICI)1097-4628(20000705)77:1<226::AID-APP29>3.0.CO;2-8
   Kim SH, 1996, MACROMOLECULES, V29, P6933, DOI 10.1021/ma960040g
   LEE HM, 1994, J RHEOL, V38, P1405, DOI 10.1122/1.550551
   Li RM, 2006, POLYM BULL, V56, P455, DOI 10.1007/s00289-005-0499-6
   Liang HJ, 1999, MACROMOLECULES, V32, P8204, DOI 10.1021/ma990563z
   Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k
   Lopez-Rodriguez N, 2006, POLYM ENG SCI, V46, P1299, DOI 10.1002/pen.20609
   Maglio G, 2004, MACROMOL CHEM PHYSIC, V205, P946, DOI 10.1002/macp.200300150
   Maglio G, 1999, MACROMOL RAPID COMM, V20, P236, DOI 10.1002/(SICI)1521-3927(19990401)20:4<236::AID-MARC236>3.0.CO;2-V
   Na YH, 2002, BIOMACROMOLECULES, V3, P1179, DOI 10.1021/bm020050r
   Newman D, 2009, MACROMOLECULES, V42, P5219, DOI 10.1021/ma9007303
   PALIERNE JF, 1990, RHEOL ACTA, V29, P204, DOI 10.1007/BF01331356
   Riemann RE, 1997, MACROMOLECULES, V30, P5476, DOI 10.1021/ma961814w
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Sarazin P, 2003, BIOMACROMOLECULES, V4, P1669, DOI 10.1021/bm030034+
   Sivalingam G, 2004, POLYM DEGRAD STABIL, V84, P393, DOI 10.1016/j.polymdegradstab.2003.12.008
   Stadler FJ, 2009, RHEOL ACTA, V48, P33, DOI 10.1007/s00397-008-0303-2
   Steinmann S, 2002, RHEOL ACTA, V41, P77, DOI 10.1007/s003970200007
   Taylor GI, 1932, P R SOC LOND A-CONTA, V138, P41, DOI 10.1098/rspa.1932.0169
   Taylor GI, 1934, P R SOC LOND A-CONTA, V146, P0501, DOI 10.1098/rspa.1934.0169
   Tsuji H, 2003, POLYM INT, V52, P269, DOI 10.1002/pi.1093
   Tsuji H, 2003, J APPL POLYM SCI, V87, P412, DOI 10.1002/app.11429
   Tsuji H, 2001, MACROMOL BIOSCI, V1, P59
   Tsuji H, 2007, J APPL POLYM SCI, V104, P831, DOI 10.1002/app.25602
   Tsuji H, 2007, POLYM INT, V56, P258, DOI 10.1002/pi.2150
   Van Hemelrijck E, 2005, J RHEOL, V49, P783, DOI 10.1122/1.1888625
   Vert M., 1992, BIODEGRADABLE POLYM
   Vinckier I, 1996, J RHEOL, V40, P613, DOI 10.1122/1.550800
   Wang J, 2006, RHEOL ACTA, V45, P741, DOI 10.1007/s00397-005-0038-2
   Wang L, 1998, POLYM DEGRAD STABIL, V59, P161, DOI 10.1016/S0141-3910(97)00196-1
   Wu DF, 2008, EUR POLYM J, V44, P2171, DOI 10.1016/j.eurpolymj.2008.04.023
   Wu DF, 2009, BIOMACROMOLECULES, V10, P417, DOI 10.1021/bm801183f
   Xing PX, 2000, MACROMOLECULES, V33, P8020, DOI 10.1021/ma000537x
   Yee M, 2007, RHEOL ACTA, V46, P653, DOI 10.1007/s00397-006-0154-7
   Yu W, 2002, J RHEOL, V46, P1401, DOI 10.1122/1.1517303
   Zhang YS, 2009, POLYM ENG SCI, V49, P2293, DOI 10.1002/pen.21456
NR 52
TC 59
Z9 61
U1 7
U2 57
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-6266
J9 J POLYM SCI POL PHYS
JI J. Polym. Sci. Pt. B-Polym. Phys.
PD APR 1
PY 2010
VL 48
IS 7
BP 756
EP 765
DI 10.1002/polb.21952
PG 10
WC Polymer Science
SC Polymer Science
GA 572QR
UT WOS:000275848400003
DA 2018-10-20
ER

PT J
AU Cannon, G
   Mauney, J
   Gong, E
   Yu, R
   Adam, R
   Estrada, C
AF Cannon, Glenn
   Mauney, Joshua
   Gong, Edward
   Yu, Richard
   Adam, Roslyn
   Estrada, Carlos
TI UTILIZATION OF SILK AS A NOVEL BIOMATERIAL IN BLADDER AUGMENTATION
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2010
VL 183
IS 4
SU S
MA 274
BP E108
EP E108
DI 10.1016/j.juro.2010.02.335
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA V45PV
UT WOS:000209829401123
DA 2018-10-20
ER

PT J
AU Morelli, A
   Chiellini, F
AF Morelli, Andrea
   Chiellini, Federica
TI Ulvan as a New Type of Biomaterial from Renewable Resources:
   Functionalization and Hydrogel Preparation
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE biomaterials; hydrogels; Ulvan; UV crosslinking
ID TISSUE ENGINEERING SCAFFOLDS; HYALURONIC-ACID HYDROGELS; CHONDROITIN
   SULFATE; IN-VITRO; GLYCIDYL METHACRYLATE; ANTIOXIDANT ACTIVITY;
   POLY(VINYL ALCOHOL); PERTUSA CHLOROPHYTA; GREEN SEAWEEDS; POLYSACCHARIDE
AB Ulvan, a sulfated cell-wall polysaccharide extracted from green seaweeds, is functionalized by grafting methacryloyl moieties as a radical polymerizable group and photopolymerized under UV irradiation in order to attain biodegradable hydrogels. The functionalization reaction is carried out by using methacrylic anhydride or glycidyl methacrylate according to two basic procedures applied to polysaccharides. The functionalization of Ulvan is determined by FT-IR and H-1 NMR spectroscopy and confirmed by DSC analysis. Hydrogels were characterized by FT-IR and by H-1 NMR spectroscopies and their swelling behaviour assessed in terms of degree of swelling using PBS 1 x pH 7.4 as a medium in order to check their stability under physiological conditions.
C1 [Morelli, Andrea; Chiellini, Federica] Univ Pisa, Lab Bioact Polymer Mat Biomed & Environm Applicat, UdR INSTM, Dept Chem & Ind Chem, I-56010 Pisa, Italy.
RP Chiellini, F (reprint author), Univ Pisa, Lab Bioact Polymer Mat Biomed & Environm Applicat, UdR INSTM, Dept Chem & Ind Chem, Via Vecchia Livornese 1291, I-56010 Pisa, Italy.
EM federica@dcci.unipi.it
RI Chiellini, Federica/F-3233-2010
OI Chiellini, Federica/0000-0003-4680-9975
FU NoE (Network of Excellence) [NMP3-CT 2004-500328]
FX This work was performed within the framework of the NoE (Network of
   Excellence) project Expertissues (NMP3-CT 2004-500328) and Expertissues
   miniproject NATCOM.
CR Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047
   Benoit DSW, 2006, TISSUE ENG, V12, P1663, DOI 10.1089/ten.2006.12.1663
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   d'Ayala GG, 2008, MOLECULES, V13, P2069, DOI 10.3390/molecules13092069
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Fletcher R.L., 1996, MARINE BENTHIC VEGET, V123, P7, DOI DOI 10.1017/S0025315400034111
   Guilherme MR, 2009, BIOMACROMOLECULES, V10, P190, DOI 10.1021/bm801250p
   Hamcerencu M, 2008, CARBOHYD POLYM, V71, P92, DOI 10.1016/j.carbpol.2007.05.021
   Hamcerencu M, 2007, POLYMER, V48, P1921, DOI 10.1016/j.polymer.2007.01.048
   Hu JF, 2001, J ASIAN NAT PROD RES, V3, P353, DOI 10.1080/10286020108040376
   Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee JB, 2004, PLANTA MED, V70, P813, DOI 10.1055/s-2004-827228
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Li Q, 2003, MACROMOLECULES, V36, P2556, DOI 10.1021/ma021190w
   Liu YX, 2009, BIOMATERIALS, V30, P196, DOI 10.1016/j.biomaterials.2008.09.041
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pitarresi G, 2003, BIOMATERIALS, V24, P4301, DOI 10.1016/S0142-9612(03)00332-6
   Qi HM, 2006, BIOORG MED CHEM LETT, V16, P2441, DOI 10.1016/j.bmcl.2006.01.076
   Qi HM, 2005, INT J BIOL MACROMOL, V37, P195, DOI 10.1016/j.ijbiomac.2005.10.008
   Reis AV, 2009, J ORG CHEM, V74, P3750, DOI 10.1021/jo900033c
   Robic A, 2009, BIOPOLYMERS, V91, P652, DOI 10.1002/bip.21195
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Shumilina EV, 2002, COLLOID J+, V64, P372, DOI 10.1023/A:1015985229667
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Thein-Han WW, 2008, MATER SCI TECH-LOND, V24, P1062, DOI 10.1179/174328408X341753
   Wang LF, 2003, CARBOHYD POLYM, V52, P389, DOI 10.1016/S0144-8617(02)00328-4
   Yu PZ, 2003, PHARMACOL RES, V48, P543, DOI 10.1016/S1043-6618(03)00215-9
   Zhang HJ, 2008, CARBOHYD POLYM, V71, P428, DOI 10.1016/j.carbpol.2007.06.012
NR 35
TC 37
Z9 38
U1 2
U2 31
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1352
EI 1521-3935
J9 MACROMOL CHEM PHYS
JI Macromol. Chem. Phys.
PD APR 1
PY 2010
VL 211
IS 7
BP 821
EP 832
DI 10.1002/macp.200900562
PG 12
WC Polymer Science
SC Polymer Science
GA 586TZ
UT WOS:000276937700012
DA 2018-10-20
ER

PT J
AU Furlani, EP
AF Furlani, Edward P.
TI Magnetic Biotransport: Analysis and Applications
SO MATERIALS
LA English
DT Review
DE magnetic biotransport; magnetophoresis; magnetic nanoparticle transport;
   magnetic drug targeting; magnetofection; bioseparation
ID CARRIER PARTICLE CAPTURE; TARGETED DRUG-DELIVERY; GENE DELIVERY;
   ON-CHIP; MAGNETOPHORETIC MICROSYSTEM; BIOMEDICAL APPLICATIONS; BEAD
   SEPARATOR; TUMOR-THERAPY; BLOOD-CELLS; NANOPARTICLES
AB Magnetic particles are finding increasing use in bioapplications, especially as carrier particles to transport biomaterials such as proteins, enzymes, nucleic acids and whole cells etc. Magnetic particles can be prepared with biofunctional coatings to target and label a specific biomaterial, and they enable controlled manipulation of a labeled biomaterial using an external magnetic field. In this review, we discuss the use of magnetic nanoparticles as transport agents in various bioapplications. We provide an overview of the properties of magnetic nanoparticles and their functionalization for bioapplications. We discuss the basic physics and equations governing the transport of magnetic particles at the micro-and nanoscale. We present two different transport models: a classical Newtonian model for predicting the motion of individual particles, and a drift-diffusion model for predicting the behavior of a concentration of nanoparticles that takes into account Brownian motion. We review specific magnetic biotransport applications including bioseparation, drug delivery and magnetofection. We demonstrate the transport models via application to these processes.
C1 SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA.
RP Furlani, EP (reprint author), SUNY Buffalo, Inst Lasers Photon & Biophoton, 432 Nat Sci Complex, Buffalo, NY 14260 USA.
EM efurlani@buffalo.edu
CR Alexiou C, 2000, CANCER RES, V60, P6641
   Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1
   Aviles MO, 2005, J MAGN MAGN MATER, V293, P605, DOI 10.1016/j.jmmm.2005.01.089
   Berry CC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224003
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Bu MQ, 2008, SENSOR ACTUAT A-PHYS, V145, P430, DOI 10.1016/j.sna.2007.12.014
   Chen HT, 2004, J MAGN MAGN MATER, V284, P181, DOI 10.1016/j.jmmm.2004.06.036
   Chen HT, 2005, J MAGN MAGN MATER, V293, P616, DOI 10.1016/j.jmmm.2005.01.080
   Choi JW, 2001, BIOSENS BIOELECTRON, V16, P409, DOI 10.1016/S0956-5663(01)00154-3
   Choi JW, 2000, SENSOR ACTUAT B-CHEM, V68, P34, DOI 10.1016/S0925-4005(00)00458-5
   Cinteza LO, 2006, MOL PHARMACEUT, V3, P415, DOI 10.1021/mp060015p
   Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6
   Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720
   Dobson J, 2006, NANOMEDICINE-UK, V1, P31, DOI 10.2217/17435889.1.1.31
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   FLETCHER D, 1991, IEEE T MAGN, V27, P3655, DOI 10.1109/20.102936
   Furlani E., 2001, PERMANENT MAGNET ELE
   Furlani EP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061914
   Furlani EP, 2007, BIOMED MICRODEVICES, V9, P451, DOI 10.1007/s10544-007-9050-x
   Furlani EP, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061919
   Furlani EP, 2007, J PHYS D APPL PHYS, V40, P1313, DOI 10.1088/0022-3727/40/5/001
   Furlani EJ, 2007, J MAGN MAGN MATER, V312, P187, DOI 10.1016/j.jmmm.2006.09.026
   Furlani EP, 2006, J APPL PHYS, V99, DOI 10.1063/1.2164531
   Furlani EP, 2006, J PHYS D APPL PHYS, V39, P1724, DOI 10.1088/0022-3727/39/9/003
   FURLANI EP, 2010, MICROFLUIDI IN PRESS
   GERBER R, 1983, IEEE T MAGN, V19, P2115, DOI 10.1109/TMAG.1983.1062795
   Gijs MAM, 2004, MICROFLUID NANOFLUID, V1, P22, DOI 10.1007/s10404-004-0010-y
   Gijs MAM, 2010, CHEM REV, V110, P1518, DOI 10.1021/cr9001929
   Goodwin S, 1999, J MAGN MAGN MATER, V194, P132, DOI 10.1016/S0304-8853(98)00584-8
   Goodwin SC, 2001, TOXICOL SCI, V60, P177, DOI 10.1093/toxsci/60.1.177
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Han KH, 2004, J APPL PHYS, V96, P5797, DOI 10.1063/1.1803628
   HAN KH, 2005, J MICROMECH SYS, V14, P422
   Hardt S, 2007, MEMS REF SHELF, P1, DOI 10.1007/978-0-387-68424-6_1
   Hergt R, 2007, J MAGN MAGN MATER, V311, P187, DOI 10.1016/j.jmmm.2006.10.1156
   Kircher MF, 2003, CANCER RES, V63, P8122
   Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711
   Levy L, 2002, CHEM MATER, V14, P3715, DOI 10.1021/cm0203013
   Linninger AA, 2008, J THEOR BIOL, V250, P125, DOI 10.1016/j.jtbi.2007.09.009
   Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2
   Liu CX, 2007, J APPL PHYS, V101, DOI 10.1063/1.2423137
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Majewski P, 2007, CRIT REV SOLID STATE, V32, P203, DOI 10.1080/10408430701776680
   Marcucci F, 2004, DRUG DISCOV TODAY, V9, P219, DOI 10.1016/S1359-6446(03)02988-X
   Medarova Z, 2006, INT J CANCER, V118, P2796, DOI 10.1002/ijc.21672
   MOLDAY RS, 1977, NATURE, V268, P437, DOI 10.1038/268437a0
   Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785
   Mykhaylyk O, 2007, NAT PROTOC, V2, P2391, DOI 10.1038/nprot.2007.352
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Nguyen N.T., 2006, FUNDAMENTALS APPL MI
   Pamme N, 2006, LAB CHIP, V6, P24, DOI 10.1039/b513005k
   Pamme N, 2006, LAB CHIP, V6, P974, DOI 10.1039/b604542a
   Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Plank C, 2003, BIOL CHEM, V384, P737, DOI 10.1515/BC.2003.082
   Plank C., 2002, EUR CELLS MAT S2, V3, P79
   Prasad Paras N., 2004, NANOPHOTONICS
   PRASAD PN, 2005, INTRO BIOPHOTONICS
   Pulfer SK, 1999, J NEURO-ONCOL, V41, P99, DOI 10.1023/A:1006137523591
   Pulfer SK, 1998, J DRUG TARGET, V6, P215, DOI 10.3109/10611869808997896
   Ritter JA, 2004, J MAGN MAGN MATER, V280, P184, DOI 10.1016/j.jmmm.2004.03.012
   Safarik I, 2002, MONATSH CHEM, V133, P737, DOI 10.1007/s007060200047
   Safarik I., 2004, BIOMAGN RES TECHNOL, V2, P1
   Safaryk I, 1997, SCI CLIN APPL MAGNET
   Sahoo Y, 2005, J APPL PHYS, V98, DOI 10.1063/1.2033145
   Sahoo Y, 2005, J PHYS CHEM B, V109, P3879, DOI 10.1021/jp045402y
   Sahoo Y, 2004, J PHYS CHEM B, V108, P3380, DOI 10.1021/jp031148i
   Schillinger U, 2005, J MAGN MAGN MATER, V293, P501, DOI 10.1016/j.jmmm.2005.01.032
   Sinha A, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2780191
   Sosnovik DE, 2008, BASIC RES CARDIOL, V103, P122, DOI 10.1007/s00395-008-0710-7
   Stamenovic D, 2000, J APPL PHYSIOL, V89, P2085
   Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9
   Sun LP, 1998, CYTOMETRY, V33, P469, DOI 10.1002/(SICI)1097-0320(19981201)33:4<469::AID-CYTO11>3.0.CO;2-6
   TAKAYASU M, 1982, IEEE T MAGN, V18, P1520, DOI 10.1109/TMAG.1982.1062072
   Takayasu M, 2000, IEEE T APPL SUPERCON, V10, P927, DOI 10.1109/77.828383
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Willard MA, 2004, INT MATER REV, V49, P125, DOI 10.1179/095066004225021882
   Williams PS, 2009, MOL PHARMACEUT, V6, P1290, DOI 10.1021/mp900018v
   Yazdankhah SP, 1999, VET MICROBIOL, V67, P113, DOI 10.1016/S0378-1135(99)00035-8
   Yellen BB, 2005, J MAGN MAGN MATER, V293, P647, DOI 10.1016/j.jmmm.2005.01.083
   Zborowski M, 2003, BIOPHYS J, V84, P2638, DOI 10.1016/S0006-3495(03)75069-3
   Zborowski M, 1999, J MAGN MAGN MATER, V194, P224, DOI 10.1016/S0304-8853(98)00581-2
   Zborowski M, 2008, LAB TECH BIOCHEM MOL, V32, P1
   Zheng Q, 2007, J PHYS CHEM C, V111, P16846, DOI 10.1021/jp074713g
NR 86
TC 38
Z9 38
U1 0
U2 45
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2010
VL 3
IS 4
BP 2412
EP 2446
DI 10.3390/ma3042412
PG 35
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LF
UT WOS:000298240800008
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Takahashi, M
   Kikuchi, M
   Takada, Y
   Okuno, O
AF Takahashi, Masatoshi
   Kikuchi, Masafumi
   Takada, Yukyo
   Okuno, Osamu
TI Corrosion Resistance of Dental Ti-Ag Alloys in NaCl Solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; dental titanium alloy; corrosion resistance; elution test;
   microstructure
ID CU ALLOYS; TITANIUM-ALLOYS; BIOCOMPATIBILITY
AB The purpose of this study was to evaluate the corrosion resistance of experimental dental Ti-Ag alloys in 0.9% NaCl solution. Open-circuit potential (OCP) measurement and elution tests of the alloys with 5-30% Ag were performed. The amounts of both Ti and Ag ions released from the alloys with Ag <= 20% were below the detection limit. A very small amount of Ti ions was released from some of the 22.5% Ag specimens and some of the 25% Ag specimens. The time for the Ti-Ag alloys with 5-25% Ag to become the stable potential was earlier than that for titanium, and the OCP of the alloys was higher than that of titanium. These results indicated that the corrosion resistance of the alloys with 5-25% Ag was equivalent to that of titanium. On the other hand, it was suggested that the precipitation of TiAg deteriorated the corrosion resistance of Ti-Ag alloys because TiAg dissolved preferentially in the NaCl solution. Ti-Ag alloys with 5-25% Ag can be used not only as dental restorative materials but also as dental implant materials. [doi:10.2320/matertrans.M2009355]
C1 [Takahashi, Masatoshi; Kikuchi, Masafumi; Takada, Yukyo; Okuno, Osamu] Tohoku Univ, Grad Sch Dent, Div Dent Biomat, Sendai, Miyagi 9808575, Japan.
RP Takahashi, M (reprint author), Tohoku Univ, Grad Sch Dent, Div Dent Biomat, Sendai, Miyagi 9808575, Japan.
CR [Anonymous], 2004, G3172 ASTM
   Eliades G, 2003, DENTAL MATERIALS IN VIVO: AGING AND RELATED PHENOMENA, P3
   ISO, 2002, 1099312 ISO
   *JIS, 2002, T0304 JIS
   Kikuchi M, 2003, DENT MATER J, V22, P191, DOI 10.4012/dmj.22.191
   Kikuchi M, 2008, DENT MATER J, V27, P216, DOI 10.4012/dmj.27.216
   Kikuchi M, 2006, DENT MATER, V22, P641, DOI 10.1016/j.dental.2005.05.015
   MACHADO AR, 1990, P I MECH ENG B-J ENG, V204, P53, DOI 10.1243/PIME_PROC_1990_204_047_02
   Murray J.L., 1987, PHASE DIAGRAMS BINAR, P6
   Takada Y, 2001, Dent Mater J, V20, P34
   Takada Y, 1996, J J DENT MAT, V16, P525
   Takada Y., 2000, CORROSION ENG, V49, P669
   Takahashi M, 2002, DENT MATER J, V21, P270, DOI 10.4012/dmj.21.270
   Takahashi M., 2009, J BIOMECH SCI ENG, V4, P318
   Takahashi M, 2006, DENT MATER J, V25, P516, DOI 10.4012/dmj.25.516
   Wang RR, 1998, J PROSTHET DENT, V80, P495, DOI 10.1016/S0022-3913(98)70018-6
   WILLIAMS RL, 1989, CRIT REV BIOCOMPAT, V5, P221
   Yoda M, 2001, BIOMATERIALS, V22, P1675, DOI 10.1016/S0142-9612(00)00329-X
NR 18
TC 8
Z9 8
U1 0
U2 7
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2010
VL 51
IS 4
SI SI
BP 762
EP 766
DI 10.2320/matertrans.M2009355
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 604FQ
UT WOS:000278263100026
OA Bronze
DA 2018-10-20
ER

PT J
AU Neupane, MP
   Lee, SJ
   Park, IS
   Park, HH
   Lee, MH
   Bae, TS
   Yu, MK
   Lee, KW
   Kim, HS
AF Neupane, Madhav Prasad
   Lee, Sook Jeong
   Park, Il Song
   Park, Hyeoung Ho
   Lee, Min Ho
   Bae, Tae Sung
   Yu, Mi Kyung
   Lee, Kwang Won
   Kim, Hyung Seop
TI Influence of the number of carboxyl groups on the nucleation of
   hydroxyapatite
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article
DE sintering; sol-gel; biomaterial; scanning electron microscopy; bone
ID GEL-DERIVED HYDROXYAPATITE; CALCIUM-PHOSPHATE CERAMICS; SIMULATED
   BODY-FLUID; SOL-GEL; COMBUSTION SYNTHESIS; CITRIC-ACID; NANOPHASE
   CERAMICS; APATITE FORMATION; PRECURSOR ROUTE; BONE GROWTH
AB This paper reports a novel means of preparing HAp crystals. X-ray diffraction showed that the lactic acid route leads to good crystallinity and pure HAp phases compared to other routes. Impurity phases disappeared with a decrease in the number of carboxyl groups. FTIR indicated the presence of carbonate substitution, which increased as the number of carboxyl groups increased. Scanning electron microscopy observations revealed morphological variation of the particles that occurred when the number of carboxyl groups was changed in the complexing agents. The changes in the morphology with the carboxyl group number were analyzed taking into account the driving force for HAp precipitation and the supersaturation level of Ca(2+) and PO(4) (3-) ions with respect to HAp. The analysis indicated that the supersaturation level of the reactants, especially the number of carboxyl groups in the complexing agent, played a predominant role in the precipitate morphology process of this reaction. Energy-dispersive X-ray spectroscopy (EDX) analysis showed that the Ca/P ratio increased as the number of carboxyl groups decreased.
C1 [Neupane, Madhav Prasad; Park, Il Song; Park, Hyeoung Ho; Lee, Min Ho; Bae, Tae Sung] Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci & Brain Korea 21, Dept Dent Biomat, Jeonju Si 561756, Jeonbuk, South Korea.
   [Lee, Sook Jeong] Univ Ulsan, Coll Med, Dept Neurol, Neural Injury Res Lab,Asan Life Sci Inst, Seoul 138736, South Korea.
   [Yu, Mi Kyung; Lee, Kwang Won] Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci & Brain Korea 21, Dept Conservat Dent, Jeonju Si 561756, Jeonbuk, South Korea.
   [Kim, Hyung Seop] Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci & Brain Korea 21, Dept Periodontol, Jeonju Si 561756, Jeonbuk, South Korea.
RP Lee, MH (reprint author), Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci & Brain Korea 21, Dept Dent Biomat, Jeonju Si 561756, Jeonbuk, South Korea.
EM mh@jbnu.ac.kr
RI Neupane, Madhav/M-7151-2014
FU Korea government (MOST) [R01-2007-000-20488-0]
FX This work was financially supported by the Korea Science & Engineering
   Foundation (KOSEF) grant funded by the Korea government (MOST) (No.
   R01-2007-000-20488-0).
CR Adhikary K, 1998, MATER RES BULL, V33, P1845, DOI 10.1016/S0025-5408(98)00183-4
   BEST S, 1994, J MATER SCI-MATER M, V5, P516, DOI 10.1007/BF00124883
   Bigi A, 2004, J SOLID STATE CHEM, V177, P3092, DOI 10.1016/j.jssc.2004.05.018
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   Coreno J, 2001, J BIOMED MATER RES, V57, P119, DOI 10.1002/1097-4636(200110)57:1<119::AID-JBM1150>3.0.CO;2-P
   FRIEDENBERG ZB, 1963, SURG GYNECOL OBSTET, V116, P588
   Fumo DA, 1997, MATER RES BULL, V32, P1459, DOI 10.1016/S0025-5408(97)00117-7
   Fumo DA, 1996, MATER RES BULL, V31, P1243, DOI 10.1016/0025-5408(96)00112-2
   HATTORI T, 1990, J AM CERAM SOC, V73, P1803, DOI 10.1111/j.1151-2916.1990.tb09841.x
   Huang JG, 2003, MATER RES BULL, V38, P149, DOI 10.1016/S0025-5408(02)00979-0
   Janackovic D, 2003, KEY ENG MAT, V240-2, P437, DOI 10.4028/www.scientific.net/KEM.240-242.437
   JUOREZ RE, 2000, J EUR CERAM SOC, V20, P133
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   Kim HW, 2004, J MATER SCI-MATER M, V15, P1129, DOI 10.1023/B:JMSM.0000046395.76435.60
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   LUI DM, 2002, BIOMATERIALS, V23, P1227
   Manso-Silvan M, 2003, J EUR CERAM SOC, V23, P243, DOI 10.1016/S0955-2219(02)00187-5
   Muthuraman M, 1998, MATER RES BULL, V33, P655, DOI 10.1016/S0025-5408(98)00005-1
   OGUCHI H, 1995, BIOMATERIALS, V16, P33, DOI 10.1016/0142-9612(95)91093-E
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P375, DOI 10.1002/jbm.820060506
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Selvan RK, 2003, MATER RES BULL, V38, P41, DOI 10.1016/S0025-5408(02)01004-8
   Seo DS, 2009, MET MATER INT, V15, P265, DOI 10.1007/s12540-009-0265-7
   STUPP SI, 1992, J BIOMED MATER RES, V26, P169, DOI 10.1002/jbm.820260204
   SUKUMAR R, 1999, MATER LETT, V39, P138
   Taguchi H, 2002, MATER RES BULL, V37, P69, DOI 10.1016/S0025-5408(01)00799-1
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Tas AC, 2005, J MATER SCI-MATER M, V16, P167, DOI 10.1007/s10856-005-5919-5
   Tkalcec E, 2001, J MATER SCI, V36, P5253, DOI 10.1023/A:1012462332440
   TONSUAADU K, 1995, THERMOCHIM ACTA, V256, P55, DOI 10.1016/0040-6031(94)02169-O
   VALLETREGI M, 1994, J SOLID STATE CHEM, V58, P112
   VANKEMENADE MJJM, 1987, J COLLOID INTERF SCI, V118, P564, DOI 10.1016/0021-9797(87)90490-5
   Varma HK, 2005, CERAM INT, V31, P109, DOI 10.1016/j.ceramint.2004.03.041
   Varma HK, 1998, CERAM INT, V24, P467, DOI 10.1016/S0272-8842(97)00038-2
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Weng WJ, 2002, MATER CHEM PHYS, V74, P92, DOI 10.1016/S0254-0584(01)00399-6
   Ye T, 1997, MATER RES BULL, V32, P501, DOI 10.1016/S0025-5408(97)00007-X
   Yeong KCB, 1999, MATER LETT, V38, P208, DOI 10.1016/S0167-577X(98)00160-8
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yue ZX, 2000, J MAGN MAGN MATER, V208, P55, DOI 10.1016/S0304-8853(99)00566-1
NR 48
TC 3
Z9 3
U1 1
U2 12
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA POSCO CENTER, 4TH FL (EAST WING), 892 DAECHI-4-DONG, KANGNAM-KU, SEOUL
   135-777, SOUTH KOREA
SN 1598-9623
J9 MET MATER INT
JI Met. Mater.-Int.
PD APR
PY 2010
VL 16
IS 2
BP 333
EP 338
DI 10.1007/s12540-010-0426-8
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 596VH
UT WOS:000277713100026
DA 2018-10-20
ER

PT J
AU Uggeri, J
   Guizzardi, S
   Scandroglio, R
   Gatti, R
AF Uggeri, Jacopo
   Guizzardi, Stefano
   Scandroglio, Renato
   Gatti, Rita
TI Adhesion of human osteoblasts to titanium: A morpho-functional analysis
   with confocal microscopy
SO MICRON
LA English
DT Review
DE Mitochondria; Adhesion; Cellspreading; Confocal microscopy; Titanium;
   Osteoblasts
ID SURFACE-ROUGHNESS; IN-VITRO; EXTRACELLULAR-MATRIX; INTEGRIN EXPRESSION;
   IMPLANT SURFACES; CELL BEHAVIOR; BONE-CELLS; TOPOGRAPHY;
   GLUCOCORTICOIDS; DIFFERENTIATION
AB Properties of surface affect the interactions between the implant and osteoblasts and direct the clinical osteointegrative outcome. The aim of this in vitro study was to describe the adhesion of living human osteoblasts to titanium disks with differently prepared surfaces: sand blasted with ZrO(2) particles and acid-etched (Soft-SLA, S-SLA) or with Al(2)O(3) particles and acid-etched (Hard-SLA, H-SLA), smooth surface (SS).
   Confocal microscopy was exploited to follow cell morpho-functional features either on living cells (cell shape with calcein-acethoxymethylester and mitochondria with tetramethylrhodamine methyl ester) or on fixed cells (immunocytochemistry of beta 1-integrin and of actin) 6 h or 24 h after seeding. The underlying surface was visualized simultaneously on the same field.
   No cytotoxic effect was detected at any time and on any surface.
   At 6 h after seeding, osteoblasts showed either a rounded or polygonal shape on both rough surfaces. Several features suggested that adhesion was faster with a higher level of organization on S-SLA than on HSLA Indeed osteoblasts grown on S-SLA were wider and with more extended protrusions than those on HSLA Active mitochondria on S-SLA occupied perinuclear areas and cellular prolongations, whereas on HSLA they were mainly focused around nucleus. Organization of integrin beta 1-subunit and actin, confirmed different kinetics of cell adhesion. At 6 h integrin beta 1-subunit was distributed along the periphery on the cell-biomaterial focal complexes in cells grown on S-SLA, whereas it was unevenly dispersed in membrane of cells cultured on H-SLA. Stress actin fibers were well defined in cells cultured on S-SLA, whereas they were scarcely evident on H-SLA Osteoblasts seeded on smooth surface for 6 h had morpho-functional features typical of adhesion, with some elements characterized by an elongated shape with an evident main longitudinal axis. At 24 h osteoblasts were spread-out onto all surfaces. Nonethless, different morphologies were shown in response to the different surfaces tested: polygonal cells prevailed on SLA surfaces, whereas almost all the cells on SS were long with two principal prolongations.
   At 24 h number of cells adhered to the three kind of surfaces was similar, but during the following three days, cells seeded on S-SLA and on SS proliferated to a greater extent than those cultured on H-SLA.
   Analysis of morpho-functional parameters performed in living cells, and in particular the study of mitochondria organization, proved to be a valuable tool to follow cell-biomaterial adhesion. A higher level of spreading occurring in osteoblasts grown on S-SLA and SS at early times accounted for a faster subsequent cell proliferation. Nonethless, these comparable activities were exerted by cells showing polygonal or elongated shapes when grown respectively on S-SLA or on SS. The former is typical of osteogenic cells, whereas the latter resumes a fibroblast-like morphology, that would result in an ineffective in vivo osteointegrative process. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Uggeri, Jacopo; Guizzardi, Stefano; Scandroglio, Renato; Gatti, Rita] Univ Parma, Dept Expt Med, Unit Histol, I-43100 Parma, Italy.
RP Uggeri, J (reprint author), Univ Parma, Dept Expt Med, Unit Histol, Via Volturno 39, I-43100 Parma, Italy.
EM jacopo.uggeri@unipr.it
OI Guizzardi, Stefano/0000-0003-2395-8767
FU Fondo Locale per la Ricerca Scientifica, University of Parma [FIL 2008]
FX This study was supported by a local research grant (FIL 2008, Fondo
   Locale per la Ricerca Scientifica, University of Parma).
CR Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   BERESFORD JN, 1984, METAB BONE DIS RELAT, V5, P229, DOI 10.1016/0221-8747(84)90064-X
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   FARLEY JR, 1994, J BONE MINER RES, V9, P497
   GALLAGHER JA, 1984, ADV EXP MED BIOL, V171, P279
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gatti R, 2008, MICRON, V39, P137, DOI 10.1016/j.micron.2006.11.009
   Gatti R, 2004, TOXICOLOGY, V204, P175, DOI 10.1016/j.tox.2004.06.023
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Guizzardi S, 2004, J PERIODONTOL, V75, P273, DOI 10.1902/jop.2004.75.2.273
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Postiglione L, 2003, J DENT RES, V82, P692, DOI 10.1177/154405910308200907
   Salido M, 2009, HISTOL HISTOPATHOL, V24, P1275, DOI 10.14670/HH-24.1275
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   SETZER B, 2008, BIOMATERIALS
   Siebers MC, 2008, J MATER SCI-MATER M, V19, P861, DOI 10.1007/s10856-007-0166-6
   Siggelkow H, 1998, CLIN CHIM ACTA, V272, P111, DOI 10.1016/S0009-8981(98)00007-2
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   STANFORD C M, 1991, Critical Reviews in Oral Biology and Medicine, V2, P83
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Tognarini I, 2008, BIOMATERIALS, V29, P809, DOI 10.1016/j.biomaterials.2007.10.043
   Uggeri J, 2007, J PERIODONTOL, V78, P1985, DOI 10.1902/jop.2007.070116
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
NR 38
TC 19
Z9 20
U1 1
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD APR
PY 2010
VL 41
IS 3
BP 210
EP 219
DI 10.1016/j.micron.2009.10.013
PG 10
WC Microscopy
SC Microscopy
GA 566BO
UT WOS:000275344900007
PM 19942444
DA 2018-10-20
ER

PT J
AU Gorustovich, AA
AF Gorustovich, Alejandro A.
TI Imaging Resin-Cast Osteocyte Lacuno-Canalicular System at Bone-Bioactive
   Glass Interface by Scanning Electron Microscopy
SO MICROSCOPY AND MICROANALYSIS
LA English
DT Article
DE resin-cast SEM; osteocytes; lacuno-canalicular system; bioactive glass
ID MARROW STROMAL CELLS; LACUNOCANALICULAR SYSTEM; IN-SITU; PARTICLES; RAT;
   DENTIN
AB The morphology of the osteocyte lacuno-canalicular system at the bone-biomaterial implant-interface has not been fully investigated. In this study, the resin-cast scanning electron microscopy technique was used, for the first time, to image the lacuno-canalicular network within neoformed bone around bioactive glass (BG) particles implanted in rat tibia bone marrow. The most salient finding was that the osteocyte canaliculi pass through the calcium-phosphorus layer formed at the bone-BG interface and reach the silica-rich layer of the reacted BG.
C1 [Gorustovich, Alejandro A.] Natl Atom Energy Commiss, Res Lab, CNEA Reg Noroeste, Salta, Argentina.
   [Gorustovich, Alejandro A.] CNR, CONICET, Salta, Argentina.
RP Gorustovich, AA (reprint author), Natl Atom Energy Commiss, Res Lab, CNEA Reg Noroeste, A4408FTV, Salta, Argentina.
EM agorustovich@gmail.com
CR AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304
   Bonewald L. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P321
   Bonewald LF, 2008, PRIMER METABOLIC BON, P22
   Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224
   Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   CURTIS TA, 1985, ANAT RECORD, V212, P336, DOI 10.1002/ar.1092120403
   Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905
   Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603
   Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001
   Gorustovich A, 2002, INT J ORAL MAX IMPL, V17, P644
   Gorustovich AA, 2006, BIOMED MATER, V1, P100, DOI 10.1088/1748-6041/1/3/002
   Gorustovich AA, 2007, J BIOMED MATER RES A, V81A, P443, DOI 10.1002/jbm.a.31071
   Gorustovich AA, 2010, J BIOMED MATER RES A, V92A, P232, DOI 10.1002/jbm.a.32355
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X
   Kamioka H, 2009, MICROSC MICROANAL, V15, P377, DOI 10.1017/S1431927609990420
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee KY, 2006, BIOMED MATER, V1, pR31, DOI 10.1088/1748-6041/1/2/R01
   Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404
   MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x
   Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009
   Okada S, 2002, MICROSC MICROANAL, V8, P104, DOI 10.1017/S1431927601020037
   Palumbo C, 2004, ANAT REC PART A, V278A, P474, DOI 10.1002/ar.a.20032
   Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241
   Reilly GC, 2001, ANN BIOMED ENG, V29, P1074, DOI 10.1114/1.1424910
   Schneider P, 2007, J BONE MINER RES, V22, P1557, DOI 10.1359/JBMR.070703
   Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008
   Tate MLK, 1998, BONE, V22, P107
   Tate MLK, 2004, INT J BIOCHEM CELL B, V36, P1, DOI 10.1016/S1357-2725(03)00241-3
   Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017
   WEBER DF, 1983, ARCH ORAL BIOL, V28, P885, DOI 10.1016/0003-9969(83)90048-1
   XIE Y, 2008, PRACTICAL MANUAL MUS, P135
NR 33
TC 5
Z9 5
U1 3
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1431-9276
EI 1435-8115
J9 MICROSC MICROANAL
JI Microsc. microanal.
PD APR
PY 2010
VL 16
IS 2
BP 132
EP 136
DI 10.1017/S1431927610000097
PG 5
WC Materials Science, Multidisciplinary; Microscopy
SC Materials Science; Microscopy
GA 576IG
UT WOS:000276137200002
PM 20187991
DA 2018-10-20
ER

PT J
AU Zmantar, T
   Kouidhi, B
   Miladi, H
   Mandouani, K
   Bakhrouf, A
AF Zmantar, Tarek
   Kouidhi, Bochra
   Miladi, Hanene
   Mandouani, Kacem
   Bakhrouf, Amina
TI A Microtiter plate assay for Staphylococcus aureus biofilm
   quantification at various pH levels and hydrogen peroxide
   supplementation
SO NEW MICROBIOLOGICA
LA English
DT Article
DE Staphylococcus aureus; Slime production; Biofilm; Hydrogen peroxide; ica
   gene; pH
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   SLIME PRODUCTION; ICA-LOCUS; EPIDERMIDIS; INFECTIONS; RESISTANCE;
   STRAINS; IMMOBILIZATION; ACCUMULATION
AB Biofilm formation is the leading cause of the pathogenesis of S. aureus associated with biomaterial infections. In S. aureus polysaccharide intercellular adhesin (PIA) was encoded by icaA and icaD genes. Production of PIA is currently responsible for staphylococcal biofilm development. In this study, S. aureus strains isolated from auricular infection (n = 46) and S. aureus ATCC 25923 were phenotyped and genotyped. Slime production was assessed using Congo red agar plate assay. In order to determine the biofilm formation capacity at various pH levels of the studied S. aureus strains, microtiter plate assay was performed. The strains were grown in medium adjusted at various pH levels (3, 5, 7, 9 and 12) and medium supplemented with hydrogen peroxide 3% (v/v). Qualitative biofilm production of S. aureus revealed that 56.5% of strains were slime producers. In addition 78.26% of strains were icaA and icaD positive. Quantitative biofilm showed that biofilm production depended on the pH value of the medium. At highly acidic (pH 3) and alkaline (pH 12) levels, biofilm formation was lower, while at pH 7 the adhesion was moderate. In addition, the cells adhered weakly after 3% hydrogen peroxide supplementation. Our results suggest that pH was a stress factor that led some S. amens strains to produce the biofilm.
C1 [Zmantar, Tarek; Kouidhi, Bochra; Miladi, Hanene; Bakhrouf, Amina] Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir 5000, Tunisia.
   [Mandouani, Kacem] Hop Ibn El JAZZAR Kairouan, Bacteriol Lab, Kairouan, Tunisia.
RP Zmantar, T (reprint author), Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Rue Avicenne, Monastir 5000, Tunisia.
EM zmantar_t@yahoo.fr
CR Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000
   Arciola CR, 2002, BIOMATERIALS, V23, P4233, DOI 10.1016/S0142-9612(02)00171-0
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Arciola CR, 2001, DIAGN MOL PATHOL, V10, P130, DOI 10.1097/00019606-200106000-00010
   Chaieb K, 2007, ANN MICROBIOL, V7, P31
   CHARACKLIS WG, 1981, BIOTECHNOL BIOENG, V23, P1923, DOI 10.1002/bit.260230902
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   ECKHARD A, 1999, ANN THORAC SURG, V68, P2123
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   Fowler VG, 2001, MED MICROBIOL IMMUN, V189, P127, DOI 10.1007/s430-001-8018-5
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   GERIN P, 1995, BIOTECHNOL BIOENG, V47, P677, DOI 10.1002/bit.260470608
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gundogan N, 2006, FOOD CONTROL, V17, P389, DOI 10.1016/j.foodcont.2005.01.006
   Hamadi F, 2005, J ADHES SCI TECHNOL, V19, P73, DOI 10.1163/1568561053066891
   Hamadi F, 2004, ANN MICROBIOL, V54, P213
   HEPTINSTALL S, 1970, NATURE, V225, P319
   Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Mempel M, 1998, J INVEST DERMATOL, V111, P452, DOI 10.1046/j.1523-1747.1998.00293.x
   Montanaro L, 1999, New Microbiol, V22, P331
   MOZES N, 1987, BIOTECHNOL BIOENG, V30, P439, DOI 10.1002/bit.260300315
   Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81
   SHEAGREN JN, 1984, NEW ENGL J MED, V310, P1368, DOI 10.1056/NEJM198405243102107
   Snoussi M, 2008, NEW MICROBIOL, V31, P489
   Stewart P. S., 2000, BIOFILMS
   TSCHESCHE R, 1951, Z NATURFORSCH B, V6, P22
   Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7
   WALDVOGEL FA, 1995, PRINCIPLES PRACTICE, P1754
   Webb JS, 1999, APPL ENVIRON MICROB, V65, P3575
   White A., 1978, PRINCIPLES BIOCH, P196
   Xu KD, 2000, MICROBIOL-UK, V146, P547, DOI 10.1099/00221287-146-3-547
   YOSPHEPURER Y, 1968, HLTH LAB SCI, V5, P233
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Zmantar T, 2008, J BASIC MICROB, V48, P308, DOI 10.1002/jobm.200700289
NR 47
TC 39
Z9 45
U1 1
U2 6
PU EDIZIONI INT SRL
PI PAVIA
PA DIV EDIMES, EDIZIONI MEDICO SCIENTIFICHE PAVIA, VIA RIVIERA, PAVIA,
   39-27100, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD APR
PY 2010
VL 33
IS 2
BP 137
EP 145
PG 9
WC Microbiology
SC Microbiology
GA 595YZ
UT WOS:000277651700005
PM 20518275
DA 2018-10-20
ER

PT J
AU Wischke, C
   Lendlein, A
AF Wischke, Christian
   Lendlein, Andreas
TI Shape-Memory Polymers as Drug Carriers-A Multifunctional System
SO PHARMACEUTICAL RESEARCH
LA English
DT Editorial Material
DE biodegradable polymer; biomaterial; controlled drug release;
   multifunctional material; shape-memory polymer
ID RELEASE
C1 [Wischke, Christian; Lendlein, Andreas] GKSS Res Ctr Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Wischke, Christian; Lendlein, Andreas] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
RP Wischke, C (reprint author), GKSS Res Ctr Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM christian.wischke@gkss.de; andreas.lendlein@gkss.de
RI Wischke, Christian/K-9651-2013; Lendlein, Andreas/K-9553-2013
OI Wischke, Christian/0000-0001-5531-9033; Lendlein,
   Andreas/0000-0003-4126-4670
CR Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Frost and Sullivan, 2008, N39F5420 FROST SULL
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   NAGAHAMA K, 2009, BIOMACROMOLECULES
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Wischke C, 2010, ADV POLYM SCI, V226, P177, DOI 10.1007/12_2009_29
   Wischke C, 2009, J CONTROL RELEASE, V138, P243, DOI 10.1016/j.jconrel.2009.05.027
   Wykrzykowska JJ, 2009, EXPERT OPIN DRUG DEL, V6, P113, DOI [10.1517/17425240802668495 , 10.1517/17425240802668495]
NR 8
TC 45
Z9 47
U1 6
U2 31
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARM RES-DORDR
JI Pharm. Res.
PD APR
PY 2010
VL 27
IS 4
BP 527
EP 529
DI 10.1007/s11095-010-0062-5
PG 3
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 568WN
UT WOS:000275556000002
PM 20127394
DA 2018-10-20
ER

PT J
AU Yu, ZX
   Mirochnitchenko, O
   Xu, CY
   Yoshizumi, A
   Brodsky, B
   Inouye, M
AF Yu, Zhuoxin
   Mirochnitchenko, Oleg
   Xu, Chunying
   Yoshizumi, Ayumi
   Brodsky, Barbara
   Inouye, Masayori
TI Noncollagenous region of the streptococcal collagen-like protein is a
   trimerization domain that supports refolding of adjacent homologous and
   heterologous collagenous domains
SO PROTEIN SCIENCE
LA English
DT Article
DE collagen; streptococcus; trimerization; folding; triple-helix
ID GROUP-A STREPTOCOCCUS; TRIPLE-HELIX FORMATION; HUMAN TYPE-I;
   CRYSTAL-STRUCTURE; SURFACE PROTEIN; OLIGOMERIZATION DOMAINS; MOLECULAR
   RECOGNITION; BACILLUS-ANTHRACIS; NC1 DOMAIN; PYOGENES
AB Proper folding of the (Gly-Xaa-Yaa)(n) sequence of animal collagens requires adjacent N- or C-terminal noncollagenous trimerization domains which often contain coiled-coil or beta sheet structure. Collagen-like proteins have been found recently in a number of bacteria, but little is known about their folding mechanism. The Scl2 collagen-like protein from Streptococcus pyogenes has an N-terminal globular domain, designated V(sp), adjacent to its triple-helix domain. The V(sp) domain is required for proper refolding of the Scl2 protein in vitro. Here, recombinant V(sp) domain alone is shown to form trimers with a significant alpha-helix content and to have a thermal stability of T(m) = 45 degrees C. Examination of a new construct shows that the V(sp) domain facilitates efficient in vitro refolding only when it is located N-terminal to the triple-helix domain but not when C-terminal to the triple-helix domain. Fusion of the V(sp) domain N-terminal to a heterologous (Gly-Xaa-Yaa)(n) sequence from Clostridium perfringens led to correct folding and refolding of this triplehelix, which was unable to fold into a triple-helical, soluble protein on its own. These results suggest that placement of a functional trimerization module adjacent to a heterologous Gly-Xaa-Yaa repeating sequence can lead to proper folding in some cases but also shows specificity in the relative location of the trimerization and triple-helix domains. This information about their modular nature can be used in the production of novel types of bacterial collagen for biomaterial applications.
C1 [Yu, Zhuoxin; Mirochnitchenko, Oleg; Xu, Chunying; Yoshizumi, Ayumi; Brodsky, Barbara; Inouye, Masayori] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.
RP Inouye, M (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 679 Hoes Lane, Piscataway, NJ 08854 USA.
EM brodsky@umdnj.edu; inouye@umdnj.edu
RI Yu, Zhuoxin/L-1512-2013
FU NIH [R21EB007198]
FX Grant sponsor: NIH grant; Grant number: R21EB007198.
CR BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   BEIER G, 1966, BIOCHEMISTRY-US, V5, P2744, DOI 10.1021/bi00872a035
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4
   Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057
   Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005
   CASWELL CC, FEMS MICROB IN PRESS
   Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x
   Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200
   Engel J, 1996, MATRIX BIOL, V15, P295, DOI 10.1016/S0945-053X(96)90130-4
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x
   HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1
   Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200
   Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1
   Latvanlehto A, 2003, J BIOL CHEM, V278, P37590, DOI 10.1074/jbc.M305974200
   Lees JF, 1997, EMBO J, V16, P908, DOI 10.1093/emboj/16.5.908
   Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001
   Lukomski S, 2000, INFECT IMMUN, V68, P6542, DOI 10.1128/IAI.68.12.6542-6553.2000
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   McAlinden A, 2002, J BIOL CHEM, V277, P41274, DOI 10.1074/jbc.M202257200
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Myllyharju Johanna, 2009, V522, P51, DOI 10.1007/978-1-59745-413-1_3
   Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106
   Pahlman LI, 2007, J BIOL CHEM, V282, P24873, DOI 10.1074/jbc.M610015200
   Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200
   Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984
   RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1649, DOI 10.1002/bip.1968.360061109
   Rasmussen M, 2000, INFECT IMMUN, V68, P6370, DOI 10.1128/IAI.68.11.6370-6377.2000
   Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200
   Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x
   Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200
   Tan L, 2010, J BACTERIOL, V192, P1259, DOI 10.1128/JB.01003-09
   Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499
   Whatmore AM, 2001, MICROBIOL-UK, V147, P419, DOI 10.1099/00221287-147-2-419
   Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
NR 44
TC 17
Z9 17
U1 2
U2 6
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD APR
PY 2010
VL 19
IS 4
BP 775
EP 785
DI 10.1002/pro.356
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 578DY
UT WOS:000276274900014
PM 20162611
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Lazard, P
   Peiffer, RL
AF Lazard, P.
   Peiffer, R. L.
TI An uncommon case of anterior segment dysgenesis in a domestic shorthair
   cat
SO REVUE DE MEDECINE VETERINAIRE
LA English
DT Article
DE Anterior segment dysgenesis; cat; coloboma; Peters' anomaly; biomaterial
   graft
ID SMALL-INTESTINAL SUBMUCOSA; LENS LUXATION; GLAUCOMA; DOGS; DEFECTS;
   REPAIR; HORSES; EYE
AB A case of anterior segment dysgenesis in an 18-month-old, one-eyed, domestic shorthair cat is reported. This congenital anomaly presented with a central corneal coloboma, a microspheric lens with a partial cataract, pupillary membrane remnants and goniodysgenesis. Treatment consisted of lens removal by phacoemulsification and a corneal graft using a porcine small intestinal submucosa biomatcrial (Vet BioSISt) to repair the cornea and preserve the vision. Intraocular pressure remained within the normal range.
   Features of this case warrant classification as Peters' anomaly, first in humans in 1887 and which consists of defective development of the posterior cornea caused by abnormal migration and differentiation of neural crest cells impeded by the late separation of the lens vesicle from the surface ectoderm.
C1 [Lazard, P.] Clin Vet, F-78100 St Germain En Laye, France.
   [Peiffer, R. L.] Merck & Co Inc, Merck Res Labs, West Point, PA 19486 USA.
RP Lazard, P (reprint author), Clin Vet, 80 Rue Pereire, F-78100 St Germain En Laye, France.
EM patrick.lazard@ladelou.com
CR Bussieres M, 2004, VET OPHTHALMOL, V7, P352, DOI 10.1111/j.1463-5224.2004.04055.x
   Calvas P, 2009, B ACAD NAT MED PARIS, V193, P45
   Cook Cynthia S., 1995, Veterinary and Comparative Ophthalmology, V5, P109
   CURTIS R, 1990, VET CLIN N AM-SMALL, V20, P755, DOI 10.1016/S0195-5616(90)50061-3
   CVEKI A, 2004, BIOESSAYS, V4, P374
   FEATHERSTONE JJ, 2001, VET OPHTHALMOL, V2, P147
   Glaze MB, 2005, CLIN TECH SMALL AN P, V20, P74, DOI 10.1053/j.ctsap.2004.12.011
   GRAHN BH, 2007, VET OPHTHALMOLOGY, V1, P355
   Gunderson CA, 1996, OPHTHALMOLOGICA, V210, P361, DOI 10.1159/000310747
   Idrees F, 2006, SURV OPHTHALMOL, V51, P213, DOI 10.1016/j.survophthal.2006.02.006
   Jacobi S, 2008, VET OPHTHALMOL, V11, P162, DOI 10.1111/j.1463-5224.2008.00614.x
   KETRING KL, 1994, ATLAS FELINE OPHTHAL
   Martin CL, 1997, VET COMP OPHTHALMOL, V7, P39
   MOLLEDA JM, 1995, J AM ANIM HOSP ASSOC, V31, P209, DOI 10.5326/15473317-31-3-209
   Narfstrom K, 1999, J Feline Med Surg, V1, P135, DOI 10.1016/S1098-612X(99)90202-4
   PEIFFER RL, 1983, J AM VET MED ASSOC, V182, P1242
   PRIESTER WA, 1972, J AM VET MED ASSOC, V160, P1504
   REGNIER A, 2008, 39 ANN M AM COLL VET
   Sowden JC, 2007, EYE, V21, P1310, DOI 10.1038/sj.eye.6702852
   Stiles J, 2007, VET OPHTHALMOLOGY, VII, P1095
   Swanson HL, 2001, J COMP PATHOL, V125, P326, DOI 10.1053/jcpa.2001.0512
   Trost K, 2007, VET OPHTHALMOL, V10, P3, DOI 10.1111/j.1463-5224.2007.00483.x
   Vanore M, 2007, VET OPHTHALMOL, V10, P93, DOI 10.1111/j.1463-5224.2007.00515.x
   WILCOCK BP, 1990, VET PATHOL, V27, P35, DOI 10.1177/030098589002700105
NR 24
TC 3
Z9 3
U1 0
U2 5
PU ECOLE NATIONALE VETERINAIRE TOULOUSE
PI TOULOUSE CEDEX 3
PA 23 CHEMIN DES CAPELLES, 31076 TOULOUSE CEDEX 3, FRANCE
SN 0035-1555
J9 REV MED VET-TOULOUSE
JI Rev. Med. Vet.
PD APR
PY 2010
VL 161
IS 4
BP 173
EP 177
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 610GT
UT WOS:000278720400005
DA 2018-10-20
ER

PT J
AU Nieponice, A
   Soletti, L
   Guan, JJ
   Hong, Y
   Gharaibeh, B
   Maul, TM
   Huard, J
   Wagner, WR
   Vorp, DA
AF Nieponice, Alejandro
   Soletti, Lorenzo
   Guan, Jianjun
   Hong, Yi
   Gharaibeh, Burhan
   Maul, Timothy M.
   Huard, Johnny
   Wagner, William R.
   Vorp, David A.
TI In Vivo Assessment of a Tissue-Engineered Vascular Graft Combining a
   Biodegradable Elastomeric Scaffold and Muscle-Derived Stem Cells in a
   Rat Model
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HUMAN BLOOD-VESSEL; BONE-MARROW-CELLS; PROGENITOR CELLS;
   SKELETAL-MUSCLE; SMALL-DIAMETER; REGENERATION; CONSTRUCTION; ARTERIES;
   VITRO
AB Limited autologous vascular graft availability and poor patency rates of synthetic grafts for bypass or replacement of small-diameter arteries remain a concern in the surgical community. These limitations could potentially be improved by a tissue engineering approach. We report here our progress in the development and in vivo testing of a stem-cell-based tissue-engineered vascular graft for arterial applications. Poly( ester urethane) urea scaffolds ( length = 10 mm; inner diameter = 1.2 mm) were created by thermally induced phase separation ( TIPS). Compound scaffolds were generated by reinforcing TIPS scaffolds with an outer electrospun layer of the same biomaterial (ES-TIPS). Both TIPS and ES-TIPS scaffolds were bulk-seeded with 10x10(6) allogeneic, LacZ-transfected, muscle-derived stem cells (MDSCs), and then placed in spinner flask culture for 48 h. Constructs were implanted as interposition grafts in the abdominal aorta of rats for 8 weeks. Angiograms and histological assessment were performed at the time of explant. Cell-seeded constructs showed a higher patency rate than the unseeded controls: 65% (ES-TIPS) and 53% ( TIPS) versus 10% ( acellular TIPS). TIPS scaffolds had a 50% mechanical failure rate with aneurysmal formation, whereas no dilation was observed in the hybrid scaffolds. A smooth-muscle-like layer of cells was observed near the luminal surface of the constructs that stained positive for smooth muscle alpha-actin and calponin. LacZ+ cells were shown to be engrafted in the remodeled construct. A confluent layer of von Willebrand Factor-positive cells was observed in the lumen of MDSC-seeded constructs, whereas acellular controls showed platelet and fibrin deposition. This is the first evidence that MDSCs improve patency and contribute to the remodeling of a tissue-engineered vascular graft for arterial applications.
C1 [Nieponice, Alejandro; Soletti, Lorenzo; Guan, Jianjun; Hong, Yi; Maul, Timothy M.; Huard, Johnny; Wagner, William R.; Vorp, David A.] Univ Pittsburgh, Dept Surg, Ctr Vasc Remodeling & Regenerat, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
   [Soletti, Lorenzo; Guan, Jianjun; Hong, Yi; Maul, Timothy M.; Huard, Johnny; Wagner, William R.; Vorp, David A.] Univ Pittsburgh, Dept Bioengn, Ctr Vasc Remodeling & Regenerat, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
   [Gharaibeh, Burhan; Huard, Johnny] Univ Pittsburgh, Dept Orthoped Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
RP Vorp, DA (reprint author), Suite 300,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM vorpda@upmc.edu
RI Vorp, David/G-5430-2014; Gharaibeh, Burhan/A-7696-2017; Maul,
   Timothy/B-1916-2010
OI Vorp, David/0000-0002-6467-2151; Maul, Timothy/0000-0003-2722-7523
FU NIH BRP [R01 HL069368]; American Heart Association [0525585U]; Ruth L.
   Kirschstein National Research Service Award [EB004791]
FX The authors would like to acknowledge funding from NIH BRP #R01 HL069368
   (to W. R. W. and D. A. V.) and American Heart Association Postdoctoral
   Fellowship 0525585U (to A.N.), and a Ruth L. Kirschstein National
   Research Service Award EB004791 (to T. M. M.)
CR American Heart Association, 2004, HEART DIS STROK STAT
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135
   Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed
   DAVIDS L, 1999, TISSUE ENG PROSTHETI, P3
   Deasy BM, 2004, CURR OPIN BIOTECH, V15, P419, DOI 10.1016/j.copbio.2004.08.004
   Deasy BM, 2001, BLOOD CELL MOL DIS, V27, P924, DOI 10.1006/bcmd.2001.0463
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142
   GRIGIONI M, 2003, VASCULAR GRAFTS EXPT, P41
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726
   Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   LANGER R, 1993, SCIENCE, V920, P260
   Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61
   Naito Y, 2003, J THORAC CARDIOV SUR, V125, P419, DOI 10.1067/mtc.2003.134
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   NIEPONICE A, 2006, ENCY BIOMATERIALS BI, P1
   Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044
   Nieponice A, 2007, J BIOMED MATER RES A, V81A, P523, DOI 10.1002/jbm.a.31041
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niklason LE, 2001, J VASC SURG, V33, P628, DOI 10.1067/mva.2001.111747
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   Payne TR, 2005, GENE THER, V12, P1264, DOI 10.1038/sj.gt.3302521
   Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Soletti L, 2006, BIOMATERIALS, V27, P4863, DOI 10.1016/j.biomaterials.2006.04.042
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Vorp DA, 2005, FRONT BIOSCI, V10, P768, DOI 10.2741/1571
   WEINTRAUB WS, 1994, AM J CARDIOL, V73, P103, DOI 10.1016/0002-9149(94)90198-8
   WILLIAMS SK, 1994, J BIOMED MATER RES, V28, P203, DOI 10.1002/jbm.820280210
NR 39
TC 80
Z9 85
U1 0
U2 22
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2010
VL 16
IS 4
BP 1215
EP 1223
DI 10.1089/ten.tea.2009.0427
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 579GJ
UT WOS:000276356700010
PM 19895206
OA Green Published
DA 2018-10-20
ER

PT J
AU Natesan, S
   Baer, DG
   Walters, TJ
   Babu, M
   Christy, RJ
AF Natesan, Shanmugasundaram
   Baer, David G.
   Walters, Thomas J.
   Babu, Mary
   Christy, Robert J.
TI Adipose-Derived Stem Cell Delivery into Collagen Gels Using Chitosan
   Microspheres
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HUMAN BONE-MARROW; REGENERATIVE MEDICINE; IN-VITRO; STROMAL CELLS;
   TISSUE REPAIR; LINEAGE CELLS; DIFFERENTIATION; VIVO; SCAFFOLD; THERAPY
AB Integration of stem cells to injured tissues requires an appropriate delivery device and scaffolding system. In the present study we have developed an in vitro strategy to load and release adipose-derived mesenchymal stem cells (ASC) from chitosan microspheres (CSM) into a collagen gel scaffold. Porous CSM of uniform size and composition were prepared and used as a stem cell carrier. ASC were allowed to attach to the microspheres and infiltrate through the microsphere pores. The number of viable cells was counted in vitro, using MTT and Calcein acetoxymethyl ester ( AM) assays, and it showed a proportional increase with seeding density and reached a maximum cell number by 24 h. The cells inside the microspheres remained metabolically active and viable, could be retrieved from the spheres, and maintained expression of stem-cell-specific markers. Electron microscopic evaluation of the cell-microsphere complex showed that the CSM were able to support cell attachment and that the cells had infiltrated into the pores of the microspheres. The ability of the cells to proliferate and differentiate into adipogenic- and osteogenic-like precursors indicates that the cells have maintained their multipotency after migration out of the microspheres. To mimic cell delivery into a tissue, ASC-loaded CSM were embedded in type-1 collagen scaffold by mixing them with type-1 collagen solution while inducing gelation. By 14 days the cells released into the collagen gel and were able to populate the entire scaffold. When observed through transmission electron microscopy, the cells align along the collagen fibrils with a characteristic fibroblast-like morphology. This study provides a model to capture pluripotent stem cells, expand their cell number within a biomaterial scaffold in vitro, and deliver within an appropriate matrix to repair damaged tissue.
C1 [Natesan, Shanmugasundaram; Baer, David G.; Walters, Thomas J.; Christy, Robert J.] USA, Inst Surg Res, Regenerat Med Res Program, Ft Sam Houston, TX 78234 USA.
   [Babu, Mary] Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
RP Christy, RJ (reprint author), USA, Inst Surg Res, Regenerat Med Res Program, 3400 Rawley Chambers Ave,Bldg 3611, Ft Sam Houston, TX 78234 USA.
EM robert.christy@amedd.army.mil
OI Natesan, Shanmugasundaram/0000-0003-4213-3111
FU University of Texas Health Science Center, San Antonio, TX [NIH-NCI P30
   CA54174, NIH-NIA P30 AG013319, NIH-NIA P01AG19316]
FX The authors would like to thank Ms. Janet Roe for isolation of adipose
   tissue and technical support. S.N. was supported by a Postdoctoral
   Fellowship Grant from the Pittsburgh Tissue Engineering Initiative.
   Confocal images were generated in the core optical imaging facility,
   which is supported by the University of Texas Health Science Center, San
   Antonio, TX, NIH-NCI P30 CA54174 ( San Antonio Cancer Institute),
   NIH-NIA P30 AG013319 (Nathan Shock Center, San Antonio, TX), and NIH-NIA
   P01AG19316. The authors also thank Dr. Robert Reddick, Medical Director,
   and Lauren Chesnut, Technical Director, Electron Microscopy Facility,
   Department of Pathology, the University of Texas Health Science Center,
   San Antonio, TX, for use of facility and assistance in the analysis of
   electron micrographs.
CR Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Arnalich-Montiel F, 2008, STEM CELLS, V26, P570, DOI 10.1634/stemcells.2007-0653
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738
   BORNSTEIN MB, 1958, LAB INVEST, V7, P134
   Brzoska M, 2005, BIOCHEM BIOPH RES CO, V330, P142, DOI 10.1016/j.bbrc.2005.02.141
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315
   De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eslaminejad MB, 2009, J BIOMED MATER RES B, V90B, P659, DOI 10.1002/jbm.b.31332
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gorodetsky R, 1999, J INVEST DERMATOL, V112, P866, DOI 10.1046/j.1523-1747.1999.00600.x
   Graziano A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000496
   Herrero EP, 2007, BIOTECHNOL PROGR, V23, P940, DOI 10.1021/bp070047p
   Kang SK, 2003, DEV BRAIN RES, V145, P141, DOI 10.1016/S0165-3806(03)00224-4
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lode A, 2008, J TISSUE ENG REGEN M, V2, P400, DOI 10.1002/term.110
   Ma K, 2009, BIOMATERIALS, V30, P3251, DOI 10.1016/j.biomaterials.2009.02.025
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Na K, 2007, J AM CHEM SOC, V129, P5788, DOI 10.1021/ja067707r
   Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d
   Owens Brett D, 2006, J Am Acad Orthop Surg, V14, pS37
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Pountos I, 2005, INJURY, V36, P8, DOI 10.1016/j.injury.2005.07.028
   Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356
   Romanov YA, 2005, B EXP BIOL MED+, V140, P138, DOI 10.1007/s10517-005-0430-z
   Sgodda M, 2007, EXP CELL RES, V313, P2875, DOI 10.1016/j.yexcr.2007.05.020
   Shanmuganathan S, 2008, CARBOHYD POLYM, V73, P201, DOI 10.1016/j.carbpol.2007.11.039
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Sylvester KG, 2004, ARCH SURG-CHICAGO, V139, P93, DOI 10.1001/archsurg.139.1.93
   Tobita M, 2008, TISSUE ENG PT A, V14, P945, DOI 10.1089/ten.tea.2007.0048
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Wang B, 2007, NEUROSCI LETT, V421, P191, DOI 10.1016/j.neulet.2007.04.081
   Wu YN, 2007, BIOMATERIALS, V28, P4056, DOI 10.1016/j.biomaterials.2007.05.039
   Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015
   Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228
   Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210
   Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006
   Zhang DZ, 2007, CHINESE MED J-PEKING, V120, P300
   Zhu Yanxia, 2009, Biotechnology Journal, V4, P1198, DOI 10.1002/biot.200800130
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 58
TC 42
Z9 42
U1 1
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2010
VL 16
IS 4
BP 1369
EP 1384
DI 10.1089/ten.tea.2009.0404
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 579GJ
UT WOS:000276356700024
PM 19916819
OA Green Published
DA 2018-10-20
ER

PT J
AU Cregg, JM
   Wiseman, SL
   Pietrzak-Goetze, NM
   Smith, MR
   Jaroch, DB
   Clupper, DC
   Gilbert, RJ
AF Cregg, Jared M.
   Wiseman, Sherri L.
   Pietrzak-Goetze, Nicole M.
   Smith, Martyn R.
   Jaroch, David B.
   Clupper, Daniel C.
   Gilbert, Ryan J.
TI A Rapid, Quantitative Method for Assessing Axonal Extension on
   Biomaterial Platforms
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID NEURITE OUTGROWTH; NERVOUS-SYSTEM; IMAGE-ANALYSIS; SPINAL-CORD;
   HYDROGEL; GUIDANCE; CULTURES; CHARGE; GEL
AB Measuring outgrowth of neuronal explants is critical in evaluating the ability of a biomaterial to act as a permissive substrate for neuronal adhesion and growth. Previous methods lack the ability to quantify robust outgrowth, or lack the capacity to quantify growth on opaque substrates because they exploit the transparent nature of culture dishes to segregate neuronal processes from an image background based on color intensity. In this study, we sought to investigate the ability of opaque silica sol-gel materials to facilitate axonal outgrowth; therefore, a method was developed for quantifying outgrowth of neurites from dorsal root ganglion explants on these unique surfaces. Dorsal root ganglia were isolated from stage-nine chick embryos and cultured for 48 h on sol-gel materials presenting agarose and chitosan polysaccharides individually or in combination. Explants were then imaged, and basic image analysis software was used by three independent observers to obtain axonal length and axonal area measurements. Robust axon length and axonal spread measurements for ganglia cultured on agarose-chitosan sol-gel matrices yield an estimate of strong neural compatibility for these substrates over silica matrices presenting no polysaccharides, or silica matrices presenting chitosan or agarose individually. We suggest that this simple protocol for quantifying material biocompatibility offers an analysis strategy that can be used universally to the same end.
C1 [Cregg, Jared M.; Wiseman, Sherri L.; Pietrzak-Goetze, Nicole M.; Gilbert, Ryan J.] Michigan Technol Univ, Regenerat & Repair Lab, Dept Biomed Engn, Houghton, MI 49931 USA.
   [Pietrzak-Goetze, Nicole M.; Clupper, Daniel C.] Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA.
   [Jaroch, David B.; Clupper, Daniel C.] Michigan Technol Univ, Dept Mat Sci & Engn, Houghton, MI 49931 USA.
RP Gilbert, RJ (reprint author), Michigan Technol Univ, Regenerat & Repair Lab, Dept Biomed Engn, 309 Minerals & Mat Engn Bldg,1400 Townsend Dr, Houghton, MI 49931 USA.
EM rgilbert@mtu.edu
OI Cregg, Jared/0000-0002-0027-9748
FU Michigan Technological University SURF Grant; Michigan Space Grant
   Consortium; National Institutes of Health [1R15HD061096-01A2]
FX The authors acknowledge the following funding sources: Michigan
   Technological University SURF Grant, Michigan Space Grant Consortium,
   and the National Institutes of Health (1R15HD061096-01A2).
CR Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bilsland J, 1999, J NEUROSCI METH, V92, P75, DOI 10.1016/S0165-0270(99)00099-0
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Dillon GP, 2000, J BIOMED MATER RES, V51, P510, DOI 10.1002/1097-4636(20000905)51:3<510::AID-JBM28>3.0.CO;2-G
   EBENDAL T, 1989, NERVE GROWTH FACTORS, P81
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006
   Hynds DL, 2002, J NEUROSCI METH, V121, P53, DOI 10.1016/S0165-0270(02)00231-5
   Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490
   Neter J., 1989, APPL LINEAR REGRESSI
   PURVES D, 1985, PRINCIPLES NEURAL DE
   Rhiner C, 2005, DEVELOPMENT, V132, P4621, DOI 10.1242/dev.02042
   Rosner H, 1997, J NEUROSCI METH, V78, P93, DOI 10.1016/S0165-0270(97)00132-5
   Shah A, 2004, J NEUROSCI METH, V136, P123, DOI 10.1016/j.jneumeth.2004.01.010
   Sisken B F, 1990, Restor Neurol Neurosci, V1, P303, DOI 10.3233/RNN-1990-13419
   SNOW DM, 1992, J NEUROBIOL, V23, P322, DOI 10.1002/neu.480230311
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   Weaver CM, 2003, J NEUROSCI METH, V124, P197, DOI 10.1016/S0165-0270(03)00017-7
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yu XJ, 2001, J NEUROSCI RES, V66, P303, DOI 10.1002/jnr.1225
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 24
TC 13
Z9 14
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR
PY 2010
VL 16
IS 2
BP 167
EP 172
DI 10.1089/ten.tec.2009.0108
PG 6
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 577ZP
UT WOS:000276263100001
PM 19409034
OA Green Published
DA 2018-10-20
ER

PT J
AU Sauerbier, S
   Stricker, A
   Kuschnierz, J
   Buhler, F
   Oshima, T
   Xavier, SP
   Schmelzeisen, R
   Gutwald, R
AF Sauerbier, Sebastian
   Stricker, Andres
   Kuschnierz, Jens
   Buehler, Felicia
   Oshima, Toshiyuki
   Xavier, Samuel Porfirio
   Schmelzeisen, Rainer
   Gutwald, Ralf
TI In Vivo Comparison of Hard Tissue Regeneration with Human Mesenchymal
   Stem Cells Processed with Either the FICOLL Method or the BMAC Method
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID ACUTE MYOCARDIAL-INFARCTION; BONE-MARROW-CELLS; SINUS AUGMENTATION;
   PROGENITOR CELLS; GRAFTS; MORBIDITY; THERAPY; BLOOD
AB Objective: To compare new bone formation in maxillary sinus augmentation procedures using biomaterial associated with mesenchymal stem cells (MSCs) separated by two different isolation methods.
   Background: In regenerative medicine open cell concentration systems are only allowed for clinical application under good manufacturing practice conditions.
   Methods: Mononuclear cells, including MSCs, were concentrated with either the synthetic poylsaccharid (FICOLL) method (classic open system-control group, n = 6 sinus) or the bone marrow aspirate concentrate (BMAC) method (closed system-test group, n = 12 sinus) and transplanted in combination with biomaterial. A sample of the cells was characterized by their ability to differentiate. After 4.1 months (SD +/- 1.0) bone biopsies were obtained and analyzed.
   Results: The new bone formation in the BMAC group was 19.9% (90% confidence interval [CI], 10.9-29), and in the FICOLL group was 15.5% (90% CI, 8.6-22.4). The 4.4% difference was not significant (90% CI, -4.6-13.5; p = 0.39). MSCs could be differentiated into osteogenic, chondrogenic, and adipogenic lineages.
   Conclusion: MSCs harvested from bone marrow aspirate in combination with bovine bone matrix particles can form lamellar bone and provide a reliable base for dental implants. The closed BMAC system is suited to substitute the open FICOLL system in bone regeneration procedures.
C1 [Sauerbier, Sebastian; Stricker, Andres; Kuschnierz, Jens; Buehler, Felicia; Oshima, Toshiyuki; Schmelzeisen, Rainer; Gutwald, Ralf] Univ Hosp Freiburg, Dept Oral & Craniomaxillofacial Surg, Freiburg, Germany.
   [Oshima, Toshiyuki] Inst Int Cooperat, Fac Hlth Sci, Okayama, Japan.
   [Xavier, Samuel Porfirio] Univ Sao Paulo, Dept Oral Maxillofacial Surg & Periodontol, Fac Dent, BR-14049 Ribeirao Preto, Brazil.
RP Sauerbier, S (reprint author), Univ Klin Zahn Mund & Kieferheilkunde, Abt Klin & Poliklin Mund & Kiefer & Gesichtschiru, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM sebastian.sauerbier@uniklinik-freiburg.de
RI Xavier, Samuel/F-7083-2012; Xavier, Samuel/E-8743-2016
OI Xavier, Samuel/0000-0001-7389-5886; Schmelzeisen,
   Rainer/0000-0002-9686-6989
FU Camlog Foundation, Basel, Switzerland
FX This study was technically supported by Harvest Technologies and
   Geistlich Biomaterials. Financial support for in vitro work was provided
   by the Camlog Foundation. The laboratory work was financially supported
   by the Camlog Foundation, Basel, Switzerland. Technical support was
   given by Geistlich Biomaterials, Wolhusen, Switzerland, and Harvest
   Technologies, Munich, Germany.
CR Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   BATES D, 2009, LANGUAGE ENV STAT CO
   Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204
   Esato K, 2002, CELL TRANSPLANT, V11, P747
   Fernandez-Aviles F, 2004, CIRC RES, V95, P742, DOI 10.1161/01.RES.0000144798.54040.ed
   GUTWALD R, 2008, J CRANIOMAXILLOFAC S, V36, P156
   Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363
   HERNANDEZALFARO F, 2005, BIOSIENCE A
   Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455
   Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Kasten P, 2008, EUR CELLS MATER, V16, P47, DOI 10.22203/eCM.v016a06
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Maiorana C, 2005, INT J ORAL MAX IMPL, V20, P261
   Marechal M, 2008, J PERIODONTOL, V79, P896, DOI [10.1902/jop.2008.070043, 10.1902/jop.2008.070043 ]
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   Pinheiro J.C., 2000, MIXED EFFECTS MODELS
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P503, DOI 10.1034/j.1600-0501.2001.120511.x
   Sakai S, 2008, ACTA ORTHOP, V79, P445, DOI 10.1080/17453670710015382
   SAUERBIER S, 2009, TISSUE ENG
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Seeger FH, 2007, EUR HEART J, V28, P766, DOI 10.1093/eurheartj/ehl509
   Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001
   Smiler Dennis, 2006, Implant Dent, V15, P229, DOI 10.1097/01.id.0000236125.70742.86
   Smiler D, 2007, IMPLANT DENT, V16, P42, DOI 10.1097/ID.0b013e3180335934
   Soltan M, 2005, IMPLANT DENT, V14, P322
   Thorwarth M, 2006, ORAL SURG ORAL MED O, V101, P309, DOI 10.1016/j.tripleo.2005.04.024
   von Arx T, 2006, CLIN ORAL IMPLAN RES, V17, P359, DOI 10.1111/j.1600-0501.2005.01234.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wongchuensoontorn C, 2009, J CRANIO MAXILL SURG, V37, P155, DOI 10.1016/j.jcms.2008.11.002
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 32
TC 43
Z9 42
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR
PY 2010
VL 16
IS 2
BP 215
EP 223
DI 10.1089/ten.tec.2009.0269
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 577ZP
UT WOS:000276263100005
PM 19473102
DA 2018-10-20
ER

PT J
AU Ganesh, M
   Gross, R
AF Ganesh, Manoj
   Gross, Richard
TI Fine-tuning biomaterial degradation by embedding hydrolytic enzymes
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Ganesh, Manoj; Gross, Richard] Polytech Inst NYU, Brooklyn, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 21
PY 2010
VL 239
MA 201-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V21DW
UT WOS:000208189304722
DA 2018-10-20
ER

PT J
AU Fields, GB
AF Fields, Gregg B.
TI Synthesis and biological applications of collagen-model triple-helical
   peptides
SO ORGANIC & BIOMOLECULAR CHEMISTRY
LA English
DT Article
ID MATRIX-METALLOPROTEINASE INHIBITORS; BASEMENT-MEMBRANE COLLAGEN;
   SOLID-PHASE SYNTHESIS; MACROPHAGE SCAVENGER RECEPTOR; HIGH-AFFINITY
   BINDING; VON-WILLEBRAND-FACTOR; AMINO-ACID-SEQUENCE; GLY-PRO-HYP;
   PROTEIN MOLECULAR ARCHITECTURE; GLYCINE-PROLINE-HYDROXYPROLINE
AB Triple-helical peptides (THPs) have been utilized as collagen models since the 1960s. The original focus for THP-based research was to unravel the structural determinants of collagen. In the last two decades, virtually all aspects of collagen structural biochemistry have been explored with THP models. More specifically, secondary amino acid analogs have been incorporated into THPs to more fully understand the forces that stabilize triple-helical structure. Heterotrimeric THPs have been utilized to better appreciate the contributions of chain sequence diversity on collagen function. The role of collagen as a cell signaling protein has been dissected using THPs that represent ligands for specific receptors. The mechanisms of collagenolysis have been investigated using THP substrates and inhibitors. Finally, THPs have been developed for biomaterial applications. These aspects of THP-based research are overviewed herein.
C1 Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.
RP Fields, GB (reprint author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.
EM fieldsg@uthscsa.edu
FU National Institutes of Health [CA98799, EB000289, MH078948]; Robert A.
   Welch Foundation; Texas Higher Education Science and Technology
   Acquisition and Retention (STAR) Award
FX I gratefully acknowledge the National Institutes of Health (CA98799,
   EB000289, and MH078948), the Robert A. Welch Foundation, and the Texas
   Higher Education Science and Technology Acquisition and Retention (STAR)
   Award for support of my laboratory's research on metalloproteases. I am
   also most grateful to Drs. Janelle L. Lauer-Fields, Trista Robichaud,
   and Margaret Ndinguri for constructing the new figures in this
   manuscript.
CR Achison M, 1996, BLOOD COAGUL FIBRIN, V7, P149, DOI 10.1097/00001721-199603000-00009
   Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668
   Agarwal G, 2002, BIOCHEMISTRY-US, V41, P11091, DOI 10.1021/bi020087w
   ALVES F, 1995, ONCOGENE, V10, P609
   Asselin J, 1999, BIOCHEM J, V339, P413, DOI 10.1042/0264-6021:3390413
   Asselin J, 1997, BLOOD, V89, P1235
   Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z
   Babu IR, 2001, J AM CHEM SOC, V123, P2079, DOI 10.1021/ja002165d
   Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200
   Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9
   Bann JG, 2003, BIOCHEMISTRY-US, V42, P4042, DOI 10.1021/bi027050w
   BAO X, 2009, P NATL ACAD IN PRESS
   Baragi VM, 2009, ARTHRITIS RHEUM, V60, P2008, DOI 10.1002/art.24629
   Barnes MJ, 1996, BIOPOLYMERS, V40, P383, DOI 10.1002/(SICI)1097-0282(1996)40:4<383::AID-BIP4>3.0.CO;2-S
   Baronas-Lowell D, 2004, J BIOL CHEM, V279, P43503, DOI 10.1074/jbc.M405979200
   Baronas-Lowell D, 2004, J BIOL CHEM, V279, P952, DOI 10.1074/jbc.M305989200
   Baronas-Lowell D, 2003, J LIQ CHROMATOGR R T, V26, P2225, DOI 10.1081/JLC-120023245
   Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918
   Barth L, 2009, ADV EXP MED BIOL, V611, P295, DOI 10.1007/978-0-387-73657-0_132
   Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5
   Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097
   Bella J, 1996, CONNECT TISSUE RES, V35, P401, DOI 10.3109/03008209609029218
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bella J, 2000, STRUCT FOLD DES, V8, pR121, DOI 10.1016/S0969-2126(00)00153-2
   Bella J, 2006, J MOL BIOL, V362, P298, DOI 10.1016/j.jmb.2006.07.014
   Berisio R, 2004, BIOPOLYMERS, V73, P682, DOI 10.1002/bip.20017
   Berisio R, 2008, J PEPT SCI, V15, P131
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   Bhate M, 2002, BIOCHEMISTRY-US, V41, P6539, DOI 10.1021/bi020070d
   BHOWMICK M, 2010, BIOPOLYMERS PE UNPUB
   Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x
   Bodian DL, 2008, BIOCHEMISTRY-US, V47, P5424, DOI 10.1021/bi800026k
   Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200
   Boulegue C, 2008, ANTIOXID REDOX SIGN, V10, P113, DOI 10.1089/ars.2007.1868
   Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   Broddefalk J, 1998, J AM CHEM SOC, V120, P7676, DOI 10.1021/ja980489k
   Broddefalk J, 1999, J ORG CHEM, V64, P8948, DOI 10.1021/jo990853d
   Brodsky B, 1995, FASEB J, V9, P1537
   BRODSKY B, 1992, BIOPOLYMERS, V32, P447, DOI 10.1002/bip.360320423
   Brodsky B, 2008, NATURE, V453, P998, DOI 10.1038/453998a
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Buevich AV, 2004, J BIOL CHEM, V279, P46890, DOI 10.1074/jbc.M407061200
   Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r
   Cai WB, 2004, J AM CHEM SOC, V126, P15030, DOI 10.1021/ja0442062
   Cai W, 2007, BIOORG CHEM, V35, P327, DOI 10.1016/j.bioorg.2007.01.003
   Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200
   Cejas MA, 2008, P NATL ACAD SCI USA, V105, P8513, DOI 10.1073/pnas.0800291105
   Cejas MA, 2007, BIOCONJUGATE CHEM, V18, P1025, DOI 10.1021/bc070105s
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   CHELBERG MK, 1990, J CELL BIOL, V111, P261, DOI 10.1083/jcb.111.1.261
   Chhabra SR, 1998, TETRAHEDRON LETT, V39, P1603, DOI 10.1016/S0040-4039(97)10828-0
   CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201
   Cohen MM, 2002, AM J MED GENET, V112, P304, DOI 10.1002/ajmg.10780
   COLE WG, 1994, PROG NUCLEIC ACID RE, V47, P29, DOI 10.1016/S0079-6603(08)60249-4
   Cudic M, 2005, J PEPT RES, V65, P272, DOI 10.1111/j.1399-3011.2005.00215.x
   Cudic M, 2009, CHEM BIOL DRUG DES, V74, P473, DOI 10.1111/j.1747-0285.2009.00885.x
   Dai N, 2008, J AM CHEM SOC, V130, P5396, DOI 10.1021/ja711021m
   Dai N, 2009, J AM CHEM SOC, V131, P13728, DOI 10.1021/ja904177k
   DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0
   Deprez P, 2000, BIOCHEM J, V350, P283, DOI 10.1042/0264-6021:3500283
   DeRider ML, 2002, J AM CHEM SOC, V124, P2497, DOI 10.1021/ja0166904
   DeSouza SJ, 1996, FASEB J, V10, P927
   Dey SK, 2006, BIOCONJUGATE CHEM, V17, P84, DOI 10.1021/bc050268l
   Dey SK, 2007, LANGMUIR, V23, P6475, DOI 10.1021/la070175n
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Doi M, 2003, J AM CHEM SOC, V125, P9922, DOI 10.1021/ja035997v
   Doss-Pepe E, 2004, BBA-PROTEINS PROTEOM, V1698, P187, DOI 10.1016/j.bbapap.2003.11.034
   Doss-Pepe E, 2000, BIOCHEMISTRY-US, V39, P14884, DOI 10.1021/bi001108u
   Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034
   Eberhardt ES, 1996, J AM CHEM SOC, V118, P12261, DOI 10.1021/ja9623119
   EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Fallas JA, 2009, J BIOL CHEM, V284, P26851, DOI 10.1074/jbc.M109.014753
   Fan CY, 2008, FASEB J, V22, P3795, DOI 10.1096/fj.08-111484
   FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043
   Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241
   Feng YB, 1997, BIOCHEMISTRY-US, V36, P8716, DOI 10.1021/bi962980z
   Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.3.CO;2-Z
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   FIELDS CG, 1995, ANAL BIOCHEM, V231, P57, DOI 10.1006/abio.1995.1503
   Fields CG, 1996, LETT PEPT SCI, V3, P3, DOI 10.1007/BF00131080
   FIELDS CG, 1993, J BIOL CHEM, V268, P14153
   FIELDS CG, 1993, BIOPOLYMERS, V33, P1695, DOI 10.1002/bip.360331107
   FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2
   Fields GB, 1995, CONNECT TISSUE RES, V31, P235, DOI 10.3109/03008209509010815
   Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   FIELDS GB, 1992, INNOVATION PERSPECTI, P153
   Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551
   Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0
   FIORI S, 2001, PEPTIDES WAVE FUTURE, P355
   Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493
   Gauba V, 2008, J AM CHEM SOC, V130, P7509, DOI 10.1021/ja801670v
   Gauba V, 2007, J AM CHEM SOC, V129, P15034, DOI 10.1021/ja075854z
   GERMANN HP, 1988, BIOPOLYMERS, V27, P157, DOI 10.1002/bip.360270112
   Goebeler M, 1996, J CELL SCI, V109, P1957
   Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575
   Goodman M, 1996, J AM CHEM SOC, V118, P5156, DOI 10.1021/ja954132h
   Goodman M, 1996, J AM CHEM SOC, V118, P10928, DOI 10.1021/ja961717i
   Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4
   Grab B, 1996, J BIOL CHEM, V271, P12234, DOI 10.1074/jbc.271.21.12234
   GUABA V, 2007, J AM CHEM SOC, V129, P2683
   Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524
   HASTY KA, 1993, MATRIX, V13, P181, DOI 10.1016/S0934-8832(11)80001-6
   Heemskerk JWM, 1999, THROMB HAEMOSTASIS, V81, P782
   Henkel W, 1999, BIOCHEMISTRY-US, V38, P13610, DOI 10.1021/bi9905157
   Herr AB, 2009, J BIOL CHEM, V284, P19781, DOI 10.1074/jbc.R109.013219
   Hodges JA, 2005, J AM CHEM SOC, V127, P15923, DOI 10.1021/ja054674r
   Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105
   Hojo H, 1997, TETRAHEDRON, V53, P14263, DOI 10.1016/S0040-4020(97)00994-0
   Holm B, 2000, TETRAHEDRON, V56, P1579, DOI 10.1016/S0040-4020(00)00061-2
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   Horng JC, 2007, PROTEIN SCI, V16, P208, DOI 10.1110/ps.062560107
   Horng JC, 2006, ORG LETT, V8, P4735, DOI 10.1021/ol061771w
   HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488
   Huntington KM, 2000, BIOCHEMISTRY-US, V39, P4543, DOI 10.1021/bi992452y
   Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067
   Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200
   Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079
   Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472
   Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j
   Jenkins CL, 2005, ORG LETT, V7, P2619, DOI 10.1021/ol050780m
   Jenkins CL, 2004, J ORG CHEM, V69, P8565, DOI 10.1021/jo49242y
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Jiravanichanun N, 2006, BIOPOLYMERS, V81, P225, DOI 10.1002/bip.20405
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   Kar K, 2008, PROTEIN SCI, V17, P1086, DOI 10.1110/ps.083441308
   Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m
   Kersteen EA, 2001, BIOPOLYMERS, V59, P24, DOI 10.1002/1097-0282(200107)59:1<24::AID-BIP1002>3.0.CO;2-N
   Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023
   Khew ST, 2008, BIOCHEMISTRY-US, V47, P585, DOI 10.1021/bi702018v
   Khew ST, 2007, TISSUE ENG, V13, P2451, DOI 10.1089/ten.2007.0063
   Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200
   Kinberger GA, 2006, INORG CHEM, V45, P961, DOI 10.1021/ic0520059
   Kinberger GA, 2002, J AM CHEM SOC, V124, P15162, DOI 10.1021/ja021203l
   Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348
   KNAUPER V, 1993, BIOCHEM J, V291, P847
   Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608
   Knight C Graham, 2004, Methods Mol Biol, V273, P349
   Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   KNUTZ T, 1995, SEA TECHNOL, V36, P68
   Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jc.M509707200
   Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200
   Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005
   Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200
   Koide T, 2007, PHILOS T R SOC B, V362, P1281, DOI 10.1098/rstb.2007.2115
   Kojima C, 2009, J AM CHEM SOC, V131, P6052, DOI 10.1021/ja809639c
   Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kramer RZ, 1998, J BIOMOL STRUCT DYN, V16, P367, DOI 10.1080/07391102.1998.10508254
   Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454
   Krishna OD, 2009, BIOMACROMOLECULES, V10, P2626, DOI 10.1021/bm900551c
   Kuhn K, 1994, Trends Cell Biol, V4, P256, DOI 10.1016/0962-8924(94)90124-4
   Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9
   Kusebauch U, 2007, CHEM-EUR J, V13, P2966, DOI 10.1002/chem.200601162
   Kwak J, 2002, J AM CHEM SOC, V124, P14085, DOI 10.1021/ja0209621
   Kwak J, 1999, BIOORGAN MED CHEM, V7, P153, DOI 10.1016/S0968-0896(98)00230-2
   Lauer JL, 1998, BIOCHEMISTRY-US, V37, P5279, DOI 10.1021/bi972958l
   Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849
   Lauer-Fields JL, 2008, J BIOL CHEM, V283, P20087, DOI 10.1074/jbc.M801438200
   Lauer-Fields JL, 2008, ANAL BIOCHEM, V373, P43, DOI 10.1016/j.ab.2007.09.014
   Lauer-Fields JL, 2007, J BIOL CHEM, V282, P142, DOI 10.1074/jbc.M605236200
   Lauer-Fields Janelle L, 2004, J Biomol Tech, V15, P305
   Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873
   Lauer-Fields JL, 2009, BIOORGAN MED CHEM, V17, P990, DOI 10.1016/j.bmc.2008.03.004
   Lauer-Fields JL, 2000, J CHROMATOGR A, V890, P117, DOI 10.1016/S0021-9673(00)00396-4
   Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282
   Lauer-Fields JL, 2003, ANAL BIOCHEM, V321, P105, DOI 10.1016/S0003-2697(03)00460-3
   Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200
   Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200
   Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118
   Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201
   Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190
   LAUERFIELDS JL, 2009, PEPTIDES BREAKING AW, P239
   Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554
   Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Lee SG, 2008, ANGEW CHEM INT EDIT, V47, P8429, DOI 10.1002/anie.200802224
   Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200
   Leo JC, 2008, PROTEIN ENG DES SEL, V21, P475, DOI 10.1093/protein/gzn025
   Li CF, 1997, BIOCHEMISTRY-US, V36, P15404, DOI 10.1021/bi971817g
   Li SZ, 2007, J ORG CHEM, V72, P3116, DOI 10.1021/jo070266p
   Li YJ, 2007, J BIOL CHEM, V282, P22699, DOI 10.1074/jbc.M702910200
   Li YJ, 2009, J BIOL CHEM, V284, P20660, DOI 10.1074/jbc.M109.018077
   Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965
   Liu XY, 1996, BIOCHEMISTRY-US, V35, P4306, DOI 10.1021/bi952270d
   Liu XY, 1998, BIOCHEMISTRY-US, V37, P15528, DOI 10.1021/bi981147u
   LONG CG, 1992, J MOL BIOL, V225, P1, DOI 10.1016/0022-2836(92)91020-P
   LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027
   Madhan B, 2008, J AM CHEM SOC, V130, P13520, DOI 10.1021/ja805496v
   Malkar NB, 2003, BIOMACROMOLECULES, V4, P518, DOI 10.1021/bm0256597
   Malkar NB, 2002, BIOCHEMISTRY-US, V41, P6054, DOI 10.1021/bi012071w
   Malkar NB, 2000, TETRAHEDRON LETT, V41, P1137, DOI 10.1016/S0040-4039(99)02281-9
   MARIN J, 2004, J ORG CHEM, P3027
   Martin R, 2003, BIOPOLYMERS, V70, P435, DOI 10.1002/bip.10464
   Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200
   MAYO KH, 1991, BIOCHEMISTRY-US, V30, P8251, DOI 10.1021/bi00247a022
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919
   MICKELSON D J, 1991, Journal of Cell Biology, V115, p287A
   Mielewczyk SS, 1996, BIOCHEMISTRY-US, V35, P11396, DOI 10.1021/bi960706z
   MILES AJ, 1994, J BIOL CHEM, V269, P30939
   MILES AJ, 1995, J BIOL CHEM, V270, P29047, DOI 10.1074/jbc.270.49.29047
   Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i
   Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j
   Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200
   Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200
   Mo X, 2006, ANGEW CHEM INT EDIT, V45, P2267, DOI 10.1002/anie.200504529
   Mohs A, 2006, J BIOL CHEM, V281, P17197, DOI 10.1074/jbc.M601763200
   Mohs A, 2005, BIOCHEMISTRY-US, V44, P1793, DOI 10.1021/bi0482708
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200
   Morton LF, 1997, J BIOL CHEM, V272, P11044
   MORTON LF, 1993, THROMB RES, V72, P367, DOI 10.1016/0049-3848(93)90148-H
   MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337
   Mountford JC, 1999, THROMB HAEMOSTASIS, V82, P1153
   Muller JCD, 2000, BIOCHEMISTRY-US, V39, P5111, DOI 10.1021/bi992724x
   MURPHY G, 1992, J BIOL CHEM, V267, P9612
   Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574
   Nishi Y, 2005, BIOCHEMISTRY-US, V44, P6034, DOI 10.1021/bi047887m
   Nishida N, 2003, NAT STRUCT BIOL, V10, P53, DOI 10.1038/nsb876
   Ohuchi E, 1997, J BIOL CHEM, V272, P2446
   Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499
   Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI [10.1002/bip.20381, 10.1002/hip.20381]
   Okuyama K, 2009, BIOPOLYMERS, V91, P361, DOI 10.1002/bip.21138
   OLSEN BR, 1999, GUIDEBOOK EXTRACELLU, P380
   Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6
   Ottl J, 1999, J PEPT SCI, V5, P103, DOI 10.1002/(SICI)1099-1387(199902)5:2<103::AID-PSC188>3.0.CO;2-N
   Ottl J, 1996, FEBS LETT, V398, P31, DOI 10.1016/S0014-5793(96)01212-4
   Ottl J, 1999, J AM CHEM SOC, V121, P653, DOI 10.1021/ja983456d
   Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821
   Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043
   Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051
   Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884
   PANASIK N, 1994, INT J PEPT PROT RES, V44, P262
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Pasquet JM, 1999, BIOCHEM J, V342, P171, DOI 10.1042/0264-6021:3420171
   Perez JL, 1996, ONCOGENE, V12, P1469
   Perret S, 2003, J BIOL CHEM, V278, P29873, DOI 10.1074/jbc.M304073200
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Persikov AV, 2003, J AM CHEM SOC, V125, P11500, DOI 10.1021/ja036673+
   Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200
   Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r
   Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342
   Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D
   Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105
   Pires MM, 2009, ANGEW CHEM INT EDIT, V48, P7813, DOI 10.1002/anie.200902375
   Pires MM, 2009, J AM CHEM SOC, V131, P2706, DOI 10.1021/ja8088845
   Ponnusamy MP, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-4
   Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Przybyla DE, 2008, J AM CHEM SOC, V130, P12610, DOI 10.1021/ja804942w
   RAINES RT, 2009, PEPTIDES YOUTH, pR91
   Rao BG, 2005, CURR PHARM DESIGN, V11, P295, DOI 10.2174/1381612053382115
   Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200
   Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990
   Renner C, 2004, BIOPOLYMERS, V76, P34, DOI 10.1002/bip.10569
   Ricard-Blum S, 2006, J BIOL CHEM, V281, P25195, DOI 10.1074/jbc.M603096200
   Romijn RA, 2003, J BIOL CHEM, V278, P15035, DOI 10.1074/jbc.M208977200
   Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556
   Ruehl M, 2002, J BIOL CHEM, V277, P26872, DOI 10.1074/jbc.M202335200
   Rump ET, 2002, CHEM-EUR J, V8, P4613, DOI 10.1002/1521-3765(20021018)8:20<4613::AID-CHEM4613>3.0.CO;2-R
   Sacca B, 2003, BIOCHEMISTRY-US, V42, P3429, DOI 10.1021/bi0206762
   Sacca B, 2002, J MOL BIOL, V324, P309, DOI 10.1016/S0022-2836(02)01065-3
   Sacca B, 2002, J PEPT SCI, V8, P192, DOI 10.1002/psc.385
   SACCA B, 2002, CHEMBIOCHEM, V9, P904
   Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101
   Salsas-Escat R, 2010, PROTEINS, V78, P325, DOI 10.1002/prot.22545
   SANTORO SA, 1994, METHOD ENZYMOL, V245, P147
   Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y
   Shah NK, 1999, BIOPOLYMERS, V49, P297
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Shoulders MD, 2009, BIOORG MED CHEM LETT, V19, P3859, DOI 10.1016/j.bmcl.2009.03.168
   SHOULDERS MD, 2007, BIOPOLYMERS, V89, P443
   Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0
   Simon-Lukasik KV, 2003, BIOPHYS J, V84, P501, DOI 10.1016/S0006-3495(03)74869-3
   Slatter DA, 2006, J MOL BIOL, V359, P289, DOI 10.1016/j.jmb.2006.02.071
   Slatter DA, 2003, J MOL BIOL, V329, P175, DOI 10.1016/S0022-2836(03)00380-2
   Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200
   STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555
   Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7
   Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275
   Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200
   Tanaka T, 1996, PROTEIN ENG, V9, P307, DOI 10.1093/protein/9.3.307
   Tanaka Y, 1998, J PEPT RES, V51, P413
   THAKUR S, 1986, BIOPOLYMERS, V25, P1081, DOI 10.1002/bip.360250608
   Thiagranjan G, 2008, J MOL BIOL, V376, P736, DOI 10.1016/j.jmb.2007.11.075
   Thomas KM, 2005, ORG LETT, V7, P2397, DOI 10.1021/ol0506720
   Tuzinski K, 1999, PEPTIDES: FRONTIERS OF PEPTIDES SCIENCE, P743
   Umashankara M, 2003, CHEM COMMUN, P2606, DOI 10.1039/b308581c
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   Verkleij MW, 1998, BLOOD, V91, P3808
   Verkleij MW, 1999, THROMB HAEMOSTASIS, V82, P1137
   Vitagliano L, 2001, PROTEIN SCI, V10, P2627
   Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9
   Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543
   Williams KE, 2009, MATRIX BIOL, V28, P373, DOI 10.1016/j.matbio.2009.04.009
   Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172
   WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888
   Xu P, 2008, BIOMACROMOLECULES, V9, P1551, DOI 10.1021/bm701365x
   Xu XP, 2007, BIOCHEM J, V406, P147, DOI 10.1042/BJ20070591
   Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
   Yamada H, 2004, BIOORG MED CHEM LETT, V14, P5677, DOI 10.1016/j.bmcl.2004.08.044
   Yamamoto K, 1997, FEBS LETT, V414, P182, DOI 10.1016/S0014-5793(97)01006-5
   Yamazaki CM, 2008, BIOPOLYMERS, V90, P816, DOI 10.1002/bip.21100
   Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837
   Yang W, 1997, BIOCHEMISTRY-US, V36, P6930, DOI 10.1021/bi970051h
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
   Yu YC, 1997, METHOD ENZYMOL, V289, P571
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200
   Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888
NR 325
TC 69
Z9 69
U1 1
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1477-0520
J9 ORG BIOMOL CHEM
JI Org. Biomol. Chem.
PD MAR 21
PY 2010
VL 8
IS 6
BP 1237
EP 1258
DI 10.1039/b920670a
PG 22
WC Chemistry, Organic
SC Chemistry
GA 564BU
UT WOS:000275187000001
PM 20204190
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bessa, PC
   Machado, R
   Nurnberger, S
   Dopler, D
   Banerjee, A
   Cunha, AM
   Rodriguez-Cabello, JC
   Redl, H
   van Griensven, M
   Reis, RL
   Casal, M
AF Bessa, Paulo C.
   Machado, Raul
   Nuernberger, Sylvia
   Dopler, Daniela
   Banerjee, Asmita
   Cunha, Antonio M.
   Carlos Rodriguez-Cabello, J.
   Redl, Heinz
   van Griensven, Martijn
   Reis, Rui L.
   Casal, Margarida
TI Thermoresponsive self-assembled elastin-based nanoparticles for delivery
   of BMPs
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Elastin-like polymer; Thermoresponsive; Delivery; Nanoparticles; BMP-2;
   BMP-14
ID BONE MORPHOGENETIC PROTEINS; IN-VITRO; GROWTH-FACTOR;
   GROWTH/DIFFERENTIATION FACTOR-5; CELLS; DIFFERENTIATION; PROLIFERATION;
   SCAFFOLDS; POLYMER; MODEL
AB Elastin-like polymers are a new type of protein-based polymers that display interesting properties in the biomaterial field. Bone morphogenetic proteins (BMPs) are cytokines with a strong ability to promote new bone formation. In this work, we explored the use of elastin-like nanoparticles (average size 237.5 +/- 3.0 nm), created by thermoresponsive self-assembly, for the combined release of bone morphogenetic protein-2 (BMP-2) and bone morphogenetic protein-14 (BMP-14). These BMPs could be encapsulated at high efficiency into the elastin-like particles and delivered in a sustained way for 14 days. The activity of the growth factors was retained, as shown by the induction of ALP activity and osteogenic mineralization in C2C12 cells. Increased bioactivity was observed with a combined release of BMP-2 and BMP-14. This approach shows a significant potential for future tissue engineering applications in bone. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Bessa, Paulo C.; Machado, Raul; Casal, Margarida] Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, P-4710057 Braga, Portugal.
   [Bessa, Paulo C.; Reis, Rui L.] Univ Minho, Res Grp 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Bessa, Paulo C.; Reis, Rui L.] PT Associated Lab, IBB, Guimaraes, Portugal.
   [Bessa, Paulo C.; Nuernberger, Sylvia; Dopler, Daniela; Banerjee, Asmita; Redl, Heinz; van Griensven, Martijn] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, A-1200 Vienna, Austria.
   [Carlos Rodriguez-Cabello, J.] Univ Valladolid, ETSII, Dept Fis Mat Condensada, BIOFORGE Res Grp, E-47011 Valladolid, Spain.
   [Carlos Rodriguez-Cabello, J.] CIBER BBN, Valladolid, Spain.
   [Cunha, Antonio M.] Univ Minho, Dept Polymer Engn, Inst Polymers & Composites, P-4800058 Guimaraes, Portugal.
RP Casal, M (reprint author), Univ Minho, Dept Biol, CBMA Ctr Mol & Environm Biol, Campus Gualtar, P-4710057 Braga, Portugal.
EM paulo.bessa@dep.uminho.pt; raulmachado@bio.uminho.pt;
   roca@bioforge.uva.es; office@trauma.lbg.ac.at;
   martijn.van.griensven@trauma.lbg.ac.at; rgreis@dep.uminho.pt;
   mcasal@bio.uminho.pt
RI CBMA, CBMA/J-1937-2016; Group, 3Bs/E-4374-2012; Rodriguez-Cabello, Jose
   Carlos/G-6555-2017; Reis, Rui L./A-8938-2008; Machado, Raul/A-8356-2012;
   van Griensven, Martijn/F-5808-2012; Casal, Margarida/B-6386-2009
OI CBMA, CBMA/0000-0002-2841-2678; Group, 3Bs/0000-0002-5195-3456;
   Rodriguez-Cabello, Jose Carlos/0000-0002-3438-858X; Reis, Rui
   L./0000-0002-4295-6129; Machado, Raul/0000-0002-9477-9945; van
   Griensven, Martijn/0000-0001-5104-9881; Casal,
   Margarida/0000-0002-0143-9758; Nurnberger, Sylvia/0000-0002-5175-5118;
   Cunha M., Antonio/0000-0003-3860-7732
FU Fundacao para a Ciencia e Tecnologia [SFRH/BD/17049/2004,
   SFRH/BD/36754/2007]; FEDER [ElastM POCI/CTM/57177/2004]; Fundacao para a
   Ciencia e Tecnologia; Marie Curie Alea Jacta EST [MEST-CT-2004-8104];
   European STREP Project HIPPOCRATES [NMP3-CT-2003-505758]; MICINN [MAT
   2007-66275-C02-01, NAN2004-08538, PSE-300100-2006-1]; JCyL [VA034A09,
   VA016B08, VA030A08]; CIBER-BBN [CB06-01-0003]; Instituto under the
   "Network Center of Regenerative Medicine and Cellular Therapy of
   Castilla and Leon"de Salud Carlos III
FX This work was supported by Fundacao para a Ciencia e Tecnologia (PhD
   grants SFRH/BD/17049/2004 and SFRH/BD/36754/2007), project ElastM
   POCI/CTM/57177/2004 funded by FEDER and Fundacao para a Ciencia e
   Tecnologia; Marie Curie Alea Jacta EST short-term grant
   (MEST-CT-2004-8104) and European STREP Project HIPPOCRATES
   (NMP3-CT-2003-505758). This work was carried out under the scope of the
   European NoE EXPERTISSUES (NMP3-CT-2004-500283). We acknowledge
   financial support from the MICINN (projects MAT 2007-66275-C02-01,
   NAN2004-08538, and PSE-300100-2006-1), the JCyL (projects VA034A09,
   VA016B08, and VA030A08), the CIBER-BBN (project CB06-01-0003), the JCyL
   and the Instituto de Salud Carlos III under the "Network Center of
   Regenerative Medicine and Cellular Therapy of Castilla and Leon".
CR Al-Aql ZS, 2008, J DENT RES, V87, P107, DOI DOI 10.1177/154405910808700215
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Bourgoin Th., 2002, Denisia, V4, P67
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chilkoti A, 2006, CURR OPIN CHEM BIOL, V10, P652, DOI 10.1016/j.cbpa.2006.10.010
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Chowdary KP, 1993, J PHARM SCI, V55, P52
   Dines JS, 2007, J SHOULDER ELB SURG, V16, p215S, DOI 10.1016/j.jse.2007.03.001
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hadjiioannou T., 1993, QUANTITATIVE CALCULA, P345
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Kadomatsu H, 2008, J PERIODONTAL RES, V43, P483, DOI 10.1111/j.1600-0765.2007.01023.x
   Machado R, 2009, J NANO RES, V6, P133, DOI 10.4028/www.scientific.net/JNanoR.6.133
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200
   Nakamura T, 2003, J PERIODONTAL RES, V38, P597, DOI 10.1034/j.1600-0765.2003.00695.x
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Raiche AT, 2004, BIOMATERIALS, V25, P677, DOI 10.1016/S0142-9612(03)00564-7
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   Reddi AH, 2005, CYTOKINE GROWTH F R, V16, P249, DOI 10.1016/j.cytogfr.2005.04.003
   Rincon AC, 2006, J BIOMED MATER RES A, V78A, P343, DOI 10.1002/jbm.a.30702
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Rodriguez-Cabello JC, 2007, J BIOMAT SCI-POLYM E, V18, P269, DOI 10.1163/156856207779996904
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Simank HG, 2004, ORTHOPADE, V33, P68, DOI 10.1007/s00132-003-0541-z
   SIMNICK AJ, 2007, J MACROMOL SCI, V47, P121
   Tajima S, 1997, ARCH DERMATOL RES, V289, P489, DOI 10.1007/s004030050227
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1992, BIOCHEM BIOPH RES CO, V188, P611, DOI 10.1016/0006-291X(92)91100-5
   Wang Xiang-jing, 2009, Journal of Atmospheric and Enviromental Optics, V4, P81, DOI 10.3969/j.issn.1673-6141.2009.02.001
   Yamashita H, 1997, EXP CELL RES, V235, P218, DOI 10.1006/excr.1997.3664
   Yilgor P, 2009, BIOMATERIALS, V30, P3551, DOI 10.1016/j.biomaterials.2009.03.024
   Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022
NR 38
TC 88
Z9 91
U1 3
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAR 19
PY 2010
VL 142
IS 3
BP 312
EP 318
DI 10.1016/j.jconrel.2009.11.003
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 582ER
UT WOS:000276579500004
PM 19913578
DA 2018-10-20
ER

PT J
AU Muller, C
   Luders, A
   Hoth-Hannig, W
   Hannig, M
   Ziegler, C
AF Mueller, Christine
   Lueders, Anne
   Hoth-Hannig, Wiebke
   Hannig, Matthias
   Ziegler, Christiane
TI Initial Bioadhesion on Dental Materials as a Function of Contact Time,
   pH, Surface Wettability, and Isoelectric Point
SO LANGMUIR
LA English
DT Article
ID BOVINE SERUM-ALBUMIN; BIOMATERIAL SURFACES; PROTEIN ADSORPTION; FORCE
   MICROSCOPY; COATED SURFACES; ADHESION FORCE; WATER; TOPOGRAPHY;
   INTERFACES; COLLOIDS
AB The adsorption of bovine serum albumin (BSA) on surfaces of dental enamel and of dental materials was investigated by scanning force spectroscopy. This method provides adhesion forces which can be measured as a function of contact time between protein and surface, pH, wettability, and isoelectric point of the surface. Whereas the chosen ceramic and composite materials resemble very well the adhesion oil natural enamel, a much stronger adhesion was found for the more hydrophobic surfaces, that is, gold, titanium, poly(methyl methacrylate) (PMMA), and poly(tetrafluoroethylene) (PTFE). On hydrophilic surfaces, adhesion is mainly influenced by the electrostatic forces' between protein and surface. However, the conformational change of BSA at pH values above pH 8 hits to be taken into account. On the very hydrophobic PTFE surface, the special interface structure between PTFE and water plays an important role which governs BSA adhesion.
C1 [Mueller, Christine; Lueders, Anne; Ziegler, Christiane] Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.
   [Mueller, Christine; Lueders, Anne; Ziegler, Christiane] Univ Kaiserslautern, Res Ctr OPTIMAS, D-67663 Kaiserslautern, Germany.
   [Hoth-Hannig, Wiebke; Hannig, Matthias] Univ Hosp Saarland, Clin Operat Dent Periodontol & Prevent Dent, D-66421 Homburg, Germany.
RP Ziegler, C (reprint author), Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.
OI Ziegler, Christiane/0000-0002-7963-3729
FU Deutsche Forschungsgemeinschaft [Zi 487/12, Ha 2718/7]; research center
   OPTIMAS of the Urtiversity of Kaiserslautem
FX The financial Support by the Deutsche Forschungsgemeinschaft (Zi 487/12
   and Ha 2718/7) and by the research center OPTIMAS of the Urtiversity of
   Kaiserslautem is greatly acknowledged. The authors thank the IVW for
   access to the electrokinetic analyzer, P. L. Geiss for access to the
   contact angle goniometer, and T. Luxbacher for fruitful discussions
   concerning isoelectric points.
CR Beattie JK, 2006, LAB CHIP, V6, P1409, DOI 10.1039/b610537h
   Bernsmann F, 2008, ANAL BIOANAL CHEM, V391, P545, DOI 10.1007/s00216-008-2014-z
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   DAWSON MM, 1986, DATA BIOCH RES
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3
   Hannig M, 2006, MG ORAL SCI, V19, P29
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   HEMMERLE J, 1999, P NATL ACAD SCI USA, V96, P67
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Kazuhiro N., 2001, J BIOSCI BIOENG, V91, P233
   Kidoaki S, 2002, COLLOID SURFACE B, V23, P153, DOI 10.1016/S0927-7765(01)00232-6
   LEE SJ, 1994, J VAC SCI TECHNOL A, V12, P2949, DOI 10.1116/1.578920
   Mondon M, 2003, ANAL BIOANAL CHEM, V375, P849, DOI 10.1007/s00216-003-1751-2
   MONDON M, 2002, THESIS U KAISERSLAUT
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   NORDE W, 1992, Clinical Materials, V11, P85, DOI 10.1016/0267-6605(92)90032-O
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Peters T., 1996, ALL ALBUMIN BIOCH GE
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   SHIRAHAMA H, 1985, COLLOID POLYM SCI, V263, P141, DOI 10.1007/BF01412788
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   STUART JK, 1995, LANGMUIR, V11, P1368, DOI 10.1021/la00004a051
   Vadillo-Rodriguez V, 2004, J COLLOID INTERF SCI, V278, P251, DOI 10.1016/j.jcis.2004.05.045
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   WALD J, INTERACTION BS UNPUB
   WATANABE N, 1986, COLLOID POLYM SCI, V264, P903, DOI 10.1007/BF01410642
   Xu LC, 2005, LANGMUIR, V21, P7491, DOI 10.1021/la0509091
   Xu LC, 2005, ENVIRON SCI TECHNOL, V39, P3592, DOI 10.1021/es048377i
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
NR 32
TC 34
Z9 34
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 16
PY 2010
VL 26
IS 6
BP 4136
EP 4141
DI 10.1021/la903299y
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 564PE
UT WOS:000275226700056
PM 19888741
DA 2018-10-20
ER

PT J
AU Rao, U
   Sridhar, R
   Sehgal, PK
AF Rao, Urmila
   Sridhar, R.
   Sehgal, P. K.
TI Biosynthesis and biocompatibility of
   poly(3-hydroxybutyrate-co-4-hydroxybutyrate) produced by Cupriavidus
   necator from spent palm oil
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Polyhydroxyalkanoates; Spent palm oil; Differential scanning
   calorimetry; NMR; Depyrogenation; Blends; Chick chorioallantoic membrane
ID ALCALIGENES-EUTROPHUS; INFLAMMATORY RESPONSE; FATTY-ACIDS;
   POLYHYDROXYALKANOATES; ANGIOGENESIS; COPOLYMER; CELLS;
   POLY(3-HYDROXYALKANOATES); ACIDOVORANS; MEMBRANE
AB The ability of Cupriavidus necator to grow and produce poly(3-hydroxybutyrate-co-4-hydroxybutyrate), P(3HB-co-4HB), on spent palm oil left after frying activities, and 1,4-butanediol as precursors of 3HB and 4HB, respectively, was evaluated. The isolated polymer was characterized by (13)C NMR spectroscopy and differential scanning calorimetry. The mole fraction of 4-hydroxybutyrate units was 15 mol% despite the presence of polar compounds like triglyceride trimers in the spent palm oil. The results demonstrate that inexpensive spent palm oil is an excellent carbon source for efficient production of PHA using C. necator. The isolated biopolyester was subjected to a depyrogenation procedure and either blended with vitamin E or physically immobilized on collagen and the biocompatibility of the biopolyester films were evaluated in chick chorioallantoic membrane (CAM). The biocompatibility evaluation indicates that the depyrogenated poly(3-hydroxybutyrate-co-4-hydroxybutyrate) blends have the potential to be developed as a new absorbable biomaterial for medical applications. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Rao, Urmila; Sehgal, P. K.] Cent Leather Res Inst, CSIR, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Rao, Urmila; Sehgal, P. K.] Cent Leather Res Inst, CSIR, Biomat Div, Madras 600020, Tamil Nadu, India.
   [Sridhar, R.] Univ Madras, Ctr Adv Studies, Madras 600020, Tamil Nadu, India.
RP Sehgal, PK (reprint author), Cent Leather Res Inst, CSIR, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
FU CSIR, Government of India
FX We are grateful to Dr. A.B. Mandal, Director, CLRI, Chennai for his kind
   permission to publish this work. The author Urmila Rao acknowledges
   CSIR, Government of India for the financial assistance in form of Senior
   Research Fellowship.
CR Akiyama M, 2003, POLYM DEGRAD STABIL, V80, P183, DOI 10.1016/S0141-3910(02)00400-7
   AKIYAMA M, 1993, BIOTECHNOL LETT, V15, P163, DOI 10.1007/BF00133017
   ALBINI A, 1987, CANCER RES, V47, P3239
   Ayorinde FO, 1998, J IND MICROBIOL BIOT, V21, P46, DOI 10.1038/sj.jim.2900555
   Berger K. G., 2005, USE PALM OIL FRYING
   BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854
   Choi MH, 1999, APPL ENVIRON MICROB, V65, P1570
   Collen A, 2003, BLOOD, V101, P1810, DOI 10.1182/blood-2002-05-1593
   Doi Y., 1990, MICROBIAL POLYESTERS
   Fukui T, 1998, APPL MICROBIOL BIOT, V49, P333, DOI 10.1007/s002530051178
   Gulland F. M. D., 1990, Veterinary Annual, V30, P126
   Haba E, 2007, BIOCHEM ENG J, V35, P99, DOI 10.1016/j.bej.2006.11.021
   HAYWOOD GW, 1991, INT J BIOL MACROMOL, V13, P83, DOI 10.1016/0141-8130(91)90053-W
   HIRAMITSU M, 1993, BIOTECHNOL LETT, V15, P461, DOI 10.1007/BF00129318
   Hong K, 1999, APPL MICROBIOL BIOT, V51, P523, DOI 10.1007/s002530051427
   Ismail R, 2005, ASIA PAC J CLIN NUTR, V14, P414
   Jackson C, 2002, CURR OPIN NEPHROL HY, V11, P295, DOI 10.1097/00041552-200205000-00005
   KAMIYA N, 1989, MACROMOLECULES, V22, P1676, DOI 10.1021/ma00194a030
   Kato M, 1996, APPL MICROBIOL BIOT, V45, P363, DOI 10.1007/s002530050697
   Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053
   Kim JS, 2005, BIOCHEM ENG J, V23, P169, DOI 10.1016/j.bej.2005.01.016
   Kimura H, 1999, CHEM LETT, P737, DOI 10.1246/cl.1999.737
   KIMURA H, 1992, BIOTECHNOL LETT, V14, P445, DOI 10.1007/BF01023164
   KLASING KC, 1991, POULTRY SCI, V70, P1176, DOI 10.3382/ps.0701176
   KUNIOKA M, 1989, APPL MICROBIOL BIOT, V30, P569
   Lee SY, 1999, APPL ENVIRON MICROB, V65, P2762
   Lee WH, 2004, POLYM DEGRAD STABIL, V84, P129, DOI 10.1016/j.polymdegradstab.2003.10.003
   LONON MK, 1988, J CLIN MICROBIOL, V26, P979
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MARZO A, 1971, CLIN CHEM, V17, P145
   MIGNATTI P, 1993, PHYSIOL REV, V73, P161
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   Pepper MS, 1996, ENZYME PROTEIN, V49, P138, DOI 10.1159/000468622
   REPASKE R, 1976, APPL ENVIRON MICROB, V32, P585
   Rossell J.B, 2001, FRYING IMPROVING QUA
   SEHGAL PK, 1999, Patent No. 1351
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   Siew EL, 2007, J BIOMED MATER RES A, V81A, P317, DOI 10.1002/jbm.a.31000
   Steinbilchel A., 1996, BIOTECHNOLOGY, P403
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Valentin HE, 1997, J BIOTECHNOL, V58, P33, DOI 10.1016/S0168-1656(97)00127-2
   Vidal-Mas J, 2001, ANTON LEEUW INT J G, V80, P57, DOI 10.1023/A:1012208225286
   Vigneswari S, 2009, J IND MICROBIOL BIOT, V36, P547, DOI 10.1007/s10295-009-0525-z
   WEARY M, 1988, BIOPHARM, V29, P22
   YAMANE T, 1992, FEMS MICROBIOL LETT, V103, P257, DOI 10.1111/j.1574-6968.1992.tb05846.x
   Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001
NR 49
TC 30
Z9 32
U1 1
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD MAR 15
PY 2010
VL 49
IS 1
BP 13
EP 20
DI 10.1016/j.bej.2009.11.005
PG 8
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 569FG
UT WOS:000275581400003
DA 2018-10-20
ER

PT J
AU Shankar, SP
   Chen, II
   Keselowsky, BG
   Garcia, AJ
   Babensee, JE
AF Shankar, Sucharita P.
   Chen, Inn Inn
   Keselowsky, Benjamin G.
   Garcia, Andres J.
   Babensee, Julia E.
TI Profiles of carbohydrate ligands associated with adsorbed proteins on
   self-assembled monolayers of defined chemistries
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE self-assembled monolayers; pattern recognition receptors; glycoprotein;
   enzyme-linked lectin assay; innate immune response
ID TOLL-LIKE RECEPTORS; C-TYPE LECTINS; DENDRITIC CELL MATURATION;
   SURFACE-CHEMISTRY; IMMUNE-RESPONSE; POLY(LACTIC-CO-GLYCOLIC ACID);
   DC-SIGN; ALPHA(1)-ACID GLYCOPROTEIN; FUNCTIONALIZED SURFACES;
   INFLAMMATORY RESPONSES
AB Conserved protein-carbohydrate-lipid pathogen-associated molecular patterns (PAMPs) interact with cells of the innate immune system to mediate antigen recognition and internalization and activation of immune cells. We examined if analogous "biomaterial-associated molecular patterns" composed of proteins, specifically their carbohydrate modifications, existed on biomaterials, which can play a role in mediating the innate immune response to biomaterials. To probe for these carbohydrates in the adsorbed protein layer, as directed by the underlying biomaterial chemistry, self-assembled monolayers (SAMs) presenting -CH(3), -OH, -COOH, or -NH(2) were preincubated with serum/plasma, and the presence of carbohydrate ligands of C-type lectin receptors (CLRs) was investigated using lectin probes in an enzyme-linked lectin assay (ELLA). Presentation of CLR ligands was detected on control tissue culture polystyrene (TCPS). Absorbances of mannose or N-acetylglucosamine increased with decreasing incubating serum concentration, whereas absorbances of sialylated epitopes or fucose remained unchanged. Absorbances of alpha-galactose or N-acetylgalactosamine decreased with decreasing incubating serum concentration; P-galactose was undetectable. Among SAM endgroups, preincubation with 10% serum resulted in differential presentation of CLR ligands: higher alpha-galactose on COOH SAMs than NH(2) or CH(3) SAMs, highest complex mannose on NH(2) SAMs, and higher complex mannose on OH SAMs than CH(3) SAMs. Least sialylated groups were detected on CH(3) SAMs. In summary, biomaterial chemistry may regulate protein adsorption and hence unique presentation of associated carbohydrates. The ultimate goal is to identify the effects of protein glycosylations associated with biomaterials in stimulating innate immune responses. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 1329-1.342, 2010
C1 [Shankar, Sucharita P.; Chen, Inn Inn; Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Shankar, Sucharita P.; Chen, Inn Inn; Babensee, Julia E.] Emory Univ, Atlanta, GA 30332 USA.
   [Keselowsky, Benjamin G.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU National Science Foundation [BES-0239152]; National Institutes of Health
   [IR01 EB004633-01A]
FX Contract grant sponsor: National Science Foundation; contract grant
   number: BES-0239152; Contract grant sponsor: National Institutes of
   Health; contract grant number: IR01 EB004633-01A
CR Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Babensee JE, 2000, TISSUE ENG, V6, P165, DOI 10.1089/107632700320784
   BALU K, 2001, INT J BIOL MACROMOL, V28, P365
   Balzarini J, 2005, MOL PHARMACOL, V67, P1556, DOI 10.1124/mol.104.005082
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1
   Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890
   Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745
   Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620
   Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x
   Capadona JR, 2003, LANGMUIR, V19, P1847, DOI 10.1021/la026244
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Chacko BK, 2001, INT J BIOL MACROMOL, V28, P365, DOI 10.1016/S0141-8130(01)00139-8
   Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552
   Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   De Carlos A, 2002, INT J ONCOL, V20, P367
   Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203
   Elliott MA, 1997, J CHROMATOGR B, V688, P229, DOI 10.1016/S0378-4347(96)00309-X
   Engering A, 2002, TRENDS IMMUNOL, V23, P480, DOI 10.1016/S1471-4906(02)02296-2
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   Ferdous Z, 2007, TISSUE ENG, V13, P1893, DOI 10.1089/ten.2006.0056
   Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723
   Franco M, 2000, J BIOMED MATER RES, V52, P261, DOI 10.1002/1097-4636(200011)52:2<261::AID-JBM4>3.0.CO;2-2
   Fujimura T, 2008, INT J CANCER, V122, P39, DOI 10.1002/ije.22958
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787
   Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5
   GEITJENBEEK TBH, 2002, J LEUKOCYTE BIOL, V71, P921
   Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Havenaar EC, 1998, GLYCOCONJUGATE J, V15, P723, DOI 10.1023/A:1006944700325
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0
   Johnson PJ, 2000, BRIT J CANCER, V83, P1330, DOI 10.1054/bjoc.2000.1441
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kanazawa N, 2002, J INVEST DERMATOL, V118, P261, DOI 10.1046/j.0022-202x.2001.01633.x
   Kanoh Y, 2004, ONCOLOGY-BASEL, V66, P365, DOI 10.1159/000079484
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   LEE RT, 1991, J BIOL CHEM, V266, P4810
   Leriche V, 2000, APPL ENVIRON MICROB, V66, P1851, DOI 10.1128/AEM.66.5.1851-1856.2000
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673
   Martins MCL, 2003, BIOMATERIALS, V24, P3697, DOI 10.1016/S0142-9612(03)00244-8
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McGreal EP, 2004, MOL IMMUNOL, V41, P1109, DOI 10.1016/j.molimm.2004.06.013
   McNally AK, 1996, AM J PATHOL, V149, P975
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   Okuyama T, 1998, CANCER, V82, P1468, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1468::AID-CNCR6>3.0.CO;2-5
   Patwa TH, 2006, ANAL CHEM, V78, P6411, DOI 10.1021/ac060726z
   Peumans W. J., 1998, HDB PLANT LECTINS PR
   Picha GJ, 1996, J BIOMED MATER RES, V30, P305
   Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004
   ROQUEBARREIRA MC, 1985, J IMMUNOL, V134, P1740
   Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11
   Sanders JE, 2002, J BIOMED MATER RES, V60, P36, DOI 10.1002/jbm.1279
   Schwendel D, 2003, LANGMUIR, V19, P2284, DOI 10.1021/la026716k
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1487, DOI 10.1002/jbm.a.32487
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   SHIBUYA N, 1987, J BIOL CHEM, V262, P1596
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Silin V, 1997, J COLLOID INTERF SCI, V185, P94, DOI 10.1006/jcis.1996.4586
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   SILVERBLATT FJ, 1983, INFECTION, V11, P235, DOI 10.1007/BF01641208
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Spreu J, 2007, IMMUNOGENETICS, V59, P903, DOI 10.1007/s00251-007-0263-1
   SUEYOSHI S, 1988, CARBOHYD RES, V178, P213, DOI 10.1016/0008-6215(88)80113-7
   Sun HF, 2003, VACCINE, V21, P849, DOI 10.1016/S0264-410X(02)00531-5
   Tabares G, 2006, GLYCOBIOLOGY, V16, P132, DOI 10.1093/glycob/cwj042
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   TURNER GA, 1992, CLIN CHIM ACTA, V208, P149, DOI 10.1016/0009-8981(92)90073-Y
   Valladeau J, 2001, J IMMUNOL, V167, P5767, DOI 10.4049/jimmunol.167.10.5767
   van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006
   van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246
   VANLEUVEN F, 1993, PROTEIN SCI, V2, P255
   Walker KB, 1998, DEV BIOL STAND, V92, P259
   Werling D, 2004, IMMUNOLOGY, V111, P41, DOI [10.1111/j.1365-2567.2004.01781.x, 10.1046/j.1365-2567.2003.01781.x]
   Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   Yung S, 2007, PERITON DIALYSIS INT, V27, P375
NR 111
TC 12
Z9 12
U1 3
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2010
VL 92A
IS 4
BP 1329
EP 1342
DI 10.1002/jbm.a.32457
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 555UM
UT WOS:000274541500012
PM 19353560
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shankar, SP
   Petrie, TA
   Garcia, AJ
   Babensee, JE
AF Shankar, Sucharita P.
   Petrie, Timothy A.
   Garcia, Andres J.
   Babensee, Julia E.
TI Dendritic cell responses to self-assembled monolayers of defined
   chemistries
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE dendritic cells; self-assembled monolayers; apoptosis; adjuvant
ID TOLL-LIKE RECEPTORS; II-MEDIATED APOPTOSIS; NECROSIS-FACTOR-ALPHA;
   IMMUNE-RESPONSE; SURFACE-CHEMISTRY; T-CELL; POLY(LACTIC-CO-GLYCOLIC
   ACID); PROTEIN ADSORPTION; INNATE IMMUNITY; IN-VITRO
AB Biomaterial contact triggers dendritic cell (DC) maturation, to an extent depending on the biomaterial, ultimately enhancing an immune response toward associated antigens, implying a role for biomaterials as adjuvants. Self-assembled monolayers (SAM) of alkanethiols on titanium/gold-coated surfaces presenting different chemistries were used to study effects of biomaterial surface chemistry on DC maturation. Although DCs treated with OH, COOH, or NH(2) SAMs showed modest maturation, those treated with CH(3) SAMs were least mature, all based on cytospins, allostimulatory capacity, or maturation marker expression. Surprisingly, DCs treated with CH(3) SAMs secreted highest levels of proinflammatory tumor necrosis factor-a (TNF-alpha) or interleukin-6 (IL-6) but were least mature. Secretion of anti-inflammatory mediators by DCs treated with CH(3) SAMs was not responsible for mitigating DC maturation under these conditions. Interestingly, elevated levels of apoptotic markers were measured associated with DCs and T cells upon CH(3) SAMs contact. Since phagocytosis of apoptotic DCs has strong immunosuppressive effects on DCs, more apoptotic DCs on CH(3) SAMs may account for lower DC maturation. Finally, higher expression of cytotoxic T lymphocyte associated antigen receptor-4 (CTLA-4) on T cells may imply a mechanism of T cell inhibition on CH(3) SAMs. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 1487-1499, 2010
C1 [Shankar, Sucharita P.; Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Shankar, Sucharita P.; Babensee, Julia E.] Emory Univ, Atlanta, GA 30332 USA.
   [Petrie, Timothy A.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU National Science Foundation [BES-0239152]; National Institutes of Health
   [1R01 EB004633-01A1]
FX Contract grant sponsor: National Science Foundation (CAREER grant);
   contract grant number: BES-0239152; Contract grant sponsor: National
   Institutes of Health; contract grant number: 1R01 EB004633-01A1
CR Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Atala A, 2004, REJUV RES, V7, P15, DOI 10.1089/154916804323105053
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Barbosa JN, 2005, MICROSC RES TECHNIQ, V66, P37, DOI 10.1002/jemt.20141
   Barbosa JN, 2005, BIOMATERIALS, V26, P3021, DOI 10.1016/j.biomaterials.2004.09.002
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barbosa JN, 2003, J BIOMED MATER RES A, V65A, P429, DOI 10.1002/jbm.a.10488
   Bayry J, 2005, J IMMUNOL, V175, P15, DOI 10.4049/jimmunol.175.1.15
   Bayry J, 2004, P NATL ACAD SCI USA, V101, P14210, DOI 10.1073/pnas.0402183101
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bertho N, 2001, HUM IMMUNOL, V62, P106, DOI 10.1016/S0198-8859(00)00240-8
   Bivas-Benita M, 2004, VACCINE, V22, P1609, DOI 10.1016/j.vaccine.2003.09.044
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545
   Clayton AR, 2003, ARTHRITIS RHEUM, V48, P2362, DOI 10.1002/art.11130
   Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020
   Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589
   Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723
   GEITENBEEK TBH, 2000, CELL, V100, P575
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0
   Johansson U, 2004, SCAND J IMMUNOL, V59, P50, DOI 10.1111/j.0300-9475.2004.01354.x
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kulig KM, 2004, TRANSPL IMMUNOL, V12, P303, DOI 10.1016/j.trim.2003.12.005
   Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Leverkus M, 2003, INT IMMUNOL, V15, P993, DOI 10.1093/intimm/dxg099
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Llull R, 1999, CLIN PLAST SURG, V26, P549
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   NASR BA, 2006, J LEUKOCYTE BIOL, V80, P774
   Newton PJ, 2003, CLIN EXP IMMUNOL, V133, P50, DOI 10.1046/j.1365-2249.2003.02202.x
   Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8
   Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077
   Porporatto C, 2005, J LEUKOCYTE BIOL, V78, P62, DOI 10.1189/jlb.0904541
   Raghuvanshi RJ, 2001, J MICROENCAPSUL, V18, P723
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Schwendel D, 2003, LANGMUIR, V19, P2284, DOI 10.1021/la026716k
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P1329, DOI 10.1002/jbm.a.32457
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SILVER JH, 1995, J BIOMED MATER RES, V29, P535, DOI 10.1002/jbm.820290414
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Skoberne M, 2005, CURR TOP MICROBIOL, V289, P259
   Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182
   Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263
   Walker KB, 1998, DEV BIOL STAND, V92, P259
   Wallet MA, 2005, CLIN MED RES, V3, P166, DOI 10.3121/cmr.3.3.166
   Walunas TL, 1998, J IMMUNOL, V160, P3855
   Wang Y, 2006, NAT MATER, V5, P791, DOI 10.1038/nmat1737
   Whitlock BB, 2000, J CELL BIOL, V151, P1305, DOI 10.1083/jcb.151.6.1305
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Zang Weiping, 2005, Am J Ther, V12, P592, DOI 10.1097/01.mjt.0000178766.60234.e2
   Zang WP, 2005, J AM SOC NEPHROL, V16, P3661, DOI 10.1681/ASN.2005050523
   Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837
NR 87
TC 9
Z9 9
U1 2
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2010
VL 92A
IS 4
BP 1487
EP 1499
DI 10.1002/jbm.a.32487
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 555UM
UT WOS:000274541500028
PM 19425048
DA 2018-10-20
ER

PT J
AU Levon, J
   Myllymaa, K
   Kouri, VP
   Rautemaa, R
   Kinnari, T
   Myllymaa, S
   Konttinen, YT
   Lappalainen, R
AF Levon, Jaakko
   Myllymaa, Katja
   Kouri, Vesa-Petteri
   Rautemaa, Riina
   Kinnari, Teemu
   Myllymaa, Sami
   Konttinen, Yrjo T.
   Lappalainen, Reijo
TI Patterned macroarray plates in comparison of bacterial adhesion
   inhibition of tantalum, titanium, and chromium compared with
   diamond-like carbon
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bacterial adhesion; diamond-like carbon; implant surfaces;
   Staphylococcus aureus; ultraviolet lithography
ID TOTAL HIP-ARTHROPLASTY; ANTIBIOTIC-RESISTANCE; AMORPHOUS-CARBON;
   COATINGS; BIOMATERIAL; INFECTION; PERFORMANCE; STAPHYLOCOCCI;
   GUIDEWIRES; PROTEINS
AB Staphylococcus aureus device-related infection is a common complication in implantology. Bacterial adhesion on implant surfaces is the initial step in the infective process. The aim was to develop a method suitable for quantitative bacterial adherence studies and to test a new diamond-like carbon (DLC) coating against commonly used metallic biomaterials with regards to Staphylococcus aureus adhesion. Patterned silicon chips with spots of tantalum, titanium, chromium, and DLC were produced using ultraviolet lithography and physical vapor deposition. These patterned chips were used as such or glued to array plates, pretreated with serum and exposed to S. aureus (S-15981) for 90 min, followed by acridine orange staining and fluorescence microscopy. An adhesion index showed that the ranking order of the biomaterials was titanium, tantalum, chromium, and DLC, with the DLC being clearly most resistant against colonization with S. aureus. Micropatterned surfaces are useful for quantitative comparison of bacterial adherence on different biomaterials. In the presence of serum, DLC is superior in its ability to resist adhesion and colonization by S. aureus compared with the commonly used biomaterial metals tantalum, titanium, and chromium. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 1606-1613, 2010
C1 [Levon, Jaakko; Kouri, Vesa-Petteri; Konttinen, Yrjo T.] Univ Helsinki, Inst Biomed, Dept Anat, FI-00014 Hy, Finland.
   [Levon, Jaakko; Kouri, Vesa-Petteri; Konttinen, Yrjo T.] Univ Helsinki, Cent Hosp, Dept Med Invartes Med, FI-00029 Helsinki, Finland.
   [Myllymaa, Katja; Myllymaa, Sami; Lappalainen, Reijo] Univ Kuopio, Dept Phys, FI-70211 Kuopio, Finland.
   [Rautemaa, Riina] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FI-00014 Hy, Finland.
   [Rautemaa, Riina] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, FIN-00029 Helsinki, Finland.
   [Rautemaa, Riina] Univ Helsinki, Cent Hosp, Diagnost Lab, Microbiol Unit, FIN-00029 Helsinki, Finland.
   [Kinnari, Teemu] Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol, FIN-00029 Helsinki, Finland.
   [Konttinen, Yrjo T.] Invalid Fdn, ORTON Orthopaed Hosp, FIN-00280 Helsinki, Finland.
   [Konttinen, Yrjo T.] COXA Hosp Joint Replacement, FIN-33520 Tampere, Finland.
RP Konttinen, YT (reprint author), Univ Helsinki, Inst Biomed, Dept Anat, Haartmaninkatu 8, FI-00014 Hy, Finland.
EM yrjo.konttinen@helsinki.fi
RI Kouri, Vesa-Petteri/M-7436-2015
OI Kouri, Vesa-Petteri/0000-0001-6256-0642; Richardson,
   Riina/0000-0002-1071-6040
FU TEKES Mirri Project; Sigrid Juselius Foundation; evo funds; Signe och
   Ane Gyllenberg Foundation; Finska Lakaresallskapet; Orion-Farmos
   Research Foundation; MNT EDA Net New Generation of Titania Project
FX Contract grant sponsors: TEKES Mirri Project, Sigrid Juselius
   Foundation, evo funds, Signe och Ane Gyllenberg Foundation, Finska
   Lakaresallskapet, Orion-Farmos Research Foundation, MNT EDA Net New
   Generation of Titania Project
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anttila A, 1997, ADV MATER, V9, P1161, DOI 10.1002/adma.19970091507
   ANWAR H, 1990, ANTIMICROB AGENTS CH, V34, P2043, DOI 10.1128/AAC.34.11.2043
   Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P173, DOI 10.1081/CLT-100102418
   Brown A, 2008, CLIN RHEUMATOL, V27, P543, DOI 10.1007/s10067-007-0788-6
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chapin K.C., 2007, MANUAL CLIN MICROBIO, V1, P334
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   ESKIN SG, 2004, BIOMATERIALS SCI INT, P237
   Francois P, 1998, ANN VASC SURG, V12, P34, DOI 10.1007/s100169900112
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   Hasebe T, 2006, DIAM RELAT MATER, V15, P129, DOI 10.1016/j.diamond.2005.08.025
   Horbett TA, 1995, ACS SYM SER, V602, P1
   JOSEFSSON G, 1993, CLIN ORTHOP RELAT R, P210
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Missirlis Y.F., 2004, EUR CELLS MATER, V8, P37
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   OLBORSKA A, 1994, DIAM RELAT MATER, V3, P899, DOI 10.1016/0925-9635(94)90296-8
   Papavasiliou AV, 2006, J BONE JOINT SURG BR, V88B, P321, DOI 10.1302/0301-620X.88B3.17136
   Rasband WS, 1997, IMAGEJ
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Sheeja D, 2005, SURF COAT TECH, V190, P231, DOI 10.1016/j.surfcoat.2004.02.051
   Sleptsov VV, 1996, DIAM RELAT MATER, V5, P483, DOI 10.1016/0925-9635(96)80064-1
   Taeger G, 2003, MATERIALWISS WERKST, V34, P1094, DOI 10.1002/mawe.200300717
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401
NR 36
TC 13
Z9 16
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2010
VL 92A
IS 4
BP 1606
EP 1613
DI 10.1002/jbm.a.32486
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 555UM
UT WOS:000274541500039
PM 19437436
DA 2018-10-20
ER

PT J
AU Wharram, SE
   Zhang, XH
   Kaplan, DL
   McCarthy, SP
AF Wharram, Scott E.
   Zhang, Xiaohui
   Kaplan, David L.
   McCarthy, Stephen P.
TI Electrospun Silk Material Systems for Wound Healing
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE crystallization; gas transmission; poly(ethylene oxide); silk; wound
   healing
ID BOMBYX-MORI SILK; FIBROIN; DEGRADATION; CHITOSAN; BIOMATERIAL;
   NANOFIBERS; SCAFFOLDS; DELIVERY; BEHAVIOR; FIBERS
AB The functional properties of six distinct electrospun silk material groups were evaluated to assess conformational and biocompatible characteristics related to wound dressings. In a hydrated state, all six silk matrices exhibited absorption, water vapor transmission, oxygen permeation and enzymatic biodegradation suitable for full-thickness wound sites. Employing constrained drying techniques, silk concentration was a determinate factor influencing material structural properties related to the storage and distribution of such wound dressing systems. Subsequently, three electrospun silk models demonstrated ideal biomaterial properties with potential utility for wound dressings.
C1 [McCarthy, Stephen P.] Univ Massachusetts Lowell, Dept Plast Engn, Lowell, MA 01854 USA.
   [Zhang, Xiaohui; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Ctr Sci & Technol, Medford, MA 02155 USA.
RP McCarthy, SP (reprint author), Univ Massachusetts Lowell, Dept Plast Engn, 1 Univ Ave, Lowell, MA 01854 USA.
EM Stephen_McCarthy@uml.edu
RI Zhang, Xiaohui/C-4569-2013
FU NIH
FX The authors thank the NIH P41 Tissue Engineering Resource Center for
   support for this research. In addition, the authors thank Christopher
   Santeufemio for material characterization assistance at the University
   of Massachusetts Lowell, Dr Shelley Rassmussen for statistical
   evaluation guidance at the University of Massachusetts Lowell, Carmen
   Preda for technical support at Tufts University and Sarah Schirmer for
   material biofunctional characterization support at NSRDEC, Natick
   Massachusetts. Finally, the authors thank Barbara Ruelle for medical
   research assistance at Emory University.
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   ALLCOCK HR, 2008, INTRO MAT CHEM, P690
   BEERS MH, 2006, MERCK MANUAL DIAGNOS, P2592
   Fink A.L, 1998, FOLDING DESIGN, V3, P9
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kim IY, 2007, INT J PHARM, V341, P35, DOI 10.1016/j.ijpharm.2007.03.042
   Kowalewski T. A., 2005, Bulletin of the Polish Academy of Sciences, Technical Sciences, V53, P385
   LAMKE LO, 1977, BURNS, V3, P159, DOI 10.1016/0305-4179(77)90004-3
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lee YM, 2000, J MATER SCI-MATER M, V11, P817, DOI 10.1023/A:1008961730929
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   LIN HJ, 2005, ADV FUNCT MATER, V15, P1241
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   PEPPAS NA, 1987, HYDROGEL MED PHARM 2
   QUEEN D, 1987, BIOMATERIALS, V8, P367, DOI 10.1016/0142-9612(87)90007-X
   Quynh TM, 2007, EUR POLYM J, V43, P1779, DOI 10.1016/j.eurpolymj.2007.03.007
   RATNER BD, 2004, BIOMATERIALS SCI INT, P40
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   van der Heijden PC, 2001, THERMOCHIM ACTA, V378, P27, DOI 10.1016/S0040-6031(01)00587-1
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang M, 2006, MACROMOLECULES, V39, P1102, DOI 10.1021/ma0517749
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   WONG C, 2006, APPL PHYS A, V82, P293
   Wu TM, 2006, POLYM DEGRAD STABIL, V91, P2198, DOI 10.1016/j.polymdegradstab.2006.01.004
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 34
TC 62
Z9 66
U1 1
U2 41
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAR 10
PY 2010
VL 10
IS 3
BP 246
EP 257
DI 10.1002/mabi.200900274
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 576IQ
UT WOS:000276138200003
PM 20119973
DA 2018-10-20
ER

PT J
AU Lu, Q
   Zhang, XH
   Hu, X
   Kaplan, DL
AF Lu, Qiang
   Zhang, Xiaohui
   Hu, Xiao
   Kaplan, David L.
TI Green Process to Prepare Silk Fibroin/Gelatin Biomaterial Scaffolds
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; scaffold; silk; tissue engineering
ID 3-DIMENSIONAL FIBROIN/COLLAGEN SCAFFOLDS; TISSUE ENGINEERING
   APPLICATIONS; FIBROIN SCAFFOLDS; GROWTH-FACTOR; IN-VITRO; CELLS;
   RELEASE; BONE; MICROSPHERES; ATTACHMENT
AB A new all-aqueous and green process is described to form three-dimensional porous silk fibroin matrices with control of structural and morphological features. Silk-based scaffolds are prepared using lyophilization. Gelatin is added to the aqueous silk fibroin solution to change the silk fibroin conformation and silk fibroin water interactions through adjusting the hydrophilic interactions in silk fibroin gelatin water systems to restrain the formation of separate sheet like structures in the material, resulting in a more homogenous structure. Water annealing is used to generate insolubility in the silk fibroin gelatin scaffold system, thereby avoiding the use of organic solvents such as methanol to lock in the beta-sheet structure. The adjusting of the concentration of gelatin, as well as the concentration of silk fibroin, leads to control of morphological and functional properties of the scaffolds. The scaffolds were homogeneous in terms of interconnected pores, with pore sizes ranging from 100 to 600 p.,M, depending on the concentration of silk fibroin used in the process. At the same time, the morphology of the scaffolds changed from lamellar sheets to porous structures based on the increase in gelatin content. Compared with salt-leaching aqueous-derived scaffolds and hexafluoroisopropanol (HFIP)-derived scaffolds, these freeze-dried scaffolds had a lower content of beta-sheet, resulting in more hydrophilic features. Most of gelatin was entrapped in the silk fibroin gelatin scaffolds, without the burst release in PBS solution. During in vitro cell culture, these silk fibroin gelatin scaffolds had improved cell-compatibility than salt-leaching silk fibroin scaffolds. This new process provides useful silk fibroin-based scaffold systems for use in tissue engineering. Furthermore, the whole process is green, including all-aqueous, room temperature and pressure, and without the use of toxic chemicals or solvents, offering new ways to load bioactive drugs or growth factors into the process.
C1 [Lu, Qiang; Zhang, Xiaohui; Hu, Xiao; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Zhang, Xiaohui/C-4569-2013; Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820
FU NIH [EB002520]; AFOSR
FX The authors thank the NIH (EB002520) and the AFOSR for support of this
   research. The authors also thank the Center for Nanoscale Systems (CNS)
   at Harvard University for SEM use.
CR Adhikari R, 2008, BIOMATERIALS, V29, P3762, DOI 10.1016/j.biomaterials.2008.06.021
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   CHEN X, 2008, BIOMATERIALS, V25, P3683
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Liu HF, 2007, BIOMACROMOLECULES, V8, P1446, DOI 10.1021/bm061025e
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   LU Q, BIOMACROMOL IN PRESS
   Lu Q, 2008, J MATER SCI-MATER M, V19, P629, DOI 10.1007/s10856-007-3180-9
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Migliaresi C, 2008, TISSUE ENG PT A, V14, P775
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   Saul JM, 2007, BIOMATERIALS, V28, P4705, DOI 10.1016/j.biomaterials.2007.07.026
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   UNGER RE, 2004, BIOMATERIALS, V25, P137
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 38
TC 50
Z9 56
U1 2
U2 74
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAR 10
PY 2010
VL 10
IS 3
BP 289
EP 298
DI 10.1002/mabi.200900258
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 576IQ
UT WOS:000276138200008
PM 19924684
DA 2018-10-20
ER

PT J
AU Xing, ZM
   Yang, GS
AF Xing, Zhimin
   Yang, Guisheng
TI Crystallization, Melting Behavior, and Wettability of
   Poly(epsilon-caprolactone) and
   Poly(epsilon-caprolactone)/poly(N-vinylpyrrolidone) Blends
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE poly(epsilon-caprolactone); poly(N-vinylpyrrolidone); differential
   scanning calorimetry; wide-angle X-ray diffraction; water absorptivity;
   contact angle
ID INDOMETHACIN CRYSTALLIZATION; ALIPHATIC POLYESTERS; SURFACE
   MODIFICATION; MOLECULAR-WEIGHT; ISOTHERMAL CRYSTALLIZATION;
   ALPHA-CYCLODEXTRIN; COPOLYMERS; POLY(VINYLPYRROLIDONE);
   POLYCAPROLACTONE; CAPROLACTONE
AB Both wettability and crystallizability control poly(epsilon-caprolactone)'s (PCL) further applications as biomaterial. The wettability is an important property that is governed by both chemical composition and surface structure. In this study, we prepared the PCL/poly(N-vinylpyrrolidone) (PVP) blends via successive in situ polymerization steps aiming for improving the wettability and decreasing crystallizability of PCL. The isothermal crystallization of PCL/PVP at different PVP concentrations was carried out. The equilibrium melting point (T-m(0)), crystallization rate, and the melting behavior after isothermal crystallization were investigated using differential scanning calorimetry (DSC). The Avrami equation was used to fit the isothermal crystallization. The DSC results showed that PVP had restraining effect on the crystallizability of PCL, and the crystallization rate of PCL decreased clearly with the increase of PVP content in the blends. The X-ray diffraction analysis (WAXD) results agreed with that. Water absorptivity and contact angle tests showed that the hydrophilic properties were improved with the increasing content of PVP in blends. The coefficient for the water diffusion into PCL/PVP blends showed to be non-Fickian in character. (C) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 115: 2747-2755, 2010
C1 [Xing, Zhimin; Yang, Guisheng] Chinese Acad Sci, Inst Chem, Joint Lab Polymer Sci & Technol, Beijing Natl Lab Mol Sci,Key Lab Engn Plast, Beijing 100080, Peoples R China.
   [Xing, Zhimin] Chinese Acad Sci, Grad Sch, Inst Chem, Beijing 100080, Peoples R China.
   [Yang, Guisheng] Shanghai Genius Adv Mat Co Ltd, Shanghai 201109, Peoples R China.
RP Yang, GS (reprint author), Chinese Acad Sci, Inst Chem, Joint Lab Polymer Sci & Technol, Beijing Natl Lab Mol Sci,Key Lab Engn Plast, Beijing 100080, Peoples R China.
EM ygs@geniuscn.com
FU 973 Program [2003CB6156002]
FX Contract grant sponsor: 973 Program; contract grant number:
   2003CB6156002.
CR Asatekin A, 2007, J MEMBRANE SCI, V298, P136, DOI 10.1016/j.memsci.2007.04.011
   Balsamo V, 2001, J POLYM SCI POL PHYS, V39, P771, DOI 10.1002/1099-0488(20010401)39:7<771::AID-POLB1052>3.0.CO;2-I
   Benoit MA, 1999, INT J PHARMACEUT, V184, P73, DOI 10.1016/S0378-5173(99)00109-X
   BITTIGER H, 1970, ACTA CRYSTALL B-STRU, VB 26, P1923, DOI 10.1107/S0567740870005198
   Bubert H, 2002, SPECTROCHIM ACTA B, V57, P1601, DOI 10.1016/S0584-8547(02)00101-5
   BUCKLEY DJ, 1962, J POLYM SCI, V56, P163, DOI 10.1002/pol.1962.1205616314
   Chen XH, 1999, MACROMOLECULES, V32, P308, DOI 10.1021/ma980895o
   Chong LW, 2007, THIN SOLID FILMS, V515, P2833, DOI 10.1016/j.tsf.2006.05.010
   Ciardelli G, 2002, MACROMOL CHEM PHYSIC, V203, P1666, DOI 10.1002/1521-3935(200207)203:10/11<1666::AID-MACP1666>3.0.CO;2-D
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   CRANK J, 1970, MATH DIFFUSION, P123
   Crowley KJ, 2003, PHARMACEUT RES, V20, P1417, DOI 10.1023/A:1025706110520
   Cyras VP, 2001, POLYM ENG SCI, V41, P1521, DOI 10.1002/pen.10851
   DAVIDSON CWR, 1986, J CONTROL RELEASE, V3, P259
   FIRESTONE BA, 1991, J APPL POLYM SCI, V43, P901, DOI 10.1002/app.1991.070430507
   Gan DJ, 2003, J POLYM SCI POL CHEM, V41, P3531, DOI 10.1002/pola.10968
   GOULET L, 1990, J POLYM SCI POL PHYS, V28, P2329, DOI 10.1002/polb.1990.090281212
   Gref R, 2002, MACROMOLECULES, V35, P9861, DOI 10.1021/ma021132a
   Huang L, 1998, POLYMER, V39, P4857, DOI 10.1016/S0032-3861(97)00568-5
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jagielski J, 2006, SURF COAT TECH, V200, P6355, DOI 10.1016/j.surfcoat.2005.11.005
   Jiang SC, 2001, POLYMER, V42, P3901, DOI 10.1016/S0032-3861(00)00565-6
   Kamei M, 2000, SURF SCI, V463, pL609, DOI 10.1016/S0039-6028(00)00635-X
   Khougaz K, 2000, J PHARM SCI, V89, P1325, DOI 10.1002/1520-6017(200010)89:10<1325::AID-JPS10>3.0.CO;2-5
   Kiss E, 2003, POLYM ADVAN TECHNOL, V14, P839, DOI 10.1002/pat.404
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lam CNC, 2001, J COLLOID INTERF SCI, V243, P208, DOI 10.1006/jcis.2001.7840
   Lemarchand C, 2003, PHARMACEUT RES, V20, P1284, DOI 10.1023/A:1025017502379
   Lin WJ, 1999, J BIOMED MATER RES, V47, P420, DOI 10.1002/(SICI)1097-4636(19991205)47:3<420::AID-JBM18>3.0.CO;2-7
   Liu H, 2006, SOFT MATTER, V2, P811, DOI 10.1039/b606654b
   Loo YL, 2000, PHYS REV LETT, V84, P4120, DOI 10.1103/PhysRevLett.84.4120
   Loo YL, 2002, MACROMOLECULES, V35, P2365, DOI 10.1021/ma011824j
   Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170
   Matsumoto T, 1999, PHARMACEUT RES, V16, P1722, DOI 10.1023/A:1018906132279
   Miyazaki T, 2004, J PHARM SCI-US, V93, P2710, DOI 10.1002/jps.20182
   Mizukoshi T, 2007, J APPL POLYM SCI, V103, P3811, DOI 10.1002/app.25191
   Nakayama A, 1997, J APPL POLYM SCI, V66, P741, DOI 10.1002/(SICI)1097-4628(19971024)66:4<741::AID-APP14>3.3.CO;2-C
   Nie KM, 2005, J POLYM SCI POL PHYS, V43, P2594, DOI 10.1002/polb.20491
   Ong C., 1978, J POLYM SCI       PS, V63, P45
   PEPPAS NA, 1983, J POLYM SCI POL PHYS, V21, P983, DOI 10.1002/pol.1983.180210614
   Piao LH, 2003, POLYMER, V44, P2025, DOI 10.1016/S0032-3861(03)00087-9
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rodrigues JS, 2003, J CONTROL RELEASE, V92, P103, DOI 10.1016/S0168-3659(03)00296-7
   SALTZMAN WM, 1997, PRINCIPLES TISSUE EN, P225
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Shin K, 2004, MACROMOL BIOSCI, V4, P1075, DOI 10.1002/mabi.200400118
   Skoglund P, 1996, J APPL POLYM SCI, V61, P2455, DOI 10.1002/(SICI)1097-4628(19960926)61:13<2455::AID-APP25>3.0.CO;2-1
   Tian D, 1997, MACROMOLECULES, V30, P406, DOI 10.1021/ma961631+
   Verreck G, 2005, BIOMATERIALS, V26, P1307, DOI 10.1016/j.biomaterials.2004.04.040
   Waddell RL, 2003, BIOTECHNOL PROGR, V19, P1767, DOI 10.1021/bp034086m
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408
   WUNDERLICH B, 1978, CRYSTAL NUCL GROWTH, V2
   Xing ZM, 2009, J APPL POLYM SCI, V111, P1676, DOI 10.1002/app.29176
   YOSHIOKA M, 1995, J PHARM SCI, V84, P983, DOI 10.1002/jps.2600840814
   Zeng XM, 2001, INT J PHARM, V218, P63, DOI 10.1016/S0378-5173(01)00613-5
   Zhang Y, 2006, MACROMOL RAPID COMM, V27, P1565, DOI 10.1002/marc.200600331
   Zhu HG, 2002, BIOMATERIALS, V23, P3141, DOI 10.1016/S0142-9612(02)00058-3
NR 59
TC 7
Z9 7
U1 0
U2 25
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 5
PY 2010
VL 115
IS 5
BP 2747
EP 2755
DI 10.1002/app.30069
PG 9
WC Polymer Science
SC Polymer Science
GA 550FP
UT WOS:000274114000028
DA 2018-10-20
ER

PT J
AU Lien, YS
   Hsieh, LS
   Wu, JCS
AF Lien, Yi-Shen
   Hsieh, Li-Shan
   Wu, Jeffrey C. S.
TI Biodiesel Synthesis by Simultaneous Esterification and
   Transesterification Using Oleophilic Acid Catalyst
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID OILS
AB Solid-acid catalysts call perform transesterification and esterification simultaneously so that free fatty acids (FFAs) in oil can be converted into biodiesel to avoid the disposal of biomaterial. A carbon catalyst was prepared by pyrolyzing glucose at 400 degrees C under a N(2) stream. The catalyst was further sulfated using concentrated sulfuric acid. Transesterification of soybean oil and methanol was carried out at 150 degrees C and 1.7 MPa in it pressurized autoclave. More than 90% biodiesel yield was achieved within 2 h with a molar ratio of methanol to soybean oil of 30:1. The total biodiesel yield for the mixture of soybean oil and palmitic acid decreased to 85% when 20 wt % palmitic acid was used. A rate equation based on the Langmuir-Hishelwood mechanism was established to describe the kinetic behavior of transesterification. The adsorption equilibrium constant of soybean oil was higher than those of the other species, implying an oleophilic surface of the sulfated carbon catalyst.
C1 [Lien, Yi-Shen; Hsieh, Li-Shan; Wu, Jeffrey C. S.] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
RP Wu, JCS (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
EM cswu@ntu.edu.tw
RI Wu, Jeffrey/B-6210-2011
OI Wu, Jeffrey/0000-0002-2231-3118
FU Ministry of Economic Affairs, Taiwan [98-EC-17-A-09-S1-019]
FX Financial support by the Ministry of Economic Affairs, Taiwan, under
   Grant 98-EC-17-A-09-S1-019 is gratefully acknowledged.
CR FREEDMAN B, 1984, J AM OIL CHEM SOC, V61, P1638, DOI 10.1007/BF02541649
   Furuta S, 2004, CATAL COMMUN, V5, P721, DOI 10.1016/j.catcom.2004.09.001
   Gerpen JV, 2006, FUEL PROCESS TECHNOL, V86, P1097, DOI DOI 10.1016/J.FUPROC.2004.11.005
   Lotero E, 2005, IND ENG CHEM RES, V44, P5353, DOI 10.1021/ie049157g
   LUPEZ DE, 2008, APPL CATAL A-GEN, V339, P76
   Ma FR, 1999, BIORESOURCE TECHNOL, V70, P1, DOI 10.1016/S0960-8524(99)00025-5
   Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002
   Mo X, 2008, J CATAL, V254, P332, DOI 10.1016/j.jcat.2008.01.011
   Takagaki A, 2006, CATAL TODAY, V116, P157, DOI 10.1016/j.cattod.2006.01.037
   Toda M, 2005, NATURE, V438, P178, DOI 10.1038/438178a
   Yan SL, 2009, APPL CATAL A-GEN, V353, P203, DOI 10.1016/j.apcata.2008.10.053
NR 11
TC 22
Z9 23
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD MAR 3
PY 2010
VL 49
IS 5
BP 2118
EP 2121
DI 10.1021/ie901496h
PG 4
WC Engineering, Chemical
SC Engineering
GA 558OC
UT WOS:000274752700017
DA 2018-10-20
ER

PT J
AU Fisher, OZ
   Khademhosseini, A
   Langer, R
   Peppas, NA
AF Fisher, Omar Z.
   Khademhosseini, Ali
   Langer, Robert
   Peppas, Nicholas A.
TI Bioinspired Materials for Controlling Stem Cell Fate
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
ID INJECTABLE HYDROGEL COMPOSITES; BONE-MARROW; CHONDROGENIC
   DIFFERENTIATION; SELF-RENEWAL; COMBINATORIAL; BIOMATERIALS; DELIVERY;
   NICHES; SPECIFICATION; SCAFFOLDS
AB Although researchers currently have limited ability to mimic the natural stem cell microenvironment, recent work at the interface of stem biology and biomaterials science has demonstrated that control over stem cell behavior with artificial microenvironments is quite advanced. Embryonic and adult stem cells are potentially useful platforms for tissue regeneration, cell-based therapeutics, and disease-in-a-dish models for drug screening. The major challenge in this field is to reliably control stem cell behavior outside the body. Common biological col trol schemes often ignore physicochemical parameters that materials scientists and engineers commonly manipulate, such as substrate topography and mechanical and rheological properties. However, with appropriate attention to these parameters, researchers have designed novel synthetic microenvironments to control stem cell behavior in rather unnatural ways.
   In this Account, we review synthetic microenvironments that aim to overcome the limitations of natural niches rather than to mimic them. A biomimetic stem cell control strategy is often limited by an incomplete understanding of the complex signaling pathways that drive stem cell behavior from early embryogenesis to late adulthood. The stem cell extracellular environment presents a miscellany of competing biological signals that keep the cell in a state of unstable equilibrium. Using synthetic polymers, researchers have designed synthetic microenvironments with an uncluttered array of cell signals, both specific and nonspecific; that are motivated by rather than modeled after biology. These have proven useful in maintaining cell potency, studying asymmetric cell division, and controlling cellular differentiation.
   We discuss recent research that highlights important biomaterials properties for controlling stem cell behavior, as well as advanced processes for selecting those materials, such as combinatorial and high-throughput screening. Much of this work has utilized micro- and nanoscale fabrication tools for controlling material properties and generating diversity in both two and three dimensions. Because of their ease of synthesis and similarity to biological soft matter, hydrogels have become a biomaterial of choice for generating 3D microenvironments. In presenting these efforts within the framework of synthetic biology, we anticipate that future researchers may exploit synthetic polymers to create microenvironments that control stem cell behavior in clinically relevant ways.
C1 [Fisher, Omar Z.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali; Langer, Robert] MIT, Harvard Massachusetts Inst Technol Div Hlth Sci &, Cambridge, MA 02139 USA.
   [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Div Pharmaceut, Austin, TX 78712 USA.
RP Langer, R (reprint author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM rlanger@mit.edu; peppas@che.utexas.edu
RI Khademhosseini, Ali/A-9435-2010
OI Khademhosseini, Ali/0000-0002-2692-1524; Khademhosseini,
   Ali/0000-0001-6322-8852
FU National Institutes of Health [EB000246, DE016516, HL60435, HL092836,
   DE019024]; Pratt Foundation [09-398]
FX This work is supported in part by the National Institutes of Health
   (Grants EB000246, DE016516, HL60435, HL092836, and DE019024), and the
   Pratt Foundation (Grant 09-398).
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   ASHTON BA, 1984, CALCIFIED TISSUE INT, V36, P83, DOI 10.1007/BF02405298
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Carpenedo RL, 2009, BIOMATERIALS, V30, P2507, DOI 10.1016/j.biomaterials.2009.01.007
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Goetz AK, 2006, P NATL ACAD SCI USA, V103, P11063, DOI 10.1073/pnas.0510926103
   Goldberg M, 2008, ADV DRUG DELIVER REV, V60, P971, DOI 10.1016/j.addr.2008.02.005
   HAKALA H, 2009, TISSUE ENG PART A, P1775
   Hosseinkhani H, 2008, J BIOMED MATER RES A, V85A, P47, DOI 10.1002/jbm.a.31327
   Hsiong SX, 2008, J BIOMED MATER RES A, V85A, P145, DOI 10.1002/jbm.a.31521
   HUANG AH, 2009, TISSUE ENG PART A, P3461
   Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   KESKAR V, 2009, TISSUE ENG PART A, P1695
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lutolf MP, 2009, ADV MATER, V21, P3255, DOI 10.1002/adma.200802582
   Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Meredith JC, 2009, J MATER CHEM, V19, P34, DOI 10.1039/b808649d
   Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027
   Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   National Research Council, 2008, INSP BIOL MOL MAT MA
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383
   Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   PETERS A, 2009, TISSUE ENG PART B-RE, P225
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SLAUGHTER BV, 2009, ADV MATER, V27, P3307
   Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje
   Tan MY, 2009, BIOMATERIALS, V30, P3234, DOI 10.1016/j.biomaterials.2009.02.013
   van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145
NR 49
TC 169
Z9 171
U1 12
U2 204
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD MAR
PY 2010
VL 43
IS 3
BP 419
EP 428
DI 10.1021/ar900226q
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 572IA
UT WOS:000275820900007
PM 20043634
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yan, J
   Pedrosa, VA
   Simonian, AL
   Revzin, A
AF Yan, Jun
   Pedrosa, Valber A.
   Simonian, Aleksandr L.
   Revzin, Alexander
TI Immobilizing Enzymes onto Electrode Arrays by Hydrogel Photolithography
   to Fabricate Multi-Analyte Electrochemical Biosensors
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE hydrogel micropatterning; enzyme-based electrodes; microfabrication;
   glucose and lactate detection
ID NANOCOMPOSITE THIN-FILMS; GLUCOSE-OXIDASE; REDOX POLYMERS; LACTATE;
   MICROELECTRODES; MICROSTRUCTURES; GLUTAMATE; RELEASE; CELLS
AB This paper describes a biomaterial microfabrication approach for interfacing functional biomolecules (enzymes) with electrode arrays. Poly (ethylene glycol) (PEG) hydrogel photopatterning was employed to integrate gold electrode arrays with the enzymes glucose oxidase (GOX) and lactate oxidase (LOX). In this process, PEG diacrylate (DA)-based prepolymer containing enzyme molecules as well as redox species (vinylferrocene) was spin-coated, registered, and UV cross-linked on top of an array of gold electrodes. As a result, enzyme-carrying circular hydrogel structures (600 mu m diameter) were fabricated on top of 300 mu m diameter gold electrodes. Importantly, when used with multiple masks, hydrogel photolithography allowed us to immobilize GOX and LOX molecules on adjacent electrodes within the same electrode array. Cyclic voltammetry and amperometry were used to characterize biosensor electrode arrays. The response of the biosensor array was linear for up to 20 mM glucose with sensitivity of 0.9 mu A cm(-2) mM(-1) and 10 mM lactate with sensitivity of 1.1 mu A cm(-2) mM(-1). Importantly, simultaneous detection of glucose and lactate from the same electrode array was demonstrated. A novel strategy for integrating biological and electrical components of a biosensor described in this paper provides the flexibility to spatially resolve and register different biorecognition elements with individual members of a miniature electrode array. Of particular interest to us are future applications of these miniature electrodes for real-time monitoring of metabolite fluxes in the vicinity of living cells.
C1 [Yan, Jun; Revzin, Alexander] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Pedrosa, Valber A.; Simonian, Aleksandr L.] Auburn Univ, Dept Mat Engn, Auburn, AL 36849 USA.
RP Revzin, A (reprint author), Univ Calif Davis, Dept Biomed Engn, 451 E Hlth Sci St 2619, Davis, CA 95616 USA.
EM arevzin@ucdavis.edu
RI Yan, Jun/E-8783-2012; Pedrosa, Valber/H-5822-2012
FU NIH [CA126716]; NSF (EFRI)
FX The financial support for this study was provided by grants (NIH
   CA126716) and NSF (EFRI) awarded to AR. Additionally, A.L.S.
   acknowledges working at the National Science Foundation during the time
   this study was carried out. The views expressed in this article are
   those of the authors and do not reflect the views of the National
   Science Foundation.
CR Belmont-Hebert C, 1998, ANAL CHEM, V70, P2949, DOI 10.1021/ac971194c
   Castillo J, 2005, BIOSENS BIOELECTRON, V20, P1559, DOI 10.1016/j.bios.2004.08.021
   Cohen AE, 2000, SENSOR ACTUAT B-CHEM, V62, P23, DOI 10.1016/S0925-4005(99)00372-X
   DEGANI Y, 1989, J AM CHEM SOC, V111, P2357, DOI 10.1021/ja00188a091
   Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478
   Guenat OT, 2006, ANAL CHEM, V78, P7453, DOI 10.1021/ac0609733
   Hodak J, 1997, LANGMUIR, V13, P2708, DOI 10.1021/la962014h
   HU Y, 1993, ANAL CHIM ACTA, P503
   Jimenez C, 1997, ANAL CHIM ACTA, V351, P169, DOI 10.1016/S0003-2670(97)00332-2
   JIMENEZ C, 1995, SENSOR ACTUAT B-CHEM, V27, P421, DOI 10.1016/0925-4005(94)01631-Q
   Jobst G, 1996, ANAL CHEM, V68, P3173, DOI 10.1021/ac950630x
   Ju HX, 1997, J CHEM SOC FARADAY T, V93, P1371, DOI 10.1039/a606680a
   Koh WG, 2005, SENSOR ACTUAT B-CHEM, V106, P335, DOI 10.1016/j.snb.2004.08.025
   KOUDELKAHEP M, 1993, ANAL CHIM ACTA, V281, P461, DOI 10.1016/0003-2670(93)85003-3
   KOUDELKAHEP M, 1997, IMMOBILIZATION ENZYM, V1, P83
   Lee JY, 2009, LANGMUIR, V25, P3880, DOI [10.1021/la803635r, 10.1021/1a803635r]
   LINDNER E, 1993, FRESEN J ANAL CHEM, V346, P584, DOI 10.1007/BF00321250
   MALITESTA C, 1990, ANAL CHEM, V62, P2735, DOI 10.1021/ac00223a016
   Merchant SA, 2009, LANGMUIR, V25, P7736, DOI 10.1021/la9004938
   Moser I, 2002, BIOSENS BIOELECTRON, V17, P297, DOI 10.1016/S0956-5663(01)00298-6
   Mugweru A, 2007, ELECTROANAL, V19, P453, DOI 10.1002/elan.200603749
   OHARA TJ, 1994, ANAL CHEM, V66, P2451, DOI 10.1021/ac00087a008
   ORAHILLY S, 2001, SCIENCE, V431, P125
   PISHKO MV, 1991, ANAL CHEM, V63, P2268, DOI 10.1021/ac00020a014
   QUINN CP, 1995, AM J PHYSIOL-ENDOC M, V269, pE155
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Revzin AF, 2002, SENSOR ACTUAT B-CHEM, V81, P359, DOI 10.1016/S0925-4005(01)00982-0
   Russell RJ, 1999, ANAL CHEM, V71, P4909, DOI 10.1021/ac990901u
   Sato N, 2006, ANAL CHIM ACTA, V565, P250, DOI 10.1016/j.aca.2006.02.041
   Sirkar K, 2000, ANAL CHEM, V72, P2930, DOI 10.1021/ac991041k
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   STRIKE DJ, 1997, IMMOBILIZATION ENZYM, V1, P93
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   TAKATSU I, 1987, SENSOR ACTUATOR, V11, P309, DOI 10.1016/0250-6874(87)80071-9
   UPDIKE SJ, 1967, NATURE, V214, P986, DOI 10.1038/214986a0
   URBAN G, 2009, MEAS SCI TECHNOL, V20
   Wagner JG, 1998, P NATL ACAD SCI USA, V95, P6379, DOI 10.1073/pnas.95.11.6379
   Wang YD, 2006, LANGMUIR, V22, P9776, DOI 10.1021/la060857v
   Yan J, 2009, BIOSENS BIOELECTRON, V24, P2604, DOI 10.1016/j.bios.2009.01.029
   Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391
   Zhu H, 2008, COLLOID SURFACE B, V64, P260, DOI 10.1016/j.colsurfb.2008.02.010
   Zhu H, 2009, ANAL CHEM, V81, P8150, DOI 10.1021/ac901390j
NR 43
TC 47
Z9 48
U1 5
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR
PY 2010
VL 2
IS 3
BP 748
EP 755
DI 10.1021/am9007819
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 572JA
UT WOS:000275825700024
PM 20356276
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Katsikogianni, MG
   Missirlis, YF
AF Katsikogianni, M. G.
   Missirlis, Y. F.
TI Interactions of bacteria with specific biomaterial surface chemistries
   under flow conditions
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bacterial adhesion; Self-assembled monolayers; Surface characterization;
   Shear rate
ID SELF-ASSEMBLED MONOLAYERS; STAPHYLOCOCCUS-EPIDERMIDIS ADHESION;
   HYDROPHOBIC SURFACES; POLYMER SURFACES; FORCE MICROSCOPY; DLVO THEORY;
   FREE-ENERGY; FILMS; INFECTIONS; DETACHMENT
AB The effect of specific chemical functionalities on the adhesion of two Staphylococcus epidermidis strains under flow was investigated by using surfaces prepared by self-assembly of alkyl silane monolayers on glass. Terminal methyl (CH(3)) and amino (NH(2)) groups were formed in Solution and by chemical vapor deposition of silanes, at elevated temperature Hydroxyl (OH)-terminated glass was used as control Surface modification was verified by contact angle and zeta potential measurements, atomic force microscopy and X-ray photoelectron spectroscopy. A parallel plate flow chamber was used to evaluate bacterial adhesion at various shear rates The effect of the solution's ionic strength oil adhesion was also studied Adhesion was found to be dependent on the monolayer's terminal functionality It was higher oil the CH(3) followed by the NH(2) and minimal on the OH-terminated glass for both strains The increase in the ionic strength significantly enhanced adhesion to the various substrates, in accordance with the Derjaguin-Landau-Verwey-Overbeek (DLVO) theory The extended DLVO theory explained well the combined effects of surface and solution properties on bacterial adhesion under low shear rates However, the increase in the shear rate restricted the predictability of the theory and revealed macrornolecular interactions between bacteria and NH(2)-terminated surfaces (C) 2009 Acta Materialia Inc Published by Elsevier Ltd All rights reserved
C1 [Katsikogianni, M. G.; Missirlis, Y. F.] Univ Patras, Lab Biomech & Biomed Engn, Dept Aeronaut & Mech Engn, Patras 26504, Greece.
RP Missirlis, YF (reprint author), Univ Patras, Lab Biomech & Biomed Engn, Dept Aeronaut & Mech Engn, Patras 26504, Greece.
OI Katsikogianni, Maria/0000-0002-1560-3993
FU Departnient of Microbiology, School of Medicine, University of Patras
FX The authors thank Professor I. Spiliopoulou, from the Departnient of
   Microbiology, School of Medicine, University of Patras, for providing
   the bacterial strains and laboratory equipment; Professor P.G.
   Koutsoukos, from the Department of Chemical Engineering, University of
   Patras, for allowing the use of the Laser Zeta Meter: Dr. B. Seifert,
   from GKSS, Berlin, for valuable discussions on the preparation of SAMs
   and Dr E. Siokou, from the FORTH/ICE-HT, Patras, for the XPS analysis.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Amanatides E, 2006, SURF COAT TECH, V200, P6331, DOI 10.1016/j.surfcoat.2005.11.002
   An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   BAIN CD, 1988, SCIENCE, V240, P62, DOI 10.1126/science.240.4848.62
   Bayoudh S, 2005, COLLOID SURFACE A, V266, P160, DOI 10.1016/j.colsurfa.2005.06.025
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P803, DOI 10.1093/jac/30.6.803
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   Duval JFL, 2005, LANGMUIR, V21, P11268, DOI 10.1021/la051735q
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Finlay JA, 2002, INTEGR COMP BIOL, V42, P1116, DOI 10.1093/icb/42.6.1116
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   GRAY ED, 1984, LANCET, V1, P365
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   Kamusewitz H, 2003, APPL PHYS A-MATER, V76, P899, DOI 10.1007/s00339-002-1972-9
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   Katsikogianni M, 2006, J MATER SCI-MATER M, V17, P679, DOI 10.1007/s10856-006-9678-8
   Katsikogianni MG, 2007, PLASMA PROCESS POLYM, V4, pS1046, DOI 10.1002/ppap.200732403
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Ma HL, 2004, J THEOR BIOL, V226, P237, DOI 10.1016/j.jtbi.2003.09.008
   MARGEL S, 1993, J BIOMED MATER RES, V27, P1463, DOI 10.1002/jbm.820271202
   Meinders JM, 1995, J COLLOID INTERF SCI, V176, P329, DOI 10.1006/jcis.1995.9960
   Missirlis YF, 2007, MATERIALWISS WERKST, V38, P983, DOI 10.1002/mawe.200700240
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   Mrksich M, 1997, CURR OPIN COLLOID IN, V2, P83, DOI 10.1016/S1359-0294(97)80012-X
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Reiniger M, 2002, SURF INTERFACE ANAL, V33, P85, DOI 10.1002/sia.1167
   RIJNAARTS HHM, 1995, J COLLOID INTERF SCI, V14, P179
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Sharp JM, 2005, LANGMUIR, V21, P8198, DOI 10.1021/la046765s
   SILVER JH, 1993, J BIOMED MATER RES, V27, P735, DOI 10.1002/jbm.820270606
   Stavridi M, 2003, MAT SCI ENG C-BIO S, V23, P359, DOI 10.1016/S0928-4931(02)00287-4
   Sugimura H, 2002, SURF INTERFACE ANAL, V34, P550, DOI 10.1002/sia.1358
   TANUMA S, 1991, SURF INTERFACE ANAL, V17, P911, DOI 10.1002/sia.740171304
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   TROUGHTON EB, 1988, LANGMUIR, V4, P365, DOI 10.1021/la00080a021
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   VANOSS CJ, 1984, COLLOID SURFACE, V8, P373, DOI 10.1016/0166-6622(84)80131-6
   Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Walker SL, 2005, APPL ENVIRON MICROB, V71, P3093, DOI 10.1128/AEM.71.6.3093-3099.2005
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
NR 58
TC 49
Z9 50
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2010
VL 6
IS 3
BP 1107
EP 1118
DI 10.1016/j.actbio.2009.08.006
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 560ZD
UT WOS:000274943500045
PM 19671455
DA 2018-10-20
ER

PT J
AU Fink, H
   Faxalv, L
   Molnar, GF
   Drotz, K
   Risberg, B
   Lindahl, TL
   Sellborn, A
AF Fink, Helen
   Faxalv, Lars
   Molnar, Gabor F.
   Drotz, Kristoffer
   Risberg, Bo
   Lindahl, Tomas L.
   Sellborn, Anders
TI Real-time measurements of coagulation on bacterial cellulose and
   conventional vascular graft materials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bacterial cellulose; Blood compatibility; Plasma coagulation; Fibrin
   formation; Thrombin generation
ID IMMUNE COMPLEMENT ACTIVATION; BLOOD-PLASMA COAGULATION; ARTIFICIAL
   SURFACES; SOLID-SURFACES; FACTOR-XII; ADSORPTION; BIOCOMPATIBILITY;
   HEMODIALYSIS; GENERATION; CONTACT
AB The search for a functional, small diameter (<5 mm) vascular graft has been ongoing for over 30 years, but yet there is no consistently reliable synthetic graft The primary mechanisms of graft failure are intimal hyperplasia. poor blood flow and surface thrombogenicity Bacterial cellulose (BC) became therefore a proposed new biosynthetic vascular graft material Since conventional methods are not suited for coagulation measurements on BC, we have adapted the automated calibrated thrombin generation method for measurements of biomaterial-induced coagulation of BC as compared with clinically used graft materials ie, expanded poly(tetrafluoroethylene) (ePTFE) and poly(ethyleneterephtalat) (PET) We have also visualized the coagulation propagation at the material surfaces Thrombin generation experiments revealed dramatic differences between the materials tested. Both ePTFE and BC were found to generate longer lag times and ttpeak values than PET Most importantly. BC was found to generate the lowest.. peak", indicating a slower coagulation process at the surface These results are also Supported by the measurements of factor XIIa generation and analysis of surface coagulation times, which were detected in the following increasing order (mean +/- SD) PET (27 +/- 8 min) < BC (46 +/- 9 min) < ePTFE (61 +/- 21 min) Real-time measurement of coagulation seems to have the potential for becoming a powerful too] for evaluation of biomaterials for blood-contacting devices (C) 2009 Acta Materialia Inc Published by Elsevier Ltd All rights reserved
C1 [Fink, Helen; Risberg, Bo; Sellborn, Anders] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Sci, Vasc Engn Ctr, SE-41345 Gothenburg, Sweden.
   [Faxalv, Lars; Lindahl, Tomas L.] Linkoping Univ, Dept Clin & Expt Med, Div Clin Chem, SE-58185 Linkoping, Sweden.
   [Molnar, Gabor F.] Semmelweis Univ, H-1085 Budapest, Hungary.
   [Drotz, Kristoffer] Chalmers Univ Technol, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
RP Sellborn, A (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Sci, Vasc Engn Ctr, SE-41345 Gothenburg, Sweden.
FU Swedish Research Council, University of Gothenburg (LUA); County Council
   of Ostergotland and Linkopings Universitet, Sweden
FX This work was funded by the Swedish Research Council, University of
   Gothenburg (LUA) and the local strategic research project Materials in
   Medicine funded by County Council of Ostergotland and Linkopings
   Universitet, Sweden, who are gratefully acknowledged.
CR Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Andersson M, 2002, J BIOMAT SCI-POLYM E, V13, P907, DOI 10.1163/156856202320401951
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Bodin A, 2005, ABSTR PAP AM CHEM S, V229, pU297
   BRASH JL, 1988, BLOOD, V71, P932
   CHATTERJEE K, 2008, J BIOMED MAT RES A
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   EMERY RW, 1993, J CARDIAC SURG, V8, P439, DOI 10.1111/j.1540-8191.1993.tb00391.x
   Faxalv L, 2008, J BIOMED MATER RES A, V85A, P1129, DOI 10.1002/jbm.a.31529
   Gerotziafas GT, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-16
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   Hansson KM, 2002, BIOSENS BIOELECTRON, V17, P747, DOI 10.1016/S0956-5663(02)00048-9
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636
   Hoenich NA, 1997, CLIN NEPHROL, V48, P253
   Hoenich NA, 1997, BIOMATERIALS, V18, P1299, DOI 10.1016/S0142-9612(97)00062-8
   Johnell M, 2002, J THORAC CARDIOV SUR, V124, P321, DOI 10.1067/mtc.2002.122551
   Keogh JR, 1996, BIOMATERIALS, V17, P1987, DOI 10.1016/0142-9612(96)00005-1
   Lai JN, 2006, APPL SURF SCI, V252, P3375, DOI 10.1016/j.apsusc.2005.05.038
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   MCCULLOUGH JN, 1990, ANN THORAC SURG, V50, P663, DOI 10.1016/0003-4975(90)90214-Q
   Phillips MR, 1998, ANN THORAC SURG, V66, P1191, DOI 10.1016/S0003-4975(98)00780-2
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   RITTER EF, 1989, AM J PHYSIOL, V257, pH1076
   Sellborn A, 2005, MOL IMMUNOL, V42, P569, DOI 10.1016/j.molimm.2004.09.015
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P287, DOI 10.1053/ejvs.2002.1810
   van Oeveren W, 2002, ARTIF ORGANS, V26, P506, DOI 10.1046/j.1525-1594.2002.06872.x
   VISSER A, 1996, BIOMATERIALS SCI INT, P50
   VROMAN L, 1964, NATURE, V204, P701, DOI 10.1038/204701b0
   VROMAN L, 1987, ANN NY ACAD SCI, V516, P300, DOI 10.1111/j.1749-6632.1987.tb33050.x
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Vroman L, 2003, J BIOMED MATER RES A, V65A, P125, DOI 10.1002/jbm.a.10480
   Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 36
TC 32
Z9 32
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2010
VL 6
IS 3
BP 1125
EP 1130
DI 10.1016/j.actbio.2009.09.019
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 560ZD
UT WOS:000274943500047
PM 19800035
DA 2018-10-20
ER

PT J
AU Keshaw, H
   Thapar, N
   Burns, AJ
   Mordan, N
   Knowles, JC
   Forbes, A
   Day, RM
AF Keshaw, Hussila
   Thapar, Nikhil
   Burns, Alan J.
   Mordan, Nicola
   Knowles, Jonathan C.
   Forbes, Alastair
   Day, Richard M.
TI Microporous collagen spheres produced via thermally induced phase
   separation for tissue regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE TIPS; Collagen; Sphere; Regenerative medicine
ID SMALL-INTESTINAL SUBMUCOSA; ANAL FISTULA PLUG; BODY-WALL REPAIR;
   CHORIOALLANTOIC MEMBRANE; ENHANCING ANGIOGENESIS; BRONCHOPLEURAL
   FISTULA; PORCINE HETEROGRAFT; GROWTH-FACTORS; GLUTARALDEHYDE; MATRICES
AB Collagen is an abundant protein found in the extracellular matrix of many tissues Due to its biocompatibility, it is a potentially ideal biomaterial for many tissue engineering applications However, harvested collagen often requires restructuring into a three-dimensional matrix to facilitate applications such as implantation into poorly accessible tissue cavities. The aim of the current study was to produce a conformable collagen-based scaffold material capable of supporting tissue regeneration for use in wound repair applications Microporous collagen spheres were prepared using a thermally induced phase separation (TIPS) technique and their biocompatibility was assessed The collagen spheres were successfully cross-linked with glutaraldehyde vapour, rendering them mechanically more stable. When cultured with myofibroblasts the collagen spheres stimulated a prolonged significant increase in secretion of the angiogenic growth factor, vascular endothelial growth factor (VEGF), compared with cells alone Control polycaprolactone (PCL) spheres failed to stimulate a similar prolonged increase in VEGF secretion. An enhanced angiogenic effect was also seen in vivo using the chick embryo membrane assay, where a significant increase in the number of blood vessels converging towards collagen spheres was observed compared with control PCL spheres. The results from this study indicate that microporous collagen spheres produced using TIPS are biologically active and could offer a novel conformable scaffold for tissue regeneration in poorly accessible wounds (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd All rights reserved.
C1 [Day, Richard M.] UCL, Biomat & Tissue Engn Grp, Ctr Gastroenterol & Nutr, Windeyer Inst, London W1T 4JF, England.
   [Keshaw, Hussila] Kings Coll London, Burdett Inst Gastrointestinal Nursing, London WC2R 2LS, England.
   [Thapar, Nikhil; Burns, Alan J.] UCL, Inst Child Hlth, Neural Dev Unit, London, England.
   [Mordan, Nicola; Knowles, Jonathan C.] UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, London, England.
RP Day, RM (reprint author), UCL, Biomat & Tissue Engn Grp, Ctr Gastroenterol & Nutr, Windeyer Inst, 46 Cleveland St, London W1T 4JF, England.
RI Burns, Alan/C-4988-2008; Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
FU Sir Halley Stewart Trust; Department of Health's NIHR; Great Ormond
   Street Hospital Childrens Charity [W1018C, V1222]; Medical Research
   Council [G0800973]
FX The work conducted in this study was supported by a grant from the Sir
   Halley Stewart Trust. Work was undertaken at UCLH/UCL, which receives
   funding from the Department of Health's NIHR Comprehensive Biomedical
   Research Centres funding scheme.
CR Ahearne M, 2008, BRIT J OPHTHALMOL, V92, P268, DOI 10.1136/bjo.2007.130104
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Bataille F, 2004, GUT, V53, P1314, DOI 10.1136/gut.2003.038208
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Blaker JJ, 2008, ACTA BIOMATER, V4, P264, DOI 10.1016/j.actbio.2007.09.011
   Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   BOON ME, 1995, BIOMATERIALS, V16, P1089, DOI 10.1016/0142-9612(95)98905-T
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   CARPENTIER A, 1974, J THORAC CARDIOV SUR, V68, P771
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chen GP, 2004, TISSUE ENG, V10, P323, DOI 10.1089/107632704323061681
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   DARDIK H, 1976, ARCH SURG-CHICAGO, V111, P60
   Franklin M E Jr, 2004, Hernia, V8, P186
   George J, 2008, J BIOMED MATER RES A, V87A, P1103, DOI 10.1002/jbm.a.32277
   GRIFFITHS RW, 1982, BRIT J PLAST SURG, V35, P519, DOI 10.1016/0007-1226(82)90056-X
   HANNAH H, 1976, CIRCULATION, V54, P27
   Himpson RC, 2007, COMP CLIN PATHOL, V16, P9
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hori Y, 2001, ASAIO J, V47, P206, DOI 10.1097/00002480-200105000-00008
   Hori Y, 2001, INT J ARTIF ORGANS, V24, P50
   HOROWITZ MS, 1974, J THORAC CARDIOV SUR, V67, P885
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Keckler SJ, 2007, ANN THORAC SURG, V84, P1383, DOI 10.1016/j.athoracsur.2007.05.009
   Keshaw H, 2009, TISSUE ENG PT A, V15, P1451, DOI 10.1089/ten.tea.2008.0203
   Kim HW, 2007, TISSUE ENG, V13, P965, DOI 10.1089/ten.2006.0299
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Ky AJ, 2008, DIS COLON RECTUM, V51, P838, DOI 10.1007/s10350-007-9191-2
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Lilli C, 2002, INT J CANCER, V98, P824, DOI 10.1002/ijc.10306
   Lomis NNT, 2000, J AM COLL SURGEONS, V190, P588, DOI 10.1016/S1072-7515(00)00237-4
   MARKOWICZ M, 2005, TOPICS TISSUE ENG, V2, P1
   MCPHERSON IM, 1986, J BIOMED MATER RES, V20, P93
   MIYATA T, 1986, Patent No. 4565580
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murray MM, 2001, BIOMATERIALS, V22, P2393
   O'Connor L, 2006, DIS COLON RECTUM, V49, P1569, DOI 10.1007/s10350-006-0695-y
   OHAN M, 2000, ORTH RES SOC ANN M T, V26
   Olmo N, 1996, J BIOMED MATER RES, V30, P77
   PARK K, 1993, BIODEGRADABLE HYDROG
   Poulose BK, 2005, J SURG RES, V123, P262, DOI 10.1016/j.jss.2004.08.011
   Ribatti D, 1996, INT J DEV BIOL, V40, P1189
   Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Schultz DJ, 2002, J AM COLL SURGEONS, V194, P541, DOI 10.1016/S1072-7515(02)01119-5
   Shaker M A, 1995, Egypt Dent J, V41, P1237
   Shelton AA, 2006, DIS COLON RECTUM, V49, P1454, DOI 10.1007/s10350-006-0619-x
   Takei T, 2007, J BIOSCI BIOENG, V104, P435, DOI 10.1263/jbb.104.435
   Tao H, 2006, J THORAC CARDIOV SUR, V132, P99, DOI 10.1016/j.jtcvs.2006.02.021
   TOMIMATSU Y, 1971, J COLLOID INTERF SCI, V36, P51, DOI 10.1016/0021-9797(71)90239-6
   van Koperen PJ, 2007, DIS COLON RECTUM, V50, P2168, DOI 10.1007/s10350-007-0298-2
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WILTING J, 1991, ANAT EMBRYOL, V183, P259
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Yao C, 2004, CELLS TISSUES ORGANS, V178, P189, DOI 10.1159/000083730
   Yao C, 2008, BIOMATERIALS, V29, P66, DOI 10.1016/j.biomaterials.2007.08.049
   Zorlutuna P, 2008, J TISSUE ENG REGEN M, V2, P373, DOI 10.1002/term.99
   ZUHDI N, 1974, ANN THORAC SURG, V17, P479, DOI 10.1016/S0003-4975(10)65683-4
NR 67
TC 21
Z9 25
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2010
VL 6
IS 3
BP 1158
EP 1166
DI 10.1016/j.actbio.2009.08.044
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 560ZD
UT WOS:000274943500051
PM 19733702
DA 2018-10-20
ER

PT J
AU Hong, D
   Chen, HX
   Ge, RS
   Li, JC
AF Hong, Dun
   Chen, Hai-Xiao
   Ge, Renshan
   Li, Ji-Cheng
TI Genetically Engineered Mesenchymal Stem Cells: The Ongoing Research for
   Bone Tissue Engineering
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE gene therapy; mesenchymal stem cells; bone; tissue engineering;
   osteoblast differentiation
ID MARROW STROMAL CELLS; MEDIATED GENE-THERAPY; GROWTH-FACTOR-I; OSTEOBLAST
   DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; TRANSCRIPTION FACTOR;
   SPINAL-FUSION; OSTEOGENIC DIFFERENTIATION; CRANIAL DEFECTS; HUMAN BMP4
AB Bone grafting is crucial in the surgical treatment of bone defects and nonunion fractures. Autogenous bone, allogenous bone, and biomaterial scaffold are three main sources of bone grafts. The biomaterial scaffold, both natural and synthetic, is widely accessible but weak in osteogenic potential. One approach to solve this problem is cell-based bone tissue engineering (BTE), established by growing living osteogenic cells on scaffold in vitro to build up its osteoinducitive capability. Mesenchymal stem cell (MSC) is suitable for use in cell-based BTE, but it remains a considerable challenge to induce MSCs to form solely bone and while preventing MSCs from differentiating into fats, muscles, and possibly neural elements in vivo. Recently, there is a drastic rise in use of genetically engineered MSCs, which can secrete growth factors or alter the transcription level, leading to osteoblast lineage commitment, bone formation, fracture repair, and spinal fusion. In this article, we reviewed the literatures regarding applications of genetically engineered MSCs in BTE. We addressed the currently applicable genes and candidate genes for MSCs modification, transduction efficiency and safety issues of the transfect vectors, and administration routes, and we briefly described in vivo tracking and potential clinical application of the genetically modified MSCs in BTE. Anat Rec, 293:531-537, 2010. (C) 2009 Wiley-Liss, Inc.
C1 [Hong, Dun; Chen, Hai-Xiao] Taizhou Hosp, Wenzhou Med Coll, Dept Orthoped, Linhai 317000, Peoples R China.
   [Hong, Dun; Li, Ji-Cheng] Zhejiang Univ, Coll Med, Inst Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China.
   [Hong, Dun; Ge, Renshan] Populat Council, New York, NY 10021 USA.
RP Chen, HX (reprint author), Taizhou Hosp, Wenzhou Med Coll, Dept Orthoped, Linhai 317000, Peoples R China.
EM hxchen-1@163.net; lijichen@zju.edu.cn
FU National Foundation for Fostering Talents of Basic Science (NFFTBS) of
   China [J0730856]; Science and Technology Department of Zhejiang
   Province, China [2007C33025]; Medicine and Health Research Fund of
   Zhejiang Province, China [2009B166]
FX Grant sponsor: National Foundation for Fostering Talents of Basic
   Science (NFFTBS) of China; Contract grant number: J0730856; Grant
   sponsor: Science and Technology Department of Zhejiang Province, China;
   Contract grant number: 2007C33025; Grant sponsor: Medicine and Health
   Research Fund of Zhejiang Province, China; Contract grant number:
   2009B166.
CR Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006
   Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841
   Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102
   Anson D.S., 2004, GENET VACCINES THER, V2, P9, DOI DOI 10.1186/1479-0556-2-9
   Bajada S, 2007, J BONE JOINT SURG BR, V89B, P1382, DOI 10.1302/0301-620X.89B10.19103
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bauer G, 2008, MOL THER, V16, P1308, DOI 10.1038/mt.2008.93
   Bi WM, 1999, NAT GENET, V22, P85
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Blum JS, 2003, HUM GENE THER, V14, P1689, DOI 10.1089/104303403322611719
   Boden SD, 1999, CLIN ORTHOP RELAT R, pS84
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Bulte JWM, 2002, J CEREBR BLOOD F MET, V22, P899, DOI 10.1097/00004647-200208000-00001
   Buxton P, 2001, J BONE JOINT SURG AM, V83A, pS23
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Byers BA, 2004, TISSUE ENG, V10, P1623, DOI 10.1089/ten.2004.10.1623
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Chhabra Anikar, 2005, J Orthop Trauma, V19, P629, DOI 10.1097/01.bot.0000177108.38461.9c
   Clarke SA, 2007, BONE, V40, P939, DOI 10.1016/j.bone.2006.11.004
   Conover CA, 2000, GROWTH HORM IGF RES, V10, pS107
   Conover CA, 2008, AM J PHYSIOL-ENDOC M, V294, pE10, DOI 10.1152/ajpendo.00648.2007
   Dayoub H, 2003, TISSUE ENG, V9, P347, DOI 10.1089/107632703764664819
   DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125
   Dumont RJ, 2002, NEUROSURGERY, V51, P1239, DOI 10.1227/01.NEU.0000031573.07141.02
   Egermann M, 2006, HUM GENE THER, V17, P507, DOI 10.1089/hum.2006.17.507
   Feeley BT, 2006, J ORTHOP RES, V24, P1709, DOI 10.1002/jor.20229
   Fisher MC, 2005, BONE, V37, P741, DOI 10.1016/j.bone.2005.07.024
   Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026
   Gazit D, 1999, J GENE MED, V1, P121, DOI 10.1002/(SICI)1521-2254(199903/04)1:2<121::AID-JGM26>3.0.CO;2-J
   Gugala Z, 2003, GENE THER, V10, P1289, DOI 10.1038/sj.gt.3302006
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Hasharoni A, 2005, J NEUROSURG-SPINE, V3, P47, DOI 10.3171/spi.2005.3.1.0047
   Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191
   Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955
   Hou Z, 1999, P NATL ACAD SCI USA, V96, P7294, DOI 10.1073/pnas.96.13.7294
   Hu J, 2007, J ORTHOP RES, V25, P241, DOI 10.1002/jor.20288
   Hurwitz DR, 1997, HUM GENE THER, V8, P137, DOI 10.1089/hum.1997.8.2-137
   Kumar S, 2004, HUM GENE THER, V15, P1197, DOI 10.1089/hum.2004.15.1197
   Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103
   Li JZ, 2003, J GENE MED, V5, P748, DOI 10.1002/jgm.412
   Li ZX, 2002, SCIENCE, V296, P497, DOI 10.1126/science.1068893
   Lieberman JR, 1998, J ORTHOP RES, V16, P330, DOI 10.1002/jor.1100160309
   Lieberman JR, 1999, J BONE JOINT SURG AM, V81A, P905, DOI 10.2106/00004623-199907000-00002
   Lou JR, 1999, J ORTHOPAED RES, V17, P43, DOI 10.1002/jor.1100170108
   Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Meiering CD, 2001, CLIN MICROBIOL REV, V14, P165, DOI 10.1128/CMR.14.1.165-176.2001
   Meijer G.J., 2007, PLOS MED, V4, pe9, DOI DOI 10.1371/JOURNAL.PMED.0040009
   Mergia A, 2003, CURR TOP MICROBIOL, V277, P131
   MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nilsson SK, 1999, J EXP MED, V189, P729, DOI 10.1084/jem.189.4.729
   Nixon AJ, 2007, ANN NY ACAD SCI, V1117, P310, DOI 10.1196/annals.1402.065
   Niyibizi C, 2004, MOL THER, V9, P955, DOI 10.1016/j.ymthe.2004.02.022
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Olmsted-Davis EA, 2002, HUM GENE THER, V13, P1337, DOI 10.1089/104303402760128568
   Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205
   Park J, 2003, GENE THER, V10, P1089, DOI 10.1038/sj.gt.3301960
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Peng HR, 2001, MOL THER, V4, P95, DOI 10.1006/mthe.2001.0423
   Ploemacher RE, 1999, LEUKEMIA, V13, P428, DOI 10.1038/sj.leu.2401363
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Riew KD, 2003, J BONE JOINT SURG AM, V85A, P866, DOI 10.2106/00004623-200305000-00014
   Rose T, 2003, LANGENBECK ARCH SURG, V388, P347, DOI 10.1007/s00423-003-0401-7
   Rosen CJ, 2000, CLIN LAB MED, V20, P591
   Rundle CH, 2003, BONE, V32, P591, DOI 10.1016/S8756-3282(03)00096-6
   Schwarzwaelder K, 2007, J CLIN INVEST, V117, P2241, DOI 10.1172/JCI31661
   Selim AA, 2003, CRIT REV EUKAR GENE, V13, P265
   Shang QX, 2001, J CRANIOFAC SURG, V12, P586, DOI 10.1097/00001665-200111000-00017
   Sugiyama O, 2003, J ORTHOPAED RES, V21, P630, DOI 10.1016/S0736-0266(02)00260-7
   Suzuki K, 2000, CELL TRANSPLANT, V9, P319, DOI 10.1177/096368970000900303
   Terrovitis JV, 2006, TISSUE ENG, V12, P2765, DOI 10.1089/ten.2006.12.2765
   THALLER SR, 1993, ANN PLAS SURG, V31, P429, DOI 10.1097/00000637-199311000-00007
   Tsuda H, 2003, MOL THER, V7, P354, DOI 10.1016/S1525-0016(02)00062-X
   Tu Q, 2007, TISSUE ENG, V13, P2431, DOI 10.1089/ten.2006.0406
   Turgeman G, 2001, J GENE MED, V3, P240
   Varady P, 2001, HUM GENE THER, V12, P697, DOI 10.1089/104303401300057423
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
   Zachos TA, 2006, J ORTHOP RES, V24, P1279, DOI 10.1002/jor.20068
   Zhang XS, 2004, J GENE MED, V6, P4, DOI 10.1002/jgm.477
   Zhao G, 2000, ENDOCRINOLOGY, V141, P2674, DOI 10.1210/en.141.7.2674
   Zhao Z, 2007, J DENT RES, V86, P1207, DOI 10.1177/154405910708601213
   Zhao ZR, 2005, MOL THER, V12, P247, DOI 10.1016/j.ymthe.2005.03.009
   Zheng H, 2004, CALCIFIED TISSUE INT, V74, P194, DOI 10.1007/s00223-003-0004-x
   Zofkova I, 2003, PHYSIOL RES, V52, P657
NR 89
TC 7
Z9 10
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1932-8486
J9 ANAT REC
JI Anat. Rec.
PD MAR
PY 2010
VL 293
IS 3
BP 531
EP 537
DI 10.1002/ar.21045
PG 7
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 566QM
UT WOS:000275387900019
PM 20027644
OA Bronze
DA 2018-10-20
ER

PT J
AU Peramo, A
   Marcelo, CL
   Goldstein, SA
   Martin, DC
AF Peramo, Antonio
   Marcelo, Cynthia L.
   Goldstein, Steven A.
   Martin, David C.
TI Improved Preservation of the Tissue Surrounding Percutaneous Devices by
   Hyaluronic Acid and Dermatan Sulfate in a Human Skin Explant Model
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Organotypic culture; Wound healing; Skin biomaterial; Implant interface;
   External fixation
ID GROWTH-FACTOR; ORGANOTYPIC CULTURES; HUMAN EPIDERMIS; ORGAN-CULTURE;
   CHONDROITIN/DERMATAN SULFATES; SERUM HYALURONATE; PROLIFERATION;
   DIFFERENTIATION; EXPRESSION; WOUNDS
AB Cellular apoptosis and proliferation was analyzed in an in vitro culture system of organotypic human skin explants in the presence or absence of external fixator pins. The effect on the tissues of a mixture of hyaluronic acid and dermatan sulfate (HA + DS) delivered at the skin-pin interface was also studied. After 2 weeks in culture, skin specimens interfaced with fixator pins showed increased keratinocyte apoptosis and proliferation compared to specimens without fixator pins. Simultaneously, a relative reduction of apoptosis and proliferation was observed in specimens treated with the HA + DS mixture, regardless of fixation pin presence. In addition, the HA + DS mixture appeared to help in the preservation of the epidermal basal membrane. It is concluded that in this in vitro model, fixator pins induce keratinocyte apoptosis and hyperproliferation, which are reduced in the presence of the HA + DS mixture. These methods may be useful for a better maintenance of the soft tissue surrounding percutaneous devices in vivo.
C1 [Peramo, Antonio; Martin, David C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Peramo, Antonio; Marcelo, Cynthia L.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
   [Goldstein, Steven A.; Martin, David C.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Goldstein, Steven A.] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA.
RP Peramo, A (reprint author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
EM aperamo@umich.edu
RI Martin, David/B-1838-2008
OI Martin, David/0000-0003-1195-3838
FU University of Michigan College of Engineering GAP
FX We thank Harald Eberhart, College of Engineering, University of
   Michigan, for help with the glass lid design. We thank Marta Dzaman,
   Morphology Core, University of Michigan for advice on specimen
   sectioning and staining. This report is presented as part of research
   efforts within an Army Research Office Multidisciplinary University
   Research Initiative award on Bio-Integrating Structural and Neural
   Prosthetic Materials and we gratefully acknowledge the funding provided.
   Support for this work was also provided by the University of Michigan
   College of Engineering GAP Funding program.
CR Agren UM, 1997, J INVEST DERMATOL, V109, P219, DOI 10.1111/1523-1747.ep12319412
   Amagai M, 1996, J INVEST DERMATOL, V106, P351, DOI 10.1111/1523-1747.ep12343081
   Balazs EA, 1998, WENN GR INT, V72, P325
   Bedoni M, 2007, J DERMATOL SCI, V46, P139, DOI 10.1016/j.jdermsci.2006.12.005
   BLANTON RA, 1992, CELL GROWTH DIFFER, V3, P791
   Breitkreutz D, 1997, DIFFERENTIATION, V61, P195, DOI 10.1046/j.1432-0436.1997.6130195.x
   BUNTROCK P, 1982, EXP PATHOL-JENA, V21, P46, DOI 10.1016/S0232-1513(82)80051-0
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   Campo GM, 2008, J APPL TOXICOL, V28, P509, DOI 10.1002/jat.1302
   Carruthers Jean, 2006, J Drugs Dermatol, V5, P959
   Dechert TA, 2006, WOUND REPAIR REGEN, V14, P252, DOI 10.1111/j.1743-6109.2006.00119.x
   DUNPHY JE, 1955, NEW ENGL J MED, V253, P847, DOI 10.1056/NEJM195511172532002
   El Ghalbzouri A, 2005, J INVEST DERMATOL, V124, P79, DOI 10.1111/j.0022-202X.2004.23549.x
   Elkayam O, 2000, CLIN RHEUMATOL, V19, P455, DOI 10.1007/s100670070005
   ENGSTROMLAURENT A, 1985, ANN RHEUM DIS, V44, P614, DOI 10.1136/ard.44.9.614
   Freitas JP, 1996, DERMATOLOGY, V192, P46, DOI 10.1159/000246314
   GALLO RL, 1996, MOL CELLULAR BIOL WO, pCH15
   Gawronska-Kozak B, 2006, WOUND REPAIR REGEN, V14, P265, DOI 10.1111/j.1743-6109.2006.00121.x
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   HEBDA PA, 1990, J INVEST DERMATOL, V95, P626, DOI 10.1111/1523-1747.ep12513528
   JIA C, 1995, WOUND REPAIR REGEN, V3, P299
   Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   Koshiishi I, 1999, ANAL BIOCHEM, V267, P222, DOI 10.1006/abio.1998.3010
   Kubo M, 1999, CLIN EXP DERMATOL, V24, P275
   LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003
   Lundgren D, 1989, J Invest Surg, V2, P17, DOI 10.3109/08941938909016501
   LUNDIN A, 1985, BRIT J DERMATOL, V112, P663, DOI 10.1111/j.1365-2133.1985.tb02334.x
   LUNDIN A, 1987, BRIT J DERMATOL, V116, P335, DOI 10.1111/j.1365-2133.1987.tb05847.x
   Maas-Szabowski N, 2000, J INVEST DERMATOL, V114, P1075, DOI 10.1046/j.1523-1747.2000.00987.x
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   MARTIKAINEN AL, 1992, J INVEST DERMATOL, V99, P623, DOI 10.1111/1523-1747.ep12668025
   MCGEE GS, 1988, J SURG RES, V45, P145, DOI 10.1016/0022-4804(88)90034-0
   McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054
   Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x
   Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031
   Passos CO, 2003, J EUR ACAD DERMATOL, V17, P14, DOI 10.1046/j.1468-3083.2003.00576.x
   Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   PENNEYS NS, 1970, ARCH DERMATOL, V101, P323, DOI 10.1001/archderm.101.3.323
   Peramo A, 2009, ANN BIOMED ENG, V37, P401, DOI 10.1007/s10439-008-9614-9
   Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P1897, DOI 10.1016/j.bios.2004.08.016
   RESAU JH, 1991, CYTOTECHNOLOGY, V7, P137, DOI 10.1007/BF00365924
   SAVAGE CR, 1973, EXP EYE RES, V15, P361, DOI 10.1016/0014-4835(73)90151-6
   Shafritz T. Alex, 1994, Wound Repair and Regeneration, V2, P270, DOI 10.1046/j.1524-475X.1994.20407.x
   Sivan V, 2002, INT J RADIAT ONCOL, V53, P385, DOI 10.1016/S0360-3016(01)02732-8
   Sondergaard K, 1997, BRIT J DERMATOL, V136, P47, DOI 10.1046/j.1365-2133.1997.d01-1141.x
   Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112
   STOSCHECK CM, 1992, J INVEST DERMATOL, V99, P645, DOI 10.1111/1523-1747.ep12668143
   Svensjo T, 2000, PLAST RECONSTR SURG, V106, P602, DOI 10.1097/00006534-200009030-00012
   Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200
   Trautmann A, 2001, J INVEST DERMATOL, V117, P927, DOI 10.1046/j.0022-202x.2001.01474.x
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   VARANI J, 1993, AM J PATHOL, V142, P189
   Voinchet V, 2006, AM J CLIN DERMATOL, V7, P353, DOI 10.2165/00128071-200607060-00003
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   WANG C, 1992, HISTOCHEMISTRY, V98, P105, DOI 10.1007/BF00717001
   Wang TW, 2006, ARTIF ORGANS, V30, P141, DOI 10.1111/j.1525-1594.2006.00200.x
   Welss T, 2004, TOXICOL IN VITRO, V18, P231, DOI 10.1016/j.tiv.2003.09.009
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   Xu W, 2006, P I MECH ENG H, V220, P661, DOI 10.1243/09544119JEIM84
NR 61
TC 6
Z9 6
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2010
VL 38
IS 3
BP 1098
EP 1110
DI 10.1007/s10439-009-9872-1
PG 13
WC Engineering, Biomedical
SC Engineering
GA 571JA
UT WOS:000275746900047
PM 20020211
DA 2018-10-20
ER

PT J
AU Ehrenfest, DMD
   Doglioli, P
   de Peppo, GM
   Del Corso, M
   Charrier, JB
AF Ehrenfest, David M. Dohan
   Doglioli, Pierre
   de Peppo, Giuseppe M.
   Del Corso, Marco
   Charrier, Jean-Baptiste
TI Choukroun's platelet-rich fibrin (PRF) stimulates in vitro proliferation
   and differentiation of human oral bone mesenchymal stem cell in a
   dose-dependent way
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE Coculture; Growth factors; Leukocyte; Platelet concentrate; Mesenchymal
   stem cell; Platelet-rich fibrin (PRF); Platelet-rich plasma (PRP)
ID TISSUE-ENGINEERED BONE; SIMULTANEOUS IMPLANT PLACEMENT;
   CALCIUM-PHOSPHATE CERAMICS; CLINICAL CASE-REPORTS; MARROW STROMAL CELLS;
   GROWTH-FACTORS; DISTRACTION OSTEOGENESIS; ANTIMICROBIAL ACTIVITY;
   GRAFTING MATERIAL; PRIMARY CULTURES
AB Background: Choukroun's platelet-rich fibrin (PRF) is an autologous leukocyte- and platelet-rich fibrin biomaterial. The purpose of this study was to analyse the in vitro effects of PRF on human bone mesenchymal stem cells (BMSC), harvested in the oral cavity after preimplant endosteal stimulation.
   Materials and methods: BMSCs from primary cultures were cultivated with or without a PRF membrane originating from the same donor as for the cells, in proliferation or osteoblastic differentiation conditions. After 7 days, the PRF membranes were removed. A series of cultures were performed using 2 PRF membranes, in order to measure the dose-dependent effect. Cell counts, cytotoxicity tests, alkaline phosphatase (ALP) activity quantification, Von Kossa staining and mineralisation nodules counts were performed at 3, 7, 14,21 and 28 days. A last independent series was carried on up to 14 days, for a morphological scanning electron microscope (SEM) observation.
   Results: PRF generated a significant stimulation of the BMSc proliferation and differentiation throughout the experimental period. This effect was dose-dependent during the first weeks in normal conditions, and during the whole experimentation in differentiation conditions. The cultures without PRF in differentiation conditions did not rise above the degree of differentiation of the cultures in normal conditions with 1 or 2 PRF up to the 14th and 28th day, respectively. The SEM culture analysis at day 14 allowed to show the mineralisation nodules which were more numerous and more structured in the groups with PRF compared to the control groups.
   Discussion and conclusions: This double contradictory proliferation/differentiation resultmaybe due to the numerous components of PRF, particularly the presence of leukocytes: any culture with PRF is in fact a coculture with leukocytes. It could be the source of differential geographic regulation processes within the culture. The combination of oral BMSC and PRF might offer many potential clinical and biotechnological applications, and deserves new studies. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Ehrenfest, David M. Dohan; de Peppo, Giuseppe M.] Gothenburg Univ, Dept Biomat, Inst Clin Sci, Sahlgrenska Acad, S-41390 Gothenburg, Sweden.
   [Ehrenfest, David M. Dohan; Del Corso, Marco; Charrier, Jean-Baptiste] LoB5 Fdn Res, Paris, France.
   [Doglioli, Pierre] Jules Ferry Inst, Cell Culture Lab, Cannes, France.
   [Charrier, Jean-Baptiste] Univ Paris Sud, Dept ENT Head & Neck Surg, Bicetre Hosp, AP HP, F-94275 Le Kremlin Bicetre, France.
RP Ehrenfest, DMD (reprint author), Gothenburg Univ, Dept Biomat, Inst Clin Sci, Sahlgrenska Acad, Medicinaregatan 8B, S-41390 Gothenburg, Sweden.
EM LoB5@mac.com
RI Dohan Ehrenfest, David/C-8866-2012
OI Del Corso, Marco/0000-0002-2882-8139
FU LoBS Foundation for Research, Paris, France
FX This work was partially supported by a grant from the LoBS Foundation
   for Research, Paris, France. The authors want to thank Dr. Antoine Diss
   (Nice, France) and Dr. Marie-Pascale Hippolyte (Montpellier, France) for
   their help during the preparation of this work.
CR ARPORNMAEKLONG P, 2004, INT J ORAL MAXILLOF, V33, P460
   Braccini F, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P255
   Cenni E, 2005, J PERIODONTOL, V76, P323, DOI 10.1902/jop.2005.76.3.323
   Cerruti HF, 2007, ARTIF ORGANS, V31, P268, DOI 10.1111/j.1525-1594.2007.00374.x
   Charrier J B, 2008, Rev Laryngol Otol Rhinol (Bord), V129, P313
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J, 2001, IMPLANTODONTIE, V42, P55
   Choukroun J I, 2007, Rev Laryngol Otol Rhinol (Bord), V128, P27
   Cieslik-Bielecka A, 2007, ORAL SURG ORAL MED O, V103, P303, DOI 10.1016/j.tripleo.2006.08.034
   Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112
   Del Corso M, 2009, J PERIODONTOL, V80, P1694, DOI 10.1902/jop.2009.090253
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P305, DOI 10.1016/j.tripleo.2006.10.009
   Dohan DM, 2007, ORAL SURG ORAL MED O, V103, P587, DOI 10.1016/j.tripleo.2007.03.016
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Ehrenfest DMD, 2009, ORAL SURG ORAL MED O, V108, P341, DOI 10.1016/j.tripleo.2009.04.020
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   EHRENFEST DMD, J PERIODONT IN PRESS
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   Everts PAM, 2008, J BIOMED MATER RES A, V85A, P1135, DOI 10.1002/jbm.a.31570
   Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.2005.01203.x
   Gurevich O, 2002, TISSUE ENG, V8, P661, DOI 10.1089/107632702760240571
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Igarashi A, 2007, TISSUE ENG, V13, P2405, DOI 10.1089/ten.2006.0340
   Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837
   Ito K, 2006, CLIN ORAL IMPLAN RES, V17, P579, DOI 10.1111/j.1600-0501.2005.01246.X
   Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511
   Keceli HG, 2008, J CLIN PERIODONTOL, V35, P255, DOI 10.1111/j.1600-051X.2007.01181.x
   Kinoshita K, 2008, J CRANIOFAC SURG, V19, P80, DOI 10.1097/scs.0b013e31815c93e3
   Kitoh H, 2004, BONE, V35, P892, DOI 10.1016/j.bone.2004.06.013
   Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019
   Lucarelli E, 2005, CLIN ORTHOP RELAT R, P62, DOI 10.1097/01.blo.0000165736.87628.12
   Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5
   Maria OM, 2007, ORAL DIS, V13, P11, DOI 10.1111/j.1601-0825.2006.01324.x
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Mazor Z, 2009, J PERIODONTOL, V80, P2056, DOI 10.1902/jop.2009.090252
   Moojen DJF, 2008, J ORTHOP RES, V26, P404, DOI 10.1002/jor.20519
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Ng AMH, 2005, J ORTHOP SCI, V10, P192, DOI 10.1007/s00776-004-0884-2
   Ohya M, 2005, CLIN ORAL IMPLAN RES, V16, P622, DOI 10.1111/j.1600-0501.2005.01136.x
   Oliva A, 2005, Int J Immunopathol Pharmacol, V18, P47
   SAADOUN AP, 2007, PRACT PROCED AESTHET, V19, P81
   Simonpieri A, 2009, IMPLANT DENT, V18, P220, DOI 10.1097/ID.0b013e31819b5e3f
   Simonpieri A, 2009, IMPLANT DENT, V18, P102, DOI 10.1097/ID.0b013e318198cf00
   Soadoun A.P., 2007, PRACT PROCED AESTHET, V19, P88
   Ueda M, 2005, INT J PERIODONT REST, V25, P129
   Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867
   Yamada Y, 2004, CLIN ORAL IMPLAN RES, V15, P589, DOI 10.1111/j.1600-0501.2004.01038.x
   Yamada Y, 2004, CELL TRANSPLANT, V13, P343, DOI 10.3727/000000004783983909
   Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284
   Zhu SJ, 2006, ORAL SURG ORAL MED O, V102, P175, DOI 10.1016/j.tripleo.2005.08.034
NR 55
TC 62
Z9 63
U1 2
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
EI 1879-1506
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD MAR
PY 2010
VL 55
IS 3
BP 185
EP 194
DI 10.1016/j.archoralbio.2010.01.004
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 579LQ
UT WOS:000276372500001
PM 20176344
DA 2018-10-20
ER

PT J
AU Paez, JMG
   Jorge-Herrero, E
   Claramunt, R
   Millan, I
   Rocha, A
   Martinez, B
   Cordon, A
   Ros, A
AF Garcia Paez, Jose Maria
   Jorge-Herrero, Eduardo
   Claramunt, Rafael
   Millan, Isabel
   Rocha, Aurora
   Martinez, Belen
   Cordon, Angeles
   Ros, Antonio
TI Propagation of Tears in Pericardium From Young Bulls: Influence of the
   Suture
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Force; Tearing; Cardiac bioprostheses; Sutures; Pericardium; Young bull
ID COLLAGEN FIBER ARCHITECTURE; BIOPROSTHETIC HEART-VALVES; BOVINE
   PERICARDIUM; FAILURE; CALCIFICATION; DURABILITY
AB The tearing of the collagen fibers of biological materials utilized in implants or bioprostheses is an important, and sometimes early cause of the failure of these devices. We studied the force necessary to propagate a tear in a biomaterial, pericardium from young bulls, and the influence of the suture. An Elmendorf pendulum capable of measuring the force necessary to tear a given length of tissue was employed. We analyzed 112 trials (70%) that proved valid after achieving the homogeneity of the samples according to their thickness, thus making the results comparable. Mean forces ranging between 19.87 and 150 N were required to propagate tears measuring from 0.25 to 2.0 cm. In the samples with a 1-cm-long suture, sewn using an edge-to-edge technique, the propagation of the tear required a mean force of 15.75 N when the suture was made of nylon and 28.73 N when Prolene was utilized. When these results were compared with the mean recorded in an unsutured control series (56.76 N), the loss of resistance was significant in both sutured series (P = 0.000 and P = 0.011, respectively). Finally, the equation that relates the force (y) with the length of the tear made in unsutured tissue (x) was also obtained: y = 58.14 + 9.62x2 (R2 = 0.924). The force necessary to produce a microtear, thus estimated, can be utilized as a parameter for comparison.
C1 [Claramunt, Rafael; Cordon, Angeles; Ros, Antonio] Univ Politecn Madrid, ETS Ingenieros Ind, Dept Meccan Estructural, Madrid, Spain.
   [Millan, Isabel] Hosp Puerta Hierro Majadahonda, Serv Bioestadist, Puerto Real, Spain.
RP Paez, JMG (reprint author), Hosp Univ Puerta Hierro Majadahonda, Unidad Bioingn Biomat & Telemed, C Manuel de Falla 2, Madrid 28222, Spain.
EM jmgpaez@telefonica.net
RI Jorge Herrero, EDUARDO/F-7240-2010
FU Fondo de Investigaciones Sanitarias, Instituto Carlos III, Ministerio de
   Sanidad y Consumo, Spain [PI050048]
FX The authors wish to thank Martha Messman for her translation, and her
   infinite patience, and the director of Matadero Madrid Norte and his
   veterinary and auxiliary teams. This study was financed by grant no.
   PI050048 from the Fondo de Investigaciones Sanitarias, Instituto Carlos
   III, Ministerio de Sanidad y Consumo, Spain.
CR Butany J, 2001, J Long Term Eff Med Implants, V11, P115
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   Garcia Paez Josd Marla, 2004, Journal of Biomedical Materials Research, V69B, P125
   GARCIA PJ, 1990, J THORAC CARDIOVASC, V100, P580
   Haziza F, 1996, J HEART VALVE DIS, V5, P35
   ISHIHARA T, 1981, AM J CARDIOL, V48, P665, DOI 10.1016/0002-9149(81)90145-4
   Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004
   Paez JMG, 2004, J BIOMED MATER RES B, V69B, P125, DOI 10.1002/jbm.b.20014
   PAEZ JMG, 1994, BIOMATERIALS, V15, P172, DOI 10.1016/0142-9612(94)90063-9
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   VONFRAUNHOFER JA, 1992, BIOMATERIALS, V13, P715, DOI 10.1016/0142-9612(92)90133-9
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   WALLEY VM, 1987, J THORAC CARDIOV SUR, V93, P925
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
NR 19
TC 3
Z9 3
U1 0
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAR
PY 2010
VL 34
IS 3
BP E65
EP E71
DI 10.1111/j.1525-1594.2009.00943.x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 571CB
UT WOS:000275725900001
PM 20447036
DA 2018-10-20
ER

PT J
AU Ando, Y
   Miyamoto, H
   Noda, I
   Miyaji, F
   Shimazaki, T
   Yonekura, Y
   Miyazaki, M
   Mawatari, M
   Hotokebuchi, T
AF Ando, Yoshiki
   Miyamoto, Hiroshi
   Noda, Iwao
   Miyaji, Fumiaki
   Shimazaki, Takafumi
   Yonekura, Yutaka
   Miyazaki, Masaki
   Mawatari, Masaaki
   Hotokebuchi, Takao
TI Effect of Bacterial Media on the Evaluation of the Antibacterial
   Activity of a Biomaterial Containing Inorganic Antibacterial Reagents or
   Antibiotics
SO BIOCONTROL SCIENCE
LA English
DT Article
DE Antibacterial biomaterial; Antibacterial evaluation method; Infection;
   Bone Cement
ID SERUM SENSITIVITY; IN-VIVO; GENTAMICIN; INFECTION; RELEASE; HIP;
   IMPLANTS; SURGERY; ANKLE; FOOT
AB Several studies have been performed to assess the effectivesness of the antibacterial coating of a biomaterial to reduce surgical site infection. However, evaluations of these materials are inconsistent, and therefore it is difficult to compare their antibacterial performance. In this study, we evaluated the influence of different media such as nutrient broth (NB), Mueller-Hinton broth (MHB) and fetal bovine serum (FBS) on the antibacterial activity of AgNO3- or gentamicin-added bone cement using a modified ISO 22196 standard to devise a method to evaluate the antibacterial activity of biomaterials in vitro. The antibacterial activity results against Staphylococcus aureus and Escherichia coli were different in each medium. The antibacterial activity of AgNO3 in FBS was lower than the other media, whereas the antibacterial activity of gentamicin in FBS was higher than in the other media. It was assumed that the fluctuating antibacterial activity was influenced by serum components. The results showed that the ISO 22196 antibacterial evaluation method is suitable to evaluate antibacterial biomaterials after modifying the medium to FBS.
C1 [Ando, Yoshiki; Miyamoto, Hiroshi] Saga Univ, Dept Pathol & Microbiol, Div Microbiol, Fac Med, Saga 8498501, Japan.
   [Ando, Yoshiki; Noda, Iwao; Miyaji, Fumiaki] Japan Med Mat Corp, Res Dept, Yodogawa Ku, Osaka 5320003, Japan.
   [Shimazaki, Takafumi; Yonekura, Yutaka; Miyazaki, Masaki; Mawatari, Masaaki; Hotokebuchi, Takao] Saga Univ, Dept Orthopaed Surg, Fac Med, Saga 8498501, Japan.
RP Ando, Y (reprint author), Saga Univ, Dept Pathol & Microbiol, Div Microbiol, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.
EM andoy@jmmc.jp
CR Ammon P, 2004, J BONE JOINT SURG BR, V86B, P962, DOI 10.1302/0301-620X.86B7.14292
   Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032
   Changez M, 2004, BIOMATERIALS, V25, P139, DOI 10.1016/S0142-9612(03)00466-6
   DAVIS BD, 1987, MICROBIOL REV, V51, P341
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   Hostacka A, 1998, J BASIC MICROB, V38, P383, DOI 10.1002/(SICI)1521-4028(199811)38:5/6<383::AID-JOBM383>3.0.CO;2-J
   Illingworth BL, 1998, J HEART VALVE DIS, V7, P524
   *INT ORG STAND, 2007, INT STAND PLAST MEAS
   *JAP STAND ASS, 2000, JAP IND STAND ANT PR, P2801
   *JAP STAND ASS, 1998, JAP IND STAND ANT TE, P2902
   Keblish DJ, 2005, J BONE JOINT SURG AM, V87A, P986, DOI 10.2106/JBJS.D.02695
   Kopp BJ, 2004, ANN PHARMACOTHER, V38, P1377, DOI 10.1345/aph.1E028
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   Luthje P, 2000, ANN CHIR GYNAECOL FE, V89, P125
   NASSER S, 1992, ORTHOP CLIN N AM, V23, P265
   Noda I, 2009, J BIOMED MATER RES B, V89B, P456, DOI 10.1002/jbm.b.31235
   Ostrander RV, 2003, CLIN ORTHOP RELAT R, P246, DOI 10.1097/01.blo.0000030176.56585.d3
   Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001
   *SOC IND TECHN ANT, 2003, SHAK METH
   *SOC IND TECHN ANT, 1998, FILM COV METH
   Suzuki Shouji, 2006, Biocontrol Science, V11, P135
   TANINGHER M, 1993, ENVIRON MOL MUTAGEN, V21, P349, DOI 10.1002/em.2850210406
   TATEDA K, 1994, J ANTIMICROB CHEMOTH, V34, P931, DOI 10.1093/jac/34.6.931
   Tsukimura N, 2009, BIOMATERIALS, V30, P3378, DOI 10.1016/j.biomaterials.2009.02.043
   Weinstein MA, 2000, J SPINAL DISORD, V13, P422, DOI 10.1097/00002517-200010000-00009
   Zhou G, 2008, J BIOMED MATER RES A, V85A, P929, DOI 10.1002/jbm.a.31527
NR 26
TC 9
Z9 9
U1 1
U2 7
PU SOC ANTIBACTERIAL & ANTIFUNGAL AGENTS, JAPAN
PI OSAKA
PA NISHI-HONMACHI 1-13-38, SHIN-KOSAN BLDG, NISHI-KU, 7 FL, OSAKA,
   550-0005, JAPAN
SN 1342-4815
EI 1884-0205
J9 BIOCONTROL SCI
JI Biocontrol Sci.
PD MAR
PY 2010
VL 15
IS 1
BP 15
EP 19
DI 10.4265/bio.15.15
PG 5
WC Biology; Biotechnology & Applied Microbiology
SC Life Sciences & Biomedicine - Other Topics; Biotechnology & Applied
   Microbiology
GA 573WS
UT WOS:000275946600003
PM 20361518
OA Bronze
DA 2018-10-20
ER

PT J
AU Uchida, K
   Tamura, A
   Yajima, H
AF Uchida, Katsumi
   Tamura, Atsushi
   Yajima, Hirofumi
TI Effect of the polymer chain length of poly(N-isopropylacrylamide) on the
   temperature-responsive phase transition behavior of its conjugates with
   [60]fullerene
SO BIOINTERPHASES
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; AQUEOUS-SOLUTIONS; THERMAL RESPONSE;
   FULLERENE; WATER; COMPLEXES; CHEMISTRY; MICELLES
AB In order to develop biomedical materials with specific functionalities, thermoresponsive conjugates [poly(N-isopropylacrylamide)-C(60) (PIPAAm-C(60))] of [60] fullerene (C(60)) and PIPAAm with two different polymer chain lengths (4 and 20 kDa) were synthesized by atom transfer radical polymerization. The effects of the polymer chain length on the temperature-responsive phase transition behavior of the synthetic PIPAAm-C(60) conjugates were probed by means of various physicochemical techniques. The coexistence of unimers and molecular assemblies of PIPAAm-C(60) was observed by gel permeation chromatography and dynamic light scattering studies in two PIPAAm-C(60) aqueous solutions below their lower critical solution temperatures (LCSTs). Additionally, below their LCSTs, differences in PIPAAm chain length gave rise to changes in the composition of the unimers and molecular assemblies. In response to temperature, the absorbance of the PIPAAm-C(60) aqueous solution changed according to a two-step behavior profile. Increasing temperature during the primary stage, where a change in the absorbance of the PIPAAm-C(60) aqueous solution took place, did not change the transition temperature, regardless of the solution concentration of PIPAAm-C(60). This absorbance change was associated with the phase transition of the molecular assemblies of PIPAAm-C(60). However, at the second stage, the transition temperature shifted to a higher value with the decrease in the concentration of PIPAAm-C(60), in the same manner as free PIPAAm chains. The second change was associated with the phase transition of the unimeric PIPAAm-C(60). Differences in PIPAAm chain length gave rise to the change in the phase transition behavior of PIPAAm-C(60) aqueous solution. Therefore, the chain length of PIPAAm was found to be a predominant factor involved in the solution characteristics of PIPAAm-C(60). Consequently, the PIPAAm-C(60) is expected to be an intelligent biomaterial possessing heat-induced accumulation and bioactivities. (C) 2010 American Vacuum Society. [DOI: 10.1116/1.3319348]
C1 [Uchida, Katsumi; Tamura, Atsushi; Yajima, Hirofumi] Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1620826, Japan.
RP Yajima, H (reprint author), Tokyo Univ Sci, Dept Appl Chem, Shinjuku Ku, 12-1 Funagawara Cho, Tokyo 1620826, Japan.
EM yajima@rs.kagu.tus.ac.jp
FU Center for Photo-Science and Technology of the Tokyo University of
   Science
FX This work was supported in part by a Grant-in-Aid from the Green
   Research Center for Photo-Science and Technology of the Tokyo University
   of Science.
CR Brettreich M, 1998, TETRAHEDRON LETT, V39, P2731, DOI 10.1016/S0040-4039(98)00491-2
   Chiang LY, 1996, TETRAHEDRON, V52, P4963, DOI 10.1016/0040-4020(96)00104-4
   Chung JE, 2000, J CONTROL RELEASE, V65, P93, DOI 10.1016/S0168-3659(99)00242-4
   Dai S, 2004, LANGMUIR, V20, P8569, DOI 10.1021/la048826s
   Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434
   FRIEDMAN SH, 1993, J AM CHEM SOC, V115, P6506, DOI 10.1021/ja00068a005
   GECKELER KE, 1994, TRENDS POLYM SCI, V2, P355
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   KRUSIC PJ, 1991, SCIENCE, V254, P1183, DOI 10.1126/science.254.5035.1183
   Lessard DG, 2001, CAN J CHEM, V79, P1870, DOI 10.1139/cjc-79-12-1870
   Nakamura E, 2003, ACCOUNTS CHEM RES, V36, P807, DOI 10.1021/ar030027y
   Nakayama M, 2005, BIOMACROMOLECULES, V6, P2320, DOI 10.1021/bm050232w
   Queffelec J, 2000, MACROMOLECULES, V33, P8629, DOI 10.1021/ma000871t
   Sushko ML, 2002, POLYMER, V43, P2769, DOI 10.1016/S0032-3861(02)00074-5
   Tabata Y, 1997, JPN J CANCER RES, V88, P1108, DOI 10.1111/j.1349-7006.1997.tb00336.x
   Tamura A, 2006, CHEM LETT, V35, P282, DOI 10.1246/cl.2006.282
   TOKUYAMA H, 1993, J AM CHEM SOC, V115, P7918, DOI 10.1021/ja00070a064
   Ungurenasu C, 2000, J MED CHEM, V43, P3186, DOI 10.1021/jm991175q
   Xia Y, 2006, MACROMOLECULES, V39, P2275, DOI 10.1021/ma0519617
   Xia Y, 2005, MACROMOLECULES, V38, P5937, DOI 10.1021/ma050261z
   YAMAGO S, 1995, CHEM BIOL, V2, P385, DOI 10.1016/1074-5521(95)90219-8
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YOSHIDA R, 1994, J BIOMAT SCI-POLYM E, V6, P585, DOI 10.1163/156856294X00536
NR 23
TC 4
Z9 4
U1 4
U2 19
PU AVS
PI RESEARCH TRIANGLE PARK
PA EDITORIAL OFFICE, 100 PARK DR, STE 105, CALLER BOX 13994, RESEARCH
   TRIANGLE PARK, NC 27709 USA
SN 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD MAR
PY 2010
VL 5
IS 1
BP 17
EP 21
DI 10.1116/1.3319348
PG 5
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA 576CN
UT WOS:000276121600003
PM 20408731
OA Bronze
DA 2018-10-20
ER

PT J
AU Stachel, I
   Schwarzenbolz, U
   Henle, T
   Meyer, M
AF Stachel, Ines
   Schwarzenbolz, Uwe
   Henle, Thomas
   Meyer, Michael
TI Cross-Linking of Type I Collagen with Microbial Transglutaminase:
   Identification of Cross-Linking Sites
SO BIOMACROMOLECULES
LA English
DT Article
ID DERMAL SHEEP COLLAGEN; GELATIN; MATRICES;
   EPSILON-(GAMMA-GLUTAMYL)LYSINE; GLUTARALDEHYDE; BIOMATERIALS;
   CARBODIIMIDE; STABILITY; SUBSTRATE; FIBRILS
AB Collagen is a Popular biomaterial. To deal with its lack of thermal stability and its weak resistance to proteolytic degradation, collagen-based materials are stabilized via different cross-linking procedures. Regarding the potential toxicity of residual cross-linking agents, enzyme-mediated cross-linking would provide an alternative and nontoxic method for collagen stabilization. The results of this Study show that type I collagen is a Substrate for mTG. However, epsilon-(gamma-glutamyl)lysine cross-links are only incorporated at elevated temperatures when the protein is partially or completely denatured. A maximum number of 5.4 cross-links per collagen monomer were found for heat-denatured collagen. Labeling with the primary amine monodansylcadaverine revealed that at least half of the cross-links are located within the triple helical region of the collagen molecule. Because the triple helix is highly ordered in its native state, this finding might explain why the glutamine residues are inaccessible for mTG under nondenaturing conditions.
C1 [Stachel, Ines; Meyer, Michael] Res Inst Leather & Plast Sheeting, D-09599 Freiberg, Germany.
   [Schwarzenbolz, Uwe; Henle, Thomas] Tech Univ Dresden, Inst Food Chem, D-01069 Dresden, Germany.
EM ines.stachel@filkfreiberg.de
RI Meyer, Michael/A-6227-2016
OI Meyer, Michael/0000-0003-2934-9962
FU Ministry of Economy of the Federal Republic of Germany
FX We thank R. Sachse for her technical assistance. This work was partly
   Supported by the Ministry of Economy of the Federal Republic of Germany.
CR ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735
   BOWNESS JM, 1987, J BIOL CHEM, V262, P1022
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chen JS, 2002, J MATER SCI-MATER M, V13, P1029, DOI 10.1023/A:1020380203499
   Collighan RJ, 2004, J AM LEATHER CHEM AS, V99, P293
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   de Wolf FA, 2003, PROGR BIOTECHNOL, V23, P133
   Ding K, 2006, J AM LEATHER CHEM AS, V101, P362
   DJABOUROV M, 1988, J PHYS-PARIS, V49, P319, DOI 10.1051/jphys:01988004902031900
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   FINK ML, 1992, ANAL BIOCHEM, V201, P270
   FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505
   Fuchsbauer HL, 1996, BIOMATERIALS, V17, P1481, DOI 10.1016/0142-9612(96)89772-9
   Garcia Y, 2008, BIOMATERIALS, V29, P857, DOI 10.1016/j.biomaterials.2007.10.053
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234
   HALLORAN O, 2006, TISSUE ENG, V12
   HULMES D, 2008, SPRINGER SCI BUSINES, P15
   Jaros D, 2006, J TEXTURE STUD, V37, P113, DOI 10.1111/j.1745-4603.2006.00042.x
   JELENSKA MM, 1980, BIOCHIM BIOPHYS ACTA, V616, P167, DOI 10.1016/0005-2744(80)90135-7
   Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729
   KLEMAN JP, 1995, BIOCHEMISTRY-US, V34, P13768, DOI 10.1021/bi00042a007
   Lastowka A, 2005, J AM LEATHER CHEM AS, V100, P196
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee DS, 2002, J AGR FOOD CHEM, V50, P7412, DOI 10.1021/jf020529a
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Lew DH, 2007, J BIOMED MATER RES B, V82B, P51, DOI 10.1002/jbm.b.30704
   Lin YK, 2006, FOOD CHEM, V99, P244, DOI 10.1016/j.foodchem.2005.06.053
   Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014
   Meyer M, 2003, BIOMACROMOLECULES, V4, P1727, DOI 10.1021/bm0341531
   MILLER EJ, 1976, MOL CELL BIOCHEM, V13, P165, DOI 10.1007/BF01731779
   Miller ML, 1999, J CHROMATOGR B, V732, P65, DOI 10.1016/S0378-4347(99)00267-4
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524
   Nielsen PM, 1995, FOOD BIOTECHNOL, V9, P119, DOI 10.1080/08905439509549889
   Nimni M E, 2001, J Long Term Eff Med Implants, V11, P151
   Nomura Yoshihiro, 2001, Animal Science Journal, V72, P322
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Partschefeld Claudia, 2007, Biotechnology Journal, V2, P462, DOI 10.1002/biot.200600226
   PISANO JJ, 1969, BIOCHEMISTRY-US, V8, P871, DOI 10.1021/bi00831a016
   SAKAMOTO H, 1994, J FOOD SCI, V59, P866, DOI 10.1111/j.1365-2621.1994.tb08146.x
   Schrieber R, 2007, GELATINE HDB THEORY
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   WOODRUFF E, 1977, INT J BIOENG, V2, P1
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 48
TC 21
Z9 22
U1 2
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2010
VL 11
IS 3
BP 698
EP 705
DI 10.1021/bm901284x
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 563VY
UT WOS:000275164500022
PM 20131754
DA 2018-10-20
ER

PT J
AU Lou, PJ
   Chiu, MY
   Chou, CC
   Liao, BW
   Young, TH
AF Lou, Pei-Jen
   Chiu, Ming-Yi
   Chou, Chi-Chun
   Liao, Bor-Wu
   Young, Tai-Horng
TI The effect of poly (ethylene-co-vinyl alcohol) on senescence-associated
   alterations of human dermal fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE Human diploid fibroblasts (HDFs); Senescence; Poly (ethylene-co-vinyl
   alcohol) (EVAL); Extracellular matrix (ECM) proteins
ID REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; EVAL MEMBRANES;
   HUMAN-CELLS; CULTURE; ACCUMULATION; BEHAVIOR; P53
AB It is well known that biomaterials play an important role in the regulation of adhesion and growth of a variety of cultured cell types. However, whether biomaterials are associated with the senescence of cultured cells is not known. The present work shows that the decrease of the hydrophobic property of poly (ethylene-co-vinyl alcohol) (EVAL) from 44 mole% to 27 mole% ethylene could induce characteristic senescence-associated phenotypic changes such as larger cell shape, re-organized actin cytoskeleton, lower proliferation capacity, higher levels of senescence-associated beta-galactosidase (SA beta-gal) activity, and upregulation of the cell-cycle inhibitor p53 and its transcriptional target p21 in the cultured human diploid fibroblasts (HDFs). Furthermore, it was found that the cultured cells recovered their ability to grow when the substrate was reused every passage. It seemed that the extracellular matrix (ECM) proteins adsorbed onto the EVAL surface might have a protective role in the cellular aging process. Therefore, whether a biomaterial strongly influences cellular aging process must be considered in the selection of a biomaterial for the biomedical application. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Chiu, Ming-Yi; Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
   [Chiu, Ming-Yi; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Inst Biomed Engn, Taipei 100, Taiwan.
   [Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei 100, Taiwan.
   [Lou, Pei-Jen] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan.
   [Chou, Chi-Chun; Liao, Bor-Wu] Cardinal Tien Hosp, Dept Otolaryngol, Yung Ho Branch, Taipei 234, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 100, Taiwan.
EM thyoung@ntu.edu.tw
OI LOU, PEI-JEN/0000-0002-3383-8593
FU National Science Council of the Republic of China; Cardinal Tien
   Hospital, Yung Ho Branch
FX The authors thank National Science Council of the Republic of China and
   Cardinal Tien Hospital, Yung Ho Branch for their financial support of
   this research.
CR Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8
   BRUNK U, 1973, EXP CELL RES, V79, P1, DOI 10.1016/0014-4827(73)90484-9
   Campisi J., 2001, TRENDS CELL BIOL, V11, pS27
   CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130
   Chen XM, 2006, J GERONTOL A-BIOL, V61, P1232, DOI 10.1093/gerona/61.12.1232
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Coates SSA, 2007, J PHARMACOL EXP THER, V322, P70, DOI 10.1124/jpet.106.118018
   CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   MACIEIRACOELHO A, 1983, INT REV CYTOL, V83, P183, DOI 10.1016/S0074-7696(08)61688-5
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   MUGANDA P, 1994, J VIROL, V68, P8028
   MURANO S, 1991, MOL CELL BIOL, V11, P3905, DOI 10.1128/MCB.11.8.3905
   NAKANISHI Y, 1988, DEVELOPMENT, V104, P51
   ROBBINS E, 1970, J EXP MED, V131, P1211, DOI 10.1084/jem.131.6.1211
   RUBELJ I, 1994, EXP CELL RES, V211, P82, DOI 10.1006/excr.1994.1062
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Twardowski ZJ, 2006, SEMIN DIALYSIS, V19, P41, DOI 10.1111/j.1525-139X.2006.00118.x
   Volloch V, 2002, MATRIX BIOL, V21, P533, DOI 10.1016/S0945-053X(02)00038-0
   Young TH, 2008, BIOMATERIALS, V29, P3521, DOI 10.1016/j.biomaterials.2008.05.013
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
   Young TH, 2001, BIOMATERIALS, V22, P1771, DOI 10.1016/S0142-9612(00)00337-9
NR 26
TC 14
Z9 14
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 7
BP 1568
EP 1577
DI 10.1016/j.biomaterials.2009.11.048
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 553GM
UT WOS:000274354400010
PM 19954840
DA 2018-10-20
ER

PT J
AU Ulrich, TA
   Jain, A
   Tanner, K
   MacKay, JL
   Kumar, S
AF Ulrich, Theresa A.
   Jain, Amit
   Tanner, Kandice
   MacKay, Joanna L.
   Kumar, Sanjay
TI Probing cellular mechanobiology in three-dimensional culture with
   collagen-agarose matrices
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Collagen; ECM (extracellular matrix); Mechanical properties;
   Elasticity; Brain
ID MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; NEURITE EXTENSION;
   CROSS-LINKING; NONLINEAR ELASTICITY; HYDROGEL SCAFFOLDS; GEL STIFFNESS;
   MIGRATION; TISSUE; PROTEOLYSIS
AB The study of how cell behavior is controlled by the biophysical properties of the extracellular matrix (ECM) is limited in part by the lack of three-dimensional (M) scaffolds that combine the biofunctionality of native ECM proteins with the tunability of synthetic materials. Here, we introduce a biomaterial platform in which the biophysical properties of collagen I are progressively altered by adding agarose. We find that agarose increases the elasticity of 3D collagen ECMs over two orders of magnitude with modest effect on collagen fiber organization. Surprisingly, increasing the agarose content slows and eventually stops invasion of glioma cells in a 3D spheroid model. Electron microscopy reveals that agarose forms a dense meshwork between the collagen fibers, which we postulate slows invasion by structurally coupling and reinforcing the collagen fibers and introducing steric barriers to motility. This is supported by time lapse imaging of individual glioma cells and multicellular spheroids, which shows that addition of agarose promotes amoeboid motility and restricts cell-mediated remodeling of individual collagen fibers. Our results are consistent with a model in which agarose shifts ECM dissipation of cell-induced stresses from non-affine deformation of individual collagen fibers to bulk-affine deformation of a continuum network. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Ulrich, Theresa A.; Jain, Amit; Tanner, Kandice; MacKay, Joanna L.; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Ulrich, Theresa A.; Kumar, Sanjay] Univ Calif Berkeley, Berkeley Joint Grad Grp Bioengn, Univ Calif San Francisco, Berkeley, CA 94720 USA.
   [MacKay, Joanna L.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.
RP Kumar, S (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM skumar@berkeley.edu
FU UC Berkeley Graduate Division; National Science Foundation; National
   Defense Science and Engineering; University of California, Berkeley; UC
   Cancer Research Coordinating Committee; Arnold and Mabel Beckman Young
   Investigator Award; NSF [CMMI 0727420]; NIH Director's New Innovator
   Award [1DP2OD004213]
FX We thank Dr. G. Min at the Electron Microscopy Laboratory at UC Berkeley
   for assistance with scanning electron microscopy, J. Pollock and Dr. K.
   Healy for technical assistance with rheology and assistance with
   equipment, and J. Dabritz (Anton Paar) and D. Leong (Technical
   Instruments) for assistance with equipment and software. TAU gratefully
   acknowledges the support of the UC Berkeley Graduate Division, National
   Science Foundation, and National Defense Science and Engineering
   Graduate Fellowships. S.K. gratefully acknowledges grant support from
   the University of California, Berkeley, the UC Cancer Research
   Coordinating Committee, the Arnold and Mabel Beckman Young Investigator
   Award, the NSF (CMMI 0727420), and the NIH Director's New Innovator
   Award (1DP2OD004213). a part of the NIH Roadmap for Medical Research.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   ARNOTT S, 1974, J MOL BIOL, V90, P269, DOI 10.1016/0022-2836(74)90372-6
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Barrangou LM, 2006, FOOD HYDROCOLLOID, V20, P184, DOI 10.1016/j.foodhyd.2005.02.019
   Batorsky A, 2005, BIOTECHNOL BIOENG, V92, P492, DOI 10.1002/bit.20614
   Beadle C, 2008, MOL BIOL CELL, V19, P3357, DOI 10.1091/mbc.E08-03-0319
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699
   Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Deisboeck TS, 2001, CELL PROLIFERAT, V34, P115, DOI 10.1046/j.1365-2184.2001.00202.x
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher D, 2009, ANN BIOMED ENG, V37, P847, DOI 10.1007/s10439-009-9661-x
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   DUTTA RC, 2003, BIOTECHNOL ADV, V27, P334
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   Gordon VD, 2003, EXP CELL RES, V289, P58, DOI 10.1016/S0014-4827(03)00256-8
   GRIESS GA, 1989, BIOPOLYMERS, V28, P1475, DOI 10.1002/bip.360280811
   HAMED G, 1975, J APPL POLYM SCI, V19, P3299, DOI 10.1002/app.1975.070191215
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Inoue N, 2006, J BIOMAT SCI-POLYM E, V17, P837, DOI 10.1163/156856206777996835
   Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887
   Lin PW, 2005, J BIOMED MATER RES B, V75B, P146, DOI 10.1002/jbm.b.30276
   Lund AW, 2008, J BIOMED MATER RES B, V87B, P213, DOI 10.1002/jbm.b.31098
   Lutolf MP, 2009, INTEGR BIOL, V1, P234
   Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Paik DC, 2001, CONNECT TISSUE RES, V42, P111, DOI 10.3109/03008200109014253
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   SIEGEL RC, 1976, J BIOL CHEM, V251, P5786
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Timmins Nicholas E., 2007, V140, P141
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2
   Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 54
TC 154
Z9 158
U1 5
U2 106
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 7
BP 1875
EP 1884
DI 10.1016/j.biomaterials.2009.10.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 553GM
UT WOS:000274354400046
PM 19926126
DA 2018-10-20
ER

PT J
AU Yamazaki, CM
   Kadoya, Y
   Hozumi, K
   Okano-Kosugi, H
   Asada, S
   Kitagawa, K
   Nomizu, M
   Koide, T
AF Yamazaki, Chisato M.
   Kadoya, Yuichi
   Hozumi, Kentaro
   Okano-Kosugi, Hitomi
   Asada, Shinichi
   Kitagawa, Kouki
   Nomizu, Motoyoshi
   Koide, Takaki
TI A collagen-mimetic triple helical supramolecule that evokes
   integrin-dependent cell responses
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Cell adhesion; ECM (extracellular matrix); Integrin; Peptide
ID PEPTIDES; BINDING; ADHESION; MOTIFS; IDENTIFICATION; HYDROGELS;
   SEQUENCE; CULTURES; DOMAINS; DESIGN
AB Collagen is an abundantly distributed extracellular matrix protein in mammalian bodies that maintains structural integrity of the organs and tissues. Besides its function as a structural protein, collagen has various biological functions which regulate cell adhesion, migration and differentiation. In order to develop totally synthetic collagen-surrogates, we recently reported a basic concept for preparing collagen-like triple helical supramolecules based on the self-assembly of staggered trimeric peptides with self-complementary shapes. In this paper, we add one of the specific cellular functions of the native collagen to the collagen-mimetic supramolecule. We synthesized a self-assembling peptide unit containing the integrin-binding sequence Gly-Phe-Hyp-Gly-Glu-Arg. The supramolecule carrying the sequence exhibited significant binding activity to human dermal fibroblasts. The supramolecular structure was found to be essential for function in in vitro cell culture. Cell adhesion was shown to be comparable to that of native collagen, and was further demonstrated to be mediated solely by integrin alpha 2 beta 1. Well-grown focal contacts and stress fibers were observed in cells spread on the supramolecular collagen-mimetic. The results demonstrate the potential of pepticle-based artificial collagen as a biomaterial for regulating specific cellular function and fate. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Yamazaki, Chisato M.; Koide, Takaki] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan.
   [Kadoya, Yuichi] Kitasato Univ, Sch Allied Hlth Sci, Dept Anat, Sagamihara, Kanagawa 2288555, Japan.
   [Hozumi, Kentaro; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan.
   [Okano-Kosugi, Hitomi; Asada, Shinichi; Kitagawa, Kouki] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Niigata 9568603, Japan.
RP Koide, T (reprint author), Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan.
EM koi@waseda.jp
FU Japan Society for the Promotion of Science [19390032]; Waseda University
   [2009 A-048]; Cosmetology Research Foundation; JSPS Research Fellowships
   [20-4506]; MEXT Japan
FX This work is supported by a Grant-in Aid for Scientific Research (B) No.
   19390032 from Japan Society for the Promotion of Science, a Waseda
   University Grant for Special Research Projects (2009 A-048), and
   Cosmetology Research Foundation. C.M.Y. thanks the JSPS Research
   Fellowships for Young Scientists No. 20-4506, and Global COE Program
   from MEXT Japan.
CR Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965
   BRODSKY B, 1992, BIOPOLYMERS, V32, P447, DOI 10.1002/bip.360320423
   Cejas MA, 2008, P NATL ACAD SCI USA, V105, P8513, DOI 10.1073/pnas.0800291105
   Cejas MA, 2007, J AM CHEM SOC, V129, P2202, DOI 10.1021/ja066986f
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Giudici C, 2008, J BIOL CHEM, V283, P19551, DOI 10.1074/jbc.M710001200
   HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143
   Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472
   Kar K, 2009, BIOCHEMISTRY-US, V48, P7959, DOI 10.1021/bi900496m
   Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005
   Kojima C, 2009, J AM CHEM SOC, V131, P6052, DOI 10.1021/ja809639c
   Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005
   Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007
   Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965
   LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Nagarkar RP, 2008, J AM CHEM SOC, V130, P4466, DOI 10.1021/ja710295t
   Okuyama K, 2008, CONNECT TISSUE RES, V49, P299, DOI 10.1080/03008200802325110
   Ottl J, 1999, J AM CHEM SOC, V121, P653, DOI 10.1021/ja983456d
   Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   Pires MM, 2009, J AM CHEM SOC, V131, P2706, DOI 10.1021/ja8088845
   Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200
   Rele S, 2007, J AM CHEM SOC, V129, P14780, DOI 10.1021/ja0758990
   Sacca B, 2002, J PEPT SCI, V8, P205, DOI 10.1002/psc.386
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275
   Yamazaki CM, 2008, BIOPOLYMERS, V90, P816, DOI 10.1002/bip.21100
NR 40
TC 23
Z9 24
U1 4
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 7
BP 1925
EP 1934
DI 10.1016/j.biomaterials.2009.10.014
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 553GM
UT WOS:000274354400052
PM 19853297
DA 2018-10-20
ER

PT J
AU Lu, XY
   Lu, HQ
   Zhao, LF
   Yang, YM
   Lu, ZH
AF Lue, Xiaoying
   Lu, Huiqin
   Zhao, Lifeng
   Yang, Yamin
   Lu, Zuhong
TI Genome-wide pathways analysis of nickel ion-induced differential genes
   expression in fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE Gene expression microarray; Real-time PCR; Pathway analysis; Molecular
   mechanism; Nickel ion
ID CELL PROLIFERATION; PROTEIN; MECHANISMS; RNA; COMPONENTS; DISTINCT;
   CDC42; MODEL
AB To reveal molecular mechanisms of the interaction between Ni(2+) and cells, cDNA microarray technology and GenMAPP analysis were utilized to investigate changes of gene expression profile and identify significant biological pathways in mouse fibroblast cells (L-929) treated by 100 mu m Ni(2+), for 12, 24, 48 and 72 h, respectively. The microarray data was validated by real-time PCR. Methylthiazolte-trazolium (MTT) analysis and flow cytometry experiment were used to assess the cellular response of L-929 cells to Ni(2+). It was found that six main biological pathways were affected by Ni(2+), with 118 differentially expressed genes involved. Further analysis illuminated that the exposure of cells to Ni(2+) may evoke series of cellular responses to hypoxia by regulating hypoxia-inducible gene expression and cause irreversible DNA damage. Cell cycle pathway analysis results showed DNA replication in S phase could be inhibited by Ni(2+), which was consistent with the data gained from flow cytometry experiment. Compared to previous researches based on conventional molecular biology experiments, the present work has not only indirectly validated the findings of other groups but also obtained several discoveries related to cell-Ni(2+) interaction, such as inhibition of electron transport chain and accumulation of extracellular matrix (ECM) collagens. The routine of the present study not only can analyze gene expression profile but also may provide a more convenient and efficient approach to explain molecular mechanisms of cell-biomaterial interaction. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Lue, Xiaoying; Lu, Huiqin; Zhao, Lifeng; Yang, Yamin; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RP Lu, XY (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
EM luxy@seu.edu.cn
RI Yang, Yamin/B-1009-2015; Lu, Zuhong/A-5448-2013
FU National Natural Science Foundation of China [30470478, 30770583]; 973
   Project [2009CB930000]; Province Natural Science Foundation of Jiangsu
   Province of China [BK2007109]
FX This paper was supported by the National Natural Science Foundation of
   China (No. 30470478, 30770583), 973 Project (No. 2009CB930000) and the
   Province Natural Science Foundation of Jiangsu Province of China (No.
   BK2007109).
CR Bal W, 1999, ARCH BIOCHEM BIOPHYS, V364, P161, DOI 10.1006/abbi.1999.1137
   Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.127.2.398
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Chang M, 2009, CELL SIGNAL, V21, P1361, DOI 10.1016/j.cellsig.2009.04.003
   Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011
   DAHLQUIST KD, 2004, CURR PROTOC BIOINFOR, pCH7
   Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200
   Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180
   Feng Z, 2007, BRAIN RES, V1177, P103, DOI 10.1016/j.brainres.2007.07.047
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Hlobilkova Alice, 2003, Biomedical Papers (Olomouc), V147, P19
   Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200
   Jang SW, 2008, CANCER RES, V68, P4559, DOI 10.1158/0008-5472.CAN-08-0021
   Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x
   Kaps C, 2006, BIOMATERIALS, V27, P3617, DOI 10.1016/j.biomaterials.2006.02.017
   Karimi Shirin, 2008, Arch Iran Med, V11, P532
   Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021
   Lamberti M, 2004, TOXICOL APPL PHARM, V195, P321, DOI 10.1016/j.taap.2003.09.022
   Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001
   Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200
   Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   MAEHLE L, 1992, CANCER RES, V52, P218
   Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Olson N Eric, 2006, NeuroRx, V3, P373
   Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201
   Pula G, 2008, PLATELETS, V19, P199, DOI 10.1080/09537100701777303
   Saed GM, 2002, FERTIL STERIL, V78, P144, DOI 10.1016/S0015-0282(02)03146-1
   Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217
   Sartini BL, 2008, BIOL REPROD, V78, P472, DOI 10.1095/biolreprod.107.064774
   Sun XJ, 2006, J PSYCHIATR NEUROSCI, V31, P189
   Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712
   Venema J, 1995, YEAST, V11, P1629, DOI 10.1002/yea.320111607
   Villas B H, 1998, Cell Vis, V5, P56
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhou DJ, 1998, CANCER RES, V58, P2182
NR 38
TC 29
Z9 31
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 8
BP 1965
EP 1973
DI 10.1016/j.biomaterials.2009.12.044
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563WR
UT WOS:000275167300001
PM 20053437
DA 2018-10-20
ER

PT J
AU Sjollema, J
   Sharma, PK
   Dijkstra, RJB
   van Dam, GM
   van der Mei, HC
   Engelsman, AF
   Busscher, HJ
AF Sjollema, Jelmer
   Sharma, Prashant K.
   Dijkstra, Rene J. B.
   van Dam, Gooitzen M.
   van der Mei, Henny C.
   Engelsman, Anton F.
   Busscher, Henk J.
TI The potential for bio-optical imaging of biomaterial-associated
   infection in vivo
SO BIOMATERIALS
LA English
DT Review
DE Biofilm; Infection; Cell viability; Fluorescence; Bioluminescence
ID VISUALIZING GENE-EXPRESSION; SMALL-COLONY VARIANTS;
   STAPHYLOCOCCUS-EPIDERMIDIS; BIOLUMINESCENCE TOMOGRAPHY; BACTERIAL
   DETACHMENT; OPTICAL-PROPERTIES; BIOFILM INFECTION; MOUSE MODEL;
   FLUORESCENCE; TISSUE
AB This review presents the current state of Bioluminescence and Fluorescent Imaging technologies (BLI and FLI) as applied to Biomaterial-Associated Infections (BAI). BLI offers the opportunity to observe the in vivo course of BAI in small animals without the need to sacrifice animals at different time points after the onset of infection. BLI is highly dependent on the bacterial cell metabolism which makes BLI a strong reporter of viable bacterial presence. Fluorescent sources are generally more stable than bioluminescent ones and specifically targeted, which renders the combination of BLI and FLI a promising tool for imaging BAI. The sensitivity and spatial resolution of both imaging tools are, however, dependent on the imaging system used and the tissue characteristics, which makes the interpretation of images, in terms of the location and shape of the illuminating source, difficult. Tomographic reconstruction of the luminescent source is possible in the most modern instruments, enabling exact localization of a colonized implant material, spreading of infecting organisms in surrounding tissue and immunological tissue reactions. BLI studies on BAI have successfully distinguished between different biomaterials with respect to the development and clearance of BAI in vivo, simultaneously reducing animal use and experimental variation. It is anticipated that bio-optical imaging will become an indispensable technology for the in vivo evaluation of antimicrobial coatings. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Sjollema, Jelmer; Sharma, Prashant K.; Dijkstra, Rene J. B.; van der Mei, Henny C.; Engelsman, Anton F.; Busscher, Henk J.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Sjollema, Jelmer; Sharma, Prashant K.; Dijkstra, Rene J. B.; van der Mei, Henny C.; Engelsman, Anton F.; Busscher, Henk J.] Univ Groningen, NL-9713 AV Groningen, Netherlands.
   [van Dam, Gooitzen M.] Univ Med Ctr Groningen, Dept Surg, NL-9713 GZ Groningen, Netherlands.
   [van Dam, Gooitzen M.] Univ Med Ctr Groningen, BioOpt Imaging Ctr, NL-9713 GZ Groningen, Netherlands.
RP Sjollema, J (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM j.sjollema@med.umcg.nl
FU BioMedical Materials institute; Dutch Ministry of Economic Affairs
FX This research forms part of the Project P4.01 NANTICO of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affairs.
CR Bien H, 2007, PHYS MED BIOL, V52, P941, DOI 10.1088/0031-9155/52/4/006
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336
   de Vries BMW, 2009, CIRCULATION, V119, pE534, DOI 10.1161/CIRCULATIONAHA.108.821389
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Doyle TC, 2004, CELL MICROBIOL, V6, P303, DOI 10.1111/j.1462-5822.2004.00378.x
   Engelsman AF, 2008, BRIT J SURG, V95, P1051, DOI 10.1002/bjs.6154
   ENGELSMAN AF, 2009, THESIS U MED CTR GRO
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Engelsman AF, 2009, ACTA BIOMATER, V5, P1905, DOI 10.1016/j.actbio.2009.01.041
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000
   Funovics M, 2003, ANAL BIOANAL CHEM, V377, P956, DOI 10.1007/s00216-003-2199-0
   Galluzzi L, 2007, J BIOTECHNOL, V127, P188, DOI 10.1016/j.jbiotec.2006.06.019
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Graves EE, 2003, MED PHYS, V30, P901, DOI 10.1118/1.1568977
   Gu XJ, 2004, OPT EXPRESS, V12, P3996, DOI 10.1364/OPEX.12.003996
   Guglielmetti S, 2008, INT J FOOD MICROBIOL, V124, P285, DOI 10.1016/j.ijfoodmicro.2008.03.033
   Holm C, 2002, BRIT J PLAST SURG, V55, P635, DOI 10.1054/bjps.2002.3969
   Howell D, 2006, BIOFOULING, V22, P401, DOI 10.1080/08927010601035738
   Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x
   Hyde D, 2009, NEUROIMAGE, V44, P1304, DOI 10.1016/j.neuroimage.2008.10.038
   ISHIMARU A, 1989, APPL OPTICS, V28, P2210, DOI 10.1364/AO.28.002210
   Kadurugamuwa JL, 2005, INFECT IMMUN, V73, P7836, DOI 10.1128/IAI.73.12.7836-7843.2005
   Kadurugamuwa JL, 2005, INFECT IMMUN, V73, P3878, DOI 10.1128/IAI.73.7.3878-3887.2005
   Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   KEIJZER M, 2009, LASER SURG MED, V9, P148
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   Kubota K, 2006, J HEPATO-BILIARY-PAN, V13, P100, DOI 10.1007/s00534-005-1014-z
   Kuroiwa T, 1998, SURG NEUROL, V50, P41, DOI 10.1016/S0090-3019(98)00055-X
   Lee S, 2008, CHEM COMMUN, P4250, DOI 10.1039/b806854m
   Leevy WM, 2008, BIOCONJUGATE CHEM, V19, P686, DOI 10.1021/bc700376v
   Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799
   Lv YJ, 2007, PHYS MED BIOL, V52, P4497, DOI 10.1088/0031-9155/52/15/009
   MEIGHEN EA, 1993, FASEB J, V7, P1016
   Montet X, 2005, CANCER RES, V65, P6330, DOI 10.1158/0008-5472.CAN-05-0382
   Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065
   Nejadnik MR, 2008, APPL ENVIRON MICROB, V74, P916, DOI 10.1128/AEM.01557-07
   Ntziachristos Vasilis, 2002, Nature Medicine, V8, P757, DOI 10.1038/nm729
   Ntziachristos V, 2002, MOL IMAGING, V1, P82, DOI 10.1162/153535002320162732
   Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831
   PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331
   Poortinga AT, 2001, BIOTECHNOL BIOENG, V76, P395, DOI 10.1002/bit.10129
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Roosjen A, 2005, J BIOMED MATER RES B, V73B, P347, DOI 10.1002/jbm.b.30227
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   Sato A, 2004, COMPARATIVE MED, V54, P631
   Sharma PK, 2005, EUR J ORAL SCI, V113, P326, DOI 10.1111/j.1600-0722.2005.00220.x
   Sharma PK, 2005, APPL ENVIRON MICROB, V71, P3668, DOI 10.1128/AEM.71.7.3668-3673.2005
   Sharma PK, 2010, SURGERY, V147, P89, DOI 10.1016/j.surg.2009.05.016
   Singh R, 2009, J MED MICROBIOL, V58, P1067, DOI 10.1099/jmm.0.009720-0
   Soubret A, 2006, PHYS MED BIOL, V51, P3983, DOI 10.1088/0031-9155/51/16/007
   Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202
   Tamagnini I, 2008, CURR MICROBIOL, V57, P245, DOI 10.1007/s00284-008-9184-y
   Tarantal AF, 2006, HUM GENE THER, V17, P1254, DOI 10.1089/hum.2006.17.1254
   Tsien RY, 2005, FEBS LETT, V579, P927, DOI 10.1016/j.febslet.2004.11.025
   Unge A, 1999, APPL ENVIRON MICROB, V65, P813
   van der Borden AJ, 2005, BIOMATERIALS, V26, P6731, DOI 10.1016/j.biomaterials.2004.04.052
   van der Mei HC, 2008, APPL ENVIRON MICROB, V74, P5511, DOI 10.1128/AEM.01119-08
   van Roessel P, 2002, NAT CELL BIOL, V4, pE15, DOI 10.1038/ncb0102-e15
   Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X
   Virostko J, 2007, APPL OPTICS, V46, P2540, DOI 10.1364/AO.46.002540
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Welsh DK, 2005, CURR OPIN BIOTECH, V16, P73, DOI 10.1016/j.copbio.2004.12.006
   Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057
   Yang M, 2000, P NATL ACAD SCI USA, V97, P12278, DOI 10.1073/pnas.97.22.12278
NR 72
TC 37
Z9 37
U1 2
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 8
BP 1984
EP 1995
DI 10.1016/j.biomaterials.2009.11.068
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563WR
UT WOS:000275167300003
PM 19969345
DA 2018-10-20
ER

PT J
AU Velard, F
   Laurent-Maquin, D
   Braux, J
   Guillaume, C
   Bouthors, S
   Jallot, E
   Nedelec, JM
   Belaaouaj, A
   Laquerriere, P
AF Velard, Frederic
   Laurent-Maquin, Dominique
   Braux, Julien
   Guillaume, Christine
   Bouthors, Sylvie
   Jallot, Edouard
   Nedelec, Jean-Marie
   Belaaouaj, Abderrazzaq
   Laquerriere, Patrice
TI The effect of zinc on hydroxyapatite-mediated activation of human
   polymorphonuclear neutrophils and bone implant-associated acute
   inflammation
SO BIOMATERIALS
LA English
DT Article
DE Inflammation; Neutrophil; Interleukin-8; Hydroxyapatite; Zinc
ID IN-VITRO; INTERLEUKIN-8; PARTICLES; CXCR1; INTERNALIZATION; EXPRESSION;
   MONOCYTES; CYTOKINE; RELEASE
AB Hydroxyapatite (HA) is widely used as coating biomaterial for prosthesis metal parts and as bone substitute. The release of HA particles induces an inflammatory response and, if uncontrolled, could result in implant loss. At the inflamed site, the polymorphonuclear cells (PMNs) represent the earliest phagocytic cells that predominate the cellular infiltrate. We have recently proposed that HA wear debris activate polymorphonuclear cells (PMNs) initiating and/or amplifying thereby the acute inflammatory response. Previous studies have shown that activation of monocytes by HA Could be modulated by supplementing this latter with the divalent cation, Zinc. The purpose of this work was to investigate the modulation of PMNs activation following exposure to zinc-substituted HA. Our study demonstrate that addition of zinc to HA particles resulted in decreased levels of the pro-inflammatory mediator interleukin-8 (IL-8) and the matrix metallo-proteinase-9. We also show that these changes involve IL-8 receptors (CXCR-1 and CXCR-2). (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Velard, Frederic; Laurent-Maquin, Dominique; Braux, Julien; Guillaume, Christine; Bouthors, Sylvie; Laquerriere, Patrice] CHU Reims, INSERM, UMR S 926, IFR 53, F-51095 Reims, France.
   [Jallot, Edouard] Univ Blaise Pascal, CNRS, IN2P3, Lab Phys Corpusculaire Clermont Ferrand,UMR 6533, F-63177 Aubiere, France.
   [Nedelec, Jean-Marie] Clermont Univ, ENSCCF, LMI, F-63177 Aubiere, France.
   [Velard, Frederic; Belaaouaj, Abderrazzaq] CHU Reims, EA 4303, IFR 53, F-51092 Reims, France.
   [Laquerriere, Patrice] CNRS, UMR 7178, IPHC, Equipe IMABIO, F-67037 Strasbourg 02, France.
RP Velard, F (reprint author), CHU Reims, INSERM, UMR S 926, IFR 53, URCA 1 Ave Marechal Juin, F-51095 Reims, France.
EM frederic.velard@univ-reims.fr
RI Laquerriere, Patrice/P-1025-2016; Bentaher, Abderrazzaq/M-4424-2017;
   NEDELEC, jean-marie/A-6920-2008; Bentaher, Abderrazzak/F-6531-2018
OI Laquerriere, Patrice/0000-0001-7637-9094; NEDELEC,
   jean-marie/0000-0002-8243-6849; VELARD, Frederic/0000-0002-4826-2160
FU INSERM; French "Agence Nationale pour la Recherche"; Region
   CHAMPAGNE-ARDENNE
FX This work was supported by INSERM, French "Agence Nationale pour la
   Recherche", and Region CHAMPAGNE-ARDENNE.
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z
   Benhayoune H, 2000, BIOMATERIALS, V21, P235, DOI 10.1016/S0142-9612(99)00138-6
   Bloebaum RD, 1997, CLIN ORTHOP RELAT R, P109
   Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353
   Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612
   Cheung HS, 1997, OSTEOARTHR CARTILAGE, V5, P145, DOI 10.1016/S1063-4584(97)80009-X
   Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510
   Grandjean-Laquerrier A, 2006, BIOMATERIALS, V27, P3195, DOI 10.1016/j.biomaterial.2006.01.024
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Haase H, 2007, BIOMETALS, V20, P579, DOI 10.1007/s10534-006-9029-8
   Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182
   Jallot E, 2005, COLLOID SURFACE B, V42, P205, DOI 10.1016/j.colsurfb.2005.03.001
   Juhasz A, 2009, OTOL NEUROTOL, V30, P559, DOI 10.1097/MAO.0b013e31819fe6ed
   Laggner H, 2006, FREE RADICAL BIO MED, V40, P436, DOI 10.1016/j.freeradbiomed.2005.08.030
   MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554
   Murgia C, 2006, CURR DRUG TARGETS, V7, P607, DOI 10.2174/138945006776818683
   Nasser MW, 2007, J BIOL CHEM, V282, P6906, DOI 10.1074/jbc.M610289200
   PIZZOFERRATO A, 1991, Clinical Materials, V7, P51, DOI 10.1016/0267-6605(91)90057-M
   PRYSTOWSKY JB, 1995, DIGEST DIS SCI, V40, P412, DOI 10.1007/BF02065430
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S
   Shetty AA, 2005, J BONE JOINT SURG BR, V87B, P1050, DOI 10.1302/0301-620X.87B8.16011
   Tikhonov I, 2001, CLIN EXP IMMUNOL, V125, P414, DOI 10.1046/j.1365-2249.2001.01626.x
   Velard F, 2009, ACTA BIOMATER, V5, P1708, DOI 10.1016/j.actbio.2009.01.008
   von Bulow V, 2007, J IMMUNOL, V179, P4180, DOI 10.4049/jimmunol.179.6.4180
   Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843
NR 27
TC 40
Z9 40
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 8
BP 2001
EP 2009
DI 10.1016/j.biomaterials.2009.11.066
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563WR
UT WOS:000275167300005
PM 19963271
DA 2018-10-20
ER

PT J
AU Pritchard, CD
   Arner, KM
   Neal, RA
   Neeley, WL
   Bojo, P
   Bachelder, E
   Holz, J
   Watson, N
   Botchwey, EA
   Langer, RS
   Ghosh, FK
AF Pritchard, Christopher D.
   Arner, Karin M.
   Neal, Rebekah A.
   Neeley, William L.
   Bojo, Peter
   Bachelder, Erika
   Holz, Jessica
   Watson, Nicki
   Botchwey, Edward A.
   Langer, Robert S.
   Ghosh, Fredrik K.
TI The use of surface modified poly(glycerol-co-sebacic acid) in retinal
   transplantation
SO BIOMATERIALS
LA English
DT Article
DE Cell adhesion; Elastomer; Laminin; Nanotopography; Polycaprolactone;
   Retina
ID RETINITIS-PIGMENTOSA; VITAMIN-A; LAMININ
AB Retinal transplantation experiments have advanced considerably during recent years, but remaining diseased photoreceptor cells in the host retina and inner retinal cells in the transplant physically obstruct the development of graft-host neuronal contacts which are required for vision. Recently, we developed methods for the isolation of donor photoreceptor layers in vitro, and the selective removal of host photoreceptors in vivo using biodegradable elastomeric membranes composed of poly(glycerol-co-sebacic acid) (PGS). Here, we report the surface modification of PGS membranes to promote the attachment of photoreceptor layers, allowing the resulting composite to be handled surgically as a single entity. PGS membranes were chemically modified with peptides containing an arginine-glycine-aspartic acid (RGD) extracellular matrix ligand sequence. PGS membranes were also coated with electrospun nanofiber meshes, containing laminin and poly(epsilon-caprolactone) (PCL). Following in vitro co-culture of biomaterial membranes with isolated embryonic retinal tissue, composites were tested for surgical handling and examined with hematoxylin and eosin staining and immunohistochemical markers. Electrospun nanofibers composed of laminin and PCL promoted sufficient cell adhesion for simultaneous transplantation of isolated photoreceptor layers and PGS membranes. Composites developed large populations of recoverin and rhodopsin labeled photoreceptors. Furthermore, ganglion cells, rod bipolar cells and All amacrine cells were absent in co-cultured retinas as observed by neurofilament, PKC and parvalbumin labeling respectively. These results facilitate retinal transplantation experiments in which a composite graft composed of a biodegradable membrane adhered to an immature retina dominated by photoreceptor cells may be delivered in a single surgery, with the possibility of improving graft-host neuronal connections. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Pritchard, Christopher D.; Neeley, William L.; Bojo, Peter; Langer, Robert S.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Arner, Karin M.; Ghosh, Fredrik K.] Univ Lund Hosp, Dept Ophthalmol, SE-22185 Lund, Sweden.
   [Neal, Rebekah A.; Botchwey, Edward A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   [Bachelder, Erika; Holz, Jessica; Watson, Nicki] Whitehead Inst, WM Keck Microscopy Facil, Cambridge, MA 02142 USA.
RP Pritchard, CD (reprint author), Room E25-342,45 Carleton St, Cambridge, MA 02142 USA.
EM cpritcha@mit.edu
OI Ghosh, Fredrik/0000-0002-3302-1233; Holz, Jessica/0000-0002-4987-3801;
   Neal, Rebekah/0000-0002-2566-3850
FU Faculty of Medicine, University of Lund; Swedish Research Council;
   Princess Margaretas Foundation for Blind Children; Torsten and Ragnar
   Soderberg Foundation; National Institutes of Health [DE013023,
   HL060435]; Richard and Gail Siegal Gift Fund; MIT/CIMIT; In Vivo
   Therapeutics Corporation; National Eye Institute [1 F32 EY018285-01]
FX We thank Kurt Broderick for assistance with clean room operation (MTL,
   MIT, Cambridge, MA), Dr. Anthony Garratt-Reed and Libby Shaw for
   assistance with SEM and XPS (CMSE, MIT, Cambridge, MA), Jonathan Shu for
   assistance with XPS (Cornell, NY), the staff of the Edgerton Center
   Student Shop for assistance with building the electrospinning apparatus
   (MIT, Cambridge, MA), and Kerry Mahon for providing lab space and
   materials for electrospinning (Stemgent, Inc., Cambridge, MA). We thank
   Elizabeth Pritchard for writing assistance (Starnberg, Germany). This
   work was supported by The Faculty of Medicine, University of Lund, The
   Swedish Research Council, The Princess Margaretas Foundation for Blind
   Children, the Torsten and Ragnar Soderberg Foundation, the National
   Institutes of Health (Grants DE013023 and HL060435), and the Richard and
   Gail Siegal Gift Fund. C.D.P. was supported by the MIT/CIMIT Medical
   Engineering Fellowship. C.D.P. and P.B. were supported by a gift to MIT
   by In Vivo Therapeutics Corporation. W.L.N. was supported by the NIH
   under Ruth L. Kirschstein National Research Service Award 1 F32
   EY018285-01 from the National Eye Institute.
CR Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008
   Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)000304
   Berson EL, 2004, ARCH OPHTHALMOL-CHIC, V122, P1306, DOI 10.1001/archopht.122.9.1306
   BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   GERARDONAVA J, 2009, NANOMED, V1, P11
   Ghosh F, 2004, RETINA-J RET VIT DIS, V24, P98, DOI 10.1097/00006982-200402000-00014
   Ghosh F, 1999, INVEST OPHTH VIS SCI, V40, P126
   Ghosh F, 2011, TISSUE ENG PT A, V17, P1675, DOI [10.1089/ten.tea.2008.0450, 10.1089/ten.TEA.2008.0450]
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366
   PRINCE JH, 1960, PIG ANATOMY HISTOLOG, P210
   Thanos C, 2005, EXPERT OPIN BIOL TH, V5, P1443, DOI 10.1517/14712598.5.11.1443
   TURNER JE, 1986, BRAIN RES, V391, P91
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
NR 20
TC 32
Z9 32
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 8
BP 2153
EP 2162
DI 10.1016/j.biomaterials.2009.11.074
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563WR
UT WOS:000275167300020
PM 19962754
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Fischer, M
   Sperling, C
   Tengvall, P
   Werner, C
AF Fischer, Marion
   Sperling, Claudia
   Tengvall, Pentti
   Werner, Carsten
TI The ability of surface characteristics of materials to trigger leukocyte
   tissue factor expression
SO BIOMATERIALS
LA English
DT Article
DE Haemocompatibility; Cell activation; Coagulation; Leukocyte; Platelet
   adhesion; Blood compatibility
ID BLOOD-COAGULATION; WHOLE-BLOOD; COMPLEMENT; ACTIVATION; PATHWAY;
   MICROPARTICLES; PLATELETS; NEUTROPHILS; HEMOSTASIS; THROMBOSIS
AB Biomaterial-induced thrombosis IS Usually attributed to blood coagulation initiated by contact phase and platelet-related reactions Considering the major role of extrinsic initiation in blood Coagulation in vivo, we studied the material related-induction of this pathway by investigating the relevance of surface properties for the expression of Tissue Factor (TF), a critical initiator of the extrinsic pathway of coagulation We incubated materials with self-assembled monolayers of alkylthiols (SAMS) displaying various ratios of -CH(3), -OH, and -CCOH terminations with fresh heparinized whole human blood in vitro The transcription of TF-mRNA in leukocytes showed clear differences in relation to Surface properties and increased over time In addition, a positive correlation between TF transcription and its presence on leukocytes, granulocyte activation, and complement activation was found Cells displaying the highest TF expression after material contact had significantly lower intracellular TF, pointing to previous TF release Yet under the conditions Of our whole blood incubation set-up within the limited time frame the observed initiation of the extrinsic pathway did not trigger blood coagulation (C) 2009 Elsevier Ltd All rights reserved.
C1 [Fischer, Marion; Sperling, Claudia; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, D-01069 Dresden, Germany.
   [Tengvall, Pentti] Gothenburg Univ, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden.
   [Werner, Carsten] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Werner, Carsten] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany.
RP Sperling, C (reprint author), Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, Hohe Str 6, D-01069 Dresden, Germany.
RI Werner, Carsten/F-8127-2010; Umlauf, Ursula/D-3356-2014
OI Werner, Carsten/0000-0003-0189-3448; 
FU the Deutsche Forschungsgemeinschaft (DFG) [SP 966/2-1]
FX This work was funded by the Deutsche Forschungsgemeinschaft (DFG SP
   966/2-1) Practical assistance was provided by Grit Eberth (IPF Dresden),
   who helped prepare the Surfaces and hemocompatibility assays, and to
   Martina Franke (IPF Dresden) who carried Out gold evaporation We also
   thank Manfred Maitz (IPF Dresden) and Thomas Luther (Medizinisches Labor
   Ostsachsen, Bautzen. Germany) for critical discussion, Phillip Seib
   (IPF) and Martina Franke (IPF Dresden) for help with PCR and western
   blot analysis, and Agneta Askendal (IFM Applied Physics at Linkoping
   University, Linkoping, Sweden) for carrying out ellipsometric
   measurements
CR Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639
   Butenas S, 2005, BLOOD, V105, P2764, DOI 10.1182/blood-2004-09-3567
   Camera M, 2003, ARTERIOSCL THROM VAS, V23, P1690, DOI 10.1161/01.ATV.0000085629.23209.AA
   Chechik V., 1999, CHEM ORGANIC DERIVAT, P551
   Chung JH, 1996, CIRCULATION, V93, P2014, DOI 10.1161/01.CIR.93.11.2014
   Eilertsen KE, 2005, BIOCHEM SOC T, V33, P418, DOI 10.1042/BST0330418
   Feijter J. D., 1978, BIOPOLYMERS, V17, P1759
   Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311
   Gorbet MB, 2005, J BIOMED MATER RES A, V74A, P511, DOI 10.1002/jbm.a.30354
   Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835
   HAKIM RM, 1984, NEW ENGL J MED, V311, P878, DOI 10.1056/NEJM198410043111403
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   KAPPELMAYER J, 1993, CIRC RES, V72, P1075, DOI 10.1161/01.RES.72.5.1075
   Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911
   Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841
   Mann KG, 2009, HAMOSTASEOLOGIE, V29, P7
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   McCrackin F. L., 1969, 479 NBS
   Muller I, 2003, FASEB J, V17, P476, DOI 10.1096/fj.02-0574fje
   Nakamura S, 2004, J THROMB HAEMOST, V2, P214, DOI 10.1111/j.1538-7836.2004.00548.x
   Orfeo T, 2005, J BIOL CHEM, V280, P42887, DOI 10.1074/jbc.M505506200
   Osterud B, 2000, THROMB HAEMOSTASIS, V83, P861
   Osterud B, 2004, J THROMB HAEMOST, V2, P218, DOI 10.1111/j.1538-7836.2004.00546.x
   OSTERUD B, 1995, BLOOD COAGUL FIBRIN, V6, P20
   Panes O, 2007, BLOOD, V109, P5242, DOI 10.1182/blood-2006-06-030619
   PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856
   PETERSEN LC, 1992, THROMB HAEMOSTASIS, V67, P537
   Polgar J, 2005, J THROMB HAEMOST, V3, P1590, DOI 10.1111/j.1538-7836.2005.01373.x
   Rauch U, 2000, BLOOD, V96, P170
   SCHWARTZ BS, 1981, J IMMUNOL, V127, P438
   Sperling C, 2007, BIOMATERIALS, V28, P3617, DOI 10.1016/j.biomaterials.2007.04.041
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Streller U, 2003, J BIOMED MATER RES B, V66B, P379, DOI 10.1002/jbm.b.10016
   Sturk-Maquelin KN, 2003, J THROMB HAEMOST, V1, P1920, DOI 10.1046/j.1538-7836.2003.00361.x
NR 34
TC 11
Z9 12
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 9
BP 2498
EP 2507
DI 10.1016/j.biomaterials.2009.12.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 566CX
UT WOS:000275348800006
PM 20035991
DA 2018-10-20
ER

PT J
AU Wang, XT
   Waldeck, H
   Kao, WJ
AF Wang, Xintong
   Waldeck, Heather
   Kao, Weiyuan J.
TI The effects of TGF-alpha, IL-1 beta and PDGF on fibroblast adhesion to
   ECM-derived matrix and KGF gene expression
SO BIOMATERIALS
LA English
DT Article
DE Keratinocyte growth factor; Granulocyte-macrophage colony-stimulating
   factor; Interpenetrating network; Interleukin-1 beta; Transforming
   growth factor-alpha; Platelet-derived growth factor-BB
ID KERATINOCYTE GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; EPITHELIAL-CELL
   CULTURE; INTERLEUKIN-1-BETA EXPRESSION; SERUM; PROTEIN; MIGRATION;
   NETWORKS; GELATIN; RGD
AB The goal Of this study was to elucidate the control mechanisms by which exogenous proteins regulate keratinocyte growth factor (KGF) expression in fibroblasts adhered to differing substrates and thereby provide insights into both fundamental in vitro cell signaling and cell-biomaterial interaction research A serum-free culture system in which cells maintained their proliferative capacity was established and employed The addition of transforming growth factor-alpha (TGF-alpha), interleukin-1 beta (IL-1 beta) and platelet-derived growth factor-BB (PDGF-BB) individually showed no effect on KGF protein release, however, IL-1 beta addition led to increased KGF mRNA transcription, intracellular KGF protein synthesis, and granulocyte-macrophage colony-stimulating factor (GM-CSF) release Intracellular KGF protein synthesis and extracellular release were enhanced when fibroblasts were treated with a combination of IL-1 beta and PDGF-BB which suggests KGF synthesis and release are largely regulated by synergistic mechanisms Surface-bound fibronectin-derived ligands and individual exogenous proteins promoted fibroblast adhesion to semi-interpenetrating polymer networks (sIPNs) but did not Stimulate KGF release despite enhancement of KGF mRNA transcription Additionally, serum conditioning was found to have a significant impact on KGF synthesis and the subsequent mechanisms controlling KGF release This study demonstrates that KGF release from fibroblasts is likely regulated by multiple mechanisms involving post-transcriptional and exocytic controls which may be impacted by the presence of serum and how serum is removed from the in vitro cell environment (C) 2009 Elsevier Ltd All rights reserved
C1 [Wang, Xintong; Kao, Weiyuan J.] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   [Waldeck, Heather; Kao, Weiyuan J.] Univ Wisconsin, Dept Biomed Engn, Coll Engn, Madison, WI 53705 USA.
   [Kao, Weiyuan J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
RI Wang, Xintong/I-8169-2013
FU NIH [R01 EB6613]
FX The authors thank Amy Chung for her guidance in the polymer Synthesis
   and RT-PCR and for her kind review of this manuscript. This work was
   supported in part by NIH Grant R01 EB6613.
CR Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792
   BRAUCHLE M, 1994, ONCOGENE, V9, P3199
   Brink HE, 2005, IN VITRO CELL DEV-AN, V41, P252
   BRONSON RE, 1988, COLLAGEN REL RES, V8, P199
   BRONSON RE, 1987, COLLAGEN REL RES, V7, P323
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   CHEDID M, 1994, J BIOL CHEM, V269, P10753
   Chung AS, 2007, J BIOMAT SCI-POLYM E, V18, P713, DOI 10.1163/156856207781034179
   Denk PO, 2000, CURR EYE RES, V20, P77, DOI 10.1076/0271-3683(200002)20:2;1-D;FT077
   Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2
   Gao Q, 2007, TISSUE ENG, V13, P179, DOI 10.1089/ten.2006.0007
   GNESSI L, 1993, ENDOCRINOLOGY, V133, P1880, DOI 10.1210/en.133.4.1880
   Hoffmann Stephan, 2005, BMC Ophthalmol, V5, P16, DOI 10.1186/1471-2415-5-16
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jaluria P, 2008, BIOTECHNOL BIOENG, V99, P1443, DOI 10.1002/bit.21707
   KAMELY D, 1976, EXP CELL RES, V97, P120, DOI 10.1016/0014-4827(76)90661-3
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   KAPLAN PL, 1982, P NATL ACAD SCI-BIOL, V79, P485, DOI 10.1073/pnas.79.2.485
   Kleinbeck KR, 2009, J BURN CARE RES, V30, P37, DOI 10.1097/BCR.0b013e3181921f98
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mass-Szabowski N., 1999, J CELL SCI, V112, P1843
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MILAM SB, 1991, J CELL PHYSIOL, V149, P173, DOI 10.1002/jcp.1041490202
   Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200
   ORNITZ DM, 2001, GENOME BIOL, V2, P512
   PUTNINS EE, 1995, J INVEST DERMATOL, V104, P989, DOI 10.1111/1523-1747.ep12606233
   Putnins EE, 1996, MATRIX BIOL, V15, P21, DOI 10.1016/S0945-053X(96)90123-7
   Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177
   Rasband WS, 1997, IMAGEJ
   Rinaldi N, 1997, ANN RHEUM DIS, V56, P729, DOI 10.1136/ard.56.12.729
   ROZEN S, 2000, BIOINFORMATICS METHO, P365, DOI DOI 10.1385/1-59259-192-2:365
   Sasaki M, 2000, MEDIAT INFLAMM, V9, P155, DOI 10.1080/09629350020002895
   Shaoul R, 2006, BIOCHEM BIOPH RES CO, V350, P825, DOI 10.1016/j.bbrc.2006.08.198
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   TAKIZAWA M, 1995, J ANTIBIOT, V48, P579, DOI 10.7164/antibiotics.48.579
   Waldeck H, 2007, J BIOMED MATER RES A, V82A, P861, DOI 10.1002/jbm.a.31054
   Weng J, 1997, CORNEA, V16, P465
   Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0
   Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786
   Witte RP, 2005, BIOMATERIALS, V26, P3673, DOI 10.1016/j.biomaterials.2004.09.054
   Yamamoto M, 1998, STROKE, V29, P1188, DOI 10.1161/01.STR.29.6.1188
   Zander L, 2008, CELL PROLIFERAT, V41, P136, DOI 10.1111/j.1365-2184.2007.00500.x
NR 42
TC 5
Z9 6
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 9
BP 2542
EP 2548
DI 10.1016/j.biomaterials.2009.12.018
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 566CX
UT WOS:000275348800011
PM 20036421
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wojtowicz, AM
   Shekaran, A
   Oest, ME
   Dupont, KM
   Templeman, KL
   Hutmacher, DW
   Guldberg, RE
   Garcia, AJ
AF Wojtowicz, Abigail M.
   Shekaran, Asha
   Oest, Megan E.
   Dupont, Kenneth M.
   Templeman, Kellie L.
   Hutmacher, Dietmar W.
   Guldberg, Robert E.
   Garcia, Andres J.
TI Coating of biomaterial scaffolds with the collagen-mimetic peptide
   GFOGER for bone defect repair
SO BIOMATERIALS
LA English
DT Article
DE Biomimetic material; Bone regeneration; ECM (extracellular matrix);
   Integrin; Peptide; Scaffold
ID HUMAN OSTEOGENIC PROTEIN-1; ORTHOPEDIC TRAUMA SURGERY; MESENCHYMAL
   STEM-CELL; SEGMENTAL DEFECT; OSTEOBLASTIC DIFFERENTIATION;
   CLINICAL-APPLICATIONS; ANIMAL-MODELS; TISSUE; INTEGRINS; SURFACES
AB Healing large bone defects and non-unions remains a significant clinical problem Current treatments, consisting of auto and allografts, are limited by donor supply and morbidity, insufficient bioactivity and risk of infection Biotherapeutics, including cells, genes and proteins, represent promising alternative therapies, but these strategies are limited by technical roadblocks to biotherapeutic delivery, cell sourcing, high cost, and regulatory hurdles. In the present study, the collagen-mimetic peptide, GFOGER, was Used to coat synthetic PCL scaffolds to promote bone formation in critically-sized segmental defects in rats GFOGER is a synthetic triple helical peptide that binds to the alpha(2)beta(1) integrin receptor involved in osteogenesis GFOGER coatings passively adsorbed onto polymeric scaffolds, in the absence of exogenous cells or growth factors, significantly accelerated and increased bone formation in non-healing femoral defects compared to uncoated scaffolds and empty defects Despite differences in bone volume, no differences in torsional strength were detected after 12 weeks, indicating that bone mass but not bone quality Was improved in this model This work demonstrates a simple, cell/growth factor-free strategy to promote bone formation in challenging, non-healing bone defects This biomaterial coating strategy represents a cost-effective and facile approach, translatable into a robust clinical therapy for musculoskeletal applications (C) 2009 Elsevier Ltd. All rights reserved
C1 [Wojtowicz, Abigail M.; Shekaran, Asha; Oest, Megan E.; Dupont, Kenneth M.; Templeman, Kellie L.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Wojtowicz, Abigail M.; Shekaran, Asha; Oest, Megan E.; Dupont, Kenneth M.; Templeman, Kellie L.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Inst Technol, Georgia Tech Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
   [Wojtowicz, Abigail M.; Shekaran, Asha; Oest, Megan E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Wojtowicz, Abigail M.; Shekaran, Asha; Oest, Megan E.] Emory Univ, Atlanta, GA 30332 USA.
   [Dupont, Kenneth M.; Templeman, Kellie L.; Guldberg, Robert E.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Hutmacher, Dietmar W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, 2314 IBB Bldg,315 Ferst Dr, Atlanta, GA 30332 USA.
OI Oest, Megan/0000-0002-7609-730X; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134; Shekaran, Asha/0000-0002-0978-6631
FU National Institutes of Health [R01 EB-004496]; Georgia Tech/Emory
   National Science Foundation ERC on the Engineering of Living Tissues
   [EEC-9731643]; Cell and Tissue Engineering NIH Biotechnology [T32
   CM-008433]
FX This work was by funded by the National Institutes of Health (R01
   EB-004496) and Georgia Tech/Emory National Science Foundation ERC on the
   Engineering Of of Living tissues (EEC-9731643). AN W. was supported by
   the Cell and Tissue Engineering NIH Biotechnology Training Grant (T32
   CM-008433). The authors gratefully acknowledge Dr. Laura O'Farrell for
   veterinary Consults, Angela Lin for technical assistance with microCT
   and Joel Boerckel, Joseph Charest, Sean Coyer, Bryan Dieickman, David
   Dumbauld, Nduka Enemchukwu, Timothy Petrie, Ed Phelps, Jennifer
   Phillips, and Rachel Whitmire for assistance with Surgical procedures
CR Alt V, 2006, CURR MED RES OPIN, V22, pS19, DOI 10.1185/030079906X80602
   Awad HA, 2007, TISSUE ENG, V13, P1973, DOI 10.1089/ten.2006.0107
   Azad V, 2009, J ORTHOP TRAUMA, V23, P267, DOI 10.1097/BOT.0b013e31819f290e
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8
   Boden SD, 2005, ORTHOP NURS, V24, P49
   Cakmak G, 2006, SAUDI MED J, V27, P777
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Chen XQ, 2007, J ORTHOP TRAUMA, V21, P693, DOI 10.1097/BOT.0b013e31815a7e91
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   COOK SD, 1995, J BONE JOINT SURG AM, V77A, P734, DOI 10.2106/00004623-199505000-00010
   COOK SD, 1994, CLIN ORTHOP RELAT R, P302
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gottfried ON, 2008, NEUROSURGERY, V63, P380, DOI 10.1227/01.NEU.0000324990.04818.13
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Guillot PV, 2007, J CELL MOL MED, V11, P935, DOI 10.1111/j.1582-4934.2007.00106.x
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Hsu WK, 2007, BONE, V40, P931, DOI 10.1016/j.bone.2006.10.030
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hutmacher DW, 2005, GENE, V347, P1, DOI 10.1016/j.gene.2004.12.040
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Mankin HJ, 2005, CLIN ORTHOP RELAT R, P210, DOI 10.1097/01.blo.0000150371.77314.52
   Marquis ME, 2008, BIOMATERIALS, V29, P1005, DOI 10.1016/j.biomaterials.2007.10.047
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Pekkarinen T, 2006, ACTA ORTHOP, V77, P952, DOI 10.1080/17453670610013286
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Sanderson C, 1997, J HISTOTECHNOL, V20, P119
   Scarano Antonio, 2003, Implant Dent, V12, P318, DOI 10.1097/01.ID.0000095467.48241.68
   SCHWARTZ CE, 2009, HLTH QUAL LIFE OUTCO, V7
   Sorger JI, 2001, CLIN ORTHOP RELAT R, P66
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 43
TC 104
Z9 105
U1 4
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2010
VL 31
IS 9
BP 2574
EP 2582
DI 10.1016/j.biomaterials.2009.12.008
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 566CX
UT WOS:000275348800015
PM 20056517
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Voss, P
   Sauerbier, S
   Wiedmann-Al-Ahmad, M
   Zizelmann, C
   Stricker, A
   Schmelzeisen, R
   Gutwald, R
AF Voss, Pit
   Sauerbier, Sebastian
   Wiedmann-Al-Ahmad, Margit
   Zizelmann, Christoph
   Stricker, Andres
   Schmelzeisen, Rainer
   Gutwald, Ralf
TI Bone regeneration in sinus lifts: comparing tissue-engineered bone and
   iliac bone
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
DE Tissue engineering; Sinus floor elevation; Dental implants; Clinical
   trial; Bone substitutes; Biomaterial
ID HUMAN OSTEOGENIC PROTEIN-1; BIODEGRADABLE POLYMER SCAFFOLDS; MANDIBULAR
   RECONSTRUCTION; FLOOR AUGMENTATION; PERIOSTEAL CELLS; MINIATURE PIGS;
   DIFFERENTIATION; BIOMATERIALS; COMBINATION; BIO-OSS(R)
AB Lifting of the sinus floor is a standard procedure for bony augmentation that enables dental implantation. Although cultivated skin and mucosal grafts are often used in plastic and maxillofacial surgery, tissue-engineered bone has not achieved the same success. We present the clinical results of dental implants placed after the insertion of periosteum-derived, tissue-engineered bone grafts in sinus lifts. Periosteal cells were isolated from biopsy specimens of periosteum, resuspended and cultured. The cell suspension was soaked in polymer fleeces. The cell polymer constructs were transplanted by sinus lift 8 weeks after harvesting. The patients (n=35) had either one or both sides operated on. Seventeen had a one-stage sinus lift with simultaneous implantation (54 implants). In 18 patients the implants were inserted 3 months after augmentation (64 implants). Selected cases were biopsied. A control group (4 I patients: one stage = 48 implants, two stage = 135 implants) had augmentation with autologous bone only. They were followed up clinically and radiologically for at least 24 months. Both implants and augmentation were significantly more successful in the control group. Failure of augmentation of the tissue-engineered bone was more common after large areas had been augmented. Eleven implants were lost in the study group and only one in the control group. Lifting the sinus floor with autologous bone is more reliable than with tissue-engineered transplants. Although lamellar bone can be found in periosteum-derived, tissue-engineered transplants, the range of indications must be limited. (C) 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Voss, Pit; Sauerbier, Sebastian; Wiedmann-Al-Ahmad, Margit; Zizelmann, Christoph; Stricker, Andres; Schmelzeisen, Rainer; Gutwald, Ralf] Univ Klin Zahn Mund & Kieferheilkunde, Abt Klin & Poliklin Mund Kiefer & Gesichtschirurg, D-79106 Freiburg, Germany.
   [Voss, Pit; Sauerbier, Sebastian; Wiedmann-Al-Ahmad, Margit; Zizelmann, Christoph; Stricker, Andres; Schmelzeisen, Rainer; Gutwald, Ralf] Univ Hosp Freiburg, Dept Oral & Maxillofacial Surg, Freiburg, Germany.
RP Sauerbier, S (reprint author), Univ Klin Zahn Mund & Kieferheilkunde, Abt Klin & Poliklin Mund Kiefer & Gesichtschirurg, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM sebastian.sauerbier@uniklinik-freiburg.de
OI Schmelzeisen, Rainer/0000-0002-9686-6989
CR Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Ebisawa K, 2004, TISSUE ENG, V10, P921, DOI 10.1089/1076327041348437
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   ISHAUG SL, 2001, J BIOMED MATER RES, V54, P216
   Jaquiery C, 2005, ANN SURG, V242, P859, DOI 10.1097/01.sla.0000189572.02554.2c
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   LEE YM, 2007, CLIN ORAL IMPLAN RES, V18, P69
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   SAUERBIER S, 2009, TISSUE ENG C
   Schimming R, 2004, J ORAL MAXIL SURG, V62, P724, DOI 10.1016/j.joms.2004.01.009
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Stricker A, 2003, CLIN ORAL IMPLAN RES, V14, P207, DOI 10.1034/j.1600-0501.2003.140211.x
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P469, DOI 10.1054/ijom.2000.0008
   Terheyden H, 1999, CLIN ORAL IMPLAN RES, V10, P510, DOI 10.1034/j.1600-0501.1999.100609.x
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
NR 25
TC 30
Z9 33
U1 0
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD MAR
PY 2010
VL 48
IS 2
BP 121
EP 126
DI 10.1016/j.bjoms.2009.04.032
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 577WE
UT WOS:000276253900009
PM 19487059
DA 2018-10-20
ER

PT J
AU Ip, AWM
   Barford, JP
   Mckay, G
AF Ip, Alvin W. M.
   Barford, John P.
   Mckay, Gordon
TI A comparative study on the kinetics and mechanisms of removal of
   Reactive Black 5 by adsorption onto activated carbons and bone char
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Adsorption; Kinetics; Reactive Black 5; Bamboo activated carbon; Bone
   char; Intraparticle diffusion
ID BASIC DYE ADSORPTION; SURFACE-CHEMISTRY; INTRAPARTICLE DIFFUSION;
   PORE-SIZE; ISOTHERM; SORPTION; WASTE; AREA; EQUILIBRIUM; ADSORBENTS
AB The adsorption of a large reactive dye, Reactive Black 5, onto four adsorbents has been studied. A commercial active carbon, F400, was selected as a standard and two active carbons prepared from bamboo, a biomaterial. The two bamboo derived carbons, BACX2 and BACX6 had high specific surface areas, namely, 2123 and 1400 m(2)/g, respectively. A fourth widely used adsorbent, bone char, was also tested. The adsorption capacities for F400, bone char, BACX2 and BACX6 were 198, 160, 286 and 473 mg/g, respectively. A series of batch kinetics were carried out to investigate the rate and possible mechanism of Reactive Black 5 adsorption. Two pseudo-kinetic models and one intraparticle diffusion model were tested. The experimental concentration versus time decay curves were best explained by the intraparticle diffusion model. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Ip, Alvin W. M.; Barford, John P.; Mckay, Gordon] Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Kowloon, Hong Kong, Peoples R China.
RP Mckay, G (reprint author), Hong Kong Univ Sci & Technol, Dept Chem & Biomol Engn, Kowloon, Hong Kong, Peoples R China.
EM kemckayg@ust.hk
OI Barford, John/0000-0003-0494-4837
CR Aksu Z, 2008, CHEM ENG J, V142, P23, DOI 10.1016/j.cej.2007.11.005
   Al-Degs Y, 2000, WATER RES, V34, P927, DOI 10.1016/S0043-1354(99)00200-6
   Allen SJ, 2004, J COLLOID INTERF SCI, V280, P322, DOI 10.1016/j.jcis.2004.08.078
   ALLEN SJ, 1989, ENVIRON POLLUT, V56, P39, DOI 10.1016/0269-7491(89)90120-6
   BELL BA, 1975, WATER RES, V9, P857, DOI 10.1016/0043-1354(75)90031-7
   BOEHM HP, 1994, CARBON, V32, P759, DOI 10.1016/0008-6223(94)90031-0
   BROWN MA, 1993, CRIT REV ENV SCI TEC, V23, P249, DOI 10.1080/10643380490434119
   Cheung CW, 2002, LANGMUIR, V18, P650, DOI 10.1021/la010706m
   Choy KKH, 2004, CHEM ENG J, V103, P133, DOI 10.1016/j.cej.2004.05.012
   Easton J.R., 1995, COLOUR DYEHOUSE EFFL
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   GILES CH, 1960, J CHEM SOC, P3973, DOI 10.1039/jr9600003973
   Gregg S. J, 1982, ADSORPTION SURFACE A
   GREGG SJ, 1977, J CHEM SOC FARADAY T, V173, P747
   Haghseresht F, 1999, CARBON, V37, P639, DOI 10.1016/S0008-6223(98)00237-1
   Hameed BH, 2008, CHEM ENG J, V144, P235, DOI 10.1016/j.cej.2008.01.028
   Hameed BH, 2008, CHEM ENG J, V139, P48, DOI 10.1016/j.cej.2007.07.089
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Ip AWM, 2008, BIORESOURCE TECHNOL, V99, P8909, DOI 10.1016/j.biortech.2008.04.076
   Ip AWM, 2009, J COLLOID INTERF SCI, V337, P32, DOI 10.1016/j.jcis.2009.05.015
   KANEKO K, 1994, J MEMBRANE SCI, V96, P59, DOI 10.1016/0376-7388(94)00126-X
   Kasaoka S., 1989, INT CHEM ENG, V29, P734
   Khaled A, 2009, DESALINATION, V238, P210, DOI 10.1016/j.desal.2008.02.014
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Li L, 2002, CARBON, V40, P2085, DOI 10.1016/S0008-6223(02)00069-6
   MAGEE RW, 1995, RUBBER CHEM TECHNOL, V68, P590, DOI 10.5254/1.3538760
   McKay G, 2008, INT J ENVIRON TECHNO, V9, P20, DOI 10.1504/IJETM.2008.017857
   Medellin-Castillo NA, 2007, IND ENG CHEM RES, V46, P9205, DOI 10.1021/ie070023n
   O'Neill C, 1999, J CHEM TECHNOL BIOT, V74, P1009, DOI 10.1002/(SICI)1097-4660(199911)74:11<1009::AID-JCTB153>3.0.CO;2-N
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Reife A, 1994, ENV CHEM DYES PIGMEN
   ROUQUEROL J, 1994, PURE APPL CHEM, V66, P1739, DOI 10.1351/pac199466081739
   SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922
   Tan IAW, 2007, CHEM ENG J, V127, P111, DOI [10.1016/j.cej.2006.09.010, 10.1016/j.cej.200609.010]
   Valix M, 2006, LANGMUIR, V22, P4574, DOI 10.1021/la051711j
NR 37
TC 93
Z9 94
U1 1
U2 22
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAR 1
PY 2010
VL 157
IS 2-3
BP 434
EP 442
DI 10.1016/j.cej.2009.12.003
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 572XB
UT WOS:000275868500019
DA 2018-10-20
ER

PT J
AU Mungkalasiri, J
   Bedel, L
   Emieux, F
   Dore, J
   Renaud, FNR
   Sarantopoulos, C
   Maury, F
AF Mungkalasiri, Jitti
   Bedel, Laurent
   Emieux, Fabrice
   Dore, Jeanne
   Renaud, Francois N. R.
   Sarantopoulos, Christos
   Maury, Francis
TI CVD Elaboration of Nanostructured TiO2-Ag Thin Films with Efficient
   Antibacterial Properties
SO CHEMICAL VAPOR DEPOSITION
LA English
DT Article
DE Anti-bacterial surfaces; DLI-MOCVD; Nanocomposite coatings; Silver
   nanoparticles; Titanium dioxide films
ID FERRITE COMPOSITE NANOPARTICLES; ATMOSPHERIC-PRESSURE MOCVD; SOL-GEL
   METHOD; BIOMATERIAL SYSTEM; PHOTOCATALYTIC ACTIVITY; STAINLESS-STEEL;
   AMMONIUM-SALTS; SILVER; BIOFILM; DEPOSITION
AB Nanostructured TiO2-Ag composite coatings are deposited by direct liquid injection metal-organic (DLI-MO) CVD at 683 K in a one-step process. Silver pivalate (AgPiv) and titanium tetra-iso-propoxide (TTIP) are used as Ag and Ti molecular precursors, respectively. Metallic silver nanoparticles are co-deposited with anatase TiO2 on stainless steel, glass, and silicon wafers. The silver particles are uniformly embedded in the oxide matrix through the entire film thickness. The influence of the growth conditions, including injection parameters, is investigated on the chemical, physical, and structural characteristics of the coatings as well as on their anti-bacterial activities. The bacterium Staphylococcus aureus is employed for anti-bacterial tests. The films are bactericidal, according to the JIS Z 2801 standard test performed in the dark, when they contain less than 1 at.-% of silver. Under UV irradiation they exhibit a photocatalytic activity which decays by increasing the silver content. As a result of this dual functionality, the TiO2-Ag nanocomposite coatings show promising potentialities as long-term anti-bacterial surfaces since self-cleaning can be achieved periodically under UV light in order to maintain an efficient anti-bacterial activity in the dark or in visible light.
C1 [Mungkalasiri, Jitti; Sarantopoulos, Christos; Maury, Francis] ENSIACET, UPS, INPT, CNRS,CIRIMAT, F-31432 Toulouse 4, France.
   [Mungkalasiri, Jitti; Bedel, Laurent; Emieux, Fabrice] CEA, DTNM, LTS, F-38054 Grenoble, France.
   [Dore, Jeanne; Renaud, Francois N. R.] Univ Lyon 1, F-69365 Lyon, France.
RP Mungkalasiri, J (reprint author), ENSIACET, UPS, INPT, CNRS,CIRIMAT, 4 Allee E Monso,BP 44362, F-31432 Toulouse 4, France.
EM francis.maury@ensiacet.fr
RI MAURY, Francis/E-6691-2011; Dom, Rekha/B-7113-2012
OI MAURY, Francis/0000-0003-2796-9738; 
FU CEA; CNRS; ANR [06-MAPR-0007-01]
FX The authors thank F.-D. Duminica (CIRMAT, Toulouse) for fruitful
   discussions in photocatalysis. C. Anglade and M. Jouve (CEA, Grenoble)
   for technical assistance and A. Di Cara for advice on antibacterial
   tests. This work was supported by CEA, CNRS, and ANR under contract
   06-MAPR-0007-01. This article is part of a special section on CVD of
   Biomaterials.
CR Amezaga-Madrid P, 2003, J PHOTOCH PHOTOBIO B, V70, P45, DOI 10.1016/S1011-1344(03)00054-X
   Arabatzis IM, 2003, APPL CATAL B-ENVIRON, V42, P187, DOI 10.1016/S0926-3373(02)00233-3
   Brook LA, 2007, SURF COAT TECH, V201, P9373, DOI 10.1016/j.surfcoat.2007.04.020
   Brook LA, 2007, J PHOTOCH PHOTOBIO A, V187, P53, DOI 10.1016/j.jphotochem.2006.09.014
   Chen X, 2000, WATER RES, V34, P4229, DOI 10.1016/S0043-1354(00)00187-1
   Coleman HM, 2005, CHEM ENG J, V113, P55, DOI 10.1016/j.cej.2005.07.015
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Duminica FD, 2007, SURF COAT TECH, V201, P9304, DOI 10.1016/j.surfcoat.2007.04.011
   Duminica FD, 2007, THIN SOLID FILMS, V515, P7732, DOI 10.1016/j.tsf.2007.03.057
   Duminica FD, 2004, SURF COAT TECH, V188, P255, DOI 10.1016/j.surfcoat.2004.08.038
   Duminica RD, 2007, SURF COAT TECH, V201, P9349, DOI 10.1016/j.surfcoat.2007.04.061
   Evans P, 2007, SURF COAT TECH, V201, P9319, DOI 10.1016/j.surfcoat.2007.04.013
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Fiss EM, 2008, ENVIRON SCI TECHNOL, V42, P976, DOI 10.1021/es702530r
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gilbert P, 2003, INT BIODETER BIODEGR, V51, P245, DOI 10.1016/S0964-8305(03)00043-X
   Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X
   He C, 2002, APPL SURF SCI, V200, P239, DOI 10.1016/S0169-4332(02)00927-3
   Jeon HJ, 2003, BIOMATERIALS, V24, P4921, DOI 10.1016/S0142-9612(03)00415-0
   Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   LUND W, 1994, PHARM CODEX, P579
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Marini M, 2007, EUR POLYM J, V43, P3621, DOI 10.1016/j.eurpolymj.2007.06.002
   Massi L, 2003, INT J ANTIMICROB AG, V21, P20, DOI 10.1016/S0924-8579(02)00271-6
   Maury F, 2007, CHEM VAPOR DEPOS, V13, P638, DOI 10.1002/cvde.200706600
   Mungkalasiri J, 2009, SURF COAT TECH, V204, P887, DOI 10.1016/j.surfcoat.2009.07.015
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rule KL, 2005, ENVIRON SCI TECHNOL, V39, P3176, DOI 10.1021/es048943+
   Ryu SW, 2004, MATER LETT, V58, P582, DOI 10.1016/S0167-577X(03)00566-4
   SENATEUR JP, Patent No. 5945162
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tang HQ, 2007, SURF COAT TECH, V201, P5633, DOI 10.1016/j.surfcoat.2006.07.171
   Walsh SE, 2003, J HOSP INFECT, V55, P98, DOI 10.1016/S0195-6701(03)00240-8
   Wan YZ, 2007, VACUUM, V81, P1114, DOI 10.1016/j.vacuum.2006.12.011
   Wataha JC, 2000, J BIOMED MATER RES, V52, P360, DOI 10.1002/1097-4636(200011)52:2<360::AID-JBM16>3.0.CO;2-B
   Zhang W, 2006, POLYMER, V47, P931, DOI 10.1016/j.polymer.2005.12.009
   Zhang XW, 2005, MATER CHEM PHYS, V91, P73, DOI 10.1016/j.matchemphys.2004.10.058
NR 42
TC 30
Z9 30
U1 3
U2 42
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0948-1907
J9 CHEM VAPOR DEPOS
JI Chem. Vapor Depos.
PD MAR
PY 2010
VL 16
IS 1-3
BP 35
EP 41
DI 10.1002/cvde.200906764
PG 7
WC Electrochemistry; Materials Science, Coatings & Films; Physics,
   Condensed Matter
SC Electrochemistry; Materials Science; Physics
GA 578BC
UT WOS:000276267300007
DA 2018-10-20
ER

PT J
AU Yang, ZX
   Dai, ZD
   Guo, C
AF Yang ZhiXian
   Dai ZhenDong
   Guo Ce
TI Morphology and mechanical properties of Cybister elytra
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE elytra; morphology; mechanical properties; light-weight structure;
   tensile test
ID LOCKING MECHANISMS; HETEROPTERA; FORCES
AB The mechanical properties and the topological structure of cross-sections found in Cybister elytra are presented. SEM images show the similar geometric structure in transverse and longitudinal sections. Elytra consist of several layers: a dense, black epicuticle, an exocuticle that is braided by several parallel chitin fiber layers in a helix structure, and many bridge piers formed by the fiber bundles that connect the exocuticle to the endodermis, forming a composite, light-weight biomaterial. The mechanical properties along the edge of elytra are measured using a nano-indenter. The hardness and modulus of fresh cybister elytra is 0.31 GPa and 6.13 GPa, respectively. The ultimate stresses of fresh elytra, measured by using a tensile test machine, are 169.2 MPa and 194.5 MPa in the transverse and longitudinal directions, respectively, which is twice higher than that of the dried one. The difference in the two directions indicates that this bio-material has been topologically optimized during evolution. The results may provide a biological template to inspire lightweight structure design for aerospace engineering.
C1 [Yang ZhiXian; Dai ZhenDong; Guo Ce] Nanjing Univ Aeronaut & Astronaut, Inst Bioinspired Struct & Surface Engn, Nanjing 210016, Peoples R China.
   [Yang ZhiXian] Nanjing Univ Aeronaut & Astronaut, Coll Mech & Elect Engn, Nanjing 210016, Peoples R China.
RP Dai, ZD (reprint author), Nanjing Univ Aeronaut & Astronaut, Inst Bioinspired Struct & Surface Engn, Nanjing 210016, Peoples R China.
EM zddai@nuaa.edu.cn
FU National Natural Science Foundation of China [50635030, 50675160];
   Aviation Science Foundation of China [2007ZA52008]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. key project: 50635030 and general project: 50675160)
   and Aviation Science Foundation of China (Grant No. 2007ZA52008).
CR Breed R. S., 1909, BIOL BULL, V6, P289
   Chen A, 2003, EWEEK, V20, P61
   [陈斌 Chen Bin], 2003, [材料研究学报, Chinese Journal of Materials Research], V17, P630
   [陈锦祥 Chen Jinxiang], 2005, [复合材料学报, Acta Materiae Compositae Sinica], V22, P103
   Chen MA, 2007, SCI TECHNOL WELD JOI, V12, P10, DOI 10.1179/174329306X131848
   Cheng Hong, 2002, Acta Entomologica Sinica, V45, P175
   Dai ZD, 2005, C OUT SPAC EXPL TECH, P68
   Dai ZD, 2008, SCI CHINA SER C, V51, P894, DOI 10.1007/s11427-008-0124-7
   Goodwyn PJP, 2003, J INSECT PHYSIOL, V49, P753, DOI 10.1016/S0022-1910(03)00112-4
   Gorb SN, 2002, INTEGR COMP BIOL, V42, P1127, DOI 10.1093/icb/42.6.1127
   Gorb SN, 2003, J MORPHOL, V257, P127, DOI 10.1002/jmor.10070
   Holleway B. A., 1997, NZ J ZOOLOGY, V24, P51
   Kurachi M, 2002, NATURWISSENSCHAFTEN, V89, P295, DOI 10.1007/s00114-002-0332-0
   Liu F, 2008, PHY REV, V77, P901
   Sachs C, 2006, J STRUCT BIOL, V155, P409, DOI 10.1016/j.jsb.2006.06.004
   *SHANGH 1 MED I, 1979, ORG EMBR, P39
   WANG Q, 1996, CHINESE J CATAL, V17, P3
   [杨志贤 YANG Zhixian], 2007, [复合材料学报, Acta Materiae Compositae Sinica], V24, P92
   YI QQ, 2006, PROG NAT SCI, V16, P365
   Zhang J, 2001, CHINESE J ANAL CHEM, V29, P70
   Zhang Yingchun, 2001, J NW U NATURAL SCI E, V31, P522
   戴振东, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P542
NR 22
TC 18
Z9 23
U1 0
U2 14
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD MAR
PY 2010
VL 55
IS 8
BP 771
EP 776
DI 10.1007/s11434-009-0363-4
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 566VI
UT WOS:000275400900016
DA 2018-10-20
ER

PT J
AU Hodzhaoglu, FV
   Nanev, CN
AF Hodzhaoglu, F. V.
   Nanev, C. N.
TI Heterogeneous versus bulk nucleation of lysozyme crystals
SO CRYSTAL RESEARCH AND TECHNOLOGY
LA English
DT Article
DE protein crystal nucleation kinetics; heterogeneous vs homogeneous
   nucleation; thin protein solution layers; forced solution flow
ID EGG-WHITE LYSOZYME; PROTEIN CRYSTALS; HYDROSTATIC-PRESSURE; SOLUTAL
   CONVECTION; CRYSTALLIZATION; GROWTH; SOLUBILITY; KINETICS; FLOW;
   ADHESION
AB Heterogeneous (on-glass) protein crystal nucleation was separated from the bulk one in systems of thin protein solution layers, confined between two glass plates of custom made quasi two-dimensional all-glass cells, as well as by applying forced protein solution flow. Two commercial samples of hen-egg-white lysozyme, Seikagaku and Sigma were used as model proteins. Applying the classical technique of separation in time of nucleation and growth stages with protein solution layers of thickness 0.05 cm we found that the on-glass crystal nucleation prevailed highly with Seikagaku HEWL, while on the opposite, bulk nucleated crystals represented the main crystal firaction in Sigma solution. Also using 0.05 cm solution layers nucleation rates were measured separately for the on-glass and bulk protein crystals. The process was investigated by varying solution layer thicknesses as well, from 0.05 down to 0.01, 0.0065 and 0.002 cm. Studying the influence of the forced protein solution flow on HEWL crystal nucleation the classical double-pulse technique was modified by separating the nucleation and growth stages not only in time, but simultaneously also in place. In this case we found that the ratio of on-glass formed crystal nuclei to bulk nuclei depended on the flow velocity, but in different manner with Seikagaku HEWL and Sigma HEWL. A plausible explanation of our experimental results is that the bulk crystal nucleation occurs on foreign surfaces as well, e.g. on rests of source biomaterial, which are always present in the protein solutions. Moreover, biomaterial seems to be more active nucleant than glass. (C) 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
C1 [Hodzhaoglu, F. V.; Nanev, C. N.] Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, BU-1113 Sofia, Bulgaria.
RP Nanev, CN (reprint author), Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, Acad G Bonchev Str,Bl 11, BU-1113 Sofia, Bulgaria.
EM nanev@ipchp.ipc.bas.bg
FU Committee for Science, Ministry of Education and Science of Bulgaria
   [D-002-3]
FX This project has been completed with the financial support of the
   Committee for Science, Ministry of Education and Science of Bulgaria,
   under contract No. D-002-3. Thank is due to Dr. I. Dimitrov for the
   critical reading of the MS and to Dipl.-Chem. L. Stanoeva, for some
   technical help.
CR Chayen NE, 1997, STRUCTURE, V5, P1269, DOI 10.1016/S0969-2126(97)00279-7
   D'Arcy A, 2003, ACTA CRYSTALLOGR D, V59, P1343, DOI 10.1107/S0907444903009430
   FEHER G, 1985, DIFFRACTION METHODS, P77
   Galkin O, 2000, J AM CHEM SOC, V122, P156, DOI 10.1021/ja9930869
   Galkin O, 1999, J PHYS CHEM B, V103, P10965, DOI 10.1021/jp992786x
   Georgieva DG, 2007, ACTA CRYSTALLOGR D, V63, P564, DOI 10.1107/S0907444907007810
   GRANT ML, 1991, J CRYST GROWTH, V108, P8, DOI 10.1016/0022-0248(91)90347-8
   GRANT ML, 1995, J CRYST GROWTH, V153, P42, DOI 10.1016/S0022-0248(08)80147-9
   Kadowaki A, 2004, J SYNCHROTRON RADIAT, V11, P38, DOI 10.1107/S0909049503023574
   Kaischew R.A., 1950, COMM BULG ACAD SCI P, V1, P100
   KAM Z, 1978, J MOL BIOL, V123, P539, DOI 10.1016/0022-2836(78)90206-1
   Lee CP, 2002, J CRYST GROWTH, V240, P531, DOI 10.1016/S0022-0248(02)00909-0
   LIN M, 1995, IMMUNOTECHNOLOGY, V1, P151, DOI 10.1016/1380-2933(95)00016-X
   Lorber B, 1996, J CRYST GROWTH, V158, P103, DOI 10.1016/0022-0248(95)00399-1
   Nanev CN, 2006, ANN NY ACAD SCI, V1077, P172, DOI 10.1196/annals.1362.013
   Nanev CN, 2007, CRYST RES TECHNOL, V42, P4, DOI 10.1002/crat.200610761
   Nanev CN, 2006, CRYST RES TECHNOL, V41, P505, DOI 10.1002/crat.200510613
   Nanev CN, 2000, CRYST RES TECHNOL, V35, P189, DOI 10.1002/(SICI)1521-4079(200002)35:2<189::AID-CRAT189>3.0.CO;2-U
   NYCE TA, 1991, J CRYST GROWTH, V110, P52, DOI 10.1016/0022-0248(91)90865-3
   OSTWALD W, 1897, Z PHYS CHEM, V22, P302
   Parmar AS, 2007, BIOPHYS CHEM, V129, P224, DOI 10.1016/j.bpc.2007.06.002
   PUSEY M, 1988, J CRYST GROWTH, V90, P105, DOI 10.1016/0022-0248(88)90304-1
   Qi JW, 2000, J CRYST GROWTH, V219, P465, DOI 10.1016/S0022-0248(00)00658-8
   ROSENBERGER F, 1988, J CRYST GROWTH, V90, P74, DOI 10.1016/0022-0248(88)90300-4
   Rosenberger F, 1996, J CRYST GROWTH, V168, P1, DOI 10.1016/0022-0248(96)00358-2
   Rosenberger F, 1996, J CRYST GROWTH, V166, P40, DOI 10.1016/0022-0248(95)00921-3
   Sazaki G, 1996, J CRYST GROWTH, V169, P355, DOI 10.1016/S0022-0248(96)00442-3
   Suzuki Y, 2000, J CRYST GROWTH, V209, P1018, DOI 10.1016/S0022-0248(99)00746-0
   Suzuki Y, 2000, J CRYST GROWTH, V208, P638, DOI 10.1016/S0022-0248(99)00537-0
   Takano KJ, 1997, J CRYST GROWTH, V171, P554, DOI 10.1016/S0022-0248(96)00702-6
   TAMMANN G, 1923, ZUSTANDSAENDERUNGEN, P222
   Tsekova D, 1999, J CRYST GROWTH, V196, P226, DOI 10.1016/S0022-0248(98)00827-6
   Vekilov PG, 1998, J CRYST GROWTH, V186, P251, DOI 10.1016/S0022-0248(97)00521-6
   Vekilov PG, 1999, J CRYST GROWTH, V196, P261, DOI 10.1016/S0022-0248(98)00840-9
   Wang LB, 2008, J CRYST GROWTH, V310, P5370, DOI 10.1016/j.jcrysgro.2008.09.125
   Webb JN, 1999, J CRYST GROWTH, V205, P563, DOI 10.1016/S0022-0248(99)00305-X
   Yin DC, 2008, CRYST RES TECHNOL, V43, P447, DOI 10.1002/crat.200710998
NR 37
TC 8
Z9 8
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0232-1300
J9 CRYST RES TECHNOL
JI Cryst. Res. Technol.
PD MAR
PY 2010
VL 45
IS 3
BP 281
EP 291
DI 10.1002/crat.200900645
PG 11
WC Crystallography
SC Crystallography
GA 568LK
UT WOS:000275523600011
DA 2018-10-20
ER

PT J
AU Bayazit, V
   Bayazit, M
   Bayazit, E
AF Bayazit, Vahdettin
   Bayazit, Murat
   Bayazit, Elif
TI EVALUATION OF BIOCERAMIC MATERIALS IN BIOLOGY AND MEDICINE
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE Bioceramic; biomaterial; biology; medicine
ID CORTICAL BONE; MINERALIZED TISSUES; FRACTURE-TOUGHNESS; CERAMICS;
   CAD/CAM; FABRICATION
AB The aim of this study was to evaluate the properties of bioceramic materials. Therefore, the use of cell technology and tissue engineering requires excellent biomaterials to retain and cultivate cells and tissues both in vitro and in vivo. Indeed, polymers and bioceramics have been developed for biomedical applications, and bioceramics have been implanted for a longer time and proved to be safe for humans. Composites of bioceramics with polymers are also recent advances in fabrication technology of bioceramics. It is lastly stressed that very few materials have been developed since the discovery of the above conventional bioceramics such as calcium phosphates, stabilized zirconia, alumina and bioactive glasses. It is necessary to create new bioceramics for a lasting development in the future. Because of the excellent biocompatibility, matching shade, good anticorrosion ability, bioceramics are ever more widely being used in the biomedical field. Most of these bioceramic appliances need to bear forces during their lives. As result of this inverstigation, bioceramics are expected to be further developed for such newly proposed aims of regenerative medicine.
C1 [Bayazit, Vahdettin] Mus Alparslan Univ, Fac Arts & Sci, Dept Biol, TR-49100 Mus, Turkey.
   [Bayazit, Murat; Bayazit, Elif] Dumlupinar Univ, Fac Engn, Dept Ceram Engn, Kutahya, Turkey.
RP Bayazit, V (reprint author), Mus Alparslan Univ, Fac Arts & Sci, Dept Biol, TR-49100 Mus, Turkey.
EM bvahdettin@yahoo.com
CR Ballarini R, 2005, INT J FRACTURE, V135, P187, DOI 10.1007/s10704-005-3949-0
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Bini F, 2002, J BIOMECH, V35, P1515, DOI 10.1016/S0021-9290(02)00182-3
   Bolton JD, 2002, KEY ENG MAT, V230-2, P447, DOI 10.4028/www.scientific.net/KEM.230-232.447
   BOSKEY AL, 2001, MECH HDB
   Buffrenil V.d., 2004, J ZOOLOGICAL SOC LON, V262, P371
   BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0
   Currey J, 2004, J THEOR BIOL, V231, P569, DOI 10.1016/j.jtbi.2004.07.013
   Currey J.D., 2002, BONES STRUCTURE MECH
   Currey JD, 2004, P ROY SOC B-BIOL SCI, V271, P517, DOI 10.1098/rspb.2003.2634
   Currey JD, 2003, ARCH ORAL BIOL, V48, P439, DOI 10.1016/S0003-9969(03)00037-2
   Day JS, 2004, J ORTHOPAED RES, V22, P465, DOI 10.1016/j.orthres.2003.05.001
   Donoghue PCJ, 2006, J EXP ZOOL PART B, V306B, P278, DOI 10.1002/jez.b.21090
   Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013
   Fujisaki K, 2007, J BIOMECH, V40, P1832, DOI 10.1016/j.jbiomech.2006.07.003
   Guazzato M, 2004, DENT MATER, V20, P441, DOI 10.1016/j.dental.2003.05.003
   ONODA GY, 1978, CERAMIC PROCESSING S
   Pinsky HM, 2007, J ENDODONT, V33, P148, DOI 10.1016/j.joen.2006.10.005
   Rudolph H, 2007, COMPUT BIOL MED, V37, P579, DOI 10.1016/j.compbiomed.2006.05.006
   Sasagawa I, 2006, MAT SCI ENG C-BIO S, V26, P630, DOI 10.1016/j.msec.2005.04.010
   Vijayan S, 2002, MATER LETT, V56, P827, DOI 10.1016/S0167-577X(02)00622-5
   Wang XL, 2006, MATER LETT, V60, P455, DOI 10.1016/j.matlet.2005.09.010
   Yeni YN, 2000, J BIOMED MATER RES, V51, P504, DOI 10.1002/1097-4636(20000905)51:3<504::AID-JBM27>3.0.CO;2-I
   Yin L, 2006, INT J MACH TOOL MANU, V46, P1013, DOI 10.1016/j.ijmachtools.2005.07.045
   Zhang FZ, 2006, J EUR CERAM SOC, V26, P667, DOI 10.1016/j.jeurceramsoc.2005.07.021
NR 25
TC 1
Z9 1
U1 0
U2 7
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD MAR
PY 2010
VL 5
IS 1
BP 267
EP 278
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 577LG
UT WOS:000276224100041
DA 2018-10-20
ER

PT J
AU Lofgren, H
   Engquist, M
   Hoffmann, P
   Sigstedt, B
   Vavruch, L
AF Lofgren, Hakan
   Engquist, M.
   Hoffmann, P.
   Sigstedt, B.
   Vavruch, L.
TI Clinical and radiological evaluation of Trabecular Metal and the
   Smith-Robinson technique in anterior cervical fusion for degenerative
   disease: a prospective, randomized, controlled study with 2-year
   follow-up
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE Spinal fusion; Cervical vertebrae; Tantalum; Trabecular Metal;
   Randomized controlled trial
ID CARBON-FIBER CAGE; LOCAL-ANESTHETIC INFUSION; DONOR SITE MORBIDITY;
   BONE-GRAFT SITE; INTERBODY FUSION; POROUS TANTALUM; ILIAC CREST;
   STATISTICAL EVALUATION; SPINAL ARTHRODESIS; CLOWARD PROCEDURE
AB A prospective, randomized, controlled study was carried out to compare the radiological and clinical outcomes after anterior cervical decompression and fusion (ACDF) with Trabecular Metal (TM) (TM) to the traditional Smith-Robinson (SR) procedure with autograft. The clinical results of cervical fusion with autograft from the iliac crest are typically satisfactory, but implications from the donor site are frequently reported. Alternative materials for cervical body interfusion have shown lower fusion rates. Trabecular Metal is a porous tantalum biomaterial with structure and mechanical properties similar to that of trabecular bone and with proven osteoconductivity. As much as 80 consecutive patients planned for ACDF were randomized for fusion with either TM or tricortical autograft from the iliac crest (SR) after discectomy and decompression. Digitized plain radiographic images of 78 (98%) patients were obtained preoperatively and at 2-year follow-up and were subsequently evaluated by two senior radiologists. Fusion/non-fusion was classified by visual evaluation of the A-P and lateral views in forced flexion/extension of the cervical spine and by measuring the mobility between the fused vertebrae. MRI of 20 TM cases at 2 years was successfully used to assess the decompression of the neural structures, but was not helpful in determining fusion/non-fusion. Pain intensity in the neck, arms and pelvis/hip were rated by patients on a visual analog scale (VAS) and neck function was rated using the Neck Disability Index (NDI) the day before surgery and 4, 12 and 24 months postoperatively. Follow-ups at 12 and 24 months were performed by an unbiased observer, when patients also assessed their global outcome. Fusion rate in the SR group was 92%, and in the TM group 69% (P < 0.05). The accuracy of the measurements was calculated to be 2.4A degrees. Operating time was shorter for fusion with TM compared with autograft; mean times were 100 min (SD 18) and 123 min (SD 23), respectively (P = 0.001). The patients' global assessments of their neck and arm symptoms 2 years postoperatively for the TM group were rated as 79% much better or better after fusion with TM and 75% using autograft. Pain scores and NDI scores were significantly improved in both groups when compared with baseline at all follow-ups, except for neck pain at 1 year for the TM group. There was no statistically significant difference in clinical outcomes between fusion techniques or between patients who appeared radiologically fused or non-fused. There was no difference in pelvic/hip pain between patients operated on with or without autograft. In our study, Trabecular Metal showed a lower fusion rate than the Smith-Robinson technique with autograft after single-level anterior cervical fusion without plating. There was no difference in clinical outcomes between the groups. The operative time was shorter with Trabecular Metal implants.
C1 [Lofgren, Hakan; Vavruch, L.] Ryhov Hosp, Neuroorthoped Ctr, S-55185 Jonkoping, Sweden.
   [Engquist, M.] Ryhov Hosp, Dept Orthoped, S-55185 Jonkoping, Sweden.
   [Hoffmann, P.; Sigstedt, B.] Ryhov Hosp, Dept Radiol, S-55185 Jonkoping, Sweden.
RP Lofgren, H (reprint author), Ryhov Hosp, Neuroorthoped Ctr, S-55185 Jonkoping, Sweden.
EM Hakan.Lofgren@lj.se
CR BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barbour SA, 2003, AM J SPORT MED, V31, P791, DOI 10.1177/03635465030310052801
   BASKIN DS, 2004, ANN M CERV SPIN RES
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Boden SD, 1996, INT SOC STUDY LUMBAR, P1284
   Bucci M N, 1998, J S C Med Assoc, V94, P9
   BUCK BE, 1989, CLIN ORTHOP RELAT R, P129
   Cannada LK, 2003, SPINE, V28, P46, DOI 10.1097/00007632-200301010-00012
   Cauthen JC, 1998, SPINE, V23, P188, DOI 10.1097/00007632-199801150-00008
   CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   DEPALMA AF, 1972, SURG GYNECOL OBSTETR, V134, P755
   Fassett DR, 2008, J NEUROSURG-SPINE, V8, P544, DOI 10.3171/SPI/2008/8/6/544
   Fernandez-Fairen M, 2008, SPINE, V33, P465, DOI 10.1097/BRS.0b013e3181657f49
   Fujibayashi S, 2008, J CLIN NEUROSCI, V15, P1017, DOI 10.1016/j.jocn.2007.05.011
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   KARRHOLM J, 1989, ACTA ORTHOP SCAND, V60, P491, DOI 10.3109/17453678909149328
   Kelly DJ, 2001, CAN J ANAESTH, V48, P1000, DOI 10.1007/BF03016591
   Lavand'homme P, 2006, CURR OPIN ANESTHESIO, V19, P556, DOI 10.1097/01.aco.0000245284.53152.1f
   Leivseth G, 2006, EUR SPINE J, V15, P774, DOI 10.1007/s00586-005-0929-z
   Levi ADO, 1998, SPINE, V23, P1245, DOI 10.1097/00007632-199806010-00014
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Lind BI, 2007, EUR SPINE J, V16, P1251, DOI 10.1007/s00586-007-0337-7
   Lofgren H, 1999, NEURO-ORTHOPEDICS, V26, P19
   Lofgren H, 2000, SPINE, V25, P1908, DOI 10.1097/00007632-200008010-00008
   Mroz TE, 2008, J AM ACAD ORTHOP SUR, V16, P559, DOI 10.5435/00124635-200810000-00001
   Peolsson A, 2007, EUR SPINE J, V16, P173, DOI 10.1007/s00586-006-0067-2
   Pollock R, 2008, EUR SPINE J, V17, P845, DOI 10.1007/s00586-008-0648-3
   Ryd L, 2000, ACTA ORTHOP SCAND, V71, P403, DOI 10.1080/000164700317393420
   Ryu SI, 2006, EUR SPINE J, V15, P157, DOI 10.1007/s00586-005-0951-1
   Samartzis Dino, 2004, Spine J, V4, P636, DOI 10.1016/j.spinee.2004.04.010
   SAVOLAINEN S, 1994, ACTA NEUROCHIR, V129, P54, DOI 10.1007/BF01400873
   Schnee CL, 1997, SPINE, V22, P2222, DOI 10.1097/00007632-199710010-00005
   SCHOETTLE T, 2005, ANN M CERV SPIN RES
   Shimamoto N, 2001, SPINE, V26, pE432
   Singh K, 2005, SPINE, V30, P2477, DOI 10.1097/01.brs.0000186323.11285.b1
   Singh K, 2007, SPINE, V32, P2790, DOI 10.1097/BRS.0b013e31815b7650
   SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009
   Svensson E, 1998, STAT MED, V17, P2923, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2923::AID-SIM104>3.0.CO;2-#
   Svensson E, 2001, J REHABIL MED, V33, P47, DOI 10.1080/165019701300006542
   Vaccaro Alexander R, 2002, Spine J, V2, P206, DOI 10.1016/S1529-9430(02)00180-8
   van Limbeek J, 2000, EUR SPINE J, V9, P129, DOI 10.1007/s005860050223
   Vavruch L, 2002, SPINE, V27, P1694, DOI 10.1097/01.BRS.0000020130.40282.B3
   VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409
   Wang JC, 1998, SPINE, V23, P1684, DOI 10.1097/00007632-199808010-00014
   WHITE AA, 1973, J BONE JOINT SURG AM, VA 55, P525, DOI 10.2106/00004623-197355030-00008
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zoega B, 2003, EUR SPINE J, V12, P631, DOI 10.1007/s00586-003-0362-x
   Zoega B, 2000, EUR SPINE J, V9, P137, DOI 10.1007/s005860050224
   ZOEGA B, 2005, ANN M CERV SPIN RES
   Zou XN, 2005, SPINE, V30, pE392, DOI 10.1097/01.brs.0000170588.80377.3f
NR 51
TC 33
Z9 38
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD MAR
PY 2010
VL 19
IS 3
BP 464
EP 473
DI 10.1007/s00586-009-1161-z
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 567DU
UT WOS:000275424100017
PM 19763634
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Roupret, M
   Misrai, V
   Vaessen, C
   Cardot, V
   Cour, F
   Richard, F
   Chartier-Kastler, E
AF Roupret, Morgan
   Misrai, Vincent
   Vaessen, Christophe
   Cardot, Vincent
   Cour, Florence
   Richard, Francois
   Chartier-Kastler, Emmanuel
TI Laparoscopic Approach for Artificial Urinary Sphincter Implantation in
   Women with Intrinsic Sphincter Deficiency Incontinence: A Single-Centre
   Preliminary Experience
SO EUROPEAN UROLOGY
LA English
DT Article
DE Urinary incontinence; Laparoscopy; Urinary sphincter; Artificial;
   Biomaterial
ID III INCONTINENCE; FEMALE-PATIENTS; MANAGEMENT; SYSTEM
AB Background: Implantation of an artificial urinary sphincter (AUS) is used as a last resort in women with stress urinary incontinence (SUI).
   Objective: To assess the early functional outcome after laparoscopic placement of an AUS in women.
   Design, setting, and participants: Twelve women with type 3 SUI underwent a laparoscopic AUS placement between 2006 and 2008. Eleven (92%) had previously undergone anti-incontinence procedures.
   Intervention: The AUS was implanted with laparoscopic access either preperitoneally or intraperitoneally. The cuff was placed around the bladder neck between the periurethral fascia and the vagina.
   Measurements: Perioperative complications were reviewed. To assess resolution of urinary incontinence, all patients were seen at 1, 3, 6, and 12 mo after the surgery and yearly thereafter.
   Results and limitations: The mean age of subjects was 56.7 +/- 12 yr (33-78). The mean body mass index was 24 +/- 2.3 (20-25). The mean preoperative closure pressure was 22 +/- 10.9 cmH(2)O (4-35). The mean operative time was 181 +/- 39 min [110-240]. Intraoperative complications occurred in three women (25%), with bladder (n = 2) and vaginal ( n = 2) injuries. These complications required open conversion. AUS implantation was postponed in one case. The mean hospital stay was 7 +/- 2.3 d (3-11). The bladder catheter was removed after a mean time of 10 +/- 8 d (2-30). Urinary retention was observed in five cases (45%) after bladder catheter removal. AUS activationwas done 4-14 wk after implantation. Mean follow-up was 12.1 +/- 8 mo (5.2-27). Incontinence was completely resolved in eight women (88%) who underwent complete laparoscopic procedure. The main limitation of the study was the limited length of follow-up.
   Conclusions: AUS implantation can be successfully achieved by laparoscopy. It appears to be technically feasible. These results are still preliminary, and further studies of larger populations with longer follow-up are needed to make any statement regarding surgical strategy. (C) 2009 European Association of Urology. Published by Elsevier B.V. All rights reserved.
C1 [Roupret, Morgan; Misrai, Vincent; Vaessen, Christophe; Cardot, Vincent; Cour, Florence; Richard, Francois; Chartier-Kastler, Emmanuel] Univ Paris 06, Fac Med, Pitie Salpetriere Hosp, Grp Hosp Univ EST,Dept Urol,AP HP, Paris, France.
RP Roupret, M (reprint author), Hosp Pitie Salpetriere, Acad Urol Dept, 47-83 Blvd Hop, F-75013 Paris, France.
EM morgan.roupret@psl.aphp.fr
CR ABBASSIAN A, 1988, J UROLOGY, V140, P512, DOI 10.1016/S0022-5347(17)41705-8
   APPELL RA, 1988, NEUROUROL URODYNAM, V7, P613, DOI 10.1002/nau.1930070611
   BLAIVAS JG, 1988, J UROLOGY, V139, P727, DOI 10.1016/S0022-5347(17)42611-5
   Costa P, 2001, J UROLOGY, V165, P1172, DOI 10.1016/S0022-5347(05)66459-2
   DIOKNO AC, 1987, J UROLOGY, V138, P778, DOI 10.1016/S0022-5347(17)43370-2
   Hoda MR, 2008, UROLOGE, V47, P1004, DOI 10.1007/s00120-008-1739-9
   Hussain M, 2005, J UROLOGY, V174, P418, DOI 10.1097/01.ju.0000165345.11199.98
   Kreder KJ, 1996, J ENDOUROL, V10, P255, DOI 10.1089/end.1996.10.255
   Lose G, 2002, INT UROGYNECOL J PEL, V13, P215, DOI 10.1007/s001920200047
   Ngninkeu BN, 2005, EUR UROL, V47, P793, DOI 10.1016/j.eururo.2005.01.010
   Petero VG, 2006, J UROLOGY, V175, P605, DOI 10.1016/S0022-5347(05)00243-0
   RICHARD F, 1996, J UROL S, V155
   RICHARD F, 1996, EUR UROL SUPPL, V32, P420
   Roupret M, 2005, PROG UROL, V15, P489
   Roupret M, 2004, J UROLOGY, V172, P236, DOI 10.1097/01.ju.0000132151.53532.86
   Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066
   Schick V, 2005, UROLOGE, V44, P794, DOI 10.1007/s00120-005-0808-6
   Storm DW, 2008, UROLOGY, V72, P1149, DOI 10.1016/j.urology.2008.07.005
   Thomas K, 2002, J UROLOGY, V167, P1720, DOI 10.1016/S0022-5347(05)65185-3
   Venn SN, 2000, J UROLOGY, V164, P702, DOI 10.1016/S0022-5347(05)67285-0
   WEBSTER GD, 1992, UROLOGY, V39, P499, DOI 10.1016/0090-4295(92)90001-D
   Wilson SK, 2003, J UROLOGY, V169, P261, DOI 10.1097/01.ju.0000040661.45037.47
NR 22
TC 28
Z9 29
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0302-2838
J9 EUR UROL
JI Eur. Urol.
PD MAR
PY 2010
VL 57
IS 3
BP 499
EP 504
DI 10.1016/j.eururo.2009.03.045
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 548TH
UT WOS:000273988700030
PM 19346059
DA 2018-10-20
ER

PT J
AU Lee, JH
   Choi, YJ
   Lim, YB
AF Lee, Jun-hyung
   Choi, Young Joo
   Lim, Yong-beom
TI Self-assembled filamentous nanostructures for drug/gene delivery
   applications
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE biomaterials; drug delivery; filamentous nanostructures; gene delivery;
   nanotechnology; self-assembly
ID BLOCK-COPOLYMER MICELLES; BETA-SHEET; GENE DELIVERY; GOLD NANOPARTICLES;
   CARBON NANOTUBES; ROD-COIL; MULTIVALENT LIGANDS; MACROMOLECULAR
   THERAPEUTICS; SUPRAMOLECULAR STRUCTURES; ARTIFICIAL VIRUSES
AB Importance of the field: Among many nanostructural shapes, filamentous shapes can have unique advantages over the others, including longer persistence in the bloodstream. With the advent of nanotechnology in recent years, a variety of shape-controlled nanostructures has been fabricated. As a wide variety of building blocks can self-assemble into filamentous nanostructures, there are many options available for biomaterial developments with filamentous nanostructures. Similarly to conventional spherical micelles, most filamentous nanostructures have hydrophobic cores where hydrophobic guest molecules can be encapsulated, which enable them to be used in drug delivery applications. Moreover, on suitable molecular design and self-assembly process control, filamentous nanostructures can also be made to deliver nucleic acids or even both drugs and nucleic acids simultaneously.
   Areas covered in this review: This review describes the self-assembly process, current developments, and prospects of filamentous nanostructures in drug and gene delivery applications.
   What the reader will gain: This review should be helpful in gaining insight into the self-assembly process and nanostructural shape control, the advantages of constructing filamentous nanostructures, and the design of more advanced nanobiomaterials.
   Take home message: At present, the development of multifunctional nanostructures is one of the main focuses in nanobiomaterial developments. In this regard, filamentous nanostructures can be good initial targets for tailor-made nanostructure developments because they have more structural variables, as compared with spherical micelles.
C1 [Lee, Jun-hyung; Lim, Yong-beom] Yonsei Univ, Dept Mat Sci & Engn, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea.
   [Choi, Young Joo] Seoul Natl Univ, Sch Publ Hlth, Inst Hlth & Environm, Seoul 110460, South Korea.
RP Lim, YB (reprint author), Yonsei Univ, Dept Mat Sci & Engn, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea.
EM yblim@yonsei.ac.kr
RI Lim, Yong-beom/D-3603-2011
FU National Research Foundation (NRF) of Korea [2009-0066736, 2009-0076516,
   2009-0082617]; Translational Research Center for Protein Function
   Control, Yonsei University [2009-0092971]; Priority Research Center
   [2009-0093823]; Yonsei University [2009-7-0126]
FX The authors thank the National Research Foundation (NRF) of Korea for
   support through Grants-in-aid 2009-0066736, 2009-0076516 and
   2009-0082617, and the grants from the Translational Research Center for
   Protein Function Control, Yonsei University (2009-0092971), Priority
   Research Center (2009-0093823) and Yonsei University Research Fund
   (2009-7-0126).
CR Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533
   Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971
   Aoyama Y, 2003, J AM CHEM SOC, V125, P3455, DOI 10.1021/ja029608t
   Appleton DJ, 2002, J FELINE MED SURG, V4, P13, DOI 10.1053/jfms.2001.0157
   Binder WH, 2006, ANGEW CHEM INT EDIT, V45, P7324, DOI 10.1002/anie.200602001
   Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q
   Chen X, 2006, J AM CHEM SOC, V128, P6292, DOI 10.1021/ja060276s
   Christian DA, 2009, MOL PHARMACEUT, V6, P1343, DOI 10.1021/mp900022m
   Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093
   Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768
   Cui H, 2009, NANO LETT, V9, P945, DOI 10.1021/nl802813f
   Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016
   E Gazit, 2007, PLENTY ROOM BIOL BOT
   Fang B, 2009, ANGEW CHEM INT EDIT, V48, P2877, DOI 10.1002/anie.200806051
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r
   Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70
   GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0
   Gillies ER, 2007, ANGEW CHEM INT EDIT, V46, P4081, DOI 10.1002/anie.200700301
   Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i
   GOODSELL DS, 2004, BIONANOTECHNOLOGY LE
   Gore T, 2001, LANGMUIR, V17, P5352, DOI 10.1021/la010223i
   Hamley IW, 2007, ANGEW CHEM INT EDIT, V46, P8128, DOI 10.1002/anie.200700861
   Han M, 2007, J CONTROL RELEASE, V121, P38, DOI 10.1016/j.jconrel.2007.05.012
   Hanson JA, 2008, NATURE, V455, P85, DOI 10.1038/nature07197
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597
   Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t
   Hu JW, 2008, J AM CHEM SOC, V130, P3236, DOI 10.1021/ja075201i
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA
   Janssen ML, 2002, CANCER RES, V62, P6146
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794
   Kim BS, 2005, J AM CHEM SOC, V127, P16333, DOI 10.1021/ja055999a
   Kim HJ, 2008, J POLYM SCI POL CHEM, V46, P1925, DOI 10.1002/pola.22569
   Kim JK, 2008, ANGEW CHEM INT EDIT, V47, P4662, DOI 10.1002/anie.200705863
   Konig HM, 2007, ANGEW CHEM INT EDIT, V46, P8334, DOI 10.1002/anie.200701167
   Kostarelos K, 2008, NAT BIOTECHNOL, V26, P774, DOI 10.1038/nbt0708-774
   Lee M, 2001, CHEM REV, V101, P3869, DOI 10.1021/cr0001131
   Lee YS., 2008, SELF ASSEMBLY NANOTE
   Lim YB, 2002, BIOCONJUGATE CHEM, V13, P952, DOI 10.1021/bc025541n
   Lim YB, 1999, J AM CHEM SOC, V121, P5633, DOI 10.1021/ja984012k
   Lim YB, 2000, J AM CHEM SOC, V122, P6524, DOI 10.1021/ja001033h
   Lim YB, 2001, J AM CHEM SOC, V123, P2460, DOI 10.1021/ja005715g
   Lim Y, 2008, ORG BIOMOL CHEM, V6, P1944, DOI 10.1039/b802470g
   Lim YB, 2008, J MATER CHEM, V18, P2909, DOI 10.1039/b802639d
   Lim YB, 2008, ANGEW CHEM INT EDIT, V47, P4525, DOI 10.1002/anie.200800266
   Lim YB, 2008, J MATER CHEM, V18, P723, DOI 10.1039/b711188f
   Lim YB, 2007, ANGEW CHEM INT EDIT, V46, P9011, DOI 10.1002/anie.200702732
   Lim YB, 2007, CHEM-ASIAN J, V2, P1363, DOI 10.1002/asia.200700163
   Lim YB, 2007, BIOMACROMOLECULES, V8, P1404, DOI 10.1021/bm0700901
   Lim YB, 2007, ANGEW CHEM INT EDIT, V46, P3475, DOI 10.1002/anie.200604576
   Lim YB, 2009, ANGEW CHEM INT EDIT, V48, P1601, DOI 10.1002/anie.200804665
   Lim YB, 2009, CHEM SOC REV, V38, P925, DOI 10.1039/b809741k
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   Mastrobattista E, 2006, NAT REV DRUG DISCOV, V5, P115, DOI 10.1038/nrd1960
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   MENGER FM, 2000, ANGEW CHEM INT EDIT, V39, P1906, DOI DOI 10.1002/1521-3773
   Mimna R, 2007, ANGEW CHEM INT EDIT, V46, P2681, DOI 10.1002/anie.200603681
   Moon KS, 2008, CHEM COMMUN, P4001, DOI 10.1039/b806559d
   Nesloney CL, 1996, BIOORGAN MED CHEM, V4, P739, DOI 10.1016/0968-0896(96)00051-X
   Oda R, 2008, J AM CHEM SOC, V130, P14705, DOI 10.1021/ja8048964
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378
   Papapostolou D, 2008, J AM CHEM SOC, V130, P5124, DOI 10.1021/ja0778444
   Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770
   Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492
   Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   Raffa V, 2008, CARBON, V46, P1600, DOI 10.1016/j.carbon.2008.06.053
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Ryu JH, 2007, J AM CHEM SOC, V129, P4808, DOI 10.1021/ja070173p
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Schatz C, 2009, ANGEW CHEM INT EDIT, V48, P2572, DOI 10.1002/anie.200805895
   Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2
   Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831
   Shi HT, 2005, ADV FUNCT MATER, V15, P442, DOI 10.1002/adfm.200400242
   Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j
   Strzalka J, 2006, NANO LETT, V6, P2395, DOI 10.1021/nl062092h
   Thoma G, 2002, ANGEW CHEM INT EDIT, V41, P3195, DOI 10.1002/1521-3773(20020902)41:17<3195::AID-ANIE3195>3.0.CO;2-X
   Tuzikov AB, 2003, CHEMBIOCHEM, V4, P147, DOI 10.1002/cbic.200390025
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Wang HF, 2006, J AM CHEM SOC, V128, P13364, DOI 10.1021/ja065455o
   Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382
   Warren SC, 2008, SCIENCE, V320, P1748, DOI 10.1126/science.1159950
   Xu PS, 2008, ANGEW CHEM INT EDIT, V47, P1260, DOI 10.1002/anie.200703203
   Yiu HHP, 2005, J MATER CHEM, V15, P3690, DOI 10.1039/b506090g
   Yoon YR, 2008, CHEM COMMUN, P1892, DOI 10.1039/b719868j
   Zhang K, 2008, BIOCONJUGATE CHEM, V19, P1880, DOI 10.1021/bc800160b
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
NR 95
TC 20
Z9 20
U1 1
U2 32
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD MAR
PY 2010
VL 7
IS 3
BP 341
EP 351
DI 10.1517/17425240903559841
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 572WK
UT WOS:000275864600007
PM 20201738
DA 2018-10-20
ER

PT J
AU Liu, S
   Elmer, C
   Low, NH
   Nickerson, MT
AF Liu, S.
   Elmer, C.
   Low, N. H.
   Nickerson, M. T.
TI Effect of pH on the functional behaviour of pea protein isolate-gum
   Arabic complexes
SO FOOD RESEARCH INTERNATIONAL
LA English
DT Article
DE Pea protein isolate; Gum Arabic; Complex coacervation; Emulsification;
   Foaming; Solubility
ID AIR-WATER-INTERFACE; POLYSACCHARIDE INTERACTIONS; WHEY PROTEINS;
   BETA-LACTOGLOBULIN; XANTHAN GUM; COACERVATION; CARBOXYMETHYLCELLULOSE;
   CARRAGEENAN; STABILITY; SYSTEMS
AB The functional behaviour (Solubility, emulsifying and foaming properties) of pea protein isolate (PPI) and gum Arabic (GA) mixtures were investigated as a function of pH (4.30-2.40) within a region dominated by complex coacervation. Emulsion stability was also investigated using a one- and two-step emulsification approach. Complex coacervation was monitored by turbidimetric acid titration at a 2:1 PPI-GA ratio to reveal the formation Of Soluble (pH 4.23) and insoluble (pH 3.77) complexes, maximum biopolymer interactions (pH 3.60), and dissolution of complexes (pH 2.62). Emulsion stability was greater for mixed systems relative to PPI alone at pHs between 3.10 and 4.00, and in those prepared using the one-step method. Foam expansion was independent of both biopolymer content and pH, whereas foam stability was improved for the mixed system between pH 3.10 and 4.00. The pH-solubility minimum was broadened relative to PPI to more acidic pHs. Findings suggest that admixtures of PPI and GA under complexing conditions could represent a new blended food and/or biomaterial ingredient. (C) 2009 Elsevier Ltd. All rights reserved
C1 [Liu, S.; Elmer, C.; Low, N. H.; Nickerson, M. T.] Univ Saskatchewan, Dept Food & Bioprod Sci, Saskatoon, SK S7N 5A8, Canada.
RP Nickerson, MT (reprint author), Univ Saskatchewan, Dept Food & Bioprod Sci, 51 Campus Dr, Saskatoon, SK S7N 5A8, Canada.
EM Michael.Nickerson@usask.ca
FU Saskatchewan Agriculture Development Fund, the Saskatchewan Ministry of
   Agriculture Strategic Research Chair Program and the Advanced Foods and
   Materials Network (AFMNet)
FX Financial assistance for this study was provided by the Saskatchewan
   Agriculture Development Fund, the Saskatchewan Ministry of Agriculture
   Strategic Research Chair Program and the Advanced Foods and Materials
   Network (AFMNet). Special thanks to Mr. Yuanlong Cao for providing
   technical assistance throughout this study.
CR *AOAC, 2003, OFF METH AN
   Braudo EE, 2001, NAHRUNG, V45, P382, DOI 10.1002/1521-3803(20011001)45:6<382::AID-FOOD382>3.0.CO;2-W
   Chourpa I, 2006, BIOMACROMOLECULES, V7, P2616, DOI 10.1021/bm060131d
   Crevieu I, 1996, NAHRUNG, V40, P237, DOI 10.1002/food.19960400502
   de Kruif CG, 2001, FOOD HYDROCOLLOID, V15, P555, DOI 10.1016/S0268-005X(01)00076-5
   de Vries R, 2003, J CHEM PHYS, V118, P4649, DOI 10.1063/1.1543981
   Dickinson E, 1998, FOOD HYDROCOLLOID, V12, P417, DOI 10.1016/S0268-005X(98)00055-1
   Dickinson E, 1998, TRENDS FOOD SCI TECH, V9, P347, DOI 10.1016/S0924-2244(98)00057-0
   Dickinson E, 2003, FOOD HYDROCOLLOID, V17, P25, DOI 10.1016/S0268-005X(01)00120-5
   Dror Y, 2006, J POLYM SCI POL PHYS, V44, P3265, DOI 10.1002/polb.20970
   DUBOIS M, 1956, ANAL CHEM, V28, P356, DOI DOI 10.1021/AC60111A017
   Ducel V, 2005, BIOMACROMOLECULES, V6, P790, DOI 10.1021/bm0494601
   Ducel V, 2004, COLLOID SURFACE A, V232, P239, DOI 10.1016/j.corlsurfa.2003.11.001
   Galazka VB, 1999, FOOD HYDROCOLLOID, V13, P425, DOI 10.1016/S0268-005X(99)00028-4
   Ganzevles RA, 2006, FOOD HYDROCOLLOID, V20, P872, DOI 10.1016/j.foodhyd.2005.08.009
   Girard M, 2004, COLLOID SURFACE B, V35, P15, DOI 10.1016/j.colsurfb.2004.02.002
   Guzey D, 2004, FOOD HYDROCOLLOID, V18, P967, DOI 10.1016/j.foodhyd.2004.04.001
   HANSEN PMT, 1971, J DAIRY SCI, V54, P830, DOI 10.3168/jds.S0022-0302(71)85927-1
   Jourdain L, 2008, FOOD HYDROCOLLOID, V22, P647, DOI 10.1016/j.foodhyd.2007.01.007
   KOH GL, 1988, J PHARM PHARMACOL, V40, P309, DOI 10.1111/j.2042-7158.1988.tb05257.x
   Liu SH, 2009, J AGR FOOD CHEM, V57, P1521, DOI 10.1021/jf802643n
   Makri EA, 2007, FOOD CHEM, V101, P37, DOI 10.1016/j.foodchem.2005.12.051
   Martinez KD, 2007, FOOD HYDROCOLLOID, V21, P804, DOI 10.1016/j.foodhyd.2006.11.005
   MORR CV, 1985, J FOOD SCI, V50, P1715, DOI 10.1111/j.1365-2621.1985.tb10572.x
   Moure A, 2006, FOOD RES INT, V39, P945, DOI 10.1016/j.foodres.2006.07.002
   Ortiz SEM, 2004, FOOD HYDROCOLLOID, V18, P1045, DOI 10.1016/j.foodhyd.2004.04.011
   Papalamprou EM, 2005, J SCI FOOD AGR, V85, P1967, DOI 10.1002/jsfa.2159
   Plashchina IG, 2001, ROY SOC CH, P293, DOI 10.1039/9781847550842-00293
   SAMANT SK, 1993, INT J FOOD SCI TECH, V28, P547
   Sanchez C, 2006, J COLLOID INTERF SCI, V299, P867, DOI 10.1016/j.jcis.2006.02.031
   Schmitt C, 1998, CRIT REV FOOD SCI, V38, P689, DOI 10.1080/10408699891274354
   Turgeon SL, 2003, CURR OPIN COLLOID IN, V8, P401, DOI 10.1016/S1359-0294(03)00093-1
   Uruakpa FO, 2005, FOOD RES INT, V38, P659, DOI 10.1016/j.foodres.2005.01.004
   Vikelouda M, 2004, FOOD HYDROCOLLOID, V18, P21, DOI 10.1016/S0268-005X(03)00038-9
   Wang YF, 1996, BIOTECHNOL PROGR, V12, P356, DOI 10.1021/bp960013+
   Weinbreck F, 2003, BIOMACROMOLECULES, V4, P293, DOI 10.1021/bm025667n
   Weinbreck F, 2003, LANGMUIR, V19, P9404, DOI 10.1021/la0348214
   Weinbreck F, 2004, J AGR FOOD CHEM, V52, P3550, DOI 10.1021/jf034969t
   Wilde P. J., 1996, METHODS TESTING PROT, P110, DOI 10. 1007/978-1-4613-1219-2
   Xie YR, 1997, J FOOD SCI, V62, P1101, DOI 10.1111/j.1365-2621.1997.tb12222.x
NR 40
TC 73
Z9 78
U1 1
U2 74
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0963-9969
J9 FOOD RES INT
JI Food Res. Int.
PD MAR
PY 2010
VL 43
IS 2
SI SI
BP 489
EP 495
DI 10.1016/j.foodres.2009.07.022
PG 7
WC Food Science & Technology
SC Food Science & Technology
GA 563TW
UT WOS:000275158400009
DA 2018-10-20
ER

PT J
AU Broekhuizen, CAN
   Sta, M
   Vandenbroucke-Grauls, CMJE
   Zaat, SAJ
AF Broekhuizen, C. A. N.
   Sta, M.
   Vandenbroucke-Grauls, C. M. J. E.
   Zaat, S. A. J.
TI Microscopic Detection of Viable Staphylococcus epidermidis in
   Peri-Implant Tissue in Experimental Biomaterial-Associated Infection,
   Identified by Bromodeoxyuridine Incorporation
SO INFECTION AND IMMUNITY
LA English
DT Article
ID SUBCUTANEOUS ABSCESS FORMATION; IN-SITU HYBRIDIZATION; ESCHERICHIA-COLI;
   BACTERIAL BIOFILMS; ACTIVE BACTERIA; SHORT-TERM; BLOOD; CELLS; MICE; DNA
AB Infection of biomedical devices is characterized by biofilm formation and colonization of surrounding tissue by the causative pathogens. To investigate whether bacteria detected microscopically in tissue surrounding infected devices were viable, we used bromodeoxyuridine (BrdU), a nucleotide analogue that is incorporated into bacterial DNA and can be detected with antibodies. Infected human tissue was obtained postmortem from patients with intravascular devices, and mouse biopsy specimens were obtained from mice with experimental biomaterial infection. In vitro experiments showed that Staphylococcus epidermidis incorporated BrdU, as judged from staining of the bacteria with anti-BrdU antibodies. After incubation of bacteria with BrdU and subsequent staining of microscopic sections with anti-BrdU antibodies, bacteria could be clearly visualized in the tissue surrounding intravascular devices of deceased patients. With this staining technique, relapse of infection could be visualized in mice challenged with a low dose of S. epidermidis and treated with dexamethasone between 14 and 21 days after challenge to suppress immunity. This confirms and extends our previous findings that pericatheter tissue is a reservoir for bacteria in biomaterial-associated infection. The pathogenesis of the infection and temporo-spatial distribution of viable, dividing bacteria can now be studied at the microscopic level by immunolabeling with BrdU and BrdU antibodies.
C1 [Broekhuizen, C. A. N.; Sta, M.; Vandenbroucke-Grauls, C. M. J. E.; Zaat, S. A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands.
   [Vandenbroucke-Grauls, C. M. J. E.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands.
RP Zaat, SAJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, Meibergdreef 15,L1-116, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR Arciola CR, 2001, DIAGN MOL PATHOL, V10, P130, DOI 10.1097/00019606-200106000-00010
   Artursson V, 2003, APPL ENVIRON MICROB, V69, P6208, DOI 10.1128/AEM.69.10.6208-6215.2003
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Borneman J, 1999, APPL ENVIRON MICROB, V65, P3398
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Caplan MJ, 2001, CUMITECH 35 POSTMORT
   Crnich CJ, 2002, CLIN INFECT DIS, V34, P1232, DOI 10.1086/339863
   Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675
   Dunne WM, 2005, TRANSFUSION, V45, P1138, DOI 10.1111/j.1537-2995.2005.04343.x
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Franke GC, 2007, J MICROBIOL METH, V71, P123, DOI 10.1016/j.mimet.2007.08.015
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   HEWITT R, 1967, J BACTERIOL, V93, P86
   Kobayashi N, 2006, JOINT BONE SPINE, V73, P745, DOI 10.1016/j.jbspin.2005.11.014
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   Krimmer V, 1999, J CLIN MICROBIOL, V37, P2667
   LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   MATSUHISA A, 1994, BIOTECH HISTOCHEM, V69, P31, DOI 10.3109/10520299409106258
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   Ochsner Peter E, 2006, Injury, V37 Suppl 2, pS49, DOI 10.1016/j.injury.2006.04.009
   Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P5728, DOI 10.1128/AEM.68.11.5728-5736.2002
   Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005
   Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07
   RENNO T, 1995, J EXP MED, V181, P2283, DOI 10.1084/jem.181.6.2283
   Salimi K, 2003, CELL TISSUE RES, V312, P135, DOI 10.1007/s00441-003-0711-7
   Seaver M, 2001, TRANSFUSION, V41, P1351, DOI 10.1046/j.1537-2995.2001.41111351.x
   STECKELBERG JM, 2000, INFECT ASS INDWELLIN, P173
   Stoodley P, 2005, CLIN ORTHOP RELAT R, P31, DOI 10.1097/01.blo.0000175129.83084.d5
   Szkaradkiewicz A, 2000, WORLD J MICROB BIOT, V16, P85, DOI 10.1023/A:1008930315300
   Thuret G, 2002, BRIT J OPHTHALMOL, V86, P1422, DOI 10.1136/bjo.86.12.1422
   Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357
   Urbach E, 1999, APPL ENVIRON MICROB, V65, P1207
   van Diepen A, 2005, INFECT IMMUN, V73, P2857, DOI 10.1128/IAI.73.5.2857-2862.2005
   Vasseur F, 1999, J IMMUNOL, V162, P5164
   VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Vuong C, 2008, J INFECT DIS, V198, P258, DOI 10.1086/589307
   Yin B, 2000, APPL ENVIRON MICROB, V66, P4361, DOI 10.1128/AEM.66.10.4361-4365.2000
NR 44
TC 20
Z9 20
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD MAR
PY 2010
VL 78
IS 3
BP 954
EP 962
DI 10.1128/IAI.00849-09
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 557FE
UT WOS:000274654200007
PM 20048041
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Gunaydin, S
   McCusker, K
   Sari, T
   Onur, MA
   Zorlutuna, Y
AF Gunaydin, Serdar
   McCusker, Kevin
   Sari, Tamer
   Onur, Mehmet Ali
   Zorlutuna, Yaman
TI Clinical performance and biocompatibility of hyaluronan-based
   heparin-bonded extracorporeal circuits in different risk cohorts
SO INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
LA English
DT Article
DE Cardiopulmonary bypass; Hyaluronic acid; Coronary artery bypass grafting
AB This prospective randomized study compares novel hyaluronan-based heparin-bonded circuits vs. uncoated controls across EuroSCORE patient risk strata including biomaterial evaluation. Over a two-year period, 90 patients undergoing coronary artery bypass grafting were prospectively randomized to one of the two perfusion protocols: Group 1 was treated with hyaluronan-based heparin-bonded preconnected circuits (Vision HFO-GBS (TM), Gish, CA, USA) and Group 2 with identical uncoated controls. Each group was composed of three subgroups (n = 15) with respect to preoperative evaluation of low (EuroSCORE 0-2), medium (3-5) and high (6+) risk patients. Blood samples were collected after induction (T1) and heparinization (T2), 15 min after cardiopulmonary bypass start (T3), before cessation of CPB (T4), 15 min after reversal (T5), and the first postoperative day (T6). In high-risk patients, platelet counts demonstrated significant preservation at T4, T5 and leukocyte counts were lower at T5 in hyaluronan group (P <= 0.05 vs. control). C3a (ng.ml(-1)) levels were significantly lower at T3 (0.2 +/- 0.04 vs. 0.31 +/- 0.05), T4 (0.25 +/- 0.04 vs. 0.51 +/- 0.05), T5 (0.38 +/- 0.04 vs. 0.56 +/- 0.05) and interleukin-6 (pg.ml(-1)) at T4 (91 +/- 18 vs. 124 +/- 20), T5 (110 +/- 20 vs. 220 +/- 25) in coated group vs. control (P <= 0.05). Protein desorption (microalbumin) on fibers (mg.mm(-3)) was less in hyaluronan vs. control groups (P <= 0.05). Hyaluronan coating reduced platelet adhesion and cell adsorption, and modulated inflammatory response in high-risk patients. (c) 2010 Published by European Association for Cardio-Thoracic Surgery. All rights reserved.
C1 [Gunaydin, Serdar] Kirikkale Univ, TR-06800 Ankara, Turkey.
   [McCusker, Kevin] New York Med Coll, Valhalla, NY 10595 USA.
   [Sari, Tamer; Zorlutuna, Yaman] Bayindir Hosp, Ankara, Turkey.
   [Onur, Mehmet Ali] Hacettepe Univ, Ankara, Turkey.
RP Gunaydin, S (reprint author), Kirikkale Univ, Angora Evleri G-8,Bl 1, TR-06800 Ankara, Turkey.
EM sgunaydin@isnet.net.tr
RI ONUR, MEHMET/G-9137-2013
OI ONUR, MEHMET/0000-0002-3630-7982
FU Research Fund of University of Kirikkale [08/34]
FX This study was supported by the Research Fund of University of Kirikkale
   (08/34).
CR Aldea GS, 2002, J THORAC CARDIOV SUR, V123, P742, DOI 10.1067/mtc.2002.120347
   Brown KA, 2001, PERFUSION-UK, V16, P75, DOI 10.1177/026765910101600i111
   Gunaydin S, 2004, PERFUSION-UK, V19, pS33, DOI 10.1191/0267659104pf718oa
   Gunaydin S, 2002, ANN THORAC SURG, V74, P819, DOI 10.1016/S0003-4975(02)03796-7
   Gunaydin S., 2004, CURR MED CHEM CARDIO, V2, P187
   Gunaydin Serdar, 2005, J Extra Corpor Technol, V37, P290
   Gunaydin S, 2009, J CARDIOVASC MED, V10, P135, DOI 10.2459/JCM.0b013e32831eef9d
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   Ovrum E, 2003, J CARDIAC SURG, V18, P140, DOI 10.1046/j.1540-8191.2003.02007.x
   Ovrum E, 2001, J THORAC CARDIOV SUR, V121, P324, DOI 10.1067/mtc.2001.111205
   REPO H, 1993, J IMMUNOL METHODS, V164, P193, DOI 10.1016/0022-1759(93)90312-U
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P794, DOI 10.1016/S0022-5223(99)70301-6
NR 13
TC 8
Z9 9
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1569-9293
J9 INTERACT CARDIOV TH
JI Interact Cardiovasc. Thorac. Surg.
PD MAR
PY 2010
VL 10
IS 3
BP 371
EP 376
DI 10.1510/icvts.2009.220756
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA V25LY
UT WOS:000208480700007
PM 20026488
OA Bronze
DA 2018-10-20
ER

PT J
AU Mohn, D
   Zehnder, M
   Imfeld, T
   Stark, WJ
AF Mohn, D.
   Zehnder, M.
   Imfeld, T.
   Stark, W. J.
TI Radio-opaque nanosized bioactive glass for potential root canal
   application: evaluation of radiopacity, bioactivity and alkaline
   capacity
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE antimicrobial; biomaterial; bismuth; nanoparticles; radiopacifier;
   sealer
ID CALCIUM HYDROXIDE; PORTLAND-CEMENT; BISMUTH OXIDE; NANOPARTICLES;
   DISINFECTION; DISSOLUTION; INCREASE; DENTIN; 45S5
AB P>Aim
   To produce novel nanosized bioactive glass particles with radio-opaque properties and high alkaline capacity and to evaluate their performance as a potential bioactive root canal dressing or filling material.
   Methodology
   Flame spray-derived bioactive glass particles in the nanometre range were produced including bismuth oxide as a radiopacifier. Calcium hydroxide, barium sulphate and bismuth oxide served as controls. Corresponding materials were compressed to obtain dense specimens with increased alkaline capacity. Radiopacity was evaluated, and in vitro bioactivity was monitored using Raman spectroscopy and scanning electron microscopy. Leaching of bismuth was controlled using atomic absorption spectroscopy.
   Results
   Bioactive glass particles with up to 50 wt% bismuth oxide revealed radiopacity with an equivalent of 4.94-mm aluminium. The introduction of bismuth into the bioactive glass altered the alkaline capacity and the in vitro bioactivity only for high bismuth oxide quantities. Bismuth oxide leaching out of the glass matrix was hardly detectable.
   Conclusion
   Bioactive glass can be modified with bismuth oxide to become radio-opaque.
C1 [Mohn, D.; Stark, W. J.] ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, CH-8093 Zurich, Switzerland.
   [Zehnder, M.; Imfeld, T.] Univ Zurich, Dept Prevent Dent Periodontol & Cariol, Ctr Dent Med, Zurich, Switzerland.
RP Stark, WJ (reprint author), ETH, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Wolfgang Pauli Str 10,HCI E107, CH-8093 Zurich, Switzerland.
EM wendelin.stark@chem.ethz.ch
RI Mohn, Dirk/K-8574-2012; Stark, Wendelin/A-8680-2008
OI Zehnder, Matthias/0000-0001-9545-7828
FU Department of Preventive Dentistry and Oral Epidemiology, University of
   Zurich
FX Funding by the Department of Preventive Dentistry and Oral Epidemiology,
   University of Zurich is kindly acknowledged. We also thank Beatrice
   Sener and Henning Scriba for their help with the digital radiographic
   analysis, Fabian Koehler for SEM images, Frank Krumeich for TEM images
   and Evagelos Athanassiou for help with the Raman spectroscopy.
CR ALACAM T, 1990, J ENDODONT, V16, P365, DOI 10.1016/S0099-2399(06)81907-2
   Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Andreasen JO, 2002, DENT TRAUMATOL, V18, P134, DOI 10.1034/j.1600-9657.2002.00097.x
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   Brunner TJ, 2006, CHEM COMMUN, P1384, DOI 10.1039/b517501a
   Grass RN, 2006, J NANOPART RES, V8, P729, DOI 10.1007/s11051-006-9097-2
   Gubler M, 2008, INT ENDOD J, V41, P670, DOI 10.1111/j.1365-2591.2008.01413.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HERMANN BW, 1920, THESIS WURZBURG
   Duarte MAH, 2009, J ENDODONT, V35, P737, DOI 10.1016/j.joen.2009.02.006
   Hwang YC, 2009, ORAL SURG ORAL MED O, V107, pE96, DOI 10.1016/j.tripleo.2008.11.015
   KANGASNIEMI IMO, 1993, J BIOMED MATER RES, V27, P1225, DOI 10.1002/jbm.820271003
   Kim EC, 2008, ORAL SURG ORAL MED O, V105, pE54, DOI 10.1016/j.tripleo.2007.08.001
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Marending M, 2009, DENT TRAUMATOL, V25, P126, DOI 10.1111/j.1600-9657.2008.00735.x
   Nair PNR, 2006, INT ENDOD J, V39, P249, DOI 10.1111/j.1365-2591.2006.01099.x
   Notingher I, 2002, MATER CHARACT, V49, P255, DOI 10.1016/S1044-5803(03)00029-9
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Saliba E, 2009, INT ENDOD J, V42, P322, DOI 10.1111/j.1365-2591.2008.01512.x
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   SLIKKERVEER A, 1989, MED TOXICOL ADV DRUG, V4, P303, DOI 10.1007/BF03259915
   Stark WJ, 2002, POWDER TECHNOL, V126, P103, DOI 10.1016/S0032-5910(02)00077-3
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
   Tanomaru M, 2008, INT ENDOD J, V41, P50, DOI 10.1111/j.1365-2591.2007.01309.x
   Vollenweider M, 2007, ACTA BIOMATER, V3, P936, DOI 10.1016/j.actbio.2007.04.003
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Waltimo T, 2009, J DENT RES, V88, P235, DOI 10.1177/0022034508330315
   Zehnder M, 2006, INT ENDOD J, V39, P952, DOI 10.1111/j.1365-2591.2006.01173.x
NR 28
TC 28
Z9 30
U1 0
U2 17
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0143-2885
J9 INT ENDOD J
JI Int. Endod. J.
PD MAR
PY 2010
VL 43
IS 3
BP 210
EP 217
DI 10.1111/j.1365-2591.2009.01660.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 553SW
UT WOS:000274388100004
PM 20158532
DA 2018-10-20
ER

PT J
AU Shapoff, CA
   Lahey, B
   Wasserlauf, PA
   Kim, DM
AF Shapoff, Cary A.
   Lahey, Brent
   Wasserlauf, Perry A.
   Kim, David M.
TI Radiographic Analysis of Crestal Bone Levels Around Laser-Lok Collar
   Dental Implants
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE RESPONSES; TITANIUM
   IMPLANTS; SOFT-TISSUE; KERATINIZED MUCOSA; CELLS; OSTEOBLASTS;
   INTEGRATION; ATTACHMENT; DIAMETER
AB This retrospective radiographic study was organized to evaluate the clinical efficacy of implants with Laser-Lok microtexturing (8- and 12-mu m grooves). A physical attachment of connective tissue fibers to the Laser-Lok microtexturing on the implant collar has been previously demonstrated using human histology, polarized light microscopy, and scanning electron microscopy. This analysis of 49 implants demonstrated a mean crestal bone loss of 0.44 mm at 2 years postrestoration and 0.46 mm at 3 years. All bone loss was contained within the height of the collar, and no bone loss was evident to the level of the implant threads. The radiographic evaluation of the clinical application of this implant supports previous findings that establishing a biologic seal of connective tissue fibers around a dental implant may be clinically relevant. (Int J Periodontics Restorative Dent 2010;30:129-137.)
C1 [Kim, David M.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Div Periodontol, Boston, MA 02115 USA.
RP Shapoff, CA (reprint author), 71 Beach Rd, Fairfield, CT 06430 USA.
EM cas@shapoff.com
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Alexander H, 2009, J BIOMED MATER RES B, V88B, P306, DOI 10.1002/jbm.b.30845
   Berglundh T, 1991, CLIN ORAL IMPLAN RES, V2, P81, DOI 10.1034/j.1600-0501.1991.020206.x
   Boyan B. D., 2000, BONE ENG, P232
   BUSER D, 1992, J PERIODONTOL, V63, P225, DOI 10.1902/jop.1992.63.3.225
   Cappiello M, 2008, INT J PERIODONT REST, V28, P347
   CHAVRIER C, 1994, CLIN ORAL IMPLAN RES, V5, P117, DOI 10.1034/j.1600-0501.1994.050301.x
   DEPORTER DA, 1988, J DENT RES, V67, P1190, DOI 10.1177/00220345880670090801
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026
   Hermann JS, 2001, CLIN ORAL IMPLAN RES, V12, P559, DOI 10.1034/j.1600-0501.2001.120603.x
   Hermann JS, 2001, INT J ORAL MAX IMPL, V16, P475
   Lazzara RJ, 2006, INT J PERIODONT REST, V26, P9
   Liljenberg B, 1997, J CLIN PERIODONTOL, V24, P119, DOI 10.1111/j.1600-051X.1997.tb00477.x
   Liljenberg B, 1996, J CLIN PERIODONTOL, V23, P1008, DOI 10.1111/j.1600-051X.1996.tb00529.x
   Lindhe J, 1998, PERIODONTOL 2000, V17, P47, DOI 10.1111/j.1600-0757.1998.tb00122.x
   LISTGARTEN MA, 1992, J DENT RES, V71, P364, DOI 10.1177/00220345920710020401
   Luongo R, 2008, INT J PERIODONT REST, V28, P551
   Moon IS, 1999, J CLIN PERIODONTOL, V26, P658, DOI 10.1034/j.1600-051X.1999.261005.x
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Piattelli A, 1997, J PERIODONTOL, V68, P694, DOI 10.1902/jop.1997.68.7.694
   QUIRYNEN M, 1992, J PROSTHET DENT, V68, P655, DOI 10.1016/0022-3913(92)90383-L
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   SCHROEDER A, 1981, J MAXILLOFAC SURG, V9, P15, DOI 10.1016/S0301-0503(81)80007-0
   Schrotenboer J, 2008, J PERIODONTOL, V79, P2166, DOI [10.1902/jop.2008.080178, 10.1902/jop.2008.080178 ]
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Tete S, 2009, INT J ORAL MAX IMPL, V24, P52
   Valencia S, 2009, INT J ORAL MAX IMPL, V24, P38
   van Steenberghe D, 1990, Int J Oral Maxillofac Implants, V5, P272
   Vigolo P, 2009, INT J ORAL MAX IMPL, V24, P103
   Weiner S, 2008, IMPLANT DENT, V17, P217, DOI 10.1097/ID.0b013e3181779016
   Yu W, 2009, INT J ORAL MAX IMPL, V24, P88
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 39
TC 27
Z9 27
U1 0
U2 0
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD MAR-APR
PY 2010
VL 30
IS 2
BP 129
EP 137
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 574WP
UT WOS:000276025200002
PM 20228972
DA 2018-10-20
ER

PT J
AU Ernstberger, T
   Buchhorn, G
   Heidrich, G
AF Ernstberger, T.
   Buchhorn, G.
   Heidrich, G.
TI RETRACTED: Magnetic resonance imaging evaluation of intervertebral test
   spacers: an experimental comparison of magnesium versus titanium and
   carbon fiber reinforced polymers as biomaterials (Retracted article. See
   vol. 184, pg. 263, 2015)
SO IRISH JOURNAL OF MEDICAL SCIENCE
LA English
DT Article; Retracted Publication
DE Magnesium alloys; Innovative biomaterials; Interbody test implants; MRI
   artifacting
ID PEDICLE SCREWS; LUMBAR SPINE; ARTIFACTS; IMPLANTS; MRI; PARAMETERS;
   ALLOYS; FUSION
AB Introduction Intervertebral spacers are made of different materials, which can affect the postfusion magnetic resonance imaging (MRI) scans. Susceptibility artifacts, especially for metallic implants, can decrease the image quality. This study aimed to determine whether magnesium as a lightweight and biocompatible metal is suitable as a biomaterial for spinal implants based on its MRI artifacting behavior.
   Materials and methods To compare artifacting behaviors, we implanted into one porcine cadaveric spine different test spacers made of magnesium, titanium, and CFRP. All test spacers were scanned using two T1-TSE MRI sequences. The artifact dimensions were traced on all scans and statistically analyzed.
   Results The total artifact volume and median artifact area of the titanium spacers were statistically significantly larger than magnesium spacers (P < 0.001), while magnesium and CFRP spacers produced almost identical artifacting behaviors (P > 0.05).
   Conclusion Our results suggest that spinal implants made with magnesium alloys will behave more like CFRP devices in MRI scans.
C1 [Ernstberger, T.; Buchhorn, G.] Univ Gottingen, Dept Orthopaed Surg, Biomat Lab, D-37075 Gottingen, Germany.
   [Heidrich, G.] Univ Gottingen, Dept Diagnost Radiol, D-37075 Gottingen, Germany.
RP Ernstberger, T (reprint author), Univ Gottingen, Dept Orthopaed Surg, Biomat Lab, Robert Koch Str 40, D-37075 Gottingen, Germany.
EM ternstberger@med.uni-goettingen.de
CR BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030
   DEBATIN JF, 1992, INVEST RADIOL, V27, P198, DOI 10.1097/00004424-199203000-00003
   ERNSTBERGER T, 2006, EUR SPINE J, V7, P1
   Ernstberger T, 2007, SPINE J, V7, P353, DOI 10.1016/j.spinee.2006.03.016
   Henk C B, 1999, Top Magn Reson Imaging, V10, P247, DOI 10.1097/00002142-199908000-00006
   Herold T, 2004, ROFO-FORTSCHR RONTG, V176, P1296, DOI 10.1055/s-2004-813404
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Malik AS, 2001, ACTA RADIOL, V42, P291, DOI 10.1034/j.1600-0455.2001.042002291.x
   Ortiz O, 1996, NEUROSURGERY, V38, P741, DOI 10.1227/00006123-199604000-00022
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   Rudisch A, 1998, SPINE, V23, P692, DOI 10.1097/00007632-199803150-00009
   RUPP R, 1993, SPINE, V18, P379
   Schreiner U, 2000, Z ORTHOP GRENZGEB, V138, P540, DOI 10.1055/s-2000-9598
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thomsen M, 2001, ORTHOPADE, V30, P540, DOI 10.1007/s001320170063
   Troitskii VV, 1944, KHIRURGIIA, V8, P41
   VACCARO AR, 1994, SPINE, V19, P1237, DOI 10.1097/00007632-199405310-00008
   Van Goethem JWM, 2002, NEURORADIOLOGY, V44, P723, DOI 10.1007/s00234-002-0790-2
   Waldman ID, 2005, AM J MED GENET B, V138B, P144
   Wang JC, 1997, J SPINAL DISORD, V10, P27
   Znamenskii MS, 1945, KHIRURGIIA, V12, P60
NR 21
TC 7
Z9 8
U1 2
U2 15
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0021-1265
EI 1863-4362
J9 IRISH J MED SCI
JI Irish J. Med. Sci.
PD MAR
PY 2010
VL 179
IS 1
BP 107
EP 111
DI 10.1007/s11845-009-0394-5
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 608JK
UT WOS:000278579700019
PM 19693644
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Santos, JR
   Alves, NM
   Mano, JF
AF Santos, Joao R.
   Alves, Natalia M.
   Mano, Joao F.
TI New Thermo-responsive Hydrogels Based on Poly
   (N-isopropylacrylamide)/Hyaluronic Acid Semi-interpenetrated Polymer
   Networks: Swelling Properties and Drug Release Studies
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE biomaterials; natural-based polymers; smart hydrogels; drug release;
   hydrogels; PNIPAAm; hyaluronic acid conjugates; semi-IPN hydrogels;
   temperature sensitive hydrogels; pH-sensitive hydrogels
ID STIMULI-RESPONSIVE POLYMERS; BIOMEDICAL APPLICATIONS;
   N-ISOPROPYLACRYLAMIDE; HYALURONIC-ACID; POLY(N-ISOPROPYLACRYLAMIDE)
   HYDROGELS; SWELLING/DESWELLING KINETICS; DELIVERY; TEMPERATURE; PH;
   ANGIOGENESIS
AB New pH and temperature sensitive semi-interpenetrated polymer networks (semi-IPNs) were developed by combining cross-linked PNIPAAm with hyaluronic acid (HA). At pH 7.4, the PNIPAAm/HA semi-IPN hydrogels had significantly greater and faster swelling at 25 degrees C and a more complete deswelling at 37 degrees C than PNIPAAm hydrogels. The temperature-dependent reversibility behavior was analyzed for biomaterial applications. Gentamicin was incorporated as a model drug, and the release profile from the hydrogels was followed under physiological conditions. The presence of HA, even in small quantities, allowed a more complete release of the gentamicin from the hydrogel. The PNIPAAm/HA semi-IPN hydrogels respond to both changes in temperature and pH making it suitable as a delivery system for therapeutics.
C1 [Santos, Joao R.; Alves, Natalia M.; Mano, Joao F.] 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Santos, Joao R.; Alves, Natalia M.; Mano, Joao F.] IBB, PT Govt Associated Lab, Guimaraes, Portugal.
RP Mano, JF (reprint author), 3Bs Res Grp Biomat Biodegradables & Biomimet, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Alves, Natalia/I-5459-2015; Mano,
   Joao/A-4418-2009
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Alves,
   Natalia/0000-0002-8741-4091
FU Fundacao para a Ciencia e Tecnologia (Portugal) [PTDC/FIS/68517/2006,
   PTDC/QUI/68804/2006]
FX This work was supported by the Fundacao para a Ciencia e Tecnologia
   (Portugal) under projects PTDC/FIS/68517/2006 and PTDC/QUI/68804/2006.
CR Ahn SK, 2008, SOFT MATTER, V4, P1151, DOI 10.1039/b714376a
   Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   ALLISON DD, 2006, REV TISSUE ENG, V12, P2131
   Alvarez-Lorenzo C, 2005, J CONTROL RELEASE, V102, P629, DOI 10.1016/j.jconrel.2004.10.021
   Asoh T, 2006, J CONTROL RELEASE, V110, P387, DOI 10.1016/j.jconrel.2005.10.013
   Cabanillas PF, 2000, INT J PHARM, V209, P15
   Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206
   Chaterji S, 2007, PROG POLYM SCI, V32, P1083, DOI 10.1016/j.progpolymsci.2007.05.018
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Coughlan DC, 2004, J CONTROL RELEASE, V98, P97, DOI 10.1016/j.jconrel.2004.04.014
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gil ES, 2007, BIOMACROMOLECULES, V8, P258, DOI 10.1021/bm060543m
   Guo BL, 2007, CARBOHYD RES, V342, P2416, DOI 10.1016/j.carres.2007.07.007
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Hsiue GH, 2002, BIOMATERIALS, V23, P457, DOI 10.1016/S0142-9612(01)00127-2
   Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   KLUMB LA, 1992, J CONTROL RELEASE, V18, P59, DOI 10.1016/0168-3659(92)90212-A
   Kulkarni RV, 2009, J BIOACT COMPAT POL, V24, P368, DOI 10.1177/0883911509104475
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   Peattie RA, 2006, BIOMATERIALS, V27, P1868, DOI 10.1016/j.biomaterials.2005.09.035
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Reddy TT, 2008, BIOMACROMOLECULES, V9, P1313, DOI 10.1021/bm701390f
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Rzaev ZMO, 2007, PROG POLYM SCI, V32, P534, DOI 10.1016/j.progpolymsci.2007.01.006
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Shi J, 2008, MACROMOL BIOSCI, V8, P260, DOI 10.1002/mabi.200700177
   Shi J, 2008, J BIOMED MATER RES B, V84B, P595, DOI 10.1002/jbm.b.30907
   Shi J, 2006, MACROMOL BIOSCI, V6, P358, DOI 10.1002/mabi.200600013
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Temtem M, 2007, GREEN CHEM, V9, P75, DOI 10.1039/b603930h
   WU JY, 2003, P INT S CONTR REL BI, V30, P696
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   YOSHIDA R, 1994, J CONTROL RELEASE, V32, P97, DOI 10.1016/0168-3659(94)90229-1
   YOSHIDA R, 1994, J BIOMAT SCI-POLYM E, V6, P585, DOI 10.1163/156856294X00536
   Zhang JT, 2008, MACROMOL RAPID COMM, V29, P593, DOI 10.1002/marc.200700778
   Zhang JT, 2009, ACTA BIOMATER, V5, P488, DOI 10.1016/j.actbio.2008.06.012
   Zhang LY, 2007, ADV MATER, V19, P2988, DOI 10.1002/adma.200601817
   Wei Z, 2006, PROG CHEM, V18, P1684
   Zhang XZ, 2002, INT J PHARM, V235, P43, DOI 10.1016/S0378-5173(01)00976-0
NR 45
TC 28
Z9 28
U1 0
U2 37
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2010
VL 25
IS 2
BP 169
EP 184
DI 10.1177/0883911509357863
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 555RR
UT WOS:000274532200004
DA 2018-10-20
ER

PT J
AU Yao, JF
   Li, XY
   Bao, CY
   Zhang, CL
   Chen, ZQ
   Fan, HS
   Zhang, XD
AF Yao, Jinfeng
   Li, Xiaoyu
   Bao, Chongyun
   Zhang, Chaoliang
   Chen, Zhiqing
   Fan, Hongsong
   Zhang, Xingdong
TI Ectopic Bone Formation in Adipose-derived Stromal Cell-seeded
   Osteoinductive Calcium Phosphate Scaffolds
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE bone tissue engineering; adipose-derived stromal cells; osteoinductive
   biphasic calcium phosphate ceramic; ectopic bone formation;
   histomorphometry; microcomputed tomography (Micro-CT)
ID MESENCHYMAL STEM-CELLS; BETA-TRICALCIUM PHOSPHATE; TISSUE-ENGINEERED
   BONE; IN-VIVO; MICRO-CT; INDUCED OSTEOGENESIS; CALVARIAL DEFECTS;
   BIOMATERIALS; REPAIR; VITRO
AB The phenomenon of osteoinduction by biomaterials has been proven and used in animals. However, whether the ability of a biomaterial to initiate bone formation in ectopic implantation sites improves the performance of such osteoinductive biomaterial as a scaffold for tissue-engineered (TE) bone remains unclear. In this study, we compared ectopic bone formation by combining autologous adipose-derived stromal cells (ADSCs) with an osteoinductive and a nonosteoinductive biphasic calcium phosphate (BCP) ceramic to create a tissue engineering construct in the muscle of dogs. Two groups of BCP scaffolds (BCP1 and BCP2) were prepared. In each group, ADSCs were seeded, and the scaffolds without seeded cells served as controls. All implants were implanted in the back muscle of 10 adult dogs for 8 weeks and 12 weeks. Microcomputed tomography (Micro-CT) analysis and histomorphometry were performed to evaluate and quantify ectopic bone formation. The results indicated that the osteoinductive BCP1 performed significantly better compared to the nonosteoinductive BCP2 in cell-based TE bone formation ectopically. The ADSCs had a significantly positive effect on the ectopic bone formation. In addition, the usefulness of Micro-CT for the efficient and nondestructive analysis of mineralized bone and calcium phosphate scaffold was confirmed.
C1 [Bao, Chongyun] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610044, Peoples R China.
   Sichuan Univ, W China Hosp Stomatol, Chengdu 610041, Peoples R China.
   [Fan, Hongsong; Zhang, Xingdong] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610025, Peoples R China.
RP Bao, CY (reprint author), Sichuan Univ, State Key Lab Oral Dis, Chengdu 610044, Peoples R China.
EM baochongyun@163.com
FU Natural Science Fund of China [NSFC: 30672337]; New Century Excellent
   Talent of Chinese Educational Ministry [NCET-06-0782]
FX This research was supported by Natural Science Fund of China (NSFC:
   30672337) and New Century Excellent Talent of Chinese Educational
   Ministry (NCET-06-0782).
CR Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934
   Cai XX, 2007, CELL BIOL INT, V31, P776, DOI 10.1016/j.cellbi.2007.01.011
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z
   Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd
   Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386
   Gamradt SC, 2004, ANN BIOMED ENG, V32, P136, DOI 10.1023/B:ABME.0000007798.78548.b8
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2006, J ORTHOP RES, V24, P867, DOI 10.1002/jor.20115
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hsu HP, 2006, J ORTHOP RES, V24, P1660, DOI 10.1002/jor.20204
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Kato M, 2006, BIOMATERIALS, V27, P3927, DOI 10.1016/j.biomaterials.2006.03.013
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Kroese-Deutman HC, 2005, BIOMATERIALS, V26, P1131, DOI 10.1016/j.biomaterials.2004.04.021
   Lin YF, 2006, MOL CELL BIOCHEM, V291, P1, DOI 10.1007/s11010-006-9188-5
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Matsushita N, 2004, J BIOMED MATER RES A, V70A, P450, DOI 10.1002/jbm.a.30102
   Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Niemeyer P, 2006, CYTOTHERAPY, V8, P354, DOI 10.1080/14653240600845187
   Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095
   Raffaghello L, 2008, STEM CELLS, V26, P151, DOI 10.1634/stemcells.2007-0416
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Ripamonti U., 2000, BONE ENG, P215
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   Vacanti CA, 1999, CLIN ORTHOP RELAT R, pS375
   VACANTI JP, 1998, ADV DRUG DELIV REV, V33, P165, DOI DOI 10.1016/SO169-409X(98)00025-8
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737
   Wright VJ, 2002, MOL THER, V6, P169, DOI 10.1006/mthe.2002.0654
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   1985, ALTERN LAB ANIM, V12, P1
NR 48
TC 15
Z9 16
U1 0
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2010
VL 24
IS 7
BP 607
EP 624
DI 10.1177/0885328209104294
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572QE
UT WOS:000275847000003
PM 19386665
DA 2018-10-20
ER

PT J
AU Inoue, M
   Rodriguez, AP
   Takagi, T
   Katase, N
   Kubota, M
   Nagai, N
   Nagatsuka, H
   Inoue, M
   Nagaoka, N
   Takagi, S
   Suzuki, K
AF Inoue, Miho
   Rodriguez, Andrea P.
   Takagi, Tohru
   Katase, Naoki
   Kubota, Midori
   Nagai, Noriyuki
   Nagatsuka, Hitoshi
   Inoue, Masahisa
   Nagaoka, Noriyuki
   Takagi, Shin
   Suzuki, Kazuomi
TI Effect of a New Titanium Coating Material (CaTiO3-aC) Prepared by
   Thermal Decomposition Method on Osteoblastic Cell Response
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE calcium titanate; hydroxyapatite; coating; titanium; osteoblasts
ID IN-VITRO; HYDROXYAPATITE; BONE; IMPLANTS; BEHAVIOR; HYDROXYLAPATITE;
   TEMPERATURE; SURFACE; ACID; VIVO
AB Titanium and hydroxyapatite (HA) are widely used as biomaterials for dental and medical applications. HA-coated titanium implants have excellent biocompatibility and mechanical properties. However, the adherence of HA film formed on titanium substrate is weak because of the lack of chemical interaction between HA and titanium. A solution to this problem is to form an intermediate film on titanium substrate, which provide excellent adherence to both titanium substrate and HA. We developed a novel biomaterial called calcium titanate-amorphous carbon (CaTiO3-aC) coating prepared by modified thermal decomposition-method. The purpose of this study was to evaluate the effect of CaTiO3-aC and HA coating (positive control), and Ti (negative control) on osteoblastic (MT3T3-E1) cell responses. An increased cellular proliferation was observed in CaTiO3-aC coating compared to HA coating. The maximum expressions of ALP activity, Col I and ALP mRNA were higher and achieved in shorter period of time in CaTiO3-aC coating compared to others. These results demonstrated that CaTiO3-aC promoted better cell attachment, cellular proliferation, and osteoblastic differentiation compared with HA. In conclusion, we suggested that CaTiO3-aC could be considered as an important candidate as a coating material.
C1 [Inoue, Miho; Rodriguez, Andrea P.; Takagi, Tohru; Katase, Naoki; Kubota, Midori; Nagai, Noriyuki; Nagatsuka, Hitoshi] Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Nagai, Noriyuki] Int Dent Hygienist Coll Okayama, Ctr Oral Hlth Sci, Okayama 7000913, Japan.
   [Inoue, Masahisa] Tokushima Bunri Univ, Lab Struct & Funct, Fac Pharmaceut Sci, Tokushima 7708514, Japan.
   [Nagaoka, Noriyuki] Okayama Univ, Electron Microscopy Lab, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Takagi, Shin] Okayama Univ, Dept Oral & Maxillofacial Reconstruct Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
   [Suzuki, Kazuomi] Okayama Univ, Dept Biomat, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan.
RP Inoue, M (reprint author), Okayama Univ, Dept Oral Pathol & Med, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008525, Japan.
EM mi8@md.okayama-u.ac.jp
RI KATASE, Naoki/B-2344-2011
FU Japan Society for the Promotion of Science for Young Scientists
   [1945179, 20592200]
FX This work was supported by grant Research Fellowships of the Japan
   Society for the Promotion of Science for Young Scientists (1945179,
   20592200).
CR Araujo JC, 2003, J ELECTRON MICROSC, V52, P429, DOI 10.1093/jmicro/52.4.429
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   Brossa F., 1993, Bio-Medical Materials and Engineering, V3, P127
   Chang YL, 1999, J ORAL MAXIL SURG, V57, P1096
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Fujishiro Y, 1998, J MATER SCI-MATER M, V9, P363, DOI 10.1023/A:1013201627622
   Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Kweh SWK, 2002, BIOMATERIALS, V23, P381, DOI 10.1016/S0142-9612(01)00116-8
   Lavos-Valereto IC, 2001, J BIOMED MATER RES, V58, P727, DOI 10.1002/jbm.1072
   LIN JHC, 1994, J BIOMED MATER RES, V28, P723, DOI 10.1002/jbm.820280609
   Lynn AK, 2002, BIOMATERIALS, V23, P1937, DOI 10.1016/S0142-9612(01)00321-0
   Maekawa K, 2007, J BIOMED MATER RES A, V82A, P195, DOI 10.1002/jbm.a.31139
   Morgan J, 1996, Implant Dent, V5, P264, DOI 10.1097/00008505-199600540-00005
   Nagai N, 2008, J HARD TISSUE BIOL, V17, P47, DOI 10.2485/jhtb.17.47
   NAKAYAMA Y, 1989, BIOMATERIALS, V10, P420, DOI 10.1016/0142-9612(89)90134-8
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   Oh S, 2005, INT J ORAL MAX IMPL, V20, P726
   OHTSUKA Y, 1994, SURF COAT TECH, V65, P224, DOI 10.1016/S0257-8972(94)80037-5
   Okauchi-Yabuuchi M, 2008, J HARD TISSUE BIOL, V17, P115, DOI 10.2485/jhtb.17.115
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   Ozeki K, 2006, J BIOMED MATER RES A, V76A, P605, DOI 10.1002/jbm.a.30574
   PARK JH, 2007, J MOL MED, V86, P117
   PILLIAR RM, 1981, CLIN ORTHOP RELAT R, V156, P249
   Rodil SE, 2005, BIO-MED MATER ENG, V15, P101
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Webster TJ, 2003, J BIOMED MATER RES A, V67A, P975, DOI 10.1002/jbm.a.10160
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yang YZ, 2003, BIOMATERIALS, V24, P5131, DOI 10.1016/S0142-9612(03)00459-9
   Zhou P, 1997, BIO-MED MATER ENG, V7, P67
NR 45
TC 12
Z9 16
U1 1
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2010
VL 24
IS 7
BP 657
EP 672
DI 10.1177/0885328209340334
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572QE
UT WOS:000275847000006
PM 19726530
DA 2018-10-20
ER

PT J
AU Chou, TGR
   Petti, CA
   Szakacs, J
   Bloebaum, RD
AF Chou, Teri G. Rosenbaum
   Petti, Cathy A.
   Szakacs, Juliana
   Bloebaum, Roy D.
TI Evaluating antimicrobials and implant materials for infection prevention
   around transcutaneous osseointegrated implants in a rabbit model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osseointegration; antimicrobial; pexiganan; tantalum; infection
ID PIN TRACT INFECTION; POROUS TANTALUM BIOMATERIAL; BONE INGROWTH;
   MAGAININ 2; IN-VITRO; PEPTIDE ANTIBIOTICS; EXTERNAL FIXATION; GOAT
   MODEL; PEXIGANAN; AMPUTEES
AB Transcutaneous osseointegrated implants can improve function for select amputee patients, but infection serves as a significant limitation of implantable transcutaneous devices. This study examined the efficacy of an anti-microbial, pexiganan acetate (SUPONEX (TM)), and a porous tantalum implant material (Trabecular Metal (TM)) in preventing pin tract infection of osseointegrated implants in a rabbit model. Thirty-seven rabbits Were randomized to three groups: Ti-control group (n = 11) with titanium alloy implant and no antimicrobial, Ti-Pexiganan group (n = 8) With titanium alloy implant and topical pexiganan acetate 1% applied daily at the skin/implant interface, and Ta-control group (n = 18) with porous tantalum implant and no antimicrobial. All implants Were placed transcutaneously through skin, muscle, and bone. Rabbits were monitored for infection for 24 weeks. We observed a 75% reduction in rates of pin tract infection in the Ti-Pexiganan group compared to that observed in the Ti-control group (p = 0.019). No difference in rates of infection was observed between the Ta-control group and the Ti-control group (1) = 0.230). In Conclusion, pexiganan acetate may be an important antimicrobial for transcutaneous osseointegrated implants. Porous tantalum Will not likely prevent pin tract infection Without additional methods of soft tissue immobilization around the implant site. (C) 2009 Wiley Periodicals, Inc.* J Biomed Mater Res 92A: 942-952, 2010
C1 [Chou, Teri G. Rosenbaum; Bloebaum, Roy D.] Bone & Joint Res Lab 151F, Dept Vet Affairs Hlth Care Syst, Salt Lake City, UT 84148 USA.
   [Petti, Cathy A.] Univ Utah, Sch Med, Dept Pathol & Med, Salt Lake City, UT 84132 USA.
   [Szakacs, Juliana] Harvard Vanguard Med Associates, Dept Pathol, Boston, MA 02215 USA.
   [Bloebaum, Roy D.] Univ Utah, Sch Med, Dept Orthopaed, Orthopaed Ctr, Salt Lake City, UT 84108 USA.
RP Bloebaum, RD (reprint author), Univ Utah, Bone & Joint Res Lab, Dept Vet Affairs, Salt Lake City Hlth Care Syst 151F, 500 Foothill Dr, Salt Lake City, UT 84148 USA.
FU Office of Research and Development; Rehabilitation RD Service; DVA SLC
   Health Care System, Salt Lake City, Utah; Department of Defense TATR
FX Contract grant sponsors: Office of Research and Development,
   Rehabilitation R&D Service, DVA SLC Health Care System, Salt Lake City,
   Utah; Department of Defense TATR
CR An YHH, 1998, J INVEST SURG, V11, P139, DOI 10.3109/08941939809032193
   Bloebaum R D, 1992, J Arthroplasty, V7, P483, DOI 10.1016/S0883-5403(05)80222-0
   Bloebaum RD, 1997, J BONE JOINT SURG AM, V79A, P1013, DOI 10.2106/00004623-199707000-00007
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.iy.13.040195.000425
   Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x
   Branemark P-I, 2005, OSSEOINTEGRATION BOO, P19
   Chan K M, 1990, Ann Acad Med Singapore, V19, P811
   Checketts RG, 2000, ORTHOFIX EXTERNAL FIXATION IN TRAUMA AND ORTHOPAEDICS, P97
   Coester Lisa M, 2006, Iowa Orthop J, V26, P48
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   DeJong ES, 2001, J TRAUMA, V50, P1008
   DESGROSEILLIERS JP, 1978, CAN MED ASSOC J, V118, P535
   Dillingham TR, 2001, AM J PHYS MED REHAB, V80, P563, DOI 10.1097/00002060-200108000-00003
   EMMANUAL J, 1987, STAIN TECHNOL, V62, P401, DOI 10.3109/10520298709108030
   FERNIE GR, 1982, ARCH PHYS MED REHAB, V63, P162
   FISCHER H, 2008, US MILITARY CASUALTY, P1
   Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204
   Fuchs PC, 1998, ANTIMICROB AGENTS CH, V42, P1213, DOI 10.1128/AAC.42.5.1213
   Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782
   Gerritsen M, 2000, J BIOMED MATER RES, V53, P702, DOI 10.1002/1097-4636(2000)53:6<702::AID-JBM13>3.0.CO;2-V
   Gopinath D, 2005, J BIOMED MATER RES A, V73A, P320, DOI 10.1002/jbm.a.30303
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hagberg K, 2001, PROSTHET ORTHOT INT, V25, P186, DOI 10.1080/03093640108726601
   Hagberg K., 2006, TRANSFEMORAL AMPUTAT, P1
   Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7
   HOFMANN AA, 2001, CLIN ORTHOP RELAT R, V388, P85
   Iwahori A, 1997, BIOL PHARM BULL, V20, P267
   Lamb HM, 1998, DRUGS, V56, P1047, DOI 10.2165/00003495-199856060-00011
   Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621
   MARSHALL DA, 1991, CLIN RES, V39, pA566
   Matsuzaki K, 1997, BBA-BIOMEMBRANES, V1327, P119, DOI 10.1016/S0005-2736(97)00051-5
   Michael J., 2000, ICAP HIGHLIGHT OSSEO
   Mutsuzaki H, 2008, J BIOMED MATER RES B, V86B, P365, DOI [10.1002/jbm.b.31029, 10.1002/jmb.b.31029]
   Neuhoff D, 2005, J Orthop Trauma, V19, P543, DOI 10.1097/01.bot.0000164592.96724.a9
   NICOLAS P, 1995, ANNU REV MICROBIOL, V49, P277, DOI 10.1146/annurev.mi.49.100195.001425
   NissenMeyer J, 1997, ARCH MICROBIOL, V167, P67, DOI 10.1007/s002030050418
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   Pendegrass CJ, 2006, J ANAT, V209, P59, DOI 10.1111/j.1469-7580.2006.00595.x
   Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS191
   Saw A, 2006, Med J Malaysia, V61 Suppl A, P62
   SCHONWETTER BS, 1995, SCIENCE, V267, P1645, DOI 10.1126/science.7886453
   Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738
   Stolzenberg ED, 1997, P NATL ACAD SCI USA, V94, P8686, DOI 10.1073/pnas.94.16.8686
   Sullivan J, 2003, PROSTHET ORTHOT INT, V27, P114, DOI 10.1080/03093640308726667
   Thomson RB, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P291
   TYTLER EM, 1995, BIOCHEMISTRY-US, V34, P4393, DOI 10.1021/bi00013a031
   van der Borden AJ, 2007, BIOMATERIALS, V28, P2122, DOI 10.1016/j.biomaterials.2007.01.001
   W-Dahl A, 2004, ARCH ORTHOP TRAUM SU, V124, P555, DOI 10.1007/s00402-004-0733-y
   Warme Winston J, 2004, Am J Orthop (Belle Mead NJ), V33, P447
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Williams S, 2007, CLIN ORTHOP RELAT R, P23, DOI 10.1097/BLO.0b013e31814da946
   Willie BM, 2004, J BIOMED MATER RES A, V69A, P567, DOI 10.1002/jbm.a.30038
   Wu SC, 2008, INT WOUND J, V5, P416, DOI 10.1111/j.1742-481X.2007.00368.x
   Yokoyama K, 2006, INJURY, V37, P554, DOI 10.1016/j.injury.2005.08.026
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
NR 60
TC 18
Z9 18
U1 0
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2010
VL 92A
IS 3
BP 942
EP 952
DI 10.1002/jbm.a.32413
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552QF
UT WOS:000274307600014
PM 19291687
DA 2018-10-20
ER

PT J
AU Solorio, LD
   Fu, AS
   Hernandez-Irizarry, R
   Alsberg, E
AF Solorio, Loran D.
   Fu, Andrew S.
   Hernandez-Irizarry, Roberto
   Alsberg, Eben
TI Chondrogenic differentiation of human mesenchymal stem cell aggregates
   via controlled release of TGF-beta 1 from incorporated polymer
   microspheres
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE MSC; cartilage; biomaterial; tissue engineering; controlled delivery
ID PROGENITOR CELLS; PROTEINS; ASSAY
AB Aggregate culture is a useful method for inducing chondrogenic differentiation of human rnesenchymal stem cells (hMSC) in a three-dimensional in vitro culture environment. Conventional aggregate culture, however, typically requires repeated growth factor supplementation during media changes, which is both expensive and time-intensive. In addition, homogenous cell differentiation is limited by the diffusion of chondrogenic growth factor from the culture medium into the aggregate and peripheral Cell Consumption of the growth factor. We have engineered a technology to incorporate growth factor-loaded polymer microspheres within hMSC aggregates themselves. Here, we report on the svstem's capacity to induce chondrogenesis via Sustained delivery of transforming growth factor-beta 1 (TGF-beta 1). Cartilage formation after 3 weeks in the absence of externally supplied growth factor approached that of aggregates cultured by conventional methods. Chondrogenesis in the central region of the aggregates is enabled at TGF-beta 1 levels much lower than those required by conventional culture using exogenously supplied TGF-beta 1, which is likely a result of the system's ability to overcome limitations of growth factor diffusion from cell culture media surrounding the exterior of the aggregates. Importantly, the inclusion of growth factor-releasing polymer rnicrospheres in hMSC aggregates could enable in vivo chondrogenesis for cartilage tissue engineering applications without extensive in vitro culture. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 1139-1144, 2010
C1 [Solorio, Loran D.; Fu, Andrew S.; Hernandez-Irizarry, Roberto; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU Ohio Department of Development (Biomedical Research and Technology
   Transfer Grant) [05-065]; NIH-NIAMS (LDS) [T32 AR007505-21A1]; The
   EIlison Medical Foundation
FX Contract grant sponsor: Ohio Department of Development (Biomedical
   Research and Technology Transfer Grant) (EA); contract grant number:
   05-065; Contract grant sponsor: NIH-NIAMS (LDS); contract grant number:
   T32 AR007505-21A1; Contract grant sponsor: The EIlison Medical
   Foundation (New Scholar in Aging Award) (EA)
CR Alsberg E, 2006, EXPERT OPIN BIOL TH, V6, P847, DOI 10.1517/14712598.6.9.847
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CARRINO DA, 1991, BIOCHEM INT, V24, P485
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   LENNON DP, 1996, METHODS MOL MED, V100, P53
   Penick KJ, 2005, BIOTECHNIQUES, V39, P687, DOI 10.2144/000112009
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   VIEREGGE LD, 2008, WORLD BIOM C 2008 AM
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
NR 15
TC 51
Z9 53
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2010
VL 92A
IS 3
BP 1139
EP 1144
DI 10.1002/jbm.a.32440
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552QF
UT WOS:000274307600034
PM 19322820
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Dai, ZD
   Yang, ZX
AF Dai, Zhendong
   Yang, Zhixiang
TI Macro-/Micro-Structures of Elytra, Mechanical Properties of the
   Biomaterial and the Coupling Strength Between Elytra in Beetles
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE beetle; elytra; mechanical properties of biomaterial; coupling force
ID LOCUST SCHISTOCERCA-GREGARIA; LOCKING MECHANISMS; INSECT CUTICLE;
   COLEOPTERA; BIOLOGY; PHYSICS; FLIGHT; HETEROPTERA; FORCES; DESIGN
AB Macro-/Micro-structures and mechanical properties of the elytra of beetles were studied. The Scan Electron Microscope (SEM) and optical microscopy were employed to observe the macro-/micro-structure of the surface texture and cross-section structure of elytra. Nano-indentation was carried out to measure the elastic modulus and the hardness of elytra. Tensile strengths of elytra in lateral and longitudinal directions were measured by a multifunctional testing machine. The coupling force between elytra was also measured and the clocking mechanism was studied. SEM images show the similar geometric structure in transverse and longitudinal sections and multilayer dense epicuticle and exocuticle, followed by bridge piers with a helix structured fibers, which connect the exocuticle to the endodermis, and form an ellipse empty to reduce the structure weight. The elastic modulus and the hardness are topologically distributed and the mechanical parameters of fresh elytra are much higher than those of dried elytra. The tensile strength of the fresh biological material is twice that of dried samples, but there is no clear difference between the data in lateral and longitudinal directions. Coupling forces measured are 6.5 to 160 times of beetles' bodyweight, which makes the scutellum very important in controlling the open and close of the elytra. The results provide a biological template to inspire lightweight structure design for aerospace engineering.
C1 [Dai, Zhendong; Yang, Zhixiang] Nanjing Univ Aeronaut & Astronaut, Inst Bioinspired Struct & Surface Engn, Nanjing 210016, Peoples R China.
RP Dai, ZD (reprint author), Nanjing Univ Aeronaut & Astronaut, Inst Bioinspired Struct & Surface Engn, Nanjing 210016, Peoples R China.
EM zddai@nuaa.edu.cn
FU National Nature Science Foundation of China [60535020, 50635030,
   50675160]; Aviation Science Funds of China [2007ZA52008]; K. C. Wong
   Education Foundation, Hong Kong
FX This work was supported by the National Nature Science Foundation of
   China (Grant Nos. 60535020, 50635030 and 50675160), the Aviation Science
   Funds of China (2007ZA52008), and the K. C. Wong Education Foundation,
   Hong Kong. The authors are grateful a lot to Prof. Lulian Vincent, who
   has polished the English and given us a lot of suggestions.
CR BEAMENT JWL, 1960, NATURE, V186, P408, DOI 10.1038/186408a0
   Breed RS, 1908, BIOL BULL-US, V15, P289, DOI 10.2307/1535924
   Chen A, 2003, EWEEK, V20, P61
   [陈斌 Chen Bin], 2003, [材料研究学报, Chinese Journal of Materials Research], V17, P630
   [陈锦祥 Chen Jinxiang], 2005, [复合材料学报, Acta Materiae Compositae Sinica], V22, P103
   Chen PY, 2008, ACTA BIOMATER, V4, P587, DOI 10.1016/j.actbio.2007.12.010
   Cheng Hong, 2002, Acta Entomologica Sinica, V45, P175
   Dai ZD, 2008, SCI CHINA SER C, V51, P894, DOI 10.1007/s11427-008-0124-7
   Frantsevich L, 2005, J EXP BIOL, V208, P3145, DOI 10.1242/jeb.01753
   Goodwyn PJP, 2003, J INSECT PHYSIOL, V49, P753, DOI 10.1016/S0022-1910(03)00112-4
   Gorb SN, 2002, INTEGR COMP BIOL, V42, P1127, DOI 10.1093/icb/42.6.1127
   Gorb SN, 2003, J MORPHOL, V257, P127, DOI 10.1002/jmor.10070
   Herbert RC, 2000, J EXP BIOL, V203, P2945
   Holleway B. A., 1997, NZ J ZOOLOGY, V24, P51
   JENSEN M, 1956, PHILOS T ROY SOC B, V239, P511, DOI 10.1098/rstb.1956.0009
   Kurachi M, 2002, NATURWISSENSCHAFTEN, V89, P295, DOI 10.1007/s00114-002-0332-0
   Li J. Q., 1996, T CHINESE SOC AGR MA, V27, P1
   Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108
   Ren Luquan, 1995, CHINESE SCI BULL, V40, P1812
   Sachs C, 2006, J STRUCT BIOL, V155, P409, DOI 10.1016/j.jsb.2006.06.004
   Smith CW, 2000, J EXP BIOL, V203, P2933
   Sun Jiu-rong, 2001, Acta Biophysica Sinica, V17, P785
   Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006
   [王辅忠 Wang Fuzhong], 2003, [材料科学与工程学报, Journal Materials Science and Engineering], V21, P134
   Wang G L, 1997, T CHINESE SOC AGR MA, V28, P5
   WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P415, DOI 10.1098/rstb.1956.0007
   WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008
   Yang GY, 2008, CHINESE PHYS LETT, V25, P1, DOI 10.1088/0256-307X/25/1/001
   [杨志贤 YANG Zhixian], 2007, [复合材料学报, Acta Materiae Compositae Sinica], V24, P92
   杨志贤, 2009, [科学通报, Chinese Science Bulletin], V54, P1767
NR 30
TC 33
Z9 34
U1 2
U2 29
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD MAR
PY 2010
VL 7
IS 1
BP 6
EP 12
DI 10.1016/S1672-6529(09)60187-6
PG 7
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA 581WN
UT WOS:000276556300002
DA 2018-10-20
ER

PT J
AU Jin, KL
   Mao, XO
   Xie, L
   Galvan, V
   Lai, B
   Wang, YM
   Gorostiza, O
   Wang, XM
   Greenberg, DA
AF Jin, Kunlin
   Mao, XiaoOu
   Xie, Lin
   Galvan, Veronica
   Lai, Bin
   Wang, Yaoming
   Gorostiza, Olivia
   Wang, Xiaomei
   Greenberg, David A.
TI Transplantation of human neural precursor cells in Matrigel scaffolding
   improves outcome from focal cerebral ischemia after delayed postischemic
   treatment in rats
SO JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
LA English
DT Article
DE ischemia; neurogenesis; neuronal progenitor cell; stem cells; stroke;
   transplantation
ID ENDOTHELIAL GROWTH-FACTOR; EMBRYONIC STEM-CELLS; FUNCTIONAL RECOVERY;
   SUBVENTRICULAR ZONE; PROGENITOR CELLS; BRAIN-LESION; ADULT RATS;
   IN-VITRO; NEUROGENESIS; STROKE
AB Transplantation of neural cells is a potential approach for stroke treatment, but disruption of tissue architecture may limit transplant efficacy. One strategy for enhancing the ability of transplants to restore brain structure and function is to administer cells together with biomaterial scaffolding. We electrocoagulated the distal middle cerebral artery in adult rats and, 3 weeks later, injected one of the following into the infarct cavity: artificial cerebrospinal fluid, Matrigel scaffolding, human embryonic stem cell-derived neuronal precursor cells, scaffolding plus cells, or cells cultured in and administered together with scaffolding. Five weeks after transplantation, the latter two groups showed similar to 50% and similar to 60% reductions, respectively, in infarct cavity volume. Rats given cells cultured in and administered together with scaffolding also showed (1) survival and neuronal differentiation of transplanted cells shown by immunostaining for neuronal marker proteins and cleaved caspase-3, and by patch-clamp recording, 8 weeks after transplantation and (2) improved outcome on tests of sensorimotor and cognitive functions, 4 to 9 weeks after transplantation. These results indicate that transplantation of human neural cells together with biomaterial scaffolding has the potential to improve the outcome from stroke, even when treatment is delayed for several weeks after the ischemic event. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 534-544; doi: 10.1038/jcbfm.2009.219; published online 14 October 2009
C1 [Jin, Kunlin; Mao, XiaoOu; Xie, Lin; Galvan, Veronica; Lai, Bin; Wang, Yaoming; Gorostiza, Olivia; Wang, Xiaomei; Greenberg, David A.] Buck Inst Age Res, Novato, CA 94945 USA.
RP Greenberg, DA (reprint author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.
EM dgreenberg@buckinstitute.org
FU NIH [NS44921, NS62414, AG21980]; Buck Institute for Age Research
FX This study was supported by NIH Grant nos NS44921 and NS62414 (DAG) and
   AG21980 (KJ) and by the Buck Institute for Age Research.
CR Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425
   Cheema ZF, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-11
   Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010
   CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T
   Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Goetz AK, 2006, P NATL ACAD SCI USA, V103, P11063, DOI 10.1073/pnas.0510926103
   Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002
   Hayashi J, 2006, J CEREBR BLOOD F MET, V26, P906, DOI 10.1038/sj.jcbfm.9600247
   Hebert M, 2008, J IMMUNOL, V181, P5963, DOI 10.4049/jimmunol.181.9.5963
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246
   Jin K, 2002, J CLIN INVEST, V110, P311, DOI 10.1172/JCI200215251
   Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3
   Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098
   Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502
   Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0
   Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064
   Magavi SS, 2000, NATURE, V405, P951
   Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P229, DOI 10.1097/00004647-199702000-00013
   Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750
   Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853
   Sarrabayrouse G, 2007, NEOPLASIA, V9, P1078, DOI 10.1593/neo.07727
   SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1
   Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Steindler DA, 2002, NAT BIOTECHNOL, V20, P1091, DOI 10.1038/nbt1102-1091
   STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135
   Sughrue ME, 2006, J NEUROSCI METH, V151, P83, DOI 10.1016/j.jneumeth.2005.04.023
   SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016
   Won SJ, 2006, BRAIN RES, V1123, P237, DOI 10.1016/j.brainres.2006.09.055
   Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/01.WCB.000014701.97890.3B
   Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8
   Zhu W, 2005, NEUROSURGERY, V57, P325, DOI 10.1227/01.NEU.0000166682.50272.BC
NR 43
TC 93
Z9 95
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0271-678X
J9 J CEREBR BLOOD F MET
JI J. Cereb. Blood Flow Metab.
PD MAR
PY 2010
VL 30
IS 3
BP 534
EP 544
DI 10.1038/jcbfm.2009.219
PG 11
WC Endocrinology & Metabolism; Hematology; Neurosciences
SC Endocrinology & Metabolism; Hematology; Neurosciences & Neurology
GA 563DV
UT WOS:000275108900009
PM 19826433
OA Green Published, Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Chiang, YC
   Chen, HJ
   Liu, HC
   Kang, SH
   Lee, BS
   Lin, FH
   Lin, HP
   Lin, CP
AF Chiang, Y. -C.
   Chen, H. -J.
   Liu, H. -C.
   Kang, S. -H.
   Lee, B. -S.
   Lin, F. -H.
   Lin, H. -P.
   Lin, C. -P.
TI A Novel Mesoporous Biomaterial for Treating Dentin Hypersensitivity
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE dentin hypersensitivity; mesoporous silica; CaO; bioactive glass; dentin
   permeability
ID DESENSITIZING AGENTS; IN-VITRO; CERVICAL DENTIN; YAG LASER;
   CYTOTOXICITY; PERMEABILITY; SENSITIVITY; OCCLUSION; BIOGLASS; TUBULES
AB An ideal material has yet to be discovered that can completely treat dentin hypersensitivity; however, calcium phosphate precipitation has exhibited potential value for the treatment of dentin hypersensitivity by the occlusion of dentinal tubules. We hypothesized that a novel mesoporous silica biomaterial (nano CaO@mesoporous silica, NCMS) containing nano-sized calcium oxide particles mixed with 30% phosphoric acid can efficiently occlude dentinal tubules and significantly reduce dentin permeability, even with the presence of pulpal pressure. This highly supersaturated Ca(2+)- and HPO(4)(2)-ion-containing NCMS paste was brushed onto dentin surfaces, and the ions diffused deeply into the dentinal tubules and formed a CaHPO(4)center dot 2H(2)O precipitation with a depth of 100 mu m. The results of the dentin permeability tests showed that the novel mesoporous material exhibited a significant reduction in dentin permeability (p < 0.05), even under simulated pulpal pressure, as compared with our previously developed material, DP-bioglass, and a commercial desensitizing material, Seal & Protect (R).
C1 [Chiang, Y. -C.; Chen, H. -J.; Liu, H. -C.; Kang, S. -H.; Lee, B. -S.; Lin, C. -P.] Natl Taiwan Univ, Sch Dent, Taipei 10016, Taiwan.
   [Chiang, Y. -C.; Chen, H. -J.; Liu, H. -C.; Kang, S. -H.; Lee, B. -S.; Lin, C. -P.] Natl Taiwan Univ, Grad Inst Clin Dent, Taipei 10016, Taiwan.
   [Chiang, Y. -C.; Chen, H. -J.; Liu, H. -C.; Kang, S. -H.; Lee, B. -S.; Lin, C. -P.] Natl Taiwan Univ Hosp, Taipei 10016, Taiwan.
   [Lin, H. -P.] Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
   [Lin, F. -H.] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
RP Lin, CP (reprint author), Natl Taiwan Univ, Sch Dent, 1 Chang Te St, Taipei 10016, Taiwan.
EM hplin@mail.ncku.edu.tw; pinlin@ntu.edu.tw
OI Lin, Chun-Pin/0000-0002-3498-1113; LEE, BOR-SHIUNN/0000-0002-8978-2111
FU National Science Council [NSC-97-2314-B-002-105]; National Taiwan
   University
FX We are grateful for financial support from the National Science Council
   (NSC-97-2314-B-002-105) and for the frontier and innovative research
   grant from the National Taiwan University.
CR ABSI EG, 1987, J CLIN PERIODONTOL, V14, P280, DOI 10.1111/j.1600-051X.1987.tb01533.x
   Addy M, 2003, INT DENT J, V53, P177, DOI 10.1111/j.1875-595X.2003.tb00768.x
   BRANNSTROM M, 1963, J AM DENT ASSOC, V66, P366
   Camps J, 2002, AM J DENT, V15, P300
   CHANG CW, 2003, FORMO J MED, V7, P42
   de Villiers MM, 2009, NANOTECHNOLOGY DRUG
   Gillam DG, 1999, ENDOD DENT TRAUMATOL, V15, P198
   ISHIKAWA K, 1994, J DENT RES, V73, P1197, DOI 10.1177/00220345940730061101
   ISHIKAWA K, 1994, J DENT RES, V73, P1462, DOI 10.1177/00220345940730081101
   Ishikawa S, 1969, Kokubyo Gakkai Zasshi, V36, P278
   Kishore A, 2002, J ENDODONT, V28, P34, DOI 10.1097/00004770-200201000-00008
   Kuo TC, 2007, J ENDODONT, V33, P451, DOI 10.1016/j.joen.2006.12.014
   Lan WH, 2004, J ENDODONT, V30, P131, DOI 10.1097/00004770-200403000-00001
   Lee BS, 2005, DENT MATER J, V24, P562, DOI 10.4012/dmj.24.562
   Lee BS, 2005, DENT MATER, V21, P511, DOI 10.1016/j.dental.2004.08.002
   Liu HC, 1998, J ENDODONT, V24, P45, DOI 10.1016/S0099-2399(98)80213-6
   PASHLEY DH, 1994, ARCH ORAL BIOL, V39, pS73, DOI 10.1016/0003-9969(94)90191-0
   PASHLEY DH, 1985, J DENT RES, V64, P613, DOI 10.1177/002203458506400419
   PASHLEY DH, 1985, ARCH ORAL BIOL, V30, P731, DOI 10.1016/0003-9969(85)90185-2
   Schwarz F, 2002, J CLIN PERIODONTOL, V29, P211, DOI 10.1034/j.1600-051x.2002.290305.x
   Suge T, 1995, J DENT RES, V74, P1709, DOI 10.1177/00220345950740101301
   TROWBRIDGE HO, 1990, DENT CLIN N AM, V34, P561
NR 22
TC 20
Z9 22
U1 1
U2 24
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2010
VL 89
IS 3
BP 236
EP 240
DI 10.1177/0022034509357148
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 554JK
UT WOS:000274431100004
PM 20110512
DA 2018-10-20
ER

PT J
AU Fischer, M
   Sperling, C
   Werner, C
AF Fischer, Marion
   Sperling, Claudia
   Werner, Carsten
TI Synergistic effect of hydrophobic and anionic surface groups triggers
   blood coagulation in vitro
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 22nd European Conference on Biomaterials
CY SEP 07-11, 2009
CL Lausanne, SWITZERLAND
ID SELF-ASSEMBLED MONOLAYERS; CONTACT ACTIVATION; PROTEIN ADSORPTION;
   PLATELET-ADHESION; CELL-ADHESION; POLYMER SURFACES; FACTOR-XII; PLASMA;
   HEMOCOMPATIBILITY; BIOMATERIALS
AB Biomaterial induced coagulation encompasses plasmatic and cellular processes. The functional loss of biomedical devices possibly resulting from these thrombotic reactions motivates the need for a better understanding of processes occurring at blood-biomaterial interfaces. Well defined model surfaces providing specific chemical-physical properties (self assembled monolayers (SAMs)) displaying hydrophobic or/and acidic terminal groups were used to uncover initial mechanisms of biomaterial induced coagulation. We investigated the influence of electrical charge and wettability on platelet- and contact activation, the two main actors of blood coagulation, which are often considered as separate mechanisms in biomaterials research. Our results show a dependence of contact activation on acidic surface groups and a correlation of platelet adhesion to surface hydrophobicity. Clot formation resulting from the interplay of blood platelets and contact activation was only found on surfaces combining both acidic and hydrophobic surface groups but not on monolayers displaying extreme hydrophobic/acidic properties.
C1 [Fischer, Marion; Sperling, Claudia; Werner, Carsten] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, Dresden, Germany.
   [Werner, Carsten] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Werner, Carsten] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, Dresden, Germany.
RP Fischer, M (reprint author), Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat Dresden, Dresden, Germany.
EM fischer-marion@ipfdd.de
RI Umlauf, Ursula/D-3356-2014; Werner, Carsten/F-8127-2010
OI Werner, Carsten/0000-0003-0189-3448
CR Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Blomback B, 2004, BIOPHYS CHEM, V112, P147, DOI 10.1016/j.bpc.2004.07.013
   Chen XY, 2007, ANAL BIOANAL CHEM, V388, P65, DOI 10.1007/s00216-006-0999-8
   Chuang WH, 2007, J BIOMED MATER RES A, V82A, P820, DOI 10.1002/jbm.a.31193
   Evans-Nguyen KM, 2005, LANGMUIR, V21, P1691, DOI 10.1021/la047303h
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   KOZIN F, 1992, INFLAMMATION BASIC P, P101
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Liebe S, 1975, Folia Haematol Int Mag Klin Morphol Blutforsch, V102, P454
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   MIYAMOTO M, 1990, BIOMATERIALS, V11, P385, DOI 10.1016/0142-9612(90)90091-4
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   RACHER A, 1998, CELL TISSUE CULTURE, P71
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Sagnella S, 2005, COLLOID SURFACE B, V42, P147, DOI 10.1016/j.colsurfb.2004.07.001
   Sanchez J, 2002, THROMB RES, V105, P407, DOI 10.1016/S0049-3848(02)00051-8
   SCHULMAN G, 1993, J AM SOC NEPHROL, V3, P1563
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Sperling C, 2007, BIOMATERIALS, V28, P3617, DOI 10.1016/j.biomaterials.2007.04.041
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Streller U, 2003, J BIOMED MATER RES B, V66B, P379, DOI 10.1002/jbm.b.10016
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Yarovaya G.A., 2002, BIOCHEMISTRY-MOSCOW, V67, P16
   Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 31
TC 11
Z9 11
U1 0
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2010
VL 21
IS 3
SI SI
BP 931
EP 937
DI 10.1007/s10856-009-3912-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568VS
UT WOS:000275552700012
PM 19851837
DA 2018-10-20
ER

PT J
AU Crespi, R
   Cappare, P
   Gherlone, E
AF Crespi, Roberto
   Cappare, Paolo
   Gherlone, Enrico
TI Osteotome Sinus Floor Elevation and Simultaneous Implant Placement in
   Grafted Biomaterial Sockets: 3 Years of Follow-Up
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Dental implants; maxillary sinus surgery; tooth socket
ID MAGNESIUM-ENRICHED HYDROXYAPATITE; MAXILLARY MOLAR EXTRACTION; CLINICAL
   REPORT; BONE-FORMATION; SITES; EXPRESSION; TEETH; RIDGE; TIME; DOG
AB Background: Immediate bone grafting procedures were proposed to preserve bone volume in residual damaged alveolar walls and to prevent the expansion of the sinus floor in the maxillary molar region. The use of an osteotome allows vertical bone augmentation and localized sinus elevation with minimal surgical trauma. The aim of this study is to evaluate the clinical outcome of implants placed in previously grafted alveoli that were expanded at a second-stage surgery by an osteotome technique.
   Methods: Twenty patients requiring extraction of one or two upper molar teeth and/or a second premolar were selected. Thirty teeth were extracted, and their fresh sockets immediately received magnesium-enriched hydroxyapatite as a graft material. Three months after bone filling, osteotome sinus floor elevations were performed in grafted sites, and 30 titanium dental implants were placed. Three months after implant placement, temporary restorations were performed. Followup examinations and intraoral digital radiographs were taken at baseline and 6, 12, 24, and 36 months after implant placement to evaluate the alveolar bone gain for each implant. Comparisons among mean values of alveolar bone gain over time were performed by the Student two-tailed t test.
   Results: At the 36-month follow-up, a survival rate of 100% was reported for all implants. The alveolar bone gain after 6 months of healing was 2.41 +/- 1.23 mm. Successively, after 12 months, the bone gain increased (3.85 +/- 1.37 mm). At 24 and 36 months after implant placement, the levels were stable (3.86 +/- 1.50 mm and 3.82 +/- 1.57 mm, respectively). Statistical analyses showed a significant difference (P <0.05) only between the 6- and 12-month values.
   Conclusion: At the 36-month follow-up, the use of the osteotome technique for vertical expansion of the grafted tissue was considered a predictable procedure in the implant surgery. J Periodon tot 2010;81:344-349.
C1 [Crespi, Roberto; Cappare, Paolo; Gherlone, Enrico] Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, I-20123 Milan, Italy.
RP Crespi, R (reprint author), Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, Via Olgettina 48, I-20123 Milan, Italy.
EM robcresp@libero.it
RI Cappare, Paolo/A-2025-2016; Gherlone, Enrico/M-7376-2016
OI Cappare, Paolo/0000-0002-7277-6583; 
CR Albrektsson T, 1986, INT J ORAL MAXILLOF, V1, P11
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Barone A, 2008, INT J PERIODONT REST, V28, P283
   Bragger U, 2004, CLIN ORAL IMPLAN RES, V15, P158, DOI 10.1111/j.1600-0501.2004.00988.x
   Bruschi GB, 1998, INT J ORAL MAX IMPL, V13, P219
   Cammack GV, 2005, INT J PERIODONT REST, V25, P231
   Crespi R, 2009, J PERIODONTOL, V80, P1616, DOI 10.1902/jop.2009.090156
   Crespi R, 2009, J PERIODONTOL, V80, P586, DOI 10.1902/jop.2009.080466
   Crespi R, 2009, J PERIODONTOL, V80, P210, DOI [10.1902/jop.2009.080400, 10.1902/jop.2009.080400 ]
   Fugazzotto PA, 2002, J PERIODONTOL, V73, P39, DOI 10.1902/jop.2002.73.1.39
   Fugazzotto PA, 2008, J PERIODONTOL, V79, P216, DOI [10.1902/jop.2008.070338, 10.1902/jop.2008.070338 ]
   Leonetti J A, 2000, Implant Dent, V9, P177, DOI 10.1097/00008505-200009020-00012
   Molly L, 2008, J PERIODONTOL, V79, P1108, DOI [10.1902/jop.2008.070476, 10.1902/jop.2008.070476 ]
   Mombelli A, 1994, Periodontol 2000, V4, P81, DOI 10.1111/j.1600-0757.1994.tb00008.x
   Norton MR, 2002, INT J ORAL MAX IMPL, V17, P249
   Okamoto T, 1983, J Nihon Univ Sch Dent, V25, P202
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.0.CO;2-I
   Rosen PS, 1999, INT J ORAL MAX IMPL, V14, P853
   Rosenquist B, 2000, CLIN ORAL IMPLAN RES, V11, P572, DOI 10.1034/j.1600-0501.2000.011006572.x
   Schwartz-Arad D, 2000, J PERIODONTOL, V71, P839, DOI 10.1902/jop.2000.71.5.839
   SchwartzArad D, 1997, J PERIODONTOL, V68, P1110, DOI 10.1902/jop.1997.68.11.1110
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   Summers R B, 1994, Compendium, V15, P702
   Summers R B, 1994, Compendium, V15, P154
   Summers R B, 1998, J Esthet Dent, V10, P164, DOI 10.1111/j.1708-8240.1998.tb00352.x
   Summers R. B., 1994, COMPENDIUM, V15, P162
   Summers RB, 1994, COMPENDIUM, V15, P158
   Summers RB, 1994, COMPENDIUM, V15, P154
   SUMMERS RB, 1994, COMPENDIUM, V15, P700
   SUMMERS RB, 1994, COMPENDIUM, V15, P702
   Toffler M, 2004, INT J ORAL MAX IMPL, V19, P266
   WEHRBEIN H, 1992, Fortschritte der Kieferorthopaedie, V53, P77, DOI 10.1007/BF02164641
NR 34
TC 20
Z9 21
U1 0
U2 6
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAR
PY 2010
VL 81
IS 3
BP 344
EP 349
DI 10.1902/jop.2010.090477
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 665FL
UT WOS:000283020500005
PM 20192859
DA 2018-10-20
ER

PT J
AU Kuo, YC
   Wang, CC
AF Kuo, Yung-Chih
   Wang, Cheng-Chin
TI Effect of bovine pituitary extract on the formation of neocartilage in
   chitosan/gelatin scaffolds
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Bovine pituitary extract; Chitosan; Gelatin; Chondrocyte; Scaffold
ID TISSUE-ENGINEERED CARTILAGE; CROSS-LINKING AGENT; ARTICULAR-CARTILAGE;
   GROWTH-FACTORS; IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; KNEE
   CHONDROCYTES; EPITHELIAL-CELLS; GENE-EXPRESSION; PORE-SIZE
AB This study investigates the influence of protein concentration in bovine pituitary extract (BPE) on the production of cartilaginous components in chitosan/gelatin (CG) scaffolds. Bovine knee chondrocytes (BKCs) in genipin-crosslinked CG scaffolds were cultured over 28 days for assessing the constructs. Scanning electron micrographs revealed that the pore structure of CG scaffolds was appropriate for cartilage tissue engineering. Also, an addition of BPE into culture medium stimulated the growth of BKCs on the pore surfaces of CG scaffolds. An increase in the protein concentration in BPE enhanced the amounts of BKCs. glycosaminoglycans and collagen. At a constant protein concentration in BPE, a scaffold prepared with a high concentration of biomaterial gels also favored the proliferation of BKCs and secretion of extracellular matrices. The histological and immunochemical staining showed chondrogenesis in the culture of BKCs using CG scaffolds and BPE-containing medium. In addition, type II collagen was synthesized in the constructs, demonstrating the chondrocytic phenotype of proliferated BKCs. Hence, combining CG scaffolds with BPE can be effectual in the regeneration of neocartilage. (C) 2009 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Kuo, Yung-Chih; Wang, Cheng-Chin] Natl Chung Cheng Univ, Dept Chem Engn, Chiayi 62102, Taiwan.
RP Kuo, YC (reprint author), Natl Chung Cheng Univ, Dept Chem Engn, Chiayi 62102, Taiwan.
EM chmyck@ccu.edu.tw
FU National Science Council of the Republic of China
FX This work was supported by the National Science Council of the Republic
   of China.
CR ASAMI O, 1984, J BIOCHEM-TOKYO, V95, P299, DOI 10.1093/oxfordjournals.jbchem.a134609
   BISSELL MJ, 1987, J CELL SCI, P327
   BOYCE ST, 1985, J TISSUE CULTURE MET, V9, P83
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chubinskaya S, 2007, OSTEOARTHR CARTILAGE, V15, P421, DOI 10.1016/j.joca.2006.10.004
   Colchester ACF, 2005, LANCET, V366, P856, DOI 10.1016/S0140-6736(05)67218-2
   Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9
   Galois L, 2006, BIOMATERIALS, V27, P79, DOI 10.1016/j.biomaterials.2005.05.098
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   GUNTHER M, 1994, ARTHRITIS RHEUM, V37, P395, DOI 10.1002/art.1780370314
   Hou QP, 2003, J BIOMED MATER RES B, V67B, P732, DOI 10.1002/jbm.b.10066
   Jiankang H., 2007, POLYMER, V48, P4578, DOI DOI 10.1016/J.POLYMER.2007.05.048
   Kent KD, 2003, IN VITRO CELL DEV-AN, V39, P388
   Khoshfetrat AB, 2008, J BIOSCI BIOENG, V106, P547, DOI 10.1263/jbb.106.547
   KOSHER RA, 1973, DEV BIOL, V35, P210, DOI 10.1016/0012-1606(73)90018-3
   Kuo YC, 2005, BIOTECHNOL PROGR, V21, P1708, DOI 10.1021/bp050234s
   KUO YC, J BIOMED MA IN PRESS
   Kuo YC, 2008, BIOMACROMOLECULES, V9, P2662, DOI 10.1021/bm800651r
   Kuo YC, 2007, BIOTECHNOL PROGR, V23, P238, DOI 10.1021/bp060253h
   Kuo YC, 2006, BIOTECHNOL PROGR, V22, P1664, DOI 10.1021/bp0602303
   Kuo YC, 2006, BIOTECHNOL BIOENG, V95, P132, DOI 10.1002/bit.21007
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   Lee JD, 1997, LIFE SCI, V61, P293
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   Lien SM, 2008, MAT SCI ENG C-BIO S, V28, P36, DOI 10.1016/j.msec.2006.12.015
   Liu J, 2009, ANIM REPROD SCI, V115, P49, DOI 10.1016/j.anireprosci.2008.11.012
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   Pei M, 2002, BIOCHEM BIOPH RES CO, V294, P149, DOI 10.1016/S0006-291X(02)00439-4
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Saini S, 2003, BIOTECHNOL PROGR, V19, P510, DOI 10.1021/bp0256519
   SCULLY SP, 2001, CLIN ORTHOP RELAT R, V391, P72
   SHUICHI M, 2001, J BIOMED MATER RES, V56, P368
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Tanaka Y, 2008, CELL BIOL INT, V32, P505, DOI 10.1016/j.cellbi.2007.12.012
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WANG HJ, 1995, BURNS, V21, P503, DOI 10.1016/0305-4179(95)00030-F
   Wang HJ, 1996, BURNS, V22, P10, DOI 10.1016/0305-4179(95)00079-8
   Wang LM, 2009, ARCH ORAL BIOL, V54, P1, DOI 10.1016/j.archoralbio.2008.06.002
   Wehner S, 2004, EUR J CELL BIOL, V83, P701, DOI 10.1078/0171-9335-00427
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
NR 49
TC 15
Z9 15
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD MAR
PY 2010
VL 41
IS 2
BP 150
EP 156
DI 10.1016/j.jtice.2009.08.011
PG 7
WC Engineering, Chemical
SC Engineering
GA 574PZ
UT WOS:000276005400004
DA 2018-10-20
ER

PT J
AU Holvoet, S
   Chevallier, P
   Turgeon, S
   Mantovani, D
AF Holvoet, Servaas
   Chevallier, Pascale
   Turgeon, Stephane
   Mantovani, Diego
TI Toward High-Performance Coatings for Biomedical Devices: Study on
   Plasma-Deposited Fluorocarbon Films and Ageing in PBS
SO MATERIALS
LA English
DT Article
DE ageing; oxidation; plasma polymers; fluorocarbon films; XPS; FTIR; AFM
ID CORROSION PROTECTION; POLYETHYLENE-GLYCOL; BIOMATERIAL THROMBOSIS;
   POLYMER DEPOSITION; MOLECULAR BARRIERS; SURFACE-PROTEINS;
   STAINLESS-STEEL; COATED-STENTS; THIN-FILMS; HEPARIN
AB High performance coatings tailored to medical devices represent a recognised approach to modulate surface properties. Plasma-deposited fluorocarbon films have been proposed as a potential stent coating. Previous studies have shown promising adhesion properties: the 35 nm-thick film sustained plastic deformation up to 25% such as induced during the clinical implantation. In this study, the compositional and morphological changes of plasma-deposited fluorocarbon films were examined during ageing in a pseudophysiological medium, a phosphate buffer solution (PBS), by angle-resolved XPS, FT-IR data and AFM images. The evolution of the ageing process is discussed: defluorination and crosslinking yielded an oxidized protective top layer onto the films, which showed further degradation.
C1 [Holvoet, Servaas; Chevallier, Pascale; Turgeon, Stephane; Mantovani, Diego] Univ Laval, Univ Hosp Res Ctr, Dept Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1K 7P4, Canada.
RP Mantovani, D (reprint author), Univ Laval, Univ Hosp Res Ctr, Dept Mat Engn, Lab Biomat & Bioengn, Quebec City, PQ G1K 7P4, Canada.
EM servaas.holvoet@crsfa.ulaval.ca; pascale.chevallier@crsfa.ulaval.ca;
   stephane.turgeon@crsfa.ulaval.ca; Diego.Mantovani@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
FU Natural Sciences and Engineering Research Council of Canada; University
   Hospital Research Center (St-Francois d'Assise Hospital) in Quebec City
FX The authors would like to thank Francois Lewis for his precious
   comments. This work was partially supported by the Natural Sciences and
   Engineering Research Council of Canada and by the University Hospital
   Research Center (St-Francois d'Assise Hospital) in Quebec City.
CR Babapulle MN, 2002, CIRCULATION, V106, P2859, DOI 10.1161/01.CIR.0000038984.30279.89
   Babapulle MN, 2002, CIRCULATION, V106, P2734, DOI 10.1161/01.CIR.0000038982.49640.70
   Barranco V, 2004, ELECTROCHIM ACTA, V49, P1999, DOI 10.1016/j.electacta.2003.12.030
   BEAMSON G, 1992, SCI ESCA300 DATABASE, P1
   Bickel C, 2001, J Interv Cardiol, V14, P407, DOI 10.1111/j.1540-8183.2001.tb00350.x
   BOLAND JL, 2000, INT J CARDIOVASC INT, V3, P215
   Caicedo M, 2008, J BIOMED MATER RES A, V86A, P905, DOI 10.1002/jbm.a.31789
   CHEVALLIER P, 2003, NEW TECHNOLOGIES VAS, P87
   Dahm KL, 2005, WEAR, V259, P933, DOI 10.1016/j.wear.2005.02.040
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Deible CR, 1999, BIOMATERIALS, V20, P101, DOI 10.1016/S0142-9612(98)00001-5
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   DeScheerder I, 1997, CIRCULATION, V95, P1549
   Dong BY, 2005, J APPL POLYM SCI, V97, P485, DOI 10.1002/app.21766
   FAVIA P, 2004, PLASMA POLYM FILMS, P25
   FDA Center for Drug Evaluation and Research, 2005, GUID IND EST MAX SAF, P1
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Gengenbach TR, 1998, SURF INTERFACE ANAL, V26, P498, DOI 10.1002/(SICI)1096-9918(199806)26:7<498::AID-SIA393>3.0.CO;2-3
   Goodwin SC, 2000, INVEST RADIOL, V35, P420, DOI 10.1097/00004424-200007000-00004
   Grundmeier G, 1998, MATER CORROS, V49, P150, DOI 10.1002/(SICI)1521-4176(199803)49:3<150::AID-MACO150>3.0.CO;2-X
   Grundmeier G, 2003, SURF COAT TECH, V174, P996, DOI 10.1016/S0257-8972(03)00606-6
   Haidopoulos M, 2005, PLASMA PROCESS POLYM, V2, P424, DOI 10.1002/ppap.200400066
   Hale P, 2008, LANGMUIR, V24, P7897, DOI 10.1021/la8002788
   Hong MK, 2003, CIRCULATION, V107, P517, DOI 10.1161/01.CIR.0000054163.42072.D4
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   HORIE M, 1995, J VAC SCI TECHNOL A, V13, P2490, DOI 10.1116/1.579493
   *IARC, 1998, IARC MON PROGR EV CA, V74, P9
   Joshi PP, 2006, APPL SURF SCI, V252, P5676, DOI 10.1016/j.apsusc.2005.07.061
   Lee HJ, 2002, J BIOMAT SCI-POLYM E, V13, P939, DOI 10.1163/156856202320401979
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Lewis AL, 2002, J BIOMED MATER RES, V63, P699, DOI 10.1002/jbm.10387
   Lewis Andrew L, 2002, J Long Term Eff Med Implants, V12, P231
   LEWIS F, 2008, J PHYS D, V41
   LEWIS F, 2010, J MAT SCI MAT UNPUB
   Lin Y, 1996, J APPL POLYM SCI, V60, P543
   MAREK M, 2003, MED DEV MAT P MAT PR, P133
   Mazumder MM, 2003, J BIOMAT SCI-POLYM E, V14, P1351, DOI 10.1163/156856203322599699
   Milella A, 2004, PLASMA PROCESS POLYM, V1, P164, DOI 10.1002/ppap.200400021
   Moffitt CE, 2000, APPL SURF SCI, V161, P481, DOI 10.1016/S0169-4332(00)00365-2
   MOFFITT CE, 2001, PLASMAS POLYM, V6, P193
   Otsuka Yoritaka, 2007, J Invasive Cardiol, V19, P71
   Rastogi AC, 2005, POLYMER, V46, P3440, DOI 10.1016/j.polymer.2004.10.082
   Ritter EF, 1997, SURGERY, V122, P888, DOI 10.1016/S0039-6060(97)90329-9
   Schwertz Dorie W, 2003, J Cardiovasc Nurs, V18, P11
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   Stuhlmeier KM, 1999, BBA-GEN SUBJECTS, V1428, P177, DOI 10.1016/S0304-4165(99)00065-3
   Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A
   Tanikella RV, 2002, J ELECTRON MATER, V31, P1096, DOI 10.1007/s11664-002-0048-0
   Wieneke H, 2002, HERZ, V27, P518, DOI 10.1007/s00059-002-2405-4
   Wijesundara MBJ, 2001, J ADHES SCI TECHNOL, V15, P599, DOI 10.1163/156856101300189952
NR 50
TC 14
Z9 14
U1 0
U2 13
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2010
VL 3
IS 3
BP 1515
EP 1532
DI 10.3390/ma3031515
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LC
UT WOS:000298240500003
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tan, CP
   Craighead, HG
AF Tan, Christine P.
   Craighead, Harold G.
TI Surface Engineering and Patterning Using Parylene for Biological
   Applications
SO MATERIALS
LA English
DT Review
DE parylene; micropatterning; surface modification; [2.2]paracyclophane;
   biomaterial; bioactive; biomolecular; nanobiotechnology; microarray;
   microfluidic
ID REACTIVE POLYMER-COATINGS; CHEMICAL-VAPOR-DEPOSITION;
   ELECTROWETTING-BASED ACTUATION; MICROFLUIDIC CHANNELS; LIPID-BILAYERS;
   POLY(P-PHENYLENE VINYLENE); FLUORESCENCE MICROSCOPY; DIFFERENT
   TEMPERATURES; LIQUID DROPLETS; C STENCILS
AB Parylene is a family of chemically vapour deposited polymer with material properties that are attractive for biomedicine and nanobiotechnology. Chemically inert parylene "peel-off" stencils have been demonstrated for micropatterning biomolecular arrays with high uniformity, precise spatial control down to nanoscale resolution. Such micropatterned surfaces are beneficial in engineering biosensors and biological microenvironments. A variety of substituted precursors enables direct coating of functionalised parylenes onto biomedical implants and microfluidics, providing a convenient method for designing biocompatible and bioactive surfaces. This article will review the emerging role and applications of parylene as a biomaterial for surface chemical modification and provide a future outlook.
C1 [Tan, Christine P.; Craighead, Harold G.] Cornell Univ, Sch Appl & Engn Phys, New York, NY 14853 USA.
   [Tan, Christine P.] Cornell Univ, Dept Biomed Engn, New York, NY 14853 USA.
RP Craighead, HG (reprint author), Cornell Univ, Sch Appl & Engn Phys, New York, NY 14853 USA.
EM cpt7@cornell.edu; hgc1@cornell.edu
FU NIH [DC07489]
FX C. P. T. is supported by the NIH (DC07489). The authors are grateful to
   Benjamin Cipriany for helpful discussions.
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Atsuta K, 2007, J MICROMECH MICROENG, V17, P496, DOI 10.1088/0960-1317/17/3/011
   Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049
   CHARLSON EM, 1992, IEEE T BIO-MED ENG, V39, P202, DOI 10.1109/10.121652
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen HY, 2008, ADV MATER, V20, P3474, DOI 10.1002/adma.200800455
   Chen HY, 2007, ADV MATER, V19, P3801, DOI 10.1002/adma.200602830
   Chen HY, 2006, J AM CHEM SOC, V128, P374, DOI 10.1021/ja057082h
   Chen HY, 2005, ANAL CHEM, V77, P6909, DOI 10.1021/ac050964e
   Chen PJ, 2006, LAB CHIP, V6, P803, DOI 10.1039/b600224b
   Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467
   Christman KL, 2009, J AM CHEM SOC, V131, P521, DOI 10.1021/ja804767j
   Coyer SR, 2007, ANGEW CHEM INT EDIT, V46, P6837, DOI 10.1002/anie.200700989
   Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061
   Delivopoulos E, 2009, BIOMATERIALS, V30, P2048, DOI 10.1016/j.biomaterials.2008.12.049
   Dusseiller MR, 2005, LAB CHIP, V5, P1387, DOI 10.1039/b509957a
   Elkasabi Y, 2006, ADV MATER, V18, P1521, DOI 10.1002/adma.200502454
   Erickson J, 2008, J NEUROSCI METH, V175, P1, DOI 10.1016/j.jneumeth.2008.07.023
   Fortin J. B., 2004, CHEM VAPOR DEPOS, P58
   Fortin J. B., 2004, CHEM VAPOR DEPOS, P62
   Fortin J.B., 2004, CHEM VAPOR DEPOS, P41
   FORTIN JB, 2004, CHEM VAPOR DEPOS, P7
   GAZICKI M, 1985, J POLYM SCI POL CHEM, V23, P2255, DOI 10.1002/pol.1985.170230815
   GAZICKI M, 1986, J POLYM SCI POL CHEM, V24, P215, DOI 10.1002/pola.1986.080240203
   GORHAM WF, 1966, J POLYM SCI A1, V4, P3027, DOI 10.1002/pol.1966.150041209
   Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m
   Hu WW, 2009, BIOMATERIALS, V30, P5785, DOI 10.1016/j.biomaterials.2009.06.041
   Hwang Kyo Seon, 2004, Journal of the Korean Physical Society, V44, P1168
   Ilic B, 2002, J VAC SCI TECHNOL B, V20, P2459, DOI 10.1116/1.1526356
   Ilic B, 2000, BIOMED MICRODEVICES, V2, P317, DOI 10.1023/A:1009911407093
   Jinno S, 2008, J BIOMED MATER RES A, V86A, P278, DOI 10.1002/jbm.a.32030
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A., 2008, MICRO NANOENGINEERIN
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   KURIBAYASHI K, 2007, P 20 INT MEMS C KOB, P501
   Lange K, 2007, SENSOR ACTUAT B-CHEM, V125, P441, DOI 10.1016/j.snb.2007.02.039
   Lahann J, 2003, ANAL CHEM, V75, P2117, DOI 10.1021/ac020557s
   Lahann J, 2002, LANGMUIR, V18, P3632, DOI 10.1021/la011464t
   Lahann J, 2002, MACROMOLECULES, V35, P4380, DOI 10.1021/ma011769e
   Lahann J, 2001, MACROMOL RAPID COMM, V22, P968
   Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1
   Lahann J, 2001, ANGEW CHEM INT EDIT, V40, P726, DOI 10.1002/1521-3773(20010216)40:4<726::AID-ANIE7260>3.0.CO;2-X
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Le Pioufle B, 2008, ANAL CHEM, V80, P328, DOI 10.1021/ac7016635
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Liu MC, 2008, SENSOR ACTUAT B-CHEM, V129, P826, DOI 10.1016/j.snb.2007.09.074
   Meng E, 2003, P MICROTAS 2003 7 IN, P1109
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Miwa J, 2008, J MICROELECTROMECH S, V17, P611, DOI 10.1109/JMEMS.2008.921706
   Moran-Mirabal JM, 2005, BIOPHYS J, V89, P296, DOI 10.1529/biophysj.104.054346
   Moran-Mirabal JM, 2007, ANAL CHEM, V79, P1109, DOI 10.1021/ac061898z
   Moran-Mirabal JN, 2008, BIOTECHNOL BIOENG, V101, P1129, DOI 10.1002/bit.21990
   Morigaki K, 2002, LANGMUIR, V18, P4082, DOI 10.1021/la0157420
   Moses JE, 2007, CHEM SOC REV, V36, P1249, DOI 10.1039/b613014n
   Nandivada H, 2005, MACROMOL RAPID COMM, V26, P1794, DOI 10.1002/marc.200500449
   Nandivada H, 2006, ANGEW CHEM INT EDIT, V45, P3360, DOI 10.1002/anie.200600357
   Nandivada H, 2008, ACS SYM SER, V977, P283
   Orth RN, 2003, BIOPHYS J, V85, P3066, DOI 10.1016/S0006-3495(03)74725-0
   Orth RN, 2003, LANGMUIR, V19, P1599, DOI 10.1021/la026314c
   Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534
   Suh KY, 2004, ADV MATER, V16, P1401, DOI 10.1002/adma.200400101
   Suzuki H, 2009, BIOMED MICRODEVICES, V11, P17, DOI 10.1007/s10544-008-9205-4
   SZWARC M, 1951, J POLYM SCI, V6, P319, DOI 10.1002/pol.1951.120060307
   Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637
   Takeuchi S, 2005, LAB CHIP, V5, P519, DOI 10.1039/b417497f
   Tan CP, 2010, NANO LETT, V10, P719, DOI 10.1021/nl903968s
   Tan CP, 2009, INTEGR BIOL, V1, P587, DOI 10.1039/b908036h
   TAN CP, 2008, P MICROTAS 2008 12 I, P1552
   Tooker A, 2005, IEEE ENG MED BIOL, V24, P30, DOI 10.1109/MEMB.2005.1549727
   Torres AJ, 2008, P NATL ACAD SCI USA, V105, P17238, DOI 10.1073/pnas.0802138105
   Vaeth KM, 1999, ADV MATER, V11, P814, DOI 10.1002/(SICI)1521-4095(199907)11:10<814::AID-ADMA814>3.0.CO;2-Z
   Vaeth KM, 2000, LANGMUIR, V16, P8495, DOI 10.1021/la000602w
   Vaeth KM, 2000, CHEM MATER, V12, P1305, DOI 10.1021/cm990642p
   Wahjudi PN, 2009, J BIOMED MATER RES A, V89A, P206, DOI 10.1002/jbm.a.31929
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Wright D, 2008, J BIOMED MATER RES A, V85A, P530, DOI 10.1002/jbm.a.31281
   Wright D, 2007, LAB CHIP, V7, P1272, DOI 10.1039/b706081e
   Xu Y, 2003, 12 INT C TRANSD SOL, P1307
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   Yoshida Y, 2006, J MICROMECH MICROENG, V16, P1550, DOI 10.1088/0960-1317/16/8/015
NR 80
TC 71
Z9 72
U1 0
U2 77
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2010
VL 3
IS 3
BP 1803
EP 1832
DI 10.3390/ma3031803
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LC
UT WOS:000298240500016
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Parenteau-Bareil, R
   Gauvin, R
   Berthod, F
AF Parenteau-Bareil, Remi
   Gauvin, Robert
   Berthod, Francois
TI Collagen-Based Biomaterials for Tissue Engineering Applications
SO MATERIALS
LA English
DT Review
DE collagen; biomaterial; soft tissue
ID VALVE HOMOGRAFT SYNERGRAFT(TM); ABDOMINAL-WALL RECONSTRUCTION; ANTERIOR
   URETHRAL STRICTURES; SMALL-INTESTINAL SUBMUCOSA; ACELLULAR DERMAL
   MATRIX; CROSS-LINKED COLLAGEN; DIABETIC FOOT ULCERS; EX-VIVO EXPANSION;
   IN-VITRO CULTURE; NERVE REGENERATION
AB Collagen is the most widely distributed class of proteins in the human body. The use of collagen-based biomaterials in the field of tissue engineering applications has been intensively growing over the past decades. Multiple cross-linking methods were investigated and different combinations with other biopolymers were explored in order to improve tissue function. Collagen possesses a major advantage in being biodegradable, biocompatible, easily available and highly versatile. However, since collagen is a protein, it remains difficult to sterilize without alterations to its structure. This review presents a comprehensive overview of the various applications of collagen-based biomaterials developed for tissue engineering, aimed at providing a functional material for use in regenerative medicine from the laboratory bench to the patient bedside.
C1 [Parenteau-Bareil, Remi; Gauvin, Robert; Berthod, Francois] CHA Univ Quebec, Hop St Sacrement, Ctr Rech FRSQ, Lab Organogenese Expt LOEX, Quebec City, PQ G1S 4L8, Canada.
   [Parenteau-Bareil, Remi; Gauvin, Robert; Berthod, Francois] Univ Laval, Fac Med, Dept Chirurg, Quebec City, PQ G1V 0A6, Canada.
RP Berthod, F (reprint author), CHA Univ Quebec, Hop St Sacrement, Ctr Rech FRSQ, Lab Organogenese Expt LOEX, Quebec City, PQ G1S 4L8, Canada.
EM remi.parenteau.1@ulaval.ca; robert.gauvin.1@ulaval.ca;
   francois.berthod@chg.ulaval.ca
CR Adhirajan N, 2009, EUR J PHARM SCI, V36, P235, DOI 10.1016/j.ejps.2008.09.010
   Adhirajan N, 2009, J PHARM PHARMACOL, V61, P1617, DOI 10.1211/jpp/61.12.0005
   Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Altman AM, 2008, AESTHET PLAST SURG, V32, P698, DOI 10.1007/s00266-008-9159-1
   Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026
   Ansaloni L, 2007, Hernia, V11, P321, DOI 10.1007/s10029-007-0225-4
   Antonicelli F, 2009, WOUND REPAIR REGEN, V17, P631, DOI 10.1111/j.1524-475X.2009.00525.x
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Bechetoille N, 2007, TISSUE ENG, V13, P2667, DOI 10.1089/ten.2006.0405
   Bechtel JFM, 2003, J HEART VALVE DIS, V12, P734
   Bellows CF, 2008, HERNIA, V12, P351, DOI 10.1007/s10029-008-0340-x
   Bentkover SH, 2009, FACIAL PLAST SURG, V25, P73, DOI 10.1055/s-0029-1220646
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Blais M, 2009, J INVEST DERMATOL, V129, P2895, DOI 10.1038/jid.2009.159
   Bouhout S, 2010, TISSUE ENG PT A, V16, P1539, DOI [10.1089/ten.tea.2009.0473, 10.1089/ten.TEA.2009.0473]
   Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   Caissie R, 2006, BIOMATERIALS, V27, P2988, DOI 10.1016/j.biomaterials.2006.01.014
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Castaneda L, 2008, BIOMACROMOLECULES, V9, P3383, DOI 10.1021/bm800793z
   Cebotari S, 2003, J HEART VALVE DIS, V12, P739
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Che ZM, 2006, BIOCHEM BIOPH RES CO, V346, P268, DOI 10.1016/j.bbrc.2006.05.111
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P297, DOI 10.1002/jbm.820110213
   CIARDELLI G, 2009, J BIOMED MATER RES A, V92, P137
   COLIN W, 1984, J DENT RES, V63, P987, DOI 10.1177/00220345840630071601
   Cook James L, 2006, J Knee Surg, V19, P159
   Corriveau MP, 2009, J PATHOL, V217, P534, DOI 10.1002/path.2482
   Cortial D, 2006, OSTEOARTHR CARTILAGE, V14, P631, DOI 10.1016/j.joca.2006.01.008
   De Franceschi L, 2005, J BIOMED MATER RES A, V75A, P612, DOI 10.1002/jbm.a.30471
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Doillon CJ, 1997, J BIOMED MATER RES, V37, P212
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Duan X, 2005, J BIOMED MATER RES A, V75A, P510, DOI 10.1002/jbm.a.30475
   Dubey DK, 2009, ACTA BIOMATER, V5, P2704, DOI 10.1016/j.actbio.2009.02.035
   Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P11, DOI 10.1177/1534734609331597
   EITAN Y, 2010, TISSUE ENG IN PRESS
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   Ellis David A F, 2007, Facial Plast Surg Clin North Am, V15, P239, DOI 10.1016/j.fsc.2007.02.006
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Farahat YA, 2009, J ENDOUROL, V23, P2001, DOI 10.1089/end.2009.0074
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Freyria AM, 2009, TISSUE ENG PT A, V15, P1233, DOI 10.1089/ten.tea.2008.0114
   Friess W, 2006, EUR J PHARM BIOPHARM, V63, P176, DOI 10.1016/j.ejpb.2005.11.007
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   Gingras M, 2008, GLIA, V56, P354, DOI 10.1002/glia.20617
   Glattauer V, 2010, J BIOMED MATER RES A, V92A, P1301, DOI 10.1002/jbm.a.32468
   Griffith M, 2009, EYE, V23, P1985, DOI 10.1038/eye.2008.409
   Grimes M, 2005, BIO-MED MATER ENG, V15, P65
   Grueterich M, 2003, SURV OPHTHALMOL, V48, P631, DOI 10.1016/j.survophthal.2003.08.003
   Gurney Theresa A, 2007, Facial Plast Surg Clin North Am, V15, P113, DOI 10.1016/j.fsc.2006.10.007
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   HUANGLEE LLH, 1994, J BIOMED MATER RES, V28, P123, DOI 10.1002/jbm.820280116
   Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641
   Inoue T, 2001, J INVEST DERMATOL, V117, P244, DOI 10.1046/j.0022-202x.2001.01431.x
   Isom-Batz G, 2009, J UROLOGY, V181, P701, DOI 10.1016/j.juro.2008.10.027
   Jayaraman Mythili, 2002, Med Sci Monit, V8, pBR481
   Jean J, 2009, J DERMATOL SCI, V53, P19, DOI 10.1016/j.jdermsci.2008.07.009
   Karr Jeff, 2008, Adv Skin Wound Care, V21, P270, DOI 10.1097/01.ASW.0000323504.68401.d6
   Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338
   Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023
   Koduri S, 2006, INT UROGYNECOL J, V17, P346, DOI 10.1007/s00192-005-0011-8
   Konuma T, 2009, ANN THORAC SURG, V88, P554
   Konuma T, 2009, ANN THORAC SURG, V88, P849, DOI 10.1016/j.athoracsur.2009.06.003
   Kumar GP, 2010, PEDIATR SURG INT, V26, P275, DOI 10.1007/s00383-009-2521-9
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536
   Laflamme K, 2005, CIRCULATION, V111, P459, DOI 10.1161/01.CIR.0000153850.53419.50
   Lagali N, 2008, INVEST OPHTH VIS SCI, V49, P3895, DOI 10.1167/iovs.07-1354
   Levis H, 2009, CURR OPIN BIOTECH, V20, P593, DOI 10.1016/j.copbio.2009.09.002
   Liao S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025019
   Liu Y, 2006, BIOMACROMOLECULES, V7, P1819, DOI 10.1021/bm060160o
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Liyanage SH, 2006, J PLAST RECONSTR AES, V59, P553, DOI 10.1016/j.bjps.2005.06.008
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Magnan Martine, 2006, J Pediatr Urol, V2, P261, DOI 10.1016/j.jpurol.2005.11.019
   MAO J, 2010, TISSUE ENG IN PRESS
   Marchesi C, 2007, GLIA, V55, P425, DOI 10.1002/glia.20470
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Mingin GC, 1999, J UROLOGY, V162, P1122, DOI 10.1016/S0022-5347(01)68092-3
   Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107
   Mulder G, 2009, WOUND REPAIR REGEN, V17, P772, DOI 10.1111/j.1524-475X.2009.00541.x
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   O'Shaughnessy TJ, 2003, NEUROSCI LETT, V340, P169, DOI 10.1016/S0304-3940(03)00083-1
   Oberson C, 2007, SWISS MED WKLY, V137, P471
   Ohan MP, 2003, J BIOMED MATER RES A, V67A, P1188, DOI 10.1002/jbm.a.20018
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Peters W J, 1980, Ann Plast Surg, V4, P133, DOI 10.1097/00000637-198002000-00010
   PONSGUIRAUD A, 2008, ANN DERMATOL VENER, V135, P171
   Powell HM, 2007, BIOMATERIALS, V28, P1084, DOI 10.1016/j.biomaterials.2006.10.011
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Rafat M, 2009, J BIOMED MATER RES A, V88A, P755, DOI 10.1002/jbm.a.31910
   Regnier M, 1997, J INVEST DERMATOL, V109, P510, DOI 10.1111/1523-1747.ep12336627
   ROE S C, 1992, Clinical Materials, V9, P149, DOI 10.1016/0267-6605(92)90094-A
   Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195
   Sano A, 2003, ADV DRUG DELIVER REV, V55, P1651, DOI 10.1016/j.addr.2003.08.005
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Schwab I R, 1999, Trans Am Ophthalmol Soc, V97, P891
   Shanmugasundaram N, 2006, J BIOMED MATER RES B, V77B, P378, DOI 10.1002/jbm.b.30405
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Shekarriz B, 2000, UROLOGY, V55, P123, DOI 10.1016/S0090-4295(99)00443-4
   Shortt AJ, 2009, BIOMATERIALS, V30, P1056, DOI 10.1016/j.biomaterials.2008.10.048
   Somers P, 2009, TISSUE ENG PT A, V15, P3597, DOI [10.1089/ten.tea.2008.0690, 10.1089/ten.TEA.2008.0690]
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Spencer NJ, 2008, BIOMATERIALS, V29, P1028, DOI 10.1016/j.biomaterials.2007.11.006
   Sripriya R, 2007, J BIOMAT SCI-POLYM E, V18, P335, DOI 10.1163/156856207779996913
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Suh H, 2002, YONSEI MED J, V43, P193, DOI 10.3349/ymj.2002.43.2.193
   Sun W., 2009, J BIOMED MATER RES A, V92A, P887
   Sun WJ, 2007, J BIOMED MATER RES A, V83A, P1054, DOI 10.1002/jbm.a.31417
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Takeshita F, 2006, CANCER SCI, V97, P689, DOI 10.1111/j.1349-7006.2006.00234.x
   Takeshita Fumitaka, 2009, V487, P83, DOI 10.1007/978-1-60327-547-7_4
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tebb TA, 2006, CYTOTECHNOLOGY, V52, P99, DOI 10.1007/s10616-006-9034-3
   Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263
   Teebken OE, 2009, EUR J VASC ENDOVASC, V37, P92, DOI 10.1016/j.ejvs.2008.10.012
   TETI A, 1992, J AM SOC NEPHROL, V2, P83
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   Trottier V, 2008, STEM CELLS, V26, P2713, DOI 10.1634/stemcells.2008-0031
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791
   Xu T, 2009, BIOMATERIALS, V30, P4377, DOI 10.1016/j.biomaterials.2009.04.047
   Yamasaki T, 2008, ARTIF ORGANS, V32, P519, DOI 10.1111/j.1525-1594.2008.00580.x
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YEO TK, 1991, AM J PATHOL, V138, P1437
   Yung CW, 2007, J BIOMED MATER RES A, V83A, P1039, DOI 10.1002/jbm.a.31431
   ZAKARIA N, 2010, TISSUE ENG IN PRESS
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhong SP, 2009, J BIOMED MATER RES A, V91A, P114, DOI 10.1002/jbm.a.32188
NR 149
TC 324
Z9 340
U1 18
U2 178
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2010
VL 3
IS 3
BP 1863
EP 1887
DI 10.3390/ma3031863
PG 25
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LC
UT WOS:000298240500019
OA DOAJ Gold, Green Published
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Calvo-Guirado, JL
   Gomez-Moreno, G
   Lopez-Mari, L
   Ortiz-Ruiz, AJ
   Guardia-Munoz, J
AF Calvo-Guirado, Jose-Luis
   Gomez-Moreno, Gerardo
   Lopez-Mari, Laura
   Ortiz-Ruiz, Antonio-Jose
   Guardia-Munoz, Javier
TI Atraumatic maxillary sinus elevation using threaded bone dilators for
   immediate implants. A three-year clinical study
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Bone dilator; osteotome; bone expansion; dental implants; atraumatic
   sinus lifting
ID FLOOR ELEVATION; GRAFTING MATERIALS; OSTEOTOME; PLACEMENT; AUGMENTATION
AB Objective: The aim of this study was to evaluate the efficacy of sinus floor elevation using sequential bone dilators. Materials and Methods: Thirty patients took part in the study (18 women and 12 men) with ages ranging between thirty-six and sixty-three years, selected according to inclusion and exclusion criteria, who showed a bone deficit in the upper posterior alveolar margin of 5-8 mm in height. Sixty expanded platform internal connection implants were placed with diameters of 4/5/4 mm and lengths varying between 10 (n=10) and 11.5 mm (n=50). Results: Data obtained were analyzed using SPSS 15.0 software. The average intra-sinus bone gain with MP3 biomaterial of porcine origin was 4.13 +/- 0.97 SD mm at the moment of implant placement, 3.90 +/- 1.15 SD mm after twelve months, 3.74 +/- 1.05 SD mm after 24 months and 3.62 +/- 1.75 SD mm after 36 months. Two implants were lost at the moment of prosthesis placement. Conclusions: Alveolar lifting technique in the upper maxilla using bone dilators achieved a 96.6 % implant success rate after a three-year follow-up. Intra-sinus bone biomaterial remodeling was 0.51 +/- 0.08 mm from day zero to the thirty-six-month follow-up. This is a procedure that reduces the amount of surgery necessary and is of both aesthetic and functional benefit to the patient.
C1 [Calvo-Guirado, Jose-Luis] Univ Murcia, Adult Integrated Dent Clin, E-30001 Murcia, Spain.
   [Calvo-Guirado, Jose-Luis; Ortiz-Ruiz, Antonio-Jose] Univ Murcia, Fac Med & Dent, E-30001 Murcia, Spain.
   [Gomez-Moreno, Gerardo; Guardia-Munoz, Javier] Univ Granada, Fac Dent, E-18071 Granada, Spain.
RP Calvo-Guirado, JL (reprint author), Mozart 1,1G, Murcia 30002, Spain.
EM joseluis.calvo@um.es
RI Gomez-Moreno, Gerardo/L-8123-2014; Ortiz Ruiz, Antonio/M-2458-2018
OI Gomez-Moreno, Gerardo/0000-0001-9094-4985; Ortiz Ruiz,
   Antonio/0000-0001-9113-8416
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Blanco J, 2008, CLIN ORAL IMPLAN RES, V19, P505, DOI 10.1111/j.1600-0501.2007.01505.x
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Calvo-Guirado Jose Luis, 2006, Med Oral Patol Oral Cir Bucal, V11, pE52
   Fermergard R, 2008, CLIN IMPLANT DENT R, V10, P62, DOI 10.1111/j.1708-8208.2007.00062.x
   Ferrigno N, 2006, CLIN ORAL IMPLAN RES, V17, P194, DOI 10.1111/j.1600-0501.2005.01192.x
   Hernandez-Alfaro F, 2008, CLIN ORAL IMPLAN RES, V19, P91, DOI 10.1111/j.1600-0501.2007.01372.x
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Kirmeier R, 2008, CLIN ORAL IMPLAN RES, V19, P366, DOI 10.1111/j.1600-0501.2007.01487.x
   Nedir R, 2009, CLIN ORAL IMPLAN RES, V20, P701, DOI 10.1111/j.1600-0501.2008.01696.x
   Penarrocha-Diago M, 2008, INT J ORAL MAX IMPL, V23, P129
   Rambla-Ferrer Javier, 2006, Med Oral Patol Oral Cir Bucal, V11, pE267
   Schmidlin PR, 2008, INT J PERIODONT REST, V28, P401
   Siddiqui Azfar A, 2006, J Oral Implantol, V32, P87, DOI 10.1563/786.1
   Sorni Marco, 2005, Med Oral Patol Oral Cir Bucal, V10 Suppl 1, pE45
   Summers R B, 1994, Compendium, V15, P702
   Summers R B, 1994, Compendium, V15, P154
   Summers RB, 1994, COMPENDIUM, V15, P158
   Summers RB, 1994, COMPENDIUM, V15, P154
   SUMMERS RB, 1994, COMPENDIUM, V15, P700
   SUMMERS RB, 1994, COMPENDIUM, V15, P702
   Toffler M, 2004, INT J ORAL MAX IMPL, V19, P266
   ZORZANO LAA, 2007, MED ORAL PATOL ORAL, V12, pE532
NR 24
TC 10
Z9 10
U1 0
U2 1
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-4447
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD MAR
PY 2010
VL 15
IS 2
BP E366
EP E370
AR 2546
DI 10.4317/medoral.15.e366
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 577PN
UT WOS:000276236500014
PM 20038919
OA Bronze
DA 2018-10-20
ER

PT J
AU Garcia-Garcia, AS
   Martinez-Gonzalez, JM
   Gomez-Font, R
   Soto-Rivadeneira, A
   Oviedo-Roldan, L
AF Garcia-Garcia, Andres S.
   Martinez-Gonzalez, Jose-Maria
   Gomez-Font, Rafael
   Soto-Rivadeneira, Angeles
   Oviedo-Roldan, Lucia
TI Current status of the torus palatinus and torus mandibularis
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Torus palatinus; torus mandibularis
ID OF-THE-LITERATURE; ORAL TORI; TEMPOROMANDIBULAR DISORDERS; PREVALENCE;
   CONCURRENCE; POPULATION; EXOSTOSES; NORWAY
AB While there is a hereditary component to tori, this does not explain all cases. Tori tend to appear more frequently during middle age of life; the torus palatinus is more commonly observed in females, but this is not the case with the torus mandibularis. Certain ethnic groups are more prone to one torus or the other. The torus is mainly removed due to prostodontic reasons, as it may also be used as biomaterial, not only in periodontology, but also in implantology. The aim of this study was a review of the literature from the past twenty years.
C1 [Garcia-Garcia, Andres S.; Soto-Rivadeneira, Angeles; Oviedo-Roldan, Lucia] Univ So Mississippi, Hattiesburg, MS 39406 USA.
   [Martinez-Gonzalez, Jose-Maria] Univ Complutense Madrid, E-28040 Madrid, Spain.
   [Gomez-Font, Rafael] European Univ Madrid, Madrid, Spain.
RP Martinez-Gonzalez, JM (reprint author), Univ Madrid, Madrid, Spain.
EM jmargo@odon.ucm.es
CR Abrams S, 2000, J Can Dent Assoc, V66, P494
   AGNIHOTRI N, 2003, PREVALENCE ORAL TORI
   Al-Bayaty HF, 2001, INT DENT J, V51, P300, DOI 10.1002/j.1875-595X.2001.tb00842.x
   Antoniades DZ, 1998, ORAL SURG ORAL MED O, V85, P552, DOI 10.1016/S1079-2104(98)90290-6
   Barker D, 2001, BRIT DENT J, V190, P474, DOI 10.1038/sj.bdj.4801009a
   BOUQUOT JE, 1986, ORAL SURG ORAL MED O, V62, P284, DOI 10.1016/0030-4220(86)90010-1
   Bruce I, 2004, INT DENT J, V54, P78, DOI 10.1111/j.1875-595X.2004.tb00259.x
   Castro Reino O, 1990, Rev Actual Odontoestomatol Esp, V50, P47
   Castro Reino O, 1990, REV ACTUAL ODONTOEST, V50, P53
   Clifford T, 1996, BRIT DENT J, V180, P382, DOI 10.1038/sj.bdj.4809094
   Curran AE, 1999, ORAL SURG ORAL MED O, V87, P600, DOI 10.1016/S1079-2104(99)70141-1
   DONADO M, 1998, CIRUGIA BUCAL PATOLO, P481
   EGGEN S, 1992, ACTA ODONTOL SCAND, V50, P1, DOI 10.3109/00016359209012739
   EGGEN S, 1994, SCAND J DENT RES, V102, P60
   EGGEN S, 1986, SCAND J DENT RES, V94, P233
   EGGEN S, 1989, ACTA ODONTOL SCAND, V47, P409, DOI 10.3109/00016358909004810
   EGGEN S, 1991, COMMUNITY DENT ORAL, V19, P32, DOI 10.1111/j.1600-0528.1991.tb00101.x
   EGGEN S, 1994, SCAND J DENT RES, V102, P54
   Ganz S D, 1997, Pract Periodontics Aesthet Dent, V9, P973
   HAUGEN LK, 1992, ACTA ODONTOL SCAND, V50, P65, DOI 10.3109/00016359209012748
   Jainkittivong A, 2000, ORAL SURG ORAL MED O, V90, P48, DOI 10.1067/moe.2000.105905
   Kerdpon D, 1999, EUR J ORAL SCI, V107, P9, DOI 10.1046/j.0909-8836.1999.eos107103.x
   MacInnis EL, 1998, INT DENT J, V48, P40, DOI 10.1111/j.1875-595X.1998.tb00692.x
   Martinez-Gonzalez JM, 1998, CIRUGIA BUCAL PATOLO, P627
   Nair R G, 1996, Int Dent J, V46, P48
   Proussaefs P, 2006, INT J PERIODONT REST, V26, P43
   REICHART PA, 1988, COMMUNITY DENT ORAL, V16, P61, DOI 10.1111/j.1600-0528.1988.tb00557.x
   Sasaki H, 1999, J PERIODONTOL, V70, P445, DOI 10.1902/jop.1999.70.4.445
   Sirirungrojying S, 1999, INT DENT J, V49, P101, DOI 10.1111/j.1875-595X.1999.tb00516.x
   Sonnier KE, 1999, J PERIODONTOL, V70, P329, DOI 10.1902/jop.1999.70.3.329
NR 30
TC 39
Z9 44
U1 0
U2 6
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-4447
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD MAR
PY 2010
VL 15
IS 2
BP E353
EP E360
AR 1336
DI 10.4317/medoral.15.e353
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 577PN
UT WOS:000276236500012
PM 19767716
OA Bronze
DA 2018-10-20
ER

PT J
AU Ricicova, M
   Kucharikova, S
   Tournu, H
   Hendrix, J
   Bujdakova, H
   Van Eldere, J
   Lagrou, K
   Van Dijck, P
AF Ricicova, Marketa
   Kucharikova, Sona
   Tournu, Helene
   Hendrix, Jelle
   Bujdakova, Helena
   Van Eldere, Johan
   Lagrou, Katrien
   Van Dijck, Patrick
TI Candida albicans biofilm formation in a new in vivo rat model
SO MICROBIOLOGY-SGM
LA English
DT Article
ID GENE-EXPRESSION; IMPLANTED BIOMATERIALS; INFECTION; PATHWAY; VITRO
AB Device-associated microbial growth, including Candida biofilms, represents more than half of all human microbial infections and, despite a relatively small risk of implant-associated diseases, this type of infection usually leads to high morbidity, increased health-care costs and prolonged antimicrobial therapy. Animal models are needed to elucidate the complex host-pathogen interactions that occur during the development of attached and structured biofilm populations. We describe here a new in vivo model to study Candida biofilm, based on the avascular implantation of small catheters in rats. Polyurethane biomaterials challenged with Candida cells were placed underneath the skin of immunosuppressed animals following only minor surgery. The model allowed the study of up to ten biofilms at once, and the recovery of mature biofilms from 2 days after implantation. The adhering inoculum was adjusted to the standard threshold of positive diagnosis of fungal infection in materials recovered from patients. Wild-type biofilms were mainly formed of hyphal cells, and they were unevenly distributed across the catheter length as observed in infected materials in clinical cases. The hyphal multilayered structure of the biofilms of wild-type strains was observed by confocal microscopy and compared to the monolayer of yeast or hyphal cells of two well-known biofilm-deficient strains, efg1 Delta/efg1 Delta cph1 Delta/cph1 Delta and bcr1 Delta/bcr1 Delta, respectively. The subcutaneous Candida biofilm model relies on the use of implanted catheters with accessible, fast and minor surgery to the animals. This model can be used to characterize the ability of antimicrobial agents to eliminate biofilms, and to evaluate the prophylactic effect of antifungal drugs and biomaterial coatings.
C1 [Ricicova, Marketa; Kucharikova, Sona; Tournu, Helene; Van Dijck, Patrick] Katholieke Univ Leuven, VIB, Dept Mol Microbiol, B-3001 Louvain, Belgium.
   [Ricicova, Marketa; Kucharikova, Sona; Tournu, Helene; Van Dijck, Patrick] Katholieke Univ Leuven, Mol Cell Biol Lab, Inst Bot & Microbiol, B-3001 Louvain, Belgium.
   [Kucharikova, Sona; Bujdakova, Helena] Comenius Univ, Fac Nat Sci, Dept Microbiol & Virol, Bratislava 84215, Slovakia.
   [Hendrix, Jelle] Katholieke Univ Leuven, Dept Chem, Lab Biochem Mol & Struct Biol, B-3001 Heverlee, Belgium.
   [Van Eldere, Johan; Lagrou, Katrien] Katholieke Univ Leuven, Dept Med Diagnost Sci, Lab Expt Microbiol, B-3000 Louvain, Belgium.
RP Van Dijck, P (reprint author), Katholieke Univ Leuven, VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31, B-3001 Louvain, Belgium.
EM Patrick.vandijck@mmbio.vib-kuleuven.be
RI HENDRIX, Jelle/H-1721-2018
OI HENDRIX, Jelle/0000-0001-5731-1297
FU FWO [G.0242.04, GP.011.06N]; Marie Curie Research Training Network
   [MCRTN-CT-2004-512481]
FX We thank Aaron Mitchell from the University of Pittsburg for the als3
   Delta/als3 Delta, bcrl Delta/bcrl Delta A and DAY185 strains. We are
   grateful to Rudy de Vos from the Department of Metallurgy and Materials
   Engineering at K.U. Leuven for SEM imaging and Valerie Pintens and
   Caroline Massonet from the Experimental Laboratory of Microbiology at K.
   U. Leuven for their help with initial animal experiments. We also thank
   Deborah Seys for technical assistance with animal experiments, and Nico
   Vangoethem for his assistance in the preparation of the figures. This
   work was supported by the FWO (G.0242.04 and W. O. G.) and by the Marie
   Curie Research Training Network (MCRTN-CT-2004-512481). M. R. received a
   grant from the FWO (GP.011.06N).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andes D, 2004, INFECT IMMUN, V72, P6023, DOI 10.1128/IAI.72.10.6023-6031.2004
   Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294
   Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Ferreira JAG, 2009, ANTIMICROB AGENTS CH, V53, P4377, DOI 10.1128/AAC.00316-09
   Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004
   GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721
   Green CB, 2005, MICROBIOL-SGM, V151, P1051, DOI 10.1099/mic.0.27696-0
   Hawser SP, 1998, J MED MICROBIOL, V47, P253, DOI 10.1099/00222615-47-3-253
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186
   Lazzell AL, 2009, J ANTIMICROB CHEMOTH, V64, P567, DOI 10.1093/jac/dkp242
   Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07
   Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X
   Martinez LR, 2006, ANTIMICROB AGENTS CH, V50, P1021, DOI 10.1128/AAC.50.3.1021-1033.2006
   Massonet C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-103
   Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001
   Mukherjee PK, 2009, INT J ANTIMICROB AG, V33, P149, DOI 10.1016/j.ijantimicag.2008.07.030
   Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005
   Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838
   Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047
   Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x
   Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063
   PAULITSCH AH, 2009, MED MYCOL, P1
   Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1016/S0378-1097(02)00853-4
   Ramage Gordon, 2001, Revista Iberoamericana de Micologia, V18, P163
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Schinabeck MK, 2004, ANTIMICROB AGENTS CH, V48, P1727, DOI 10.1128/AAC.48.5.1727-1732.2004
   Sellam A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-25
   Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x
   Van Wijngaerden E, 1999, J ANTIMICROB CHEMOTH, V44, P669, DOI 10.1093/jac/44.5.669
   VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170
   Zhao X, 2006, MICROBIOL-SGM, V152, P2287, DOI 10.1099/mic.0.28959-0
NR 37
TC 56
Z9 60
U1 0
U2 9
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD MAR
PY 2010
VL 156
BP 909
EP 919
DI 10.1099/mic.0.033530-0
PN 3
PG 11
WC Microbiology
SC Microbiology
GA 576ZS
UT WOS:000276189600027
PM 19959578
OA Bronze
DA 2018-10-20
ER

PT J
AU Lam, KH
   Cheng, SY
   Lam, PL
   Yuen, CWM
   Wong, RSM
   Lau, FY
   Lai, PBS
   Gambari, R
   Chui, CH
AF Lam, K. H.
   Cheng, S. Y.
   Lam, P. L.
   Yuen, C. W. M.
   Wong, R. S. M.
   Lau, F. Y.
   Lai, P. B. S.
   Gambari, R.
   Chui, C. H.
TI Microencapsulation: past, present and future
SO MINERVA BIOTECNOLOGICA
LA English
DT Review
DE Biocompatible materials; Drug Delivery Systems; Capsules
ID CONTROLLED-RELEASE; DRUG-DELIVERY; CHITOSAN MICROSPHERES; ALGINATE
   MICROCAPSULES; METHODOLOGICAL SURVEY; FRAGRANT OIL; EMULSION; STABILITY;
   MICROPARTICLES; POLYMERIZATION
AB Biomaterial is one of the most rapidly expanding fields in medical industry. With the increasing concern and consideration of healthcare towards the public, scientists from the field of material science have tended to exploit novel biotechnologies for producing the biomaterials including microcapsules in order to satisfy the need from the users. Here we have reviewed the past history of microcapsule development and its versatile application. Additionally, we also make use of the microencapsulation technology to encapsulate the poor soluble celecoxib into the ingestible chitosan (a linear polysaccharide) shell. In conclusion, we believe that the development of the microcapsules related biomaterials as a safe drug delivery model may help to improve the therapeutic actions of the conventional drug from the convenience and absorption point of view.
C1 [Gambari, R.] Univ Ferrara, BioPharmaNet, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy.
   [Lam, K. H.; Cheng, S. Y.; Lam, P. L.; Yuen, C. W. M.; Chui, C. H.] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
   [Wong, R. S. M.; Lau, F. Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.
   [Lai, P. B. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.
RP Gambari, R (reprint author), Univ Ferrara, BioPharmaNet, Dept Biochem & Mol Biol, I-44100 Ferrara, Italy.
EM gam@unife.it; chchui@graduate.hku.hk
RI Lai, Paul/K-8556-2015; Gambari, Roberto/F-9555-2015
OI Lai, Paul/0000-0002-9469-6728; Gambari, Roberto/0000-0001-9205-6033;
   Lam, Kim Hung/0000-0003-2161-2367; Wong, Raymond/0000-0002-9011-4268
FU Institutes of Textiles and Clothing, The Hong Kong Polytechnic
   University [1ZV5L]; AIRC (Italian Association for Cancer Research)
FX The authors wish to acknowledge the financial support to this work from
   the junior academic staff starting fund from Institutes of Textiles and
   Clothing, The Hong Kong Polytechnic University to Dr. C. H. Chui
   (1ZV5L). Dr. C. H. Chui is supported by the Assistant Professorship
   kindly offered by Prof. X.M. Tao. Prof. R. Gambari is sponsored by AIRC
   (Italian Association for Cancer Research).
CR ARSHADY R, 1993, POLYM ENG SCI, V33, P865, DOI 10.1002/pen.760331402
   ARSHADY R, 1992, COLLOID POLYM SCI, V270, P717, DOI 10.1007/BF00776142
   Bayomi MA, 2004, DRUG DEV IND PHARM, V30, P329, DOI 10.1081/DDC-120030425
   BERISTAIN CI, 1995, DRY TECHNOL, V13, P455, DOI 10.1080/07373939508916965
   CHENG SY, 2009, C INTJ MOL MED, V24, P411
   CHILVERS GR, 1988, Patent No. 8808747
   Dhawan S, 2004, AAPS PHARMSCITECH, V5
   Edris A, 2001, NAHRUNG, V45, P133, DOI 10.1002/1521-3803(20010401)45:2<133::AID-FOOD133>3.0.CO;2-C
   FILIPOVICGRCIC J, 1995, INT J PHARMACEUT, V116, P39, DOI 10.1016/0378-5173(94)00269-B
   Genta I., 1999, CHITIN CHITINASES, P305
   GENTA P, 2003, CARBOHYD POLYM, V52, P11
   Gupta Venkadari Rammohan, 2007, Acta Pharmaceutica (Zagreb), V57, P173, DOI 10.2478/v10007-007-0014-8
   Guzey D, 2006, ADV COLLOID INTERFAC, V128, P227, DOI 10.1016/j.cis.2006.11.021
   Hari PR, 1996, J MICROENCAPSUL, V13, P319, DOI 10.3109/02652049609026019
   Higuera-Ciapara I, 2004, CARBOHYD POLYM, V56, P41, DOI 10.1016/j.carbpol.2003.11.012
   Hsieh WC, 2006, COLLOID SURFACE B, V53, P209, DOI 10.1016/j.colsurfb.2006.09.008
   Jumaa M, 2002, EUR J PHARM BIOPHARM, V53, P115, DOI 10.1016/S0939-6411(01)00191-6
   Kim JC, 2006, COLLOID SURFACE B, V52, P52, DOI 10.1016/j.colsurfb.2006.07.001
   Klinkesorn U, 2009, FOOD CHEM, V114, P1308, DOI 10.1016/j.foodchem.2008.11.012
   Kulkarni AR, 2000, J CONTROL RELEASE, V63, P97, DOI 10.1016/S0168-3659(99)00176-5
   LAGES R, 2003, FTC INT APPL, V2, P642
   Lai MK, 2004, J MICROENCAPSUL, V21, P307, DOI 10.1080/02652040410001673928
   Lee HY, 2002, J MICROENCAPSUL, V19, P559, DOI 10.1080/02652040210140472
   Lin LC, 2006, BIOMED ENG-APP BAS C, V18, DOI 10.4015/S1016237206000270
   LUPPI II, 2006, REC PROGR MED PLANTS, V12, P307
   Madene A, 2006, INT J FOOD SCI TECH, V41, P1, DOI 10.1111/j.1365-2621.2005.00980.x
   Mi FL, 2002, CARBOHYD POLYM, V48, P61, DOI 10.1016/S0144-8617(01)00212-0
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nelson G, 2002, INT J PHARM, V242, P55, DOI 10.1016/S0378-5173(02)00141-2
   Nuijen B, 2001, INVEST NEW DRUG, V19, P143, DOI 10.1023/A:1010682916808
   Palmieri GF, 2002, INT J PHARM, V242, P175, DOI 10.1016/S0378-5173(02)00148-5
   Pandey R, 2003, TUBERCULOSIS, V83, P373, DOI 10.1016/j.tube.2003.07.001
   Park SJ, 2004, COLLOID SURFACE B, V38, P35, DOI 10.1016/j.colsurfb.2004.08.008
   Peniche C, 2004, FOOD HYDROCOLLOID, V18, P865, DOI 10.1016/j.foodhyd.2004.02.001
   Peniche C, 2003, MACROMOL BIOSCI, V3, P511, DOI 10.1002/mabi.200300019
   POLK AE, 1994, AQUACULT ENG, V13, P311, DOI 10.1016/0144-8609(94)90018-3
   Remunan-Lopez C, 1998, EUR J PHARM BIOPHARM, V45, P49, DOI 10.1016/S0939-6411(97)00122-7
   Saravanan M, 2003, J MICROENCAPSUL, V20, P289, DOI 10.1080/0265204031000093087
   Shao YY, 2009, MAT SCI ENG C-BIO S, V29, P936, DOI 10.1016/j.msec.2008.08.017
   Sharma D, 1996, ONCOL RES, V8, P281
   Shi XY, 2002, BIOMATERIALS, V23, P4469, DOI 10.1016/S0142-9612(02)00165-5
   Simon B, 2006, MICROENCAPSULATION M
   Sui W, 2008, COLLOID SURFACE B, V65, P69, DOI 10.1016/j.colsurfb.2008.02.022
   Surh J, 2009, FOOD SCI BIOTECHNOL, V18, P299
   TAGIEDDIN F, 2004, MICROCAPSULES BIOMAT, V25, P1937
   TEFFT J, 1993, J CONTROL RELEASE, V27, P27, DOI 10.1016/0168-3659(93)90054-9
   VARONA M, 2009, CHEM ENG PROCES PRIC, V48, P1121
   Xu YM, 2003, INT J PHARM, V250, P215, DOI 10.1016/S0378-5173(02)00548-3
   YAO PC, 2000, Patent No. 0016985
   Youan BBC, 2004, DRUG DELIV, V11, P209, DOI 10.1080/10717540490280363
   Zhao QH, 2007, NANOMED-NANOTECHNOL, V3, P63, DOI 10.1016/j.nano.2006.11.007
   Zheng CH, 2004, BIOCHEM BIOPH RES CO, V323, P1321, DOI 10.1016/j.bbrc.2004.09.007
   陈智彬, 2008, [中国男科学杂志, Chinese Journal of Andrology], V22, P50
NR 53
TC 8
Z9 8
U1 1
U2 46
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 1120-4826
J9 MINERVA BIOTECNOL
JI Minerva Biotechnol.
PD MAR
PY 2010
VL 22
IS 1
BP 23
EP 28
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 632QF
UT WOS:000280440200004
DA 2018-10-20
ER

PT J
AU Gatenholm, P
   Klemm, D
AF Gatenholm, Paul
   Klemm, Dieter
TI Bacterial Nanocellulose as a Renewable Material for Biomedical
   Applications
SO MRS BULLETIN
LA English
DT Article
ID MICROBIAL CELLULOSE; NANOFIBERS; CELLS
AB Nanocellulose, such as that produced by the bacteria Gluconacetobacter xylinus (bacterial cellulose, BC), is an emerging biomaterial with great potential as a biological implant, wound and burn dressing material, and scaffolds for tissue regeneration. BC has remarkable mechanical properties despite the fact that it contains up to 99% water. The water-holding ability is the most probable reason why BC implants do not elicit any foreign body reaction. Moreover, the nanostructure and morphological similarities with collagen make BC attractive for cell immobilization and cell support. The architecture of BC materials can be engineered over length scales ranging from nano to macro by controlling the biofabrication process. This article describes current and future applications of BC in the biomedical field.
C1 [Gatenholm, Paul] Chalmers, Wallenberg Wood Sci Ctr, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
   [Klemm, Dieter] Polymet Jena, D-07745 Jena, Germany.
RP Gatenholm, P (reprint author), Chalmers, Wallenberg Wood Sci Ctr, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
EM paul.gatenholm@chalmers.se; Dieter.Klemm@uni-jena.de
CR *AM HEART ASS, 1999, 2000 HEART STROK STA
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Bodin A, 2006, J BIOMAT SCI-POLYM E, V17, P435, DOI 10.1163/156856206776374106
   BODIN A, 2007, J TISSUE ENG REGEN M, V48, P7623
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   BROWN M, 2007, CELLULOSE MOL STRUCT
   Brown R.M., 2007, CELLULOSE MOL STRUCT
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dahman Y, 2009, J NANOSCI NANOTECHNO, V9, P5105, DOI 10.1166/jnn.2009.1466
   Esguerra M., 2009, J BIOMED MAT RES A
   Gelin K, 2007, POLYMER, V48, P7623, DOI 10.1016/j.polymer.2007.10.039
   Greisler H P, 1990, Ann Vasc Surg, V4, P98, DOI 10.1007/BF02042699
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESSLER N, 2008, THESIS U JENA GERMAN
   Hon DNS, 2001, WOOD CELLULOSIC CHEM
   Kamide K, 2005, CELLULOSE CELLULOSE
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 1998, COMPREHENSIVE CELLUL, VI
   KLEMM D, 2002, BIOPOLYMERS, P257
   Klemm D, 2006, ADV POLYM SCI, V205, P49, DOI 10.1007/12_097
   Klemm D, 2009, MACROMOL SYMP, V280, P60, DOI 10.1002/masy.200950608
   MERTENS RA, 1995, J VASC SURG, V21, P782, DOI 10.1016/S0741-5214(05)80009-6
   NOGI M, 2009, ADV MATER, V20, P1849
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   SZILAGYI DE, 1986, J VASC SURG, V3, P421
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   YAMANAKA S, 1989, J MATER SCI, V24, P3414
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   ZIMMERMANN KA, 2009, MAT SCI ENG C, V29, P1942
   Zugenmaier P, 2007, CRYSTALLINE CELLULOS
NR 37
TC 115
Z9 117
U1 8
U2 107
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0883-7694
EI 1938-1425
J9 MRS BULL
JI MRS Bull.
PD MAR
PY 2010
VL 35
IS 3
BP 208
EP 213
DI 10.1557/mrs2010.653
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 568MS
UT WOS:000275527100016
DA 2018-10-20
ER

PT J
AU Waugh, DG
   Lawrence, J
   Walton, CD
   Zakaria, RB
AF Waugh, D. G.
   Lawrence, J.
   Walton, C. D.
   Zakaria, R. B.
TI On the effects of using CO2 and F-2 lasers to modify the wettability of
   a polymeric biomaterial
SO OPTICS AND LASER TECHNOLOGY
LA English
DT Article
DE Laser; Nylon 6,6; Wettability
ID SURFACE MODIFICATION; BACTERIAL ADHESION; CELL-CULTURE; LOTUS LEAF;
   RADIATION; DROPLETS
AB Enhancement of the surface properties of a material by means of laser radiation has been amply demonstrated previously. In this work a comparative study for the surface modification of nylon 6,6 has been conducted in order to vary the wettability characteristics using CO2 and excimer lasers. This was done by producing 50 mm spaced (with depths between 1 and 10 mm) trench-like patterns using various laser parameters such as varying the laser power for the CO2 laser and number of pulses for the excimer laser. Topographical changes were analysed using optical microscopy and white light interferometry which indicated that both laser systems can be implemented for modifying the topography of nylon 6,6. Variations in the surface chemistry were evaluated using energy-dispersive X-ray spectroscopy and X-ray photoelectron spectroscopy analysis which showed that the O-2 increased by upto 1.5 at% and decreased by upto 1.6 at% for the CO2 and F-2 laser patterned samples, respectively. Modification of the wettability characteristics was quantified by measuring the advancing contact angle, which was found to increase in all instances for both laser systems. Emery paper roughened samples were also analysed in the same manner to determine that the topographical pattern played a major role in the wettability characteristics of nylon 6,6. From this, it is proposed that the increase in contact angle for the laser processed samples is due to a mixed intermediate state wetting regime owed to the periodic surface roughness brought about by the laser-induced trench-like topographical patterns. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Waugh, D. G.; Lawrence, J.] Univ Loughborough, Wolfson Sch Mech & Mfg Engn, Loughborough LE11 3TU, Leics, England.
   [Walton, C. D.; Zakaria, R. B.] Univ Hull, Dept Phys Sci, Kingston Upon Hull HU6 7RX, Yorks, England.
RP Waugh, DG (reprint author), Univ Loughborough, Wolfson Sch Mech & Mfg Engn, Loughborough LE11 3TU, Leics, England.
EM D.G.Waugh@lboro.ac.uk
RI ZAKARIA, ROZALINA/B-5370-2010
OI ZAKARIA, ROZALINA/0000-0002-6445-3039; Lawrence,
   Jonathan/0000-0002-1649-9948; Waugh, David/0000-0002-7186-2797
FU EPSRC [EP/E046851/1]; Engineering and Physical Sciences Research Council
   [EP/E046851/1]
FX We would like to thank Directed Light Inc., East Midlands NHS Innovation
   Hub, Nobel Biocare and Photomachining Inc. for all of their much
   appreciated support. This study is financially supported by the EPSRC
   (No. EP/E046851/1).
CR Arefi-Khonsari F, 2005, SURF COAT TECH, V200, P14, DOI 10.1016/j.surfcoat.2005.02.184
   Ball MD, 2004, J MATER SCI-MATER M, V15, P447, DOI 10.1023/B:JMSM.0000021118.85955.4a
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Chen XL, 2009, SCI CHINA SER G, V52, P233, DOI 10.1007/s11433-009-0041-1
   Cheng Y.T., 2005, APPL PHYS LETT, V86
   Hao L, 2005, LASER SURFACE TREATMENT OF BIO-IMPLANT MATERIALS, P1, DOI 10.1002/0470033975
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   Jung YC, 2007, SCRIPTA MATER, V57, P1057, DOI 10.1016/j.scriptamat.2007.09.004
   Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033
   Kietzig AM, 2009, LANGMUIR, V25, P4821, DOI 10.1021/la8037582
   KIM MS, 2007, PROG POLYM SCI
   Lawrence J, 2001, MAT SCI ENG A-STRUCT, V303, P142, DOI 10.1016/S0921-5093(00)01851-7
   Lawrence J., 2001, LASER MODIFICATION W
   Lee SM, 2007, J MICROMECH MICROENG, V17, P687, DOI 10.1088/0960-1317/17/4/003
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mirzadeh H, 2003, RADIAT PHYS CHEM, V67, P381, DOI 10.1016/S0969-806X(03)00071-9
   Ouhlal M, 2004, J ADHESION, V80, P467, DOI 10.1080/00218460490477107
   Pappas D, 2006, SURF COAT TECH, V201, P4384, DOI 10.1016/j.surfcoat.2006.08.068
   Pfleging W, 2007, APPL SURF SCI, V253, P9177, DOI 10.1016/j.apsusc.2007.05.047
   RANCE DG, 1982, SURFACE ANAL PRETREA, P121
   Sarantopoulou E, 2007, APPL SURF SCI, V253, P7884, DOI 10.1016/j.apsusc.2007.02.071
   SKORDOULIS CD, 1995, APPL SURF SCI, V86, P239, DOI 10.1016/0169-4332(94)00413-7
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   THE KS, 2008, P 3 IEEE INT C NAN M
   TIAW KS, 2007, J ALLOYS COMPD
   Waugh DG, 2009, MAT SCI ENG C-MATER, V29, P2514, DOI 10.1016/j.msec.2009.07.020
   WAUGH DG, IACLEO 2008 P 2008, V101, P61
   Wu XD, 2005, LANGMUIR, V21, P2665, DOI 10.1021/la050275y
   Yoon TO, 2008, OPT EXPRESS, V16, P12715, DOI 10.1364/OE.16.012715
   Yu FY, 2005, BIOMATERIALS, V26, P2307, DOI 10.1016/j.biomaterials.2004.07.021
   Zhao Q, 2007, INT J ADHES ADHES, V27, P85, DOI 10.1016/j.ijadhadh.2006.01.001
   Zorba V, 2008, ADV MATER, V20, P4049, DOI 10.1002/adma.200800651
NR 32
TC 9
Z9 9
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0030-3992
J9 OPT LASER TECHNOL
JI Opt. Laser Technol.
PD MAR
PY 2010
VL 42
IS 2
BP 347
EP 356
DI 10.1016/j.optlastec.2009.08.004
PG 10
WC Optics; Physics, Applied
SC Optics; Physics
GA 547MF
UT WOS:000273892500019
DA 2018-10-20
ER

PT J
AU Levin, B
   Redmond, SL
   Rajkhowa, R
   Eikelboom, RH
   Marano, RJ
   Atlas, MD
AF Levin, Brett
   Redmond, Sharon Leanne
   Rajkhowa, Rangam
   Eikelboom, Robert Henry
   Marano, Robert Jeffery
   Atlas, Marcus David
TI Preliminary results of the application of a silk fibroin scaffold to
   otology
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article
ID MYRINGOPLASTY
AB The surgical treatment to repair chronic tympanic membrane perforations is myringoplasty. Although multiple autologous grafts, allografts, and synthetic graft materials have been used over the years, no single graft material is superior for repairing all perforation types. Recently, the remarkable properties of silk fibroin protein have been studied, with biomedical and tissue engineering applications in mind, across a number of medical and surgical disciplines. The present study examines the use of silk fibroin for its potential suitability as an alternative graft in myringoplasty surgery by investigating the growth and proliferation of human tympanic membrane keratinocytes on a silk fibroin scaffold in vitro. Light microscopy, immunofluorescent staining, and confocal imaging all reveal promising preliminary results. The biocompatibility, transparency, stability, high tensile strength, and biodegradability of fibroin make this biomaterial an attractive option to study for this utility. (C) 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
C1 [Levin, Brett; Redmond, Sharon Leanne; Eikelboom, Robert Henry; Marano, Robert Jeffery; Atlas, Marcus David] Univ Western Australia, Sch Surg, Ear Sci Inst Australia, Perth, WA 6009, Australia.
   [Levin, Brett; Redmond, Sharon Leanne; Eikelboom, Robert Henry; Marano, Robert Jeffery; Atlas, Marcus David] Univ Western Australia, Sch Surg, Ear Sci Ctr, Perth, WA 6009, Australia.
   [Levin, Brett; Atlas, Marcus David] Sir Charles Gairdner Hosp, Perth, WA, Australia.
   [Atlas, Marcus David] St John God Hosp, Perth, WA, Australia.
   [Rajkhowa, Rangam] Deakin Univ, Ctr Mat & Fibre Innovat, Geelong, Vic 3217, Australia.
RP Levin, B (reprint author), Univ Western Australia, Queen Elizabeth II Med Ctr, Ear Sci Ctr, Sch Surg, 2nd Floor,M Block, Nedlands, WA 6009, Australia.
EM blevin@med.usyd.edu.au
RI Redmond, Sharon/B-8701-2009; Marano, Robert/A-3552-2015; Eikelboom,
   Robert/B-2820-2013
OI Marano, Robert/0000-0001-9565-3167; Eikelboom,
   Robert/0000-0003-2911-5381
FU Garnett Passe and Rodney Williams Memorial Foundation; Australian
   government; Garnett Passe; Rodney Williams Memorial Foundation
FX Garnett Passe and Rodney Williams Memorial Foundation: funding of
   research. Centre for Material and Fibre Innovation, Deakin University,
   Geelong, Victoria: manufacture and provision of silk fibroin membranes
   used in the study. Dr. Paul Rigby: assistance with confocal microscopy
   carried out using facilities at the Centre for Microscopy,
   Characterisation and Analysis, The University of Western Australia,
   which are supported by university, state, and federal government
   funding.; Competing interests: Brett Levin, Ear Science Institute
   Australia (ESIA): scholarship, research, employment contract has an
   arrangement in place for a share in any proceeds of work undertaken at
   ESIA in the event of future commercialization of the work; Sharon Leanne
   Redmond, Robert Henry Eikelboom, Robert Jeffery Marano, ESIA: salary,
   employment contract has an arrangement in place for a share in any
   proceeds of work undertaken at ESIA in the event of future
   commercialization of the work; Rangam Rajkhowa, Deakin University:
   International Post Graduate Research Scholarship from Australian
   government, with an arrangement in place for a share in any proceeds of
   work undertaken at Deakin University in the event of future
   commercialization of the work; Marcus David Atlas, ESIA and University
   of Western Australia: salary, employment contract has an arrangement in
   place for a share in any proceeds of work undertaken at ESIA in the
   event of future commercialization of the work.; The Garnett Passe and
   Rodney Williams Memorial Foundation funds Dr. Levin's Master of Medical
   Science in Otolaryngology Head and Neck Surgery; research and manuscript
   form part of the higher degree; funds allow for conducting of the entire
   study, including data collection and analysis.
CR Aggarwal R, 2006, J LARYNGOL OTOL, V120, P429, DOI 10.1017/S0022215106000697
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Inwood JL, 2003, CLIN OTOLARYNGOL, V28, P396, DOI 10.1046/j.1365-2273.2003.00716.x
   Maria PLS, 2007, WOUND REPAIR REGEN, V15, P450, DOI 10.1111/j.1524-475X.2007.00251.x
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
NR 5
TC 20
Z9 21
U1 0
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
EI 1097-6817
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD MAR
PY 2010
VL 142
IS 3
SU 1
BP S33
EP S35
DI 10.1016/j.otohns.2009.06.746
PG 3
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 625DY
UT WOS:000279875800007
PM 20176279
DA 2018-10-20
ER

PT J
AU dos Anjos, BSC
   Revoredo, ECV
   Galembeck, A
AF dos Anjos, Bora S. C.
   Revoredo, Eliane C. V.
   Galembeck, Andre
TI Silicone-Polyacrylate Chemical Compatibilization With Organosilanes
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID ETHYLENE METHYL ACRYLATE; BONE-CEMENT; RUBBER; POLYMETHYLMETHACRYLATE;
   BLENDS; POLYSILOXANE; POLYETHYLENE; BIOMATERIAL
AB Silicone-polyacrylate polymer blends were prepared using methacryloxy-propyl-trimethoxysilane (MAPTMS) as a compatibilizing agent (chemical linker). Energy dispersive X-ray spectroscopy elemental mapping showed silicon and carbon rich regions corresponding to poly(dimethyl-siloxane) (PDMS) and poly(methyl methacrylate) PMMA domains. Infrared spectroscopy confirmed that covalent bonds are formed between PMMA and the organosilane, MAPTMS. The organosilane addition decreased the water-to-blend contact angles and tended to increase the modulus of elasticity and tensile strength of the resulting PDMS-PMMA blends. Cytotoxicity was not detectable for any samples. Silicone-based materials are currently used as prosthetic materials to replace damaged tissues; the methodology described here can be readily adapted to this application with improved performance. POLYM. ENG. SCI., 50:606-612, 2010. (C) 2009 Society of Plastics Engineers
C1 [dos Anjos, Bora S. C.; Galembeck, Andre] Univ Fed Pernambuco, CCEN, Dept Quim Fundamental, BR-50670901 Recife, PE, Brazil.
   [Revoredo, Eliane C. V.] Hosp Canc Pernambuco, Ctr Reabilitacao Bucomaxilofacial, BR-50040000 Recife, PE, Brazil.
   [Galembeck, Andre] Ctr Tecnol Estrateg Nordeste CETENE, BR-50670901 Recife, PE, Brazil.
RP Galembeck, A (reprint author), Univ Fed Pernambuco, CCEN, Dept Quim Fundamental, Av Prof Luiz Freire S-N,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM andre@ufpc.br
RI Galembeck, Andre/A-6392-2008
OI Galembeck, Andre/0000-0002-6361-9869
FU Ministerio da Saude; DECIT; CNPq [505388/04-9]; PROCAD/CAPES; CAPES
FX Contract grant sponsor: Ministerio da Saude - DECIT and CNPq: Contract
   grant number: Proc. 505388/04-9: contract grant sponsors: PROCAD/CAPES.
   CAPES Fellowship.
CR *ASTM, 2006, F89584 ASTM
   *ASTM, 1981, 412 ASTM
   Aziz T, 2003, J DENT, V31, P67, DOI 10.1016/S0300-5712(02)00084-2
   Bagal A, 2007, ARCH FACIAL PLAST S, V9, P275, DOI 10.1001/archfaci.9.4.275
   BARNHART G W, 1960, J Dent Res, V39, P836, DOI 10.1177/00220345600390041001
   Birkefeld AB, 2004, BIOMATERIALS, V25, P4405, DOI 10.1016/j.biomaterials.2003.10.093
   Bruens ML, 2003, J CRANIOFAC SURG, V14, P63, DOI 10.1097/00001665-200301000-00011
   Chiarini L, 2004, J CRANIO MAXILL SURG, V32, P5, DOI 10.1016/j.jcms.2003.08.005
   Dewimille L, 2005, POLYMER, V46, P4135, DOI 10.1016/j.polymer.2005.02.049
   HAUG SP, 1992, J PROSTHET DENT, V68, P644, DOI 10.1016/0022-3913(92)90381-J
   Hou SS, 2001, POLYMER, V42, P9505, DOI 10.1016/S0032-3861(01)00465-7
   ISO 10993-5, 1999, 109935 ISO
   Jana RN, 2007, J THERMOPLAST COMPOS, V20, P75, DOI 10.1177/0892705707073082
   Joseph S, 2005, POLYMER, V46, P9385, DOI 10.1016/j.polymer.2005.07.053
   Khorasani MT, 2005, COLLOID SURFACE B, V41, P169, DOI 10.1016/j.colsurfb.2004.12.007
   Kim SB, 2004, BIOMATERIALS, V25, P5715, DOI 10.1016/j.biomaterials.2004.01.022
   Kovac S, 2004, J ARTHROPLASTY, V19, P664, DOI 10.1016/j.arth.2004.01.010
   Kwon SK, 2002, POLYM ENG SCI, V42, P2165, DOI 10.1002/pen.11106
   LEVIER RR, 1995, J CLIN EPIDEMIOL, V48, P513, DOI 10.1016/0895-4356(94)00207-7
   Nzihou A, 1998, POWDER TECHNOL, V99, P60, DOI 10.1016/S0032-5910(98)00091-6
   Olah A, 2005, APPL SURF SCI, V239, P410, DOI 10.1016/j.apsusc.2004.06.005
   Patel M, 2005, POLYM TEST, V24, P663, DOI 10.1016/j.polymertesting.2005.03.013
   Richmond R, 2004, DENT MATER, V20, P124, DOI 10.1016/S0109-5641(03)00083-6
   Rutherford SW, 2007, J COLLOID INTERF SCI, V306, P228, DOI 10.1016/j.jcis.2006.10.068
   SANTRA RN, 1993, POLYM ENG SCI, V33, P1352, DOI 10.1002/pen.760332008
   Tordjeman P, 2001, J RHEOL, V45, P995, DOI 10.1122/1.1378027
   Tsukeoka T, 2006, BIOMATERIALS, V27, P3897, DOI 10.1016/j.biomaterials.2006.03.002
   Werner L, 2006, J CATARACT REFR SURG, V32, P499, DOI 10.1016/j.jcrs.2005.12.137
   2005, US PHARMACOPEIA, V28
NR 29
TC 1
Z9 1
U1 1
U2 9
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD MAR
PY 2010
VL 50
IS 3
BP 606
EP 612
DI 10.1002/pen.21504
PG 7
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 561VT
UT WOS:000275008700021
DA 2018-10-20
ER

PT J
AU Zhou, D
   McMurray, G
AF Zhou, Debao
   McMurray, Gary
TI Modeling of blade sharpness and compression cut of biomaterials
SO ROBOTICA
LA English
DT Article
DE Modeling; Blade; Compression cut; Sharpness
ID CHEESE
AB To realize the automation of biomaterial Cutting, the interaction between the blade and biomaterial deserves insight understanding. In this paper, a blade-compression cutting model is developed. The influences from the material properties, deformation, and blade properties on the cutting force are thoroughly explained. An approach to describe the sharpness of a blade is provided and its applicability is experimentally demonstrated. Based on the material property and knife sharpness property, the required force to realize compression cut can be predicted. This provides the reference force trajectory for the automation of biomaterial compression cutting
C1 [Zhou, Debao] Univ Minnesota, Dept Mech & Ind Engn, Duluth, MN 55812 USA.
   [McMurray, Gary] Georgia Tech Res Inst, Food Proc Technol Div, ATAS Lab, Atlanta, GA 30332 USA.
RP Zhou, D (reprint author), Univ Minnesota, Dept Mech & Ind Engn, Duluth, MN 55812 USA.
EM dzhou@domn.edu
CR *ABB INC, 2000, PRODUCT MANUAL IRB 1
   *ATI INC, 1998, ATI IND AUT INC PUBL
   Atkins AG, 2004, J MATER SCI, V39, P2761, DOI 10.1023/B:JMSC.0000021451.17182.86
   ATKINS AG, 1985, ELASTIC PLASTIC FRAC
   Bishu R. P., 1996, ADV OCCUP ERGON SAF, V2, P479
   BLACK D, 1985, BIOENGINEERING SKIN, V1, P111
   Bourne M C, 2002, FOOD TEXTURE VISCOSI
   Brown T, 2005, J FOOD ENG, V70, P165, DOI 10.1016/j.jfoodeng.2004.09.022
   Dempsey PG, 2004, J OCCUP ENVIRON HYG, V1, P167, DOI 10.1080/15459620490424465
   FISCHERCRIPPS A, 2000, INTRO CONTACT MECH, P107
   Hellan K., 1984, INTRO FRACTURE MECH
   Kamyab I, 1998, J MATER SCI, V33, P2763, DOI 10.1023/A:1017517332112
   Mahvash M., 2001, HAPTICS E, V2, P1
   McCarthy CT, 2007, ENG FRACT MECH, V74, P2205, DOI 10.1016/j.engfracmech.2006.10.015
   MCCARTHY CT, 2004, P ASM INT C MAT PROC, P140
   MCGORRY RW, 2005, APPL ERGON, V35, P71
   Michael W.H., 1998, STRESS ANAL FIBER RE
   MOORE MA, 1979, J AGR ENG RES, V24, P11, DOI 10.1016/0021-8634(79)90057-X
   RECUM A, HDB BIOMATERIALS EVA, P539
   Reilly GA, 2004, J MATER PROCESS TECH, V153, P261, DOI 10.1016/j.jmatprotec.2004.04.297
   Szabo RL, 2001, AIHAJ, V62, P428
   Timoshenko S. P., 1970, THEORY ELASTICITY
   YOSHIHARA H, 2005, J INT ACAD WOOD SCI, V39, P114
NR 23
TC 5
Z9 5
U1 1
U2 16
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0263-5747
J9 ROBOTICA
JI Robotica
PD MAR
PY 2010
VL 28
SI SI
BP 311
EP 319
DI 10.1017/S0263574709990385
PN 2
PG 9
WC Robotics
SC Robotics
GA 564WG
UT WOS:000275248300015
DA 2018-10-20
ER

PT J
AU Richmond, JC
   Weitzel, PP
AF Richmond, John C.
   Weitzel, Paul P.
TI Bioresorbable Scaffolds for Anterior Cruciate Ligament Reconstruction:
   Do We Need an Off-the-Shelf ACL Substitute?
SO SPORTS MEDICINE AND ARTHROSCOPY REVIEW
LA English
DT Review
DE anterior cruciate ligament; ACL; scaffold; silk; knee; ligament
ID LONG-TERM; ALLOGRAFT; SCIENCE
AB Currently available anterior cruciate ligament (ACL) graft sources, autograft and allograft, present potential problems that a natural biomaterial ACL graft might be able to solve. Earlier efforts in the development of synthetic ACL grafts were less than optimal, and those devices have largely been abandoned. We can learn from these past failures, and potentially develop a bioresorbable scaffold for ACL reconstruction, which will provide immediate stability, promote and direct tissue in growth, and degrade at an appropriate rate, without harmful wear debris. We have developed a modified silk scaffold, which is currently being evaluated in humans in a pilot study.
C1 Tufts Univ, Sch Med, Dept Orthoped Surg, New England Baptist Hosp, Boston, MA 02111 USA.
   Boston Sports & Shoulder Ctr, Chestnut Hill, MA USA.
RP Richmond, JC (reprint author), 125 Parker Hill Ave, Boston, MA 02120 USA.
EM jrichmon@nebh.org
CR Altman GH, 2008, J AM ACAD ORTHOP SUR, V16, P177, DOI 10.5435/00124635-200804000-00001
   Frank CB, 1997, J BONE JOINT SURG AM, V79A, P1556, DOI 10.2106/00004623-199710000-00014
   Horan RL, 2006, J BIOMECH, V39, P2232, DOI 10.1016/j.jbiomech.2005.07.007
   JACKSON DW, 1993, AM J SPORT MED, V21, P176, DOI 10.1177/036354659302100203
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   MASCARENHAS B, 2008, MJM, V11, P29
   OLSON EJ, 1988, AM J SPORT MED, V16, P558, DOI 10.1177/036354658801600602
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   RICHMOND JC, 1992, AM J SPORT MED, V20, P24, DOI 10.1177/036354659202000107
   Singhal MC, 2007, ARTHROSCOPY, V23, P469, DOI 10.1016/j.arthro.2006.12.010
NR 10
TC 3
Z9 4
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1062-8592
J9 SPORTS MED ARTHROSC
JI Sports Med. Arthrosc. Rev.
PD MAR
PY 2010
VL 18
IS 1
BP 40
EP 42
DI 10.1097/JSA.0b013e3181cdb493
PG 3
WC Sport Sciences
SC Sport Sciences
GA 564SA
UT WOS:000275235900008
PM 20160629
DA 2018-10-20
ER

PT J
AU Xue, Y
   Liu, X
   Sun, J
AF Xue, Yang
   Liu, Xin
   Sun, Jiao
TI PU/PTFE-stimulated monocyte-derived soluble factors induced inflammatory
   activation in endothelial cells
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Biomaterials; Human umbilical-vein endothelial cells (HUVECs);
   Monocytes; Coculture; Inflammatory activation
ID PLASMA-TREATED PET; NF-KAPPA-B; ADHESION MOLECULES; VASCULAR GRAFTS;
   LEUKOCYTE ADHESION; IN-VITRO; EXPRESSION; POLYTETRAFLUOROETHYLENE;
   POLYURETHANES; PTFE
AB Polyurethane (PU) and polytetrafluoroethylene (PTFE) are two commonly used blood-contacting biomaterials. In the present study, we used a noncontact coculture model to evaluate the thrombosis-causing potential of monocyte-mediated PU and PTFE. We used human endothelial cells from umbilical cord (HUVECs) and human monocytes (THP1 cells). The THP1 cells were directly exposed to PU/PTFE, and the resultant cell-free supernatants were harvested for stimulating HUVECs. The treated HUVECs constituted the test group. HUVECs treated with supernatants of LPS-stimulated THP1 cells were used as the positive controls. To investigate the effects of the supernatant treatment on HUVECs, we measured the expression of the leukocyte-endothelial-cell adhesion molecules (CAMs) CD54 (ICAM-1), CD106 (VCAM-1), and CD62E (E-selectin) and evaluated the release of tissue factor (TF). The results demonstrated that both PU and PTFE induced the expressions of CD62E and TF. These activation effects were accompanied by activation of the NF-kappa B transcription factor. To further investigate the monocyte-derived soluble factors that might contribute to these effects, we evaluated the effects of the PU/PTFE stimulation on the expression of reactive oxygen species (ROS), TNF-alpha, IL-1 beta, and IL-6 in monocyte monocultures. In comparison with the results for the negative control, both PU and PTFE significantly induced ROS release after 0.5 h, while the expressions of TNF-alpha, IL-1 beta, and IL-6 were variably increased after 24 h. Our results suggest that the biomaterial induces monocytic activation and subsequently causes the release of soluble factors, which contribute to the inflammatory activation in HUVECs. (C) 2009 Elsevier Ltd. All rights reserved.
C1 Shanghai Biomat Res & Testing Ctr, Shanghai 200023, Peoples R China.
   Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200011, Peoples R China.
   Shanghai Key Lab Stomatol, Shanghai 200011, Peoples R China.
RP Sun, J (reprint author), 716 Xie Tu Rd, Shanghai 200023, Peoples R China.
EM jiaosun59@yahoo.com
FU Natural Science Foundation of China [30670556, 30270390]; Shanghai
   Sci-Tech Committee Foundation [08DZ2291600]; Shanghai Leading Academic
   Discipline Project [S30206]
FX This work was supported by grants from Natural Science Foundation of
   China (Nos. 30670556, 30270390), Shanghai Sci-Tech Committee Foundation
   (08DZ2291600) and Shanghai Leading Academic Discipline Project (No.
   S30206).
CR ALHUNEIDI W, 1990, INT ANGIOL, V9, P16
   Bhardwaj RS, 1997, J MATER SCI-MATER M, V8, P737, DOI 10.1023/A:1018552326808
   CAMERON D, 1996, J CARDIOVASC PHARM, V27, P1
   Crespo I, 2008, BRIT J NUTR, V100, P968, DOI 10.1017/S0007114508966083
   Defrere J, 1992, Acta Chir Belg, V92, P217
   Du XL, 1999, FREE RADICAL BIO MED, V27, P752, DOI 10.1016/S0891-5849(99)00079-9
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gulbins H, 2006, THORAC CARDIOV SURG, V54, P102, DOI 10.1055/s-2005-865916
   HERRING M, 1978, SURGERY, V84, P498
   Horstman LL, 2004, FRONT BIOSCI, V9, P1118, DOI 10.2741/1270
   Imbert E, 2001, J BIOMED MATER RES, V56, P376, DOI 10.1002/1097-4636(20010905)56:3<376::AID-JBM1106>3.0.CO;2-R
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JIAO S, 2008, ADV MAT RES, V47, P1423
   LANGER R, 1993, SCIENCE, V920, P260
   LANNERSTAD O, 1987, EUR SURG RES, V19, P6, DOI 10.1159/000128674
   Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719
   Macnair R, 1998, P I MECH ENG H, V212, P465, DOI 10.1243/0954411981534222
   Magder S, 2006, J VASC RES, V43, P447, DOI 10.1159/000095162
   Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435
   McMillan R, 2001, J BIOMED MATER RES, V54, P272, DOI 10.1002/1097-4636(200102)54:2<272::AID-JBM15>3.0.CO;2-3
   Moon MK, 2009, VASC PHARMACOL, V50, P116, DOI 10.1016/j.vph.2008.11.007
   NAWROTH PP, 1986, J EXP MED, V163, P740, DOI 10.1084/jem.163.3.740
   Pu FR, 2002, BIOMATERIALS, V23, P4705, DOI 10.1016/S0142-9612(02)00219-3
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Remy-Zolghadri M, 2004, J VASC SURG, V39, P613, DOI 10.1016/j.jvs.2003.08.007
   Rinder C, 1996, J CARDIOVASC PHAR S1, V27, P6
   Rose SL, 2005, J BIOMED MATER RES A, V72A, P269, DOI 10.1002/jbm.a.30222
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sundaram S, 1996, BIOMATERIALS, V17, P1041, DOI 10.1016/0142-9612(96)84681-3
   Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830
   van der Zijpp YJT, 2003, J BIOMED MATER RES A, V65A, P51, DOI 10.1002/jbm.a.10327
   VONRECUM AF, 1978, J BIOMED MATER RES, V12, P743, DOI 10.1002/jbm.820120513
   WESTLIN WF, 1993, AM J PATHOL, V142, P117
   Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592
   Yu H, 2003, J VASC SURG, V38, P557, DOI 10.1016/S0741-5214(03)00334-3
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 36
TC 5
Z9 6
U1 1
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD MAR
PY 2010
VL 24
IS 2
BP 404
EP 410
DI 10.1016/j.tiv.2009.10.018
PG 7
WC Toxicology
SC Toxicology
GA 574LW
UT WOS:000275991700008
PM 19895882
DA 2018-10-20
ER

PT J
AU Steck, E
   Burkhardt, M
   Ehrlich, H
   Richter, W
AF Steck, Eric
   Burkhardt, Michaela
   Ehrlich, Hermann
   Richter, Wiltrud
TI Discrimination between cells of murine and human origin in
   xenotransplants by species specific genomic in situ hybridization
SO XENOTRANSPLANTATION
LA English
DT Article
DE human Alu repeat; in situ hybridization; mouse SINE repeats; species
   specificity; xenotransplant
ID MESENCHYMAL STEM-CELLS; NUDE-MOUSE; BONE; MICE; MODEL; TRANSPLANTATION;
   DNA; DIFFERENTIATION; CHONDROGENESIS; CALCIFICATION
AB Xenotransplantation of human cells into immune compromised host species is an important experimental setup to follow the faith of implanted cells and the contribution of host cells to tissue regenerates. In this context, it is of major relevance to discriminate between transplanted and host cells. Labeling techniques of donor cells frequently reach only part of the cells, have the risk of influencing their natural biological activity and may allow label transmission to host cells via vesicles or phagocytosis. To allow positive detection of donor and host cells on histological sections of a transplant, we have developed a method to identify mouse cells by in situ hybridization of murine specific genomic repetitive elements (SINE/B1, SINE/B2) which we combined with human cell detection using Alu in situ hybridization. We describe generation of mouse specific probes, hybridization and read out using biomaterial supported human chondrocyte constructs implanted subcutaneously in mice. Mouse specific genomic repeats identified attached or invaded host cells in the transplants with human specific signals confined to regions of cartilage-like extracellular matrix. The method is suitable to discriminate specifically between cells of human and mouse origin without overlap of unspecific staining.
C1 [Steck, Eric; Burkhardt, Michaela; Richter, Wiltrud] Orthopaed Univ Hosp, Res Ctr Expt Orthopaed, D-69118 Heidelberg, Germany.
   [Ehrlich, Hermann] Tech Univ Dresden, Inst Bioanalyt Chem, Biominerals Biocomposites & Biomimet Grp, D-8027 Dresden, Germany.
RP Steck, E (reprint author), Orthopaed Univ Hosp, Res Ctr Expt Orthopaed, Schlierbacher Landstr 200A, D-69118 Heidelberg, Germany.
EM eric.steck@med.uni-heidelberg.de
RI Richter, Wiltrud/V-3217-2017; Ehrlich, Hermann/I-5481-2015; Ehrlich,
   Hermann/J-6698-2012
OI Richter, Wiltrud/0000-0003-4694-2768; Ehrlich,
   Hermann/0000-0003-3654-0810; Ehrlich, Hermann/0000-0003-3654-0810
FU Deutsche Forschungsgemeinschaft [STE1131/1-2]
FX The authors thank Kathrin Brohm and Patricia Janicki for assistance by
   construct generation and ectopic transplantation and Jorg Fellenberg for
   valuable scientific discussion. This work was supported by a grant of
   the Deutsche Forschungsgemeinschaft (STE1131/1-2).
CR Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798
   Benz K, 2002, BIOCHEM BIOPH RES CO, V293, P284, DOI 10.1016/S0006-291X(02)00223-1
   Bissig KD, 2007, P NATL ACAD SCI USA, V104, P20507, DOI 10.1073/pnas.0710528105
   DEMARCHEZ M, 1987, TRANSPLANTATION, V43, P896, DOI 10.1097/00007890-198743060-00025
   Dickhut A, 2008, FRONT BIOSCI, V13, P4517, DOI 10.2741/3020
   Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   Ghodsizad A, 2009, HEART, V95, P27, DOI 10.1136/hrt.2007.139329
   GRIEND DJV, 2009, PROSTATE, V69, P1557
   Kass DH, 1997, GENETICA, V99, P1, DOI 10.1023/A:1018350810791
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kerbel RS, 2003, CANCER BIOL THER, V2, pS134
   Kiessling Fabian, 2008, V185, P305, DOI 10.1007/978-3-540-77496-9_13
   Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233
   KRAYEV AS, 1980, NUCLEIC ACIDS RES, V8, P1201, DOI 10.1093/nar/8.6.1201
   OBARA T, 1986, AM J PATHOL, V122, P386
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025
   Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730
   Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com
   Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2
   Warncke B, 2004, VIRCHOWS ARCH, V444, P74, DOI 10.1007/s00428-003-0891-2
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Weisberg TF, 1996, MOL CELL PROBE, V10, P139, DOI 10.1006/mcpr.1996.0019
   Yang M, 2004, CANCER RES, V64, P8651, DOI 10.1158/0008-5472.CAN-04-3118
   Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729
   Yonou H, 2001, CANCER RES, V61, P2177
NR 27
TC 25
Z9 25
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0908-665X
J9 XENOTRANSPLANTATION
JI Xenotransplantation
PD MAR-APR
PY 2010
VL 17
IS 2
BP 153
EP 159
DI 10.1111/j.1399-3089.2010.00577.x
PG 7
WC Medicine, Research & Experimental; Transplantation
SC Research & Experimental Medicine; Transplantation
GA 583GG
UT WOS:000276661000026
PM 20522248
DA 2018-10-20
ER

PT J
AU Xu, XX
   Nie, FL
   Zhang, JX
   Zheng, W
   Zheng, YF
   Hu, C
   Yang, G
AF Xu, X. X.
   Nie, F. L.
   Zhang, J. X.
   Zheng, W.
   Zheng, Y. F.
   Hu, C.
   Yang, G.
TI Corrosion and ion release behavior of ultra-fine grained bulk pure
   copper fabricated by ECAP in Hanks solution as potential biomaterial for
   contraception
SO MATERIALS LETTERS
LA English
DT Article
DE Metals and alloys; Nanomaterials; Ultra-fine grained copper; ECAP;
   Corrosion behavior; Ion release
ID SIMULATED UTERINE FLUID; DEVICE; OXYGEN
AB Ultra-fine grained (UFG) bulk pure copper has been successfully fabricated by equal-channel angular pressing (ECAP), with the grain size about 380 nm after 8 passes. The potentiodynamic polarization results of the ECAP copper specimens tested in Hanks solution revealed that the corrosion current of UFG copper is higher than that of the coarse grained copper. The cupric ion release behaviors of UFG copper immersed in Hanks solution for 30 days only displayed a burst release during the first 3 days (in comparison to the 1-2 months for the conventional Cu) from 115 mu g/day to 12.5 mu g/day, after which the ion release remained constant and slow. During the immersion experiments. Cu(2)O was the only corrosion product found on the surface and it took 10 days or so to form a uniform Cu(2)O layer. Uniform corrosive damage on the surface and few localized corrosion is observed. The above results indicate that UFG copper could have high potential as biomedical materials for contraception. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Nie, F. L.; Zheng, Y. F.] Peking Univ, Coll Engn, Beijing 100871, Peoples R China.
   [Xu, X. X.; Zhang, J. X.; Zheng, W.; Zheng, Y. F.] Harbin Engn Univ, Ctr Biomed Mat & Engn, Harbin 150001, Peoples R China.
   [Hu, C.; Yang, G.] Cent Iron & Steel Res Inst, Inst Struct Mat, Beijing 100081, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
CR Bastidas JM, 2000, CONTRACEPTION, V61, P395, DOI 10.1016/S0010-7824(00)00124-4
   Cao B, 2008, BIOMED MATER, V3, P1
   CHI IC, 1995, ADV DRUG DELIVER REV, V17, P165, DOI 10.1016/0169-409X(95)00085-L
   ELCHALAL U, 1995, ADV DRUG DELIVER REV, V17, P151, DOI 10.1016/0169-409X(95)00084-K
   Iwahashi Y, 1996, SCRIPTA MATER, V35, P143, DOI 10.1016/1359-6462(96)00107-8
   Jang YH, 2006, J MATER SCI, V41, P4293, DOI 10.1007/s10853-006-6992-y
   Kosonen A., 1980, MED INTRAUTERINE DEV, P22
   Luo W, 2007, MAT SCI ENG A-STRUCT, V452, P524, DOI 10.1016/j.msea.2006.10.123
   Maier HJ, 2006, INT J FATIGUE, V28, P243, DOI 10.1016/j.ijfatigue.2005.05.004
   Miyamoto H, 2008, CORROS SCI, V50, P1215, DOI 10.1016/j.corsci.2008.01.024
   Mora N, 2002, BIOMATERIALS, V23, P667, DOI 10.1016/S0142-9612(01)00154-5
   THIERY M, 1987, CONTRACEPTION, V35, P163, DOI 10.1016/S0010-7824(87)80007-0
   Trzaska M, 2007, J APPL ELECTROCHEM, V37, P1009, DOI 10.1007/s10800-007-9341-1
   Vinogradov A, 1999, SCRIPTA MATER, V41, P319, DOI 10.1016/S1359-6462(99)00170-0
   Wang YM, 2002, APPL PHYS LETT, V80, P2395, DOI 10.1063/1.1465528
   WELTER JM, 2006, BETTER PROPERTIES IN, P27
   Xia XP, 2007, CONTRACEPTION, V76, P326, DOI 10.1016/j.contraception.2007.06.006
   Yamasaki T, 2001, MAT SCI ENG A-STRUCT, V318, P122, DOI 10.1016/S0921-5093(01)01332-6
   Yang ZH, 2008, MATER LETT, V62, P4226, DOI 10.1016/j.matlet.2008.06.046
   Zhang C, 1996, CORROS SCI, V38, P635, DOI 10.1016/0010-938X(95)00154-C
   Zhu YT, 2004, SCRIPTA MATER, V51, P825, DOI 10.1016/j.scriptamat.2004.05.006
NR 21
TC 24
Z9 25
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD FEB 28
PY 2010
VL 64
IS 4
BP 524
EP 527
DI 10.1016/j.matlet.2009.11.065
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 547VS
UT WOS:000273918300010
DA 2018-10-20
ER

PT J
AU Shah, RN
   Shah, NA
   Lim, MMD
   Hsieh, C
   Nuber, G
   Stupp, SI
AF Shah, Ramille N.
   Shah, Nirav A.
   Lim, Marc M. Del Rosario
   Hsieh, Caleb
   Nuber, Gordon
   Stupp, Samuel I.
TI Supramolecular design of self-assembling nanofibers for cartilage
   regeneration
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE self-assembling biomaterials; chondral defects; microfracture; peptide
   amphiphiles; transforming growth factor
ID PEPTIDE-AMPHIPHILE NANOFIBERS; ARTICULAR-CARTILAGE; THICKNESS DEFECTS;
   GROWTH; REPAIR; MICROFRACTURE; CELLS; DEGENERATION; SURFACES; MATRIX
AB Molecular and supramolecular design of bioactive biomaterials could have a significant impact on regenerative medicine. Ideal regenerative therapies should be minimally invasive, and thus the notion of self-assembling biomaterials programmed to transform from injectable liquids to solid bioactive structures in tissue is highly attractive for clinical translation. We report here on a coassembly system of peptide amphiphile (PA) molecules designed to form nanofibers for cartilage regeneration by displaying a high density of binding epitopes to transforming growth factor beta-1 (TGF beta-1). Growth factor release studies showed that passive release of TGF beta-1 was slower from PA gels containing the growth factor binding sites. In vitro experiments indicate these materials support the survival and promote the chondrogenic differentiation of human mesenchymal stem cells. We also show that these materials can promote regeneration of articular cartilage in a full thickness chondral defect treated with microfracture in a rabbit model with or even without the addition of exogenous growth factor. These results demonstrate the potential of a completely synthetic bioactive biomaterial as a therapy to promote cartilage regeneration.
C1 [Shah, Ramille N.; Hsieh, Caleb; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Shah, Ramille N.; Hsieh, Caleb; Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Shah, Nirav A.] Northwestern Univ, Dept Orthopaed Surg, Chicago, IL 60611 USA.
   [Lim, Marc M. Del Rosario] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Nuber, Gordon] NW Inst Orthopaed, Chicago, IL 60611 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
RP Stupp, SI (reprint author), Northwestern Univ, Dept Mat Sci & Engn, Cook Hall,Room 1127,2220 Campus Dr, Evanston, IL 60208 USA.
EM s-stupp@northwestern.edu
RI Stupp, Samuel/B-6737-2009; Shah, Ramille/E-3737-2010
FU National Institutes of Health [5-R01-EB003806]; Nanotope, Inc.
FX We thank A. Cheetham for PA synthesis, A. Mata for SEM, M. Seniw for
   assistance with illustrations, the Center for Comparative Medicine
   (Northwestern University) for assistance with animal surgeries,
   Pathology Core (Robert H. Lurie Comprehensie Cancer Center, Northwestern
   University) for histological processing, and the Institute for
   BioNanotechnology in Medicine at Northwestern University for facilities
   support. This work was supported by the National Institutes of Health
   Grant 5-R01-EB003806 and Nanotope, Inc.
CR Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u
   Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   Claussen RC, 2003, J AM CHEM SOC, V125, P12680, DOI 10.1021/ja035882r
   Dounchis JS, 1997, J ORTHOPAED RES, V15, P803, DOI 10.1002/jor.1100150603
   Frisbie DD, 2003, CLIN ORTHOP RELAT R, P215, DOI 10.1097/01.blo.0000030514.43495.f3
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hoess RH, 2001, CHEM REV, V101, P3205, DOI 10.1021/cr000056b
   Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Jackson DW, 2001, CLIN ORTHOP RELAT R, pS14
   Jiang HZ, 2007, SOFT MATTER, V3, P454, DOI 10.1039/b614426h
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Klagsbrun M, 1992, Semin Cancer Biol, V3, P81
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   McLennan IS, 2002, INT J DEV BIOL, V46, P559
   O'Connor WJ, 2000, ORTHOP CLIN N AM, V31, P399, DOI 10.1016/S0030-5898(05)70159-0
   O'Driscoll SW, 1998, J BONE JOINT SURG AM, V80A, P1795, DOI 10.2106/00004623-199812000-00011
   ODRISCOLL SW, 1986, J BONE JOINT SURG AM, V68A, P1017, DOI 10.2106/00004623-198668070-00008
   PARALKAR VM, 1991, DEV BIOL, V143, P303, DOI 10.1016/0012-1606(91)90081-D
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Williams Riley J 3rd, 2007, Instr Course Lect, V56, P419
NR 25
TC 298
Z9 302
U1 10
U2 143
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 23
PY 2010
VL 107
IS 8
BP 3293
EP 3298
DI 10.1073/pnas.0906501107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 563KN
UT WOS:000275130900006
PM 20133666
OA Green Published, Bronze
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Phelps, EA
   Landazuri, N
   Thule, PM
   Taylor, WR
   Garcia, AJ
AF Phelps, Edward A.
   Landazuri, Natalia
   Thule, Peter M.
   Taylor, W. Robert
   Garcia, Andres J.
TI Bioartificial matrices for therapeutic vascularization
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; hydrogel; ischemia; PEG; VEGF
ID ENDOTHELIAL GROWTH-FACTOR; CELL-MIGRATION; LIMB ISCHEMIA; HIND-LIMB;
   ANGIOGENESIS; HYDROGELS; MORPHOGENESIS; DELIVERY; MICROENVIRONMENTS;
   MECHANISMS
AB Therapeutic vascularization remains a significant challenge in regenerative medicine applications. Whether the goal is to induce vascular growth in ischemic tissue or scale up tissue-engineered constructs, the ability to induce the growth of patent, stable vasculature is a critical obstacle. We engineered polyethylene glycol-based bioartificial hydrogel matrices presenting protease-degradable sites, cell-adhesion motifs, and growth factors to induce the growth of vasculature in vivo. Compared to injection of soluble VEGF, these matrices delivered sustained in vivo levels of VEGF over 2 weeks as the matrix degraded. When implanted subcutaneously in rats, degradable constructs containing VEGF and arginine-glycine-aspartic acid tripeptide induced a significant number of vessels to grow into the implant at 2 weeks with increasing vessel density at 4 weeks. The mechanism of enhanced vascularization is likely cell-demanded release of VEGF, as the hydrogels may degrade substantially within 2 weeks. In a mouse model of hind-limb ischemia, delivery of these matrices resulted in significantly increased rate of reperfusion. These results support the application of engineered bioartificial matrices to promote vascularization for directed regenerative therapies.
C1 [Phelps, Edward A.; Garcia, Andres J.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Phelps, Edward A.; Garcia, Andres J.] Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Landazuri, Natalia; Taylor, W. Robert] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30332 USA.
   [Thule, Peter M.] Emory Univ, Sch Med, Atlanta Vet Affairs Med Ctr, Div Endocrinol Metab & Lipids, Decatur, GA 30033 USA.
   [Taylor, W. Robert] Vet Affairs Med Ctr, Div Cardiol, Decatur, GA 30033 USA.
   [Taylor, W. Robert] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Phelps, Edward/Q-1302-2016
OI Phelps, Edward/0000-0001-8666-805X; Landazuri,
   Natalia/0000-0002-7182-8767
FU National Institute of Health [R01-EB004496]; Georgia Tech/Emory Center
   for the Engineering of Living Tissues; Atlanta Clinical and
   Translational Science Institute; Juvenile Diabetes Research Foundation;
   American Heart Association
FX We thank A. Zisch for donation of the VEGF<INF>121</INF>-cys plasmid and
   helpful suggestions, and we thank A. Lin and A. Wojtowicz for technical
   assistance with the micro-CT image analysis. This work was supported by
   the National Institute of Health Grant R01-EB004496, the Georgia
   Tech/Emory Center for the Engineering of Living Tissues and the Atlanta
   Clinical and Translational Science Institute, an Innovation Grant from
   the Juvenile Diabetes Research Foundation, and an American Heart
   Association Predoctoral Fellowship (E. A. P.). The authors thank J.L.
   West and J.J. Moon (Rice University) for helpful suggestions.
CR *AM HEART ASS, PER ART DIS QUICK FA
   American Heart Association, HEART DIS STROK STAT
   Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Cazalis CS, 2004, BIOCONJUGATE CHEM, V15, P1005, DOI 10.1021/bc049903y
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Couffinhal T, 1998, AM J PATHOL, V152, P1667
   Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003
   Duvall CL, 2008, ARTERIOSCL THROM VAS, V28, P290, DOI 10.1161/ATVBAHA.107.158485
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   Ehrbar M, 2008, BIOMATERIALS, V29, P1720, DOI 10.1016/j.biomaterials.2007.12.002
   Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hummers LK, 2004, ARTHRITIS RHEUM, V50, pS630
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226
   SIMONS M, 2005, CIRCULATION, V111, P1566
   Sun QH, 2005, PHARM RES, V22, P1110, DOI 10.1007/s11095-005-5644-2
   Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371
   Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463
   Tse HF, 2007, J CARDIOVASC PHARM T, V12, P89, DOI 10.1177/1074248407303139
   van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 35
TC 162
Z9 161
U1 3
U2 47
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 23
PY 2010
VL 107
IS 8
BP 3323
EP 3328
DI 10.1073/pnas.0905447107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 563KN
UT WOS:000275130900011
PM 20080569
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Lerum, RV
   Bermudez, H
AF Lerum, Ronald V.
   Bermudez, Harry
TI Controlled Interfacial Assembly and Transfer of Brushlike Copolymer
   Films
SO CHEMPHYSCHEM
LA English
DT Article
DE amphiphiles; biomembranes; polymers; self-assembly; thin films
ID AIR-WATER-INTERFACE; LANGMUIR-BLODGETT; AIR/WATER INTERFACE;
   POLY(ETHYLENE OXIDE); PROTEIN ADSORPTION; BLOCK-COPOLYMERS; POLYMER
   BRUSHES; CELL-ADHESION; CHAIN-LENGTH; MONOLAYERS
AB The self-assembly and compression of polybutadiene-b-poly(ethylene oxide) (PBd-PEO) at the air/water interface enables control over surface density, height, and film structure. Interfacial transfer was performed by a combination of Langmuir-Blodgett (LB) and Langmuir-Schaefer (LS) techniques, resulting in monolayer and bilayer films. Ellipsometry and wettability results were used to characterize the efficiency of transfer and to determine the properties of the resulting films, confirming a brushlike monolayer. Importantly, a high surface density is essential to obtain the desired film structure (i.e. a dense brush) and surface properties. The films were challenged by adsorption of fibrinogen, and the results are consistent with the notion of a PEO-enriched, and protein-repellant, bilayer surface. Such a bilayer film provides an opportunity for a tunable biomaterial interface to probe cell-surface interactions.
C1 [Lerum, Ronald V.; Bermudez, Harry] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
RP Bermudez, H (reprint author), Univ Massachusetts, Dept Polymer Sci & Engn, 120 Governors Dr, Amherst, MA 01003 USA.
EM bermudez@polysci.umass.edu
RI Bermudez, Harry/C-8547-2012
OI Bermudez, Harry/0000-0003-0457-5963
FU NSF Materials Research Science & Engineering Center; Healey Endowment
FX This work was financially supported by the NSF Materials Research
   Science & Engineering Center and by a Healey Endowment Faculty Research
   Grant. We also thank Micheal Smith for technical assistance.
CR Battaglia G, 2005, J AM CHEM SOC, V127, P8757, DOI 10.1021/ja050742y
   Baum K, 1998, J AM CHEM SOC, V120, P2993, DOI 10.1021/ja973666a
   Biesalski MA, 2006, BIOMATERIALS, V27, P1259, DOI 10.1016/j.biomaterials.2005.08.002
   Blodgett KB, 1935, J AM CHEM SOC, V57, P1007, DOI 10.1021/ja01309a011
   Bosker WTE, 2005, J COLLOID INTERF SCI, V286, P496, DOI 10.1016/j.jcis.2005.01.091
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Cheyne RB, 2005, LANGMUIR, V21, P5453, DOI 10.1021/la0503707
   daSilva AMG, 1996, LANGMUIR, V12, P6547
   de Vos WM, 2009, LANGMUIR, V25, P4490, DOI 10.1021/la803576k
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Deschenes L, 2008, LANGMUIR, V24, P3699, DOI 10.1021/la702141h
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   Efremova NV, 2001, LANGMUIR, V17, P7628, DOI 10.1021/la010405c
   Fan XW, 2006, BIOMACROMOLECULES, V7, P2443, DOI 10.1021/bm060276k
   Gao LC, 2006, LANGMUIR, V22, P6234, DOI 10.1021/la060254j
   GLASS JE, 1968, J PHYS CHEM-US, V72, P4459, DOI 10.1021/j100859a015
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   HENDERSON JA, 1993, MACROMOLECULES, V26, P4591, DOI 10.1021/ma00069a027
   HOFFMAN AS, 1986, J BIOMED MATER RES, V20, pR9, DOI 10.1002/jbm.820200903
   HONIG EP, 1973, J COLLOID INTERF SCI, V45, P92, DOI 10.1016/0021-9797(73)90245-2
   HORBETT TA, 1987, ACS SYM SER, V343, P1
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Joncheray TJ, 2007, LANGMUIR, V23, P2423, DOI 10.1021/la062626u
   KAWAGUCHI M, 1988, LANGMUIR, V4, P407, DOI 10.1021/la00080a025
   Langmuir I, 1938, J AM CHEM SOC, V60, P1351, DOI 10.1021/ja01273a023
   Logan JL, 2005, LANGMUIR, V21, P7380, DOI 10.1021/la050787c
   MACDONALD RC, 1987, P NATL ACAD SCI USA, V84, P4089, DOI 10.1073/pnas.84.12.4089
   Matmour R, 2007, LANGMUIR, V23, P649, DOI 10.1021/la062256+
   MORIIZUMI T, 1988, THIN SOLID FILMS, V160, P413, DOI 10.1016/0040-6090(88)90088-0
   OSBORN TD, 1995, BIOPHYS J, V68, P1364, DOI 10.1016/S0006-3495(95)80309-7
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Ryan AJ, 2005, FARADAY DISCUSS, V128, P55, DOI 10.1039/b405700g
   Ryley S, 2000, THIN SOLID FILMS, V370, P294, DOI 10.1016/S0040-6090(99)00876-7
   SCHNEIDER J, 1989, MACROMOLECULES, V22, P205, DOI 10.1021/ma00191a039
   Scomparin C, 2009, EUR PHYS J E, V28, P211, DOI 10.1140/epje/i2008-10407-3
   Sedev RV, 1996, J COLLOID INTERF SCI, V180, P36, DOI 10.1006/jcis.1996.0271
   Sharma S, 2004, LANGMUIR, V20, P348, DOI 10.1021/la0347531
   Su ZH, 1997, MACROMOLECULES, V30, P840, DOI 10.1021/ma961396v
   Tsukanova V, 2003, MACROMOLECULES, V36, P7227, DOI 10.1021/ma0257806
   WATANABE M, 1987, MACROMOLECULES, V20, P452, DOI 10.1021/ma00168a045
NR 44
TC 5
Z9 5
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1439-4235
J9 CHEMPHYSCHEM
JI ChemPhysChem
PD FEB 22
PY 2010
VL 11
IS 3
BP 665
EP 669
DI 10.1002/cphc.200900738
PG 5
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 564UQ
UT WOS:000275243700019
PM 20029885
DA 2018-10-20
ER

PT J
AU Rethore, G
   Pandit, A
AF Rethore, Gildas
   Pandit, Abhay
TI Use of Templates to Fabricate Nanoscale Spherical Structures for Defined
   Architectural Control
SO SMALL
LA English
DT Review
ID DISTILLATION-PRECIPITATION POLYMERIZATION; HOLLOW SILICA NANOPARTICLES;
   SUPERCRITICAL CARBON-DIOXIDE; CONTROLLED DRUG-DELIVERY; OF-THE-ART;
   CORE-SHELL; ACRYLIC-ACID; POROUS SILICA; IN-VITRO; DISPERSION
   POLYMERIZATION
AB Architectural design of biomaterial structures is essential to reach the full/potential of the materials' chemical and biological properties. Clinically, these properties depend on the targeted applications of delivery, such as tissue regeneration, imaging, or cancer. To get an efficient material for biological applications, key properties are needed, such as degradability, low toxicity, cell specificity, relative efficiency, and capability of delivering multiple molecules. In recent years, significant progress has been made through either the design of the material itself (synthetic or natural polymers, dendrimers, crosslinking) or the fabrication technique (nozzle reactor, emulsion, and template). The combination of these materials and techniques results in a large variety of biomaterials that have varied shape and physico-chemical and biological properties. Nevertheless, these inherent properties are not sufficient and interest in discovering and developing new techniques that present these biomaterials in different light is now under focus. A useful strategy to prepare biomaterials with unique and novel architectures is through the use of templates that have defined geometrical features. This holds great promise, especially for the development of hollow structures, such as spheres. The nanoscale structural design of biomaterials via the use of templates and their potential clinical applications are discussed. In addition, the conceptual hurdles that must be overcome to produce applications that are clinically relevant are examined.
C1 [Rethore, Gildas; Pandit, Abhay] NUI Galway, Network Excellence Funct Biomat, Galway, Ireland.
RP Pandit, A (reprint author), NUI Galway, Network Excellence Funct Biomat, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; RETHORE, Gildas/B-1974-2015
OI Pandit, Abhay/0000-0002-6292-4933; 
FU Debra Ireland
FX This work was supported by Debra Ireland.
CR Agrawal M, 2008, LANGMUIR, V24, P1013, DOI 10.1021/la702509j
   Ameller T, 2003, INT J CANCER, V106, P446, DOI 10.1002/ijc.11248
   Antipov AA, 2002, COLLOID SURFACE A, V198, P535, DOI 10.1016/S0927-7757(01)00956-6
   Aznar AJ, 1996, MICROPOROUS MATER, V6, P105, DOI 10.1016/0927-6513(95)00096-8
   Bai F, 2004, MACROMOLECULES, V37, P9746, DOI 10.1021/ma048566l
   Bai F, 2007, EUR POLYM J, V43, P3923, DOI 10.1016/j.eurpolymj.2007.06.024
   Bai F, 2006, EUR POLYM J, V42, P2088, DOI 10.1016/j.eurpolymj.2006.03.030
   Bamnolker H, 1997, J MATER SCI LETT, V16, P1412, DOI 10.1023/A:1018565428355
   Billotey C, 2003, MAGN RESON MED, V49, P646, DOI 10.1002/mrm.10418
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Bourgeat-Lami E, 1998, J COLLOID INTERF SCI, V197, P293, DOI 10.1006/jcis.1997.5265
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   Caruso F, 2001, CHEM MATER, V13, P109, DOI 10.1021/cm001164h
   Caruso F, 2001, ADV MATER, V13, P1090, DOI 10.1002/1521-4095(200107)13:14<1090::AID-ADMA1090>3.0.CO;2-H
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chen JF, 2004, BIOMATERIALS, V25, P723, DOI 10.1016/S0142-9612(03)00566-0
   Chen JF, 2000, IND ENG CHEM RES, V39, P948, DOI 10.1021/ie990549a
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Chun MK, 2002, J CONTROL RELEASE, V81, P327, DOI 10.1016/S0168-3659(02)00078-0
   Cui JW, 2009, J COLLOID INTERF SCI, V330, P488, DOI 10.1016/j.jcis.2008.10.075
   Cui T, 2005, ADV FUNCT MATER, V15, P481, DOI 10.1002/adfm.200400327
   Dahne L, 2001, J AM CHEM SOC, V123, P5431, DOI 10.1021/ja002911e
   Dejugnat C, 2004, LANGMUIR, V20, P7265, DOI 10.1021/la049706n
   Denizot B, 1999, J COLLOID INTERF SCI, V209, P66, DOI 10.1006/jcis.1998.5850
   Ding SJ, 2009, POLYMER, V50, P1609, DOI 10.1016/j.polymer.2009.01.056
   Ding Y, 2006, BIOMACROMOLECULES, V7, P1766, DOI 10.1021/bm060085h
   Ding Y, 2004, ANGEW CHEM INT EDIT, V43, P6369, DOI 10.1002/anie.200460408
   Donath E., 1998, ANGEW CHEM INT EDIT, V37, P2201
   Dong AG, 2002, CHEM MATER, V14, P3217, DOI 10.1021/cm025577p
   Feng B, 2009, J ALLOY COMPD, V473, P356, DOI 10.1016/j.jallcom.2008.05.094
   Fernandez-Garcia M, 2004, CHEM REV, V104, P4063, DOI 10.1021/cr030032f
   Fleming MS, 2001, CHEM MATER, V13, P2210, DOI 10.1021/cm010168z
   Gallardo J, 2002, BIOMATERIALS, V23, P4277, DOI 10.1016/S0142-9612(02)00190-4
   Giersig M, 1997, ADV MATER, V9, P570, DOI 10.1002/adma.19970090712
   Graf C, 2002, LANGMUIR, V18, P524, DOI 10.1021/la011093g
   Graff A, 2001, LANGMUIR, V17, P919, DOI 10.1021/la001306m
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   Hirayama F, 1999, ADV DRUG DELIVER REV, V36, P125, DOI 10.1016/S0169-409X(98)00058-1
   Huang HY, 1999, J AM CHEM SOC, V121, P3805, DOI 10.1021/ja983610w
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Imhof A, 2001, LANGMUIR, V17, P3579, DOI 10.1021/la001604j
   Itoh Y, 2006, BIOMACROMOLECULES, V7, P2715, DOI 10.1021/bm060289y
   Ji LJ, 2006, CHEM COMMUN, P1206, DOI 10.1039/b514260a
   Jia HF, 2003, BIOTECHNOL BIOENG, V84, P406, DOI 10.1002/bit.10781
   KAWAHASHI N, 1991, J MATER CHEM, V1, P577, DOI 10.1039/jm9910100577
   KAWAHASHI N, 1991, J COLLOID INTERF SCI, V143, P103, DOI 10.1016/0021-9797(91)90442-B
   Kawahashi N, 2000, J MATER CHEM, V10, P2294, DOI 10.1039/b000788i
   Khan EA, 2009, MICROPOR MESOPOR MAT, V118, P210, DOI 10.1016/j.micromeso.2008.08.031
   Khanal A, 2007, J AM CHEM SOC, V129, P1534, DOI 10.1021/ja0684904
   Kim BJ, 2002, POLYMER, V43, P111, DOI 10.1016/S0032-3861(01)00614-0
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   Kim TH, 2005, MACROMOLECULES, V38, P6423, DOI 10.1021/ma0502708
   Kitano M, 2007, APPL CATAL A-GEN, V325, P1, DOI 10.1016/j.apcata.2007.03.013
   Klingshirn C, 2007, CHEMPHYSCHEM, V8, P782, DOI 10.1002/cphc.200700002
   Kortesuo P, 2001, J CONTROL RELEASE, V76, P227, DOI 10.1016/S0168-3659(01)00428-X
   Kosuge K, 2001, MICROPOR MESOPOR MAT, V44, P139, DOI 10.1016/S1387-1811(01)00177-9
   Kosuge K, 1995, CHEM MATER, V7, P2241, DOI 10.1021/cm00060a009
   Kozlovskaya V, 2006, CHEM MATER, V18, P328, DOI 10.1021/cm0517364
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Li GC, 2004, MATER LETT, V58, P2768, DOI 10.1016/j.matlet.2004.04.031
   Li GL, 2008, POLYMER, V49, P3436, DOI 10.1016/j.polymer.2008.06.004
   Li J, 2007, J AM CHEM SOC, V129, P15839, DOI 10.1021/ja073521w
   Li J, 2009, J COLLOID INTERF SCI, V332, P231, DOI 10.1016/j.jcis.2008.12.058
   Li WH, 2000, MACROMOLECULES, V33, P4354, DOI 10.1021/ma9920691
   Li WZ, 2005, J SOLID STATE CHEM, V178, P390, DOI 10.1016/j.jssc.2004.09.037
   Li ZZ, 2004, J CONTROL RELEASE, V98, P245, DOI 10.1016/j.jconrel.2004.04.019
   Liu T, 2006, CHEM ENG SCI, V61, P3129, DOI 10.1016/j.ces.2005.11.052
   Liu T, 2005, J POLYM SCI POL CHEM, V43, P2546, DOI 10.1002/pola.20728
   Liu T, 2006, MACROMOLECULES, V39, P6489, DOI 10.1021/ma061260p
   Lu X, 2007, CHEM ENG SCI, V62, P4880, DOI 10.1016/j.ces.2007.01.061
   Luna-Xavier JL, 2002, J COLLOID INTERF SCI, V250, P82, DOI 10.1006/jcis.2002.8310
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Marinakos SM, 2001, J PHYS CHEM B, V105, P8872, DOI 10.1021/jp010820d
   Marinakos SM, 1999, J AM CHEM SOC, V121, P8518, DOI 10.1021/ja990945k
   Mauser T, 2004, MACROMOL RAPID COMM, V25, P1781, DOI 10.1002/marc.200400331
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Nakayama H, 2003, BIOTECHNOL BIOENG, V84, P96, DOI 10.1002/bit.10755
   OCANA M, 1991, LANGMUIR, V7, P2911, DOI 10.1021/la00060a008
   Oungbho K, 1997, INT J PHARM, V156, P229, DOI 10.1016/S0378-5173(97)00201-9
   PAINE AJ, 1990, MACROMOLECULES, V23, P3104, DOI 10.1021/ma00214a012
   Pastoriza-Santos I, 2000, LANGMUIR, V16, P2731, DOI 10.1021/la991212g
   Patil GV, 2003, DRUG DEVELOP RES, V58, P219, DOI 10.1002/ddr.10157
   Perruchot C, 2001, LANGMUIR, V17, P4479, DOI 10.1021/la0102758
   Pich A, 2005, POLYMER, V46, P1077, DOI 10.1016/j.polymer.2004.11.043
   Pu HT, 2009, J COLLOID INTERF SCI, V331, P389, DOI 10.1016/j.jcis.2008.11.037
   RETHORE G, TISSUE EN C IN PRESS
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   Rhodes KH, 2000, CHEM MATER, V12, P2832, DOI 10.1021/cm000438y
   Roberts TPL, 2000, EUR J RADIOL, V34, P166, DOI 10.1016/S0720-048X(00)00197-2
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sertchook H, 2003, CHEM MATER, V15, P1690, DOI 10.1021/cm020980h
   Shchukin DG, 2003, MATER LETT, V57, P1743, DOI 10.1016/S0167-577X(02)01061-3
   Shi LJ, 2007, MACROMOLECULES, V40, P4635, DOI 10.1021/ma070443o
   Shi XY, 2006, MOL PHARMACEUT, V3, P144, DOI 10.1021/mp050078s
   Shiho H, 2000, COLLOID POLYM SCI, V278, P270, DOI 10.1007/s003960050043
   SHINODA T, 1995, CHEM LETT, P495, DOI 10.1246/cl.1995.495
   Shutava T, 2005, MACROMOLECULES, V38, P2850, DOI 10.1021/ma047629x
   Stein A, 2001, MICROPOR MESOPOR MAT, V44, P227, DOI 10.1016/S1387-1811(01)00189-5
   Sukhorukov GB, 2005, SMALL, V1, P194, DOI 10.1002/smll.200400075
   Suzuki K, 2001, J CONTROL RELEASE, V75, P183, DOI 10.1016/S0168-3659(01)00393-5
   Tabata Y, 2005, DRUG DISCOV TODAY, V10, P1639, DOI 10.1016/S1359-6446(05)03639-1
   Tabata Y., 2003, TISSUE ENG, V9, P5
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Tartaj P, 2001, ADV MATER, V13, P1620, DOI 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z
   Temuujin J, 2003, APPL CLAY SCI, V22, P187, DOI 10.1016/S0169-1317(02)00158-8
   Temuujin J, 2001, POWDER TECHNOL, V121, P259, DOI 10.1016/S0032-5910(01)00363-1
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Tiarks F, 2001, LANGMUIR, V17, P5775, DOI 10.1021/la010445g
   Tissot I, 2002, CHEM MATER, V14, P1325, DOI 10.1021/cm0112441
   Tsai MS, 2006, J NON-CRYST SOLIDS, V352, P2829, DOI 10.1016/j.jnoncrysol.2006.03.050
   UGELSTAD J, 1992, PROG POLYM SCI, V17, P87, DOI 10.1016/0079-6700(92)90017-S
   Valtchev V, 2002, CHEM MATER, V14, P956, DOI 10.1021/cm010927d
   Valtchev V, 2001, MICROPOR MESOPOR MAT, V43, P41, DOI 10.1016/S1387-1811(00)00345-0
   Wang AJ, 2007, MAT SCI ENG A-STRUCT, V460, P1, DOI 10.1016/j.msea.2007.02.043
   Wang XD, 2000, CHEM COMMUN, P2161, DOI 10.1039/b006539k
   Wang XC, 2008, MATER CHEM PHYS, V112, P319, DOI 10.1016/j.matchemphys.2008.05.035
   Wang YJ, 2008, NANO LETT, V8, P1741, DOI 10.1021/nl080877c
   Wang YJ, 2006, CHEM MATER, V18, P4089, DOI 10.1021/cm060866p
   Wang ZX, 2008, CHEM MATER, V20, P3251, DOI 10.1021/cm8001223
   Wang ZJ, 2008, COLLOID SURFACE A, V326, P29, DOI 10.1016/j.colsurfa.2008.05.010
   Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01
   WILCOX DL, 1995, MATER RES SOC SYMP P, V372, P3
   Wu W, 2007, J MAGN MAGN MATER, V311, P578, DOI 10.1016/j.jmmm.2006.08.016
   Xiao DS, 2009, POLYMER, V50, P560, DOI 10.1016/j.polymer.2008.11.022
   Xu XL, 2004, J AM CHEM SOC, V126, P7940, DOI 10.1021/ja049453k
   Yang Y, 2005, MATER CHEM PHYS, V92, P164, DOI 10.1016/j.matchemphys.2005.01.007
   YASSAR A, 1987, POLYM COMMUN, V28, P103
   Yin Y, 2001, CHEM MATER, V13, P1146, DOI 10.1021/cm000933u
   Zelikin AN, 2007, ACS NANO, V1, P63, DOI 10.1021/nn700063w
   Zhang G, 2007, ADV DRUG DELIVER REV, V59, P360, DOI 10.1016/j.addr.2007.03.018
   Zhang K, 2006, COLLOID SURFACE A, V277, P145, DOI 10.1016/j.colsurfa.2005.11.049
   Zhao QH, 2007, NANOMED-NANOTECHNOL, V3, P63, DOI 10.1016/j.nano.2006.11.007
   Zhong ZY, 2000, ADV MATER, V12, P206, DOI 10.1002/(SICI)1521-4095(200002)12:3<206::AID-ADMA206>3.0.CO;2-5
NR 138
TC 35
Z9 35
U1 3
U2 98
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1613-6810
J9 SMALL
JI Small
PD FEB 22
PY 2010
VL 6
IS 4
BP 488
EP 498
DI 10.1002/smll.200901253
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 565AJ
UT WOS:000275260100001
PM 20077516
DA 2018-10-20
ER

PT J
AU Kopecek, J
   Kopeckova, P
AF Kopecek, Jindrich
   Kopeckova, Pavla
TI HPMA copolymers: Origins, early developments, present, and future
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE N-(2-hydroxypropyl)methacrylamide; Cancer; Cleavable spacers;
   Bioconjugates; Hydrogels; Self-assembly
ID OVARIAN-CARCINOMA CELLS; ENZYMATICALLY DEGRADABLE BONDS;
   N-(2-HYDROXYPROPYL)METHACRYLAMIDE CO-POLYMERS; DRUG-DELIVERY SYSTEMS;
   DOXORUBICIN INDUCES APOPTOSIS; SYNTHETIC INFUSION SOLUTIONS;
   RECEPTOR-BINDING EPITOPES; OLIGOPEPTIDE SIDE-CHAINS; NUCLEAR-PORE
   COMPLEX; BOUND DOXORUBICIN
AB The overview covers the discovery of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers, initial studies on their synthesis, evaluation of biological properties, and explorations of their potential as carriers of biologically active compounds in general and anticancer drugs in particular. The focus is on the research in the authors' laboratory - the development of macromolecular therapeutics for the treatment of cancer and musculoskeletal diseases. In addition, the evaluation of HPMA (co)polymers as building blocks of modified and new biomaterials is presented: the utilization of semitelechelic poly(HPMA) and HPMA copolymers for the modification of biomaterial and protein surfaces and the design of hybrid block and graft HPMA copolymers that self-assemble into smart hydrogels. Finally, suggestions for the design of second-generation macromolecular therapeutics are portrayed. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kopecek, Jindrich; Kopeckova, Pavla] Univ Utah, Dept Bioengn, Dept Pharmaceut & Phamaceut Chem, Salt Lake City, UT 84112 USA.
RP Kopecek, J (reprint author), Univ Utah, Dept Bioengn, Dept Pharmaceut & Phamaceut Chem, Salt Lake City, UT 84112 USA.
EM Jindrich.kopecek@utah.edu
FU Czechoslovak Academy of Sciences; National Institutes of Health
   [CA51578, CA132831, GM069847, E13005288, TW006260]; Department of
   Defense [W81XWH-04-1-0900]; University of Utah Research Foundation
FX The research in the authors' laboratory was supported in part by the
   Czechoslovak Academy of Sciences, the National Institutes of Health
   (recently NIH grants CA51578, CA132831, GM069847, E13005288, and
   TW006260), Department of Defense grant W81XWH-04-1-0900, and the
   University of Utah Research Foundation. The HPMA journey since 1973 was
   really enjoyable thanks to our coworkers and numerous collaborators. We
   are truly indebted to all of them: their scientific contributions are
   reflected in the references.
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
   ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531
   Becer CR, 2009, ANGEW CHEM INT EDIT, V48, P4900, DOI 10.1002/anie.200900755
   Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj/leu/2402415
   BOHDANECKY M, 1974, EUR POLYM J, V10, P405, DOI 10.1016/0014-3057(74)90204-3
   Callahan J, 2006, BIOMACROMOLECULES, V7, P2347, DOI 10.1021/bm060336m
   Callahan J, 2009, BIOMACROMOLECULES, V10, P1704, DOI 10.1021/bm801514x
   CARTLIDGE S A, 1987, Journal of Controlled Release, V4, P265, DOI 10.1016/0168-3659(87)90018-6
   CARTLIDGE S A, 1987, Journal of Controlled Release, V4, P253, DOI 10.1016/0168-3659(87)90017-4
   CARTLIDGE S A, 1986, Journal of Controlled Release, V3, P55, DOI 10.1016/0168-3659(86)90064-7
   Censi R, 2009, J CONTROL RELEASE, V140, P230, DOI 10.1016/j.jconrel.2009.06.003
   Chen L, 2000, BIOCONJUGATE CHEM, V11, P734, DOI 10.1021/bc000046h
   Chen XY, 2006, NAT CHEM BIOL, V2, P351, DOI 10.1038/nchembio0706-351
   CHIU HC, 1993, BIOCONJUGATE CHEM, V4, P290, DOI 10.1021/bc00022a007
   Chivukula P, 2006, BIOMATERIALS, V27, P1140, DOI 10.1016/j.biomaterials.2005.07.020
   Choi WM, 1999, J BIOACT COMPAT POL, V14, P447, DOI 10.1177/088391159901400601
   CHYTRY V, 1978, MAKROMOL CHEM, V179, P329
   CUCHELKAR V, UNPUB
   CUCHELKAR V, 2006, POLYM DRUG DELIVERY, P155
   Cuchelkar V., 2008, MOL PHARM, V5, P696
   Cuchelkar V, 2008, MACROMOL BIOSCI, V8, P375, DOI 10.1002/mabi.200700240
   DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9
   Demoy M, 2000, J CONTROL RELEASE, V69, P185, DOI 10.1016/S0168-3659(00)00301-1
   Ding H, 2006, BIOCONJUGATE CHEM, V17, P514, DOI 10.1021/bc0523162
   Ding H, 2007, J DRUG TARGET, V15, P465, DOI 10.1080/10611860701500016
   Ding H, 2006, BIOMACROMOLECULES, V7, P3037, DOI 10.1021/bm060508f
   DROBNIK J, 1976, MAKROMOL CHEM, V177, P2833
   DROBNIK J, 1978, Patent No. 4097470
   DUNCAN R, 1984, ADV POLYM SCI, V57, P51
   DUNCAN R, 1983, MAKROMOL CHEM, V184, P1997
   DUNCAN R, 1986, BIOCHIM BIOPHYS ACTA, V880, P62, DOI 10.1016/0304-4165(86)90120-0
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   DUNCAN R, 1980, BIOCHEM BIOPH RES CO, V94, P284, DOI 10.1016/S0006-291X(80)80218-X
   DUNCAN R, 1982, BIOSCIENCE REP, V2, P1041, DOI 10.1007/BF01122173
   DUNCAN R, 1983, BIOCHIM BIOPHYS ACTA, V755, P518, DOI 10.1016/0304-4165(83)90258-1
   DUNCAN R, 1985, MAKROMOL CHEM S, V9, P3
   DUNCAN R, 1989, J CONTROL RELEASE, V9, P21
   Dvorak M, 1999, J CONTROL RELEASE, V60, P321, DOI 10.1016/S0168-3659(99)00087-5
   Ehrlich P., 1906, STUDIES IMMUNITY
   Feldherr CM, 1997, J CELL SCI, V110, P3065
   Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516
   Gao SQ, 2008, PHARM RES-DORDR, V25, P218, DOI 10.1007/s11095-007-9465-3
   Gao SQ, 2007, J CONTROL RELEASE, V117, P179, DOI 10.1016/j.jconrel.2006.10.024
   Gao SQ, 2009, MACROMOL BIOSCI, V9, P1135, DOI 10.1002/mabi.200900147
   Gao SQ, 2006, J CONTROL RELEASE, V110, P323, DOI 10.1016/j.jconrel.2005.10.004
   Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3
   GIVENTAL' N. I., 1965, ANTIBIOTKI, V10, P701
   GRIM Y, 1991, NEW POLYM MAT, V3, P49
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607
   Hongrapipat J, 2008, INT J PHARM, V351, P259, DOI 10.1016/j.ijpharm.2007.09.018
   Hongrapipat J, 2008, MOL PHARMACEUT, V5, P696, DOI 10.1021/mp800006e
   Jacob MH, 2005, BIOCHEMISTRY-US, V44, P13664, DOI 10.1021/bi051205t
   JAIN RK, 1989, JNCI-J NATL CANCER I, V81, P570, DOI 10.1093/jnci/81.8.570
   JATZKEWITZ H, 1955, Z NATURFORSCH PT B, V10, P27
   Jensen KD, 2002, BIOCONJUGATE CHEM, V13, P975, DOI 10.1021/bc025559y
   Johnson RN, 2009, BIOCONJUGATE CHEM, V20, P129, DOI 10.1021/bc800351m
   KAMEI S, 1995, PHARM RES-DORDR, V12, P663, DOI 10.1023/A:1016247206531
   Kasuya Y, 2002, PHARMACEUT RES, V19, P115, DOI 10.1023/A:1014216712820
   Kasuya Y, 2001, J CONTROL RELEASE, V74, P203, DOI 10.1016/S0168-3659(01)00318-2
   Kasuya Y, 2001, BIOORG MED CHEM LETT, V11, P2089, DOI 10.1016/S0960-894X(01)00374-2
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Kopecek J, 1974, Polim Med, V4, P109
   KOPECEK J, 1981, MAKROMOL CHEM, V182, P799
   KOPECEK J, 1973, EUR POLYM J, V9, P7, DOI 10.1016/0014-3057(73)90063-3
   Kopecek J, 1977, Polim Med, V7, P191
   KOPECEK J, 1992, J CONTROL RELEASE, V19, P121, DOI 10.1016/0168-3659(92)90070-8
   KOPECEK J, 1984, BIOMATERIALS, V5, P19, DOI 10.1016/0142-9612(84)90062-0
   Kopecek J, 2001, MACROMOL SYMP, V174, P31, DOI 10.1002/1521-3900(200109)174:1<31::AID-MASY31>3.0.CO;2-6
   KOPECEK J, 1974, EUR POLYM J, V10, P465, DOI 10.1016/0014-3057(74)90193-1
   KOPECEK J, 1987, Journal of Controlled Release, V6, P315, DOI 10.1016/0168-3659(87)90085-X
   KOPECEK J, 1973, J BIOMED MATER RES, V7, P111, DOI 10.1002/jbm.820070109
   KOPECEK J, 1973, J BIOMED MATER RES, V7, P179, DOI 10.1002/jbm.820070206
   KOPECEK J, 1981, MAKROMOL CHEM, V182, P2941
   KOPECEK J, 1977, MAKROMOL CHEM, V178, P2169
   Kopecek J., 1982, IUPAC MACROMOLECULES, P305
   KOPECEK J, 1977, 17 PRAG MICR MACR I
   Kopecek J., 1981, SYSTEMIC ASPECTS BIO, VII, P159
   KOPECEK J, 1977, S POLYM 77 VARN BULG
   Kopecek J., 1983, CONTROLLED DRUG DELI, VI, P81
   KOPECEK J, 2003, B TECH GATTEFOSSE, V96, P9
   KOPECEK J, 1977, Patent No. 4062831
   KOPECEK J, 1979, J POLYM SCI       PS, V66, P15
   KOPECEK J, 1991, Patent No. 5037883
   KOPECEK J, 1978, IUPAC INT S MACR CHE
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kopecek J, 2007, POLYM INT, V56, P1078, DOI 10.1002/pi.2253
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   KOPECKOVA P, 1994, J CONTROL RELEASE, V28, P211, DOI 10.1016/0168-3659(94)90168-6
   KRINICK NL, 1994, J BIOMAT SCI-POLYM E, V5, P303, DOI 10.1163/156856294X00040
   KRINICK NL, 1991, HDB EXPT PHARM, V100, P105
   LAANE A, 1981, COLLECT CZECH CHEM C, V46, P1466, DOI 10.1135/cccc19811466
   Laane A., 1985, MAKROMOL CHEM S, V9, P35
   Line BR, 2005, J NUCL MED, V46, P1552
   LIU J, ENDOCYTIC UPTA UNPUB
   Liu JH, 2009, MOL PHARMACEUT, V6, P959, DOI 10.1021/mp8002682
   Liu XM, 2008, PHARM RES-DORD, V25, P2910, DOI 10.1007/s11095-008-9683-3
   Loe D. W., 1996, European Journal of Cancer, V32A, P945, DOI 10.1016/0959-8049(96)00046-9
   Lu JM, 1999, INT J ONCOL, V15, P5
   Lu ZR, 2001, POLYMERIC DRUGS AND DRUG DELIVERY SYSTEMS, P1
   Lu ZR, 2000, BIOCONJUGATE CHEM, V11, P3, DOI 10.1021/bc990098a
   Lu ZR, 1998, BIOCONJUGATE CHEM, V9, P793, DOI 10.1021/bc980058r
   Lu ZR, 1999, NAT BIOTECHNOL, V17, P1101
   MAEDA H, 1992, BIOCONJUGATE CHEM, V3, P351, DOI 10.1021/bc00017a001
   Malugin A, 2007, J CONTROL RELEASE, V124, P6, DOI 10.1016/j.jconrel.2007.08.016
   Malugin A, 2006, MOL PHARMACEUT, V3, P351, DOI 10.1021/mp050065e
   Malugin A, 2004, MOL PHARMACEUT, V1, P174, DOI 10.1021/mp049967q
   Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   MATHE G, 1958, CR HEBD ACAD SCI, V246, P1626
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7
   Miller SC, 2008, PHARM RES-DORDR, V25, P2889, DOI 10.1007/s11095-008-9706-0
   Minko T, 2000, INT J CANCER, V86, P108, DOI 10.1002/(SICI)1097-0215(20000401)86:1<108::AID-IJC17>3.0.CO;2-8
   Minko T, 1999, J CONTROL RELEASE, V59, P133, DOI 10.1016/S0168-3659(98)00186-2
   Minko T, 1999, PHARMACEUT RES, V16, P986, DOI 10.1023/A:1018959029186
   Minko T, 2001, J CONTROL RELEASE, V71, P227, DOI 10.1016/S0168-3659(01)00220-6
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Nishiyama N, 2003, CANCER RES, V63, P7876
   Noguchi Y, 1998, JPN J CANCER RES, V89, P307, DOI 10.1111/j.1349-7006.1998.tb00563.x
   Nori A, 2005, ADV DRUG DELIVER REV, V57, P609, DOI 10.1016/j.addr.2004.10.006
   Nori A, 2003, BIOCONJUGATE CHEM, V14, P44, DOI 10.1021/bc0255900
   OBEREIGNER B, 1979, J POLYM SCI POL SYM, P41
   OBEREIGNER B, 1977, 17 PRAG MICR MACR I
   Omelyanenko V, 1998, J CONTROL RELEASE, V53, P25, DOI 10.1016/S0168-3659(97)00235-6
   Omelyanenko V, 1996, J DRUG TARGET, V3, P357, DOI 10.3109/10611869608996827
   Omelyanenko V, 1999, PHARMACEUT RES, V16, P1010, DOI 10.1023/A:1018975414165
   Omelyanenko V, 1998, INT J CANCER, V75, P600, DOI 10.1002/(SICI)1097-0215(19980209)75:4<600::AID-IJC18>3.0.CO;2-C
   Oupicky D, 1999, J BIOACT COMPAT POL, V14, P213, DOI 10.1177/088391159901400302
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   PALUSKA E, 1980, FOLIA BIOL-PRAGUE, V26, P304
   PALUSKA E, 1986, FOLIA BIOL-PRAGUE, V32, P91
   Pan HZ, 2008, MOL PHARMACEUT, V5, P548, DOI 10.1021/mp800003u
   Pan HZ, 2008, MACROMOL BIOSCI, V8, P599, DOI 10.1002/mabi.200700338
   Pan HZ, 2006, J DRUG TARGET, V14, P425, DOI 10.1080/10611860600834219
   Panarin E.F., 1968, KHIM PHARM ZHUR, V2, P28
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc01-06-0308
   Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798
   Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289
   Peterson CM, 1996, CANCER RES, V56, P3980
   Putnam D, 1995, ADV POLYM SCI, V122, P55
   Rademaker-Lakhai JM, 2004, CLIN CANCER RES, V10, P3386, DOI 10.1158/1078-0432.CCR-03-0315
   Radu LC, 2009, MACROMOL BIOSCI, V9, P36, DOI 10.1002/mabi.200800193
   Radu-Wu LC, 2009, BIOMACROMOLECULES, V10, P2319, DOI 10.1021/bm9005084
   Rebuffat A, 2001, NAT BIOTECHNOL, V19, P1155, DOI 10.1038/nbt1201-1155
   REJMANOVA P, 1981, MAKROMOL CHEM, V182, P1899
   REJMANOVA P, 1985, BIOMATERIALS, V6, P45, DOI 10.1016/0142-9612(85)90037-7
   REJMANOVA P, 1977, MAKROMOL CHEM, V178, P2159
   REJMANOVA P, 1983, MAKROMOL CHEM, V184, P2009
   RIHOVA B, 1986, J CHROMATOGR, V376, P221, DOI 10.1016/S0378-4347(00)80839-7
   RIHOVA B, 1988, CLIN IMMUNOL IMMUNOP, V46, P100
   Rihova B, 2002, ADV DRUG DELIVER REV, V54, P653
   Rihova B, 2001, MACROMOL SYMP, V172, P21, DOI 10.1002/1521-3900(200107)172:1<21::AID-MASY21>3.0.CO;2-C
   RIHOVA B, 1985, Journal of Controlled Release, V2, P289
   RIHOVA B, 1984, BIOMATERIALS, V5, P143, DOI 10.1016/0142-9612(84)90048-6
   RIHOVA B, 1983, FOLIA MICROBIOL, V28, P217, DOI 10.1007/BF02884085
   RIHOVA B, 1993, J CONTROL RELEASE, V25, P71, DOI 10.1016/0168-3659(93)90096-N
   Rihova B., 1985, MAKROMOL CHEM S, V9, P13
   Rihova B, 2009, TRENDS BIOTECHNOL, V27, P11, DOI 10.1016/j.tibtech.2008.10.006
   RINGSDORF H, 1975, J POLYM SCI POL SYM, P135
   Sakuma S, 2002, J BIOACT COMPAT POL, V17, P305, DOI 10.1106/088391102029557
   Sakuma S, 2001, J CONTROL RELEASE, V75, P365, DOI 10.1016/S0168-3659(01)00405-9
   Scales CW, 2005, BIOMACROMOLECULES, V6, P1846, DOI 10.1021/bm0503017
   Schoemaker NE, 2002, BRIT J CANCER, V87, P608, DOI 10.1038/sj.bjc.6600516
   Segal E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005233
   Seymour LW, 2009, INT J ONCOL, V34, P1629, DOI 10.3892/ijo_00000293
   Seymour LW, 2002, J CLIN ONCOL, V20, P1668, DOI 10.1200/JCO.20.6.1668
   SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106
   Shiah JG, 2001, J CONTROL RELEASE, V74, P249, DOI 10.1016/S0168-3659(01)00325-X
   Shiah JG, 2001, EUR J CANCER, V37, P131, DOI 10.1016/S0959-8049(00)00374-9
   Shiah JG, 1999, J CONTROL RELEASE, V61, P145, DOI 10.1016/S0168-3659(99)00113-3
   Shiah JG, 1998, DRUG DELIV, V5, P119, DOI 10.3109/10717549809031387
   Shiah JG, 1997, J PHYS CHEM B, V101, P6803, DOI 10.1021/jp970360h
   Shiah JG, 2000, CLIN CANCER RES, V6, P1008
   SHUMrKHINA K. I., 1966, ANTIBIOTIKI, V11, P767
   SIMECKOVA J, 1986, J BIOACT COMPAT POLY, V1, P20
   SOLOVSKIJ MV, 1983, BIOMATERIALS, V4, P44, DOI 10.1016/0142-9612(83)90069-8
   SPRINCL L, 1973, J BIOMED MATER RES, V7, P123, DOI 10.1002/jbm.820070110
   Sprincl L, 1971, J Biomed Mater Res, V5, P197, DOI 10.1002/jbm.820050307
   SPRINCL L, 1976, J BIOMED MATER RES, V10, P953, DOI 10.1002/jbm.820100612
   SPRINCL L, 1971, Journal of Biomedical Materials Research, V5, P447, DOI 10.1002/jbm.820050503
   Stastny M, 2002, J CONTROL RELEASE, V81, P101, DOI 10.1016/S0168-3659(02)00047-0
   SUBR V, 1990, Journal of Biomaterials Science Polymer Edition, V1, P261
   Subr V, 2002, J BIOACT COMPAT POL, V17, P105, DOI 10.1106/088391102024442
   SUBR V, 1988, J CONTROL RELEASE, V8, P133, DOI 10.1016/0168-3659(88)90039-9
   Tabata Y, 1997, DRUG DELIV, V4, P213, DOI 10.3109/10717549709051895
   TAKAKURA Y, 1990, PHARMACEUT RES, V7, P339, DOI 10.1023/A:1015807119753
   Tang AJ, 2003, PHARMACEUT RES, V20, P360, DOI 10.1023/A:1022639701388
   Teodorescu M, 1999, MACROMOLECULES, V32, P4826, DOI 10.1021/ma990175x
   Terwogt JMM, 2001, ANTI-CANCER DRUG, V12, P315
   TEW KD, 1994, CANCER RES, V54, P4313
   Thomson AH, 1999, BRIT J CANCER, V81, P99, DOI 10.1038/sj.bjc.6690657
   Tijerina M, 2003, PHOTOCHEM PHOTOBIOL, V77, P645, DOI 10.1562/0031-8655(2003)077<0645:MOCIHO>2.0.CO;2
   Tijerina M, 2003, PHARMACEUT RES, V20, P728, DOI 10.1023/A:1023425300829
   ULBRICH K, 1981, MAKROMOL CHEM, V182, P1917
   ULBRICH K, 1995, J CONTROL RELEASE, V34, P155, DOI 10.1016/0168-3659(95)00004-R
   Ulbrich K, 2000, J BIOACT COMPAT POL, V15, P4, DOI 10.1106/3FRB-DC5H-VAAD-ARPX
   ULBRICH K, 1982, BIOMATERIALS, V3, P150, DOI 10.1016/0142-9612(82)90004-7
   ULBRICH K, 1974, J BIOMED MATER RES, V8, P155, DOI 10.1002/jbm.820080205
   ULBRICH K, 1986, MAKROMOL CHEM, V187, P1131
   ULBRICH K, 1980, BIOMATERIALS, V1, P199, DOI 10.1016/0142-9612(80)90017-4
   ULBRICH K, 1987, MAKROMOL CHEM, V188, P1261
   Vasey PA, 1999, CLIN CANCER RES, V5, P83
   Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075
   VOLDRICH Z, 1975, J BIOMED MATER RES, V9, P675, DOI 10.1002/jbm.820090612
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang D, 2004, PHARM RES, V21, P1741, DOI 10.1023/B:PHAM.0000045232.18134.e9
   Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j
   Wang D, 2007, BIOCONJUGATE CHEM, V18, P1375, DOI 10.1021/bc7002132
   Wang D, 2006, MOL PHARMACEUT, V3, P717, DOI 10.1021/mp0600539
   WEDGE SR, 1991, BRIT J CANCER, V63, P546, DOI 10.1038/bjc.1991.128
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WICHTERLE O, 1968, Patent No. 3408429
   Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775
   Wroblewski S, 2000, J BIOMED MATER RES, V51, P329, DOI 10.1002/1097-4636(20000905)51:3<329::AID-JBM6>3.0.CO;2-0
   Wroblewski S, 2001, J DRUG TARGET, V9, P85, DOI 10.3109/10611860108997920
   WU K, DRUG FREE MACR UNPUB
   Wu K, 2008, MACROMOL CHEM PHYS, V209, P467, DOI 10.1002/macp.200700486
   Yang J, 2008, BIOMACROMOLECULES, V9, P510, DOI 10.1021/brn701001f
   Yang JY, 2006, BIOMACROMOLECULES, V7, P1187, DOI 10.1021/bm051002k
   YEH PY, 1994, J POLYM SCI POL CHEM, V32, P1627, DOI 10.1002/pola.1994.080320904
   Yuan WW, 2008, J AM CHEM SOC, V130, P15760, DOI 10.1021/ja805634x
NR 223
TC 312
Z9 316
U1 10
U2 157
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD FEB 17
PY 2010
VL 62
IS 2
BP 122
EP 149
DI 10.1016/j.addr.2009.10.004
PG 28
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 569ES
UT WOS:000275579900002
PM 19919846
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Uemura, M
   Refaat, MM
   Shinoyama, M
   Hayashi, H
   Hashimoto, N
   Takahashi, J
AF Uemura, Makoto
   Refaat, Mohamed M.
   Shinoyama, Mizuya
   Hayashi, Hideki
   Hashimoto, Nobuo
   Takahashi, Jun
TI Matrigel Supports Survival and Neuronal Differentiation of Grafted
   Embryonic Stem Cell-Derived Neural Precursor Cells
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Article
DE extracellular matrix; transplantation; inflammation; embryonic stem
   cells
ID EXTRACELLULAR-MATRIX; DOPAMINERGIC-NEURONS; PROGENITOR CELLS; ES CELLS;
   PARKINSONS-DISEASE; BASEMENT-MEMBRANE; IN-VIVO; TISSUE; TRANSPLANTATION;
   RATS
AB Cell replacement therapy holds great promise as a means of treating neurological disorders, including Parkinson's disease. However, one of the major obstacles to the success of this treatment is the low survival rate of grafted cells, which probably results from mechanical damage, acute inflammation, and immunological rejection. To overcome this problem, we investigated the effect of different types of extracellular matrix (ECM) on the survival and differentiation of embryonic stem (ES) cell-derived neural precursor cells (NPCs). We tested materials from natural sources, including collagen, ornithine/laminin, and growth factor-reduced Matrigel (gfrMG), as well as the synthetic biomaterial PuraMatrix, which consists of self-assembling polypeptides. GfrMG efficiently supported cell survival, migration, and neurite outgrowth in vitro and promoted proliferation of grafted cells in vivo, resulting in larger graft volume and an increase in the number of TH-positive dopaminergic neurons in the graft. GfrMG did not induce dopaminergic differentiation directly; rather, it reduced the invasion of pan-leukocytic CD45-positive cells into the graft. Insofar as the inflammatory or immune response in the host brain inhibits neuronal differentiation of grafted NPCs, gfrMG may increase the number of TH-positive cells by suppressing this effect. Thus, gfrMG appears to provide a suitable scaffold that supports survival and differentiation of NPCs. However, because it is derived from mouse sarcomas, a human-derived matrix or synthetic biomaterial must be developed for clinical applications. (C) 2009 Wiley-Liss, Inc.
C1 [Takahashi, Jun] Kyoto Univ, Inst Frontier Med Sci, Dept Biol Repair, Sakyo Ku, Kyoto 6068507, Japan.
   [Refaat, Mohamed M.; Shinoyama, Mizuya; Hayashi, Hideki; Hashimoto, Nobuo; Takahashi, Jun] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan.
   [Refaat, Mohamed M.] Kanazawa Univ Hosp, Dept Neurosurg, Kanazawa, Ishikawa, Japan.
RP Takahashi, J (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Biol Repair, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.
EM jbtaka@frontier.kyoto-u.ac.jp
FU JSPS; Kobe Cluster MEXT; MEXT of Japan; Takeda Science Foundation
FX Contract grant sponsor: JSPS Grant-in-Aid for Scientific Research;
   Contract grant sponsor: Kobe Cluster MEXT; Contract grant sponsor:
   Leading Project from the MEXT of Japan; Contract grant sponsor: Takeda
   Science Foundation.
CR Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4
   Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711
   CAO F, 2007, J TISSUE EN IN PRESS
   Emgard M, 2003, J NEUROCHEM, V86, P1223, DOI 10.1046/j.1471-4159.2003.01931.x
   Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119
   HUBERT T, 2008, CELL MOL LIFE SCI
   IDEGUCHI M, 2008, J NEUROSCI IN PRESS
   Kalluri HSG, 2007, EUR J NEUROSCI, V25, P1041, DOI 10.1111/j.1460-9568.2007.05336.x
   Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0
   Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Kurosaka K, 2003, J IMMUNOL, V171, P4672, DOI 10.4049/jimmunol.171.9.4672
   Kutschka I, 2006, CIRCULATION, V114, P1167
   Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711
   Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064
   Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MA W, 2008, BMC DEV BIOL, V8
   Matsuura R, 2006, STEM CELLS, V24, P624, DOI 10.1634/stemcells.2005-0344
   Mirza B, 2004, BRAIN RES BULL, V63, P105, DOI 10.1016/j.brainresbull.2004.01.009
   Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417
   Nishino H, 2000, EXP NEUROL, V164, P209, DOI 10.1006/exnr.2000.7426
   Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296
   Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Patino Maria G, 2002, Implant Dent, V11, P280, DOI 10.1097/00008505-200207000-00014
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514
   Sortwell CE, 2000, EXP NEUROL, V165, P268, DOI 10.1006/exnr.2000.7476
   Takenaga M, 2007, CELL TRANSPLANT, V16, P57, DOI 10.3727/000000007783464434
   Tisay KT, 1999, J NEUROSCI, V19, P9890
   Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103
   Weinand C, 2007, TISSUE ENG, V13, P757, DOI 10.1089/ten.2006.0083
   Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50
   Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   YOSHINO JE, 1990, GLIA, V3, P315, DOI 10.1002/glia.440030502
   Zawada WM, 1998, BRAIN RES, V786, P96, DOI 10.1016/S0006-8993(97)01408-X
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
NR 42
TC 82
Z9 84
U1 1
U2 21
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0360-4012
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD FEB 15
PY 2010
VL 88
IS 3
BP 542
EP 551
DI 10.1002/jnr.22223
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 552FU
UT WOS:000274274700009
PM 19774667
DA 2018-10-20
ER

PT J
AU Sitarz, M
   Bulat, K
   Szumera, M
AF Sitarz, Maciej
   Bulat, Katarzyna
   Szumera, Magdalena
TI Aluminium influence on the crystallization and bioactivity of
   silico-phosphate glasses from NaCaPO4-SiO2 system
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Bioglass; Direct crystallization; Biomaterials; Glass-ceramic
ID IN-VITRO; PHASE
AB Silico-phosphate glasses of XCaPO4-SiO2 (X - Na+ and/or K+) system have been the subject of the presented investigations. One of the most important problems is to ensure proper biomaterial mechanical resistance. This can be achieved by introduction of proper additions, usually Al3+, into glass structure or/and partial glass devitrification. To design direct crystallization process properly it is necessary to know the texture and structure of the glassy precursor. Microscopic investigations have made it possible to find out that in all the glasses studied liquation takes place. A small addition of Al3+ influences homogeneity of the glass texture. It has been established (EDX investigations) that addition of aluminium dramatically changes the composition of the matrix and inclusions. Spectroscopic investigations (FTIR, NMR) have shown that both, the matrix and the inclusions exhibit domain composition whose structure is close to that of the corresponding crystalline phases. Domains can be considered as the specific "crystallization nuclei" which have a decisive impact on the process of directed glass crystallization. Based on DTA examinations it has been found out that crystallization of the glasses from XCaPO4-SiO2 system is a multistep process while the crystallization of glasses from XCaPO4-SiO2-AlPO4 system is a one step process. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Sitarz, Maciej; Bulat, Katarzyna; Szumera, Magdalena] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
RP Sitarz, M (reprint author), AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
EM msitarz@agh.edu.pl
RI Sitarz, Maciej/Q-7487-2016
OI Sitarz, Maciej/0000-0002-8339-2710
FU Polish Ministry of Science and Higher Education [N N507393135]
FX This work was supported by Polish Ministry of Science and Higher
   Education under Grant No. N N507393135.
CR GORLICH E, 1977, REV INT HAUTES TEMP, V14, P201
   Handke M, 2003, J MOL STRUCT, V651, P39, DOI 10.1016/S0022-2860(03)00099-1
   Hench L.L., 1972, J BIOMED MATER RES, V5, P117
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Kokubo T., 1992, P INT C GLASS MADR, V7, P119
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   LI PJ, 1994, J NON-CRYST SOLIDS, V168, P281, DOI 10.1016/0022-3093(94)90340-9
   Oliveira JM, 2002, BIOMATERIALS, V23, P371, DOI 10.1016/S0142-9612(01)00115-6
   PETIL O, 1996, J BIOMED MATER RES, V30, P509
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   Rawlings Rees D., 1993, Clinical Materials, V14, P155, DOI 10.1016/0267-6605(93)90038-9
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sitarz M, 2008, J THERM ANAL CALORIM, V91, P255, DOI 10.1007/s10973-007-8374-3
   Sitarz M, 2005, J MOL STRUCT, V744, P621, DOI 10.1016/j.molstruc.2004.12.050
   Sitarz M, 1999, J MOL STRUCT, V511, P281, DOI 10.1016/S0022-2860(99)00169-6
   SITARZ M, 1999, J MOL STRUCT, V512, P281
   Sitarz M, 2008, J MOL STRUCT, V887, P237, DOI 10.1016/j.molstruc.2007.12.030
   Sitarz M, 2008, J MOL STRUCT, V887, P229, DOI 10.1016/j.molstruc.2008.02.002
NR 20
TC 8
Z9 8
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD FEB 15
PY 2010
VL 356
IS 4-5
BP 224
EP 231
DI 10.1016/j.jnoncrysol.2009.11.012
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 565MA
UT WOS:000275296000006
DA 2018-10-20
ER

PT J
AU Huether, R
   Liu, ZJ
   Xu, H
   Wang, BC
   Pletnev, VZ
   Mao, QL
   Duax, WL
   Umland, TC
AF Huether, Robert
   Liu, Zhi-Jie
   Xu, Hao
   Wang, Bi-Cheng
   Pletnev, Vladimir Z.
   Mao, Qilong
   Duax, William L.
   Umland, Timothy C.
TI Sequence fingerprint and structural analysis of the SCOR enzyme A3DFK9
   from Clostridium thermocellum
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE SCOR; SDR; cofactor binding; proton transfer; fingerprint variation;
   A3DFK9; Cthe_1510
ID SHORT-CHAIN DEHYDROGENASES/REDUCTASES; ACTIVE-SITE; SOFTWARE; SDR;
   CRYSTALLOGRAPHY; RECOGNITION; SUPPLEMENT; CATALYSIS; ALIGNMENT;
   REDUCTASE
AB We have identified a highly conserved fingerprint of 40 residues in the TGYK subfamily of the short-chain oxidoreductase enzymes. The TGYK subfamily is defined by the presence of an N-terminal TGxxxGxG motif and a catalytic YxxxK motif. This subfamily contains more than 12,000 members, with individual members displaying unique substrate specificities. The 40 fingerprint residues are critical to catalysis, cofactor binding, protein folding, and oligomerization but are substrate independent. Their conservation provides critical insight into evolution of the folding and function of TGYK enzymes. Substrate specificity is determined by distinct combinations of residues in three flexible loops that make up the substrate-binding pocket. Here, we report the structure determinations of the TGYK enzyme A3DFK9 from Clostridium themocellum in its apo form and with bound NAD+ cofactor. The function of this protein is unknown, but our analysis of the substrate-binding loops putatively identifies A3DFK9 as a carbohydrate or polyalcohol metabolizing enzyme. C. thermocellum has potential commercial applications because of its ability to convert biomaterial into ethanol. A3DFK9 contains 31 of the 40 TGYK subfamily fingerprint residues. The most significant variations are the substitution of a cysteine (Cys84) for a highly conserved glycine within a characteristic VNNAG motif, and the substitution of a glycine (Gly106) for a highly conserved asparagine residue at a helical kink. Both of these variations occur at positions typically participating in the formation of a catalytically important proton transfer network. An alternate means of stabilizing this proton wire was observed in the A3DFK9 crystal structures.
C1 [Pletnev, Vladimir Z.; Mao, Qilong; Duax, William L.; Umland, Timothy C.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA.
   [Huether, Robert; Duax, William L.; Umland, Timothy C.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA.
   [Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Xu, Hao; Wang, Bi-Cheng] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.
   [Pletnev, Vladimir Z.] Russian Acad Sci, Inst Bioorgan Chem, Moscow 117997, Russia.
RP Duax, WL (reprint author), Hauptman Woodward Med Res Inst, 700 Ellicott St, Buffalo, NY 14203 USA.
EM duax@hwi.buffalo.edu; umland@hwi.buffalo.edu
RI Pletnev, Vladimir/Q-6151-2016; Liu, Zhi-Jie/A-3946-2012; Huether,
   Robert/E-9638-2012
OI Liu, Zhi-Jie/0000-0001-7279-2893; Huether, Robert/0000-0001-7077-7470;
   Umland, Timothy/0000-0002-0772-9510
FU NIH [DK026546]
FX Grant sponsor: NIH; Grant number: DK026546.
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   DeLano WL, 2002, PYMOL MOL GRAPHICS S
   Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005
   Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488
   Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925
   Duax WL, 2005, ANN NY ACAD SCI, V1061, P135, DOI 10.1196/annals.1336.015
   Duax WL, 2005, PROTEINS, V61, P900, DOI 10.1002/prot.20687
   Duax WL, 2003, PROTEINS, V53, P931, DOI 10.1002/prot.10512
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200
   Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149
   Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200
   Haapalainen AM, 2003, STRUCTURE, V11, P87, DOI 10.1016/S0969-2126(02)00931-0
   Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507
   Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977
   JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001
   Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0
   McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170
   Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422
   Obeyesekere VR, 1998, BIOCHEM BIOPH RES CO, V250, P469, DOI 10.1006/bbrc.1998.9313
   Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pletnev VZ, 2005, J STEROID BIOCHEM, V94, P327, DOI 10.1016/j.jsbmb.2004.12.031
   Pletnev VZ, 2004, PROTEINS, V57, P294, DOI 10.1002/prot.20205
   Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008
   Reading PC, 2003, J EXP MED, V197, P1269, DOI 10.1084/jem.20022201
   Sundlov JA, 2006, ACTA CRYSTALLOGR D, V62, P734, DOI 10.1107/S0907444906015824
   Tanaka N, 2001, CURR ORG CHEM, V5, P89, DOI 10.2174/1385272013375751
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Zhou HP, 1999, BIOCHEM BIOPH RES CO, V257, P414, DOI 10.1006/bbrc.1999.0356
   1999, EUR J BIOCH, V264, P610
   1994, ACTA CRYSTALLOGR D, V50, P760
NR 40
TC 1
Z9 1
U1 1
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-3585
J9 PROTEINS
JI Proteins
PD FEB 15
PY 2010
VL 78
IS 3
BP 603
EP 613
DI 10.1002/prot.22584
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 547XR
UT WOS:000273923700009
PM 19774618
DA 2018-10-20
ER

PT J
AU Ding, M
   Cheng, LM
   Bollen, P
   Schwarz, P
   Overgaard, S
AF Ding, Ming
   Cheng, Liming
   Bollen, Peter
   Schwarz, Peter
   Overgaard, Soren
TI Glucocorticoid Induced Osteopenia in Cancellous Bone of Sheep Validation
   of Large Animal Model for Spine Fusion and Biomaterial Research
SO SPINE
LA English
DT Article
DE glucocorticoid induced osteoporosis; spine fusion; microarchitecture;
   mechanical property; biomarker; sheep model
ID FRACTURE TREATMENT; TRABECULAR BONE; ILIAC CREST; OSTEOPOROSIS; AGE;
   MICROARCHITECTURE; OVARIECTOMY; INHIBITION; METABOLISM; CALCANEUS
AB Study Design. Glucocorticoid with low calcium and phosphorus intake induces osteopenia in cancellous bone of sheep.
   Objective. To validate a large animal model for spine fusion and biomaterial research.
   Summary of Background Data. A variety of ovariectomized animals has been used to study osteoporosis. Most experimental spine fusions were based on normal animals, and there is a great need for suitable large animal models with adequate bone size that closely resemble osteoporosis in humans.
   Methods. Eighteen female skeletal mature sheep were randomly allocated into 3 groups, 6 each. Group 1 (GC-1) received prednisolone (GC) treatment (0.60 mg/kg/day, 5 times weekly) for 7 months. Group 2 (GC-2) received the same treatment as GC-1 for 7 months followed by 3 months without treatment. Group 3 was left untreated and served as the controls. All sheep received restricted diet with low calcium and phosphorus during experiment. After killing the animals, cancellous bone specimens from the vertebra, femurs, and tibias were micro-CT scanned and tested mechanically. Serum biomarkers were determined.
   Results. In lumbar vertebra, the GC treatment resulted in significant decrease of cancellous bone volume fraction and trabecular thickness, and bone strength. However, the microarchitecture and bone strength of GC-2 recovered to a similar level of the controls. A similar trend of microarchitectural changes was also observed in the distal femur and proximal tibia of both GC treated sheep. The bone formation marker serum-osteocalcin was largely reduced in GC-1 compared to the controls, but recovered with a rebound increase at month 10 in GC-2.
   Conclusion. The current investigation demonstrates that the changes in microarchitecture and mechanical properties were comparable with those observed in humans after long-term GC treatment. A prolonged GC treatment is needed for a long-term observation to keep osteopenic bone. This model resembles long- term glucocorticoid treated osteoporotic model, and is useful in preclinical studies.
C1 [Ding, Ming; Cheng, Liming; Overgaard, Soren] Univ So Denmark, Orthopaed Res Lab, Dept Orthopaed O, Odense Univ Hosp,Inst Clin Res, DK-5000 Odense C, Denmark.
   [Schwarz, Peter] Glostrup Univ Hosp, Dept Geriatr, Res Ctr Ageing & Osteoporosis, Glostrup, Denmark.
   [Bollen, Peter] Univ So Denmark, Biomed Lab, DK-5000 Odense, Denmark.
RP Ding, M (reprint author), Univ So Denmark, Orthopaed Res Lab, Dept Orthopaed O, Odense Univ Hosp,Inst Clin Res, JB Winsloewsvej 15,3rd floor, DK-5000 Odense C, Denmark.
EM ming.ding@ouh.regionsyddanmark.dk
OI Ding, Ming/0000-0002-6610-8079; Schwarz, Peter/0000-0002-0483-8594;
   Overgaard, Soren/0000-0001-6829-4787; Bollen, Peter/0000-0003-3796-1609
CR Amling M, 1996, J BONE MINER RES, V11, P36, DOI 10.1002/jbmr.5650110107
   Augat P, 2003, J BIOMED MATER RES A, V66A, P457, DOI 10.1002/jbm.a.10601
   CHAVASSIEUX P, 1993, OSTEOPOROSIS INT, V3, P97, DOI 10.1007/BF01623380
   Ding M, 2003, CALCIFIED TISSUE INT, V72, P737, DOI 10.1007/s00223-002-2066-6
   Ding M, 2006, CALCIFIED TISSUE INT, V78, P113, DOI 10.1007/s00223-005-0028-5
   Ding M, 1997, J BONE JOINT SURG BR, V79B, P995, DOI 10.1302/0301-620X.79B6.7538
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Ding M, 2002, J ORTHOPAED RES, V20, P615, DOI 10.1016/S0736-0266(01)00132-2
   Egermann M, 2008, LAB ANIM-UK, V42, P453, DOI 10.1258/la.2007.007001
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7
   *FOOD DRUG ADM, 1994, GUID PRECL CLIN EV A
   Geusens P, 1996, CALCIFIED TISSUE INT, V59, P315
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5
   LAAN RFJM, 1993, CALCIFIED TISSUE INT, V52, P5, DOI 10.1007/BF00675619
   Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P480, DOI 10.1007/s001980200058
   Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   MOSEKILDE L, 1987, BONE, V8, P79, DOI 10.1016/8756-3282(87)90074-3
   OCONNELL SL, 1993, CALCIFIED TISSUE INT, V53, P117, DOI 10.1007/BF01321889
   Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0
   Ross PD, 1996, ARCH INTERN MED, V156, P1399, DOI 10.1001/archinte.156.13.1399
   Schorlemmer S, 2005, BONE, V37, P491, DOI 10.1016/j.bone.2005.05.002
   Schorlemmer S, 2003, J BONE MINER RES, V18, P2010, DOI 10.1359/jbmr.2003.18.11.2010
   Sigrist IM, 2007, J BONE MINER METAB, V25, P28, DOI 10.1007/s00774-006-0724-x
   Thorndike E. A., 1998, Frontiers in Bioscience, V3, pC17
   Turner A.S., 1995, BONE, V17, P395
   Zarrinkalam MR, 2009, EUR SPINE J, V18, P244, DOI 10.1007/s00586-008-0813-8
NR 31
TC 35
Z9 36
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD FEB 15
PY 2010
VL 35
IS 4
BP 363
EP 370
DI 10.1097/BRS.0b013e3181b8e0ff
PG 8
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 565VS
UT WOS:000275323800001
PM 20110841
DA 2018-10-20
ER

PT J
AU Xie, Y
   Zhou, J
   Jiang, SY
AF Xie, Yun
   Zhou, Jian
   Jiang, Shaoyi
TI Parallel tempering Monte Carlo simulations of lysozyme orientation on
   charged surfaces
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article
DE biochemistry; biomedical materials; biosensors; electrostatics;
   molecular biophysics; molecular orientation; Monte Carlo methods;
   proteins
ID SELF-ASSEMBLED MONOLAYERS; OF-STATES SIMULATIONS; PROTEIN ADSORPTION;
   MOLECULAR SIMULATION; WATER INTERFACE; ION-EXCHANGE; BINDING
   ORIENTATION; NEUTRON REFLECTION; ALPHA-LACTALBUMIN; SOLID-SURFACES
AB In this work, the parallel tempering Monte Carlo (PTMC) algorithm is applied to accurately and efficiently identify the global-minimum-energy orientation of a protein adsorbed on a surface in a single simulation. When applying the PTMC method to simulate lysozyme orientation on charged surfaces, it is found that lysozyme could easily be adsorbed on negatively charged surfaces with "side-on" and "back-on" orientations. When driven by dominant electrostatic interactions, lysozyme tends to be adsorbed on negatively charged surfaces with the side-on orientation for which the active site of lysozyme faces sideways. The side-on orientation agrees well with the experimental results where the adsorbed orientation of lysozyme is determined by electrostatic interactions. As the contribution from van der Waals interactions gradually dominates, the back-on orientation becomes the preferred one. For this orientation, the active site of lysozyme faces outward, which conforms to the experimental results where the orientation of adsorbed lysozyme is co-determined by electrostatic interactions and van der Waals interactions. It is also found that despite of its net positive charge, lysozyme could be adsorbed on positively charged surfaces with both "end-on" and back-on orientations owing to the nonuniform charge distribution over lysozyme surface and the screening effect from ions in solution. The PTMC simulation method provides a way to determine the preferred orientation of proteins on surfaces for biosensor and biomaterial applications.
C1 [Xie, Yun; Zhou, Jian] S China Univ Technol, Sch Chem & Chem Engn, Guangdong Prov Key Lab Green Chem Prod Technol, Guangzhou 510640, Guangdong, Peoples R China.
   [Jiang, Shaoyi] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Zhou, J (reprint author), S China Univ Technol, Sch Chem & Chem Engn, Guangdong Prov Key Lab Green Chem Prod Technol, Guangzhou 510640, Guangdong, Peoples R China.
EM jianzhou@scut.edu.cn
RI Zhou, Jian/E-4504-2011; Xie, Yun/N-4746-2017
OI Zhou, Jian/0000-0002-3033-7785; Xie, Yun/0000-0002-0525-8540
FU Program for New Century Excellent Talents in University [NCET-07-0313];
   National Natural Science Foundation of China [20706019, 20876052]
FX This work is supported by the Program for New Century Excellent Talents
   in University (Grant No. NCET-07-0313) and the National Natural Science
   Foundation of China (Grant Nos. 20706019 and 20876052). The
   computational resources for this project are provided by SCUTGrid at
   South China University of Technology. We thank Michael Hague and Dr.
   Andrew Au for proofreading of the manuscript.
CR Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   BERG BA, 1991, PHYS LETT B, V267, P249, DOI 10.1016/0370-2693(91)91256-U
   Brash J. L., 1995, ACS SYM SER, V602, P1
   Castells V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031912
   Chen SF, 2003, LANGMUIR, V19, P2859, DOI 10.1021/la026498v
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Daly SM, 2003, LANGMUIR, V19, P3848, DOI 10.1021/la026690x
   Deitcher RW, 2009, BIOTECHNOL BIOENG, V102, P1416, DOI 10.1002/bit.22171
   Dismer F, 2008, J CHROMATOGR A, V1194, P11, DOI 10.1016/j.chroma.2007.12.085
   Dismer F, 2007, J CHROMATOGR A, V1149, P312, DOI 10.1016/j.chroma.2007.03.074
   Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h
   Falkenhagen D, 1999, ARTIF ORGANS, V23, P81, DOI 10.1046/j.1525-1594.1999.06292.x
   Faller R, 2002, J CHEM PHYS, V116, P5419, DOI 10.1063/1.1456504
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510
   GALISTEO F, 1995, COLLOID SURFACE B, V4, P389, DOI 10.1016/0927-7765(94)01182-5
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   HAYNES CA, 1994, J COLLOID INTERF SCI, V164, P394, DOI 10.1006/jcis.1994.1182
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim DT, 2002, LANGMUIR, V18, P5841, DOI 10.1021/la0256331
   Knotts TA, 2005, PROTEINS, V61, P385, DOI 10.1002/prot.20581
   Knotts TA, 2008, BIOPHYS J, V94, P4473, DOI 10.1529/biophysj.107.123158
   Kofke DA, 2002, J CHEM PHYS, V117, P6911, DOI 10.1063/1.1507776
   Kone A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1917749
   Lenhoff AM, 2008, LANGMUIR, V24, P5991, DOI 10.1021/la8004163
   Lewus RK, 1998, IND ENG CHEM RES, V37, P1079, DOI 10.1021/ie970506z
   Liwo A, 1997, J COMPUT CHEM, V18, P849, DOI 10.1002/(SICI)1096-987X(199705)18:7<849::AID-JCC1>3.0.CO;2-R
   Lu JR, 2007, CURR OPIN COLLOID IN, V12, P9, DOI 10.1016/j.cocis.2007.02.001
   Luo QL, 1998, J COLLOID INTERF SCI, V200, P104, DOI 10.1006/jcis.1997.5364
   LYUBARTSEV AP, 1992, J CHEM PHYS, V96, P1776, DOI 10.1063/1.462133
   Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3
   Nada H, 2008, J PHYS CHEM B, V112, P7111, DOI 10.1021/jp711977g
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Oberholzer MR, 1999, LANGMUIR, V15, P3905, DOI 10.1021/la981199k
   Ortiz V, 2003, CHEM PHYS LETT, V368, P452, DOI 10.1016/S0009-2614(02)01897-3
   Raffaini G, 2004, LANGMUIR, V20, P3371, DOI 10.1021/la0357716
   Rathore N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1831273
   Rathore N, 2003, BIOPHYS J, V85, P3963, DOI 10.1016/S0006-3495(03)74810-3
   Rathore N, 2003, J CHEM PHYS, V118, P4285, DOI 10.1063/1.1542598
   Rathore N, 2002, J CHEM PHYS, V116, P7225, DOI 10.1063/1.1463059
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Raz SR, 2008, BIOSENS BIOELECTRON, V24, P552, DOI 10.1016/j.bios.2008.05.010
   Rezwan K, 2005, BIOMATERIALS, V26, P4351, DOI 10.1016/j.biomaterials.2004.11.017
   Robeson JL, 1996, LANGMUIR, V12, P6104, DOI 10.1021/la960476p
   Sagara T, 2006, J PHYS CHEM B, V110, P16550, DOI 10.1021/jp0629240
   Su TJ, 1998, LANGMUIR, V14, P438, DOI 10.1021/la970623z
   Sun Y, 2005, LANGMUIR, V21, P5616, DOI 10.1021/la046932o
   Svec F, 1996, SCIENCE, V273, P205, DOI 10.1126/science.273.5272.205
   SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607
   SWENDSEN RH, 1987, PHYS REV LETT, V58, P86, DOI 10.1103/PhysRevLett.58.86
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   Trzaskowski B, 2005, J PHYS CHEM B, V109, P17734, DOI 10.1021/jp052015v
   Tsao HK, 1998, J COLLOID INTERF SCI, V202, P527, DOI 10.1006/jcis.1998.5471
   Van Tomme SR, 2005, J CONTROL RELEASE, V110, P67, DOI 10.1016/j.jconrel.2005.09.005
   Wang F, 2008, BIOINTERPHASES, V3, P9, DOI 10.1116/1.2840054
   Wang XQ, 2009, J COLLOID INTERF SCI, V332, P96, DOI 10.1016/j.jcis.2008.12.055
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   Yan QL, 1999, J CHEM PHYS, V111, P9509, DOI 10.1063/1.480282
   Zhang AJ, 2009, PROG CHEM, V21, P1408
   Zheng J, 2004, LANGMUIR, V20, P8931, DOI 10.1021/la036345n
   Zhou J, 2004, J PHYS CHEM B, V108, P17418, DOI 10.1021/jp038048x
   Zhou J, 2004, J CHEM PHYS, V121, P1050, DOI 10.1063/1.1757434
   Zhou J, 2003, LANGMUIR, V19, P3472, DOI 10.1021/la026871z
   Zhou J, 2007, BIOPHYS J, V92, P4289, DOI 10.1529/biophysj.106.094425
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 68
TC 59
Z9 61
U1 3
U2 43
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-9606
J9 J CHEM PHYS
JI J. Chem. Phys.
PD FEB 14
PY 2010
VL 132
IS 6
AR 065101
DI 10.1063/1.3305244
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 555MR
UT WOS:000274516400031
PM 20151757
DA 2018-10-20
ER

PT J
AU Lee, JH
   Rim, NG
   Jung, HS
   Shin, H
AF Lee, Ji Hye
   Rim, Nae Gyune
   Jung, Hyun Suk
   Shin, Heungsoo
TI Control of Osteogenic Differentiation and Mineralization of Human
   Mesenchymal Stem Cells on Composite Nanofibers Containing Poly
   [lactic-co-(glycolic acid)] and Hydroxyapatite
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE differential scanning calorimetry; human mesenchymal stem cells;
   hydroxyapatite; fibers; osteogenic differentiation
ID GUIDED TISSUE REGENERATION; BETA-TRICALCIUM PHOSPHATE; IN-VITRO; BONE
   REGENERATION; PROGENITOR CELLS; SCAFFOLDS; NANOCOMPOSITE; NANOPARTICLES;
   OSTEOBLASTS; GELATIN
AB We fabricated composite fibrous scaffolds from blends of poly (lactide-co-glycolide) (PLGA) and nano-sized hydroxyapatite (HA) via electrospinning. SEM-EDX and AFM analysis demonstrated that HA was homogeneously dispersed in the nanofibers, and the roughness increased along with the amount of incorporated HA. When hMSCs were cultured on these PLGA/HA composite nanofibers, we found that incorporation of HA on the nanofibers did not affect cell viability whereas increased ALP activity and expression of osteogenic genes as well as the calcium mineralization of hMSCs. Our results indicate that the composite nanofibers can be offered as a potential bone regenerative biomaterial for stem cell based therapies.
C1 [Lee, Ji Hye; Rim, Nae Gyune; Shin, Heungsoo] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea.
   [Jung, Hyun Suk] Kookmin Univ, Dept Adv Mat Engn, Seoul 136702, South Korea.
RP Shin, H (reprint author), Hanyang Univ, Coll Engn, Dept Bioengn, 17 Haengdang Dong, Seoul 133791, South Korea.
EM hshin@hanyang.ac.kr
RI Jung, Hyun Suk/D-4745-2011; Jung, Hyun Suk/H-3659-2015
OI Jung, Hyun Suk/0000-0002-7803-6930
FU Seoul Development Institute [CR070027]
FX This work was supported by the Seoul R&BD Program (CR070027) funded by
   the Seoul Development Institute (to H. Shin and H. S. Jung).
CR BHATTACHARYA R, 2009, BIOCHIM BIOPHYS ACTA, V4, P698
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hosseinkhani H, 2008, J BIOMED MATER RES A, V85A, P47, DOI 10.1002/jbm.a.31327
   Hyonchol K, 2002, COLLOID SURFACE B, V25, P33, DOI 10.1016/S0927-7765(01)00299-5
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P328, DOI 10.1002/mabi.200700107
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jose MV, 2009, ACTA BIOMATER, V5, P305, DOI 10.1016/j.actbio.2008.07.019
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Kim GM, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/4/046003
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   Kim SS, 2007, J BIOMED MATER RES A, V80A, P206, DOI 10.1002/jbm.a.30836
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030
   LIN L, 2008, J BIOMED MATER RES A, V2, P326
   Liu HN, 2008, ACTA BIOMATER, V4, P1472, DOI 10.1016/j.actbio.2008.02.025
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Liu YK, 2009, J BIOMED MATER RES A, V90A, P1083, DOI 10.1002/jbm.a.32192
   Mao X, 2005, TISSUE CELL, V37, P349, DOI 10.1016/j.tice.2005.05.003
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008
   Ngiam M, 2009, TISSUE ENG PT A, V15, P535, DOI 10.1089/ten.tea.2008.0011
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0
   Song JH, 2008, J MATER SCI-MATER M, V19, P2925, DOI 10.1007/s10856-008-3420-7
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Venugopal J, 2008, J MATER SCI-MATER M, V19, P2039, DOI 10.1007/s10856-007-3289-x
   Venugopal J, 2008, J BIOMED MATER RES A, V85A, P408, DOI 10.1002/jbm.a.31538
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150
   Wutticharoenmongkol P, 2007, BIOMACROMOLECULES, V8, P2602, DOI 10.1021/bm700451p
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
NR 41
TC 72
Z9 78
U1 2
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD FEB 11
PY 2010
VL 10
IS 2
BP 173
EP 182
DI 10.1002/mabi.200900169
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 561PK
UT WOS:000274990100007
PM 19685498
DA 2018-10-20
ER

PT J
AU Beutner, R
   Michael, J
   Schwenzer, B
   Scharnweber, D
AF Beutner, Rene
   Michael, Jan
   Schwenzer, Bernd
   Scharnweber, Dieter
TI Biological nano-functionalization of titanium-based biomaterial
   surfaces: a flexible toolbox
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE immobilization; implant; electrochemistry; bioactive molecules; nucleic
   acid; conjugate
ID SELF-ASSEMBLED MONOLAYERS; CALCIUM-PHOSPHATE COATINGS; BONE-IMPLANT
   INTERFACE; ANODIC OXIDE-FILMS; TOTAL HIP-REPLACEMENT; COLLAGEN TYPE-I;
   CELL-ADHESION; OSTEOBLAST ADHESION; DENTAL IMPLANTS; ALKANEPHOSPHATE
   MONOLAYERS
AB Surface functionalization with bioactive molecules (BAMs) on a nanometre scale is a main field in current biomaterial research. The immobilization of a vast number of substances and molecules, ranging from inorganic calcium phosphate phases up to peptides and proteins, has been investigated throughout recent decades. However, in vitro and in vivo results are heterogeneous. This may be at least partially attributed to the limits of the applied immobilization methods. Therefore, this paper highlights, in the first part, advantages and limits of the currently applied methods for the biological nano-functionalization of titanium-based biomaterial surfaces. The second part describes a new immobilization system recently developed in our groups. It uses the nanomechanical fixation of at least partially single-stranded nucleic acids (NAs) into an anodic titanium oxide layer as an immobilization principle and their hybridization ability for the functionalization of the surface with BAMs conjugated to the respective complementary NA strands.
C1 [Beutner, Rene; Scharnweber, Dieter] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Michael, Jan; Schwenzer, Bernd] Tech Univ Dresden, Chair Biochem, Dept Chem, D-01069 Dresden, Germany.
RP Scharnweber, D (reprint author), Tech Univ Dresden, Max Bergmann Ctr Biomat, Budapester Str 27, D-01069 Dresden, Germany.
EM dieter.scharnweber@tu-dresden.de
RI Scharnweber, Dieter/B-3382-2010
OI Scharnweber, Dieter/0000-0003-0369-5189
CR Adden N, 2006, BIOMACROMOLECULES, V7, P2552, DOI 10.1021/bm060473j
   Adden N, 2006, LANGMUIR, V22, P8197, DOI 10.1021/la060754c
   Ahn JM, 2002, MINI-REV MED CHEM, V2, P463, DOI 10.2174/1389557023405828
   ALADJEM A, 1973, J MATER SCI, V8, P688, DOI 10.1007/BF00561225
   Alberti P, 2003, P NATL ACAD SCI USA, V100, P1569, DOI 10.1073/pnas.0335459100
   Alberti P, 2006, ORG BIOMOL CHEM, V4, P3383, DOI 10.1039/b605739j
   Andersen FF, 2008, NUCLEIC ACIDS RES, V36, P1113, DOI 10.1093/nar/gkm1124
   Auernheimer J, 2005, CHEMBIOCHEM, V6, P2034, DOI 10.1002/cbic.200500031
   Bagno A, 2007, BONE, V40, P693, DOI 10.1016/j.bone.2006.10.007
   Beissenhirtz MK, 2006, ORG BIOMOL CHEM, V4, P3392, DOI 10.1039/b607033g
   BEUTNER R, 2007, BIOMATERIALIEN, V8, P25
   Beutner R, 2009, BIOMATERIALS, V30, P2774, DOI 10.1016/j.biomaterials.2009.01.047
   BLACKWOOD DJ, 1989, ELECTROCHIM ACTA, V34, P1505, DOI 10.1016/0013-4686(89)87033-1
   Borsari V, 2009, J BIOMED MATER RES A, V89A, P550, DOI 10.1002/jbm.a.31995
   Bozzini B, 2008, J MATER SCI-MATER M, V19, P3443, DOI 10.1007/s10856-008-3487-1
   Brunette D. M., 2001, TITANIUM MED, P145
   Chaki NK, 2002, BIOSENS BIOELECTRON, V17, P1, DOI 10.1016/S0956-5663(01)00277-9
   Cheng XL, 2004, BIOMATERIALS, V25, P5395, DOI 10.1016/j.biomaterials.2003.12.045
   Choi SW, 2007, NANO LETT, V7, P172, DOI 10.1021/nl0626232
   Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686
   Clair S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2876421
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   De Giglio E, 1999, J BIOMAT SCI-POLYM E, V10, P845, DOI 10.1163/156856299X00919
   De Giglio E, 2001, J BIOMAT SCI-POLYM E, V12, P63, DOI 10.1163/156856201744452
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   DELPLANCKE JL, 1988, ELECTROCHIM ACTA, V33, P1551, DOI 10.1016/0013-4686(88)80224-X
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Ellingsen JE, 2006, PERIODONTOL 2000, V41, P136, DOI 10.1111/j.1600-0757.2006.00175.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Fahlman RP, 2003, NANO LETT, V3, P1073, DOI 10.1021/nl034267i
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Gan L, 2004, BIOMATERIALS, V25, P5313, DOI 10.1016/j.biomaterials.2003.12.039
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Gnauck M, 2007, LANGMUIR, V23, P377, DOI 10.1021/la0606648
   GOPEL W, 1984, SURF SCI, V139, P333, DOI 10.1016/0039-6028(84)90054-2
   Guo KT, 2007, MINI-REV MED CHEM, V7, P701
   Guo KT, 2007, BIOMATERIALS, V28, P468, DOI 10.1016/j.biomaterials.2006.09.021
   Hahner G, 2001, LANGMUIR, V17, P7047, DOI 10.1021/la010713a
   HAYASHI K, 1994, BIOMATERIALS, V15, P1187, DOI 10.1016/0142-9612(94)90241-0
   He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Huang E, 2001, LANGMUIR, V17, P1215, DOI 10.1021/la001019i
   Huang Hui, 2003, J Oral Implantol, V29, P73, DOI 10.1563/1548-1336(2003)029<0073:EOFORI>2.3.CO;2
   Johnsen SP, 2006, J BONE JOINT SURG BR, V88B, P1303, DOI 10.1302/0301-620X.88B10.17399
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kamkin AN, 1996, PROT MET+, V32, P214
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1999, Adv Dent Res, V13, P8
   KHALIL N, 1986, ELECTROCHIM ACTA, V31, P1279, DOI 10.1016/0013-4686(86)80148-7
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Kim TI, 2008, CURR PHARM DESIGN, V14, P2201, DOI 10.2174/138161208785740171
   Klinger MM, 1998, CRIT REV ORAL BIOL M, V9, P449, DOI 10.1177/10454411980090040401
   Krupa D, 2005, ANAL BIOANAL CHEM, V381, P617, DOI 10.1007/s00216-004-2983-5
   Kunze J, 2005, Z PHYS CHEM, V219, P1561, DOI 10.1524/zpch.2005.219.11.1561
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LAUSMAA J, 1988, SURFACE CHARACTERIZA, P161
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+
   Liu HB, 2008, CHEMPHYSCHEM, V9, P1979, DOI 10.1002/cphc.200800381
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114
   Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Mani G, 2008, LANGMUIR, V24, P6774, DOI 10.1021/la8003646
   Martin SM, 2004, J BIOMED MATER RES A, V70A, P10, DOI 10.1002/jbm.a.30052
   Michael J, 2007, J BIOMED MATER RES B, V80B, P146, DOI 10.1002/jbm.b.30579
   Michael J, 2009, BIOCONJUGATE CHEM, V20, P710, DOI 10.1021/bc800372e
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200
   OHTSUKA T, 1985, J ELECTROCHEM SOC, V132, P787, DOI 10.1149/1.2113958
   Ohtsuka T, 1997, CORROS SCI, V39, P1253, DOI 10.1016/S0010-938X(97)00025-5
   Park S.H., 2006, ANGEW CHEM, V118, P749
   Pebe P, 1997, Implant Dent, V6, P259
   Philippin G, 2003, APPL SURF SCI, V212, P530, DOI 10.1016/S0169-4332(03)00051-5
   Popa MV, 2008, J MATER SCI-MATER M, V19, P1, DOI 10.1007/s10856-007-3271-7
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ratner B. D., 2001, TITANIUM MED, P1
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   ROSSLER S, 2001, J MATER SCI-MATER M, V12, P871
   ROSSLER S, 2002, COLLOID SURFACE B, V26, P387, DOI DOI 10.1016/S0927-7765(02)00025-5
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   Scharnweber D, 2007, J MATER SCI-MATER M, V18, P391, DOI 10.1007/s10856-006-0704-7
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   Scharnweber D, 2004, BIOMATERIALS, V25, P2371, DOI 10.1016/j.biomaterials.2003.09.025
   Scharnweber D, 2009, RECENT DEV ADV MED D, P101
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Schliephake H, 2009, CLIN ORAL IMPLAN RES, V20, P31, DOI 10.1111/j.1600-0501.2008.01603.x
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   SCHUTZ RW, 1997, SURFACE PERFORMANCE, P1
   Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499
   Seeman NC, 1999, TRENDS BIOTECHNOL, V17, P437, DOI 10.1016/S0167-7799(99)01360-8
   SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Shchepinov MS, 1997, NUCLEIC ACIDS RES, V25, P4447, DOI 10.1093/nar/25.22.4447
   Shchepinov MS, 1999, NUCLEIC ACIDS RES, V27, P3035, DOI 10.1093/nar/27.15.3035
   SHIBATA T, 1995, CORROS SCI, V37, P253, DOI 10.1016/0010-938X(94)00133-Q
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   SODEK J, 1992, INT CONGR SER, V1002, P297
   Spori DM, 2007, LANGMUIR, V23, P8053, DOI 10.1021/la700474v
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Teng SH, 2008, J MATER SCI-MATER M, V19, P2453, DOI 10.1007/s10856-008-3370-0
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Valentin Andreas H., 2004, Keio Journal of Medicine, V53, P166, DOI 10.2302/kjm.53.166
   van Steenberghe D, 2002, CLIN ORAL IMPLAN RES, V13, P617, DOI 10.1034/j.1600-0501.2002.130607.x
   van Steenberghe D, 2003, PERIODONTOL 2000, V33, P163, DOI 10.1046/j.0906-6713.2003.03313.x
   Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i
   VROMAN L, 1969, Journal of Biomedical Materials Research, V3, P669, DOI 10.1002/jbm.820030410
   Wach JY, 2008, CHEM-EUR J, V14, P10579, DOI 10.1002/chem.200801134
   Waddington R J, 2001, J Orthod, V28, P281, DOI 10.1093/ortho/28.4.281
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P1001, DOI 10.1111/j.1600-051X.2008.01321.x
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Zhang M, 2007, SURF COAT TECH, V201, P7252, DOI 10.1016/j.surfcoat.2007.01.043
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zorn G, 2007, J MATER SCI-MATER M, V18, P1309, DOI 10.1007/s10856-006-0117-7
   Zorn G, 2005, CHEM MATER, V17, P4218, DOI 10.1021/cm050477f
   Zoulalian V, 2006, J PHYS CHEM B, V110, P25603, DOI 10.1021/jp066811s
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 134
TC 52
Z9 54
U1 1
U2 42
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD FEB 6
PY 2010
VL 7
SU 1
BP S93
EP S105
DI 10.1098/rsif.2009.0418.focus
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 572GD
UT WOS:000275814700009
PM 19889692
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU McNamara, LE
   Dalby, MJ
   Riehle, MO
   Burchmore, R
AF McNamara, Laura E.
   Dalby, Matthew J.
   Riehle, Mathis O.
   Burchmore, Richard
TI Fluorescence two-dimensional difference gel electrophoresis for
   biomaterial applications
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE fluorescence two-dimensional difference gel electrophoresis;
   two-dimensional gel; biomaterials; cell-material interactions;
   topography; scarce samples
ID LASER CAPTURE MICRODISSECTION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY;
   MICROARRAY EXPERIMENTS; MESSENGER-RNA; DIGE ANALYSIS; EXPRESSION;
   CANCER; DYES; PROTEINS
AB Fluorescence two-dimensional difference gel electrophoresis (DiGE) is rapidly becoming established as a powerful technique for the characterization of differences in protein expression levels between two or more conditions. In this review, we consider the application of DiGE-both minimal and saturation labelling-to biomaterials research, considering the challenges and rewards of this approach.
C1 [McNamara, Laura E.; Dalby, Matthew J.; Riehle, Mathis O.] Univ Glasgow, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
   [McNamara, Laura E.; Burchmore, Richard] Univ Glasgow, Sir Henry Wellcome Funct Genom Facil, Div Mol & Cellular Biol, Glasgow G12 8QQ, Lanark, Scotland.
RP McNamara, LE (reprint author), Univ Glasgow, Ctr Cell Engn, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM l.mcnamara.1@research.gla.ac.uk
RI Burchmore, Richard/A-1896-2011; Riehle, Mathis/A-3427-2011; Dalby,
   Matthew/G-2426-2012
OI Riehle, Mathis/0000-0001-7988-1514; Dalby, Matthew/0000-0002-0528-3359;
   Burchmore, Richard/0000-0003-1663-9004
FU BBSRC [BB/D526329/1]; MRC
FX L. E. M. is funded by BBSRC Doctoral Training Grant BB/D526329/1. M.J.D.
   and R.B. are funded by the BBSRC and MRC, respectively. The authors
   would like to thank Ms F. Kantawong and Dr K. Jayawardena for their
   assistance and advice, and all in the Sir Henry Wellcome Functional
   Genomics Facility and the Centre for Cell Engineering for help and
   fruitful discussion.
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   AMANCHY R, 2005, SCI STKE, pPL2, DOI DOI 10.1126/STKE.2672005PL2
   Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607
   Carrette O, 2006, NAT PROTOC, V1, P812, DOI 10.1038/nprot.2006.117
   Chan HL, 2005, PROTEOMICS, V5, P2908, DOI 10.1002/pmic.200401300
   Craven RA, 2002, AM J PATHOL, V160, P815, DOI 10.1016/S0002-9440(10)64904-8
   Dani Diksha, 2008, Biotechnology Journal, V3, P817, DOI 10.1002/biot.200800030
   Derhami K, 2001, J BIOMED MATER RES, V56, P234, DOI 10.1002/1097-4636(200108)56:2<234::AID-JBM1090>3.3.CO;2-R
   Dinnes DLM, 2007, J BIOMED MATER RES A, V80A, P895, DOI 10.1002/jbm.a.30967
   Dittmer A, 2006, ELECTROPHORESIS, V27, P2844, DOI 10.1002/elps.200500785
   Greengauz-Roberts O, 2005, PROTEOMICS, V5, P1746, DOI 10.1002/pmic.200401068
   Hannigan A, 2007, J PROTEOME RES, V6, P3422, DOI 10.1021/pr0606878
   Kantawong F, 2009, J R SOC INTERFACE, V6, P1075, DOI 10.1098/rsif.2008.0447
   Kantawong F, 2009, ACTA BIOMATER, V5, P1137, DOI 10.1016/j.actbio.2008.11.001
   Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g
   Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683
   Karp NA, 2007, MOL CELL PROTEOMICS, V6, P1354, DOI 10.1074/mcp.M600274-MCP200
   Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485
   Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102
   Kirana C, 2009, PROTEOMICS, V9, P485, DOI 10.1002/pmic.200800197
   Kondo T, 2003, PROTEOMICS, V3, P1758, DOI 10.1002/pmic.200300531
   Kondo T, 2006, NAT PROTOC, V1, P2940, DOI 10.1038/nprot.2006.421
   Li C, 2004, MOL CELL PROTEOMICS, V3, P399, DOI 10.1074/mcp.M300133-MCP200
   Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274
   MARYHUARD T, 2007, BIOINFORMATICS, V23, P313
   Masayo Y, 2009, J PROTEOMICS BIOINFO, V2, P1
   Mayrhofer C, 2006, PROTEOMICS, V6, P579, DOI 10.1002/pmic.200500104
   Mirza SP, 2008, PHYSIOL GENOMICS, V33, P3, DOI 10.1152/physiolgenomics.00292.2007
   Mouledous Lionel, 2002, J Biomol Tech, V13, P258
   Oehlers LP, 2007, COMP BIOCHEM PHYS C, V145, P120, DOI 10.1016/j.cbpc.2006.06.005
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Pozner-Moulis S, 2007, LAB INVEST, V87, P251, DOI 10.1038/labinvest.3700515
   Shaw J, 2003, PROTEOMICS, V3, P1181, DOI 10.1002/pmic.200300439
   Sitek B, 2005, PROTEOMICS, V5, P2665, DOI 10.1002/pmic.200401298
   Sitek B, 2006, PROTEOMICS, V6, P4337, DOI 10.1002/pmic.200500739
   Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468
   Suehara Y, 2009, PROTEOM CLIN APPL, V3, P584, DOI 10.1002/prca.200800168
   Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256
   Tannu NS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-270
   Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2
   Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133
   Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234
   Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422
   Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103
   Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o
   Xu JL, 2008, PROTEOMICS, V8, P4249, DOI 10.1002/pmic.200800103
   Zellner M, 2008, ELECTROPHORESIS, V29, P3621, DOI 10.1002/elps.200700935
   Zhang WY, 2007, BIOINFORMATICS, V23, P1217, DOI 10.1093/bioinformatics/btm081
   Zhou G, 2002, MOL CELL PROTEOMICS, V1, P117, DOI 10.1074/mcp.M100015-MCP200
   Zolotarjova N, 2005, PROTEOMICS, V5, P3304, DOI 10.1002/pmic.200402021
NR 50
TC 20
Z9 21
U1 2
U2 15
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD FEB 6
PY 2010
VL 7
SU 1
BP S107
EP S117
DI 10.1098/rsif.2009.0177.focus
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 572GD
UT WOS:000275814700010
PM 19570793
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Bettinger, CJ
   Bao, ZA
AF Bettinger, Christopher J.
   Bao, Zhenan
TI Organic Thin-Film Transistors Fabricated on Resorbable Biomaterial
   Substrates
SO ADVANCED MATERIALS
LA English
DT Article
ID FIELD-EFFECT TRANSISTORS; IN-VIVO DEGRADATION; BIODEGRADABLE POLYMERS;
   EXTERNAL FIXATION; BIOCOMPATIBILITY; DEVICES; VITRO; SCAFFOLDS;
   MICROCHIP; MELANINS
AB Organic electronics and biodegradable materials have the potential to be integrated to create a new class of electronic devices for the use in biomedical and environmental applications. Organic thin-film field-effect transistors fabricated using a biodegradable material platform exhibit water stable performance and degrade in vitro.
RP Bao, ZA (reprint author), 381 North South Mall,Stauffer 3,Room 113, Stanford, CA 94305 USA.
EM zbao@stanford.edu
RI Bettinger, Christopher/A-3895-2009
FU National Institutes of Health [1F32NS064771-01]; Office of Naval
   Research [N000140810654]; NIH
FX The authors acknowledge Debbie Lin and Anatoly Sokolov for assistance in
   sample preparation and instrumentation. Financial support for this
   project was provided by the National Institutes of Health (grant no.
   1F32NS064771-01) and the Office of Naval Research (N000140810654) MURI
   project. C.J.B. was funded by a Ruth L. Kirschstein NIH fellowship.
   Supporting Information is available online from Wiley InterScience or
   from the author.
CR Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Briseno AL, 2006, ADV MATER, V18, P2320, DOI 10.1002/adma.200600634
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Edelman ER, 2001, CIRCULATION, V103, P429
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Fortunato E, 2008, IEEE ELECTR DEVICE L, V29, P988, DOI 10.1109/LED.2008.2001549
   Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803
   Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x
   Jang Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2093940
   Jin SH, 2004, J KOREAN PHYS SOC, V44, P181
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Kim SH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2374864
   Kim YH, 2004, IEEE ELECTR DEVICE L, V25, P702, DOI 10.1109/LED.2004.836502
   Kushto GP, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1867568
   Locklin J, 2006, ADV MATER, V18, P2989, DOI 10.1002/adma.200601608
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Maliakal A., 2007, ORGANIC FIELD EFFECT, P229
   Mallick A. B., 2007, ORGANIC FIELD EFFECT, P159
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   NAPOLITANO A, 1995, TETRAHEDRON, V51, P5913, DOI 10.1016/0040-4020(95)00259-B
   Oh JH, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2803073
   Paetau I., 1994, Journal of Environmental Polymer Degradation, V2, P211, DOI 10.1007/BF02067447
   Prescott JH, 2006, NAT BIOTECHNOL, V24, P437, DOI 10.1038/nbt1199
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Roberts ME, 2008, P NATL ACAD SCI USA, V105, P12134, DOI 10.1073/pnas.0802105105
   Roberts ME, 2009, ORG ELECTRON, V10, P377, DOI 10.1016/j.orgel.2008.12.001
   Rogers JA, 2001, P NATL ACAD SCI USA, V98, P4835, DOI 10.1073/pnas.091588098
   Santini JT, 1999, NATURE, V397, P335
   Singh TB, 2005, ADV MATER, V17, P2315, DOI 10.1002/adma.200501109
   Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102
   Stadler P, 2007, ORG ELECTRON, V8, P648, DOI 10.1016/j.orgel.2007.05.003
   Tamai H, 2000, CIRCULATION, V102, P399
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
NR 40
TC 186
Z9 188
U1 7
U2 111
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD FEB 2
PY 2010
VL 22
IS 5
BP 651
EP +
DI 10.1002/adma.200902322
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 556TP
UT WOS:000274615600017
PM 20217767
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lv, SJ
   Liu, LY
   Yang, WT
AF Lv, Shengjie
   Liu, Lianying
   Yang, Wantai
TI Preparation of Soft Hydrogel Nanoparticles with PNIPAm Hair and
   Characterization of Their Temperature-Induced Aggregation
SO LANGMUIR
LA English
DT Article
ID INVERSE MICROEMULSION POLYMERIZATION; SURFACE GRAFT-POLYMERIZATION;
   VOLUME PHASE-TRANSITION; DRUG-DELIVERY; N-ISOPROPYLACRYLAMIDE;
   POLY(N-ISOPROPYLACRYLAMIDE) MICROGELS; POLYELECTROLYTE BRUSHES; CORE;
   WATER; COPOLYMERS
AB There exists a great number Of publications concerning lie synthesis of core-shell and/or hairy particles by means of controlled/living polymerization. Nevertheless, how to fabricate ultrafine nanosized hairy particles, especially polymeric soft hairy particles, remains a significant challenge. This paper presents a simple self-developed approach consisting of a two-step photoinduced polymerization of cross-linked polyacrylamide (CLPAM) soft hydrogel nanoparticles (5-10 nm in diameter) grafted with poly(N-isopropylcarylamide) (PNIPAm) chains. The architecture of such ultrafine soft water-swollen CLPAM@PNIPAm core/shell nanoparticles (20-35 rim in diameter) demonstrated very specific temperature sensitive behaviors. During heating a fast association process was observed at approximately 33-34 degrees C and the singular hairy particles with 34 nm diameters clustered into aggregates that were similar to 120 nm in diameter. Raising the temperature further, however, led to a decrease in size to about 100 nm at 45 degrees C. This behavior was attributed to the formation of hydrophobic shell layers accompanying the shrinkage of PNIPAm chains with chain polar transformations. With the contraction pressure produced by further shrinkage of the hydrophobic shell layers, the soft fully swollen PAM cores expelled water and diminished in size. During the cooling process, these contracted cores that were trapped in the aggregates gave rise to all early dissociation. The hydrophilic hairy CLPAM@PNIPAm particles are believed to be potentially useful as carriers to specific target regions, e.g., cells for controlled drug delivery and other smart biomaterial applications.
C1 [Lv, Shengjie; Liu, Lianying; Yang, Wantai] Beijing Univ Chem Technol, Coll Mat Sci & Engn, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
RP Yang, WT (reprint author), Beijing Univ Chem Technol, Coll Mat Sci & Engn, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
EM yangwt@mail.buct.edu.cn
OI Lu, Shengjie/0000-0003-3365-6383
FU National Science Foundation of China (NSFC) [50433040]; Beijing
   Municipal Education Commission (BMEC) [XK100100433]
FX We gratefully acknowledge the Major Project (No. 50433040) from the
   National Science Foundation of China (NSFC) and the Major Project
   (XK100100433) for Polymer Chemistry and Physics Subject Construction
   from Beijing Municipal Education Commission (BMEC), for Financial
   support to this work.
CR BHATTACHARYYA K, 1986, J PHYS CHEM-US, V90, P3987, DOI 10.1021/j100408a032
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Cavalieri F, 2008, BIOMACROMOLECULES, V9, P1967, DOI 10.1021/bm800225v
   Cheng H, 2006, MACROMOLECULES, V39, P2325, DOI 10.1021/ma052561m
   Convertine AJ, 2006, MACROMOLECULES, V39, P1724, DOI 10.1021/ma0523419
   Gan DJ, 2003, ANAL CHIM ACTA, V496, P53, DOI 10.1016/S0003-2670(03)00989-9
   Gan DJ, 2001, J AM CHEM SOC, V123, P7511, DOI 10.1021/ja010609f
   Gao D, 2008, NANO LETT, V8, P3320, DOI 10.1021/nl8017274
   Gao D, 2007, ANGEW CHEM INT EDIT, V46, P2224, DOI 10.1002/anie.200603927
   Guo X, 2000, LANGMUIR, V16, P8719, DOI 10.1021/la000319x
   Guo X, 1999, MACROMOLECULES, V32, P6043, DOI 10.1021/ma990609o
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hay DNT, 2004, J AM CHEM SOC, V126, P2290, DOI 10.1021/ja039023e
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   Hou Y, 2008, BIOMATERIALS, V29, P3175, DOI 10.1016/j.biomaterials.2008.04.024
   HUBER DL, 2003, SCIENCE, V301, P52
   Jones CD, 2000, MACROMOLECULES, V33, P8301, DOI 10.1021/ma001398m
   Jones CD, 2003, LANGMUIR, V19, P4544, DOI 10.1021/la034392+
   Jung T, 2000, EUR J PHARM BIOPHARM, V50, P147, DOI 10.1016/S0939-6411(00)00084-9
   Juranicova V, 1998, ANGEW MAKROMOL CHEM, V258, P27
   KAWAGUCHI H, 2002, ACS SYM SER, V801, P307
   Kizhakkedathu JN, 2004, MACROMOLECULES, V37, P734, DOI 10.1021/ma034934u
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu LY, 2004, J POLYM SCI POL CHEM, V42, P846, DOI 10.1002/pola.11033
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   Maeda Y, 2001, LANGMUIR, V17, P7535, DOI 10.1021/la010007+
   Maeda Y, 2000, LANGMUIR, V16, P7503, DOI 10.1021/la0001575
   Nayak S, 2005, ANGEW CHEM INT EDIT, V44, P7686, DOI 10.1002/anie.200501321
   Nayak S, 2004, CHEM MATER, V16, P2623, DOI 10.1021/cm049650i
   Ni H, 2007, MACROMOLECULES, V40, P6370, DOI 10.1021/ma070358g
   Nolan CM, 2006, BIOMACROMOLECULES, V7, P2918, DOI 10.1021/bm060718s
   Oh JK, 2008, PROG POLYM SCI, V33, P448, DOI 10.1016/j.progpolymsci.2008.01.002
   OTAKE K, 1990, MACROMOLECULES, V23, P283, DOI 10.1021/ma00203a049
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pileni MP, 1997, LANGMUIR, V13, P3266, DOI 10.1021/la960319q
   PILENI MP, 1985, CHEM PHYS LETT, V118, P414, DOI 10.1016/0009-2614(85)85402-6
   Pileni MP, 2003, NAT MATER, V2, P145, DOI 10.1038/nmat817
   Ranganathan K, 2008, MACROMOLECULES, V41, P4226, DOI 10.1021/ma800094d
   Renteria M, 2005, J POLYM SCI POL CHEM, V43, P2495, DOI 10.1002/pola.20721
   Santos AM, 2005, POLYMER, V46, P1181, DOI 10.1016/j.polymer.2004.11.069
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schillemans JP, 2006, MACROMOLECULES, V39, P5885, DOI 10.1021/ma060727t
   SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106
   Takata S, 2003, POLYMER, V44, P495, DOI 10.1016/S0032-3861(02)00768-1
   TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820
   Tsuji S, 2006, MACROMOLECULES, V39, P4338, DOI 10.1021/ma052343t
   Wang Q, 2007, POLYMER, V48, P6581, DOI 10.1016/j.polymer.2007.08.018
   Wang YX, 2007, MACROMOLECULES, V40, P756, DOI 10.1021/ma062252b
   Wang YX, 2005, MACROMOL RAPID COMM, V26, P87, DOI 10.1002/marc.200400488
   Wang YX, 2004, LANGMUIR, V20, P6225, DOI 10.1021/la0493924
   Wei GW, 2008, J PHYS CHEM C, V112, P10827, DOI 10.1021/jp800741t
   Woodward NC, 2003, LANGMUIR, V19, P3202, DOI 10.1021/la02088li
   Wu C, 1996, PHYS REV LETT, V77, P3053, DOI 10.1103/PhysRevLett.77.3053
   Wyss A, 2004, BIOTECHNOL BIOENG, V86, P563, DOI 10.1002/bit.20050
   Xiao XC, 2004, LANGMUIR, V20, P5247, DOI 10.1021/la036230j
   Xing CM, 2003, POLYM J, V35, P613, DOI 10.1295/polymj.35.613
   Yamato M, 2007, PROG POLYM SCI, V32, P1123, DOI 10.1016/j.progpolymsci.2007.06.002
   Yang P, 2007, J AM CHEM SOC, V129, P1541, DOI 10.1021/ja063716o
   Yang WT, 1996, J APPL POLYM SCI, V62, P533, DOI 10.1002/(SICI)1097-4628(19961017)62:3<533::AID-APP11>3.0.CO;2-#
   Ye J, 2008, LANGMUIR, V24, P2727, DOI 10.1021/la703018p
   Zhang GZ, 2001, J AM CHEM SOC, V123, P1376, DOI 10.1021/ja003889s
   Zhao HC, 2007, LANGMUIR, V23, P1810, DOI 10.1021/la061954r
   ZHU PW, 1994, PHYS REV E, V50, P1360, DOI 10.1103/PhysRevE.50.1360
NR 64
TC 15
Z9 15
U1 3
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 2
PY 2010
VL 26
IS 3
BP 2076
EP 2082
DI 10.1021/la9025766
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 546SM
UT WOS:000273831700109
PM 19795850
DA 2018-10-20
ER

PT J
AU Akpalo, E
   Larreta-Garde, V
AF Akpalo, Edefia
   Larreta-Garde, Veronique
TI Increase of fibrin gel elasticity by enzymes: A kinetic approach
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biogels; Enzyme mechanism; Viscoelasticity; Mechanical properties
ID CROSS-LINKING; TRANSGLUTAMINASE; POLYMERIZATION; MATRIX; CLOT; ALPHA
AB Two enzymes, thrombin and transglutaminase, both participate in the formation of fibrin networks and contribute to the mechanical strength of biogels. A theoretical model built from the available kinetic data showed that a competition may take place between the two enzymes for their common substrate, fibrinogen. To evidence this phenomenon experimentally, the concentrations of the reactants were varied and the theological properties of the resulting fibrin gels explored. The elasticity of the gels was not a singular function of the transglutaminase concentration, the optimum being also related to fibrinogen and thrombin concentrations. Thrombin concentration influenced the kinetics of gelation, but not the evolution of the mechanical properties of the gel. An indirect relationship between gel elasticity and thrombin concentration was observed upon covalent binding. The liquid phase inside the gel contained a high amount of soluble proteins when a high transglutaminase concentration was used. The impact of this competition between the two enzymes, demonstrated here for the first time, is evaluated for biomaterial elaboration. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Akpalo, Edefia; Larreta-Garde, Veronique] Univ Cergy Pontoise, F-95000 Cergy Pontoise, France.
RP Larreta-Garde, V (reprint author), Univ Cergy Pontoise, F-95000 Cergy Pontoise, France.
EM veronique.larreta-garde@u-cergy.fr
RI larreta garde, veronique/E-9356-2013
OI larreta garde, veronique/0000-0003-3500-1364
CR Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743
   Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102
   DARE E, 2007, J BONE JOINT SURG BR, V90, P130
   DOOLITTLE RF, 2003, BLOOD REV, V13, P87
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Giraudier S, 2004, BIOMACROMOLECULES, V5, P1662, DOI 10.1021/bm049670d
   Gosal WS, 2000, CURR OPIN COLLOID IN, V5, P188, DOI 10.1016/S1359-0294(00)00057-1
   Haroon ZA, 1999, FASEB J, V13, P1787
   Larreta-Garde V, 2002, J THEOR BIOL, V217, P105, DOI 10.1006/yjtbi.3010
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039
   Mosesson MW, 2000, FIBRINOLYSIS PROTEOL, V14, P182, DOI 10.1054/fipr.2000.0054
   Murthy SNP, 2000, P NATL ACAD SCI USA, V97, P44, DOI 10.1073/pnas.97.1.44
   Nishinari K, 2003, CURR OPIN COLLOID IN, V8, P396, DOI 10.1016/S1359-0294(03)00099-2
   OKADA M, 1985, J BIOL CHEM, V260, P1811
   OLEXA SA, 1980, P NATL ACAD SCI-BIOL, V77, P1374, DOI 10.1073/pnas.77.3.1374
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176
   Ronfard V, 2001, P NATL ACAD SCI USA, V98, P4504, DOI 10.1073/pnas.071631698
   Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4
   SCHWARTZ RA, 2007, FACTOR 13 E MED WEBM
   SHIMIZU A, 1988, BIOPHYS J, V53, P311, DOI 10.1016/S0006-3495(88)83108-4
   Sobel JH, 1996, J BIOL CHEM, V271, P19288, DOI 10.1074/jbc.271.32.19288
   Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003
   Sun Y, 2005, BIOPOLYMERS, V77, P257, DOI 10.1002/bip.20177
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 27
TC 9
Z9 9
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2010
VL 6
IS 2
BP 396
EP 402
DI 10.1016/j.actbio.2009.08.001
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552GX
UT WOS:000274277800009
PM 19664730
DA 2018-10-20
ER

PT J
AU Nam, K
   Kimura, T
   Funamoto, S
   Kishida, A
AF Nam, Kwangwoo
   Kimura, Tsuyoshi
   Funamoto, Seiichi
   Kishida, Akio
TI Preparation of a collagen/polymer hybrid gel for tissue membranes. Part
   II: In vitro and in vivo biological properties of the collagen gels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Collagen; Phospholipid polymer; Inflammatory response; In vitro and in
   vivo studies
ID DERMAL SHEEP COLLAGENS; CROSS-LINKED COLLAGEN; PHOSPHOLIPID POLYMERS;
   MACROPHAGE ADHESION; SURFACE-CHEMISTRY; CELL; BIOMATERIAL;
   PHOSPHORYLCHOLINE; BIOCOMPATIBILITY; ANGIOGENESIS
AB The aim of the present study was to evaluate the biological properties of a collagen-phospholipid polymer hybrid gel (MiC30 gel) designed for use as a tissue membrane. The following four types of collagen gels were synthesized and tested in vitro and in vivo: physically cross-linked collagen gel (Uc gel), N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC)/N-hydroxysuccinimide-cross-linked collagen gel (EN gel), MiC30 gel and glutaraldehyde-cross-linked collagen gel (G gel). The cell adhesivity and proliferation rate were observed to be lowest for the MiC30 gel and highest for the Uc gel, indicating that the phospholipid-polymer-covered surface of the collagen gel interacted weakly with cells. The collagen gel was implanted into rats subcutaneously and was observed 1, 2 and 8 weeks after implantation. The Uc gel and G gel were degraded and induced an inflammatory response. Granulation was not observed for 8 weeks after implantation and the formation of foreign body giant cells was observed around both the Uc and G gels. On the other hand, cell infiltration and degradation were not observed in the case of the EN and MiC30 gels. The formation of foreign body giant cells was suppressed and the healing process was accelerated. The MiC30 gel is suitable for use as a biomaterial that is stable in vivo because it suppresses the foreign body response and accelerates the healing process. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Nam, Kwangwoo; Kimura, Tsuyoshi; Funamoto, Seiichi; Kishida, Akio] Tokyo Med & Dent Univ, Div Biofunct Mol, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Nam, Kwangwoo; Kimura, Tsuyoshi; Kishida, Akio] JST CREST, Kawaguchi, Saitama 3320012, Japan.
RP Kishida, A (reprint author), Tokyo Med & Dent Univ, Div Biofunct Mol, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM kishida.fm@tmd.ac.jp
RI Nam, Kwangwoo/E-1540-2011
FU Japan Health Sciences Foundation; Ministry of Health, Labour and
   Welfare, Japan; Core Research for Evolutional Science and Technology
   (CREST) of the Japan Science and Technology Agency (JST)
FX This work was supported in part by Grants-in-Aid from Research on Health
   Sciences focusing on Drug Innovation from the Japan Health Sciences
   Foundation and Research on the Human Genome, Tissue Engineering, Health
   and Labour Science Research Grant, Ministry of Health, Labour and
   Welfare, Japan. This work was also partly supported by a Grant-in-Aid
   from the Core Research for Evolutional Science and Technology (CREST) of
   the Japan Science and Technology Agency (JST). We would like to thank
   Professor Kazuhiko Ishihara of the University of Tokyo for his kind
   assistance and advice on the preparation and analysis of the MPC
   polymer.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chiba N, 2007, EUR SURG RES, V39, P103, DOI 10.1159/000099598
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P139, DOI 10.1002/jbm.820290202
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Everaerts F, 2004, BIOMATERIALS, V25, P5523, DOI 10.1016/j.biomaterials.2003.12.054
   Gratzer PF, 2001, J BIOMED MATER RES, V58, P172, DOI 10.1002/1097-4636(2001)58:2<172::AID-JBM1004>3.0.CO;2-9
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Iwasaki Y, 2002, BIOMATERIALS, V23, P3897, DOI 10.1016/S0142-9612(02)00135-7
   Iyonaga K, 1997, HISTOCHEM J, V29, P105, DOI 10.1023/A:1026477104227
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   Liu L, 2007, BIOMATERIALS, V28, P3807, DOI 10.1016/j.biomaterials.2007.04.025
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Marzec E, 2008, BIOPHYS CHEM, V132, P89, DOI 10.1016/j.bpc.2007.10.012
   MCPHERSON JM, 1987, J BIOMED MATER RES, V20, P93
   Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Nam KW, 2002, BIOMACROMOLECULES, V3, P100, DOI 10.1021/bm015589o
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   Nam K, 2007, BIOMATERIALS, V28, P3153, DOI 10.1016/j.biomaterials.2007.03.001
   Nam K, 2007, BIOMATERIALS, V28, P1, DOI 10.1016/j.biomaterials.2006.08.002
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   SCHOR AM, 1979, INT J CANCER, V24, P225, DOI 10.1002/ijc.2910240215
   Strodtbeck F., 2001, NEWBORN INFANT NURS, V1, P43, DOI DOI 10.1053/NBIN.2001.23176
   van Wachem PB, 1999, J BIOMED MATER RES, V47, P270, DOI 10.1002/(SICI)1097-4636(199911)47:2<270::AID-JBM18>3.0.CO;2-D
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Watanabe J, 2003, ARTIF ORGANS, V27, P242, DOI 10.1046/j.1525-1594.2003.07015.x
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   WISSINK MJB, 1999, THESIS U TWENTE, P159
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Ye SH, 2006, BIOMATERIALS, V27, P1955, DOI 10.1016/j.biomaterials.2005.09.041
NR 38
TC 11
Z9 11
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2010
VL 6
IS 2
BP 409
EP 417
DI 10.1016/j.actbio.2009.06.022
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552GX
UT WOS:000274277800011
PM 19539060
DA 2018-10-20
ER

PT J
AU Vlad, MD
   Sindilar, EV
   Marinoso, ML
   Poeata, I
   Torres, R
   Lopez, J
   Barraco, M
   Fernandez, E
AF Vlad, M. D.
   Sindilar, E. V.
   Marinoso, M. L.
   Poeata, I.
   Torres, R.
   Lopez, J.
   Barraco, M.
   Fernandez, E.
TI Osteogenic biphasic calcium sulphate dihydrate/iron-modified
   alpha-tricalcium phosphate bone cement for spinal applications: In vivo
   study
SO ACTA BIOMATERIALIA
LA English
DT Article
DE alpha-Tricalcium phosphate; Calcium sulphate; Hydroxyapatite; Bone
   cement; Vertebroplasty
ID ORTHOPHOSPHATE CEMENTS; CAHPO4-ALPHA-CA-3(PO4)(2) SYSTEM;
   CLINICAL-APPLICATIONS; MECHANICAL-PROPERTIES; COMPRESSIVE STRENGTH;
   DISSOLUTION RATES; HYDRAULIC CEMENTS; GRAFT SUBSTITUTE; SETTING
   REACTION; HYDROXYAPATITE
AB In this study, the biocompatibility and the osteogenic features of a new iron-modified alpha-tricalcium phosphate (IM/alpha-TCP) and calcium sulphate dihydrate (CSD) biphasic cement (IM/alpha-TCP/CSD-BC) have been investigated in terms of the in vivo cement resorption, bone tissue formation and host tissue response on sheep animal model. Histological evaluation performed on undecalcified cement-bone specimens assessed the in vivo behaviour. It has been shown that the new IM/alpha-TCP/CSD-BC has the ability to produce firm bone binding in vivo (i.e. bioactivity). Qualitative histology proved cement biocompatibility, osteoconduction and favourable resorption, mainly through a macrophage-mediated mechanism. The results showed that the new cements have biocompatible and osteogenic features of interest as possible cancellous bone replacement biomaterial for minimally invasive spinal surgery applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Vlad, M. D.; Torres, R.; Lopez, J.; Barraco, M.; Fernandez, E.] Tech Univ Catalonia, Div Biomat & Bioengn, IRGASC, E-08028 Barcelona, Spain.
   [Vlad, M. D.; Poeata, I.] Gr T Popa Univ Med & Pharm, Fac Med Bioengn, Iasi 700454, Romania.
   [Sindilar, E. V.] Univ Ion Ionescu de la Brad Agr Sci & Vet Med, Fac Vet Med, Iasi, Romania.
   [Marinoso, M. L.] Hosp del Mar, IMIM, Dept Pathol, Barcelona, Spain.
RP Fernandez, E (reprint author), Tech Univ Catalonia, Div Biomat & Bioengn, IRGASC, Avda Diagonal 647, E-08028 Barcelona, Spain.
EM enrique.fernandez@upc.edu
OI Torres, Ricardo/0000-0001-8030-5522
CR Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   [Anonymous], 1993, ANN BOOK ASTM STAND, V04, P444
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Barralet JE, 2002, BIOMATERIALS, V23, P3063, DOI 10.1016/S0142-9612(01)00401-X
   BERMUDEZ O, 1993, J MATER SCI-MATER M, V4, P389, DOI 10.1007/BF00122197
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 2004, BIOMATERIALS, V25, P741, DOI 10.1016/S0142-9612(03)00573-8
   Bohner M, 2003, BIOMATERIALS, V24, P3463, DOI 10.1016/S0142-9612(03)00234-5
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Bohner M, 2001, KEY ENG MATER, V192, P765
   BOHNER M, 2000, INJURY, V31, pD37, DOI DOI 10.1016/S0020-1383(00)80022-4
   Brown W.E., 1986, CEMENTS RES PROGR, P351
   BROWN WE, 1985, Patent No. 4518430
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   Charriere E, 2003, BIOMATERIALS, V24, P809, DOI 10.1016/S0142-9612(02)00406-4
   Cheung HS, 1997, OSTEOARTHR CARTILAGE, V5, P145, DOI 10.1016/S1063-4584(97)80009-X
   CHOW LC, 1991, MATER RES SOC SYMP P, V179, P3
   CHOW LC, 1992, J CERAM SOC JPN, V99, P927
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   COTRAN R, 2004, ROBBINS COTRAN PATHO, P14
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z
   Dreesman H., 1892, BEITR KLIN CHIR, V9, P804
   DRIESSENS FCM, 1993, J MATER SCI-MATER M, V4, P503, DOI 10.1007/BF00120130
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Fernandez E, 2005, J MATER SCI, V40, P3677, DOI 10.1007/s10853-005-0614-y
   Fernandez E, 2005, BIOMATERIALS, V26, P3395, DOI 10.1016/j.biomaterials.2004.09.023
   Fernandez E, 1998, J BIOMED MATER RES, V41, P560, DOI 10.1002/(SICI)1097-4636(19980915)41:4<560::AID-JBM7>3.0.CO;2-A
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Fernandez E, 1998, J BIOMED MATER RES, V42, P403, DOI 10.1002/(SICI)1097-4636(19981205)42:3<403::AID-JBM8>3.0.CO;2-N
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P177, DOI 10.1023/A:1008989525461
   FERNANDEZ E, 2006, WILEY ENCY BIOMEDICA, P1, DOI DOI 10.1002/9780471740360.EBS1367
   Frankenburg EP, 1998, J BONE JOINT SURG AM, V80A, P1112, DOI 10.2106/00004623-199808000-00004
   Frayssinet P, 2000, J MATER SCI-MATER M, V11, P811, DOI 10.1023/A:1008909714090
   Fulmer MT, 2002, BIOMATERIALS, V23, P751, DOI 10.1016/S0142-9612(01)00180-6
   Gisep A, 2003, J BIOMED MATER RES A, V66A, P532, DOI 10.1002/jbm.a.10593
   Gitelis S, 2001, ORTHOPEDICS, V24, P162
   Hankermeyer CR, 2002, BIOMATERIALS, V23, P743, DOI 10.1016/S0142-9612(01)00179-X
   Harada Y, 1996, J BIOMED MATER RES, V31, P19, DOI 10.1002/(SICI)1097-4636(199605)31:1<19::AID-JBM3>3.3.CO;2-L
   Heini PF, 2001, EUR SPINE J, V10, pS203, DOI 10.1007/s005860100308
   HENZE MW, 2004, CELL, V117, P285
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   Kacena MA, 2004, BIOTECH HISTOCHEM, V79, P185, DOI 10.1080/10520290400015506
   Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   LEMAITRE J, 1995, INNOV TECH BIOL MED, V16, P109
   Lemaitre J, 1987, SIL IND CERAM SCI TE, V52, P141
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   Lewis G, 2007, J BIOMED MATER RES B, V81B, P371, DOI 10.1002/jbm.b.30674
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Markovic M, 2000, KEY ENG MATER, V192-1, P773
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Nelson CL, 2002, J ORTHOPAED RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4
   Nomoto T, 2006, J MATER SCI-MATER M, V17, P379, DOI 10.1007/s10856-006-8242-x
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.0.CO;2-I
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Parikh SN, 2002, ORTHOPEDICS, V25, P1301
   PIOLETTI DP, 2000, BIOMATERIALS, V21
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Sarda S, 2003, J BIOMED MATER RES A, V65A, P215, DOI 10.1002/jbm.a.10458
   Sarkar J, 2003, J BIOL CHEM, V278, P44018, DOI 10.1074/jbc.M304926200
   Sarkar MR, 2001, J BIOMED MATER RES, V58, P329, DOI 10.1002/1097-4636(2001)58:3<329::AID-JBM1025>3.0.CO;2-9
   Silva SN, 2003, J BIOMED MATER RES A, V65A, P475, DOI 10.1002/jbm.a.10544
   SUGAMA T, 1992, J AM CERAM SOC, V75, P2076, DOI 10.1111/j.1151-2916.1992.tb04468.x
   Takagi S, 2001, J MATER SCI-MATER M, V12, P135, DOI 10.1023/A:1008917910468
   Takegami K, 1998, J BIOMED MATER RES, V43, P210, DOI 10.1002/(SICI)1097-4636(199822)43:2<210::AID-JBM16>3.0.CO;2-L
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Tyllianakis M, 2002, ORTHOPEDICS, V25, P311
   Vlad MD, 2008, J MATER SCI-MATER M, V19, P3575, DOI 10.1007/s10856-008-3513-3
   Vlad MD, 2008, SPINE, V33, P2290, DOI 10.1097/BRS.0b013e31817eccab
   VLAD MD, OSTEOGENIC BIP UNPUB
   Wulfhekel U, 1999, ACTA HAEMATOL-BASEL, V101, P7, DOI 10.1159/000040914
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   2005, MONOGRAPHIE EDITEE A
NR 83
TC 25
Z9 27
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2010
VL 6
IS 2
BP 607
EP 616
DI 10.1016/j.actbio.2009.07.010
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552GX
UT WOS:000274277800034
PM 19607944
DA 2018-10-20
ER

PT J
AU Zhang, SX
   Zhang, XN
   Zhao, CL
   Li, JA
   Song, Y
   Xie, CY
   Tao, HR
   Zhang, Y
   He, YH
   Jiang, Y
   Bian, YJ
AF Zhang, Shaoxiang
   Zhang, Xiaonong
   Zhao, Changli
   Li, Jianan
   Song, Yang
   Xie, Chaoying
   Tao, Hairong
   Zhang, Yan
   He, Yaohua
   Jiang, Yao
   Bian, Yujun
TI Research on an Mg-Zn alloy as a degradable biomaterial
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mg-Zn alloy; Degradation; Mechanical properties; Cytotoxicity; In vivo
   biocompatibility
ID IN-VIVO CORROSION; BIODEGRADABLE MAGNESIUM SCAFFOLDS; PURE MAGNESIUM;
   PART I; BONE; BEHAVIOR; VITRO; COMPOSITES; MECHANISMS; SURFACE
AB In this study a binary Mg-Zn magnesium alloy was researched as a degradable biomedical material. An Mg-Zn alloy fabricated with high-purity raw materials and using a clean melting process had very low levels of impurities. After solid solution treatment and hot working the grain size of the Mg-Zn alloy was finer and a uniform single phase was gained. The mechanical properties of this Mg-Zn alloy were suitable for implant applications, i.e. the tensile strength and elongation achieved were similar to 279.5 MPa and 18.8%, respectively.
   The results of in vitro degradation experiments including electrochemical measurements and immersion tests revealed that the zinc could elevate the corrosion potential of Mg in simulated body fluid (SBF) and reduce the degradation rate. The corrosion products on the surface of Mg-Zn were hydroxyapatite (HA) and other Mg/Ca phosphates in SBF. In addition, the influence caused by in vitro degradation on mechanical properties was studied, and the results showed that the bending strength of Mg-Zn alloy dropped sharply in the earlier stage of degradation, while smoothly during the later period.
   The in vitro cytotoxicity of Mg-Zn was examined. The result 0-1 grade revealed that the Mg-Zn alloy was harmless to L-929 cells. For in vivo experiments, Mg-Zn rods were implanted into the femoral shaft of rabbits. The radiographs illustrated that the magnesium alloy could be gradually absorbed in vivo at about 2.32 mm/yr degradation rate obtained by weight loss method. Hematoxylin and eosin (HE) stained section around Mg-Zn rods suggested that there were newly formed bone surrounding the implant.
   HE stained tissue (containing heart, liver, kidney and spleen tissues) and the biochemical measurements, including serum magnesium, serum creatinine (CREA), blood urea nitrogen (BUN), glutamic-pyruvic transaminase (GPT) and creatine kinase (CK) proved that the in vivo degradation of Mg-Zn did not harm the important organs. Moreover, no adverse effects of hydrogen generated by degradation had been observed and also no negative effects caused by the release of zinc were detected. These results suggested that the novel Mg-Zn binary alloy had good biocompatibility in vivo. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Shaoxiang; Zhang, Xiaonong; Zhao, Changli; Li, Jianan; Song, Yang; Xie, Chaoying] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, Shanghai 200240, Peoples R China.
   [Tao, Hairong; Zhang, Yan; He, Yaohua; Jiang, Yao] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
   [Zhang, Xiaonong; Bian, Yujun] Shanghai Origin Mat & Med Technol Co Ltd, Shanghai 200240, Peoples R China.
RP Zhang, XN (reprint author), Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composites, 800 DongChun Rd, Shanghai 200240, Peoples R China.
EM xnzhang@sjtu.edu.cn
FU National Natural Science Foundation of China [30772182]; Shanghai Jiao
   Tong University [YG2007MS26, YG2009MS53]; 863 High-tech Plan of China
   [2009AA03Z424]
FX The authors are grateful for the supports from the National Natural
   Science Foundation of China (No. 30772182), Shanghai Jiao Tong
   University Interdisciplinary Research Grants (Grant No. YG2007MS26 and
   YG2009MS53) and the 863 High-tech Plan of China (No.2009AA03Z424).
CR Abd El-Rahman SS, 2003, PHARMACOL RES, V47, P189, DOI 10.1016/S1043-6618(02)00336-5
   AMERICAN SOCIETY FOR TESTING MATERIALS, 1999, ANN BOOK ASTM STAND
   American Society for Testing Materials, 2004, ANN BOOK ASTM STAND
   ANSI/AAMI, 1999, 109935 ANSIAAMI ISO
   ANSI/AAMI, 1999, 1099351999 ANSIAAMI
   ASTM S., 2000, ANN BOOK ASTM STAND
   Haferkamp H., 2003, MAGNESIUM ALLOYS TEC, P226
   HASHIZUME M, 1993, MOL CELL BIOCHEM, V122, P59, DOI 10.1007/BF00925737
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Mordike B., 2006, MAGNESIUM TECHNOLOGY, P76
   Okamoto H, 1994, J PHASE EQUILIB, V15, P129, DOI DOI 10.1007/BF02667700
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   Shi ZM, 2006, SURF COAT TECH, V201, P492, DOI 10.1016/j.surfcoat.2005.11.081
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   SIMARANOV AY, 1991, PROT MET+, V27, P329
   Song G, 1997, CORROS SCI, V39, P855, DOI 10.1016/S0010-938X(96)00172-2
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   *STAND ADM PRC, 16886152003 STAND AD
   Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Yang WD, 2006, J RARE EARTH, V24, P369, DOI 10.1016/S1002-0721(06)60126-9
   Yumiko N., 1997, FUNDAM APPL TOXICOL, V37, P106
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang E, 2008, MAT SCI ENG A-STRUCT, V488, P102, DOI 10.1016/j.msea.2007.10.056
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang J, 2009, ANIMAL, V3, P1, DOI [10.1017/S1751731108003054, 10.1109/ISDRS.2009.5378133]
   ZHANG X, 2005, Patent No. 2005101117954
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 46
TC 536
Z9 579
U1 43
U2 421
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2010
VL 6
IS 2
BP 626
EP 640
DI 10.1016/j.actbio.2009.06.028
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552GX
UT WOS:000274277800036
PM 19545650
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Hoene, A
   Walschus, U
   Patrzyk, M
   Finke, B
   Lucke, S
   Nebe, B
   Schroeder, K
   Ohl, A
   Schlosser, M
AF Hoene, A.
   Walschus, U.
   Patrzyk, M.
   Finke, B.
   Lucke, S.
   Nebe, B.
   Schroeder, K.
   Ohl, A.
   Schlosser, M.
TI In vivo investigation of the inflammatory response against allylamine
   plasma polymer coated titanium implants in a rat model
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biocompatibility; In vivo investigation; Titanium; Plasma
   polymerization; Morphometry
ID SURFACE; HYALURONAN; ADHESION
AB Titanium (Ti) is an established biomaterial for bone replacement. However, facilitation of osteoblast attachment by surface modification with chemical groups could improve the implant performance. Therefore, this study aimed to evaluate the effect of a plasma polymerized allylamine (PPAAm) layer on the local inflammation in a rat model. Three series (RM76AB, RM78AB, RM77AB) of PPAAm-treated Ti plates were prepared using different plasma conditions. Twelve male LEW.1A rats received one plate of each series and one uncoated control plate implanted into the back musculature. After 7, 14 and 56 days, four rats were euthanized to remove the implants with surrounding tissue. Total monocytes/ macrophages, tissue macrophages, T-cells and MHC-class-II-positive cells were morphometrically counted. On day 14, the macrophage/monocyte number was significantly higher for the controls than for the PPAAm samples. On day 56, the RM76AB and RM78AB samples had significantly lower numbers than RM77AB and the controls. The same was found for the tissue macrophages. No change over time and no differences between the implants were found for the T-cells. For the number of MHC-class-II-positive cells, a significant decrease was found only for the RM78AB implants between day 14 and day 56. Physico-chemical analysis of the PPAAm implants revealed that the RM77AB implants had the lowest water absorption, the highest nitrogen loss and the lowest oxygen uptake after sonication. These results demonstrate that the PPAAm samples and the controls were comparable regarding local inflammation, and that different plasma conditions lead to variations in the material properties which influence the tissue reaction. (C) 2009 Actor Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Walschus, U.; Lucke, S.; Schlosser, M.] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Karlsburg, Germany.
   [Hoene, A.; Patrzyk, M.] Ernst Moritz Arndt Univ Greifswald, Dept Surg, Greifswald, Germany.
   [Finke, B.; Schroeder, K.; Ohl, A.] Leibniz Inst Plasma Sci & Technol INP, Greifswald, Germany.
   [Nebe, B.] Univ Rostock, Dept Internal Med, D-2500 Rostock, Germany.
RP Schlosser, M (reprint author), Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Karlsburg, Germany.
EM schlosse@uni-greifswald.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905; Walschus, Uwe/0000-0001-9368-8315;
   Finke, Birgit/0000-0002-5941-0376
FU Federal state of Mecklenburg-Vorpommern; Helmholtz Association of German
   Research Centres [VH-MV1]; Federal Ministry of Education and Research
   [13N9779]
FX The authors are grateful to Kirsten Tornow and Urte Kellner for
   excellent technical support. The authors thank Marion Frant from iba
   Heiligenstadt, Germany, for the zeta-potential measurements. This study
   was supported by the Federal state of Mecklenburg-Vorpommern and the
   Helmholtz Association of German Research Centres (Grant No. VH-MV1) and
   by the Federal Ministry of Education and Research (Grant No. 13N9779,
   Campus PlasmaMed).
CR Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Cohen M, 2003, BIOPHYS J, V85, P1996, DOI 10.1016/S0006-3495(03)74627-X
   Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x
   Esposito M., 2001, TITANIUM MED, P172
   FINKE B, 2009, PLASMA P PO IN PRESS, V6
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   KLEE D, 2000, ADV POLYM SCI, V149, P1
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Nebe JGB, 2008, METALLIC BIOMATERIAL, P179
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Schlosser M, 2005, J BIOMED MATER RES A, V72A, P317, DOI 10.1002/jbm.a.30240
   Schwarz F, 2007, J PERIODONTOL, V78, P2171, DOI 10.1902/jop.2007.070157
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Textor M., 2001, TITANIUM MED, P172
   Timmons RB, 2004, PLASMA POLYM FILMS, P217
   Walschus U, 2009, ACTA BIOMATER, V5, P776, DOI 10.1016/j.actbio.2008.09.003
   Wilhelm L, 2007, J BIOMED MATER RES A, V83A, P104, DOI 10.1002/jbm.a.31209
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 22
TC 24
Z9 24
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2010
VL 6
IS 2
BP 676
EP 683
DI 10.1016/j.actbio.2009.09.003
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552GX
UT WOS:000274277800041
PM 19751851
DA 2018-10-20
ER

PT J
AU Hu, Y
   Cai, KY
   Luo, Z
   Hu, R
AF Hu, Yan
   Cai, Kaiyong
   Luo, Zhong
   Hu, Ran
TI Construction of Polyethyleneimine-beta-cyclodextrin/pDNA Multilayer
   Structure for Improved In Situ Gene Transfection
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID LOW-MOLECULAR-WEIGHT; DNA DELIVERY; PLASMID DNA; NONVIRAL VECTOR;
   THIN-FILMS; THERAPY; RELEASE; SURFACE; SYSTEM
AB This study reports in situ gene delivery from gene-functionalized poly(D,L-lactic acid) (PDLLA, M(w) of around 2.0 x 10(5) g mol(-1)) films, which were constructed via layer-by-layer (LbL) assembly technique with low molecular weight polyethylenimine-beta-cyclodextrin (PEI-CD) conjugate and plasmid DNA (pDNA). PEI-CD was characterized by Fourier transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR), respectively. The buildup of multilayered PEI-CD/pDNA pairs onto PDLLA films was monitored with contact angle measurements and UV-Vis spectrometer, respectively. A sustained release of pDNA from multilayered films was observed for 28 h. The mechanism of in situ gene delivery on PDLLA film was investigated in this study as well. Spherical PEI-CD/pDNA complexes were formed and released following the deconstruction of multilayered films, which was confirmed by transmission electron microscopy (TEM) and gel electrophoresis, respectively. Surface mediated in situ gene transfection. was achieved when culturing hepatoma G2 (HepG2) and human embryonic kidney 293 (HEK293) onto PEI-CD/pDNA multilayered films. Furthermore, PEI-CD improved the gene transfection efficiency when compared with that of PEI. Such gene-functionalized biomaterial reported here has potential application in tissue engineering and implant technology.
C1 [Hu, Yan; Cai, Kaiyong; Luo, Zhong] Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China.
   [Hu, Ran] Third Mil Med Univ, Dept Clin Med, Chongqing 400038, Peoples R China.
RP Hu, Y (reprint author), Chongqing Univ, Coll Bioengn, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China.
EM kaiyong_cai@cqu.edu.cn
RI Cai, Kaiyong/B-3061-2012; 蔡, 开勇/G-1233-2011; Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
FU Natural Science Foundation of China and Chongqing [50603032,
   CSTC-2006BB4001]; Program for New Century Excellent Talents in
   University [NCET-07-0904]; Innovation Foundation of Chongqing University
   [200707A1A0190256]; "111 project" [B06023]
FX We gratefully acknowledge the financial supports from Natural Science
   Foundation of China and Chongqing (50603032 and CSTC-2006BB4001),
   Program for New Century Excellent Talents in University (NCET-07-0904),
   Innovation Foundation of Chongqing University (200707A1A0190256), and
   "111 project" (B06023).
CR Ahn CH, 2002, J CONTROL RELEASE, V80, P273, DOI 10.1016/S0168-3659(01)00547-8
   Bellocq NC, 2004, BIOCONJUGATE CHEM, V15, P1201, DOI 10.1021/bc0498119
   Blacklock J, 2007, BIOMATERIALS, V28, P117, DOI 10.1016/j.biomaterials.2006.08.035
   Cai KY, 2008, ANGEW CHEM INT EDIT, V47, P7479, DOI 10.1002/anie.200800412
   Cai KY, 2008, J BIOMED MATER RES A, V84A, P516, DOI 10.1002/jbm.a.31458
   Cook SE, 2005, J CONTROL RELEASE, V105, P151, DOI 10.1016/j.jconrel.2005.03.011
   Croyle MA, 1998, PHARMACEUT RES, V15, P1348, DOI 10.1023/A:1011985101580
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Forrest ML, 2005, BIOTECHNOL BIOENG, V89, P416, DOI 10.1002/bit.20356
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jiang CY, 2006, ADV MATER, V18, P829, DOI 10.1002/adma.200502444
   Karamouzis MV, 2007, CURR GENE THER, V7, P446, DOI 10.2174/156652307782793487
   Kim JS, 1998, J CONTROL RELEASE, V53, P175, DOI 10.1016/S0168-3659(97)00251-4
   Kim ST, 2007, BIOMATERIALS, V28, P3360, DOI 10.1016/j.biomaterials.2007.03.029
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Nixon AJ, 2007, ANN NY ACAD SCI, V1117, P310, DOI 10.1196/annals.1402.065
   Park IK, 2006, LANGMUIR, V22, P8478, DOI 10.1021/la061757s
   PETERSEN H, 2002, BIOCONJUG CHEM, V13, P12
   Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553
   Ren KF, 2006, BIOMATERIALS, V27, P1152, DOI 10.1016/j.biomaterials.2005.07.021
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Son HJ, 2007, ARCH PHARM RES, V30, P1047, DOI 10.1007/BF02993975
   TAKESHI S, 2002, MACROMOLECULES, V35, P8656
   Tang GP, 2006, J GENE MED, V8, P736, DOI 10.1002/jgm.874
   van den Beucken JJJP, 2006, BIOMATERIALS, V27, P691, DOI 10.1016/j.biomaterials.2005.06.015
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Yamashita A, 2006, CHEMBIOCHEM, V7, P297, DOI 10.1002/cbic.200500348
   Yamauchi F, 2006, BIOMATERIALS, V27, P3497, DOI 10.1016/j.biomaterials.2006.02.004
   Zanta MA, 1997, BIOCONJUGATE CHEM, V8, P839, DOI 10.1021/bc970098f
NR 34
TC 14
Z9 14
U1 1
U2 30
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD FEB
PY 2010
VL 12
IS 1-2
BP B18
EP B25
DI 10.1002/adem.200980006
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 568YL
UT WOS:000275562300012
DA 2018-10-20
ER

PT J
AU Amador, G
   Gautier, H
   Le Mabecque, V
   Miegeville, AF
   Potel, G
   Bouler, JM
   Weiss, P
   Caillon, J
   Jacqueline, C
AF Amador, G.
   Gautier, H.
   Le Mabecque, V.
   Miegeville, A. F.
   Potel, G.
   Bouler, J. -M.
   Weiss, P.
   Caillon, J.
   Jacqueline, C.
TI In Vivo Assessment of the Antimicrobial Activity of a Calcium-Deficient
   Apatite Vancomycin Drug Delivery System in a Methicillin-Resistant
   Staphylococcus aureus Rabbit Osteomyelitis Experimental Model
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID INFECTIONS; MANAGEMENT; BONE
AB The antimicrobial activities of calcium-deficient apatite loaded with different concentrations (25, 100, and 500 mu g/mg) of vancomycin as a filling biomaterial were evaluated in a methicillin-resistant Staphylococcus aureus (MRSA) rabbit acute osteomyelitis model. Bacterial counts in bone, bone marrow, and joint fluid samples treated with forms of the apatite were compared to those in tissue samples receiving a constant intravenous vancomycin infusion after 4 days. This study demonstrates that using a calcium-deficient apatite loaded with vancomycin dramatically decreases the bacterial counts in bone and marrow.
C1 [Amador, G.; Le Mabecque, V.; Miegeville, A. F.; Potel, G.; Caillon, J.; Jacqueline, C.] Fac Med, EA 3826, UPRES, UFR Med, F-44035 Nantes, France.
   [Amador, G.; Potel, G.; Caillon, J.] CHU Nantes, F-44035 Nantes, France.
   [Amador, G.; Le Mabecque, V.; Miegeville, A. F.; Potel, G.; Caillon, J.; Jacqueline, C.] Univ Nantes, F-44035 Nantes, France.
   [Gautier, H.; Bouler, J. -M.; Weiss, P.] INSERM, UMRS 791, Lab Osteoarticular & Dent Tissue Engn 1, F-44042 Nantes, France.
RP Caillon, J (reprint author), Fac Med, EA 3826, UPRES, UFR Med, 1 Rue Gaston Veil, F-44035 Nantes, France.
EM jocelyne.caillon@univ-nantes.fr
RI GAUTIER, Helene/P-3011-2014; Weiss, Pierre/P-1372-2014
OI Weiss, Pierre/0000-0002-6159-8590; Jacqueline,
   Cedric/0000-0001-9606-5930; BOULER, Jean-Michel/0000-0001-9784-5584
CR Berberich E., 2005, P 21 ANN S COMP GEOM, P99
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191
   DUCKWORTH GJ, 1993, BRIT MED J, V307, P1049, DOI 10.1136/bmj.307.6911.1049
   ESPINOZA LR, 2007, CECIL MED, P293
   Hawkshead JJ, 2009, J PEDIATR ORTHOPED, V29, P85, DOI 10.1097/BPO.0b013e3181901c3a
   HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005
   Obadia L, 2003, BIOMATERIALS, V24, P1265, DOI 10.1016/S0142-9612(02)00446-5
   Sax, 1999, Curr Infect Dis Rep, V1, P261, DOI 10.1007/s11908-999-0028-0
   WALDVOGEL FA, 1980, NEW ENGL J MED, V303, P360, DOI 10.1056/NEJM198008143030703
   Wysocki M, 2001, ANTIMICROB AGENTS CH, V45, P2460, DOI 10.1128/AAC.45.9.2460-2467.2001
   Yin LY, 2005, J ANTIMICROB CHEMOTH, V55, P995, DOI 10.1093/jac/dki109
NR 12
TC 7
Z9 8
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD FEB
PY 2010
VL 54
IS 2
BP 950
EP 952
DI 10.1128/AAC.00434-09
PG 3
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 547BR
UT WOS:000273860600056
PM 19933800
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Spyratou, E
   Asproudis, I
   Tsoutsi, D
   Bacharis, C
   Moutsouris, K
   Makropoulou, M
   Serafetinides, AA
AF Spyratou, E.
   Asproudis, I.
   Tsoutsi, D.
   Bacharis, C.
   Moutsouris, K.
   Makropoulou, M.
   Serafetinides, A. A.
TI UV laser ablation of intraocular lenses: SEM and AFM microscopy
   examination of the biomaterial surface
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE UV polymer ablation; Intraocular lenses; AFM; SEM
ID PHOTOREFRACTIVE KERATECTOMY; POLY(METHYL METHACRYLATE);
   ULTRAVIOLET-RADIATION; ORGANIC POLYMERS; YAG LASER;
   POLYMETHYLMETHACRYLATE; PMMA; IMPLANTATION; ABSORPTION; POLYIMIDE
AB Several new materials and patterns are studied for the formation and etching of intraocular lenses (IOLs), in order to improve their optical properties, to reduce the diffractive aberrations and to decrease the incidence of posterior capsular opacification. The aim of this study is to investigate the use of UV (lambda = 266 nm) laser pulses to ablate the intraocular lenses materials, and thus to provide an alternative to conventional surface shaping techniques for IOLs fabrication. Ablation experiments were conducted using various polymer substrates of hydrophobic acrylic IOLs and PMMA IOLs. We investigated the ablation efficiency and the morphology of the ablated area by imaging the surface modi. cation with atomic force microscopy (AFM) and scanning electron microscopy (SEM). The morphological appearance of IOL samples reveals the effect of a photochemical and photothermal ablation mechanism. (C) 2009 Elsevier B. V. All rights reserved.
C1 [Spyratou, E.; Bacharis, C.; Moutsouris, K.; Makropoulou, M.; Serafetinides, A. A.] Natl Tech Univ Athens, Dept Phys, Sch Appl Math & Phys Sci, Athens 15780, Greece.
   [Asproudis, I.] Univ Hosp Ioannina, Dept Ophthalmol, Ioannina 45110, Greece.
   [Tsoutsi, D.] Univ Ioannina, Dept Chem, GR-45110 Ioannina, Greece.
RP Spyratou, E (reprint author), Natl Tech Univ Athens, Dept Phys, Sch Appl Math & Phys Sci, Zografou Campus, Athens 15780, Greece.
EM ellas5@central.ntua.gr
RI Moutsouris, Kyros/M-8861-2015
OI Moutsouris, Kyros/0000-0001-7301-6589; Serafetinides,
   Alexandros/0000-0001-5284-0050
CR Bityurin N, 2003, CHEM REV, V103, P519, DOI 10.1021/cr010426b
   Bozukova D, 2007, BIOMACROMOLECULES, V8, P2379, DOI 10.1021/bm0701649
   BRANNON JH, 1985, J APPL PHYS, V58, P2036, DOI 10.1063/1.336012
   DANIELZIK B, 1986, APPL PHYS LETT, V48, P212, DOI 10.1063/1.96798
   Davison JA, 2006, J CATARACT REFR SURG, V32, P849, DOI 10.1016/j.jcrs.2006.02.006
   DOYLE RJ, 1968, BIOCHEM BIOPH RES CO, V31, P869, DOI 10.1016/0006-291X(68)90532-9
   Dyer PE, 2003, APPL PHYS A-MATER, V77, P167, DOI 10.1007/s00339-003-2137-1
   FUXBRUNER A, 1990, APPL OPTICS, V29, P5380, DOI 10.1364/AO.29.005380
   GEOFFREY TD, 1999, INVEST OPHTH VIS SCI, V40, P2752
   GORODETSKY G, 1985, APPL PHYS LETT, V46, P828, DOI 10.1063/1.95898
   Javitt JC, 2000, OPHTHALMOLOGY, V107, P2040, DOI 10.1016/S0161-6420(00)00368-7
   KRAFF MC, 1983, J AM INTRAOCUL IMPLA, V93, P301
   Krajnovich DJ, 1997, J APPL PHYS, V82, P427, DOI 10.1063/1.366290
   Laube T, 2004, OPHTHALMOLOGY, V111, P880, DOI 10.1016/j.ophtha.2003.08.031
   Lembares A, 1997, INVEST OPHTH VIS SCI, V38, P1283
   Lindstrom R L, 1994, Trans Am Ophthalmol Soc, V92, P235
   Liu ZQ, 2000, APPL SURF SCI, V165, P303, DOI 10.1016/S0169-4332(00)00499-2
   Lombardo M, 2006, J CATARACT REFR SURG, V32, P1378, DOI 10.1016/j.jcrs.2006.02.068
   Lukyanchuk B, 1996, APPL PHYS A-MATER, V62, P397, DOI 10.1007/BF01567110
   Manns F, 1996, APPL OPTICS, V35, P3338, DOI 10.1364/AO.35.003338
   McLeod SD, 2003, BRIT J OPHTHALMOL, V87, P1083, DOI 10.1136/bjo.87.9.1083
   MUNNERLYN CR, 1988, J CATARACT REFR SURG, V14, P46, DOI 10.1016/S0886-3350(88)80063-4
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   PEYMAN GA, 1989, OPHTHALMOLOGY, V96, P1160
   PITTS DG, 1970, AMER J OPT ARCH AM A, V47, P535
   PREUSS S, 1993, APPL PHYS LETT, V62, P3051
   SANKAR V, 2004, TRENDS BIOMATER ARTI, V17, P24
   Sato H., 2001, J PHOTOCH PHOTOBIO C, V2, P139
   Sen HN, 2004, J CATARACT REFR SURG, V30, P2483, DOI 10.1016/j.jcrs.2004.04.049
   Shen JH, 1997, LASER SURG MED, V21, P179, DOI 10.1002/(SICI)1096-9101(1997)21:2<179::AID-LSM9>3.0.CO;2-N
   SPEAR JD, 1991, J APPL PHYS, V70, P580, DOI 10.1063/1.349659
   Spyratou E, 2008, LASER MED SCI, V23, P179, DOI 10.1007/s10103-007-0468-4
   SRINIVASAN R, 1989, SPIE, V1064, P77
   SRINIVASAN V, 1986, J APPL PHYS, V59, P3861, DOI 10.1063/1.336728
   Steinert RF, 1999, OPHTHALMOLOGY, V106, P1243, DOI 10.1016/S0161-6420(99)00704-6
   Stoliarov SI, 2003, POLYMER, V44, P883, DOI 10.1016/S0032-3861(02)00761-9
   TSUNEKAWA M, 1994, J APPL PHYS, V76, P5598, DOI 10.1063/1.358487
   Wee SW, 2001, B KOR CHEM SOC, V22, P914
   WILSON SE, 1984, OPTHALMOLOGY, V94, P7
   ZHILIGILEI LV, 1999, APPL PHYS LETT, V74, P1341
NR 40
TC 13
Z9 13
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 1
PY 2010
VL 256
IS 8
BP 2539
EP 2545
DI 10.1016/j.apsusc.2009.10.101
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 544PM
UT WOS:000273670700042
DA 2018-10-20
ER

PT J
AU Saeed, D
   Horvath, DJ
   Massiello, AL
   Ootaki, Y
   Benefit, S
   Golding, LAR
   Fukamachi, K
AF Saeed, Diyar
   Horvath, David J.
   Massiello, Alex L.
   Ootaki, Yoshio
   Benefit, Stephen
   Golding, Leonard A. R.
   Fukamachi, Kiyotaka
TI Use of Zirconia Ceramic in the DexAide Right Ventricular Assist Device
   Journal Bearing
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Biocompatible materials; Nonpulsatile flow; Surface properties; Ceramic
   materials; Zirconium
ID BIOMATERIAL; BLOOD
AB Our aim was to evaluate the potential use of zirconium oxide (zirconia) as a blood journal bearing material in the DexAide right ventricular assist device. The DexAide titanium stator was replaced by a zirconia stator in several blood pump builds, without changing the remaining pump hardware components. In vitro pump performance and efficiency were evaluated at a predetermined pump speed and flow. Motor power consumption decreased by 20%, and DexAide battery life was extended to over 12 h on two fully charged batteries. The zirconia stator was also successfully evaluated in a severe start/stop test pre- and postexposure of the zirconia to accelerated simulated biologic aging. This study's outcomes indicated the advantages of zirconia as an alternate journal bearing material for the DexAide device.
C1 [Saeed, Diyar; Horvath, David J.; Massiello, Alex L.; Ootaki, Yoshio; Benefit, Stephen; Golding, Leonard A. R.; Fukamachi, Kiyotaka] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA.
RP Fukamachi, K (reprint author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.
CR CAO H, 2000, Patent No. 6158984
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Fukamachi K, 2005, ASAIO J, V51, P730, DOI 10.1097/01.mat.0000181031.6690.b6
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Mahmood AK, 2003, ARTIF ORGANS, V27, P169, DOI 10.1046/j.1525-1594.2003.07097.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
NR 7
TC 4
Z9 4
U1 1
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD FEB
PY 2010
VL 34
IS 2
BP 146
EP 149
DI 10.1111/j.1525-1594.2009.00757.x
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 556VL
UT WOS:000274621300015
PM 19821816
DA 2018-10-20
ER

PT J
AU Peramo, A
   Marcelo, CL
   Goldstein, SA
   Martin, DC
AF Peramo, Antonio
   Marcelo, Cynthia L.
   Goldstein, Steven A.
   Martin, David C.
TI Continuous Delivery of Biomaterials to the Skin-Percutaneous Device
   Interface Using a Fluid Pump
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Medical device; Skin biomaterial; Implant interface; Osseointegration;
   Implants
ID SODIUM LAURYL SULFATE; IN-VIVO; EXTERNAL FIXATION; IMPLANTS; PINS
AB We have developed an in vitro culture system composed of organotypic human skin explants interfaced with titanium rods attached to a fluid pump. This device was designed to mimic the process of natural mucosa delivery at the point where a rigid, permanent object penetrates living skin. Full thickness human breast skin explants discarded from surgeries were cultured at different time points at the air-liquid interface. The skin specimens were punctured to fit at the bottom of hollow cylindrical titanium rods. Sodium lauryl sulfate (SLS) was delivered continuously to the specimens through the rods by using an attached fluid pump. Histological analysis of the skin explants as well as no-pump controls was then performed. Our results show substantial differences between controls, where no material was pumped at the interface of rod-skin, and specimens treated with SLS, indicating that the technique of pumping the material is effective in producing observable epithelial changes. These results suggest that an adaptation of this type of device may be useful for the treatment of complications arising from the contact between tissues and percutaneous devices in vivo.
C1 [Peramo, Antonio; Marcelo, Cynthia L.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
   [Peramo, Antonio; Martin, David C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Goldstein, Steven A.; Martin, David C.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Goldstein, Steven A.] Univ Michigan, Dept Orthoped Surg, Ann Arbor, MI 48109 USA.
   [Martin, David C.] Univ Michigan, Ctr Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Peramo, A (reprint author), Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
EM aperamo@umich.edu
RI Martin, David/B-1838-2008
OI Martin, David/0000-0003-1195-3838
FU Army Research Office
FX Acknowledgments: We thank Harald Eberhart, College of Engineering,
   University of Michigan, for help with the glass lid design. We also
   thank Chris Strayhorn, Dental School Histology Core Facility, University
   of Michigan, for help in immunostaining techniques. This report is
   presented as part of the research efforts within the Army Research
   Office Multidisciplinary University Research Initiative award on
   Bio-Integrating Structural and Neural Prosthetic Materials and we
   gratefully acknowledge the funding provided. Invention disclosures
   related to these percutaneous delivery devices have been filed with the
   University of Michigan Technology Transfer Office and provisional
   patents have been filed with the U.S. Patent and Trademark Office.
CR ARO HT, 1993, J TRAUMA, V35, P776, DOI 10.1097/00005373-199311000-00022
   Bedoni M, 2007, J DERMATOL SCI, V46, P139, DOI 10.1016/j.jdermsci.2006.12.005
   BRANEMARK PI, 1982, SCAND J PLAST RECONS, V16, P17, DOI 10.3109/02844318209006565
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   Medalie DA, 1996, J INVEST DERMATOL, V107, P121, DOI 10.1111/1523-1747.ep12298363
   Meulenbelt HEJ, 2006, DISABIL REHABIL, V28, P603, DOI 10.1080/09638280500277032
   Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481
   Moroni A, 1996, J ORTHOP TRAUMA, V10, P236, DOI 10.1097/00005131-199605000-00003
   Peramo A, 2009, ANN BIOMED ENG, V37, P401, DOI 10.1007/s10439-008-9614-9
   Pickup JC, 2005, BIOSENS BIOELECTRON, V20, P1897, DOI 10.1016/j.bios.2004.08.016
   Torma H, 2008, J INVEST DERMATOL, V128, P1212, DOI 10.1038/sj.jid.5701170
   VARANI J, 1993, DERMATOLOGY, V187, P19, DOI 10.1159/000247191
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
NR 15
TC 3
Z9 3
U1 0
U2 2
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD FEB
PY 2010
VL 34
IS 2
BP E27
EP E33
DI 10.1111/j.1525-1594.2009.00931.x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 556VL
UT WOS:000274621300001
PM 20420587
DA 2018-10-20
ER

PT J
AU Toita, S
   Morimoto, N
   Akiyoshi, K
AF Toita, Sayaka
   Morimoto, Nobuyuki
   Akiyoshi, Kazunari
TI Functional Cycloamylose as a Polysaccharide-Based Biomaterial:
   Application in a Gene Delivery System
SO BIOMACROMOLECULES
LA English
DT Article
ID LARGE-RING CYCLODEXTRINS; PHYSICOCHEMICAL PROPERTIES; POLYAMIDOAMINE
   DENDRIMER; COMPLEX-FORMATION; AQUEOUS-SOLUTION; DRUG-DELIVERY; IN-VITRO;
   POLYETHYLENIMINE; TRANSFECTION; CONFORMATION
AB Cycloamylose (CA) exhibits difference,; in geometry and greater colloidal stability compared with amylose. Here we report the synthesis of a cationic CA derivative and its application for gene delivery Cationic CA (catCA) and cationic amylose (catAmy) were synthesized by introducing spermine groups The interactions between catCA or catAmy with plasmid DNA encoding firefly luciferase was examined by gel electrophoresis, dynamic light scattering, and transmission electron microscopy. Activity as I gene delivery system was evaluated by flow cytometry and luciferase assays. CatCA formed I condensed pDNA complex (similar to 250 nm in size). The catCA complex showed enhanced cellular uptake and greater transfection efficiency than the catAmy complex. Hemolysis by membrane destabilization and the effects of hydroxychloroquine on transfection ability suggest that the formation of a supramolecular complex with CA is important for high transfection activity These results suggested that CA can be used its new polysaccharide-based biomaterials.
C1 [Toita, Sayaka; Morimoto, Nobuyuki; Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Akiyoshi, Kazunari] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Chiyoda Ku, Tokyo 1010062, Japan.
RP Akiyoshi, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM akiyoshi.org@tmd.ac.jp
FU JST; Ministry of Education, Culture, Sports, Science Technology
   [20240047, 18GS0421]; JSPS [20-4657]
FX We thank Dr. Shin-ichi Kitamura (Osaka Prefecture University), Dr.
   Yoshinobu Terada, and Dr. Takeshi Takaha (Ezakj Glico Co, Ltd.) for
   their helpful discussions of cycloamylose. We also thank Mr Akihiko
   Watanabe and Mr Yuki Soma (Tokyo Medical and Dental University) for
   technical help and advice. This work was supported by the "Research
   Program on Development of Innovative Technology" from JST, a
   Grant-in-Aid for Scientific Research from the Ministry of Education,
   Culture, Sports, Science & Technology (nos 20240047 and 18GS0421), and
   by a JSPS fellowship grant (no. 20-4657).
CR Arima H, 2001, BIOCONJUGATE CHEM, V12, P476, DOI 10.1021/bc000111n
   Ayame H, 2008, BIOCONJUGATE CHEM, V19, P882, DOI 10.1021/bc700422s
   Azzam T, 2004, J CONTROL RELEASE, V96, P309, DOI 10.1016/j.jconrel.2004.01.022
   Behr JP, 1997, CHIMIA, V51, P34
   Gonzalez H, 1999, BIOCONJUGATE CHEM, V10, P1068, DOI 10.1021/bc990072j
   Henry SM, 2006, BIOMACROMOLECULES, V7, P2407, DOI 10.1021/bm060143z
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Jacob J., 1998, ANGEW CHEM INT EDIT, V37, P605
   Kanatani I, 2006, J CONTROL RELEASE, V116, P75, DOI 10.1016/j.jconrel.2006.09.001
   Karinaga R, 2006, BIOMATERIALS, V27, P1626, DOI 10.1016/j.biomaterials.2005.08.023
   Kihara F, 2003, BIOCONJUGATE CHEM, V14, P342, DOI 10.1021/bc025613a
   Kitamura S, 1999, MACROMOL RAPID COMM, V20, P612, DOI 10.1002/(SICI)1521-3927(19991201)20:12<612::AID-MARC612>3.0.CO;2-E
   Kitamura S, 1997, CARBOHYD RES, V304, P303, DOI 10.1016/S0008-6215(97)00278-4
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Machida S, 2000, FEBS LETT, V486, P131, DOI 10.1016/S0014-5793(00)02258-4
   Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g
   Mun S, 2009, CARBOHYD POLYM, V77, P223, DOI 10.1016/j.carbpol.2008.12.041
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Pun SH, 2004, BIOCONJUGATE CHEM, V15, P831, DOI 10.1021/bc049891g
   Saenger WR, 1998, CHEM REV, V98, P1787, DOI 10.1021/cr9700181
   Shim MS, 2008, BIOMACROMOLECULES, V9, P444, DOI 10.1021/bm7007313
   Shimada J, 1996, MACROMOLECULES, V29, P6408, DOI 10.1021/ma9603387
   Takaha T, 1996, J BIOL CHEM, V271, P2902, DOI 10.1074/jbc.271.6.2902
   Tomono K, 2002, J INCL PHENOM MACRO, V44, P267, DOI 10.1023/A:1023044902943
   Ueda H, 2002, J INCL PHENOM MACRO, V44, P403, DOI 10.1023/A:1023063718215
   Ueda H, 2002, J INCL PHENOM MACRO, V44, P53, DOI 10.1023/A:1023055516398
   Wakabayashi D., 2004, BIOMACROMOLECULES, V5, P2128
   Xiong XB, 2009, BIOMATERIALS, V30, P242, DOI 10.1016/j.biomaterials.2008.09.025
   Yamashita A, 2006, CHEMBIOCHEM, V7, P297, DOI 10.1002/cbic.200500348
   Yang S, 2009, J CONTROL RELEASE, V135, P159, DOI 10.1016/j.jconrel.2008.12.015
NR 30
TC 35
Z9 36
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2010
VL 11
IS 2
BP 397
EP 401
DI 10.1021/bm901109z
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 551MZ
UT WOS:000274215000012
PM 20039667
DA 2018-10-20
ER

PT J
AU Hill, P
   Brantley, H
   Van Dyke, M
AF Hill, Paulina
   Brantley, Helen
   Van Dyke, Mark
TI Some properties of keratin biomaterials: Kerateines
SO BIOMATERIALS
LA English
DT Article
DE Keratin; Biomaterial; Protein; Hydrogel; Scaffold; Hair
ID HUMAN HAIR; WOOL; FILMS; DIFFERENTIATION; CULTIVATION; FABRICATION;
   FOLLICLE; MOUSE; MODEL; HYDROXYAPATITE
AB Keratins are a family of structural proteins that can be isolated from a variety of tissues. "Soft" keratins are cytoskeletal elements found in epithelial tissues while protective tissues such as nails. hooves, and hair are composed of "hard" keratins. Hard keratins have been the subject of biomaterials investigations for more than three decades. Numerous methods exist for denaturing these proteins which are characterized by a high sulfur content and extensive disulfide bonding, under either oxidative or reductive conditions, extracting them from tissue and processing them into various physical states such as gels, films, coatings, and fibers. Kerateines or keratoses (oxidatively or reductively derived, respectively), alone or in combination with other biomaterials, have been tested in a small number of systems to demonstrate feasibility for medical applications such as wound healing, bone regeneration, hemostasis, and peripheral nerve repair. These investigations have shown generally good compatibility with cells and tissues, but the focus of prior investigations has been fairly narrow, and as a result there is relatively little published data on the general behavior of keratin biomaterials in biological systems beyond cell culture assays. The goal of this study was to produce a reduced form of keratin biomaterial, kerateine, using a typical and well-published technique, and characterize several aspects of its behavior that may have implications to its general use as a biomaterial. Kerateines were extracted from human hair, fabricated into gels and porous scaffolds, characterized, and placed into biological systems to determine their interactions with cells and tissue. Initially, the proteins were analyzed for molecular weight and amino acid content, as well as their ability to facilitate cell adhesion and proliferation. Crosslinked hydrogels were investigated for their hydrolytic stability in vitro; the micro-architecture and in vivo tissue response of lyophilized gels was also studied. These experiments both confirmed and expanded earlier findings that kerateines demonstrate excellent compatibility in biological systems. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Hill, Paulina; Brantley, Helen; Van Dyke, Mark] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Van Dyke, M (reprint author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM mavandyk@wfubmc.edu
FU Errett Fisher Foundation; US Army
FX The authors gratefully acknowledge the funding support provided by the
   Errett Fisher Foundation and the US Army. The authors would also like to
   thank Jacquie Burnell for assistance with histological analysis, Sang
   Jin Lee for SEM support, and Jillian Rouse for conducting the thiol
   assays.
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anker CA, 1972, US patent, Patent No. 3642498
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Belcarz A, 2009, J BIOMED MATER RES B, V89B, P102, DOI 10.1002/jbm.b.31192
   BENNETT HPJ, 1986, J CHROMATOGR, V359, P221, DOI 10.1016/0021-9673(86)80076-0
   BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204
   BREINL F, 1907, Z PHYSL CHEM, V52, P158
   BUCHANAN JH, 1977, BIOCHEM J, V167, P489, DOI 10.1042/bj1670489
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   EARLAND C, 1956, BIOCHIM BIOPHYS ACTA, V22, P405, DOI 10.1016/0006-3002(56)90048-8
   ELLMAN G, 1959, ARCH BIOCHEM BIOPHYS, V82, P7
   Fujii T, 2008, J MATER SCI-MATER M, V19, P2335, DOI 10.1007/s10856-007-3341-x
   Goddard DR, 1934, J BIOL CHEM, V106, P605
   HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D
   Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354
   IDE Y, 2004, J SOC FIBER SCI TECH, V60, P844
   ITO H, 1982, KOBUNSHI RONBUNSHU, V39, P249, DOI 10.1295/koron.39.249
   JONES CM, 1991, DEVELOPMENT, V111, P531
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Kawano Y, 1975, KAGAKU TO SEIBUTSU, V13, P291
   LYONS KM, 1990, DEVELOPMENT, V109, P833
   MACLAREN JA, 1962, AUST J CHEM, V15, P824, DOI 10.1071/CH9620824
   MIES HH, 1987, J CHROMATOGR, V405, P365, DOI 10.1016/S0021-9673(01)81778-7
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   ODONNELL IJ, 1964, AUST J BIOL SCI, V17, P973, DOI 10.1071/BI9640973
   Okamoto S., 1977, NIPPON SHOKUHIN KOGY, V24, P40
   Panteleyev AA, 2001, J CELL SCI, V114, P3419
   Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381
   ROTHMAN J, 1991, Patent No. 9102538
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   SIMMONDS DH, 1958, TEXT RES J, V28, P314
   Stenn K S, 1994, J Dermatol Sci, V7 Suppl, pS109, DOI 10.1016/0923-1811(94)90042-6
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tanabe T, 2004, MAT SCI ENG C-BIO S, V24, P441, DOI 10.1016/j.msec.2003.11.004
   THOMAS H, 1986, INT J BIOL MACROMOL, V8, P258, DOI 10.1016/0141-8130(86)90038-3
   THOMPSON E.O.P., 1959, AUSTRALIAN JOUR BIOL SCI, V12, P282
   VALHERIE I, 1992, THESIS I NATL SCI AP
   van de Locht M, 1987, MELLIAND TEXTILBERIC, V10, P780
   Van Dyke ME, 2002, ABSTR PAP AM CHEM S, V224, pU36
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   WIDRA A, 2004, Patent No. 6746836
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
NR 48
TC 132
Z9 137
U1 5
U2 108
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 4
BP 585
EP 593
DI 10.1016/j.biomaterials.2009.09.076
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 538EP
UT WOS:000273167400001
PM 19822360
DA 2018-10-20
ER

PT J
AU Rogers, TH
   Babensee, JE
AF Rogers, Todd H.
   Babensee, Julia E.
TI Altered adherent leukocyte profile on biornaterials in Toll-like
   receptor 4 deficient mice
SO BIOMATERIALS
LA English
DT Article
DE Biomaterials; Toll-like receptors; Host response; Acute inflammation
ID ACUTE INFLAMMATORY RESPONSES; FIBRINOGEN ADSORPTION; TISSUE RESPONSES;
   DENDRITIC CELLS; BIOMATERIALS; TOLL-LIKE-RECEPTOR-4; ADHESION; ANTIGEN;
   TLR4; RECOGNITION
AB The host response to a biomaterial is characterized by both acute recruitment and attachment of cells as well as chronic encapsulating tissue reaction. The implantation procedure induces production of damage-associated molecular patterns (DAMPs) which may contribute to host recognition of the material. Toll-like receptors (TLRs) are pattern recognition receptors (PRRs) that bind not only pathogen-associated molecular patterns (PAMPs) but also DAMPs. We sought to investigate whether TLR4/DAMP interactions were involved in the acute and chronic inflammatory response to an implanted biomaterial. When PET discs were implanted intraperitoneally for 16 h, no differences were found in the number of leukocytes recruited between TLR4(+) (C57BL/10J) and TLR4(-) (C57BL/10ScNJ) mice. However, a significant shift in the leukocyte profile on the biomaterial surface was observed for TLR4(-) mice. While the total number of adherent cells was the same in both strains, TLR4(+) mice had a profile with equivalent neutrophil and monocyte/macrophage presence on the material surface, and TLR4(-) mice had a profile of predominantly neutrophils with fewer monocyte/macrophages. When implants were placed subcutaneously for 2 weeks, the fibrous capsule thicknesses were not different between TLR4(+) and TLR4(-) mouse strains. These findings illustrate that TLR4 may play a role in the initial recognition of a biomaterial by directing the adhesive cellular profile. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr Atlanta, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU Georgia Tech/Emory Center; Engineering Research Council; National
   Science Foundation [EEC-9731643]
FX The authors would like to thank Dr. Andres Garcia of Georgia Institute
   of Technology for providing the PET material for implantation. This work
   was supported by funding from the Georgia Tech/Emory Center (GTEC) for
   the Engineering of Living Tissues, an Engineering Research Council (ERC)
   program of the National Science Foundation under award number
   EEC-9731643.
CR Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BARSNESS K, 2004, AM J PHYSIOL-REG I, V281, pR592
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   BETTINGER DA, 1994, J TRAUMA, V36, P810, DOI 10.1097/00005373-199406000-00010
   Brodbeck WG, 2003, J MATER SCI-MATER M, V14, P671, DOI 10.1023/A:1024951330265
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603
   Chen CJ, 2006, J CLIN INVEST, V116, P2262, DOI 10.1172/JCI28075
   Ding ZM, 1999, J IMMUNOL, V163, P5029
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Hamdy S, 2008, VACCINE, V26, P5046, DOI 10.1016/j.vaccine.2008.07.035
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Levy RM, 2006, AM J PHYSIOL-REG I, V291, pR970, DOI 10.1152/ajpregu.00793.2005
   Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08
   Monick MM, 2002, AM J PHYSIOL-LUNG C, V283, pL390, DOI 10.1152/ajplung.00437.2001
   Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200
   Paterson HM, 2003, J IMMUNOL, V171, P1473, DOI 10.4049/jimmunol.171.3.1473
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathol.3.121806.151456
   Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268
   Schlosser E, 2008, VACCINE, V26, P1626, DOI 10.1016/j.vaccine.2008.01.030
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Tang LP, 2002, J BIOMED MATER RES, V62, P471, DOI 10.1002/jbm.10271
   Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200
   Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127
   Ward JR, 2006, BIOCHEM BIOPH RES CO, V341, P299, DOI 10.1016/j.bbrc.2005.12.188
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 49
TC 19
Z9 20
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 4
BP 594
EP 601
DI 10.1016/j.biomaterials.2009.09.077
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 538EP
UT WOS:000273167400002
PM 19818491
OA Green Accepted
DA 2018-10-20
ER

PT J
AU George, PA
   Quinn, K
   Cooper-White, JJ
AF George, Peter A.
   Quinn, Katie
   Cooper-White, Justin J.
TI Hierarchical scaffolds via combined macro- and micro-phase separation
SO BIOMATERIALS
LA English
DT Article
DE Nanotechnology; Integrin clustering; Self assembly; Surface
   modification; Block copolymer
ID COPOLYMER; THERMODYNAMICS
AB Recent advances in biomaterial surface engineering have shown that surface biomechanical, spatial and topographical properties can elicit control over fundamental biological processes such as cell shape, proliferation, differentiation and apoptosis. Along these lines, we have very recently shown that the self-assembly of block copolymers into thin films can be used as an extremely labile method to precisely position cellular adhesion molecules, at nanometre lateral spacings, to effect control over cell attachment and morphology. Here, we extend our work in 2-dimensional block copolymer films into the production of 3-dimensional porous block copolymer scaffolds. The reported method combines macro-scale temperature induced phase separation and micro-phase separation of block copolymers to produce highly porous scaffolds with surfaces comprised of nano-scale self-assembled block copolymer domains, representing a significant advance in currently available scaffold engineering technologies. The phase behaviour of these polymer-solvent systems is described and potential mechanisms leading to the observed structure formation are presented. The nano-domains have thereafter been functionalised with CGRGDS peptides throughout the scaffold and shown to effect changes in cell attachment and spreading, in agreement with previous 2-dimensional studies. These multi-scale, functional scaffolds are easy to manufacture and scaleable, making them ideal candidates for tissue engineering applications. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
C1 [Cooper-White, Justin J.] Univ Queensland, Sch Engn, Brisbane, Qld 4072, Australia.
   Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Sch Engn, Bld 75,Cnr Cooper & Coll Rds, Brisbane, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Cooper-White, Justin/B-2567-2010
OI Cooper-White, Justin/0000-0002-1920-8229
CR ALBERTS B, 1994, MOL BIOL CELL
   BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521
   Boontongkong Y, 2002, MACROMOLECULES, V35, P3647, DOI 10.1021/ma0117357
   FLORY PJ, 1956, PROC R SOC LON SER-A, V234, P60, DOI 10.1098/rspa.1956.0015
   GEORGE PA, 2009, BIOMATERIALS
   George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Kim HD, 2004, BIOMATERIALS, V25, P2319, DOI 10.1016/j.biomaterials.2003.09.011
   Macchiarini P., LANCET, V372, P2023
   Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Vacanti CA, 2006, J CELL MOL MED, V10, P569, DOI 10.2755/jcmm010.003.20
   VACANTI JP, 1988, J PEDIAT SURG, V23
   van Krevelen D. W, 1990, PROPERTIES POLYM THE
NR 14
TC 46
Z9 46
U1 2
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 4
BP 641
EP 647
DI 10.1016/j.biomaterials.2009.09.094
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 538EP
UT WOS:000273167400007
PM 19836830
DA 2018-10-20
ER

PT J
AU Puckett, SD
   Taylor, E
   Raimondo, T
   Webster, TJ
AF Puckett, Sabrina D.
   Taylor, Erik
   Raimondo, Theresa
   Webster, Thomas J.
TI The relationship between the nanostructure of titanium surfaces and
   bacterial attachment
SO BIOMATERIALS
LA English
DT Article
DE Titanium; Nanotopography; Bacteria; Adhesion; Fibronectin
ID INCREASED OSTEOBLAST; NANOPHASE CERAMICS; STAPHYLOCOCCUS-AUREUS;
   EXTERNAL FIXATION; STAINLESS-STEEL; ADHESION; INFECTIONS; ADHERENCE;
   BIOFILMS; ADSORPTION
AB Infection of an orthopedic prosthesis is undesirable and causes a decrease in the success rate of an implant. Reducing the adhesion of a broad range of bacteria could be an attractive means to decrease infection and allow for subsequent appropriate tissue integration with the biomaterial surface. In this in vitro study, nanometer sized topographical features of titanium (Ti) surfaces, which have been previously shown to enhance select protein adsorption and subsequent osteoblast (bone-forming cell) functions, were investigated as a means to also reduce bacteria adhesion. This study examined the adhesion of Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa on conventional Ti, nanorough Ti produced by electron beam evaporation, and nanotubular and nanotextured Ti produced by two different anodization processes. This study found that compared to conventional (nano-smooth) Ti, the nanorough Ti surfaces produced by electron beam evaporation decreased the adherence of all of the aforementioned bacteria the most. The conventional and nanorough Ti surfaces were found to have crystalline TiO2 while the nanotubular and nanotextured Ti surfaces were found to be amorphous. The surface chemistries were similar for the conventional and nanorough Ti while the anodized Ti surfaces contained fluorine. Therefore, the results of this study in vitro study demonstrated that certain nanometer sized Ti topographies may be useful for reducing bacteria adhesion while promoting bone tissue formation and, thus, should be further studied for improving the efficacy of Ti-based orthopedic implants. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02917 USA.
   Brown Univ, Dept Orthopaed, Providence, RI 02917 USA.
RP Webster, TJ (reprint author), Brown Univ, Div Engn, Providence, RI 02917 USA.
EM thomas_webster@brown.edu
FU VA Pre-Doctoral Associated Health Rehabilitation Research; Department of
   Veterans Affairs [A3772C]; National Science Foundation
FX The authors wish to acknowledge the VA Pre-Doctoral Associated Health
   Rehabilitation Research Fellowship Program and the Department of
   Veterans Affairs, RR & D, A3772C for funding along with the National
   Science Foundation Graduate K-12 Teaching Fellowship. The authors also
   wish to acknowledge the Microelectronics Facility and the Leduc
   Bioimaging Facility at Brown University as well as the University of
   Rhode Island Surface Characterization Laboratory. Lastly, the authors
   would like to thank Mr. Anthony McCormick for his help with SEM.
CR Anagnostou F, 2006, BIOMATERIALS, V27, P3912, DOI 10.1016/biomaterials.2006.03.004
   Baquero F, 1997, J ANTIMICROB CHEMOTH, V39, P1, DOI 10.1093/jac/39.suppl_1.1
   BURKE DW, 1991, J BONE JOINT SURG BR, V73, P33
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Cohen A, 2007, NANOSCALE RES LETT, V2, P385, DOI 10.1007/s11671-007-9069-1
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Correa CB, 2009, J PROSTHODONT, V18, P382, DOI 10.1111/j.1532-849X.2009.00463.x
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Eick S, 2004, J ORAL REHABIL, V31, P278, DOI 10.1046/j.0305-182X.2003.01233.x
   Ejiofor JU, 2004, INT J POWDER METALL, V40, P43
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   GREEN SA, 1984, J BONE JOINT SURG AM, V66A, P1092, DOI 10.2106/00004623-198466070-00017
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hyde FW, 1997, J IND MICROBIOL BIOT, V19, P142, DOI 10.1038/sj.jim.2900448
   Katsikogianni M, 2006, J MATER SCI-MATER M, V17, P679, DOI 10.1007/s10856-006-9678-8
   Khang D, 2007, BIOMATERIALS, V28, P4756, DOI 10.1016/j.biomaterials.2007.07.018
   Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Lerouge S, 1996, J BIOMED MATER RES, V32, P627, DOI 10.1002/(SICI)1097-4636(199612)32:4<627::AID-JBM16>3.0.CO;2-A
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   Miller R, 2005, J RESIDUALS SCI TECH, V2, P1
   Moroni A, 2002, J ORTHOP TRAUMA, V16, P189, DOI 10.1097/00005131-200203000-00009
   Palma M, 1999, J BACTERIOL, V181, P2840
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Puckett S, 2008, INT J NANOMED, V3, P229
   Raulio M, 2008, J IND MICROBIOL BIOT, V35, P751, DOI 10.1007/s10295-008-0343-8
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   vanLenthe GH, 1997, J BONE JOINT SURG BR, V79B, P117, DOI 10.1302/0301-620X.79B1.6808
   VONRECUM AF, 1981, CRC CR REV BIOM ENG, V5, P37
   Ward BC, 2007, MAT SCI ENG C-BIO S, V27, P575, DOI 10.1016/j.msec.2006.05.032
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WENTWORTH JS, 1991, BIOFOULING, V4, P99
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zlowodzki M, 2007, INT ORTHOP, V31, P409, DOI 10.1007/s00264-006-0187-7
NR 46
TC 305
Z9 307
U1 18
U2 219
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 4
BP 706
EP 713
DI 10.1016/j.biomaterials.2009.09.081
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 538EP
UT WOS:000273167400013
PM 19879645
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Tao, AR
   DeMartini, DG
   Izumi, M
   Sweeney, AM
   Holt, AL
   Morse, DE
AF Tao, Andrea R.
   DeMartini, Daniel G.
   Izumi, Michi
   Sweeney, Alison M.
   Holt, Amanda L.
   Morse, Daniel E.
TI The role of protein assembly in dynamically tunable bio-optical tissues
SO BIOMATERIALS
LA English
DT Article
DE Nanoparticle; Self Assembly; Protein; Biomimetic material; Structural
   Color; Lens
ID POLYMER NANOCOMPOSITES; IRIDOPHORES; CRYSTALLIN; HYDROGELS; COLOR
AB Cephalopods are nicknamed the "masters of disguise" for their highly evolved camouflage mechanisms, including the hallmark ability to rapidly change the color and reflectance of their skin. Previously, reflectin proteins were identified as the major biomaterial component of iridosomes [1], specialized light-reflecting architectures that contribute intense structural color to squid skin, eyes, and organs [2-5]. Supramolecular assembly of reflectin has been recognized as a key property in the protein's function [6]. Here, we report the first cloning and expression of a specific reflectin protein found in the responsive iridophore cells of the squid Loligo pealeii, which are unique in their ability to switch on/off and change color. We demonstrate that these iridophores can be chemically tuned to reflect the entire visible spectrum. By examining recombinant reflectin, we show that this dynamic optical function is facilitated by the hierarchical assembly of nanoscale protein particles that elicit large volume changes upon condensation. These findings provide insight into the design and synthesis of biomaterials for complex, responsive function in optical applications. (C) 2009 Elsevier Ltd. All rights reserved.
C1 Univ Calif Santa Barbara, Inst Collaborat Biotechnol, Santa Barbara, CA 93106 USA.
   Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.
RP Tao, AR (reprint author), Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA.
EM atao@ucsd.edu; d_morse@lifesci.ucsb.edu
RI DeMartini, Daniel/D-1264-2017
OI DeMartini, Daniel/0000-0002-2377-3749
FU U.S. Army Research Office [W911NF-06-1-0285]; University of California
   Office
FX This research was supported by grant #W911NF-06-1-0285 from the U.S.
   Army Research Office. We thank K. Linberg and Y. Li from UC Santa
   Barbara and R. Hanlon and L. Mathger from the Marine Biological
   Laboratory at Woods Hole for helpful discussions. We also thank T.
   Athens from Outer Banks Commercial Fisheries (Oxnard, CA) for providing
   live squid and D. Ceperley from SRI (Menlo Park, CA) for use of the
   MATLAB script. We gratefully acknowledge the Materials Research
   Laboratory and California NanoSystems Institute at UC Santa Barbara for
   use of their facilities. A.R.T. gratefully acknowledges the University
   of California Office of the President Postdoctoral Fellowship Program.
CR ARNOLD JM, 1974, BIOL BULL, V147, P522, DOI 10.2307/1540737
   ARNOLD JM, 1967, J ULTRA MOL STRUCT R, V20, P410, DOI 10.1016/S0022-5320(67)80109-6
   Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307
   CLONEY RA, 1983, AM ZOOL, V23, P581
   COOPER KM, 1990, CELL TISSUE RES, V259, P15, DOI 10.1007/BF00571425
   Crookes WJ, 2004, SCIENCE, V303, P235, DOI 10.1126/science.1091288
   DAN WU, 1993, ANGEW CHEM INT EDIT, V32, P819
   Dawson KA, 2002, CURR OPIN COLLOID IN, V7, P218, DOI 10.1016/S1359-0294(02)00052-3
   Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024
   Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352
   Hanlon RT, 1999, BIOL BULL, V197, P49, DOI 10.2307/1542996
   Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843
   Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6
   IZUMI M, J R SOC INT IN PRESS, DOI DOI 10.1098/RSIF2009.0299
   Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   Kramer RM, 2007, NAT MATER, V6, P533, DOI 10.1038/nmat1930
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   Lyman J, 1940, J MAR RES, V3, P134
   MIROW S, 1972, Z ZELLFORSCH MIK ANA, V125, P176, DOI 10.1007/BF00306787
   PIATIGORSKY J, 1977, SCIENCE, V196, P1345, DOI 10.1126/science.559349
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   WANG N, 1994, BIOPHYS J, V66, P2181, DOI 10.1016/S0006-3495(94)81014-8
NR 26
TC 46
Z9 46
U1 3
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 5
BP 793
EP 801
DI 10.1016/j.biomaterials.2009.10.038
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548FV
UT WOS:000273946100001
PM 19906421
DA 2018-10-20
ER

PT J
AU Sivaraman, B
   Latour, RA
AF Sivaraman, Balakrishnan
   Latour, Robert A.
TI The relationship between platelet adhesion on surfaces and the structure
   versus the amount of adsorbed fibrinogen
SO BIOMATERIALS
LA English
DT Article
DE Adsorption; Fibrinogen; Protein adsorption; Platelet adhesion;
   Haemocompatibility
ID PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; PROCOAGULANT
   ACTIVITY; BLOOD COMPATIBILITY; ADSORPTION; BINDING; CONFORMATION;
   FIBRONECTIN; ACTIVATION; BEHAVIOR
AB While platelet adhesion to biomaterial surfaces is widely recognized to be related to adsorbed fibrinogen (Fg), it has remained controversial whether platelet adhesion is in response to the adsorbed amount or the adsorbed conformation of this protein. To address this issue, we designed a series of platelet adhesion studies to clearly separate these two factors, thus enabling us to definitively determine whether it is the amount or the conformation of adsorbed Fg that mediates platelet response. Fg was adsorbed to a broad range of surface chemistries from a wide range of solution concentrations, with the amount and conformation of adsorbed Fg determined by absorbance and circular dichroism (CD) spectropolarimetry, respectively. Platelet adhesion response was determined by lactate dehydrogenase (LDH) assay and scanning electron microscopy (SEM). Our results show that platelet adhesion is strongly correlated with the degree of adsorption-induced unfolding of Fg (r(2) = 0.96) with essentially no correlation with the amount of Fg adsorbed (r(2) = 0.04). Platelet receptor inhibitor studies using an RGDS peptide reduced platelet adhesion by only about 50%, and SEM results show that adherent platelets after RGDS blocking were much more rounded with minimal extended filopodia compared with the unblocked platelets. These results provide definitive proof that the conformation of adsorbed Fg is the critical determinant of platelet adhesion, not the amount of Fg adsorbed, with adsorption-induced unfolding potentially exposing two distinctly different types of platelet binding sites in Fg; one that induces platelet adhesion alone and one that induces both platelet adhesion and activation. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Sivaraman, Balakrishnan; Latour, Robert A.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, 501 Rhodes Engn Ctr, Clemson, SC 29634 USA.
EM latourr@clemson.edu
RI Sivaraman, Balakrishnan/G-6886-2012
OI Sivaraman, Balakrishnan/0000-0002-4538-8665
FU NIH [P20 RR-016461]; National Center for Research Resources
FX The authors would like to thank numerous volunteers for kindly donating
   blood for these studies, as well as the staff at the Redfern Health
   Center at Clemson University for their assistance with the blood-draw
   process. We are grateful to Dr. Dan Simionescu, Dr. Agneta Simionescu,
   Aby Abraham Thyparambil and Dr. Kenan Fears for valuable discussions and
   technical assistance. We are also grateful to Dr. James Harriss at
   Clemson University, for fabrication of the gold-coated surfaces used in
   our studies. This project was partially supported by NIH Grant Number
   P20 RR-016461 from the National Center for Research Resources.
CR Abraham GA, 2001, BIOMATERIALS, V22, P1971, DOI 10.1016/S0142-9612(00)00381-1
   AKAIKE T, 1979, KOBUNSHI RONBUNSHU, V36, P217, DOI 10.1295/koron.36.217
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Dee K.C., 2002, INTRO TISSUE BIOMATE, P37
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B
   Dyr JE, 1998, SENSOR ACTUAT B-CHEM, V51, P268, DOI 10.1016/S0925-4005(98)00204-4
   Fears KP, 2009, LANGMUIR, V25, P9319, DOI 10.1021/la901885d
   GARTNER TK, 1985, J BIOL CHEM, V260, P1891
   Gooding JJ, 2003, ELECTROANAL, V15, P81, DOI 10.1002/elan.200390017
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Grunkemeier JM, 2001, J BIOMAT SCI-POLYM E, V12, P1, DOI 10.1163/156856201744416
   HAVERSTICK DM, 1985, BLOOD, V66, P946
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Latour R. A., 2008, ENCY BIOMATERIALS BI, P270
   LINDON JN, 1986, BLOOD, V68, P355
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Qiu JS, 2005, J CHROMATOGR A, V1073, P263, DOI 10.1016/j.chroma.2004.10.045
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Van de Walle GR, 2007, BLOOD, V109, P595, DOI 10.1182/blood-2005-11-011775
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
NR 34
TC 147
Z9 150
U1 3
U2 80
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 5
BP 832
EP 839
DI 10.1016/j.biomaterials.2009.10.008
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548FV
UT WOS:000273946100006
PM 19850334
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, SF
   Kucharski, C
   Doschak, MR
   Sebald, W
   Uludag, H
AF Zhang, Sufeng
   Kucharski, Cezary
   Doschak, Michael R.
   Sebald, Walter
   Uludag, Hasan
TI Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery
SO BIOMATERIALS
LA English
DT Article
DE Bone morphogenetic protein-2; Polyethylenimine-PEG; Bovine serum
   albumin; Nanoparticle; In vivo; Ectopic bone formation
ID BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; RAT ECTOPIC MODEL;
   IN-VIVO; BIOMATERIAL CARRIERS; GENE DELIVERY; PHARMACOKINETICS;
   OSTEOINDUCTION; FUSION; REGENERATION
AB Bone Morphogenetic Protein-2 (BMP-2) plays an important role in stimulating new bone formation, and has been utilized in clinical bone repair by implantation. In this study, we report a nanoparticulate (NP) system for BMP-2 delivery based on bovine serum albumin (BSA) NPs stabilized with a poly(ethylene glycol) modified polyethylenimine (PEI-PEG) coating. PEI-PEG with different PEG substitutions were synthesized, and the cell viability assay showed PEG substitution greatly reduced the cytotoxicity of the native PEI. Furthermore, PEI-PEG coated BSA NPs demonstrated smaller size and decreased zeta potential compared to PEI-coated NPs. The bioactivity of the encapsulated BMP-2 and the toxicity of PEI-PEG coated NPs were examined by the alkaline phosphatase (ALP) induction assay and the MTT assay, respectively, using human C2C12 cells. The results indicated that BMP-2 remained bioactive in NPs and PEI-PEG coating was advantageous in reducing the NP toxicity as compared to PEI. A 7-day pharmacokinetics study showed the BMP-2 retention in PEI-PEG coated NPs was similar to the uncoated NPs, but lower than that of the PEI-coated NPs. The osteoinductivity of BMP-2 delivered in NPs was determined by subcutaneous implantation in rats, and the results revealed that PEI-PEG coated BSA NPs induced significant de novo bone formation after implantation, while PEI-coated NPs demonstrated much less bone formation. We conclude that BMP-2 delivered by PECylated PEI-coated BSA NPs displays favorable biocompatibility and promotes new bone formation after implantation. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Zhang, Sufeng; Kucharski, Cezary; Uludag, Hasan] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2M7, Canada.
   [Doschak, Michael R.; Uludag, Hasan] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2M7, Canada.
   [Sebald, Walter] Univ Wurzburg, Theodor Boveri Inst Biowissensch, Wurzburg, Germany.
   [Uludag, Hasan] Univ Alberta, Fac Med, Dept Biomed Engn, Edmonton, AB, Canada.
RP Uludag, H (reprint author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2M7, Canada.
EM hasan.uludag@ualberta.ca
OI Doschak, Michael/0000-0002-0293-6596
FU Canadian Institutes of Health Research (CIHR); Canadian Foundation for
   Innovation (CFI); Alberta Heritage Foundation for Medical Research
   (AHFMR)
FX The authors thank the technicians, Mr. Charles Tran and Ms. Jillian
   Chapman in the Pharmacy Micro-CT (PMCT) imaging laboratory (Faculty of
   Pharmacy and Pharmaceutical Sciences, University of Alberta), for their
   assistance with the micro-CT study. This project was financially
   supported by an operating grant from the Canadian Institutes of Health
   Research (CIHR). Infrastructure support was provided by Canadian
   Foundation for Innovation (CFI) and Alberta Heritage Foundation for
   Medical Research (AHFMR).
CR Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   Barboza EP, 2000, J PERIODONTOL, V71, P488, DOI 10.1902/jop.2000.71.3.488
   Baskin DS, 2003, SPINE, V28, P1219, DOI 10.1097/00007632-200306150-00003
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   Boyne PJ, 2001, J BONE JOINT SURG AM, V83A, pS146
   Bullock J, 1997, ANAL BIOCHEM, V254, P254, DOI 10.1006/abio.1997.2405
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Chen FM, 2007, J CONTROL RELEASE, V121, P81, DOI 10.1016/j.jconrel.2007.05.023
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   Cook SD, 1999, ORTHOPEDICS, V22, P669
   Dinopoulos H, 2007, CURR ORTHOPAED, V21, P268, DOI 10.1016/j.cuor.2007.07.007
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Gittens SA, 2005, MOL PHARMACEUT, V2, P392, DOI 10.1021/mp050017u
   Helm GA, 1997, J NEUROSURG, V86, P93, DOI 10.3171/jns.1997.86.1.0093
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, P605
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S, P604
   Hinds K.D., 2005, BIOMATERIALS DELIVER, P120
   Kim SE, 2008, J BIOMED SCI, V15, P771, DOI 10.1007/s11373-008-9277-4
   Kunath K, 2002, PHARMACEUT RES, V19, P810, DOI 10.1023/A:1016152831963
   Lane JM, 2001, J BONE JOINT SURG AM, V83A, pS161
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Levine JP, 1997, ANN PLAS SURG, V39, P158, DOI 10.1097/00000637-199708000-00008
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Mishra V, 2006, J DRUG TARGET, V14, P45, DOI 10.1080/10611860600612953
   Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017
   Pathak Y., 2007, NANOPARTICULATE DRUG, P185
   PERRINE TD, 1967, J POLYM SCI A1, V5, P1993, DOI 10.1002/pol.1967.150050816
   Petersen H, 2002, BIOCONJUGATE CHEM, V13, P845, DOI 10.1021/bc025529v
   Remaut K, 2007, BIOMACROMOLECULES, V8, P1333, DOI 10.1021/bm0611578
   RENGACHARY SS, 2002, NEUROSURG FOCUS, V13, P1
   Ripamonti U, 2001, J BONE JOINT SURG AM, V83A, pS116
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Sandhu HS, 2002, SPINE, V27, pS32, DOI 10.1097/01.BRS.0000020732.97264.BA
   Sykaras Nikitas, 2003, J Oral Sci, V45, P57
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Tang GP, 2003, BIOMATERIALS, V24, P2351, DOI 10.1016/S0142-9612(03)00029-2
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Varkey M, 2006, CLIN ORTHOP RELAT R, P113, DOI 10.1097/01.blo.0000200236.84189.87
   von Harpe A, 2000, J CONTROL RELEASE, V69, P309, DOI 10.1016/S0168-3659(00)00317-5
   Waku T, 2007, MACROMOLECULES, V40, P6385, DOI 10.1021/ma0707638
   WANG EA, 1993, TRENDS BIOTECHNOL, V11, P379, DOI 10.1016/0167-7799(93)90096-R
   Wang GL, 2008, PHARM RES-DORD, V25, P2896, DOI 10.1007/s11095-008-9692-2
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Westerhuis RJ, 2005, INJURY, V36, P1405, DOI 10.1016/j.injury.2005.02.047
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   YIGOR P, 2009, BIOMATERIALS, V30, P3551
   Zhang SF, 2008, BIOTECHNOL PROGR, V24, P945, DOI 10.1002/btpr.12
   Zhang SF, 2007, MACROMOL BIOSCI, V7, P656, DOI 10.1002/mabi.200600286
   Zhang SF, 2009, BIOMATERIALS, V30, P5143, DOI 10.1016/j.biomaterials.2009.05.060
   Zhao BH, 2006, J BIOL CHEM, V281, P23246, DOI 10.1074/jbc.M511039200
NR 59
TC 57
Z9 60
U1 3
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 5
BP 952
EP 963
DI 10.1016/j.biomaterials.2009.10.011
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548FV
UT WOS:000273946100021
PM 19878992
DA 2018-10-20
ER

PT J
AU Wang, XQ
   Yucel, T
   Lu, Q
   Hu, X
   Kaplan, DL
AF Wang, Xiaoqin
   Yucel, Tuna
   Lu, Qiang
   Hu, Xiao
   Kaplan, David L.
TI Silk nanospheres and microspheres from silk/pva blend films for drug
   delivery
SO BIOMATERIALS
LA English
DT Article
DE Silk; Fibroin; Polyvinyl alcohol (PVA); Nanospheres; Microspheres; Drug
   release
ID CONTROLLED-RELEASE; POLY(VINYL ALCOHOL); FIBROIN NANOPARTICLES;
   BIOMATERIAL COATINGS; IN-VITRO; SCAFFOLDS; ENCAPSULATION; THERAPEUTICS;
   POLYMER; CANCER
AB Silk fibroin protein-based micro- and nanospheres provide new options for drug delivery due to their biocompatibility, biodegradability and their tunable drug loading and release properties. In the present study, we report a new aqueous-based preparation method for silk spheres with controllable sphere size and shape. The preparation was based on phase separation between silk fibroin and polyvinyl alcohol (PVA) at a weight ratio of 1/1 and 1/4. Water-insoluble silk spheres were easily obtained from the blend in a three step process: (1) air-drying the blend solution into a film, (2) film dissolution in water and (3) removal of residual PVA by subsequent centrifugation. In both cases, the spheres had approximately 30% beta-sheet content and less than 5% residual PVA. Spindle-shaped silk particles, as opposed to the spherical particles formed above, were obtained by stretching the blend films before dissolving in water. Compared to the 1/1 ratio sample, the silk spheres prepared from the 1/4 ratio sample showed a more homogeneous size distribution ranging from 300 nm up to 20 mu m. Further studies showed that sphere size and polydispersity could be controlled either by changing the concentration of silk and PVA or by applying ultrasonication on the blend solution. Drug loading was achieved by mixing model drugs in the original silk solution. The distribution and loading efficiency of the drug molecules in silk spheres depended on their hydrophobicity and charge, resulting in different drug release profiles. The entire fabrication procedure could be completed within one day. The only chemical used in the preparation except water was PVA, an FDA-approved ingredient in drug formulations. Silk micro- and nanospheres reported have potential as drug delivery carriers in a variety of biomedical applications. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Wang, Xiaoqin; Yucel, Tuna; Lu, Qiang; Hu, Xiao; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820
FU NIH P41 Tissue Engineering Resource Center [P41 EB002520]
FX We thank the NIH P41 Tissue Engineering Resource Center (P41 EB002520)
   for support of this work.
CR Abdelwahed W, 2006, INT J PHARM, V309, P178, DOI 10.1016/j.ijpharm.2005.10.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Chen JC, 2003, J ENG TECHNOL, V20, P12
   Chiellini F, 2008, NANOMEDICINE-UK, V3, P367, DOI 10.2217/17435889.3.3.367
   Dai LX, 2002, J APPL POLYM SCI, V86, P2342, DOI 10.1002/app.11260
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81
   Gupta V, 2009, INT J NANOMED, V4, P115
   Hino Tomoaki, 2000, Pharmacy and Pharmacology Communications, V6, P335
   Hoet P. H. M., 2004, J NANOBIOTECHNOL, V2, P1, DOI DOI 10.1186/1477-3155-2-12
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kaplan D, 1994, SILK POLYM MAT SCI B
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Lee KE, 2003, J MICROENCAPSUL, V20, P489, DOI 10.1080/0265204031000093032
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu YC, 1996, J MACROMOL SCI PURE, VA33, P209, DOI 10.1080/10601329608010864
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Rytting E, 2008, EXPERT OPIN DRUG DEL, V5, P629, DOI [10.1517/17425247.5.6.629 , 10.1517/17425240802141568]
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Tanaka T, 1997, POLYM INT, V42, P107, DOI 10.1002/(SICI)1097-0126(199701)42:1<107::AID-PI686>3.0.CO;2-9
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang YQ, 2008, CHEM J CHINESE U, V29, P628
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
NR 44
TC 198
Z9 215
U1 18
U2 202
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 6
BP 1025
EP 1035
DI 10.1016/j.biomaterials.2009.11.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548RY
UT WOS:000273985100002
PM 19945157
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jiang, FX
   Yurke, B
   Schloss, RS
   Firestein, BL
   Langrana, NA
AF Jiang, Frank X.
   Yurke, Bernard
   Schloss, Rene S.
   Firestein, Bonnie L.
   Langrana, Noshir A.
TI The relationship between fibroblast growth and the dynamic stiffnesses
   of a DNA crosslinked hydrogel
SO BIOMATERIALS
LA English
DT Article
DE Dynamic stiffness; DNA crosslinked hydrogels; Crosslinking density;
   Projection area; Aspect ratio; FAK expression
ID CELL-MATRIX ADHESIONS; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES;
   SUBSTRATE; SHAPE; TRANSDUCTION; MORPHOLOGY; MIGRATION; SURFACES; TENSION
AB The microenvironment of cells is dynamic and undergoes remodeling with time. This is evident in development, aging, pathological processes, and at tissue-biomaterial interfaces, But in contrast, the majority of the biomimetic materials have static properties. Here, we show that a previously developed DNA crosslinked hydrogel circumvents the need of environmental factors and undergoes controlled stiffness change via DNA delivery, a feasible approach to initiate property changes in vivo, different from previous attempts. Two types of fibroblasts, L929 and GFP, were subject to the alterations in substrate rigidity presented in the hydrogels. Our results show that exogenous DNA does not cause appreciable cell shape change. Cells do respond to mechanical alterations as demonstrated in the cell projection area and polarity (e.g., Soft vs. Soft -> Medium), and the responses vary depending on magnitude (e.g., Soft -> Medium vs. Soft -> Stiff) and range of stiffness changes (e.g.. Soft -> Medium vs. Medium -> Stiff). The two types of fibroblasts share specific responses in common (e.g., Soft -> Medium), while differ in others (e.g., Medium -> Stiff). For each cell type, the projection area and polarity respond differently. This approach provides insight into pathology (e.g., cancer) and tissue functioning, and assists in designing biomaterials with controlled dynamic stiffness by choosing the range and magnitude of stiffness change. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
C1 [Jiang, Frank X.; Schloss, Rene S.; Langrana, Noshir A.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Firestein, Bonnie L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.
   [Langrana, Noshir A.] Rutgers State Univ, Dept Mech & Aerosp Engn, Piscataway, NJ 08854 USA.
   [Yurke, Bernard] Boise State Univ, Dept Mat Sci & Engn, Boise, ID 83725 USA.
   [Yurke, Bernard] Boise State Univ, Dept Elect & Comp Engn, Boise, ID 83725 USA.
RP Langrana, NA (reprint author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
EM Langrana@rutgers.edu
RI Jiang, Frank/A-9800-2010
OI Firestein, Bonnie/0000-0002-1679-3565
FU New Jersey Commission on Spinal Cord Research [07A-019-SCR1]
FX This study was supported by a grant from the New Jersey Commission on
   Spinal Cord Research (Grant # 07A-019-SCR1). We thank Margaret Julias
   and Drs. David Shreiber and Helen Buettner from Chemical and Biochemical
   Engineering Department and Biomedical Engineering Department at Rutgers
   University for offering L929 and GFP fibroblasts.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Bischofs IB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021911
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   Chen CS, 2005, MRS BULL, V30, P194, DOI 10.1557/mrs2005.52
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FRANZE K, 2009, MECHANOSENSITIVITY N
   Geiger B, 2001, SCIENCE, V294, P1661, DOI 10.1126/science.1066919
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007
   Goldmann WH, 2002, CELL BIOL INT, V26, P313, DOI 10.1006/cbir.2002.0857
   Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009
   Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   James J, 2008, CELL MOTIL CYTOSKEL, V65, P841, DOI 10.1002/cm.20305
   Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003
   Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z
   JIANG X, 2007, OPEN NEUROSCI J, V1, P7
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030
   Lahann J, 2005, MRS BULL, V30, P185, DOI 10.1557/mrs2005.50
   Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263
   LIN D, 2006, J MATER RES, V20, P1456, DOI DOI 10.1557/JMR.2005.0186
   Lin DC, 2004, J BIOMECH ENG-T ASME, V126, P104, DOI 10.1115/1.1645529
   Marquez JP, 2006, ANN BIOMED ENG, V34, P1475, DOI 10.1007/s10439-006-9160-2
   Mrksich M, 2005, MRS BULL, V30, P180, DOI 10.1557/mrs2005.49
   Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2
   Silver FH, 2003, J APPL PHYSIOL, V95, P2134, DOI 10.1152/japplphysiol.00429.2003
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Thoumine O, 1996, J PHYS III, V6, P1555, DOI 10.1051/jp3:1996202
   Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037
   Wang Q, 2008, ACTA BIOMATER, V4, P844, DOI 10.1016/j.actbio.2008.01.017
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524
   Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189
NR 51
TC 34
Z9 35
U1 0
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 6
BP 1199
EP 1212
DI 10.1016/j.biomaterials.2009.10.050
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548RY
UT WOS:000273985100020
PM 19931905
DA 2018-10-20
ER

PT J
AU Kim, MH
   Hong, HN
   Hong, JP
   Park, CJ
   Kwon, SW
   Kim, SH
   Kang, G
   Kim, M
AF Kim, Min Hwan
   Hong, Hea Nam
   Hong, Joon Pio
   Park, Chan Jeoung
   Kwon, Seog Woon
   Kim, Soon Hee
   Kang, Gilson
   Kim, Mijung
TI The effect of VEGF on the myogenic differentiation of adipose tissue
   derived stem cells within thermosensitive hydrogel matrices
SO BIOMATERIALS
LA English
DT Article
DE Adipose tissue derived stem cell; Thermosensitive hydrogel; MPEG-PCL;
   Soft-tissue engineering; Vascular endothelial cell growth factor;
   Vascularization
ID PCL DIBLOCK COPOLYMER; MUSCLE REGENERATION; IN-VIVO; GROWTH
AB We investigated the combination of human adipose tissue derived stem cells (ADSC) and in vivo gel-forming methoxy poly (ethyleneglycol)-poly (epsilon-caprolactone) (MPEG-PCL) as a muscle regeneration matrix, with and without inclusion of vascular endothelial cell growth factor (VEGF). VEGF(165)-treated stem cell grafts showed significant proliferation and differentiation into muscle tissue in vivo. Importantly, the inclusion of VEGF enhanced vascularization. This scaffold supported preconditioned ADSC, and allowed them to differentiate into mature muscle tissues in vivo, indicating that ADSC of human origin and MPEG-PCL scaffolds provided an appropriate environment for cellular growth and expansion. Our results thus provide a potential solution to the major obstacle encountered in the engineering of thick complex tissues, which require an adequate blood supply to maintain cell viability during tissue growth and to induce appropriate structural organization. Therefore. the combination of ADSC and in vivo gel-forming MPEG-PCL with VEGF(165) might serve as a suitable non-invasive biomaterial for clinical muscle regeneration applications. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Kim, Mijung] Univ Ulsan, Coll Med, Asan Inst Life Sci, Cell & Mol Biol Lab,Dept Lab Med,Asan Med Ctr, Seoul 138736, South Korea.
   [Hong, Hea Nam] Univ Ulsan, Coll Med, Dept Anat & Cell Biol, Seoul 138736, South Korea.
   [Hong, Joon Pio] Univ Ulsan, Coll Med, Dept Plast Surg, Asan Med Ctr, Seoul 138736, South Korea.
   [Kim, Soon Hee; Kang, Gilson] Chonbuk Natl Univ, Dept Polymer Sci & Technol, Polymer BIN Fus Res Team, Jeonju, South Korea.
RP Kim, M (reprint author), Univ Ulsan, Coll Med, Asan Inst Life Sci, Cell & Mol Biol Lab,Dept Lab Med,Asan Med Ctr, 388-1 PoongNap Dong, Seoul 138736, South Korea.
EM mjkimhsc@korea.com
FU Asan Foundation, Seoul, Korea [2008-052]; Korea Science and Engineering
   Foundation (KOSEF), Korea [R11-2002-097-06004-0]
FX This study was supported by grants from the Asan Foundation (#2008-052),
   Seoul, Korea and from Korea Science and Engineering Foundation (KOSEF),
   Korea (# R11-2002-097-06004-0).
CR Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007
   Barrilleaux B, 2006, TISSUE ENG, V12, P3007, DOI 10.1089/ten.2006.12.3007
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   HERMANN DM, 2009, J CEREB BLOOD FLOW M
   Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u
   Kim MS, 2006, TISSUE ENG, V12, P2863, DOI 10.1089/ten.2006.12.2863
   Kim M, 2006, BIOCHEM BIOPH RES CO, V348, P386, DOI 10.1016/j.bbrc.2006.07.063
   Law PK, 2004, MOL CELL BIOCHEM, V263, P173, DOI 10.1023/B:MCBI.0000041859.60354.f5
   Lee PY, 2007, MOL THER, V15, P1189, DOI 10.1038/sj.mt.6300156
   Maulik N, 2008, J MOL CELL CARDIOL, V44, P219, DOI 10.1016/j.yjmcc.2007.11.012
   Shibuya M, 2008, BMB REP, V41, P278, DOI 10.5483/BMBRep.2008.41.4.278
   TANZI MC, 2006, BASIC APPL MYOL, V16, P117
   van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017
   Yan H, 2005, BIOCHEM BIOPH RES CO, V336, P287, DOI 10.1016/j.bbrc.2005.08.066
   Yau TM, 2005, CIRCULATION, V112, P1123
NR 16
TC 36
Z9 37
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 6
BP 1213
EP 1218
DI 10.1016/j.biomaterials.2009.10.057
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548RY
UT WOS:000273985100021
PM 19914711
DA 2018-10-20
ER

PT J
AU Gu, RL
   Sun, WH
   Zhou, H
   Wu, ZN
   Meng, ZY
   Zhu, XX
   Tang, Q
   Dong, J
   Dou, GF
AF Gu, Ruolan
   Sun, Wenzhong
   Zhou, Hong
   Wu, Zhuona
   Meng, Zhiyun
   Zhu, Xiaoxia
   Tang, Qing
   Dong, Ji
   Dou, Guifang
TI The performance of a fly-larva shell-derived chitosan sponge as an
   absorbable surgical hemostatic agent
SO BIOMATERIALS
LA English
DT Article
DE Chitosan; Haemostasis; Hepatocyte; Platelet activation; Blood
   compatibility
ID IN-VITRO EVALUATION; ANTIMICROBIAL PROPERTIES; OXIDIZED CELLULOSE;
   INJURY MODEL; SCAFFOLDS; BIOCOMPATIBILITY; DERIVATIVES; ACTIVATION;
   CHITIN
AB Chitosan is a versatile biomaterial lately used as a new generation of local hemostatic agent approved to date for external use only. Here we introduced a fly-larva shell-derived chitosan sponge (CS) and its feasibility for internal use as an absorbable surgical hemostatic agent was evaluated in a rat hepatic hemorrhage model. CS was a better implantable hemostatic material than gelatin sponge (GS) or oxidized cellulose (OC) in both the acute and chronic bleeding models. The better efficacy of CS may be due to its greater ability to enhance platelet activation, erythrocyte aggregation and morphological alteration, and thrombin generation at sites it is applied than GS or OC. Moreover, preliminary safety evaluations have demonstrated excellent blood and cell compatibility in hemorheological measurements, blood coagulation analysis, histological evaluations and hepatocytes culture experiments. None of CS, GS, or OC induced acute inflammation or other adverse effects while normal tissue growth and vascularization were observed in each case 4 weeks after each hemostatic agent had been implanted. Thus, CS has promising properties as an absorbable, implantable agent for promoting perioperative hemostasis and this material warrants further study. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Gu, Ruolan; Sun, Wenzhong; Wu, Zhuona; Meng, Zhiyun; Zhu, Xiaoxia; Tang, Qing; Dou, Guifang] Beijing Inst Transfus Med, State Key Lab Drug Metab, Beijing 100850, Peoples R China.
   [Zhou, Hong] Beijing Inst Transfus Med, Lab Hematol Biochem, Beijing 100850, Peoples R China.
   [Tang, Qing] 306 Hosp PLA, Dept Pharm, Beijing 100101, Peoples R China.
   [Dong, Ji] Beijing Inst Radiat Med, Lab Histopathol, Beijing 100850, Peoples R China.
RP Dou, GF (reprint author), Beijing Inst Transfus Med, State Key Lab Drug Metab, 27 Taiping Rd, Beijing 100850, Peoples R China.
EM douguifang@vip.163.com
FU National Technology Research and Development [2009ZX09301-002];
   International Technology Cooperation Item [2005DFA30080]
FX The authors appreciate financial support from the National Technology
   Research and Development Project (Grant No.2009ZX09301-002) and the
   International Technology Cooperation Item (Grant No.2005DFA30080). Also,
   the authors would like to thank Beijing YiShouLong Insects Development
   and Research Centre for donating the artificially fed fly-larva shells
   used in this study.
CR Brodbelt AR, 2002, ANN ROY COLL SURG, V84, P97
   Chan P, 2007, BIOMATERIALS, V28, P540, DOI 10.1016/j.biomaterials.2006.08.046
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Fernandez-Saiz P, 2008, INT J FOOD MICROBIOL, V124, P13, DOI 10.1016/j.ijfoodmicro.2007.12.019
   Fischer TH, 2005, BIOMATERIALS, V26, P5433, DOI 10.1016/j.biomaterials.2005.01.023
   Gabay M, 2006, AM J HEALTH-SYST PH, V63, P1244, DOI 10.2146/ajhp060003
   Gustafson SB, 2007, PREHOSP EMERG CARE, V11, P172, DOI 10.1080/10903120701205893
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kafedjiiski K, 2005, BIOMATERIALS, V26, P819, DOI 10.1016/j.biomaterials.2004.03.011
   Kennedy R, 1996, SURGERY, V120, P866, DOI 10.1016/S0039-6060(96)80096-1
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   KITAMURA K, 1995, SURG TODAY, V25, P433, DOI 10.1007/BF00311821
   Krizova P, 2007, J BIOMED MATER RES A, V82A, P274, DOI 10.1002/jbm.a.31060
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Smith CJ, 2008, MICROSC RES TECHNIQ, V71, P721, DOI 10.1002/jemt.20612
   Sohn VY, 2009, J SURG RES, V154, P258, DOI 10.1016/j.jss.2008.07.040
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   Xie H, 2008, J BIOMED MATER RES B, V85B, P267, DOI 10.1002/jbm.b.30946
   Xie H, 2009, AM J SURG, V197, P510, DOI 10.1016/j.amjsurg.2007.12.050
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Yang J, 2008, J BIOMED MATER RES B, V84B, P131, DOI 10.1002/jbm.b.30853
NR 32
TC 44
Z9 49
U1 7
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 6
BP 1270
EP 1277
DI 10.1016/j.biomaterials.2009.10.023
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548RY
UT WOS:000273985100028
PM 19880175
DA 2018-10-20
ER

PT J
AU Wenk, E
   Murphy, AR
   Kaplan, DL
   Meinel, L
   Merkle, HP
   Uebersax, L
AF Wenk, Esther
   Murphy, Amanda R.
   Kaplan, David L.
   Meinel, Lorenz
   Merkle, Hans P.
   Uebersax, Lorenz
TI The use of sulfonated silk fibroin derivatives to control binding,
   delivery and potency of FGF-2 in tissue regeneration
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Chemical modification; Growth factors; Extracellular
   matrix; Tissue regeneration
ID FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS;
   BONE-LIKE TISSUE; IN-VITRO; HEPARAN-SULFATE; OSTEOGENIC DIFFERENTIATION;
   BOMBYX-MORI; BIOMIMETIC MATERIALS; SIGNALING PATHWAYS
AB The development of biomaterials that mimic the physiological binding of growth factors to the extracellular matrix (ECM) is an appealing strategy for advanced growth factor delivery systems. In vivo, fibroblast growth factor 2 (FGF-2) binds to the sulfated glycosaminoglycan heparan sulfate, which is a major component of the ECM. Therefore, we tested whether silk fibroin (SF) decorated with a sulfonated moiety could mimic the natural ECM environment and lead to advanced delivery of this heparin-binding growth factor. Using a diazonium coupling reaction, modified SF derivatives containing approximately 20, 40, 55 and 70 sulfonic acid groups per SF molecule were obtained. Films of the SF derivative decorated with 70 sulfonic acid groups per SF molecule resulted in a 2-fold increase in FGF-2 binding as compared to native SF. More than 99% of bound FGF-2 could be retained on all SF derivatives. However, protection of FGF-2 potency was only achieved with at least 40 sulfonic acid groups per SF molecule, as observed by reduced metabolic activity and enhanced levels of phosphorylated extracellular signal-regulated kinases (pERK1/2) in cultured human mesenchymal stem cells (hMSCs). This study introduces a first step towards the development of an ECM-mimicking biomaterial for sustained, non-covalent binding, controlled delivery and preserved potency of biomolecules. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Meinel, Lorenz] ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland.
   [Murphy, Amanda R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Meinel, L (reprint author), ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, HCI J 390-1,Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
EM lorenz.meinel@pharma.ethz.ch
RI Meinel, Lorenz/D-9997-2015; Merkle, Hans/A-4381-2014
OI Meinel, Lorenz/0000-0002-7549-7627; 
FU ETH Zurich; NSF International program (LM, DK); Ruth L Kirschstein
   National Research Service; NIH/NIAMS; Swiss National Science Foundation
   (SNF)
FX We thank Trudel Inc. (Zurich, Switzerland) for cocoon supply. Financial
   support from ETH Zurich is greatly appreciated. We also thank Eva Beurer
   for the help with the contact angle measurements. We thank the NSF
   International program (LM, DK) for support of this program. A.M. would
   like to acknowledge the Ruth L Kirschstein National Research Service
   Award Postdoctoral Fellowship supported by NIH/NIAMS for funding. LU
   would like to acknowledge the Swiss National Science Foundation (SNF)
   fellowship for prospective researchers.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O
   Carcamo-Orive I, 2008, EXP CELL RES, V314, P1777, DOI 10.1016/j.yexcr.2008.01.020
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chen PR, 2005, BIOMATERIALS, V26, P6579, DOI 10.1016/j.biomaterials.2005.03.037
   Chua CC, 2004, CIRC RES, V94, P316, DOI 10.1161/01.RES.0000112965.70691.AC
   COLTRINI D, 1993, EUR J BIOCHEM, V214, P51, DOI 10.1111/j.1432-1033.1993.tb17895.x
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Garcia-Maya M, 2006, J CELL PHYSIOL, V206, P386, DOI 10.1002/jcp.20483
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Giuliani R, 1999, J CELL SCI, V112, P2597
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2
   Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442
   Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104
   HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X
   Henry SP, 1997, J PHARMACOL EXP THER, V281, P810
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   HOJIMA Y, 1984, BLOOD, V63, P1453
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200
   Kunou M, 2000, BIOMACROMOLECULES, V1, P451, DOI 10.1021/bm000011k
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Matsusaki M, 2005, BIOMACROMOLECULES, V6, P400, DOI 10.1021/bm049492o
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5
   Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M
   RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   SILVERBERG M, 1987, ANN NY ACAD SCI, V516, P268, DOI 10.1111/j.1749-6632.1987.tb33047.x
   SMITH JC, 1982, NATURE, V296, P154, DOI 10.1038/296154a0
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Tanghetti E, 2002, ONCOGENE, V21, P3889, DOI 10.1038/sj.onc.1205407
   Taylor PM, 2007, PHILOS T R SOC B, V362, P1313, DOI 10.1098/rstb.2007.2117
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vincent TL, 2007, OSTEOARTHR CARTILAGE, V15, P752, DOI 10.1016/j.joca.2007.01.021
   Vlodavsky I, 1996, CANCER METAST REV, V15, P177, DOI 10.1007/BF00437470
   WANG JS, 1993, ACTA ORTHOP SCAND, V64, P557, DOI 10.3109/17453679308993692
   Wang JS, 1996, J ORTHOP RES, V14, P316, DOI 10.1002/jor.1100140222
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079
   Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W
   Zamora PO, 2002, BIOCONJUGATE CHEM, V13, P920, DOI 10.1021/bc0155216
   Zheng Q, 2007, BIOL CHEM, V388, P755, DOI 10.1515/BC.2007.082
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 71
TC 52
Z9 57
U1 1
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2010
VL 31
IS 6
BP 1403
EP 1413
DI 10.1016/j.biomaterials.2009.11.006
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548RY
UT WOS:000273985100043
PM 19942287
DA 2018-10-20
ER

PT J
AU Merolli, A
   Nicolais, L
   Ambrosio, L
   Santin, M
AF Merolli, Antonio
   Nicolais, Luigi
   Ambrosio, Luigi
   Santin, Matteo
TI A degradable soybean-based biomaterial used effectively as a bone filler
   in vivo in a rabbit
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID SOY PHYTOESTROGENS; ISOFLAVONES; SCAFFOLDS; OSTEOPOROSIS; EXTRACTION;
   GENISTEIN; CHITOSAN; PROTEIN; HEALTH; CELLS
AB The 'gold standard' for bone filling is currently the bone autograft, but its use is limited by material availability and by the possible risks of infection or other donor site morbidity. Materials proposed so far as bone fillers do not show all the characteristics which are desirable. These are (a) osteoconductivity, (b) controlled biodegradation and (c) ease of adaptation to the implantation site. Recently, a new class of biodegradable material based on soybeans has been presented which shows good mechanical properties and an intrinsic bioactivity on inflammatory and tissue cells in vitro. The authors investigated the morphology in vivo of bone response in repairing a surgical lesion in the presence of granules of a novel soybean-based biomaterial (SB), comparing it with a sham-operated contralateral lesion of critical size (non-healing model); 26 operations were performed in New Zealand White rabbits, with back scattered electron microscopy as the analysis technique of choice. Implantation of SB granules over 8 weeks produced bone repair with features distinct from those obtained by healing in a non-treated defect. New and progressively maturing trabeculae appeared in the animal group where SB granules were implanted, while sham operation produced only a rim of pseudo-cortical bone still featuring a large defect. The trabeculae forming in the presence of SB granules had features typical of reticular bone. These findings suggest that the bone regeneration potential of SB granules and their intrinsic bioactivity, combined with their relatively easy and cost-effective preparation procedures, make them suitable candidates as a bone filler in clinical applications.
C1 [Merolli, Antonio] Univ Cattolica Sacro Cuore, Dept Orthopaed Surg, I-00168 Rome, Italy.
   [Nicolais, Luigi; Ambrosio, Luigi] CNR, Inst Composite & Biomed Mat, I-80130 Naples, Italy.
   [Santin, Matteo] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Merolli, A (reprint author), Univ Cattolica Sacro Cuore, Dept Orthopaed Surg, Complesso Columbus,Via Moscati 31, I-00168 Rome, Italy.
RI Merolli, Antonio/F-9081-2011
OI Merolli, Antonio/0000-0001-5704-2066; AMBROSIO,
   LUIGI/0000-0002-8367-2405
CR Albertazzi P, 2002, CLIMACTERIC, V5, P190, DOI 10.1080/713605224
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Barbanti SH, 2004, J MATER SCI-MATER M, V15, P1315, DOI 10.1007/s10856-004-5740-6
   Coraca DC, 2008, J MATER SCI-MATER M, V19, P2699, DOI 10.1007/s10856-008-3397-2
   d'Ayala GG, 2007, J BIOMED MATER RES A, V81A, P811, DOI 10.1002/jbm.a.31009
   De la Riva B, 2009, EUR J PHARM BIOPHARM, V73, P50, DOI 10.1016/j.ejpb.2009.04.014
   Fernandes G, 2003, PROSTAG LEUKOTR ESS, V68, P361, DOI 10.1016/S0952-3278(03)00060-7
   Fernandes G, 2008, FRONT BIOSCI, V13, P4015, DOI 10.2741/2989
   GIBSON GJ, 1988, MUSCULOSKELETAL SYST, V5, P81
   Grieshop CM, 2001, J AGR FOOD CHEM, V49, P2669, DOI 10.1021/jf0014009
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Horiuchi Toshiyuki, 2005, Clin Calcium, V15, P1507
   Ishimi Y, 2009, FORUM NUTR, V61, P104, DOI 10.1159/000212743
   Lee M, 2009, BIOMATERIALS, V30, P6094, DOI 10.1016/j.biomaterials.2009.07.046
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Ma DF, 2008, CLIN NUTR, V27, P57, DOI 10.1016/j.clnu.2007.10.012
   Merolli A, 2006, J MATER SCI-MATER M, V17, P789, DOI 10.1007/s10856-006-9836-z
   Messina M, 2000, J Ren Nutr, V10, P63, DOI 10.1016/S1051-2276(00)90001-3
   Middleton E, 2000, PHARMACOL REV, V52, P673
   MORRIS C, 2006, J NUTR, V136, P1
   Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297
   Nodar MD, 2002, FOOD SCI TECHNOL INT, V8, P337, DOI 10.1106/108201302031651
   Poulsen RC, 2008, NUTR REV, V66, P359, DOI 10.1111/j.1753-4887.2008.00046.x
   Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   Setchell KDR, 2002, J NUTR, V132, P3577
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Vatanparast H, 2007, NUTR REV, V65, P294, DOI 10.1301/nr.2007jun.294-299
   Wuttke W, 2007, AGEING RES REV, V6, P150, DOI 10.1016/j.arr.2007.05.001
   Zhang Y., 2008, Inflammopharmacology, V16, P213, DOI 10.1007/s10787-008-8018-7
   Zimmermann C E, 2001, Clin Oral Investig, V5, P214
NR 33
TC 18
Z9 20
U1 0
U2 11
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2010
VL 5
IS 1
AR 015008
DI 10.1088/1748-6041/5/1/015008
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 551XT
UT WOS:000274247400008
PM 20124667
DA 2018-10-20
ER

PT J
AU Zhu, LP
   Li, YG
   Zhang, QH
   Wang, HZ
   Zhu, MF
AF Zhu, Liping
   Li, Yaogang
   Zhang, Qinghong
   Wang, Hongzhi
   Zhu, Meifang
TI Fabrication of monodisperse, large-sized, functional biopolymeric
   microspheres using a low-cost and facile microfluidic device
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Biomaterial; Functional; Monodisperse; Microfluidic device;
   Microspheres; Large-sized
ID IRON-OXIDE NANOPARTICLES; MAGNETIC POLYMER MICROSPHERES; IN-SITU
   ENCAPSULATION; CELL ENCAPSULATION; MINIEMULSION POLYMERIZATION; ALGINATE
   MICROBEADS; DOUBLE EMULSIONS; MICROCAPSULES; MICROPARTICLES; PARTICLES
AB We report a novel and facile method for fabricating coaxial microfluidic devices processing various dimensions at low cost, in which polypropylene hollow fibers or glass capillaries are used as the tip of the dispersed phase injection tube. With this coaxial microfluidic device, monodisperse biocompatible microspheres ranging from 300 to 800 mu m were obtained by collecting oil-in-water or water-in-oil emulsions and solidifying the suspended microspheres. Microsphere size could be controlled by changing the tips or tuning the concentrations of the dispersed and continuous phases. By adding functional nanoparticles into the dispersed phase, it was demonstrated that fluorescent and magnetic microspheres can be fabricated easily using these microfluidic devices.
C1 [Zhu, Liping; Li, Yaogang; Zhang, Qinghong; Wang, Hongzhi; Zhu, Meifang] Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
RP Wang, HZ (reprint author), Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, 2999 N Renmin Rd, Shanghai 201620, Peoples R China.
EM wanghz@dhu.edu.cn; zmf@dhu.edu.cn
FU Shanghai Municipal Education Commission [07SG37]; Natural Science
   Foundation of China [50772022, 50772127]; Shanghai Leading Academic
   Discipline Project [B603]; Cultivation Fund of the Key Scientific and
   Technical Innovation Project [708039]; Program of Introducing Talents of
   Discipline to Universities [111-2-04]
FX We gratefully acknowledge the financial supports by Shanghai Municipal
   Education Commission (No. 07SG37), Natural Science Foundation of China
   (No. 50772022, 50772127), Shanghai Leading Academic Discipline Project
   (B603), the Cultivation Fund of the Key Scientific and Technical
   Innovation Project (No. 708039), and the Program of Introducing Talents
   of Discipline to Universities (No. 111-2-04).
CR Abraham S, 2006, LAB CHIP, V6, P752, DOI 10.1039/b518006f
   Bhatia SR, 2005, CURR OPIN COLLOID IN, V10, P45, DOI 10.1016/j.cocis.2005.05.004
   Capretto L, 2008, LAB CHIP, V8, P617, DOI 10.1039/b714876c
   Chandy T, 1999, ARTIF ORGANS, V23, P894, DOI 10.1046/j.1525-1594.1999.06244.x
   Choi CH, 2007, BIOMED MICRODEVICES, V9, P855, DOI 10.1007/s10544-007-9098-7
   Dendukuri D, 2005, LANGMUIR, V21, P2113, DOI 10.1021/la047368k
   Holgado MA, 2008, INT J PHARMACEUT, V358, P27, DOI 10.1016/j.ijpharm.2008.02.012
   Horak D, 2006, J APPL POLYM SCI, V102, P4348, DOI 10.1002/app.24923
   Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006
   Hung LH, 2008, LAB CHIP, V8, P983, DOI 10.1039/b717710k
   Jaiswal JK, 2004, TRENDS CELL BIOL, V14, P497, DOI 10.1016/j.tcb.2004.07.012
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   Lee WB, 2009, BIOMED MICRODEVICES, V11, P161, DOI 10.1007/s10544-008-9221-4
   Li LL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/40/405102
   Liu K, 2006, LANGMUIR, V22, P9453, DOI 10.1021/la061729+
   Liu SQ, 2003, BIOMACROMOLECULES, V4, P1784, DOI 10.1021/bm034189t
   Lu SH, 2006, J POLYM SCI POL CHEM, V44, P4187, DOI 10.1002/pola.21525
   Martin-Banderas L, 2005, SMALL, V1, P688, DOI 10.1002/smll.200500087
   Morimoto Y, 2009, BIOMED MICRODEVICES, V11, P369, DOI 10.1007/s10544-008-9243-y
   Nisisako T, 2004, CHEM ENG J, V101, P23, DOI 10.1016/j.cej.2003.11.019
   Nisisako T, 2002, LAB CHIP, V2, P24, DOI 10.1039/b108740c
   Okassa LN, 2007, EUR J PHARM BIOPHARM, V67, P31, DOI 10.1016/j.ejpb.2006.12.020
   Okushima S, 2004, LANGMUIR, V20, P9905, DOI 10.1021/la0480336
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Orive G, 2005, BIOMACROMOLECULES, V6, P927, DOI 10.1021/bm049380x
   Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004
   Park SJ, 2004, J COLLOID INTERF SCI, V271, P336, DOI 10.1016/j.jcis.2003.08.067
   Poe SL, 2006, ANGEW CHEM INT EDIT, V45, P1544, DOI 10.1002/anie.200503925
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sakai S, 2008, J BIOMED MATER RES A, V85A, P345, DOI 10.1002/jbm.a.31299
   Shen LF, 1999, LANGMUIR, V15, P447, DOI 10.1021/la9807661
   Stsiapura V, 2004, ANAL BIOCHEM, V334, P257, DOI 10.1016/j.ab.2004.07.006
   Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852
   Sun Y, 2006, J MACROMOL SCI B, V45, P653, DOI 10.1080/00222340600770319
   Sun Y, 2007, J COLLOID INTERF SCI, V308, P332, DOI 10.1016/j.jcis.2006.12.076
   Tatard VM, 2005, BIOMATERIALS, V26, P3727, DOI 10.1016/j.biomaterials.2004.09.042
   Teh SY, 2008, LAB CHIP, V8, P198, DOI 10.1039/b715524g
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164
   Wang HZ, 2005, ADV FUNCT MATER, V15, P603, DOI 10.1002/adfm.200400164
   Wang WC, 2008, CHINESE SCI BULL, V53, P1165, DOI 10.1007/s11434-007-0512-6
   Wilson JT, 2008, ADV DRUG DELIVER REV, V60, P124, DOI 10.1016/j.addr.2007.08.034
   Xu JH, 2009, BIOMED MICRODEVICES, V11, P243, DOI 10.1007/s10544-008-9230-3
   Xu SQ, 2005, ANGEW CHEM INT EDIT, V44, P724, DOI 10.1002/anie.200462226
   Yin W, 2007, CHEM MATER, V19, P2930, DOI 10.1021/cm070214g
   Zhang H, 2006, J AM CHEM SOC, V128, P12205, DOI 10.1021/ja0635682
   Zhang XL, 2009, BIOMED MICRODEVICES, V11, P795, DOI 10.1007/s10544-009-9294-8
   Zhu XX, 2008, J MATER CHEM, V18, P5060, DOI 10.1039/b812473f
NR 48
TC 14
Z9 16
U1 5
U2 66
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD FEB
PY 2010
VL 12
IS 1
BP 169
EP 177
DI 10.1007/s10544-009-9373-x
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 564EB
UT WOS:000275195000020
PM 19924539
DA 2018-10-20
ER

PT J
AU Zhang, M
AF Zhang, Mei
TI Heating-Induced Conformational Change of a Novel beta-(1 -> 3)-D-Glucan
   from Pleurotus geestanus
SO BIOPOLYMERS
LA English
DT Article
DE polysaccharide; conformation; thermal-sensitive
ID TRIPLE-HELICAL POLYSACCHARIDE; ORDER-DISORDER TRANSITION;
   SCHIZOPHYLLUM-COMMUNE POLYSACCHARIDE; AQUEOUS-SOLUTIONS;
   LIGHT-SCATTERING; DILUTE-SOLUTION; COMPLEXES; LENTINAN; WATER; DNA
AB Recently, we isolated and purified a neutral polysaccharide (PGN) from edible fungus Pleurotus geestanus. Its structure was characterized by a range of physical-chemical methods, including high performance anion exchange chromatography, uronic acid, and protein analyses, size exclusion chromatography with ultraviolet, refractive index and light scattering defectors, and nuclear magnetic resonance. Our results revealed that PGN is a novel beta-(1 -> 3)-D-glucan with glucose attached to every other sugar residues at Position 6 in the backbone. It has a degree of branching of 1/2. Such structure is different from typical beta-(1 -> 3)-D-glucans schizophyllan and lentinan in which DB is 1/3 and 2/5, respectively. Rheological study showed a very interesting melting behavior of PGN in water solution: heating PGN in water leads to two transitions, in the range of 8-12.5 degrees C and 25-60 degrees C, respectively. The melting behavior and conformational changes were characterized by rheometry, micro-differential scan calorimetry, atomic force microscopy, static and dynamic light scattering at different temperatures. The first heating-induced transition corresponds to the disintegration of polymer bundles into small helical clusters, resembling the heating-induced dissociation of SPG in water at 7 degrees C; the second one might correspond to the dissociation of helical strands to individual chains. The ability of PGN to undergo a conformation/viscosity transition in water upon heating is very valuable to immobilize cells or enzymes or therapeutic DNA/RNA, which makes PGN a potentially useful biomaterial. (C) 2009 Wiley Periodicals, Inc. Biopolymers 93: 121-131, 2010.
C1 Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China.
RP Zhang, M (reprint author), Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China.
EM rosellezhang@gmail.com
FU Hong Kong Special Administration Region (HKSAR)
FX Contract grant sponsor: Hong Kong Special Administration Region (HKSAR)
   Earmarked Project
CR Anada T, 2005, J CONTROL RELEASE, V108, P529, DOI 10.1016/j.jconrel.2005.08.019
   BERRY GC, 1966, J CHEM PHYS, V44, P4550, DOI 10.1063/1.1726673
   Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890
   DESLANDES Y, 1980, MACROMOLECULES, V13, P1466, DOI 10.1021/ma60078a020
   Fang YP, 2005, BIOMACROMOLECULES, V6, P3202, DOI 10.1021/bm0505383
   GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044
   Hayashi Y, 2002, BIOPOLYMERS, V63, P21, DOI 10.1002/bip.1059
   HIRAO T, 1990, BIOPOLYMERS, V29, P1867, DOI 10.1002/bip.360291417
   ITOU T, 1987, CARBOHYD RES, V160, P243, DOI 10.1016/0008-6215(87)80315-4
   KASHIWAGI Y, 1981, MACROMOLECULES, V14, P1220, DOI 10.1021/ma50006a016
   Kony DB, 2007, BIOPHYS J, V93, P442, DOI 10.1529/biophysj.106.086116
   Miyoshi K, 2005, BIOMACROMOLECULES, V6, P1540, DOI 10.1021/bm049218u
   Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004
   Sakurai K, 2001, J INCL PHENOM MACRO, V41, P173, DOI 10.1023/A:1014463712915
   SATO T, 1983, MACROMOLECULES, V16, P185, DOI 10.1021/ma00236a006
   Sletmoen M, 2005, BIOPOLYMERS, V79, P115, DOI 10.1002/bip20340
   Tada R, 2007, CARBOHYD RES, V342, P2611, DOI 10.1016/j.carres.2007.08.016
   Takahashi Y., 1984, REP PROG POLYM PHYS, V27, P767
   TERAMOTO A, 1995, BIOPOLYMERS, V36, P803, DOI 10.1002/bip.360360612
   Vos AP, 2007, CRIT REV IMMUNOL, V27, P97, DOI 10.1615/CritRevImmunol.v27.i2.10
   WHISTLER RL, 1995, IND GUMS POLYSACCHAR
   Xu XJ, 2004, BIOMACROMOLECULES, V5, P1893, DOI 10.1021/bm049785h
   Zhang XF, 2004, BIOPOLYMERS, V75, P187, DOI 10.1002/bip.20112
NR 23
TC 8
Z9 8
U1 0
U2 14
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD FEB
PY 2010
VL 93
IS 2
BP 121
EP 131
DI 10.1002/bip.21303
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 533FM
UT WOS:000272809100001
PM 19768780
DA 2018-10-20
ER

PT J
AU Huang, TH
   Hsieh, SS
   Liu, SH
   Chang, FL
   Lin, SC
   Yang, RS
AF Huang, Tsang-Hai
   Hsieh, Sandy S.
   Liu, Shing-Hwa
   Chang, Feng-Ling
   Lin, Shang-Chih
   Yang, Rong-Sen
TI Swimming Training Increases the Post-Yield Energy of Bone in Young Male
   Rats
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
DE Exercise; Bone mineral density; Non-weight bearing; Biomechanics;
   Toughness
ID WEIGHT-BEARING EXERCISE; CORTICAL BONE; MECHANICAL-PROPERTIES; MINERAL
   DENSITY; BIOCHEMICAL MARKERS; ENDURANCE EXERCISE; TRABECULAR BONE; TERM
   EXERCISE; WISTAR RATS; ADULT RATS
AB The purpose of this study is to investigate the effects of non-weight-bearing exercise on growing bone. Male Wistar rats (7 week-old) were assigned to one baseline control group, one control group and two swimming training groups, which were trained with 2 and 4% body-weight mass added, respectively. After an 8-week training period, three groups showed significant development compared to the baseline control group. Among the three 15-week-old groups, swimming-trained rats were lower in body weight (BW), densitometry and size-related measurements. In femoral biomechanical testing, swimming training groups were significantly lower in yield moment and ultimate moment, which may be due to a significantly lower long bone cross-sectional moment of inertia. However, the two swimming groups were higher in post-yield energy absorption and displacement. Further, in estimated tissue-level biomaterial properties, no differences were shown in yield stress, strain or toughness among the three groups. Using BW as a covariate, results of ANCOVA showed no differences in size-related parameters among the three groups, and some parameters were even higher in the two swimming groups. Regarding Pearson's correlation, size-related parameters correlated well to BW and whole bone strength but not to tissue post-yield behaviors. In conclusion, when compared to age-matched control group, swimming rats showed lower bone strength and lower yield energy absolutely at the structural level, but similar yield stress and yield toughness at the tissue level. Moreover, swimming training benefited growing bone in post-yield behaviors. Further studies should investigate the parameters that contribute to this exercise-induced post-yield behavior.
C1 [Yang, Rong-Sen] Natl Taiwan Univ & Hosp, Dept Orthopaed, Taipei 100, Taiwan.
   [Huang, Tsang-Hai] Natl Cheng Kung Univ, Inst Phys Educ Hlth & Leisure Studies, Tainan 70101, Taiwan.
   [Hsieh, Sandy S.] Natl Taiwan Normal Univ, Grad Inst Exercise & Sport Sci, Taipei, Taiwan.
   [Liu, Shing-Hwa] Natl Taiwan Univ, Inst Toxicol, Taipei 10764, Taiwan.
   [Chang, Feng-Ling] Natl Taiwan Normal Univ, Dept Phys Educ, Taipei, Taiwan.
   [Lin, Shang-Chih] Natl Cent Univ, Dept Mech Engn, Tao Yuan, Taiwan.
RP Yang, RS (reprint author), Natl Taiwan Univ & Hosp, Dept Orthopaed, 7 Chung Shan S Rd, Taipei 100, Taiwan.
EM rsyang@ntuh.gov.tw
OI LIU, SHING-HWA/0000-0002-9976-1197; Yang, Rong-Sen/0000-0002-0553-4779
FU National Science Council [NSC-89-2314-B-002-380]
FX This study was supported by a grant from the National Science Council
   (NSC-89-2314-B-002-380, TAIWAN). Jae Cody is appreciated for her
   editorial assistance.
CR Aoi W, 2004, INT J SPORTS MED, V25, P339, DOI 10.1055/s-2004-815846
   Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081
   Boskey AL, 1999, J BONE MINER RES, V14, P330, DOI 10.1359/jbmr.1999.14.3.330
   Brahm H, 1997, CALCIFIED TISSUE INT, V61, P448, DOI 10.1007/s002239900366
   Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159
   Burr DB, 2002, BONE, V31, P8, DOI 10.1016/S8756-3282(02)00815-3
   Cortright RN, 1997, PHYSIOL BEHAV, V62, P105, DOI 10.1016/S0031-9384(97)00148-0
   Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889
   CURREY JD, 1979, J BIOMECH, V12, P459, DOI 10.1016/0021-9290(79)90031-9
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   DOHM GL, 1978, P SOC EXP BIOL MED, V158, P622
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Gomes RJ, 2006, GROWTH HORM IGF RES, V16, P326, DOI 10.1016/j.ghir.2006.07.003
   Gustavsson A, 2003, CALCIFIED TISSUE INT, V73, P108, DOI 10.1007/s00223-002-2026-1
   Hackney AC, 1996, MED SCI SPORT EXER, V28, P180, DOI 10.1097/00005768-199602000-00005
   Hart KJ, 2001, J APPL PHYSIOL, V91, P1663
   Herrmann M, 2007, CLIN CHEM LAB MED, V45, P1381, DOI 10.1515/CCLM.2007.282
   Hind K, 2007, BONE, V40, P14, DOI 10.1016/j.bone.2006.07.006
   Honda A, 2001, J BONE MINER RES, V16, P1688, DOI 10.1359/jbmr.2001.16.9.1688
   Huang TH, 2003, J APPL PHYSIOL, V95, P300, DOI 10.1152/japplphysiol.01076.2002
   Huang TH, 2002, BONE, V30, P293, DOI 10.1016/S8756-3282(01)00659-7
   Huang TH, 2008, J BONE MINER METAB, V26, P350, DOI 10.1007/s00774-007-0831-3
   Huang TH, 2008, BONE, V42, P1154, DOI 10.1016/j.bone.2008.01.032
   Jurimae Toivo, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P579, DOI 10.2114/jpa.24.579
   Linthorst ACE, 2008, STRESS, V11, P88, DOI 10.1080/10253890701533231
   Magkos F, 2007, CLIN J SPORT MED, V17, P123, DOI 10.1097/JSM.0b013e318032129d
   Maimoun L, 2004, INT J SPORTS MED, V25, P230, DOI 10.1055/s-2003-45257
   NYSKA M, 1995, INT J EXP PATHOL, V76, P241
   PARFITT AM, 1983, J CLIN INVEST, V72, P1396, DOI 10.1172/JCI111096
   PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0
   Puustjarvi K, 1999, J BONE MINER RES, V14, P321, DOI 10.1359/jbmr.1999.14.3.321
   RICO H, 1991, MINER ELECTROL METAB, V17, P321
   SELLERS TL, 1988, J APPL PHYSIOL, V65, P173
   SIEMON NJ, 1973, NATURE, V243, P541, DOI 10.1038/243541a0
   SIMKIN A, 1989, J BIOMECH, V22, P845, DOI 10.1016/0021-9290(89)90068-7
   Skedros JG, 2006, J EXP BIOL, V209, P3025, DOI 10.1242/jeb.02304
   SNYDER A, 1992, MECH AGEING DEV, V66, P59, DOI 10.1016/0047-6374(92)90073-M
   SUOMINEN H, 1993, SPORTS MED, V16, P316, DOI 10.2165/00007256-199316050-00003
   SWISSASIVAN A, 1990, CALCIFIED TISSUE INT, V47, P173, DOI 10.1007/BF02555984
   TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K
   Voide R, 2008, J BONE MINER RES, V23, P1194, DOI [10.1359/jbmr.080311, 10.1359/JBMR.080311]
   Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002
   Wallace JM, 2009, CALCIFIED TISSUE INT, V84, P297, DOI 10.1007/s00223-009-9228-8
   Walsh NP, 1998, SPORTS MED, V26, P177, DOI 10.2165/00007256-199826030-00004
   Walsh NP, 1998, EUR J APPL PHYSIOL O, V77, P434, DOI 10.1007/s004210050356
   Wang XD, 2001, J ORTHOPAED RES, V19, P1021, DOI 10.1016/S0736-0266(01)00047-X
   Warner SE, 2006, CALCIFIED TISSUE INT, V79, P395, DOI 10.1007/s00223-005-0293-3
   Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 49
TC 11
Z9 13
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0171-967X
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PD FEB
PY 2010
VL 86
IS 2
BP 142
EP 153
DI 10.1007/s00223-009-9320-0
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 546JX
UT WOS:000273808200007
PM 19957166
DA 2018-10-20
ER

PT J
AU Roriz, VM
   Rosa, AL
   Peitl, O
   Zanotto, ED
   Panzeri, H
   de Oliveira, PT
AF Roriz, Virgilio M.
   Rosa, Adalberto L.
   Peitl, Oscar
   Zanotto, Edgar D.
   Panzeri, Heitor
   de Oliveira, Paulo T.
TI Efficacy of a bioactive glass-ceramic (Biosilicate (R)) in the
   maintenance of alveolar ridges and in osseointegration of titanium
   implants
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterials; bone repair; dental sockets; osseointegration; titanium
   implants
ID GUIDED BONE REGENERATION; SINUS FLOOR ELEVATION; NARROW SIZE RANGE;
   DENTAL IMPLANTS; EXTRACTION; DEFECTS; AUGMENTATION; PARTICLES;
   ALLOGRAFT; MEMBRANES
AB Objectives
   The aims of this research were to evaluate the efficacy of a bioactive glass-ceramic (Biosilicate (R)) and a bioactive glass (Biogran (R)) placed in dental sockets in the maintenance of alveolar ridge and in the osseointegration of Ti implants.
   Material and methods
   Six dogs had their low premolars extracted and the sockets were implanted with Biosilicate (R), Biogran (R) particles, or left untreated. After the extractions, measurements of width and height on the alveolar ridge were taken. After 12 weeks a new surgery was performed to take the final ridge measurements and to insert bilaterally three Ti implants in biomaterial-implanted and control sites. Eight weeks post-Ti implant placement block biopsies were processed for histological and histomorphometric analysis. The percentages of bone-implant contact (BIC), of mineralized bone area between threads (BABT), and of mineralized bone area within the mirror area (BAMA) were determined.
   Results
   The presence of Biosilicate (R) or Biogran (R) particles preserved alveolar ridge height without affecting its width. No significant differences in terms of BIC, BAMA, and BABT values were detected among Biosilicate (R), Biogran (R), and the non-implanted group.
   Conclusions
   The results of the present study indicate that filling of sockets with either Biosilicate (R) or Biogran (R) particles preserves alveolar bone ridge height and allows osseointegration of Ti implants.
   To cite this article:Roriz VM, Rosa AL, Peitl O, Zanotto ED, Panzeri H, de Oliveira PT. Efficacy of a bioactive glass-ceramic (Biosilicate (R)) in the maintenance of alveolar ridges and in osseointegration of titanium implants.Clin. Oral Impl. Res. 21, 2010; 148-155.doi: 10.1111/j.1600-0501.2009.01812.x.
C1 [Roriz, Virgilio M.] Univ Sao Paulo, Sch Dent, Dept Oral & Maxillofacial Surg & Periodontol, Fac Dent, BR-14040904 Ribeirao Preto, Brazil.
   [Peitl, Oscar; Zanotto, Edgar D.] Univ Fed Sao Carlos, DEMa, BR-13560 Sao Carlos, SP, Brazil.
RP Roriz, VM (reprint author), Univ Sao Paulo, Sch Dent, Dept Oral & Maxillofacial Surg & Periodontol, Fac Dent, Av Cafe S-N, BR-14040904 Ribeirao Preto, Brazil.
EM vmroriz@hotmail.com
RI PANZERI, HEITOR/B-3497-2013; Zanotto, Edgar/A-7992-2011; Rosa,
   Adalberto/A-6314-2008; Tambasco de Oliveira, Paulo/F-9749-2010
OI Zanotto, Edgar/0000-0003-4931-4505; Rosa, Adalberto/0000-0002-6495-2778;
   Tambasco de Oliveira, Paulo/0000-0002-6662-0486
FU The State of Sao Paulo Research Foundation (FAPESP, Brazil); The
   National Council of Scientific and Technological Development (CNPq,
   Brazil - Fundo Verde-Amarelo); The Coordination for Improvement of
   Higher Education (CAPES, Brazil)
FX The authors thank The State of Sao Paulo Research Foundation (FAPESP,
   Brazil), The National Council of Scientific and Technological
   Development (CNPq, Brazil - Fundo Verde-Amarelo), and The Coordination
   for Improvement of Higher Education (CAPES, Brazil) for the financial
   support; Dr Christian Ravagnani for the preparation of the Biosilicate
   (R) particles, and Mr Sebastiao Carlos Bianco (Faculty of Dentistry of
   Ribeirao Preto, University of Sao Paulo) for technical assistance. The
   authors declare that they have no conflict of interest.
CR Abrahamsson I, 2001, INT J ORAL MAX IMPL, V16, P323
   Camargo PM, 2000, ORAL SURG ORAL MED O, V90, P581, DOI 10.1067/moe.2000.110035
   Carmagnola D, 2000, J CLIN PERIODONTOL, V27, P799, DOI 10.1034/j.1600-051x.2000.027011799.x
   Carmagnola D, 2008, CLIN ORAL IMPLAN RES, V19, P1246, DOI 10.1111/j.1600-0501.2008.01584.x
   Fritz ME, 1996, J PERIODONTOL, V67, P245, DOI 10.1902/jop.1996.67.3.245
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P358
   Gorustovich A, 2002, INT J ORAL MAX IMPL, V17, P644
   Hall EE, 1999, J PERIODONTOL, V70, P526, DOI 10.1902/jop.1999.70.5.526
   HENCH LL, 1980, J BIOMED MATER RES, V14, P803, DOI 10.1002/jbm.820140611
   Iasella JM, 2003, J PERIODONTOL, V74, P990, DOI 10.1902/jop.2003.74.7.990
   Johnson MW, 1997, INT J ORAL MAX IMPL, V12, P835
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   Lekovic V, 1998, J PERIODONTOL, V69, P1044, DOI 10.1902/jop.1998.69.9.1044
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Maniatopoulos C, 1986, Int J Oral Maxillofac Implants, V1, P31
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nevins M, 1998, Int J Periodontics Restorative Dent, V18, P34
   Nishida T, 2006, J PERIODONTOL, V77, P983, DOI 10.1902/jop.2006.050170
   Norton MR, 2002, INT J ORAL MAX IMPL, V17, P249
   Novaes A B Jr, 2001, Implant Dent, V10, P192
   Novaes AB, 2004, CLIN ORAL IMPLAN RES, V15, P34, DOI 10.1046/j.1600-0501.2003.00968.x
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Rosa Adalberto Luiz, 2006, Implant Dent, V15, P97, DOI 10.1097/01.id.0000202418.04896.94
   Schepers E, 1998, INT J ORAL MAX IMPL, V13, P655
   Schepers E J, 1993, Implant Dent, V2, P151, DOI 10.1097/00008505-199309000-00002
   Simon BI, 2000, J PERIODONTOL, V71, P1774, DOI 10.1902/jop.2000.71.11.1774
   Stentz WC, 1997, J PERIODONTOL, V68, P933, DOI 10.1902/jop.1997.68.10.933
   Stvrtecky R, 2003, J PROSTHET DENT, V90, P424, DOI 10.1016/j.prosdent.2003.08.004
   Tadjoedin ES, 2002, CLIN ORAL IMPLAN RES, V13, P428, DOI 10.1034/j.1600-0501.2002.130412.x
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   Tavares MG, 2007, CLIN ORAL IMPLAN RES, V18, P452, DOI 10.1111/j.1600-0501.2007.01344.x
   Watzinger F, 2000, BRIT J ORAL MAX SURG, V38, P312, DOI 10.1054/bjom.1999.0228
   Wheeler DL, 1998, J BIOMED MATER RES, V41, P527, DOI 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.0.CO;2-E
   ZANOTTO ED, 2004, Patent No. 2004074199
NR 35
TC 33
Z9 37
U1 0
U2 7
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2010
VL 21
IS 2
BP 148
EP 155
DI 10.1111/j.1600-0501.2009.01812.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 543CY
UT WOS:000273548800003
PM 19912271
DA 2018-10-20
ER

PT J
AU Wohlfahrt, JC
   Monjo, M
   Ronold, HJ
   Aass, AM
   Ellingsen, JE
   Lyngstadaas, SP
AF Wohlfahrt, Johan Caspar
   Monjo, Marta
   Ronold, Hans Jacob
   Aass, Anne Merete
   Ellingsen, Jan Eirik
   Lyngstadaas, Staale Petter
TI Porous titanium granules promote bone healing and growth in rabbit tibia
   peri-implant osseous defects
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE histology; in vivo; osseous defects; porous titanium granules;
   re-generation
ID MESENCHYMAL STEM-CELLS; PLATELET INTERACTIONS; GRINDING TECHNIQUE; OXIDE
   THICKNESS; FEMORAL STEM; WHOLE-BLOOD; PARTICLES; SURFACES; BIOMATERIAL;
   ACTIVATION
AB Objectives
   The aim of this study was to investigate the osteoconductive properties and biological performance of porous titanium granules used in osseous defects adjacent to titanium implants.
   Material and methods
   In this animal experimental study, calibrated defects were prepared in the tibias of 24 New Zealand rabbits. The defects were randomized into two tests and one control group. The test defects were grafted with either metallic or oxidized porous titanium granules (PTG or WPTG, respectively), whereas control defects were left empty (sham). The defects were closed with a submerged coin shaped titanium implant. Defects were left for healing for 4 weeks. After healing, the implants were removed and the new bone tissue formed onto the implant surface was analyzed for run x 2, osteocalcin, collagen-I, tartrate-resistant acid phosphatase, H+-ATPase, tumor necrosis factor-alpha, interleukin (IL)-6 and IL-10 gene expression using reverse transcriptase polymerase chain reactuion. Wound fluid from the healed defects was analyzed for lactate dehydrogenase and alkaline phosphatase activity. Finally osteoconductivity was analyzed by micro-computed tomography and histology.
   Results
   Significantly more new bone formed in PTG and WPTG grafted defects compared with sham. The new bone grew both through the porosities of the granules and onto the implant surfaces. The WPTG group showed significantly less expression of key inflammation markers, but with no significant difference in a marker for necrosis. The WPTG also showed a significant increase in collagen-I mRNA expression compared with PTG.
   Conclusion
   The results suggest that PTG and WPTG are both osteoconductive materials that can be used to promote bone formation in osseous defects adjacent to titanium implants without hampering implant osseointegration.
   To cite this article:Wohlfahrt JC, Monjo M, R circle divide nold HJ, Aass AM, Ellingsen JE, Lyngstadaas SP. Porous titanium granules promote bone healing and growth in rabbit tibia peri-implant osseous defects.Clin. Oral Impl. Res. 21, 2010; 165-173.doi: 10.1111/j.1600-0501.2009.01813.x.
C1 [Wohlfahrt, Johan Caspar; Monjo, Marta; Lyngstadaas, Staale Petter] Univ Oslo, Inst Clin Odontol, Dept Biomat, NO-0317 Oslo, Norway.
   [Ronold, Hans Jacob] Univ Oslo, Inst Clin Odontol, Dept Prosthodont, NO-0317 Oslo, Norway.
   [Aass, Anne Merete] Univ Oslo, Inst Clin Odontol, Dept Periodontol, NO-0317 Oslo, Norway.
   [Ellingsen, Jan Eirik] Univ Oslo, Inst Clin Odontol, Oral Res Lab, NO-0317 Oslo, Norway.
RP Wohlfahrt, JC (reprint author), Univ Oslo, Inst Clin Odontol, Dept Biomat, POB 1109 Blindern, NO-0317 Oslo, Norway.
EM johancw@odont.uio.no
OI Monjo, Marta/0000-0002-2731-9527; Ellingsen, Jan
   Eirik/0000-0001-9182-6251
FU Norwegian Research Council
FX The authors wish to thank Mr Lars Bruce for his valuable input during
   the planning and initiation of the study. We highly appreciate the
   contribution from Professor Adrian Smith and Mrs Patricia Engen (The
   Norwegian School of Veterinary Science), the excellent technical
   assistance with the analyses of the biological markers from Mrs Britt
   Kvam and Mrs Marina Rubert (Oral Research Laboratory, Faculty of
   Dentistry, University of Oslo) and Professor Leiv Sandvik for valuable
   input on the statistics. Test materials were provided by Tigran
   Technologies AB. The study was sponsored by a grant from the Norwegian
   Research Council.
CR Alffram PA, 2007, UPSALA J MED SCI, V112, P183, DOI 10.3109/2000-1967-192
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Cooper LF, 2006, BIOMATERIALS, V27, P926, DOI 10.1016/j.biomaterials.2005.07.009
   Davies John E, 2003, J Dent Educ, V67, P932
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Eriksson C, 2001, BIOMATERIALS, V22, P1987, DOI 10.1016/S0142-9612(00)00382-3
   Fagerland MW, 2009, STAT MED, V28, P1487, DOI 10.1002/sim.3561
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDSBY RA, 2000, KUBY IMMUNOLOGY
   Gruber R, 2002, CLIN ORAL IMPLAN RES, V13, P529, DOI 10.1034/j.1600-0501.2002.130513.x
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898
   MALONEY WJ, 1990, J BONE JOINT SURG AM, V72A, P1025, DOI 10.2106/00004623-199072070-00011
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   Monjo M, 2008, BIOMATERIALS, V29, P3771, DOI 10.1016/j.biomaterials.2008.06.001
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   OSBORN JF, 1980, EUROPEAN SOC BIOMATE
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010
   Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J
   Schilephake H., 2002, INT J ORAL MAXILLOF, V31, P469, DOI DOI 10.1054/IJOM.2002.0244
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   TORGERSEN S, 1995, ACTA ODONTOL SCAND, V53, P65, DOI 10.3109/00016359509005948
   Turner TM, 2007, UPSALA J MED SCI, V112, P191, DOI 10.3109/2000-1967-193
   Wang ML, 2003, J ORTHOPAED RES, V21, P697, DOI 10.1016/S0736-0266(02)00241-3
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Wilke A, 2002, Z ORTHOP GRENZGEB, V140, P83, DOI 10.1055/s-2002-22096
NR 34
TC 29
Z9 30
U1 1
U2 14
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2010
VL 21
IS 2
BP 165
EP 173
DI 10.1111/j.1600-0501.2009.01813.x
PG 9
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 543CY
UT WOS:000273548800005
PM 19912270
OA Green Published
DA 2018-10-20
ER

PT J
AU Hempel, U
   Hefti, T
   Kalbacova, M
   Wolf-Brandstetter, C
   Dieter, P
   Schlottig, F
AF Hempel, Ute
   Hefti, Thomas
   Kalbacova, Marie
   Wolf-Brandstetter, Cornelia
   Dieter, Peter
   Schlottig, Falko
TI Response of osteoblast-like SAOS-2 cells to zirconia ceramics with
   different surface topographies
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE adhesion; differentiation; mineralization; osteoblasts; proliferation
   surface topography; zirconia ceramics
ID TITANIUM IMPLANTS; MINIATURE PIGS; IN-VIVO; OXIDE; OSSEOINTEGRATION;
   BIOMATERIAL; ROUGHNESS; ADHESION; MAXILLA; SCALE
AB Objectives
   Zirconia is a suitable biomaterial for use in medicine (stomatology, orthopaedics) due to its good biocompatibility and outstanding mechanical properties. This study compares the effect of (i) zirconia to the widely used titanium and (ii) zirconia with two different surface topographies (sandblasted and sandblasted/etched) on the adhesion, proliferation and differentiation of SAOS-2 osteoblasts.
   Methods
   SAOS-2 cells were cultured on either sandblasted or sandblasted/etched zirconia and compared with sandblasted/etched titanium. 2 and 24 h after plating, cell morphology was investigated by scanning electron microscope (SEM) and fluorescence imaging. At 24 and 48 h, cell number-relevant parameters were determined. Alkaline phosphatase (ALP) activity and mineral accumulation were measured at days 8, 11, 15 and day 22 of culture, respectively.
   Results
   SEM and fluorescence images revealed a faster spreading as well as higher number of adherent cells after 24 h incubation on zirconia compared with titanium. Also, the cellular metabolic activity after 24 h and the proliferation rate after 48 h is higher with zirconia compared with titanium. Zirconia had a more pronounced effect compared with titanium on the differentiation of SAOS-2 cells: ALP activity, an early differentiation marker increased earlier and mineralization, a late differentiation marker was increased. Only minor differences were found between zirconia with two different surface topographies; etched zirconia promoted slightly greater the differentiation of SAOS-2 cells.
   Conclusions
   These data indicate that zirconia mediates a pronounced stronger effect on the adhesion, proliferation and differentiation compared with titanium; and that topographical differences of zirconia have minor effects on osteoblast biology.
   To cite this article:Hempel U, Hefti T, Kalbacova M, Wolf-Brandstetter C, Dieter P, Schlottig F. Response of osteoblast-like SAOS-2 cells to zirconia ceramics with different surface topographies.Clin. Oral Impl. Res. 21, 2010; 174-181.doi: 10.1111/j.1600-0501.2009.01797.x.
C1 [Hempel, Ute; Kalbacova, Marie; Dieter, Peter] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol Chem, D-01307 Dresden, Germany.
   [Hefti, Thomas; Schlottig, Falko] Thommen Med AG, Waldenburg, Switzerland.
   [Wolf-Brandstetter, Cornelia] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01307 Dresden, Germany.
RP Hempel, U (reprint author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol Chem, Fiedlerstr 42, D-01307 Dresden, Germany.
EM ute.hempel@tu-dresden.de
RI Hubalek Kalbacova, Marie/G-2307-2017
OI Hubalek Kalbacova, Marie/0000-0002-3886-2218
FU Robert Mathys Foundation in Bettlach
FX The authors thank Christine Kupke and Carolin Preissler for technical
   cell culture assistance. Additionally, the authors thank Claudia
   Schneider and Fabrizio Bigolin from the Robert Mathys Foundation in
   Bettlach for supporting them with roughness measurements and the SEM
   examinations, respectively.
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024
   Kohal RJ, 2006, CLIN ORAL IMPLAN RES, V17, P565, DOI 10.1111/j.1600-0501.2006.01252.X
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Pautke C, 2004, ANTICANCER RES, V24, P3743
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   RODAN SB, 1987, CANCER RES, V47, P4961
   Scarano Antonio, 2003, J Oral Implantol, V29, P8, DOI 10.1563/1548-1336(2003)029<0008:BRTZCI>2.3.CO;2
   Schwartz Zvi, 2005, Alpha Omegan, V98, P9
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Sollazzo V, 2008, J BIOMED MATER RES B, V84B, P550, DOI 10.1002/jbm.b.30903
   Tsaryk R, 2007, BIOMATERIALS, V28, P806, DOI 10.1016/j.biomaterials.2006.09.033
   Wennerberg A, 1996, THESIS GOTEBORG U
   Wieland M, 2001, INT J ORAL MAX IMPL, V16, P163
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhao G, 2006, CLIN ORAL IMPLAN RES, V17, P258, DOI 10.1111/j.1600-0501.2005.01195.x
NR 29
TC 52
Z9 52
U1 1
U2 19
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD FEB
PY 2010
VL 21
IS 2
BP 174
EP 181
DI 10.1111/j.1600-0501.2009.01797.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 543CY
UT WOS:000273548800006
PM 19709059
DA 2018-10-20
ER

PT J
AU Choi, J
   Bischof, JC
AF Choi, Jeunghwan
   Bischof, John C.
TI Review of biomaterial thermal property measurements in the cryogenic
   regime and their use for prediction of equilibrium and non-equilibrium
   freezing applications in cryobiology
SO CRYOBIOLOGY
LA English
DT Review
DE Thermal property; Cryogenic; Glycerol; Numerical prediction; Phase
   change; Heat transfer; Non-equilibrium; Crystallization
ID TISSUE HEAT-TRANSFER; DIFFERENTIAL SCANNING CALORIMETRY; AMORPHOUS
   STATE; AQUEOUS-SOLUTIONS; MASS-TRANSFER; PHASE-CHANGE; VASCULAR
   MICROSTRUCTURE; QUANTITATIVE-ANALYSIS; SUBZERO TEMPERATURES;
   DIMETHYL-SULFOXIDE
AB It is well accepted in cryobiology that the temperature history and cooling rates experienced in biomaterials during freezing procedures correlate strongly with biological outcome. Therefore, heat transfer measurement and prediction in the cryogenic regime is central to the field. Although direct measurement of temperature history (i.e. heat transfer) can be performed, accuracy is usually achieved only for local measurements within a given system and cannot be readily generalized to another system without the aid of predictive models. The accuracy of these models rely upon thermal properties which are known to be highly dependent on temperature, and in the case of significant cryoprotectant loading, also on crystallized fraction. In this work, we review the available thermal properties of biomaterials in the cryogenic regime. The review shows a lack of properties for many biomaterials in the subzero temperature domain, and especially for systems with cryoprotective agents. Unfortunately, use of values from the limited data available (usually only down to -40 degrees C) lead to an underestimation of thermal property change (i.e. conductivity rise and specific heat drop due to ice crystallization) with lower temperatures. Conversely, use of surrogate values based solely on ice thermal properties lead to an overestimation of thermal property change for most biomaterials. Additionally, recent work extending the range of available thermal properties to -150 degrees C has shown that the thermal conductivity will drop in both PBS and tissue (liver) due to amorphous/glassy phases (versus crystalline) of biomaterials with the addition of cryoprotective additives such as glycerol. Thus, we investigated the implications of using approximated or constant property values versus measured temperature-dependent values for predicting temperature history during freezing in PBS (phosphate-buffered saline)and porcine liver with and without cryoprotectants (glycerol). Using measured property values (thermal conductivity, specific heat, and latent heat of phase change) of porcine liver, a standard was created which showed that values based on surrogate ice properties under-predicted cooling times, while constant properties (i.e. based on limited data reported near the freezing point) over-predicted cooling times. Additionally, a new iterative numerical method that accommodates non-equilibrium cooling effects as a function of time and position (i.e. crystallization versus amorphous phase) was used to predict temperature history during freezing in glycerol loaded systems. Results indicate that in addition to the increase in cooling times due to the lowering of thermal diffusivity with more glycerol, non-equilibrium effects such as the prevention of maximal crystallization (i.e. amorphous phases) will further increase required cooling times. It was also found that the amplified effect of non-equilibrium cooling and crystallization with system size prevents the thermal history to be described with non-dimensional lengths, such as was possible under equilibrium cooling. These results affirm the need to use accurate thermal properties that incorporate temperature dependence and crystallized fraction. Further studies are needed to extract thermal properties of other important biomaterials in the subzero temperature domain and to develop accurate numerical methods which take into account non-equilibrium cooling events encountered in cryobiology when partial or total vitrification occurs. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Choi, Jeunghwan; Bischof, John C.] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Urol Surg, Minneapolis, MN 55455 USA.
RP Bischof, JC (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.
EM bischof@umn.edu
FU United States National Science Foundation [NSF CTS 0313934]; National
   Institutes of Health [NIH 2R01 CA075284]; Center for Research in
   Education and Simulation Technologies (CREST) at the University of
   Minnesota
FX This work was supported by the United States National Science Foundation
   (NSF CTS 0313934), the National Institutes of Health (NIH 2R01
   CA075284), and the Center for Research in Education and Simulation
   Technologies (CREST) at the University of Minnesota.
CR ALEXIADES V, 1993, MATH MODELING MELTIN
   *ASHRAE, 2002, ASHRAE HDB REFR, P81
   ASHWORTH T, 1972, P 4 INT CRYOG ENG C
   BAI XM, 1991, J BIOMECH ENG-T ASME, V113, P423, DOI 10.1115/1.2895422
   BALASUBR.TA, 1974, J HEAT TRANS-T ASME, V96, P296, DOI 10.1115/1.3450195
   Balasubramaniam TA, 1997, J BIOMECH ENG-T ASME, V99, P148
   BALD WB, 1982, REP PROG PHYS, V45, P1381, DOI 10.1088/0034-4885/45/12/001
   BENZINGER TH, 1972, TEMPERATURE ITS MEAS
   Bird R. Byron, 2002, TRANSPORT PHENOMENA
   BIRGE NO, 1986, PHYS REV B, V34, P1631, DOI 10.1103/PhysRevB.34.1631
   Bischof JC, 2007, ANN BIOMED ENG, V35, P292, DOI 10.1007/s10439-006-9176-7
   BISCHOF JC, 1993, J HEAT TRANS-T ASME, V115, P1029, DOI 10.1115/1.2911357
   Bischof JC, 2006, HEAT MASS TRANSFER, V42, P955, DOI 10.1007/s00231-006-0138-2
   Bischof JC, 1997, CRYOBIOLOGY, V34, P42, DOI 10.1006/cryo.1996.1978
   BISCHOF JC, 1992, J BIOMECH ENG-T ASME, V114, P467, DOI 10.1115/1.2894096
   BOUTRON P, 1979, CRYOBIOLOGY, V16, P83, DOI 10.1016/0011-2240(79)90015-4
   BOUTRON P, 1979, CRYOBIOLOGY, V16, P372, DOI 10.1016/0011-2240(79)90050-6
   BOUTRON P, 1979, CRYOBIOLOGY, V16, P557, DOI 10.1016/0011-2240(79)90074-9
   BOUTRON P, 1982, CRYOBIOLOGY, V19, P550, DOI 10.1016/0011-2240(82)90184-5
   BOUTRON P, 1986, CRYOBIOLOGY, V23, P88, DOI 10.1016/0011-2240(86)90022-2
   BOUTRON P, 1978, CRYOBIOLOGY, V12, P93
   BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   BUDMAN H, 1986, J BIOMECH ENG-T ASME, V108, P42, DOI 10.1115/1.3138578
   CAHILL DG, 1987, PHYS REV B, V35, P4067, DOI 10.1103/PhysRevB.35.4067
   CHARNY CK, 1992, ADV HEAT TRANSFER, V22, P19
   Chato J.C., 1968, S THERM PROBL BIOT A, P16
   Chato JC, 1985, HEAT TRANSFER MED BI, P167
   Chen M M, 1980, Ann N Y Acad Sci, V335, P137, DOI 10.1111/j.1749-6632.1980.tb50742.x
   CHEN MM, 1981, J BIOMECH ENG-T ASME, V103, P253
   CHEN MM, 1977, 77WAHT42 ASME
   Cheng HLM, 2002, J MAGN RESON IMAGING, V16, P598, DOI 10.1002/jmri.10199
   CHERNEEVA LI, 1956, REPORT VNIKHI
   CHIU J, 1979, THERMOCHIM ACTA, V34, P267, DOI 10.1016/0040-6031(79)87116-6
   Choi JH, 2008, CRYOBIOLOGY, V57, P79, DOI 10.1016/j.cryobio1.2008.05.004
   Choi JH, 2008, INT J HEAT MASS TRAN, V51, P640, DOI 10.1016/j.ijheatmasstransfer.2007.04.041
   Choi Y., 1986, FOOD ENG PROCESS APP, V1, P93
   COGER R, 1990, CRYO-LETT, V11, P359
   COGER R, 1995, PRESERVATION TECHNIQ, P1567
   COMINI G, 1976, J HEAT TRANS-T ASME, V98, P543, DOI 10.1115/1.3450598
   Comini G., 1974, International Journal for Numerical Methods in Engineering, V8, P613, DOI 10.1002/nme.1620080314
   COOK HF, 1952, BRIT J APPL PHYS, V3, P1, DOI 10.1088/0508-3443/3/1/302
   COOPER TE, 1972, J HEAT TRANSF, V94, P133, DOI 10.1115/1.3449883
   *CRC, 2006, HDB CHEM PHYS, P6
   Devireddy RV, 2002, J HEAT TRANS-T ASME, V124, P365, DOI 10.1115/1.1445134
   Diller K. R., 1992, BIOENGINEERING HEAT, P157
   DILLER KR, 2000, CRC HDB THERMAL ENG, P4114
   DILLER KR, 1985, AICHE S SERIES, P234
   Duck F., 1990, PHYS PROPERTIES TISS
   Fennema O. R., 1973, LOW TEMPERATURE PRES
   Fleming A. K., 1969, Journal of Food Technology, V4, P199, DOI 10.1089/153082002762205098
   Franks F, 1982, WATER COMPREHENSIVE, V7, P215
   GORI F, 1977, P 1 MED C MED BIOL E, P3
   GRAYSON J, 1952, J PHYSIOL-LONDON, V118, P54, DOI 10.1113/jphysiol.1952.sp004772
   HAN B, 2005, CRYOBIOLOGY, V52, P146
   Han B., 2004, CELL PRESERV TECHNOL, V2, P91
   HARTMANN U, 1991, CRYOBIOLOGY, V28, P115, DOI 10.1016/0011-2240(91)90014-F
   HAYES LJ, 1983, J ENERG RESOUR-ASME, V105, P431, DOI 10.1115/1.3230948
   HAYES LJ, 1988, CRYOBIOLOGY, V25, P67, DOI 10.1016/0011-2240(88)90022-3
   HAYES LJ, 1986, NUMERICAL METHODS HE, P63
   He Xiaoming, 2003, Crit Rev Biomed Eng, V31, P355, DOI 10.1615/CritRevBiomedEng.v31.i56.10
   HENRIQUES FC, 1947, REV SCI INSTRUM, V18, P673, DOI 10.1063/1.1741041
   Hey JM, 1997, J NON-CRYST SOLIDS, V211, P262, DOI 10.1016/S0022-3093(96)00637-0
   Hey JM, 1998, CRYOBIOLOGY, V37, P119, DOI 10.1006/cryo.1998.2108
   HILL JAMES E., 1967, FOOD TECHNOL, V21, P91
   Hobbs P. V., 1974, ICE PHYS
   JIJI LM, 1984, J BIOMECH ENG-T ASME, V106, P331, DOI 10.1115/1.3138502
   JOCHEM M, 1993, WARME STOFFUBERTRAG, V28, P195, DOI 10.1007/BF01541190
   KARLSSON J, 2000, CRYOPRESERVATION PRI, P293
   KARLSSON JOM, 1994, J APPL PHYS, V75, P4442, DOI 10.1063/1.355959
   Karlsson JOM, 1996, BIOMATERIALS, V17, P243, DOI 10.1016/0142-9612(96)85562-1
   Karlsson JOM, 2001, CRYOBIOLOGY, V42, P154, DOI 10.1006/cryo.2001.2318
   KEATING MY, 1990, THERMOCHIM ACTA, V166, P69, DOI 10.1016/0040-6031(90)80170-4
   KHANNA YP, 1988, POLYM ENG SCI, V28, P1034, DOI 10.1002/pen.760281604
   KLINGER J, 1972, PHYSICS CHEM ICE, P114
   KORBER C, 1983, J CRYST GROWTH, V61, P307, DOI 10.1016/0022-0248(83)90367-6
   KOUROSH S, 1990, INT J HEAT MASS TRAN, V33, P39, DOI 10.1016/0017-9310(90)90139-L
   LENTZ CP, 1961, FOOD TECHNOL-CHICAGO, V15, P243
   Lunardini V. J., 1981, HEAT TRANSFER COLD C
   Macfarlane Douglas R., 1992, V1, P221
   MEHL PM, 1996, ADV LOW TEMPERATURE, P185
   MILLER HL, 1963, FOOD TECHNOL-CHICAGO, V17, P490
   MOLINE SW, 1961, FOOD TECHNOL-CHICAGO, V15, P228
   Morley M. J., 1966, J FOOD TECHNOL, V1, P303
   NEWMAN AA, 1968, PHYS PROPERTIES GLYC, P21
   NISHIJIMA Y, 1960, B CHEM SOC JPN, V33, P1649, DOI 10.1246/bcsj.33.1649
   OCALLAGHAN MG, 1982, INT J HEAT MASS TRAN, V25, P553, DOI 10.1016/0017-9310(82)90058-8
   Ozisik M, 1994, FINITE DIFFERENCE ME
   PENNES HH, 1948, J APPL PHYSIOL, V1, P93
   POPPENDIEK HF, 1966, WHOLE ORGAN FREEZING
   Rabin Y, 1998, J BIOMECH ENG-T ASME, V120, P32, DOI 10.1115/1.2834304
   RARD JA, 1979, J SOLUTION CHEM, V8, P701, DOI 10.1007/BF00648776
   Rewcastle JC, 2001, MED PHYS, V28, P1125, DOI 10.1118/1.1374246
   Riedel L., 1957, KALTETECHNIK, V9, P38
   RINFRET AP, 1960, ANN NY ACAD SCI, V85, P576, DOI 10.1111/j.1749-6632.1960.tb49984.x
   Rubinsky B, 2000, ANNU REV BIOMED ENG, V2, P157, DOI 10.1146/annurev.bioeng.2.1.157
   RUBINSKY B, 1984, CRYOBIOLOGY, V21, P303, DOI 10.1016/0011-2240(84)90326-2
   RUBINSKY B, 1981, INT J HEAT MASS TRAN, V24, P1987, DOI 10.1016/0017-9310(81)90121-6
   Rupp CC, 2002, CRYOBIOLOGY, V45, P167, DOI 10.1016/S0011-2240(02)00125-6
   SMITH DJ, 1999, 5 ASME JSME JOINT TH
   Sweat V.E., 1994, ENG PROPERTIES FOODS, P99
   Tanaka K., 1978, Journal of the Chemical Society Faraday Transactions I, P1879
   Vachon R I., 1967, 7 INT C MED BIOL ENG, P502
   VALVANO JW, 1988, LOW TEMPERATURE BIOT, P331
   VENDRIK AJH, 1957, J APPL PHYSIOL, V11, P211
   VIGIER G, 1987, CRYOBIOLOGY, V24, P345, DOI 10.1016/0011-2240(87)90038-1
   VOLLER V, 1981, INT J HEAT MASS TRAN, V24, P545, DOI 10.1016/0017-9310(81)90062-4
   WEINBAUM S, 1984, J BIOMECH ENG-T ASME, V106, P321, DOI 10.1115/1.3138501
   WOODAMS EDWARD E., 1968, FOOD TECHNOL, V22, P150
   Zhang A, 2004, CELL PRESERV TECHNOL, V2, P157, DOI 10.1089/153834404774101990
NR 109
TC 51
Z9 55
U1 0
U2 31
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD FEB
PY 2010
VL 60
IS 1
SI SI
BP 52
EP 70
DI 10.1016/j.cryobiol.2009.11.004
PG 19
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 568KL
UT WOS:000275521100007
PM 19948163
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gibson, NM
   Luo, TJM
   Shenderova, O
   Choi, YJ
   Fitzgerald, Z
   Brenner, DW
AF Gibson, N. M.
   Luo, T. J. M.
   Shenderova, O.
   Choi, Y. J.
   Fitzgerald, Z.
   Brenner, D. W.
TI Fluorescent dye adsorption on nanocarbon substrates through
   electrostatic interactions
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on New Diamond and Nano Carbons (NDNC 2009)
CY JUN 07-11, 2009
CL Traverse City, MI
DE Nanoparticle; Nanodiamond; Adsorption; Biomaterial; Surface modification
ID DIAMOND NANOPARTICLES; CARBON NANOTUBES; NANODIAMONDS; BIOCOMPATIBILITY;
   COATINGS
AB Nanodiamonds (NDs) with modified surface functional groups and surface characteristics are an attractive model to understand adsorption mechanisms of molecules on substrates. The research described in this paper illustrates the binding mechanisms of fluorescent dyes to ND surfaces as these interactions are extremely useful in many biomedical ND applications. A thorough study of binding and release mechanisms was completed using an assortment of carbon based nanoparticles, including NDs, onion-like carbon. and single-wall nanohorns. Surface charge interactions were studied in combination with surface areas, configurations, and modifications in order to determine which is responsible for the largest adsorption capacity and strongest binding. Adsorption studies were carried out using UV-Vis measurements followed by maximum binding capacity determination using the Langmuir isotherm and related transform equations. Langmuir and transform calculations further reveal the specific surface area covered by adsorbents for select nanocarbon materials. In addition. cyclic voltammetry measurements confirm that dye adsorbed onto NDs exhibits equal electrochemical properties as in its unbound state. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Gibson, N. M.; Luo, T. J. M.; Shenderova, O.; Choi, Y. J.; Fitzgerald, Z.; Brenner, D. W.] N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   [Shenderova, O.] Int Technol Ctr, Res Triangle Pk, NC USA.
RP Gibson, NM (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Box 7907, Raleigh, NC 27695 USA.
EM nmgibson@ncsu.edu
RI Brenner, Donald/D-1741-2009
CR Chao JI, 2007, BIOPHYS J, V93, P2199, DOI 10.1529/biophysj.107.108134
   Gibson N, 2009, DIAM RELAT MATER, V18, P620, DOI 10.1016/j.diamond.2008.10.049
   GIBSON NM, LANGMUIR UNPUB
   GILES CH, 1974, J COLLOID INTERF SCI, V47, P755, DOI 10.1016/0021-9797(74)90252-5
   Gitig DM, 2001, MOL BIOTECHNOL, V19, P179, DOI 10.1385/MB:19:2:179
   Grichko V., 2007, NANOBIOTECHNOLOGY, V2, P37
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   KOSSOVSKY N, 1995, BIOCONJUGATE CHEM, V6, P507, DOI 10.1021/bc00035a001
   Liu KK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/32/325102
   Poh WC, 2004, LANGMUIR, V20, P5484, DOI 10.1021/la0490947
   Puzyr AP, 2007, DIAM RELAT MATER, V16, P2124, DOI 10.1016/j.diamond.2007.07.025
   Puzyr AP, 2007, DOKL BIOCHEM BIOPHYS, V417, P299, DOI 10.1134/S1607672907060026
   SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216
   Schrand AM, 2007, DIAM RELAT MATER, V16, P2118, DOI 10.1016/j.diamond.2007.07.020
   Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v
   Stewart James J. P., STEWART COMPUTATIONA
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   WARING MJ, 1965, J MOL BIOL, V13, P269, DOI 10.1016/S0022-2836(65)80096-1
   Yu SJ, 2005, J AM CHEM SOC, V127, P17604, DOI 10.1021/ja0567081
NR 21
TC 13
Z9 13
U1 1
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD FEB-MAR
PY 2010
VL 19
IS 2-3
BP 234
EP 237
DI 10.1016/j.diamond.2009.10.005
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 563BX
UT WOS:000275101800031
DA 2018-10-20
ER

PT J
AU Han, JG
   Wang, ZJ
   Gao, ZG
   Xu, HM
   Yang, ZH
   Jin, ML
AF Han, Jia Gang
   Wang, Zhen Jun
   Gao, Zhi Gang
   Xu, Hui Min
   Yang, Zeng Hui
   Jin, Mu Lan
TI Pelvic Floor Reconstruction Using Human Acellular Dermal Matrix After
   Cylindrical Abdominoperineal Resection
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
DE Cylindrical abdominoperineal resection; Pelvic reconstruction; Human
   acellular dermal matrix; Complication
ID ABDOMINIS MYOCUTANEOUS FLAP; TOTAL MESORECTAL EXCISION; LOW
   RECTAL-CANCER; WALL RECONSTRUCTION; HERNIA REPAIR; RISK-FACTORS;
   PERINEAL; DEFECTS; SURGERY; MESH
AB PURPOSE: Patients who undergo cylindrical abdominoperineal resection can have significant complications, especially those who require pelvic reconstruction using myocutaneous flaps. Reconstruction using a biomaterial may be a novel alternative. The purpose of this study is to report the initial results of pelvic reconstruction using human acellular dermal matrix after cylindrical abdominoperineal resection.
   METHODS: Between January 2008 and February 2009, pelvic floor reconstruction was performed in 12 consecutive patients who underwent cylindrical abdominoperineal resection for advanced ultralow rectal cancer.
   RESULTS: Two weeks after the operation, primary complete healing of the perineal wound was seen in 11 patients. At a median follow-up of 8 months, there was no perineal wound breakdown, bulge, or herniation. One patient had an asymptomatic seroma, one patient had a perineal wound infection, and 4 patients had perineal pain that resolved.
   CONCLUSIONS: Human acellular dermal matrix provided a safe alternative for the reconstruction of large pelvic defect in the patients after cylindrical abdominoperineal resection.
C1 [Han, Jia Gang; Wang, Zhen Jun; Gao, Zhi Gang; Xu, Hui Min; Yang, Zeng Hui] Capital Med Univ, Beijing Chaoyang Hosp, Dept Gen Surg, Beijing 100020, Peoples R China.
   [Jin, Mu Lan] Capital Med Univ, Beijing Chaoyang Hosp, Dept Histopathol, Beijing 100020, Peoples R China.
RP Wang, ZJ (reprint author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Gen Surg, 8 Gongtinan Lu, Beijing 100020, Peoples R China.
EM wang3zj@sohu.com
FU New Century Educational Talents Plan of Chinese Education Ministry,
   China [NCET-05-0200]; National Natural Science Fund Projects, China
   [30772123]; Program for Outstanding Medical Academic Leader, Beijing
   [2009-1-03]; Youth Foundation of Beijing Chaoyang Hospital
FX Supported by the New Century Educational Talents Plan of Chinese
   Education Ministry, China (No. NCET-05-0200), National Natural Science
   Fund Projects, China (No. 30772123), Program for Outstanding Medical
   Academic Leader, Beijing (2009-1-03), and Youth Foundation of Beijing
   Chaoyang Hospital.
CR Abbott DE, 2008, DIS COLON RECTUM, V51, P1237, DOI 10.1007/s10350-008-9359-4
   Artioukh DY, 2007, COLORECTAL DIS, V9, P362, DOI 10.1111/j.1463-1318.2006.01159.x
   Bell SW, 2005, BRIT J SURG, V92, P482, DOI 10.1002/bjs.4857
   Bullard KM, 2005, DIS COLON RECTUM, V48, P438, DOI 10.1007/s10350-004-0827-1
   Butler CE, 2005, PLAST RECONSTR SURG, V116, P1263, DOI 10.1097/01.prs.0000181692.71901.bd
   Candage R, 2008, SURGERY, V144, P703, DOI 10.1016/j.surg.2008.06.018
   Christian CK, 2005, DIS COLON RECTUM, V48, P43, DOI 10.1007/s10350-004-0855-x
   Disa JJ, 1996, PLAST RECONSTR SURG, V97, P801, DOI 10.1097/00006534-199604000-00017
   Dulucq JL, 2006, SURG ENDOSC, V20, P414, DOI 10.1007/s00464-005-0193-7
   Glasberg SB, 2006, PLAST RECONSTR SURG, V118, P8, DOI 10.1097/01.prs.0000220470.97776.f5
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Holm T, 2007, BRIT J SURG, V94, P232, DOI 10.1002/bjs.5489
   Houvenaeghel G, 2005, EJSO, V31, P1185, DOI 10.1016/j.ejso.2005.07.004
   Jernigan TW, 2003, ANN SURG, V238, P349, DOI 10.1097/01.sla.0000086544.42647.84
   Jin J, 2007, J AM COLL SURGEONS, V205, P654, DOI 10.1016/j.jamcollsurg.2007.06.012
   Korn JM, 2009, HERNIA, V13, P329, DOI 10.1007/s10029-008-0449-y
   Kouraklis G, 2002, DIS COLON RECTUM, V45, P836, DOI 10.1097/01.DCR.0000017587.54619.3C
   Marr R, 2005, ANN SURG, V242, P74, DOI 10.1097/01.sla.0000167926.60908.15
   Martin-Duce A, 2001, Hernia, V5, P70
   Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B
   Miles WK, 2000, PLAST RECONSTR SURG, V105, P2387, DOI 10.1097/00006534-200006000-00012
   Nagtegaal ID, 2005, J CLIN ONCOL, V23, P9257, DOI 10.1200/JCO.2005.02.9231
   Nissan A, 2001, DIS COLON RECTUM, V44, P27, DOI 10.1007/BF02234816
   Patton JH, 2007, AM J SURG, V193, P360, DOI 10.1016/j.amjsurg.2006.09.021
   Said HK, 2007, GYNECOL ONCOL, V107, P578, DOI 10.1016/j.ygyno.2007.08.063
   Silverman R P, 2004, Hernia, V8, P336, DOI 10.1007/s10029-004-0241-6
   Tei TM, 2003, BRIT J SURG, V90, P575, DOI 10.1002/bjs.4073
   Uranues S, 2008, J AM COLL SURGEONS, V207, P663, DOI 10.1016/j.jamcollsurg.2008.06.330
   Waddell BE, 2000, ARCH SURG-CHICAGO, V135, P1212, DOI 10.1001/archsurg.135.10.1212
   West NP, 2008, J CLIN ONCOL, V26, P3517, DOI 10.1200/JCO.2007.14.5961
   Wibe A, 2004, DIS COLON RECTUM, V47, P48, DOI 10.1007/s10350-003-0012-y
   Wille-Jorgensen P, 2009, INT J COLORECTAL DIS, V24, P323, DOI 10.1007/s00384-008-0607-9
   Wong AK, 2008, PLAST RECONSTR SURG, V121, P1144, DOI 10.1097/01.prs.0000302505.43942.07
NR 33
TC 45
Z9 52
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD FEB
PY 2010
VL 53
IS 2
BP 219
EP 223
DI 10.1007/DCR.0b013e3181b715b5
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 550PJ
UT WOS:000274140100016
PM 20087098
DA 2018-10-20
ER

PT J
AU Lee, SH
   Hwang, SO
   Shin, M
AF Lee, Seung-Hyun
   Hwang, Soon-Ok
   Shin, Malshick
TI Properties of Novel Starch Isolated from Castanopsis cuspidate Fruit
   Grown in a Subtropical Zone of Korea
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE Castanopsis cuspidate fruit; starch; physicochemical property; pasting;
   thermal property
ID PHYSICOCHEMICAL PROPERTIES; AMYLOSE CONTENT; MAIZE STARCHES;
   AMYLOPECTIN; RICE; GELATION; STORAGE; FLOURS; WHEAT
AB To develop a plant-based biomaterial Source, the physicochemical properties of starch from Castanopsis cuspidate fruit, grown in Jindo, Korea, were investigated. The starch was isolated from the fruit using an alkali steeping method. This starch had high amylose content (56.1%). The total dietary fiber and water binding capacity of starch were 7.1 and 140.8%, respectively. The swelling power of the starch increased more rapidly than that of the flour, and the solubility of the flour was higher than that of the starch but it did not change with increasing temperature. The starch exhibited B-type crystallinity, and the starch granules were polygonal or irregular shapes. The initial pasting temperature of the flour was higher than that of the starch. The peak, trough, and final viscosities of the starch were 631.1, 364.4, and 461.8 RVU, respectively. The starch for onset gelatinization temperature (T(o)), peak temperature (T(p)), conclusion temperature (T(c)), and enthalpy of gelatinization (Delta H) were 56.0, 61.3, 72.4 degrees C, and 14.1 J/g, respectively.
C1 [Shin, Malshick] Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea.
   Chonnam Natl Univ, Human Ecol Res Inst, Kwangju 500757, South Korea.
RP Shin, M (reprint author), Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea.
EM msshin@jnu.ac.kr
FU Korea Forest Research Institute (KFRI)
FX This study was supported by a research grant from Korea Forest Research
   Institute (KFRI) in 2007.
CR AACC, 2000, 6102 AACC
   AACC Approved methods of the American Association of Cereal Chemists, 2000, 4415A AACC
   *AOAC, 2000, 99143 AOAC
   BILIADERIS CG, 1986, J AGR FOOD CHEM, V34, P6, DOI 10.1021/jf00067a002
   Case SE, 1998, J CEREAL SCI, V27, P301, DOI 10.1006/jcrs.1997.0164
   Cheetham NWH, 1997, CARBOHYD POLYM, V33, P251, DOI 10.1016/S0144-8617(97)00033-7
   Choi H, 2004, STARCH-STARKE, V56, P469, DOI 10.1002/star.200300273
   Chung KM, 2000, CEREAL CHEM, V77, P567, DOI 10.1094/CCHEM.2000.77.5.567
   ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33
   Fitt L. E., 1984, STARCH CHEM TECHNOLO, P675
   Iturriaga L, 2004, FOOD RES INT, V37, P439, DOI 10.1016/j.foodres.2003.12.005
   Kang HJ, 2003, J AGR FOOD CHEM, V51, P6598, DOI 10.1021/jf0344946
   Kim ByungSup, 1995, Korean Journal of Plant Pathology, V11, P158
   KIM JH, 1990, KOREAN J ECOL, V13, P33
   Kim SH, 2008, FOOD SCI BIOTECHNOL, V17, P534
   Kohyama K, 2006, CARBOHYD POLYM, V63, P82, DOI 10.1016/j.carbpol.2005.08.004
   KWEON MR, 1993, KOREAN J FOOD SCI TE, V25, P698
   LEE JC, 1990, INT J IMMUNOTHER, V6, P1
   MEDCALF DG, 1965, CEREAL CHEM, V42, P558
   MILES MJ, 1985, CARBOHYD RES, V135, P271, DOI 10.1016/S0008-6215(00)90778-X
   MURA JP, 1997, J AGR FOOD CHEM, V45, P3848
   Ratnayake WS, 2002, STARCH-STARKE, V54, P217, DOI 10.1002/1521-379X(200206)54:6<217::AID-STAR217>3.0.CO;2-R
   Singh GD, 2009, STARCH-STARKE, V61, P35, DOI 10.1002/star.200800233
   Song JY, 2008, FOOD SCI BIOTECHNOL, V17, P20
   Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001
   Thitipraphunkul K, 2003, CARBOHYD POLYM, V54, P489, DOI 10.1016/j.carbpol.2003.08.003
   WANG G, 2007, ISFIS ACTA HORTICULT, V804
   WANG LZ, 1994, CEREAL CHEM, V71, P443
   WILLIAMS PC, 1970, CEREAL CHEM, V47, P411
NR 29
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1226-7708
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD FEB
PY 2010
VL 19
IS 1
BP 63
EP 68
DI 10.1007/s10068-010-0009-y
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA 567WK
UT WOS:000275478300009
DA 2018-10-20
ER

PT J
AU Extremina, CI
   da Fonseca, AF
   Granja, PL
   Fonseca, AP
AF Extremina, Clara I.
   da Fonseca, A. Freitas
   Granja, Pedro L.
   Fonseca, Antonio P.
TI Anti-adhesion and antiproliferative cellulose triacetate membrane for
   prevention of biomaterial-centred infections associated with
   Staphylococcus epidermidis
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Article
DE Staphylococcus epidermidis; Adhesion; Antimicrobial agents; Cellulose
   triacetate
ID CATHETER; ADHESION
AB The initial step in preventing biomaterial-associated infections consists of preventing bacterial adhesion to the device surface. One possible approach is the design of antibiotic-releasing biomaterials. Cellulose triacetate (CTA) membranes with the antibiotic imipenem (IPM) entrapped (CTA-IPM) were prepared. The material was characterised in terms of surface morphology by scanning electron microscopy, surface free energy of interaction and X-ray photoelectron spectroscopy (XPS). Antibiotic release studies were also performed. In vitro adhesion of Staphylococcus epidermidis RP62A to CTA-IPM was investigated using a modified microtitre plate assay, and the antibacterial activity of the CTA-IPM membrane was assessed by a modified Kirby-Bauer test, which showed effective entrapment of the antibiotic as confirmed by XPS and hydrophilicity assays. Release studies showed that this drug-polymer conjugate serves as an adequate reservoir for sustained release of IPM over a period of 71 h at an effective bacteriostatic concentration. Moreover, bacterial adhesion tests showed a statistically significant decrease in the adhesion of S. epidermidis RP62A to CTA-IPM compared with its adhesion to CTA alone. The present innovative approach is capable of providing a membrane with anti-adhesive and antiproliferative properties, thus encouraging in vivo studies to provide a better simulation of the clinical situation. (C) 2009 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
C1 [Extremina, Clara I.; Fonseca, Antonio P.] Univ Porto, Fac Farm, REQUIMTE, P-4050047 Oporto, Portugal.
   [Extremina, Clara I.; Granja, Pedro L.] Univ Porto, INEB, P-4150180 Oporto, Portugal.
   [da Fonseca, A. Freitas] Escola Super Saude, Inst Piaget, P-4405678 Gulpilhares, Vila Nova Gaia, Portugal.
   [Fonseca, Antonio P.] Univ Porto, Fac Med, P-4200319 Oporto, Portugal.
RP Extremina, CI (reprint author), Univ Porto, Fac Farm, REQUIMTE, Rua Anibal Cunha 164, P-4050047 Oporto, Portugal.
EM extremina@gmail.com
RI REQUIMTE, AL/H-9106-2013; Granja, Pedro/B-1685-2008; Chaves,
   Pedro/K-1288-2013
OI Granja, Pedro/0000-0003-2761-4929; 
CR AKIYAMA H, 1979, J UROLOGY, V121, P40, DOI 10.1016/S0022-5347(17)56652-5
   Amaral IF, 2006, J APPL POLYM SCI, V102, P276, DOI 10.1002/app.23737
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bhat NV, 2000, J APPL POLYM SCI, V76, P258, DOI 10.1002/(SICI)1097-4628(20000411)76:2<258::AID-APP15>3.0.CO;2-U
   Clinical and Laboratory Standards Institute, 2006, M100S16 CLSI
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donelli G, 2002, J CHEMOTHERAPY, V14, P501, DOI 10.1179/joc.2002.14.5.501
   ELAM JH, 1992, BIOMATERIALS, V14, P233
   Fonseca AP, 2004, J MED MICROBIOL, V53, P903, DOI 10.1099/jmm.0.45637-0
   Fonseca AP, 2001, J MATER SCI-MATER M, V12, P543, DOI 10.1023/A:1011227915575
   Ge YG, 2004, ANTIMICROB AGENTS CH, V48, P1384, DOI 10.1128/AAC.48.4.1384-1396.2004
   GRANJA PL, 1996, POLYM MED SURG PIMS, P73
   Martinez-Martinez L, 1991, Enferm Infecc Microbiol Clin, V9, P543
   Thomas M.J.K., 1996, ULTRAVIOLET VISIBLE
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
NR 15
TC 8
Z9 9
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD FEB
PY 2010
VL 35
IS 2
BP 164
EP 168
DI 10.1016/j.ijantimicag.2009.09.017
PG 5
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 545GD
UT WOS:000273719600011
PM 19942411
DA 2018-10-20
ER

PT J
AU Palmieri, A
   Pezzetti, F
   Brunelli, G
   Martinelli, M
   Lo Muzio, L
   Scarano, A
   Scapoli, L
   Arlotti, M
   Guerzoni, L
   Carinci, F
AF Palmieri, Annalisa
   Pezzetti, Furio
   Brunelli, Giorgio
   Martinelli, Marcella
   Lo Muzio, Lorenzo
   Scarano, Antonio
   Scapoli, Luca
   Arlotti, Marzia
   Guerzoni, Laura
   Carinci, Francesco
TI Anorganic Bovine Bone (Bio-Oss) Regulates miRNA of Osteoblast-like Cells
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID MAXILLARY SINUS AUGMENTATION; PLATELET-RICH PLASMA; RNA-INTERFERENCE;
   FLOOR AUGMENTATION; C-ELEGANS; DICER; IMPLANTS; HYDROXYAPATITE;
   EXPRESSION; MODELS
AB Bio-Oss (Geistlich) is composed of anorganic bovine bone and has been widely used in several bone regeneration procedures during oral surgery. However, how this biomaterial enhances osteoblast activity to promote bone formation is not completely understood, MicroRNAs (miRNAs) represent a class of small, functional, noncoding RNAs of 19 to 23 nucleotides that regulate the transcription of messenger RNAs (mRNAs) in proteins, In this study, the miRNA microarray technique was used to investigate translation regulation in an osteoblast-like cell line (MG63) exposed to Bio-Oss. Nine up-regulated miRNAs (mir-423, mir-492, mir-191, mir-23a, mir-377, mir-494, mir-214, mir-193b, mir-320) and 4 down-regulated miRNAs (mir-27a, mir-24, mir-188, let-7c) were identified. Because each miRNA regulates 100 mRNAs, only mRNAs related to bone formation were analyzed. The vast majority of detected mRNAs are down-regulated, including some homeobox genes (genes that regulate the morphogenesis of an entire segment of the body), such as noggin and EN1. An indirect positive effect was demonstrated on bone morphogenetic protein-4. To the authors' knowledge, the data reported here are the first on translation regulation in osteoblasts exposed to Bio-Oss. This study may be relevant in better understanding the molecular mechanism of bone regeneration and used as a potential tool for analyzing the combined use of cytokines. (Int J Periodontics Restorative Dent 2010;30:83-87.)
C1 [Brunelli, Giorgio; Carinci, Francesco] Univ Ferrara, Sect Maxillofacial Surg, Dept DMCCC, I-44100 Ferrara, Italy.
   [Scarano, Antonio] Univ G dAnnunzio, Dent Clin, Chieti, Italy.
   [Lo Muzio, Lorenzo] Univ Foggia, Dent Clin, Foggia, Italy.
   [Pezzetti, Furio; Martinelli, Marcella; Scapoli, Luca] Univ Bologna, Inst Histol, Bologna, Italy.
   [Pezzetti, Furio; Martinelli, Marcella; Scapoli, Luca] CARISBO Fdn, Ctr Mol Genet, Bologna, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Sect Maxillofacial Surg, Dept DMCCC, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
RI Scarano, Antonio/F-6961-2017; Scapoli, Luca/C-6152-2008
OI Scarano, Antonio/0000-0003-1374-6146; Scapoli, Luca/0000-0003-4006-9910
FU University of Ferrara, Italy; PRIN 2005 [2005067555-002]; Fondazione
   CARIFE; Fondazione CARISBO
FX This work was supported by grants from the University of Ferrara, Italy
   (FC), PRIN 2005 prot. 2005067555-002 (FC), Fondazione CARIFE (FC), and
   the Fondazione CARISBO (FP).
CR Ambros V, 2003, CELL, V114, P269, DOI 10.1016/S0092-8674(03)00562-2
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Cheng H, 2004, J BONE JOINT SURG AM, V86-A, P141
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819
   Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703
   Froum SJ, 1998, INT J PERIODONT REST, V18, P529
   Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7
   Haas R, 2002, INT J ORAL MAX IMPL, V17, P337
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Herrero J, 2003, BIOINFORMATICS, V19, P655, DOI 10.1093/bioinformatics/btg040
   Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961
   Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5
   Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   Maiorana C, 2003, INT J PERIODONT REST, V23, P227
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   MOSS EG, 2003, MICRORNAS NONCODING, P98
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646
   Sennerby L, 1999, SINUS BONE GRAFT, P95
   Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P10515
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   Vaquerizas JM, 2004, BIOINFORMATICS, V20, P3656, DOI 10.1093/bioinformatics/bth401
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wheeler SL, 1997, J ORAL MAXIL SURG, V55, P1287, DOI 10.1016/S0278-2391(97)90186-5
   Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444
   Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017
   MICROCOSM TARGETS VE
   BABELOMICS FATIGO
NR 36
TC 17
Z9 18
U1 0
U2 9
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD FEB
PY 2010
VL 30
IS 1
BP 83
EP 87
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 563KH
UT WOS:000275130200009
PM 20224834
DA 2018-10-20
ER

PT J
AU Lippi, G
   Franchini, M
   Banfi, G
AF Lippi, G.
   Franchini, M.
   Banfi, G.
TI Red Blood Cell-Mimicking Synthetic Biomaterial Particles: The New
   Frontier of Blood Doping?
SO INTERNATIONAL JOURNAL OF SPORTS MEDICINE
LA English
DT Editorial Material
ID TRANSFUSIONS
C1 [Lippi, G.] Azienda Osped Univ Parma, Dipartimento Patol & Med Lab, UO Diagnost Ematochim, I-43126 Parma, Italy.
   [Franchini, M.] Azienda Osped Univ Parma, Dipartimento Patol & Med Lab, UO Immunoematol & Trasfus, I-43126 Parma, Italy.
   [Banfi, G.] IRCCS Galeazzi, Milan, Italy.
RP Lippi, G (reprint author), Azienda Osped Univ Parma, Dipartimento Patol & Med Lab, UO Diagnost Ematochim, Via Gramsci 14, I-43126 Parma, Italy.
EM glippi@ao.pr.it
OI Banfi, Giuseppe/0000-0001-9578-5338
CR Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Guan F, 2009, INT J SPORTS MED, V30, P80, DOI 10.1055/s-0028-1103283
   Kohler M, 2008, INT J SPORTS MED, V29, P1, DOI 10.1055/s-2007-989369
   Lippi G, 2007, INT J SPORTS MED, V28, P446, DOI 10.1055/s-2007-965188
   LIPPI G, 2009, EUR J APPL PHYS 0916
   Lippi G, 2007, BRIT J SPORT MED, V41, P625, DOI 10.1136/bjsm.2007.035519
   Lippi G, 2006, CLIN CHEM LAB MED, V44, P1395, DOI 10.1515/CCLM.2006.262
   Lippi G, 2006, CRIT REV CL LAB SCI, V43, P349, DOI 10.1080/10408360600755313
   Morkeberg J, 2009, INT J SPORTS MED, V30, P285, DOI 10.1055/s-0028-1105938
   Sanchis-Gomar F, 2010, INT J SPORTS MED, V31, P5, DOI 10.1055/s-0029-1239500
   SCALCO FB, 2008, J SCI MED SPORT 0901
   Voss SC, 2007, INT J SPORTS MED, V28, P633, DOI 10.1055/s-2007-965076
NR 12
TC 10
Z9 10
U1 1
U2 12
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0172-4622
J9 INT J SPORTS MED
JI Int. J. Sports Med.
PD FEB
PY 2010
VL 31
IS 2
BP 75
EP 76
DI 10.1055/s-0030-1247540
PG 2
WC Sport Sciences
SC Sport Sciences
GA 552NB
UT WOS:000274297400001
PM 20135581
DA 2018-10-20
ER

PT J
AU Levine, DL
   Dharia, MA
   Siggelkow, E
   Crowninshield, RD
   Degroff, DA
   Wentz, DH
AF Levine, Danny L.
   Dharia, Mehul A.
   Siggelkow, Eik
   Crowninshield, Roy D.
   Degroff, Dale A.
   Wentz, Douglas H.
TI Repair of Periprosthetic Pelvis Defects With Porous Metal Implants: A
   Finite Element Study
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE finite element analysis; pelvis; osteolysis; augment; Trabecular Metal
   (TM)
ID TANTALUM BIOMATERIAL; COMPUTED-TOMOGRAPHY; HIP-ARTHROPLASTY; CONTACT
   FORCES; BONE; OSTEOLYSIS; VALIDATION; RECONSTRUCTION; CEMENT; MODEL
AB Periacetabular osteolysis is a potentially difficult surgical challenge, which can often drive the choice of reconstruction methods used hip revision hip replacement. For smaller defects, impaction of bone grafts may be sufficient, but larger defects can require filler materials that provide structural support in addition to filling a void. This study utilized finite element analysis (FEA) to examine the state of stress in periprosthetic pelvic bone when subjected to a stair-climbing load and in the presence of two simulated defects, to show the effect of implanting a defect repair implant fabricated from Trabecular Metal (TM) Even a small medial bone defect showed a local stress elevation of 4 X compared with that seen with acetabular implant supported by intact periacetabular bone. Local bone stress was much greater (8 X the baseline level),for a defect case in which the loss of bone superior to the acetabular implant permitted significant migration. FEA results showed that a repair of the small defect with a Trabecular Metal (TM) restrictor lowered periprosthetic bone stress to a level comparable to that in,the case of a primary implant. For the larger defect case, the use of a Trabecular Metal (TM) augment provides structural stabilization and helps to restore the THR head center: However, stress in the adjacent periprosthetic bone is lower than that observed in the defect-free acetabulum. In the augment case, the load path between the femoral head and the pelvis now passes through the augment as the superior rim of the acetabulum has been replaced. Contact-induced stress in the augment is similar in magnitude to that seen in the superior rim of the baseline case, although the stress pattern in the augment is noticeably different from that in intact bone. [DOI: 10.1115/1.4000853]
C1 [Levine, Danny L.; Dharia, Mehul A.; Degroff, Dale A.; Wentz, Douglas H.] Zimmer Inc, Orthopaed Implant Div, Warsaw, IN 46580 USA.
   [Siggelkow, Eik] Zimmer GmbH, Orthopaed Implant Div, CH-4804 Winterthur, Switzerland.
   [Crowninshield, Roy D.] Crowninshield Inc, Asheville, NC 28803 USA.
RP Levine, DL (reprint author), Zimmer Inc, Orthopaed Implant Div, POB 708,1800 W Ctr St, Warsaw, IN 46580 USA.
EM danny.levine@zimmer.com
FU Bioengineering Division of ASME
FX Contributed by the Bioengineering Division of ASME for publication in
   the JOURNAL OF BIOMECHANICAL ENGINEERING.
CR Anderson AE, 2005, J BIOMECH ENG-T ASME, V127, P364, DOI 10.1115/1.1894148
   Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Chiang PP, 2003, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000096816.78689.e5
   Claus AM, 2003, J ARTHROPLASTY, V18, P112, DOI 10.1054/arth.2003.50078
   DALSTRA M, 1995, J BIOMECH ENG-T ASME, V117, P272, DOI 10.1115/1.2794181
   DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N
   Durr HR, 2004, ACTA ORTHOP SCAND, V75, P554, DOI 10.1080/00016470410001411
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   FITZPATRICK D, 1997, P 21 ANN M AM SOC BI
   Gross AE, 2004, CLIN ORTHOP RELAT R, P193, DOI 10.1097/01.blo.0000149822.49890.5e
   Heiner AD, 2005, J BIOMECH, V38, P811, DOI 10.1016/j.jbiomech.2004.05.005
   Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2
   Kitamura N, 2005, J BONE JOINT SURG AM, V87A, P1542, DOI 10.2106/JBJS.D.02882
   Kurtz SM, 2002, BIOMATERIALS, V23, P3681, DOI 10.1016/S0142-9612(02)00102-3
   LEVENSTON ME, 1992, P 38 ANN M ORTH RES, P536
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   Li ZP, 2007, J BIOMECH ENG-T ASME, V129, P129, DOI 10.1115/1.2472367
   LIU YK, 1987, J BIOMED MATER RES, V21, P247, DOI 10.1002/jbm.820210208
   Looney RJ, 2002, ARTHRITIS RES, V4, P59, DOI 10.1186/ar384
   MAJUMDER S, 2004, TRENDS BIOMATER ARTI, V17, P48
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   Paprosky Wayne G, 2002, Am J Orthop (Belle Mead NJ), V31, P459
   Paprosky WG, 1999, J BONE JOINT SURG AM, V81A, P280, DOI 10.2106/00004623-199902000-00015
   SCHULLER HM, 1993, J BONE JOINT SURG BR, V75, P468
   SIGGELKOW E, 2000, THESIS U ROSTOCK GER
   Speirs AD, 2007, CLIN BIOMECH, V22, P431, DOI 10.1016/j.clinbiomech.2006.12.003
   Sporer SM, 2006, J ARTHROPLASTY, V21, P83, DOI 10.1016/j.arth.2006.05.008
   Stiehl JB, 2004, J ARTHROPLASTY, V19, P508, DOI 10.1016/j.arth.2003.11.005
   Sutherland AG, 2000, INT ORTHOP, V24, P19, DOI 10.1007/s002640050005
   Taylor WR, 2006, J BIOMECH, V39, P791, DOI 10.1016/j.jbiomech.2005.02.006
   Wright JM, 2001, J BONE JOINT SURG AM, V83A, P529, DOI 10.2106/00004623-200104000-00007
   Yoshida H, 2006, J BIOMECH, V39, P1996, DOI 10.1016/j.jbiomech.2005.06.026
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   *ZIMM INC, 97725513800 ZIMM INC
NR 36
TC 4
Z9 4
U1 0
U2 8
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD FEB
PY 2010
VL 132
IS 2
AR 021006
DI 10.1115/1.4000853
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 570AN
UT WOS:000275644100006
PM 20370243
DA 2018-10-20
ER

PT J
AU Vaisman, B
   Motiei, M
   Nyska, A
   Domb, AJ
AF Vaisman, Boris
   Motiei, Menachem
   Nyska, Abraham
   Domb, Abraham J.
TI Biocompatibility and safety evaluation of a ricinoleic acid-based
   poly(ester-anhydride) copolymer after implantation in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ricinoleic acid-based polymer; poly(ester-anhydride) copolymer;
   biodegradable polymer; injectable drug-delivery scaffold; implant;
   biocompatibility
ID CONTROLLED-RELEASE POLYMER; DRUG-DELIVERY SYSTEMS; SITU GELLING POLYMER;
   BRAIN BIOCOMPATIBILITY; BIODEGRADABLE CARRIER; FUEL SUBSTRATE;
   CASTOR-OIL; PACLITAXEL; TOXICITY; MODEL
AB The aim of this Study was to evaluate the safety and tissue compatibility of an injectable biodegradable poly(ester-anhydride) copolymer of ricinoleic acid (RA) and sebacic acid (SA) in rats. The absorbable biomaterial containing 70% w/w of RA and 30% w/w of SA [P(SA-RA) 3:7] was implanted in rats in two separate studies: (1) at high doses subcutaneously (SC) and intramuscularly (IM) simultaneously into the same animal and (2) intracranially (IC). The safety was established in the high-dose administration experiment. No systemic tissue damage, polymer-related lesions, or abnormalities could be detected in the animals. The histopathological evaluation of the SC and IM P(SA-RA) 3:7 implanted sites Suggested a typical foreign body reaction (FBR) to biomaterials, and was characterized by excellent tissue repair and good tissue tolerance. In the second experiment, no neurological deficits or behavior changes suggestive of systemic or localized toxicity were observed in the animals implanted IC with the polymer. Only minimal, well-demarcated inflammatory response was observed on days 14 and 21 and consisted of glia cells. No abnormalities were noted in the brain tissue parenchyma located further from the edges of the implant. These results demonstrated that the P(SA-RA) 3:7 copolymer was tolerated well by the animals and compatible with rat subcutaneous, Muscle and brain tissues. The biodegradable polymeric system described here could be used as a scaffold for varied applications in localized and sustained delivery of therapeutic agents. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 419-431, 2010
C1 [Motiei, Menachem] Hebrew Univ Jerusalem, Dept Pharmacol, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
   [Nyska, Abraham] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel.
   [Vaisman, Boris; Domb, Abraham J.] Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
RP Domb, AJ (reprint author), Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, IL-91905 Jerusalem, Israel.
EM avid@ekmd.huji.ac.il
OI Domb, Abraham J./0000-0002-2241-7726
CR ANDERSON JM, 2002, J CONTROL RELEASE, V80, P9
   [Anonymous], 2007, US PHARM 30 NAT FORM
   BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472
   BREM H, 1992, J CONTROL RELEASE, V19, P325, DOI 10.1016/0168-3659(92)90087-8
   Burdock GA, 2006, FOOD CHEM TOXICOL, V44, P1689, DOI 10.1016/j.fct.2006.05.007
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Gad Shayne C., 1994, P221
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Gopferich A, 1997, HDB BIODEGRADABLE PO, P451
   GRECO AV, 1992, ANN NUTR METAB, V36, P1, DOI 10.1159/000177693
   GREGO AV, 1995, CLIN NUTR, V14, P143, DOI 10.1016/S0261-5614(95)80011-5
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kou JH, 1997, J CONTROL RELEASE, V43, P123, DOI 10.1016/S0168-3659(96)01477-0
   Krasko MY, 2007, J CONTROL RELEASE, V117, P90, DOI 10.1016/j.jconrel.2006.10.010
   Krasko MY, 2006, BIOMACROMOLECULES, V7, P2461, DOI 10.1021/bm060255q
   Krasko MY, 2005, BIOMACROMOLECULES, V6, P1877, DOI 10.1021/bm049228v
   Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651
   Lee J, 2006, TOXICOL APPL PHARM, V215, P64, DOI 10.1016/j.tapp.2006.02.009
   Mokry J, 2000, BIOTECHNOL PROGR, V16, P897, DOI 10.1021/bp000113m
   Pawar R, 2004, CURR MED CHEM, V11, P397, DOI 10.2174/0929867043455981
   Pradilla G, 2006, J NEURO-ONCOL, V76, P131, DOI 10.1007/s11060-005-5531-z
   Rees D. Cooper, 1994, P275
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Sharp PE, 1998, LAB RATS
   Shikanov A, 2006, BIOMACROMOLECULES, V7, P288, DOI 10.1021/bm050648
   Shikanov A, 2005, J CONTROL RELEASE, V105, P52, DOI 10.1016/j.jconrel.2005.02.018
   Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101
   Shikanov A, 2007, J CONTROL RELEASE, V117, P97, DOI 10.1016/j.jconrel.2006.10.014
   TAMARGO RJ, 1989, J BIOMED MATER RES, V23, P253, DOI 10.1002/jbm.820230209
   TAMARGO RJ, 1993, CANCER RES, V53, P329
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Teomim D, 1999, J BIOMED MATER RES, V45, P258, DOI 10.1002/(SICI)1097-4636(19990605)45:3<258::AID-JBM14>3.0.CO;2-W
   Ueda H, 2007, J BIOMED MATER RES A, V83A, P656, DOI 10.1002/jbm.a.31226
   Vaisman B, 2008, J AM OIL CHEM SOC, V85, P169, DOI 10.1007/s11746-007-1172-z
   WALTER KA, 1994, CANCER RES, V54, P2207
   WATSON WC, 1963, J PHARM PHARMACOL, V15, P183, DOI 10.1111/j.2042-7158.1963.tb12768.x
   Weingand K, 1996, FUND APPL TOXICOL, V29, P198, DOI 10.1006/faat.1996.0022
   Wilson R, 1998, FOOD CHEM TOXICOL, V36, P711, DOI 10.1016/S0278-6915(98)00057-X
   WYKES LME, 2003, HDB PHARM EXCIPIENTS, P104
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
NR 41
TC 19
Z9 19
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2010
VL 92A
IS 2
BP 419
EP 431
DI 10.1002/jbm.a.32342
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 540UD
UT WOS:000273364300002
PM 19191319
DA 2018-10-20
ER

PT J
AU Bai, ZJ
   Filiaggi, MJ
   Sanderson, RJ
   Lohstreter, LB
   McArthur, MA
   Dahn, JR
AF Bai, Zhijun
   Filiaggi, M. J.
   Sanderson, R. J.
   Lohstreter, L. B.
   McArthur, M. A.
   Dahn, J. R.
TI Surface characteristics and protein adsorption on combinatorial binary
   Ti-M (Cr, Al, Ni) and Al-M (Ta, Zr) library films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE combinatorial materials science; metallic biomaterials; surface oxides;
   protein adsorption; high throughput measurement; microstructure;
   roughness; titanium; aluminum
ID ION MASS-SPECTROMETRY; BOVINE SERUM-ALBUMIN; ADSORBED PROTEIN;
   METAL-SURFACES; FIBRINOGEN ADSORPTION; OXIDE SURFACES; TITANIUM;
   ROUGHNESS; BIOMATERIALS; SPECTROSCOPY
AB Systematic studies of protein adsorption onto metallic biomaterial surfaces are generally lacking. Here, combinatorial binary library films with compositional gradients of Ti1-xCrx, Ti1-xAlx, Ti1-xNix and Al1-xTax, (0 < x < 1) and Al1-yZry (0 < y < 0.5) as well as corresponding pure metal films were sputtered onto clean Si surfaces. Bulk and surface chemistry, film microstructure, and surface roughness were subsequently correlated to fibrinogen or albumin adsorption measured using a high throughput wavelength dispersive spectroscopy technique. X-ray diffraction revealed these binary films to have crystalline phases present primarily at either extreme of the compositional library and an amorphous zone dominating along the gradient. These mirror-like films were generally found by atomic force microscopy to have a roughness of less than 8 nm, with any relative increases in roughness consistent with the development of crystalline phases. Surface chemistry by quantitative high-resolution X-ray photoelectron spectroscopy differed significantly from bulk film composition as measured by electron microprobe, with TiO2 and Al2O3 preferentially forming on the binary film surfaces. Correspondingly, protein adsorption onto these films closely correlated with their surface oxide fractions. Aluminum deposited as either a constant-composition film or as part of a binary library consistently adsorbed the least amount of albumin and fibrinogen, with alumina-enrichment of the surface oxide correlating with this adsorption. Overall, this combinatorial materials approach coupled with high-throughput surface analytical methods provides an efficient method of screening potential metallic biomaterials that may enable as well systematic studies of surface properties driving protein adsorption on these metal / metal oxide systems. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 521-532, 2010
C1 [Bai, Zhijun; Filiaggi, M. J.] Dalhousie Univ, Sch Biomed Engn, Halifax, NS B3H 3J5, Canada.
   [Bai, Zhijun; Sanderson, R. J.; McArthur, M. A.; Dahn, J. R.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
   [Filiaggi, M. J.] Dalhousie Univ, Dept Appl Oral Sci, Halifax, NS B3H 3J5, Canada.
   [Lohstreter, L. B.] Medtronic Inc, Minneapolis, MN USA.
   [Dahn, J. R.] Dalhousie Univ, Dept Chem, Halifax, NS B3H 3J5, Canada.
RP Filiaggi, MJ (reprint author), Dalhousie Univ, Sch Biomed Engn, 5981 Univ Ave, Halifax, NS B3H 3J5, Canada.
EM filiaggi@dal.ca
RI Bai, Zhijun/D-6522-2011
FU Mecltronic, Inc. (USA)
FX Contract grant sponsor: Mecltronic, Inc. (USA)
CR Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   BAI Z, 2006, ASM HDB C, V13, P837
   Bai ZJ, 2008, SURF SCI, V602, P795, DOI 10.1016/j.susc.2007.12.009
   BEARDEN JA, 1967, REV MOD PHYS, V39, P78, DOI 10.1103/RevModPhys.39.78
   BRASH JL, 1987, PROTEINS INTERFACES
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Chen KC, 1997, J MATER RES, V12, P1472, DOI 10.1557/JMR.1997.0203
   CUYPERS PA, 1977, ANN NY ACAD SCI, V283, P77, DOI 10.1111/j.1749-6632.1977.tb41754.x
   Dahn JR, 2002, CHEM MATER, V14, P3519, DOI 10.1021/cm020236x
   Ellingham H.J., 1944, J SOC CHEM IND LOND, V63, P125
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   FENG L, 1995, PROTEINS INTERFACES, V2, P66
   Frateur I, 2007, ELECTROCHIM ACTA, V52, P7660, DOI 10.1016/j.electacta.2006.12.060
   Fuss C, 2001, J VASC INTERV RADIOL, V12, P677, DOI 10.1016/S1051-0443(07)61437-7
   Gettens RTT, 2005, J BIOMED MATER RES A, V72A, P246, DOI 10.1002/jbm.a.30218
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V218, P404, DOI 10.1006/jcis.1999.6434
   Han M, 2003, LANGMUIR, V19, P9868, DOI 10.1021/la030132g
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Horbett T. A., 1995, PROTEINS INTERFACES, VII
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   Jackson DR, 2000, LANGMUIR, V16, P5449, DOI 10.1021/la991497x
   LIAO P, 2008, J PHYS CONDENS MATT
   Liu FY, 1998, APPL RADIAT ISOTOPES, V49, P67
   Malmsten M, 2003, BIOPOLYMERS INTERFAC
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   MATTSON JS, 1973, SCIENCE, V181, P1055, DOI 10.1126/science.181.4104.1055
   Mikhalovska LI, 2004, THROMB HAEMOSTASIS, V92, P1032, DOI 10.1160/TH04-03-0171
   Omanovic S, 1999, LANGMUIR, V15, P8315, DOI 10.1021/la990474f
   Palmaz JC, 2001, J VASC INTERV RADIOL, V12, P789, DOI 10.1016/S1051-0443(07)61502-4
   Palmaz JC, 2007, CARDIOVASC INTER RAD, V30, P1095, DOI 10.1007/s00270-007-9164-9
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Rockwell GP, 2007, APPL SURF SCI, V253, P5943, DOI 10.1016/j.apsusc.2006.12.120
   SAWYER PN, 1984, BIOMATER ARTIF CELL, V12, P161, DOI 10.3109/10731198409118831
   SHARMA CP, 1992, J BIOMED MATER RES, V26, P1179, DOI 10.1002/jbm.820260908
   Sheardown H, 1997, COLLOID SURFACE B, V10, P29, DOI 10.1016/S0927-7765(97)00045-3
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   Sprague EA, 2005, J ENDOVASC THER, V12, P594, DOI 10.1583/05-1555.1
   SUNNY MC, 1990, J BIOMED MATER RES, V24, P455, DOI 10.1002/jbm.820240404
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TENGVALL P, 2001, TITANIUM MED, P457
   Wagner MS, 2003, BIOMATERIALS, V24, P1897, DOI 10.1016/S0142-9612(02)00612-9
   Wagner MS, 2002, J BIOMAT SCI-POLYM E, V13, P407, DOI 10.1163/156856202320253938
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   WELINKLINTSTROM S, 1993, J COLLOID INTERF SCI, V158, P188, DOI 10.1006/jcis.1993.1246
   Wieneke H, 2003, CATHETER CARDIO INTE, V60, P399, DOI 10.1002/ccd.10664
   Wieneke H, 2002, HERZ, V27, P518, DOI 10.1007/s00059-002-2405-4
   WILLIAMS DF, 1985, J BIOMED MATER RES, V19, P313, DOI 10.1002/jbm.820190312
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
NR 54
TC 11
Z9 11
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2010
VL 92A
IS 2
BP 521
EP 532
DI 10.1002/jbm.a.32398
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 540UD
UT WOS:000273364300012
PM 19235218
DA 2018-10-20
ER

PT J
AU Yang, P
   Wang, CS
   Shi, ZB
   Huang, X
   Dang, XQ
   Li, XD
   Lin, SF
   Wang, KZ
AF Yang, Pei
   Wang, Chunsheng
   Shi, Zhibin
   Huang, Xin
   Dang, Xiaoqian
   Li, Xudong
   Lin, Shien-Fong
   Wang, Kunzheng
TI rhVEGF(165) delivered in a porous beta-tricalcium phosphate scaffold
   accelerates bridging of critical-sized defects in rabbit radii
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE adsorption; biomaterial; osteogenesis; tissue engineering; vascular
   endothelial growth factor
ID ENDOTHELIAL GROWTH-FACTOR; SEGMENTAL BONE DEFECTS; TISSUE-ENGINEERED
   BONE; MORPHOGENETIC PROTEIN-2; CHEMOTACTIC MIGRATION; AUTOLOGOUS BONE;
   IN-VIVO; VEGF; ANGIOGENESIS; REPAIR
AB Segmental bone defects are a common obstacle in major orthopedic procedures, and the treatment of these defects remains a challenging clinical problem. Bone tissue engineering has been attracting much attention in recent years. We evaluated the ability of the specific combination of 3 mu g rhVEGF(165) with a novel porous beta-tricalcium phosphate (beta-TCP) scaffold coated with fibrin sealant (FS) to facilitate bone regeneration. Unilateral 15-mm long critical-sized defects were prepared in the radial diaphysis of rabbits and treated with rhVEGF(165)/FS/scaffold or FS/scaffold. Healing of the defects was assessed at 4, 8, and 12 weeks, radiologically, histologically, and biomechanically. The results of the study demonstrated that the critical-sized defects in the midshaft of the rabbit radius, treated with rhVEGF(165) incorporated in porous beta-TCP scaffold by FS, can be completely bridged by cortical bone in 12 weeks. The bone marrow space was also reformed histologically and radiologically at 12 weeks postsurgery in the rhVEGF(165)-treated group. Furthermore, biomechanical examination demonstrated that the segmental bone defects were not only radiologically and histologically repaired but were also mechanically repaired. Interestingly, none of the defects was completely repaired at 12 weeks following treatment with FS/scaffold without rhVEGF(165). A solution-driven process is likely the predominant mechanism of accelerating biodegradation of the beta-TCP scaffold in the presence of rhVEGF(165); furthermore, cell-mediated phagocytosis also contributes to biodegradation of the biomaterials. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 626-640, 2010
C1 [Yang, Pei; Wang, Chunsheng; Shi, Zhibin; Dang, Xiaoqian; Wang, Kunzheng] Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 2, Coll Med, Xian 710049, Shaanxi, Peoples R China.
   [Huang, Xin] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 1, Coll Med, Xian 710049, Shaanxi, Peoples R China.
   [Li, Xudong] Univ Virginia, Hlth Med Ctr, Dept Orthopaed Surg, Res Ctr, Charlottesville, VA USA.
   [Lin, Shien-Fong] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.
RP Wang, KZ (reprint author), Xi An Jiao Tong Univ, Dept Orthopaed, Affiliated Hosp 2, Coll Med, Xian 710049, Shaanxi, Peoples R China.
EM kunzhengwang@126.com
RI Lin, Shien-Fong/A-7604-2009
FU National Nature Science Foundation of China [30371443, 30600624]
FX Contract grant sponsor: National Nature Science Foundation of China;
   contract grant number: 30371443/30600624
CR ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024
   An SP, 2005, J TISSUE ENG RECONST, V1, P323
   Chen ZZ, 2004, RAPID PROTOTYPING J, V10, P327, DOI 10.1108/13552540410562368
   Clarke SA, 2007, BONE, V40, P939, DOI 10.1016/j.bone.2006.11.004
   DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   DENHOLLANDER W, 1991, BIOMATERIALS, V12, P569, DOI 10.1016/0142-9612(91)90053-D
   Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116
   Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerber HP, 1999, NAT MED, V5, P623
   Giardino R, 2006, BIOMED PHARMACOTHER, V60, P386, DOI 10.1016/j.biopha.2006.07.004
   Guo XM, 2004, TISSUE ENG, V10, P1830, DOI 10.1089/ten.2004.10.1830
   Hu YY, 2003, J BIOMED MATER RES A, V67A, P591, DOI 10.1002/jbm.a.10070
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kleinheinz J, 2005, J ORAL MAXIL SURG, V63, P1310, DOI 10.1016/j.joms.2005.05.303
   KMAKI H, 2006, BIOMATERIALS, V27, P5118
   Kurashina K, 1997, BIOMATERIALS, V18, P539, DOI 10.1016/S0142-9612(96)00162-7
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lode A, 2007, J BIOMED MATER RES A, V81A, P474, DOI 10.1002/jbm.a.31024
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Rabie ABM, 2004, ARCH ORAL BIOL, V49, P1025, DOI 10.1016/j.archoralbio.2004.05.012
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Sahni A, 2000, BLOOD, V96, P3772
   Saito M, 2000, J Orthop Sci, V5, P275, DOI 10.1007/s007760050163
   Seeherman H, 2001, J BONE JOINT SURG AM, V83A, pS79
   Seeherman HJ, 2006, J BONE JOINT SURG AM, V88A, P1553, DOI 10.2106/JBJS.E.01006
   Sheller MR, 2004, J ORTHOPAED RES, V22, P1094, DOI 10.1016/j.orthres.2004.03.009
   SHI GX, 2001, J FUNCT POLYM, V149, P7
   Spyridopoulos I, 1997, J MOL CELL CARDIOL, V29, P1321, DOI 10.1006/jmcc.1996.0365
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Tang TT, 2007, J BONE JOINT SURG BR, V89B, P127, DOI 10.1302/0301-620X.89B1.18350
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WITTBJER J, 1982, SCAND J PLAST RECONS, V16, P239, DOI 10.3109/02844318209026214
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
   ZHOU RF, 2000, TIANJIN MED J, V28, P153
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 48
TC 10
Z9 10
U1 3
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2010
VL 92A
IS 2
BP 626
EP 640
DI 10.1002/jbm.a.32403
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 540UD
UT WOS:000273364300023
PM 19235222
DA 2018-10-20
ER

PT J
AU Wang, Y
   Zhang, LH
   Hu, M
   Wen, WS
   Xiao, HX
   Niu, Y
AF Wang, Yan
   Zhang, Lihai
   Hu, Min
   Wen, Weisheng
   Xiao, Hongxi
   Niu, Yu
TI Effect of chondroitin sulfate modification on rhBMP-2 release kinetics
   from collagen delivery system
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; chondroitin sulfate; rhBMP-2; delivery vehicle; release
   kinetics
ID BONE MORPHOGENETIC PROTEINS; RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS;
   MATRIX; PHARMACOKINETICS; REPLACEMENT; ADSORPTION; ADHESION; CELLS; SITE
AB Protein delivery systems focus on protecting the protein that directly affects release kinetics. This Study was carried out to determine the effect of surface polar group and fiber structure in a recombinant human bone morphogenetic protein-2 (rhBMP-2) protecting system based on a collagen matrix on its pharmacokinetics (PK) and osteoinductive activity In this study, two types of collagen carriers were made for rhBMP-2 protecting system. The PKs of rhBMPs within collagen (Col) and collagen-chondroitin sulfate (Col-CS) carriers were determined using (251)I-labeled proteins in rat ectopic assay. The two carriers were characterized with surface energy and hydrophilicity. We observed that the osteoinductivity of these two scaffolds seemed to depend on two parameters: the nature of the carrier material and the release kinetics of the carriers. Results indicated that with CS modification, the initial burst release of rhBMP-2 from Col-CS scaffold was much higher than collagen scaffold. The subsequent PKs at longer times were not strongly dependent on the carriers. These differences were expected to affect the osteoinductive activity of the implants. It was concluded that surface energy played a significant role in the release PK of implanted rhBMP and higher initial burst is favorable to bone regeneration near the matrix. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 693-701, 2010
C1 [Wang, Yan; Zhang, Lihai] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China.
   [Hu, Min; Wen, Weisheng; Xiao, Hongxi; Niu, Yu] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.
RP Zhang, LH (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China.
EM zhanglihai@gmail.com
FU National Natural Science Foundation [30700848, 30772443]; Natural
   Science Foundation of Beijing [7042058]
FX Contract grant sponsor: Natural Science Foundation of Beijing; contract
   grant number: 7042058
CR Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   CHEN CS, 1995, BIOMATERIALS, V16, P777, DOI 10.1016/0142-9612(95)99640-8
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Janes KA, 2001, J CONTROL RELEASE, V73, P255, DOI 10.1016/S0168-3659(01)00294-2
   Lam XM, 2000, J CONTROL RELEASE, V67, P281, DOI 10.1016/S0168-3659(00)00224-8
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081
   NATSUME T, 1993, J BIOMED MATER RES, V27, P867, DOI 10.1002/jbm.820270705
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zhang LH, 2005, ARTIF CELL BLOOD SUB, V33, P215, DOI 10.1081/BIO-200055912
   Zhang LH, 2005, J BIOMED MATER RES A, V73A, P468, DOI 10.1002/jbm.a.30363
   Zhang LH, 2002, ARTIF CELL BLOOD SUB, V30, P319, DOI 10.1081/BIO-120006122
   Zhang QQ, 1997, J MATER SCI TECHNOL, V13, P179
   Ziegler J, 2002, J BIOMED MATER RES, V59, P422, DOI 10.1002/jbm.1258
NR 27
TC 11
Z9 11
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2010
VL 92A
IS 2
BP 693
EP 701
DI 10.1002/jbm.a.32190
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 540UD
UT WOS:000273364300029
PM 19263491
DA 2018-10-20
ER

PT J
AU Chang, KY
   Hung, LH
   Chu, IM
   Ko, CS
   Lee, YD
AF Chang, Kuo-Yung
   Hung, Li-Han
   Chu, I-Ming
   Ko, Chih-Shen
   Lee, Yu-Der
TI The application of type II collagen and chondroitin sulfate grafted PCL
   porous scaffold in cartilage tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE articular cartilage; surface modification; type II collagen; chondroitin
   sulfate; poly(epsilon-caprolactone)
ID CHONDROCYTE-MATRIX INTERACTIONS; HUMAN ENDOTHELIAL-CELLS; IN-VITRO;
   SURFACE MODIFICATION; ARTICULAR-CARTILAGE; POLY(L-LACTIC ACID);
   POLY(EPSILON-CAPROLACTONE); COPOLYMER; BEHAVIOR; GROWTH
AB This study investigates a poly(v-caprolactone)graft-type- II collagen-graft-chondroitin sulfate (PCL-g-COLg-CS) biomaterial as a scaffold for cartilage tissue engineering. Biodegradable polyester, PCL, was utilized to fabricate three-dimensional (3D) porous scaffolds by particulate leaching. The PCL scaffold was then surface modified by chemical bonding of 1,6-hexanediamine and the grafting of a bioactive polymer layer of COL and CS with the help of 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) on the modified PCL surface to produce PCL-g-COL and PCL-g-COL-g-CS, respectively. The characteristics of these modified and grafted matrices were examined by ESCA, aminolysis, collagen and CS assay, porosity and water-binding capacity. Grafted COL and CS markedly increased water-binding capacity, and promoted the spreading and growth of chondrocytes. During a 4-week culture period, PCL-g-COL and PCL-g COL-g-CS matrices both provided more cell proliferation, as determined by measuring the DNA assay. Additionally, a larger amount of secreted collagen and glycosaminoglycans (GAGs) appeared in the PCL-g-COL-g-CS matrices than in the control (PCL) as indicated by the histochemical sections via Hematoxylin and eosin (H&E) stain, Masson trichrome stain and Safranin-O stain. The chondrocytes were induced to function normally; the cell phenotype was maintained, and the GAGs and collagen in the PCL-g-COL-g-CS scaffold were secreted in vitro. These results serve as a basis for future studies of the fabrication process and reveal the potential biocompatibility of the biomimetic matrix for regenerating articular cartilage or other organs. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 712-723, 2010
C1 [Chang, Kuo-Yung; Hung, Li-Han; Chu, I-Ming; Ko, Chih-Shen; Lee, Yu-Der] Natl Tsing Hua Univ 101, Dept Chem Engn, Hsinchu 300, Taiwan.
RP Lee, YD (reprint author), Natl Tsing Hua Univ 101, Dept Chem Engn, Sect 2,Kuang Fu Rd, Hsinchu 300, Taiwan.
EM ydlee@che.nthu.edu.tw
FU Ministry of Economic Affairs of the Republic of China, Taiwan
   [93EC-17-A-17-S1-0009]
FX Contract grant sponsor: Ministry of Economic Affairs of the Republic of
   China, Taiwan; contract grant number: 93EC-17-A-17-S1-0009
CR AYAD S, 1994, EXTRACELLULAR MATRIX
   Bei JZ, 1997, POLYM ADVAN TECHNOL, V8, P693, DOI 10.1002/(SICI)1099-1581(199711)8:11<693::AID-PAT702>3.0.CO;2-B
   Breinan HA, 2001, J ORTHOPAED RES, V19, P482, DOI 10.1016/S0736-0266(00)90015-9
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chung TW, 2005, J BIOMED MATER RES A, V72A, P213, DOI 10.1002/jbm.a.30225
   Deng C, 2007, POLYMER, V48, P139, DOI 10.1016/j.polymer.2006.10.046
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   Dong CM, 2005, J CONTROL RELEASE, V107, P53, DOI 10.1016/j.jconrel.2005.05.024
   Enobakhare B. O., 1997, ANAL BIOCHEM, V243, P1189
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   Ingber D, 1993, PHYS FORCES MAMMALIA
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kuberka M, 2002, INT J ARTIF ORGANS, V25, P67
   Lee CT, 2006, BIOMACROMOLECULES, V7, P2200, DOI 10.1021/bm060451x
   Lee CT, 2006, BIOMACROMOLECULES, V7, P1179, DOI 10.1021/bm050995j
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Nezu T, 2000, BIOMATERIALS, V21, P415, DOI 10.1016/S0142-9612(99)00204-5
   Oyane A, 2005, J BIOMED MATER RES A, V75A, P138, DOI 10.1002/jbm.a.30397
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Park SJ, 2005, COLLOID SURFACE B, V43, P138, DOI 10.1016/j.colsurfb.2005.04.006
   Pena J, 2006, J BIOMED MATER RES A, V76A, P788, DOI 10.1002/jbm.a.30547
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Prabu P, 2006, J BIOMED MATER RES A, V79A, P153, DOI 10.1002/jbm.a.30715
   Risbud M, 2001, CELL TRANSPLANT, V10, P755, DOI 10.3727/000000001783986224
   Stryer L., 1988, BIOCHEMISTRY-US
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   Tiaw KS, 2005, BIOMATERIALS, V26, P763, DOI 10.1016/j.biomaterials.2004.03.010
   Wang LC, 2005, WIREL COMMUN MOB COM, V5, P397, DOI 10.1002/wcm.299
   Xiao YM, 2007, MATER LETT, V61, P2601, DOI 10.1016/j.matlet.2006.10.006
   Xiong XB, 2007, BIOMACROMOLECULES, V8, P874, DOI 10.1021/bm060967g
   Yang L, 2003, EUR J CARDIO-THORAC, V24, P201, DOI 10.1016/S1010-7940(03)00263-X
   Yang Y, 2003, NUCL INSTRUM METH B, V207, P165, DOI 10.1016/S0168-583X(03)00456-7
   Young RD, 2002, OSTEOARTHR CARTILAGE, V10, P420, DOI 10.1053/joca.2002.0530
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 44
TC 44
Z9 47
U1 4
U2 60
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2010
VL 92A
IS 2
BP 712
EP 723
DI 10.1002/jbm.a.32198
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 540UD
UT WOS:000273364300031
PM 19274722
DA 2018-10-20
ER

PT J
AU Patchipulusu, S
   Turturro, M
   Hall, CL
AF Patchipulusu, Sirisha
   Turturro, Michael
   Hall, Connie L.
TI Monocyte-derived macrophage microparticles impart tissue factor activity
   to biomaterial surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; thrombosis; tissue factor; microparticles
ID FACTOR PATHWAY INHIBITOR; PLATELET P-SELECTIN; IN-VIVO; CARDIOPULMONARY
   BYPASS; THROMBUS FORMATION; FACTOR-X; COAGULATION; PROCOAGULANT; MAC-1;
   CELLS
AB The initiation of coagulation on biomaterials is attributed to the contact pathway of coagulation. However, recent discoveries of blood-borne tissue factor (TF) activity suggest that the TF pathway of coagulation may contribute to thrombosis on biomaterials. To evaluate the role of TF bearing microparticles to biomaterial thrombogenicity, the adhesion of monocyte-derived macrophage microparticles (MMPs) to bare, bovine serum albumin (BSA) blocked, and plasma-coated materials was examined. MMP suspensions consisted of 20-37% TF positive particles that exhibited TF activity. Data from static experiments with polyethylene (PE), polydimethylsiloxane (PDMS), polystyrene (PS), and glass knitted and woven Dacron (R) grafts showed that MMPs adhered to uncoated, and plasma coated surfaces supported TF activity, whereas surfaces blocked with BSA supported less activity. Flow studies were performed on plasma-coated glass and tissue culture-treated polystyrene (TCPS) as a model system to demonstrate deposition and firm adhesion of microparticles under physiologic flow conditions. MMPs deposited and imparted TF activity to plasma-coated glass at wall shear rates of 100, 400, and 1200 sec(-1). Deposition on TCPS was comparable to glass at 100 sec(-1), but virtually nonexistent at the two higher shear rates after a I h perfusion, implying material and shear dependent adhesion. The localization of procoagulant MMPs to biomaterial surfaces could lead to an increased risk of tlrombosis on cardiovascular implants beyond that anticipated by the contact pathway alone. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 724-732, 2010
C1 [Patchipulusu, Sirisha; Turturro, Michael; Hall, Connie L.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
RP Hall, CL (reprint author), IIT, Dept Biomed Engn, 3255 S Dearborn St WH 314, Chicago, IL 60616 USA.
EM hallc@iit.edu
FU Midwest Affiliate of the American Heart Association [0750198Z]
FX Contract grant sponsor: Midwest Affiliate of the American Heart
   Association; contract grant number: 0750198Z
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639
   Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x
   Brisset AC, 2003, THROMB HAEMOSTASIS, V90, P511, DOI 10.1160/TH02-12-0291
   del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095
   Diamant M, 2002, CIRCULATION, V106, P2442, DOI 10.1161/01.CIR.0000036596.59665.C6
   Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868
   Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x
   Freyssinet JM, 1999, THROMB HAEMOSTASIS, V82, P727
   Furie B, 2006, BLOOD CELL MOL DIS, V36, P177, DOI 10.1016/j.bcmd.2005.12.018
   Furie B, 2004, TRENDS MOL MED, V10, P171, DOI 10.1016/j.molmed.2004.02.008
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   KAPPELMAYER J, 1993, CIRC RES, V72, P1075, DOI 10.1161/01.RES.72.5.1075
   Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053
   Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841
   Nieuwland R, 1997, CIRCULATION, V96, P3534
   Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229
   Palmerini T, 2004, J AM COLL CARDIOL, V44, P1570, DOI 10.1016/j.jacc.2004.07.028
   Philippou H, 2000, THROMB HAEMOSTASIS, V84, P124
   Plescia J, 1996, BIOCHEM J, V319, P873, DOI 10.1042/bj3190873
   Rauch U, 2000, BLOOD, V96, P170
   Raybagkar DA, 2004, ASAIO J, V50, P301, DOI 10.1097/01.MAT.0000132261.38356.5A
   Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693
   Steppich B, 2005, THROMB HAEMOSTASIS, V93, P35, DOI 10.1160/TH04-06-0393
   Sturk-Maquelin KN, 2003, J THROMB HAEMOST, V1, P1920, DOI 10.1046/j.1538-7836.2003.00361.x
   TANS G, 1991, BLOOD, V77, P2641
   Turitto VT, 1998, THROMB RES, V92, pS25, DOI 10.1016/S0049-3848(98)00157-1
   Vandendries ER, 2004, THROMB HAEMOSTASIS, V92, P459, DOI 10.1160/TH04-05-0306
   Wolf Z, 2006, CYTOM PART A, V69A, P192, DOI 10.1002/cyto.a.20238
   Yu JL, 2004, J THROMB HAEMOST, V2, P2065, DOI 10.1111/j.1538-7836.2004.00972.x
NR 32
TC 3
Z9 4
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2010
VL 92A
IS 2
BP 724
EP 732
DI 10.1002/jbm.a.32320
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 540UD
UT WOS:000273364300032
PM 19274723
DA 2018-10-20
ER

PT J
AU Shankar, SP
   Babensee, JE
AF Shankar, Sucharita P.
   Babensee, Julia E.
TI Comparative characterization of cultures of primary human macrophages or
   dendritic cells relevant to biomaterial studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE peripheral blood mononuclear cells; macrophages; dendritic cells;
   biomaterials
ID FOREIGN-BODY RESPONSE; MHC CLASS-II; IN-VITRO; POLY(LACTIC-CO-GLYCOLIC
   ACID); MONOCYTES MACROPHAGES; IMMUNE-RESPONSE; HUMAN BLOOD; T-CELL;
   SURFACE-CHEMISTRY; PRESENT ANTIGEN
AB Macrophages are central mediators of biomaterial-associated Wound healing. Dendritic cells (DCs) link innate and adaptive immunity and are important in the context of the host response to combination products. Starting with human peripheral blood mononuclear cells (PBMCs), DCs were derived from monocytes upon culture with granulocyte macrophage colony-stimulating factor and interleukin-4; macrophages were derived from monocytes upon culture without cytokines. Macrophage or DC cultures were characterized at relevant timepoints in both adherent and nonadherent fractions on control Primaria (TM) surfaces to characterize and define these inflammatory/immune cells as a prequel to their use in hi vitro test biomaterial-host response studies. At day 10 (typical time for harvesting macrophages for subsequent treatment with test biomaterials), macrophages were CD11c+, macrophage mannose receptor (MMR)+, CD14+, and CD64+. At day 6 (typical time for harvesting of DCs after 24-h treatment with test biomaterials), DCs were CD1c+, CD11c+, CD123+, MMR+, CD14+, and CD64-. Furthermore, CD3+ and CD4+ T lymphocytes and CD19+ and CD24+ B lymphocytes were present in both Cultures at all time-points, although to different extents. Immature DCs (similar to 15 mu m), were rounded but presented extensive dendritic processes upon maturation with lipopolysaccharide. Alternatively, adherent macrophages (similar to 15-20 mu m) displayed internalized lipids and exhibited few membrane processes. The characterization and comparison of existing techniques to establish reliable, reproducible primary cultures of DCs or macrophages provides an important basis for examining and interpreting complex macrophage/DC-lymphocyte-orchestrated host responses in future studies with equivalent cell populations on test biomaterials. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 791-800, 2010
C1 [Babensee, Julia E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU National Science Foundation (NSF) [BES-0239152]; NIH [1RO1
   EB004633-01A1]
FX The authors thank Peng Meng Kou (Georgia ffistitute of Technology) for
   assistance with flow cytometry data analysis and Amanda Walls (Georgia
   Institute of Technology) for assistance with establishing the macrophage
   Culture protocol. The phlebotomists at the Georgia Tech Student Health
   Center and blood donors are also acknowledged. This work was funded by a
   National Science Foundation (NSF) CAREER grant no. BES-0239152 and by an
   NIH grant 1RO1 EB004633-01A1.
CR Akbar SMF, 2006, CURR MED CHEM, V13, P3113, DOI 10.2174/092986706778742882
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bayry J, 2005, J IMMUNOL, V175, P15, DOI 10.4049/jimmunol.175.1.15
   Bayry J, 2004, P NATL ACAD SCI USA, V101, P14210, DOI 10.1073/pnas.0402183101
   Bender A, 1996, J IMMUNOL METHODS, V196, P121, DOI 10.1016/0022-1759(96)00079-8
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011
   Cao XC, 2002, J IMMUNOL, V169, P4770, DOI 10.4049/jimmunol.169.9.4770
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574
   Duddy ME, 2001, CLIN EXP IMMUNOL, V123, P280, DOI 10.1046/j.1365-2249.2001.01433.x
   Finkelman FD, 1996, J IMMUNOL, V157, P1406
   Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1
   GUIDOS C, 1984, J IMMUNOL, V133, P1179
   Hoves S, 2006, J IMMUNOL, V177, P2691, DOI 10.4049/jimmunol.177.4.2691
   INABA K, 1987, J EXP MED, V165, P1403, DOI 10.1084/jem.165.5.1403
   Janeway CA, 1998, SEMIN IMMUNOL, V10, P349, DOI 10.1006/smim.1998.0142
   Johansson U, 2004, SCAND J IMMUNOL, V59, P50, DOI 10.1111/j.0300-9475.2004.01354.x
   Jones JA, 2004, J BIOMAT SCI-POLYM E, V15, P567, DOI 10.1163/156856204323046843
   Knijff EM, 2006, BIOL PSYCHIAT, V59, P317, DOI 10.1016/j.biopsych.2005.06.041
   Kushnir N, 1998, J IMMUNOL, V160, P1774
   Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547
   LENSCHOW DJ, 1993, P NATL ACAD SCI USA, V90, P11054, DOI 10.1073/pnas.90.23.11054
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   Pickl WF, 1996, J IMMUNOL, V157, P3850
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   Rubakova E, 2007, TUBERCULOSIS, V87, P134, DOI 10.1016/j.tube.2006.06.002
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Santin AD, 1999, IMMUNOBIOLOGY, V200, P187, DOI 10.1016/S0171-2985(99)80069-2
   SETUM CM, 1991, DIABETES, V40, P1719, DOI 10.2337/diabetes.40.12.1719
   SHANKAR SP, DENDRITIC CELL UNPUB
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Stivaktakis N, 2005, J BIOMED MATER RES A, V73A, P332, DOI 10.1002/jbm.a.30300
   Tang Ling-ling, 2005, J Zhejiang Univ Sci B, V6, P1176, DOI 10.1631/jzus.2005.B1176
   Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390
   Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6
   Triozzi PL, 1997, J LEUKOCYTE BIOL, V61, P600
   Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000
   van der Wel NN, 2003, MOL BIOL CELL, V14, P3378, DOI 10.1091/mbc.E02-11-0744
   Van Gool SW, 1999, EUR J IMMUNOL, V29, P2367, DOI 10.1002/(SICI)1521-4141(199908)29:08<2367::AID-IMMU2367>3.0.CO;2-3
   Werling D, 2004, IMMUNOLOGY, V111, P41, DOI [10.1111/j.1365-2567.2004.01781.x, 10.1046/j.1365-2567.2003.01781.x]
   Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xu H, 1995, ADV EXP MED BIOL, V378, P75
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   Zou GM, 2002, EUR CYTOKINE NETW, V13, P186
   ZVAIFLER NJ, 1985, J CLIN INVEST, V76, P789, DOI 10.1172/JCI112036
NR 62
TC 3
Z9 3
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2010
VL 92A
IS 2
BP 791
EP 800
DI 10.1002/jbm.a.32406
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 540UD
UT WOS:000273364300039
PM 19274715
DA 2018-10-20
ER

PT J
AU Heath, DE
   Cooper, SL
AF Heath, Daniel E.
   Cooper, Stuart L.
TI Interaction of Endothelial Cells with Methacrylic Terpolymer
   Biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE methacrylic terpolymer; mechanical properties; cell-material
   interactions; endothelialization; cytocompatibility
ID MECHANICAL-PROPERTIES; COMPLIANCE MISMATCH; BIOMEDICAL APPLICATIONS;
   INTIMAL HYPERPLASIA
AB A biomaterial system with tunable mechanical properties was synthesized through random copolymerization of hexyl methacrylate, methyl methacrylate, and methacrylic acid. The composition, molecular weight, water absorption, glass transition temperature, and tensile properties of the polymer system were characterized, and the biocompatibility of the material was demonstrated by the ability of human umbilical vein endothelial cells to adhere, proliferate, and spread on the polymer surface. No difference was observed in the behavior of the endothelial cells on the materials regardless of material stiffness. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 289-297, 2010
C1 [Heath, Daniel E.; Cooper, Stuart L.] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
RP Cooper, SL (reprint author), Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
EM cooper.1682@osu.edu
OI Heath, Daniel/0000-0003-3171-886X
FU Ohio State University Nanoscale Science and Engineering Center (NSEC)
   [EEC-0425626]
FX Contract grant sponsor: Ohio State University Nanoscale Science and
   Engineering Center (NSEC); contract grant number: EEC-0425626
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Ballyk PD, 1998, J BIOMECH, V31, P229
   BILLMEYER FW, 1984, TXB POLYM SCI, P337
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Dietz HP, 2003, INT UROGYNECOL J PEL, V14, P239, DOI 10.1007/s00192-003-1041-8
   Fussell GW, 2004, BIOMATERIALS, V25, P2971, DOI 10.1016/j.biomaterials.2003.09.062
   Fussell GW, 2004, J BIOMED MATER RES A, V70A, P265, DOI 10.1002/jbm.a.30074
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Kawalec JS, 1998, J BIOMED MATER RES, V41, P534, DOI 10.1002/(SICI)1097-4636(19980915)41:4<534::AID-JBM4>3.0.CO;2-D
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Ratner B.D., 2004, BIOMATERIALS SCI
   ROBINSON RP, 1981, J BIOMED MATER RES, V15, P203, DOI 10.1002/jbm.820150208
   SANATY M, 1998, INT J OPTH, V212, P328
   TRUBEL W, 1995, EUR J VASC ENDOVASC, V10, P415, DOI 10.1016/S1078-5884(05)80163-7
   Veleva AN, 2005, J BIOMED MATER RES A, V74A, P117, DOI 10.1002/jbm.a.30349
   Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
NR 19
TC 11
Z9 11
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2010
VL 92B
IS 2
BP 289
EP 297
DI 10.1002/jbm.b.31514
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552CZ
UT WOS:000274266200001
PM 19927330
DA 2018-10-20
ER

PT J
AU Wu, J
   Liu, ZM
   Zhao, XH
   Gao, Y
   Hu, J
   Gao, B
AF Wu, Jiang
   Liu, Zheng-Ming
   Zhao, Xiang-Hui
   Gao, Yang
   Hu, Jiang
   Gao, Bo
TI Improved Biological Performance of Microarc-Oxidized Low-Modulus
   Ti-24Nb-4Zr-7.9Sn Alloy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biocompatibility; beta-titanium alloys; Ti-24Nb-4Zr-7.9Sn; osteoblast
ID BONE RESPONSE; IN-VITRO; TITANIUM IMPLANTS; BIOMEDICAL APPLICATIONS;
   SURFACE MODIFICATION; ARC OXIDATION; OSTEOBLAST; BEHAVIOR; GROWTH;
   BIOMATERIAL
AB Ti-24Nb-4Zr-7.9Sn (TNZS) is a newly developed beta-titanium alloy with low modulus and it has been considered as good material for dental or orthopedic implant. The purpose of the current study is to evaluate the effect of micro-arc oxidation (MAO) treatment on the biological performance of TNZS surface. The phases, morphology and chemical composition of the MAO-treated surface were characterized by X-ray diffraction, energy dispersive spectroscope and scanning electron microscopy analysis respectively. Then we tested the biocompatibility by examining the cell morphology and viability of osteoblast cells growing on MAO-TNZS surface. The bone binding strength of the specimens was evaluated by removal torque test after implantation in rabbit tibiae for 6 weeks. Compared with the nonetreated titanium and TNZS specimens, MAO treated TNZS specimens showed a significant increase (p<0.05) in hydrophilicity, roughness, cell viability and removal torque forces. In summary, MAO treatment helps to form a porous surface with a biologically active bone-like apatite layer on TNZS specimens, which may improve the biological response of MAO-TNZS implants. (C) 2009 Wiley Periodicals. Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 298-306. 2010
C1 [Wu, Jiang; Gao, Yang; Hu, Jiang; Gao, Bo] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China.
   [Liu, Zheng-Ming] Nanjing Univ, Nanjing Stomatol Hosp, Nanjing 210008, Peoples R China.
   [Zhao, Xiang-Hui] Fourth Mil Med Univ, Sch Basic Med, Xian 710032, Peoples R China.
RP Gao, B (reprint author), Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China.
EM gaobo@fmmu.edu.cn
CR [Anonymous], 74051997 ISO
   Bhattarai SR, 2006, J BIOMED MATER RES A, V78A, P247, DOI 10.1002/jbm.a.30695
   Bloebaum RD, 1997, J BONE JOINT SURG AM, V79A, P1013, DOI 10.2106/00004623-199707000-00007
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   CHRISTIAN MP, 1998, ORTHOP CLIN N AM, V29, P571
   D'Lima DD, 1998, J ARTHROPLASTY, V13, P928, DOI 10.1016/S0883-5403(98)90201-7
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   Fini M, 1999, BIOMATERIALS, V20, P1587, DOI 10.1016/S0142-9612(99)00060-5
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Huang P, 2004, J BIOMED MATER RES B, V70B, P187, DOI 10.1002/jbm.b.30009
   Huiskes R, 1993, Acta Orthop Belg, V59 Suppl 1, P118
   Koike M, 2001, J ORAL REHABIL, V28, P540, DOI 10.1046/j.1365-2842.2001.00690.x
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Schreckenbach JP, 1999, J MATER SCI-MATER M, V10, P453, DOI 10.1023/A:1008988706980
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   Steketee M, 2001, MOL BIOL CELL, V12, P2378, DOI 10.1091/mbc.12.8.2378
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Sul YT, 2001, J MATER SCI-MATER M, V12, P1025, DOI 10.1023/A:1012837905910
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Wei DQ, 2007, ACTA BIOMATER, V3, P817, DOI 10.1016/j.actbio.2007.03.001
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   [张立钊 ZHANG Lizhao], 2008, [牙体牙髓牙周病学杂志, Chinese Journal of Conservative Dentistry], V18, P277
   Zhao ZW, 2007, J MATER SCI-MATER M, V18, P2275, DOI 10.1007/s10856-007-3115-5
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 35
TC 29
Z9 30
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2010
VL 92B
IS 2
BP 298
EP 306
DI 10.1002/jbm.b.31515
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552CZ
UT WOS:000274266200002
PM 19904739
DA 2018-10-20
ER

PT J
AU Willie, BM
   Yang, X
   Kelly, NH
   Merkow, J
   Gagne, S
   Ware, R
   Wright, TM
   Bostrom, MPG
AF Willie, Bettina M.
   Yang, Xu
   Kelly, Natalie H.
   Merkow, Justin
   Gagne, Shawn
   Ware, Robin
   Wright, Timothy M.
   Bostrom, Mathias P. G.
TI Osseointegration into a Novel Titanium Foam Implant in the Distal Femur
   of a Rabbit
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE osseointegration; bone ingrowth; titanium foam; rabbit; push-out testing
ID POROUS TANTALUM BIOMATERIAL; BONE-INGROWTH; ACETABULAR COMPONENTS;
   MODEL; FIXATION; HUMANS; ALLOY
AB A novel porous titanium foam implant has recently been developed to enhance biological fixation of orthopaedic implants to bone. The aim of this study was to examine the mechanical and histological characteristics of bone apposition into two different pore sizes of this titanium foam (565 and 464 micron mean void intercept length) and to compare these characteristics to those obtained with a fully porous conventionally sintered titanium bead implant. Cylindrical implants were studied in a rabbit distal femoral intramedullary osseointegration model at time zero and at 3, 6, and 12 weeks. The amount of bone ingrowth, amount of periprosthetic bone, and mineral apposition rate of periprosthetic bone measured did not differ among the three implant designs at 3, 6, or 12 weeks. By 12 weeks, the interface stiffness and maximum load of the beaded implant was significantly greater than either foam implant. No significant difference was found in the interface stiffness or maximum load between the two foam implant designs at 3, 6, or 12 weeks. The lower compressive modulus of the foam compared to the more dense sintered beaded implants likely contributed to the difference in failure mode. However, the foam implants have a similar compressive modulus to other clinically successful coatings, suggesting they are nonetheless clinically adequate. Additional studies are required to confirm this in weight-bearing models. Histological data suggest that these novel titanium foam implants are a promising alternative to current porous coatings and should be further investigated for clinical application in cementless joint replacement. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 92B: 479-488, 2010
C1 [Willie, Bettina M.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Willie, Bettina M.; Yang, Xu; Kelly, Natalie H.; Merkow, Justin; Gagne, Shawn; Ware, Robin; Wright, Timothy M.; Bostrom, Mathias P. G.] Hosp Special Surg, New York, NY 10021 USA.
RP Willie, BM (reprint author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
EM bettina.willie@charite.de
RI Willie, Bettina/G-2397-2014
OI Willie, Bettina/0000-0003-2907-3580; Kelly, Natalie/0000-0002-2022-5800
FU Musculoskeletal Repair and Regeneration Core Center [NIH AR046121]
FX Contract grant sponsor: Musculoskeletal Repair and Regeneration Core
   Center; Contract grant number: NIH AR046121.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Berzins A, 2000, MECH TESTING BONE BO, P463
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, ORTHOPEDICS, V22, P810
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, P173
   COOK SD, 1988, CLIN ORTHOP RELAT R, P90
   Deglurkar M, 2007, J BIOMED MATER RES B, V80B, P528, DOI 10.1002/jbm.b.30627
   DHERT WJA, 1992, J BIOMED MATER RES, V26, P119, DOI 10.1002/jbm.820260111
   Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215
   FROST HM, 1986, INTERMEDIARY ORG SKE
   Galante J, 1971, Orthop Clin North Am, V2, P139
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   Hofmann AA, 2006, CLIN ORTHOP RELAT R, P200, DOI 10.1097/01.blo.0000238838.18799.61
   JASTY M, 1993, J BIOMED MATER RES, V27, P639, DOI 10.1002/jbm.820270511
   Jinno T, 2002, J ARTHROPLASTY, V17, P902, DOI 10.1054/arth.2002.34821
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   JONES LC, 1987, CLIN ORTHOP RELAT R, P192
   Krygier JJ, 1999, P SIROT SYDN AUSTR
   LANDON GC, 1986, CLIN ORTHOP RELAT R, P49
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   Scott MC., 2008, COMMUNICATION
   Stewart M, 2004, J BIOMED MATER RES A, V69A, P1, DOI 10.1002/jbm.a.20071
   SUMNER DR, 1990, J ORTHOPAED RES, V8, P448, DOI 10.1002/jor.1100080316
   SUMNER DR, 1995, J ARTHROPLASTY, V10, P157, DOI 10.1016/S0883-5403(05)80122-6
   Whiteside LA, 2001, CLIN ORTHOP RELAT R, P77
   Willie BM, 2004, J BIOMED MATER RES A, V69A, P567, DOI 10.1002/jbm.a.30038
NR 27
TC 17
Z9 17
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2010
VL 92B
IS 2
BP 479
EP 488
DI 10.1002/jbm.b.31541
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 552CZ
UT WOS:000274266200023
PM 20024964
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Venkatesan, N
   Shroff, S
   Jayachandran, K
   Doble, M
AF Venkatesan, Nandakumar
   Shroff, Sunil
   Jayachandran, Karthik
   Doble, Mukesh
TI Polymers as Ureteral Stents
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
ID URINARY-TRACT-INFECTIONS; BACTERIAL BIOFILM FORMATION; IN-VITRO;
   SURFACE-PROPERTIES; METHACRYLATE POLYMERS; URETHRAL CATHETERS;
   PROTEUS-MIRABILIS; DRAINAGE STENT; UROLOGICAL USE; FLOW MODEL
AB Ureteral stents find wide application in urology. The majority of patients with indwelling ureteral stents are at an increased risk of urinary tract infection. Stent encrustation and its associated complications lead to significant morbidity. This review critically evaluates various polymers that find their application as ureteral stents with regard to various issues such as encrustation, bacterial colonization, urinary tract infections, and related clinical issues. A complete literature survey was performed, and all the relevant articles were scrutinized thoroughly. We discuss issues of encrustation/biofilm formation, new approaches to their testing, polymers currently available for use, new biomaterials, coatings, and novel ureteral stent designs, thereby providing a complete update on recent advances in the development of stents. Finally, we discuss the future of biomaterial use in the urinary tract.
C1 [Venkatesan, Nandakumar; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
   [Shroff, Sunil; Jayachandran, Karthik] Sri Ramachandra Univ & Res Inst, Dept Urol, Madras, Tamil Nadu, India.
RP Doble, M (reprint author), Indian Inst Technol, Dept Biotechnol, Sch Biosci Bldg, Madras 600036, Tamil Nadu, India.
EM mukeshd@iitm.ac.in
OI Venkatesan, Nandakumar/0000-0002-2073-9887; Doble,
   Mukeshd/0000-0002-4335-0698; Shroff, Sunil/0000-0003-3719-2862
CR Arguinarena FJT, 2004, J UROLOGY, V172, P620, DOI 10.1097/01.ju.0000130674.86474.7f
   AXELSSON H, 1977, SCAND J UROL NEPHROL, V11, P283, DOI 10.3109/00365597709179966
   Barbalias GA, 2002, EUR UROL, V42, P276, DOI 10.1016/S0302-2838(02)00281-6
   Bouzidi H, 2008, PROG UROL, V18, P230, DOI 10.1016/j.purol.2008.02.004
   Cadieux P, 2003, COLLOID SURFACE B, V28, P95, DOI 10.1016/S0927-7765(02)00147-9
   Candela JV, 1997, J ENDOUROL, V11, P45, DOI 10.1089/end.1997.11.45
   Cauda F, 2008, J ENDOUROL, V22, P465, DOI 10.1089/end.2007.0218
   Choong SKS, 2000, BJU INT, V86, P414, DOI 10.1046/j.1464-410X.2000.00861.x
   Christman MS, 2009, J UROLOGY, V181, P392, DOI 10.1016/j.juro.2008.08.125
   Cormio L, 1995, Scand J Urol Nephrol Suppl, V171, P1
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Damiano R, 2002, UROL INT, V69, P136, DOI 10.1159/000065563
   Desgrandchamps F, 1997, BRIT J UROL, V79, P24, DOI 10.1046/j.1464-410X.1997.02775.x
   ELFAQIH SR, 1991, J UROLOGY, V146, P1487, DOI 10.1016/S0022-5347(17)38146-6
   Fellstrom B, 1985, UROLITHIASIS RELATED, P831
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Gorman SP, 2003, J PHARM PHARMACOL, V55, P461, DOI 10.1211/002235702856
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   Gu JD, 2001, WORLD J MICROB BIOT, V17, P173, DOI 10.1023/A:1016687630330
   Hendlin K, 2006, UROLOGY, V67, P679, DOI 10.1016/j.urology.2005.10.038
   Hildebrandt P, 2001, BIOMATERIALS, V22, P503, DOI 10.1016/S0142-9612(00)00217-9
   Ho CH, 2008, J ENDOUROL, V22, P1427, DOI 10.1089/end.2008.0037
   HOFMANN R, 1989, WORLD J UROL, V7, P154, DOI 10.1007/BF01637374
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   John T, 2007, J ENDOUROL, V21, P1211, DOI 10.1089/end.2007.9904
   Jones DS, 2006, J BIOMED MATER RES B, V78B, P230, DOI 10.1002/jbm.b.30474
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   KITAMURA T, 1982, KIDNEY INT, V21, P379, DOI 10.1038/ki.1982.33
   Kulkarni RP, 1999, BJU INT, V83, P755
   Kumon H, 2001, INT J ANTIMICROB AG, V17, P311, DOI 10.1016/S0924-8579(00)00360-5
   Lam JS, 2004, UROLOGY, V64, P9, DOI 10.1016/j.urology.2004.03.005
   Lingeman JE, 2003, J ENDOUROL, V17, P169, DOI 10.1089/089277903321618734
   Lingeman JE, 2003, J UROLOGY, V169, P1682, DOI 10.1097/01.ju.0000055600.18515.a1
   Lumiaho J, 1999, J ENDOUROL, V13, P107, DOI 10.1089/end.1999.13.107
   Lumiaho J, 2007, J ENDOUROL, V21, P1559, DOI 10.1089/end.2005.0085
   Morris NS, 1998, J HOSP INFECT, V39, P227, DOI 10.1016/S0195-6701(98)90262-6
   Nurdin N, 1996, J APPL POLYM SCI, V61, P1939, DOI 10.1002/(SICI)1097-4628(19960912)61:11<1939::AID-APP8>3.0.CO;2-K
   Oh SJ, 2005, INT J UROL, V12, P548, DOI 10.1111/j.1442-2042.2005.01089.x
   Petas A, 1998, BIOMATERIALS, V19, P677, DOI 10.1016/S0142-9612(97)00171-3
   PETER J, 2005, INT J ANTIMICROB A S, V26, pS1
   RABINOW BE, 1994, J BIOMAT SCI-POLYM E, V6, P91, DOI 10.1163/156856295X00788
   Reid G, 1999, J ENDOUROL, V13, P1, DOI 10.1089/end.1999.13.1
   Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1
   REID G, 1995, COLLOID SURFACE B, V5, P171, DOI 10.1016/0927-7765(95)01208-Z
   Riedl CR, 2002, INT J ANTIMICROB AG, V19, P507, DOI 10.1016/S0924-8579(02)00097-3
   Robert M, 1997, UROL INT, V58, P100, DOI 10.1159/000282959
   ROBERTSO.WG, 1973, CLIN CHIM ACTA, V43, P31, DOI 10.1016/0009-8981(73)90114-9
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   Sabbuba N, 2002, BJU INT, V89, P55, DOI 10.1046/j.1464-410X.2002.02560.x
   Saint S, 2003, INFECT DIS CLIN N AM, V17, P411, DOI 10.1016/S0891-5520(03)00011-4
   Santin M, 2003, J Appl Biomater Biomech, V1, P67
   Santin M, 1999, BIOMATERIALS, V20, P1245, DOI 10.1016/S0142-9612(99)00026-5
   Schierholz JM, 1999, INFUSIONSTHERAPIE, V26, P278
   Schierholz JM, 2002, INT J ANTIMICROB AG, V19, P511, DOI 10.1016/S0924-8579(02)00096-1
   SU LM, 2002, CAMPBELLS UROLOGY, pCH97
   Tenke P, 2004, INT J ANTIMICROB AG, V23, pS67, DOI 10.1016/j.ijantimicag.2003.12.007
   Tunney MM, 1997, INT J PHARMACEUT, V151, P121, DOI 10.1016/S0378-5173(97)04902-8
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   TUNNEY MM, 1996, EUR J PHARM SCI, V4, P177
   Winson L, 1997, Br J Nurs, V6, P1229
   Wollin TA, 1998, J ENDOUROL, V12, P101, DOI 10.1089/end.1998.12.101
   Yoshimura K, 1997, BRIT J UROL, V80, P64, DOI 10.1046/j.1464-410X.1997.00189.x
NR 65
TC 40
Z9 42
U1 2
U2 31
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD FEB
PY 2010
VL 24
IS 2
BP 191
EP 198
DI 10.1089/end.2009.0516
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 554GM
UT WOS:000274423500003
PM 20073560
DA 2018-10-20
ER

PT J
AU Pichugin, VF
   Surmenev, RA
   Surmeneva, MA
AF Pichugin, V. F.
   Surmenev, R. A.
   Surmeneva, M. A.
TI Hydroxyapatite Thin Films Prepared by RF-Magnetron-Sputtered Deposition
   for Medical Application
SO JOURNAL OF IRON AND STEEL RESEARCH INTERNATIONAL
LA English
DT Article
DE hydroxyapatite; rf-magnetron spattered deposition; bioactive coatings;
   biomaterials
ID CALCIUM-PHOSPHATE COATINGS; LOAD-BEARING IMPLANTS;
   MECHANICAL-PROPERTIES; TITANIUM; NICKEL
AB The biomaterial science shows an important interest in the production of biocompatible ceramic-like coatings capable to improve the interaction of metal implant to the living tissue. Among the materials used for coating fabrication the most interesting is hydroxyapatite (HA) due to its similarities with the mineral part of the bone. Coatings were prepared by radio-frequency (RF-) magnetron sputtering technique, starting from pure HA. The HA thin films were characterized in terms of structure and chemical composition by many techniques such as Fourier spectroscopy (FTIR), X-ray diffraction (XPS), Rutherford backscattering (RBS) and nanoindentation technique (Vicker's indenter). There were established that deposited coating has the structure of crystalline hydroxyapatite or amorphous one with calcium to phosphorus ratio (Ca/P) in the range 1.53 - 3.88. Calcium phosphate coating with the structure of hydroxyapatite reduces the nickel release rate from NiTi substrates in aqueous saline solution over 7 - 10 times.
C1 [Pichugin, V. F.; Surmenev, R. A.; Surmeneva, M. A.] Tomsk Polytech Univ, Tomsk, Russia.
RP Pichugin, VF (reprint author), Tomsk Polytech Univ, Tomsk, Russia.
RI Surmenev, Roman/A-2492-2014
OI Surmenev, Roman/0000-0002-8061-3047
FU RFBR [08-02-12133, 02.512.11.2285]
FX The authors are grateful to Professor M. Epple (University
   Duisburg-Essen) for his fruitful discussions and help. This work was
   supported by RFBR (project 08-02-12133) and state contract No.
   02.512.11.2285.
CR Boyd AR, 2007, NUCL INSTRUM METH B, V258, P421, DOI 10.1016/j.nimb.2007.02.072
   Boyd AR, 2006, SURF COAT TECH, V200, P6002, DOI [10.1016/j.surfcoat.2005.09.032, 10.1016/j.surfcoat.09.032]
   Callister W. D., 2000, MAT SCI ENG
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   GONZALEZDIAZ PF, 1977, J SOLID STATE CHEM, V22, P193, DOI 10.1016/0022-4596(77)90037-8
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   LIEBERMAN MA, 1994, PRINCIPLES PLASMA DI, P565
   Nelea V, 2003, SURF COAT TECH, V173, P315, DOI 10.1016/S0257-8972(03)00729-1
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Pearse R.W.B., 1976, IDENTIFICATION MOL S, P407
   Peitsch T, 2007, J BIOMED MATER RES A, V82A, P731, DOI 10.1002/bjm.a.31097
   Pichugin VF, 2008, SURF COAT TECH, V202, P3913, DOI 10.1016/j.surfcoat.2008.01.038
   PICHUGIN VF, 2006, IZVESTIA VUZOV PHYS, V8, P387
   Ruddell DE, 2000, J BIOMED MATER RES, V51, P316, DOI 10.1002/1097-4636(20000905)51:3<316::AID-JBM4>3.0.CO;2-G
   Shabalovskaya S, 2008, ACTA BIOMATER, V4, P447, DOI 10.1016/j.actbio.2008.01.013
   Shtansky DV, 2006, SURF COAT TECH, V201, P4111, DOI 10.1016/j.surfcoat.2006.08.012
   Shtansky DV, 2006, BIOMATERIALS, V27, P3519, DOI 10.1016/j.biomaterials.2006.02.012
   Shtansky DV, 2005, BIOMATERIALS, V26, P2909, DOI 10.1016/j.biomaterials.2004.09.010
   Shtansky DV, 2005, SURF COAT TECH, V200, P208, DOI 10.1016/j.surfcoat.2005.02.126
   Stoch A, 2000, J MOL STRUCT, V555, P375, DOI 10.1016/S0022-2860(00)00623-2
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tabor D., 1951, HARDNESS METALS
   van der Wal E, 2006, BIOMATERIALS, V27, P1333, DOI 10.1016/j.biomaterials.2005.09.006
   van der Wal E, 2005, APPL SURF SCI, V246, P183, DOI 10.1016/j.apsusc.2004.11.006
   VONKEUDELL A, 2000, J PLASMA SOURCES SCI, V9, P445
   Wolke JGC, 1997, BIOMATERIALS, V18, P483, DOI 10.1016/S0142-9612(96)00164-0
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i
   Yan YG, 2006, J BIOMED MATER RES A, V76A, P744, DOI 10.1002/jbm.a.30483
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
   ZYMAN Z, 1993, BIOMATERIALS, V14, P1140, DOI 10.1016/0142-9612(93)90158-X
NR 34
TC 0
Z9 0
U1 0
U2 6
PU JOURNAL IRON STEEL RESEARCH  EDITORIAL BOARD
PI BEIJING
PA NO. 76 XUEYUAN SOUTH-ROAD, BEIJING 100081, PEOPLES R CHINA
SN 1006-706X
EI 2210-3988
J9 J IRON STEEL RES INT
JI J. Iron Steel Res. Int.
PD FEB
PY 2010
VL 17
SU 1
BP 113
EP 121
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 584DC
UT WOS:000276729300022
DA 2018-10-20
ER

PT J
AU Giavaresi, G
   Fini, M
   Salvage, J
   Aldini, NN
   Giardino, R
   Ambrosio, L
   Nicolais, L
   Santin, M
AF Giavaresi, Gianluca
   Fini, Milena
   Salvage, Jonathan
   Aldini, Nicolo Nicoli
   Giardino, Roberto
   Ambrosio, Luigi
   Nicolais, Luigi
   Santin, Matteo
TI Bone regeneration potential of a soybean-based filler: experimental
   study in a rabbit cancellous bone defects
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; FREEZE-DRIED BONE; HUMAN EXTRACTION SOCKETS;
   IN-VITRO; HYDROXYAPATITE; ALLOGRAFT; CELLS; DIFFERENTIATION;
   DEGRADATION; OSTEOBLASTS
AB Autologous and allogenic bone grafts are considered as materials of choice for bone reconstructive surgery, but limited availability, risks of transmittable diseases and inconsistent clinical performances have prompted the development of alternative biomaterials. The present work compares the bone regeneration potential of a soybean based bone filler (SB bone filler) in comparison to a commercial 50:50 poly(d,l lactide-glycolide)-based bone graft (Fisiograft(A (R)) gel) when implanted into a critical size defect (6-mm diameter, 10-mm length) in rabbit distal femurs. The histomorphometric and microhardness analyses of femoral condyles 4, 8, 16 and 24 weeks after surgery showed that no significant difference was found in the percentage of both bone repair and bone in-growth in the external, medium and inner defect areas. The SB filler-treated defects showed significantly higher outer bone formation and microhardness results at 24 weeks than Fisiograft(A (R)) gel (P < 0.05). Soybean-based biomaterials clearly promoted bone repair through a mechanism of action that is likely to involve both the scaffolding role of the biomaterial for osteoblasts and the induction of their differentiation.
C1 [Salvage, Jonathan; Santin, Matteo] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
   [Giavaresi, Gianluca; Fini, Milena; Aldini, Nicolo Nicoli; Giardino, Roberto] Rizzoli Orthopaed Inst, Lab Surg Preclin Studies, Bologna, Italy.
   [Ambrosio, Luigi; Nicolais, Luigi] CNR, Inst Composite & Biomed Mat IMCB, I-80125 Naples, Italy.
RP Santin, M (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Cockcroft Bldg,Lewes Rd, Brighton BN2 4GJ, E Sussex, England.
EM m.santin@brighton.ac.uk
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; AMBROSIO, LUIGI/0000-0002-8367-2405;
   Giavaresi, Gianluca/0000-0001-7843-5969
FU UK South East Proof of Concept
FX This work has been supported by a UK South East Proof of Concept grant.
   The Authors wish to thank: (1) Mr. Keith Smith for his assistance in
   language supervision; and (2) Claudio Dal Fiume, Paola Chiavelli, Nicola
   Corrado, Alberto Ianni and Patrizia Nini of the Laboratory of Surgical
   Preclinical Studies, Rizzoli Orthopaedic Institute (Bologna, Italy) for
   their technical assistance.
CR Barbanti SH, 2004, J MATER SCI-MATER M, V15, P1315, DOI 10.1007/s10856-004-5740-6
   BECKER W, 1994, J PERIODONTOL, V65, P1128, DOI 10.1902/jop.1994.65.12.1128
   Bodde EWH, 2007, J BIOMED MATER RES A, V82A, P711, DOI 10.1002/bjm.a.30990
   BOWEN JA, 1989, J PERIODONTOL, V60, P647, DOI 10.1902/jop.1989.60.12.647
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Donati D, 2008, INJURY, V39, pS65, DOI 10.1016/S0020-1383(08)70017-2
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, V225, P7
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Helms MW, 2005, J PATHOL, V206, P366, DOI 10.1002/path.1785
   Huja SS, 1998, J ORTHOPAED RES, V16, P54, DOI 10.1002/jor.1100160110
   Huja SS, 2000, MECH TESTING BONE BO, P247
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lu J, 2008, SPINE, V33, P242, DOI 10.1097/BRS.0b013e318162451b
   McKee MD, 2005, J ORTHOP TRAUMA, V19, pS26, DOI 10.1097/00005131-200511101-00008
   MELLONIG JT, 1984, INT J PERIODONT REST, V4, P41
   Middleton E, 2000, PHARMACOL REV, V52, P673
   Morgan EF, 2008, BONE, V43, P1031, DOI 10.1016/j.bone.2008.07.251
   Morris C, 2006, J NUTR, V136, P1166
   Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297
   Nagai N, 2007, J BIOMED MATER RES A, V82A, P395, DOI 10.1002/jbm.a.31110
   Nodar MD, 2002, FOOD SCI TECHNOL INT, V8, P337, DOI 10.1106/108201302031651
   Ogose A, 2005, J BIOMED MATER RES B, V72B, P94, DOI 10.1002/jbm.b.30136
   PANJAITAN N, 2000, J FOOD SCI, V65, P399
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Phelps JB, 2000, J BIOMED MATER RES, V51, P735, DOI 10.1002/1097-4636(20000915)51:4<735::AID-JBM23>3.0.CO;2-G
   Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539
   Rimondini L, 2005, ORAL SURG ORAL MED O, V99, P148, DOI 10.1016/j.tripleo.2004.05.010
   Russell JL, 2000, MED HYPOTHESES, V55, P474, DOI 10.1054/mehy.2000.1095
   Salernitano E, 2003, J Appl Biomater Biomech, V1, P3
   SANTIN M, 2001, Patent No. 0103464
   Santin M, 2007, BIOMACROMOLECULES, V8, P2706, DOI 10.1021/bm0703362
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   Specchia N, 2002, J MATER SCI, V37, P577, DOI 10.1023/A:1013725809480
   Trejo PM, 2000, J PERIODONTOL, V71, P1852, DOI 10.1902/jop.2000.71.12.1852
   Tschon M, 2007, INT J ARTIF ORGANS, V30, P352
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
NR 40
TC 26
Z9 26
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2010
VL 21
IS 2
BP 615
EP 626
DI 10.1007/s10856-009-3870-6
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 554LK
UT WOS:000274436300028
PM 19771493
DA 2018-10-20
ER

PT J
AU Fu, SZ
   Guo, G
   Wang, XL
   Zhou, LX
   Liu, TT
   Dong, PW
   Luo, F
   Gu, YC
   Shi, XY
   Zhao, X
   Wei, YQ
   Qian, ZY
AF Fu, Shaozhi
   Guo, Gang
   Wang, Xinlong
   Zhou, Liangxue
   Liu, Tingting
   Dong, Pengwei
   Luo, Feng
   Gu, Yingchun
   Shi, Xingyu
   Zhao, Xia
   Wei, Yuquan
   Qian, Zhiyong
TI Preparation and Characterization of n-Hydroxyapatite/PCL-Pluronic-PCL
   Nanocomposites for Tissue Engineering
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE n-Hydroxyapatite; PCL-Pluronic-PCL; Block Copolymer; Nanocomposites;
   In-Situ Combination
ID IN-VITRO; EPSILON-CAPROLACTONE; NANO-HYDROXYAPATITE; COMPOSITE
   SCAFFOLDS; BLOCK-COPOLYMERS; BONE; BIOMATERIAL; DEGRADATION;
   POLYLACTIDE; MICELLES
AB In this paper, a new kind of polymeric nanocomposite materials based on nano-hydroxyapatite (n-HA) and PCL-Pluronic-PCL (PCFC) copolymer were prepared by in situ combination method. Firstly, the PCFC copolymer was synthesized by ring-opening polymerization of e-caprolactone initiated by Pluronic (PEG-PPG-PEG); Secondly, n-HA powder were combined with PCFC to form polymeric composites in the presence of hexamethylene diisocyanate (HDI). The obtained composites were characterized by (1)H-NMR, FTIR, XRD, TEM, SEM, DTA/TGA, and tensile testing. The results revealed that n-HA could be dispersed into polymer matrix uniformly, and the n-HA/PCFC composite showed great mechanical properties when the content of n-HA was 10 wt%. The microstructure and thermal properties of the composites were discussed in the paper too. The experimental results suggested that this polymeric nanocomposite might have great potential application in the field of tissue engineering.
C1 [Fu, Shaozhi; Guo, Gang; Zhou, Liangxue; Liu, Tingting; Dong, Pengwei; Luo, Feng; Gu, Yingchun; Shi, Xingyu; Zhao, Xia; Wei, Yuquan; Qian, Zhiyong] Sichuan Univ, State Key Lab Biotherapy, W China Hosp, W China Med Sch, Chengdu 610041, Peoples R China.
   [Wang, Xinlong] Sichuan Univ, Coll Chem Engn, Chengdu 610065, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, State Key Lab Biotherapy, W China Hosp, W China Med Sch, Chengdu 610041, Peoples R China.
RI Fu, ShaoZhi/L-4019-2017; Liu, Yifei/L-7828-2014
OI Fu, ShaoZhi/0000-0002-8666-4304; Liu, Yifei/0000-0002-1087-9827
FU National 863 High-Tech Project [2007AA021902]; Sichuan Prominent Young
   Talents Program [07ZQ026-033]; Sichuan Key Project of Science and
   Technology [2007SGY019]; New Century Excellent Talents in University
   [NCET-08-0371]; Chinese Key Basic Research Program [2010CB529906]
FX We acknowledge the financial supports of National 863 High-Tech Project
   (2007AA021902), Sichuan Prominent Young Talents Program (07ZQ026-033),
   Sichuan Key Project of Science and Technology (2007SGY019), New Century
   Excellent Talents in University (NCET-08-0371), and Chinese Key Basic
   Research Program (2010CB529906).
CR Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Choi DW, 2004, MATER RES BULL, V39, P417, DOI 10.1016/j.materresbull.2003.10.013
   Deng C, 2007, CURR APPL PHYS, V7, P679, DOI 10.1016/j.cap.2007.03.005
   Dung TH, 2008, J NANOSCI NANOTECHNO, V8, P5326, DOI 10.1166/jnn.2008.1219
   Gou ML, 2008, J NANOSCI NANOTECHNO, V8, P2357, DOI 10.1166/jnn.2008.310
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Ha JC, 1999, J CONTROL RELEASE, V62, P381, DOI 10.1016/S0168-3659(99)00167-4
   Hombreiro-Perez M, 2000, J CONTROL RELEASE, V65, P429
   Honda M, 2003, BIOMATERIALS, V24, P3511, DOI 10.1016/S0142-9612(03)00210-2
   HONLLINGER JO, 2000, TISSUE ENG, V6, P341
   Hsieh MF, 2008, J NANOSCI NANOTECHNO, V8, P2362, DOI 10.1166/jnn.2008.322
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Jin SH, 2008, J NANOSCI NANOTECHNO, V8, P5076, DOI 10.1166/jnn.2008.1232
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee Y, 2008, J NANOSCI NANOTECHNO, V8, P5236, DOI 10.1166/jnn.2008.1384
   Liu CB, 2007, COLLOID SURFACE A, V302, P430, DOI 10.1016/j.colsurfa.2007.03.006
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   MASAKI H, 2000, J ORAL MAXILLOFAC SU, V58, P767
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   PERRIN DE, 1997, HDB BIODEGRADABLE PO, P63
   PETRICCA SE, 2006, ACTA BIOMATER, V2, P19
   Qian ZY, 2003, POLYM DEGRAD STABIL, V81, P279, DOI 10.1016/S0141-3910(03)00098-3
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Utracki LA, 2008, J NANOSCI NANOTECHNO, V8, P1582, DOI 10.1166/jnn.2008.004
   Xu H., 2001, J CHIN PHARM SCI, V10, P203
   YLINEN P, 1994, J MATER SCI-MATER M, V5, P522, DOI 10.1007/BF00124884
   Yoon SB, 2008, J NANOSCI NANOTECHNO, V8, P5261, DOI 10.1166/jnn.2008.1045
   Zhang X, 2006, POLYM DEGRAD STABIL, V91, P1202, DOI 10.1016/j.polymdegradstab.2005.02.006
   Zhou SB, 2007, CHEM MATER, V19, P247, DOI 10.1021/cm0619398
NR 38
TC 17
Z9 17
U1 3
U2 21
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2010
VL 10
IS 2
BP 711
EP 718
DI 10.1166/jnn.2010.1888
PG 8
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 545CK
UT WOS:000273709900006
PM 20352708
DA 2018-10-20
ER

PT J
AU Chew, BH
   Lange, D
   Paterson, RF
   Hendlin, K
   Monga, M
   Clinkscales, KW
   Shalaby, SW
   Hadaschik, BA
AF Chew, Ben H.
   Lange, Dirk
   Paterson, Ryan F.
   Hendlin, Kari
   Monga, Manoj
   Clinkscales, Kenneth W.
   Shalaby, Shalaby W.
   Hadaschik, Boris A.
TI Next Generation Biodegradable Ureteral Stent in a Yucatan Pig Model
SO JOURNAL OF UROLOGY
LA English
DT Article
DE ureter; stents; absorbable implants; swine; complications
ID DRAINAGE STENT; PORCINE MODEL; TRIAL
AB Purpose: Ureteral stents are commonly used to facilitate kidney drainage but they may produce significant stent symptoms and morbidity, and require a secondary procedure for removal. Previous biodegradable stents showed bioincompatibility or inconsistent degradation, requiring extra procedures to remove undegraded stent fragments. We previously reported a first generation biodegradable stent composed of suture-like material that required placement through the lumen of a sheath and degraded by 10 weeks. We now report second and third generation biodegradable stents that degrade more rapidly and can be placed directly over a polytetrafluoroethylene guidewire.
   Materials and Methods: Two groups of 16 Yucatan pigs each were unilaterally stented endoscopically with a control nondegradable (biostable) stent or a second generation degradable Uriprene (R) stent. Blood studies, renal ultrasound and excretory urography were done throughout the study to determine renal function, hydronephrosis and stent degradation. Genitourinary organs were harvested at necropsy for pathological analysis. A third generation stent designed to improve degradation time was bilaterally implanted endoscopically into 4 Yorkshire Farm pigs (total of 8 stents), followed by excretory urography weekly to assess degradation and kidney function. Biomaterial parameters were tested.
   Results: Second generation stents began degrading at 2 weeks and were completely degraded by 10 weeks. All third generation stents were degraded by 4 weeks. Hydronephrosis was considerably less in the Uriprene group than in control biostable stented kidneys. Biostable stented ureters showed an average higher degree of inflammation, uropathy and nephropathy. Physical characteristics indicate that Uriprene stents are significantly more resistant to stent compression and have markedly higher tensile strength and coil strength comparable to that of other commercially available plastic stents.
   Conclusions: Our study confirms that Uriprene stents are biocompatible and provide good renal drainage. They hold promise for decreasing the need for a secondary procedure and stent related morbidity, such as infection and irritative symptoms.
C1 [Chew, Ben H.; Lange, Dirk; Paterson, Ryan F.] Univ British Columbia, Vancouver Gen Hosp, Dept Urol Sci, Stone Ctr, Vancouver, BC V6H 3Z6, Canada.
   [Hendlin, Kari; Monga, Manoj] Univ Minnesota, Minneapolis, MN USA.
   [Clinkscales, Kenneth W.; Shalaby, Shalaby W.] Poly Med Inc, Anderson, SC USA.
   [Hadaschik, Boris A.] Univ Heidelberg, Dept Urol, D-6900 Heidelberg, Germany.
RP Chew, BH (reprint author), Univ British Columbia, Vancouver Gen Hosp, Dept Urol Sci, Stone Ctr, Room 242,2660 Oak St, Vancouver, BC V6H 3Z6, Canada.
EM ben.chew@ubc.ca
FU Michael Smith Foundation for Health Research Scholarship (BHC); Canadian
   Urology Association Foundation Scholarship (BHC)
FX Supported by a Michael Smith Foundation for Health Research Scholarship
   (BHC) and a Canadian Urology Association Foundation Scholarship (BHC).
CR Auge BK, 2002, J UROLOGY, V168, P808, DOI 10.1016/S0022-5347(05)64748-9
   Hadaschik BA, 2008, J UROLOGY, V180, P1161, DOI 10.1016/j.juro.2008.05.003
   Hendlin K, 2006, UROLOGY, V67, P679, DOI 10.1016/j.urology.2005.10.038
   Hendlin K, 2006, UROLOGY, V68, P42, DOI 10.1016/j.urology.2006.01.062
   Joshi HB, 2003, J UROLOGY, V169, P1065, DOI 10.1097/01.ju.0000048980.33855.90
   Kinn AC, 2002, UROL RES, V30, P213, DOI 10.1007/s00240-002-0258-1
   Lingeman JE, 2003, J ENDOUROL, V17, P169, DOI 10.1089/089277903321618734
   Lingeman JE, 2003, J UROLOGY, V169, P1682, DOI 10.1097/01.ju.0000055600.18515.a1
   Olweny EO, 2002, J UROLOGY, V167, P2198, DOI 10.1016/S0022-5347(05)65128-2
   Paick SH, 2003, UROLOGY, V62, P214, DOI 10.1016/S0090-4295(03)00325-X
   Paz A, 2005, J ENDOUROL, V19, P147, DOI 10.1089/end.2005.19.147
   RAMSAY JWA, 1985, BRIT J UROL, V57, P630, DOI 10.1111/j.1464-410X.1985.tb07021.x
   Singh V, 2005, INT UROL NEPHROL, V37, P541, DOI 10.1007/s11255-004-4704-6
NR 13
TC 30
Z9 36
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD FEB
PY 2010
VL 183
IS 2
BP 765
EP 771
DI 10.1016/j.juro.2009.09.073
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 543AD
UT WOS:000273540600144
PM 20022028
DA 2018-10-20
ER

PT J
AU Horie, RT
   Sakamoto, T
   Nakagawa, T
   Tabata, Y
   Okamura, N
   Tomiyama, N
   Tachibana, M
   Ito, J
AF Horie, Rie T.
   Sakamoto, Tatsunori
   Nakagawa, Takayuki
   Tabata, Yasuhiko
   Okamura, Noboru
   Tomiyama, Naoki
   Tachibana, Mitsuhiro
   Ito, Juichi
TI Sustained Delivery of Lidocaine Into the Cochlea Using Poly
   Lactic/Glycolic Acid Microparticles
SO LARYNGOSCOPE
LA English
DT Article; Proceedings Paper
CT 32nd Annual Midwinter Meeting of the
   Association-for-Research-in-Otolaryngology
CY FEB 14-19, 2009
CL Baltimore, MD
SP Assoc Res Otolaryngol
DE Biomaterial; drug-delivery system; inner ear; poly lactic/glycolic acid;
   tinnitus
ID INNER-EAR; TINNITUS; BEHAVIOR; THERAPY
AB Objectives/Hypothesis: Lidocaine is a local anesthetic that is known to suppress tinnitus via systemic or local application; however, this effect has only limited duration. The current study aimed to establish a method for the sustained delivery of lidocaine into the cochlea using poly lactic/glycolic acid (PLGA) microparticles.
   Study Design: Experimental study.
   Methods: Lidocaine-loaded PLGA microparticles were produced and their in vitro-release profiles were examined. The lidocaine concentrations in the perilymph were measured at different time points following the application of the lidocaine-loaded PLGA microparticles to the round-window membranes of guinea pigs. The possible adverse effects of the local application of lidocaine-loaded PLGA microparticles were also examined.
   Results: The in vitro analyses revealed that the microparticles were capable of the sustained delivery of lidocaine. The in vivo experiments demonstrated the sustained delivery of lidocaine into the cochlear fluid, and the maintenance of high lidocaine concentrations in the perilymph for up to 3 days after application. Nyptagmus and inflammation in the middle ear mucosa were not detected after the local application of lidocaine-loaded PLGA microparticles, although temporary hearing loss was observed.
   Conclusions: Lidocaine-loaded PLGA microparticles were shown to be capable of the sustained delivery of lidocaine into the cochlea, suggesting that they could be used for the attenuation of peripheral tinnitus.
C1 [Nakagawa, Takayuki] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan.
   [Tachibana, Mitsuhiro] Kyoto Univ, Dept Pathol & Biol Dis, Kyoto 6068507, Japan.
   [Tachibana, Mitsuhiro] Kyoto Univ, Dept Diagnost Pathol, Grad Sch Med, Kyoto 6068507, Japan.
   [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto 6068507, Japan.
   [Okamura, Noboru; Tomiyama, Naoki] Mukogawa Womans Univ, Dept Pharmaceut Sci, Nishinomiya, Hyogo, Japan.
RP Nakagawa, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kawaharacho 54, Kyoto 6068507, Japan.
EM tnakagawa@ent.kuhp.kyoto-u.ac.jp
RI Sakamoto, Tatsunori/N-3046-2015
OI Sakamoto, Tatsunori/0000-0001-6669-7013
CR Bauer Carol A, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P413, DOI 10.1097/01.moo.0000134443.29853.09
   Chen PC, 2004, J BIOMED MATER RES A, V70A, P412, DOI 10.1002/jbm.a.30086
   DeLucchi E, 2000, Int Tinnitus J, V6, P37
   ENGLESSON S, 1976, ACTA OTO-LARYNGOL, V82, P297, DOI 10.3109/00016487609120910
   Laurikainen E, 1997, ACTA OTO-LARYNGOL, V117, P523, DOI 10.3109/00016489709113432
   LAURIKAINEN E, 1992, ACTA OTO-LARYNGOL, V112, P800, DOI 10.3109/00016489209137477
   Lee KY, 2007, OTOL NEUROTOL, V28, P976, DOI 10.1097/MAO.0b013e31811f40db
   Magnusson AK, 2003, NEUROSCIENCE, V120, P1105, DOI 10.1016/S0306-4522(03)00407-X
   MURAI K, 1992, AM J OTOL, V13, P454
   Ruel J, 2008, J NEUROSCI, V28, P7313, DOI 10.1523/JNEUROSCI.5335-07.2008
   Sakata H, 2001, Int Tinnitus J, V7, P46
   Tan J, 2007, NEUROSCIENCE, V145, P715, DOI 10.1016/j.neuroscience.2006.11.067
   THOMSON PD, 1973, ANN INTERN MED, V78, P499, DOI 10.7326/0003-4819-78-4-499
   Trellakis S, 2007, PROG BRAIN RES, V166, P303, DOI 10.1016/S0079-6123(07)66028-2
   Turner JG, 2007, PROG BRAIN RES, V166, P147, DOI 10.1016/S0079-6123(07)66013-0
NR 15
TC 29
Z9 31
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0023-852X
J9 LARYNGOSCOPE
JI Laryngoscope
PD FEB
PY 2010
VL 120
IS 2
BP 377
EP 383
DI 10.1002/lary.20713
PG 7
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA 556QA
UT WOS:000274605000029
PM 19950377
DA 2018-10-20
ER

PT J
AU Rouse, JG
   Van Dyke, ME
AF Rouse, Jillian G.
   Van Dyke, Mark E.
TI A Review of Keratin-Based Biomaterials for Biomedical Applications
SO MATERIALS
LA English
DT Review
DE keratin; human hair protein; natural biomaterial; protein film; scaffold
ID HUMAN HAIR KERATINS; KERATEINE BLEND FILMS; INTERMEDIATE-FILAMENTS;
   SPONGE SCAFFOLDS; PROTEIN FILMS; FOLLICLE; WOOL; CULTIVATION;
   EXPRESSION; CATALOG
AB Advances in the extraction, purification, and characterization of keratin proteins from hair and wool fibers over the past century have led to the development of a keratin-based biomaterials platform. Like many naturally-derived biomolecules, keratins have intrinsic biological activity and biocompatibility. In addition, extracted keratins are capable of forming self-assembled structures that regulate cellular recognition and behavior. These qualities have led to the development of keratin biomaterials with applications in wound healing, drug delivery, tissue engineering, trauma and medical devices. This review discusses the history of keratin research and the advancement of keratin biomaterials for biomedical applications.
C1 [Rouse, Jillian G.; Van Dyke, Mark E.] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
RP Van Dyke, ME (reprint author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
EM jrouse@wfubmc.edu; mavandyk@wfubmc.edu
RI Richter, Jillian/C-1914-2013
OI Richter, Jillian/0000-0002-2233-1711
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793
   Aluigi A, 2007, J APPL POLYM SCI, V104, P863, DOI 10.1002/app.25623
   Aluigi A, 2008, EUR POLYM J, V44, P2465, DOI 10.1016/j.eurpolymj.2008.06.004
   Anker CA, 1972, US patent, Patent No. 3642498
   Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Beyer C., 1907, Get pat, Patent No. 22643
   BREINL F, 1907, Z PHYSL CHEM, V52, P158
   BUCHANAN JH, 1977, BIOCHEM J, V167, P489, DOI 10.1042/bj1670489
   Coulombe PA, 2000, TRENDS CELL BIOL, V10, P420, DOI 10.1016/S0962-8924(00)01828-6
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   Dale HN, 1932, PHARM J, V129, P494
   EARLAND C, 1956, BIOCHIM BIOPHYS ACTA, V22, P405, DOI 10.1016/0006-3002(56)90048-8
   FRASER RDB, 1986, P NATL ACAD SCI USA, V83, P1179, DOI 10.1073/pnas.83.5.1179
   Fujii T, 2004, BIOL PHARM BULL, V27, P1433, DOI 10.1248/bpb.27.1433
   Fujii T, 2004, BIOL PHARM BULL, V27, P89, DOI 10.1248/bpb.27.89
   Goddard DR, 1935, J BIOL CHEM, V112, P361
   GOLDSMITH BB, 1909, Patent No. 922692
   Hofmeier J., 1905, Ger pat, Patent No. 184915
   Ikkai F, 2002, BIOMACROMOLECULES, V3, P482, DOI 10.1021/bm010160i
   ITO H, 1982, KOBUNSHI RONBUNSHU, V39, P249, DOI 10.1295/koron.39.249
   Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x
   JARMAN T, 1985, WORLD BIOTECH REPORT, V1, P505
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Katoh K, 2004, J APPL POLYM SCI, V91, P756, DOI 10.1002/app.13236
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Kawano Y, 1975, KAGAKU TO SEIBUTSU, V13, P291
   KIKKAWA M, 1974, HIKAKU KAGAKU, V20, P151
   Kurimoto A, 2003, J BIOSCI BIOENG, V96, P307, DOI 10.1263/jbb.96.307
   Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6
   Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874
   Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200
   Lee K.Y., 2001, FIBER POLYM, V2, P71
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   Lissizin T., 1928, Z PHYSL CHEM, V173, P309
   Lissizin T., 1915, BIOCH B, V4, P18
   Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005
   MATSUNGA A, 1981, HIKAKU KAGAKU, V27, P21
   MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7
   Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6
   NEUBERG C, 1909, Patent No. 926999
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Okamoto S., 1977, NIPPON SHOKUHIN KOGY, V24, P40
   Orwin D. F. G, 1979, FIBROUS PROTEINS SCI, P271
   Peplow PV, 2004, J MATER SCI-MATER M, V15, P1217, DOI 10.1007/s10856-004-5803-8
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   RIVETT DE, 1996, LENNOX LEGACY
   Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X
   Schweizer J, 2007, EXP CELL RES, V313, P2010, DOI 10.1016/j.yexcr.2007.02.032
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   STEINERT PM, 1976, BIOCHEM BIOPH RES CO, V70, P221, DOI 10.1016/0006-291X(76)91131-1
   Stenn KS, 1999, EXP DERMATOL, V8, P229
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   THOMAS H, 1986, INT J BIOL MACROMOL, V8, P258, DOI 10.1016/0141-8130(86)90038-3
   Tonin C, 2007, J THERM ANAL CALORIM, V89, P601, DOI 10.1007/s10973-006-7557-7
   van de Locht M, 1987, MELLIAND TEXTILBERIC, V10, P780
   VANDENBERGH J, 1941, Patent No. 51000577
   Varesano A, 2008, J POLYM SCI POL PHYS, V46, P1193, DOI 10.1002/polb.21452
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wrzesniewska-Tosik K, 2007, FIBRES TEXT EAST EUR, V15, P157
   Yamauchi K, 2003, MAT SCI ENG C-BIO S, V23, P467, DOI 10.1016/S09284931(02)00280-1
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   YU JL, 1993, J INVEST DERMATOL, V101, pS56, DOI 10.1111/1523-1747.ep12362635
   ZDENKO S, 1924, Z PHYSL CHEM, V136, P160
   ZHEN LS, 2005, BEN CAO GANG MU
   ZOCCOLA M, 2007, E POLYM
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
   1993, KOGYO ZAIRYO, V41, P106
NR 75
TC 180
Z9 188
U1 5
U2 131
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD FEB
PY 2010
VL 3
IS 2
BP 999
EP 1014
DI 10.3390/ma3020999
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864LA
UT WOS:000298240300012
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Tang, ZP
   Chen, XY
   Zeng, WG
   Xu, SB
   Xie, XW
   Tang, RH
   Zhu, SQ
AF Tang, Zhouping
   Chen, Xingyong
   Zeng, Wengao
   Xu, Shabei
   Xie, Xuewei
   Tang, Ronghua
   Zhu, Suiqiang
TI Biocompatibility of a collagen-heparin sulfate scaffold implanted into
   porcine brain
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE biomaterial; scaffold; collagen; heparin sulfate; neuronal apoptosis;
   biocompatibility; nerve tissue engineering; neural regeneration
ID TISSUE-PLASMINOGEN-ACTIVATOR; INTRACEREBRAL HEMORRHAGE; NERVE
   REGENERATION; EDEMA FORMATION; PROTEOGLYCANS; APOPTOSIS; CELLS;
   COMPATIBILITY; FILAMENTS; SURVIVAL
AB BACKGROUND: Collagen-heparin sulfate scaffolds have been widely used to repair nerve injury and promote nerve regeneration. Previous research has evaluated scaffold biocompatibility by measuring gliocyte proliferation but not neuronal apoptosis.
   OBJECTIVE: To explore the biocompatibility of collagen-heparin sulfate scaffold in porcine brain by detecting peripheral neural apoptosis and protein expression.
   DESIGN, TIME AND SETTING: A randomized, controlled animal experiment was performed at the Laboratory of Neurology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, between March and June, 2008.
   MATERIALS: Rabbit anti-human Bax, Caspase-3 polyclonal antibody, rat anti-human Bcl-2 polyclonal antibody, streptavidin biotin-peroxidase complex (SABC) immunohistochemical kit, and TUNEL kit (Roche, USA) were used in this study.
   METHODS: Twenty adult piglets were randomly evenly divided into implantation and control groups. A collagen-heparin sulfate scaffold was implanted from the anterior fontanelle into the brain in the implantation group. The same puncture but no scaffold implantation was made in the control group.
   MAIN OUTCOME MEASURES: Cell apoptosis was detected using TUNEL; Bax, Bcl-2, and Caspase-3 expressions were measured using the SABC method.
   RESULTS: At days 1, 3, 7, and 14 after scaffold implantation, a few apoptotic cells were observed in the brain tissues near the puncture site, with more apoptotic cells in the implantation group (P < 0.05). However, both groups showed similar apoptosis levels by day 30 after implantation. Implantation increased Bax, Bcl-2, and Caspase-3 expressions on days 3 and 7 after implantation (P < 0.05) but decreased the ratio of Bcl-2 to Bax in the implantation group was significantly lower on days 3 and 7 (P < 0.05), with no significant difference by day 30 after implantation (P > 0.05).
   CONCLUSION: The collagen-heparin sulfate scaffold has good biocompatibility to porcine brain tissues.
C1 [Tang, Zhouping; Zeng, Wengao; Xu, Shabei; Xie, Xuewei; Tang, Ronghua; Zhu, Suiqiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurol, Wuhan 430030, Hubei, Peoples R China.
   [Chen, Xingyong] Fujian Prov Hosp, Dept Neurol, Fuzhou 350001, Fujian Province, Peoples R China.
RP Zhu, SQ (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurol, Wuhan 430030, Hubei, Peoples R China.
FU National Natural Science Foundation of China [30570628, 30770751]
FX Supported by: the National Natural Science Foundation of China, No.
   30570628, 30770751
CR Bai Y, 2009, NEUROSCIENCE, V160, P371, DOI 10.1016/j.neuroscience.2009.01.076
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   Hu K, 2008, J BIOMED MATER RES A, V84A, P483, DOI 10.1002/jbm.a.31440
   Inada Yuji, 2007, Neurosurgery, V61, pE1105
   Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Marceau N, 2007, EXP CELL RES, V313, P2265, DOI 10.1016/j.yexcr.2007.03.038
   Raaphorst GP, 2000, J THERM BIOL, V25, P305, DOI 10.1016/S0306-4565(99)00103-5
   RAN L, 2005, HUAZHONG KEJI DAXUE, V25, P393
   Rice MA, 2005, OTOLARYNG CLIN N AM, V38, P199, DOI 10.1016/j.otc.2004.10.010
   Rohde V, 2002, J NEUROSURG, V97, P954, DOI 10.3171/jns.2002.97.4.0954
   Sigal LH, 2003, JCR-J CLIN RHEUMATOL, V9, P267, DOI 10.1097/01.rhu.0000081261.38158.44
   The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB
   Thiex R, 2003, NEUROL RES, V25, P254, DOI 10.1179/016164103101201463
   Wang Xi-Ge, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P255
   Wen JY, 2007, TECHNOL CANCER RES T, V6, P635, DOI 10.1177/153303460700600607
   Woo KM, 2007, BIOMATERIALS, V28, P2622, DOI 10.1016/j.biomaterials.2007.02.004
   WU CH, 2009, J MAT SCI MAT MED
   XINGYONG C, 2008, ZHONGGUO KANGFU YIXU, V33, P135
   Xu XL, 2007, J BIOL CHEM, V282, P2363, DOI 10.1074/jbc.M604218200
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Yoshii S, 2001, J BIOMED MATER RES, V56, P400, DOI 10.1002/1097-4636(20010905)56:3<400::AID-JBM1109>3.3.CO;2-Z
   Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103
NR 25
TC 2
Z9 2
U1 0
U2 10
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD FEB
PY 2010
VL 5
IS 3
BP 191
EP 196
DI 10.3969/j.issn.1673-5374.2010.03.005
PG 6
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 573PA
UT WOS:000275925400005
DA 2018-10-20
ER

PT J
AU Pradhan, S
   Liu, C
   Zhang, C
   Jia, XQ
   Farach-Carson, MC
   Witt, RL
AF Pradhan, Swati
   Liu, Chao
   Zhang, Chu
   Jia, Xinqiao
   Farach-Carson, Mary C.
   Witt, Robert L.
TI Lumen formation in three-dimensional cultures of salivary acinar cells
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   American-Academy-of-Otolaryngology-Head-and-Neck-Surgery-Foundation
CY OCT 04-07, 2009
CL San Diego, CA
SP Amer Acad Otolaryngol Head & Neck Surg Fdn
ID GLAND TISSUE; MORPHOGENESIS
AB OBJECTIVE: Development of an artificial salivary gland will benefit patients with xerostomia after radiation therapy for upper respiratory cancer. The goal is to devise a three-dimensional (3D) culture system in which salivary cells differentiate into polarized acini that express essential biomarkers and directionally secrete a-amylase. Differentiated acini-like structures in a 3D biomaterial-based scaffold will mimic salivary gland functions.
   STUDY DESIGN: Cells were seeded onto HA-based hydrogels containing PlnDIV peptide and allowed to differentiate into acini-like structures. Cell viability and phenotype were examined.
   SETTING: Laboratory-based tissue procurement study.
   SUBJECTS AND METHODS: Salivary gland tissue was obtained from patients undergoing surgery. Marker expression established the phenotype of salivary gland cells. Perlecan/HSPG2, an important component of the basement membrane, was highly expressed in salivary gland tissue. A culture system consisting of hyaluronic acid (HA) hydrogel and a coupled bioactive peptide derived from domain IV of perlecan (PlnDIV) was used. Prior studies demonstrated differentiation of acinar cells into lobular structures that mimicked intact glands when cultured on PlnDIV peptide coated surfaces.
   RESULTS: Lobular acini-like structures formed on hydrogels and expressed tight junction components such as zona occludens 1. Acini-like structures were stained for the presence of a-amylase. Live/dead staining revealed the presence of apoptotic cells in the center of the acini-like structures, indicative of lumen formation.
   CONCLUSION: A novel system supporting acini-like assembly in a 3D culture system was established. Presence of biomarkers and secretion of salivary enzymes confirms functionality in vitro. Future experiments will test the 3D system in an animal model. (C) 2010 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
C1 [Pradhan, Swati; Zhang, Chu; Farach-Carson, Mary C.] Univ Delaware, Dept Biol Sci, Newark, DE USA.
   [Pradhan, Swati; Zhang, Chu; Jia, Xinqiao; Farach-Carson, Mary C.; Witt, Robert L.] Univ Delaware, Ctr Translat Canc Res, Newark, DE USA.
   [Liu, Chao; Jia, Xinqiao] Univ Delaware, Dept Mat Sci & Engn, Newark, DE USA.
   [Witt, Robert L.] Christiana Care Hlth Syst, Newark, DE USA.
   [Farach-Carson, Mary C.] Rice Univ, Houston, TX USA.
   [Witt, Robert L.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA.
RP Witt, RL (reprint author), Christiana Hosp, Med Arts Pavil 1,Suite 112,4745 Ogletown Stanton, Newark, DE 19713 USA.
EM RobertLWitt@gmail.com
CR Atkinson Jane C, 2005, Dent Clin North Am, V49, P309, DOI 10.1016/j.cden.2004.10.002
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Joraku A, 2005, LARYNGOSCOPE, V115, P244, DOI 10.1097/01.mlg.0000154726.77915.cc
   Joraku A, 2007, DIFFERENTIATION, V75, P318, DOI 10.1111/j.1432-0436.2006.00138.x
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Melnick M, 2000, CRIT REV ORAL BIOL M, V11, P199, DOI 10.1177/10454411000110020401
   Nagler RM, 2003, ARCH OTOLARYNGOL, V129, P247, DOI 10.1001/archotol.129.2.247
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   PRADHAN S, 2009, TISSUE ENG A    0421
   SHERWOOD L, 2007, HUMAN PHYSL CELLS SY, pV1
   Szlavik V, 2008, TISSUE ENG PT A, V14, P1915, DOI 10.1089/ten.tea.2007.0208
NR 12
TC 28
Z9 29
U1 0
U2 9
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0194-5998
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD FEB
PY 2010
VL 142
IS 2
BP 191
EP 195
DI 10.1016/j.otohns.2009.10.039
PG 5
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 582CZ
UT WOS:000276574500008
PM 20115973
DA 2018-10-20
ER

PT J
AU Chen, WQ
   Priewalder, H
   John, JPP
   Lubec, G
AF Chen, Wei-Qiang
   Priewalder, Helga
   John, Julius Paul Pradeep
   Lubec, Gert
TI Silk cocoon of Bombyx mori: Proteins and posttranslational modifications
   - heavy phosphorylation and evidence for lysine-mediated cross links
SO PROTEOMICS
LA English
DT Article
DE 2-DE; Animal proteomics; Phosphorylation; PTMs; Silk protein
ID C-13 NMR-SPECTROSCOPY; SOLID-STATE C-13; STRUCTURAL-ANALYSIS; L-CHAIN;
   FIBROIN; SERICIN; ACID; GENE; P25; IDENTIFICATION
AB Although silk is used to produce textiles and serves as a valuable biomaterial in medicine, information on silk proteins of the cocoon is limited. Scanning electron microscopy was applied to morphologically characterise the sample and the solubility of cocoon in lithium thiocyanate and 2-DE was carried out with multi-enzyme in-gel digestion followed by MS identification of silk-peptides. High-sequence coverage of the silk cocoon proteins fibroin light and heavy chain, sericins and fibrohexamerins was revealed and PTMs as heavy phosphorylation of silk fibroin heavy chain; lysine hydroxylation and Lys->allysine formation have been observed providing evidence for lysine-mediated cross linking of silk as found in collagens, which has not been reported so far. Tyrosine oxidation verified the presence of dityrosine cross links. A high degree of sequence conflicts probably representing single-nucleotide polymorphisms was observed. PTM and sequence conflicts may be modulating structure and physicochemical properties of silk.
C1 [Chen, Wei-Qiang; John, Julius Paul Pradeep; Lubec, Gert] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.
   [Priewalder, Helga] Geol Survey Austria, Dept Paleontol, Vienna, Austria.
RP Lubec, G (reprint author), Med Univ Vienna, Dept Pediat, Waehringer Guertel 18, A-1090 Vienna, Austria.
EM gert.lubec@meduniwien.ac.at
OI Lubec, Gert/0000-0002-6333-9461; CHEN, Weiqiang/0000-0002-7720-4816
CR Ahmad R, 2004, DNA CELL BIOL, V23, P149, DOI 10.1089/104454904322964742
   Asakura T, 2002, BIOCHEMISTRY-US, V41, P4415, DOI 10.1021/bi0119013
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Craig CL, 2002, COMP BIOCHEM PHYS B, V133, P493, DOI 10.1016/S1096-4959(02)00095-7
   Endrizzi BJ, 2006, LANGMUIR, V22, P11305, DOI 10.1021/la0618216
   Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hou Y, 2007, INSECT BIOCHEM MOLEC, V37, P486, DOI 10.1016/j.ibmb.2007.02.011
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   MITA K, 1994, J MOL EVOL, V38, P583
   Moon Myung-Jin, 2003, Korean Journal of Biological Sciences, V7, P35
   Nirmala X, 2001, INSECT MOL BIOL, V10, P437, DOI 10.1046/j.0962-1075.2001.00282.x
   Robins SP, 2007, BIOCHEM SOC T, V35, P849, DOI 10.1042/BST0350849
   Sell DR, 2007, BIOCHEM J, V404, P269, DOI 10.1042/BJ20061645
   Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005
   Sobott F, 2009, J AM SOC MASS SPECTR, V20, P1652, DOI 10.1016/j.jasms.2009.04.023
   Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Tanaka K, 2001, INSECT BIOCHEM MOLEC, V31, P665, DOI 10.1016/S0965-1748(00)00173-9
   Teramoto H, 2006, MACROMOLECULES, V39, P6, DOI 10.1021/ma0521147
   Teramoto H, 2004, BIOMACROMOLECULES, V5, P1392, DOI 10.1021/bm034537r
   Wang SP, 2006, ACTA BIOCH BIOPH SIN, V38, P507, DOI 10.1111/j.1745-7270.2006.00189.x
   Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Yao JM, 2004, BIOMACROMOLECULES, V5, P1763, DOI 10.1021/bm049831d
   Zhang PB, 2006, PROTEOMICS, V6, P2586, DOI 10.1002/pmic.200500348
   Zhang PB, 2005, BIOSCI BIOTECH BIOCH, V69, P2086, DOI 10.1271/bbb.69.2086
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zurovec M, 1998, J BIOL CHEM, V273, P15423, DOI 10.1074/jbc.273.25.15423
NR 34
TC 36
Z9 37
U1 1
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD FEB
PY 2010
VL 10
IS 3
BP 369
EP 379
DI 10.1002/pmic.200900624
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 557YU
UT WOS:000274707400002
PM 20029844
DA 2018-10-20
ER

PT J
AU Haque, MA
   Nagaoka, M
   Hexig, B
   Akaike, T
AF Haque, Md Amranul
   Nagaoka, Masato
   Hexig, Bayar
   Akaike, Toshihiro
TI Artificial extracellular matrix for embryonic stem cell cultures: a new
   frontier of nanobiomaterials
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Review
DE embryonic stem cell; extracellular matrix (ECM); chimeric protein;
   homogeneous cell culture
ID IMMOBILIZED E-CADHERIN; SERUM-FREE CULTURE; ES CELLS; DIFFERENTIATION;
   GROWTH; PROLIFERATION; PLURIPOTENCY; HEPATOCYTES; MAINTENANCE; INDUCTION
AB Nanobiomaterials can play a central role in regenerative medicine and tissue engineering by facilitating cellular behavior and function, such as those where extracellular matrices (ECMs) direct embryonic stem (ES) cell morphogenesis, proliferation, differentiation and apoptosis. However, controlling ES cell proliferation and differentiation using matrices from natural sources is still challenging due to complex and heterogeneous culture conditions. Moreover, the systemic investigation of the regulation of self-renewal and differentiation to lineage specific cells depends on the use of defined and stress-free culture conditions. Both goals can be achieved by the development of biomaterial design targeting ECM or growth factors for ES cell culture. This targeted application will benefit from expansion of ES cells for transplantation, as well as the production of a specific differentiated cell type either by controlling the differentiation in a very specific pathway or by elimination of undesirable cell types.
C1 [Haque, Md Amranul; Nagaoka, Masato; Hexig, Bayar; Akaike, Toshihiro] Tokyo Inst Technol, Gaduate Sch Biosci & Biotechnol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan.
   [Nagaoka, Masato] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.
RP Haque, MA (reprint author), Tokyo Inst Technol, Gaduate Sch Biosci & Biotechnol, Dept Biomol Engn, Yokohama, Kanagawa 2268501, Japan.
EM takaike@bio.titech.ac.jp
RI Nagaoka, Masato/J-1551-2014
FU ministry of education, culture, sports, science and technology
FX This work was supported in part by the ministry of education, culture,
   sports, science and technology.
CR Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147
   Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503
   AZUMA K, 2009, BIOMATERIALS, V31, P802
   Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487
   Chase LG, 2007, CURR OPIN CHEM BIOL, V11, P367, DOI 10.1016/j.cbpa.2007.06.421
   Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008
   Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035
   Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004
   Dasgupta A, 2005, BIOTECHNOL BIOENG, V92, P257, DOI 10.1002/bit.20676
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102
   Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0
   James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706
   Kim SH, 2007, TISSUE ENG, V13, P601, DOI 10.1089/ten.2006.0104
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3
   Nagaoka M, 2002, BIOTECHNOL LETT, V24, P1857, DOI 10.1023/A:1020905532227
   NAGAOKA M, 2008, J BIOL CHEM, V26, P26468
   Nagaoka M, 2008, J CELL BIOCHEM, V103, P296, DOI 10.1002/jcb.21406
   Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015
   NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449
   Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9
   Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189
   Ogiwara K, 2005, BIOTECHNOL LETT, V27, P1633, DOI 10.1007/s10529-005-2605-0
   Parashurama N, 2008, STEM CELLS, V26, P474, DOI 10.1634/stemcells.2007-0303
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979
   Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Tanaka Y, 1998, P ASSOC AM PHYSICIAN, V110, P118
   Thomson JA, 1996, BIOL REPROD, V55, P254, DOI 10.1095/biolreprod55.2.254
   Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X
NR 42
TC 7
Z9 7
U1 2
U2 20
PU NATL INST MATERIALS SCIENCE
PI IBARAKI
PA NATL INST MATERIALS SCIENCE, 1-2-1 SENGEN, TSUKUBA-CITY, IBARAKI,
   305-0047, JAPAN
SN 1468-6996
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PD FEB
PY 2010
VL 11
IS 1
AR 014106
DI 10.1088/1468-6996/11/1/014106
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 586KU
UT WOS:000276907900007
PM 27877321
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shikinami, Y
   Kawabe, Y
   Yasukawa, K
   Tsuta, K
   Kotani, Y
   Abumi, K
AF Shikinami, Yasuo
   Kawabe, Yasuhiro
   Yasukawa, Kazuhiro
   Tsuta, Kaoru
   Kotani, Yoshihisa
   Abumi, Kuniyoshi
TI A biomimetic artificial intervertebral disc system composed of a cubic
   three-dimensional fabric
SO SPINE JOURNAL
LA English
DT Article
DE Artificial intervertebral disc; Cubic three-dimensional fabrics;
   Biomimetic; Long-term dynamic durability; Animal study
AB BACKGROUND CONTEXT: In the quest for clinically functional artificial intervertebral discs (AIDs), multidisciplinary technologies have been employed. Existing solid mobile AIDs essentially consist of the superposition of solid plates and core materials; however, it is thought that an ideal surgical AID technology has not yet been developed. To overcome the limitation of these existing AIDs, we developed a unique flexible AID disc system on the basis of our original biomimetic concept. The AID is composed of a cubic three-dimensional fabric (3DF) with a triaxial fiber alignment, which offers biomimetic long-term dynamic mechanical behavior along with durability.
   PURPOSE: This article substantiates the potential clinical use of the 3DF disc system that quite differs from existing ones.
   STUDY DESIGN: We designed the lumbar and cervical 3DF discs that improved the structural weaknesses caused by the collagenous fiber alignment of biological intervertebral disc. Bioresorbable hydroxyapatite particles were deposited on the surface layer of the 3DF disc to promote new bony ingrowth and to ensure secure binding at the interface of the contacting vertebral bodies. Astand-alone system was devised for surgical reliability in terms of both positioning and fixation, allowing tight press fitting with the vertebral bodies. Bioactive and bioresorbable pins were penetrated through the 3DF disc body and projected from the surface to allow ideal insertion and fixation to the disc space, preserving the precise position during dynamical movement. In vitro endurance of the 3DF disc was examined under long-term alternating stresses, and the in vivo animal tests were conducted in the intervertebral lumbar discs at L5-L6 excised from baboons and replaced with the lumbar 3DF disc.
   METHODS: The static mechanical endurance was assessed through a creep test. In vitro endurance of the 3DF disc under repetitive stresses including axial compressing, flexion-extension, torsional twisting, and lateral bending were applied to the 3DF disc for a long-term for up to 105 million stresses, which is roughly equivalent to exposure of natural biological movement for more than 50 years. In the animal test, eight baboons were euthanized 6 months postoperatively. To their extracted spines, six pure moments (flexion and extension, left and right lateral bending, and left and right torsion) were applied vertically to the superior end of the specimen and then values of range of motions (ROMs) were calculated. Histological analyses were conducted on 12 reticuloendothelial and systemic tissues.
   RESULTS: The 3DF disc retained its biomimetic "J-shaped" stress-strain behavior without generating wear debris for up to 105 million stresses. A 130-N loading for the creep test decreased the height of 0.3 mm during 80 to 1,000 hours. In the biomechanical test, ROM values of axial rotation and flexion-extension showed no significant difference from the intact excluding that of lateral bending because the location of each pin to stand alone certainly controlled the bending behavior only. The histological analysis indicated no significant pathologic changes induced by the 3DF disc.
   CONCLUSIONS: The 3DF disc system is clinically suitable for human disc replacement arthroplasty based on the findings of long-term durability with dynamic motion in vitro and effective animal tests in vivo. This system surely overcomes the limitations of existing solid AIDs, and the clinical potential of the biomimetic 3DF discs has been verified. This new biomaterial technology delivers most of the functions and characteristics required by a clinically available AID if applied correctly by surgeons. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Shikinami, Yasuo] Shikinami Yasuo Inst, Shimogyo Ku, Kyoto 6008815, Japan.
   [Kawabe, Yasuhiro; Yasukawa, Kazuhiro; Tsuta, Kaoru] Takiron Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan.
   [Kotani, Yoshihisa; Abumi, Kuniyoshi] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
RP Shikinami, Y (reprint author), Shikinami Yasuo Inst, Shimogyo Ku, 6-301 Kyoto Res Pk,93 Awata Cho, Kyoto 6008815, Japan.
EM keep-wave-person.shikinami@mbn.nifty.com
FU Foundation of Advanced Technology Initiative for New Industry Creation
   of Japan
FX Supported by the Foundation of Advanced Technology Initiative for New
   Industry Creation of Japan.
CR American Society for Testing and Materials, 2007, ANN BOOK ASTM STAND, V8.01, P765
   Anderson PA, 2004, SPINE, V29, P2779, DOI 10.1097/01.brs.0000146460.11591.8a
   [Anonymous], 1819212008 INT ORG S
   ARMSTRONG JR, 1965, LUMBAR DISC LESIONS
   ASTM International, 2008, ANN BOOK ASTM STAND
   Bao QB, 1996, BIOMATERIALS, V17, P1157, DOI 10.1016/0142-9612(96)84936-2
   BENZEL EC, 2001, BIOMECHANICS SPINE S
   Engelthardt S, 2007, ORTHOPAEDIC PRODUCT, P32
   Geisler FH, 2005, SPINAL INSTRUMENTATI, P1173
   Hallab N, 2003, SPINE, V28, pS139, DOI 10.1097/01.BRS.0000092214.87225.80
   HEDMAN TP, 1991, SPINE, V16, pS256, DOI 10.1097/00007632-199106001-00016
   Jensen WK, 2005, SPINE, V30, P2497, DOI 10.1097/01.brs.0000186322.61823.f3
   Kadaya K, 2001, SPINE, V26, P1562
   Kotani Y, 2005, J NEUROSURG-SPINE, V2, P188, DOI 10.3171/spi.2005.2.2.0188
   Kotani Y, 2004, J NEUROSURG, V100, P337, DOI 10.3171/spi.2004.100.4.0337
   Kotani Y, 2002, SPINE, V27, P929, DOI 10.1097/00007632-200205010-00008
   Kotani Y, 2006, EUR SPINE J, V15, P1511, DOI 10.1007/s00586-006-0086-z
   Ooij A, 2007, SPINE, V32, P223
   Serhan HA, 2006, SPINE, V31, P1900, DOI 10.1097/01.brs.0000228716.60863.ab
   Shikinami Y, 2004, ADV FUNCT MATER, V14, P1039, DOI 10.1002/adfm.200305038
   Shikinami Y, 1998, BIOMATERIALS, V19, P617, DOI 10.1016/S0142-9612(97)00152-X
   Skrzypiec DM, 2007, EUR SPINE J, V16, P1701, DOI 10.1007/s00586-007-0458-z
   Szpalski M, 2002, EUR SPINE J, V11, pS65, DOI 10.1007/s00586-002-0474-y
   Takahata M, 2003, SPINE, V28, P637, DOI 10.1097/00007632-200304010-00003
   Vincent JFV, 2006, J R SOC INTERFACE, V3, P471, DOI 10.1098/rsif.2006.0127
NR 25
TC 9
Z9 12
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
J9 SPINE J
JI Spine Journal
PD FEB
PY 2010
VL 10
IS 2
BP 141
EP 152
DI 10.1016/j.spinee.2009.10.008
PG 12
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA V29KB
UT WOS:000208746200009
PM 19944651
DA 2018-10-20
ER

PT J
AU Byeon, JW
AF Byeon, Jai Won
TI EFFECT OF INDIUM ADDITION ON MICROSTRUCTURE AND STRENGTH OF Au-Pt-Cu-Sn
   DENTAL BIOMATERIAL
SO SURFACE REVIEW AND LETTERS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Functional Materials/Advances in
   Functional Materials Conference
CY JUN 15-18, 2009
CL Jinju City, SOUTH KOREA
DE Dental Au-Pt-Cu-Sn-In alloy; indium addition; aging heat treatment;
   Pt(3)(Sn, In)
ID ALLOY
AB Through our previous screening experiments for a new dental alloy design, an Au-11.9Pt-0.6Cu-0.5Sn alloy was selected as a candidate in terms of good strength and surface properties. In this report, the effects of In (indium) on the microstructures and hardness of a dental Au11.9Pt- 0.6Cu-0.5Sn-xIn alloy (where x = 0, 0.25, 0.5, 0.75, and 1.0 wt.%) was investigated. The hardness of the Au-11.9Pt-0.6Cu-0.5Sn-xIn alloys increased with increasing In content up to 0.75 wt.% and then started to decrease with further increase in In content. Particularly, the alloy containing 0.75% In exhibited noticeably high hardness of 172 Hv. With the addition of In to the Au-Pt-Cu-Sn alloy, grain size decreased and a large number of fine precipitates were formed. The precipitates were identified as Pt(3)(Sn, In) by convergent beam electron diffraction (CBED) and nanospot energy dispersive spectroscopy (EDS). The increased hardness with the addition of In was attributed to the precipitation hardening of Pt(3)(Sn, In) and the grain refinement.
C1 Seoul Natl Univ Technol, Dept Mat Sci & Engn, Seoul, South Korea.
RP Byeon, JW (reprint author), Seoul Natl Univ Technol, Dept Mat Sci & Engn, Seoul, South Korea.
EM byeonjw@snut.ac.kr
CR HISATSUNE K, 1987, J DEN MAT, V16, P54
   Kim MH, 2006, MATER SCI FORUM, V510-511, P278, DOI 10.4028/www.scientific.net/MSF.510-511.278
   LEE SH, 2006, BIOMATERIALS RES, V8, P250
   LEIFELDER KF, 1966, J DENT RES, V45, P392
   Shiraishi T, 2002, J MATER SCI-MATER M, V13, P979, DOI 10.1023/A:1019868831701
NR 5
TC 1
Z9 1
U1 1
U2 9
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-625X
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD FEB
PY 2010
VL 17
IS 1
BP 99
EP 103
DI 10.1142/S0218625X10014028
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 607JV
UT WOS:000278499800018
DA 2018-10-20
ER

PT J
AU Mellgren, A
AF Mellgren, Anders
TI Fecal Incontinence
SO SURGICAL CLINICS OF NORTH AMERICA
LA English
DT Article
DE Fecal incontinence; Sphincteroplasty; Sacral nerve stimulation;
   Injectable biomaterials; Evaluation
ID SACRAL NERVE-STIMULATION; ANAL-SPHINCTER DYSFUNCTION; INJECTABLE
   SILICONE BIOMATERIAL; ARTIFICIAL BOWEL SPHINCTER; DOUBLE-BLIND
   CROSSOVER; ANTERIOR SPHINCTEROPLASTY; URINARY-INCONTINENCE; SINGLE
   INSTITUTION; NEUROMODULATION; PREVALENCE
AB Fecal incontinence is a debilitating and socially embarrassing condition. Significant advances in the evaluation and treatment of this condition have been made in recent years, and several new treatment modalities are in the pipeline to be made available to affected patients. This article reviews the workup and operative and nonoperative management of fecal incontinence, and it discusses the emerging role of methods, such as bioinjectable agents and sacral nerve stimulation.
C1 Univ Minnesota, Div Colon & Rectal Surg, Minneapolis, MN 55407 USA.
RP Mellgren, A (reprint author), Univ Minnesota, Div Colon & Rectal Surg, Pelv Floor Ctr,2800 Chicago Ave S 300, Minneapolis, MN 55407 USA.
EM amellgren@crsal.org
CR Altomare DF, 2004, BRIT J SURG, V91, P1352, DOI 10.1002/bjs.4600
   BAETEN CGMI, 1995, NEW ENGL J MED, V332, P1600, DOI 10.1056/NEJM199506153322403
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   ENCK P, 1991, INT J COLORECTAL DIS, V6, P143, DOI 10.1007/BF00341234
   Ganio E, 2001, DIS COLON RECTUM, V44, P965, DOI 10.1007/BF02235484
   Ganio E, 2001, DIS COLON RECTUM, V44, P619, DOI 10.1007/BF02234555
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Ho Yik-Hong, 2005, Aust J Rural Health, V13, P28, DOI 10.1111/j.1440-1854.2004.00642.x
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Jarrett MED, 2004, BRIT J SURG, V91, P755, DOI 10.1002/bjs.4545
   Kalantar JS, 2002, MED J AUSTRALIA, V176, P54
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kenefick NJ, 2003, BRIT J SURG, V90, P1256, DOI 10.1002/bjs.4196
   Kenefick NJ, 2002, BRIT J SURG, V89, P896, DOI 10.1046/j.1365-2168.2002.02119.x
   Lehur PA, 1998, INT J COLORECTAL DIS, V13, P88, DOI 10.1007/s003840050141
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Leroi AM, 2001, DIS COLON RECTUM, V44, P779, DOI 10.1007/BF02234695
   Madoff RD, 1999, GASTROENTEROLOGY, V116, P549, DOI 10.1016/S0016-5085(99)70176-9
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Matzel KE, 2001, DIS COLON RECTUM, V44, P59, DOI 10.1007/BF02234822
   Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Norton C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub2
   Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   NORTON C, 2000, COCHRANE DB SYST REV, P2111
   Oliveira L, 1996, BRIT J SURG, V83, P502, DOI 10.1002/bjs.1800830421
   Parker SC, 2003, DIS COLON RECTUM, V46, P722, DOI 10.1097/01.DCR.0000070530.79998.86
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Pettit PDM, 2002, CURR OPIN OBSTET GYN, V14, P521, DOI 10.1097/00001703-200210000-00014
   Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120
   SCOTT FB, 1974, J UROLOGY, V112, P75, DOI 10.1016/S0022-5347(17)59647-0
   Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2
   TANAGHO EA, 1993, NEUROUROL URODYNAM, V12, P487, DOI 10.1002/nau.1930120508
   TANAGHO EA, 1982, UROLOGY, V20, P614, DOI 10.1016/0090-4295(82)90312-0
   Tjandra JJ, 2004, ANZ J SURG, V74, P1098, DOI 10.1111/j.1445-1433.2004.03259.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   Trowbridge ER, 2006, AM J OBSTET GYNECOL, V195, P1753, DOI 10.1016/j.ajog.2006.07.030
   Uludag O, 2004, DIS COLON RECTUM, V47, P1350, DOI 10.1007/s10350-004-0589-9
   Vaizey CJ, 2000, DIS COLON RECTUM, V43, P298, DOI 10.1007/BF02258292
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
NR 47
TC 14
Z9 16
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0039-6109
J9 SURG CLIN N AM
JI Surg. Clin.-North Am.
PD FEB
PY 2010
VL 90
IS 1
BP 185
EP +
DI 10.1016/j.suc.2009.10.006
PG 11
WC Surgery
SC Surgery
GA 601KP
UT WOS:000278058300016
PM 20109642
DA 2018-10-20
ER

PT J
AU Dickhut, A
   Dexheimer, V
   Martin, K
   Lauinger, R
   Heisel, C
   Richter, W
AF Dickhut, Andrea
   Dexheimer, Verena
   Martin, Katja
   Lauinger, Rebekka
   Heisel, Christian
   Richter, Wiltrud
TI Chondrogenesis of Human Mesenchymal Stem Cells by Local Transforming
   Growth Factor-Beta Delivery in a Biphasic Resorbable Carrier
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; TRANSMISSION ELECTRON-MICROSCOPY;
   BONE MORPHOGENETIC PROTEIN; IN-VITRO CHONDROGENESIS; CARTILAGE REPAIR;
   ARTICULAR-CARTILAGE; PROGENITOR CELLS; GENE-EXPRESSION; FIBRIN SEALANT;
   OSTEOCHONDRAL DEFECTS
AB Little is known about the potential of growth factor-augmented biphasic implants composed of a gel and a solid scaffold to enhance chondrogenesis of mesenchymal stem cells (MSCs). We analyzed whether a collagen type I/III carrier and fibrin glue (FG) combined to a biphasic construct support in vitro chondrogenesis of MSCs and allow for local release of bioactive transforming growth factor-beta1 (TGF-beta 1). Further, a possible advantage of partial autologous fibrin glue (PAF) over commercial FG was assessed. Collagen carriers seeded with 5 x 10(5) human MSCs with or without FG, PAF, or TGF-beta 1-upgraded FG were cultured for 6 weeks in chondrogenic medium with or without TGF-beta 1. Pellets with or without FG/PAF served as controls. FG and collagen carriers allowed strong upregulation of COL2A1, AGC, and COL10A1 mRNA, deposition of collagen-type II, and mediated a significantly higher proteoglycan content compared with biomaterial-free pellets. Collagen-carrier groups contained significantly more proteoglycan than FG and PAF pellets, whereas biphasic PAF-carrier constructs were inferior to FG-carrier constructs. Upgrading of biphasic FG-carrier constructs with 50 ng TGF-beta 1/construct mediated chondrogenesis as successfully as supply of TGF-beta 1 via the medium. In conclusion, the biphasic carrier constructs showed a high biofunctionality by continuous form stability with improved chondrogenesis and long-term local supply of bioactive TGF-beta 1 which may be useful to enhance matrix-assisted repair strategies for damaged cartilage.
C1 [Dickhut, Andrea; Dexheimer, Verena; Lauinger, Rebekka; Heisel, Christian; Richter, Wiltrud] Orthopaed Univ Hosp, Div Expt Orthopaed, D-69118 Heidelberg, Germany.
   [Martin, Katja] Geistlich Pharma AG, Div Surg, Wolhusen, Switzerland.
RP Richter, W (reprint author), Orthopaed Univ Hosp, Div Expt Orthopaed, Schlierbacher Landstr 200A, D-69118 Heidelberg, Germany.
EM Wiltrud.Richter@ok.uni-heidelberg.de
RI Richter, Wiltrud/V-3217-2017
OI Richter, Wiltrud/0000-0003-4694-2768
FU Stiftung Orthopadische Universitatsklinik Heidelberg; Geistlich Pharma
   AG
FX The authors thank S. Gantz for statistical analysis and K. Goetzke for
   technical assistance in histology. This work was supported by a grant of
   research funds from Stiftung Orthopadische Universitatsklinik Heidelberg
   (80%) and Geistlich Pharma AG (20%).
CR Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bilgen B, 2007, J TISSUE ENG REGEN M, V1, P436, DOI 10.1002/term.56
   Boeuf S, 2008, J PATHOL, V216, P158, DOI 10.1002/path.2389
   Brittberg M, 1997, BIOMATERIALS, V18, P235, DOI 10.1016/S0142-9612(96)00117-2
   Buchta C, 2005, BIOMATERIALS, V26, P6233, DOI 10.1016/j.biomaterials.2005.04.014
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Campbell JJ, 2006, BIORHEOLOGY, V43, P455
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Catelas I, 2008, TISSUE ENG PT C-METH, V14, P119, DOI 10.1089/ten.tec.2007.0262
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dickhut A, 2008, FRONT BIOSCI, V13, P4517, DOI 10.2741/3020
   Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673
   Dorotka R, 2005, OSTEOARTHR CARTILAGE, V13, P655, DOI 10.1016/j.joca.2005.04.001
   Ehlers EM, 1999, ANN ANAT, V181, P513, DOI 10.1016/S0940-9602(99)80055-7
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Fan HB, 2008, BIOMACROMOLECULES, V9, P927, DOI 10.1021/bm7013203
   Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com
   Fuss M, 2000, ANN ANAT, V182, P303
   Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139
   Haddo O, 2004, KNEE, V11, P51, DOI 10.1016/S0968-0160(03)00041-3
   Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Ishii I, 2007, J BONE JOINT SURG BR, V89B, P693, DOI 10.1302/0301-620X.89B5.18450
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195
   KAWAMURA M, 1988, CLIN ORTHOP RELAT R, V235, P302
   Kessler MW, 2008, SPORTS MED ARTHROSC, V16, P246, DOI 10.1097/JSA.0b013e31818d56b3
   Kim HJ, 2007, CONNECT TISSUE RES, V48, P309, DOI 10.1080/03008200701692610
   Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508
   Kramer J, 2006, CELL MOL LIFE SCI, V63, P616, DOI 10.1007/s00018-005-5527-z
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Li Z, 2009, TISSUE ENG PT A, V15, P1729, DOI 10.1089/ten.tea.2008.0247
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Munirah S, 2007, J BONE JOINT SURG BR, V89B, P1099, DOI 10.1302/0301-620X.89B8
   Nehrer S, 2008, CLIN ORTHOP RELAT R, V466, P1849, DOI 10.1007/s11999-008-0322-4
   Nehrer S, 2006, EUR J RADIOL, V57, P3, DOI 10.1016/j.ejrad.2005.08.005
   Noth U, 2007, J BIOMED MATER RES A, V83A, P626, DOI 10.1002/jbm.a.31254
   Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180
   Park JS, 2008, TRANSPLANTATION, V85, P589, DOI 10.1097/TP.0b013e3181639b3a
   Park JS, 2009, J BIOMED MATER RES A, V91A, P408, DOI 10.1002/jbm.a.32271
   PARK JS, J BIOMED A IN PRESS
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Petratos PB, 2002, WOUND REPAIR REGEN, V10, P252, DOI 10.1046/j.1524-475X.2002.10409.x
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Van Osch GJVM, 1998, MATRIX BIOL, V17, P413, DOI 10.1016/S0945-053X(98)90101-9
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Woods A, 2007, ENDOCRINOLOGY, V148, P5030, DOI 10.1210/en.2007-0695
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 67
TC 26
Z9 28
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD FEB
PY 2010
VL 16
IS 2
BP 453
EP 464
DI 10.1089/ten.tea.2009.0168
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 552XT
UT WOS:000274329000011
PM 19705961
DA 2018-10-20
ER

PT J
AU Vavken, P
   Murray, MM
AF Vavken, Patrick
   Murray, Martha M.
TI Translational Studies in Anterior Cruciate Ligament Repair
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID PLATELET-RICH PLASMA; PATELLAR-TENDON-BONE; TISSUE ENGINEERING
   APPLICATIONS; BIODEGRADABLE GELATIN HYDROGEL; PRIMARY
   SURGICAL-TREATMENT; FIBROBLASTS IN-VITRO; TERM FOLLOW-UP;
   GROWTH-FACTORS; ACL RECONSTRUCTION; HIGH PREVALENCE
AB Translational research, which can be explained as the principle of combining advances in both basic research and clinical understanding in a bedside-to-bench-to-bedside approach, has become one of the central themes of present-day medical research. One orthopedic problem that has strongly benefited from such an approach is tissue-engineering-enhanced primary repair of the anterior cruciate ligament. Recent years have shown a clearer definition of the clinical problem and established an underlying mechanistic cause of the incapacity of the anterior cruciate ligament to heal-the premature loss of provisional scaffold in the wound site. These clinical findings were then translated into a research objective, namely, to replace the missing scaffold with a biomaterial with appropriate structural and bio-stimulatory characteristics. Subsequently, a tissue-engineering-based treatment using a collagen-platelet composite was developed and tested in vitro. After proofing the efficacy of this new treatment in the laboratory, it was translated into a potential clinical application, which showed highly successful results in structural integrity and biomechanical capacity in large animal testing. This approach of defining the scientific mechanism underlying a clinical observation and then using that information to design new therapies is but one example of how translational research in tissue engineering can help define and develop new treatments for challenging problems faced by patients.
C1 [Vavken, Patrick; Murray, Martha M.] Harvard Univ, Sch Med, Dept Orthoped Surg, Sports Med Res Lab,Childrens Hosp Boston, Boston, MA 02115 USA.
RP Murray, MM (reprint author), Harvard Univ, Sch Med, Dept Orthoped Surg, Sports Med Res Lab,Childrens Hosp Boston, 300 Longwood Ave,Enders 1016, Boston, MA 02115 USA.
EM martha.murray@childrens.harvard.edu
CR ABE S, 1993, ARTHROSCOPY, V9, P394, DOI 10.1016/S0749-8063(05)80313-5
   Adachi N, 2002, ACTA ORTHOP SCAND, V73, P330, DOI 10.1080/000164702320155356
   Akeda K, 2006, SPINE, V31, P959, DOI 10.1097/01.brs.0000214942.78119.24
   Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008
   ARENDT E, 1995, AM J SPORT MED, V23, P694, DOI 10.1177/036354659502300611
   Biau DJ, 2006, BRIT MED J, V332, P995, DOI 10.1136/bmj.38784.384109.2F
   BROMMER EJP, 1992, THROMB HAEMOSTASIS, V68, P180
   Brown TD, 2002, J BONE JOINT SURG AM, V84A, P1473, DOI 10.2106/00004623-200208000-00026
   Carpenter JE, 1999, CLIN ORTHOP RELAT R, pS296
   Carpenter JE, 2004, BIOMATERIALS, V25, P1715, DOI 10.1016/S0142-9612(03)00507-6
   Casteleyn P P, 1999, Acta Orthop Belg, V65, P327
   Cenni E, 2009, J MATER SCI-MATER M, V20, P45, DOI 10.1007/s10856-008-3544-9
   Cho S, 2004, J ORTHOP SCI, V9, P296, DOI 10.1007/s00776-004-0779-2
   Cohen M, 2007, ARTHROSCOPY, V23, P629, DOI 10.1016/j.arthro.2007.03.094
   DANIEL DM, 1994, AM J SPORT MED, V22, P632, DOI 10.1177/036354659402200511
   El-Sharkawy H, 2007, J PERIODONTOL, V78, P661, DOI 10.1902/jop.2007.060302
   ENGLUND M, 2006, OSTEOARTHR CARTIL S2, V14, pS121
   ENGSTROM B, 1991, AM J SPORT MED, V19, P372, DOI 10.1177/036354659101900408
   Falconiero RP, 1998, ARTHROSCOPY, V14, P197, DOI 10.1016/S0749-8063(98)70041-6
   FLEMING BC, 2009, JORTHOP RES, P23509
   Fredriksson K, 2006, AM J PHYSIOL-LUNG C, V290, pL326, DOI 10.1152/ajplung.00057.2005
   Fredriksson K, 2004, SCAND J IMMUNOL, V59, P559, DOI 10.1111/j.1365-3083.2004.01433.x
   Fufa D, 2008, J ORAL MAXIL SURG, V66, P684, DOI 10.1016/j.joms.2007.06.635
   Gillquist J, 1999, SPORTS MED, V27, P143, DOI 10.2165/00007256-199927030-00001
   Gomez-Barrena E, 2008, ACTA ORTHOP, V79, P39, DOI 10.1080/17453670710014743
   Griffin LY, 2006, AM J SPORT MED, V34, P1512, DOI 10.1177/0363546506286866
   HEINO J, 1984, EXP CELL BIOL, V52, P347
   HOWELL SM, 1995, AM J SPORT MED, V23, P42, DOI 10.1177/036354659502300107
   Ishida K, 2007, TISSUE ENG, V13, P1103, DOI 10.1089/ten.2006.0193
   Jacobson M, 2008, WOUND REPAIR REGEN, V16, P370, DOI 10.1111/j.1524-475X.2008.00376.x
   Jager A, 2003, Z ORTHOP GRENZGEB, V141, P42, DOI 10.1055/s-2003-37361
   JOHNSON LL, 1993, ARTHROSCOPY, V9, P131, DOI 10.1016/S0749-8063(05)80362-7
   JOSHI S, 2009, COLLAGEN PLATELET CO, P23509
   KAPLAN N, 1990, AM J SPORT MED, V18, P354, DOI 10.1177/036354659001800404
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Kessler MA, 2008, KNEE SURG SPORT TR A, V16, P442, DOI 10.1007/s00167-008-0498-x
   Lanzetta Albino, 2004, Italian Journal of Anatomy and Embryology, V109, P167
   Liden M, 2008, ARTHROSCOPY, V24, P899, DOI 10.1016/j.arthro.2008.04.066
   LIND M, 2009, KNEE SURG SPORT TR A, V2, P117
   Linko E., 2005, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001356.PUB3
   Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396
   Lohmander LS, 2004, ARTHRITIS RHEUM, V50, P3145, DOI 10.1002/art.20589
   LOHMANDER LS, 1994, ACTA ORTHOP SCAND, V65, P605, DOI 10.3109/17453679408994613
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MARSHALL JL, 1982, AM J SPORT MED, V10, P103, DOI 10.1177/036354658201000208
   Meunier A, 2007, SCAND J MED SCI SPOR, V17, P230, DOI 10.1111/j.1600-0838.2006.00547.x
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2009, J ORTHOP RES, V27, P639, DOI 10.1002/jor.20796
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Murray MM, 1999, J ORTHOP RES, V17, P18, DOI 10.1002/jor.1100170105
   Murray MM, 2000, J ORTHOP RES, V18, P557, DOI 10.1002/jor.1100180407
   Murray MM, 2002, J ORTHOPAED RES, V20, P875, DOI 10.1016/S0736-0266(01)00156-5
   Murray MM, 2001, BIOMATERIALS, V22, P2393
   Murray MM, 2000, J BONE JOINT SURG AM, V82A, P1387, DOI 10.2106/00004623-200010000-00004
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   NEUMAN P, 2009, OSTEOARTHR CARTILAGE, V3, P284
   Neuman P, 2008, AM J SPORT MED, V36, P1717, DOI 10.1177/0363546508316770
   Ochi M, 1999, J BONE JOINT SURG BR, V81B, P902, DOI 10.1302/0301-620X.81B5.9202
   ODENSTEN M, 1984, ACTA ORTHOP SCAND, V55, P270, DOI 10.3109/17453678408992354
   PALMER MP, 2008, J ORTHOP RES, P23509
   PARKMAN R, 1976, J EXP MED, V144, P1520, DOI 10.1084/jem.144.6.1520
   PAYE M, 1989, HAEMOSTASIS, V19, P274
   Poolman RW, 2007, ACTA ORTHOP, V78, P350, DOI 10.1080/17453670710013915
   Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P1542, DOI 10.2106/JBJS.F.01292
   Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627
   Rosc D, 2002, MED SCI MONITOR, V8, pCR371
   Selmi TAS, 2006, KNEE, V13, P353, DOI 10.1016/j.knee.2006.02.014
   Seon JK, 2006, INT ORTHOP, V30, P94, DOI 10.1007/s00264-005-0036-0
   SHERMAN MF, 1991, AM J SPORT MED, V19, P243, DOI 10.1177/036354659101900307
   Soderman K, 2002, SCAND J MED SCI SPOR, V12, P65, DOI 10.1034/j.1600-0838.2002.120201.x
   Valeriani M, 1999, ACTA NEUROL SCAND, V99, P303, DOI 10.1111/j.1600-0404.1999.tb00680.x
   van der Hart Cor P, 2008, J Orthop Surg Res, V3, P24, DOI 10.1186/1749-799X-3-24
   von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136
   WARREN RF, 1983, CLIN ORTHOP RELAT R, P65
NR 76
TC 20
Z9 20
U1 2
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD FEB
PY 2010
VL 16
IS 1
BP 5
EP 11
DI 10.1089/ten.teb.2009.0147
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 554GJ
UT WOS:000274423200002
PM 20143926
DA 2018-10-20
ER

PT J
AU Reumann, MK
   Weiser, MC
   Mayer-Kuckuk, P
AF Reumann, Marie K.
   Weiser, Mitchell C.
   Mayer-Kuckuk, Philipp
TI Musculoskeletal molecular imaging: a comprehensive overview
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; CANCER BONE METASTASIS;
   POSITRON-EMISSION-TOMOGRAPHY; NEAR-INFRARED FLUORESCENCE;
   COLLAGEN-INDUCED ARTHRITIS; NONINVASIVE OPTICAL-DETECTION; IN-VIVO
   VISUALIZATION; NUDE-MOUSE MODEL; PROSTATE-CANCER; BREAST-CANCER
AB Molecular imaging permits non-invasive visualization and measurement of molecular and cell biology in living subjects, thereby complementing conventional anatomical imaging. Herein, we review the emerging application of molecular imaging for the study of musculoskeletal biology. Utilizing mainly bioluminescence and fluorescence techniques, molecular imaging has enabled in-vivo studies of (i) the activity of osteoblasts, osteoclasts and hormones, (ii) the mechanisms of pathological cartilage and bone destruction, (iii) skeletal gene and cell therapy with and without biomaterial support, and (iv) the cellular processes in osteolysis and osteomyelitis. In these applications, musculoskeletal molecular imaging demonstrated feasibility for research in a myriad of musculoskeletal conditions ranging from bone fracture and arthritis to skeletal cancer. Importantly, these advances herald great potential for innovative clinical imaging in orthopedics, rheumatology, and oncology.
C1 [Reumann, Marie K.; Weiser, Mitchell C.; Mayer-Kuckuk, Philipp] Hosp Special Surg, Bone Cell Biol & Imaging Lab, New York, NY 10021 USA.
RP Mayer-Kuckuk, P (reprint author), Hosp Special Surg, Bone Cell Biol & Imaging Lab, Caspary Res Bldg,Rm 623,535 E 70th St, New York, NY 10021 USA.
EM mayerkuckukp@hss.edu
OI Weiser, Mitchell/0000-0002-8116-5020
FU National Institutes of Health [AR055294]
FX We are indebted to Drs. P. Lassota (Boston, USA), C.-C. Gluer (Kiel,
   Germany), W. Semmler (Heidelberg, Germany), and R. Bhakta (New York,
   USA) for comments and corrections on the manuscript. Our work is
   supported by the National Institutes of Health (grant number AR055294 to
   PMK).
CR Aslan H, 2006, J BONE MINER RES, V21, P1935, DOI 10.1359/JBMR.060819
   Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565
   Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533
   Bennink RJ, 2008, J NUCL MED, V49, P1380, DOI 10.2967/jnumed.108.051755
   Biswal S, 2007, RADIOLOGY, V244, P651, DOI 10.1148/radiol.2443060295
   Blasberg RG, 2003, J CLIN INVEST, V111, P1620, DOI 10.1172/JCI200318855
   Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490
   Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168
   Burton DW, 2005, PROSTATE, V62, P275, DOI 10.1002/pros.20146
   Canon JR, 2008, CLIN EXP METASTAS, V25, P119, DOI 10.1007/s10585-007-9127-1
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441
   Chanda D, 2008, MOL THER, V16, P871, DOI 10.1038/mt.2008.48
   Chen Wei-Tsung, 2004, Mol Imaging, V3, P159, DOI 10.1162/1535350042380290
   Chen WT, 2005, ARTHRITIS RES THER, V7, pR310, DOI 10.1186/ar1483
   Ciana P, 2001, MOL ENDOCRINOL, V15, P1104, DOI 10.1210/me.15.7.1104
   Ciana P, 2003, NAT MED, V9, P82, DOI 10.1038/nm809
   Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x
   Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   Feeley BT, 2006, J ORTHOP RES, V24, P1709, DOI 10.1002/jor.20229
   Fritz V, 2008, STEM CELLS, V26, P2981, DOI 10.1634/stemcells.2008-0139
   Gafni Y, 2004, MOL THER, V9, P587, DOI 10.1016/j.ymthe.2003.12.009
   Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333
   Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011
   Hansch A, 2004, ARTHRITIS RHEUM, V50, P961, DOI 10.1002/art.20112
   Hansch A, 2004, INVEST RADIOL, V39, P626, DOI 10.1097/01.rli.0000139008.04288.fd
   Hasharoni A, 2005, J NEUROSURG-SPINE, V3, P47, DOI 10.3171/spi.2005.3.1.0047
   Hildebrandt IJ, 2004, CLIN IMMUNOL, V111, P210, DOI 10.1016/j.clim.2003.12.018
   Hirbe AC, 2007, BLOOD, V109, P3424, DOI 10.1182/blood-2006-09-048686
   Honigman A, 2001, MOL THER, V4, P239, DOI 10.1006/mthe.2001.0437
   Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x
   Iris Bar, 2003, J Bone Miner Res, V18, P570
   Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164
   Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3
   Jing XH, 2008, JOINT BONE SPINE, V75, P432, DOI 10.1016/j.jbspin.2007.09.013
   Kalikin LM, 2003, CANCER BIOL THER, V2, P656
   Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102
   Kozloff KM, 2007, J BONE MINER RES, V22, P1208, DOI 10.1359/JBMR.070504
   Kozloff KM, 2009, BONE, V44, P190, DOI 10.1016/j.bone.2008.10.036
   Lai WFT, 2004, OSTEOARTHR CARTILAGE, V12, P239, DOI 10.1016/j.joca.2003.11.005
   LEE SW, 2008, J ORTHOP RES, V27, P295
   Leo BM, 2004, SPINE, V29, P838, DOI 10.1097/00007632-200404150-00004
   Li D, 2008, J ORTHOP RES, V26, P96, DOI 10.1002/jor.20452
   Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403
   Mayer-Kuckuk P, 2006, BONE, V39, P965, DOI 10.1016/j.bone.2006.05.009
   McQueen FM, 2007, BEST PRACT RES CL RH, V21, P841, DOI 10.1016/j.berh.2007.05.001
   Miller RE, 2008, MOL CANCER THER, V7, P2160, DOI 10.1158/1535-7163.MCT-08-0046
   Mouchess ML, 2006, J COMPUT ASSIST TOMO, V30, P525, DOI 10.1097/00004728-200605000-00030
   Murray LJ, 2003, CLIN EXP METASTAS, V20, P757, DOI 10.1023/B:CLIN.0000006873.65590.68
   Nakajima A, 2001, J CLIN INVEST, V107, P1293, DOI 10.1172/JCI12037
   Nakajima Atsuo, 2006, Journal of Nippon Medical School, V73, P298, DOI 10.1272/jnms.73.298
   Nakashima-Matsushita N, 1999, ARTHRITIS RHEUM-US, V42, P1609, DOI 10.1002/1529-0131(199908)42:8<1609::AID-ANR7>3.0.CO;2-L
   Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074
   Olivo C, 2008, J ORTHOP RES, V26, P901, DOI 10.1002/jor.20582
   Paulos CM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1944
   Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027
   Pichler BJ, 2008, J NUCL MED, V49, p5S, DOI 10.2967/jnumed.108.045880
   Pichler Bernd J., 2008, V185, P109, DOI 10.1007/978-3-540-72718-7_6
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ren PG, 2008, BIOMATERIALS, V29, P4760, DOI 10.1016/j.biomaterials.2008.09.004
   Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211
   Serganova I, 2009, FASEB J, V23, P2662, DOI 10.1096/fj.08-126920
   Sheyn D, 2008, GENE THER, V15, P257, DOI 10.1038/sj.gt.3303070
   Silva MJ, 2006, BONE, V39, P229, DOI 10.1016/j.bone.01.149
   Simon GH, 2006, EUR J NUCL MED MOL I, V33, P998, DOI 10.1007/s00259-006-0081-y
   Sims TL, 2009, J PEDIATR SURG, V44, P204, DOI 10.1016/j.jpedsurg.2008.10.041
   Sprague JE, 2007, J NUCL MED, V48, P311
   Tannehill-Gregg SH, 2006, CLIN EXP METASTAS, V23, P19, DOI 10.1007/s10585-006-9008-z
   Tarner IH, 2002, CLIN IMMUNOL, V105, P304, DOI 10.1006/clim.2002.5299
   Thudi NK, 2008, PROSTATE, V68, P1116, DOI 10.1002/pros.20776
   Tjuvajev JG, 1996, CANCER RES, V56, P4087
   Turk MJ, 2002, ARTHRITIS RHEUM, V46, P1947, DOI 10.1002/art.10405
   van der Pluijm G, 2005, CANCER RES, V65, P7682, DOI 10.1158/0008-5472.CAN-04-4188
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949
   Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775
   Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694
   Wunder A, 2004, ARTHRITIS RHEUM-US, V50, P2459, DOI 10.1002/art.20379
   Wunder Andreas, 2005, Mol Imaging, V4, P1
   YAGHOUBI SS, 2007, J BIOMED OPT, V12
   Yang M, 2006, CLIN CANCER RES, V12, P2602, DOI 10.1158/1078-0432.CCR-05-2050
   Yazici C, 2008, BIOMATERIALS, V29, P3882, DOI 10.1016/j.biomaterials.2008.06.007
   Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148
   Zhang J, 2004, PROSTATE, V59, P360, DOI 10.1002/pros.20019
   Zhang N, 2003, J IMMUNOL, V170, P6307, DOI 10.4049/jimmunol.170.12.6307
   Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125
   Zilberman Y, 2008, J ORTHOP RES, V26, P522, DOI 10.1002/jor.20518
   Zilberman Yoram, 2008, V455, P261, DOI 10.1007/978-1-59745-104-8_18
NR 91
TC 13
Z9 13
U1 0
U2 6
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD FEB
PY 2010
VL 28
IS 2
BP 93
EP 101
DI 10.1016/j.tibtech.2009.11.004
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 555ZX
UT WOS:000274556900005
PM 20045210
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cass, P
   Knower, W
   Pereeia, E
   Holmes, NP
   Hughes, T
AF Cass, Peter
   Knower, Warren
   Pereeia, Eliana
   Holmes, Natalie P.
   Hughes, Tim
TI Preparation of hydrogels via ultrasonic polymerization
SO ULTRASONICS SONOCHEMISTRY
LA English
DT Article
DE Ultrasound; Sonochemistry; Hydrogel; Polymerization
ID IRRADIATED EMULSION POLYMERIZATION; METHYL-METHACRYLATE; RADICAL
   POLYMERIZATION; POLYSTYRENE LATEX; BLOCK-COPOLYMERS; DEGRADATION;
   INITIATION; STYRENE; SONICATION; DECOMPOSITION
AB Several acrylic hydrogels were prepared via ultrasonic polymerization of water soluble monomers and macromonomers. Ultrasound was used to create initiating radicals in viscous aqueous monomer solutions using the additives glycerol, sorbitol or glucose in an open system at 37 degrees C. The water soluble additives were essential for the hydrogel production, glycerol being the most effective. Hydrogels were prepared from the monomers 2-hydroxyethyl methacrylate, poly(ethylene glycol) dimethacrylate, dextran methacrylate, acrylic acid/ethylene glycol dimethacrylate and acrylamide/bis-acrylamide. For example a 5% w/w Solution of dextran methacrylate formed a hydrogel in 6.5 min in a 70% w/w solution of glycerol in water at 37 degrees C with 20 kHz ultrasound, 56 w cm(-2). The ultrasonic polymerization method described here has a wide range of applications such a biomaterial synthesis where initiators are not desired. Crown Copyright (C) 2009 Published by Elsevier B.V. All rights reserved.
C1 [Cass, Peter; Knower, Warren; Pereeia, Eliana; Holmes, Natalie P.; Hughes, Tim] CSIRO Mol & Hlth Technol, Clayton, Vic 3168, Australia.
RP Cass, P (reprint author), CSIRO Mol & Hlth Technol, Bayview Ave, Clayton, Vic 3168, Australia.
EM Pete.Cass@csiro.au
RI Holmes, Natalie/G-7912-2013; Hughes, Timothy/A-9319-2011
OI Holmes, Natalie/0000-0002-8860-7098; Hughes, Timothy/0000-0002-7990-4509
CR Ashokkumar M, 1999, REV CHEM ENG, V15, P41, DOI 10.1515/REVCE.1999.15.1.41
   Bartsch M, 2006, MACROMOL CHEM PHYSIC, V207, P209, DOI 10.1002/macp.200500380
   BIGG S, 1995, MACROMOLECULES, V28, P4877, DOI 10.1021/ma00118a013
   Bradley MA, 2005, MACROMOLECULES, V38, P6346, DOI 10.1021/ma0473622
   CASS P, 2008, Patent No. 2008905787
   Choi M, 2007, MACROMOL SYMP, V249, P350, DOI 10.1002/masy.200750403
   Chou HCJ, 1999, J APPL POLYM SCI, V72, P797, DOI 10.1002/(SICI)1097-4628(19990509)72:6<797::AID-APP7>3.0.CO;2-Z
   Cooper G, 1996, J COLLOID INTERF SCI, V184, P52, DOI 10.1006/jcis.1996.0596
   Degirmenci M, 2004, J POLYM SCI POL CHEM, V42, P534, DOI 10.1002/pola.10879
   DOULAH MS, 1978, J APPL POLYM SCI, V22, P1735, DOI 10.1002/app.1978.070220622
   ENCINA MV, 1980, J POLYM SCI POL LETT, V18, P757, DOI 10.1002/pol.1980.130181201
   Feng MH, 2000, J BIOMAT SCI-POLYM E, V11, P537, DOI 10.1163/156856200743850
   GRABAR P, 1948, CR HEBD ACAD SCI, V226, P1821
   Harvey CJ, 2002, CLIN RADIOL, V57, P157, DOI 10.1053/crad.2001.0918
   He YH, 2005, J POLYM SCI POL PHYS, V43, P2617, DOI 10.1002/polb.20544
   Hill DJT, 1996, RADIAT PHYS CHEM, V48, P605, DOI 10.1016/0969-806X(96)00084-9
   Kobayashi D, 2008, CHEM ENG J, V135, P43, DOI 10.1016/j.cej.2007.05.015
   Kojima Y, 2001, ULTRASON SONOCHEM, V8, P75, DOI 10.1016/S1350-4177(00)00064-X
   Kojima Y, 2001, ULTRASON SONOCHEM, V8, P81, DOI 10.1016/S1350-4177(00)00068-7
   KRISHNA CM, 1989, J PHYS CHEM-US, V93, P5166, DOI 10.1021/j100350a029
   KRUUS P, 1988, ULTRASONICS, V26, P352, DOI 10.1016/0041-624X(88)90035-2
   Kuijpers MWA, 2002, SCIENCE, V298, P1969, DOI 10.1126/science.1078022
   Lebovitz AH, 2003, POLYMER, V44, P2823, DOI 10.1016/S0032-3861(03)00225-8
   Liao YQ, 2001, J POLYM SCI POL CHEM, V39, P3356, DOI 10.1002/pola.1318
   LINDSTROM O, 1951, J PHYS COLLOID CHEM, V55, P1139, DOI 10.1021/j150490a004
   Luche JL, 1996, ULTRASON SONOCHEM, V3, pS215, DOI 10.1016/S1350-4177(96)00029-6
   Mason TJ, 2007, PROG BIOPHYS MOL BIO, V93, P166, DOI 10.1016/j.pbiomolbio.2006.07.007
   Ooi SK, 2000, ULTRASON SONOCHEM, V7, P125, DOI 10.1016/S1350-4177(99)00040-1
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   Price GJ, 2004, RES CHEM INTERMEDIAT, V30, P807, DOI 10.1163/1568567041856972
   Price GJ, 1996, POLYMER, V37, P3971, DOI 10.1016/0032-3861(96)00197-8
   SUSLICK KS, 1986, J AM CHEM SOC, V108, P5641, DOI 10.1021/ja00278a055
   THERMES F, 1992, PHARM RES-DORDR, V9, P1563, DOI 10.1023/A:1015856223252
   TROMMSDORFF E, 1948, MAKROMOL CHEM, V1, P169
   Wang RL, 2005, J SUPERCRIT FLUID, V33, P269, DOI 10.1016/j.superflu.2004.08.008
   Wnag C, 2006, ACTA POLYM SIN, P1038
   Xia HS, 2003, CHEM MATER, V15, P3879, DOI 10.1021/cm0341890
   XIUYUAN N, 2001, EUR POLYM J, V37, P201
   Yin NW, 2006, ULTRASON SONOCHEM, V13, P345, DOI 10.1016/j.ultsonch.2005.03.006
   Zhang JZ, 2004, J APPL POLYM SCI, V94, P763, DOI 10.1002/app.20948
   Zheng YP, 1999, CAN J PHYS, V77, P927, DOI 10.1139/cjp-77-12-927
NR 41
TC 23
Z9 23
U1 2
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1350-4177
J9 ULTRASON SONOCHEM
JI Ultrason. Sonochem.
PD FEB
PY 2010
VL 17
IS 2
BP 326
EP 332
DI 10.1016/j.ultsonch.2009.08.008
PG 7
WC Acoustics; Chemistry, Multidisciplinary
SC Acoustics; Chemistry
GA 534TI
UT WOS:000272919800011
PM 19762267
DA 2018-10-20
ER

PT J
AU Fan, J
   Yu, WD
AF Fan, Jie
   Yu, Wei-dong
TI Biomaterials from wool wastes: characterization of cortical
   cells/chitosan composite
SO WASTE MANAGEMENT & RESEARCH
LA English
DT Article
DE wool waste; keratin; chitosan; composite; biomaterial
ID KERATIN SPONGE SCAFFOLDS; CHEMICAL COMPOSITION; CHITOSAN FILMS;
   STRUCTURAL-CHANGES; FIBER KERATIN; SPECTROSCOPY; FABRICATION; FORM
AB Anisotropic cortical cells were extracted from waste wool fibres by formic acid-ultrasonic treatment and successively included in different proportions in a chitosan matrix to make film-forming composites, suitable for film casting and filament spinning. The morphological, chemical, thermal and mechanical properties of the composite film were investigated by scanning electron microscopy (SEM), light microscopy, X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, differential scanning calorimetric (DSC) and tensile tests, respectively. The cortical cells/chitosan composite is capable of forming translucent composite films with acceptable mechanical and thermal properties. The chitosan composite film with addition of 30 wt.% cortical cells showed values of 29.6 +/- 2.9 MPa for ultimate strength, 5.6 +/- 0.3% for ultimate elongation and 35.3 +/- 1.4 MPa for Young's modulus, all higher than that of the pure chitosan film. DSC results revealed that the decomposition temperature of the composite film shifted to a higher temperature compared to the base materials, by increasing the mass fraction of cortical cells. XRD patterns showed that the crystallinity of biocomposite films increased with the addition of cortical cells. In addition, the FT-IR spectra of the composite film indicated that no chemical reaction occurs between cortical cells and chitosan; only a physical mixture of its constituents was present.
C1 [Fan, Jie; Yu, Wei-dong] Donghua Univ, TMT Lab, Coll Text, Shanghai 201620, Peoples R China.
RP Yu, WD (reprint author), Donghua Univ, TMT Lab, Coll Text, 2999 N Renmin Rd, Shanghai 201620, Peoples R China.
EM wdyu@dhu.edu.cn
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Bourtoom T, 2008, LWT-FOOD SCI TECHNOL, V41, P1633, DOI 10.1016/j.lwt.2007.10.014
   BRADBURY JH, 1967, AUST J CHEM, V20, P2803, DOI 10.1071/CH9672803
   Cao JN, 1997, J APPL POLYM SCI, V63, P411, DOI 10.1002/(SICI)1097-4628(19970124)63:4<411::AID-APP1>3.0.CO;2-U
   CHAPMAN GV, 1968, ARCH BIOCHEM BIOPHYS, V127, P157, DOI 10.1016/0003-9861(68)90212-9
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Fan J, 2008, INT J NONLIN SCI NUM, V9, P293
   Fan J, 2007, PROCEEDINGS OF THE 2007 INTERNATIONAL CONFERENCE ON ADVANCED FIBERS AND POLYMER MATERIALS VOLS 1 AND 2, P721
   Fraser RDB, 1980, LINN SOC S SER, V9, P67
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   HE JH, 2008, CHAOS SOLITON FRACT, V41, P1839
   Julkapill NM, 2008, MAT SCI ENG C-BIO S, V28, P1100, DOI 10.1016/j.msec.2007.05.003
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   KATOH K, 2004, AICHI KEN SANGYO GIJ, V3, P126
   Kulkarni V. G., 1971, APPL POLYM S, V18, P127
   KULKARNI VG, 1974, AUST J BIOL SCI, V27, P383, DOI 10.1071/BI9740383
   Nie HM, 2008, J CONTROL RELEASE, V129, P207, DOI 10.1016/j.jconrel.2008.04.018
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   Nunthanid J, 2004, J CONTROL RELEASE, V99, P15, DOI 10.1016/j.jconrel.2004.06.008
   Peesan M, 2005, CARBOHYD POLYM, V60, P343, DOI 10.1016/j.carbpol.2005.01.008
   Phisalaphong M, 2008, CARBOHYD POLYM, V74, P482, DOI 10.1016/j.carbpol.2008.04.004
   Pielesz A, 2000, SPECTROCHIM ACTA A, V56, P1409, DOI 10.1016/S1386-1425(99)00271-1
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Singh DK, 1998, CARBOHYD POLYM, V36, P251, DOI 10.1016/S0144-8617(97)00260-9
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tanabe T, 2004, MAT SCI ENG C-BIO S, V24, P441, DOI 10.1016/j.msec.2003.11.004
   Thanpitcha T, 2006, CARBOHYD POLYM, V64, P560, DOI 10.1016/j.carbpol.2005.11.026
   Wojciechowska E, 1999, J MOL STRUCT, V511, P307, DOI 10.1016/S0022-2860(99)00173-8
   Wojciechowska E, 2004, J MOL STRUCT, V704, P315, DOI 10.1016/j.molstruc.2004.03.044
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
   Zheng Hua, 2002, Wuhan University Journal of Natural Sciences, V7, P107
NR 34
TC 13
Z9 13
U1 4
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0734-242X
J9 WASTE MANAGE RES
JI Waste Manage. Res.
PD FEB
PY 2010
VL 28
IS 1
BP 44
EP 50
DI 10.1177/0734242X09336312
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 542IP
UT WOS:000273486900007
PM 19767325
DA 2018-10-20
ER

PT J
AU Agrawal, P
   Strijkers, GJ
   Nicolay, K
AF Agrawal, Prashant
   Strijkers, Gustav J.
   Nicolay, Klaas
TI Chitosan-based systems for molecular imaging
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Chitosan; Molecular imaging; Imaging techniques; Imaging agents; MRI;
   CT; Ultrasound; Optical imaging
ID IRON-OXIDE NANOPARTICLES; NEUTRON-CAPTURE THERAPY; OPTICAL COHERENCE
   TOMOGRAPHY; FLUORESCENT PROTEIN FAMILY; ULTRASOUND CONTRAST AGENT;
   N-ACYLATED CHITOSAN; IN-VIVO; MAGNETIC-RESONANCE; DRUG-DELIVERY; QUANTUM
   DOTS
AB Molecular imaging enables the non-invasive assessment of biological and biochemical processes in living subjects. Such technologies therefore have the potential to enhance our understanding of disease and drug activity during preclinical and clinical drug development. Molecular imaging allows a repetitive and non-invasive study of the same living subject using identical or alternative biological imaging assays at different time points, thus harnessing the statistical power of longitudinal studies, and reducing the number of animals required and cost. Chitosan is a hydrophilic and non-antigenic biopolymer and has a low toxicity toward mammalian cells. Hence, it has great potential as a biomaterial because of its excellent biocompatibility. Conjugated to additional materials, chitosan composites result in a new class of biomaterials that possess mechanical, physicochemical and functional properties, which have potential for use in advanced biomedical imaging applications. The present review will discuss the strengths, limitations and challenges of molecular imaging as well as applications of chitosan nanoparticles in the field of molecular imaging. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Agrawal, Prashant; Strijkers, Gustav J.; Nicolay, Klaas] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands.
RP Agrawal, P (reprint author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM p.agrawal@tue.nl
RI Nicolay, Klaas/F-4192-2010; Strijkers, Gustav/H-3158-2011
OI Nicolay, Klaas/0000-0002-4179-616X
FU European Commission [LSHB-CT-2005-512146]; MediTrans
   [NMP4-CT-2006-026668]; BSIK [BSIK03033]
FX The authors' work in the field of MRI contrast agents and MRI-based
   molecular imaging is funded in part by the European Commission
   FP6-projects DiMI (project number LSHB-CT-2005-512146) and MediTrans
   (project number NMP4-CT-2006-026668), as well as by the BSIK program
   entitled Molecular imaging of Ischemic Heart Disease (project number
   BSIK03033). Parts of these studies are performed in the framework of the
   European Cooperation in the field of Scientific and Technical Research
   (COST) D38 Action Metal-Based Systems for Molecular Imaging
   Applications.
CR Ai H, 2005, ADV MATER, V17, P1949, DOI 10.1002/adma.200401904
   ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1068, P133, DOI 10.1016/0005-2736(91)90201-I
   Bekeredjian R, 2005, ULTRASOUND MED BIOL, V31, P687, DOI 10.1016/j.ultrasmedbio.2004.08.002
   Bhattarai SR, 2007, CARBOHYD POLYM, V69, P467, DOI 10.1016/j.carbpol.2007.01.006
   BOAS DA, 1994, P NATL ACAD SCI USA, V91, P4887, DOI 10.1073/pnas.91.11.4887
   Boesch Chris, 1999, Molecular Aspects of Medicine, V20, P185, DOI 10.1016/S0098-2997(99)00007-2
   Boppart SA, 1997, P NATL ACAD SCI USA, V94, P4256, DOI 10.1073/pnas.94.9.4256
   Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117
   Bremer C, 2001, RADIOLOGE, V41, P131, DOI 10.1007/s001170050955
   BRITTON C, 1998, ANN NY ACAD SCI, V838, P29
   Buehler C, 1999, IEEE ENG MED BIOL, V18, P23, DOI 10.1109/51.790988
   Burch S, 2005, J ORTHOP RES, V23, P995, DOI 10.1016/j.orthres.2004.12.014
   Cavalli R, 2009, INT J PHARMACEUT, V378, P215, DOI 10.1016/j.ijpharm.2009.05.058
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   Chang YC, 2005, MACROMOL BIOSCI, V5, P254, DOI 10.1002/mabi.200400153
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x
   Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079
   de Lussanet QG, 2005, RADIOLOGY, V235, P65, DOI 10.1148/radiol.2351040411
   Deckers R, 2008, J MAGN RESON IMAGING, V27, P400, DOI 10.1002/jmri.21272
   Dellian M, 2000, BRIT J CANCER, V82, P1513
   Demidova TN, 2005, J PHOTOCH PHOTOBIO B, V81, P15, DOI 10.1016/j.jphotobiol.2005.05.007
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7
   FOCHER B, 1986, MAKROMOL CHEM, V187, P2609
   FOLLI S, 1994, CANCER RES, V54, P2643
   Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436
   Ge YQ, 2009, NANOSCALE RES LETT, V4, P287, DOI 10.1007/s11671-008-9239-9
   Gonzalez Salvador, 1999, Journal of Medicine (Westbury), V30, P337
   Grayburn PA, 2002, ECHOCARDIOGR-J CARD, V19, P259, DOI 10.1046/j.1540-8175.2002.00259.x
   Gupta AK, 2005, BIOMATERIALS, V26, P1565, DOI 10.1016/j.biomaterials.2004.05.022
   GUPTA KC, 2000, POLYM REV, V40, P273
   Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1
   Hak S, 2009, EUR J PHARM BIOPHARM, V72, P397, DOI 10.1016/j.ejpb.2008.09.017
   Hari PR, 1996, J MICROENCAPSUL, V13, P319, DOI 10.3109/02652049609026019
   Hari PR, 1996, J APPL POLYM SCI, V59, P1795
   Hein S, 2008, MATER SCI TECH-LOND, V24, P1053, DOI 10.1179/174328408X341744
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8
   HOFFMAN PM, 2005, CHEMOSENSITIVITY, V2, P297
   Hogemann D, 2001, RADIOLOGE, V41, P116, DOI 10.1007/s001170050953
   Hogemann D, 2002, EUR J NUCL MED MOL I, V29, P400, DOI 10.1007/s00259-002-0765-x
   Holme KR, 1997, CARBOHYD RES, V302, P7, DOI 10.1016/S0008-6215(97)00117-1
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Hwang HY, 2008, J CONTROL RELEASE, V128, P23, DOI 10.1016/j.jconrel.2008.02.003
   Jain S, 2006, J PHARM PHARMACOL, V58, P303, DOI 10.1211/jpp.58.3.0003
   JEREMY CH, 1997, PHYS MED BIOL, V5, P825
   Jia ZS, 2001, CARBOHYD RES, V333, P1, DOI 10.1016/S0008-6215(01)00112-4
   Jiang HL, 2007, GENE THER, V14, P1389, DOI 10.1038/sj.gt.3302997
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Kim DG, 2006, INT J PHARM, V319, P130, DOI 10.1016/j.ijpharm.2006.03.040
   Kim EM, 2006, NUCL MED BIOL, V33, P529, DOI 10.1016/j.nucmedbio.2006.03.005
   Kim JH, 2008, BIOMATERIALS, V29, P1920, DOI 10.1016/j.biomaterials.2007.12.038
   KLEIN WP, 1995, NUCL SCI S MED IM 19
   Kohler N, 2004, J AM CHEM SOC, V126, P7206, DOI 10.1021/ja049195r
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kuno M, 2000, J CHEM PHYS, V112, P3117, DOI 10.1063/1.480896
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299
   Lammers T, 2008, BRIT J CANCER, V99, P392, DOI 10.1038/sj.bjc.6604483
   Le Tien C, 2003, J CONTROL RELEASE, V93, P1, DOI 10.1016/S0168-3659(03)00327-4
   Lee CM, 2006, DRUG DEVELOP RES, V67, P884, DOI 10.1002/ddr.20155
   Lee CM, 2009, INT J PHARMACEUT, V371, P163, DOI 10.1016/j.ijpharm.2008.12.021
   Lee HS, 2005, J MAGN MAGN MATER, V293, P102, DOI 10.1016/j.jmmm.2005.01.049
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Liang HF, 2006, BIOCONJUGATE CHEM, V17, P291, DOI 10.1021/bc0502107
   Lillo LE, 1997, CARBOHYD POLYM, V34, P397, DOI 10.1016/S0144-8617(97)00117-3
   Liu CG, 2005, J AGR FOOD CHEM, V53, P1728, DOI 10.1021/jf040304v
   Liu ZL, 2004, J NUCL MED, V45, P1251
   Liu ZL, 2002, J NUCL MED, V43, P933
   LUCIA ADR, 1999, J MAGN RESON IMAGING, V10, P395
   Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741
   Lum AFH, 2006, J CONTROL RELEASE, V111, P128, DOI 10.1016/j.jconrel.2005.11.006
   Luo XL, 2004, ANAL BIOCHEM, V334, P284, DOI 10.1016/j.ab.2004.07.005
   Lutz JF, 2006, BIOMACROMOLECULES, V7, P3132, DOI 10.1021/bm0607527
   Ma HL, 2007, INT J PHARM, V333, P177, DOI 10.1016/j.ijpharm.2006.10.006
   Mahmood U, 2004, IEEE ENG MED BIOL, V23, P58, DOI 10.1109/MEMB.2004.1337950
   Mahmood U, 2002, ACAD RADIOL, V9, P629, DOI 10.1016/S1076-6332(03)80306-9
   Mahmood U, 1999, RADIOLOGY, V213, P866, DOI 10.1148/radiology.213.3.r99dc14866
   Masters BR, 1997, BIOPHYS J, V72, P2405, DOI 10.1016/S0006-3495(97)78886-6
   McVeigh ER, 2006, CIRC RES, V98, P879, DOI 10.1161/01.RES.0000216870.73358.d9
   MEEREN RMA, 2009, J AM SOC MASS SPECTR, V20, P1006
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   MIYAZAKI S, 1994, BIOL PHARM BULL, V17, P745
   Monsky WL, 1999, CANCER RES, V59, P4129
   Morawski AM, 2005, CURR OPIN BIOTECH, V16, P89, DOI 10.1016/j.copbio.2004.11.001
   Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002
   Mulder WJM, 2007, NANOMEDICINE-UK, V2, P307, DOI 10.2217/17435889.2.3.307
   Mulder WJM, 2006, NMR BIOMED, V19, P142, DOI 10.1002/nbm.1011
   Muller K, 2007, BIOMATERIALS, V28, P1629, DOI [10.1016/j.biomaterials.2006.12.003, 10.1016/j.biomaterials.2006.12.002]
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u
   NEWPORT DF, 2003, PHYS MED BIOL, V48, P1519
   Ntziachristos V, 2000, P NATL ACAD SCI USA, V97, P2767, DOI 10.1073/pnas.040570597
   Park K, 2007, J CONTROL RELEASE, V122, P305, DOI 10.1016/j.jconrel.2007.04.009
   Park MJ, 2006, LANGMUIR, V22, P1375, DOI 10.1021/la052218a
   Park Y, 2008, J CONTROL RELEASE, V128, P217, DOI 10.1016/j.jconrel.2008.03.019
   Perazella MA, 2007, CLIN J AM SOC NEPHRO, V2, P200, DOI 10.2215/CJN.00030107
   Peyker A, 2005, CHEMBIOCHEM, V6, P78, DOI 10.1002/cbic.200400280
   Phelps ME, 2000, J NUCL MED, V41, P661
   Pomper MG, 2004, IEEE ENG MED BIOL, V23, P28, DOI 10.1109/MEMB.2004.1337947
   RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215
   Saha TK, 2006, CARBOHYD RES, V341, P2835, DOI 10.1016/j.carres.2006.09.016
   SAKIYAMA T, 1993, J APPL POLYM SCI, V50, P2021, DOI 10.1002/app.1993.070501121
   Seeley EH, 2008, PROTEOM CLIN APPL, V2, P1435, DOI 10.1002/prca.200800013
   Sharma P, 2006, ADV COLLOID INTERFAC, V123, P471, DOI 10.1016/j.cis.2006.05.026
   Shi ZL, 2009, ACS APPL MATER INTER, V1, P328, DOI 10.1021/am8000538
   SIMON RA, 1997, PHYS MED BIOL, V5, P841
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Smith PG, 2005, GENE THER, V12, P1465, DOI 10.1038/sj.gt.3302543
   Soga O, 2005, J CONTROL RELEASE, V103, P341, DOI 10.1016/j.jconrel.2004.12.009
   Storm G, 1998, PHARM SCI TECHNOL TO, V1, P19, DOI 10.1016/S1461-5347(98)00007-8
   Sun C, 2006, J BIOMED MATER RES A, V78A, P550, DOI 10.1002/jbm.a.30781
   TAKAHASHI T, 1990, INT J PHARM, V61, P35, DOI 10.1016/0378-5173(90)90041-2
   Tan WB, 2005, ADV MATER, V17, P2375, DOI 10.1002/adma.200401650
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037
   Tokumitsu H, 1999, PHARMACEUT RES, V16, P1830, DOI 10.1023/A:1018995124527
   Tokumitsu H, 2000, STP PHARMA SCI, V10, P39
   Torchilin VP, 2007, PHARM RES, V24, P2333, DOI 10.1007/s11095-007-9463-5
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Townsend DW, 2004, J NUCL MED, V45, p4S
   Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017
   Unger EC, 1998, ACAD RADIOL, V5, pS247, DOI 10.1016/S1076-6332(98)80119-0
   Unger EC, 1998, INVEST RADIOL, V33, P886, DOI 10.1097/00004424-199812000-00007
   Weber DA, 1999, J NUCL CARDIOL, V6, P332, DOI 10.1016/S1071-3581(99)90046-6
   Weecharangsan W, 2008, INT J PHARMACEUT, V348, P161, DOI 10.1016/j.ijpharm.2007.07.011
   WEINMANN HJ, 1984, PHYSIOL CHEM PHYS ME, V16, P167
   Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949
   Weissleder R, 2001, RADIOLOGY, V219, P316, DOI 10.1148/radiology.219.2.r01ma19316
   Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290
   Winter PM, 2007, EXPERT REV MED DEVIC, V4, P137, DOI 10.1586/17434440.4.2.137
   Won J, 2005, SCIENCE, V309, P121, DOI 10.1126/science.1112869
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
   Yang YH, 2004, ANAL CHIM ACTA, V525, P213, DOI 10.1016/j.aca.2004.07.071
   Yanushevich YG, 2005, RUSS J BIOORG CHEM+, V31, P43, DOI 10.1007/s11171-005-0005-9
   Zhang C, 2003, EUR POLYM J, V39, P1629, DOI 10.1016/S0014-3057(03)00068-5
   Zhu AP, 2005, BIOMATERIALS, V26, P6873, DOI 10.1016/j.biomaterials.2005.05.021
NR 147
TC 96
Z9 100
U1 0
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD JAN 31
PY 2010
VL 62
IS 1
BP 42
EP 58
DI 10.1016/j.addr.2009.09.007
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 563LU
UT WOS:000275134500005
PM 19861142
DA 2018-10-20
ER

PT J
AU Chrzanowski, W
   Valappil, SP
   Dunnill, CW
   Abou Neel, EA
   Lee, K
   Parkin, IP
   Wilson, M
   Armitage, DA
   Knowles, JC
AF Chrzanowski, Wojciech
   Valappil, Sabeel P.
   Dunnill, Charles W.
   Abou Neel, Ensanya A.
   Lee, Kevin
   Parkin, Ivan P.
   Wilson, Michael
   Armitage, David A.
   Knowles, Jonathan C.
TI Impaired bacterial attachment to light activated Ni-Ti alloy
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nickel titanium; Staphylococcus aureus; SEM/FIB; Bacterial attachment
ID ENHANCED PHOTOCATALYTIC ACTIVITY; FERRITE COMPOSITE NANOPARTICLES;
   SHAPE-MEMORY ALLOY; IN-VITRO; BIOMATERIAL SYSTEM; MAGNETIC CORE;
   STAPHYLOCOCCUS-AUREUS; SURFACE-TREATMENT; ESCHERICHIA-COLI;
   NITROGEN-SOURCE
AB Ni-Ti alloy due to its unique mechanical properties, is used for many types of implants. Failure of these implants can be attributed to many different factors: however infections are a common problem. In this paper, the attachment of the bacteria, Staphylococcus aureus, to the Ni-Ti Surface modified by a range of processes with and without of light activation (used to elicit antimicrobial properties of materials) was assessed and related to different surface characteristics. Before the light activation the number of bacterial colony forming units was the greatest for the samples thermally oxidised at 600 degrees C. This sample and the spark oxidised samples showed the highest photocatalytic activity but only the thermally oxidised samples at 600 degrees C showed a significant drop of S. aureus attachment. The findings in this study indicate that light activation and treating samples at 600 degrees C is a promising method for Ni-Ti implant applications with inherent antimicrobial properties. Light activation was shown to be an effective way to trigger photocatalytic reactions on samples covered with relatively thick titanium dioxide via accumulation of photons in the surface and a possible increase in defects which may result in free oxygen. Moreover, light activation caused an increase in the total surface energy. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chrzanowski, Wojciech; Valappil, Sabeel P.; Abou Neel, Ensanya A.; Knowles, Jonathan C.] UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
   [Lee, Kevin] London Ctr Nanotechnol, London WC1H 0AH, England.
   [Dunnill, Charles W.; Parkin, Ivan P.] UCL, Ctr Mat Chem, Dept Chem, London WC1H 0AJ, England.
   [Armitage, David A.] De Montfort Univ, Leicester Sch Pharm, Leicester LE1 9BH, Leics, England.
   [Wilson, Michael] UCL Eastman Dent Inst, Div Microbial Dis, London WC1X 8LD, England.
RP Knowles, JC (reprint author), UCL Eastman Dent Inst, Div Biomat & Tissue Engn, 256 Grays Rd, London WC1X 8LD, England.
EM j.knowles@eastman.ucl.ac.uk
RI Dom, Rekha/B-7113-2012; Abou Neel, Ensanya/J-6908-2013; Knowles,
   Jonathan Campbell/B-9019-2008; Valappil, Sabeel/A-1460-2009;
   Chrzanowski, Wojciech/B-5478-2010; Dunnill, Charles/C-1359-2008; Wilson,
   Michael/D-2085-2009
OI Knowles, Jonathan Campbell/0000-0003-3917-3446; Dunnill,
   Charles/0000-0003-4052-6931; Parkin, Ivan/0000-0002-4072-6610
FU Engineering and Physical Sciences Research Council [EP/E026141/1]
CR ARCIOLA CR, 2006, INT J ARTIF ORGANS, V26, P1119
   Barr ere F., 1999, BONE, V25, p107S
   Bekbolet M, 1996, CHEMOSPHERE, V32, P959, DOI 10.1016/0045-6535(95)00359-2
   BOULANGEPETERMANN L, 1993, J ADHES SCI TECHNOL, V7, P221, DOI 10.1163/156856193X00673
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chen MF, 2004, MAT SCI ENG C-BIO S, V24, P497, DOI 10.1016/j.msec.2003.11.001
   Cheng Y, 2006, MAT SCI ENG A-STRUCT, V438, P1146, DOI 10.1016/j.msea.2005.12.073
   Chrzanowski W, 2008, J MATER SCI-MATER M, V19, P1553, DOI 10.1007/s10856-008-3374-9
   Chrzanowski W, 2008, ACTA BIOMATER, V4, P1969, DOI 10.1016/j.actbio.2008.05.010
   Chu CL, 2005, J BIOMED MATER RES A, V75A, P595, DOI 10.1002/jbm.a.30465
   CUI FZ, 2005, FABRICATION CHARACTE, P595
   Cui ZD, 2008, MAT SCI ENG C-BIO S, V28, P1117, DOI 10.1016/j.msec.2007.05.006
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Draper ERC, 1997, MED ENG PHYS, V19, P690, DOI 10.1016/S1350-4533(97)00037-4
   Dunnill CW, 2009, J MATER CHEM, V19, P8747, DOI 10.1039/b913793a
   Dunnill CW, 2009, CHEM VAPOR DEPOS, V15, P171, DOI 10.1002/cvde.200806274
   Dunnill CWH, 2009, J PHOTOCH PHOTOBIO A, V207, P244, DOI 10.1016/j.jphotochem.2009.07.024
   EWALD A, 2006, BIOMEDICAL ENG, V5
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V60, P89, DOI 10.1016/0378-1097(89)90083-9
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   Gu YW, 2005, APPL SURF SCI, V252, P2038, DOI 10.1016/j.apsusc.2005.03.207
   Gu YW, 2005, BIOMATERIALS, V26, P6916, DOI [10.1016/j.biomaterials.2005.04.051, 10.1016/j.biomaterials.2005.04.51]
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Harris LG, 2007, J MATER SCI-MATER M, V18, P1151, DOI 10.1007/s10856-007-0143-0
   Hassel AW, 2004, MINIM INVASIV THER, V13, P240, DOI 10.1080/13645700410020278
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   Leeuwenburgh S, 2001, J BIOMED MATER RES, V56, P208, DOI 10.1002/1097-4636(200108)56:2<208::AID-JBM1085>3.0.CO;2-R
   Li CY, 2007, MAT SCI ENG C-BIO S, V27, P122, DOI 10.1016/j.msec.2006.03.004
   Mali S, 2009, MAT SCI ENG C-MATER, V29, P2417, DOI 10.1016/j.msec.2009.07.003
   MATSUNAGA T, 1995, ENVIRON SCI TECHNOL, V29, P501, DOI 10.1021/es00002a028
   Misra RDK, 2009, ACTA BIOMATER, V5, P1455, DOI 10.1016/j.actbio.2008.12.017
   O'Brien B, 2002, BIOMATERIALS, V23, P1739, DOI 10.1016/S0142-9612(01)00299-X
   Parkin IP, 2005, J MATER CHEM, V15, P1689, DOI 10.1039/b412803f
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rohanizadeh R, 2004, J BIOMED MATER RES A, V71A, P343, DOI 10.1002/jbm.a.30171
   SAITO T, 1992, J PHOTOCH PHOTOBIO B, V14, P369, DOI 10.1016/1011-1344(92)85115-B
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Schlegel Urs, 2006, Injury, V37 Suppl 2, pS67, DOI 10.1016/j.injury.2006.04.011
   Shevchenko N, 2004, APPL SURF SCI, V235, P126, DOI 10.1016/j.apsusc.2004.05.273
   Shiraishi K, 2009, SURF INTERFACE ANAL, V41, P17, DOI 10.1002/sia.2965
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   TAKEUCHI K, 2005, ENHANCED INTRINSIC B, DOI DOI 10.1002/JBM.A.30227
   WATTS RJ, 1995, WATER RES, V29, P95, DOI 10.1016/0043-1354(94)E0122-M
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Wirth C, 2008, MAT SCI ENG C-BIO S, V28, P990, DOI 10.1016/j.msec.2007.10.085
   Yeung KWK, 2008, MAT SCI ENG C-BIO S, V28, P454, DOI 10.1016/j.msec.2007.04.023
NR 53
TC 11
Z9 11
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 30
PY 2010
VL 30
IS 2
BP 225
EP 234
DI 10.1016/j.msec.2009.10.003
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA 549VE
UT WOS:000274081600001
PM 30011612
DA 2018-10-20
ER

PT J
AU Kalita, SJ
   Verma, S
AF Kalita, Samar J.
   Verma, Saurabh
TI Nanocrystalline hydroxyapatite bioceramic using microwave radiation:
   Synthesis and characterization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Nanocrystalline hydroxyapatite; Nano-powder; Microwave radiation;
   Calcium phosphate; Biomaterial
ID CALCIUM-PHOSPHATE CERAMICS; IN-SITU SYNTHESIS; THERMAL-DECOMPOSITION;
   LOW-TEMPERATURE; RAPID FORMATION; IRRADIATION; POWDERS; PARTICLES;
   STABILITY; COATINGS
AB In this work, we synthesized bioactive hydroxyapatite (Ca-10(PO4)(6)(OH)(2), HAp) ceramic powder in the lower-end of nano-regime using microwave radiation, which offers several advantages. The powder was synthesized using calcium nitrate tetrahydrate and sodium phosphate dibasic anhydrous as the starting materials. EDTA served as the complex reagent. The pH of the final suspension was adjusted to 9 by adding ammonium hydroxide. Applied microwave power of 600 W. pH of the suspension, mole ratio of Ca/P in the staring chemicals, and the chelating effect of EDTA served as the factors in the synthesis of nanocrystalline HAp powder. The synthesized powder was studied using various characterizing techniques viz., XRD, SEM, HR-TEM, EDS, TG/DTA and FT-IR to determine powder morphology, particle-size, crystallinity, phases, elemental composition and thermal behavior. Results confirmed highly crystalline nano-powder (5-30 nm) with elemental composition of Ca and P in HAp phase and possessed mixed (elliptical and rod-shape) morphology. Using the Scherrer formula, the average crystallite size was found to be 12 nm. The FT-IR confirmed that the powder is of typical apatite structure. Thermal analysis showed a remarkably lower initial dehydroxylation temperature, compared to micron sized HAp, as reported in literature. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kalita, Samar J.; Verma, Saurabh] Univ Cent Florida, Dept Mech Mat & Aerosp Engn, Orlando, FL 32816 USA.
RP Kalita, SJ (reprint author), Univ N Dakota, Engineered Surfaces Ctr, Sch Engn & Mines, Stop 8391, Grand Forks, ND 58202 USA.
EM samar.kalita@und.nodak.edu
FU University of Central Florida (UCF)
FX The authors acknowledge the University of Central Florida (UCF) for
   financial support in this research. The authors also acknowledge
   experimental support from Prof Sudipta Seal of AMPAC, UCF, FL and Dr.
   Nahid Mohajeri of Florida Solar Energy Center, Cocoa, FL and editorial
   help by Chayanika D. Kalita in preparing this manuscript. Assistance
   from Materials Characterization Facility of UCF is thankfully
   recognized, as well.
CR Anee TK, 2003, MATER CHEM PHYS, V80, P725, DOI 10.1016/S0254-0584(03)00116-0
   Arami H, 2009, J ALLOY COMPD, V469, P391, DOI 10.1016/j.jallcom.2008.01.116
   BEST S, 1994, J MATER SCI-MATER M, V5, P516, DOI 10.1007/BF00124883
   BRES EF, 2005, EUR INT NAN MAT, V3
   Christian G. D., 2003, ANAL CHEM
   Cihlar J, 1999, J MATER SCI, V34, P6121, DOI 10.1023/A:1004769820545
   DRIESSENS FCM, 1978, CALC TISS RES, V26, P127, DOI 10.1007/BF02013247
   Groot K. D., 1990, HDB BIOACTIVE CERAMI, V2, P3
   Gross KA, 1998, J MATER SCI, V33, P3985, DOI 10.1023/A:1004605014652
   Han JK, 2006, MATER CHEM PHYS, V99, P235, DOI 10.1016/j.matchemphys.2005.10.017
   Han YC, 2004, MATER RES BULL, V39, P25, DOI 10.1016/j.materresbull.2003.09.022
   HARRISON A, 2004, COMPREHENSIVE COORDI, P741
   Hartmann P, 2001, J SOLID STATE CHEM, V160, P460, DOI 10.1006/jssc.2001.9274
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   HIROAKI K, 1999, J CERAM SOC JPN, V82, P2257
   Ito A, 1996, J CRYST GROWTH, V163, P311, DOI 10.1016/0022-0248(95)00955-8
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P837, DOI 10.1016/j.msec.2006.09.036
   Katakam S, 2003, MATER LETT, V57, P2716, DOI 10.1016/S0167-577X(02)01364-2
   Kelsall RW, 2005, NANOSCALE SCIENCE AND TECHNOLOGY, pXIV
   Kumar TSS, 2000, BIOMATERIALS, V21, P1623
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Lee YT, 2007, MATER CHEM PHYS, V104, P249, DOI 10.1016/j.matchemphys.2007.02.009
   LEGEROS RZ, 1978, CALC TISS RES, V26, P111, DOI 10.1007/BF02013245
   LI YB, 1994, BIOMATERIALS, V15, P835
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Luo P, 1995, MAT SCI ENG C-BIOMIM, V3, P75, DOI 10.1016/0928-4931(95)00089-5
   Manjubala I, 2001, MATER CHEM PHYS, V71, P272, DOI 10.1016/S0254-0584(01)00293-0
   Meejoo S, 2006, THERMOCHIM ACTA, V447, P115, DOI 10.1016/j.tca.2006.04.013
   Parhi P, 2004, MATER LETT, V58, P3610, DOI 10.1016/j.matlet.2004.06.056
   Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021
   Ramachandra R. R., 1997, J MATER SCI-MATER M, V8, P511
   Rameshbabu N, 2009, CURR APPL PHYS, V9, pS29, DOI 10.1016/j.cap.2008.08.018
   REHMAN I, 1995, BIOCERAMICS, V8, P163
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   Siddharthan A, 2006, SCRIPTA MATER, V55, P175, DOI 10.1016/j.scriptamat.2006.03.044
   Socrates G., 2001, INFRARED RAMAN CHARA
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Varma HK, 1998, CERAM INT, V24, P467, DOI 10.1016/S0272-8842(97)00038-2
   Vijayan S, 2002, MATER LETT, V56, P827, DOI 10.1016/S0167-577X(02)00622-5
   Wang T, 2004, J EUR CERAM SOC, V24, P693, DOI 10.1016/S0955-2219(03)00248-6
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Xu JL, 2005, BIOMATERIALS, V26, P2197, DOI 10.1016/j.biomaterials.2004.06.042
   Yang C, 2009, SOLID STATE SCI, V11, P1923, DOI 10.1016/j.solidstatesciences.2009.07.013
   Yang ZW, 2004, MATER LETT, V58, P3586, DOI 10.1016/j.matlet.2004.06.046
   Yeong KCB, 2001, BIOMATERIALS, V22, P2705, DOI 10.1016/S0142-9612(00)00257-X
   Yoon SY, 2005, MATER CHEM PHYS, V91, P48, DOI 10.1016/j.matchemphys.2004.10.049
   YOUNG RA, 1974, J DENT RES, V53, P193, DOI 10.1177/00220345740530020601
NR 51
TC 78
Z9 81
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JAN 30
PY 2010
VL 30
IS 2
BP 295
EP 303
DI 10.1016/j.msec.2009.11.007
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 549VE
UT WOS:000274081600010
PM 30011620
DA 2018-10-20
ER

PT J
AU Zhang, Y
   Li, JP
   An, GM
   He, XL
AF Zhang, Yang
   Li, Jianping
   An, Guimin
   He, Xiuli
TI Highly porous SnO2 fibers by electrospinning and oxygen plasma etching
   and its ethanol-sensing properties
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Highly porous; Tin dioxide fibers; Electrospinning; Plasma etching;
   Ethanol-sensing properties
ID GAS SENSORS; COMPOSITE FIBER; THIN-FILMS; TIN OXIDE; NANOFIBERS;
   NANOWIRES; MEMBRANES; FABRICATION; NANOBELTS; GROWTH
AB Highly porous fibers are of great benefit to many applications, such as filtration, biomaterial devices and sensing materials. The Current work is focused on preparing highly Porous fibers. It demonstrates the feasibility of preparing porous SnO2 fibers through electrospinning of poly(vinyl alcohol) (PVA)/SnCl4 center dot 5H(2)O composite and oxygen plasma etching. The process parameters of oxygen plasma etching, including etching power and etching time, were investigated. The morphology and crystal structure of the electrospun fibers were analyzed by scanning electron Microscope (SEM) and X-ray diffraction (XRD), and the ethanol-sensing properties of the porous fibers were tested. It is found that porous SnO2 fibers are composed of many nano-size fibrils which are perpendicular to fiber axis. The porous fibers exhibit large response. low detection limit (<1 ppb) to ethanol. (C) 2009 Published by Elsevier B.V.
C1 [Zhang, Yang] Chinese Acad Meteorol Sci, Lab Lightning Phys & Protect Engn, Beijing 100081, Peoples R China.
   [Zhang, Yang; Li, Jianping; He, Xiuli] Chinese Acad Sci, Inst Elect, State Key Lab Transducer Technol, Beijing 100190, Peoples R China.
   [An, Guimin] Chinese Acad Sci, Inst Chem, BNLMS, Beijing 100190, Peoples R China.
RP Zhang, Y (reprint author), Chinese Acad Meteorol Sci, Lab Lightning Phys & Protect Engn, Beijing 100081, Peoples R China.
EM zhangyang@cams.cma.gov.cn
CR Comini E, 2005, SENSOR ACTUAT B-CHEM, V111, P2, DOI 10.1016/j.snb.2005.06.031
   Dharmaraj N, 2006, SPECTROCHIM ACTA A, V64, P136, DOI 10.1016/j.saa.2005.07.007
   Gong JW, 2004, SENSOR ACTUAT B-CHEM, V102, P117, DOI 10.1016/j.snb.2004.02.055
   Guan HY, 2003, INORG CHEM COMMUN, V6, P1409, DOI 10.1016/j.inoche.2003.08.021
   Han SO, 2005, MATER LETT, V59, P2998, DOI 10.1016/j.matlet.2005.05.003
   He XL, 2003, SENSOR ACTUAT B-CHEM, V93, P463, DOI 10.1016/S0925-4005(03)00205-3
   Hu JQ, 2003, CHEM PHYS LETT, V372, P758, DOI 10.1016/S0009-2614(03)00503-7
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kessick R, 2006, SENSOR ACTUAT B-CHEM, V117, P205, DOI 10.1016/j.snb.2005.11.045
   Kim HR, 2009, SENSOR ACTUAT B-CHEM, V136, P138, DOI 10.1016/j.snb.2008.11.016
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li D, 2004, NANO LETT, V4, P933, DOI 10.1021/nl049590f
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lu F, 2000, SENSOR ACTUAT B-CHEM, V66, P225, DOI 10.1016/S0925-4005(00)00371-3
   Luo SH, 2006, NANOTECHNOLOGY, V17, P1695, DOI 10.1088/0957-4484/17/6/025
   Luoh R, 2006, COMPOS SCI TECHNOL, V66, P2436, DOI 10.1016/j.compscitech.2006.03.012
   Macias M, 2005, MICROPOR MESOPOR MAT, V86, P1, DOI 10.1016/j.micromeso.2005.05.053
   McCann JT, 2006, J AM CHEM SOC, V128, P1436, DOI 10.1021/ja056810y
   Onozuka K, 2006, NANOTECHNOLOGY, V17, P1026, DOI 10.1088/0957-4484/17/4/030
   Patil SB, 2007, SENSOR ACTUAT B-CHEM, V125, P126, DOI 10.1016/j.snb.2007.01.047
   Qi ZH, 2009, MATER LETT, V63, P415, DOI 10.1016/j.matlet.2008.10.059
   Ren GL, 2006, REACT FUNCT POLYM, V66, P1559, DOI 10.1016/j.reactfunctpolym.2006.05.005
   Sakai G, 2001, SENSOR ACTUAT B-CHEM, V80, P125, DOI 10.1016/S0925-4005(01)00890-5
   Salehi A, 2003, SENSOR ACTUAT B-CHEM, V96, P88, DOI 10.1016/S0925-4005(03)00490-8
   Shen YB, 2009, SENSOR ACTUAT B-CHEM, V135, P524, DOI 10.1016/j.snb.2008.09.010
   Shutov AA, 2006, TECH PHYS+, V51, P1093, DOI 10.1134/S1063784206080214
   Veleirinho B, 2009, PROCESS BIOCHEM, V44, P353, DOI 10.1016/j.procbio.2008.11.008
   Wang D, 2006, SENSOR ACTUAT B-CHEM, V117, P183, DOI 10.1016/j.snb.2005.11.022
   Yang MR, 2007, SENSOR ACTUAT B-CHEM, V122, P269, DOI 10.1016/j.snb.2006.05.034
   Yang XG, 2005, THIN SOLID FILMS, V478, P228, DOI 10.1016/j.tsf.2004.11.102
   Yang XH, 2004, INORG CHEM COMMUN, V7, P176, DOI 10.1016/j.inoche.2003.10.035
   Yip J, 2006, APPL SURF SCI, V253, P2493, DOI 10.1016/j.apsusc.2006.05.004
   Zhang Y, 2008, SENSOR ACTUAT B-CHEM, V132, P67, DOI 10.1016/j.snb.2008.01.006
   Zhao J, 2006, SENSOR ACTUAT B-CHEM, V115, P460, DOI 10.1016/j.snb.2005.10.024
NR 34
TC 101
Z9 106
U1 4
U2 83
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JAN 29
PY 2010
VL 144
IS 1
BP 43
EP 48
DI 10.1016/j.snb.2009.10.012
PG 6
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 561AR
UT WOS:000274947800008
DA 2018-10-20
ER

PT J
AU Hafaid, I
   Chebil, S
   Korri-Youssoufi, H
   Bessueille, F
   Errachid, A
   Sassi, Z
   Ali, Z
   Abdelghani, A
   Jaffrezic-Renault, N
AF Hafaid, Imen
   Chebil, Syrine
   Korri-Youssoufi, Hafsa
   Bessueille, Francois
   Errachid, Abdelhamid
   Sassi, Zina
   Ali, Zulfiqur
   Abdelghani, Adnane
   Jaffrezic-Renault, Nicole
TI Effect of electrical conditions on an impedimetric immunosensor based on
   a modified conducting polypyrrole
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Review
DE Immunosensors; Conducting polymer; Impedance spectroscopy; His-tag
   antibody
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ANTIBODY-ANTIGEN REACTIONS;
   HISTIDINE-TAGGED PROTEINS; POLYMER; FILMS; BIOSENSORS; ELECTRODES;
   BIOCOMPATIBILITY; IMMOBILIZATION; AMPLIFICATION
AB This work has explored the development of impedimetric immunosensors based on a conducting co-polypyrrole film to which a histidine tag antibody has been bound Using a complex NTA chelator coordinated with copper as metal. The electrical properties of the copolymer film have been characterized by electrochemical impedance spectroscopy (EIS). The experimental study of EIS was performed over a range of dc voltages from 0V to -1.4V (vs. saturated calomel electrode SCE) where the polypyrrole layers transit from their conducting to insulating state and to demonstrate the contribution of the copper complex as redox probe. The electrical behavior of the biomaterial at these various potentials was studied according to an equivalent circuit fitting the experimental parameters. The results indicated that better immunosensor characteristics were obtained at an applied potential of -1400mV where the reduction Of copper occurs. The impedance obtained at this potential shows a linear variation of charge transfer resistance (R-ct) with the specific antigen concentration in the range 0.1-10 ng mL(-1) with a detection limit of 0.1 ng mL(-1). Moreover, this study demonstrates that these immunosensors exhibit high sensitivity, stability and reproducibility. (C) 2009 Elsevier B.V. All rights reserved
C1 [Hafaid, Imen; Bessueille, Francois; Errachid, Abdelhamid; Jaffrezic-Renault, Nicole] Univ Lyon 1, Analyt Sci Lab, CNRS, UMR 5180, F-69622 Villeurbanne, France.
   [Hafaid, Imen; Sassi, Zina] Inst Natl Sci Appl, Ampere Lab, F-69621 Villeurbanne, France.
   [Chebil, Syrine; Korri-Youssoufi, Hafsa] Univ Paris 11, CNRS, Equipe Chim Bioorgan & Bioinorgan, ICMMO,UMR 8182, F-91405 Orsay, France.
   [Ali, Zulfiqur] Univ Teesside, Middlesbrough TS1 3BA, Tees Valley, England.
   [Abdelghani, Adnane] IPEST, Unite Rech Phys Semicond & Capteurs, Tunis 2070, Tunisia.
RP Hafaid, I (reprint author), Univ Lyon 1, Analyt Sci Lab, CNRS, UMR 5180, 43 Blvd 11 Novembre 1918, F-69622 Villeurbanne, France.
EM imen_haf@yahoo.fr
OI Korri-Youssoufi, Hafsa/0000-0002-5858-5385; Ali,
   Zulfiqur/0000-0001-9884-8146
FU European Commission [FP6-IST-34256]; NATO [CLG 982802]
FX This work was supported by European Commission through DVT-IMP project
   (FP6-IST-34256) and by NATO through CLG grant # CLG 982802.
CR Atta NF, 2007, APPL SURF SCI, V253, P4273, DOI 10.1016/j.apsusc.2006.09.025
   Azioune A, 2005, ELECTROCHIM ACTA, V50, P1661, DOI 10.1016/j.electacta.2004.10.014
   BARTLETT PN, 1993, SYNTHETIC MET, V61, P15, DOI 10.1016/0379-6779(93)91194-7
   Bayramoglu G, 2006, SEP PURIF TECHNOL, V50, P229, DOI 10.1016/j.seppur.2005.11.030
   Blankespoor R, 2005, LANGMUIR, V21, P3362, DOI 10.1021/la047139y
   CHEBIL S, ADV MAT UNPUB
   Chinn D, 1999, SYNTHETIC MET, V102, P930, DOI 10.1016/S0379-6779(98)00963-1
   Ciumasu IM, 2005, BIOSENS BIOELECTRON, V21, P354, DOI 10.1016/j.bios.2004.10.027
   Diagne AA, 2007, CR CHIM, V10, P558, DOI 10.1016/j.crci.2006.03.006
   DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/0368-1874(81)87387-X
   Ehrenbeck C, 1998, ELECTROCHIM ACTA, V43, P2781, DOI 10.1016/S0013-4686(98)00019-X
   Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Gurunathan K, 2003, MATER LETT, V57, P1642, DOI 10.1016/S0167-577X(02)01045-5
   Haddour N, 2005, J AM CHEM SOC, V127, P5752, DOI 10.1021/ja050390v
   Hafaiedh I, 2008, MAT SCI ENG C-BIO S, V28, P584, DOI 10.1016/j.msec.2007.10.064
   Hallik A, 2006, SYNTHETIC MET, V156, P488, DOI 10.1016/j.synthmet.2006.02.004
   HEINZE J, 1993, BER BUNSEN PHYS CHEM, V97, P502, DOI 10.1002/bbpc.19930970345
   Helali S, 2008, MAT SCI ENG C-BIO S, V28, P826, DOI 10.1016/j.msec.2007.10.078
   KANAZAWA KK, 1981, SYNTHETIC MET, V4, P119, DOI 10.1016/0379-6779(81)90027-8
   Khan W, 2007, ACTA BIOMATER, V3, P541, DOI 10.1016/j.actbio.2007.01.006
   Lange U, 2008, ANAL CHIM ACTA, V614, P1, DOI 10.1016/j.aca.2008.02.068
   Macdonald DD, 2006, ELECTROCHIM ACTA, V51, P1376, DOI 10.1016/j.electacta.2005.02.107
   Malhotra BD, 2006, ANAL CHIM ACTA, V578, P59, DOI 10.1016/j.aca.2006.04.055
   OGASAWARA M, 1986, SYNTHETIC MET, V14, P61
   Omastova M, 1999, SYNTHETIC MET, V102, P1251, DOI 10.1016/S0379-6779(98)01453-2
   Ouerghi O, 2001, J ELECTROANAL CHEM, V501, P62, DOI 10.1016/S0022-0728(00)00485-X
   Park IS, 2006, ANAL CHIM ACTA, V578, P19, DOI 10.1016/j.aca.2006.07.015
   Patil RC, 2006, PROG ORG COAT, V57, P332, DOI 10.1016/j.porgcoat.2006.09.012
   Pei RJ, 2001, BIOSENS BIOELECTRON, V16, P355, DOI 10.1016/S0956-5663(01)00150-6
   Ramanaviciene A, 2007, J PHARM PHARMACOL, V59, P311, DOI 10.1211/jpp.59.2.0017
   Ramanavicius A, 2006, ELECTROCHIM ACTA, V51, P6025, DOI 10.1016/j.electacta.2005.11.052
   Ramanavicius A, 1999, ANAL CHEM, V71, P3581, DOI 10.1021/ac981201c
   Ramon-Azcon J, 2008, BIOSENS BIOELECTRON, V23, P1367, DOI 10.1016/j.bios.2007.12.010
   Sahin E, 2006, ORG ELECTRON, V7, P351, DOI 10.1016/j.orgel.2006.04.001
   Saoudi B, 2000, SENSOR ACTUAT B-CHEM, V62, P35, DOI 10.1016/S0925-4005(99)00356-1
   Sargent A, 1999, ELECTROCHIM ACTA, V44, P4667, DOI 10.1016/S0013-4686(99)00265-0
   SEZAI SA, 2008, SURFACE COATINGS TEC, V202, P3997
   SHIMIDZU T, 1987, J ELECTROANAL CHEM, V224, P123, DOI 10.1016/0022-0728(87)85088-X
   STUBB H, 1993, MAT SCI ENG R, V10, P85, DOI 10.1016/0920-2307(93)90004-X
   SUGANO T, 1987, SYNTHETIC MET, V17, P685, DOI 10.1016/0379-6779(87)90820-4
   Travas-Sejdic J, 2006, CURR APPL PHYS, V6, P562, DOI 10.1016/j.cap.2005.11.061
   Wang MJ, 2004, BIOSENS BIOELECTRON, V19, P575, DOI 10.1016/S0956-5663(03)00252-5
NR 43
TC 41
Z9 41
U1 0
U2 35
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD JAN 29
PY 2010
VL 144
IS 1
BP 323
EP 331
DI 10.1016/j.snb.2009.08.058
PG 9
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 561AR
UT WOS:000274947800050
OA Green Published
DA 2018-10-20
ER

PT J
AU Boudou, T
   Crouzier, T
   Ren, KF
   Blin, G
   Picart, C
AF Boudou, Thomas
   Crouzier, Thomas
   Ren, Kefeng
   Blin, Guillaume
   Picart, Catherine
TI Multiple Functionalities of Polyelectrolyte Multilayer Films: New
   Biomedical Applications
SO ADVANCED MATERIALS
LA English
DT Review
ID BY-LAYER DEPOSITION; ATOMIC-FORCE MICROSCOPY; EXPONENTIALLY GROWING
   MULTILAYERS; HUMAN UMBILICAL ARTERIES; CELL-ADHESION PROPERTIES;
   FIBROBLAST-GROWTH-FACTOR; PHOTO-CROSS-LINKING; SMOOTH-MUSCLE-CELLS;
   HUMAN SERUM-ALBUMIN; POLY-L-LYSINE
AB The design of advanced functional materials with nanometer- and micrometer-scale control over their properties is of considerable interest for both fundamental and applied studies because of the many potential applications for these materials in the fields of biomedical materials, tissue engineering, and regenerative medicine. The layer-by-layer deposition technique introduced in the early 1990s by Decher, Moehwald, and Lvov is a versatile technique, which has attracted an increasing number of researchers in recent years due to its wide range of advantages for biomedical applications: ease of preparation under "mild" conditions compatible with physiological media, capability of incorporating bioactive molecules, extra cellular matrix components and biopolymers in the films, tunable mechanical properties, and spatio-temporal control over film organization. The last few years have seen a significant increase in reports exploring the possibilities offered by diffusing molecules into films to control their internal structures or design "reservoirs", as well as control their mechanical properties. Such properties, associated with the chemical properties of films, are particularly important for designing biomedical devices that contain bioactive molecules. In this review, we highlight recent work on designing and controlling film properties at the nanometer and micrometer scales with a view to developing new biomaterial coatings, tissue engineered constructs that could mimic in vivo cellular microenvironments, and stem cell "niches".
C1 [Boudou, Thomas; Ren, Kefeng; Picart, Catherine] Grenoble INP, LMGP, MINATEC, CNRS,UMR 5628, F-38016 Grenoble, France.
   [Crouzier, Thomas; Blin, Guillaume; Picart, Catherine] Univ Montpellier 2, CNRS, UMR 5235, F-34095 Montpellier 05, France.
RP Picart, C (reprint author), Grenoble INP, LMGP, MINATEC, CNRS,UMR 5628, 3 Parvis Louis Neel, F-38016 Grenoble, France.
EM Catherine.picart@minatec.grenoble-inp.fr
RI Boudou, Thomas/A-9089-2013; Ren, Ke-feng/I-3593-2012
OI Crouzier, Thomas/0000-0002-1981-3736; PICART,
   Catherine/0000-0002-4854-6366; Boudou, Thomas/0000-0002-6821-2937;
   PICART, Catherine/0000-0003-0130-1000
FU "Association Francaise contre les Myopathies" (AFM); "Association pour
   la Recherche sur la Cancer" (ARC); "Fondation Recherche Medicale" (FRM);
   ANR PNANO program; Institut Universitaire de France
FX The authors gratefully acknowledge the financial support of the
   "Association Francaise contre les Myopathies" (AFM), the "Association
   pour la Recherche sur la Cancer" (ARC), the "Fondation Recherche
   Medicale" (FRM), and the ANR PNANO program. C. P. is a junior Member of
   the "Institut Universitaire de France" whose support is gratefully
   acknowledged.
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Ai H, 2002, BIOMACROMOLECULES, V3, P560, DOI 10.1021/bm015659r
   ALBERTS W, 1994, MOL BIOL CELL
   Ball V, 2005, LANGMUIR, V21, P8526, DOI 10.1021/la050866o
   Ballt V, 2009, LANGMUIR, V25, P3593, DOI 10.1021/la803730j
   Battle AR, 2009, ADV FUNCT MATER, V19, P201, DOI 10.1002/adfm.200800483
   Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Benkirane-Jessel N, 2004, ADV FUNCT MATER, V14, P174, DOI 10.1002/adfm.200304413
   Berg J M, 2002, BIOCHEMISTRY
   Berg MC, 2006, BIOMACROMOLECULES, V7, P357, DOI 10.1021/bm050174e
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Berthelemy N, 2008, ADV MATER, V20, P2674, DOI 10.1002/adma.200702418
   Blacklock J, 2007, BIOMATERIALS, V28, P117, DOI 10.1016/j.biomaterials.2006.08.035
   Blacklock J, 2009, BIOMATERIALS, V30, P939, DOI 10.1016/j.biomaterials.2008.10.012
   Boulmedais F, 2003, LANGMUIR, V19, P440, DOI 10.1021/la0264522
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Boulmedais F, 2003, LANGMUIR, V19, P9873, DOI 10.1021/la0348259
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Bratskaya S, 2007, BIOMACROMOLECULES, V8, P2960, DOI 10.1021/bm700620j
   BRUNOT C, 2008, DENT MAT
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Cai KY, 2008, ANGEW CHEM INT EDIT, V47, P7479, DOI 10.1002/anie.200800412
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Caruso F, 1999, MACROMOLECULES, V32, P2317, DOI 10.1021/ma980674i
   Caruso F, 1997, LANGMUIR, V13, P3422, DOI 10.1021/la960821a
   Chen AA, 2009, BIOMATERIALS, V30, P1113, DOI 10.1016/j.biomaterials.2008.10.055
   Chen AM, 2001, BIODRUGS, V15, P833, DOI 10.2165/00063030-200115120-00005
   Chen J, 2007, SMALL, V3, P636, DOI 10.1002/smll.200600301
   Chien HW, 2009, BIOMATERIALS, V30, P2209, DOI 10.1016/j.biomaterials.2008.12.060
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Cho J, 2004, J AM CHEM SOC, V126, P2270, DOI 10.1021/ja039830d
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Collin D, 2004, MACROMOLECULES, V37, P10195, DOI 10.1021/ma048683g
   Coviello T, 2006, EXPERT OPIN DRUG DEL, V3, P395, DOI 10.1517/17425247.3.3.395
   Croll TI, 2006, BIOMACROMOLECULES, V7, P1610, DOI 10.1021/bm060044l
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Crouzier T, 2009, BIOMACROMOLECULES, V10, P433, DOI 10.1021/bm8012378
   Dai JH, 2001, LANGMUIR, V17, P931, DOI 10.1021/la001363f
   Darabi R, 2008, CELL CYCLE, V7, P1732, DOI 10.4161/cc.7.12.6159
   De Geest BG, 2007, CHEM SOC REV, V36, P636, DOI 10.1039/b600460c
   Debreczeny M, 2003, J PHYS CHEM B, V107, P12734, DOI 10.1021/jp035037v
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DECHER G, 1994, THIN SOLID FILMS, V244, P772, DOI 10.1016/0040-6090(94)90569-X
   DECHER JB, 2003, MULTILAYER THIN FILM
   Delajon C, 2005, LANGMUIR, V21, P8509, DOI 10.1021/la050407n
   Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Dimitrova M, 2008, P NATL ACAD SCI USA, V105, P16320, DOI 10.1073/pnas.0800156105
   Dimitrova M, 2007, ADV FUNCT MATER, V17, P233, DOI 10.1002/adfm.200600155
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dubas ST, 2001, LANGMUIR, V17, P7725, DOI 10.1021/la0112099
   Dubas ST, 1999, MACROMOLECULES, V32, P8153, DOI 10.1021/ma981927a
   El Haitami AE, 2009, LANGMUIR, V25, P2282, DOI 10.1021/la803534y
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Etienne O, 2005, BIOMATERIALS, V26, P6704, DOI 10.1016/j.biomaterials.2005.04.068
   Fatisson J, 2008, LANGMUIR, V24, P3294, DOI 10.1021/1a7023204
   Ferri JK, 2006, MACROMOLECULES, V39, P1532, DOI 10.1021/ma0516485
   Fery A, 2001, LANGMUIR, V17, P3779, DOI 10.1021/la102612
   Fischlechner M, 2007, NANO LETT, V7, P3540, DOI [10.1021/nl0723580, 10.1021/nI0723580]
   Forry SP, 2006, LANGMUIR, V22, P5770, DOI 10.1021/la053244b
   Francius G, 2006, MICROSC RES TECHNIQ, V69, P84, DOI 10.1002/jemt.20275
   Francius G, 2007, J PHYS CHEM C, V111, P8299, DOI 10.1021/jp070435+
   Francius G, 2007, LANGMUIR, V23, P2602, DOI 10.1021/la0629101
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Garza JM, 2004, LANGMUIR, V20, P7298, DOI 10.1021/la049106o
   Garza JM, 2005, LANGMUIR, V21, P12372, DOI 10.1021/la051465b
   Gergely C, 2004, LANGMUIR, V20, P5575, DOI 10.1021/la049932x
   Gheith MK, 2005, ADV MATER, V17, P2663, DOI 10.1002/adma.200500366
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   Guillaume-Gentil O, 2008, ADV MATER, V20, P560, DOI 10.1002/adma.200700758
   Guyomard A, 2005, MACROMOLECULES, V38, P5737, DOI 10.1021/ma050867n
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793
   Halthur TJ, 2006, LANGMUIR, V22, P11065, DOI 10.1021/la0607712
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Han JT, 2005, J PHYS CHEM B, V109, P20773, DOI 10.1021/jp052691x
   Haynie DT, 2004, LANGMUIR, V20, P4540, DOI 10.1021/la036330p
   Haynie DT, 2005, BIOMACROMOLECULES, V6, P2895, DOI 10.1021/bm050525p
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Heuvingh J, 2005, LANGMUIR, V21, P3165, DOI 10.1021/la047388m
   Hillberg AL, 2006, BIOMACROMOLECULES, V7, P2742, DOI 10.1021/bm060266j
   Houska M, 2008, J BIOMED MATER RES A, V86A, P769, DOI 10.1002/ibm.a.31663
   Huang LY, 2008, COLLOID SURFACE B, V61, P43, DOI 10.1016/j.colsurfb.2007.07.004
   Huang LY, 2006, J NANOSCI NANOTECHNO, V6, P3163, DOI 10.1166/jnn.2006.430
   Hubsch E, 2005, LANGMUIR, V21, P3664, DOI 10.1021/la047258d
   Hubsch E, 2004, LANGMUIR, V20, P1980, DOI 10.1021/la0361870
   Izquierdo A, 2005, LANGMUIR, V21, P7558, DOI 10.1021/la047407s
   Izumrudov V, 2003, LANGMUIR, V19, P5188, DOI 10.1021/la034360m
   Jaber JA, 2006, J AM CHEM SOC, V128, P2940, DOI 10.1021/ja055892n
   Jaber JA, 2006, CURR OPIN COLLOID IN, V11, P324, DOI 10.1016/j.cocis.2006.09.008
   Jaber JA, 2007, LANGMUIR, V23, P896, DOI 10.1021/la061839g
   Jackler G, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041912
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Ji J, 2006, ADV MATER, V18, P1441, DOI 10.1002/adma.200502453
   Jia NQ, 2007, NANO LETT, V7, P2976, DOI 10.1021/nl071114c
   Jiang CY, 2004, ADV MATER, V16, P157, DOI 10.1002/adma.200306010
   Jiang CY, 2004, LANGMUIR, V20, P882, DOI 10.1021/la0355085
   Jomaa HW, 2005, LANGMUIR, V21, P8081, DOI 10.1021/la051117+
   Jourdainne L, 2008, LANGMUIR, V24, P7842, DOI 10.1021/la7040168
   Kerdjoudj H, 2008, J AM COLL CARDIOL, V52, P1589, DOI 10.1016/j.jacc.2008.08.009
   Kerdjoudj H, 2007, ADV FUNCT MATER, V17, P2667, DOI 10.1002/adfm.200600795
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Kharlampieva E, 2004, LANGMUIR, V20, P9677, DOI 10.1021/la048763d
   Kidambi S, 2004, J AM CHEM SOC, V126, P16286, DOI 10.1021/ja046188u
   Kidambi S, 2008, ADV FUNCT MATER, V18, P294, DOI 10.1002/adfm.200601237
   Kidambi S, 2008, LANGMUIR, V24, P224, DOI 10.1021/la702925r
   Kidambi S, 2007, MACROMOL BIOSCI, V7, P344, DOI 10.1002/mabi.200600205
   Kinnane CR, 2009, SMALL, V5, P444, DOI 10.1002/smll.200801012
   Koktysh DS, 2002, ADV FUNCT MATER, V12, P255, DOI 10.1002/1616-3028(20020418)12:4<255::AID-ADFM255>3.0.CO;2-1
   Kreke MR, 2005, BIOMATERIALS, V26, P2975, DOI 10.1016/j.biomaterials.2004.08.013
   Krol S, 2004, IEEE T NANOBIOSCI, V3, P32, DOI 10.1109/TNB.2004.824279
   Krol S, 2006, NANO LETT, V6, P1933, DOI 10.1021/nl061049r
   Kujawa P, 2005, J AM CHEM SOC, V127, P9224, DOI 10.1021/ja044385n
   Kujawa P, 2007, BIOMACROMOLECULES, V8, P3169, DOI 10.1021/bm7006339
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumara MT, 2007, BIOMACROMOLECULES, V8, P3718, DOI 10.1021/bm7005449
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Laugel N, 2006, J PHYS CHEM B, V110, P19443, DOI 10.1021/jp062264z
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Lavalle P, 2004, J PHYS CHEM B, V108, P635, DOI 10.1021/jp035740j
   Lavalle P, 2004, MACROMOLECULES, V37, P1159, DOI 10.1021/ma035326h
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lee H, 2008, ADV MATER, V20, P1619, DOI 10.1002/adma.200702378
   Lee SS, 2001, MACROMOLECULES, V34, P5358, DOI 10.1021/ma0022304
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li BY, 2004, BIOMACROMOLECULES, V5, P1667, DOI 10.1021/bm0496155
   Li BY, 2005, J NANOSCI NANOTECHNO, V5, P2042, DOI 10.1166/jnn.2005.503
   Li M, 2005, J NANOSCI NANOTECHNO, V5, P1809, DOI 10.1166/jnn.2005.436
   Li MY, 2005, IEEE T NANOBIOSCI, V4, P170, DOI 10.1109/TNB.2005.850477
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lin YH, 2007, SOFT MATTER, V3, P432, DOI 10.1039/b617343h
   Lingstrom R, 2008, J COLLOID INTERF SCI, V328, P233, DOI 10.1016/j.jcis.2008.08.065
   Liu M, 2007, LANGMUIR, V23, P9378, DOI 10.1021/la7002996
   LIU X, 2005, MACROMOL BIOSCI, V5
   Liu XH, 2008, ADV MATER, V20, P4148, DOI 10.1002/adma.200800881
   Liu XH, 2005, J BIOMED NANOTECHNOL, V1, P54, DOI 10.1166/jbn.2005.013
   Liu YX, 2005, COLLOID SURFACE B, V46, P117, DOI 10.1016/j.colsurfb.2005.09.005
   Lourenco JMC, 2004, LANGMUIR, V20, P8103, DOI 10.1021/la049872v
   Lu YX, 2008, LANGMUIR, V24, P8050, DOI 10.1021/la800998n
   Lu ZZ, 2008, BIOMATERIALS, V29, P733, DOI 10.1016/j.biomaterials.2007.10.033
   LVOV Y, 1994, PHYSICA B, V198, P89, DOI 10.1016/0921-4526(94)90134-1
   Lynn DM, 2007, ADV MATER, V19, P4118, DOI 10.1002/adma.200701748
   Ma L, 2007, J BIOMED MATER RES B, V83B, P285, DOI 10.1002/jbm.b.30794
   Malcher M, 2008, LANGMUIR, V24, P10209, DOI 10.1021/la8014755
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   Markutsya S, 2005, ADV FUNCT MATER, V15, P771, DOI 10.1002/adfm.200400149
   Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108
   McAloney RA, 2001, LANGMUIR, V17, P6655, DOI 10.1021/la010136q
   Mehta G, 2007, ADV FUNCT MATER, V17, P2701, DOI 10.1002/adfm.200700016
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Mermut O, 2003, MACROMOLECULES, V36, P8819, DOI 10.1021/ma034967+
   Meyer F, 2008, BIOMATERIALS, V29, P618, DOI 10.1016/j.biomaterials.2007.10.027
   Mhamdi L, 2006, MAT SCI ENG C-BIO S, V26, P273, DOI 10.1016/j.msec.2005.10.049
   Moby V, 2007, BIOMACROMOLECULES, V8, P2156, DOI 10.1021/bm070348n
   Mohammed JS, 2004, BIOMACROMOLECULES, V5, P1745, DOI 10.1021/bm0498631
   Mohammed JS, 2006, LANGMUIR, V22, P2738, DOI 10.1021/la0525473
   Muller S, 2008, ADV FUNCT MATER, V18, P1767, DOI 10.1002/adfm.200701233
   Nadiri A, 2007, SMALL, V3, P1577, DOI 10.1002/smll.200700115
   Nakahara Y, 2007, J BIOMAT SCI-POLYM E, V18, P1565
   Nazaran P, 2007, J PHYS CHEM B, V111, P8572, DOI 10.1021/jp068768e
   Nichols JE, 2009, BIOMATERIALS, V30, P1071, DOI 10.1016/j.biomaterials.2008.10.041
   Nolte AJ, 2008, MACROMOLECULES, V41, P5793, DOI 10.1021/ma800732j
   Nolte AJ, 2007, MACROMOLECULES, V40, P5479, DOI 10.1021/ma070807c
   Nolte M, 2006, CHEMPHYSCHEM, V7, P1985, DOI 10.1002/cphc.200600300
   Olenych SG, 2005, BIOMACROMOLECULES, V6, P3252, DOI 10.1021/bm050298r
   Olugebefola SC, 2006, LANGMUIR, V22, P5958, DOI 10.1021/la060315d
   Olugebefola SC, 2008, LANGMUIR, V24, P5172, DOI 10.1021/la703936p
   Ostrander JW, 2001, J AM CHEM SOC, V123, P1101, DOI 10.1021/ja0029578
   Park J, 2005, ADV MATER, V17, P2575, DOI 10.1002/adma.200501075
   Park MK, 2004, J AM CHEM SOC, V126, P13723, DOI 10.1021/ja0484707
   Park MK, 2005, LANGMUIR, V21, P5272, DOI 10.1021/la047008x
   Pastorino L, 2006, IEE P-NANOBIOTECHNOL, V153, P16, DOI 10.1049/ip-nbt:200500030
   Pavoor PV, 2004, MACROMOLECULES, V37, P4865, DOI 10.1021/ma049777t
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2005, MICROSC RES TECHNIQ, V66, P43, DOI 10.1002/jemt.20142
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Picart C, 2007, COLLOID SURFACE A, V303, P30, DOI 10.1016/j.colsurfa.2007.02.015
   Pilbat AM, 2006, LANGMUIR, V22, P5753, DOI 10.1021/la060454v
   Pilbat AM, 2007, LANGMUIR, V23, P8236, DOI 10.1021/la700839p
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+
   Podsiadlo P, 2008, NANO LETT, V8, P1762, DOI 10.1021/nl8011648
   Podsiadlo P, 2007, NANO LETT, V7, P1224, DOI [10.1021/nl0700649, 10.1021/nI0700649]
   Podsiadlo P, 2007, ADV MATER, V19, P949, DOI 10.1002/adma.200602706
   Porcel C, 2007, LANGMUIR, V23, P1898, DOI 10.1021/la062728k
   Porcel C, 2006, LANGMUIR, V22, P4376, DOI 10.1021/la053218d
   Quinn A, 2008, ADV FUNCT MATER, V18, P17, DOI 10.1002/adfm.200700472
   Quinn A, 2007, LANGMUIR, V23, P4944, DOI 10.1021/la0634746
   Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553
   RATNER BD, 1996, BIOMATERIALS SICENCE
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Reisch A, 2009, LANGMUIR, V25, P3610, DOI 10.1021/la8037846
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Reyes DR, 2004, LANGMUIR, V20, P8805, DOI 10.1021/la049249a
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Richert L., 2004, LANGMUIR, V1, P284
   Riegler H, 2002, LANGMUIR, V18, P6694, DOI 10.1021/la020108n
   Rinckenbach S, 2008, J BIOMED MATER RES A, V84A, P576, DOI 10.1002/jbm.a.31333
   Rudra JS, 2006, J BIOMAT SCI-POLYM E, V17, P1301, DOI 10.1163/156856206778667433
   Safouane M, 2005, J COLLOID INTERF SCI, V292, P86, DOI 10.1016/j.jcis.2005.05.061
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Salomaki M, 2007, J PHYS CHEM B, V111, P8509, DOI 10.1021/jp067344h
   Salomaki M, 2005, LANGMUIR, V21, P11232, DOI 10.1021/la051600k
   Salomaki M, 2004, MACROMOLECULES, V37, P9585, DOI 10.1021/ma048701u
   Salomaki M, 2004, LANGMUIR, V20, P3679, DOI 10.1021/la036328y
   Salomaki M, 2008, MACROMOLECULES, V41, P4423, DOI 10.1021/ma800315j
   Salomaki M, 2009, BIOMACROMOLECULES, V10, P294, DOI 10.1021/bm8010177
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schlenoff JB, 2000, LANGMUIR, V16, P9968, DOI 10.1021/la001312i
   Schlenoff JB, 1998, J AM CHEM SOC, V120, P7626, DOI 10.1021/ja980350+
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Schneider A, 2007, LANGMUIR, V23, P2655, DOI 10.1021/la062163s
   Schneider A, 2007, BIOMACROMOLECULES, V8, P139, DOI 10.1021/bm060765k
   Schneider A, 2006, BIOMACROMOLECULES, V7, P2882, DOI 10.1021/bm0605208
   Schoeler B, 2006, BIOMACROMOLECULES, V7, P2065, DOI 10.1021/bm060378a
   Schonhoff M, 2007, COLLOID SURFACE A, V303, P14, DOI 10.1016/j.colsurfa.2007.02.054
   SCHOUTEN C, 2009, J BIOMED A IN PRESS
   Schuetz P, 2003, ADV FUNCT MATER, V13, P929, DOI 10.1002/adfm.200304483
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   SEMENOV V, 2009, TISSUE EN A IN PRESS
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Shi F, 2005, ADV MATER, V17, P1005, DOI 10.1002/adma.200402090
   Shim BS, 2007, NANO LETT, V7, P3266, DOI 10.1021/nl071245d
   Simon-Assmann P, 1993, Semin Cell Biol, V4, P221, DOI 10.1006/scel.1993.1026
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Song ZJ, 2009, MACROMOL BIOSCI, V9, P268, DOI 10.1002/mabi.200800164
   Sperling C, 2006, J BIOMED MATER RES A, V76A, P681, DOI 10.1002/jbm.a.30519
   Srivastava S, 2008, ACCOUNTS CHEM RES, V41, P1831, DOI 10.1021/ar8001377
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Such GK, 2007, NANO LETT, V7, P1706, DOI 10.1021/nl070698f
   Sui ZJ, 2003, LANGMUIR, V19, P2491, DOI 10.1021/la026531d
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Sukhishvili SA, 2006, MACROMOLECULES, V39, P8873, DOI 10.1021/ma061617p
   Sun B, 2007, LANGMUIR, V23, P8452, DOI 10.1021/la7010875
   Swiston AJ, 2008, NANO LETT, V8, P4446, DOI 10.1021/nl802404h
   Szyk L, 2001, LANGMUIR, V17, P6248, DOI 10.1021/la0104469
   Tan QG, 2005, J MATER SCI-MATER M, V16, P687, DOI 10.1007/s10856-005-2541-5
   Tan QG, 2003, BIOMATERIALS, V24, P4699, DOI 10.1016/S0142-9612(03)00363-6
   Tanchak OM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2943201
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Teramura Y, 2008, BIOCONJUGATE CHEM, V19, P1389, DOI 10.1021/bc800064t
   Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050
   Tezcaner A, 2006, BIOMACROMOLECULES, V7, P86, DOI 10.1021/bm0506134
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thompson MT, 2006, BIOMACROMOLECULES, V7, P1990, DOI 10.1021/bm060146b
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Thorne RG, 2008, P NATL ACAD SCI USA, V105, P8416, DOI 10.1073/pnas.0711345105
   Tong WJ, 2005, CHEM MATER, V17, P4610, DOI 10.1021/cm0507516
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   van den Beucken JJJP, 2007, ACTA BIOMATER, V3, P587, DOI 10.1016/j.actbio.2006.12.007
   van den Beucken JJJR, 2007, J BIOMED MATER RES B, V81B, P231, DOI 10.1002/jbm.b.30658
   Vautier D, 2003, CELL MOTIL CYTOSKEL, V56, P147, DOI 10.1002/cm.10140
   Vazquez CP, 2009, LANGMUIR, V25, P3556, DOI 10.1021/la803577t
   Veerabadran NG, 2007, MACROMOL BIOSCI, V7, P877, DOI 10.1002/mabi.200700061
   Vodouhe C, 2006, BIOMATERIALS, V27, P4149, DOI 10.1016/j.biomaterials.2006.03.024
   Vodouhe C, 2005, BIOMATERIALS, V26, P545, DOI 10.1016/j.biomaterials.2004.02.057
   von Klitzing R, 2006, PHYS CHEM CHEM PHYS, V8, P5012, DOI 10.1039/b607760a
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Wang F, 2007, LANGMUIR, V23, P9540, DOI 10.1021/1a701969q
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Wilson JT, 2007, BIOMATERIALS, V28, P609, DOI 10.1016/j.biomaterials.2006.09.003
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Wu XD, 2004, BIOMACROMOLECULES, V5, P1214, DOI 10.1021/bm034540a
   Wu ZR, 2007, J BIOMED MATER RES A, V81A, P355, DOI 10.1002/jbm.a.30993
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Yoo PJ, 2008, ACS NANO, V2, P561, DOI 10.1021/nn700404y
   Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596
   Yuan WY, 2007, LANGMUIR, V23, P13046, DOI 10.1021/la702774a
   Zacharia NS, 2007, MACROMOLECULES, V40, P9523, DOI 10.1021/ma071828+
   Zacharia NS, 2007, MACROMOLECULES, V40, P1598, DOI 10.1021/ma061080f
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
   Zhai L, 2006, NANO LETT, V6, P1213, DOI 10.1021/nl060644q
   Zhang J, 2005, BIOMATERIALS, V26, P3353, DOI 10.1016/j.biomaterials.2004.08.019
   Zhang L, 2005, LANGMUIR, V21, P5439, DOI 10.1021/la0501381
   Zhang LB, 2007, CHEM MATER, V19, P948, DOI 10.1021/cm062535i
   Zhang L, 2008, BIOMACROMOLECULES, V9, P185, DOI 10.1021/bm700967k
   Zhang L, 2007, ACS NANO, V1, P476, DOI 10.1021/nn700267g
   Zhu HG, 2004, J BIOMED MATER RES B, V71B, P159, DOI 10.1002/jbm.b.30080
   Zhu HG, 2003, BIOMACROMOLECULES, V4, P378, DOI 10.1021/bm025773p
NR 304
TC 435
Z9 441
U1 13
U2 358
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JAN 26
PY 2010
VL 22
IS 4
BP 441
EP 467
DI 10.1002/adma.200901327
PG 27
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 554GV
UT WOS:000274424400002
PM 20217734
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Shoichet, MS
AF Shoichet, Molly S.
TI Polymer Scaffolds for Biomaterials Applications
SO MACROMOLECULES
LA English
DT Review
ID DEGRADABLE HYDROGEL MATRICES; TISSUE ENGINEERING SCAFFOLDS; IN-VITRO
   DEGRADATION; CO-PEG NETWORKS; STEM-CELLS; EXTRACELLULAR-MATRIX; NEURITE
   OUTGROWTH; GROWTH-FACTOR; SPINAL-CORD; POLY(DL-LACTIC-CO-GLYCOLIC ACID)
AB Biomaterials have been used extensively in medical, personal care, and food applications, with many similar polymers being used across disciplines. This Perspective will emphasize polymers used in medicine and specifically those designed as scaffolds for use in tissue engineering and regenerative medicine. The areas of active research in tissue engineering include: biomaterials design-incorporation of the appropriate chemical, physical, and mechanical/structural properties to guide cell and tissue organization; cell/scaffold integration-inclusion into the biomaterial scaffold of either cells for transplantation or biomolecules to attract cells, including stein cells, from the host to promote integration with the tissue after implantation; and biomolecule delivery-inclusion of growth factors and/or small molecules or peptides that promote cell survival and tissue regeneration. While a significant and growing area of regenerative medicine involves the stimulation of endogenous Stein Cells, this Perspective will emphasize polymer scaffolds used for delivery of cells and biomolecules. The challenges and solutions pursued in designing polymeric biomaterial scaffolds with the appropriate 3-dimensional structure will be explored.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Dept Chem, Inst Biomat & Biomed Engn,Donnelly Ctr Cellular &, Toronto, ON M5S 3E1, Canada.
RP Shoichet, MS (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Dept Chem, Inst Biomat & Biomed Engn,Donnelly Ctr Cellular &, 160 Coll St,Room 514, Toronto, ON M5S 3E1, Canada.
EM molly.shoichet@utoronto.ca
FU NSERC; Canada Council; Killam Foundation
FX I thank Michael Sefton (University Professor, University of Toronto) for
   thoughtful discussions and the Shoichet Bioengineering Research
   Laboratory, particularly Doug Baumann, Karyn Ho, and Katarina Vulic, all
   of whom hold NSERC postgraduate scholarships, for their important
   insights. I thank Karyn Ho (University of Toronto) for the cover art,
   TOC graphic, and Figure 9; Katarina Vulic for Figures I and 2; Prof. Nic
   Leipzig (Akron University) for Figure 5; and Cole DeForest and Prof
   Kristi Anseth (University of Colorado) for Figure 8c. I am grateful to
   the Canada Council for the Arts, Killam Foundation for a Killam Research
   Fellowship.
CR Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Armani DL, 2001, ANN NY ACAD SCI, V936, P566
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Broadhead KW, 2002, BIOMATERIALS, V23, P4689, DOI 10.1016/S0142-9612(02)00212-0
   Brown AL, 2007, WOUND REPAIR REGEN, V15, pA28
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burns JW, 1997, EUR J SURG, V163, P40
   Butler MJ, 2007, J BIOMED MATER RES A, V82A, P265, DOI 10.1002/jbm.a.31314
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Cao X, 2003, NEUROSCIENCE, V122, P381, DOI 10.1016/j.neuroscience.2003.08.018
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Causa F, 2007, BIOMATERIALS, V28, P5093, DOI 10.1016/j.biomaterials.2007.07.030
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   Dean D, 2003, TISSUE ENG, V9, P495, DOI 10.1089/107632703322066679
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   Fromstein JD, 2008, TISSUE ENG PT A, V14, P369, DOI 10.1089/tea.2006.0410
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Gianolio DA, 2008, BIOCONJUGATE CHEM, V19, P1767, DOI 10.1021/bc8000479
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2005, BIOMACROMOLECULES, V6, P2833, DOI 10.1021/bm0503322
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Gupta D, 2009, BIOMATERIALS, V30, P2085, DOI 10.1016/j.biomaterials.2008.12.079
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   HAYAMI JW, 2009, J BIOMED MAT RES A
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Homma A, 2009, BIOORGAN MED CHEM, V17, P4647, DOI 10.1016/j.bmc.2009.04.063
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Hubbell JA, 1995, U.S.A Patent Application, Patent No. 5410016
   Ingber D E, 2004, Mech Chem Biosyst, V1, P53
   Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Jones KS, 2004, TRANSPLANTATION, V78, P1454, DOI 10.1097/01.TP.0000142094.63083.FB
   Katayama Y, 2006, BIOMATERIALS, V27, P505, DOI 10.1016/j.biomaterials.2005.07.016
   Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b
   Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006
   Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI [10.1021/bp070352a, 10.1021/bp.070352a]
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Klein A W, 2001, Facial Plast Surg Clin North Am, V9, P205
   Kumar N, 2002, ADV DRUG DELIVER REV, V54, P889, DOI 10.1016/S0169-409X(02)00050-9
   LACY PE, 1991, SCIENCE, V254, P1782, DOI 10.1126/science.1763328
   Lahooti S, 2000, BIOMATERIALS, V21, P987, DOI 10.1016/S0142-9612(99)00251-3
   Lavik EB, 2005, BIOMATERIALS, V26, P3187, DOI 10.1016/j.biomaterials.2004.08.022
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Luo Y, 2004, BIOMACROMOLECULES, V5, P2315, DOI 10.1021/bm0495811
   MA XJ, 1994, ARTIF CELL BLOOD SUB, V22, P43, DOI 10.3109/10731199409117399
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Madlambayan GJ, 2006, BIOL BLOOD MARROW TR, V12, P1020, DOI 10.1016/j.bbmt.2006.07.005
   Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   MERRILL EW, 1982, T AM SOC ART INT ORG, V28, P482
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x
   Ng TF, 2007, STEM CELLS, V25, P1552, DOI 10.1634/stemcells.2006-0780
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Porpiglia F, 2007, J ENDOUROL, V21, P423, DOI 10.1089/end.2006.0265
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Riddle KW, 2004, J BIOMAT SCI-POLYM E, V15, P1561, DOI 10.1163/1568562042459742
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAARI H, 1989, ANN RHEUM DIS, V48, P565, DOI 10.1136/ard.48.7.565
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Saneinejad S, 2000, J BIOMED MATER RES, V50, P465, DOI 10.1002/(SICI)1097-4636(20000615)50:4<465::AID-JBM1>3.3.CO;2-B
   SAWHNEY AS, 2001, Patent No. 6177095
   Sebra RP, 2007, ACTA BIOMATER, V3, P151, DOI 10.1016/j.actbio.2006.07.010
   Sell SA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/045001
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Timmer MD, 2003, BIOMACROMOLECULES, V4, P1026, DOI 10.1021/bm0300150
   Ueda H, 2003, ADV DRUG DELIVER REV, V55, P501, DOI 10.1016/S0169-409X(03)00037-1
   Walther T, 2005, J THORAC CARDIOV SUR, V129, P359, DOI 10.1016/j.jtcvs.2004.07.011
   Wan LS, 2009, J BIOMED MATER RES A, V89A, P168, DOI 10.1002/jbm.a.31907
   WEST JL, 1995, BIOMATERIALS, V16, P1153, DOI 10.1016/0142-9612(95)93579-3
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yang J, 2006, J CONTROL RELEASE, V116, P193, DOI 10.1016/j.jconrel.2006.06.022
   Zawko SA, 2008, J BIOMED MATER RES A, V87A, P1044, DOI 10.1002/jbm.a.31845
   Ziebell MR, 2001, CHEM BIOL, V8, P1081, DOI 10.1016/S1074-5521(01)00078-3
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 123
TC 233
Z9 237
U1 11
U2 256
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD JAN 26
PY 2010
VL 43
IS 2
BP 581
EP 591
DI 10.1021/ma901530r
PG 11
WC Polymer Science
SC Polymer Science
GA 543YQ
UT WOS:000273618100001
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Dahou, W
   Ghemati, D
   Oudia, A
   Aliouche, D
AF Dahou, Wassila
   Ghemati, Djamila
   Oudia, Atika
   Aliouche, Djamel
TI Preparation and biological characterization of cellulose graft
   copolymers
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Cellulose carbamate; Graft polymerization; Acrylic acid; Acrylonitrile;
   Absorbency; Antimicrobial activity
ID COMPLEX ABSORBENT STRUCTURE; MONOMERS; POLYMER; ACRYLONITRILE;
   BIOTEXTILES; ABSORPTION; CARBAMATE
AB Acrylic acid (AA) and acrylonitrile (AN) were graft polymerized onto cellulose fluff pulp using ceric ammonium nitrate as initiator. The resulting copolymers were saponified with dilute Sodium hydroxide and characterized by FT-IR, SEM and TGA. The potential value of the modified cellulose was assessed through measurements of absorbency properties. A fibre-hydrogel was prepared by an addition of a bifunctional monomer, ethyleneglycol dimethacrylate (EDMA) used for grafting. In second approach, biocide cellulose carbamate was prepared by impregnating the fibres in aqueous thiourea solution and subsequent grafting with acrylonitrile. Antimicrobial activity of the treated cellulose sample was studied against Escherichia coli, Pseudomonas aeruginosa and Bacillus subtilis according to AATCC test method 100-1999. The results show that the treated fibre gives higher anti microbial activity. The strong antimicrobial functions achieved on modified fibres, proved that the synthesized biomaterial was effective, very simple and practical to the textile finishing industry. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Dahou, Wassila; Ghemati, Djamila; Aliouche, Djamel] M Bougara Univ, FSI, Lab Fibrous Polymers Treatment & Forming, Boumerdes, Algeria.
   [Oudia, Atika] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Aliouche, D (reprint author), M Bougara Univ, FSI, Lab Fibrous Polymers Treatment & Forming, Boumerdes, Algeria.
EM aliouche_dj@umbb.dz
CR Aliouche D, 2000, ANN CHIM-SCI MAT, V25, P557, DOI 10.1016/S0151-9107(01)80010-6
   Aliouche D, 2001, CHEM ENG J, V81, P317, DOI 10.1016/S1385-8947(00)00198-4
   Aliouche D, 2006, ANN CHIM-SCI MAT, V31, P527, DOI 10.3166/acsm.31.527-540
   Bhattacharya A, 2004, PROG POLYM SCI, V29, P767, DOI 10.1016/j.progpolymsci.2004.05.002
   Chen CC, 1985, ABSORBENCY, P197
   Cheremisinoff NP, 1997, HDB ENG POLYM MAT, P810
   FERNANDEZ MJ, 1990, MAKROMOL CHEM, V191, P1287
   Ghemati D, 2009, APPL BIOCHEM BIOTECH, V159, P532, DOI 10.1007/s12010-008-8473-z
   Gupta KC, 2002, J APPL POLYM SCI, V86, P2631, DOI 10.1002/app.111448
   Gurdag G, 2001, J APPL POLYM SCI, V80, P2267, DOI 10.1002/app.1331
   HEBEISH A, 1978, TEXT RES J, V48, P468, DOI 10.1177/004051757804800807
   Hon D.N., 1982, ACS SYM SER, P187
   Kamel S, 2006, J APPL POLYM SCI, V100, P329, DOI 10.1002/app.23317
   Karadag E, 1996, BIOMATERIALS, V17, P67, DOI 10.1016/0142-9612(96)80757-5
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   LASZKIEWICZ B, 1989, J THERM ANAL, V35, P2235
   LEPOUTRE P, 1975, J APPL POLYM SCI, V19, P1257, DOI 10.1002/app.1975.070190505
   Ma MH, 2005, DYES PIGMENTS, V66, P33, DOI 10.1016/j.dyepig.2004.09.001
   MANSOUR OY, 1991, J APPL POLYM SCI, V43, P1147, DOI 10.1002/app.1991.070430615
   McDowall D. J., 1984, PROG POLYM SCI, V10, P1, DOI DOI 10.1016/0079-6700(84)90005-4
   Nasef MM, 2004, PROG POLYM SCI, V29, P499, DOI 10.1016/j.progpolymsci.2004.01.003
   Oudia A, 2009, J ANAL APPL PYROL, V85, P19, DOI 10.1016/j.jaap.2008.09.015
   Ratner B. D., 1996, SURFACE MODIFICATION
   Rezai E, 1997, J APPL POLYM SCI, V65, P1463
   Segal L, 1961, TEXT RES J, V31, P460, DOI DOI 10.1177/004051756103100510
   SHUKLA SR, 1994, J APPL POLYM SCI, V54, P279, DOI 10.1002/app.1994.070540302
   Yu HF, 2007, CELLULOSE, V14, P99, DOI 10.1007/s10570-006-9080-1
NR 27
TC 59
Z9 63
U1 0
U2 42
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1369-703X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD JAN 15
PY 2010
VL 48
IS 2
BP 187
EP 194
DI 10.1016/j.bej.2009.10.006
PG 8
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA 553EX
UT WOS:000274350000007
DA 2018-10-20
ER

PT J
AU Serna, DD
   Moore, JL
   Rayson, GD
AF Serna, Debbie D.
   Moore, Jessica L.
   Rayson, Gary D.
TI Site-specific Eu(III) binding affinities to a Datura innoxia biosorbent
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Datura innoxia; Metal ion binding; Biosorption; Binding affinities
ID METAL ION-EXCHANGE; BIOSORPTION; BIOMATERIAL; DISTRIBUTIONS;
   SPECTROSCOPY; COMPETITION; EQUILIBRIA; ALGAE
AB The binding of Eu(III) to a biosorbent derived from cultured cells of the plant Datura innoxia, have been investigated through elucidation of apparent affinity constants associated with different chemical environments present on the cell wall. Adsorption isotherms for separate types of binding sites were generated using metal ion luminescence measurements. Application of regularized regression analysis to these isotherm data for four chemically distinguishable sites revealed the presence of sites exhibiting both low (mean log K(app) = -0.3 to 0.6) and higher (mean log K(app) = 3.2-3.5) apparent affinities for pH conditions of 2.0, 4.0, and 5.0. Low affinity sites were observed for all pH conditions and attributed to non-specific binding of the metal ions to the negatively charged biomaterial. The pH-dependent higher affinity sites are ascribed to specific sites involving either an ion-exchange mechanism or formation of weak surface-metal ion complexes. These results differed significantly from a similar analysis of total metal binding isotherms that indicated mean log K(app) values of -0.5 to 0.25 (low affinity) and 5.6-6.0 (high affinity). (C) 2009 Elsevier B.V. All rights reserved.
C1 [Serna, Debbie D.; Moore, Jessica L.; Rayson, Gary D.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.
RP Rayson, GD (reprint author), New Mexico State Univ, Dept Chem & Biochem, Box 30001,MSC 3C, Las Cruces, NM 88003 USA.
EM garayson@nmsu.edu
FU National Institutes of Health; National Science Foundation
FX The authors gratefully acknowledge the financial assistance of the
   National Institutes of Health through the MBRS-RISE program (DDS and
   JLM), and the National Science Foundation Advancement of Graduate
   Education and the Professoriate (DDS).
CR CERNIK M, 1995, ENVIRON SCI TECHNOL, V29, P413, DOI 10.1021/es00002a018
   CHONG KH, 1995, BIOTECHNOL BIOENG, V47, P451, DOI 10.1002/bit.260470406
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   DRAKE LR, 1995, INSTRUM SCI TECHNOL, V23, P57, DOI 10.1080/10739149508011697
   Drake LR, 1997, APPL SPECTROSC, V51, P1476, DOI 10.1366/0003702971939253
   Drake LR, 1996, ANAL CHEM, V1, P22
   Gardea-Torresdey JL, 1999, J HAZARD MATER, V69, P41, DOI 10.1016/S0304-3894(99)00057-6
   Gardea-Torresdey JL, 2001, ENVIRON TOXICOL CHEM, V20, P2572, DOI 10.1897/1551-5028(2001)020<2572:AOCIBC>2.0.CO;2
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   Graces JL, 2004, J CHEM PHYS, V120, P9266
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   Lin S, 1996, ANAL CHEM, V68, P4087, DOI 10.1021/ac960569b
   Lin S, 2002, ADV ENVIRON RES, V6, P523, DOI 10.1016/S1093-0191(01)00078-8
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   Schiewer S, 1996, ENVIRON SCI TECHNOL, V30, P2921, DOI 10.1021/es950800n
   Texier AC, 2000, ENVIRON SCI TECHNOL, V34, P610, DOI 10.1021/es990668h
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
   Vulava VM, 2000, ENVIRON SCI TECHNOL, V34, P2149, DOI 10.1021/es990214k
   Williams PA, 2003, J HAZARD MATER, V99, P277, DOI 10.1016/S0304-3894(03)00005-0
   Xia HY, 2002, ADV ENVIRON RES, V7, P157, DOI 10.1016/S1093-0191(01)00121-6
   Xia HY, 2000, ADV ENVIRON RES, V4, P69
NR 23
TC 5
Z9 7
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JAN 15
PY 2010
VL 173
IS 1-3
BP 409
EP 414
DI 10.1016/j.jhazmat.2009.08.102
PG 6
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 537SZ
UT WOS:000273135600055
PM 19836885
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kurosu, S
   Matsumoto, H
   Chiba, A
AF Kurosu, Shingo
   Matsumoto, Hiroaki
   Chiba, Akihiko
TI Grain refinement of biomedical Co-27Cr-5Mo-0.16N alloy by reverse
   transformation
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Co-Cr-Mo alloys; Grain refinement; Reverse phase
   transformation; Mechanical properties
ID AUSTENITIC STAINLESS-STEEL; HIGH-NITROGEN; MECHANICAL-PROPERTIES
AB Advanced grain refinement of a biomedical Ni-free Co-27Cr-5Mo-0.16N alloy without hot or cold plastic deformation was successfully achieved by a reverse transformation from a lamellar (hcp + Cr(2)N) phase to an fcc phase. The technique consisted of a two-step heat treatment. First, the solution-treated specimen was subjected to isothermal aging at 1073 K for 90 ks, forming a lamellar structure of hcp and Cr2N phases. Then, the aged specimen having a completely lamellar microstructure was reverse-treated at temperatures from 1273 to 1473 K, where the fcc phase is stable. The resultant grains were approximately 1/10 of their initial size. Moreover, tensile testing after reverse transformation showed excellent strength with good ductility compared to samples examined before the reverse transformation. Our results will contribute to the development of biomedical Ni-free Co-Cr-Mo-N alloys with refined grain size and good mechanical properties, without requiring any hot workings. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Kurosu, Shingo; Matsumoto, Hiroaki; Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Chiba, A (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM a.chiba@imr.tohoku.ac.jp
RI Chiba, Akihiko/D-1326-2011
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
FX This research was supported by a grant for Cooperation of Innovative
   Technology and Advanced Research in Evolutional Area from the Ministry
   of Education, Culture, Sports, Science, and Technology of Japan.
CR Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   IMMARIGEON JP, 1984, METALL TRANS A, V15, P339, DOI 10.1007/BF02645120
   LIPPARED HE, 1999, PROCESS METALLURGY W, P98
   MUKAIDA Y, 2004, TETSU HAGANE, V86, P472
   Nakada N, 2007, SCRIPTA MATER, V57, P153, DOI 10.1016/j.scriptamat.2007.03.022
   SIMMONS JW, 1995, METALL MATER TRANS A, V26, P2579, DOI 10.1007/BF02669416
   Vanderschaeve F, 1995, J MATER SCI, V30, P6035, DOI 10.1007/BF01151525
   VANDERVOORT GF, 1999, METALLOGRAPHY PRINCI, P435
NR 8
TC 48
Z9 49
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JAN 15
PY 2010
VL 64
IS 1
BP 49
EP 52
DI 10.1016/j.matlet.2009.10.001
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 532UQ
UT WOS:000272775900016
DA 2018-10-20
ER

PT J
AU Zelzer, M
   Alexander, MR
AF Zelzer, Mischa
   Alexander, Morgan R.
TI Nanopores in Single- and Double-Layer Plasma Polymers Used for Cell
   Guidance in Water and Protein Containing Buffer Solutions
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID RAY PHOTOELECTRON-SPECTROSCOPY; X-RAY; FILMS; SURFACES; ALLYLAMINE;
   OXIDATION; POLYMERIZATION; GRADIENTS; COATINGS
AB To investigate the behavior of plasma Polymers in biomaterial applications, we studied plasma polymerized hexane (ppHex) and plasma polymerized allylamine (ppAAm) in pure, buffered, and protein containing aqueous Solutions. We report for the first time oil nanoscale pores formed on ppHex deposits upon exposure to water and Surface blistering of ppHex deposited oil ppAAm in water. We demonstrate that the nature of the Solution influenced the feature formation. These studies are necessary to monitor the changes of the plasma polymer Surfaces applied in cell guidance. The surface chemical and topographical data from single- and double-layer plasma polymer films were compared. We further demonstrate that the differences in surface chemistry and topography that develop during aqueous exposure between the single- and double-layer plasma polymer deposits do not affect the adhesion of cells to the Surface. These novel nanostructured Surfaces may prove useful as membranes or Structured films in biotechnological applications.
C1 [Zelzer, Mischa; Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
RP Alexander, MR (reprint author), Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
EM morgan.alexander@nottingham.ac.uk
RI Alexander, Morgan/C-2506-2009
OI Alexander, Morgan/0000-0001-5182-493X
FU EPSRC [GR/S55026/0]; XPS
FX Funding from the EPSRC for MZ (Grant GR/S55026/0) is gratefully
   acknowledged. We thank Emily Smith for support With the XPS
   measurements.
CR BAIN CD, 1988, J AM CHEM SOC, V110, P5897, DOI 10.1021/ja00225a050
   BARRY JJ, 2006, ADV MATER, P1406
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Bullett NA, 2001, SURF INTERFACE ANAL, V31, P1074, DOI 10.1002/sia.1146
   Chen Q, 2004, CHEM MATER, V16, P614, DOI 10.1021/cm034529h
   Forch R, 2005, PLASMA PROCESS POLYM, V2, P351, DOI 10.1002/ppap.200400083
   GENGENBACH TR, 1994, J POLYM SCI POL CHEM, V32, P1399, DOI 10.1002/pola.1994.080320801
   Gengenbach TR, 1998, J POLYM SCI POL CHEM, V36, P985, DOI 10.1002/(SICI)1099-0518(19980430)36:6<985::AID-POLA14>3.0.CO;2-H
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P611, DOI 10.1002/(SICI)1096-9918(19960916)24:9<611::AID-SIA169>3.0.CO;2-7
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P271, DOI 10.1002/(SICI)1096-9918(199604)24:4<271::AID-SIA116>3.3.CO;2-A
   GENGENBACH TR, 1999, J POLYM SCI A, P2192
   Jeon HS, 2004, J POLYM SCI POL PHYS, V42, P2522, DOI 10.1002/polb.20131
   Lejeune M, 2005, SURF SCI, V583, pL142, DOI 10.1016/j.susc.2005.03.031
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Muir BW, 2007, PLASMA PROCESS POLYM, V4, P433, DOI 10.1002/ppap.200600175
   Notara M, 2007, J MATER SCI-MATER M, V18, P329, DOI 10.1007/s10856-006-0697-2
   ROBINSON D, 2008, ADV MAT WEINHEIM, V6, P1166
   SHEN KC, 2003, LANGMUIR, V5, P1692
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Tamirisa PA, 2006, MACROMOLECULES, V39, P7092, DOI 10.1021/ma060944u
   TARASOVA A, 2008, PLASMA PROCESS POLYM, V2, P175
   Thissen H, 2006, BIOMATERIALS, V27, P35, DOI 10.1016/j.biomaterials.2005.05.037
   Valsesia A, 2007, J PHYS D APPL PHYS, V40, P2341, DOI 10.1088/0022-3727/40/8/S13
   van Os MT, 1999, CHEM MATER, V11, P3252, DOI 10.1021/cm991068k
   Vasilev K, 2008, J PHYS CHEM B, V112, P10915, DOI 10.1021/jp803678w
   WELLS N, 2009, BIOMATERIALS, V6, P1066
   Whittle JD, 2000, CHEM MATER, V12, P2664, DOI 10.1021/cm0002158
   YANG J, 2009, ADV MATER, V3, P300
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhang Z, 2003, SURF COAT TECH, V174, P588, DOI 10.1016/S0257-8972(03)00806-5
NR 31
TC 4
Z9 4
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JAN 14
PY 2010
VL 114
IS 1
BP 569
EP 576
DI 10.1021/jp908516r
PG 8
WC Chemistry, Physical
SC Chemistry
GA 541GY
UT WOS:000273404500067
PM 19938852
DA 2018-10-20
ER

PT J
AU Rudra, JS
   Tian, YF
   Jung, JP
   Collier, JH
AF Rudra, Jai S.
   Tian, Ye F.
   Jung, Jangwook P.
   Collier, Joel H.
TI A self-assembling peptide acting as an immune adjuvant
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; epitope; nanofiber; self-assembly; vaccine
ID T-CELL EPITOPES; B-CELL; ENDOTHELIAL-CELLS; NANOFIBERS; BIOMATERIALS;
   SCAFFOLDS; VACCINES; IMMUNOGENICITY; HYDROGELS; MICROENVIRONMENTS
AB The development of vaccines and other immunotherapies has been complicated by heterogeneous antigen display and the use of incompletely defined immune adjuvants with complex mechanisms of action. We have observed strong antibody responses in mice without the coadministration of any additional adjuvant by non-covalently assembling a T and B cell epitope peptide into nanofibers using a short C-terminal peptide extension. Self-assembling peptides have been explored recently as scaffolds for tissue engineering and regenerative medicine, but our results indicate that these materials may also be useful as chemically defined adjuvants. In physiological conditions, these peptides self-assembled into long, unbranched fibrils that displayed the epitope on their surfaces. IgG1, IgG2a, and IgG3 were raised against epitope-bearing fibrils in levels similar to the epitope peptide delivered in complete Freund's adjuvant (CFA), and IgM production was even greater for the self-assembled epitope. This response was dependent on self-assembly, and the self-assembling sequence was not immunogenic by itself, even when delivered in CFA. Undetectable levels of interferon-gamma, IL-2, and IL-4 in cultures of peptide-challenged splenocytes from immunized mice suggested that the antibody responses did not involve significant T cell help.
C1 [Rudra, Jai S.; Tian, Ye F.; Jung, Jangwook P.; Collier, Joel H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
   [Collier, Joel H.] Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA.
   [Tian, Ye F.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
RP Collier, JH (reprint author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM collier@uchicago.edu
FU National Institutes of Health (NIDCR) [R21DE017703]; National Institutes
   of Health (NIBIB) [7R21EB007335, 1R01EB009701]
FX We thank Karl Matlin, Anita Chong, Roger Sciammas, Jose Guevara-Patino,
   James McCracken, Audrea Troutman, and David Hilde-man for helpful
   discussions. This research was supported in part by the National
   Institutes of Health (NIDCR, grant number R21DE017703 and NIBIB grant
   numbers 7R21EB007335 and 1R01EB009701). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the NIH. TEM and CD were performed at the University
   of Chicago Electron Microscopy Facility and Biophysics Core Facility,
   respectively.
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Bettahi I, 2009, CANCER IMMUNOL IMMUN, V58, P187, DOI 10.1007/s00262-008-0537-y
   Cao CH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-25
   Carcaboso AM, 2004, PHARM RES, V21, P121, DOI 10.1023/B:PHAM.0000012159.20895.5b
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Collier JH, 2008, SOFT MATTER, V4, P2310, DOI 10.1039/b805563g
   Daftarian P, 2006, VACCINE, V24, P5235, DOI 10.1016/j.vaccine.2006.03.079
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   DINTZIS HM, 1976, P NATL ACAD SCI USA, V73, P3671, DOI 10.1073/pnas.73.10.3671
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Ilyinskii PO, 2008, VACCINE, V26, P3223, DOI 10.1016/j.vaccine.2008.03.078
   Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x
   Jones KS, 2008, BIOTECHNOL PROGR, V24, P807, DOI [10.1002/btpr.10, 10.1021/bp.10]
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   JUNG JP, 2010, BIOPOLYMERS IN PRESS
   Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maraskovsky E, 2009, IMMUNOL CELL BIOL, V87, P371, DOI 10.1038/icb.2009.21
   Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510
   Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003
   McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914
   MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.immunol.13.1.655
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g
   Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Riley JM, 2009, BIOTECHNOL BIOENG, V103, P241, DOI 10.1002/bit.22274
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sun HX, 2009, VACCINE, V27, P1787, DOI 10.1016/j.vaccine.2009.01.091
   Test ST, 2001, INFECT IMMUN, V69, P3031, DOI 10.1128/IAI.69.5.3031-3040.2001
   Toth I, 2008, INT J PEPT RES THER, V14, P333, DOI 10.1007/s10989-008-9147-y
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Vos Q, 2000, IMMUNOL REV, V176, P154
   WEN L, 1994, NATURE, V369, P654, DOI 10.1038/369654a0
   Wendorf J, 2006, J PHARM SCI-US, V95, P2738, DOI 10.1002/jps.20728
   Yang M, 2009, BIOCHEM BIOPH RES CO, V378, P203, DOI 10.1016/j.bbrc.2008.11.037
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 48
TC 201
Z9 203
U1 6
U2 86
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 12
PY 2010
VL 107
IS 2
BP 622
EP 627
DI 10.1073/pnas.0912124107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 543FY
UT WOS:000273559300021
PM 20080728
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Lavanant, L
   Pullin, B
   Hubbell, JA
   Klok, HA
AF Lavanant, Laurent
   Pullin, Brian
   Hubbell, Jeffrey A.
   Klok, Harm-Anton
TI A Facile Strategy for the Modification of Polyethylene Substrates with
   Non-Fouling, Bioactive Poly(poly(ethylene glycol) methacrylate) Brushes
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE atom transfer radical polymerization (ATRP); bromination; cell adhesion;
   polyethylene (PE); polymer brushes
ID TRANSFER RADICAL POLYMERIZATION; LOW-DENSITY POLYETHYLENE; RAY
   PHOTOELECTRON-SPECTROSCOPY; SURFACE MODIFICATION; CELL-ADHESION;
   GRAFT-POLYMERIZATION; FILMS; FUNCTIONALIZATION; BIOCOMPATIBILITY;
   POLYSTYRENE
AB This manuscript reports a facile strategy for the modification of polyethylene, a widely used biomaterial, with a thin non-biofouling coating that can act as a platform to introduce biochemical cues to control and direct, e.g., cell adhesion and proliferation. The non-biofouling coating is produced, following a two-step strategy involving photobromination of the polyethylene substrate followed by surface-initiated ATRP of poly(ethylene glycol) methacrylate. The resulting coatings, which are referred to as polymer brushes, are robust and withstand prolonged exposure to aqueous ethanol and phosphate buffered saline and also do not show any signs of detachment or degradation in the in vivo studies over a period of 10 d. Functionalization of these polymer brush coatings with extracellular matrix derived peptide sequences, promotes adhesion and spreading of endothelial cells.
C1 [Lavanant, Laurent; Klok, Harm-Anton] Ecole Polytech Fed Lausanne, Inst Mat, Lab Polymeres, CH-1015 Lausanne, Switzerland.
   [Pullin, Brian; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.
   [Pullin, Brian; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.
RP Klok, HA (reprint author), Ecole Polytech Fed Lausanne, Inst Mat, Lab Polymeres, Batiment MXD,Stn 12, CH-1015 Lausanne, Switzerland.
EM harm-anton.klok@epfl.ch
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
FU KTI/CTI
FX The authors are grateful to Boyana Apostolovic for her help with the
   peptide synthesis and to Dr. Marcel Gyger, Pierre Latin, and Miriellu
   Pasquier for the support with the in vivo experiments. This research was
   financially supported by KTI/CTI.
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Balamurugan S, 2001, POLYMER, V42, P2501, DOI 10.1016/S0032-3861(00)00632-7
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Brown AA, 2005, EUR POLYM J, V41, P1757, DOI 10.1016/j.eurpolymj.2005.02.026
   Caldwell RA, 2002, J BIOMED MATER RES, V62, P514, DOI 10.1002/jbm.10249
   CHEW A, 1986, J COLLOID INTERF SCI, V110, P88, DOI 10.1016/0021-9797(86)90355-3
   Desai SM, 2004, ADV POLYM SCI, V169, P231, DOI 10.1007/b13524
   Desai SM, 2003, POLYMER, V44, P7645, DOI 10.1016/j.polymer.2003.09.060
   Edmondson S, 2004, CHEM SOC REV, V33, P14, DOI 10.1039/b210143m
   ELMAN JF, 1990, MACROMOLECULES, V23, P3922, DOI 10.1021/ma00219a010
   Ishihara K, 2000, COLLOID SURFACE B, V18, P325, DOI 10.1016/S0927-7765(99)00158-7
   Jennings GK, 2004, ADV MATER, V16, P1983, DOI 10.1002/adma.200400810
   Kim KS, 2003, POLYMER, V44, P6287, DOI 10.1016/S0032-3861(03)00674-8
   Kiss E, 1996, LANGMUIR, V12, P1651, DOI 10.1021/la9505879
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Min K, 2002, J POLYM SCI POL CHEM, V40, P892, DOI 10.1002/pola.10160
   Pyun J, 2003, MACROMOL RAPID COMM, V24, P1043, DOI 10.1002/marc.200300078
   Richey T, 2000, BIOMATERIALS, V21, P1057, DOI 10.1016/S0142-9612(99)00281-1
   Sugiyama K, 2000, MACROMOL MATER ENG, V282, P5, DOI 10.1002/1439-2054(20001001)282:1<5::AID-MAME5>3.0.CO;2-H
   Tugulu S, 2005, BIOMACROMOLECULES, V6, P1602, DOI 10.1021/bm050016n
   Tugulu S, 2008, BIOMACROMOLECULES, V9, P906, DOI 10.1021/bm7012939
   Tugulu S, 2007, BIOMATERIALS, V28, P2536, DOI 10.1016/j.biomaterials.2007.02.006
   WANG JH, 1997, PLASMAS POLYM, V2, P245
   Wang P, 2001, J MATER CHEM, V11, P2951, DOI 10.1039/b101974k
   Wischerhoff E, 2008, ANGEW CHEM INT EDIT, V47, P5666, DOI 10.1002/anie.200801202
   Xu FJ, 2007, IND ENG CHEM RES, V46, P4866, DOI 10.1021/ie0701367
   Xu FJ, 2004, BIOMACROMOLECULES, V5, P2392, DOI 10.1021/bm049675a
   Yamamoto K, 2002, J POLYM SCI POL CHEM, V40, P3350, DOI 10.1002/pola.10435
   Zheng GD, 2002, MACROMOLECULES, V35, P6828, DOI 10.1021/ma0121464
NR 30
TC 36
Z9 37
U1 2
U2 54
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JAN 11
PY 2010
VL 10
IS 1
BP 101
EP 108
DI 10.1002/mabi.200900205
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 553VK
UT WOS:000274394700010
PM 19890949
DA 2018-10-20
ER

PT J
AU Wattamwar, PP
   Mo, YQ
   Wan, R
   Palli, R
   Zhang, QW
   Dziubla, TD
AF Wattamwar, Paritosh P.
   Mo, Yiqun
   Wan, Rong
   Palli, Roshan
   Zhang, Qunwei
   Dziubla, Thomas D.
TI Antioxidant Activity of Degradable Polymer Poly(trolox ester) to
   Suppress Oxidative Stress Injury in the Cells
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID CARBONIC-ANHYDRASE; PULSE-RADIOLYSIS; TROLOX-C; NANOPARTICLES;
   ACTIVATION; RESPONSES; ELECTRON; DELIVERY; OXIDE
AB Oxidative stress is a pathological condition that has been implicated as a central player in a variety of diseases, including vascular and neurodegenerative diseases. More recently, oxidative stress has also been shown to be involved in the biological incompatibility of many materials especially at the nanoscale. As such, there is a critical need for new biomaterials that can inhibit this response, improving the compatibility of medical devices. In this work, trolox, a synthetic antioxidant and water-soluble analogue of Vitamin E, is polymerized to form an oxidation active polymer as a new class of biomaterial. Synthesized poly(trolox ester) polymers were formulated into nanoparticles using a single emulsion technique, and their size was controlled by changing the polymer concentration in the organic solvent. Nanoparticle cytotoxicity, protective effects against cellular oxidative stress, and degradation kinetics were all evaluated. Poly(trolox ester) nanoparticles were found to have little to no cytotoxicity and were capable of suppressing cellular oxidative stress induced by cobalt nanoparticles. In vitro degradation studies of poly(trolox ester) nanoparticles indicate that the antioxidant activity of nanoparticles was derived from its enzymatic degradation to release active antioxidants.
C1 [Wattamwar, Paritosh P.; Palli, Roshan; Dziubla, Thomas D.] Univ Kentucky, Dept Chem & Mat Engn, Coll Engn, Lexington, KY 40506 USA.
   [Mo, Yiqun; Wan, Rong; Zhang, Qunwei] Univ Louisville, Dept Environm & Occupat Hlth Sci, Louisville, KY 40292 USA.
RP Wattamwar, PP (reprint author), Univ Kentucky, Dept Chem & Mat Engn, Coll Engn, 177 F Paul Anderson Tower, Lexington, KY 40506 USA.
EM dziubla@engr.uky.edu
RI Wattamwar, Paritosh/O-2319-2016
OI Wattamwar, Paritosh/0000-0003-1937-0944
FU University of Kentucky Research Trust Fund
FX University of Kentucky Research Trust Fund, Dr. Hilt for access to FTIR
   facility in his lab and Department of Chemistry NMR facility. Supporting
   Information is available online from Wiley InterScience or from the
   author.
CR Aldini G, 2001, FREE RADICAL BIO MED, V31, P1043, DOI 10.1016/S0891-5849(01)00684-0
   Allcock H. R., 2003, CONT POLYM CHEM
   ARAI H, 1995, LIPIDS, V30, P135, DOI 10.1007/BF02538266
   Bucio E, 2006, POLYM BULL, V56, P163, DOI 10.1007/s00289-005-0487-x
   CADENAS E, 1989, FEBS LETT, V253, P235, DOI 10.1016/0014-5793(89)80966-4
   DAVIES MJ, 1988, BIOCHEM J, V255, P513
   Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9
   Fleming C, 2005, NAT CHEM BIOL, V1, P270, DOI 10.1038/nchembio730
   FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   HENRY RP, 1986, J APPL PHYSIOL, V60, P638
   Jiang WW, 2007, J BIOMED MATER RES A, V82A, P492, DOI 10.1002/jbm.a.31175
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013
   Muzykantov VR, 2001, J CONTROL RELEASE, V71, P1, DOI 10.1016/S0168-3659(01)00215-2
   POCKER Y, 1972, BIOCHEMISTRY-US, V11, P698, DOI 10.1021/bi00755a005
   Priyadarsini KI, 2001, CHEM RES TOXICOL, V14, P567, DOI 10.1021/tx000239t
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Shive M. S., 1997, ADV DRUG DELIV REV, V28, P5
   SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wan R, 2008, TOXICOL APPL PHARM, V233, P276, DOI 10.1016/j.taap.2008.08.022
   WIENER H, 1986, J MOL CATAL, V37, P45, DOI 10.1016/0304-5102(86)85136-7
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams SR, 2009, BIOMACROMOLECULES, V10, P155, DOI 10.1021/bm801058j
   Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k
   Yang SC, 2008, BIOCONJUGATE CHEM, V19, P1164, DOI 10.1021/bc700442g
   Zhang QW, 2005, AM J PHYSIOL-LUNG C, V289, pL954, DOI 10.1152/ajplung.00210.2005
   Zhu MT, 2008, TOXICOLOGY, V247, P102, DOI 10.1016/j.tox.2008.02.011
NR 30
TC 39
Z9 39
U1 4
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JAN 8
PY 2010
VL 20
IS 1
BP 147
EP 154
DI 10.1002/adfm.200900839
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 549JR
UT WOS:000274044900017
DA 2018-10-20
ER

PT J
AU Han, J
   Branford-White, CJ
   Zhu, LM
AF Han, Jie
   Branford-White, Christopher J.
   Zhu, Li-Min
TI Preparation of poly(epsilon-caprolactone)/poly(trimethylene carbonate)
   blend nanofibers by electrospinning
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE PCL; PTMC; Electrospinning; Nanofibers; Biomaterial
ID CONTROLLED-RELEASE; POLYMER NANOFIBERS; COPOLYMER; COLLAGEN; COMPLEX;
   FIBERS; CELL
AB Poly(epsilon-caprolactone) (PCL)/poly(trimethylene carbonate) (PTMC) blend nanofibers have been prepared for the first time using an electrospinning process. The mixed dichloromethane (DCM) and N,N-dimethylformamide (DMF) (75/25, v/v) was found to be the most suitable solvent for electrospinning. Various blends of PCL/PTMC solutions were investigated for the formation of nano-scale fibers and it was found that the average diameter of the fibers was reduced and the morphology became finer when PTMC content was increased. FT-IR and DSC analysis indicated that the molecular interactions between PCL and PTMC were weak and they were phase-separated in the fibers. Due to the biocompatible properties of PCL and PTMC, the spun nanofibers developed here could have applications in the biomedical field. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Han, Jie; Zhu, Li-Min] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
   [Branford-White, Christopher J.] London Metropolitan Univ, Inst Hlth Res & Policy, London N7 8DB, England.
RP Zhu, LM (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, 2999 N Renmin Rd, Shanghai 201620, Peoples R China.
EM lzhu@dhu.edu.cn
FU UK-CHINA Joint Laboratory for Therapeutic Textiles based in Donghua
   University; Ministry of Education of China [B07024]
FX This work was financially supported by UK-CHINA Joint Laboratory for
   Therapeutic Textiles based in Donghua University, in part by Biomedical
   Textile Materials "111 Project" from Ministry of Education of China (No.
   B07024).
CR ALBERTSSON AC, 1992, J MACROMOL SCI PURE, V29, P43, DOI 10.1080/10101329208054106
   Aussawasathien D, 2008, J MEMBRANE SCI, V315, P11, DOI 10.1016/j.memsci.2008.01.049
   Chen ZG, 2007, MATER LETT, V61, P3490, DOI 10.1016/j.matlet.2006.11.104
   Fabre T, 2001, BIOMATERIALS, V22, P2951, DOI 10.1016/S0142-9612(01)00012-6
   Fong H., 2007, POLYM NANOSTRUCTURES, P451
   GU SY, 2009, MAT SCI ENG C-BIO S, DOI DOI 10.1016/J.MSEC.2009.02.01
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ignatova M, 2007, EUR POLYM J, V43, P1609, DOI 10.1016/j.eurpolymj.2007.02.020
   Ji LW, 2009, ELECTROCHEM COMMUN, V11, P684, DOI 10.1016/j.elecom.2009.01.018
   JIA YT, 2005, J LIAODONG U, V12, P32
   Kenawy ER, 2009, MATER CHEM PHYS, V113, P296, DOI 10.1016/j.matchemphys.2008.07.081
   Kim TG, 2007, INT J PHARM, V338, P276, DOI 10.1016/j.ijpharm.2007.01.040
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liao YL, 2008, POLYMER, V49, P5294, DOI 10.1016/j.polymer.2008.09.045
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Luyten MC, 1997, POLYMER, V38, P509, DOI 10.1016/S0032-3861(96)00556-3
   Maretschek S, 2008, J CONTROL RELEASE, V127, P180, DOI 10.1016/j.jconrel.2008.01.011
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Patel AC, 2006, NANO LETT, V6, P1042, DOI 10.1021/nl0604560
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Qin YY, 2006, J BIOMED MATER RES B, V79B, P312, DOI 10.1002/jbm.b.30544
   Song Y, 2008, J CONTROL RELEASE, V132, pE79, DOI 10.1016/j.jconrel.2008.09.071
   Suwantong O, 2007, POLYMER, V48, P7546, DOI 10.1016/j.polymer.2007.11.019
   Wang H, 1998, J POLYM SCI POL CHEM, V36, P695, DOI 10.1002/(SICI)1099-0518(19980415)36:5<695::AID-POLA3>3.0.CO;2-L
   Xu J, 2009, MATER LETT, V63, P658, DOI 10.1016/j.matlet.2008.12.014
   Xu XL, 2009, EUR J PHARM BIOPHARM, V72, P18, DOI 10.1016/j.ejpb.2008.10.015
   Yang DZ, 2007, CARBOHYD POLYM, V69, P538, DOI 10.1016/j.carbpol.2007.01.008
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
NR 29
TC 44
Z9 45
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 5
PY 2010
VL 79
IS 1
BP 214
EP 218
DI 10.1016/j.carbpo1.2009.07.052
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 523GA
UT WOS:000272059200030
DA 2018-10-20
ER

PT J
AU Hsieh, AH
   Twomey, JD
AF Hsieh, Adam H.
   Twomey, Julianne D.
TI Cellular mechanobiology of the intervertebral disc: New directions and
   approaches
SO JOURNAL OF BIOMECHANICS
LA English
DT Review
DE Intervertebral disc; Nucleus pulposus; Notochordal; Annulus fibrosus;
   Interlamellar
ID ISSLS PRIZE WINNER; RAT-TAIL MODEL; DYNAMIC HYDROSTATIC-PRESSURE;
   NOTOCHORDAL NUCLEUS PULPOSUS; INTRA-ABDOMINAL PRESSURE;
   AGE-RELATED-CHANGES; CELLS IN-VITRO; ANNULUS FIBROSUS; ANULUS FIBROSUS;
   GENE-EXPRESSION
AB The more we learn about the intervertebral disc (IVD), the more we come to appreciate the intricacies involved in transmission of forces through the ECM to the cell, and in the biological determinants of its response to mechanical stress. This review highlights recent developments in our knowledge of IVD physiology and examines their impact on cellular mechanobiology. Discussion centers around the continually evolving cellular and microstructural anatomy of the nucleus pulposus (NP) and the annulus fibrosus (AF) in response to complex stresses generated in support of axial load and spinal motion. Particular attention has been given to cells from the immature NP and the interlamellar AF, and assessment of their potential mechanobiologic contributions to the health and function of the IVD. In addition, several innovative approaches that have been brought to bear on studying the interplay between disc cells and their micromechanical environment are discussed. Techniques for "engineering" cellular function and technologies for fabricating more structurally defined biomaterial scaffolds have recently been employed in disc research. Such tools can be used to elucidate the biological and physical mechanisms by which different IVD cell populations are regulated by mechanical stress, and contribute to advancement of preventative and therapeutic measures. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Hsieh, Adam H.; Twomey, Julianne D.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Hsieh, Adam H.] Univ Maryland, Dept Orthopaed, Baltimore, MD 21201 USA.
RP Hsieh, AH (reprint author), Univ Maryland, Dept Bioengn, Orthopaed Mechanobiol Lab, Jeong H Kim Engn Bldg,Room 3242, College Pk, MD 20742 USA.
EM hsieh@umd.edu
RI Hsieh, Adam/A-5684-2010
OI Hsieh, Adam/0000-0003-3162-1152
FU National Institutes of Health [AR054051]; National Science Foundation
   [CBET-0845754]; National Institute of Standards and Technology;
   University of Maryland, College Park
FX The authors would like to thank the National Institutes of Health
   (AR054051), the National Science Foundation (CBET-0845754), the National
   Institute of Standards and Technology, and the University of Maryland,
   College Park for providing funding that supported some of the work
   mentioned as well as the preparation of this manuscript.
CR Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287
   Adams MA, 1996, SPINE, V21, P434, DOI 10.1097/00007632-199602150-00006
   ADAMS P, 1977, RHEUMATOL REHABIL, V16, P22, DOI 10.1093/rheumatology/16.1.22
   ANDERSSON GBJ, 1977, CLIN ORTHOP RELAT R, P156
   Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399
   BANCROFT M, 1976, J EMBRYOL EXP MORPH, V35, P383
   BROBERG KB, 1980, SPINE, V5, P155, DOI 10.1097/00007632-198003000-00010
   Bruehlmann SB, 2004, SPINE, V29, P2612, DOI 10.1097/01.brs.0000146465.05972.56
   Bruehlmann SB, 2004, J BIOMECH, V37, P223, DOI 10.1016/S0021-9290(03)00244-6
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   BUCKWALTER JA, 1989, J ORTHOP RES, V7, P146, DOI 10.1002/jor.1100070121
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   BUCKWALTER JA, 1985, J BONE JOINT SURG AM, V67A, P284, DOI 10.2106/00004623-198567020-00016
   BUCKWALTER JA, 1976, J BONE JOINT SURG AM, V58, P73, DOI 10.2106/00004623-197658010-00013
   CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905
   Chan D, 2006, EUR SPINE J, V15, pS317, DOI 10.1007/s00586-006-0171-3
   Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008
   Chen J, 2006, EUR SPINE J, V15, P303
   Ching CTS, 2004, MED ENG PHYS, V26, P587, DOI 10.1016/j.medengphy.2004.03.006
   Ching CTS, 2003, CLIN BIOMECH, V18, P182, DOI 10.1016/S0268-0033(02)00188-2
   Cholewicki J, 1999, J BIOMECH, V32, P13, DOI 10.1016/S0021-9290(98)00129-8
   Cloyd JM, 2007, SPINE, V32, P1826, DOI 10.1097/BRS.0b013e3181132a9d
   COLE TC, 1986, BIOCHIM BIOPHYS ACTA, V880, P209, DOI 10.1016/0304-4165(86)90082-6
   Court C, 2001, Spine J, V1, P239, DOI 10.1016/S1529-9430(01)00056-0
   Court C, 2007, EUR SPINE J, V16, P1899, DOI 10.1007/s00586-007-0476-x
   Cui M, 2008, SPINE J, V8, P287, DOI 10.1016/j.spinee.2007.05.012
   Daggfeldt K, 1997, J BIOMECH, V30, P1149, DOI 10.1016/S0021-9290(97)00096-1
   DONOHUE PJ, 1988, BIOCHEM J, V251, P739, DOI 10.1042/bj2510739
   Ekstrom L, 2004, J SPINAL DISORD TECH, V17, P312, DOI 10.1097/01.bsd.0000092068.78152.00
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Errington RJ, 1998, J ANAT, V192, P369, DOI 10.1046/j.1469-7580.1998.19230369.x
   EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267
   GABAI AS, 2007, INT SOC STUD LUMB SP
   GHOSH P, 1976, GERONTOLOGY, V22, P124
   GRILLNER S, 1978, ACTA PHYSIOL SCAND, V103, P275, DOI 10.1111/j.1748-1716.1978.tb06215.x
   Grotmol S, 2003, ANAT EMBRYOL, V207, P263, DOI 10.1007/s00429-003-0349-y
   Gu WY, 1999, J BIOMECH, V32, P1177, DOI 10.1016/S0021-9290(99)00118-9
   GUEHRING T, 2005, EUR SPINE J
   Guehring T, 2009, ARTHRITIS RHEUM-US, V60, P1026, DOI 10.1002/art.24407
   Handa T, 1997, SPINE, V22, P1085, DOI 10.1097/00007632-199705150-00006
   Hastreiter D, 2001, J ORTHOP RES, V19, P597, DOI 10.1016/S0736-0266(00)00069-3
   Hayes AJ, 2001, MATRIX BIOL, V20, P107, DOI 10.1016/S0945-053X(01)00125-1
   Heuer F, 2008, J BIOMECH, V41, P1086, DOI 10.1016/j.jbiomech.2007.11.019
   HICKEY DS, 1980, J ANAT, V131, P81
   HICKEY DS, 1980, SPINE, V5, P106, DOI 10.1097/00007632-198003000-00004
   HOLZAPFEL GA, 2005, BIOMECH MODEL MECHAN
   Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4
   Hsieh AH, 2005, J BIOMECH ENG-T ASME, V127, P1158, DOI 10.1115/1.2073467
   Hsieh AH, 2003, SPINE, V28, P1781, DOI 10.1097/01.BRS.0000083282.82244.F3
   HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402
   Hunter Christopher J., 2007, Molecular & Cellular Biomechanics, V4, P227
   Hunter CJ, 2004, J ANAT, V205, P357, DOI 10.1111/j.0021-8782.2004.00352.x
   Hunter CJ, 2004, SPINE, V29, P1099, DOI 10.1097/00007632-200405150-00010
   Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002
   Hutton WC, 2001, CLIN BIOMECH, V16, P728, DOI 10.1016/S0268-0033(01)00080-8
   HWANG D, 2009, ASME SUMM BIOENG C L
   Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013
   Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407
   Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224
   Ishihara H, 1996, J APPL PHYSIOL, V80, P839
   Jackson AR, 2008, SPINE, V33, P1, DOI 10.1097/BRS.0b013e31815e4136
   JOHNSON EF, 1982, J ANAT, V135, P301
   JOHNSTONE B, 1992, SPINE, V17, P412, DOI 10.1097/00007632-199204000-00006
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kasra M, 2006, J ORTHOP RES, V24, P1967, DOI 10.1002/jor.20253
   Kim KW, 2003, SPINE, V28, P982, DOI 10.1097/00007632-200305150-00005
   KORECKI CL, 2008, J ORTHOP RES
   LI G, 2009, EUR SPINE J, V5
   Little JP, 2008, COMPUT METHOD BIOMEC, V11, P95, DOI 10.1080/10255840701552143
   Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004
   Lotz JC, 2000, SPINE, V25, P1477, DOI 10.1097/00007632-200006150-00005
   Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9
   Lotz JC, 2002, BIOCHEM SOC T, V30, P853, DOI 10.1042/bst0300853
   Lotz JC, 2008, EUR SPINE J, V17, P1149, DOI 10.1007/s00586-008-0721-y
   MacLean JJ, 2005, J ORTHOP RES, V23, P1120, DOI 10.1016/j.orthres.2005.01.020
   MacLean JL, 2004, J ORTHOP RES, V22, P1193, DOI 10.1016/j.orthres.2004.04.004
   MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011
   Melrose J, 2003, EUR SPINE J, V12, P57, DOI 10.1007/s00586-002-0434-6
   Melrose J, 2001, J ANAT, V198, P3, DOI 10.1046/j.1469-7580.2001.19810003.x
   Melrose J, 2008, EUR SPINE J, V17, P314, DOI 10.1007/s00586-007-0538-0
   Miyamoto H, 2006, SPINE, V31, P4, DOI 10.1097/01.brs.0000192682.87267.2a
   Moon SH, 2008, SPINE, V33, P1850, DOI 10.1097/BRS.0b013e31817e1cd7
   MORSCHAUSER MA, 2009, T 55 ANN M ORTH RES, V34, P1656
   Nerlich AG, 1998, VIRCHOWS ARCH, V432, P67, DOI 10.1007/s004280050136
   Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001
   Nerurkar NL, 2007, J ORTHOP RES, V25, P1018, DOI 10.1002/jor.20384
   NESSON SC, 2008, T 54 ANN M ORTH RES, V33, P46
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   OLCZYK K, 1994, Z RHEUMATOL, V53, P19
   Onan OA, 1998, SPINE, V23, P430, DOI 10.1097/00007632-199802150-00005
   ORTOLANI F, 1988, BASIC APPL HISTOCHEM, V32, P443
   PANJABI M, 1989, SPINE, V14, P1002, DOI 10.1097/00007632-198909000-00015
   Parsons MJ, 2002, DEVELOPMENT, V129, P3137
   Patwardhan AG, 1999, SPINE, V24, P1003, DOI 10.1097/00007632-199905150-00014
   PEARCE RH, 1989, J ORTHOP RES, V7, P861, DOI 10.1002/jor.1100070612
   Pettway Z, 1996, EXP CELL RES, V225, P195, DOI 10.1006/excr.1996.0170
   Pezowicz CA, 2006, J ANAT, V208, P317, DOI 10.1111/j.1469-7580.2006.00536.x
   Platz F, 2006, ANN ANAT, V188, P289, DOI 10.1016/j.aanat.2006.01.009
   Poiraudeau S, 1999, SPINE, V24, P837, DOI 10.1097/00007632-199905010-00002
   Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3
   Rannou F, 2003, J CELL BIOCHEM, V90, P148, DOI 10.1002/jcb.10608
   RASTOGI A, 2009, T 55 ANN M ORTH RES, P1788
   Rastogi A, 2009, J CELL PHYSIOL, V220, P698, DOI 10.1002/jcp.21816
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   Rohlmann A, 2001, Spine (Phila Pa 1976), V26, pE557, DOI 10.1097/00007632-200112150-00014
   RUFAI A, 1995, ANAT EMBRYOL, V192, P53
   SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206
   SANDELL LJ, 1991, J CELL BIOL, V114, P1307, DOI 10.1083/jcb.114.6.1307
   SANDELL LJ, 1994, MICROSC RES TECHNIQ, V28, P470, DOI 10.1002/jemt.1070280603
   Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004
   Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001
   Setton LA, 2004, SPINE, V29, P2710, DOI 10.1097/01.brs.0000146050.57722.2a
   Shine KM, 2008, J ORTHOP RES, V26, P1398, DOI 10.1002/jor.20614
   SMITH TJ, 1991, SPINE, V16, P1204, DOI 10.1097/00007632-199110000-00013
   Soukane DM, 2007, J BIOMECH, V40, P2645, DOI 10.1016/j.jbiomech.2007.01.003
   SOWA G, 2008, AM J PHYS MED REHABI
   Steck E, 2005, STEM CELLS, V23, P403, DOI 10.1634/stemcells.2004-0107
   Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029
   Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812
   STEVENS RL, 1979, BIOCHEM J, V179, P561, DOI 10.1042/bj1790561
   STOKES I, 1985, J BIOMECH, V18, P1, DOI 10.1016/0021-9290(85)90040-5
   STOKES IAF, 1987, J ORTHOPAED RES, V5, P348, DOI 10.1002/jor.1100050306
   Suzuki T, 2009, EUR SPINE J, V18, P263, DOI 10.1007/s00586-008-0873-9
   Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235
   URBAN JPG, 1988, SPINE, V13, P179, DOI 10.1097/00007632-198802000-00009
   Videman T, 2006, SPINE, V31, P671, DOI 10.1097/01.brs.0000202558.86309.ea
   Vilovic K, 2001, CELLS TISSUES ORGANS, V169, P347, DOI 10.1159/000047901
   Walsh AJL, 2004, J BIOMECH, V37, P329, DOI 10.1016/S0021-9290(03)00290-2
   Wang H, 2004, J MOL MED-JMM, V82, P126, DOI 10.1007/s00109-003-0507-y
   Wilke HJ, 2003, SPINE, V28, P2585, DOI 10.1097/01.BRS.0000096673.16363.C7
   Wuertz K, 2009, J ORTHOP RES
   YANG L, 2008, J BIOMED MAT RES A
   Yerramalli CS, 2007, BIOMECH MODEL MECHAN, V6, P13, DOI 10.1007/s10237-006-0043-0
   Yoon ST, 2004, SPINE, V29, P2603, DOI 10.1097/01.brs.0000146103.94600.85
   Yu J, 2005, SPINE, V30, P1815, DOI 10.1097/01.brs.0000173899.97415.5b
   Yu J, 2002, BIOCHEM SOC T, V30, P848, DOI 10.1042/bst0300848
   Yu J, 2007, J ANAT, V210, P460, DOI 10.1111/j.1469-7580.2007.00707.x
   Zhang YJ, 2006, SPINE, V31, P2173, DOI 10.1097/01.brs.0000232792.66632.d8
   Zhu Y, 2001, DEV DYNAM, V220, P350, DOI 10.1002/dvdy.1115
NR 139
TC 41
Z9 46
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PD JAN 5
PY 2010
VL 43
IS 1
SI SI
BP 137
EP 145
DI 10.1016/j.jbiomech.2009.09.019
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 547SL
UT WOS:000273909400019
PM 19828150
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Zhang, P
   Chen, G
   Zheng, XF
AF Zhang, P.
   Chen, G.
   Zheng, X. F.
BE Skrotzki, W
   Oertel, CG
   Biermann, H
   Heilmaier, M
TI Preparation and mechanical property of polymer-based biomaterials
SO 15TH INTERNATIONAL CONFERENCE ON THE STRENGTH OF MATERIALS (ICSMA-15)
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 15th International Conference on the Strength of Materials (ICSMA 15)
CY AUG 16-21, 2009
CL Dresden, GERMANY
ID SMART BIOCONJUGATE; VIBRATION CONTROL; HYDROGELS
AB The porous polymer-based biomaterial has been synthesized from PLGA, dioxane and tricalcium phosphate (TCP) by low-temperature deposition process. The deformation behaviours and fracture mechanism of polymer-based biomaterials were investigated using the compression test and the finite element (FE) simulation. The results show that the stress-strain of compression process includes linear elastic stage I, platform stage II and densification stage III, and the fracture mechanism can be considered as brittle fracture.
C1 [Zhang, P.; Chen, G.; Zheng, X. F.] Harbin Inst Technol, Sch Mat Sci & Engn, Weihai 264209, Peoples R China.
RP Zhang, P (reprint author), Harbin Inst Technol, Sch Mat Sci & Engn, Weihai 264209, Peoples R China.
EM pzhang@yeah.net
CR Andreeva DV, 2008, MATER TODAY, V11, P24, DOI 10.1016/S1369-7021(08)70204-9
   Haraguchi K, 2006, BIOMACROMOLECULES, V7, P3267, DOI 10.1021/bm060549b
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Oupicky D, 2003, MACROMOLECULES, V36, P6863, DOI 10.1021/ma034039a
   Sardar M, 2003, BIOTECHNOL PROGR, V19, P1654, DOI 10.1021/bp034080x
   Sharma S, 2003, BIOMACROMOLECULES, V4, P330, DOI 10.1021/bm0256799
   Song G, 2006, ENG STRUCT, V28, P1513, DOI 10.1016/j.engstruct.2006.02.002
   Stoop R, 2008, INJURY, V39, P77
   Wei KX, 2006, J SOUND VIB, V298, P1150, DOI 10.1016/j.jsv.2006.05.033
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Yokoyama M, 2002, DRUG DISCOV TODAY, V7, P426, DOI 10.1016/S1359-6446(02)02216-X
NR 12
TC 1
Z9 1
U1 0
U2 6
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2010
VL 240
AR 012152
DI 10.1088/1742-6596/240/1/012152
PG 4
WC Materials Science, Multidisciplinary; Physics, Multidisciplinary
SC Materials Science; Physics
GA BTC87
UT WOS:000286515800152
OA Bronze
DA 2018-10-20
ER

PT S
AU Safonov, V
   Zykova, A
   Smolik, J
   Rogovska, R
   Donkov, N
   Georgieva, V
AF Safonov, V.
   Zykova, A.
   Smolik, J.
   Rogovska, R.
   Donkov, N.
   Georgieva, V.
BE DimovaMalinovska, D
   Nesheva, D
   Petrov, AG
   Primatarowa, MT
TI The surface parameters modifications at nano scale for biomedical
   applications
SO 16 ISCMP: PROGRESS IN SOLID STATE AND MOLECULAR ELECTRONICS, IONICS AND
   PHOTONICS
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT Conference on 16 ISCMP
CY AUG 29-SEP 03, 2010
CL Varna, BULGARIA
SP Inst Solid State Phys Bulgarian Acad Sci
ID THIN-FILMS; ENERGY
AB Functional coatings deposition is an effective way of surface modification with direct control of stoichiometry, impurity elements, functional groups and surface charges. Modified surface properties such as composition, roughness, wettability have effect on the most important processes at biomaterial interface. The aim of present study was the analysis of surface roughness and surface free energy parameters of oxide Al2O3 and Ta2O5 coatings and the possibility to separate the influence of such factors on the regularities and mechanisms of nano materials interactions with the biological objects.
C1 [Safonov, V.; Zykova, A.] Kharkov Inst Phys & Technol, NSC, Kharkov, Ukraine.
RP Zykova, A (reprint author), Kharkov Inst Phys & Technol, NSC, Kharkov, Ukraine.
EM zykov@bi.com.ua
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Dhayal M, 2008, APPL SURF SCI, V254, P3331, DOI 10.1016/j.apsusc.2007.11.026
   Donkov N, 2010, Journal of Physics: Conference Series, V223, DOI 10.1088/1742-6596/223/1/012030
   Hammer D A, 1987, J BIOPHYS, V52, P475
   Links J, 1998, BIOMATERIALS, V19, P2219
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Rogowska R, 2006, PROBLEMY EKSPLOATACJ, V61, P193
   Todorova Z, 2006, PLASMA PROCESS POLYM, V3, P174, DOI 10.1002/ppap.200500110
   Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7
   Zykova A., 2007, PROBLEMS ATOMIC SCI, V13, P200
NR 10
TC 8
Z9 8
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2010
VL 253
AR 012068
DI 10.1088/1742-6596/253/1/012068
PG 4
WC Physics, Atomic, Molecular & Chemical
SC Physics
GA BYS85
UT WOS:000300022100068
OA Bronze
DA 2018-10-20
ER

PT S
AU Jia, YY
   Tan, RB
   Wang, Y
   Lin, QJ
   Shi, Y
   Zhou, YL
AF Jia, Yuanyuan
   Tan, Renbo
   Wang, Yan
   Lin, Qijiang
   Shi, Yi
   Zhou, Yulai
BE Yu, W
   Zhang, M
   Wang, L
   Song, Y
TI Preliminary Investigation on Cell Biocompatibility of Hydrated Bacterial
   Cellulose
SO 2010 3RD INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND
   INFORMATICS (BMEI 2010), VOLS 1-7
SE International Conference on Biomedical Engineering and Informatics
LA English
DT Proceedings Paper
CT 2010 3rd International Conference on Biomedical Engineering and
   Informatics (BMEI 2010)
CY OCT 16-18, 2010
CL Yantai Univ, Yantai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc
HO Yantai Univ
DE bacterial cellulose (BC); cell compatibility; tissue engineering; rat
   fibroblast (FB)
ID BIOMEDICAL APPLICATIONS; MICROBIAL CELLULOSE
AB In order to explore the possibility of using bacterial cellulose (BC) as scaffold in tissue engineering, fibroblasts (FB) were cultured as seed cells on hydrated membrane of bacterial cellulose (BC). First, FBs were isolated by dispase-collagenase system from the dermis of the back skin of newborn (within 24 hours) rats and were adherently cultured in DMEM medium with newborn calf serum (10%) under 5% CO2 and 37 degrees C at a density of 1.0x105 cell/ml. The growth curve of FBs was determined by MTT method. Second, the subcultured rat FBs were inoculated on hydrated membrane of BC as scaffold, at a density of 3.0x10(5) cell/ml. At different time intervals, the growth of cells on scaffold was determined by morphological characterization, such as HE staining, optical microscope, and scanning electron microscope (SEM). From the third to the seventh day of culture, the rat FBs were in logarithmic growth phase and showed strong proliferation, which might be well suited to be seed cells cultured on BC scaffold. After the inoculation for 3 days, rat FBs entered into the scaffold, and integrated closely with BC, which supported proliferation of cells. Excellent biocompatibility was verified in our experiment. The results suggested the potential for this biomaterial as a scaffold for tissue engineering.
C1 [Tan, Renbo; Wang, Yan; Lin, Qijiang; Shi, Yi; Zhou, Yulai] Jilin Univ, Pharmaceut Sch, Expt Ctr Bioengn, Changchun 130021, Jilin, Peoples R China.
   [Jia, Yuanyuan] Tianjin Univ Sci & Technol, Minist Educ, Coll Biotechnol, Key Lab Ind Microbiol, Tianjin 300457, Peoples R China.
RP Zhou, YL (reprint author), Jilin Univ, Pharmaceut Sch, Expt Ctr Bioengn, Changchun 130021, Jilin, Peoples R China.
EM zhouylnew@yahoo.com.cn
FU Science and Technology Agency of Jilin Province [20010407, 200905136];
   Major State Basic Research Development Program [2007CB714305]
FX The authors wish to acknowledge the Science and Technology Agency of
   Jilin Province for the financial support of Project No. 20010407 and No.
   200905136. China Ministry of Science and Technology is appreciated for
   the support of Major State Basic Research Development Program (No.
   2007CB714305).
CR Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   IGUCHI M, 2000, J MATER SCI, V35, P2997
   JIA H, 2009, 2 INT C BIOMEDICAL E
   Jia SR, 2004, BIOTECHNOL BIOPROC E, V9, P166, DOI 10.1007/BF02942287
   JIA YY, 2009, P 3 INT C BIOINF BIO
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Tang WH, 2010, WORLD J MICROB BIOT, V26, P125, DOI 10.1007/s11274-009-0151-y
   Wan WK, 2006, ACS SYM SER, V938, P221
NR 11
TC 1
Z9 1
U1 0
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1948-2914
BN 978-1-4244-6496-8
J9 INT CONF BIOMED
PY 2010
BP 1710
EP 1713
DI 10.1109/BMEI.2010.5639737
PG 4
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BVY38
UT WOS:000293143502091
DA 2018-10-20
ER

PT S
AU Xu, WF
AF Xu, Wenfeng
GP IEEE
TI The mechanical properties of Carbon fiber/Polylatide/Chitosan composites
SO 2010 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL
   ENGINEERING (ICBBE 2010)
SE International Conference on Bioinformatics and Biomedical Engineering
LA English
DT Proceedings Paper
CT 4th International Conference on Bioinformatics and Biomedical
   Engineering (iCBBE)
CY JUN 18-20, 2010
CL Chengdu, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Sichuan Univ, Wuhan Univ
DE Carbon fiber; Polylatide; Chitosan; mechanical properties
ID SCAFFOLDS
AB The Carbon fiber/Polylatide/Chitosan(C/PLA/CS) biomaterial composites were fabricated by using solvent blending and immersed glue moulding process, and the mechanical properties of the composites before and after degradation were researched in bending and shear modes. The results shows that the C/PLA/CS composites have excellent mechanical properties, while the volume fraction of CF and mass fraction of CS increases, there are peak values with shear or bending strength and modulus, including maximums of shear strength and modulus of 330 MPa and 16 Gpa, bending strength of 446 MPa and 23 Gpa respectively. With the time of degradation goes, the shear strength and modulus fall about 30% and 31%, and the bending strength and modulus fall about 24% and 39% after degradation in vitro for 20 weeks respectively. It is strongly suggested that the loss of strength and modulus after degadation formed firstly by the interface stress corrosion of phosphate buffer solution(PBS) simulative body fluid, and subsequently by a combination of the interface stress corrosion and the degradation of PLA and CS.
C1 [Xu, Wenfeng] Chongqing Univ Arts & Sci, Coll Chem & Environm Engn, Chongqing 402160, Peoples R China.
RP Xu, WF (reprint author), Chongqing Univ Arts & Sci, Coll Chem & Environm Engn, Chongqing 402160, Peoples R China.
EM xwf_228@163.com
FU Science and Technic Study Foundation of Chongqing municipal education
   commission of China [KJ081205, KJ091213]; National Natural Science
   Foundation of China [30870609]
FX The research was supported by the Science and Technic Study Foundation
   of Chongqing municipal education commission of China under Grant No.
   KJ081205, KJ091213 and the National Natural Science Foundation of China
   under Grant No. 30870609.
CR Bai Yanbin, 2006, POLYM B, V3, P46
   Hatta H, 2001, CARBON, V39, P83, DOI 10.1016/S0008-6223(00)00083-X
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   [齐锦刚 Qi Jingang], 2005, [复合材料学报, Acta Materiae Compositae Sinica], V22, P34
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 8
TC 0
Z9 0
U1 1
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2151-7614
BN 978-1-4244-4713-8
J9 INT CONF BIOINFORM
PY 2010
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BH0ZM
UT WOS:000397260202046
DA 2018-10-20
ER

PT S
AU Zhang, XF
   Liu, TL
   Sheng, WH
   Xie, YF
   Miao, JC
   Yang, JC
AF Zhang, Xiaofeng
   Liu, Tielian
   Sheng, Weihua
   Xie, Yufeng
   Miao, Jingcheng
   Yang, Jicheng
GP IEEE
TI Enhanced capillary formation by transplanted Ad-VEGF(165) transgenic
   epithelial cells on silk fibroin films
SO 2010 4TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL
   ENGINEERING (ICBBE 2010)
SE International Conference on Bioinformatics and Biomedical Engineering
LA English
DT Proceedings Paper
CT 4th International Conference on Bioinformatics and Biomedical
   Engineering (iCBBE)
CY JUN 18-20, 2010
CL Chengdu, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Sichuan Univ, Wuhan Univ
DE silk protein, vascular endothelial growth factor (VEGF); human corneal
   epithelial; recombinant adenovirus; cornea
ID ENDOTHELIAL GROWTH-FACTOR; CORNEAL NEOVASCULARIZATION; IN-VITRO; VEGF;
   ANGIOGENESIS; MODEL; LYMPHANGIOGENESIS; DELIVERY; VIVO
AB Vascular endothelial growth factors (VEGF) regulate multiple physiological and pathological processes including angiogenesis, i.e. growth of new blood vessels, a hallmark of wound healing. To improve VEGF blood life-time for enhanced angiogenesis in clinical applications, we investigate the possibility of cell transplant therapy using implanting silk protein film substrates loaded with VEGF-transfected THCE cells into a rabbit corneal model. Significantly enhanced corneal neovascularization is observed. THCE cells were cultivated on silk protein films (SF) and transfected with the Ad-VEGF165 for 48 hours. In vitro ELISA testing showed that Ad-VEGF165 transfected THCE cells expressed significantly higher levels of VEGF then self-secreted VEGF level in untransfected THCE cells. Interestingly, Ang1 and EGF levels were also higher in VEGF-transfected cells. After the transfection, the SF materials(4 mm x 3mm) were implanted into corneal stromal. Images of the corneal vasculature showed significant angiogenesis induced by VEGF-transfected THCE cells. One month after the implantation, corneal neovasculars extended to the margin of the pupil, with bifurcation and loops formation and the mean area of neovascularization was drastically increased. Immunostain-ing specimens all showed positive staining for CD34 on corneal stromal. It is concluded that cornea neovascularization was successfully induced by implanting SF/THCE-Ad-VEGF165 in rabbit corneal stroma. The regenerated silk fibroin films had good biological compatibility with THCE. Not only the expression level of the target VEGF gene was elevated, but also related genes such as Ang1 and EGF were also activated. These results indicate that regenerated silk fibroin films are a practical biomaterial platform that, once modified with transgenic seed cells, can provide multiple functions such as induced angiogenesis and enhanced tissue wound healing. (Abstract)
C1 [Zhang, Xiaofeng; Liu, Tielian; Sheng, Weihua; Xie, Yufeng; Miao, Jingcheng; Yang, Jicheng] Soochow Univ, Coll Med, Cell & Mol Biol Inst, Suzhou 215123, Peoples R China.
RP Yang, JC (reprint author), Soochow Univ, Coll Med, Cell & Mol Biol Inst, Suzhou 215123, Peoples R China.
EM jcyang@suda.edu.cn
FU Major State Basic Research Development Program of China (973 Program)
   [2005CB623906]; Medical Development Foundation of Soochow University
   [EE134702]
FX This work was supported by the Major State Basic Research Development
   Program of China (973 Program), No. 2005CB623906 and the Grant from
   Medical Development Foundation of Soochow University. No. EE134702.
CR Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Cho CH, 2006, P NATL ACAD SCI USA, V103, P4946, DOI 10.1073/pnas.0506352103
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dell S, 2006, INVEST OPHTH VIS SCI, V47, P1928, DOI 10.1167/iovs.05-1071
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   [龚爱华 Gong Aihua], 2005, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V24, P38
   Hosseini H, 2007, CLIN EXP OPHTHALMOL, V35, P745, DOI 10.1111/j.1442-9071.2007.01572.x
   Huang Quan, 2007, J SOOCHOW U ENG SCI, V27, P1
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Liu Tielian, 2008, J CLIN REHABILITATIV, V41, P8103
   Ma DHK, 2006, PROG RETIN EYE RES, V25, P563, DOI 10.1016/j.preteyeres.2006.09.001
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Sennlaub F, 1999, INVEST OPHTH VIS SCI, V40, P2773
   [盛伟华 Sheng Weihua], 2005, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V24, P277
   Shi WY, 2006, INVEST OPHTH VIS SCI, V47, P3339, DOI 10.1167/iovs.05-1425
   SHIMA DT, 1995, FEBS LETT, V370, P203, DOI 10.1016/0014-5793(95)00831-S
   Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346
   Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793
   Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2
   Zacchigna S, 2005, AM J PATHOL, V167, P981, DOI 10.1016/S0002-9440(10)61188-1
   Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330
NR 28
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2151-7614
BN 978-1-4244-4713-8
J9 INT CONF BIOINFORM
PY 2010
PG 6
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BH0ZM
UT WOS:000397260206159
DA 2018-10-20
ER

PT B
AU Pramanik, K
AF Pramanik, K.
GP IEEE
TI Biomaterials for Tissue Engineered Scaffolds
SO 2010 ADVANCED TECHNOLOGIES FOR ENHANCING QUALITY OF LIFE (AT-EQUAL)
LA English
DT Proceedings Paper
CT Conference on Advanced Technologies for Enhanced Quality of Life
   (AT-EQUAL)/ARTIPED Conference/REMEDIS Conference/PRO-NEURO
   Conference/Summer School Conference on SOCORO
CY JUL 15-18, 2010
CL Iasi, ROMANIA
SP IEEE Comp Soc
ID EXTRACELLULAR-MATRIX; FREEFORM FABRICATION; PROTEIN ADSORPTION; POLYMER
   SCAFFOLDS; POROUS SCAFFOLDS; GROWTH-FACTORS; IN-VITRO; COLLAGEN;
   ARCHITECTURE; DIFFERENTIATION
AB In recent years the development of tissue engineered scaffolds from biodegradable polymers has been advancing because of their use as support material for tissue regeneration. This paper describes the various ideal biopolymers and their essential characteristics to suitable for tissue engineering applications. The functional characteristics of biomaterial include the optimization of porosity, wetability, biocompatibility, surface topology and mechanical property to mimic the ECM function. The scaffold can be designed and fabricated by porogen leaching, thermally induced phase separation, emulsion polymerization, electro spinning and SFF for designing of 3-D scaffolds. Surface modification of scaffold is important to improve their mechanical and chemical properties which can be achieved by suitable chemical and/or irradiation. The scaffold must be biocompatible in order to provide the proper microenvironment for tissue-scaffold interaction. A brief of the ongoing research in the area of scaffold development for bone and cartilage tissue repair is also described.
C1 Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela, India.
RP Pramanik, K (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela, India.
EM kpr@nitrkl.ac.in
RI Pramanik, Krishna/M-3729-2018
OI Pramanik, Krishna/0000-0002-5676-7740
CR Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Black Jonathan, 2006, BIOL PERFORMANCE MAT, P3
   Calvert P, 1998, MAT SCI ENG C-BIO S, V6, P167, DOI 10.1016/S0928-4931(98)00046-0
   Cao Y, 2006, J BIOMAT SCI-POLYM E, V17, P369, DOI 10.1163/156856206776374142
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Das S, 2003, RAPID PROTOTYPING J, V9, P43, DOI 10.1108/13552540310455656
   Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Feijen J, 1991, ARTIFICIAL ORG, P199
   Freed L. E., 2000, PRINCIPLES TISSUE EN, P143
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401
   KERENYI T, 1985, EXP MOL PATHOL, V43, P151, DOI 10.1016/0014-4800(85)90036-X
   Kitano H., 2000, J PHYSCHEM, P11
   LAIHO M, 1989, CANCER RES, V49, P2533
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEUSHNER JRA, 1984, ATHEROSCLEROSIS, V50, P11, DOI 10.1016/0021-9150(84)90004-2
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   Miko AG, 2000, ELECTRON J BIOTECHN, V13, P114
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Morra M., 2001, BIOMATERIAL SURFACE, P1
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Salzmann E., 1969, BIOMED MAT RES, V3, P69
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Taipale J, 1997, FASEB J, V11, P51
   Vogel WF, 2001, EUR J DERMATOL, V11, P506
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Xiong Z, 2002, SCRIPTA MATER, V46, P771, DOI 10.1016/S1359-6462(02)00071-4
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
NR 46
TC 0
Z9 0
U1 0
U2 11
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
BN 978-0-7695-4280-5
PY 2010
BP 93
EP 99
DI 10.1109/ATEQUAL.2010.7
PG 7
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BAN66
UT WOS:000304854700022
DA 2018-10-20
ER

PT S
AU Fassina, L
   Saino, E
   Visai, L
   Avanzini, MA
   De Angelis, MGC
   Benazzo, F
   Van Vlierberghe, S
   Dubruel, P
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   Avanzini, Maria Antonietta
   De Angelis, Maria Gabriella Cusella
   Benazzo, Francesco
   Van Vlierberghe, Sandra
   Dubruel, Peter
   Magenes, Giovanni
GP IEEE
TI Use of a gelatin cryogel as biomaterial scaffold in the differentiation
   process of human bone marrow stromal cells
SO 2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 32nd Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBC 10)
CY AUG 30-SEP 04, 2010
CL Buenos Aires, ARGENTINA
SP IEEE Engn Med & Biol Soc (EMBS)
ID IN-VITRO; CALCIFICATION; DEGRADATION; HYDROGELS; COLLAGEN; PROTEIN
AB Biomaterials have been widely used in reconstructive bone surgery to heal critical-size long bone defects due to trauma, tumor resection, and tissue degeneration. In particular, gelatin cryogel scaffolds are promising new biomaterials owing to their biocompatibility; in addition, the in vitro modification of biomaterials with osteogenic signals enhances the tissue regeneration in vivo, suggesting that the biomaterial modification could play an important role in tissue engineering. In this study we have followed a biomimetic strategy where differentiated human bone marrow stromal cells built their extracellular matrix onto gelatin cryogel scaffolds. In comparison with control conditions without differentiation medium, the use of a differentiation medium increased, in vitro, the coating of gelatin cryogel with bone proteins (decorin, osteocalcin, osteopontin, type-I collagen, and type-III collagen). The differentiation medium aimed at obtaining a better in vitro modification of gelatin cryogel in terms of cell colonization and coating with osteogenic signals, like bone matrix proteins. The modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, CIT, Dipartimento Informat & Sistemist, Via Ferrata 1, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia; De Angelis, Maria Gabriella Cusella] Univ Pavia, CIT, Dipartimento Biochim, I-27100 Pavia, Italy.
   [Avanzini, Maria Antonietta] IRCCS San Matteo Pavia, Oncoematol Pediatricaa, Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, IRCCS San Matteo, Dipartimento SMEC, I-27100 Pavia, Italy.
   [Van Vlierberghe, Sandra; Dubruel, Peter] Univ Ghent, Biomat Res Grp, B-9000 Ghent, Belgium.
RP Fassina, L (reprint author), Univ Pavia, CIT, Dipartimento Informat & Sistemist, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it; enrica.saino@unipv.it; livia.visai@unipv.it;
   ma.avanzini@smatteo.pv.it; cusella@unipv.it; francesco.benazzo@unipv.it;
   sandra.vanvlierberghe@ugent.be; peter.dubruel@ugent.be;
   giovanni.magenes@unipv.it
RI Fassina, Lorenzo/K-9283-2015; Magenes, Giovanni/C-4202-2012
OI Fassina, Lorenzo/0000-0002-5587-4632; Magenes,
   Giovanni/0000-0002-7558-1490; Cusella De Angelis, Maria
   Gabriella/0000-0003-2642-3346
FU Fondazione Cariplo Grant; PRIN Grant from Italian Ministry MUR; FIRB
   Grant from Italian Ministry MIUR [RBIP06FH7J]
FX This work was supported by Fondazione Cariplo Grant (2006) to F. B., by
   PRIN Grant (2006) from Italian Ministry MUR to L. V., and by FIRB Grant
   (CINECA no. RBIP06FH7J) from Italian Ministry MIUR to M. G. C. De A..
CR Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234
   KASUGAI S, 1992, J CELL PHYSIOL, V152, P467, DOI 10.1002/jcp.1041520305
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Pozzi S, 2006, EXP HEMATOL, V34, P934, DOI 10.1016/j.exphem.2006.03.007
   Ripamonti U, 2006, J ANAT, V209, P447, DOI 10.1111/j.1469-7580.2006.00635.x
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649
   Van Vlierberghe S, 2009, J BIOMAT SCI-POLYM E, V20, P1417, DOI 10.1163/092050609X12457418905508
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
NR 21
TC 15
Z9 15
U1 0
U2 16
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-4124-2
J9 IEEE ENG MED BIO
PY 2010
BP 247
EP 250
DI 10.1109/IEMBS.2010.5627475
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BTS36
UT WOS:000287964000060
PM 21096747
DA 2018-10-20
ER

PT S
AU Ahmed, M
   Hamilton, G
   Seifalian, AM
AF Ahmed, Maqsood
   Hamilton, George
   Seifalian, Alexander M.
GP IEEE
TI Viscoelastic Behaviour of a Small Calibre Vascular Graft Made from a
   POSS-Nanocomposite
SO 2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 32nd Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBC 10)
CY AUG 30-SEP 04, 2010
CL Buenos Aires, ARGENTINA
SP IEEE Engn Med & Biol Soc (EMBS)
ID BYPASS
AB Small calibre (<6mm) polytetrafluoroethylene (PTFE) bypass grafts have poor medium and long term patency due to the development of neointimal hyperplasia at the distal anastomosis. The inelasticity of PTFE is implicated in this mechanism of failure. We have developed a novel polyhedral oligomeric silsesquioxane (POSS) nanocage incorporated into a poly(carbonate) urethane (PCU) biomaterial with enhanced biostability and improved antithrombogenicity making it ideal for cardiovascular applications. In this study the compliance and viscous component of a POSS-PCU small calibre graft was measured using a biomimetic pulsatile flow circuit and wall tracking ultrasound. A POSS-PCU graft displays elastic and viscous behaviour similar to the native artery. Furthermore, platelet adhesion and activation studies suggest POSS-PCU is a more biocompatible material than current industry favourite ePTFE. Alleviating the thrombogenicity of grafts and the mechanical mismatch between artery and graft is encouraging for the short and long term patency of the POSS-PCU graft.
C1 [Ahmed, Maqsood] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England.
   [Hamilton, George; Seifalian, Alexander M.] UCL, Ctr Nanotechnol Regenerat Med, Div Surg & Intervent Sci, London, England.
RP Ahmed, M (reprint author), UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England.
EM maqsood.ahmed@ucl.ac.uk; A.Seifalian@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
FU EPSRC; Wellcome Trust
FX This work was supported by the EPSRC and Wellcome Trust
CR FURIE B, 2004, NEW ENGL J MED, V359, P938
   Giudiceandrea A, 2000, J ARTIF ORGANS, V3, P16
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GOSLING RG, 1976, P PEREGRINUS UK IEE, V21, P73
   HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Lakhani K, 2002, CIRCULATION, V106, P81, DOI 10.1161/01.CIR.0000020681.19400.8A
   Post S, 2001, EUR J VASC ENDOVASC, V22, P226, DOI 10.1053/ejvs.2001.1424
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   Sarkar S, 2009, J BIOMECH, V42, P722, DOI 10.1016/j.jbiomech.2009.01.003
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   Visontai Z, 2000, EUR RESPIR J, V16, P1134, DOI 10.1034/j.1399-3003.2000.16f20.x
NR 12
TC 5
Z9 7
U1 0
U2 11
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-4124-2
J9 IEEE ENG MED BIO
PY 2010
BP 251
EP 254
DI 10.1109/IEMBS.2010.5627472
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BTS36
UT WOS:000287964000061
PM 21096748
DA 2018-10-20
ER

PT S
AU Paula, PMC
   Rodrigues, SSFR
   Brasil, LM
   Silva, RC
   da Rocha, AF
AF Paula, Patricia M. C.
   Rodrigues, Suelia S. F. R.
   Brasil, Lourdes M.
   Silva, Rita C.
   da Rocha, Adson F.
GP IEEE
TI Analysis of Biomaterial Latex-Derived Flow Mechanical Controller
SO 2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 32nd Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBC 10)
CY AUG 30-SEP 04, 2010
CL Buenos Aires, ARGENTINA
SP IEEE Engn Med & Biol Soc (EMBS)
AB This paper describes the basic guidelines for developing an innovative biomedical device. It covers the issues of researching about a suitable material, developing a new device, and testing its proprieties to check its effectiveness. The goal of the device is to control food flow into the esophagus, reducing its volume and the speed of food intake to help in the treatment of obesity. This module, called Esophageal Flow Controller (EFC (R)), is made of latex. Three different models of prototypes were developed, and 10 units of each model had their constructive and mechanical characteristics evaluated. All of them have followed the same manufacturing cycle. The results showed that the Esophageal Flow Control module has all the essential characteristics of an effective device for flow control in the esophagus.
C1 [Paula, Patricia M. C.] Univ Brasilia, Dept Elect Engn, Brasilia, DF, Brazil.
   [Rodrigues, Suelia S. F. R.; Brasil, Lourdes M.; Silva, Rita C.; da Rocha, Adson F.] Univ Brasilia, Dept Elect Engn, Engn & Innovat Lab, BR-70910900 Brasilia, DF, Brazil.
RP Paula, PMC (reprint author), Univ Brasilia, Dept Elect Engn, Brasilia, DF, Brazil.
EM patricia.enge@gmail.com; suelia@unb.br; lmbrasil@gmail.com;
   ritasilva@unb.br; adson@unb.br
RI Rodrigues Fleury Rosa, Suelia/C-8264-2014
OI Rodrigues Fleury Rosa, Suelia/0000-0002-1247-9050
CR ALVES MRC, 2004, THESIS U ESTADUAL CA
   [Anonymous], 1990, ANN BOOK ASTM STAND
   ASTM, 1998, ANN BOOK ASTM STAND
   AUZAC J, 1981, PHYSL RUBBER TREE LA, P60
   BLOW CM, 1996, RUBBER TECHNOLOGY MA
   FRADE MAC, 2004, MED CUTAN IBER LAT A, V32, P157
   JACOB RF, 2006, THESIS U SAO PAULO
   MRUE F, 1996, THESIS U SAO PAULO
   MRUE F, 2000, THESIS U SAO PAULO
   OLIVEIRA JAA, 2003, REV BRAS OTORRINOLAR, V69, P649, DOI DOI 10.1590/S0034-72992003000500010
   PERES ACC, 2006, POLIMEROS, V16, P1
   Rodrigues S. S. F. R., 2009, DESENVOLVIMENTO SIST, V1, P121
   TROMBETTA F, 2007, TECNOLOGIA LATICES
   Wititsuwannakul D, 2003, J APPL POLYM SCI, V87, P90, DOI 10.1002/app.11674
   LECT NOTES METHODE F
NR 15
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-4124-2
J9 IEEE ENG MED BIO
PY 2010
BP 263
EP 267
DI 10.1109/IEMBS.2010.5627442
PG 5
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BTS36
UT WOS:000287964000064
PM 21096751
DA 2018-10-20
ER

PT S
AU Sant, S
   Khademhosseini, A
AF Sant, Shilpa
   Khademhosseini, Ali
GP IEEE
TI Fabrication and Characterization of Tough Elastomeric Fibrous Scaffolds
   for Tissue Engineering Applications
SO 2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 32nd Annual International Conference of the IEEE
   Engineering-in-Medicine-and-Biology-Society (EMBC 10)
CY AUG 30-SEP 04, 2010
CL Buenos Aires, ARGENTINA
SP IEEE Engn Med & Biol Soc (EMBS)
ID POLY(GLYCEROL SEBACATE); BIODEGRADABLE ELASTOMER
AB Development of biodegradable tough elastomeric scaffolds are important for engineering tissues such as myocardium and heart valves that experience dynamic environments in vivo. Biomaterial scaffolds should ideally provide appropriate physical, chemical and mechanical cues to the seeded cells to closely mimic the native ECM. Collagen fibers form an important component of native myocardium as well as heart valve leaflets and provide necessary tensile properties to these tissues. Amongst various polymers, collagen mimicking biodegradable elastomer, Poly(glycerol-sebacate) (PGS) has shown great promise in microfabricated scaffolds for cardiac tissue engineering. However, its use is limited by its solubility and the ability to cast nano-/microfibrous structures. For its superior mechanical properties, thermal or UV crosslinking of the pre-polymer is required under high temperatures and vacuum limiting fabrication of fibers. In this work, we fabricated electrospun PGS fibers were fabricated by simply blending it with biodegradable polycaprolactone (PCL) polymer without any post-processing. It was hypothesized that microfibrous PGS-PCL scaffolds would provide appropriate physical (fibrous structure) and chemical (balanced hydrophilicity and hydrophobicity) to the cells in addition to the mechanical properties.
OI Sant, Shilpa/0000-0002-2017-9584
FU NIDCR NIH HHS [RL1 DE019024, RL1 DE019024-04, DE019024]; NHLBI NIH HHS
   [R01 HL092836, HL092836, R01 HL092836-02]; NIBIB NIH HHS [EB007249, R21
   EB007249, R21 EB007249-02]
CR Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Freytes DO, 2009, J CELL BIOCHEM, V108, P1047, DOI 10.1002/jcb.22355
   Gao J, 2008, J BIOMED MATER RES A, V85A, P1120, DOI 10.1002/jbm.a.32028
   Hacking SA, 2009, J DENT RES, V88, P409, DOI 10.1177/0022034509334774
   Hwang CM, 2009, BIOMED MICRODEVICES, V11, P739, DOI 10.1007/s10544-009-9287-7
   Hwang CM, 2008, LANGMUIR, V24, P6845, DOI 10.1021/la800253b
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Ifkovits JL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034104
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liao S, 2006, BIOMED MATER, V1, pR45, DOI 10.1088/1748-6041/1/3/R01
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Redenti S, 2009, BIOMATERIALS, V30, P3405, DOI 10.1016/j.biomaterials.2009.02.046
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
NR 29
TC 12
Z9 12
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-4124-2
J9 IEEE ENG MED BIO
PY 2010
BP 3546
EP 3548
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BTS36
UT WOS:000287964003236
PM 21096824
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Ali, M
   Miller, J
   Kim, S
   Takak, S
   Kara, T
AF Ali, M.
   Miller, J.
   Kim, S.
   Takak, S.
   Kara, T.
GP IEEE
TI A finite element study of a foam filled composite graded cellular
   structure
SO 2010 IEEE 36TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 2010 IEEE 36th Annual Northeast Bioengineering Conference
CY MAR 26-28, 2010
CL Columbia Univ, New York, NY
SP IEEE
HO Columbia Univ
AB The research material presented in this paper is a continuation of work done in analyzing impact properties of a biomaterial found in a banana peel [1]. Important energy absorbing characteristics, e. g., plateau stress, locking stress, deformation mode and crushing progression, collapsing mechanism, and crushing stroke of the foam filled (peel) structure are compared with the previously analyzed unfilled composite graded (peel) structure. The addition of foam to the structure smoothens and increases the crushing force, and reduces the global locking strain.
C1 [Ali, M.] Univ Alaska Anchorage, Dept Mech, Anchorage, AK 99508 USA.
   [Miller, J.; Kim, S.; Takak, S.; Kara, T.] Univ Alaska Anchorage, Dept Comp Syst Engn, Anchorage, AK 99508 USA.
RP Ali, M (reprint author), Univ Alaska Anchorage, Dept Mech, Anchorage, AK 99508 USA.
CR ALI M, 2008, INT J ADV ENG SOFTWA, V38
   ALI M, 2006, P 32 NE BIOENG C APR
   ALI M, 2006, P 19 ANN INT AB US C
   ALI M, 2009, ASME IM ECE LAK BUEN
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-6924-6
J9 NORTHEAST BIOENGIN C
PY 2010
PG 2
WC Engineering, Biomedical
SC Engineering
GA BTO96
UT WOS:000287664400025
DA 2018-10-20
ER

PT S
AU Seil, JT
   Webster, TJ
AF Seil, Justin T.
   Webster, Thomas J.
GP IEEE
TI Zinc oxide nanoparticle and polymer antimicrobial biomaterial composites
SO 2010 IEEE 36TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 2010 IEEE 36th Annual Northeast Bioengineering Conference
CY MAR 26-28, 2010
CL Columbia Univ, New York, NY
SP IEEE
HO Columbia Univ
ID PARTICLE-SIZE
AB Particulate zinc oxide (ZnO) is a known antibacterial agent. Studies show that reducing the size of ZnO particles to nanoscale dimensions further enhances their antibacterial properties. Polymers, like all biomaterials, run the risk of harboring bacteria which may produce an antibiotic-resistant biofilm. The addition of ZnO nanoparticles, to form a composite, may reduce undesirable bacteria activity. The purpose of the present in vitro study was to investigate the antibacterial properties of ZnO nanoparticles when incorporated into a polymer biomaterial. Staphylococcus aureus were seeded at a known cell density onto coverslips coated in a film of polyvinyl chloride (PVC) with varying concentrations of ZnO nanoparticles. Samples were maintained for 24 or 72 h. Crystal violet staining indicated a reduced presence of biofilm on ZnO nanoparticle and polymer composites compared to pure polymer. Live/dead assays provided images to confirm reduced presence of active bacteria on samples with ZnO nanoparticles. Development of this technology may improve biomaterial effectiveness for applications, such as endotrachial tubes and implanted biomaterials, which are prone to bacterial infection.
C1 [Seil, Justin T.; Webster, Thomas J.] Brown Univ, Div Engn, Lab Nanomed Res, Providence, RI 02912 USA.
RP Seil, JT (reprint author), Brown Univ, Div Engn, Lab Nanomed Res, Providence, RI 02912 USA.
CR Dodd AC, 2006, J NANOPART RES, V8, P43, DOI 10.1007/s11051-005-5131-z
   Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687
   Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 5
TC 0
Z9 0
U1 1
U2 7
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-6924-6
J9 NORTHEAST BIOENGIN C
PY 2010
PG 2
WC Engineering, Biomedical
SC Engineering
GA BTO96
UT WOS:000287664400007
DA 2018-10-20
ER

PT S
AU Zhang, LJ
   Webster, TJ
AF Zhang, Lijuan
   Webster, Thomas J.
GP IEEE
TI Decreased lung carcinoma cell density on select polymer nanometer
   surface features for lung replacement therapies
SO 2010 IEEE 36TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 2010 IEEE 36th Annual Northeast Bioengineering Conference
CY MAR 26-28, 2010
CL Columbia Univ, New York, NY
SP IEEE
HO Columbia Univ
AB PLGA (poly-lactic-co-glycolic acid) has been widely used as a biomaterial in regenerative medicine due to its biocompatibility and biodegradability. The purpose of the present in vitro research was to prepare PLGA films with various nanometer surface features and determine whether lung cancer epithelial cells respond differently to such topographies. Different size polystyrene beads were used to cast poly(dimethylsiloxane) (PDMS) molds which were used as templates to create nano-featured PLGA films. Atomic force microscopy (AFM) images and root mean square (RMS) roughness values indicated that the intended spherical surface nano-topographies on PLGA were formed. A solution evaporation method was also utilized to modify PLGA surface features by using 8 wt % and 4 % chloroform solutions. Most importantly, lung cancer epithelial cells adhered less on the PLGA surfaces with RMS values of 0.62, 2.23 and 5.42 nm after 4 hours of culture compared to any other PLGA surface created here. After 3 days, PLGA surfaces with an RMS value of 0.62 nm had much lower cell density than any other sample. In this manner, PLGA with specific nanometer surface features may inhibit lung cancer cell density, providing an important biomaterial for the treatment of lung cancer with wide range of applications.
C1 [Zhang, Lijuan] Brown Univ, Dept Chem, Providence, RI 02912 USA.
   [Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
RP Zhang, LJ (reprint author), Brown Univ, Dept Chem, Providence, RI 02912 USA.
FU Hermann foundation; Northeastern Research Center for AFM
FX The authors would like to thank the Hermann foundation for funding and
   Northeastern Research Center for AFM use.
CR Carpenter J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/50/505103
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-6924-6
J9 NORTHEAST BIOENGIN C
PY 2010
PG 2
WC Engineering, Biomedical
SC Engineering
GA BTO96
UT WOS:000287664400065
DA 2018-10-20
ER

PT S
AU Kang, M
   Gao, JX
   Tang, LP
AF Kang, Mingon
   Gao, Jean X.
   Tang, Liping
BE Park, T
   Chen, L
   Wong, L
   Tsui, S
   Ng, M
   Hu, X
TI Computational Modeling of Phagocyte Transmigration during
   Biomaterial-Mediated Foreign Body Responses
SO 2010 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE
SE IEEE International Conference on Bioinformatics and Biomedicine-BIBM
LA English
DT Proceedings Paper
CT IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
CY DEC 18-21, 2010
CL Hong Kong, HONG KONG
SP IEEE Computer Soc, Hong Kong Univ of Sci & Technol, IEEE Croucher Fdn, KC wong Edu Fdn, BIBS, DNA link, Medicinal Bioconvergence Res Center of Korea
DE biological system modeling; nonlinear estimation; parameter estimation;
   reverse engineering
AB One of the major obstacles in computational modeling of a biological system is to determine a large number of parameters in the mathematical equations representing biological properties of the system. To tackle this problem, we have developed a global optimization method, called Discrete Selection Levenberg-Marquardt (DSLM), for parameter estimation. For fast computational convergence, DSLM suggests a new approach for the selection of optimal parameters in the discrete spaces, while other global optimization methods such as genetic algorithm and simulated annealing use heuristic approaches that do not guarantee the convergence. As a specific application example, we have targeted understanding phagocyte transmigration which is involved in the fibrosis process for biomedical device implantation. The goal of computational modeling is to construct an analyzer to understand the nature of the system. Also, the simulation by computational modeling for phagocyte transmigration provides critical clues to recognize current knowledge of the system and to predict yet-to-be observed biological phenomenon.
C1 [Kang, Mingon; Gao, Jean X.] Univ Texas Arlington, Dept Comp Sci, Arlington, TX 76019 USA.
   [Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
RP Kang, M (reprint author), Univ Texas Arlington, Dept Comp Sci, Arlington, TX 76019 USA.
EM mingon.kang@mavs.uta.edu; gao@uta.edu; ltang@uta.edu
FU NIH [R01EB007271]
FX The authors gratefully thank the support from NIH under grant
   R01EB007271.
CR CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   DENNIS JE, 1981, ACM T MATH SOFTWARE, V7, P348, DOI 10.1145/355958.355965
   Nielsen H. B., TECH REP
   Tang L., 1998, P NATL ACAD SCI, V95
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
NR 5
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2156-1125
EI 2156-1133
BN 978-1-4244-8307-5
J9 IEEE INT C BIOINFORM
PY 2010
BP 609
EP 612
PG 4
WC Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Medical Informatics
SC Computer Science; Mathematical & Computational Biology; Medical
   Informatics
GA BI3RN
UT WOS:000411398300107
OA Green Accepted
DA 2018-10-20
ER

PT B
AU Chen, TX
   Nie, HL
   Wang, W
   Branford-White, C
   Zhu, LM
AF Chen Tian-xiang
   Nie Hua-li
   Wang Wen
   Branford-White, Christopher
   Zhu Li-min
GP Donghua Univ, Coll Textiles
TI Modified Nylon-membrane with Biomass as Biopolymer Sorbents for Removal
   of Ni(II) and Mg(II)
SO 2010 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 28-29, 2010
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Donghua Univ, China Coll Textile, Key Lab Textile Sci & Technol, Minist Educ, Donghua Univ, Inst Biolog Sci & Biotechnol
HO Donghua Univ, Songjiang Campus
DE nylon-membrane; biomass; Ni(II); Mg(II)
ID HEAVY-METAL IONS; AQUEOUS-SOLUTIONS; BIOSORPTION; ADSORPTION; CADMIUM;
   LEAD; PRECIPITATION; DESORPTION; EFFLUENTS; ALGAE
AB Biosorption is an emerging and attractive technology which involves sorption of dissolved substances by a biomaterial. It is a potential technique for the removal of heavy metals from industrial waste water. In this study, We modified the surface of nylon-membrane with biomass (Aspergullus oryzae) as biopolymer a sorbent, and the biomass-membrane biosorption characteristics of Ni(II) and Mg(II) ions from aqueous solution were also studied. Optimum biosorption conditions were determined as a function of pH, contact time, and temperature. Langmuir, Freundlich models were applied to describe the biosorption isotherm of the metal ions. The results showed Aspergullus oryzae-membrane biomass was much better biopolymer sorbent for the removal of the both heavy metals from aqueous solution.
C1 [Chen Tian-xiang; Nie Hua-li; Wang Wen; Zhu Li-min] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
RP Zhu, LM (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
EM niehuali@dhu.edu.cn; lzhu@dhu.edu.cn
CR Bulut Y, 2007, J HAZARD MATER, V149, P35, DOI 10.1016/j.jhazmat.2007.03.044
   Chu KH, 1997, WATER SCI TECHNOL, V35, P115, DOI 10.1016/S0273-1223(97)00121-2
   Ferreira C, 2005, ENG GEOL, V77, P339, DOI 10.1016/j.enggeo.2004.07.024
   Gaballah I, 1998, J GEOCHEM EXPLOR, V62, P241, DOI 10.1016/S0375-6742(97)00068-X
   Goksungur Y, 2005, BIORESOURCE TECHNOL, V96, P103, DOI 10.1016/j.biortech.2003.04.002
   Gupta VK, 2001, WATER RES, V35, P4079, DOI 10.1016/S0043-1354(01)00138-5
   Hasan S, 2007, SEPAR SCI TECHNOL, V42, P717, DOI 10.1080/01496390601173952
   Lo WH, 1999, CHEMOSPHERE, V39, P2723, DOI 10.1016/S0045-6535(99)00206-4
   Martins BL, 2006, BIOCHEM ENG J, V27, P310, DOI 10.1016/j.bej.2005.08.007
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   Matlock MM, 2001, J HAZARD MATER, V84, P73, DOI 10.1016/S0304-3894(01)00190-X
   Nourbakhsh MN, 2002, CHEM ENG J, V85, P351
   Rostami K, 2002, CHEM ENG J, V89, P239, DOI 10.1016/S1385-8947(02)00131-6
   Sag Y, 2000, PROCESS BIOCHEM, V35, P801, DOI 10.1016/S0032-9592(99)00154-5
   Solmaz SKA, 2007, DESALINATION, V217, P301, DOI 10.1016/j.desal.2007.04.053
   Volesky B, 2001, HYDROMETALLURGY, V59, P203, DOI 10.1016/S0304-386X(00)00160-2
NR 16
TC 0
Z9 0
U1 0
U2 0
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-701-1
PY 2010
BP 183
EP 187
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BQX64
UT WOS:000282065600036
DA 2018-10-20
ER

PT S
AU Omokanwaye, T
   Owens, D
   Wilson, O
AF Omokanwaye, Tiffany
   Owens, Donae
   Wilson, Otto, Jr.
BE Herold, KE
   Bentley, WE
   Vossoughi, J
TI Identification of Bacteria and Sterilization of Crustacean Exoskeleton
   Used as a Biomaterial
SO 26TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE: SBEC 2010
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 26th Southern Biomedical Engineering Conference, SBEC 2010
CY APR 30-MAY 02, 2010
CL Univ Maryland, College Park, MD
SP Natl Sci Fdn, Biomed Engn Soc Chongqing, Natl Canc Inst (NCI)
HO Univ Maryland
DE Crustacean; Microbiology; Sterilization; Biomaterial
AB Derivatives of the crustacean exoskeleton like chitin have a long history of being used as biomaterials. In the BONE/CRAB lab, the blue claw crab exoskeleton is our biomaterial of choice for a possible bone implant material. The blue claw crustacean, Callinectes sapidus, is found in the Chesapeake Bay. Chitinolytic bacteria, such as those belonging to the Vibrio and Bacillus genera, are common to marine crustaceans. Previous in vitro studies in our lab indicated that bacterial contamination is a major concern. One of the fundamental considerations with the use of an implant biomaterial is sterilization. Materials implanted into the human body must be sterile to avoid subsequent infection or other more serious consequences. An effective sterilization method strikes a balance between the required sterility level and minimum detrimental effect on the properties of the biomaterial while being cost-effective, simple, and readily available. The objective of this study was to isolate, identify bacterial contaminants and develop the best sterilization method for those bacteria found on blue claw crab exoskeleton. Bacteria belonging to the genera Bacillus were identified based on bacterial growth morphologies of dry, dull, raised, rough, and white-grey appearance on LB agar. Bacillus members form endospores which are difficult to eliminate and poses a significant concern for implantable materials. There was no bacterial growth on the TCBS agar plates which is a differential and selective media for Vibrio species. Antimicrobial susceptibility tests were conducted to measure the effectiveness of 70% isopropyl alcohol, povidone-iodine, and household bleach against the bacteria found. The susceptibility tests revealed sensitivities towards the compounds studied. Bacterial identification and susceptibility provide vital guidance to the best method to sterilize while maintaining biological performance. Further studies will evaluate the effect the sterilization protocol has on the physical, chemical, and biological properties of the implant material.
C1 [Omokanwaye, Tiffany; Wilson, Otto, Jr.] Catholic Univ Amer, Dept Biomed Engn, 620 Michigan Ave NE, Washington, DC 20064 USA.
   [Owens, Donae] Benjamin Banneker Academ High Sch, Washington, DC 20064 USA.
RP Wilson, O (reprint author), Catholic Univ Amer, Dept Biomed Engn, 620 Michigan Ave NE, Washington, DC 20064 USA.
EM wilsono@cua.edu
FU NSF Biomaterials Program [DMR-0645675]
FX The authors would like to acknowledge support from the NSF Biomaterials
   Program (grant number DMR-0645675).
CR Aktuganov GE, 2003, MICROBIOLOGY+, V72, P313, DOI 10.1023/A:1024200132596
   Blom M, 1999, J CLIN MICROBIOL, V37, P2312
   BOULIGAND Y, 1972, TISSUE CELL, V4, P189, DOI 10.1016/S0040-8166(72)80042-9
   COATES D, 1978, J CLIN PATHOL, V31, P148, DOI 10.1136/jcp.31.2.148
   Giraud-Guille MM, 2004, CR PALEVOL, V3, P503, DOI 10.1016/j.crpv.2004.07.004
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Leboffe MJ, 2005, PHOTOGRAPHIC ATLAS M
   Mazzola PG, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-24
   Meyers MA, 2006, JOM-US, V58, P35, DOI 10.1007/s11837-006-0138-1
   Morejón-Alonso Loreley, 2007, Mat. Res., V10, P15, DOI 10.1590/S1516-14392007000100005
   MORRIS GK, 1979, J CLIN MICROBIOL, V9, P79
   Perry H, 2001, PROJECT OCEANOGRAPHY
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Smith CA, 1991, MOL CELL BIOCH BIOL
   Vogan CL, 2002, MICROBIOL-SGM, V148, P743, DOI 10.1099/00221287-148-3-743
   Wise DL, 2002, BIOMATERIALS ENG DEV
NR 16
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-14997-9
J9 IFMBE PROC
PY 2010
VL 32
BP 418
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BBO72
UT WOS:000307744700106
DA 2018-10-20
ER

PT S
AU Urbanchek, MG
   Shim, BS
   Baghmanli, Z
   Wei, B
   Schroeder, K
   Langhals, NB
   Miriani, RM
   Egeland, BM
   Kipke, DR
   Martin, DC
   Cederna, PS
AF Urbanchek, M. G.
   Shim, B. S.
   Baghmanli, Z.
   Wei, B.
   Schroeder, K.
   Langhals, N. B.
   Miriani, R. M.
   Egeland, B. M.
   Kipke, D. R.
   Martin, D. C.
   Cederna, P. S.
BE Herold, KE
   Bentley, WE
   Vossoughi, J
TI Conduction Properties Of Decellularized Nerve Biomaterials
SO 26TH SOUTHERN BIOMEDICAL ENGINEERING CONFERENCE: SBEC 2010
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 26th Southern Biomedical Engineering Conference, SBEC 2010
CY APR 30-MAY 02, 2010
CL Univ Maryland, College Park, MD
SP Natl Sci Fdn, Biomed Engn Soc Chongqing, Natl Canc Inst (NCI)
HO Univ Maryland
DE poly(3,4,-ethylenedioxythiophene); peripheral nerve; decellular nerve;
   nerve conduction
ID POLYMERIZATION
AB The purpose of this study is to optimize poly(3,4,ethylenedioxythiophene) (PEDOT) polymerization into decellular nerve scaffolding for interfacing to peripheral nerves. Our ultimate aim is to permanently implant highly conductive peripheral nerve interfaces between amputee, stump, nerve fascicles and prosthetic electronics. Decellular nerve (DN) scaffolds are an FDA approved biomaterial (Axogen (TM)) with the flexible tensile properties needed for successful permanent coaptation to peripheral nerves. Biocompatible, electroconductive, PEDOT facilitates electrical conduction through PEDOT coated acellular muscle. New electrochemical methods were used to polymerize various PEDOT concentrations into DN scaffolds without the need for a final dehydration step. DN scaffolds were then tested for electrical impedance and charge density. PEDOT coated DN scaffold materials were also implanted as 15-20mm peripheral nerve grafts. Measurement of in-situ nerve conduction immediately followed grafting. DN showed significant improvements in impedance for dehydrated and hydrated, DN, polymerized with moderate and low PEDOT concentrations when they were compared with DN alone (a <= 0.05). These measurements were equivalent to those for DN with maximal PEDOT concentrations. In-situ, nerve conduction measurements demonstrated that DN alone is a poor electro-conductor while the addition of PEDOT allows DN scaffold grafts to compare favorably with the "gold standard", autograft (Table 1). Surgical handling characteristics for conductive hydrated PEDOT DN scaffolds were rated 3 (pliable) while the dehydrated models were rated 1 (very stiff) when compared with autograft ratings of 4 (normal). Low concentrations of PEDOT on DN scaffolds provided significant increases in electro active properties which were comparable to the densest PEDOT coatings. DN pliability was closely maintained by continued hydration during PEDOT electrochemical polymerization without compromising electroconductivity.
C1 [Urbanchek, M. G.; Baghmanli, Z.; Wei, B.; Langhals, N. B.; Miriani, R. M.; Egeland, B. M.; Kipke, D. R.; Cederna, P. S.] Univ Michigan, Dept Plast Surg, 109 Zina Pitcher Pl,BSRB 2023, Ann Arbor, MI 48109 USA.
   [Shim, B. S.; Martin, D. C.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Schroeder, K.] Hope Coll, Coll Literature Sci & Arts, Holland, MI USA.
RP Urbanchek, MG (reprint author), Univ Michigan, Dept Plast Surg, 109 Zina Pitcher Pl,BSRB 2023, Ann Arbor, MI 48109 USA.
EM Melurban@umich.edu
RI Martin, David/B-1838-2008
OI Martin, David/0000-0003-1195-3838; Langhals,
   Nicholas/0000-0003-0644-9020; Shim, Bong Sup/0000-0003-3205-6191
FU Department of Defense Multidisciplinary University Research Initiative
   (MURI) [W911NF0610218]
FX The views expressed in this work are those of the authors and do not
   necessarily reflect official Army policy. This work was supported by the
   Department of Defense Multidisciplinary University Research Initiative
   (MURI) program administered by the Army Research Office under grant
   W911NF0610218
CR Egeland BM, 2009, PLAST RECONSTR SURG, V123, P26
   Frost CM, 2009, PLAST RECONSTR SURG, V123, P12
   Institute for Laboratory Animal Research, 1996, GUID CAR US LAB AN
   Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116
   Peramo A, 2008, TISSUE ENG PT A, V14, P423, DOI 10.1089/tea.2007.0123
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Urbanchek MG, PLAST RECONSTR SURG, V123, P89
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
NR 8
TC 7
Z9 7
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-14997-9
J9 IFMBE PROC
PY 2010
VL 32
BP 430
EP +
PG 2
WC Engineering, Biomedical
SC Engineering
GA BBO72
UT WOS:000307744700109
PM 21841944
OA Green Accepted
DA 2018-10-20
ER

PT S
AU Mezel, C
   Hallo, L
   Souquet, A
   Bourgeade, A
   Breil, J
   Hebert, D
   Guillemot, F
   Saut, O
AF Mezel, C.
   Hallo, L.
   Souquet, A.
   Bourgeade, A.
   Breil, J.
   Hebert, D.
   Guillemot, F.
   Saut, O.
BE Gamucci, A
   Giulietti, A
   Labate, L
TI Toward a new nanoLIFT transfer process
SO 2ND INTERNATIONAL CONFERENCE ON ULTRA-INTENSE LASER INTERACTION SCIENCE
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 2nd International Conference on Ultra-Intense Laser Interaction Science
CY MAY 24-29, 2009
CL Frascati, ITALY
SP Lab Nazl Frascati, Ist Nazl Fisca Nucl, Ist Processi Chimico Fisici Consiglio Nazl Ric, Inst IRAMIS Commissariat Energie Atomique, Amplitude Technol, CVI Melles Griot, Thales Laser, Unibiomedics
DE Laser absorption; Bioprinting; Shock waves; Ionization
AB The Laser Induced Forward Transfer (LIFT) is a direct-write technique used to print biological materials such as living cells or molecules. During the LIFT process, the biomaterial to be printed is deposited on a target submitted to a nanosecond laser shot, and the ejecta are collected onto a receiving substrate. Despite the several advantages of this technique (control of the propelled quantity, no spoiling of the substrate), it remains difficult to be employed due to the high sensitivity of its control parameters. Recently, Duocastella published some experimental results which exhibit the real-time jet formation process, under conditions similar to those present in the LIFT process [I].
   In the first Section, a typical experimental setup for LIFT process is presented. Then, simulations of Duocastella's and Guillemot's [2] experiments are carried out to model the jet formation in water when irradiated by an ultraviolet nanosecond laser pulse. The 2D axisymmetric hydrodynamic code CHIC (Code d'Hydrodynamique et d'Implosion du CELIA) [3] is used for these simulations with included equations of state (EOS) to take into account the behavior of water under standard conditions. Finally, an improvement of the LIFT technique which consists in using femtosecond lasers instead of nanosecond ones, is presented. It would allow to process smaller bioelements and to control the jet diameter, as it is directly related to the laser beam waist.
C1 [Mezel, C.; Hallo, L.; Souquet, A.; Bourgeade, A.; Breil, J.; Hebert, D.; Guillemot, F.; Saut, O.] Univ Bordeaux 1, CELIA, F-33405 Talence, France.
   [Souquet, A.; Guillemot, F.] Univ Bordeaux 2, INSERM, UMR 577, F-33076 Bordeaux, France.
   [Bourgeade, A.; Hebert, D.] CEA CESTA, Le Barp, France.
   [Saut, O.] Univ Bordeaux 1, IMB, Bordeaux, France.
RP Mezel, C (reprint author), Univ Bordeaux 1, CELIA, F-33405 Talence, France.
RI BOURGEADE, Antoine/B-3720-2012; Guillemot, Fabien/F-5174-2012
OI BOURGEADE, Antoine/0000-0002-2488-9639; Guillemot,
   Fabien/0000-0002-4263-4365
CR Bourgeade A, 2004, J SUPERCOMPUT, V28, P279, DOI 10.1023/B:SUPE.0000022100.04162.86
   Duocastella M, 2008, APPL PHYS A-MATER, V93, P453, DOI 10.1007/s00339-008-4781-y
   Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029
   Hallo L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024101
   Juodkazis S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.166101
   Maire PH, 2008, INT J NUMER METH FL, V56, P1417, DOI 10.1002/fld.1564
   Mezel C, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2974800
NR 7
TC 0
Z9 0
U1 0
U2 7
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0746-6
J9 AIP CONF PROC
PY 2010
VL 1209
BP 67
EP +
PG 2
WC Physics, Applied
SC Physics
GA BRN62
UT WOS:000283180100017
DA 2018-10-20
ER

PT S
AU Yang, YH
   Barabino, GA
AF Yang, Y. -H.
   Barabino, G. A.
BE Lim, CT
   Goh, JCH
TI Interplay between Hypoxia and Hydrodynamic Force in Three-Dimensional
   Cultivation of Articular Cartilage
SO 6TH WORLD CONGRESS OF BIOMECHANICS (WCB 2010), PTS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th World Congress of Biomechanics (WCB 2010)
CY AUG 01-06, 2010
CL Biomed Engn Soc Singapore, Singapore, SINGAPORE
SP Global Enterprise Micromechan & Mol Med, Natl Univ Singapore (NUS), Li Ning, Singapore Tourism Board, Singapore Exhibit & Convent Bur, Profess Engn Publish
HO Biomed Engn Soc Singapore
DE Hypoxia; Hydrodynamic; Wavy-walled bioreactor; Nitric oxide; Cartilage
ID TISSUE-ENGINEERED CARTILAGE; LOW-OXYGEN TENSION; NITRIC-OXIDE;
   CHONDROCYTES; BIOREACTOR
AB Mimicking the hypoxic environment (1%similar to 7% O-2) of native cartilage results in improved secretion of extracellular matrix (ECM) by chondrocytes in monolayer culture. However, investigations of the role of hypoxia in long-term three-dimensional (3D) development of biomaterial-based cartilage constructs are limited. The major challenge to overcome is the insufficient oxygen delivery to the inner core of cell-scaffold constructs, which may result in anoxic conditions (<< 11%) that are linked to nitric oxide (NO)-induced damage to ECM and is associated with diseases such as osteoarthritis. To evaluate the interaction between hypoxia and hydrodynamic stimuli, chondrocyte-seeded PGA scaffolds were cultured in a petri dish (static) or a wavy-walled bioreactor (dynamic) under ambient (21%) or hypoxic (5%) conditions for 28 days, followed by biochemical and immunohistochemical evaluation. We found that sulfated glycosaminoglycan (GAG) production increased under 5% O-2 in the presence of hydrodynamic forces, whereas total collagen content was down-regulated by hypoxia in both static and dynamic groups. Greater amounts of soluble GAG were released into media under hypoxia and under mixing. In addition, expression of inducible nitric oxide synthase (iNOS) increased under static and under hypoxic conditions, revealing that NO production was elevated. Significantly decreased collagen content of Hypoxic-Static constructs may indicate that suboptimal oxygen and NO levels might be reached. These findings suggest that hydrodynamic forces are required for 3D regeneration of articular cartilage under hypoxia, but further study is required to enhance retention of soluble GAG within the construct and to minimize NO damage to collagen fibrils.
C1 [Yang, Y. -H.; Barabino, G. A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
RP Yang, YH (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM barabino@gatech.edu
OI Yang, Yueh-Hsun/0000-0003-0298-8641
FU National Science Foundation [NSF0602608]
FX This work was supported by the National Science Foundation [NSF0602608].
CR Cao M, 1997, BIOCHEM J, V324, P305, DOI 10.1042/bj3240305
   Coyle CH, 2009, J ORTHOP RES, V27, P793, DOI 10.1002/jor.20816
   Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   Hashimoto K, 2006, INFLAMM RES, V55, P72, DOI 10.1007/s00011-005-0012-6
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   PLAAS AHK, 1983, BIOCHEM J, V214, P855, DOI 10.1042/bj2140855
   Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1
   Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545
   SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292
   SVALASTOGA E, 1989, ACTA VET SCAND, V30, P121
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Zhou SD, 2004, ARTHRITIS RHEUM, V50, P3915, DOI 10.1002/art.20675
NR 13
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-14514-8
J9 IFMBE PROC
PY 2010
VL 31
BP 127
EP +
PN 1-3
PG 2
WC Engineering, Biomedical
SC Engineering
GA BBF91
UT WOS:000306716100033
DA 2018-10-20
ER

PT S
AU Sarangi, S
AF Sarangi, S.
BE Lim, CT
   Goh, JCH
TI On the Mullins Effect of Soft-Biological Tissues: A Comparison between
   Material Models with Experimental Results
SO 6TH WORLD CONGRESS OF BIOMECHANICS (WCB 2010), PTS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th World Congress of Biomechanics (WCB 2010)
CY AUG 01-06, 2010
CL Biomed Engn Soc Singapore, Singapore, SINGAPORE
SP Global Enterprise Micromechan & Mol Med, Natl Univ Singapore, Li Ning, Singapore Tou5rism Board, Singapore Exhibit & Convent Bur, Profess Engn Publish
HO Biomed Engn Soc Singapore
DE Mullins effect; residual strain; limited elasticity; thoracic aortic
   tissue; skin tissues
ID EXTENSIBILITY; RUBBER
AB A constitutive theory for isotropic stress-softening, limited elastic soft-biological tissues is introduced. The model is applied to study the stress-softening and residual strain effects in simple uniaxial extension of soft-biological tissues. Phenomenological correlation of the residual strain with the current strain and maximum previous strain is obtained. The idealized stress-softening material model is applied to study the small amplitude, free longitudinal oscillations of a load about finite static stretch. The results are illustrated considering the parent material for Gent type limited elastic model and purely elastic Fung type biomaterial model. The stress-softening with residual strain effects are characterized by modifying Zuniga-Beatty front factor damage function. The material model for stress-softening are compared with experimental data for thoracic aortic tissue of male human subjects and skin tissues of mouse provided by others. It is observed that stress-softening, limited elastic Gent type material model best characterizes the experimental data.
C1 Indian Inst Technol Patna, Dept Mech Engn, Patna 800013, Bihar, India.
RP Sarangi, S (reprint author), Indian Inst Technol Patna, Dept Mech Engn, Patna 800013, Bihar, India.
EM somsara@iitp.ac.in
CR Beatty MF, 2009, Z ANGEW MATH PHYS, V60, P971, DOI 10.1007/s00033-008-8127-6
   Dorfmann A, 2004, INT J SOLIDS STRUCT, V41, P1855, DOI 10.1016/j.ijsolstr.2003.11.014
   Ehret AE, 2009, INT J PLASTICITY, V25, P901, DOI 10.1016/j.ijplas.2008.06.001
   FUNG YCB, 1967, AM J PHYSIOL, V213, P1532
   Gent AN, 1996, RUBBER CHEM TECHNOL, V69, P59, DOI 10.5254/1.3538357
   Horgan CO, 2003, BIOMECH MODEL MECHAN, V1, P251, DOI 10.1007/s10237-002-0022-z
   LAWTON RW, 1951, J APPL PHYS, V22, P1340, DOI 10.1063/1.1699863
   Mullins L., 1948, J RUBBER RES, V21, P281
   Munoz MJ, 2008, J BIOMECH, V41, P93, DOI 10.1016/j.jbiomech.2007.07.013
   Zuniga AE, 2002, Z ANGEW MATH PHYS, V53, P794, DOI 10.1007/PL00022513
NR 10
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-14514-8
J9 IFMBE PROC
PY 2010
VL 31
BP 1032
EP 1035
PN 1-3
PG 4
WC Engineering, Biomedical
SC Engineering
GA BBF91
UT WOS:000306716100263
DA 2018-10-20
ER

PT S
AU Reinis, A
   Vetra, J
   Stunda, A
   Berzina-Cimdina, L
   Kroica, J
   Kuznecova, V
   Rostoka, D
AF Reinis, A.
   Vetra, J.
   Stunda, A.
   Berzina-Cimdina, L.
   Kroica, J.
   Kuznecova, V.
   Rostoka, D.
BE Lim, CT
   Goh, JCH
TI In vitro and in vivo Examinations for Detection of Minimal Infective
   Dose for Biomaterials
SO 6TH WORLD CONGRESS OF BIOMECHANICS (WCB 2010), PTS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th World Congress of Biomechanics (WCB 2010)
CY AUG 01-06, 2010
CL Biomed Engn Soc Singapore, Singapore, SINGAPORE
SP Global Enterprise Micromechan & Mol Med, Natl Univ Singapore (NUS), Li Ning, Singapore Tourism Board, Singapore Exhibit & Convent Bur, Profess Engn Publish
HO Biomed Engn Soc Singapore
DE biomaterials; adhesion; Pseidomonas aeruginosa; Staphylococcus aureus
AB The objective of the study is to examine the minimal infective dose of Staphylococcus epidermidis and Pseudomonas aeruginosa on biomaterials in vivo and in vitro. In this research originally synthesized bioactive biomaterials - 4N glass and 4NK glass-ceramics are calcium phosphate with Na2O and Nb2O5 additives with different crystallinity. For microbiological investigation of biomaterials S.epidermidis strain ATCC 12228, Ps.aeruginosa strain ATCC 27853, 4 rabbit animal models, broth and agar, scanned electron microscope Tescan, Vortex centrifuge, sonicator and histological methods were used. We observed that different biomaterials had various attachments of S.epidermidis and Ps.aeruginosa in laboratory animal models. The minimal infective dose of S.epidermidis for biomaterial 4NK is more than 10(3) CFU/ml, for biomaterial 4N less than 10(3) CFU/ml. The minimal infective dose of Ps.aeruginosa for biomaterial 4N and biomaterial 4NK is less than 10(3) CFU/ml.
C1 [Reinis, A.; Vetra, J.; Kroica, J.; Kuznecova, V.; Rostoka, D.] Riga Stradins Univ, Dept Biol & Microbiol, Dzirciema 16, Riga, Latvia.
   [Stunda, A.; Berzina-Cimdina, L.] Riga Tech Univ, Riga Biomat Innovat & Dev Ctr, Riga, Latvia.
RP Reinis, A (reprint author), Riga Stradins Univ, Dept Biol & Microbiol, Dzirciema 16, Riga, Latvia.
EM areinis@apollo.lv
OI Stunda-Zujeva, Agnese/0000-0003-4970-5186
FU European Social Fund Multidisciplinary Research in
   BiomaterialsTechnology of New Scientist Group
   [2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090, PVS ID1380]
FX This work has been partly supported by the European Social Fund within
   the project "Multidisciplinary Research in Biomaterials Technology of
   New Scientist Group", No.2009/0199/1DP/1.1.1.2.0/09/APIA/VIAA/090, (PVS
   ID1380).
CR Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Reinis A, 2009, 26 ICC INT P MED, P133
   Salms G, 2002, STOMATOLOGIJA, V4, P2
   Skagers A, 2002, STOMATOLOGIJA, V4, P36
   SLUTSKY L, 2001, BIOL ASPECTS BIOMATE, P25
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
   Yuehuei H.A, 2000, HDB BACTERIAL ADHESI, P11
NR 7
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-14514-8
J9 IFMBE PROC
PY 2010
VL 31
BP 1204
EP +
PN 1-3
PG 3
WC Engineering, Biomedical
SC Engineering
GA BBF91
UT WOS:000306716100305
DA 2018-10-20
ER

PT S
AU Mingthong, P
   Veerasai, W
   Aeimbhu, A
AF Mingthong, P.
   Veerasai, W.
   Aeimbhu, A.
BE Lim, CT
   Goh, JCH
TI Fabrication of Titanium Oxide Nanotube Arrays on Titanium Implants: The
   Effect of Electrolytes Conditions
SO 6TH WORLD CONGRESS OF BIOMECHANICS (WCB 2010), PTS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th World Congress of Biomechanics (WCB 2010)
CY AUG 01-06, 2010
CL Biomed Engn Soc Singapore, Singapore, SINGAPORE
SP Global Enterprise Micromechan & Mol Med, Natl Univ Singapore (NUS), Li Ning, Singapore Tourism Board, Singapore Exhibit & Convent Bur, Profess Engn Publish
HO Biomed Engn Soc Singapore
DE Biomaterial; Titanium; Anodic oxidation; Titanium oxide nanotubes
ID CELL-ADHESION; NANOMETER; FEATURES
AB The primary aim of this study is to observe the influence of an applied voltages and a concentration of electrolyte on anodic oxide layer properties such as morphology, wettability and microstructural. First, sample was anodised under different voltages ranging from 10-40 volts in 0.1M H2SO4/0.075wt% HF. Anodised samples were characterised by Scanning Electron Microscope (SEM) and X-ray Diffraction technique (XRD). It was observed that an applied voltage at 20 volts, an interconnected pore network can be fabricated. Second, sample was prepared in 0.1M H2SO4 with the concentration of HF range from 0.075 -0.5 wt% at the applied potential of 20 volts. Based on experimental results, the microstructure of anodic oxide layers depends strongly on the formation potential and the HF concentration. Nanopores can be formed under a range of experimental conditions. Moreover, it was found that titanium oxide nanotube arrays are formed in 0.1M H2SO4/0.4wt% HF. XRD patterns of anodised samples showed the tubes crystallised in a coexistent of titanium and titanium oxide phases. The anodised surfaces are more hydrophobic than the untreated surface.
C1 [Mingthong, P.; Aeimbhu, A.] Srinakharinwirot Univ, Fac Sci, Dept Phys, Sukhumvit 23, Bangkok 10110, Thailand.
   [Veerasai, W.] Mahidol Univ, Fac Sci, Dept Chem, Bangkok 10400, Thailand.
RP Aeimbhu, A (reprint author), Srinakharinwirot Univ, Fac Sci, Dept Phys, Sukhumvit 23, Bangkok 10110, Thailand.
EM areeya@swu.ac.th
FU Srinakharinwirot University
FX This work was supported by the Faculty of Science, Srinakharinwirot
   University.
CR Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   Gabbi C, 2005, ANN FM VET PARMA, V25, P307
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
NR 6
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-14514-8
J9 IFMBE PROC
PY 2010
VL 31
BP 1208
EP +
PN 1-3
PG 2
WC Engineering, Biomedical
SC Engineering
GA BBF91
UT WOS:000306716100306
DA 2018-10-20
ER

PT S
AU Zhou, G
   Wang, J
   Fan, YB
   Song, W
   Cao, Y
AF Zhou, G.
   Wang, J.
   Fan, Y. B.
   Song, W.
   Cao, Y.
BE Lim, CT
   Goh, JCH
TI Study on Nano-Hydroxyapatite/Silk Fibroin Biomedical Composite under
   Biomimetic Mineralization
SO 6TH WORLD CONGRESS OF BIOMECHANICS (WCB 2010), PTS 1-3
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th World Congress of Biomechanics (WCB 2010)
CY AUG 01-06, 2010
CL Biomed Engn Soc Singapore, Singapore, SINGAPORE
SP Global Enterprise Micromechan & Mol Med, Natl Univ Singapore (NUS), Li Ning, Singapore Tourism Board, Singapore Exhibit & Convent Bur, Profess Engn Publish
HO Biomed Engn Soc Singapore
DE Nano-hydroxyapatite; silk fibroin; composite; biomimetic mineralization
ID BONE; STRENGTH; SILK
AB A novel nano-Hydroxyapatite/Silk Fibroin (n-HA/SF) composite was prepared by biomimetic mineralization method. It was revealed that the inorganic phase in the composite was n-HA with low crystallinity. The composite exhibited a higher compressive strength, which was closely related to the perfect incorporation of SF macromolecules into the composite. The chemical interactions occurring between phase and the organic matrix were thought to improve the interfacial bonding and thus resulted in the enhanced mechanical strength. Finally, MTT and SEM results showed that this synthesized composite was nontoxic and no allergic, and possessed excellent compatibility. Therefore, the n-HA/SF composite prepared in this paper was prospective to be used as a new biomaterial for bone repair or substitute.
C1 [Zhou, G.; Fan, Y. B.; Song, W.] Beihang Univ, Key Lab Biomech & Mechanobiol, Minist Educ, Sch Biol Sci & Med Engn, Xue Yuan Rd 37, Beijing 100191, Peoples R China.
   [Wang, J.; Cao, Y.] Hainan Univ, Sch Mat &Chem Engn, Rubber Res Inst, Hainan 571101, Peoples R China.
RP Fan, YB (reprint author), Beihang Univ, Key Lab Biomech & Mechanobiol, Minist Educ, Sch Biol Sci & Med Engn, Xue Yuan Rd 37, Beijing 100191, Peoples R China.
EM yubofan@buaa.edu.cn
FU national natural science foundation of China [10925208, 50803032];
   International Foundation of State Science and Technology Ministry
   [2009DFA92551]; Chinese Academy of Tropical Agricultural Sciences
   [XJSYWFZX2009-19]
FX This work was sponsored by the national natural science foundation of
   China (10925208,50803032), International Foundation of State Science and
   Technology Ministry (2009DFA92551), Chinese Academy of Tropical
   Agricultural Sciences(XJSYWFZX2009-19).
CR Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   COOK SD, 1992, J BIOMED MATER RES, V26, P989, DOI 10.1002/jbm.820260803
   Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a
   Fantner Georg E., 2005, NAT MATER, V4, P612
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   Madurantakama Parthasarathy A., 2009, BIOMAT, V30, P5456
   Mao CB, 1999, J MATER CHEM, V9, P2573, DOI 10.1039/a901309a
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   Rhee SH, 2002, J MATER SCI-MATER M, V13, P597, DOI 10.1023/A:1015135112302
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
NR 14
TC 1
Z9 2
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-642-14514-8
J9 IFMBE PROC
PY 2010
VL 31
BP 1218
EP +
PN 1-3
PG 2
WC Engineering, Biomedical
SC Engineering
GA BBF91
UT WOS:000306716100309
DA 2018-10-20
ER

PT J
AU Phillips, JE
   Petrie, TA
   Creighton, FP
   Garcia, AJ
AF Phillips, Jennifer E.
   Petrie, Timothy A.
   Creighton, Francis P.
   Garcia, Andres J.
TI Human mesenchymal stem cell differentiation on self-assembled monolayers
   presenting different surface chemistries
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Adipogenesis; Fibronectin; Human mesenchymal stem cell; Osteogenesis;
   Chrondrogenesis
ID BONE-MARROW; INTEGRIN EXPRESSION; IN-VITRO; CHONDROGENIC
   DIFFERENTIATION; EXTRACELLULAR-MATRIX; ADIPOCYTE DIFFERENTIATION;
   FIBRONECTIN CONFORMATION; PROGENITOR CELLS; MICRON-SCALE; ADHESION
AB Human mesenchymal stem cells (hMSCs) have tremendous potential as a cell source for regenerative medicine due to their capacity for differentiation into a wide range of connective tissue cell types. Although significant progress has been made in the identification of defined growth factor conditions to induce lineage commitment, the effect of underlying biomaterial properties on functional differentiation is far less understood. Here we conduct a systematic assessment of the role for surface chemistry on cell growth, morphology, gene expression and function during hMSC commitment along osteogenic, chondrogenic and adipogenic lineages. Using self-assembled monolayers of omega-functionalized alkanethiols on gold as model substrates, we demonstrate that biomaterial surface chemistry differentially modulates hMSC differentiation in a lineage-dependent manner. These results highlight the importance of initial biomaterial surface chemistry on long-term functional differentiation of adult stem cells, and suggest that surface properties are a critical parameter that must be considered in the design of biomaterials for stem cell-based regenerative medicine strategies. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Petrie, Timothy A.; Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Creighton, Francis P.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Creighton, Francis P.] Emory Univ, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Petrie, Timothy A.; Garcia, Andres J.] Georgia Inst Technol, Georgia Tech Emory Ctr Engn Living Tissues, Atlanta, GA 30332 USA.
   [Phillips, Jennifer E.; Petrie, Timothy A.; Garcia, Andres J.] Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Petit Inst Bioengn & Biosci, 315 Ferst Dr,Room 2314, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
OI Phillips-Cremins, Jennifer/0000-0002-4702-0450
FU NIH [R01-EB004496]; National Science Foundation
FX This work was funded by the NIH (R01-EB004496). J.E.P. was supported by
   a National Science Foundation Graduate Research Fellowship.
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   BAIN CD, 1988, SCIENCE, V240, P62, DOI 10.1126/science.240.4848.62
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Delorme Bruno, 2007, V140, P67
   Docheva D, 2007, J CELL MOL MED, V11, P21, DOI 10.1111/j.1582-4934.2007.00001.x
   Fink T, 2004, STEM CELLS, V22, P1346, DOI 10.1634/stemcells.2004-0038
   Franco M, 2000, J BIOMED MATER RES, V52, P261, DOI 10.1002/1097-4636(200011)52:2<261::AID-JBM4>3.0.CO;2-2
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Goessler UR, 2008, INT J MOL MED, V21, P271
   Goessler UR, 2006, INT J MOL MED, V17, P301
   Goessler UR, 2005, IN VIVO, V19, P501
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Jones JA, 2008, J BIOMED MATER RES A, V86A, P261, DOI 10.1002/jbm.a.31660
   Kawaguchi N, 2003, J CELL SCI, V116, P3893, DOI 10.1242/jcs.00699
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118
   Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   PETRIE TA, 2008, J CELL MOL MED
   Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   RODRIGUEZFERNAN.JL, 1989, DIFFERENTIATION, V42, P65
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 55
TC 108
Z9 112
U1 3
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2010
VL 6
IS 1
BP 12
EP 20
DI 10.1016/j.actbio.2009.07.023
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 537BM
UT WOS:000273087900002
PM 19632360
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, JS
   Lee, JS
   Murphy, WL
AF Lee, Jae Sam
   Lee, Jae Sung
   Murphy, William L.
TI Modular peptides promote human mesenchymal stem cell differentiation on
   biomaterial surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone regeneration; Bone morphogenetic protein; Osteocalcin;
   Hydroxyapatite; Osteogenesis
ID BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS;
   OSTEOCALCIN-DEFICIENT MICE; IN-VITRO; OSTEOPONTIN; HYDROXYAPATITE; VIVO;
   CALCIFICATION; OSTEOBLASTS; EXPRESSION
AB Molecular design strategies in biomedical applications often involve creating modular "fusion" proteins, in which distinct domains within a single molecule can perform multiple functions. We have synthesized a new class of modular peptides that include a biologically active sequence derived from the growth factor BMP-2 and a series of hydroxyapatite-binding sequences inspired by the N-terminal alpha-helix of osteocalcin. These modular peptides can bind in a sequence-dependent manner to the surface of "bone-like" hydroxyapatite coatings, which are nucleated and grown on a biodegradable polymer surface via a biomimetic process. The BMP-2-derived sequence of the modular peptides is biologically active, as measured by its ability to promote osteogenic differentiation of human mesenchymal stem cells. Our study indicates that the modular peptides described here are multifunctional, and the characteristics of this approach suggest that it can potentially be applied to a range of biomaterials for regenerative medicine applications. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lee, Jae Sam; Lee, Jae Sung; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA.
RP Murphy, WL (reprint author), Univ Wisconsin, Dept Biomed Engn Pharmacol & Mat Sci & Engn, Madison, WI 53706 USA.
EM wlmurphy@wisc.edu
RI Murphy, William/I-4096-2014
FU National Institutes of Health [R03AR052893]; Wallace H. Coulter
   Foundation
FX The authors acknowledge funding from the National Institutes of Health
   (R03AR052893) and the Wallace H. Coulter Foundation (Translational
   Research Partnership).
CR Balasundaram G, 2008, J BIOMED MATER RES A, V84A, P447, DOI 10.1002/jbm.a.31388
   Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5
   Becker J, 2006, CLIN ORAL INVEST, V10, P217, DOI 10.1007/s00784-006-0049-0
   Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1
   Capriotti LA, 2007, J AM CHEM SOC, V129, P5281, DOI 10.1021/ja070356b
   Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230
   Cohen MM, 2002, AM J MED GENET, V109, P87, DOI 10.1002/ajmg.10289
   Diefenderfer DL, 2003, CONNECT TISSUE RES, V44, P305, DOI 10.1080/03008200390181825
   Dowd TL, 2001, BBA-MOL BASIS DIS, V1535, P153, DOI 10.1016/S0925-4439(00)00094-6
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Gadeau AP, 2001, J HISTOCHEM CYTOCHEM, V49, P79, DOI 10.1177/002215540104900108
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   HUNTER MS, 1996, PSYCHOL REPROD, V1, P59
   Kamitakahara M, 2007, BIOMED MATER, V2, pR17, DOI 10.1088/1748-6041/2/4/R01
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Liu HW, 2007, TISSUE ENG, V13, P1113, DOI 10.1089/ten.2006.0209
   MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286
   Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   POSER JW, 1979, J BIOL CHEM, V254, P431
   Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2005, J BIOMED MATER RES A, V72A, P77, DOI 10.1002/jbm.a.30208
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Short B, 2003, ARCH MED RES, V34, P565, DOI 10.1016/j.arcmed.2003.09.007
   Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331
   Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911
   Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3
   Wang XL, 2006, STEM CELLS, V24, P482, DOI 10.1634/stemcells.2005-0219
   Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D
NR 37
TC 66
Z9 66
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2010
VL 6
IS 1
BP 21
EP 28
DI 10.1016/j.actbio.2009.08.003
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 537BM
UT WOS:000273087900003
PM 19665062
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gualandi, C
   White, LJ
   Chen, L
   Gross, RA
   Shakesheff, KM
   Howdle, SM
   Scandola, M
AF Gualandi, Chiara
   White, Lisa J.
   Chen, Liu
   Gross, Richard A.
   Shakesheff, Kevin M.
   Howdle, Steven M.
   Scandola, Mariastella
TI Scaffold for tissue engineering fabricated by non-isothermal
   supercritical carbon dioxide foaming of a highly crystalline polyester
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Supercritical CO(2); Scaffold; Foaming; Biomaterial; Tissue engineering
ID OMEGA-PENTADECALACTONE; EPSILON-CAPROLACTONE; DRUG-DELIVERY; POLYMERS;
   BONE; CO2; TEMPERATURE; COMPOSITES; PRESSURE; SYSTEMS
AB Porous scaffolds of a random co-polymer of omega-pentadecalactone (PDL) and epsilon-caprolactone (CL) (poly(PDL-CL)), synthesized by biocatalysis, were fabricated by supercritical carbon dioxide (scCO(2)) foaming. The co-polymer, containing 31 mol.% CL units, is highly crystalline (T(m) = 82 degrees C, Delta H(m) = 105 J g(-1)) thanks to the ability of the two monomer units to co-crystallize. The co-polymer can be successfully foamed upon homogeneous absorption of scCO(2) at T > T(m). The effect of soaking time, depressurization rate and cooling rate on scaffold porosity, pore size distribution and pore interconnectivity was investigated by micro X-ray computed tomography. Scaffolds with a porosity in the range 42-76% and an average pore size of 100-375 mu m were successfully obtained by adjusting the main foaming parameters. Process conditions in the range investigated did not affect the degree of crystallinity of poly(PDL-CL) scaffolds. A preliminary study of the mechanical properties of the scaffolds revealed that poly(PDL-CL) foams may find application in the regeneration of cartilage tissue. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Howdle, Steven M.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   [Gualandi, Chiara; Scandola, Mariastella] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy.
   [Gualandi, Chiara; Scandola, Mariastella] Univ Bologna, INSTM UdR Bologna, I-40126 Bologna, Italy.
   [White, Lisa J.; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Chen, Liu; Gross, Richard A.] NYU, Polytech Inst, NSF I UCRC Biocatalysis & Bioproc Macromol, Brooklyn, NY 11201 USA.
RP Howdle, SM (reprint author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.
EM Steve.Howdle@nottingham.ac.uk; mariastella.scandola@unibo.it
RI Howdle, Steven/A-2954-2010; gualandi, chiara/A-5935-2015; Shakesheff,
   Kevin/O-6371-2018
OI Howdle, Steven/0000-0001-5901-8342; gualandi,
   chiara/0000-0002-2020-1892; Shakesheff, Kevin/0000-0003-3236-2439;
   White, Lisa/0000-0003-0571-999X
FU University of Bologna; Engineering and Physical Sciences Research
   Council, UK [EP/C534247/1]; Italian Ministry of Foreign Affairs;
   Engineering and Physical Sciences Research Council [GR/S27269/01,
   EP/C534247/1]
FX This work was supported by a "Marco Polo" research grant from University
   of Bologna and by the Engineering and Physical Sciences Research
   Council, UK, through the "REMEDI" project, Grant No. EP/C534247/1.
   Financial support from Italian Ministry of Foreign Affairs (Directorate
   General for Cultural Promotion and Cooperation - Significant Bilateral
   Project Italy-USA) is acknowledged. The authors also thank the National
   Science Foundation (NSF) and the industrial members of the NSF I/UCRC
   for Biocatalysis and Bioprocessing of Macromolecules at the Polytechnic
   Institute of New York University and Mr R. Wilson and Mr P. Fields for
   technical assistance.
CR Arora KA, 1998, MACROMOLECULES, V31, P4614, DOI 10.1021/ma971811z
   Barry JJA, 2005, J MATER CHEM, V15, P4881, DOI [10.1039/b507722m, 10.1039/b597722m]
   Barry JJA, 2006, J MATER SCI, V41, P4197, DOI 10.1007/s10853-006-7023-8
   Black J., 1998, HDB BIOMATERIAL PROP
   Ceccorulli G, 2005, BIOMACROMOLECULES, V6, P902, DOI 10.1021/bm0493279
   CHOW TS, 1980, MACROMOLECULES, V13, P362, DOI 10.1021/ma60074a029
   Cotugno S, 2005, IND ENG CHEM RES, V44, P1795, DOI 10.1021/ie049445c
   COUCHMAN PR, 1978, MACROMOLECULES, V11, P117, DOI 10.1021/ma60061a021
   Davies OR, 2008, ADV DRUG DELIVER REV, V60, P373, DOI 10.1016/j.addr.2006.12.001
   Doroudiani S, 1996, POLYM ENG SCI, V36, P2645, DOI 10.1002/pen.10664
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Fox G., 1956, B AM PHYS SOC, V1, P123
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   GOEL SK, 1994, POLYM ENG SCI, V34, P1137, DOI 10.1002/pen.760341407
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jenkins MJ, 2006, EUR POLYM J, V42, P3145, DOI 10.1016/j.eurpolymj.2006.07.022
   Kumar A, 2000, MACROMOLECULES, V33, P6303, DOI 10.1021/ma000344+
   Kutz M., 2003, STANDARD HDB BIOMEDI
   Lopez-Periago AM, 2008, J MATER SCI, V43, P1939, DOI 10.1007/s10853-008-2461-0
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Mathieu LM, 2005, J BIOMED MATER RES A, V75A, P89, DOI 10.1002/jbm.a.30385
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Oliveira NS, 2006, J POLYM SCI POL PHYS, V44, P1010, DOI 10.1002/polb.20746
   Quirk RA, 2004, CURR OPIN SOLID ST M, V8, P313, DOI 10.1016/j.cossms.2003.12.004
   Royer JR, 2001, J POLYM SCI POL PHYS, V39, P3055, DOI 10.1002/polb.10057
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Tomasko DL, 2003, IND ENG CHEM RES, V42, P6431, DOI 10.1021/ie030199z
   Tsivintzelis I, 2007, J SUPERCRIT FLUID, V42, P265, DOI 10.1016/j.supflu.2007.02.009
   Woods HM, 2004, J MATER CHEM, V14, P1663, DOI 10.1039/b315262f
NR 32
TC 34
Z9 36
U1 3
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2010
VL 6
IS 1
BP 130
EP 136
DI 10.1016/j.actbio.2009.07.020
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 537BM
UT WOS:000273087900015
PM 19619678
DA 2018-10-20
ER

PT J
AU Reza, AT
   Nicoll, SB
AF Reza, Anna T.
   Nicoll, Steven B.
TI Characterization of novel photocrosslinked carboxymethylcellulose
   hydrogels for encapsulation of nucleus pulposus cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Carboxymethylcellulose; Hydrogels; Nucleus pulposus;
   Photopolymerization; Mechanical properties
ID INTERVERTEBRAL DISC CELLS; EXTRACELLULAR-MATRIX PRODUCTION;
   HYALURONIC-ACID NETWORKS; HYDROSTATIC-PRESSURE; GENE-EXPRESSION;
   BIOMEDICAL APPLICATIONS; 3-DIMENSIONAL CULTURE; MECHANICAL-PROPERTIES;
   IN-VITRO; CARTILAGE
AB Back pain is a significant clinical concern often associated with degeneration of the intervertebral disc (IVD). Tissue engineering strategies may provide a viable IVD replacement therapy; however, an ideal biomaterial scaffold has yet to be identified. One candidate material is carboxymethylcellulose (CMC), a water-soluble derivative of cellulose. In this study, 90 and 250 kDa CMC polymers were modified with functional methacrylate groups and photocrosslinked to produce hydrogels at different macromer concentrations. At 7 days, bovine nucleus pulposus (NP) cells encapsulated in these hydrogels were viable, with values for the elastic modulus ranging from 1.07 +/- 0.06 to 4.29 +/- 1.25 kPa. Three specific formulations were chosen for further study based on cell viability and mechanical integrity assessments: 4% 90 kDa, 2% 250 kDa and 3% 250 kDa CIVIC. The equilibrium weight swelling ratio of these formulations remained steady throughout the 2 week study (46.45 +/- 3.14, 48.55 +/- 2.91 and 42.41 +/- 3.06, respectively). The equilibrium Young's modulus of all cell-laden and cell-free control samples decreased over time, with the exception of cell-laden 3% 250 kDa CIVIC constructs, indicating an interplay between limited hydrolysis of interchain crosslinks and the elaboration of a functional matrix. Histological analyses of 3% 250 kDa CMC hydrogels confirmed the presence of rounded cells in lacunae and the pericellular deposition of chondroitin sulfate proteoglycan, a phenotypic NP marker. Taken together, these studies support the use of photocrosslinked CMC hydrogels as tunable biomaterials for NP cell encapsulation. (C) 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Reza, Anna T.; Nicoll, Steven B.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
RP Nicoll, SB (reprint author), Univ Penn, Dept Bioengn, Room 240 Skirkanich Hall,210 S 33rd St, Philadelphia, PA 19104 USA.
EM nicoll@seas.upenn.edu
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Baer AE, 2001, J ORTHOPAED RES, V19, P2, DOI 10.1016/S0736-0266(00)00003-6
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2003, J BIOMED MATER RES A, V67A, P1430, DOI 10.1002/jbm.a.20003
   Buckwalter J A, 1998, Iowa Orthop J, V18, P1
   Buckwalter J.A., 2000, ORTHOPAEDIC BASIC SC, P557
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Byers BA, 2008, TISSUE ENG PT A, V14, P1821, DOI 10.1089/ten.tea.2007.0222
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Chou AI, 2006, SPINE, V31, P1875, DOI 10.1097/01.brs.0000229222.98051.9a
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Chou AI, 2008, TISSUE ENG PT A, V14, P2079, DOI 10.1089/ten.tea.2007.0337
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   ELISSEEFF JH, 1999, P NATL ACAD SCI USA, V16, P3104
   FRYMOYER JW, 1991, ORTHOP CLIN N AM, V22, P263
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   HALL S, 2003, BASIC BIOMECHANICS, P276
   Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002
   Hutton WC, 2001, CLIN BIOMECH, V16, P728, DOI 10.1016/S0268-0033(01)00080-8
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kim KS, 2009, TISSUE ENG PT A, V15, P3201, DOI [10.1089/ten.tea.2008.0704, 10.1089/ten.TEA.2008.0704]
   Larson JW, 2006, J BONE JOINT SURG AM, V88A, P83, DOI 10.2106/JBJS.F.00043
   Leone G, 2008, J MATER SCI-MATER M, V19, P2873, DOI 10.1007/s10856-008-3412-7
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   MALDONADO BA, 1992, J ORTHOP RES, V10, P677, DOI 10.1002/jor.1100100510
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Melrose J, 2001, CELLS TISSUES ORGANS, V168, P137, DOI 10.1159/000047829
   Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419
   Neidlinger-Wilke C, 2005, J NEUROSURG-SPINE, V2, P457, DOI 10.3171/spi.2005.2.4.0457
   Neidlinger-Wilke C, 2006, EUR SPINE J, V15, pS372, DOI 10.1007/s00586-006-0112-1
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Ogushi Y, 2007, J BIOSCI BIOENG, V104, P30, DOI 10.1263/jbb.104.30
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   Pal K, 2006, BIOMED MATER, V1, P85, DOI 10.1088/1748-6041/1/2/006
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   Risbud MV, 2006, SPINE, V31, P884, DOI 10.1097/01.brs.0000209335.57767.b5
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Sakai S, 2009, ACTA BIOMATER, V5, P554, DOI 10.1016/j.actbio.2008.10.010
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403
   VISTICA DT, 1991, CANCER RES, V51, P2515
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wang JY, 2001, SPINE, V26, P1747, DOI 10.1097/00007632-200108150-00003
NR 58
TC 72
Z9 74
U1 2
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2010
VL 6
IS 1
BP 179
EP 186
DI 10.1016/j.actbio.2009.06.004
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 537BM
UT WOS:000273087900021
PM 19505596
DA 2018-10-20
ER

PT J
AU Ojeda-Uribe, M
   Herbrecht, R
   Kiefer, MH
   Schultz, P
   Chain, J
   Chenard, MP
   Servant, JM
   Debry, C
AF Ojeda-Uribe, Mario
   Herbrecht, Raoul
   Kiefer, Marie Helene
   Schultz, Philippe
   Chain, Jorge
   Chenard, Marie-Pierre
   Servant, Jean Marie
   Debry, Christian
TI Lessons from a Case of Oromandibular Mucormycosis Treated with Surgery
   and a Combination of Amphotericin B Lipid Formulation plus Caspofungin
SO ACTA HAEMATOLOGICA
LA English
DT Article
DE Acute myeloid leukaemia; Amphotericin B lipid formulation; Caspofungin;
   Mandibular prosthesis; Mucormycosis
ID DISSEMINATED ZYGOMYCOSIS; THERAPY; SURVIVAL; LEUKEMIA; COMPLEX; PATIENT;
   SAFETY; PLATE
AB A rare case of oromandibular Rhizopus oryzae infection is described in a 55-year-old woman with acute myeloid leukaemia and decompensated diabetes mellitus. The infection developed during induction chemotherapy when the patient was neutropenic. She was treated with a combination of amphotericin B lipid formulation and caspofungin plus surgery. Debridement surgery included excision of the lower lip, chin, floor of the mouth, a portion of the tongue, as well as mandibular resection at the level of the horizontal branches. Eight weeks of combined antifungal therapy were followed by secondary prophylaxis with amphotericin B lipid formulation during consolidation chemotherapy after achieving complete response of both leukaemia and mucormycosis. Reconstructive surgery was carried out including insertion of a new biomaterial porous mandibular prosthesis, which showed excellent functionality after long-term follow-up, followed by several plastic surgery procedures once good tolerability and no adverse effects of the prosthesis were observed. This case shows that a well-coordinated multidisciplinary approach is critical to increase the chances of clinical success in this life-threatening infection. Copyright (c) 2010 S. Karger AG, Basel
C1 [Ojeda-Uribe, Mario] Hop E Muller, Dept Hematol, FR-68070 Mulhouse, France.
   [Kiefer, Marie Helene] Hop E Muller, Microbiol Lab, FR-68070 Mulhouse, France.
   [Chain, Jorge] Hop E Muller, Serv Radiol, FR-68070 Mulhouse, France.
   [Herbrecht, Raoul] Hop Hautepierre, Serv Oncol & Hematol, Strasbourg, France.
   [Schultz, Philippe; Debry, Christian] Hop Hautepierre, Serv ORL & Chirurg Cervicofacial, Strasbourg, France.
   [Chenard, Marie-Pierre] Hop Hautepierre, Serv Anat Pathol, Strasbourg, France.
   [Servant, Jean Marie] Hop St Louis, Dept Chirurg Plast, Paris, France.
RP Ojeda-Uribe, M (reprint author), Hop E Muller, Dept Hematol, 20 Ave Dr Laennec, FR-68070 Mulhouse, France.
EM ojedam@evhr.net
RI Herbrecht, Raoul/D-3471-2013; Chenard, Marie-Pierre/O-2373-2016
OI Herbrecht, Raoul/0000-0002-9381-4876; Ojeda-Uribe,
   Mario/0000-0001-6881-6055
CR Almyroudis NG, 2007, ANTIMICROB AGENTS CH, V51, P2587, DOI 10.1128/AAC.00452-07
   Arden RL, 1999, ARCH OTOLARYNGOL, V125, P68, DOI 10.1001/archotol.125.1.68
   Barron MA, 2005, J CLIN MICROBIOL, V43, P2012, DOI 10.1128/JCM.43.4.2012-2014.2005
   BOYD JB, 1995, PLAST RECONSTR SURG, V95, P1018, DOI 10.1097/00006534-199505000-00010
   Gonzalez CE, 2002, INFECT DIS CLIN N AM, V16, P895, DOI 10.1016/S0891-5520(02)00037-5
   Greenberg RN, 2006, ANTIMICROB AGENTS CH, V50, P126, DOI 10.1128/AAC.50.1.126-133.2006
   GUEMBE M, 2007, ANTIMICROB AGENTS CH, V51, P3547
   Ibrahim AS, 2005, ANTIMICROB AGENTS CH, V49, P721, DOI 10.1128/AAC.49.2.721-727.2005
   JONES AC, 1993, ORAL SURG ORAL MED O, V75, P455, DOI 10.1016/0030-4220(93)90170-9
   Larsen K, 2003, ORL J OTO-RHINO-LARY, V65, P57, DOI 10.1159/000068657
   Nicholson RE, 1997, ARCH OTOLARYNGOL, V123, P217
   Pagano L, 2004, HAEMATOLOGICA, V89, P207
   Paydas S, 2003, AM J MED, V114, P618, DOI 10.1016/S0002-9343(03)00092-5
   Reed C, 2008, CLIN INFECT DIS, V47, P364, DOI 10.1086/589857
   Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579
   Schultz P, 2002, ANN THORAC SURG, V73, P1747, DOI 10.1016/S0003-4975(02)03569-5
   Spellberg B, 2005, ANTIMICROB AGENTS CH, V49, P830, DOI 10.1128/AAC.49.2.830-832.2005
   Spellberg B, 2009, CLIN INFECT DIS, V48, P1743, DOI 10.1086/599105
   TEDDER M, 1994, ANN THORAC SURG, V57, P1044, DOI 10.1016/0003-4975(94)90243-7
   Vazquez L, 2005, Haematologica, V90, pECR39
   Walsh TJ, 2001, ANTIMICROB AGENTS CH, V45, P3487, DOI 10.1128/AAC.45.12.3487-3496.2001
   Walsh TJ, 1998, CLIN INFECT DIS, V26, P1383, DOI 10.1086/516353
   Witz F, 2000, BLOOD, V96, p504A
NR 23
TC 8
Z9 8
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0001-5792
J9 ACTA HAEMATOL-BASEL
JI Acta Haematol.
PY 2010
VL 124
IS 2
BP 98
EP 102
DI 10.1159/000315675
PG 5
WC Hematology
SC Hematology
GA 653BT
UT WOS:000282059300006
PM 20689269
DA 2018-10-20
ER

PT S
AU Ghodssi, R
   Dykstra, P
   Meyer, M
   Koev, S
   Gerasopoulos, K
   Luo, XL
   Rubloff, G
   Bentley, W
   Payne, G
   Culver, J
AF Ghodssi, Reza
   Dykstra, Peter
   Meyer, Mariana
   Koev, Stephan
   Gerasopoulos, Konstantinos
   Luo, Xiaolong
   Rubloff, Gary
   Bentley, William
   Payne, Gregory
   Culver, James
BE Gusev, E
   Garfunkel, E
   Dideikin, A
TI INTEGRATION OF DIVERSE BIOLOGICAL MATERIALS IN MICRO/NANO DEVICES
SO ADVANCED MATERIALS AND TECHNOLOGIES FOR MICRO/NANO-DEVICES, SENSORS AND
   ACTUATORS
SE NATO Science for Peace and Security Series B-Physics and Biophysics
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Advanced Materials and Technologies
   for Micro/Nano-Devices Sensors and Actuators
CY JUN 29-JUL 02, 2009
CL St Petersburg, RUSSIA
SP NATO
DE MEMS; chitosan; Tobacco mosaic virus; biosensors; lab on a chip
ID PATTERNED SURFACES; CHITOSAN; HYBRIDIZATION; ELECTRODES; BIOSENSOR;
   CATECHOL; FILM
AB This paper describes key examples of our work on biomaterial integration for functionalization and characterization in microdevices. We use the polysaccharide chitosan for immobilization of DNA and proteins in micro-fabricated sensors to make them responsive to a particular sample. In some cases, the use of chitosan was shown to improve the detection signal by a factor of 100 compared to devices without chitosan. We have developed a method for depositing Tobacco mosaic virus on micro scale electrodes in order to increase the effective surface area in a battery. Consequently, the capacity was increased by a factor of 6 compared to devices with planar electrodes. We have demonstrated the culturing of bacteria in a microfluidic test platform. The growth of bacteria over time is measured optically to provide information about the bacterial response to different stimuli. In a related demonstration, bacterial enzymes are assembled in a fluidic channel and their products under varying conditions are detected with a microcantilever sensor. The use of microfabricated devices for these experiments enables high-density, high-throughput measurements of the biomaterials to be performed.
C1 [Ghodssi, Reza; Dykstra, Peter; Koev, Stephan] Univ Maryland, Syst Res Inst, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
   [Meyer, Mariana; Luo, Xiaolong] Univ Maryland, Syst Res Inst, Fischell Dep Bio Engn, College Pk, MD 20742 USA.
   [Gerasopoulos, Konstantinos; Rubloff, Gary] Univ Maryland, Syst Res Inst, Dept Mat Sci & Engn, College Pk, MD 20742 USA.
   [Bentley, William; Payne, Gregory; Culver, James] Univ Maryland, Biotechnol Inst, College Pk, MD 20742 USA.
RP Ghodssi, R (reprint author), Univ Maryland, Syst Res Inst, Dept Elect & Comp Engn, College Pk, MD 20742 USA.
EM ghodssi@umd.edu
OI Luo, Xiaolong/0000-0002-9939-2766
FU R.W. Deutsch Foundation; National Science Foundation Emerging Frontiers
   in Research and Innovation (NSF-EFRI); Laboratory for Physical Sciences;
   Maryland NanoCenter and its FabLab
FX The authors would like to thank the R.W. Deutsch Foundation and the
   National Science Foundation Emerging Frontiers in Research and
   Innovation (NSF-EFRI) for funding this work. This work has been
   supported in part by the Laboratory for Physical Sciences. We also
   appreciate the support of the Maryland NanoCenter and its FabLab.
CR Boehm DA, 2007, SENSOR ACTUAT B-CHEM, V126, P508, DOI 10.1016/j.snb.2007.03.043
   Caruso F, 1997, SENSOR ACTUAT B-CHEM, V41, P189, DOI 10.1016/S0925-4005(97)80294-8
   Cowan SE, 2001, BIOTECHNOL LETT, V23, P1235, DOI 10.1023/A:1010581503842
   Dykstra P, 2009, SENSOR ACTUAT B-CHEM, V138, P64, DOI 10.1016/j.snb.2009.01.065
   Fernandes R, 2009, BIOTECHNOL BIOENG, V102, P390, DOI 10.1002/bit.22078
   GERASOPOULOS K, 2008, J MICROMECHANICS MIC, V18
   He XL, 2008, J BIOCHEM BIOPH METH, V70, P823, DOI 10.1016/j.jbbm.2007.06.002
   Humble PH, 2001, J ELECTROCHEM SOC, V148, pA1357, DOI 10.1149/1.1417975
   Jung CT, 2003, FOOD CHEM TOXICOL, V41, P885, DOI 10.1016/S0278-6915(03)00040-1
   KOEV ST, 2009, IEEE T BIOMEDI UNPUB
   Koev ST, 2007, LAB CHIP, V7, P103, DOI 10.1039/b609149k
   Lee KB, 2003, J MICROELECTROMECH S, V12, P840, DOI 10.1109/JMEMS.2003.820272
   Lee SY, 2005, NANOTECHNOLOGY, V16, pS435, DOI 10.1088/0957-4484/16/7/019
   Luo XL, 2008, LAB CHIP, V8, P420, DOI 10.1039/b713756g
   Meyers SR, 2009, BIOMATERIALS, V30, P277, DOI 10.1016/j.biomaterials.2008.08.042
   Royston E, 2008, LANGMUIR, V24, P906, DOI 10.1021/la7016424
   Starek Andrzej, 2003, Int J Occup Med Environ Health, V16, P113
   Xu DK, 2005, ANAL CHEM, V77, P5107, DOI 10.1021/ac050192m
   Yang DP, 2007, MOLECULES, V12, P878, DOI 10.3390/12040878
   Yao W, 2009, BIOSENS BIOELECTRON, V24, P3269, DOI 10.1016/j.bios.2009.04.016
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yi HM, 2005, LANGMUIR, V21, P2104, DOI 10.1021/la047529k
NR 22
TC 0
Z9 0
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1871-465X
BN 978-90-481-3805-0
J9 NATO SCI PEACE SEC B
PY 2010
BP 275
EP +
DI 10.1007/978-90-481-3807-4_22
PG 2
WC Nanoscience & Nanotechnology; Remote Sensing
SC Science & Technology - Other Topics; Remote Sensing
GA BPW81
UT WOS:000280184600022
DA 2018-10-20
ER

PT S
AU Cremasco, A
   Ferreira, I
   Caram, R
AF Cremasco, A.
   Ferreira, I.
   Caram, R.
BE Rosa, LG
   Margarido, F
TI Effect of Heat Treatments on Mechanical Properties and Fatigue
   Resistance of Ti-35Nb Alloy used as Biomaterial
SO ADVANCED MATERIALS FORUM V, PT 1 AND 2
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Materials Symposium/14th Conference of the
   Sociedade-Portuguesa-de-Materiais
CY APR 05-08, 2009
CL Lisbon, PORTUGAL
SP Soc Portuguesa Mat, TMS, Fundacao Calouste Gulbenkian, Fundacao Luso Amer, ELNOR, Paralab, Leica, INCM, SECIL, Gravimeta, CIMPOR, Werfen Grp, IZASA, OLYMPUS, JLF, Dias Sousa
DE Titanium alloys; Biomaterials; Microstructure; Fatigue strength;
   Mechanical properties
ID BIOMEDICAL APPLICATIONS; TITANIUM-ALLOYS; TI-29NB-13TA-4.6ZR;
   MICROSTRUCTURE; PERFORMANCE
AB Titanium alloys form the most versatile class of metallic materials used as biomaterials. Among them it is foreseen that the beta type titanium alloy will be a prominent one for orthopedic applications. Aim of the present work was to prepare and characterize a beta type titanium alloy containing 35 wt.% Nb. Samples were cooled from the beta phase temperatures at different rates. This work includes the effects of heat treatment on the microstructure and hardness, tensile and fatigue properties in air at room temperature. The results showed that microstructure of slow cooled samples are formed by precipitates of alpha and omega phases in a beta matrix. After rapid cooling, the microstructure consists of beta phase and alpha" martensite. Mechanical testing showed that the elastic modulus and Vickers hardness of slow cooled samples were significantly higher than that obtained by rapid cooling. On the other hand, it was observed that slow cooled samples showed higher tensile strength and lower ductility. The rapid cooled sample showed fatigue resistance higher than that of slow cooled samples.
C1 [Cremasco, A.; Ferreira, I.; Caram, R.] Univ Estadual Campinas, BR-13083970 Campinas, SP, Brazil.
RP Cremasco, A (reprint author), Univ Estadual Campinas, CP 6122, BR-13083970 Campinas, SP, Brazil.
EM alessandra@fem.unicamp.br; itamar@fem.unicamp.br; rcaram@fem.unicamp.br
RI Cremasco, Alessandra/C-1769-2012; Caram, Rubens/C-2068-2012
OI Caram, Rubens/0000-0001-6996-5116
CR Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   *ASM, 1990, MET HDB ASM, V12
   Boehlert CJ, 2005, MAT SCI ENG C-BIO S, V25, P263, DOI 10.1016/j.msec.2004.12.011
   DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   Kocan M, 2005, J MATER ENG PERFORM, V14, P765, DOI 10.1361/105994905X75583
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Li SJ, 2004, BIOMATERIALS, V25, P3369, DOI 10.1016/j.biomaterials.2003.09.108
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 2007, INT J FATIGUE, V29, P992, DOI 10.1016/j.ijfatigue.2006.09.021
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Zhentao Y., 2006, MAT SCI ENG A-STRUCT, V438-440, P391, DOI DOI 10.1016/J.MSEA.2005.12.079
NR 13
TC 1
Z9 1
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 636-637
BP 68
EP 75
DI 10.4028/www.scientific.net/MSF.636-637.68
PN 1-2
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BQE07
UT WOS:000280763200012
DA 2018-10-20
ER

PT S
AU Li, F
   Su, YL
   Shi, DF
   Wang, CT
AF Li, Feng
   Su, Yonglin
   Shi, Dufang
   Wang, Chengtao
BE Ma, L
   Wang, C
   Yang, W
TI Comparison of human articular cartilage and polyvinyl alcohol hydrogel
   as artificial cartilage in microstructure analysis and unconfined
   compression
SO ADVANCED POLYMER PROCESSING
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT Advanced Polymer Processing International Forum 2009 (APPF 2009)
CY AUG 19-21, 2009
CL Qingdao, PEOPLES R CHINA
DE Biomaterial; Cartilage; Hydrogel; Microstructure; Compression
ID SURFACE; WEAR; MORPHOLOGY; FRICTION; JOINTS; KNEE
AB Many biomaterials have been developed to replace articular cartilage. One of these materials, polyvinyl alcohol (PVA) hydrogel is proposed to be used as artificial cartilage in joint replacement. To better understand the differences between human articular cartilage and PVA hydrogel, microstructure analysis and unconfined compression were developed. In microstructure analysis, the surface of articular cartilage was smooth and free from any significant morphological features. Some small holes were found in the surface and cross-section of PVA hydrogel. The porous structure of PVA hydrogel was observed clearly by Environmental scanning electron microscopy (ESEM). In unconfined compression tests, the compression modulus of articular cartilage was higher than that of PVA hydrogel. In the creep tests, the strain value of articular cartilage was lower than that of PVA hydrogel all the time. It is indicated that the microstructure of each material has a great influence on their biphasic property which related to their mechanical behavior.
C1 [Li, Feng; Su, Yonglin; Shi, Dufang; Wang, Chengtao] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200030, Peoples R China.
RP Li, F (reprint author), Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200030, Peoples R China.
EM happywind@sjtu.edu.cn; yonglinsu@sjtu.edu.cn; shidufang2003@163.com;
   trib@sjtu.edu.cn
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   BLOEBAUM RD, 1980, J ANAT, V131, P333
   BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013
   CLARKE IC, 1971, ANN RHEUM DIS, V30, P15, DOI 10.1136/ard.30.1.15
   Di Fazio F, 2002, J BONE JOINT SURG AM, V84A, P204, DOI 10.2106/00004623-200202000-00006
   Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167
   Garner D L, 1971, Ann Rheum Dis, V30, P3, DOI 10.1136/ard.30.1.3
   Graindorge SL, 2000, WEAR, V241, P143, DOI 10.1016/S0043-1648(00)00386-0
   Kobayashi S, 1996, J ANAT, V188, P311
   LINN F C, 1968, Journal of Biomechanics, V1, P193, DOI 10.1016/0021-9290(68)90004-3
   MOW VC, 1980, SIAM REV, V22, P275, DOI 10.1137/1022056
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Pawaskar SS, 2007, P I MECH ENG J-J ENG, V221, P165, DOI 10.1243/13506501JET241
   Pickard JE, 1998, BIOMATERIALS, V19, P1807, DOI 10.1016/S0142-9612(98)00147-1
   Shklyar T, 2008, Biophysics, V53, P544, DOI 10.1134/S0006350908060146
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Unsworth A, 1995, TRIBOL INT, V28, P485, DOI 10.1016/0301-679X(95)00027-2
   WRIGHT V, 1976, J ANAT, V121, P107
   WU G, 2007, THESIS SHANGHAI JIAO, P58
NR 20
TC 5
Z9 5
U1 5
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
J9 ADV MAT RES
PY 2010
VL 87-88
BP 188
EP 193
DI 10.4028/www.scientific.net/AMR.87-88.188
PG 6
WC Polymer Science
SC Polymer Science
GA BQE29
UT WOS:000280767400036
DA 2018-10-20
ER

PT S
AU Barbosa, L
   Salgado, L
   Karsokas, N
   Nagamine, MK
AF Barbosa, L.
   Salgado, L.
   Karsokas F, N.
   Nagamine, Marcia Kazumi
BE Salgado, L
   Ambrozio, F
TI Characterization of HDH titanium powder for biomaterial applications
SO ADVANCED POWDER TECHNOLOGY VII
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 7th International Latin-American Conference on Powder Technology
CY NOV 10, 2009
CL Atibaia, BRAZIL
SP Abbott, Arotec, Avure, Basf, Brats, BS, Dafratec, Dorst, EDG, Emic, Engefor, EPM, GIG, GKN, GM, Haver, Hoganas, Instrutecnica, Magneti Marelli, Mahle, Metaldyne, Metalpo, Mextra, Panalytical, Shimadzu, Yuelong, Zoz
DE Powder metallurgy; biomaterial; titanium alloys
AB Several materials have been used as surgical implants since the 16(th) century. Materials can be implanted in the human body; however, the choice of the appropriate material is based on the required mechanical, physical, chemical, and biological properties. Until now two classes of metals namely stainless steel and cobalt-chromium-molybdenum alloys became known as materials for implant applications. They were considered suitable for surgical implant procedures but many researchers and surgeons were not completely satisfied with their performance. The main problem of the modern science is to find a material that perfectly restores tissues damaged after accidents or diseases. The trend of the current research in orthopedic prosthesis is based on the development of titanium alloys composed of non-toxic elements with low modulus of elasticity. Powder metallurgy techniques have beenused to produce controlled porous structures such as the porous coating applied for dental and orthopedic surgical implants which allows bone tissue grown within the implant surface, improving fixation. The development of porous metallic biomaterials associated with their biomedical applications is an important research area. To obtain a good one implant successful therapy the composition, size, form and topography of the alloys are extremely important.
EM luzinete_barbosa@ipen.br; lucio@brats.com.br; lucio@brats.com.br
RI Nagamine, Marcia/C-9798-2014
CR HIN TS, 2004, ENG MAT BIOMEDICAL A, P1
   Oliveira M.V., 2002, Mat. Res., V5, P269, DOI 10.1590/S1516-14392002000300009
   Schwanke CM, 2001, KEY ENG MAT, V189-1, P264, DOI 10.4028/www.scientific.net/KEM.189-191.264
   Seah KHW, 1998, CORROS SCI, V40, P547, DOI 10.1016/S0010-938X(97)00152-2
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   SUMITA M, 2004, ENG MAT BIOMEDICAL A, P2
   Ueta MCC, 2005, MATER SCI FORUM, V498-499, P211, DOI 10.4028/www.scientific.net/MSF.498-499.211
   WILLIAMS DF, 1974, J BIOMED MATER RES, V8, P1, DOI 10.1002/jbm.820080303
NR 8
TC 1
Z9 1
U1 2
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2010
VL 660-661
BP 188
EP 193
DI 10.4028/www.scientific.net/MSF.660-661.188
PG 6
WC Materials Science, Coatings & Films
SC Materials Science
GA BXA67
UT WOS:000295548800032
DA 2018-10-20
ER

PT S
AU Liu, A
   An, J
   Chua, CK
   Leong, KF
AF Liu, A.
   An, J.
   Chua, C. K.
   Leong, K. F.
BE Zhao, J
   Kunieda, M
   Yang, G
   Yuan, XM
TI A Portable Device for Fabricating Biomaterial Microfiber Bundles
SO ADVANCED PRECISION ENGINEERING
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT ICoPE2010/13th ICPE International Conference on Advanced Precision
   Engineering
CY JUL 28-30, 2010
CL Singapore, SINGAPORE
SP Singapore Inst Mfg Technol, Japan Soc Precis Engn, Nanyang Technol Univ, Natl Univ Singapore
DE Scaffold; Design; Microfiber; Tissue engineering; Biomaterials;
   Polycaprolactone
ID TISSUE; SCAFFOLDS; FIBERS
AB Engineered tendon and ligament scaffolds are ideally a bunch of biocompatible and biodegradable microfibers that are three-dimensionally aligned with no fusion between individual fibers. In this paper, a simple yet effective device that is able to fabricate this nearly native structure is presented, including design and operation method. Briefly, the device is die-free and requires only simple components such as a plate with an orifice, an aluminum holder, a ring heater and a rotating mandrel. The fabrication is done by a single step with microfiber (10 mu m diameter) bundles being directly obtained at a very low take-up speed. The as-spun microfiber bundles appear silvery and shiny, apparently similar to a native tendon. This device and the method associated opens up a new way to diversify the structure of biomaterials.
C1 [Liu, A.; An, J.; Chua, C. K.; Leong, K. F.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
RP Liu, A (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM anjia@pmail.ntu.edu.sg; mckchua@ntu.edu.sg; mkfleong@ntu.edu.sg
RI Leong, Kah-Fai/B-6183-2009
CR Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chua CK, 2010, INNOVATIVE DEVELOPMENTS IN DESIGN AND MANUFACTURING, P31
   Chua CK, 2010, INNOVATIVE DEVELOPMENTS IN DESIGN AND MANUFACTURING, P45, DOI 10.1201/9780203859476.ch6
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Deng D, 2009, BIOMATERIALS, V30, P6724, DOI 10.1016/j.biomaterials.2009.08.054
   Hwang CM, 2008, LANGMUIR, V24, P6845, DOI 10.1021/la800253b
   HWANG CM, 2009, CONTROLLED CELLULAR, P1
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   RICCI JL, 1984, J BIOMED MATER RES, V18, P1073, DOI 10.1002/jbm.820180910
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Simpson RL, 2008, J BIOMED MATER RES B, V84B, P17, DOI 10.1002/jbm.b.30839
   Williamson MR, 2004, BIOMATERIALS, V25, P459, DOI 10.1016/S0142-9612(03)00536-2
NR 16
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2010
VL 447-448
BP 750
EP 754
DI 10.4028/www.scientific.net/KEM.447-448.750
PG 5
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BVM71
UT WOS:000291897500146
DA 2018-10-20
ER

PT S
AU Hakim, L
   Yaakob, Z
   Ismail, M
   Daud, WRW
AF Hakim, Lukman
   Yaakob, Zahira
   Ismail, Manal
   Daud, Wan Ramli Wan
BE Zhao, J
   Kunieda, M
   Yang, G
   Yuan, XM
TI Nickel-Hydroxyapatite as Biomaterial Catalysts for Hydrogen Production
   via Glycerol Steam Reforming
SO ADVANCED PRECISION ENGINEERING
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT ICoPE2010/13th ICPE International Conference on Advanced Precision
   Engineering
CY JUL 28-30, 2010
CL Singapore, SINGAPORE
SP Singapore Inst Mfg Technol, Japan Soc Precis Engn (JSPE), Nanyang Technol Univ, Natl Univ Singapore
DE Glycerol; steam reforming; nickel/hydroxyapatite catalyst; hydrogen
   production; surface area
AB Nickel-hydroxyapatite as biomaterial catalysts exhibited high activity and selectivity in glycerol steam reforming. The catalytic steam reforming of glycerol (C3H8O3) for the production of hydrogen is carried out over nickel supported on hydroxyapatite [Ca-5(PO4)(3)(OH)] catalyst at 600 degrees C with atmospheric pressure and 120 minute time reaction. The catalysts were prepared by mean of wet impregnation method and varied nickel loadings (3, 6, 12 %) on hydroxyapatite. It is found that the 3% wt% Ni/HAP show higher hydrogen production rate over the other nickel loadings on hydroxyapatite, which is correlated with Ni/HAP catalyst surface area measured by BET adsorbtion and morphology of catalysts. Glycerol steam reforming with water-to-glycerol feed ratio 8/1 much more hydrogen production (77-82%) compared feed ratio 4/1. The catalysts were characterised by BET surface area and SEM-EDX techniques.
C1 [Hakim, Lukman] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43600, Malaysia.
   [Yaakob, Zahira] Univ Kebangsaan Malaysia, Dept Chem Engn, Bangi 43600, Malaysia.
RP Hakim, L (reprint author), Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43600, Malaysia.
EM hakim@eng.ukm.my; zahira@eng.ukm.my; manal@eng.ukm.my; wramli@eng.ukm.my
RI Daud, Wan Ramli/B-3635-2013; ISMAIL, MANAL/E-2501-2011
OI Daud, Wan Ramli/0000-0002-1023-456X; 
CR Adhikari S, 2007, INT J HYDROGEN ENERG, V32, P2875, DOI 10.1016/j.ijhydene.2007.03.023
   ADIKAHRI S, 2008, RENEW ENERG, V33, P2097
   Ashok J, 2008, CATAL LETT, V121, P283, DOI 10.1007/s10562-007-9334-z
   Atir R, 2006, SYNTHETIC COMMUN, V36, P111, DOI 10.1080/00397910500330619
   *CRS, 2004, HYDR EC FUELL CELL
   CUI Y, 2009, APPL CATALYST B
   *EUR COMM, 2003, 20719 EUR EN
   HAMMARI EL, 2004, J SOLID STATE CHEM, V177, P134
   Iriondo A, 2008, TOP CATAL, V49, P46, DOI 10.1007/s11244-008-9060-9
   KANEDA K, 2003, J AM CHEM SOC, P121
   MARQUES A, 2006, NANOMACROPOROUS BIOA
   Prelot B, 2005, MAT SCI ENG C-BIO S, V25, P553, DOI 10.1016/j.msec.2005.07.008
   Zhang BC, 2007, INT J HYDROGEN ENERG, V32, P2367, DOI 10.1016/j.ijhydene.2006.11.003
NR 13
TC 3
Z9 3
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2010
VL 447-448
BP 770
EP +
DI 10.4028/www.scientific.net/KEM.447-448.770
PG 3
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BVM71
UT WOS:000291897500150
DA 2018-10-20
ER

PT B
AU Koumpoyiannis, SD
   Aravas, N
   Varitimidis, S
   Houstis, EN
   Bagiatis, V
   Malizos, K
AF Koumpoyiannis, S. D.
   Aravas, N.
   Varitimidis, S.
   Houstis, E. N.
   Bagiatis, V.
   Malizos, K.
BE Charalambopoulos, A
   Fotiadis, DI
   Polyzos, D
TI SIGNIFICANCE OF SIZE AND LOCATION OF THE LESION FOR PROGNOSIS OF
   COLLAPSE OF OSTEONECROSIS OF THE FEMORAL HEAD FOR PATIENTS TREATED WITH
   TANTALUM ROD
SO ADVANCED TOPICS IN SCATTERING THEORY AND BIOMEDICAL ENGINEERING
LA English
DT Proceedings Paper
CT 9th International Workshop on Mathematical Methods in Scattering Theory
   and Biomedical Engineering
CY OCT 09-11, 2009
CL Patras, GREECE
ID AVASCULAR NECROSIS; CORE DECOMPRESSION; QUANTIFICATION; BIOMATERIAL;
   PREDICTION; MRI
AB The purpose of this study is to predict osteonecrosis of the femoral head by examining location and size of the lesion of the femoral head. A triangulation approximation algorithm is used for the computation of the geometric center of the lesion based on MRI scans for patients treated with a tantalum rod.
   Twenty nine patients (thirty four hips) with osteonecrosis of the femoral head were treated with the tantalum rod procedure. The mean age was 39,21 years (14 - 59). All necrotic lesions were confirmed by magnetic resonance imaging. A customized triangulation approximation algorithm was developed in order to compute the geometric center of the lesion of the reconstructed model. Lesion volume, the distance from the origin (p or R), latitude (p) and longitude (0) of the geometric center of the lesion within the femoral head were calculated.
   The mean follow-up was 3 (1-7) years. Ten hips (29.4%) showed radiographic progression. Statistical method Cox regression analysis showed that lesion volume and longitude angle (0) were important factors to predict radiographic progression. Lesions having an angle (0) of [15 - 35 degrees] and [50 degrees - 60 degrees] and size c in Steinberg scale with lesion size greater than 27% of the femoral head were more likely to develop radiographic progression. For hips that developed radiographic progression out of this range, lesion size was the only significant factor.
   The results suggest that lesion volume is an important factor strongly correlated with the risk of collapse of the femoral head. The location of the lesion of the necrotic area is an important supplemental parameter in order to predict with accuracy the progression of the disease. However further studies with the current algorithm that computes the geometric center of the lesion, larger study groups and long-term follow-up are needed in order to predict accurately the progression of the disease and the collapse of the femoral head.
C1 [Koumpoyiannis, S. D.; Houstis, E. N.] Univ Thessaly, Dept Comp & Commun Engn, Volos, Greece.
   [Aravas, N.] Univ Thessaly, Dept Mech Engn Engn, Volos, Greece.
   [Varitimidis, S.; Malizos, K.] Univ Hosp Larissa, Dept Orthopaed, Larisa, Greece.
   [Bagiatis, V.] Univ Thessaly, Dept Biochem & Biotechnol, Larisa, Greece.
RP Koumpoyiannis, SD (reprint author), Univ Thessaly, Dept Comp & Commun Engn, Volos, Greece.
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Heiner AD, 2001, T ORTHOP RES SOC, V26, P480
   ITO H, 1999, CLIN ORTHOP RELAT R, V358, P149
   KERBOUL M, 1974, J BONE JOINT SURG BR, VB 56, P291
   KOO KH, 1995, J BONE JOINT SURG BR, V77B, P875
   Malizos KN, 2001, SKELETAL RADIOL, V30, P686, DOI 10.1007/s002560100399
   Mazieres B, 1997, ANN RHEUM DIS, V56, P747, DOI 10.1136/ard.56.12.747
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   Mont MA, 1997, CLIN ORTHOP RELAT R, P91
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Nishii T, 2002, J ORTHOPAED RES, V20, P130, DOI 10.1016/S0736-0266(01)00063-8
   NISHII T, 2002, CLIN ORTHOP RELAT R, V400, P149
   SHIMIZU K, 1994, J BONE JOINT SURG AM, V76A, P215, DOI 10.2106/00004623-199402000-00007
   Soucacos PN, 2001, CLIN ORTHOP RELAT R, P120
   Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71
   STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34
   STEINBERG ME, 1999, CLIN ORTHOP RELAT R, V367, P262
   Sugano N, 1994, Clin Orthop Relat Res, P190
   SUGANO N, 1994, CLIN ORTHOP RELAT R, V303, P155
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Zoroofi RA, 2001, COMPUT MED IMAG GRAP, V25, P511, DOI 10.1016/S0895-6111(01)00013-1
NR 22
TC 0
Z9 0
U1 1
U2 1
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
BN 978-981-4322-02-7
PY 2010
BP 235
EP 253
DI 10.1142/9789814322034_0025
PG 19
WC Engineering, Biomedical
SC Engineering
GA BG9ZY
UT WOS:000394395600025
DA 2018-10-20
ER

PT S
AU Mallick, KK
AF Mallick, Kajal K.
BE Narayan, R
   McKittrick, J
TI FREEZE CASTING OF POROUS BIOMATERIAL SCAFFOLDS FOR BONE TISSUE
   ENGINEERING
SO ADVANCES IN BIOCERAMICS AND BIOTECHNOLOGIES
SE Ceramic Transactions
LA English
DT Proceedings Paper
CT 8th Pacific Rim Conference on Ceramic and Glass Technology
CY MAY 31-JUN 05, 2009
CL Vancouver, CANADA
SP Amer Ceram Soc
ID BIOACTIVE GLASS 45S5; TAPE CAST; CRYSTALLIZATION; POLYETHYLENE;
   TEMPERATURE; CERAMICS; BEHAVIOR; GROWTH; FLUID
AB This paper firstly reviews the current trends in fabrication techniques to produce porous inorganic biomaterial constructs for hard tissue augmentation. Of these, simple and cost effective freeze casting method has been employed over the last few years to process mainly bioceramics but has often met with difficulty in controlling variously oriented pore structures. The present work also compares two novel freeze casting methods using camphene and a mixture of water and glycerol in fabricating excellent networked 3-D porous structures of Bioglass and hydroxyapatite. It was possible to control the development of dendritic pore microstructure by the control and optimization of the process parameters such as mould temperature (0 to -196 degrees C), temperature of freezing vehicle, glycerol concentration (5-40wt%) and temperature gradient driving the solidification and/or sublimation. DTA-TGA, XRD, density, and SEM analysis of bioscaffolds, air sintered up to 1100 degrees C, showed monotonic correlations between porosity, pore size, orientation and solid loading (10-70%). A maximum porosity of 90% was achieved for stnictures with micro and macropores of 2-120 mu m, a clinically viable range that is amenable for bone in-growth and revascularization.
C1 Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
RP Mallick, KK (reprint author), Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
EM k.k.mallick@warwick.ac.uk
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Banchet V, 2004, SURF INTERFACE ANAL, V36, P658, DOI 10.1002/sia.1916
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   Chatzistavrou X, 2004, PHYS STATUS SOLIDI A, V201, P944, DOI 10.1002/pssa.200306776
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   Clupper DC, 2002, BIOMATERIALS, V23, P2599, DOI 10.1016/S0142-9612(01)00398-2
   Clupper DC, 2001, J BIOMED MATER RES, V57, P532, DOI 10.1002/1097-4636(20011215)57:4<532::AID-JBM1199>3.0.CO;2-3
   El-Ghannam A, 2001, J BIOMED MATER RES, V55, P387, DOI 10.1002/1097-4636(20010605)55:3<387::AID-JBM1027>3.0.CO;2-V
   ElBatal HA, 2003, MATER CHEM PHYS, V80, P599, DOI 10.1016/S0254-0584(03)00082-8
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Fu Q, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025005
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jun IK, 2006, J AM CERAM SOC, V89, P391, DOI 10.1111/j.1551-2916.2005.00707.x
   KAJAL K, 2009, J AM CERAM SOC, V92, pS85
   KELER KA, 1996, PROCESSING FABRICATI, V5, P557
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Kokubo T, 1997, AN QUIM, V93, pS49
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   Lu K, 2006, J AM CERAM SOC, V89, P2459, DOI 10.1111/j.1551-2916.2006.01111.x
   Mikos A. G., 1998, FRONTIERS TISSUE ENG, P3
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   RUBINSTEIN ER, 1991, J CRYST GROWTH, V112, P97, DOI 10.1016/0022-0248(91)90915-R
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   Sofie SW, 2001, J AM CERAM SOC, V84, P1459
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   UCHIDA A, 1984, J BONE JOINT SURG BR, V66, P269
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
   Yoon BH, 2007, J AM CERAM SOC, V90, P1744, DOI 10.1111/j.1551-2916.2007.01670.x
NR 38
TC 2
Z9 2
U1 0
U2 11
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 978-0-470-90548-7
J9 CERAM TRANS
PY 2010
VL 218
BP 23
EP 36
PG 14
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BTL79
UT WOS:000287225900004
DA 2018-10-20
ER

PT S
AU Hermansson, L
   Faris, A
   Gomez-Ortega, G
   Loof, J
AF Hermansson, Leif
   Faris, Adam
   Gomez-Ortega, Gunilla
   Loof, Jesper
BE Narayan, R
   Colombo, P
TI BIOCOMPATIBILITY ASPECTS OF INJECTABLE CHEMICALLY BONDED CERAMICS OF THE
   SYSTEM CaO-Al(2)O(3)-P(2)O(5)-SiO(2)
SO ADVANCES IN BIOCERAMICS AND POROUS CERAMICS II
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 33rd International Conference on Advanced Ceramics and Composites
CY JAN 18-23, 2009
CL Daytona Beach, FL
ID BIOMATERIALS; INTEGRATION; ALUMINATE; TISSUE
AB The paper will discuss the biocompatibility including bioactivity of the system CaO - Al(2)O(3) - P(2)O(5) - SiO(2). The bioactivity was determined in vitro by studying the formation of apatite on the biomaterial surface when soaked in simulated body fluid. Complementary in vivo biocompatibility and bioactivity studies were conducted in animals (rabbit femur and tibia and sheep vertebrae). The evaluation included histology, X-ray diffraction and high resolution TEM using specific site sample preparation using FIB-technique. General aspects of biocompatibility including cytotoxicity, sensitization, irritation/intracutaneous reactivity, systemic toxicity, sub-acute, sub-chronic and chronic toxicity, genotoxicity, carcinogenicity, and haemocompatibility were also evaluated. It is concluded that the injectable biomaterials in the system studied seem to fulfill the required biocompatibility for the intended clinical use by meeting all the toxicological endpoints referred to in the harmonized standard ISO 10993:2003.
C1 [Hermansson, Leif; Faris, Adam; Gomez-Ortega, Gunilla; Loof, Jesper] Doxa AB, SE-75451 Uppsala, Sweden.
RP Hermansson, L (reprint author), Doxa AB, Axel Johanssons Gata 4-6, SE-75451 Uppsala, Sweden.
EM leif.hermansson@doxa.se
CR Axen N., 2004, P 9 CER CELLS TISS F
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   *EN, 1991, 299171994ISO9917 EN
   Engqvist H, 2004, J BIOMED MATER RES B, V69B, P94, DOI 10.1002/jbm.b.20042
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   Engqvist H., 2005, TRENDS BIOMATERIALS, V19, P27
   ENGQVIST H, 2004, CERAMIC T, V164
   Faris A., 2006, KEY ENG MATER, V309-11, P1401
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hermansson L., 2008, TRENDS BIOMAER ARTIF, V22, P134
   HERMANSSON L, 2008, P ICC 2 VER IN PRESS
   Hermansson L., 2006, KEY ENG MATER, V49, P21
   Hermansson L, 2009, KEY ENG MAT, V396-398, P183, DOI 10.4028/www.scientific.net/KEM.396-398.183
   *ISO, 109932003 ISO
   *ISO, 10993121992 ISO
   KRAFT L, 2002, AM CERAM SOC ADV C B, V23
   KRAFT L, 2002, THESIS UPPSALA U SWE
   LIU Y, 1992, CHEM-BIOL INTERACT, V85, P69, DOI 10.1016/0009-2797(92)90053-N
   LIU Y, 2002, THESIS UPPSLA U
   Loof J, 2008, KEY ENG MATER, V361-363, P369
   Loof J., 2008, THESIS UPPSALA U
   Loof J, 2008, DENT MATER, V24, P653, DOI 10.1016/j.dental.2007.06.028
   Nilsson M., 2003, THESIS LUND U
   SCHMALZ G, 2002, CARD C JUL
   TANG ATH, J BIOMED MAT RES, V45, P214
   Williams D.D., 1987, DEFINITIONS BIOMATER, P66
NR 26
TC 0
Z9 0
U1 0
U2 2
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-0-470-45756-6
J9 CERAM ENG SCI PROC
PY 2010
VL 30
IS 6
BP 59
EP 70
PG 12
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BQI72
UT WOS:000281126500006
DA 2018-10-20
ER

PT S
AU Hermansson, L
   Faris, A
   Gomez-Ortega, G
   Kuoppala, J
   Loof, J
AF Hermansson, Leif
   Faris, Adam
   Gomez-Ortega, Gunilla
   Kuoppala, John
   Loof, Jesper
BE Narayan, R
   Colombo, P
TI ASPECTS OF DENTAL APPLICATIONS BASED ON MATERIALS OF THE SYSTEM
   CaO-Al(2)O(3)-P(2)O(5)-H(2)O
SO ADVANCES IN BIOCERAMICS AND POROUS CERAMICS II
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 33rd International Conference on Advanced Ceramics and Composites
CY JAN 18-23, 2009
CL Daytona Beach, FL
ID IN-VIVO; CALCIUM ALUMINATE; BIOMATERIALS; INTEGRATION; IMPLANTS; BONE
AB The chemically bonded bioceramics (CBC), also known as inorganic cements, are based on materials of the system CaO-Al(2)O(3)-P(2)O(5)-SiO(2) (CAPS) comprising phosphates, aluminates and silicates. This paper deals with the property profile of CBC-biomaterials mainly based on hydrates of Ca-aluminates and phosphates (CAPH), identified dental applications, some unique features and challenges. The following product areas have been identified based on experimental material data, pre-clinical studies, pilot studies and on-going clinical studies: dental cement, endodontic products (orthograde and retrograde), sealants, restoratives, underfillings, and pastes for augmentation and dental implant coatings. It is concluded that a potential use of the CAPH-materials for dental applications is based on the following features: nanostructural integration with tissue, possible apatite formation, and a mass increase yielding early point welding between the biomaterial and surrounding tissue. Consequences of nanostructural contact integration of the CAPH-system are reduced risk of secondary caries and restoration failure, and reduced post-operative sensitivity.
C1 [Hermansson, Leif; Faris, Adam; Gomez-Ortega, Gunilla; Kuoppala, John; Loof, Jesper] Doxa AB, SE-75451 Uppsala, Sweden.
RP Hermansson, L (reprint author), Doxa AB, Axel Johanssons Gata 4-6, SE-75451 Uppsala, Sweden.
EM leif.hermansson@doxa.se
CR Adolfsson E, 1999, BIOMATERIALS, V20, P1263, DOI 10.1016/S0142-9612(99)00018-6
   Alamo H.L., 1999, INT ENDOD J, V32, P197
   Axen N, 2005, KEY ENG MAT, V284-286, P831, DOI 10.4028/www.scientific.net/KEM.284-286.831
   BULTMARK F, 2008, J MAT SCI UNPUB
   *DENTSPL, 2003, PROROOT MTA
   Ellingsen JE, 2003, BIOIMPLANT INTERFACE
   Engqvist H, 2004, J BIOMED MATER RES B, V69B, P94, DOI 10.1002/jbm.b.20042
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   ENGQVIST H, 2004, CERAMIC T, V164
   HAMMER JE, 1972, J BIOM RES, V6, P1
   Hauman CHJ, 2003, INT ENDOD J, V36, P147, DOI 10.1046/j.1365-2591.2003.00637.x
   HEINTRICHT RL, 1971, J BIOM RES, V5, P25
   Hermansson L, 2003, KEY ENG MAT, V247, P437, DOI 10.4028/www.scientific.net/KEM.247.437
   Hermansson L., 2006, Advances in Science and Technology, V49, P21, DOI 10.4028/www.scientific.net/AST.49.21
   HERMANSSON L, 2006, KEY ENG MATER, V309, P829
   HERMANSSON L, 2009, DAYT BEACH IN PRESS
   Hermansson L, 2009, KEY ENG MAT, V396-398, P183, DOI 10.4028/www.scientific.net/KEM.396-398.183
   KRAFT L, 2002, AM CERAM SOC ADV C B, V23
   KRAFT L, 2000, INT RILEM, V17, P401
   KRAFT L, 2002, THESIS UPPSALA U SWE
   LIU, 2002, THESIS UPPSALA U
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Loof J., 2008, THESIS UPPSALA U
   LOOF J, 2005, KEY ENG MATER, V284, P145
   Mjor I., 2000, INT DENT J, V50, P50
   Niederman R, 2003, INT ENDOD J, V36, P577, DOI 10.1046/j.1365-2591.2003.00696.x
   Nilsson M., 2003, THESIS LUND U
   Noort R, 1994, INTRO DENT MAT
   PAMEIJER CH, 2008, 3098 IADR
   PAMEIJER CH, 2009, IADR C MIAM IN PRESS
   PAMEIJER SR, 2008, 3100 IADR
   POLHAGEN L, 2 YEAR RETROSP UNPUB
   RASHEDI A, 2001, TREATMENT PERIAPICAL
   RAVAGLIOLO A, 1992, BIOCERAMICS
   Rickerby D. S., 1991, ADV SURFACE COATINGS
   SCHNEIDER JM, 2000, J APPL D, V33, P173
   Vercaigne S, 1998, CLIN ORAL IMPLAN RES, V9, P261, DOI 10.1034/j.1600-0501.1998.090407.x
NR 37
TC 0
Z9 0
U1 0
U2 2
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-0-470-45756-6
J9 CERAM ENG SCI PROC
PY 2010
VL 30
IS 6
BP 71
EP 82
PG 12
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BQI72
UT WOS:000281126500007
DA 2018-10-20
ER

PT S
AU Moawad, HM
   Wang, S
   Jain, H
   Falk, MM
AF Moawad, H. M.
   Wang, S.
   Jain, H.
   Falk, M. M.
BE Narayan, R
   Colombo, P
TI EFFECT OF ZINC ON BIOACTIVITY OF NANO-MACROPOROUS SODA-LIME
   PHOSPHOFLUOROSILICATE GLASS-CERAMIC
SO ADVANCES IN BIOCERAMICS AND POROUS CERAMICS II
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 33rd International Conference on Advanced Ceramics and Composites
CY JAN 18-23, 2009
CL Daytona Beach, FL
ID CALCIUM-PHOSPHATE FORMATION; BIOGLASS
AB Multi-scale porosity is desirable for the use of biocompatible glass and glass-ceramics as a bioscaffold material because porosity promotes cell attachment and thus better acceptance of the scaffolds. Recently, we demonstrated the fabrication of soda-lime phosphofluorosilicate glass-ceramics with porosity ranging from several nanometers to >100 micrometers by the melt-quench-heat-etch method, and optimized the phase distribution for rapid growth of hydroxyapatite (HA). In this work we have extended the usefulness of this class of biomaterial by adding ZnO that is believed to stimulate bone growth. Starting with 48SiO(2)-2.7P(2)O(5)-4CaF(2)-xZnO-yCaO-zNa(2)O glasses with x=0.0, 0.5, 1, 3, 5, 8, 10, y+z =45.3-x (mol %), nano-macro porous glass-ceramics were fabricated. We observed the formation of many crystalline phases, but mainly sodium calcium silicate, calcium phosphate, and fluorapatite. In general, the addition of ZnO improves glass durability. For 3 mol % HA is formed in simulated body fluid, but for higher concentration the surface layer deviates from HA composition significantly.
C1 [Moawad, H. M.; Wang, S.; Jain, H.] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA.
   [Falk, M. M.] Lehigh Univ, Dept Sci Biol, Bethlehem, PA 18015 USA.
RP Moawad, HM (reprint author), Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA.
FU National Science Foundation [DMR-0409588]; Materials World Network
   [DMR-0602975]; National Institutes of Health (NIH) [GM55725]
FX This work was initiated and continued as an international collaboration
   with support fromNational Science Foundation (International Materials
   Institute for New Functionality in Glass (DMR-0409588) and Materials
   World Network (DMR-0602975) programs). MMF is funded by the National
   Institutes of Health (NIH, NIGMS, grant GM55725). We thank Drs. Amp K.
   Sengupta and Sudipta Sarkar for help with the ICP measurements.
CR Balas F, 2001, J MATER RES, V16, P1345, DOI 10.1557/JMR.2001.0187
   BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Chen XF, 1998, CERAM INT, V24, P401, DOI 10.1016/S0272-8842(97)00028-X
   ElBatal HA, 2003, MATER CHEM PHYS, V80, P599, DOI 10.1016/S0254-0584(03)00082-8
   ELMER TH, 1970, J AM CERAM SOC, V53, P171, DOI 10.1111/j.1151-2916.1970.tb12064.x
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Jalota S, 2006, J MATER SCI-MATER M, V17, P697, DOI 10.1007/s10856-006-9680-1
   Kim HM, 2001, KEY ENG MATER, V192-195, P47, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.47
   Li N, 2005, CERAM INT, V31, P641, DOI 10.1016/j.ceramint.2004.05.011
   Marques AC, 2007, PHYS CHEM GLASSES-B, V48, P65
   Mathew M, 2001, J RES NATL INST STAN, V106, P1035, DOI 10.6028/jres.106.054
   Moawad HMM, 2007, J AM CERAM SOC, V90, P1934, DOI 10.1111/j.1551-2916.2007.01659.x
   MOAWAD HMM, J MAT SCI M IN PRESS
   MOAWAD HMM, 2008, BIOL GEOPOLYMER CERA, V28, P183
   Neel E. A. A., 2005, ACTA BIOMATER, V1, P553
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   Rahaman MN, 2005, CERAM ENG SCI PROC, V26, P3
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
NR 23
TC 0
Z9 0
U1 0
U2 1
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-0-470-45756-6
J9 CERAM ENG SCI PROC
PY 2010
VL 30
IS 6
BP 179
EP +
PG 3
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BQI72
UT WOS:000281126500017
DA 2018-10-20
ER

PT S
AU Menon, AK
   Kalita, SJ
AF Menon, Arun Kumar
   Kalita, Samar Jyoti
BE Narayan, R
   Colombo, P
TI POROUS SCAFFOLDS USING NANOCRYSTALLINE TITANIA FOR BONE GRAFT
   APPLICATIONS
SO ADVANCES IN BIOCERAMICS AND POROUS CERAMICS II
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 33rd International Conference on Advanced Ceramics and Composites
CY JAN 18-23, 2009
CL Daytona Beach, FL
ID MECHANICAL-PROPERTIES; CERAMICS; DIOXIDE; SCIENCE
AB The need for a better scaffold to treat large bone-defects resulting from skeletal conditions still prevails, and it has been a challenge to meet all the biomedical requirements. It is established that an ideal bone scaffold should: (a) be osteogenic and resorbable, (b) have porous structure with interconnectivity, (c) possess suitable surface chemistry for cell attachment, differentiation and proliferation, and (d) match with the mechanical properties of the tissue being replaced. It is hypothesized that these requirements could be fulfilled by creating scaffolds using nanocrystalline titanium dioxide (TiO(2)) via proper manufacturing technique/s. Nano-TiO(2) has shown improved mechanical strength and osteoblast functions, and proved to be a promising orthopedic biomaterial.
   Formerly, we developed a simple sol-gel technique to synthesize 5-12 nm anatase powder. In this work, we used the same technique to produce TiO(2) nanopowder and fabricated porous scaffolds, using Poly (ethylene glycol) (PEG) as the pore-forming agent. The calcined nanopowder was homogenously mixed with 5, 10 and 15 wt. % of PEG and then cold-die compacted in a steel mold at 19.4 MPa. Controlled porosity scaffolds were fabricated through the indirect Fused Deposition Modeling process. The green samples/ molds were sintered in air, at 1500 degrees C to obtain the porous scaffolds with interconnectivity.
   The porous scaffolds were characterized for microstructure, phase purity, porosity, surface pore size, compression and biaxial flexural strength. XRD technique was used to analyze the phase/s. SEM was used to study the microstructure. Porosity was measured using immersion technique. Bulk density decreased with the increase in porosity of the structures. Density decreased from 3.79 g/cc to 3.03 Wee as porosity increased from 9% to 22%. Biaxial flexural strength test was performed as per ASTM F-394. Flexural strength of 128(+/- 7) MPa and 85(+/- 6) MPa were achieved in structures with 9% and 18% porosity, respectively.
C1 [Menon, Arun Kumar; Kalita, Samar Jyoti] Univ Cent Florida, Dept Mech Mat & Aerosp Engn, Orlando, FL 32816 USA.
RP Menon, AK (reprint author), Univ Cent Florida, Dept Mech Mat & Aerosp Engn, POB 162450, Orlando, FL 32816 USA.
CR Akiyoshi MM, 2002, AM CERAM SOC BULL, V81, P39
   Albano MP, 2008, CERAM INT, V34, P1983, DOI 10.1016/j.ceramint.2007.07.028
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Dubrovinsky LS, 2001, NATURE, V410, P653, DOI 10.1038/35070650
   Kalita SJ, 2008, MATER CHEM PHYS, V109, P392, DOI 10.1016/j.matchemphys.2007.12.031
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x
   Ohji T, 2008, MAT SCI ENG A-STRUCT, V498, P5, DOI 10.1016/j.msea.2007.09.104
   Qiu SP, 2006, MAT SCI ENG A-STRUCT, V435, P327, DOI 10.1016/j.msea.2006.07.062
   SCHEFFLER M, 2005, CELLULAR CERAMICS ST, P342
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yoon BH, 2008, SCRIPTA MATER, V58, P537, DOI 10.1016/j.scriptamat.2007.11.006
   Zhuang HY, 2008, MAT SCI ENG C-BIO S, V28, P1462, DOI 10.1016/j.msec.2008.04.001
   1998, POROSITY CERAMICS, P315
NR 15
TC 0
Z9 0
U1 0
U2 2
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-0-470-45756-6
J9 CERAM ENG SCI PROC
PY 2010
VL 30
IS 6
BP 191
EP 201
PG 11
WC Materials Science, Ceramics; Materials Science, Biomaterials
SC Materials Science
GA BQI72
UT WOS:000281126500018
DA 2018-10-20
ER

PT S
AU Tanaka, K
   Uchiyama, M
AF Tanaka, Kazuto
   Uchiyama, Masatoshi
BE Aliabadi, MH
   Abela, S
   Baragetti, S
   Guagliano, M
   Lee, HS
TI Effect of Vitamin-E Addition on Fatigue Crack Growth Property of Ultra
   High Molecular Weight Polyethylene
SO ADVANCES IN FRACTURE AND DAMAGE MECHANICS VIII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 8th International Conference on Fracture and Damage Mechanics
CY SEP 08-10, 2009
CL MALTA
DE Ultra High Molecular Weight Polyethylene; Biomaterial; Knee joint;
   Fatigue Crack growth; Vitamin-E; Oxidization
ID UHMWPE
AB In order to understand the influence of gamma-irradiation, accelerated aging and Vitamin-E addition on the fatigue crack growth properties of UHMWPE, fatigue crack growth tests of UHMWPE plates using compact tension specimens were carried out. The specimen conditioned in gamma-irradiation and accelerated aging (the gamma-aging specimen) has faster fatigue crack growth rate than the virgin specimens. For the Vitamin-E added specimen (the VE specimen), however, Delta K threshold of the gamma-aging VE specimen is smaller than that of the VE specimen. This result shows that the addition of Vitamin-E reduced the decrease of Delta K threshold by gamma-irradiation and accelerated aging.
C1 [Tanaka, Kazuto] Doshisha Univ, Dept Biomed Engn, 1-3 Miyakodani, Kyotanabe, Kyoto 6100394, Japan.
   [Uchiyama, Masatoshi] Kyoto Univ, Dept Engn Mech, Kyoto 6068501, Japan.
RP Tanaka, K (reprint author), Doshisha Univ, Dept Biomed Engn, 1-3 Miyakodani, Kyotanabe, Kyoto 6100394, Japan.
EM ktanaka@mail.doshisha.ac.jp
CR Edidin AA, 2002, J BIOMED MATER RES, V61, P312, DOI 10.1002/jbm.10135
   Lewis G, 1997, J BIOMED MATER RES, V38, P55, DOI 10.1002/(SICI)1097-4636(199721)38:1<55::AID-JBM8>3.0.CO;2-G
   Medel F, 2004, BIOMATERIALS, V25, P9, DOI 10.1016/S0142-9612(03)00464-2
   Tomita N, 1999, J BIOMED MATER RES, V48, P474
   TOMITA N, 1996, J MUSCULOSKELETAL SY, V9, P489
   YAMAGUCHI M, 1999, J JOINT SURG, V18, P1420
NR 6
TC 1
Z9 1
U1 3
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2010
VL 417-418
BP 93
EP +
PG 2
WC Engineering, Multidisciplinary; Mechanics
SC Engineering; Mechanics
GA BPM63
UT WOS:000279319200024
DA 2018-10-20
ER

PT S
AU Chen, MH
   Shi, TC
   Hu, X
   Cai, JH
AF Chen, M. H.
   Shi, T. C.
   Hu, X.
   Cai, J. H.
BE Zuo, DW
   Guo, H
   Xu, HL
   Su, C
   Liu, CJ
   Jin, W
TI Analysis of Nozzles of Rapid Prototyping System Oriented to
   Bio-Manufacture
SO ADVANCES IN FUNCTIONAL MANUFACTURING TECHNOLOGIES
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 2nd International Conference on Functional Manufacturing Technologies
CY AUG 06-09, 2010
CL Harbin, PEOPLES R CHINA
DE bio-manufacture; rapid prototyping; nozzle
AB Bio-manufacture is an interdisciplinary research area, which is based on the development of rapid prototyping technology, biomaterial and biomedicine technologies. It brings a new revolution in manufacturing science. Producing scaffolds of high performance is the purpose of bio-manufacture. For many rapid prototyping, which is suitable for bio-manufacture, the core difference lies in their enable technology. Extrusion-based rapid prototyping technology is an important branch of rapid prototyping, and each system has different nozzle device. In this paper, through in-depth research and analysis of structure, performance and materials used of spray head in the market for bio-manufacture, it can provide scientific basis for selecting more suitable spray head of rapid prototyping for bio-manufacture.
C1 [Chen, M. H.; Shi, T. C.; Hu, X.; Cai, J. H.] Hangzhou Dianzi Univ, Biomfg Res Ctr, Hangzhou 310037, Zhejiang, Peoples R China.
RP Chen, MH (reprint author), Hangzhou Dianzi Univ, Biomfg Res Ctr, Hangzhou 310037, Zhejiang, Peoples R China.
EM meihua2572@163.com; stc@hdu.edu.cn
CR B Liu, 2009, CHINA Patent, Patent No. [200,820,206,342.9, 2008202063429]
   Chen Z P, 2000, HONG KONG Patent, Patent No. [00,203, 338.0, 002033380]
   F LIU, 2006, MECH ENG, V42, P13
   Kruth J.P., 1998, CIRP ANN-MANUF TECHN, V2, P525
   Lan H, 2009, COMPUT IND, V60, P643, DOI 10.1016/j.compind.2009.05.003
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Le JIN, 2009, TSINGHUA SCI TECHNOL, V49
   Lee CS, 2007, J MATER PROCESS TECH, V187, P627, DOI 10.1016/j.jmatprotec.2006.11.095
   Liang D R, 2006, ENG PLASTICS APPL, V34, P62
   Liu Bin, 2009, ENG PLASTICS APPL, V37, P71
   Liu Bin, 2008, ENG PLASTICS APPL, V36, P68
   LIU Feng, 2009, TSINGHUA SCI TECHNOL, V14, P116
   Lu B H, 2000, CHINA MECH ENG, V11, P149
   Pahole I, 2005, J MATER PROCESS TECH, V164, P1416, DOI 10.1016/j.jmatprotec.2005.02.167
   Tyberg J, 1999, MATER DESIGN, V20, P77, DOI 10.1016/S0261-3069(99)00012-6
   Utela Ben, 2008, MANUFACTURING PROCES, V10, P96
   Wang Tianming, 2006, Chinese Journal of Mechanical Engineering, V42, P178
   Wu R D, 2005, CHINA Patent, Patent No. [200,510,011,113.2, 2005100111132]
   Wu R D, 2006, CHINA Patent, Patent No. [200,610,076,248.1, 2006100762481]
   Xiong Z, 2005, RAPID PROTOTYPING J, V11, P160, DOI 10.1108/13552540510601282
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 21
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-0-87849-236-7
J9 APPL MECH MATER
PY 2010
VL 33
BP 132
EP 138
DI 10.4028/www.scientific.net/AMM.33.132
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BZX08
UT WOS:000303187100028
DA 2018-10-20
ER

PT S
AU Tan, MJ
   Hassan, SF
   Akahori, T
   Niinomi, M
AF Tan, Ming-Jen
   Hassan, Syed Fida
   Akahori, Toshikazu
   Niinomi, Mitsuo
BE Wang, J
   Mathew, P
   Li, XP
   Huang, CZ
   Zhu, HT
TI Formability of Ti-29Nb-13Ta-4.6Zr Biomaterial at High Temperatures
SO ADVANCES IN MATERIALS PROCESSING IX
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 9th Asia-Pacific Conference on Materials Processing
CY JUN 07-10, 2010
CL Univ New S Wales, Sydney, AUSTRALIA
SP Univ New S Wales, Natl Univ Singapore, Nanyang Technol Univ, Shandong Univ
HO Univ New S Wales
DE beta Ti Alloy; Biomaterial; Mechanical Properties; Superplasticity
ID TITANIUM-ALLOYS; BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES;
   DEFORMATION
AB Ti-29Nb-13Ta-4.6Zr has been recently developed as a biomaterial showing most potential. The study here was conducted to investigate the high temperature deformation behavior under uniaxial tensile stress at various temperatures (i.e., 700 degrees C, 800 degrees C and 900 degrees C) with different initial strain rates at atmospheric condition. Results of the high temperature tensile tests show a significant improved elongation-to-failure of this novel biomaterial at elevated temperatures compared to open literature, and hence its formability potential.
C1 [Tan, Ming-Jen] Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore, Singapore.
   [Hassan, Syed Fida] King Fahd Univ Petr & Minerals, Dept Engn Mech, Dhahran, Saudi Arabia.
   [Akahori, Toshikazu; Niinomi, Mitsuo] Tohoku Univ, Mat Res Inst, Sendai, Miyagi 980, Japan.
RP Tan, MJ (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore, Singapore.
EM mmjtan@ntu.edu.sg; sfhassan@kfupm.edu.sa; akahori@imr.tohoku.ac.jp;
   niinomi@imr.tohoku.ac.jp
RI Tan, Ming-Jen/A-3862-2011
OI Tan, Ming-Jen/0000-0002-3583-1723
CR Akahori T, 2007, MATER SCI FORUM, V561-565, P1505, DOI 10.4028/www.scientific.net/MSF.561-565.1505
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   HIDALGOPRADA B, 1985, SCRIPTA METALL MATER, V19, P1235, DOI 10.1016/0036-9748(85)90245-5
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Zhou Q, 2005, MATER SCI FORUM, V475-479, P2299, DOI 10.4028/www.scientific.net/MSF.475-479.2299
   Zhu XJ, 2005, SCRIPTA MATER, V52, P651, DOI 10.1016/j.scriptamat.2004.11.017
NR 11
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2010
VL 443
BP 620
EP +
DI 10.4028/www.scientific.net/KEM.443.620
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BRW82
UT WOS:000283804900103
DA 2018-10-20
ER

PT S
AU Altankov, G
   Groth, T
   Engel, E
   Gustavsson, J
   Pegueroles, M
   Aparicio, C
   Gil, FJ
   Ginebra, MP
   Planell, JA
AF Altankov, George
   Groth, Thomas
   Engel, Elisabeth
   Gustavsson, Jonas
   Pegueroles, Marta
   Aparicio, Conrado
   Gil, Francesc J.
   Ginebra, Maria-Pau
   Planell, Josep A.
BE Shastri, VP
   Altankov, G
   Lendlein, A
TI Development of Provisional Extracellular Matrix on Biomaterials
   Interface: Lessons from In Vitro Cell Culture
SO ADVANCES IN REGENERATIVE MEDICINE: ROLE OF NANOTECHNOLOGY AND
   ENGINEERING PRINCIPLES
SE NATO Science for Peace and Security Series A-Chemistry and Biology
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Nanoengineered Systems for
   Regenerative Medicine
CY SEP 21-24, 2007
CL Varna, BULGARIA
DE Biomaterials interface; Fibronectin matrix; Reorganizattion; Provisional
   ECM; Cellular interaction
ID SUBSTRATUM-BOUND FIBRONECTIN; SURFACE-ROUGHNESS; TITANIUM SURFACES;
   FIBROBLAST ADHESION; PROLIFERATION; DIFFERENTIATION; BIOCOMPATIBILITY;
   WETTABILITY; FIBRINOGEN; DYNAMICS
AB The initial cellular events that take place at the biomaterials interface mimic to a certain extent the natural interaction of cells with the extracellular matrix (ECM). The cells adhering to the adsorbed soluble matrix proteins, such as fibronectin (FN) and fibrinogen (FNG) tend to re-arrange them in fibril-like pattern. Using model surfaces we have demonstrated that this cellular activity is abundantly dependent on the surface properties of materials, such as wettability, surface chemistry, charge and topography. This raises the possibility that tissue compatibility of materials is connected with the allowance of cells to remodel substratum associated proteins presumably to form provisional ECM. We have further shown that antibodies which bind beta(1) and alpha(v), integrins (subunits of the FN and FNG receptors respectively) may induce their linear rearrangement on the dorsal surface of living cells - a phenomenon presumably related to the same early molecular events of fibrillar matrix assembly. Because the quantitative measurements revealed that this receptor dynamics is strongly altered on the low compatible (hydrophobic) substrata we hypothesized that in order to be biocompatible, materials need to adsorb matrix proteins loosely, i.e. in such a way that the cells can easily remove and organize them in matrix-like fibrils via coordinated functioning of integrins. More recent studies on the fate of FN on some real biomaterial surfaces, including different rough titanium (Ti) and hydroxyapatite (HA) cements and the surface of biosensors confirmed this point of view. They also show that quantitative measurements of adsorbed matrix proteins and their dynamic rearrangement at cell-material interface might provide insight to the biocompatibility of given material and even predict its tissue integration.
C1 [Altankov, George] Bulgarian Acad Sci, Inst Biophys, Sofia, Bulgaria.
   [Altankov, George] ICREA, Barcelona, Spain.
   [Altankov, George] IBEC, Barcelona, Spain.
   [Groth, Thomas] Univ Halle Wittenberg, Dept Pharm, Halle, Germany.
   [Engel, Elisabeth; Gustavsson, Jonas; Pegueroles, Marta; Aparicio, Conrado; Gil, Francesc J.; Ginebra, Maria-Pau; Planell, Josep A.] Univ Politecn Cataluna, Dept Mat Sci, E-08028 Barcelona, Spain.
RP Altankov, G (reprint author), Bulgarian Acad Sci, Inst Biophys, Sofia, Bulgaria.
EM george.altankov@icrea.es
RI Engel, Elisabeth/D-4365-2014; Ginebra, Maria-Pau/J-8149-2017
OI Engel, Elisabeth/0000-0003-4855-8874; Ginebra,
   Maria-Pau/0000-0002-4700-5621; PEGUEROLES, MARTA/0000-0002-7895-8337;
   Aparicio, Conrado/0000-0003-2969-6067
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altankov G, 1997, J BIOMAT SCI-POLYM E, V8, P721, DOI 10.1163/156856297X00524
   Altankov G, 2005, J BIOMAT SCI-POLYM E, V16, P23, DOI 10.1163/1568562052843320
   ALTANKOV G, 1995, EXP CELL RES, V216, P299, DOI 10.1006/excr.1995.1038
   Altankov G, 2001, EXP DERMATOL, V10, P80, DOI 10.1034/j.1600-0625.2001.010002080.x
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Baumann WH, 1999, SENSOR ACTUAT B-CHEM, V55, P77, DOI 10.1016/S0925-4005(99)00116-1
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Coelho NM, 2009, ASSEMBLY ADSOR UNPUB
   Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DONALDSON DJ, 1989, J CELL SCI, V94, P101
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Griffin L, 2002, SCIENCE, V259, P1009
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   GRONOWICZ GA, 1991, ENDOCRINOLOGY, V128, P1107, DOI 10.1210/endo-128-2-1107
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Gustavsson J, 2007, J MATER SCI-MATER M, V19, P1839
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Hynes RO, 1990, FIBRONECTINS
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lowenstaim HA, 1989, BIOMINERALISATION
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maneva-Radicheva L, 2008, HISTOL HISTOPATHOL, V23, P833, DOI 10.14670/HH-23.833
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   NORDAHL J, 1995, CALCIFIED TISSUE INT, V57, P442, DOI 10.1007/BF00301948
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Pegueroles M, 2009, ACTA BIOMAT IN PRESS, DOI [10.1016/j.actbio.2009.07, DOI 10.1016/J.ACTBIO.2009.07]
   Pereira M, 2002, J CELL SCI, V115, P609
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Richards RG, 1996, INJURY, V27, P38
   Schoning MJ, 1998, SENSOR ACTUAT B-CHEM, V47, P225, DOI 10.1016/S0925-4005(98)00027-6
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Sohrabi A, 2000, J BIOMED MATER RES, V50, P43, DOI 10.1002/(SICI)1097-4636(200004)50:1<43::AID-JBM7>3.0.CO;2-A
   Spie J, 2002, ANN NY ACAD SCI, V961, P1
   Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zlatanov I, 2005, BIOPHYS J, V89, P3555, DOI 10.1529/biophysj.105.061119
NR 51
TC 5
Z9 5
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1874-6489
BN 978-90-481-8788-1
J9 NATO SCI PEACE SEC A
JI NATO Sci. Peace Secur. Ser. A-Chem. Biol.
PY 2010
BP 19
EP +
DI 10.1007/978-90-481-8790-4_2
PG 5
WC Cell & Tissue Engineering; Engineering, Biomedical; Nanoscience &
   Nanotechnology; Multidisciplinary Sciences
SC Cell Biology; Engineering; Science & Technology - Other Topics
GA BST17
UT WOS:000285737600002
DA 2018-10-20
ER

PT S
AU Groth, T
   Liu, ZM
   Niepel, M
   Peschel, D
   Kirchhof, K
   Altankov, G
   Faucheux, N
AF Groth, Thomas
   Liu, Zhen-Mei
   Niepel, Marcus
   Peschel, Dieter
   Kirchhof, Kristin
   Altankov, George
   Faucheux, Nathalie
BE Shastri, VP
   Altankov, G
   Lendlein, A
TI Chemical and Physical Modifications of Biomaterial Surfaces to Control
   Adhesion of Cells
SO ADVANCES IN REGENERATIVE MEDICINE: ROLE OF NANOTECHNOLOGY AND
   ENGINEERING PRINCIPLES
SE NATO Science for Peace and Security Series A-Chemistry and Biology
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Nanoengineered Systems for
   Regenerative Medicine
CY SEP 21-24, 2007
CL Varna, BULGARIA
DE Biomaterials; Surface modification; Self assembled monolayer; Poly
   (ethylene glycol); Layer-by-layer technique; Cell adhesion
ID SELF-ASSEMBLED MONOLAYERS; POLYPROPYLENE MICROFILTRATION MEMBRANES;
   POLY(ETHER IMIDE) MEMBRANES; PROTEIN ADSORPTION; BIOMEDICAL
   APPLICATIONS; GRAFTING DENSITY; MODEL SURFACES; POLYETHYLENTEREPHTALAT
   MEMBRANES; POLYELECTROLYTE MULTILAYERS; FIBRONECTIN CONFORMATION
AB Cell adhesion is a prerequisite for healing of implant materials and colonization of tissue engineering scaffolds. Hence, it is a crucial task to control adhesion of cells on biomaterials, which can be achieved by surface modification. Different techniques can be used to modify the surface of materials, which have the desired physical and chemical properties, but lack sufficient biocompatibility. Among the techniques of surface modification, a number of self assembly methods have the advantage to work in solutions, so that different shaped materials can be modified easily. Self assembly methods selected in this study were chemisorption and covalent binding of alkylsiloxanes on glass (i), photochemical binding of polyethylene glycol on hydrophobic polymers (ii) and alternating adsorption of polyanions and polycations to assemble nanostructured multilayers on charged surfaces (iii). These methods enable to obtain control on adhesion of cells on different classes of biomaterials, which eventually may promote subsequent processes like cell growth and differentiation.
C1 [Groth, Thomas; Liu, Zhen-Mei; Niepel, Marcus; Peschel, Dieter; Kirchhof, Kristin] Univ Halle Wittenberg, Inst Pharm, Biomed Mat Grp, D-06120 Halle, Saale, Germany.
   [Altankov, George] ICREA, Inst Bioengn Catalunya, Barcelona, Spain.
   [Faucheux, Nathalie] Univ Sherbrooke, Dept Chem Engn, Sherbrooke, PQ J1K 2R1, Canada.
RP Groth, T (reprint author), Univ Halle Wittenberg, Inst Pharm, Biomed Mat Grp, D-06120 Halle, Saale, Germany.
EM thomas.groth@pharmazie.uni-halle.de
RI Niepel, Marcus/G-2340-2011
OI Niepel, Marcus/0000-0002-4479-1225
FU Deutsche Forschungsgemeinschaft [Gr 1290/4-1, Gr 1290/4-2]; European
   Union funded Marie-Curie Fellowships to George Altankov
   [HPMF-CT-2001-01275]; Nathalie Faucheux [HPMF-CT-2000-00883]; Zhen-Mei
   Liu [MIF1-CT2005-021845]
FX A part of the results presented here is based on contributions from
   previous projects and co-operations with Mathias Ulbricht, University
   Essen-Duisburg and Volkmar Thom, Sartorius AG. Financial support for
   these studies was provided by Deutsche Forschungsgemeinschaft (Gr
   1290/4-1 and Gr 1290/4-2) and European Union funded Marie-Curie
   Fellowships to George Altankov (HPMF-CT-2001-01275), Nathalie Faucheux
   (HPMF-CT-2000-00883) and Zhen-Mei Liu (MIF1-CT2005-021845).
CR Ahn SJ, 2004, ADV MATER, V16, P2141, DOI 10.1002/adma.200401055
   Albrecht W, 2003, MACROMOL CHEM PHYSIC, V204, P510, DOI 10.1002/macp.200390016
   Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Altankov G, 1997, J BIOMAT SCI-POLYM E, V8, P721, DOI 10.1163/156856297X00524
   Altankov G, 2003, MATERIALWISS WERKST, V34, P1120, DOI 10.1002/mawe.200300699
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Atkin R, 2003, ADV COLLOID INTERFAC, V103, P219, DOI 10.1016/S0001-8686(03)00002-2
   Bacakova L, 2001, J BIOMAT SCI-POLYM E, V12, P817, DOI 10.1163/156856201750411684
   Behrens SH, 2001, J CHEM PHYS, V115, P6716, DOI 10.1063/1.1404988
   BERGERON E, 2007, BIOMATERIALS RES ADV, P21
   BIRD RI, 1994, CLIN SCI, V78, pP78
   BONGRAND P, 1982, PROG SURF SCI, V12, P217, DOI 10.1016/0079-6816(82)90007-7
   Bretagnol F, 2007, ADV MATER, V19, P1947, DOI 10.1002/adma.200602523
   Brown MB, 2005, J EUR ACAD DERMATOL, V19, P308, DOI 10.1111/j.1468-3083.2004.01180.x
   Chen Y, 2001, ELECTROPHORESIS, V22, P187, DOI 10.1002/1522-2683(200101)22:2<187::AID-ELPS187>3.0.CO;2-0
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Croll TI, 2006, BIOMACROMOLECULES, V7, P1610, DOI 10.1021/bm060044l
   Curtis A, 2004, IEEE T NANOBIOSCI, V3, P293, DOI 10.1109/TNB.2004.837898
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Filippini P, 2001, J BIOMED MATER RES, V55, P338, DOI 10.1002/1097-4636(20010605)55:3<338::AID-JBM1022>3.3.CO;2-E
   Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X
   Fukuda T, 2000, MACROMOL RAPID COMM, V21, P151, DOI 10.1002/(SICI)1521-3927(200003)21:4<151::AID-MARC151>3.0.CO;2-3
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Goldstein AS, 2002, J BIOMED MATER RES, V59, P665, DOI 10.1002/jbm.1276
   Gopinadhan M, 2007, J PHYS CHEM B, V111, P8426, DOI 10.1021/jp067402z
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Groth T, 1997, J BIOMAT SCI-POLYM E, V8, P797, DOI 10.1163/156856297X00326
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P497, DOI 10.1163/156856294X00464
   GROTH T, 1992, ATLA-ALTERN LAB ANIM, V20, P390
   Guo L, 2008, BIOMATERIALS, V29, P23, DOI [10.1016/j.biomaterials.2007.08.043, 10.1016/j.biomaterials.2007-08.043]
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hamerli P, 2003, SURF COAT TECH, V174, P574, DOI 10.1016/S0257-8972(03)00685-6
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Huang S, 2000, EXP CELL RES, V261, P91, DOI 10.1006/excr.2000.5044
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Iwasaki Y, 1999, J BIOMAT SCI-POLYM E, V10, P513, DOI 10.1163/156856299X00450
   Jauregui H O, 1987, ASAIO Trans, V33, P66, DOI 10.1097/00002480-198704000-00004
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Kondyurin A, 2006, NUCL INSTRUM METH B, V251, P413, DOI 10.1016/j.nimb.2006.06.027
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Liu ZM, 2006, ENZYME MICROB TECH, V39, P868, DOI 10.1016/j.enzmictec.2006.01.016
   Liu ZM, 2005, J MEMBRANE SCI, V249, P21, DOI 10.1016/j.memsci.2004.10.001
   Liu ZM, 2004, EUR POLYM J, V40, P2077, DOI 10.1016/j.eurpolymj.2004.05.020
   LIU ZM, BIOMATERIALS UNPUB
   LIU ZM, 2010, EUR POLYM J UNPUB
   Lodish H, 2004, MOL CELL BIOL
   Ma ZW, 2003, J BIOMAT SCI-POLYM E, V14, P13, DOI 10.1163/15685620360511119
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Mullaney M, 1999, ARTIF ORGANS, V23, P87, DOI 10.1046/j.1525-1594.1999.06280.x
   Muller M, 2001, MACROMOL RAPID COMM, V22, P390, DOI 10.1002/1521-3927(20010301)22:6<390::AID-MARC390>3.0.CO;2-B
   Muller M, 1999, MACROMOL RAPID COMM, V20, P607
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Pasche S, 2005, J PHYS CHEM B, V109, P17545, DOI 10.1021/jp050431+
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Remy-Kristensen A, 2001, BBA-BIOMEMBRANES, V1514, P21, DOI 10.1016/S0005-2736(01)00359-5
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1
   Satoh T, 2004, POLYM ADVAN TECHNOL, V15, P720, DOI 10.1002/pat.486
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Seifert B, 2002, ARTIF ORGANS, V26, P189, DOI 10.1046/j.1525-1594.2002.06876.x
   Singh N, 2007, BIOMATERIALS, V28, P763, DOI 10.1016/j.biomaterials.2006.09.036
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   Szleifer I, 1997, PHYSICA A, V244, P370, DOI 10.1016/S0378-4371(97)00293-8
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   TROMMLER A, 1985, BIOPHYS J, V48, P835, DOI 10.1016/S0006-3495(85)83842-X
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Tzoneva R, 2008, J BIOMAT SCI-POLYM E, V19, P837, DOI 10.1163/156856208784613523
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Vermette P, 2003, COLLOID SURFACE B, V28, P153, DOI 10.1016/S0927-7765(02)00160-1
   Vert M, 2000, J BIOMAT SCI-POLYM E, V11, P1307, DOI 10.1163/156856200744345
   Vitte J, 2005, CLIN HEMORHEOL MICRO, V33, P167
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Xu T, 2007, MAT SCI ENG C-BIO S, V27, P579, DOI 10.1016/j.msec.2006.05.029
   Xu XD, 2006, THIN SOLID FILMS, V514, P182, DOI 10.1016/j.tsf.2006.02.095
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
   ZAJAC R, 1995, PHYS REV E, V52, P6536, DOI 10.1103/PhysRevE.52.6536
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 119
TC 9
Z9 9
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1874-6489
BN 978-90-481-8788-1
J9 NATO SCI PEACE SEC A
JI NATO Sci. Peace Secur. Ser. A-Chem. Biol.
PY 2010
BP 253
EP +
DI 10.1007/978-90-481-8790-4_13
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical; Nanoscience &
   Nanotechnology; Multidisciplinary Sciences
SC Cell Biology; Engineering; Science & Technology - Other Topics
GA BST17
UT WOS:000285737600013
DA 2018-10-20
ER

PT S
AU Rickert, D
   Fuhrmann, R
   Hiebl, B
   Lendlein, A
   Franke, RP
AF Rickert, Dorothee
   Fuhrmann, Rosemarie
   Hiebl, Bernhard
   Lendlein, Andreas
   Franke, Ralf-Peter
BE Shastri, VP
   Altankov, G
   Lendlein, A
TI Results of Biocompatibility Testing of Novel, Multifunctional Polymeric
   Implant Materials In-Vitro and In-Vivo
SO ADVANCES IN REGENERATIVE MEDICINE: ROLE OF NANOTECHNOLOGY AND
   ENGINEERING PRINCIPLES
SE NATO Science for Peace and Security Series A-Chemistry and Biology
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Nanoengineered Systems for
   Regenerative Medicine
CY SEP 21-24, 2007
CL Varna, BULGARIA
DE Regenerative medicine; Multifunctional biomaterials; Sterilization;
   Biocompatibility testing; Extracellular matrix remodeling;
   Biofunctionality testing in-vivo
ID SHAPE-MEMORY; REGENERATIVE MEDICINE; MATRIX METALLOPROTEINASES;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; ANIMAL-MODEL; STEM-CELLS;
   STERILIZATION; FIBROBLASTS; EXPRESSION; BIOMATERIALS
AB Extensive in-vitro and in-vivo evaluation of the biocompatibility of biomaterials intended for clinical applications is necessary to provide information on the interactions that take place between the organism and these materials under specific implant conditions. Sterilization of polymer-based implant materials is a basic requirement but can lead to their damage or destruction. Low-temperature plasma (LTP) or ethylene oxide (EO) sterilization are objects of intensive research and were applied on the materials used in this program. After 4 weeks of polymer incubation in minimal essential medium (MEM), samples, sterilized by LTP, gave a markedly higher mean cell lysis rate (3.7 +/- 2.5%) than EO sterilized samples (0.9 +/- 0.3%). To achieve relevant in-vitro results on biomaterial-cell interactions, biocompatibility testing was carried out with cultures of locotypical cells, e.g. cells of the upper aerodigestive tract (ADT). Primary cell cultures of the oral cavity, the pharynx and the esophagus showed region-typical varying relationships between epithelial, fibroblastic and smooth muscle cells. Proper wound healing is thought to be required for the integration of biomaterials and angiogenesis is a prerequisite for this process. A focus of the present work was the influence of polymer-based implant materials and their degradation products on angiogenesis in-vivo. After 48 h, none of the polymer samples demonstrated development of an avascular region in the chorioallantoic membrane (CAM) test. A key process in proper wound healing is the tightly controlled degradation and regeneration of the extracellular matrix (ECM). A biomaterial for the reconstruction of the upper ADT is subjected to varying pH values and enzymatic, bacterial and mechanical stress during the digestive and the swallowing process. These complex conditions can currently only be investigated in-vivo in an animal model. As a model the stomach of the rat was selected, in which a biomaterial can be investigated under extreme chemical, enzymatic, bacteriological and mechanical conditions. Other parameters investigated are the impermeability of the polymer-tissue closure and the tissue regeneration after defect reconstruction. The fluid tight integration of a long term resorbable AB-copolymer network in the surrounding tissue of the gastric wall of Sprague Dawley rats could be demonstrated.
C1 [Rickert, Dorothee] Marienhosp Stuttgart, Boheimstr 37, D-70199 Stuttgart, Germany.
   [Fuhrmann, Rosemarie; Franke, Ralf-Peter] Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
   [Hiebl, Bernhard; Lendlein, Andreas] GKSS Res Ctr Geesthacht GmbH, Polymer Res Inst, D-14513 Teltow, Germany.
RP Rickert, D (reprint author), Marienhosp Stuttgart, Boheimstr 37, D-70199 Stuttgart, Germany.
EM D.Rickert@gmx.de; Lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Hiebl,
   Bernhard/0000-0002-6450-0675
CR Ahsan T, 2005, Orthod Craniofac Res, V8, P134, DOI 10.1111/j.1601-6343.2005.00326.x
   ASTM International, 1992, ASTM DES F813 83 STA, P239
   Atala A, 2005, EXPERT OPIN BIOL TH, V5, P879, DOI 10.1517/14712598.5.7.879
   Bennett JH, 2000, EUR J ORAL SCI, V108, P281, DOI 10.1034/j.1600-0722.2000.108004281.x
   Breymann C, 2006, STEM CELL REV, V2, P87
   Burslem Richard, 2005, Med Device Technol, V16, P40
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CLARK R. A. F., 1995, MOL CELLULAR BIOL WO
   El Mansouri H, 1999, J APPL POLYM SCI, V71, P371, DOI 10.1002/(SICI)1097-4628(19990118)71:3<371::AID-APP2>3.3.CO;2-D
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Goldman M, 1998, J MATER SCI-MATER M, V9, P207, DOI 10.1023/A:1008836107186
   GRIERSON JP, 1995, J BIOL CHEM, V270, P4451, DOI 10.1074/jbc.270.9.4451
   Humes DH, 2005, T AM CLIN CLIMAT ASS, V116, P167
   Ioannidou E, 2006, CURR PHARM DESIGN, V12, P2397, DOI 10.2174/138161206777699007
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   Kume S, 2005, DEV GROWTH DIFFER, V47, P393
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lemmon Christopher A, 2005, Mech Chem Biosyst, V2, P1
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2005, CLIN HEMORHEOL MICRO, V32, P105
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Lerouge S, 2000, J BIOMED MATER RES, V52, P774
   Messer RLW, 2006, J BIOMED MATER RES A, V79A, P16, DOI 10.1002/jbm.a.30703
   Moses MA, 1996, J CELL BIOCHEM, V60, P379, DOI 10.1002/(SICI)1097-4644(19960301)60:3<379::AID-JCB9>3.3.CO;2-0
   Mudera VC, 2000, CELL MOTIL CYTOSKEL, V45, P1, DOI 10.1002/(SICI)1097-0169(200001)45:1<1::AID-CM1>3.0.CO;2-J
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Ravanti L, 2000, INT J MOL MED, V6, P391
   Reed JA, 2006, J ENVIRON PATHOL TOX, V25, P537, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i3.10
   Rickert D, 2006, EUR ARCH OTO-RHINO-L, V263, P215, DOI 10.1007/s00405-005-0950-1
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2002, BIOMED TECH, V47, P285, DOI 10.1515/bmte.2002.47.11.285
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P47
   Rickert D, 2006, BIOMED TECH, V51, P116, DOI 10.1515/BMT.2006.020
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Shen JY, 2007, BIOMACROMOLECULES, V8, P376, DOI 10.1021/bm060766c
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Simmons A, 2006, BIOMATERIALS, V27, P4484, DOI 10.1016/j.biomaterials.2006.04.017
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Stangegaard M, 2006, MOL BIOSYST, V2, P421, DOI 10.1039/b608239d
   Stayton P S, 2005, Orthod Craniofac Res, V8, P219, DOI 10.1111/j.1601-6343.2005.00336.x
   Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x
   Vaalamo M, 1999, HUM PATHOL, V30, P795, DOI 10.1016/S0046-8177(99)90140-5
NR 48
TC 0
Z9 0
U1 3
U2 10
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1874-6489
BN 978-90-481-8788-1
J9 NATO SCI PEACE SEC A
JI NATO Sci. Peace Secur. Ser. A-Chem. Biol.
PY 2010
BP 285
EP +
DI 10.1007/978-90-481-8790-4_14
PG 5
WC Cell & Tissue Engineering; Engineering, Biomedical; Nanoscience &
   Nanotechnology; Multidisciplinary Sciences
SC Cell Biology; Engineering; Science & Technology - Other Topics
GA BST17
UT WOS:000285737600014
DA 2018-10-20
ER

PT J
AU Guix, M
   Perez-Lopez, B
   Sahin, M
   Roldan, M
   Ambrosi, A
   Merkoci, A
AF Guix, Maria
   Perez-Lopez, Briza
   Sahin, Melike
   Roldan, Monica
   Ambrosi, Adriano
   Merkoci, Arben
TI Structural characterization by confocal laser scanning microscopy and
   electrochemical study of multi-walled carbon nanotube tyrosinase matrix
   for phenol detection
SO ANALYST
LA English
DT Article
ID PASTE ELECTRODES; BIOSENSOR; COMPOSITE; ROUGHNESS; CELLS; WATER;
   GRAPHITE; OXIDASE; SENSORS; ENZYMES
AB A novel visualization methodology based on the use of immunofluorescence and Confocal Laser Scanning Microscopy (CLSM) was used to quantify and visualize tyrosinase enzyme within a MWCNTs matrix immobilized onto carbon based screen-printed electrodes. CLSM was shown to be an extremely powerful technique which allowed a clear visualization of the distribution of the enzyme within both the MWCNTs and carbon based layers and provided additional and useful morphological data for a better understanding of the interaction between biomolecules and electrode materials. Transmission Electron Microscopy (TEM) and Scanning Electron Microscopy (SEM) were also employed to fully characterize the system components. The proposed MWCNT/Tyrosinase matrix was applied to the detection of phenol, as an alternative biosensor material. Electrochemical analytical performances of the biosensor were investigated in order to determine the optimal fabrication design along with the enzyme stability. The biosensor based on the developed biomaterial matrix proved promising results in terms of cost, simplicity and analytical performance. A detection limit of 1.35 mu M and a sensitivity of 47.4 mu A mM(-1) within a linear response range of 2.5 to 75 mu M phenol were obtained. The biosensor performed well as a disposable device and could be stored in a refrigerator ( 18 degrees C) without loss of activity for up to 2 months.
C1 [Guix, Maria; Perez-Lopez, Briza; Sahin, Melike; Ambrosi, Adriano; Merkoci, Arben] Catalan Inst Nanotechnol, Nanobioelect & Biosensors Grp, Bellaterra 08193, Spain.
   [Guix, Maria] Autonomous Univ Barcelona, Bellaterra 08193, Spain.
   [Sahin, Melike] Akdeniz Univ, Antalya, Turkey.
   [Roldan, Monica] Autonomous Univ Barcelona, Microscopy Serv, Bellaterra 08193, Spain.
RP Merkoci, A (reprint author), Catalan Inst Nanotechnol, Nanobioelect & Biosensors Grp, UAB Campus, Bellaterra 08193, Spain.
EM arben.merkoci.icn@uab.es
RI Ambrosi, Adriano/B-5539-2011; Merkoci, Arben/C-7211-2008; Guix Noguera,
   Maria/B-3475-2017
OI Ambrosi, Adriano/0000-0002-0581-4658; Merkoci,
   Arben/0000-0003-2486-8085; Guix Noguera, Maria/0000-0002-5219-6434
FU Spanish Ministry of Science and Innovation [MAT2008-03079/NAN,
   BES-2009-023939]
FX The financial support from the Spanish Ministry of Science and
   Innovation through project MAT2008-03079/NAN and predoctoral fellowship
   (BES-2009-023939 given to M. G.) are acknowledged.
CR Alarcon-Angeles G, 2008, CARBON, V46, P898, DOI 10.1016/j.carbon.2008.02.025
   [Anonymous], 1997, 4287 ISO
   Antunes FV, 2000, INT J FATIGUE, V22, P781, DOI 10.1016/S0142-1123(00)00048-7
   Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.006
   BYFIELD MP, 1994, BIOSENS BIOELECTRON, V9, P373, DOI 10.1016/0956-5663(94)80038-3
   Carralero V, 2006, BIOSENS BIOELECTRON, V22, P730, DOI 10.1016/j.bios.2006.02.012
   Chalal M, 2009, MACROMOLECULES, V42, P2749, DOI 10.1021/ma802820w
   Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95
   CHRISWELL CD, 1975, ANAL CHEM, V47, P1325, DOI 10.1021/ac60358a005
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   Fanjul-Bolado P, 2008, ELECTROCHIM ACTA, V53, P3635, DOI 10.1016/j.electacta.2007.12.044
   Gong KP, 2005, ANAL SCI, V21, P1383, DOI 10.2116/analsci.21.1383
   GORTON L, 1995, ELECTROANAL, V7, P23, DOI 10.1002/elan.1140070104
   Isik B, 2008, INT J ADV MANUF TECH, V37, P42, DOI 10.1007/s00170-007-0946-7
   JANDA V, 1984, J CHROMATOGR, V283, P309, DOI 10.1016/S0021-9673(00)96266-6
   KALCHER K, 1995, ELECTROANAL, V7, P5, DOI 10.1002/elan.1140070103
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kim MA, 2003, ANAL CHIM ACTA, V479, P143, DOI 10.1016/S0003-2670(02)01538-6
   Kochana J, 2008, ANAL BIOANAL CHEM, V391, P1275, DOI 10.1007/s00216-007-1798-6
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Li J, 2010, SOFT MATTER, V6, P542, DOI 10.1039/b918218g
   Li XC, 2008, ELECTROCHEM COMMUN, V10, P851, DOI 10.1016/j.elecom.2008.03.019
   Liu HS, 2009, MOL VIS, V15, P505
   Liu Z, 2009, ANGEW CHEM INT EDIT, V48, P7668, DOI 10.1002/anie.200902612
   Lopez BP, 2009, ANALYST, V134, P60, DOI 10.1039/b808387h
   Luo HX, 2001, ANAL CHEM, V73, P915, DOI 10.1021/ac000967l
   Manahan S. E., 1991, ENV CHEM
   Meyyappan M., 2005, CARBON NANOTUBES SCI
   Montereali MR, 2005, INT J ENVIRON AN CH, V85, P795, DOI 10.1080/03067310500149775
   Perez B, 2005, J NANOSCI NANOTECHNO, V5, P1694, DOI 10.1166/jnn.2005.400
   Poerschmann J, 1997, ANAL CHEM, V69, P597, DOI 10.1021/ac9609788
   Pohl M, 2002, WEAR, V252, P501, DOI 10.1016/S0043-1648(02)00003-0
   Rogers KR, 2000, ELECTROCHIM ACTA, V45, P4373, DOI 10.1016/S0013-4686(00)00544-2
   Sanchez S, 2008, ANAL CHEM, V80, P6508, DOI 10.1021/ac7025282
   Serra B, 2002, BIOSENS BIOELECTRON, V17, P217, DOI 10.1016/S0956-5663(01)00269-X
   Serra B, 1999, ANALUSIS, V27, P592, DOI 10.1051/analusis:1999270592
   Shan D, 2003, ELECTROANAL, V15, P1506, DOI 10.1002/elan.200302740
   Solna R, 2005, ELECTROANAL, V17, P2137, DOI 10.1002/elan.200403343
   Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v
   TAKASHIMA RW, 2004, REACT FUNCT POLYM, V59, P163
   Tasis D, 2003, CHEM-EUR J, V9, P4001, DOI 10.1002/chem.200304800
   Wang BQ, 2000, J ELECTROANAL CHEM, V487, P45, DOI 10.1016/S0022-0728(00)00152-2
   Wang J, 2004, ANALYST, V129, P1, DOI 10.1039/b313431h
   Wang SC, 2009, ELECTROCHEM COMMUN, V11, P34, DOI 10.1016/j.elecom.2008.10.019
   Wu W, 2009, ACS NANO, V3, P2740, DOI 10.1021/nn9005686
   Yan YM, 2006, ADV MATER, V18, P2639, DOI 10.1002/adma.200600028
   Yogeswaran U, 2008, ANAL LETT, V41, P210, DOI 10.1080/00032710701792638
   Yu X, 2006, J AM CHEM SOC, V128, P11199, DOI 10.1021/ja062117e
   Zhang T, 2003, ANAL CHIM ACTA, V489, P199, DOI 10.1016/S0003-2670(03)00758-X
   Zhang X, 2008, ELECTROCHEMICAL SENSORS, BIOSENSORS AND THEIR BIOMEDICAL APPLICATIONS, P1
NR 50
TC 15
Z9 15
U1 4
U2 24
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PY 2010
VL 135
IS 8
BP 1918
EP 1925
DI 10.1039/c000929f
PG 8
WC Chemistry, Analytical
SC Chemistry
GA 628AR
UT WOS:000280087000011
PM 20532304
DA 2018-10-20
ER

PT S
AU Keung, AJ
   Kumar, S
   Schaffer, DV
AF Keung, Albert J.
   Kumar, Sanjay
   Schaffer, David V.
BE Schekman, R
   Goldstein, L
   Lehmann, R
TI Presentation Counts: Microenvironmental Regulation of Stem Cells by
   Biophysical and Material Cues
SO ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26
SE Annual Review of Cell and Developmental Biology
LA English
DT Review; Book Chapter
DE microenvironment; niche; biomaterial; biophysics; mechanotransduction
ID NEURAL PROGENITOR CELLS; EPIDERMAL-GROWTH-FACTOR; FOCAL ADHESION KINASE;
   COLONY-FORMING CELLS; FLUID SHEAR-STRESS; SELF-RENEWAL; BONE-MARROW;
   SELECTIVE DIFFERENTIATION; ENDOTHELIAL-CELLS; STOCHASTIC-MODEL
AB Stem cells reside in adult and embryonic tissues in a broad spectrum of developmental stages and lineages, and they are thus naturally exposed to diverse microenvironments or niches that modulate their hallmark behaviors of self-renewal and differentiation into one or more mature lineages. Within each such microenvironment, stem cells sense and process multiple biochemical and biophysical cues, which can exert redundant, competing, or orthogonal influences to collectively regulate cell fate and function. The proper presentation of these myriad regulatory signals is required for tissue development and homeostasis, and their improper appearance can potentially lead to disease. Whereas these complex regulatory cues can be challenging to dissect using traditional cell culture paradigms, recently developed engineered material systems offer advantages for investigating biochemical and biophysical cues, both static and dynamic, in a controlled, modular, and quantitative fashion. Advances in the development and use of such systems have helped elucidate novel regulatory mechanisms controlling stem cell behavior, particularly the importance of solid-phase mechanical and immobilized biochemical microenvironmental signals, with implications for basic stem cell biology, disease, and therapeutics.
C1 [Keung, Albert J.; Schaffer, David V.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.
   [Kumar, Sanjay; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
RP Keung, AJ (reprint author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.
EM skumar@berkeley.edu; schaffer@berkeley.edu
FU NIDCR NIH HHS [R21 DE018044, R21DE018044]; NIH HHS [DP2 OD004213,
   1DP2OD004213]; NIBIB NIH HHS [R21 EB007295, R21EB007295]; NCI NIH HHS
   [U54 CA143836, 1U54CA143836]
CR Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073
   Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200
   Antia M, 2008, FARADAY DISCUSS, V139, P229, DOI 10.1039/b718714a
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Benoit DSW, 2007, J BIOMED MATER RES A, V81A, P259, DOI 10.1002/jbm.a.31292
   BJERKNES M, 1985, BIOPHYS J, V48, P85, DOI 10.1016/S0006-3495(85)83762-0
   Boonen KJM, 2008, TISSUE ENG PART B-RE, V14, P419, DOI 10.1089/ten.teb.2008.0045
   Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009
   Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103
   Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386
   Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Danchakoff V, 1916, AM J ANAT, V20, P255, DOI 10.1002/aja.1000200302
   Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131
   Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1
   Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010
   Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GOLDSTEIN SA, 1983, J BIOMECH, V16, P965, DOI 10.1016/0021-9290(83)90097-0
   Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227
   Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701
   Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208
   Hansen KC, 2009, MOL CELL PROTEOMICS, V8, P1648, DOI 10.1074/mcp.M900039-MCP200
   Hasan M, 1999, J IMMUNOL, V162, P1064
   Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118
   Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263
   Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Igishi T, 1999, J BIOL CHEM, V274, P30738, DOI 10.1074/jbc.274.43.30738
   Illi B, 2005, CIRC RES, V96, P501, DOI 10.1161/01.RES.0000159181.06379.63
   Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200
   Jakkaraju S, 2005, DEV CELL, V9, P39, DOI 10.1016/j.devcel.2005.04.015.
   Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239
   Jensen UB, 1999, DEVELOPMENT, V126, P2409
   Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857
   JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0
   Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105
   Kamal A, 2000, CURR OPIN CELL BIOL, V12, P503, DOI 10.1016/S0955-0674(00)00123-X
   Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KHACHIGIAN LM, 1992, PATHOLOGY, V24, P280, DOI 10.3109/00313029209068882
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598
   Klees RF, 2005, MOL BIOL CELL, V16, P881
   Klotzsch E, 2009, P NATL ACAD SCI USA, V106, P18267, DOI 10.1073/pnas.0907518106
   Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754
   KORNBERG L, 1992, J BIOL CHEM, V267, P23439
   Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705
   Krilleke D, 2009, BIOCHEM SOC T, V37, P1201, DOI 10.1042/BST0371201
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103
   Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   Lu W, 2008, MOL CELL BIOCHEM, V311, P233, DOI 10.1007/s11010-008-9713-9
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933
   Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019
   Martinez-Agosto JA, 2007, GENE DEV, V21, P3044, DOI 10.1101/gad.1602607
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103
   Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821
   Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2
   Miyake K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2234648
   Mohr JC, 2006, BIOMATERIALS, V27, P6032, DOI 10.1016/j.biomaterials.2006.07.012
   Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0
   NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pirone DM, 2004, J MAMMARY GLAND BIOL, V9, P405, DOI 10.1007/s10911-004-1410-z
   Pons S, 2000, DEVELOPMENT, V127, P333
   Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Ridley A, 2000, J CELL BIOL, V150, pF107, DOI 10.1083/jcb.150.4.F107
   Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986
   Saitoh S, 2000, ANAT RECORD, V260, P392, DOI 10.1002/1097-0185(20001201)260:4<392::AID-AR90>3.0.CO;2-O
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Schnepel J, 2000, J PROTEIN CHEM, V19, P685, DOI 10.1023/A:1007104420017
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4
   Shenghui H., 2009, ANNU REV CELL DEV BI, V25, P377, DOI DOI 10.1146/ANNUREV.CELLBIO.042308.113248
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313
   Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9
   Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256
   Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660
   Taqvi S, 2006, J BIOMED MATER RES A, V79A, P689, DOI 10.1002/jbm.a.30916
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013
   Thakar RG, 2008, SMALL, V4, P1416, DOI 10.1002/smll.200701302
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102
   TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29
   Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659
   Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y
   Varnum-Finney B, 2000, J CELL SCI, V113, P4313
   VOGEL H, 1968, J CELL PHYSIOL, V72, P221, DOI 10.1002/jcp.1040720309
   Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8
   Wang J, 1997, EXP CELL RES, V237, P445, DOI 10.1006/excr.1997.3811
   Wellman P., 1999, BREAST TISSUE STIFFN
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yamamoto K, 2005, AM J PHYSIOL-HEART C, V288, pH1915, DOI 10.1152/ajpheart.00956.2004
   Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u
   Zandstra PW, 1997, P NATL ACAD SCI USA, V94, P4698, DOI 10.1073/pnas.94.9.4698
   Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648
   Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5
NR 146
TC 86
Z9 86
U1 2
U2 38
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1081-0706
BN 978-0-8243-3126-9
J9 ANNU REV CELL DEV BI
JI Annu. Rev. Cell Dev.Biol.
PY 2010
VL 26
BP 533
EP 556
DI 10.1146/annurev-cellbio-100109-104042
PG 24
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA BSL42
UT WOS:000284856700021
PM 20590452
DA 2018-10-20
ER

PT J
AU Born, R
   Ehrlich, H
   Bazhenov, V
   Shapkin, NP
AF Born, Rene
   Ehrlich, Hermann
   Bazhenov, Vasiliy
   Shapkin, Nikolay P.
TI Investigation of nanoorganized biomaterials of marine origin
SO ARABIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Biomineralization; Demineralization; Sponges; Bamboo corals; FTIR
   spectroscopy; Raman spectroscopy; Scanning electron and light microscopy
ID 1ST EVIDENCE; SPONGES; SKELETONS; PORIFERA; CHITIN
AB Naturally occurring nanoorganized biomaterials of marine origin provide an abundant source of novel bone and cartilage replacement materials, and enable the development of novel biomimetic composites. The design of novel biomaterial relies on an understanding of the organic matrices and templating structures. The aim of the present study was to investigate the composition and the properties of skeletal structures of marine sponge (Verongula gigantea) and octocorals (Isidella sp.) in particular by using instrumental analytical (i.e. electron transmission and scanning microscopic methods, vibrational spectroscopies) methods. Modern gentle demineralization techniques were used. It was shown, that the demosponge V. gigantea has much potential as a biomaterial due to the multilayered structure of its rigid fibrous skeletons. The results of FTIR and Raman spectroscopy unambiguously showed that all specimens of the investigated sponge have a-chitin as the main skeletal component. Nano-crystalline aragonite was isolated and identified in V. gigantea, a sponge usually described as lacking a mineral skeleton. Bamboo corals of the Isididae family were additionally investigated. An inorganic component within the deep-sea octocoral Isidella sp. could be clearly identified as calcite by using Raman spectroscopy. The organic part was identified as a nanoorganized fibrillar proteinaceous matrix with acidic properties. (C) 2009 King Saud University. All rights reserved.
C1 [Born, Rene] Tech Univ Dresden, Inst Mat Sci, D-01062 Dresden, Germany.
   [Ehrlich, Hermann] Tech Univ Dresden, Inst Bioanalyt Chem, D-01062 Dresden, Germany.
   [Bazhenov, Vasiliy; Shapkin, Nikolay P.] Far Eastern Natl Univ, Inst Chem & Appl Ecol, Vladivostok 690650, Russia.
RP Born, R (reprint author), Tech Univ Dresden, Inst Mat Sci, D-01062 Dresden, Germany.
EM rene.born@tu-dresden.de
RI Ehrlich, Hermann/J-6698-2012; Born, Rene/D-8798-2011; Ehrlich,
   Hermann/I-5481-2015; Bazhenov, Vasilii/J-6065-2012
OI Ehrlich, Hermann/0000-0003-3654-0810; Born, Rene/0000-0001-6793-2273;
   Ehrlich, Hermann/0000-0003-3654-0810; Bazhenov,
   Vasilii/0000-0002-1346-1151; Shapkin, Nikolay/0000-0001-7602-156X
FU German-Russian DAAD
FX The authors thank Dr. Gert Richter, Dr. Heike Meissner, Peter Etnoyer,
   Ortrud Trommer and Ines Kleiber for technical support and comments. This
   work has been partially supported by German-Russian DAAD Program
   "Mikhail Lomonossov".
CR De Gussem K, 2005, SPECTROCHIM ACTA A, V61, P2896, DOI 10.1016/j.saa.2004.10.038
   Ehrlich H, 2006, MATERIALWISS WERKST, V37, P552, DOI 10.1002/mawe.200600036
   Ehrlich H, 2003, VDI BERICHT, V1803, P287
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P473, DOI 10.1002/jez.b.21174
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   Ehrlich H, 2009, MICRON, V40, P169, DOI 10.1016/j.micron.2008.06.004
   Erwin PM, 2007, INVERTEBR BIOL, V126, P220, DOI 10.1111/j.1744-7410.2007.00092.x
   FAULKNER J, 2001, NAT PROD REP, V19, P1
   GALAT A, 1978, B ACAD POL SCI BIOL, V26, P519
   Green D, 2003, TISSUE ENG, V9, P1159, DOI 10.1089/10763270360728062
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
NR 11
TC 4
Z9 5
U1 0
U2 13
PU KING SAUD UNIV PRESS, KING SAUD UNIV
PI RIYADH
PA PO BOX 68953, RIYADH, 11537, SAUDI ARABIA
SN 1878-5352
J9 ARAB J CHEM
JI Arab. J. Chem.
PD JAN
PY 2010
VL 3
IS 1
BP 27
EP 32
DI 10.1016/j.arabjc.2009.12.005
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 756LW
UT WOS:000290013700005
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lee, JK
   Ryu, YH
   Ahn, JI
   Kim, MK
   Lee, TS
   Kim, JC
AF Lee, Jeong-Kyu
   Ryu, Yang-Hwan
   Ahn, Jae-Il
   Kim, Mi-Kyung
   Lee, Tae-Soo
   Kim, Jae-Chan
TI The Effect of Lyophilization on Graft Acceptance in Experimental
   Xenotransplantation Using Porcine Cornea
SO ARTIFICIAL ORGANS
LA English
DT Article
DE alpha-Gal; Lyophilization; Porcine cornea; Rejection;
   Xenotransplantation
ID ACUTE REJECTION; XENOGRAFTS; EPIKERATOPHAKIA; TISSUE; TRANSPLANTATION;
   RETROVIRUS; ALLOGRAFTS; LENTICULES; INNATE; CELLS
AB The immunogenicity of lyophilized porcine cornea is unknown. The purpose of this study was to examine the possibility of using lyophilized porcine cornea as a substrate for ocular surface reconstruction. A porcine cornea stromal button was freeze-dried and vacuum-packed. Lyophilized and fresh porcine corneas were examined histologically, and then implanted into intrastromal pockets in live rat corneas. Cytokine concentrations in plasma and protein extracts from the corneal buttons of rats were measured using the fluorokine multianalyte profiling assay, and histologic examination was performed. Immunoreactivity to the alpha-gal epitope was not found in lyophilized porcine corneas, whereas it was found in several keratocytes in fresh porcine corneas. The median survival time of rat corneas receiving lyophilized porcine transplants was 28.0 days, significantly longer than the 14.0-day survival of rat corneas that received fresh porcine transplants (P < 0.05). CD45RO(+) and CD68(+) cells were observed in rejected corneas, and interleukin-2 and interferon-gamma were elevated in rat plasma and corneal tissue. The lyophilized porcine corneal stroma, which is devoid of alpha-gal epitope, is less antigenic, and may be a useful biomaterial for ocular surface reconstruction and corneal collagen supplementation.
C1 [Lee, Jeong-Kyu; Ryu, Yang-Hwan; Kim, Jae-Chan] Chung Ang Univ Hosp, Dept Ophthalmol, Seoul, South Korea.
   [Ahn, Jae-Il] Dongguk Univ, Dept Chem & Biochem Engn, Seoul, South Korea.
   [Kim, Mi-Kyung] Chung Ang Univ, Coll Med, Dept Pathol, Seoul 140757, South Korea.
   [Lee, Tae-Soo] Korea Univ, Kuro Hosp, Dept Ophthalmol, Seoul, South Korea.
RP Kim, JC (reprint author), Chung Ang Univ, Coll Med, Yongsan Hosp, Dept Ophthalmol, 65-207 Hangangro,3 Ga, Seoul 140757, South Korea.
EM jck50ey@kornet.net
CR ALLDREDGE OC, 1981, ARCH OPHTHALMOL-CHIC, V99, P599, DOI 10.1001/archopht.1981.03930010599002
   Amano S, 2003, CURR EYE RES, V26, P313, DOI 10.1076/ceyr.26.5.313.15440
   Cardozo LAM, 2004, TRANSPLANTATION, V78, P1721, DOI 10.1097/01.TP.0000147341.40485.B4
   Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012
   COLLINS BH, 1995, J IMMUNOL, V154, P5500
   Coombes AGA, 2001, BRIT J OPHTHALMOL, V85, P788, DOI 10.1136/bjo.85.7.788
   Coronado GS, 2000, AM J VET RES, V61, P665, DOI 10.2460/ajvr.2000.61.665
   Crawford MJ, 2004, AM J SPORT MED, V32, P580, DOI 10.1177/0363546504263404
   Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50
   Fox A, 2001, J IMMUNOL, V166, P2133, DOI 10.4049/jimmunol.166.3.2133
   GOOD AH, 1992, TRANSPL P, V24, P559
   Goodman DJ, 1996, TRANSPLANTATION, V61, P763, DOI 10.1097/00007890-199603150-00016
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   KREUZ FP, 1951, J BONE JOINT SURG AM, V33-A, P863, DOI 10.2106/00004623-195133040-00005
   Kubo M, 2001, INVEST OPHTH VIS SCI, V42, P1539
   Lee HI, 2007, XENOTRANSPLANTATION, V14, P612, DOI 10.1111/j.1399-3089.2007.00433.x
   MOORE MB, 1987, INVEST OPHTH VIS SCI, V28, P555
   Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236
   PEPOSE JS, 1991, CORNEA, V10, P105, DOI 10.1097/00003226-199103000-00003
   ROSTRON CK, 1988, BRIT J OPHTHALMOL, V72, P354, DOI 10.1136/bjo.72.5.354
   Stone KR, 1998, TRANSPLANTATION, V65, P1577, DOI 10.1097/00007890-199806270-00007
   Tanaka K, 2005, TRANSPLANTATION, V79, P1317, DOI 10.1097/01.TP.0000158714.09346.A6
   Tanaka K, 2001, INVEST OPHTH VIS SCI, V42, P2878
   TRINKAUSRANDALL V, 1988, INVEST OPHTH VIS SCI, V29, P393
   ZAVALA E Y, 1985, CLAO Journal, V11, P155
NR 25
TC 6
Z9 6
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JAN
PY 2010
VL 34
IS 1
BP 37
EP 45
DI 10.1111/j.1525-1594.2009.00789.x
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 546OX
UT WOS:000273821200005
PM 19821814
DA 2018-10-20
ER

PT J
AU Amemiya, T
   Nakamura, T
   Yamamoto, T
   Kinoshita, S
   Kanamura, N
AF Amemiya, Takeshi
   Nakamura, Takahiro
   Yamamoto, Toshiro
   Kinoshita, Shigeru
   Kanamura, Narisato
TI Immunohistochemical study of oral epithelial sheets cultured on amniotic
   membrane for oral mucosal reconstruction
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Oral epithelium; amniotic membrane; immunohistochemistry; tissue
   engineering; reconstruction
ID TRANSPLANTATION; CELLS
AB We immunohistochemically evaluated whether oral epithelial cells grown on amniotic membrane (AM) would be an effective biomaterial for reconstructing oral mucosal defects. Oral mucosal epithelial cells from albino rabbits were grown for 2-3 weeks on an AM carrier in a co-culture with 3T3 fibroblasts. The rabbits' oral mucosal defects were reconstructed by autologous transplantation of the oral epithelial sheets. The oral epithelial sheets and reconstructed tissues were then examined histologically and immunohistochemically. After 2-3 weeks of culture, the rabbit oral mucosal epithelial cells developed 5 7 layers of stratification on the AM. Immunohistochemistry revealed that they expressed keratins 4/13, integrin alpha 6, alpha 5 chain and collagen type III, but not keratins 1/10. The transplanted sheets attached to the mucosal defects, and AM fragments disappeared from the transplant area. Immunohistochemical patterns revealed properties of the mucous membrane and basement membrane components in the reconstructed epithelia. The results of this experiment showed that the AM-cultured oral epithelial sheets resulted in mucosa-like differentiation, and adhered to the mucosal defects. Therefore, AM-cultured oral epithelial sheets might be a useful biomaterial for oral mucosal reconstruction.
C1 [Amemiya, Takeshi] Kyoto Prefectural Univ Med, Dept Dent Med, Grad Sch Med Sci, Kamigyo Ku, Kyoto 6028566, Japan.
   [Nakamura, Takahiro; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Ophthalmol, Kyoto 6028566, Japan.
   [Nakamura, Takahiro] Doshisha Univ, Res Ctr Regenerat Med, Kyoto 602, Japan.
RP Amemiya, T (reprint author), Kyoto Prefectural Univ Med, Dept Dent Med, Grad Sch Med Sci, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.
EM amemiya@koto.kpu-m.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan [18592192]
FX This work was supported by a Grant-in-Aid for Scientific Research (No.
   18592192) from the Ministry of Education, Culture, Sports, Science and
   Technology (MEXT), Japan.
CR Amemiya T, 2004, J ORAL TISSUE ENG, V1, P89
   Bell E, 1995, Tissue Eng, V1, P163, DOI 10.1089/ten.1995.1.163
   COLOCHO G, 1974, ARCH SURG-CHICAGO, V109, P370
   DAVIS JW, 1910, J HOPKINS MED J, V15, P307
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   HATA K, 1995, ANN PLAS SURG, V34, P530, DOI 10.1097/00000637-199505000-00013
   Lin L, 2002, INVEST OPHTH VIS SCI, V43, P2615
   Maragou P, 1999, ORAL DIS, V5, P20
   Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195
   NANAEV AK, 1991, PLACENTA, V12, P573, DOI 10.1016/0143-4004(91)90493-Y
   STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970
   Sumi Y, 1999, ORAL DIS, V5, P307
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
NR 15
TC 8
Z9 9
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2010
VL 20
IS 1
BP 37
EP 45
DI 10.3233/BME-2010-0613
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 605CW
UT WOS:000278326000004
PM 20448302
DA 2018-10-20
ER

PT J
AU Mueller-Rath, R
   Gavenis, K
   Andereya, S
   Mumme, T
   Albrand, M
   Stoffel, M
   Weichert, D
   Schneider, U
AF Mueller-Rath, Ralf
   Gavenis, Karsten
   Andereya, Stefan
   Mumme, Torsten
   Albrand, Monique
   Stoffel, Marcus
   Weichert, Dieter
   Schneider, Ulrich
TI Condensed cellular seeded collagen gel as an improved biomaterial for
   tissue engineering of articular cartilage
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Condensed collagen gel; cartilage; tissue engineering; biomechanics;
   chondrocyte
ID MATRIX SYNTHESIS; ATELOCOLLAGEN GEL; IN-VITRO; CHONDROCYTES;
   PROLIFERATION; REPAIR; DEFECTS; DIFFERENTIATION; TRANSPLANTATION;
   SCAFFOLD
AB Three-dimensional autologous chondrocyte implantation based on collagen gel as matrix scaffold has become a clinically applied treatment for focal defects of articular cartilage. However, the low biomechanical properties of collagen gel makes intraoperative handling difficult and creates the risk of early damages to the vulnerable implant. The aim of the study was to create a stabilized form of collagen gel and to evaluate its biomechanical and biochemical properties.
   Collagen type-I gel was seeded with human articular chondrocytes. 20 samples were subject to condensation which was achieved mechanically by compression and filtration. Control samples were left uncondensed. From both types of gels 10 samples were used for initial biomechanical evaluation by means of unconfined compression and 10 samples were cultivated under standard conditions in vitro. Following cultivation the samples were evaluated by conventional histology and immunohistochemistry. The proliferation rate was calculated and matrix gene expression was quantified by real-time PCR.
   The biomechanical tests revealed a higher force carrying capacity of the condensed specimens. Strain rate dependency and relaxation was seen in both types of collagen gel representing viscoelastic material properties. Cells embedded within the condensed collagen gel were able to produce extracellular matrix proteins and showed proliferation.
   Condensed collagen gel represents a mechanically improved type of biomaterial which is suitable for three-dimensional autologous chondrocyte implantation.
C1 [Mueller-Rath, Ralf; Gavenis, Karsten; Andereya, Stefan; Mumme, Torsten] Univ Aachen, Dept Orthopaed Surg, D-5100 Aachen, Germany.
   [Albrand, Monique; Stoffel, Marcus; Weichert, Dieter] Univ Aachen, Inst Mech, D-5100 Aachen, Germany.
   [Schneider, Ulrich] Arthro Nova Clin, Ringsee, Germany.
RP Mueller-Rath, R (reprint author), Orthopaed Clin, Breite Str 96, D-41460 Neuss, Germany.
EM mueller-rath@opn-neuss.de
FU Deutsche Arthrosehilfe e.V.; Aachener Kompetenzzentrum Medizintechnik
   (AKM)
FX This work was supported in part by the Deutsche Arthrosehilfe e.V. and
   Aachener Kompetenzzentrum Medizintechnik (AKM).
CR Andereya S, 2006, Z ORTHOP GRENZGEB, V144, P272, DOI 10.1055/s-2006-933445
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Chaipinyo K, 2004, J ORTHOPAED RES, V22, P446, DOI 10.1016/j.orthres.2003.07.001
   Chaipinyo K, 2002, J ORTHOPAED RES, V20, P1070, DOI 10.1016/S0736-0266(02)00025-6
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   Fuss M, 2000, ANN ANAT, V182, P303
   Giannoni P, 2005, TISSUE ENG, V11, P237, DOI 10.1089/ten.2005.11.237
   Gigante A, 2003, J MATER SCI-MATER M, V14, P713, DOI 10.1023/A:1024915817061
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   Kuriwaka M, 2003, TISSUE ENG, V9, P41, DOI 10.1089/107632703762687528
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Schmidt-Rohlfing B, 2004, Z ORTHOP GRENZGEB, V142, P350, DOI 10.1055/s-2004-822829
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   Tallheden T, 2005, ARTHRITIS RES THER, V7, pR560, DOI 10.1186/ar1709
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
NR 24
TC 10
Z9 10
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2010
VL 20
IS 6
BP 317
EP 328
DI 10.3233/BME-2010-0645
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 711MR
UT WOS:000286596200002
PM 21263178
DA 2018-10-20
ER

PT J
AU Kahle, M
   Wiesmann, HP
   Berr, K
   Depprich, RA
   Kubler, NR
   Naujoks, C
   Cohnen, M
   Ommerborn, MA
   Meyer, U
   Handschel, J
AF Kahle, Maren
   Wiesmann, Hans-Peter
   Berr, Karin
   Depprich, Rita A.
   Kuebler, Norbert R.
   Naujoks, Christian
   Cohnen, Matthias
   Ommerborn, Michelle A.
   Meyer, Ulrich
   Handschel, Joerg
TI Embryonic stem cells induce ectopic bone formation in rats
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Embryonic stem cells; bone tissue engineering; ectopic bone formation;
   bone regeneration
ID RECONSTRUCTION THERAPIES; MOUSE EMBRYOS; IN-VITRO; DIFFERENTIATION;
   GRAFT; PRINCIPLES; MARROW; REPAIR; SERUM
AB Background: Surgery often leads to massive destruction of the skeleton. Cell-based bone reconstruction therapies promise new therapeutic opportunities for the repair of bone. Embryonic stem cells (ESCs) can be differentiated into osteogenic cells and are a potential cell source for bone tissue engineering. The purpose of this in vivo study was to investigate the bone formation in various constructs containing ESCs (with and without micromass technology) and insoluble collagenous bone matrix (ICBM).
   Methods: Murine ESCs were cultured as monolayer cultures as well as micromasses and seeded on ICBM. These constructs were implanted in immunodeficient rats. After one week, one, two and three months CT-scans were performed to detect any calcifications and the rats were sacrificed.
   Results: The radiological examination shows a steep increase of the mineralized tissue in group 1 (ICBM + seeded ESC). This increase can be considered as statistical significant. In contrast, the volume of the mineralization in group 2 (ICBM+ESC-spheres) and group 3 (ESC-spheres) does not increase significantly during the study.
   Conclusion: ESCs in combination with ICBM do promote ectopic bone formation in vivo. Thus, this cell population as well as the biomaterial ICBM might be promising components for bone tissue engineering.
C1 [Berr, Karin; Depprich, Rita A.; Kuebler, Norbert R.; Naujoks, Christian; Meyer, Ulrich; Handschel, Joerg] Univ Dusseldorf, Dept Cranio & Maxillofacial Surg, D-40225 Dusseldorf, Germany.
   [Kahle, Maren; Wiesmann, Hans-Peter] Univ Munster, Dept Cranio & Maxillofacial Surg, Munster, Germany.
   [Cohnen, Matthias] Stadt Kliniken Neuss Lukaskrankenhaus, Inst Clin Radiol & Nucl Med, Neuss, Germany.
   [Ommerborn, Michelle A.] Univ Dusseldorf, Dept Operat & Prevent Dent & Endodont, D-40225 Dusseldorf, Germany.
RP Handschel, J (reprint author), Univ Dusseldorf, Dept Cranio & Maxillofacial Surg, Moorenstr 5,Geb 18-73, D-40225 Dusseldorf, Germany.
EM handschel@med.uni-duesseldorf.de
FU Forschungskom-mission der Medizinischen Fakultat der
   Heinrich-Heine-Universitat Dusseldorf
FX We are very grateful to Prof. Dr. K. Pfeffer, Institut fur Mikrobiologie
   an der Heinrich-Heine-Universitat Dusseldorf, who provided the murine
   ESCs. This study was funded by Forschungskom-mission der Medizinischen
   Fakultat der Heinrich-Heine-Universitat Dusseldorf.
CR Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   BINDERMAN I, 1990, CRC HDB BIOACTIVE CE, P45
   Burt RK, 2004, J EXP MED, V199, P895, DOI 10.1084/jem.20031916
   Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386
   Chaudhry GR, 2004, J BIOMED BIOTECHNOL, P203, DOI 10.1155/S111072430431003X
   Chin ACP, 2010, STEM CELLS DEV, V19, P753, DOI 10.1089/scd.2009.0210
   Cohen Steven R, 2004, Neurosurg Focus, V16, pE12
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Depprich R, 2005, ORAL MAXILLOFAC SURG, V9, P363, DOI 10.1007/s10006-005-0644-2
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Handschel J, 2002, BIOMATERIALS, V23, P1689, DOI 10.1016/S0142-9612(01)00296-4
   HANDSCHEL J, 2007, KLIN KIEFER PLASTISC, P99
   Handschel J, 2006, INT J ORAL MAX IMPL, V21, P890
   Handschel Jorg, 2008, Head Face Med, V4, P10, DOI 10.1186/1746-160X-4-10
   Handschel Jorg G K, 2007, Head Face Med, V3, P4, DOI 10.1186/1746-160X-3-4
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Holmes RE, 2004, CLIN PLAST SURG, V31, P393, DOI 10.1016/j.cps.2004.03.003
   Kasaj Adrian, 2008, Head Face Med, V4, P22, DOI 10.1186/1746-160X-4-22
   Langenbach F, 2010, TISSUE ENG PT A, V16, P759, DOI [10.1089/ten.tea.2009.0131, 10.1089/ten.TEA.2009.0131]
   Lee KW, 2010, STEM CELLS DEV, V19, P557, DOI 10.1089/scd.2009.0147
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   MEYER U, 2009, FUNDAMENTALS TISSUE, P820
   Meyer U, 2006, INT J ORAL MAX IMPL, V21, P899
   Meyer Ulrich, 2005, Head Face Med, V1, P2, DOI 10.1186/1746-160X-1-2
   Puricelli Edela, 2006, Head Face Med, V2, P43, DOI 10.1186/1746-160X-2-43
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   Velich N, 2004, J CRANIOFAC SURG, V15, P11, DOI 10.1097/00001665-200401000-00006
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
   Wurzler K K, 2004, Mund Kiefer Gesichtschir, V8, P83
   Yamaguchi M, 2002, CYTOTHERAPY, V4, P109, DOI 10.1080/146532402317381811
   Zavazava N, 2003, EXPERT OPIN BIOL TH, V3, P5
   zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1
NR 40
TC 12
Z9 12
U1 0
U2 10
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2010
VL 20
IS 6
BP 371
EP 380
DI 10.3233/BME-2010-0650
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 711MR
UT WOS:000286596200007
PM 21263183
DA 2018-10-20
ER

PT J
AU Engelsman, AF
   Saldarriaga-Fernandez, IC
   Nejadnik, MR
   van Dam, GM
   Francis, KP
   Ploeg, RJ
   Busscher, HJ
   van der Mei, HC
AF Engelsman, Anton F.
   Saldarriaga-Fernandez, Isabel C.
   Nejadnik, M. Reza
   van Dam, Gooitzen M.
   Francis, Kevin P.
   Ploeg, Rutger J.
   Busscher, Henk J.
   van der Mei, Henny C.
TI The risk of biomaterial-associated infection after revision surgery due
   to an experimental primary implant infection
SO BIOFOULING
LA English
DT Article
DE Staphylococcus aureus; bioluminescence; in vivo; vancomycin; rifampicin;
   bio-optical imaging
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM INFECTION; IN-VIVO; MOUSE MODEL;
   ANTIBIOTICS; TISSUE; MICE; VANCOMYCIN; RESISTANCE; JOINT
AB The fate of secondary biomaterial implants was determined by bio-optical imaging and plate counting, after antibiotic treatment of biomaterials-associated-infection (BAI) and surgical removal of an experimentally infected, primary implant. All primary implants and tissue samples from control mice showed bioluminescence and were culture-positive. In an antibiotic treated group, no bioluminescence was detected and only 20% of all primary implants and no tissue samples were culture-positive. After revision surgery, bioluminescence was detected in all control mice. All the implants and 80% of all tissue samples were culture-positive. In contrast, in the antibiotic treated group, 17% of all secondary implants and 33% of all tissue samples were culture-positive, despite antibiotic treatment. The study illustrates that due to the BAI of a primary implant, the infection risk of biomaterial implants is higher in revision surgery than in primary surgery, emphasizing the need for full clearance of the infection, as well as from surrounding tissues prior to implantation of a secondary implant.
C1 [Engelsman, Anton F.; Saldarriaga-Fernandez, Isabel C.; Nejadnik, M. Reza; Busscher, Henk J.; van der Mei, Henny C.] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9700 AD Groningen, Netherlands.
   [Engelsman, Anton F.; Saldarriaga-Fernandez, Isabel C.; Nejadnik, M. Reza; van Dam, Gooitzen M.; Francis, Kevin P.; Ploeg, Rutger J.; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, NL-9700 AD Groningen, Netherlands.
   [Engelsman, Anton F.; van Dam, Gooitzen M.; Francis, Kevin P.; Ploeg, Rutger J.] Univ Med Ctr Groningen, Dept Surg, NL-9700 AD Groningen, Netherlands.
   [van Dam, Gooitzen M.; Francis, Kevin P.] Univ Med Ctr Groningen, BioOpt Imaging Ctr Groningen, NL-9700 AD Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, POB 196, NL-9700 AD Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cyrochristos DJ, 2009, AM SURGEON, V75, P1132
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.2007.6100247
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Engelsman AF, 2009, J BIOMED MATER RES B, V88B, P123, DOI 10.1002/jbm.b.31158
   Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000
   GREENBERG JJ, 2010, HERNIA           JUN, DOI DOI 10.1007/S10029-010-0694-8
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003
   Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003
   LICHT MR, 1995, J UROLOGY, V154, P387, DOI 10.1016/S0022-5347(01)67058-7
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Monzon M, 2002, DIAGN MICR INFEC DIS, V44, P319, DOI 10.1016/S0732-8893(02)00464-9
   Monzon M, 2001, J ORTHOPAED RES, V19, P820, DOI 10.1016/S0736-0266(00)00076-0
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068
   Stoppa R, 2003, Hernia, V7, P57, DOI 10.1007/s10029-002-0107-8
   Wilcox MH, 2001, J ANTIMICROB CHEMOTH, V47, P171, DOI 10.1093/jac/47.2.171
   Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005
   Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945
   Yu J, 2005, J ANTIMICROB CHEMOTH, V55, P528, DOI 10.1093/jac/dki053
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 29
TC 24
Z9 24
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PY 2010
VL 26
IS 7
BP 761
EP 767
DI 10.1080/08927014.2010.515027
PG 7
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA 650XJ
UT WOS:000281887300002
PM 20737327
DA 2018-10-20
ER

PT J
AU Ho, KKK
   Cole, N
   Chen, RX
   Willcox, MDP
   Rice, SA
   Kumar, N
AF Ho, Kitty K. K.
   Cole, Nerida
   Chen, Renxun
   Willcox, Mark D. P.
   Rice, Scott A.
   Kumar, Naresh
TI Characterisation and in vitro activities of surface attached
   dihydropyrrol-2-ones against Gram-negative and Gram-positive bacteria
SO BIOFOULING
LA English
DT Article
DE dihydropyrrolone; biomaterial; quorum sensing; Pseudomonas;
   Staphylococcus
ID PSEUDOMONAS-AERUGINOSA BIOFILM; VIRULENCE-GENE-EXPRESSION; CENTRAL
   VENOUS CATHETERS; ALGA DELISEA-PULCHRA; STAPHYLOCOCCUS-AUREUS;
   HALOGENATED FURANONES; NOSOCOMIAL INFECTIONS; BACILLUS-SUBTILIS;
   ANTIBACTERIAL; PREVENTION
AB Bacterial infection of biomedical devices is still a major barrier to their use. This is compounded by increasing antibiotic resistance. Here, the specific covalent attachment of a series of dihydropyrrol-2-one (DHP), analogues of bacterial quorum sensing inhibitors, to surfaces via a Michael-type addition reaction is described. Differences in efficiency of attachment related to the substituent groups were found by X-ray photoelectron spectroscopy. The physical characteristics of the surfaces were further explored by atomic force microscopy and contact angle measurements. The ability of these coatings to prevent the formation of a biofilm by Pseudomonas aeruginosa and Staphylococcus aureus was examined using confocal laser scanning microscopy and image analysis. The DHP-treated surfaces showed significant reductions in bacterial adhesion without increased killing for both strains of bacteria (p < 0.001). 5-Methylene-1-(prop-2-enoyl)-4-phenyl-dihydropyrrol-2-one was identified as having broad spectrum activity and consequently represents an excellent candidate for the development of novel surfaces for the prevention of biomedical device infections.
C1 [Ho, Kitty K. K.; Chen, Renxun; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
   [Cole, Nerida; Willcox, Mark D. P.] Brien Holden Vis Inst, Sydney, NSW 2052, Australia.
   [Cole, Nerida; Willcox, Mark D. P.] Vis CRC, Sydney, NSW 2052, Australia.
   [Cole, Nerida; Willcox, Mark D. P.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia.
RP Kumar, N (reprint author), Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
EM n.kumar@unsw.edu.au
RI Chen, Renxun/G-7015-2014
OI Chen, Renxun/0000-0003-0828-9980; cole, nerida/0000-0002-9866-4694;
   rice, scott/0000-0002-9486-2343
FU NHMRC; Australian Research Council [DP0663368, DP1095159]; Australian
   Postgraduate award
FX RC was supported by an NHMRC Dora Lush Biomedical Postgraduate Research
   Scholarship and the Australian Research Council's Discovery Projects
   funding scheme (project number DP0663368) and KH was supported by an
   Australian Postgraduate award and the Australian Research Council's
   Discovery Projects funding scheme (project number DP1095159). The
   authors would like to thank the Electron Microscopy Unit at the
   University of New South Wales Analytical Centre for assistance with the
   atomic force micrographs.
CR Al-Bataineh SA, 2006, SURF SCI, V600, P952, DOI 10.1016/j.susc.2005.12.028
   Bainbridge JWB, 1998, BRIT J OPHTHALMOL, V82, P1312, DOI 10.1136/bjo.82.11.1312
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Baveja JK, 2004, BIOMATERIALS, V25, P5013, DOI 10.1016/j.biomaterials.2004.02.007
   BIERBAUM K, 1995, LANGMUIR, V11, P512, DOI 10.1021/la00002a025
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chlebicki J, 2005, J SURFACTANTS DETERG, V8, P227, DOI 10.1007/s11743-005-0350-6
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   Defez C, 2008, J HOSP INFECT, V68, P130, DOI 10.1016/j.jhin.2007.11.005
   DENYS R, 1993, TETRAHEDRON, V49, P11213, DOI 10.1016/S0040-4020(01)81808-1
   DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996
   Goh WK, 2007, TETRAHEDRON LETT, V48, P2287, DOI 10.1016/j.tetlet.2007.01.165
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Holman WL, 2003, ANN THORAC SURG, V75, pS48, DOI 10.1016/S0003-4975(03)00479-X
   HOYLE BD, 1992, ANTIMICROB AGENTS CH, V36, P2054, DOI 10.1128/AAC.36.9.2054
   Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x
   Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552
   Jones MB, 2005, J INFECT DIS, V191, P1881, DOI 10.1086/429696
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   Kjelleberg S, 1997, AQUAT MICROB ECOL, V13, P85, DOI 10.3354/ame013085
   Kuehl R, 2009, ANTIMICROB AGENTS CH, V53, P4159, DOI 10.1128/AAC.01704-08
   Kumar N, 2008, In Furanone compounds and lactam analogues thereof, Patent No. [W02008040097, 2008040097]
   Kumar N., 2007, WO Patent, Patent No. [WO2007085042, 2007085042]
   Lam PK, 2004, BRIT J BIOMED SCI, V61, P125, DOI 10.1080/09674845.2004.11732656
   Lonn-Stensrud J, 2009, J ANTIMICROB CHEMOTH, V63, P309, DOI 10.1093/jac/dkn501
   Magalhaes JL, 2002, SURF INTERFACE ANAL, V33, P293, DOI 10.1002/sia.1186
   MAKI DG, 1988, AM J MED, V85, P307, DOI 10.1016/0002-9343(88)90579-7
   Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283
   NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064
   Poston RS, 2003, J HEART LUNG TRANSPL, V22, P914, DOI 10.1016/S1053-2498(02)00645-9
   Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006
   Rasband W., 1997, IMAGEJ IMAGE PROCESS
   Rasmussen TB, 2000, MICROBIOL-UK, V146, P3237, DOI 10.1099/00221287-146-12-3237
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   READ R, 2001, Patent No. 0176594
   REICHELT JL, 1984, HYDROBIOLOGIA, V116, P158, DOI 10.1007/BF00027657
   Ren D, 2002, LETT APPL MICROBIOL, V34, P293, DOI 10.1046/j.1472-765x.2002.01087.x
   Ren DC, 2004, APPL ENVIRON MICROB, V70, P4941, DOI 10.1128/AEM.70.8.4941-4949.2004
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Tenover FC, 2001, CLIN INFECT DIS, V33, pS108, DOI 10.1086/321834
   Tozzi P, 2001, EUR J CARDIO-THORAC, V19, P729, DOI 10.1016/S1010-7940(01)00675-3
   Vlessis AA, 1997, J HEART VALVE DIS, V6, P443
   Weyand M, 1997, TRANSPLANT P, V29, P3327, DOI 10.1016/S0041-1345(97)00932-9
   Zingg W, 2008, BEST PRACT RES-CLIN, V22, P407, DOI 10.1016/j.bpa.2008.05.007
NR 50
TC 13
Z9 13
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
J9 BIOFOULING
JI Biofouling
PY 2010
VL 26
IS 8
BP 913
EP 921
DI 10.1080/08927014.2010.531463
PG 9
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA 680EM
UT WOS:000284215200005
PM 21038151
DA 2018-10-20
ER

PT J
AU Fassina, L
   Saino, E
   De Angelis, MGC
   Magenes, G
   Benazzo, F
   Visai, L
AF Fassina, Lorenzo
   Saino, Enrica
   De Angelis, Maria Gabriella Cusella
   Magenes, Giovanni
   Benazzo, Francesco
   Visai, Livia
TI Low-Power Ultrasounds as a Tool to Culture Human Osteoblasts inside
   Cancellous Hydroxyapatite
SO BIOINORGANIC CHEMISTRY AND APPLICATIONS
LA English
DT Article
ID POLYURETHANE POROUS SCAFFOLD; CALCIFIED MATRIX PRODUCTION;
   BONE-FORMATION; SAOS-2 CELLS; IN-VITRO; CALCIFICATION; DEGRADATION;
   BIOREACTOR; SURFACE; REPAIR
AB Bone graft substitutes and cancellous biomaterials have been widely used to heal critical-size long bone defects due to trauma, tumor resection, and tissue degeneration. In particular, porous hydroxyapatite is widely used in reconstructive bone surgery owing to its biocompatibility. In addition, the in vitro modification of cancellous hydroxyapatite with osteogenic signals enhances the tissue regeneration in vivo, suggesting that the biomaterial modification could play an important role in tissue engineering. In this study, we have followed a tissue-engineering strategy where ultrasonically stimulated SAOS-2 human osteoblasts proliferated and built their extracellular matrix inside a porous hydroxyapatite scaffold. The ultrasonic stimulus had the following parameters: average power equal to 149 mW and frequency of 1.5 MHz. In comparison with control conditions, the ultrasonic stimulus increased the cell proliferation and the surface coating with bone proteins ( decorin, osteocalcin, osteopontin, type-I collagen, and type-III collagen). The mechanical stimulus aimed at obtaining a better modification of the biomaterial internal surface in terms of cell colonization and coating with bone matrix. The modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
   [Fassina, Lorenzo; Saino, Enrica; De Angelis, Maria Gabriella Cusella; Magenes, Giovanni; Benazzo, Francesco; Visai, Livia] Univ Pavia, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   [De Angelis, Maria Gabriella Cusella] Univ Pavia, Dipartimento Med Sperimentale, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, Dipartimento SMEC, IRCCS San Matteo, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632; Cusella De Angelis, Maria
   Gabriella/0000-0003-2642-3346
FU Fondazione Cariplo [2004.1424/10.8485, 2006.0581/10.8485]; Italian
   Ministry of Education, University and Research [RBIP06FH7J]
FX The authors thank L. W. Fisher, K. Martin, S. Setti, R. Cadossi, A.
   Mortara, D. Picenoni, and P. Vaghi. Hydroxyapatite disks were kindly
   provided by Geistlich Pharma (Wolhusen, Switzerland). The FAST
   ultrasound generator was a gift from Igea (Carpi, Italy). This work was
   supported by Fondazione Cariplo Grants (2004.1424/10.8485 and
   2006.0581/10.8485) to Francesco Benazzo, by PRIN Grant (2006) from
   Italian Ministry of Education, University and Research to Livia Visai,
   and by FIRB Grant (RBIP06FH7J) from Italian Ministry of Education,
   University and Research to Maria Gabriella Cusella De Angelis.
CR Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338
   Artzi Z, 2001, INT J PERIODONT REST, V21, P395
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   COHEN RE, 1994, J PERIODONTOL, V65, P1008, DOI 10.1902/jop.1994.65.11.1008
   Deb S, 2010, J MATER SCI-MATER M, V21, P893, DOI 10.1007/s10856-009-3936-5
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Fassina L, 2009, TISSUE ENG PART C-ME, V15, P233, DOI 10.1089/ten.tec.2008.0398
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   FRANCIS L, ACTA BIOMAT IN PRESS
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P138, DOI 10.2106/JBJS.G.01218
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ripamonti U, 2006, J ANAT, V209, P447, DOI 10.1111/j.1469-7580.2006.00635.x
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Stephan EB, 1999, J PERIODONTOL, V70, P364, DOI 10.1902/jop.1999.70.4.364
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
NR 25
TC 8
Z9 8
U1 0
U2 3
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1565-3633
J9 BIOINORG CHEM APPL
JI Bioinorg. Chem. Appl.
PY 2010
AR 456240
DI 10.1155/2010/456240
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear;
   Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 596LA
UT WOS:000277685100001
PM 20379359
OA Green Published, Other Gold, Bronze
DA 2018-10-20
ER

PT J
AU Lu, SZ
   Wang, XQ
   Lu, Q
   Zhang, XH
   Kluge, JA
   Uppal, N
   Omenetto, F
   Kaplan, DL
AF Lu, Shenzhou
   Wang, Xiaoqin
   Lu, Qiang
   Zhang, Xiaohui
   Kluge, Jonathan A.
   Uppal, Neha
   Omenetto, Fiorenzo
   Kaplan, David L.
TI Insoluble and Flexible Silk Films Containing Glycerol
SO BIOMACROMOLECULES
LA English
DT Article
ID BOMBYX-MORI SILK; FIBROIN MEMBRANE; MECHANICAL-PROPERTIES; POLY(ETHYLENE
   OXIDE); PHYSICAL-PROPERTIES; BLEND FILMS; BIOMATERIAL; SPECTROSCOPY;
   TRANSITION; RESPONSES
AB We directly prepared insoluble silk films by blending with glycerol and avoiding the use of organic solvents. The ability to blend a plasticizer like glycerol with a hydrophobic protein like silk and achieve stable material systems above a critical threshold of glycerol is in important new finding with importance for green chemistry approaches to new and more flexible silk-based biomaterials. The aqueous solubility, biocompatibility, and well-documented use of glycerol as a plasticizer with other biopolymers prompted its inclusion in silk fibroin solutions to assess impact on silk film behavior. Processing was performed in water rather than organic solvents to enhance the potential biocompatibility of these biomaterials. The films exhibited modified morphologies that could be controlled on the basis of the blend composition and also exhibited altered mechanical properties, such as improved elongation at break, when compared with pure silk fibroin films. Mechanistically, glycerol appears to replace water in silk fibroin chain hydration, resulting in the initial stabilization of helical structures in the films, as opposed to random coil or P-sheet structures. The use of glycerol in combination with silk fibroin in materials processing expands the functional features attainable with this fibrous protein, and in particular, in the formation of more flexible films with potential utility in a range of biomaterial and device applications.
C1 [Lu, Shenzhou; Wang, Xiaoqin; Lu, Qiang; Zhang, Xiaohui; Kluge, Jonathan A.; Uppal, Neha; Omenetto, Fiorenzo; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   [Lu, Shenzhou; Lu, Qiang] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215021, Peoples R China.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Zhang, Xiaohui/C-4569-2013; Lu, Shenzhou/P-6519-2015
OI Lu, Shenzhou/0000-0003-4188-2057; Keshav, Neha/0000-0003-4307-2955
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2002, J APPL POLYM SCI, V84, P1963, DOI 10.1002/app.10491
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   CANETTI M, 1989, BIOPOLYMERS, V28, P1613, DOI 10.1002/bip.360280910
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Dai LX, 2002, J APPL POLYM SCI, V86, P2342, DOI 10.1002/app.11260
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Kawahara Y, 2006, MACROMOL MATER ENG, V291, P458, DOI 10.1002/mame.200500350
   Kesenci K, 2001, J BIOMAT SCI-POLYM E, V12, P337, DOI 10.1163/156856201750180852
   KITAGAWA T, 2001, J APPL POLYM SCI, V80, P928
   LAWRENCE BD, 2009, EFFECT HYDRATI UNPUB
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
NR 34
TC 88
Z9 89
U1 4
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2010
VL 11
IS 1
BP 143
EP 150
DI 10.1021/bm900993n
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 541GE
UT WOS:000273402500018
PM 19919091
DA 2018-10-20
ER

PT J
AU Hook, AL
   Anderson, DG
   Langer, R
   Williams, P
   Davies, MC
   Alexander, MR
AF Hook, Andrew L.
   Anderson, Daniel G.
   Langer, Robert
   Williams, Paul
   Davies, Martyn C.
   Alexander, Morgan R.
TI High throughput methods applied in biomaterial development and discovery
SO BIOMATERIALS
LA English
DT Review
DE Microarray; Biomaterials discovery; High throughput; Surface analysis;
   Polymerisation
ID CELL MICROARRAY APPLICATIONS; SURFACE-PLASMON MICROSCOPY; SELF-ASSEMBLED
   MONOLAYERS; EMBRYONIC STEM-CELLS; CHEMICAL GRADIENTS; POLYMER
   MICROARRAYS; COMBINATORIAL LIBRARY; ADSORBED PROTEINS; IDENTIFICATION;
   FABRICATION
AB The high throughput discovery of new bio materials can be achieved by rapidly screening many different materials synthesised by a combinatorial approach to identify the optimal composition that fulfils a particular biomedical application. Here we review the literature in this area and conclude that for polymers this process is best achieved in a microarray format, which enable thousands of cell-material interactions to be monitored on a single chip. Polymer microarrays can be formed by printing pre-synthesised polymers or by printing monomers onto the chip where on-slide polymerisation is initiated. The surface properties of the material can be analysed and correlated to the biological performance using high throughput surface analysis, including time-of-flight secondary ion mass spectrometry (ToF-SIMS), X-ray photoelectron spectroscopy (XPS) and water contact angle (WCA) measurements. This approach enables the surface properties responsible for the success of a material to be understood, which in turn provides the foundations of future material design. The high throughput discovery of materials using polymer microarrays has been explored for many cell-based applications including the isolation of specific cells from heterogeneous populations, the attachment and differentiation of stem cells and the controlled transfection of cells. Further development of polymerisation techniques and high throughput biological assays amenable to the polymer microarray format will broaden the combinatorial space and biological phenomenon that polymer microarrays can explore, and increase their efficacy. This will, in turn, facilitate the discovery of optimised polymeric materials for many biomaterial applications. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Hook, Andrew L.; Davies, Martyn C.; Alexander, Morgan R.] Univ Nottingham, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   [Anderson, Daniel G.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Williams, Paul] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England.
RP Alexander, MR (reprint author), Univ Nottingham, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
EM morgan.alexander@nottingham.ac.uk
RI Alexander, Morgan/C-2506-2009; Hook, Andrew/K-6924-2012; Williams,
   Paul/A-5629-2011
OI Alexander, Morgan/0000-0001-5182-493X; Hook, Andrew/0000-0001-7756-8444;
   Davies, Martyn/0000-0001-7695-0596; Williams, Paul/0000-0002-1920-5036
FU Wellcome Trust [085246]
FX Financial support from the Wellcome Trust is kindly acknowledged
   (085246).
CR Alexander MR, 2004, J MATER CHEM, V14, P408, DOI 10.1039/b311256j
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Ariga K, 2006, J NANOSCI NANOTECHNO, V6, P2278, DOI 10.1166/jnn.2006.503
   Barber ZH, 2008, MATER SCI TECH-LOND, V24, P757, DOI 10.1179/174328408X293612
   Bretagnol F, 2006, PLASMA PROCESS POLYM, V3, P443, DOI 10.1002/ppap.200600015
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brockman JM, 2000, ANNU REV PHYS CHEM, V51, P41, DOI 10.1146/annurev.physchem.51.1.41
   Chan CM, 1996, SURF SCI REP, V24, P3
   Chen B, 2003, SOLID STATE ELECTRON, V47, P841, DOI 10.1016/S0038-1101(02)00443-4
   Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804
   Cull TR, 2007, ADV MATER, V19, P2355, DOI 10.1002/adma.200602661
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   Delehanty JB, 2004, BIOSENS BIOELECTRON, V20, P773, DOI 10.1016/j.bios.2004.04.016
   Diaz-Mochon JJ, 2007, CHEM SOC REV, V36, P449, DOI 10.1039/b511848b
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   HANAK JJ, 1970, J MATER SCI, V5, P964, DOI 10.1007/BF00558177
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Henry OYF, 2008, BIOSENS BIOELECTRON, V23, P1769, DOI 10.1016/j.bios.2008.02.010
   Hook AL, 2009, ACTA BIOMATER, V5, P2350, DOI 10.1016/j.actbio.2009.03.040
   Hook AL, 2006, BIOSENS BIOELECTRON, V21, P2137, DOI 10.1016/j.bios.2005.10.008
   Hook AL, 2006, TRENDS BIOTECHNOL, V24, P471, DOI 10.1016/j.tibtech.2006.08.001
   Hook AL, 2009, LANGMUIR, V25, P9173, DOI 10.1021/la900735n
   Hook AL, 2009, BIOMACROMOLECULES, V10, P573, DOI 10.1021/bm801217n
   Huber J, 2008, ADV MATER, V20, P1978, DOI 10.1002/adma.200702702
   JIAO YP, 2007, J BIOMED MATER RES, V2, pR24
   Kamyshny A, 2005, MACROMOL RAPID COMM, V26, P281, DOI 10.1002/marc.200400522
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Kumar A, 2005, ENG LIFE SCI, V5, P215, DOI 10.1002/elsc.200420075
   Kurkuri MD, 2009, BIOMACROMOLECULES, V10, P1163, DOI 10.1021/bm801417s
   Lee BH, 2004, BIOTECHNOL BIOPROC E, V9, P69, DOI 10.1007/BF02932987
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Levin IW, 2005, ANNU REV PHYS CHEM, V56, P429, DOI 10.1146/annurev.physchem.56.092503.141205
   Liberski A, 2009, CHEM COMMUN, P334, DOI 10.1039/b816920a
   LOWE G, 1995, CHEM SOC REV, V24, P309, DOI 10.1039/cs9952400309
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Mant A, 2006, BIOMATERIALS, V27, P5299, DOI 10.1016/j.biomaterials.2006.04.040
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Meier MAR, 2004, J MATER CHEM, V14, P3289, DOI 10.1039/b406497f
   Meredith JC, 2009, J MATER CHEM, V19, P34, DOI 10.1039/b808649d
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Mott M, 1999, J AM CERAM SOC, V82, P1653, DOI 10.1111/j.1151-2916.1999.tb01982.x
   Pardo L, 2003, LANGMUIR, V19, P1462, DOI 10.1021/la026171u
   Perelaer J, 2006, ADV MATER, V18, P2101, DOI 10.1002/adma.200502422
   Pernagallo S, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034112
   Pernagallo S, 2009, LAB CHIP, V9, P397, DOI 10.1039/b808363k
   Poncin-Epaillard F, 2003, J BIOMAT SCI-POLYM E, V14, P1005, DOI 10.1163/156856203769231538
   Portal C, 2007, ORG BIOMOL CHEM, V5, P587, DOI 10.1039/b614923e
   Rawsterne RE, 2007, ACTA BIOMATER, V3, P715, DOI 10.1016/j.actbio.2007.02.006
   Reddington E, 1998, SCIENCE, V280, P1735, DOI 10.1126/science.280.5370.1735
   ROTHENHAUSLER B, 1988, NATURE, V332, P615, DOI 10.1038/332615a0
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123
   Sorrell CD, 2007, J PHYS CHEM B, V111, P4060, DOI 10.1021/jp069057j
   Tare RS, 2009, BIOMATERIALS, V30, P1045, DOI 10.1016/j.biomaterials.2008.10.038
   Taylor M, 2008, MACROMOL RAPID COMM, V29, P1298, DOI 10.1002/marc.200800171
   Taylor M, 2007, LANGMUIR, V23, P6875, DOI 10.1021/la070100j
   Taylor M, 2009, SURF INTERFACE ANAL, V41, P127, DOI 10.1002/sia.2969
   Tekin E, 2004, J MATER CHEM, V14, P2627, DOI 10.1039/b407478e
   THISSEN H, 2006, P SPIE, V6413
   Tourniaire G, 2006, CHEM COMMUN, P2118, DOI 10.1039/b602009g
   TREADO PJ, 1994, APPL SPECTROSC REV, V29, P1, DOI 10.1080/05704929408000896
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Unciti-Broceta A, 2008, J COMB CHEM, V10, P179, DOI 10.1021/cc7001556
   Urquhart AJ, 2007, WOODHEAD PUBL MATER, P175
   Urquhart AJ, 2008, ANAL CHEM, V80, P135, DOI 10.1021/ac071560k
   Urquhart AJ, 2007, ADV MATER, V19, P2486, DOI 10.1002/adma.200700949
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Venkatasubbarao S, 2004, TRENDS BIOTECHNOL, V22, P630, DOI 10.1016/j.tibtech.10.008
   VROMAN L, 1962, NATURE, V196, P476, DOI 10.1038/196476a0
   Wang J, 2005, MACROMOL RAPID COMM, V26, P304, DOI 10.1002/marc.200400460
   Wang JS, 1998, SCIENCE, V279, P1712, DOI 10.1126/science.279.5357.1712
   Webster DC, 2008, MACROMOL CHEM PHYS, V209, P237, DOI 10.1002/macp.200700558
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   XIANG XD, 1995, SCIENCE, V268, P1738, DOI 10.1126/science.268.5218.1738
   Yang F, 2009, COMB CHEM HIGH T SCR, V12, P554, DOI 10.2174/138620709788681916
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yasuda H., 1985, PLASMA POLYM
   YEATMAN E, 1987, ELECTRON LETT, V23, P1091, DOI 10.1049/el:19870762
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhang R, 2008, CHEM COMMUN, P1317, DOI 10.1039/b717932d
   Zhao X, 2002, J MATER SCI, V37, P1987, DOI 10.1023/A:1015247131016
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 92
TC 113
Z9 114
U1 6
U2 157
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 2
BP 187
EP 198
DI 10.1016/j.biomaterials.2009.09.037
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 528JK
UT WOS:000272440000002
PM 19815273
DA 2018-10-20
ER

PT J
AU Regan, EM
   Uney, JB
   Dick, AD
   Zhang, YW
   Nunez-Yanez, J
   McGeehan, JP
   Claeyssens, F
   Kelly, S
AF Regan, Edward M.
   Uney, James B.
   Dick, Andrew D.
   Zhang, Yiwei
   Nunez-Yanez, Jose
   McGeehan, Joseph P.
   Claeyssens, Frederik
   Kelly, Stephen
TI Differential patterning of neuronal, glial and neural progenitor cells
   on phosphorus-doped and UV irradiated diamond-like carbon
SO BIOMATERIALS
LA English
DT Article
DE Neural cell; Progenitor cell; Neural network; Nerve guide; Diamond;
   Micropatterning
ID SURFACE-PROPERTIES; THIN-FILMS; COATINGS; HEMOCOMPATIBILITY; BLOOD; DLC;
   SI; SPECTROSCOPY; DEPOSITION; ADHESION
AB Diamond-like carbon (DLC) is an attractive biomaterial for coating human implantable devices. Our particular research interest is in developing DLC as a coating material for implants and electrical devices for the nervous system. We previously reported that DLC is not toxic to N2a neuroblastoma cells or primary cortical neurons and showed that phosphorus-doped DLC (P:DLC) could be used to produce patterned neuron networks. In the present study we complement and extend these findings by exploring patterning of dorsal root ganglion (DRG) explants, human neural progenitor cells (hNPC) and U-87 astroglioma cells on P:DLC. Further P:DLC data is provided to highlight that P:DLC can be used as an effective coating material for in vitro multi-electrode arrays (MEAs) with potential for patterning groups of neurons on selected electrodes. We also introduce ultraviolet (UV) irradiation as a simple treatment to render DLC neurocompatible. We show that UV:DLC can be used to support patterned and unpatterned cortical neuron growth. These findings strongly support the use of DLC as tailorable and tuneable substrate to study neural cell biology in vitro and in vivo. We conclude that DLC is a well-suited candidate material for coating implantable devices in the human nervous system. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Claeyssens, Frederik] Univ Sheffield, Dept Mat Engn, Biomat & Tissue Engn Grp, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England.
   [Dick, Andrew D.; Zhang, Yiwei; Nunez-Yanez, Jose; McGeehan, Joseph P.] Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1TH, Avon, England.
   [Dick, Andrew D.] Univ Bristol, Bristol Eye Hosp, Bristol BS1 2LX, Avon, England.
   [Regan, Edward M.; Uney, James B.; Kelly, Stephen] Univ Bristol, Henry Wellcome LINE, Bristol BS1 2LX, Avon, England.
RP Claeyssens, F (reprint author), Univ Sheffield, Dept Mat Engn, Biomat & Tissue Engn Grp, Kroto Res Inst, Broad Lane, Sheffield S3 7HQ, S Yorkshire, England.
EM F.Claeyssens@sheffield.ac.uk; Stephen.kelly@bristol.ac.uk
RI Kelly, Stephen/A-8307-2010; Claeyssens, Frederik/E-4781-2011
OI Claeyssens, Frederik/0000-0002-1030-939X; Nunez-Yanez,
   Jose/0000-0002-5153-5481
FU Wellcome Trust; Micron Foundation; EPSRC Life Science Interface
   [EP/C532066/1]; Engineering and Physical Sciences Research Council
   [EP/C532066/1]
FX The authors thank the Wellcome Trust and the Micron Foundation for
   financial support for this work programme. EMR was supported by a Micron
   Foundation scholarship, FC was supported by an EPSRC Life Science
   Interface Fellowship (EP/C532066/1). We would also like to thank Dr
   Maeve Caldwell and Dr Louise Richards for their expert assistance with
   hNPC and DRG explant cultures. respectively; Dr Clive Svendsen for
   provision of hNPCs; Mr Matthew Keasey is thanked for his assistance with
   MTT assays; and Dr Monica Berry for her scientific input, discussion and
   critical reading of the manuscript. Thanks also go to Professor Mike
   Ashfold, Dr Gareth Fuge and Dr James Smith from the department of
   Chemistry for use of equipment and expertise.
CR Chai F, 2008, ACTA BIOMATER, V4, P1369, DOI 10.1016/j.actbio.2008.04.011
   Claeyssens F, 2004, DALTON T, P3085, DOI 10.1039/b402740j
   Claeyssens F, 2004, APPL PHYS A-MATER, V79, P1237, DOI 10.1007/s00339-004-2726-7
   Dorner-Reisel A, 2008, ANAL BIOANAL CHEM, V390, P1487, DOI 10.1007/s00216-007-1744-7
   Fuge GM, 2004, DIAM RELAT MATER, V13, P1442, DOI 10.1016/j.diamond.2003.11.069
   Gorham J, 2005, J PHYS CHEM B, V109, P20379, DOI 10.1021/jp0521196
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Ignatius MJ, 1998, J BIOMED MATER RES, V40, P264, DOI 10.1002/(SICI)1097-4636(199805)40:2<264::AID-JBM11>3.3.CO;2-N
   Jones DS, 2006, J BIOMED MATER RES B, V78B, P230, DOI 10.1002/jbm.b.30474
   Kelly S, 2008, BIOMATERIALS, V29, P2573, DOI 10.1016/j.biomaterials.2008.03.001
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Kwok SCH, 2004, J BIOMED MATER RES A, V70A, P107, DOI 10.1002/jbm.a.30070
   Liu C, 2008, COLLOID SURFACE B, V61, P182, DOI 10.1016/j.colsurfb.2007.08.008
   Lo SF, 2008, J CLIN NURS, V17, P1973, DOI 10.1111/j.1365-2702.2007.02264.x
   Okpalugo TIT, 2008, J BIOMED MATER RES B, V85B, P188, DOI 10.1002/jbm.b.30934
   Okpalugo TIT, 2004, J BIOMED MATER RES A, V71A, P201, DOI 10.1002/jbm.a.30104
   Randeniya LK, 2009, ACTA BIOMATER, V5, P1791, DOI 10.1016/j.actbio.2009.01.013
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Roy RK, 2007, J BIOMED MATER RES B, V83B, P72, DOI 10.1002/jbm.b.30768
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   Stevens KNJ, 2009, BIOMATERIALS, V30, P3682, DOI 10.1016/j.biomaterials.2009.03.054
   Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5
NR 23
TC 29
Z9 30
U1 1
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 2
BP 207
EP 215
DI 10.1016/j.biomaterials.2009.09.042
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 528JK
UT WOS:000272440000004
PM 19833386
DA 2018-10-20
ER

PT J
AU Chiu, LLY
   Radisic, M
AF Chiu, Loraine L. Y.
   Radisic, Milica
TI Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for
   vascularization of engineered tissues
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; Cardiac tissue engineering; Endothelial cell; Collagen;
   Growth factors; Scaffold
ID ENDOTHELIAL GROWTH-FACTOR; CARDIAC TISSUE; IN-VITRO; FUNCTIONAL
   NEOVASCULARIZATION; MYOCARDIAL-INFARCTION; CONTROLLED-RELEASE; TUBE
   FORMATION; STEM-CELLS; ANGIOGENESIS; COLLAGEN
AB The aim of this study was to engineer a biomaterial capable of supporting vascularization in vitro and in vivo. We covalently immobilized vascular endothelial growth factor (VEGF) and Angiopoietin-1 (Ang1) onto three-dimensional porous collagen scaffolds using 1-ethyl-3-[3-dimethylaminopropy]carbodiimide hydrochloride (EDC) chemistry. Over both 3 and 7 days in vitro, seeded endothelial cells (ECs) had increased proliferation on scaffolds with immobilized VEGF and/or Ang1 compared to unmodified scaffolds and soluble growth factor controls. Notably, the group with co-immobilized VEGF and Ang1 showed significantly higher cell number (P = 0.0079), higher overall lactate production rate (P = 0.0044) and higher overall glucose consumption rate (P = 0.0034) at Day 3, compared to its corresponding soluble control for which growth factors were added to culture medium. By Day 7, hematoxylin and eosin, live/dead, CD31, and von Willebrand factor staining all showed improved tube formation by ECs when cultivated on scaffolds with co-immobilized growth factors. Interestingly, scaffolds with co-immobilized VEGF and Ang1 showed increased EC infiltration in the chorioallantoic membrane (CAM) assay, compared to scaffolds with independently immobilized VEGF/Ang1. This study presents an alternative method for promoting the formation of vascular structures, via covalent immobilization of angiogenic growth factors that are more stable than soluble ones and have a localized effect. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Radisic, Milica] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5S 3G9, Canada.
   [Chiu, Loraine L. Y.; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
RP Radisic, M (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St,Rm 407, Toronto, ON M5S 3G9, Canada.
EM m.radisic@utoronto.ca
FU Canadian Institutes of Health Research (CIHR); Heart and Stroke
   Foundation of Ontario [NA 6077]; NSERC Alexander Graham Bell Canada
FX This study was supported by Canadian Institutes of Health Research
   (CIHR) grant for the Cardiac Regeneration Project (CARE project), Heart
   and Stroke Foundation of Ontario (NA 6077), and NSERC Alexander Graham
   Bell Canada Graduate Scholarship (to L.L.Y.C.). We thank Dr. Ren-Ke Li,
   Dr. Richard D. Weisel and Ms. Marya Ahmed for helpful discussions, Dr.
   Hannah Song for help with confocal microscopy, Mr. Billy Cheng and Prof.
   Mark Kortschot for help with mechanical testing.
CR Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S525-0016(03)00034-0
   Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443
   Benest AV, 2006, MICROCIRCULATION, V13, P423, DOI 10.1080/10739680600775940
   Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Brown MA, 2008, BIOTECHNOL PROGR, V24, P907, DOI [10.1002/btpr.11, 10.1021/bp.11]
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082
   Chen HK, 2005, EUR J CLIN INVEST, V35, P677, DOI 10.1111/j.1365-2362.2005.01565.x
   Chen PR, 2005, BIOMATERIALS, V26, P6579, DOI 10.1016/j.biomaterials.2005.03.037
   Cheng M, 2007, TISSUE ENG, V13, P2709, DOI 10.1089/ten.2006.0414
   CHIU LL, 2008, TISSUE ENG A
   Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101
   Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2
   Dallabrida Susan M, 2005, Circ Res, V96, pe8, DOI 10.1161/01.RES.0000158285.57191.60
   DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Feraud O, 2001, LAB INVEST, V81, P1669, DOI 10.1038/labinvest.3780380
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291
   Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019
   George ML, 2000, CLIN CANCER RES, V6, P3147
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jho D, 2005, CIRC RES, V96, P1282, DOI 10.1161/01.RES.0000171894.03801.03
   Jiang F, 2008, J CELL MOL MED, V12, P2062, DOI 10.1111/j.1582-4934.2008.00199.x
   Kim SH, 2007, PEPTIDES, V28, P2125, DOI 10.1016/j.peptides.2007.08.010
   Kroon ME, 2000, BLOOD, V96, P2775
   Kumar P, 2005, LAB INVEST, V85, P756, DOI 10.1038/labinvest.3700272
   Kutryk MJB, 2003, MICROSC RES TECHNIQ, V60, P138, DOI 10.1002/jemt.10252
   Kwak HJ, 2000, CIRCULATION, V101, P2317, DOI 10.1161/01.CIR.101.19.2317
   Leclerc C, 2008, J BIOMED MATER RES A, V86A, P1033, DOI 10.1002/jbm.a.31751
   Lee H, 2007, J BIOACT COMPAT POL, V22, P89, DOI 10.1177/0883911506073363
   Lee KY, 2000, NATURE, V408, P998
   Lee RJ, 2000, CIRCULATION, V102, P898
   Metheny-Barlow LJ, 2004, MICROVASC RES, V68, P221, DOI 10.1016/j.mvr.2004.08.005
   Morisada T, 2006, ENDOTHELIUM-J ENDOTH, V13, P71, DOI 10.1080/10623320600697989
   Morritt AN, 2007, CIRCULATION, V115, P353, DOI 10.1161/CIRCULATIONAHA.106.657379
   Oates M, 2007, BIOMATERIALS, V28, P3679, DOI 10.1016/j.biomaterials.2007.04.042
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Radisic M, 2009, TISSUE ENG PT A, V15, P851, DOI 10.1089/ten.tea.2008.0223
   RAKUSAN K, 1982, GROWTH, V46, P275
   Riley CM, 2006, BIOMATERIALS, V27, P5935, DOI 10.1016/j.biomaterials.2006.08.029
   Saito M, 2003, CANCER SCI, V94, P782, DOI 10.1111/j.1349-7006.2003.tb01519.x
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Tsuda Y, 2007, BIOMATERIALS, V28, P4939, DOI 10.1016/j.biomaterials.2007.08.002
   von Walter M, 2008, ACTA BIOMATER, V4, P997, DOI 10.1016/j.actbio.2008.01.020
   Wang ZY, 2007, BIOCHEM BIOPH RES CO, V359, P685, DOI 10.1016/j.bbrc.2007.05.172
   WEST DC, 2001, ANGIOGENESIS PROTOCO, P107
   WILTING J, 1993, CELL TISSUE RES, V274, P163, DOI 10.1007/BF00327997
   Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108
   Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333
   Zacchigna S, 2007, HUM GENE THER, V18, P515, DOI 10.1089/hum.2006.162
   Zhou L, 2005, GENE THER, V12, P196, DOI 10.1038/sj.gt.3302416
   Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382
   Zhu WH, 2002, AM J PATHOL, V161, P823, DOI 10.1016/S0002-9440(10)64242-3
NR 69
TC 144
Z9 153
U1 7
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 2
BP 226
EP 241
DI 10.1016/j.biomaterials.2009.09.039
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 528JK
UT WOS:000272440000006
PM 19800684
DA 2018-10-20
ER

PT J
AU Yang, TL
   Hsiao, YC
   Lin, SJ
   Lee, HW
   Lou, PJ
   Ko, JY
   Young, TH
AF Yang, Tsung-Lin
   Hsiao, Ya-Chuan
   Lin, Sung-Jan
   Lee, Hao-Wei
   Lou, Pei-Jen
   Ko, Jenq-Yuh
   Young, Tai-Horng
TI Biomaterial mediated epithelial-mesenchymal interaction of salivary
   tissue under serum free condition
SO BIOMATERIALS
LA English
DT Article
DE Epithelial-mesenchymal interaction; Polyvinylidene fluoride; Salivary
   gland; Biomaterials; Morphogenesis; Serum
ID GLAND BRANCHING MORPHOGENESIS; BASEMENT-MEMBRANE COMPONENTS;
   SUBMANDIBULAR-GLAND; HEPATOCYTE ATTACHMENT; EMBRYONIC MICE;
   GROWTH-FACTOR; BASAL LAMINA; IN-VITRO; CHITOSAN; EXPRESSION
AB Many organs develop from epithelial-mesenchymal interactions such that in order to regenerate these organs, it might be a preferable strategy to recapitulate this process. However, in the current culture system designed for tissue interaction, the supplement of serum is required. The aim of this study is to explore the possibility of reproducing epithelial-mesenchymal interaction and ensuing morphogenesis in a serum-free condition. In accordance with the previous studies, by using a standard model of murine fetal submandibular gland (SMG), the tissue interaction and the morphogenesis were largely dependent on serum. Nonetheless, when tissue recombinants were cultivated on polyvinylidene fluoride (PVDF), but not on other biomaterials, the serum-deprived effect could be rescued. On PVDF, SMG tissue recombinant was able to increase epithelial size, de novo synthesize basement membrane, and develop new branches without serum. Although the gene expression levels of selected morphogens were not significantly altered, the precise localization of morphogenetic-decisive extracellular matrix such as type III collagen and the superior adsorbing capacity of essential diffusible factors like fibroblast growth factor 7 (FGF7) might account for PVDF effect. Accordingly, the result demonstrates that it is possible to establish a serum-free system that is competent in facilitating epithelial-mesenchymal interaction of salivary tissue. With PVDF, the crosstalk between SMG epithelia and mesenchyme could be sustained without serum. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Yang, Tsung-Lin; Lou, Pei-Jen; Ko, Jenq-Yuh] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.
   [Yang, Tsung-Lin] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Otolaryngol, Touliu, Yunlin, Taiwan.
   [Lin, Sung-Jan; Lee, Hao-Wei; Young, Tai-Horng] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan.
   [Lin, Sung-Jan; Lee, Hao-Wei; Young, Tai-Horng] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Hsiao, Ya-Chuan] Taipei City Hosp, Zhongxing Branch, Dept Ophthalmol, Taipei, Taiwan.
   [Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.
RP Yang, TL (reprint author), Natl Taiwan Univ Hosp, Dept Otolaryngol, 1 Sec 1 Jen Ai Rd, Taipei, Taiwan.
EM yangtl@ntu.edu.tw; thyoung@ntu.edu.tw
OI Lin, Sung-Jan/0000-0003-1325-3464; LOU, PEI-JEN/0000-0002-3383-8593;
   YANG, TSUNG-LIN/0000-0001-6521-8631
FU National Science Council of the Republic of China; National Taiwan
   University Hospital; National Health Research Institutes; Taipei City
   Hospital
FX The authors thank National Science Council of the Republic of China,
   National Taiwan University Hospital, National Health Research
   Institutes, and Taipei City Hospital for their financial support of this
   research. The authors also thank the staff of the Eighth Core Lab,
   Department of Medical Research, National Taiwan University Hospital for
   technical support during the study.
CR BANERJEE SD, 1977, J CELL BIOL, V73, P445, DOI 10.1083/jcb.73.2.445
   BERNFIELD M, 1982, DEV BIOL, V90, P291, DOI 10.1016/0012-1606(82)90378-5
   BOHNERT A, 1986, CELL TISSUE RES, V244, P413
   Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7
   BRAUCHLE M, 1994, ONCOGENE, V9, P3199
   Chen MH, 2005, J BIOMED MATER RES A, V74A, P254, DOI 10.1002/jbm.a.30376
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   GROBSTEIN C, 1953, SCIENCE, V118, P52, DOI 10.1126/science.118.3054.52
   GROBSTEIN C, 1953, J MORPHOL, V93, P383
   GUENARD V, 1991, BIOMATERIALS, V12, P259, DOI 10.1016/0142-9612(91)90210-2
   Havlickova B, 2004, BRIT J DERMATOL, V151, P753, DOI 10.1111/j.1365-2133.2004.06184.x
   Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172
   Hogan BLM, 1998, CURR OPIN GENET DEV, V8, P481, DOI 10.1016/S0959-437X(98)80121-4
   Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039
   Iwai K, 1998, DEV GROWTH DIFFER, V40, P327
   KADOYA Y, 1991, ANAT EMBRYOL, V183, P491
   KADOYA Y, 1989, J HISTOCHEM CYTOCHEM, V37, P1387, DOI 10.1177/37.9.2768808
   Kadoya Yuichi, 2005, Anatomical Science International, V80, P71, DOI 10.1111/j.1447-073x.2005.00102.x
   Kim BS, 2004, BIOTECHNOL LETT, V26, P709, DOI 10.1023/B:BILE.0000024093.94151.d8
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Krasteva N, 2002, BIOMATERIALS, V23, P2467, DOI 10.1016/S0142-9612(01)00381-7
   Kuure S, 2000, MECH DEVELOP, V92, P31, DOI 10.1016/S0925-4773(99)00323-8
   Laroche G., 1995, J BIOMED MATER RES, V29, P1523
   LAWSON KA, 1974, J EMBRYOL EXP MORPH, V32, P469
   Lu HF, 2003, BIOMATERIALS, V24, P4893, DOI 10.1016/S0142-9612(03)00404-6
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandl EW, 2002, TISSUE ENG, V8, P573, DOI 10.1089/107632702760240490
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   NAKANISHI Y, 1988, DEVELOPMENT, V104, P51
   Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Noguchi Y, 2006, DEV DYNAM, V235, P403, DOI 10.1002/dvdy.20651
   Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7
   PLUSKAL MG, 1986, BIOTECHNIQUES, V4, P272
   Ropiquet F, 1999, INT J CANCER, V82, P237, DOI 10.1002/(SICI)1097-0215(19990719)82:2<237::AID-IJC14>3.3.CO;2-H
   SIMONASSMANN P, 1988, DEVELOPMENT, V102, P339
   Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690
   TAKAHASHI Y, 1991, DEVELOPMENT, V111, P327
   Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006
   TYLER MS, 1977, J EMBRYOL EXP MORPH, V38, P37
   Umeda Y, 2001, DEV BIOL, V237, P202, DOI 10.1006/dbio.2001.0351
   Yamazaki K, 2005, MOL REPROD DEV, V72, P291, DOI 10.1002/mrd.20347
   Yang TL, 2008, BIOMATERIALS, V29, P2501, DOI 10.1016/j.biomaterials.2008.02.014
   Yang TL, 2008, BIOMED ENG-APP BAS C, V20, P287, DOI [10.1142/S1016237208000908, 10.4015/S1016237208000908]
   Yang TL, 2009, J CELL MOL MED, V13, P2853, DOI 10.1111/j.1582-4934.2008.00425.x
   Yang TL, 2009, BIOCHEM BIOPH RES CO, V381, P466, DOI 10.1016/j.bbrc.2008.10.116
NR 48
TC 17
Z9 18
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 2
BP 288
EP 295
DI 10.1016/j.biomaterials.2009.09.052
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 528JK
UT WOS:000272440000012
PM 19853295
DA 2018-10-20
ER

PT J
AU Vasilev, K
   Mierczynska, A
   Hook, AL
   Chan, J
   Voelcker, NH
   Short, RD
AF Vasilev, Krasimir
   Mierczynska, Agnieszka
   Hook, Andrew L.
   Chan, Joseph
   Voelcker, Nicolas H.
   Short, Rob D.
TI Creating gradients of two proteins by differential passive adsorption
   onto a PEG-density gradient
SO BIOMATERIALS
LA English
DT Article
DE PEG gradient; Protein gradients; Protein adsorption; Plasma deposition;
   Surface grafting
ID SURFACE CHEMICAL GRADIENTS; POLYMER SURFACES; WETTABILITY GRADIENT;
   CHEMOKINE RECEPTORS; MORPHOGEN GRADIENT; CELL-PROLIFERATION; PLASMA
   POLYMERS; ADHESION; TISSUE; METASTASIS
AB Many fundamental biological processes, including early embryo development, immune responses and the progression of pathogens, are mediated by gradients of biological molecules. Understanding these vital physiological processes requires the development of biomaterial platforms that can mimic them in-vitro. Such platforms include laboratory generated surface gradients of biological molecules. In this work, we report a method for the generation of surface gradients of two proteins. We used a surface grafting density gradient of polyethylene glycol (PEG) to control protein adsorption. In addition, we used protein size as a tool to control the position and the adsorbed amount of both proteins. To demonstrate our concept, we used fibrinogen as an example of a large protein and lysozyme as an example of a small protein. However, we speculate that the same strategy could be extended to any other pair of large and small proteins. We used X-ray photoelectron spectroscopy and sessile drop contact angle measurements to determine the chemical composition and wettability of the gradients. Protein adsorption was studied by surface plasmon resonance imaging. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Vasilev, Krasimir; Short, Rob D.] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
   [Mierczynska, Agnieszka; Chan, Joseph] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5095, Australia.
   [Hook, Andrew L.; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Adelaide, SA 5001, Australia.
RP Vasilev, K (reprint author), Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
EM krasimir.vasilev@unisa.edu.au
RI Vasilev, Krasimir/C-5248-2008; Hook, Andrew/K-6924-2012; Short,
   Robert/D-4580-2009; Voelcker, Nicolas/D-6199-2012
OI Hook, Andrew/0000-0001-7756-8444; Voelcker, Nicolas/0000-0002-1536-7804;
   Mierczynska-Vasilev, Agnieszka/0000-0002-4758-968X
CR Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238
   Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001
   Beck AJ, 1998, J CHEM SOC FARADAY T, V94, P559, DOI 10.1039/a707376c
   Beck AJ, 1996, POLYMER, V37, P5537, DOI 10.1016/S0032-3861(96)00479-X
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005
   CHEETHAM JC, 1992, J MOL BIOL, V224, P613, DOI 10.1016/0022-2836(92)90548-X
   Cole MA, 2007, SMART MATER STRUCT, V16, P2222, DOI 10.1088/0964-1726/16/6/025
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Eccles SA, 2005, CURR OPIN GENET DEV, V15, P77, DOI 10.1016/j.gde.2004.12.001
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Hook AL, 2006, BIOSENS BIOELECTRON, V21, P2137, DOI 10.1016/j.bios.2005.10.008
   Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b
   Kim MS, 2008, PROG POLYM SCI, V33, P138, DOI 10.1016/j.progpolymsci.2007.06.001
   Kingshott P, 2002, BIOMATERIALS, V23, P4775, DOI 10.1016/S0142-9612(02)00228-4
   Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x
   Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222
   LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Luo LQ, 2006, NATURE, V439, P23, DOI 10.1038/439023a
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Parry KL, 2006, SURF INTERFACE ANAL, V38, P1497, DOI 10.1002/sia.2400
   Pasche S, 2003, LANGMUIR, V19, P9216, DOI 10.1021/la034111y
   Plummer ST, 2003, LANGMUIR, V19, P7528, DOI 10.1021/la030075r
   Raballo R, 2000, J NEUROSCI, V20, P5012
   Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030
   UEDAYUKOSHI T, 1995, LANGMUIR, V11, P4135, DOI 10.1021/la00010a080
   Vasilyev A, 2009, PLOS BIOL, V7, P101, DOI 10.1371/journal.pbio.1000009
   Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148
   Wells N, 2009, BIOMATERIALS, V30, P1066, DOI 10.1016/j.biomaterials.2008.10.027
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   Whittle JD, 2000, CHEM MATER, V12, P2664, DOI 10.1021/cm0002158
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104
NR 40
TC 42
Z9 42
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 3
BP 392
EP 397
DI 10.1016/j.biomaterials.2009.09.056
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532IA
UT WOS:000272739200002
PM 19811821
DA 2018-10-20
ER

PT J
AU Brubaker, CE
   Kissler, H
   Wang, LJ
   Kaufman, DB
   Messersmith, PB
AF Brubaker, Carrie E.
   Kissler, Hermann
   Wang, Ling-Jia
   Kaufman, Dixon B.
   Messersmith, Phillip B.
TI Biological performance of mussel-inspired adhesive in extrahepatic islet
   transplantation
SO BIOMATERIALS
LA English
DT Article
DE Biomimetic material; Tissue adhesive; Islet; Diabetes; Hydrogel;
   Biocompatibility
ID PANCREATIC-ISLETS; MYTILUS-EDULIS; POLYPEPTIDE MIMICS; CROSS-LINKING;
   SITE; HYDROGELS; PROTEINS; GELATION; GRAFTS; BLOOD
AB There is significant need for effective medical adhesives that function reliably on wet tissue surfaces with minimal inflammatory insult. To address these performance characteristics, we have generated a synthetic adhesive biomaterial inspired by the protein glues of marine mussels. In-vivo performance was interrogated in a murine model of extrathepatic syngeneic islet transplantation, as an alternative to standard portal administration. The adhesive precursor polymer consisted of a branched poly(ethylene glycol) (PEG) core, whose endgroups were derivatized with catechol, a functional group abundant in mussel adhesive proteins. Under oxidizing conditions, adhesive hydrogels formed in less than 1 min from catechol-derivatized PEG (cPEG) solutions. Upon implantation, the cPEG adhesive elicited minimal acute or chronic inflammatory response in C57BL6 mice, and maintained an intact interface with supporting tissue for up to one year. in-situ cPEG adhesive formation was shown to efficiently immobilize transplanted islets at the epididymal fat pad and external liver surfaces, permitting normoglycemic recovery and graft revascularization. These findings establish the use of synthetic, biologically-inspired adhesives for islet transplantation at extrahepatic sites. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Brubaker, Carrie E.; Messersmith, Phillip B.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Brubaker, Carrie E.; Kaufman, Dixon B.; Messersmith, Phillip B.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Kissler, Hermann; Wang, Ling-Jia; Kaufman, Dixon B.] Northwestern Univ, Dept Surg, Div Organ Transplantat, Feinberg Sch Med, Chicago, IL 60611 USA.
RP Messersmith, PB (reprint author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
EM philm@northwestern.edu
RI Messersmith, Phil/B-6695-2009; Messersmith, Phillip/F-3433-2013
OI Messersmith, Phillip/0000-0002-1197-333X
FU National Institutes of Health [EB003806, DE014193]; Northwestern
   University Regenerative Medicine Training Program [NIH DA022881]
FX This study was supported by National Institutes of Health grants
   EB003806 and DE014193. C.E.B. acknowledges the Northwestern University
   Regenerative Medicine Training Program for support (NIH DA022881). We
   thank Dr. Bruce Lee for discussions regarding cPEG synthesis and
   Nicholas Talarico of the Pathology Core Facility, Robert H. Lurie Cancer
   Center, Northwestern University, for his assistance with histology and
   immunohistochemistry. Dr. Harsha Kulkarni is acknowledged for assistance
   with mouse monitoring and care.
CR Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
   Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059
   Burke SA, 2007, BIOMED MATER, V2, P203, DOI 10.1088/1748-6041/2/4/001
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Chen XJ, 2007, TRANSPLANTATION, V84, P122, DOI 10.1097/01.tp.0000266909.58117.e3
   Chen XJ, 2006, TRANSPLANTATION, V81, P1421, DOI 10.1097/01.tp.0000206109.71181.bf
   Cheung CY, 2006, BIOCONJUGATE CHEM, V17, P1036, DOI 10.1021/bc060023o
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Elsner M, 2000, DIABETOLOGIA, V43, P1528, DOI 10.1007/s001250051564
   FRITSCHY WM, 1991, TRANSPLANTATION, V52, P777, DOI 10.1097/00007890-199111000-00004
   Hu BH, 2003, J AM CHEM SOC, V125, P14298, DOI 10.1021/ja038593b
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391
   Moberg L, 2005, CLIN EXP IMMUNOL, V142, P125, DOI 10.1111/j.1365-2249.2005.02883.x
   Notkins AL, 2002, J BIOL CHEM, V277, P43545, DOI 10.1074/jbc.R200012200
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Shao H, 2009, MACROMOL BIOSCI, V9, P464, DOI 10.1002/mabi.200800252
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   Tatehata H, 2000, J APPL POLYM SCI, V76, P929, DOI 10.1002/(SICI)1097-4628(20000509)76:6<929::AID-APP20>3.0.CO;2-F
   van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x
   van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   Wang J, 2007, BIOMATERIALS, V28, P3456, DOI 10.1016/j.biomaterials.2007.04.009
   WEBER LM, 2008, J BIOMED MATER RES A, V90, P720
   Westwood G, 2007, MACROMOLECULES, V40, P3960, DOI 10.1021/ma0703002
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Yin M, 2009, BIOMATERIALS, V30, P2764, DOI 10.1016/j.biomaterials.2009.01.039
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 38
TC 176
Z9 181
U1 14
U2 171
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 3
BP 420
EP 427
DI 10.1016/j.biomaterials.2009.09.062
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532IA
UT WOS:000272739200006
PM 19811819
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Schneider, RK
   Puellen, A
   Kramann, R
   Raupach, K
   Bornemann, J
   Knuechel, R
   Perez-Bouza, A
   Neuss, S
AF Schneider, Rebekka K.
   Puellen, Andrea
   Kramann, Rafael
   Raupach, Kerstin
   Bornemann, Joerg
   Knuechel, Ruth
   Perez-Bouza, Alberto
   Neuss, Sabine
TI The osteogenic differentiation of adult bone marrow and perinatal
   umbilical mesenchymal stem cells and matrix remodelling in
   three-dimensional collagen scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Human mesenchymal stem cells; Bone tissue engineering; Collagen
   scaffold; Matrix remodelling; Extracellular matrix; Metalloproteinases
ID HEMATOPOIETIC PROGENITOR CELLS; STROMAL CELLS; IN-VITRO; CORD;
   EXPRESSION; THERAPY; METALLOPROTEINASES; TRANSPLANTATION; HUCPVCS;
   BIOLOGY
AB Adult human mesenchymal stem cells from bone marrow (BM-MSC) represent a promising source for skeletal regeneration. Perinatal MSC from Wharton's Jelly of the umbilical cord (UC-MSC) are expected to possess enhanced differentiation capacities due to partial expression of pluripotency markers. For bone tissue engineering, it is important to analyse in vitro behaviour of stem cell/biomaterial hybrids concerning in vivo integration into injured tissue via migration, matrix remodelling and differentiation. This study compares the cell-mediated remodelling of three-dimensional collagen I/III gels during osteogenic differentiation of both cell types. When activated through collagen contact and subjected to osteogenic differentiation, UC-MSC differ from BM-MSC in expression and synthesis of extracellular matrix (ECM) proteins as shown by histology, immunohistochemistry, Western Blot analysis and realtime-RT-PCR. The biosynthetic activity was accompanied in both cell types by the ultrastructural appearance of hydroxyapatite/calcium crystals and osteogenic gene induction. Following secretion of matrix metalloproteinases (MMP), both MSC types migrated into and colonised the collagenous matrix causing matrix strengthening and contraction. These results indicate that UC-MSC and BM-MSC display all features needed for effective bone fracture healing. The expression of ECM differs in both cell types considerably, suggesting different mechanisms for bone formation and significant impact for bone tissue engineering. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Schneider, Rebekka K.; Puellen, Andrea; Raupach, Kerstin; Knuechel, Ruth; Perez-Bouza, Alberto; Neuss, Sabine] Rhein Westfal TH Aachen, Inst Pathol, Univ Hosp, D-52074 Aachen, Germany.
   [Kramann, Rafael] Rhein Westfal TH Aachen, Univ Hosp, Div Nephrol & Clin Immunol, D-52074 Aachen, Germany.
   [Bornemann, Joerg] Rhein Westfal TH Aachen, Univ Hosp, Electron Microscop Facil, D-52074 Aachen, Germany.
RP Neuss, S (reprint author), Rhein Westfal TH Aachen, Inst Pathol, Univ Hosp, Pauwelsstr 30, D-52074 Aachen, Germany.
EM sneuss-stein@ukaachen.de
OI Kramann, Rafael/0000-0003-4048-6351
CR Bailey MM, 2007, TISSUE ENG, V13, P2003, DOI 10.1089/ten.2006.0150
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625
   Bieback Karen, 2007, Curr Stem Cell Res Ther, V2, P310, DOI 10.2174/157488807782793763
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Campagnoli C, 2002, BJOG-INT J OBSTET GY, V109, P952, DOI 10.1016/S1470-0328(02)02011-6
   Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Ennis J, 2008, METHOD CELL BIOL, V86, P121, DOI 10.1016/S0091-679X(08)00007-1
   Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Guillot PV, 2008, BLOOD, V111, P1717, DOI 10.1182/blood-2007-08-105809
   Horwitz EM, 2001, CYTOTHERAPY, V3, P399, DOI 10.1080/146532401753277562
   Jager M, 2005, ANN BIOMED ENG, V33, P1319, DOI 10.1007/s10439-005-5889-2
   Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561
   Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118
   Mannello F, 2006, STEM CELLS, V24, P475, DOI 10.1634/stemcells.2005-0333
   Mannello F, 2006, STEM CELLS, V24, P1904, DOI 10.1634/stemcells.2005-0608
   Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462
   NEUSS S, 2009, CELLS TISSUES ORGANS
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110
   Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422
   Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100
   Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007
   Sarugaser Rahul, 2009, V482, P269, DOI 10.1007/978-1-59745-060-7_17
   Schneider RKM, 2008, DIFFERENTIATION, V76, P156, DOI 10.1111/j.1432-0436.2007.00204.x
   Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x
   Stark HJ, 2004, BIOL PROCED ONLINE, V6, P55, DOI DOI 10.1251/BP072
   Sun XD, 2009, BIOMATERIALS, V30, P1222, DOI 10.1016/j.biomaterials.2008.10.020
   Wagner W, 2007, EXP HEMATOL, V35, P314, DOI 10.1016/j.exphem.2006.10.003
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y
   ZHANG ZY, 2008, STEM CELLS
NR 42
TC 120
Z9 127
U1 3
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 3
BP 467
EP 480
DI 10.1016/j.biomaterials.2009.09.059
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532IA
UT WOS:000272739200011
PM 19815272
DA 2018-10-20
ER

PT J
AU Vasilev, K
   Poh, Z
   Kant, K
   Chan, J
   Michelmore, A
   Losic, D
AF Vasilev, Krasimir
   Poh, Zihan
   Kant, Krishna
   Chan, Joseph
   Michelmore, Andrew
   Losic, Dusan
TI Tailoring the surface functionalities of titania nanotube arrays
SO BIOMATERIALS
LA English
DT Article
DE Titanium oxide; Titania nanotubes; Surface modifications; Plasma
   polymerizations
ID NANOPOROUS ALUMINA MEMBRANES; ANODIC OXIDE-FILMS; TIO2 NANOTUBES; PLASMA
   POLYMER; ETHYLENE-GLYCOL; POROUS SILICON; CELL-ADHESION; FABRICATION;
   SCALE; COATINGS
AB Nanotubular titanium oxide (TiO2) produced by self-ordering processes using electrochemical anodization have been extensively explored in recent years as a new biomaterial for implants, drug delivery systems, cell growth, biosensors, immunoisolations, bioartificial organs and tissue engineering. Chemical inertness is the main weakness of this material when placed in contact with biological systems and surface modification is a possible solution of this problem. The aim of this study is to develop a flexible and facile method for surface modification of TiO2 nanotubes to tailor new interfacial properties important in many biomedical applications. TiO2 nanotubes were prepared by electrochemical anodization of titanium foil using ethylene glycol: NH4F electrolyte (2% water and 0.3% NH4F). Plasma surface modification using allylamine (AA) as a precursor has been applied to generate a thin and chemically reactive polymer (AAPP) film rich in amine groups on top of the TiCl2 nanotube surface. This initial polymer film was used for further surface functionalization by attachment of desired molecules. Two modification techniques were used to demonstrate the flexibility for building of new functionalities on titania nanotube surface: electrostatic adsorption of poly(sodium styrenesulfonate) (PSS) as an example of layer-by-layer assembly (LbL), and covalent coupling of poly(ethylene glycol) (PEG) as an example of creating a protein-resistant surface. These approaches for tailoring the surface chemistry and wettability of TiO2 nanotubes offer considerable prospects for advancing their interfacial properties to improve existing and develop new functional biomaterials for diverse biomedical applications. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
C1 [Poh, Zihan; Kant, Krishna; Chan, Joseph; Losic, Dusan] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5095, Australia.
   [Vasilev, Krasimir; Michelmore, Andrew] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
   [Vasilev, Krasimir] Univ S Australia, Sch Adv Mfg & Mech Engn, Adelaide, SA 5095, Australia.
RP Losic, D (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes Campus, Adelaide, SA 5095, Australia.
EM dusan.losic@unisa.edu.au
RI Losic, Dusan/B-2436-2009; Vasilev, Krasimir/C-5248-2008; Michelmore,
   Andrew/D-3015-2013
OI Losic, Dusan/0000-0002-1930-072X; Michelmore,
   Andrew/0000-0003-3215-8841; Kant, Krishna/0000-0003-2948-9471
FU Australian Research Council; University of South Australia
FX The authors acknowledge the financial support of the Australian Research
   Council and the University of South Australia for this work.
CR Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Balaur E, 2005, ELECTROCHEM COMMUN, V7, P1066, DOI 10.1016/j.elecom.2005.07.014
   Bocking T, 2008, ADV FUNCT MATER, V18, P3827, DOI 10.1002/adfm.200800640
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Chik H, 2004, MAT SCI ENG R, V43, P103, DOI 10.1016/j.mser.2003.12.001
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dhayal M, 2003, SURF COAT TECH, V162, P294, DOI 10.1016/S0257-8972(02)00701-6
   DIGGLE JW, 1969, CHEM REV, V69, P365, DOI 10.1021/cr60259a005
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Ghicov A, 2009, CHEM COMMUN, P2791, DOI 10.1039/b822726h
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   GRIMES CA, 2007, J MATER CHEM, V17, P451
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hook AL, 2008, SURF SCI, V602, P1883, DOI 10.1016/j.susc.2008.03.029
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   ITO Y, 1991, J BIOMED MATER RES, V25, P1347, DOI 10.1002/jbm.820251104
   Jani AMM, 2009, CHEM COMMUN, P3062, DOI 10.1039/b901745c
   Kalbacova M, 2008, PHYS STATUS SOLIDI-R, V2, P194, DOI 10.1002/pssr.200802080
   Kant K, 2009, PHYS STATUS SOLIDI-R, V3, P139, DOI 10.1002/pssr.200903087
   Keogh JR, 1996, BIOMATERIALS, V17, P1987, DOI 10.1016/0142-9612(96)00005-1
   Kingshott P, 2002, BIOMATERIALS, V23, P4775, DOI 10.1016/S0142-9612(02)00228-4
   KINGSHOTT P, 2002, BIOMATERIALS, V23, P334
   Losic D, 2005, NANOTECHNOLOGY, V16, P2275, DOI 10.1088/0957-4484/16/10/049
   LOSIC D, EXPERT OPIN IN PRESS, DOI DOI 10.1517/174252409033008571
   Losic D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245704
   Losic D, 2009, SMALL, V5, P1392, DOI 10.1002/smll.200801645
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Muir BW, 2008, LANGMUIR, V24, P3828, DOI 10.1021/la702689t
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   OMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Paulose M, 2008, J MEMBRANE SCI, V319, P199, DOI 10.1016/j.memsci.2008.03.050
   Peng LL, 2009, NANO LETT, V9, P1932, DOI 10.1021/nl9001052
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Popat KC, 2004, J MEMBRANE SCI, V243, P97, DOI 10.1016/j.memsci.2004.05.030
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Prakasam HE, 2007, J PHYS CHEM C, V111, P7235, DOI 10.1021/jp070273h
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   Schmid G, 2002, J MATER CHEM, V12, P1231, DOI 10.1039/b110753b
   Sharma S, 2002, LANGMUIR, V18, P8728, DOI 10.1021/la026097f
   Shrestha NK, 2009, ANGEW CHEM INT EDIT, V48, P969, DOI 10.1002/anie.200804429
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Song YY, 2009, J AM CHEM SOC, V131, P4230, DOI 10.1021/ja810130h
   Swan EEL, 2005, BIOMATERIALS, V26, P1969, DOI 10.1016/j.biomaterials.2004.07.001
   Thierry B, 2008, LANGMUIR, V24, P10187, DOI 10.1021/la801140u
   Vasilev K, 2004, J CHEM PHYS, V120, P3439, DOI 10.1063/1.1640341
   Vasilev K, 2008, J PHYS CHEM B, V112, P10915, DOI 10.1021/jp803678w
   von Wilmowsky C, 2009, J BIOMED MATER RES B, V89B, P165, DOI 10.1002/jbm.b.31201
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zwilling V, 1999, SURF INTERFACE ANAL, V27, P629, DOI 10.1002/(SICI)1096-9918(199907)27:7<629::AID-SIA551>3.0.CO;2-0
NR 55
TC 131
Z9 132
U1 2
U2 132
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 3
BP 532
EP 540
DI 10.1016/j.biomaterials.2009.09.074
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532IA
UT WOS:000272739200017
PM 19819014
DA 2018-10-20
ER

PT J
AU Moraes, C
   Wang, GH
   Sun, Y
   Simmons, CA
AF Moraes, Christopher
   Wang, GongHao
   Sun, Yu
   Simmons, Craig A.
TI A microfabricated platform for high-throughput unconfined compression of
   micropatterned biomaterial arrays
SO BIOMATERIALS
LA English
DT Article
DE Hydrogel; Micropatterning; Biomaterial arrays; High-throughput;
   Mechanical stimulation; Compression
ID CELL-CULTURE; POLYETHYLENE-GLYCOL; ARTICULAR-CARTILAGE; IN-VITRO;
   MECHANICAL STIMULATION; 3-DIMENSIONAL CULTURE; HYDROGEL SCAFFOLDS;
   GROWTH-FACTORS; STEM-CELLS; DIFFERENTIATION
AB High-throughput screening techniques for cellular response are often unable to account for several factors present in the in vivo environment, many of which have been shown to modulate cellular response to the screened parameter. Culture in three-dimensional biomaterials and active mechanical stimulation are two such factors. In this work, we integrate these microenvironmental parameters into a versatile microfabricated device, capable of simultaneously applying a range of cyclic, compressive mechanical forces to cells encapsulated in an array of micropatterned biomaterials. The fabrication techniques developed here are broadly applicable to the integration of three-dimensional culture systems in complex multilayered polymeric microdevices. Compressive strains ranging from 6% to 26% were achieved simultaneously across the biomaterial array. As a first demonstration of this technology, nuclear and cellular deformation in response to applied compression was assessed in C3H10T1/2 mouse mesenchymal stem cells encapsulated within poly(ethylene glycol) hydrogels. Biomaterial, cellular, and nuclear deformations were non-linearly related. Parametric finite element simulations suggested that this phenomenon was due to the relative stiffness differences between the hydrogel matrix and that of the encapsulated cell and nucleus, and to strain stiffening of the matrix with increasing compression. This complex mechanical interaction between cells and biomaterials further emphasizes the need for high-throughput approaches to conduct mechanically active experiments in three-dimensional culture. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Moraes, Christopher; Wang, GongHao; Sun, Yu; Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Moraes, Christopher; Sun, Yu; Simmons, Craig A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Simmons, Craig A.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
RP Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada.
EM sun@mie.utoronto.ca; simmons@mie.utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772; Sun, Yu/0000-0001-7895-0741; Moraes,
   Christopher/0000-0002-8950-2212
FU Natural Sciences and Engineering Research Council of Canada; Canadian
   Institutes of Health Research [CHRPJ 323533-06]; Ontario Graduate
   Scholarship program; Canada Research Chairs in Micro and Nano
   Engineering Systems
FX We thank Morakot Likhitpanichkul and Mohamed Abdelgawad for helpful
   suggestions and advice, and Christopher Yip and Gary Mo from the Centre
   for Studies in Molecular Imaging for microscopy expertise and use of
   equipment. We acknowledge microfabrication support from the Emerging
   Communications Technology Institute and the Toronto Microfluidics
   Foundry. We acknowledge financial support from the Natural Sciences and
   Engineering Research Council of Canada and the Canadian Institutes of
   Health Research (CHRPJ 323533-06), the Ontario Graduate Scholarship
   program to CM, and the Canada Research Chairs in Micro and Nano
   Engineering Systems to YS, and in Mechanobiology to CAS.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095
   Ethier CR, 2007, CAMB TEXT BIOMED ENG, P1, DOI 10.2277/ 0521841127
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360
   Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780
   Jongpaiboonkit L, 2008, BIOMATERIALS, V29, P3346, DOI 10.1016/j.biomaterials.2008.04.040
   Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096
   Khademhosseini A, 2004, LAB CHIP, V4, P425, DOI 10.1039/b404842c
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014
   Lee WCC, 2007, BIOMECH MODEL MECHAN, V6, P265, DOI 10.1007/s10237-006-0053-y
   Liu JJ, 2009, LAB CHIP, V9, P1301, DOI 10.1039/b819219g
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988
   MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026
   Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mehta G, 2009, ANAL CHEM, V81, P3714, DOI 10.1021/ac802178u
   Moraes C, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065015
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Panda P, 2008, LAB CHIP, V8, P1056, DOI 10.1039/b804234a
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Pelaez D, 2009, STEM CELLS DEV, V18, P93, DOI 10.1089/scd.2008.0030
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200
   Sim WY, 2007, LAB CHIP, V7, P1775, DOI 10.1039/b712361m
   Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Wang DL, 2007, SPINE, V32, P2521, DOI 10.1097/BRS.0b013e318158cb61
   Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Weber LM, 2006, ACTA BIOMATER, V2, P1, DOI 10.1016/j.actbio.2005.10.005
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yanagisawa M, 2007, LIFE SCI, V81, P405, DOI 10.1016/j.lfs.2007.06.004
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
NR 62
TC 58
Z9 59
U1 5
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2010
VL 31
IS 3
BP 577
EP 584
DI 10.1016/j.biomaterials.2009.09.068
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 532IA
UT WOS:000272739200022
PM 19819010
DA 2018-10-20
ER

PT J
AU Jung, JP
   Gasiorowski, JZ
   Collier, JH
AF Jung, Jangwook P.
   Gasiorowski, Joshua Z.
   Collier, Joel H.
TI Fibrillar Peptide Gels in Biotechnology and Biomedicine
SO BIOPOLYMERS
LA English
DT Review
DE peptides; peptidomimetics; crosslinking; biomaterials
ID SELF-ASSEMBLING PEPTIDES; COLLAGEN TRIPLE HELICES; BETA-HAIRPIN
   HYDROGELS; AMPHIPHILE NANOFIBERS; SUPRAMOLECULAR HYDROGELS;
   ENDOTHELIAL-CELLS; ANTIGEN PATTERNS; AMYLOID FIBRILS; SMALL-MOLECULE;
   SCAFFOLDS
AB Peptides, peptidomimetics, and peptide derivatives that self-assemble into fibrillar gels have received increasing interest as synthetic extracellular matrices for applications in 3D cell culture and regenerative medicine. Recently, several of these fibrillizing molecules have been functionalized with bioactive components and chemical features such as cell-binding ligands, degradable sequences, drug eluting compounds, and cross-linkable groups, thereby producing gels that can reliably display multiple factors simultaneously, This capacity for incorporating precise levels of many different biological and chemical factors is advantageous given the natural complexity of cell-matrix interactions that many current biomaterial strategies seek to mimic. In this review, recent efforts in the area of fibril-forming peptide materials are described, and advantages of biomaterials containing multiple modular elements are outlined. fit addition, a few hurdles and open questions surrounding fibrillar peptide gels are discussed, including issues of the materials' structural heterogeneity challenges in fully characterizing the diversity of their self-assembled structures, and incomplete knowledge of how the materials are processed in vivo. (C) 2010 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 94: 49-59, 2010.
C1 [Jung, Jangwook P.; Gasiorowski, Joshua Z.; Collier, Joel H.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
   [Jung, Jangwook P.; Gasiorowski, Joshua Z.; Collier, Joel H.] Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA.
   [Jung, Jangwook P.] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA.
RP Collier, JH (reprint author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM collier@uchicago.edu
FU National Science Foundation [CHE-0802286]; National Institutes of Health
   (NIDCR, NIBIB) [DE017703, EB007135]; American Heart Association; 
   [0665218B]
FX Contract giant sponsor: National Science Foundation (CAREER Award)
   Contract grant number CHE-0802286 Contract giant sponsor: National
   Institutes of Health (NIDCR, NIBIB) Contract grant numbers: DE017703,
   EB007135 Contract grant sponsor: American Heart Association Contract
   grant number: 0665218B.
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236
   Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Behanna HA, 2007, J AM CHEM SOC, V129, P321, DOI 10.1021/ja062415b
   Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006
   Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019
   Carrick LM, 2007, TETRAHEDRON, V63, P7457, DOI 10.1016/j.tet.2007.05.036
   Chau Y, 2008, BIOMATERIALS, V29, P1713, DOI 10.1016/j.biomaterials.2007.11.046
   Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Collier JH, 2008, SOFT MATTER, V4, P2310, DOI 10.1039/b805563g
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dubois G, 2008, J BIOMED MATER RES B, V87B, P222, DOI 10.1002/jbm.b.31099
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fehr T, 1997, J EXP MED, V185, P1785, DOI 10.1084/jem.185.10.1785
   Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006
   Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003
   Galler KM, 2008, TISSUE ENG PT A, V14, P2051, DOI 10.1089/ten.tea.2007.0413
   Gao J, 2009, J AM CHEM SOC, V131, P11286, DOI 10.1021/ja9042142
   Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gras SL, 2008, BIOMATERIALS, V29, P1553, DOI 10.1016/j.biomaterials.2007.11.028
   Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Haines-Butterick LA, 2008, BIOMATERIALS, V29, P4164, DOI 10.1016/j.biomaterials.2008.07.009
   Hamley IW, 2007, ANGEW CHEM INT EDIT, V46, P8128, DOI 10.1002/anie.200700861
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   HIGASHI N, 2008, SELF ASSEMBLED NANOM, V1, P27
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Hsu L, 2008, J AM CHEM SOC, V130, P3892, DOI 10.1021/ja076553s
   Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kapadia MR, 2008, J VASC SURG, V47, P173, DOI 10.1016/j.jvs.2007.09.005
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   Kodama H, 2004, CHEM COMMUN, P2876, DOI 10.1039/b409641j
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Kopecek J, 2009, ACTA BIOMATER, V5, P805, DOI 10.1016/j.actbio.2008.10.001
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Kretsinger JK, 2005, BIOMATERIALS, V26, P5177, DOI 10.1016/j.biomaterials.2005.01.029
   Laromaine A, 2007, J AM CHEM SOC, V129, P4156, DOI 10.1021/ja0706504
   Larsen P, 2008, APPL ENVIRON MICROB, V74, P1517, DOI 10.1128/AEM.02274-07
   Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mackay JP, 2001, STRUCTURE, V9, P83, DOI 10.1016/S0969-2126(00)00559-1
   MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580
   Makabe K, 2008, J MOL BIOL, V378, P459, DOI 10.1016/j.jmb.2008.02.051
   Makabe K, 2008, J AM CHEM SOC, V130, P14370, DOI 10.1021/ja805011h
   Makabe K, 2007, J AM CHEM SOC, V129, P14661, DOI 10.1021/ja074252c
   Makabe K, 2006, P NATL ACAD SCI USA, V103, P17753, DOI 10.1073/pnas.0606690103
   Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d
   Nagarkar RP, 2008, J AM CHEM SOC, V130, P4466, DOI 10.1021/ja710295t
   Nagarkar Radhika P., 2008, V474, P61, DOI 10.1007/978-1-59745-480-3_5
   OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Ozbas B, 2007, J PHYS CHEM B, V111, P13901, DOI 10.1021/jp075117p
   Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926
   Papapostolou D, 2008, J AM CHEM SOC, V130, P5124, DOI 10.1021/ja0778444
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Rajagopal K, 2006, EUR BIOPHYS J BIOPHY, V35, P162, DOI 10.1007/s00249-005-0017-7
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Reches M, 2007, J NANOSCI NANOTECHNO, V7, P2239, DOI 10.1166/jnn.2007.645
   RILEY JM, 2009, J BIOTECHNOL BIOENG, V103, P241
   Russell P, 2008, INVEST OPHTH VIS SCI, V49, P629, DOI 10.1167/iovs.07-1192
   Sargeant TD, 2008, J TISSUE ENG REGEN M, V2, P455, DOI 10.1002/term.117
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Scanlon S, 2009, SOFT MATTER, V5, P1237, DOI 10.1039/b815558e
   Segers VFM, 2007, DRUG DISCOV TODAY, V12, P561, DOI 10.1016/j.drudis.2007.05.003
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8
   Sontjens SHM, 2000, J AM CHEM SOC, V122, P7487, DOI 10.1021/ja000435m
   Storrie H, 2007, BIOMATERIALS, V28, P4608, DOI 10.1016/j.biomaterials.2007.06.026
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yang Z, 2008, ACCOUNTS CHEM RES, V41, P315, DOI 10.1021/ar7001914
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Yang ZM, 2004, CHEM COMMUN, P2424, DOI 10.1039/b408897b
   Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 103
TC 97
Z9 99
U1 1
U2 59
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD JAN
PY 2010
VL 94
IS 1
BP 49
EP 59
DI 10.1002/bip.21326
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 554GC
UT WOS:000274422500005
PM 20091870
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Baldwin, AD
   Kiick, KL
AF Baldwin, Aaron D.
   Kiick, Kristi L.
TI Polysaccharide-Modified Synthetic Polymeric Biomaterials
SO BIOPOLYMERS
LA English
DT Review
DE biomaterial; polysaccharide-modified polymer; polysaccharide conjugates;
   hydrogel
ID FIBROBLAST-GROWTH-FACTOR; HYALURONIC-ACID HYDROGELS; HEPARINIZED
   COLLAGEN MATRICES; DEGRADABLE DEXTRAN HYDROGELS; TISSUE-ENGINEERING
   SCAFFOLDS; BONE MORPHOGENIC PROTEIN-2; ADVERSE CLINICAL EVENTS; VOCAL
   FOLD REGENERATION; GLYCOL) STAR COPOLYMER; MESENCHYMAL STEM-CELLS
AB This review presents an overview of polysaccharide-conjugated synthetic polymers and their use in tissue-engineered scaffolds and drug-delivery applications. This topic will be divided into four categories: (1) polymeric materials modified with non-mammalian polysaccharides such as alginate, chitin, and dextran; (2) polymers modified with mammalian polysaccharides such as hyaluronan, chondroitin sulfate, and heparin; (3) multi-polysaccharide-derivatized polymer conjugate systems; and (4) polymers containing polysaccharidemimetic molecules. Each section will discuss relevant conjugation techniques, analysis, and the impact of these materials as micelles, particles, or hydrogels to sed in in-vitro and in-vivo biomaterial applications. (C) 2010 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 94: 128-140, 2010.
C1 [Baldwin, Aaron D.; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Baldwin, Aaron D.; Kiick, Kristi L.] Delaware Biotechnol Inst, Newark, DE 19711 USA.
RP Kiick, KL (reprint author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
EM kiick@udel.edu
FU National Science Foundation [DGF-02-11651]; National Institutes of
   Health [5-P20-RR015588, 1-ROI-EB003172]; Arnold and Mabel Beckman
   Foundation; Nemours Foundation
FX Contract grant sponsor: National Science Foundation Contract grant
   number; DGF-02-11651. Contract grant sponsor: National Institutes of
   Health Contract grant sponsor: 5-P20-RR015588, 1-ROI-EB003172 Contract
   granat sponsor: Arnold and Mabel Beckman Foundation Contract grant
   sponsor: Nemours Foundation
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bhattarai N, 2004, MACROMOL BIOSCI, V5, P107, DOI 10.1002/mabi.200400140
   Bhattarai N, 2006, INT J NANOMED, V1, P181, DOI 10.2147/nano.2006.1.2.181
   BLAINE G, 1947, ANN SURG, V125, P102
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Bray HG, 1944, BIOCHEM J, V38, P142, DOI 10.1042/bj0380142
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Bryant SJ, 2004, MACROMOLECULES, V37, P6726, DOI 10.1021/ma0499324
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Capila I., 2002, ANGEW CHEM INT EDIT, V1, 3, p[41, 390], DOI DOI 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.C0;2-B
   Chahine NO, 2005, BIOPHYS J, V89, P1543, DOI 10.1529/biophysj.104.057315
   Chen J, 1999, ULTRAMICROSCOPY, V79, P89, DOI 10.1016/S0304-3991(99)00060-1
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chinen N, 2003, J BIOMED MATER RES A, V67A, P61, DOI 10.1002/jbm.a.10061
   Choi YS, 1999, BIOMATERIALS, V20, P409, DOI 10.1016/S0142-9612(98)00180-X
   Chong BF, 2005, APPL MICROBIOL BIOT, V66, P341, DOI 10.1007/s00253-004-1774-4
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   Chung HJ, 2006, PHARM RES, V23, P1835, DOI 10.1007/s11095-006-9039-9
   Cushing MC, 2007, BIOMATERIALS, V28, P3378, DOI 10.1016/j.biomaterials.2007.04.005
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0
   Dumitriu S., 1996, POLYSACCHARIDES MED
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Feng H, 2006, BIOMACROMOLECULES, V7, P3069, DOI 10.1021/bm060568l
   Fischer G., 1861, ANN CHEM PHARM, V117, P111
   Flynn L, 2007, BIOMATERIALS, V28, P3834, DOI 10.1016/j.biomaterials.2007.05.002
   Fujioka M, 2004, MACROMOL RAPID COMM, V25, P1776, DOI 10.1002/marc.200400288
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Gilbert ME, 2004, LARYNGOSCOPE, V114, P1406, DOI 10.1097/00005537-200408000-00017
   GILCHRIST T, 1983, BIOMATERIALS, V4, P317, DOI 10.1016/0142-9612(83)90036-4
   GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317
   Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Hamidi M, 2006, DRUG DELIV, V13, P399, DOI 10.1080/10717540600814402
   HARRISON JH, 1954, ANN SURG, V139, P137, DOI 10.1097/00000658-195402000-00002
   Hennink WE, 2004, INT J PHARM, V277, P99, DOI 10.1016/j.ijpharm.2003.02.002
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Hu FQ, 2006, COLLOID SURFACE B, V50, P97, DOI 10.1016/j.colsurfb.2006.04.009
   Hu FQ, 2008, EUR J PHARM BIOPHARM, V70, P749, DOI 10.1016/j.ejpb.2008.06.015
   Huang X., 2004, J POLYM SCI A, V42, P5054
   Huang X, 2007, TISSUE ENG, V13, P2645, DOI 10.1089/ten.2007.0084
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishihara M, 2001, J BIOMED MATER RES, V56, P536, DOI 10.1002/1097-4636(20010915)56:4<536::AID-JBM1125>3.3.CO;2-R
   Ishihara M, 2000, J BIOMED MATER RES, V50, P144, DOI 10.1002/(SICI)1097-4636(200005)50:2<144::AID-JBM8>3.0.CO;2-S
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Ju HK, 2001, POLYMER, V42, P6851, DOI 10.1016/S0032-3861(01)00143-4
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim JH, 2002, POLYMER, V43, P7549, DOI 10.1016/S0032-3861(02)00675-4
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   KIM SH, 2009, MATER SCI ENG, P196
   Kim SH, 2007, PEPTIDES, V28, P2125, DOI 10.1016/j.peptides.2007.08.010
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Krishna O. D., 2009, BIOPOLYMERS, V94, P32
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumashiro Y, 2001, BIOMACROMOLECULES, V2, P874, DOI 10.1021/bm015527y
   Kurisawa M, 1998, MACROMOL CHEM PHYSIC, V199, P2613, DOI 10.1002/macp.1998.021991134
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Lansdown A B, 1994, J R Coll Surg Edinb, V39, P284
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee CT, 2007, BIOMOL ENG, V24, P131, DOI 10.1016/j.bioeng.2006.05.010
   Lee CT, 2006, BIOMACROMOLECULES, V7, P2200, DOI 10.1021/bm060451x
   Lee CT, 2006, BIOMACROMOLECULES, V7, P1179, DOI 10.1021/bm050995j
   Lee H, 2009, MACROMOL BIOSCI, V9, P336, DOI 10.1002/mabi.200800229
   Lee H, 2009, J BIOMED MATER RES A, V88A, P797, DOI 10.1002/jbm.a.31983
   Lee JS, 2007, J CONTROL RELEASE, V117, P204, DOI 10.1016/j.jconrel.2006.11.004
   Lee KW, 2006, NUTR DIS PREV, V4, P139
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Li Q, 2003, MACROMOLECULES, V36, P2556, DOI 10.1021/ma021190w
   Linhardt RJ, 2007, SEMIN THROMB HEMOST, V33, P453, DOI 10.1055/s-2007-982076
   Liu L, 2004, EUR POLYM J, V40, P2739, DOI 10.1016/j.eurpolymj.2004.07.016
   Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Malmsten M, 2003, BIOPOLYMERS INTERFAC
   Marumo Kenji, 2004, Journal of Infection and Chemotherapy, V10, P288, DOI 10.1007/s10156-004-0342-2
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Maynard HD, 2005, ACTA BIOMATER, V1, P451, DOI 10.1016/j.actbio.2005.04.004
   McGonigle JS, 2008, J BIOMAT SCI-POLYM E, V19, P1021, DOI 10.1163/156856208784909381
   McLean J, 1916, AM J PHYSIOL, V41, P250
   Meyer K, 1934, J BIOL CHEM, V107, P629
   Naessens M, 2005, J CHEM TECHNOL BIOT, V80, P845, DOI 10.1002/jctb.1322
   Nakamura S, 2006, J BIOMED MATER RES A, V78A, P364, DOI 10.1002/jbm.a.30688
   Neufeld G, 1999, FASEB J, V13, P9
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   PARK KM, ACTA BIOMAT IN PRESS
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peattie RA, 2004, BIOMATERIALS, V25, P2789, DOI 10.1016/j.biomaterials.2003.09.054
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Price RD, 2007, J PLAST RECONSTR AES, V60, P1110, DOI 10.1016/j.bjps.2007.03.005
   Qu X, 2000, POLYMER, V41, P4589, DOI 10.1016/S0032-3861(99)00685-0
   Qu X, 1999, J APPL POLYM SCI, V74, P3193, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3193::AID-APP23>3.0.CO;2-V
   Qu X, 1999, J APPL POLYM SCI, V74, P3186, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3186::AID-APP22>3.0.CO;2-Y
   Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h
   Reis RL, 2008, WOODHEAD PUBL MATER, P1
   Reyes JMG, 2005, INVEST OPHTH VIS SCI, V46, P1247, DOI 10.1167/iovs.04-1192
   Riley CM, 2006, BIOMATERIALS, V27, P5935, DOI 10.1016/j.biomaterials.2006.08.029
   Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200
   ROSENFELD EL, 1957, CLIN CHIM ACTA, V2, P105, DOI 10.1016/0009-8981(57)90090-6
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Seal BL, 2006, ACTA BIOMATER, V2, P241, DOI 10.1016/j.actbio.2005.12.008
   Seal BL, 2006, MACROMOLECULES, V39, P2268, DOI 10.1021/ma0524528
   Seal BL, 2003, BIOMACROMOLECULES, V4, P1572, DOI 10.1021/bm0342032
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Serban MA, 2008, ACTA BIOMATER, V4, P67, DOI 10.1016/j.actbio.2007.09.006
   SERY TW, 1956, J BACTERIOL, V71, P373
   SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540290114450
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392
   Strehin I, 2009, J CATARACT REFR SURG, V35, P567, DOI 10.1016/j.jcrs.2008.11.035
   Sun GM, 2006, CARBOHYD POLYM, V65, P273, DOI 10.1016/j.carbpol.2006.01.015
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Tae G, 2007, BIOMACROMOLECULES, V8, P1979, DOI 10.1021/bm0701189
   Tanihara M, 2001, J BIOMED MATER RES, V56, P216, DOI 10.1002/1097-4636(200108)56:2<216::AID-JBM1086>3.3.CO;2-E
   Tipson R. S., 1985, ADV CARBOHYDRATE CHE
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Volpi N, 2006, ADV PHARMACOL, V53, pXXV
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Watanabe H, 1998, J BIOCHEM-TOKYO, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wu Y, 2005, CARBOHYD POLYM, V59, P165, DOI 10.1016/j.carbpol.2004.09.006
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1931, DOI 10.1021/bm0500042
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
   Yamaguchi N, 2007, J AM CHEM SOC, V129, P3040, DOI 10.1021/ja0680358
   YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432
   YAMAOKA T, 1995, J PHARM PHARMACOL, V47, P479, DOI 10.1111/j.2042-7158.1995.tb05835.x
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yu HJ, 2006, BIOPOLYMERS, V83, P233, DOI 10.1002/bip.20551
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
   Zhang JX, 2008, BIOMATERIALS, V29, P4521, DOI 10.1016/j.biomaterials.2008.08.008
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
   Zhang XZ, 2004, J MATER SCI-MATER M, V15, P865, DOI 10.1023/B:JMSM.0000036274.83104.fe
   Zhang XZ, 2004, BIOMATERIALS, V25, P4719, DOI 10.1016/j.biomaterials.2003.11.040
   Zhang YL, 2001, J BIOMED MATER RES, V54, P1
   Zhang YL, 2002, J BIOMED MATER RES, V59, P318, DOI 10.1002/jbm.1248
   Zhang YL, 2000, J POLYM SCI POL CHEM, V38, P2392, DOI 10.1002/1099-0518(20000701)38:13<2392::AID-POLA120>3.0.CO;2-P
   Zhang YL, 1999, J POLYM SCI POL CHEM, V37, P4554, DOI 10.1002/(SICI)1099-0518(19991215)37:24<4554::AID-POLA13>3.0.CO;2-T
NR 173
TC 149
Z9 151
U1 11
U2 192
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD JAN
PY 2010
VL 94
IS 1
BP 128
EP 140
DI 10.1002/bip.21334
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 554GC
UT WOS:000274422500011
PM 20091875
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yamada, Y
   Hozumi, K
   Katagiri, F
   Kikkawa, Y
   Nomizu, M
AF Yamada, Yuji
   Hozumi, Kentaro
   Katagiri, Fumihiko
   Kikkawa, Yamato
   Nomizu, Motoyoshi
TI Biological Activity of Laminin Peptide-Conjugated Alginate and Chitosan
   Matrices
SO BIOPOLYMERS
LA English
DT Article
DE laminin peptide; cell adhesion; alginate chitosan; integrin; syndecan
ID CELL-BINDING SEQUENCES; ALPHA-1 CHAIN; DRUG-DELIVERY; G-DOMAIN;
   SYNTHETIC PEPTIDES; BASEMENT-MEMBRANE; TISSUE; BIOMATERIALS; SITES;
   ADHESION
AB Laminin active peptide conjugated chitosan mambrane have been previously demonstrated as a useful biomaterial for tissue engineering Here three laminin active peptides, A99 (AGTFAIRGDNPOG) AG73 (RKRLQVQLSIRT) and EF1zz (ATLQLQEGRLHFXFDLGKGR, X Nle), which interact with integrin alpha v beta 3, syndecans, and integrin 1213, respectively, were conjugated to alginate and evaluated the biological activities A99-alginate (3-3000 ng/min(2)) promoted cell attachment depending on the amount of alginate More than 300 ng/mm(2) of the, A99-alginate matrices effectively promoted cell attachment, cell spreading with well-organized actin stress fibers, and neurite outgrowth AG73- and EF1zz-alginates promoted strong cell attachment at the all amounts (3-3000 ng/mm(2)) A99-alginate (30-3000 ng/mm(2)) promoted strong neurite outgrowth but lower amounts of A99-alginate (3 ng/mm(2)) showed weak activity In contrast, AG73-alginates (3-30 ng/mm(2)) showed strong neurite outgrowth activity but higher amounts of AG73-alginate (300-3000 ng/mm(2)) decreased the activity These data indicate that neurite outgrowth activity of peptide-alginate matrices is peptide specific and the activity is dependent on the amount of alginate Further, biological activities of the peptides on alginate and chitosan matrices were different, suggesting that the integrin- and syndecan-mediated cellular functions on the peptide-matrices are highly influenced by the scaffold structure including polysaccharide types and amounts The laminin active peptide-conjugated alginate and chitosan matrices can control receptor type specific junctions and are useful for tissue engineering (C) 2010 Wiley Periodicals, Inc Biopolymers (Pept Sci) 94 711-720,2010
C1 [Yamada, Yuji; Hozumi, Kentaro; Katagiri, Fumihiko; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Tokyo 1920392, Japan.
RI Kikkawa, Yamato/D-1503-2010
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [17390024, 17014081, 2175017]
FX Contract grant sponsor Scientific Research from the Ministry of
   Education, Cultures, Sports, Science and Technology of Japan; Contract
   grant number 17390024 17014081 2175017
CR BADVLAK SF, 2007, BIOMATERIALS, V28, P3587
   BADVLAK SF, 2009, ACTA BIOMATER, V5, P1
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Cardenas G, 2008, J MATER SCI-MATER M, V19, P2397, DOI 10.1007/s10856-007-3275-3
   Chiu CT, 2008, J MATER SCI-MATER M, V19, P2503, DOI 10.1007/s10856-008-3389-2
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Dhoot NO, 2003, J PHARM SCI, V92, P679, DOI 10.1002/jps.19104
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hosoya K, 2004, J BIOMED MATER RES A, V71A, P596, DOI 10.1002/jbm.a.30189
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Masuda R, 2009, WOUND REPAIR REGEN, V17, P127, DOI 10.1111/j.1524-475X.2008.00450.x
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   MOCHIZUKI M, 2003, FASEB J, V17, P876
   Mochizuki M, 2007, BIOPOLYMERS, V88, P122, DOI 10.1002/bip.20684
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Renner C, 2004, BIOPOLYMERS, V76, P34, DOI 10.1002/bip.10569
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
NR 42
TC 23
Z9 23
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2010
VL 94
IS 6
SI SI
BP 711
EP 720
DI 10.1002/bip.21429
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 702ME
UT WOS:000285898000005
PM 20564024
DA 2018-10-20
ER

PT S
AU Fuchs, S
   Dohle, E
   Kolbe, M
   Kirkpatrick, CJ
AF Fuchs, Sabine
   Dohle, Eva
   Kolbe, Marlen
   Kirkpatrick, Charles James
BE Kasper, C
   VanGriensven, M
   Portner, R
TI Outgrowth Endothelial Cells: Sources, Characteristics and Potential
   Applications in Tissue Engineering and Regenerative Medicine
SO BIOREACTOR SYSTEMS FOR TISSUE ENGINEERING II: STRATEGIES FOR THE
   EXPANISON AND DIRECTED DIFFERENTIATION OF STEM CELLS
SE Advances in Biochemical Engineering-Biotechnology
LA English
DT Article; Book Chapter
DE Bone tissue engineering; Co-culture models; Endothelial progenitor
   cells; Vascularization
ID HUMAN PERIPHERAL-BLOOD; ANGIOGENIC GROWTH-FACTORS; MESENCHYMAL
   STEM-CELLS; UMBILICAL-CORD BLOOD; PROGENITOR CELLS; IN-VITRO;
   BONE-MARROW; HUMAN OSTEOPROGENITORS; COCULTURE MODEL; GENE-EXPRESSION
AB Endothelial progenitor cells from peripheral blood or cord blood are attracting increasing interest as a potential cell source for cellular therapies aiming to enhance the neovascularization of tissue engineered constructs or ischemic tissues. The present review focus on a specific population contained in endothelial progenitor cell cultures designated as outgrowth endothelial cells (OEC) or endothelial colony forming cells from peripheral blood or cord blood. Special attention will be paid to what is currently known in terms of the origin and the cell biological or functional characteristics of OEC. Furthermore, we will discuss current concepts, how OEC might be integrated in complex tissue engineered constructs based on biomaterial or co-cultures, with special emphasis on their potential application in bone tissue engineering and related vascularization strategies.
C1 [Fuchs, Sabine; Dohle, Eva; Kolbe, Marlen; Kirkpatrick, Charles James] Univ Med Johannes Gutenberg Univ, Inst Pathol, Mainz, Germany.
RP Fuchs, S (reprint author), Univ Med Johannes Gutenberg Univ, Inst Pathol, Langenbeckstr 1, Mainz, Germany.
EM fuchss@uni-mainz.de
CR Allen J, 2008, TISSUE ENG PT A, V14, P183, DOI 10.1089/ten.a.2007.0265
   ANKA N, 2007, BIOTECHNOL BIOENG, V98, P306
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   AU P, 2008, BLOOD
   Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318
   Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677
   Berthod F, 2006, J CELL PHYSIOL, V207, P491, DOI 10.1002/jcp.20584
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002
   Corselli M, 2008, EXP HEMATOL, V36, P340, DOI 10.1016/j.exphem.2007.10.008
   Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   DOHLE E, 2009, TISSUE ENG PART A
   ELAINE F, 2008, DERMATOL SURG, V34, P137
   Elbjeirami WM, 2006, TISSUE ENG, V12, P381, DOI 10.1089/ten.2006.12.381
   Finkenzeller G, 2006, TISSUE ENG, V12, P2889, DOI 10.1089/ten.2006.12.2889
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Fuchs S, 2006, CELL TISSUE RES, V326, P79, DOI 10.1007/s00441-006-0222-4
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Gehling UM, 2000, BLOOD, V95, P3106
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerber HP, 1999, NAT MED, V5, P623
   Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001
   Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033
   Gu F, 2004, J CONTROL RELEASE, V96, P463, DOI 10.1016/j.jconrel.2004.02.021
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Gulati R, 2003, CIRC RES, V93, P1023, DOI 10.1161/01.RES.0000105569.77539.21
   Hoffmann J, 2008, J BIOMED MATER RES A, V84A, P614, DOI 10.1002/jbm.a.31309
   Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024
   Hristov M, 2007, THROMB HAEMOSTASIS, V98, P274, DOI 10.1160/TH07-03-0181
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Jiang Aixiang, 2007, J Bioinform Comput Biol, V5, P875, DOI 10.1142/S0219720007002989
   Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   KOLBE M, 2009, TISSUE ENG PART C ME
   KUSANO KF, 2005, NAT MED, V11, P197
   Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071
   Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Meury T, 2006, J CELL BIOCHEM, V98, P992, DOI 10.1002/jcb.20818
   Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016
   Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156
   Peichev M, 2000, BLOOD, V95, P952
   Pelosi E, 2002, BLOOD, V100, P3203, DOI 10.1182/blood-2002-05-1511
   Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083
   Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0
   Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362
   Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327
   Ribatti D, 2001, J VASC RES, V38, P389, DOI 10.1159/000051070
   Rivron NC, 2008, EUR CELLS MATER, V15, P27, DOI 10.22203/eCM.v015a03
   Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685
   Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Schmidt D, 2006, ANN THORAC SURG, V82, P1465, DOI 10.1016/j.athoracsur.2006.05.066
   Serrano MC, 2008, J BIOMED MATER RES A, V87A, P964, DOI 10.1002/jbm.a.31728
   Shepherd BR, 2006, FASEB J, V20, P1739, DOI 10.1096/fj.05-5682fje
   Shi Q, 1998, BLOOD, V92, P362
   Shirota T, 2003, TISSUE ENG, V9, P473, DOI 10.1089/107632703322066651
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203
   Somani A, 2007, TRANSL RES, V150, P30, DOI 10.1016/j.trsl.2007.02.002
   Stahl A, 2004, BIOCHEM BIOPH RES CO, V322, P684, DOI 10.1016/j.bbrc.2004.07.175
   Steurer Michael, 2008, BMC Res Notes, V1, P71, DOI 10.1186/1756-0500-1-71
   TAKAHITO Y, 2002, J CELL PHYSL, V193, P225
   Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142
   Veleva AN, 2008, BIOMATERIALS, V29, P3656, DOI 10.1016/j.biomaterials.2008.05.022
   Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001
   Wu HK, 2005, J SURG RES, V126, P193, DOI 10.1016/j.jss.2005.01.016
   Yan C, 2009, J CELL BIOCHEM, V106, P353
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
   Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433
   Yuasa T, 2002, J CELL PHYSIOL, V193, P225, DOI 10.1002/jcp.10166
NR 84
TC 29
Z9 29
U1 1
U2 8
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0724-6145
BN 978-3-642-16050-9
J9 ADV BIOCHEM ENG BIOT
JI Adv. Biochem. Eng. Biotechnol.
PY 2010
VL 123
BP 201
EP 217
DI 10.1007/10_2009_65
D2 10.1007/978-3-642-16051-6
PG 17
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BRV89
UT WOS:000283765600008
PM 20182927
DA 2018-10-20
ER

PT J
AU Kim, HW
   Kang, W
   Jeon, E
   Jang, JH
AF Kim, Hae-Won
   Kang, Wonmo
   Jeon, Eunyi
   Jang, Jun-Hyeog
TI Construction and expression of a recombinant fibronectin(III)10 protein
   for integrin-mediated cell adhesion
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Bone; Fibronectin; Cell adhesion; Extracellular matrix
ID RECEPTORS
AB Specific sequences of cell-adhesive peptide/proteins are often required for the bio-inert synthetic polymers to improve cell adhesion. We have developed a recombinant fibronectin fragment (FN(III)10), the central cell-binding domain containing RGD motif, to endow biomaterial surfaces with abilities to promote an integrin-mediated cell adhesion. Immobilized FN(III)10 stimulated adhesion of MC3TC-E1 cells in an integrin-dependent manner.
C1 [Kang, Wonmo; Jeon, Eunyi; Jang, Jun-Hyeog] Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.
   [Kim, Hae-Won] Dankook Univ, Sch Dent, Dept Biomat Sci, Seoul, South Korea.
   [Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Seoul, South Korea.
   [Kim, Hae-Won] Dankook Univ, Biomat & Tissue Engn Lab, Dept Nanobiomed Sci, Seoul, South Korea.
   [Kim, Hae-Won] Dankook Univ, WCU Res Ctr, Seoul, South Korea.
RP Jang, JH (reprint author), Inha Univ, Sch Med, Dept Biochem, Inchon, South Korea.
EM juhjang@inha.edu
FU Ministry for Health, Welfare and Family Affairs, Republic of Korea
   [A084458]
FX This study was supported by a grant of the Korea Healthcare technology
   R&D Project, Ministry for Health, Welfare and Family Affairs, Republic
   of Korea (A084458).
CR AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863
   Choung PH, 2002, BIOCHEM BIOPH RES CO, V295, P898, DOI 10.1016/S0006-291X(02)00774-X
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kang W, 2008, BIOTECHNOL LETT, V30, P55, DOI 10.1007/s10529-007-9522-3
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
NR 9
TC 9
Z9 9
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD JAN
PY 2010
VL 32
IS 1
BP 29
EP 33
DI 10.1007/s10529-009-0111-5
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 530CG
UT WOS:000272565900004
PM 19707723
DA 2018-10-20
ER

PT J
AU von der Mark, K
   Park, J
   Bauer, S
   Schmuki, P
AF von der Mark, Klaus
   Park, Jung
   Bauer, Sebastian
   Schmuki, Patrik
TI Nanoscale engineering of biomimetic surfaces: cues from the
   extracellular matrix
SO CELL AND TISSUE RESEARCH
LA English
DT Review
DE Extracellular matrix; Biomimetic materials; Tissue engineering;
   Nanotechnology; Nanotopography
ID ARG-GLY-ASP; TIO2 NANOTUBE SURFACES; HEPARAN-SULFATE PROTEOGLYCAN;
   COLLAGENASE GENE-EXPRESSION; CAPILLARY-LIKE STRUCTURES;
   HUMAN-ENDOTHELIAL CELLS; IN-VITRO; OSTEOBLAST ADHESION; DRUG-DELIVERY;
   ORTHOPEDIC APPLICATIONS
AB The ultimate goal in the design of biomimetic materials for use in tissue engineering as permanent or resorbable tissue implants is to generate biocompatible scaffolds with appropriate biomechanical and chemical properties to allow the adhesion, ingrowth, and survival of cells. Recent efforts have therefore focused on the construction and modification of biomimetic surfaces targeted to support tissue-specific cell functions including adhesion, growth, differentiation, motility, and the expression of tissue-specific genes. Four decades of extensive research on the structure and biological influence of the extracellular matrix (ECM) on cell behavior and cell fate have shown that three types of information from the ECM are relevant for the design of biomimetic surfaces: ( 1) physical properties ( elasticity, stiffness, resilience of the cellular environment), ( 2) specific chemical signals from peptide epitopes contained in a wide variety of extracelluar matrix molecules, and ( 3) the nanoscale topography of microenvironmental adhesive sites. Initial physical and chemical approaches aimed at improving the adhesiveness of biomaterial surfaces by sandblasting, particle coating, or etching have been supplemented by attempts to increase the bioactivity of biomaterials by coating them with ECM macromolecules, such as fibronectin, elastin, laminin, and collagens, or their integrin-binding epitopes including RGD, YIGSR, and GFOGER. Recently, the development of new nanotechnologies such as photo- or electron-beam nanolithography, polymer demixing, nano-imprinting, compression molding, or the generation of TiO2 nanotubes of defined diameters (15-200 nm), has opened up the possibility of constructing biomimetic surfaces with a defined nanopattern, eliciting tissue-specific cellular responses by stimulating integrin clustering. This development has provided new input into the design of novel biomaterials. The new technologies allowing the construction of a geometrically defined microenvironment for cells at the nanoscale should facilitate the investigation of nanotopography-dependent mechanisms of integrin-mediated cell signaling.
C1 [von der Mark, Klaus; Park, Jung] Friedrich Alexander Univ Erlangen Nuremberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany.
   [Bauer, Sebastian; Schmuki, Patrik] Friedrich Alexander Univ Erlangen Nuremberg, Dept Mat Sci, Inst Surface Chem & Corros LKO, D-91054 Erlangen, Germany.
RP von der Mark, K (reprint author), Friedrich Alexander Univ Erlangen Nuremberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, Glueckstr 6, D-91054 Erlangen, Germany.
EM kvdmark@molmed.uni-erlangen.de
RI Zhou, Feng/E-9510-2011
FU Deutsche Forschungsgemeinschaft (DFG) [MA534/20-1, MA534/24-1, SCHM
   1597/9-1]
FX We thank the Deutsche Forschungsgemeinschaft for financial support of
   our work on TiO<INF>2</INF> nanotubes (DFG grants MA534/20-1,
   MA534/24-1, SCHM 1597/9-1; see Figs. 3, 4, 5).
CR AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Andreiotelli M, 2009, CLIN IMPLANT DENT R, V11, P158, DOI 10.1111/j.1708-8208.2008.00105.x
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Arnaout MA, 2002, IMMUNOL REV, V186, P125, DOI 10.1034/j.1600-065X.2002.18612.x
   Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H
   Ayad S., 1998, EXTRACELLULAR MATRIX
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   BARD JBL, 1975, J CELL BIOL, V67, P400, DOI 10.1083/jcb.67.2.400
   Bauer S, 2006, ELECTROCHEM COMMUN, V8, P1321, DOI 10.1016/j.elecom.2006.05.030
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   BECKER U, 1975, EUR J BIOCHEM, V54, P359, DOI 10.1111/j.1432-1033.1975.tb04146.x
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   BINDER PS, 1991, INVEST OPHTH VIS SCI, V32, P2234
   BIRK DE, 1986, J CELL BIOL, V103, P231, DOI 10.1083/jcb.103.1.231
   Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Brinckmann J., 2005, COLLAGEN PRIMER STRU
   BURGESON RE, 1988, ANNU REV CELL BIOL, V4, P551, DOI 10.1146/annurev.cellbio.4.1.551
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Cavalcanti-Adam EA, 2008, HFSP J, V2, P276, DOI 10.2976/1.2976662
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Cavalcanti-Adam Elisabetta Ada, 2005, Prog Orthod, V6, P232
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chajra H, 2008, BIO-MED MATER ENG, V18, pS33
   CHAMBARD M, 1981, J CELL BIOL, V91, P157, DOI 10.1083/jcb.91.1.157
   CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P986, DOI 10.1016/j.biocel.2003.12.002
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Choudhary S, 2006, INT J NANOMED, V1, P41, DOI 10.2147/nano.2006.1.1.41
   Chung S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015019
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Conner KA, 2003, J PERIODONTOL, V74, P658, DOI 10.1902/jop.2003.74.5.658
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   CUNNINGHAM LW, 1987, STRUCTURAL CONTRAC D
   Curtis ASG, 2006, J R SOC INTERFACE, V3, P393, DOI 10.1098/rsif.2005.0104
   Dailey L, 2003, J CELL BIOL, V161, P1053, DOI 10.1083/jcb.200302075
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   DALBY MJ, 2005, EUR CELLS MATER, V9, P8
   Davies JE, 1996, ANAT REC, V245, P426
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   DENDUNNEN WFA, 1993, MICROSURG, V14, P508, DOI 10.1002/micr.1920140808
   Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200
   Eble JA, 2001, OSTEOARTHR CARTILAGE, V9, pS131
   EKAPUTRA AK, 2009, TISSUE EN A IN PRESS
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Emerich DF, 2007, J DRUG TARGET, V15, P163, DOI 10.1080/10611860701231810
   Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ergun C, 2009, J BIOMED MATER RES A, V89A, P727, DOI 10.1002/jbm.a.32035
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   FUERER C, 2009, DEV DYN IN PRESS
   Fujihara K, 2004, BIOMATERIALS, V25, P3877, DOI 10.1016/j.biomaterials.2003.10.050
   Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghicov A, 2008, SMALL, V4, P1063, DOI 10.1002/smll.200701244
   Giancotti FG, 2003, DEV CELL, V4, P149, DOI 10.1016/S1534-5807(03)00034-0
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799
   Goodman SB, 2009, J BIOMED MATER RES A, V90A, P603, DOI 10.1002/jbm.a.32063
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Grashoff C, 2003, EMBO REP, V4, P432, DOI 10.1038/sj.embor.embor801
   Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   Hattori K, 2000, J Orthop Sci, V5, P57, DOI 10.1007/s007760050009
   HAUSSER H, 1994, FEBS LETT, V353, P243, DOI 10.1016/0014-5793(94)01044-7
   Hay E.D., 1983, Modern Cell Biology, V2, P509
   HEDBOM E, 1993, J BIOL CHEM, V268, P27307
   HEINEGARD D, 1987, METHOD ENZYMOL, V144, P305
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   Hirschfeld-Warneken VC, 2008, EUR J CELL BIOL, V87, P743, DOI 10.1016/j.ejcb.2008.03.011
   Hocking AM, 1998, MATRIX BIOL, V17, P1
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Hu J, 2008, BIOMATERIALS, V29, P3815, DOI 10.1016/j.biomaterials.2008.06.015
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866
   Hunziker EB, 1996, HISTOCHEM CELL BIOL, V106, P375
   Huo FW, 2008, SCIENCE, V321, P1658, DOI 10.1126/science.1162193
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702
   Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609
   Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2
   Jalali S, 2001, P NATL ACAD SCI USA, V98, P1042, DOI 10.1073/pnas.031562998
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263
   Karlinsey RL, 2006, BIOINSPIR BIOMIM, V1, P12, DOI 10.1088/1748-3182/1/1/002
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Keeney M, 2009, TISSUE ENG PART C-ME, V15, P265, DOI 10.1089/ten.tec.2008.0365
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Khakbaznejad A, 2004, J BIOMED MATER RES A, V70A, P206, DOI 10.1002/jbm.a.30058
   Khang D, 2008, BIOMED MICRODEVICES, V19, P19
   Khang D, 2006, INT J NANOMED, V1, P65, DOI 10.2147/nano.2006.1.1.65
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X
   Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159
   KIM HW, 2009, BIOTECHNOL IN PRESS
   KING SR, 1991, SURGERY, V109, P76
   Knabe C, 2004, BIOMATERIALS, V25, P4911, DOI 10.1016/j.biomaterials.2004.01.059
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82
   Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853
   Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   KUHN K, 1986, RHEUMATOLOGY, V10, P29
   KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H
   KUO SC, 1993, BIOPHYS J, V65, P2191, DOI 10.1016/S0006-3495(93)81277-3
   KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903
   Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009
   Larsson S, 2006, SCAND J SURG, V95, P111, DOI 10.1177/145749690609500206
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   LAURENT TC, 1992, FASEB J, V6, P2397
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   LEE EYHP, 1985, P NATL ACAD SCI USA, V82, P1419, DOI 10.1073/pnas.82.5.1419
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Lee SW, 2006, ADV MATER, V18, P1133, DOI 10.1002/adma.200600070
   Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Li JH, 2008, J MATER SCI-MATER M, V19, P2595, DOI 10.1007/s10856-007-3354-5
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liao E, 2007, TISSUE ENG, V13, P537, DOI 10.1089/ten.2006.0117
   Lin CH, 2008, TISSUE ENG PART C-ME, V14, P69, DOI 10.1089/tec.2007.0336
   Lind M, 2008, CONNECT TISSUE RES, V49, P437, DOI 10.1080/03008200802325037
   Liu CZ, 2009, ACTA BIOMATER, V5, P661, DOI 10.1016/j.actbio.2008.09.022
   Liu J, 2009, SMALL, V5, P536, DOI 10.1002/smll.200801440
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Macak JM, 2007, SMALL, V3, P300, DOI 10.1002/smll.200600426
   Macak JM, 2005, ANGEW CHEM INT EDIT, V44, P2100, DOI 10.1002/anie.200462459
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Malicev E, 2007, BIOTECHNOL BIOENG, V96, P364, DOI 10.1002/bit.21038
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   MAUCH C, 1989, FEBS LETT, V250, P301, DOI 10.1016/0014-5793(89)80743-4
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Millward-Sadler SJ, 2004, ANN BIOMED ENG, V32, P435, DOI 10.1023/B:ABME.0000017538.72511.48
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   MOHRI H, 1991, AM J HEMATOL, V37, P14, DOI 10.1002/ajh.2830370105
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   MORRIS NP, 2002, CONNECTIVE TISSUE IT, P41
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Muller LJ, 2004, EXP EYE RES, V78, P493, DOI 10.1016/S0014-4835(03)00206-9
   NOMIZU M, 1993, CANCER RES, V53, P3459
   Oh IK, 2005, J MATER SCI-MATER M, V16, P635, DOI 10.1007/s10856-005-2534-4
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   OLDBERG A, 1990, BIOCHEM SOC T, V18, P789, DOI 10.1042/bst0180789
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Pacifici M, 2005, J BONE MINER METAB, V23, P191, DOI 10.1007/s00774-004-0584-1
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   PFAFF M, 1994, J BIOL CHEM, V269, P20233
   Ponader S, 2008, J BIOMED MATER RES A, V84A, P1111, DOI 10.1002/jbm.a.31540
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   PYTELA R, 1987, METHOD ENZYMOL, V144, P475
   Raja PMV, 2007, TOXICOL LETT, V169, P51, DOI 10.1016/j.toxlet.2006.12.003
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239
   Responte Donald J., 2007, Critical Reviews in Biomedical Engineering, V35, P363
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Richardson TP, 2001, CRIT REV EUKAR GENE, V11, P47
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363
   ROYCE PM, 2002, CONNECTIVE TISSUE IT
   Ruggiero F, 2008, METHODS, V45, P75, DOI 10.1016/j.ymeth.2008.01.003
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Ruszczak Z, 1999, DERMATOLOGY, V199, P285, DOI 10.1159/000018305
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Salter DM, 1997, J BONE MINER RES, V12, P1133, DOI 10.1359/jbmr.1997.12.7.1133
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Sasaki T, 2001, FEBS LETT, V509, P181, DOI 10.1016/S0014-5793(01)03167-2
   Sato M, 2008, J BIOMED MATER RES A, V84A, P265, DOI 10.1002/jbm.a.31469
   Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200
   Schenk RK, 1998, PERIODONTOL 2000, V17, P22, DOI 10.1111/j.1600-0757.1998.tb00120.x
   SCHENK RK, 2002, CONNECTIVE TISSUE IT, P67
   Schmidt RC, 2009, J BIOMED MATER RES A, V90A, P1252, DOI 10.1002/jbm.a.32501
   Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005
   Schwartz Zvi, 2005, Alpha Omegan, V98, P9
   SENIOR RM, 1980, J CLIN INVEST, V66, P859, DOI 10.1172/JCI109926
   SHAPIRO HS, 1993, MATRIX, V13, P431, DOI 10.1016/S0934-8832(11)80109-5
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2009, NAT NANOTECHNOL, V4, P82, DOI 10.1038/nnano.2008.424
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Singh R, 2009, EXP MOL PATHOL, V86, P215, DOI 10.1016/j.yexmp.2008.12.004
   Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3
   Spatz J. P., 2004, NANOBIOTECHNOLOGY, P53
   Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x
   Staunton David, 2009, V522, P73, DOI 10.1007/978-1-59745-413-1_5
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Still J, 2003, BURNS, V29, P837, DOI 10.1016/S0305-4179(03)00164-5
   Stoddart MJ, 2009, REGEN MED, V4, P81, DOI 10.2217/17460751.4.1.81
   STREULI CH, 1990, J CELL BIOL, V110, P1405
   SUN X, 1992, J CELL BIOL, V118, P693, DOI 10.1083/jcb.118.3.693
   Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636
   Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2
   Takagi M, 2001, J BONE MINER RES, V16, P79, DOI 10.1359/jbmr.2001.16.1.79
   Tang SQ, 2007, BIOMED MATER, V2, pS135, DOI 10.1088/1748-6041/2/3/S10
   TASHIRO K, 1991, J CELL PHYSIOL, V146, P451, DOI 10.1002/jcp.1041460316
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Tiitu V, 2008, BIO-MED MATER ENG, V18, P225, DOI 10.3233/BME-2008-0529
   TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9
   Tortelli F, 2009, EUR CELLS MATER, V17, P1
   Tryggvason K, 1993, CURR OPIN CELL BIOL, V5, P877, DOI 10.1016/0955-0674(93)90038-R
   Tsuchiya H, 2005, SMALL, V1, P722, DOI 10.1002/smll.200400163
   Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VIGNY M, 1988, J CELL PHYSIOL, V137, P321, DOI 10.1002/jcp.1041370216
   Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012
   Volpi N, 2009, CURR MED CHEM, V16, P1718, DOI 10.2174/092986709788186138
   von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200
   von der Mark H, 2007, J MOL BIOL, V371, P1188, DOI 10.1016/j.jmb.2007.05.074
   von der Mark K., 2002, CONNECTIVE TISSUE IT, P293
   Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Ward BC, 2006, BIOMATERIALS, V27, P3064, DOI 10.1016/j.biomaterials.2005.12.027
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   Xiong JY, 2008, J MECH BEHAV BIOMED, V1, P269, DOI 10.1016/j.jmbbm.2007.09.003
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yao C, 2008, J BIOMED MATER RES A, V85A, P157, DOI 10.1002/jbm.a.31551
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   YURCHENCO PD, 1990, FASEB J, V4, P1577
   Zhang CM, 2005, CHINESE J ASTRON AST, V5, P21, DOI 10.1088/1009-9271/5/S1/21
   Zhou QH, 2009, J DRUG TARGET, V17, P364, DOI 10.1080/10611860902807046
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 271
TC 199
Z9 202
U1 12
U2 264
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD JAN
PY 2010
VL 339
IS 1
BP 131
EP 153
DI 10.1007/s00441-009-0896-5
PG 23
WC Cell Biology
SC Cell Biology
GA 548IF
UT WOS:000273953300012
PM 19898872
DA 2018-10-20
ER

PT B
AU Bruns, S
   Stark, Y
   Marten, D
   Allmeling, C
   Kasper, C
   Stahl, F
   Scheper, T
AF Bruns, Stephanie
   Stark, Yvonne
   Marten, Dana
   Allmeling, Christina
   Kasper, Cornelia
   Stahl, Frank
   Scheper, Thomas
BE Noll, T
TI A Preliminary Study on Spider Silk as Biomaterial for Peripheral Nerve
   Regeneration
SO CELLS AND CULTURE
SE ESACT Proceedings
LA English
DT Proceedings Paper
CT 20th ESACT Meeting
CY JUN 17-OCT 05, 2007
CL Dresden, GERMANY
SP ESACT
DE Immortalized Schwann cells; Mechanical properties of spider silk; PC-12
   cells; Peripheral nerve regeneration; Spider silk
ID GAP
AB Biomaterials for Tissue Engineering applications have to be biocompatible and biodegradable, they should enhance cell adhesion and enable sufficient nutrient transport. Moreover, in regard to nerve repair they have to provide high mechanical stability in addition to sufficient elasticity. Spider silk ought to combine all mentioned properties and, thus, is investigated in this study concerning its cytotoxicity, mechanical properties and applicability in cell culture. Experiments are performed with the established cell lines PC-12 cells and immortalized Schwann cells, often used for neurobiological and neurochemical studies and well described in the literature. Cells were cultured in the presence and on spider silk respectively. Cytotoxicity, viability (MTT-assay) and proliferation (BrdU-assay) of the cell lines growing on the spider silk strands were investigated. Additionally, morphology of cell settling and spreading of the cells on the strands were observed by means of confocal and SEM micrographs. Mechanical properties as mechanical strength and elasticity were evaluated subject to an increasing filament cross section. The results indicate the excellent suitability of spider silk for enhanced guided nerve repair.
C1 [Bruns, Stephanie; Stark, Yvonne; Marten, Dana; Kasper, Cornelia; Stahl, Frank; Scheper, Thomas] Leibniz Univ Hannover, Inst Tech Chem, Callinstr 3, D-30167 Hannover, Germany.
   [Allmeling, Christina] Hannover Med Sch, Klin Plast Hand & Wiederherstellungschirurg, D-30659 Hannover, Germany.
RP Scheper, T (reprint author), Leibniz Univ Hannover, Inst Tech Chem, Callinstr 3, D-30167 Hannover, Germany.
EM scheper@iftc.uni-hannover.de
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   SUEMATSU N, 1989, MICROSURG, V10, P71, DOI 10.1002/micr.1920100112
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 978-90-481-3419-9; 978-90-481-3418-2
J9 ESACT PROCEED
PY 2010
VL 4
BP 573
EP 578
DI 10.1007/978-90-481-3419-9_99
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA BH3JS
UT WOS:000399748800099
DA 2018-10-20
ER

PT J
AU Breyner, NM
   Hell, RCR
   Carvalho, LRP
   Machado, CB
   Peixoto, IN
   Valerio, P
   Pereira, MM
   Goes, AM
AF Breyner, Natalia M.
   Hell, Rafaela C. R.
   Carvalho, Luiza R. P.
   Machado, Carolina B.
   Peixoto Filho, Inacio N.
   Valerio, Patricia
   Pereira, Marivalda M.
   Goes, Alfredo M.
TI Effect of a Three-Dimensional Chitosan Porous Scaffold on the
   Differentiation of Mesenchymal Stem Cells into Chondrocytes
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Chitosan; Mesenchymal stem cells; Gelatin; Scaffold; Chondrogenesis;
   Chondrogenic medium
ID TISSUE-ENGINEERING APPLICATIONS; CHONDROGENIC DIFFERENTIATION; IN-VITRO;
   CARTILAGE; DEXAMETHASONE; COMPOSITES; CONSTRUCTS; MATRIX; GROWTH
AB Cartilage tissue has a poor capacity for self-repair, especially in the case of severe cartilage damage due to trauma or agerelated degeneration. Cell-based tissue engineering using scaffolds has provided an option for the repair of cartilage tissue. The present work demonstrates that a three-dimensional (3D) chitosan scaffold increases the efficiency of the adhesion and differentiation of mesenchymal stem cells (MSCs) after the addition of a chondrogenic medium. These culture conditions promoted MSC differentiation into chondrocytes during the first 9 weeks of monolayer or 3D culture in a scaffold composed of chitosan or chitosan/gelatin. The results demonstrated that a chitosan scaffold caused a reduction in alkaline phosphatase production and an increase in the collagen concentration indicating phenotypic changes in the cells. In support of these results, the production of collagen type II by the MSCs cultured in the chitosan scaffold increased after 3 weeks of culture, indicating the beginning of differentiation. However, the addition of gelatin to the chitosan scaffold did not improve on the results obtained with chitosan alone. These results suggest that this 3D chitosan scaffold is a promising candidate for biomaterial implants designed to promote MSC colonization and has applications in regenerative medicine. Copyright (C) 2009 S. Karger AG, Basel
C1 [Breyner, Natalia M.; Hell, Rafaela C. R.; Carvalho, Luiza R. P.; Machado, Carolina B.; Peixoto Filho, Inacio N.; Valerio, Patricia; Goes, Alfredo M.] Univ Fed Minas Gerais, Inst Biol Sci, Biochem & Immunol Dept, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pereira, Marivalda M.] Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-31270901 Belo Horizonte, MG, Brazil.
RP Goes, AM (reprint author), Univ Fed Minas Gerais, Inst Biol Sci, Biochem & Immunol Dept, Caixa Postal 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM goes@icb.ufmg.br
OI Barcellos Machado, Carolina/0000-0003-4420-6097
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES/Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais
   (FAPEMIG/Brazil); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq/Brazil)
FX This investigation was supported by the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES/Brazil), Fundacao de Amparo a
   Pesquisa do Estado de Minas Gerais (FAPEMIG/Brazil) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil).
CR Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Gao Jizong, 2002, Tissue Engineering, V8, P827, DOI 10.1089/10763270260424187
   HUANG CK, 2008, PLAST RECONSTR SURG, V2, P411
   LEE J, 2005, BIOMATERIALS, V25, P4163
   Lima EG, 2004, BIORHEOLOGY, V41, P577
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   Machado CB, 2007, BIOMED MATER, V2, P124, DOI 10.1088/1748-6041/2/2/010
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   McMahon LA, 2008, BIOCHEM BIOPH RES CO, V368, P990, DOI 10.1016/j.bbrc.2008.01.160
   Medrado GCB, 2006, BIOMED MATER, V1, P155, DOI 10.1088/1748-6041/1/3/010
   Mehlhorn AT, 2007, CELL PROLIFERAT, V40, P809, DOI 10.1111/j.1365-2184.2007.00473.x
   Mouw JK, 2005, OSTEOARTHR CARTILAGE, V13, P828, DOI 10.1016/j.joca.2005.04.020
   Noth U, 2002, TISSUE ENG, V8, P131, DOI 10.1089/107632702753503126
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   SCHNEIDERBAUER MM, 2004, CELL SIGNAL, V16, P133
   Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
NR 27
TC 37
Z9 41
U1 0
U2 9
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2010
VL 191
IS 2
BP 119
EP 128
DI 10.1159/000231472
PG 10
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA 545ZI
UT WOS:000273775800005
PM 19641289
DA 2018-10-20
ER

PT J
AU Ryglova, S
   Sucharda, Z
   Cerny, M
   Suchy, T
   Supova, M
   Zaloudkova, M
AF Ryglova, Sarka
   Sucharda, Zbynek
   Cerny, Martin
   Suchy, Tomas
   Supova, Monika
   Zaloudkova, Margit
TI PARTICULATE COMPOSITE ON THE BASIS OF HA AND TCP MICROPARTICLES AND
   NANOPARTICLES AS A POSSIBLE BIOMATERIAL FOR SPINE THERAPY
SO CERAMICS-SILIKATY
LA English
DT Article
DE Particulate composite; Preparation; Hydroxyapatite; Tricalcium
   phosphate; Polydimethylsiloxane; Compressive strength
ID SURFACE MODIFICATION; MECHANICAL-PROPERTIES; BONE; HYDROXYAPATITE;
   NANOCOMPOSITES; APATITE; SCAFFOLD; ACID; GLUTARALDEHYDE; REPLACEMENT
AB The aim of this experimental work was to propose a technology for preparing a particle-reinforced composite based on thermosetting polydimethylsiloxane resin matrix (PDMS) reinforced with hydroxyapatite (HA) or tricalciumphosphate (TCP) microparticles/nanoparticles for application as an intervertebral filling biomaterial situated inside a load-bearing PEEK cage. In addition, we determined the effect of microparticle and nanoparticle additives (HA, TCP) on the mechanical characteristics of the particulate composite, namely modulus of elasticity in compression (E-c) and compressive strength (sigma). In this work, the proposed technology for preparing these particle composites with a thermosetting matrix functioned quite satisfactorily. We can conclude that with rising volume of the particle composite filling up to 25 vol.%, the E-c and sigma(cM) also rose to twice the values for the pure PDMS matrix. The effect of nanoparticles on the mechanical properties was more pronounced.
C1 [Ryglova, Sarka; Sucharda, Zbynek; Cerny, Martin; Suchy, Tomas; Supova, Monika; Zaloudkova, Margit] ASCR, Inst Rock Struct & Mech Vvi, Dept Composite & Carbon Mat, Prague 18209, Czech Republic.
   [Suchy, Tomas] Czech Tech Univ, Biomech Lab, Fac Mech Engn, Dept Mech Biomech & Mechatron, Prague 16607, Czech Republic.
RP Ryglova, S (reprint author), ASCR, Inst Rock Struct & Mech Vvi, Dept Composite & Carbon Mat, V Holesovickach 41, Prague 18209, Czech Republic.
EM ryglova@irsm.cas.cz
RI Cerny, Martin/G-4476-2014; Suchy, Tomas/D-5838-2013; Supova,
   Monika/G-4473-2014
FU Ministry of Industry and Trade of the Czech Republic Program - TANDEM
   [FT-TA3/131]; Ministry of Education [MSM 6840770012]
FX This study was supported by the Ministry of Industry and Trade of the
   Czech Republic Program - TANDEM, No. FT-TA3/131. Research on problems of
   spinal diseases focused on degenerative and post-traumatic states of the
   spine, applying findings in tissue engineering, vertebra biomechanics,
   osseointegration of artificial replacements and revising their failures,
   was supported by the Ministry of Education project Transdisciplinary
   Research in Biomedical Engineering II., No. MSM 6840770012.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Balik K, 2009, CERAM-SILIKATY, V53, P310
   Borum L, 2003, BIOMATERIALS, V24, P3681, DOI 10.1016/S0142-9612(03)00240-0
   Borum-Nicholas L, 2003, BIOMATERIALS, V24, P3671, DOI 10.1016/S0142-9612(03)00239-4
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Chang MC, 2002, BIOMATERIALS, V23, P3879, DOI 10.1016/S0142-9612(02)00133-3
   Damia C, 2006, MATER LETT, V60, P3192, DOI 10.1016/j.matlet.2006.02.071
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Eberl DD, 1996, 96 US GEOL SURV, V96
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   HANDSCHIN RG, 1995, BONE, V16, pS355, DOI 10.1016/S8756-3282(95)80385-8
   Homaeigohar SS, 2006, J EUR CERAM SOC, V26, P273, DOI 10.1016/j.jeurceramsoc.2004.10.003
   Hong Jac L., 2007, EUR POLYM J, V43, P1602
   Hron P, 2003, POLYM INT, V52, P1531, DOI 10.1002/pi.1273
   Huttunen M, 2006, ACTA BIOMATER, V2, P575, DOI 10.1016/j.actbio.2006.03.008
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Jie W, 2004, EUR POLYM J, V40, P509, DOI 10.1016/j.eurpolymj.2003.10.028
   Kang Y, 2008, MATER LETT, V62, P2029, DOI 10.1016/j.matlet.2007.11.014
   Karlinsey RL, 2010, ACTA BIOMATER, V6, P969, DOI 10.1016/j.actbio.2009.08.034
   Kim HW, 2007, J BIOMED MATER RES A, V83A, P169, DOI 10.1002/jbm.a.31247
   Lee D, 2009, MAT SCI ENG C-BIO S, V29, P69, DOI 10.1016/j.msec.2008.05.017
   Marciniak J, 1997, ENG BIOMATER, V1, P12
   Miao X, 2005, MATER LETT, V59, P4000, DOI 10.1016/j.matlet.2005.07.062
   Murugan R, 2006, MATER LETT, V60, P2844, DOI 10.1016/j.matlet.2006.01.104
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   Rozenberg BA, 2008, PROG POLYM SCI, V33, P40, DOI 10.1016/j.progpolymsci.2007.07.004
   Ryglova S, 2007, CERAM-SILIKATY, V51, P89
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suchy T., 2007, ENG BIOMATER, V1-2, P69
   Suchy T, 2008, CERAM-SILIKATY, V52, P29
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   Tanaka H, 2004, J COLLOID INTERF SCI, V269, P358, DOI 10.1016/j.jcis.2003.07.039
   Vaccaro Alexander R, 2003, Spine J, V3, P227, DOI 10.1016/S1529-9430(02)00412-6
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   WARREN BE, 1950, J APPL PHYS, V21, P595, DOI 10.1063/1.1699713
   Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008
   Yasuda HY, 2002, SCI TECHNOL ADV MAT, V3, P29, DOI 10.1016/S1468-6996(01)00149-8
NR 41
TC 3
Z9 3
U1 0
U2 10
PU INST CHEMICAL TECHNOLOGY, DEPT GLASS CERAMICS
PI PRAGUE
PA TECHNICKA 5, PRAGUE 166 28, CZECH REPUBLIC
SN 0862-5468
J9 CERAM-SILIKATY
JI Ceram.-Silik.
PY 2010
VL 54
IS 4
BP 386
EP 397
PG 12
WC Materials Science, Ceramics
SC Materials Science
GA 704CD
UT WOS:000286027800015
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Almine, JF
   Bax, DV
   Mithieux, SM
   Nivison-Smith, L
   Rnjak, J
   Waterhouse, A
   Wise, SG
   Weiss, AS
AF Almine, Jessica F.
   Bax, Daniel V.
   Mithieux, Suzanne M.
   Nivison-Smith, Lisa
   Rnjak, Jelena
   Waterhouse, Anna
   Wise, Steven G.
   Weiss, Anthony S.
TI Elastin-based materials
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID IN-VITRO; DERMAL SUBSTITUTE; COLLAGEN/ELASTIN-MEMBRANE; RECONSTRUCTIVE
   SURGERY; EXTRACELLULAR-MATRIX; MECHANICAL-BEHAVIOR; PROTEIN POLYMER;
   ALPHA-ELASTIN; TISSUE-REPAIR; CROSS-LINKING
AB Elastin is a versatile elastic protein that dominates flexible tissues capable of recoil, and facilitates commensurate cell interactions in these tissues in all higher vertebrates. Elastin's persistence and insolubility hampered early efforts to construct versatile biomaterials. Subsequently the field has progressed substantially through the adapted use of solubilized elastin, elastin-based peptides and the increasing availability of recombinant forms of the natural soluble elastin precursor, tropoelastin. These interactions allow for the formation of a sophisticated range of biomaterial constructs and composites that benefit from elastin's physical properties of innate assembly and elasticity, and cell interactive properties as discussed in this tutorial review.
C1 [Almine, Jessica F.; Bax, Daniel V.; Mithieux, Suzanne M.; Nivison-Smith, Lisa; Rnjak, Jelena; Waterhouse, Anna; Wise, Steven G.; Weiss, Anthony S.] Univ Sydney, Sch Mol Sci, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Sci, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
RI Wise, Steven/G-2630-2018; Rnjak-Kovacina, Jelena/B-8928-2014;
   Waterhouse, Anna/E-2464-2011; Wise, Steven/B-1858-2009
OI Wise, Steven/0000-0001-7964-819X; Waterhouse, Anna/0000-0003-1498-9393;
   Wise, Steven/0000-0001-7964-819X; Mithieux, Suzanne/0000-0001-6160-9352;
   WEISS, ANTHONY/0000-0002-8106-4836; Nivison-Smith,
   Lisa/0000-0001-6677-1949
FU Australian Research Council; National Heart Foundation; National Health
   AMP; Medical Research Council
FX This work was supported by grants from the Australian Research Council,
   National Heart Foundation and National Health & Medical Research
   Council.
CR Annabi N, 2009, BIOMATERIALS, V30, P4550, DOI 10.1016/j.biomaterials.2009.05.014
   Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   BARNES MJ, 1979, HAEMOSTASIS, V8, P158
   Bax DV, 2009, ACTA BIOMATER, V5, P3371, DOI 10.1016/j.actbio.2009.05.016
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Coquerel B, 2009, GLIA, V57, P1716, DOI 10.1002/glia.20884
   de Vries H J, 1994, Wound Repair Regen, V2, P37, DOI 10.1046/j.1524-475X.1994.20107.x
   DEVRIES HJC, 1995, BRIT J DERMATOL, V132, P690
   Dutoya S, 1998, BIOMATERIALS, V19, P147, DOI 10.1016/S0142-9612(97)00214-7
   Dutoya S, 2000, BIOMATERIALS, V21, P1521, DOI 10.1016/S0142-9612(99)00274-4
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Grieshaber SE, 2009, MACROMOLECULES, V42, P2532, DOI 10.1021/ma802791z
   GROSSO LE, 1993, BIOCHEMISTRY-US, V32, P13369, DOI 10.1021/bi00211a052
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   Haslik W, 2007, BURNS, V33, P364, DOI 10.1016/j.burns.2006.07.021
   Haslik W, 2010, J PLAST RECONSTR AES, V63, P360, DOI 10.1016/j.bjps.2008.09.026
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hinds MT, 2006, J BIOMED MATER RES A, V77A, P458, DOI 10.1002/jbm.a.30571
   HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436
   Hinek A, 2005, J DERMATOL SCI, V39, P155, DOI 10.1016/j.jdermsci.2005.04.002
   Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72
   Hwang D, 2009, INT J PHARM, V368, P215, DOI 10.1016/j.ijpharm.2008.10.021
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Ito S, 1997, Cardiovasc Surg, V5, P176, DOI 10.1016/S0967-2109(97)00004-5
   Janorkar AV, 2008, BIOMATERIALS, V29, P625, DOI 10.1016/j.biomaterials.2007.10.022
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013
   Karnik SK, 2003, MATRIX BIOL, V22, P409, DOI 10.1016/S0945-053X(03)00076-3
   Klein B, 2001, J MATER SCI-MATER M, V12, P419, DOI 10.1023/A:1011249020155
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   LI M, 2005, P IEEE ENG MED BIOL, V6, P5858
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Martinez-Osorio H, 2009, CURR EYE RES, V34, P48, DOI 10.1080/02713680802542053
   Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018
   Miyamoto K, 2009, INT J BIOL MACROMOL, V45, P33, DOI 10.1016/j.ijbiomac.2009.03.014
   Na K, 2008, LANGMUIR, V24, P4917, DOI 10.1021/la702796y
   Nagapudi K, 2005, BIOMATERIALS, V26, P4695, DOI 10.1016/j.biomaterials.2004.11.027
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Ozturk N, 2009, BIOMATERIALS, V30, P5417, DOI 10.1016/j.biomaterials.2009.06.044
   Palmaz JC, 2007, CARDIOVASC INTER RAD, V30, P1095, DOI 10.1007/s00270-007-9164-9
   Pocza P, 2008, INT J CANCER, V122, P1972, DOI 10.1002/ijc.23296
   Prager MR, 2003, SURGERY, V134, P80, DOI 10.1067/msy.2003.179
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   Ryssel H, 2008, BURNS, V34, P93, DOI 10.1016/j.burns.2007.01.018
   Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8
   Sales VL, 2007, CIRCULATION, V116, pI55, DOI 10.1161/CIRCULATIONAHA.106.6806637
   Sallach RE, 2009, J BIOMAT SCI-POLYM E, V20, P1629, DOI 10.1163/156856208X386228
   Schenke-Layland K, 2009, BIOMATERIALS, V30, P4665, DOI 10.1016/j.biomaterials.2009.05.033
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Smith MJ, 2008, ACTA BIOMATER, V4, P58, DOI 10.1016/j.actbio.2007.08.001
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Straley Karin S, 2009, Front Neuroeng, V2, P9, DOI 10.3389/neuro.16.009.2009
   Swierczewska M, 2008, ACTA BIOMATER, V4, P827, DOI 10.1016/j.actbio.2007.11.004
   Taddese S, 2009, MATRIX BIOL, V28, P84, DOI 10.1016/j.matbio.2008.12.002
   Thomas V, 2009, BIOTECHNOL BIOENG, V104, P1025, DOI 10.1002/bit.22467
   van Zuijlen PPM, 2001, PLAST RECONSTR SURG, V108, P1938, DOI 10.1097/00006534-200112000-00014
   van Zuijlen PPM, 2002, BURNS, V28, P151, DOI 10.1016/S0305-4179(01)00085-7
   van Zuijlen PPM, 2000, PLAST RECONSTR SURG, V106, P615, DOI 10.1097/00006534-200009030-00014
   Wagenseil JE, 2005, AM J PHYSIOL-HEART C, V289, pH1209, DOI 10.1152/ajpheart.00046.2005
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Yang GC, 2002, J AM CHEM SOC, V124, P10648, DOI 10.1021/ja027302g
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
NR 78
TC 97
Z9 99
U1 2
U2 66
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2010
VL 39
IS 9
BP 3371
EP 3379
DI 10.1039/b919452p
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 641FJ
UT WOS:000281109900004
PM 20449520
DA 2018-10-20
ER

PT J
AU Hicks, MR
   Kowalski, J
   Rodger, A
AF Hicks, Matthew R.
   Kowalski, Jarosav
   Rodger, Alison
TI LD spectroscopy of natural and synthetic biomaterials
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID FLOW LINEAR DICHROISM; WALLED CARBON NANOTUBES; COUETTE-FLOW;
   CIRCULAR-DICHROISM; ELECTRONIC-SPECTRUM; NUCLEIC-ACIDS; PROTEIN FIBER;
   DNA-STRUCTURE; ORIENTATION; BINDING
AB The structural characterization of biomaterials is challenging because they are usually too large for NMR or high resolution mass spectrometry and not well-enough structured for X-ray crystallography. Structural characterization and kinetic analysis for such systems thus has to proceed by collecting complementary data from a wide range of different techniques. This tutorial review describes how linear dichroism, a polarized absorbance spectroscopy technique applied to oriented molecular systems, can be used to provide useful data on biomaterials. In particular LD can provide information about relative orientations of sub-units of biomaterials and orientations of the whole biomaterial with respect to an orientation axis. An outline of linear dichroism and a summary of the artifacts to be avoided are followed by a description of how Couette flow linear dichroism has been used for a range of biomaterial systems including: DNA; DNA: ligand systems; cytoskeletal fibrous proteins; synthetic protein fibres; membrane proteins in liposomes; bacteriophage; carbon nanotubes; and peptidoglycan systems.
C1 [Hicks, Matthew R.; Kowalski, Jarosav; Rodger, Alison] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
RP Hicks, MR (reprint author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.
EM a.rodger@warwick.ac.uk
RI Rodger, Alison/A-1063-2009; Hicks, Matthew/C-9109-2011
OI Rodger, Alison/0000-0002-7111-3024; 
CR ALBINSSON B, 1989, J PHYS CHEM-US, V93, P6646, DOI 10.1021/j100355a016
   Ardhammar M, 1998, J AM CHEM SOC, V120, P9957, DOI 10.1021/ja981102g
   Atkins P W, 1991, PHYS CHEM
   Atkins PW, 1983, MOL QUANTUM MECH
   Bromley EHC, 2010, BIOPHYS J, V98, P1668, DOI 10.1016/j.bpj.2009.12.4309
   Bulheller BM, 2007, PHYS CHEM CHEM PHYS, V9, P2020, DOI 10.1039/b615870f
   Cathcart H, 2008, J AM CHEM SOC, V130, P12734, DOI 10.1021/ja803273s
   CHOU PJ, 1993, J AM CHEM SOC, V115, P1205, DOI 10.1021/ja00057a001
   CLACK BA, 1992, BIOPOLYMERS, V32, P795, DOI 10.1002/bip.360320708
   CLARK LB, 1977, J AM CHEM SOC, V99, P3934, DOI 10.1021/ja00454a006
   CLARK LB, 1990, J PHYS CHEM-US, V94, P2873, DOI 10.1021/j100370a027
   Cordes DB, 2005, ORG BIOMOL CHEM, V3, P1708, DOI 10.1039/b418953a
   Dafforn TR, 2004, BIOPHYS J, V86, P404, DOI 10.1016/S0006-3495(04)74116-8
   Dicko C, 2008, BIOPHYS J, V95, P5974, DOI 10.1529/biophysj.108.139964
   GARDING L, 1979, CHEM PHYS, V41, P431
   GORDON DJ, 1971, ARCH BIOCHEM BIOPHYS, V142, P481, DOI 10.1016/0003-9861(71)90511-X
   Hannon Michael J, 2001, Angew Chem Int Ed Engl, V40, P879, DOI 10.1002/1521-3773(20010302)40:5<879::AID-ANIE879>3.0.CO;2-X
   Hicks MR, 2008, J MOL BIOL, V383, P358, DOI 10.1016/j.jmb.2008.07.091
   Hicks MR, 2009, ANALYST, V134, P1623, DOI 10.1039/b902523e
   HIORT C, 1990, J AM CHEM SOC, V112, P1971, DOI 10.1021/ja00161a050
   HOLLAS JM, 1992, MODERN SPECTROSCOPY
   Holmen A, 1997, J AM CHEM SOC, V119, P12240, DOI 10.1021/ja9710262
   Jablonski A, 1934, NATURE, V133, P140, DOI 10.1038/133140a0
   Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104
   Kliger D. S., 1990, POLARIZED LIGHT OPTI
   MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862
   Marrington R, 2005, ANALYST, V130, P1608, DOI 10.1039/b506149k
   Marrington R, 2004, J BIOL CHEM, V279, P48821, DOI 10.1074/jbc.M404944200
   Marrington R, 2004, BIOPHYS J, V87, P2002, DOI 10.1529/biophysj.103.035022
   Marrington R, 2006, CHIRALITY, V18, P680, DOI 10.1002/chir.20305
   Marsh D, 2000, BIOPHYS J, V78, P2499, DOI 10.1016/S0006-3495(00)76795-6
   Marshall KE, 2010, BIOPHYS J, V98, P330, DOI 10.1016/j.bpj.2009.10.020
   MATSUOKA Y, 1982, BIOPOLYMERS, V21, P2433, DOI 10.1002/bip.360211208
   Meistermann I, 2002, P NATL ACAD SCI USA, V99, P5069, DOI 10.1073/pnas.062634499
   Michl J, 1986, SPECTROSCOPY POLARIZ
   Monthioux M, 2006, CARBON, V44, P1621, DOI 10.1016/j.carbon.2006.03.019
   NORDEN B, 1977, SPECTROSC LETT, V10, P483, DOI 10.1080/00387017708065503
   NORDEN B, 1978, APPL SPECTROSC REV, V14, P157, DOI 10.1080/05704927808060393
   Norden B, 2010, LINEAR DICHROISM AND CIRCULAR DICHROISM: A TEXTBOOK ON POLARIZED LIGHT SPECTROSCOPY, P1
   NORDH J, 1986, EUR BIOPHYS J BIOPHY, V14, P113
   PACHECOGOMEZ R, 2010, COMMUNICATION
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Patel KK, 2002, J INORG BIOCHEM, V91, P220, DOI 10.1016/S0162-0134(01)00423-8
   Rajendra J, 2005, CHEM-EUR J, V11, P4841, DOI 10.1002/chem.200500093
   Rajendra J, 2004, J AM CHEM SOC, V126, P11182, DOI 10.1021/ja048720j
   Rodger A, 2002, PHYS CHEM CHEM PHYS, V4, P4051, DOI 10.1039/b205080n
   Rodger A, 2001, EUR J INORG CHEM, P2311
   Rodger A, 2000, CHIRALITY, V12, P221, DOI 10.1002/(SICI)1520-636X(2000)12:4<221::AID-CHIR9>3.0.CO;2-3
   RODGER A, 1997, CIRCULAR DICHROISM L
   Rodger A, 2006, PHYS CHEM CHEM PHYS, V8, P3161, DOI 10.1039/b604810m
   SNOWDON R, 2009, UNPUB
   TJERNELD F, 1982, BIOPOLYMERS, V21, P343, DOI 10.1002/bip.360210209
   Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004
   WADA A, 1972, APPL SPECTROSC REV, V6, P1, DOI 10.1080/05704927208060364
   WADA A, 1964, BIOPOLYMERS, V2, P361, DOI 10.1002/bip.1964.360020407
   Wang YA, 2006, J MOL BIOL, V361, P209, DOI 10.1016/j.jmb.2006.06.027
   WILLIAMS AL, 1986, NUCLEIC ACIDS RES, V14, P6649, DOI 10.1093/nar/14.16.6649
   Woody R.W., 2007, METHODS PROTEIN STRU, P291
   ZALOUDEK F, 1985, J AM CHEM SOC, V107, P7344, DOI 10.1021/ja00311a022
NR 59
TC 34
Z9 34
U1 1
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2010
VL 39
IS 9
BP 3380
EP 3393
DI 10.1039/b912917k
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA 641FJ
UT WOS:000281109900005
PM 20672156
DA 2018-10-20
ER

PT J
AU Dobelin, N
   Luginbuhl, R
   Bohner, M
AF Doebelin, Nicola
   Luginbuehl, Reto
   Bohner, Marc
TI Synthetic Calcium Phosphate Ceramics for Treatment of Bone Fractures
SO CHIMIA
LA English
DT Article
DE Biomaterial; Bone substitute; Calcium phosphate; Medical device
ID BETA-TRICALCIUM PHOSPHATE; GRAFT SUBSTITUTES; OCTACALCIUM PHOSPHATE;
   MECHANICAL-PROPERTIES; METAL-IONS; CEMENT; BRUSHITE; HYDROXYAPATITE;
   STRONTIUM; BIOLOGY
AB Bone is a complex natural material with outstanding mechanical properties and remarkable self-healing capabilities. The mechanical strength is achieved by a complex structure of a mineral part comprising apatitic calcium phosphate crystals embedded in an organic matrix. Bone also contains several types of cells constantly replacing mature bone with new bone. These cells are able to seal fractures and fill gaps with new bone in case of structural damage. However, if a defect exceeds a critical size, surgery is necessary to fill the void with a spacer in order to prevent soft tissue from growing into the defect and delaying the healing process. The spacers, also known as bone grafts, can either be made of fresh bone from the patient, of processed bone from donor organisms, or of synthetic materials chemically similar to the mineral part of bone. Synthetic bone void fillers are also known as bone graft substitutes. This review aims at explaining the biological and chemical background that lead to the development of synthetic bone graft substitutes and gives an overview of the current state of development. It also highlights the multidisciplinary nature of biomaterials research, which combines cell biology and medicine with chemistry, mineralogy, crystallography, and mechanical engineering.
C1 [Doebelin, Nicola; Luginbuehl, Reto; Bohner, Marc] RMS Fdn, CH-2544 Bettlach, Switzerland.
RP Dobelin, N (reprint author), RMS Fdn, Bischmattstr 12, CH-2544 Bettlach, Switzerland.
EM nicola.doebelin@rms-foundation.ch
RI Bohner, Marc/F-3828-2011
OI Bohner, Marc/0000-0002-5079-3286
CR ALBEE H, 1920, ANN SURG, V71, P32
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barrere F., 1999, BIOCERAMICS, V12, P125
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   BAUDINETTE RV, 1974, NATURE, V248, P83, DOI 10.1038/248083b0
   Bechert DW, 2000, EXP FLUIDS, V28, P403, DOI 10.1007/s003480050400
   Bigi A, 1997, J INORG BIOCHEM, V66, P259, DOI 10.1016/S0162-0134(96)00219-X
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032
   Bohner M, 2003, BIOMATERIALS, V24, P3463, DOI 10.1016/S0142-9612(03)00234-5
   Bohner M, 2000, INJURY, V31, pS37
   BOHNER M, 1993, HYDRAULIC PROPERTIES, P95
   BOHNER M, 2006, EUR CELLS MATER, V11, P16
   Bohner M, 2009, ACTA BIOMATER, V5, P3524, DOI 10.1016/j.actbio.2009.05.024
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Bonderer LJ, 2009, J MATER RES, V24, P2741, DOI 10.1557/JMR.2009.0340
   BROWN WALTER E., 1966, CLIN ORTHO RELAT RES, V44, P205
   BROWN WE, 1983, J DENT RES, V62, P672
   BUCKWALTER JA, 1995, J BONE JOINT SURG AM, V77A, P1256, DOI 10.2106/00004623-199508000-00019
   Buckwalter JA, 1996, AAOS INSTR COURS LEC, V45, P387
   CAMERON HU, 1977, J BIOMED MATER RES, V11, P179, DOI 10.1002/jbm.820110204
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Carrodeguas RG, 2008, J AM CERAM SOC, V91, P1281, DOI 10.1111/j.1551-2916.2008.02294.x
   Cutright D E, 1972, Oral Surg Oral Med Oral Pathol, V33, P850, DOI 10.1016/0030-4220(72)90457-4
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Deeks ED, 2010, DRUGS, V70, P733, DOI 10.2165/10481900-000000000-00000
   Dreesman H., 1892, BEITR KLIN CHIR, V9, P804
   DRISKELL T, 1973, J DENT RES, V52, P123
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   EDBERG E, 1930, ACTA CHIR SCAND, V67, P313
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Galea LG, 2008, BIOMATERIALS, V29, P3400, DOI 10.1016/j.biomaterials.2008.04.041
   Gartner L. P., 1997, COLOR TXB HISTOLOGY
   GATTI AM, 1990, BIOMATERIALS, V11, P513, DOI 10.1016/0142-9612(90)90068-2
   GETTER L, 1972, J ORAL SURG, P30
   GLIMCHER MJ, 1959, REV MOD PHYS, V31, P359, DOI 10.1103/RevModPhys.31.359
   GLIMCHER MJ, 1981, J CRYST GROWTH, V53, P100, DOI 10.1016/0022-0248(81)90058-0
   Grover LM, 2008, KEY ENG MATER, V361-363, P311, DOI 10.4028/www.scientific.net/KEM.361-363.311
   Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X
   Haldeman M. D., 1934, ARCH SURG-CHICAGO, P385
   JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601
   Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   KOSTER K, 1976, LANGENBECK ARCH CHIR, V341, P77, DOI 10.1007/BF01262779
   Kumar M, 1999, J BIOMED MATER RES, V45, P302, DOI 10.1002/(SICI)1097-4636(19990615)45:4<302::AID-JBM4>3.0.CO;2-A
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   Larsson S, 2006, SCAND J SURG, V95, P111, DOI 10.1177/145749690609500206
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   LEMAITRE J, 1994, OBERFLACHEN WERKSTOF, V9, P13
   Lin EP, 2004, AM J NEURORADIOL, V25, P175
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   McConnell D, 1937, AM MINERAL, V22, P977
   McKittrick J, 2010, MAT SCI ENG C-MATER, V30, P331, DOI 10.1016/j.msec.2010.01.011
   MEJDOUBI E, 1993, SULFUR PHOSPHORUS, V77, P284
   Minkin C, 1999, Adv Dent Res, V13, P49
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   NYSTROM G, 1928, ACTA CHIR SCAND, V63, P296
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   POSNER AS, 1985, CLIN ORTHOP RELAT R, P87
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   Somrani S, 2003, J MATER CHEM, V13, P888, DOI 10.1039/b210900j
   STEWART WJ, 1934, GYN OBST STAG, V59, P867
   Takagi S, 2003, J BIOMED MATER RES B, V67B, P689, DOI 10.1002/jbm.b.10065
   Tamimi F., 2007, J BIOMED MATER RES A, V81, P93
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   TEITELBAUM ISL, 2000, SCIENCE, V289, P1504
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Tofighi A, 2009, KEY ENG MAT, V396-398, P281, DOI 10.4028/www.scientific.net/KEM.396-398.281
   VANLANDUYT P, 1997, J LEMAITRE BIOCERAMI, V10, P477
   VEREECKE G, 1990, J CRYST GROWTH, V104, P820, DOI 10.1016/0022-0248(90)90108-W
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   WELCH JH, 1961, J CHEM SOC, P4442, DOI 10.1039/jr9610004442
   Yeom JS, 2003, J BONE JOINT SURG BR, V85B, P83, DOI 10.1302/0301-620X.85B1.13026
   Yoshida K, 2006, J AM CERAM SOC, V89, P688, DOI 10.1111/j.1551-2916.2005.00727.x
   Yoshida K, 2005, J AM CERAM SOC, V88, P2315, DOI 10.1111/j.1551-2916.2005.00399.x
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 82
TC 13
Z9 13
U1 4
U2 33
PU SWISS CHEMICAL SOC
PI BERN
PA SCHWARZTORSTRASSE 9, CH-3007 BERN, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2010
VL 64
IS 10
BP 723
EP 729
DI 10.2533/chimia.2010.723
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 677YU
UT WOS:000284033900007
PM 21138161
DA 2018-10-20
ER

PT J
AU Bono, E
   Mathes, SH
   Franscini, N
   Graf-Hausner, U
AF Bono, Epifania
   Mathes, Stephanie H.
   Franscini, Nicola
   Graf-Hausner, Ursula
TI Tissue Engineering - The Gateway to Regenerative Medicine
SO CHIMIA
LA English
DT Article
DE Automation; Biomaterials; Disc regeneration; Soft tissue; Tissue
   regeneration
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; LINKED COLLAGEN MEMBRANES; CELL
   TRANSPLANTATION; GROWTH; RAT
AB Tissue Engineering as an emerging biotechnology sector aims at the in vitro regeneration of diseased tissues and promises to profoundly change medical practice offering the possibility of regenerating tissues and organs instead of just repairing them (regenerative medicine) Improved healing processes and a higher quality of life are the expected results This article gives an overview of different technologies for regenerative medicine and presents results of our own current applied research and development A recent project was successfully closed with the development of a natural biomaterial for soft tissue oral defects The establishment of an in vitro bioreactor system enabled us to simulate the mechanical and biological environment in a healing wound and to investigate the suitability of different implant materials for the oral tissue regeneration Moreover focusing the attention on an alternative method for the intervertebral disc (IVD) regeneration we established a new tissue engineered approach, based on the three-dimensional (3D) culture of autologous human IVD cells into a polyurethane (PU)-fibrin composite IVD cells were able to proliferate and, thanks to the 3D conditions, to differentiate expressing the typical native tissue markers The development of an automated platform was the goal of an additional project to standardize the cell culture technology, increase the bio-safety and reduce the production costs moving tissue engineering nearer to clinical application
C1 [Bono, Epifania; Mathes, Stephanie H.; Franscini, Nicola; Graf-Hausner, Ursula] Zurich Univ Appl Sci, Inst Chem & Biol Chem, CH-8820 Wadenswil, Switzerland.
RP Graf-Hausner, U (reprint author), Zurich Univ Appl Sci, Inst Chem & Biol Chem, Campus Reidbach,Einsiedlerstr 31, CH-8820 Wadenswil, Switzerland.
FU Spine Research Group; University of Zurich; Geistlich Pharma AG; Tecan
   Schweiz AG; polyMaterials AG; CTI
FX We thank our collaboration partners of the Spine Research Group
   University of Zurich and our industrial partners Geistlich Pharma AG
   Tecan Schweiz AG polyMaterials AG and CTI for funding
CR Behring J, 2008, ODONTOLOGY, V96, P1, DOI 10.1007/s10266-008-0087-y
   BOCK AK, 2003, 21000 EUR EN
   Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x
   Cheng B, 2002, MICROSURG, V22, P133, DOI 10.1002/micr.21740
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4
   Hammond JS, 2006, EXPERT REV MED DEVIC, V3, P21, DOI 10.1586/17434440.3.1.21
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Jham BC, 2009, J ORAL MAXIL SURG, V67, P280, DOI 10.1016/j.joms.2008.01.052
   Jung RE, 2004, INT J PERIODONT REST, V24, P545
   Kato R, 2010, TISSUE ENG PART C-ME, V16, P947, DOI [10.1089/ten.tec.2009.0305, 10.1089/ten.TEC.2009.0305]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Mathes SH, 2010, BIOTECHNOL BIOENG, V107, P1033
   Mauth C, 2009, EUR CELLS MATER, V18, P27, DOI 10.22203/eCM.v018a03
   Micheli LJ, 2006, J PEDIATR ORTHOPED, V26, P455, DOI 10.1097/01.bpo.0000224565.72762.eb
   Penn MS, 2002, PROG CARDIOVASC DIS, V45, P21, DOI 10.1053/pcad.2002.123466
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Schwarz F, 2006, CLIN ORAL IMPLAN RES, V17, P403, DOI 10.1111/j.1600-0501.2005.01225.x
   Studer SP, 2000, J PROSTHET DENT, V83, P402, DOI 10.1016/S0022-3913(00)70034-5
   Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P146, DOI 10.1111/j.1600-0501.2009.01784.x
   Tran N, 2003, BIORHEOLOGY, V40, P411
   TRAVIA G, 2003, ANN BURNS FIRE DISAS, V16, P1
   WANG M, 2010, TISSUE ENG PART C-ME, V24, P1
NR 26
TC 3
Z9 3
U1 2
U2 15
PU SWISS CHEMICAL SOC
PI BERN
PA SCHWARZTORSTRASSE 9, CH-3007 BERN, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2010
VL 64
IS 11
BP 808
EP 812
DI 10.2533/chimia.2010.808
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 694EH
UT WOS:000285277300010
PM 21197846
DA 2018-10-20
ER

PT S
AU Wang, LL
   Wang, XF
   Jiang, HT
   Yu, CL
AF Wang, Li-li
   Wang, Xiu-feng
   Jiang, Hong-tao
   Yu, Cheng-long
BE Pan, W
   Gong, JH
TI Preparation of Porous Hydroxyapatite-Zirconia Composite Scaffolds by
   Combination of Gel-Casting and Polymer Sponge Methods
SO CHINESE CERAMICS COMMUNICATIONS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th China International Conference on High-Performance Ceramics (CICC-6)
CY AUG 16-19, 2009
CL Harbin, PEOPLES R CHINA
SP Chinese Ceram Soc, Harbin Inst Technol, Tsinghua Univ, State Key Lab New Ceram & Fine Processing, Adv Ceram Div
DE HA-ZrO2 porous scaffold; Gel-casting; Polymer sponge method; Porosity
AB Hydroxyapatite (HA) doped with 3%yttria-stabilized 20wt% zirconia (ZrO2) ceramic were developed in order to produce a porous composite biomaterial by integrating the gel-casting technique with polymer sponge method with improved mechanical strength and controllable porous structure. The pore morphology, size, and distribution of the scaffolds were characterized using an electron microscope. The scaffolds prepared have an open, uniform and interconnected porous structure with a pore size of 300 similar to 500 mu m. The porosity of the open pores in the scaffold can be controlled by changing HA-ZrO2 composite concentration and it is between 87%similar to 35%. A compressive strength of 12MPa for HA-ZrO2 porous scaffolds with HA-ZrO2 concentration of 55wt% was achieved, which is comparable to that of cortical bone.
C1 [Wang, Li-li; Wang, Xiu-feng; Jiang, Hong-tao; Yu, Cheng-long] Shaanxi Univ Sci & Technol, Xian 710021, Peoples R China.
RP Wang, LL (reprint author), Shaanxi Univ Sci & Technol, Xian 710021, Peoples R China.
EM wanglili@sust.edu.cn
CR HUANG CY, 2000, CHINESE J BIOMEDICAL, V19, P281
   Kim H.M., 2003, BIOMATERIALS, V25, P78
   Li A.M., 2004, ACTA MAT COMPOSITE S, V5, P98
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Luyten J., 2002, KEY ENG MATER, V24, P206
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   ROOP KR, 2002, MATER LETT, V7, P133
   Tian JT, 2001, J MATER SCI, V36, P3061, DOI 10.1023/A:1017935411108
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 9
TC 3
Z9 3
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-275-6
J9 ADV MATER RES-SWITZ
PY 2010
VL 105-106
BP 616
EP 619
DI 10.4028/www.scientific.net/AMR.105-106.616
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA BTX15
UT WOS:000288352100166
DA 2018-10-20
ER

PT J
AU Mayer, A
   Lee, S
   Jung, F
   Grutz, G
   Lendlein, A
   Hiebl, B
AF Mayer, A.
   Lee, S.
   Jung, F.
   Gruetz, G.
   Lendlein, A.
   Hiebl, B.
TI CD14(+) CD163(+) IL-10(+) monocytes/macrophages: Pro-angiogenic and non
   pro-inflammatory isolation, enrichment and long-term secretion profile
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Monocytes; CD14; CD163; IL-10; VEGF; cytokine delivery
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; RECEPTOR ANTAGONIST; HUMAN
   MONOCYTES; MACROPHAGES; ACTIVATION; CELL; INTERLEUKIN-10; GLYCOCALYX;
   EXPRESSION
AB The establishment of a stable endothelial layer on a biomaterial suture is a well known strategy to achieve hemo-compatibility. The endothelialisation is supported by factors as e. g. vascular endothelial growth factor (VEGF), which can be secreted by monocytes/macrophages (mo/m Phi) in an angiogenic milieu. In order to avoid detrimental inflammation triggered by these mo/m Phi, we established a protocol for the generation of alternatively activated macrophages and studied their response towards VEGF-A(165). We could generate sufficient amounts of these CD14(+) CD163(+) IL-10(+) mo/m Phi from buffy coats (8.6 +/- 4.7 x 10(5) cells/ml buffy coat). Furthermore, we achieved a VEGF-A165 secretion in the nanogram range. The VEGF-A(165) secretion increased 2.1-fold within 14 days from 7.6 +/- 2.2 to 16.1 +/- 2.5 ng/ml when the cells were grown with a VEGF-A(165) supplemented (10 ng/ml) cell culture medium. Within this time period the secretion levels of other pro-angiogenic growth factors (bFGF, PDGF-BB) and immunomodulatory cytokines (IL-10, IL-12, IL-1ra, TNF alpha, IFN gamma) reached only the picogram range. These results suggest that angiogenically stimulated CD14(+) CD163(+) IL-10(+) mo/m Phi might be useful as a cellular cytokine delivery system supporting endothelialisation of biomaterials without inducing pro-inflammatory effects.
C1 [Mayer, A.; Lee, S.; Jung, F.; Gruetz, G.; Lendlein, A.; Hiebl, B.] GKSS Res Ctr Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Jung, F.; Lendlein, A.] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
RP Hiebl, B (reprint author), GKSS Res Ctr Geesthacht GmbH, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM bernhard.hiebl@gkss.de
RI Lendlein, Andreas/K-9553-2013; Jung, Friedrich/L-1301-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Jung,
   Friedrich/0000-0001-8098-7180; Hiebl, Bernhard/0000-0002-6450-0675
CR Abramson SB, 2002, RHEUMATOLOGY, V41, P972, DOI 10.1093/rheumatology/41.9.972
   Akeson A, 2010, MICROVASC RES, V80, P65, DOI 10.1016/j.mvr.2010.02.001
   [Anonymous], 2010, CLIN HEMORHEOL MICRO, V44, P1
   ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   Bottomley MJ, 2000, CLIN EXP IMMUNOL, V119, P182, DOI 10.1046/j.1365-2249.2000.01097.x
   Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587
   Citarella BV, 2009, PEDIATR RES, V65, P425, DOI 10.1203/PDR.0b013e318199384d
   Clark AN, 2007, CIRC RES, V101, P1130, DOI 10.1161/CIRCRESAHA.107.150110
   CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535
   Coyle CH, 2007, J BIOMATER APPL, V22, P55, DOI 10.1177/0885328206069152
   DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303
   De Waal Malefyt Rene, 1993, Journal of Immunology, V151, P6370
   Drake-Holland Angela J., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P118
   Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401
   FISCHER CD, 2006, DEGRADATIONSUNTERSUC
   Goldbach-Mansky R, 2009, ANN NY ACAD SCI, V1182, P111, DOI 10.1111/j.1749-6632.2009.05159.x
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x
   Heldin CH, 1999, PHYSIOL REV, V79, P1283
   Hiebl B, 2008, CLIN HEMORHEOL MICRO, V40, P37, DOI 10.3233/CH-2008-1061
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Joyce DA, 1996, J INTERF CYTOK RES, V16, P511, DOI 10.1089/jir.1996.16.511
   JUNG F, 2010, MRS B IN PRESS
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Melillo G, 1999, CANCER RES, V59, P5433
   Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x
   Patterson C, 2000, CIRCULATION, V102, P940, DOI 10.1161/01.CIR.102.9.940
   Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   *TWM ASS, 2000, 48 GEN ASS WORLD MED
   VANFURTH R, 1979, BLOOD, V54, P485
   VANHAL PTW, 1995, CELL PROLIFERAT, V28, P533, DOI 10.1111/j.1365-2184.1995.tb00042.x
   VANNIER E, 1992, P NATL ACAD SCI USA, V89, P4076, DOI 10.1073/pnas.89.9.4076
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Xue L, 2002, SURGERY, V132, P259, DOI 10.1067/msy.2002.125720
NR 35
TC 13
Z9 13
U1 1
U2 5
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2010
VL 46
IS 2-3
BP 217
EP 223
DI 10.3233/CH-2010-1348
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 689QC
UT WOS:000284942300014
PM 21135497
DA 2018-10-20
ER

PT J
AU Hiebl, B
   Fuhrmann, R
   Jung, F
   Kratz, K
   Lendlein, A
   Franke, RP
AF Hiebl, B.
   Fuhrmann, R.
   Jung, F.
   Kratz, K.
   Lendlein, A.
   Franke, R. P.
TI Degradation of and angiogenesis around multiblock copolymers containing
   poly (p-dioxanone)- and poly(epsilon-caprolactone)-segments
   subcutaneously implanted in the rat neck
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 15th Conference of the
   European-Society-of-Clinical-Hemorheology-and-Microcirculation
CY JUN 28-JUL 01, 2009
CL St Moritz, SWITZERLAND
SP European Soc Clin Hemorheol & Microcirculat
DE PDC; degradation; angiogenesis; biomaterial; immunhistochemistry
ID MULTIFUNCTIONAL POLYMERIC BIOMATERIALS; SHAPE-MEMORY POLYMERS; IN-VITRO;
   TISSUE; NETWORKS; MODEL
AB The degradation behavior and the effect on angiogenesis of multiblock copolymers based on poly(p-dioxanone)- and poly(epsilon-caprolactone)-segments (PDC) were studied in vivo. PDC is a multifunctional biomaterial combining degradability and shape-memory capabilities. The "in vivo" degradation of PDC is characterized by a fragmentation occurring at the material tissue interface. This observation is consistent with the enzyme supported degradation behaviour, which was determined "in vitro". PDC revealed to induce the formation of blood micro-vessels nearby in the periimplantary tissues. Both might explain the good PDC integration into tissues in terms of a strong connection between the implant and the periimplantary tissue. Micro blood-vessels might be involved in the clearance of the small particles, which appear in the periimplantary tissue when PDC degrades.
C1 [Hiebl, B.; Jung, F.; Kratz, K.; Lendlein, A.; Franke, R. P.] GKSS Res Ctr GmbH, Ctr Biomat Dev, Teltow, Germany.
   [Hiebl, B.; Jung, F.; Kratz, K.; Lendlein, A.; Franke, R. P.] GKSS Res Ctr GmbH, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, Teltow, Germany.
   [Fuhrmann, R.; Franke, R. P.] Univ Ulm, Cent Inst Biomed Tech, Ulm, Germany.
RP Hiebl, B (reprint author), GKSS Res Ctr GmbH, Ctr Biomat Dev, Teltow, Germany.
EM bernhard.hiebl@web.de
RI Jung, Friedrich/L-1301-2013; Lendlein, Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670; Hiebl, Bernhard/0000-0002-6450-0675
CR BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   Behl M, 2007, SOFT MATTER, V3, P58, DOI 10.1039/b610611k
   Bertmer M, 2005, MACROMOLECULES, V38, P3793, DOI 10.1021/ma0501489
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Choi NY, 2007, SOFT MATTER, V3, P901, DOI 10.1039/b702515g
   Grablowitz H, 2007, J MATER CHEM, V17, P4050, DOI 10.1039/b707104c
   HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734
   Hiebl B, 2009, MATER RES SOC SYMP P, V1140, P143
   Kaessmeyer S, 2009, CLIN HEMORHEOL MICRO, V41, P83, DOI 10.3233/CH-2009-1159
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   Rickert D, 2006, EUR ARCH OTO-RHINO-L, V263, P215, DOI 10.1007/s00405-005-0950-1
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Robey TC, 2000, ARCH OTOLARYNGOL, V126, P985, DOI 10.1001/archotol.126.8.985
   Zajaczkowski MB, 2003, TISSUE ENG, V9, P525, DOI 10.1089/107632703322066705
NR 19
TC 6
Z9 6
U1 5
U2 13
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2010
VL 45
IS 2-4
BP 117
EP 122
DI 10.3233/CH-2010-1289
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 633CW
UT WOS:000280478100006
PM 20675891
DA 2018-10-20
ER

PT J
AU Santos, FA
   Pochapski, MT
   Martins, MC
   Zenobio, EG
   Spolidoro, LC
   Marcantonio, E
AF Santos, Fabio Andre
   Pochapski, Marcia Thais
   Martins, Marilia Campagnoni
   Zenobio, Elton Goncalves
   Spolidoro, Luis Carlos
   Marcantonio, Elcio, Jr.
TI Comparison of Biomaterial Implants in the Dental Socket: Histological
   Analysis in Dogs
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE bioactive glass; biocompatibility; biomaterials; bone substitute;
   hydroxyapatite
ID BIOACTIVE GLASS PARTICLES; DIFFERENT GRAFTING MATERIALS; BONE DEFECTS;
   POROUS HYDROXYAPATITE; EXTRACTION SOCKETS; ALVEOLAR RIDGE; BIO-OSS;
   AUGMENTATION; REGENERATION; MONKEYS
AB Background:
   Bone graft procedures have been used commonly in buco-maxillo-facial surgery. For this reason, many researchers have evaluated the bone substitutes.
   Purpose:
   The present study evaluated soft and hard tissue reactions to two different hydroxyapatites HAs (synthetic HA and natural HA) and bioactive glass implanted into the sockets immediately after extraction.
   Materials and Methods:
   First and third upper and lower premolars, on both sides, were extracted from six female dogs. The alveolar sockets were randomly assigned to four groups: Group 1 - control (unfilled), Group 2 - filled with synthetic hydroxyapatite, Group 3 - filled with bovine bone mineral (natural HA), and Group 4 - filled with bioactive glass. The animals were euthanized at 4 weeks (n = 2), 8 weeks (n = 2), and 28 weeks (n = 2) after extraction. The mandible and maxilla of each animal were removed for histological analysis to determine soft tissue reactions, newly formed bone, bone characteristics, and presence or absence of implanted materials.
   Results:
   Most particles of synthetic hydroxyapatite had bone formation on their surface, although some particles showed a layer of fibrous connective tissue. The bovine bone mineral group exhibited particles partially replaced with bone formation. The bioactive glass group showed particles with a thin layer of calcified tissue, but was absent in some specimens, suggesting complete resorption.
   Conclusion:
   All biomaterials had similar behavior. Bovine bone mineral, compared to synthetic hydroxyapatite and bioactive glass, showed a larger number of particles covered with osseous tissue. All biomaterials interfered with the socket repair process.
C1 [Santos, Fabio Andre] Univ Estadual Ponta Grossa, Dept Periodont, Sch Dent, Ponta Grossa, Parana, Brazil.
   [Pochapski, Marcia Thais] Univ Estadual Campinas, Dept Pharmacol Anesthesiol & Therapeut, Campinas, SP, Brazil.
   [Martins, Marilia Campagnoni] Univ Fed Parana, Sch Dent, Dept Periodont, BR-80060000 Curitiba, Parana, Brazil.
   [Zenobio, Elton Goncalves] Pontificia Univ Catolica Minas Gerais, Dept Periodont, Sch Dent, Belo Horizonte, MG, Brazil.
   [Spolidoro, Luis Carlos; Marcantonio, Elcio, Jr.] Sao Paulo State Univ, UNESP, Sch Dent, Dept Periodont, Araraquara, SP, Brazil.
RP Santos, FA (reprint author), Univ Estadual Ponta Grossa, Dept Periodont, Sch Dent, Ponta Grossa, Parana, Brazil.
EM fasantos11@gmail.com
RI Marcantonio, Elcio/A-4784-2008
OI Marcantonio, Elcio/0000-0003-1294-2305; Marcantonio Junior,
   Elcio/0000-0002-9660-4524
CR ALRHEUMY KA, 2001, INT J ORAL MAXILLOF, V16, P105
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   Cancian DCJ, 2004, INT J ORAL MAX IMPL, V19, P73
   Cardaropoli G, 2005, J CLIN PERIODONTOL, V32, P435, DOI 10.1111/j.1600-051X.2005.00692.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   El-Ghannam A, 2004, INT J ORAL MAX IMPL, V19, P184
   Fleckenstein KB, 2006, J PERIODONTOL, V77, P39, DOI 10.1902/jop.2006.77.1.39
   Furusawa T, 1998, INT J ORAL MAX IMPL, V13, P672
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Hall EE, 1999, J PERIODONTOL, V70, P526, DOI 10.1902/jop.1999.70.5.526
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Indovina A, 2002, J ORAL MAXIL SURG, V60, P53, DOI 10.1053/joms.2002.0000
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Melo LGN, 2005, CLIN ORAL IMPLAN RES, V16, P683, DOI 10.1111/j.1600-0501.2004.01090.x
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   PINHOLT EM, 1991, SCAND J DENT RES, V99, P154
   Pochapski M. T., 2006, J ORAL SCI, V48, P219
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P487, DOI 10.1034/j.1600-0501.1997.080607.x
   Redondo LM, 1995, INT J ORAL MAX SURG, V24, P445, DOI 10.1016/S0901-5027(05)80475-8
   Schepers E, 1998, INT J ORAL MAX IMPL, V13, P655
   Silva RV, 2005, INT J ORAL MAX SURG, V34, P178, DOI 10.1016/j.ijom.2004.06.005
   Tamimi FM, 2006, J CLIN PERIODONTOL, V33, P922, DOI 10.1111/j.1600-051X.2006.01004.x
   Thorwarth M, 2007, BRIT J ORAL MAX SURG, V45, P41, DOI 10.1016/j.bjoms.2006.03.013
   Turunen T, 2004, CLIN ORAL IMPLAN RES, V15, P135, DOI 10.1111/j.1600-0501.2004.00989.x
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   Wheeler DL, 1998, J BIOMED MATER RES, V41, P527, DOI 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.0.CO;2-E
NR 27
TC 22
Z9 25
U1 0
U2 4
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1523-0899
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PY 2010
VL 12
IS 1
BP 18
EP 25
DI 10.1111/j.1708-8208.2008.00126.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 553TA
UT WOS:000274388500003
PM 18783409
DA 2018-10-20
ER

PT J
AU Araujo, MG
   Liljenberg, B
   Lindhe, J
AF Araujo, Mauricio G.
   Liljenberg, Birgitta
   Lindhe, Jan
TI Dynamics of Bio-Oss (R) Collagen incorporation in fresh extraction
   wounds: an experimental study in the dog
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; extraction socket; grafting; healing
ID OSTEOPONTIN MESSENGER-RNA; ANORGANIC BOVINE BONE; TOOTH EXTRACTION;
   DENTAL IMPLANTS; PART 1; TISSUE; SOCKETS; RAT; EXPRESSION; AUGMENTATION
AB Aim
   The objective of this experiment was to analyze processes involved in the incorporation of Bio-Oss (R) Collagen in host tissue during healing following tooth extraction and grafting.
   Methods
   Five beagle dogs were used. Four premolars in the mandible ((3)P(3), (4)P(4)) were hemi-sected, the distal roots were removed and the fresh extraction socket filled with Bio-Oss (R) Collagen. The mucosa was mobilized and the extraction site was closed with interrupted sutures. The tooth extraction and grafting procedures were scheduled in such a way that biopsies representing 1 and 3 days, as well as 1, 2 and 4 weeks of healing could be obtained. The dogs were euthanized and perfused with a fixative. Each experimental site, including the distal socket area, was dissected. The sites were decalcified in EDTA, and serial sections representing the central part of the socket were prepared in the mesio-distal plane and parallel with the long axis of the extraction socket. Sections were stained in hematoxylin and eosin and were used for the overall characteristics of the tissues in the extraction socket. In specimens representing 1, 2 and 4 weeks of healing the various tissue elements were assessed using a morphometric point counting procedure. Tissue elements such as cells, fibers, vessels, leukocytes and mineralized bone were determined. In deparaffinized sections structures and cells positive for tartrate-resistant acid phosphatase activity (TRAP), alkaline phosphatase and osteopontin were identified.
   Results
   The biomaterial was first trapped in the fibrin network of the coagulum. Neutrophilic leukocytes [polymorphonuclear (PMN) cells] migrated to the surface of the foreign particles. In a second phase the PMN cells were replaced by multinuclear TRAP-positive cells (osteoclasts). The osteoclasts apparently removed material from the surface of the xenogeneic graft. When after 1-2 weeks the osteoclasts disappeared from the Bio-Oss (R) granules they were followed by osteoblasts that laid down bone mineral in the collagen bundles of the provisional matrix. In this third phase the Bio-Oss (R) particles became osseointegrated.
   Conclusions
   It was demonstrated that the incorporation of Bio-Oss (R) in the tissue that formed in an extraction wound involved a series of different processes.
   To cite this article:AraUjo MG, Liljenberg B, Lindhe J. Dynamics of Bio-Oss (R) Collagen incorporation in fresh extraction wounds: an experimental study in the dog. Clin. Oral Impl. Res. 21, 2010; 55-64.
C1 [Araujo, Mauricio G.] Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
   [Liljenberg, Birgitta; Lindhe, Jan] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Gothenburg, Sweden.
RP Araujo, MG (reprint author), Rua Silva Jardim 15,Sala 03, BR-87013010 Maringa, Parana, Brazil.
EM odomar@hotmail.com
CR AMLER MH, 1969, ORAL SURG ORAL MED O, V27, P309, DOI 10.1016/0030-4220(69)90357-0
   ARAI N, 1993, BONE MINER, V22, P129, DOI 10.1016/S0169-6009(08)80224-3
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   CARMAGNOLA D, 2003, CLIN ORAL IMPLAN RES, V14, P835
   CHEN J, 1991, HISTOCHEM J, V23, P281, DOI 10.1007/BF01045047
   EVIAN CI, 1982, J PERIODONTOL, V53, P81, DOI 10.1902/jop.1982.53.2.81
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Iezzi G, 2008, J PERIODONTOL, V79, P192, DOI 10.1902/jop.2008.070105 
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   KAWAGUCHI H, 1993, CELL MATER, V3, P337
   Kinane DF, 2000, PERIODONTOL 2000, V24, P215, DOI 10.1034/j.1600-0757.2000.2240110.x
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   MARK MP, 1988, DIFFERENTIATION, V37, P123, DOI 10.1111/j.1432-0436.1988.tb00804.x
   MERRY K, 1993, J CELL SCI, V104, P1013
   Nevins M, 2006, INT J PERIODONT REST, V26, P19
   NISHIYAMA K, 1990, CRC HDB BIOACTIVE CE, V2, P87
   PIETROKOVSKI J, 1967, J PROSTHET DENT, V17, P21, DOI 10.1016/0022-3913(67)90046-7
   Pietrokovski Jaime, 2007, J Prosthodont, V16, P141, DOI 10.1111/j.1532-849X.2007.00165.x
   PINERO GJ, 1995, ARCH ORAL BIOL, V40, P145, DOI 10.1016/0003-9969(94)00144-Z
   Ratner B D, 2001, J Dent Educ, V65, P1340
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   TOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   Traini T, 2008, J PERIODONTOL, V79, P1232, DOI [10.1902/jop.2008.070504, 10.1902/jop.2008.070504 ]
   Zitzmann N U, 2001, Int J Periodontics Restorative Dent, V21, P288
NR 32
TC 77
Z9 77
U1 1
U2 11
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JAN
PY 2010
VL 21
IS 1
BP 55
EP 64
DI 10.1111/j.1600-0501.2009.01854.x
PG 10
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 533PE
UT WOS:000272835900008
PM 20070748
DA 2018-10-20
ER

PT J
AU Brown, SR
   Wadhawan, H
   Nelson, RL
AF Brown, Steven R.
   Wadhawan, Himanshu
   Nelson, Richard L.
TI Surgery for faecal incontinence in adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Fecal Incontinence [surgery]; Pelvic Floor [surgery]; Randomized
   Controlled Trials as Topic; Adult; Humans
ID ANAL-SPHINCTER REPAIR; PELVIC FLOOR REPAIR; INJECTABLE SILICONE
   BIOMATERIAL; RANDOMIZED CONTROLLED-TRIAL; SACRAL NERVE-STIMULATION;
   DOUBLE-BLIND CROSSOVER; CLINICAL-TRIAL; RISK-FACTORS; PREVALENCE;
   PHYSIOLOGY
AB Background
   Faecal incontinence is a debilitating problem with significant medical, social and economic implications. Treatment options include conservative, non-operative interventions (e.g. pelvic floor muscle training, biofeedback, drugs) and surgical procedures. A surgical procedure may be aimed at correcting an obvious mechanical defect, or augmenting a functionally deficient but structurally intact sphincter complex.
   Objectives
   To assess the effects of surgical techniques for the treatment of faecal incontinence in adults who do not have rectal prolapse. Our aim was firstly to compare surgical management with non-surgical management and secondly, to compare the various surgical techniques.
   Search strategy
   Electronic searches of the Cochrane Incontinence Group Specialised Register (searched 26 November 2009), the Cochrane Colorectal Cancer Group Specialised Register (searched 26 November 2009), CENTRAL (The Cochrane Library 2009) and EMBASE (1 January 1998 to 30 June 2009) were undertaken. The British Journal of Surgery (1 January 1995 to 30 June 2009) ColorectalDiseases (1 January 2000 to 30 June 2009) and the Diseases of the Colon and Rectum (1 January 1995 to 30 June 2009) were specifically handsearched. The proceedings of the UK Association of Coloproctology meeting held from 1999 to 2009 were perused. Reference lists of all relevant articles were searched for further trials.
   Selection criteria
   All randomised or quasi-randomised trials of surgery in the management of adult faecal incontinence (other than surgery for rectal prolapse).
   Data collection and analysis Three reviewers independently selected studies from the literature, assessed the methodological quality of eligible trials and extracted data. The three primary outcome measures were: change or deterioration in incontinence, failure to achieve full continence, and the presence of faecal urgency.
   Main results Thirteen trials were included with a total sample size of 440 participants. Two trials included a group managed non- surgically. One trial compared levator with anal plug electrostimulation and one compared artificial bowel sphincter with best supportive care. The artificial bowel sphincter resulted in significant improvements in at least one primary outcome but numbers were small. The other trial showed no difference in primary outcome measures.
   Eleven trials compared different surgical interventions. These included anterior levatorplasty versus postanal repair, anterior levatorplasty versus total pelvic floor repair, total pelvic floor versus postanal repair, end to end versus overlap sphincter repair, overlap repair with or without a defunctioning stoma or with or without biofeedback, injection of silicone, hydrogel, physiological saline, carbon beads or collagen bulking agents, total pelvic floor repair versus repair plus internal sphincter plication and neosphincter formation versus total pelvic floor repair. Sacral nerve stimulation and injectables are also considered in separate Cochrane reviews. Only one comparison had more than one trial (total pelvic floor versus postanal repair, 44 participants) and no trial showed any difference in primary outcome measures.
C1 [Brown, Steven R.] No Gen Hosp, Sheffield Teaching Hosp, Dept Surg, Sheffield S5 7AU, S Yorkshire, England.
   [Nelson, Richard L.] No Gen Hosp, Dept Gen Surg, Sheffield S5 7AU, S Yorkshire, England.
RP Brown, SR (reprint author), No Gen Hosp, Sheffield Teaching Hosp, Dept Surg, Herried Rd,Sheffield S7, Sheffield S5 7AU, S Yorkshire, England.
EM stevebrown@doctors.org.uk
FU NHS; Chief Scientist Office, Scottish Executive Health Department, UK
FX External sources; NHS National R& D Programme for People with Physical
   and Complex Disabilities, UK.; Chief Scientist Office, Scottish
   Executive Health Department, UK.
CR ANDREW J, 1964, BRAIN, V87, P233, DOI 10.1093/brain/87.2.233
   *BLADD BOW FDN, 2000, MAK CAS INT CONT SER
   BURNSTOCK G, 1990, CIBA F SYMP, V151, P18
   BURNSTOCK G, 1990, CIBA F SYMP, V151, P2
   BYAR DP, 1976, NEW ENGL J MED, V295, P74, DOI 10.1056/NEJM197607082950204
   CARRARO PS, 1994, BRIT J SURG, V81, P140
   Chen ASH, 1998, DIS COLON RECTUM, V41, P1005, DOI 10.1007/BF02237391
   COUNIHAN TC, 2005, CURRENT THERAPY COLO, P105
   Davis KJ, 2004, ALIMENT PHARM THERAP, V20, P539, DOI 10.1111/j.1365-2036.2004.02119.x
   de Groat W.C., 1990, CIBA F SYMP, V151
   DEEN KI, 1993, BRIT J SURG, V80, P794, DOI 10.1002/bjs.1800800648
   DEEN KI, 1995, DIS COLON RECTUM, V38, P14, DOI 10.1007/BF02053851
   DEGROAT WC, 1990, CIBA F SYMP, V151, P27
   FeltBersma RJF, 1997, DIS COLON RECTUM, V40, P811, DOI 10.1007/BF02055438
   Fernando R, 2004, NEUROUROL URODYNAM, V23, P411
   Fernando RJ, 2006, OBSTET GYNECOL, V107, P1261, DOI 10.1097/01.AOG.0000218693.24144.bd
   Fitzpatrick M, 2000, AM J OBSTET GYNECOL, V183, P1220, DOI 10.1067/mob.2000.108880
   FITZPATRICK M, 1999, COLORECTAL DIS S1, V1, P10
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Hasegawa H, 2000, DIS COLON RECTUM, V43, P961, DOI 10.1007/BF02237359
   Higgins JPT, 2008, COCHRANE COLLABORATI
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   Kalantar JS, 2002, MED J AUSTRALIA, V176, P54
   Kamm MA, 1998, BRIT MED J, V316, P528, DOI 10.1136/bmj.316.7130.528
   Keating JP, 1997, DIS COLON RECTUM, V40, P896, DOI 10.1007/BF02051195
   Lam TCF, 1999, COLORECTAL DIS, V1, P197
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   LODER PB, 1993, BRIT J SURG, V80, P1352, DOI 10.1002/bjs.1800801053
   MacArthur C, 1997, BRIT J OBSTET GYNAEC, V104, P46, DOI 10.1111/j.1471-0528.1997.tb10648.x
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub3
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Mellgren A, 1999, DIS COLON RECTUM, V42, P857, DOI 10.1007/BF02237089
   Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2
   Nakayama H, 1997, STROKE, V28, P58, DOI 10.1161/01.STR.28.1.58
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Nordenstam J, 2008, BJOG-INT J OBSTET GY, V115, P857, DOI 10.1111/j.1471-0528.2008.01726.x
   O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6
   Osterberg A, 2004, BRIT J SURG, V91, P1131, DOI 10.1002/bjs.4577
   Parellada CM, 1998, DIS COLON RECTUM, V41, P593, DOI 10.1007/BF02235265
   PARKS AG, 1975, P ROY SOC MED, V68, P681
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Pfeifer J, 1997, DIS COLON RECTUM, V40, P79, DOI 10.1007/BF02055686
   Rainey J B, 1990, J R Coll Surg Edinb, V35, P101
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Ryhammer AM, 1997, DIS COLON RECTUM, V40, P287, DOI 10.1007/BF02050417
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8
   SUN WM, 1990, GUT, V31, P1056, DOI 10.1136/gut.31.9.1056
   Takahashi T, 2002, DIS COLON RECTUM, V45, P915, DOI 10.1007/s10350-004-6328-4
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Tou S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001758.pub2
   TURNBERG L, 1995, INCONTINENCE CAUSES
   Uher EM, 1998, DIS COLON RECTUM, V41, P1165, DOI 10.1007/BF02239440
   Vaizey CJ, 2000, DIS COLON RECTUM, V43, P298, DOI 10.1007/BF02258292
   VAIZEY CJ, BRIT J SURG, V5, P596
   van Tets WF, 1998, DIS COLON RECTUM, V41, P365, DOI 10.1007/BF02237493
   Ware JE, 1993, SF 36 HLTH SURVEY MA
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
   WILLIAMS A, 2004, P INT CONT SOC UK 11, P33
   Yoshioka K, 1999, DIS COLON RECTUM, V42, P252, DOI 10.1007/BF02237137
   ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x
NR 67
TC 19
Z9 20
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2010
IS 9
AR CD001757
DI 10.1002/14651858.CD001757.pub3
PG 85
WC Medicine, General & Internal
SC General & Internal Medicine
GA 649KF
UT WOS:000281767000003
PM 20824829
DA 2018-10-20
ER

PT J
AU Maeda, Y
   Laurberg, S
   Norton, C
AF Maeda, Yasuko
   Laurberg, Soren
   Norton, Christine
TI Perianal injectable bulking agents as treatment for faecal incontinence
   in adults
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID INTERNAL ANAL-SPHINCTER; SILICONE BIOMATERIAL PTQ(TM); AUTOLOGOUS FAT;
   INJECTION; MANAGEMENT; IMPLANTS; DYSFUNCTION; COLLAGEN
AB Background
   Faecal incontinence is a complex and distressing condition with significant medical and social implications. Injection of perianal bulking agents has been used to treat the symptoms of passive faecal incontinence. However, various different agents have been used without a standardised technique and the supposed benefit of the treatment is largely pragmatic with a limited clinical research base. Objectives
   To determine the effectiveness of perianal injection of bulking agents for the treatment of faecal incontinence in adults.
   Search strategy
   We searched the Cochrane Incontinence Group Specialised Register of trials (searched 10 June 2009), ZETOC (searched 18 July 2009), clinical trials registries (searched 18 July 2009) and the reference lists of relevant articles.
   Selection criteria
   All randomised or quasi-randomised controlled trials comparing use of injectable bulking agents for faecal incontinence with any alternative treatments or placebo were reviewed to evaluate the therapeutic effects. Case-control and cohort studies were also reviewed to assess risks and complications associated with the treatment.
   Data collection and analysis
   Two reviewers assessed the methodological quality of eligible trials and independently extracted data from included trials using a range of pre-specified outcome measures.
   Main results
   Four eligible randomised trials were identified with a total of 176 patients. All trials but one were at an uncertain or high risk of bias. Most trials reported a short term benefit from injections regardless of the material used as outcome measures improved over time. A silicone biomaterial (PTQ (TM)), was shown to provide some advantages and was safer in treating faecal incontinence than carbon-coated beads (Durasphere (R)) in the short term. Similarly, there were short term benefits from injections delivered under ultrasound guidance compared with digital guidance. However, PTQ (TM) did not demonstrate obvious clinical benefit compared to control injection of normal saline. No long term evidence on outcomes was available and further conclusions were not warranted from the available data.
   Authors' conclusions
   A definitive conclusion cannot be drawn regarding the effectiveness of perianal injection of bulking agents for faecal incontinence due to the limited number of identified trials together with methodological weaknesses. Within the available data, however, we found no reliable evidence for effectiveness of one treatment over another in improving faecal incontinence. Larger well-designed trials with adequate numbers of subjects using reliable validated outcome measures are needed to allow definitive assessment of the treatment for both effectiveness and safety.
C1 [Maeda, Yasuko] Aarhus Univ Hosp, Surg Res Unit, DK-8000 Aarhus, Denmark.
   [Laurberg, Soren] Aarhus Univ Hosp, Dept Surg, DK-8000 Aarhus, Denmark.
   [Norton, Christine] Bucks New Univ, Uxbridge, Middx, England.
   [Norton, Christine] Imperial Coll Healthcare NHS Trust, Uxbridge, Middx, England.
RP Maeda, Y (reprint author), Aarhus Univ Hosp, Surg Res Unit, Tage Hansens Gade 2, DK-8000 Aarhus, Denmark.
EM yazmaeda@googlemail.com
RI Maeda, Yasuko/B-6123-2016
OI Maeda, Yasuko/0000-0002-4081-4741
CR Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   Brown SR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001757.pub2
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Chassagne P, 1999, AM J MED, V106, P185, DOI 10.1016/S0002-9343(98)00407-0
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   da Silva GM, 2003, DIS COLON RECTUM, V46, P1492, DOI 10.1097/01.DCR.0000093642.39267.67
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   DEHLI T, RANDOMIZED CONTROLLE
   Dehli Trond, 2007, Tidsskr Nor Laegeforen, V127, P2934
   Deutekom M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005086.pub2
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   FELTBERSMA RJ, 1996, DIS COLON RECTUM, V39, P78
   Feretis C, 2001, DIS COLON RECTUM, V44, P1605, DOI 10.1007/BF02234379
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Gett RM, 2007, ANZ J SURG S1, V77, pA16
   Kumar D, 1998, BRIT J SURG, V85, P978
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   Lindsey I, 2004, DIS COLON RECTUM, V47, P1643, DOI 10.1007/s10350-004-0651-7
   LUO C, 2009, COLORECTAL DIS  0306
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2
   Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x
   Norton C, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002111.PUB2
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Smart N, 2008, COLORECTAL DIS, V10, P628, DOI 10.1111/j.1463-1318.2008.01475.x
   Smart N, 2005, COLORECTAL DIS, V7, P59
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   van der Hagen SJ, 2007, BRIT J SURG, V94, P222, DOI 10.1002/bjs.5463
   Weiss EG, 2002, DIS COLON RECTUM, V45, pA46
   Wexner SD, 1996, DIS COLON RECTUM, V39, P957, DOI 10.1007/BF02054681
   Wheeler TL, 2007, CURR OPIN OBSTET GYN, V19, P474, DOI 10.1097/GCO.0b013e3282ef4142
NR 46
TC 22
Z9 22
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1469-493X
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2010
IS 5
AR CD007959
DI 10.1002/14651858.CD007959.pub2
PG 32
WC Medicine, General & Internal
SC General & Internal Medicine
GA 595LD
UT WOS:000277611100024
PM 20464759
OA Bronze
DA 2018-10-20
ER

PT J
AU Chollet, C
   Lazare, S
   Guillemot, F
   Durrieu, MC
AF Chollet, C.
   Lazare, S.
   Guillemot, F.
   Durrieu, M. C.
TI Impact of RGD micro-patterns on cell adhesion
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Cell adhesion; Micro-patterning; Poly-(ethylene terephthalate); RGD
   peptides; Surface modification
ID IN-VITRO; TOPOGRAPHICAL CONTROL; SURFACE-CHEMISTRY; FIBRONECTIN;
   ATTACHMENT; BONE; BEHAVIOR; POLY(ETHYLENE-TEREPHTHALATE); ORGANIZATION;
   LITHOGRAPHY
AB In older to avoid the problems related to biomaterial use (inflammation, infections, aseptic loosening, etc.), a new approach consisting of associating the material and autologous cells before implantation is being developed, thus requiring a perfect cooperation between the material's surface and the cell To improve cell adhesion to biomaterials. a suitable method is to functionalize their sui face by pro-adhesive ligand grafting. The aim of this study was to covalently graft RGD containing peptides onto a poly-(ethylene terephthalate) surface in well-defined microstructures 111 order to control MC3T3 cell adhesion We followed two different routes for obtaining micro-patterned materials (1) a photoablation technique using an excimer laser and (2) a photolithography process The resulting patterns were characterized by optical microscopy, scanning electron microscopy, optical profilometry and high resolution mu-imager The biological evaluation of cell adhesion onto the micro-patterned surfaces was carried out using optical microscopy, scanning electron microscopy and fluorescence microscopy Cells seeded onto photolithographical or photoablated micro-patterned PET exhibited an alignment with the RGD domains and appeal to be connecting through pseudopods extending towards each other Whatever the technique used to create micro-patterns, a cell alignment occurs once the thickness of the RGD line leaches similar to 100 mu m These results prove the importance of microstructured sun faces for the elaboration of tissue engineered biomaterials (C) 2009 Published by Elsevier B V
C1 [Chollet, C.; Guillemot, F.; Durrieu, M. C.] INSERM, U577, F-33076 Bordeaux, France.
   [Chollet, C.; Guillemot, F.; Durrieu, M. C.] Univ Bordeaux 2, F-33076 Bordeaux, France.
   [Lazare, S.] Univ Bordeaux 1, CNRS, UMR 5255, Inst Mol Sci, F-33405 Talence, France.
RP Chollet, C (reprint author), INSERM, U577, F-33076 Bordeaux, France.
RI Guillemot, Fabien/F-5174-2012; DURRIEU, Marie-Christine/I-4358-2016
OI Guillemot, Fabien/0000-0002-4263-4365; DURRIEU,
   Marie-Christine/0000-0003-0583-9289
CR Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Blanchemain N, 2005, EUR J VASC ENDOVASC, V29, P628, DOI 10.1016/j.ejvs.2005.02.020
   Britland S., 1997, EXP BIOL ONLINE, V1, P1
   Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012
   Chollet C., 2007, ITBM RBM, V28, P2
   Chollet C, 2006, J LASER MICRO NANOEN, V1, P226, DOI 10.2961/jlmn.2006.03.0015
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dadsetan M, 2001, J BIOMED MATER RES, V57, P183, DOI 10.1002/1097-4636(200111)57:2<183::AID-JBM1157>3.0.CO;2-M
   Dadsetan M, 2001, J BIOMED MATER RES, V54, P540
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Dewez JL, 1997, J COLLOID INTERF SCI, V191, P1, DOI 10.1006/jcis.1997.4908
   Duncan AC, 2007, COLLOID SURFACE B, V54, P150, DOI 10.1016/j.colsurfb.2006.09.013
   Duncan AC, 2004, APPL SURF SCI, V221, P93, DOI 10.1016/S0169-4332(03)00819-5
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Faucheux N, 2006, BIOMATERIALS, V27, P234, DOI 10.1016/j.biomaterials.2005.05.076
   Gappa-Fahlenkamp H, 2005, BIOMATERIALS, V26, P3479, DOI 10.1016/j.biomaterials.2004.09.028
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Huang TT, 2003, BIOTECHNOL BIOENG, V83, P416, DOI 10.1002/bit.10680
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Mayer G, 2006, BIOMATERIALS, V27, P553, DOI 10.1016/j.biomaterials.2005.05.096
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mikulikova R, 2005, BIOMATERIALS, V26, P5572, DOI 10.1016/j.biomaterials.2005.02.010
   Miller JS, 2006, BIOTECHNOL BIOENG, V93, P1060, DOI 10.1002/bit.20809
   Nakanishi J, 2008, ANAL SCI, V24, P67, DOI 10.2116/analsci.24.67
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   VASILEV AV, 2005, IZV AKAD NAUK BIOL+, V1, P5
   Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Weisbuch F, 2004, THIN SOLID FILMS, V453, P394, DOI 10.1016/j.tsf.2003.11.182
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
NR 50
TC 18
Z9 21
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN 1
PY 2010
VL 75
IS 1
BP 107
EP 114
DI 10.1016/j.colsurfb.2009.08.024
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 609YR
UT WOS:000278695300014
PM 19775874
DA 2018-10-20
ER

PT B
AU Amor, N
   Geris, L
   Sloten, JV
   Van Oosterwyck, H
AF Amor, Nadya
   Geris, Liesbet
   Sloten, Jos Vander
   Van Oosterwyck, Hans
BE Miller, K
   Nielsen, PMF
TI Biomaterial Surface Characteristics Modulate the Outcome of Bone
   Regeneration Around Endosseous Oral Implants: In Silico Modeling and
   Simulation
SO COMPUTATIONAL BIOMECHANICS FOR MEDICINE
LA English
DT Proceedings Paper
CT Computational Biomechanics Medicine IV
CY SEP 24, 2009
CL London, ENGLAND
DE Mathematical modeling; Numerical simulation; Blood platelet; Bone
   regeneration; Biomaterial; Pen-implant endosseous healing
ID PLATELET INTERACTIONS; FORMATION ADJACENT; TITANIUM; ROUGHNESS;
   FIBROBLASTS; OSTEOBLASTS; CELLS; DOG
AB Experimental investigations have demonstrated the importance of platelets and their activation for bone regeneration around oral implants. This study aimed to numerically demonstrate the key role of activated platelets which is controlled by implant surface characteristics. The cellular activities involved in the process of pen-implant endosseous healing can be represented by migration, proliferation, differentiation, removal, extracellular matrix synthesis and degradation, and growth factor production/release and decay. These activities are described by a system of highly coupled non-linear partial differential equations of taxis diffusion reaction type. Moreover, cell biomaterial interactions were treated by including surface-specific model parameters. A well-designed in vivo model that looked at healing around oral implants with different surface properties was selected from literature to validate the results. Numerical simulations agreed well with the experimentally observed healing response and demonstrated that platelet-related model parameters, which were dependent on implant surface characteristics, modulate the pattern of healing.
C1 [Amor, Nadya; Geris, Liesbet; Sloten, Jos Vander; Van Oosterwyck, Hans] Katholieke Univ Leuven, Div Biomech & Engn Design, Dept Mech Engn, B-3001 Louvain, Belgium.
RP Amor, N (reprint author), Katholieke Univ Leuven, Div Biomech & Engn Design, Dept Mech Engn, B-3001 Louvain, Belgium.
EM nadya.amor@gmail.com
RI Van Oosterwyck, Hans/C-2528-2016
OI Van Oosterwyck, Hans/0000-0002-2142-9717; geris,
   liesbet/0000-0002-8180-1445
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   Amor N, 2009, COMPUT METHOD BIOMEC, V12, P459, DOI 10.1080/10255840802687392
   ANDERSON JM, 2000, BONE ENG, P81
   Bailon-Plaza A, 2001, J THEOR BIOL, V212, P191, DOI 10.1006/jtbi.2001.2372
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Davies J.E., 2000, BONE ENG, P1
   Davies JE, 1996, ANAT REC, V245, P426
   Davies John E, 2003, J Dent Educ, V67, P932
   Gemmell CH, 2000, BONE ENG, P108
   Geris L, 2006, MED BIOL ENG COMPUT, V44, P280, DOI 10.1007/s11517-006-0040-6
   Gerisch A, 2006, MATH COMPUT MODEL, V43, P49, DOI 10.1016/j.mcm.2004.05.016
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Schwartz Z, 1999, Adv Dent Res, V13, P38
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
NR 24
TC 0
Z9 0
U1 3
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
BN 978-1-4419-5873-0
PY 2010
BP 95
EP 106
DI 10.1007/978-1-4419-5874-7_11
PG 12
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA BRM53
UT WOS:000283101400011
DA 2018-10-20
ER

PT S
AU Munoz, AI
   Vidal, CV
AF Igual Munoz, A.
   Valero Vidal, C.
BE Hansen, DC
   Alfantazi, A
   Gelling, VJ
TI Influence of electrochemical conditions on CoCrMo behaviour in simulated
   body fluid by step polarization technique
SO CORROSION (GENERAL) - 217TH ECS MEETING
SE ECS Transactions
LA English
DT Proceedings Paper
CT Symposium on Corrosion General Session held during the 217th Meeting of
   the Electrochemical-Society (ECS)
CY APR 25-30, 2010
CL Vancouver, CANADA
SP Electrochem Soc (ECS), Corros
ID IMPEDANCE SPECTROSCOPY; STAINLESS-STEEL; PASSIVE FILM; CORROSION; ALLOY;
   IRON
AB Corrosion processes occurring at implant surfaces, the role of oxide films in the corrosion process, alloy biocompatibility and the electrochemical response of alloys to mechanical or electrical transients are all important in the behaviour and success of implant alloys. Most transition metal alloys used in medicine (i.e. Titanium, CoCrMo alloys, stainless steels) have a passive film which spontaneously forms on the surface of the alloy and it provides a kinetic barrier to corrosion reactions. Oxide film structure and morphology are susceptible to the potential which exists across the alloy-solution interface. The present study presents an electrochemical technique based on the application of a potential step and measuring the current transient response to the step in potential. Electrochemical Impedance Spectroscopy (EIS) was carried out in order to provide information concerning the electrical character of the interface. The current density response and the properties of the interface (biomaterial/body fluid) depends on the solution chemistry and the way potential is achieved.
C1 [Igual Munoz, A.; Valero Vidal, C.] Univ Politecn Valencia, Dept Ingn Quim & Nucl, Valencia 46022, Spain.
RP Munoz, AI (reprint author), Univ Politecn Valencia, Dept Ingn Quim & Nucl, Camino Vera S-N, Valencia 46022, Spain.
RI igual munoz, anna/K-7996-2014; Valero-Vidal, Carlos/B-2681-2018
OI igual munoz, anna/0000-0002-1372-621X; Valero-Vidal,
   Carlos/0000-0001-7420-4194
CR Bai Zhijun, 2009, ASM HDB C, V13C, P837
   Bastos AC, 2006, CORROS SCI, V48, P1500, DOI 10.1016/j.corsci.2005.05.021
   Bommersbach P, 2005, ELECTROCHIM ACTA, V51, P1076, DOI 10.1016/j.electacta.2005.06.001
   Contu F, 2002, J BIOMED MATER RES, V62, P412, DOI 10.1002/jbm.10329
   Cosman NP, 2005, J ELECTROANAL CHEM, V574, P261, DOI 10.1016/j.jelechem.2004.08.007
   FERREIRA MGS, 1985, J ELECTROCHEM SOC, V132, P760, DOI 10.1149/1.2113954
   Gilbert J.L., 1998, BIOMED MAT RES, V40, P233
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Milosev I, 2003, ELECTROCHIM ACTA, V48, P2767, DOI 10.1016/S0013-4686(03)00396-7
   Munoz AI, 2007, J ELECTROCHEM SOC, V154, pC562, DOI 10.1149/1.2764238
   Sieber IV, 2006, CORROS SCI, V48, P3472, DOI 10.1016/j.corsci.2005.12.008
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Vidal CV, 2009, ELECTROCHIM ACTA, V54, P1798, DOI 10.1016/j.electacta.2008.10.018
   Virtanen S, 2008, ACTA BIOMATER, V4, P468, DOI 10.1016/j.actbio.2007.12.003
NR 14
TC 0
Z9 0
U1 0
U2 3
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 S MAIN ST, PENNINGTON, NJ 08534-2839 USA
SN 1938-5862
BN 978-1-60768-200-4
J9 ECS TRANSACTIONS
PY 2010
VL 28
IS 24
BP 25
EP 35
DI 10.1149/1.3496420
PG 11
WC Electrochemistry
SC Electrochemistry
GA BEZ76
UT WOS:000318942600003
DA 2018-10-20
ER

PT J
AU Khosravi-Darani, K
AF Khosravi-Darani, Kianoush
TI Research Activities on Supercritical Fluid Science in Food Biotechnology
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Supercritical fluid; cold pasteurization; extraction; biochemical
   reaction; biomaterial recovery
ID PRESSURE CARBON-DIOXIDE; HIGH HYDROSTATIC-PRESSURE; BACILLUS-SUBTILIS
   SPORES; MICRO-BUBBLE METHOD; ACID METHYL-ESTERS; ESCHERICHIA-COLI;
   BETA-GALACTOSIDASE; CO2 EXTRACTION; EXPLOSIVE DECOMPRESSION;
   LACTOBACILLUS-PLANTARUM
AB This article serves as an overview, introducing the currently popular area of supercritical fluids and their uses in food biotechnology. Within each application, and wherever possible, the basic principles of the technique, as well as a description of the history, instrumentation, methodology, uses, problems encountered, and advantages over the traditional, non-supercritical methods are given. Most current commercial application of the supercritical extraction involve biologically-produced materials; the technique may be particularly relevant to the extraction of biological compounds in cases where there is a requirement for low-temperature processing, high mass-transfer rates, and negligible carrying over of the solvent into the final product. Special applications to food processing include the decaffeination of green coffee beans, the production of hops extracts, the recovery of aromas and flavors from herbs and spices, the extraction and fractionation of edible oils, and the removal of contaminants, among others. New advances, in which the extraction is combined with reaction or crystallization steps, may further increase the attractiveness of supercritical fluids in the bioprocess industries. To develop and establish a novel and effective alternative to heating treatment, the lethal action of high hydrostatic pressure CO2 on microorganisms, with none or only a minimal heating process, has recently received a great deal of attention.
C1 Shahid Beheshti Univ, MC, Natl Nutr & Food Technol Res Inst, Dept Food Technol Res, Tehran, Iran.
RP Khosravi-Darani, K (reprint author), Shahid Beheshti Univ, MC, Natl Nutr & Food Technol Res Inst, Dept Food Technol Res, POB 19395-4741, Tehran, Iran.
EM Kiankh@yahoo.com
RI Osorio Tobon, Juan Felipe/G-6877-2012
OI , National Nutrition & Food Technology Research
   Institute/0000-0002-5182-4419; Khosravi-darani,
   Kianoush/0000-0002-0269-6385
CR AALTONEN O, 1991, CHEMTECH, V21, P240
   ARAI K, 1986, YUKAGAKU, V35, P267
   ARREOLA AG, 1991, J FOOD SCI, V56, P1030, DOI 10.1111/j.1365-2621.1991.tb14634.x
   Athes V, 1998, EUR J BIOCHEM, V255, P206, DOI 10.1046/j.1432-1327.1998.2550206.x
   Ballestra P, 1996, J FOOD SCI, V61, P829, DOI 10.1111/j.1365-2621.1996.tb12212.x
   Bertucco A., 2001, HIGH PRESSURE PROCES, P626
   BLICKSTAD E, 1981, J APPL BACTERIOL, V50, P493, DOI 10.1111/j.1365-2672.1981.tb04252.x
   Bruna D., 1994, HIGH PRESSURES FOOD, P248
   Brunner G, 2005, J FOOD ENG, V67, P21, DOI 10.1016/j.jfoodeng.2004.05.060
   Bruno T. J., 1993, RECOVERY PROCESSES B, P303
   Cansell F, 1998, REV I FR PETROL, V53, P71
   Castor TP, 1995, Supercritical fluid disruption of and extraction from microbial cells, Patent No. [5380826, US 5380826 A]
   Clery-Barraud C, 2004, APPL ENVIRON MICROB, V70, P635, DOI 10.1128/AEM.70.1.635-637.2004
   CLOUSTON JG, 1969, J BACTERIOL, V97, P684
   CUOGHI F, 1993, IND ALIMENT-ITALY, V32, P956
   Debs-Louka E, 1999, APPL ENVIRON MICROB, V65, P626
   Degraeve P, 1996, BBA-PROTEIN STRUCT M, V1292, P61, DOI 10.1016/0167-4838(95)00196-4
   Degraeve P, 1997, ENZYME MICROB TECH, V20, P550, DOI 10.1016/S0141-0229(96)00202-5
   Dellaglio F, 1999, ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY, P121
   Denery JR, 2004, ANAL CHIM ACTA, V501, P175, DOI 10.1016/j.aca.2003.09.026
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   Enomoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1133, DOI 10.1271/bbb.61.1133
   Erkmen O, 2000, FOOD MICROBIOL, V17, P589, DOI 10.1006/fmic.2000.0361
   Erkmen O, 2001, J FOOD ENG, V47, P7, DOI 10.1016/S0260-8774(00)00091-1
   Erkmen O, 2000, J SCI FOOD AGR, V80, P1365, DOI 10.1002/1097-0010(200007)80:9<1365::AID-JSFA652>3.3.CO;2-G
   Erkmen O, 1997, FOOD SCI TECHNOL-LEB, V30, P826
   Erkmen O, 2000, FOOD MICROBIOL, V17, P225, DOI 10.1006/fmic.1999.0308
   Erkmen O, 2001, J FOOD ENG, V50, P25, DOI 10.1016/S0260-8774(00)00191-6
   Erkmen O, 2001, J BIOSCI BIOENG, V92, P39, DOI 10.1263/jbb.92.39
   Erkmen O, 2001, INT J FOOD MICROBIOL, V65, P131, DOI 10.1016/S0168-1605(00)00499-2
   Fages J, 1998, ASAIO J, V44, P289
   Flament I., 1994, SUPERCRITICAL FLUIDS, P62
   FLAMENT I, 1994, PROCESSING FOOD BIOM, P62
   FOSTER JW, 1962, J BACTERIOL, V83, P330
   FRASER D, 1951, NATURE, V167, P33, DOI 10.1038/167033b0
   GAST K, 2001, P 2 INT M HIGH PRESS, P11
   GAST K, 2003, P 6 INT S SUP FLUIDS, P35
   Gould G. W., 1973, Acta Alimentaria Academiae Scientiarum Hungaricae, V2, P377
   Gould GW, 2003, ACTA ALIMENT HUNG, V32, P215
   Guarsie G. B., 1994, SUPERCRITICAL FLUID, P27
   Guvenc A, 1998, J SUPERCRIT FLUID, V13, P325, DOI 10.1016/S0896-8446(98)00067-9
   HAAS GJ, 1989, J FOOD SAFETY, V9, P253, DOI 10.1111/j.1745-4565.1989.tb00525.x
   HAMMAM H, 1992, J SUPERCRIT FLUID, V5, P101, DOI 10.1016/0896-8446(92)90026-G
   Hampson JW, 1999, J AM OIL CHEM SOC, V76, P1371, DOI 10.1007/s11746-999-0152-x
   HASHIZUME C, 1995, BIOSCI BIOTECH BIOCH, V59, P1455, DOI 10.1271/bbb.59.1455
   Hejazi P, 2003, BIOTECHNOL PROGR, V19, P1519, DOI 10.1021/bp034010q
   Heremans K, 1998, BBA-PROTEIN STRUCT M, V1386, P353, DOI 10.1016/S0167-4838(98)00102-2
   Hong SI, 1999, INT J FOOD SCI TECH, V34, P125, DOI 10.1046/j.1365-2621.1999.00241.x
   Hong SI, 2001, INT J FOOD MICROBIOL, V63, P19, DOI 10.1016/S0168-1605(00)00393-7
   Ibanez E, 1997, J AGR FOOD CHEM, V45, P3940, DOI 10.1021/jf970309a
   IKUSHIMA Y, 1989, IND ENG CHEM RES, V28, P1364, DOI 10.1021/ie00093a014
   IKUSHIMA Y, 1988, IND ENG CHEM RES, V27, P818, DOI 10.1021/ie00077a017
   ISENSCHMID A, 1995, J BIOTECHNOL, V39, P229, DOI 10.1016/0168-1656(95)00018-L
   ISHIKAWA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1949, DOI 10.1271/bbb.59.1949
   Ishikawa H, 1997, BIOSCI BIOTECH BIOCH, V61, P1022, DOI 10.1271/bbb.61.1022
   Jay A.J., 1991, J SUPERCRIT FLUID, V4, P131
   Juhasz T, 2003, CHEM BIOCHEM ENG Q, V17, P131
   Kamarei A. R., 1988, USP, Patent No. [4749522, 4,749,522]
   KAMAT SV, 1995, CRIT REV BIOTECHNOL, V15, P41, DOI 10.3109/07388559509150531
   KAMIHIRA M, 1987, AGR BIOL CHEM TOKYO, V51, P407, DOI 10.1080/00021369.1987.10868053
   KASCHE V, 1988, BIOTECHNOL LETT, V10, P569, DOI 10.1007/BF01027131
   Khosravi-Darani K, 2004, BIOTECHNOL PROGR, V20, P1757, DOI 10.1021/bp0498037
   Khosravi-Darani K, 2003, J CHEM ENG DATA, V48, P860, DOI 10.1021/je020168v
   Khosravi-Darani K., 2005, CRIT REV BIOTECHNOL, V25, P1
   Kim KH, 2001, BIORESOURCE TECHNOL, V77, P139, DOI 10.1016/S0960-8524(00)00147-4
   KIMBALL DA, 1987, J FOOD SCI, V52, P481, DOI 10.1111/j.1365-2621.1987.tb06644.x
   King M. B., 1993, EXTRACTION NATURAL P, P981
   Knorr D, 1995, HIGH PRESSURE PROCES, P123
   Lin H, 1994, US patent, Patent No. 5306637
   Lin H.M., 1992, BIOTECHNOL PROGR, V15, P41
   LITALIEN Y, 1989, BIOTECHNOL BIOENG, V33, P471, DOI 10.1002/bit.260330412
   Ludwig H, 1994, HIGH PRESSURE RES, V12, P251, DOI 10.1080/08957959408201665
   Ludwig H., 1994, HIGH PRESSURE RES, V12, P193
   LUDWIG H, 1997, PHARM IND, V59, P335
   Lund BM, 2002, INT J FOOD MICROBIOL, V77, P135, DOI 10.1016/S0168-1605(02)00057-0
   MARIEOLIVE MN, 2000, HIGH PRESSURE RES, V19, P317
   Marongiu B, 2004, J ESSENT OIL RES, V16, P256, DOI 10.1080/10412905.2004.9698715
   Matsuda T, 2004, CATAL TODAY, V96, P103, DOI 10.1016/j.cattod.2004.06.111
   McHugh M. A., 1994, SUPERCRITICAL FLUIDS, P189
   Medina AR, 1998, BIOTECHNOL ADV, V16, P517, DOI 10.1016/S0734-9750(97)00083-9
   Mesiano AJ, 1999, CHEM REV, V99, P623, DOI 10.1021/cr970040u
   Mira B, 1999, J SUPERCRIT FLUID, V14, P95, DOI 10.1016/S0896-8446(98)00111-9
   MOLIN G, 1983, EUR J APPL MICROBIOL, V18, P214, DOI 10.1007/BF00501511
   Mozhaev VV, 1996, BIOTECHNOL BIOENG, V52, P320, DOI 10.1002/(SICI)1097-0290(19961020)52:2<320::AID-BIT12>3.0.CO;2-N
   NAKAMURA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1297, DOI 10.1271/bbb.58.1297
   NAKAMURA K, 1990, TRENDS BIOTECHNOL, V8, P288, DOI 10.1016/0167-7799(90)90200-H
   NAKAMURA K, 1990, ENZYME ENG, V10, P319
   Nakayama A, 1996, APPL ENVIRON MICROB, V62, P3897
   Nguyen U., 1994, SUPERCRITICAL FLUID, P103
   Paidhungat M, 2002, APPL ENVIRON MICROB, V68, P3172, DOI 10.1128/AEM.68.6.3172-3175.2002
   PURI VP, 1983, BIOTECHNOL BIOENG, V26, P3149
   QUIRIN KW, 1988, DENSE GASES EXTRACTI, P218
   Raso J, 1998, J APPL MICROBIOL, V85, P17, DOI 10.1046/j.1365-2672.1998.00460.x
   REPS A, 1994, PRESSURES FOOD SCI B, P265
   RIZVI SSH, 1994, SUPERCRITICAL FLUID, P90
   Roberts CM, 1996, J APPL BACTERIOL, V81, P363
   Sanal IS, 2005, J SUPERCRIT FLUID, V34, P331, DOI 10.1016/j.supflu.2004.08.005
   Sanal IS, 2004, J SUPERCRIT FLUID, V32, P221, DOI 10.1016/j.supflu.2004.02.002
   Sarkari M., 1993, BIOTECHNOL BIOENG, V65, P258
   Schreck C., 1997, HIGH PRESSURE RES BI, P37
   SKERGET M, 1995, FLUID PHASE EQUILIBR, V109, P131, DOI 10.1016/0378-3812(95)02717-S
   Smelt JPPM, 1998, TRENDS FOOD SCI TECH, V9, P152, DOI 10.1016/S0924-2244(98)00030-2
   SOJKA B, 1994, PHARM IND, V56, P660
   Sojka B, 1997, PHARM IND, V59, P436
   Spilimbergo S, 2003, BIOTECHNOL BIOENG, V84, P627, DOI 10.1002/bit.10783
   Spilimbergo S, 2002, J SUPERCRIT FLUID, V22, P55, DOI 10.1016/S0896-8446(01)00106-1
   Teja AS, 2000, IND ENG CHEM RES, V39, P4442, DOI 10.1021/ie000915m
   TEMELLI F, 1988, FOOD TECHNOL-CHICAGO, V42, P145
   Vijayan S., 1994, SUPERCRITICAL FLUIDS, P74
   WANG L, 2002, BIOTECHNOL ANN REV, V8, P67
   Watanabe T., 2004, FOOD SCI TECHNOL RES, V70, P635
   Wells Sharon L, 2001, Angew Chem Int Ed Engl, V40, P518, DOI 10.1002/1521-3773(20010202)40:3<518::AID-ANIE518>3.0.CO;2-4
   YALPANI M, 1993, POLYMER, V34, P1102, DOI 10.1016/0032-3861(93)90237-5
   Yamaguchi K., 1986, J JPN OIL CHEM SOC, V35, P260
   Yoshida T, 2003, BIOMASS BIOENERG, V26, P71, DOI 10.1016/S0961-9534(03)00063-1
   ZAGROBELNY J, 1992, BIOTECHNOL PROGR, V8, P421, DOI 10.1021/bp00017a008
   Zheng YZ, 1996, BIOTECHNOL LETT, V18, P451, DOI 10.1007/BF00143469
NR 117
TC 21
Z9 23
U1 2
U2 56
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1040-8398
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PY 2010
VL 50
IS 6
BP 479
EP 488
AR PII 922844563
DI 10.1080/10408390802248759
PG 10
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA 610BP
UT WOS:000278704800001
PM 20544439
DA 2018-10-20
ER

PT J
AU Okazaki, M
AF Okazaki, Masayuki
TI Creation of highly functional CO(3)Ap-collagen scaffold biomaterials
SO DENTAL MATERIALS JOURNAL
LA English
DT Review
DE Scaffold biomaterials; CO(3)Ap-collagen; High function
ID BONE-FORMATION; PEPTIDE SVVYGLR; GROWTH-FACTOR; OSTEOPONTIN; CARBONATE;
   ADHESION; ACCELERATION; ANGIOGENESIS; COMPOSITE; BEHAVIOR
AB Physicochemical properties of apatites are affected dramatically by the substitution of trace elements. Especially, biological apatites constituting bone and teeth contain several wt% of CO32- ions, which are related to the crystallinity and solubility. Recently, scaffold biomaterials are being developed with a shape-maintaining property in addition to large pores and high porosity, into which cells can easily invade. To develop a new biodegradable scaffold biomaterial, bone-like carbonate apatites (CO(3)Ap) were synthesized and CO(3)Ap collagen scaffolds were created. This scaffold biomaterial is useful for regions with bone regeneration ability. When these sponge-frame complexes with rh-BMP2 were implanted beneath the periosteum cranii of rats, sufficient new bone was created at the surface of the periosteum cranii after 4 weeks' implantation. Furthermore, when a CO(3)Ap-collagen sponge containing SVVYGLR peptide was implanted as a graft into a tissue defect created in rat tibia, the migration of numerous vascular endothelial cells, as well as prominent angiogenesis inside the graft, could be detected after 1 week. Thus, the modification of higher functions such as cytokine and angiogenesis factors is effective for low regeneration regions using tissue engineering biomaterials.
C1 Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Hiroshima 7348553, Japan.
RP Okazaki, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Hiroshima 7348553, Japan.
EM okazakix@hiroshima-u.ac.jp
CR Alberts B, 1994, MOL BIOL CELL, P949
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   Fuse Y, 2007, DENT MATER J, V26, P814, DOI 10.4012/dmj.26.814
   Hamada Y, 2004, DENT MATER J, V23, P650, DOI 10.4012/dmj.23.650
   Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001
   Hamada Y, 2007, DENT MATER J, V26, P487, DOI 10.4012/dmj.26.487
   Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200
   Hirata I, 2007, J ARTIF ORGANS, V10, P212, DOI 10.1007/s10047-007-0391-2
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P564, DOI 10.1002/jbm.1055
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   LANGE TS, 1994, EXP CELL RES, V214, P381, DOI 10.1006/excr.1994.1271
   Le Geros R.Z, 1991, MONOGRAPHS ORAL SCI, V15, P108
   LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409
   Matsuura A, 2009, DENT MATER J, V28, P234, DOI 10.4012/dmj.28.234
   MILES AEW, 1967, STRUCTURAL CHEM ORG, P165
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OKAZAKI M, 1981, CARIES RES, V15, P477, DOI 10.1159/000260555
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Shibuya M, 1995, ADV CANCER RES, V67, P281, DOI 10.1016/S0065-230X(08)60716-2
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   Tanaka E, 1996, BIOL PHARM BULL, V19, P1141
   Tieliewuhan Y, 2004, DENT MATER J, V23, P258, DOI 10.4012/dmj.23.258
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VANWAZER JR, 1958, PHOSPHORUS ITS COMPO, P530
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328
   Yokota R, 2006, DENT MATER J, V25, P597, DOI 10.4012/dmj.25.597
NR 31
TC 5
Z9 5
U1 0
U2 13
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD JAN
PY 2010
VL 29
IS 1
BP 1
EP 8
DI 10.4012/dmj.2009-R01
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 576FF
UT WOS:000276129000001
PM 20379005
OA Bronze
DA 2018-10-20
ER

PT J
AU Okuda, Y
   Noda, M
   Kono, H
   Miyamoto, M
   Sato, H
   Ban, S
AF Okuda, Yuji
   Noda, Makoto
   Kono, Hiroshi
   Miyamoto, Motoharu
   Sato, Hideo
   Ban, Seiji
TI Radio-opacity of core materials for all-ceramic restorations
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Radio-opacity; Zirconia; Alumina
ID POLYCRYSTALLINE CERAMICS; GRAIN-SIZE; ZIRCONIA; BIOMATERIAL; TITANIUM
AB The aim of this study was to investigate and compare the radio-opacity of core materials for all-ceramic restorations, such as zirconia (NANOZR and Y-TZP) and alumina, against commercially pure titanium (cpTi) and aluminum. X-ray images were taken under general settings using an X-ray film. The X-ray film images were scanned using a digital scanner, and the darkness at the central area of each specimen image was quantitatively analyzed using an image analysis software. Amongst the materials investigated, alumina showed the most transparency against X-rays. Conversely, both types of zirconia showed the highest radio-opacity, whereby that of NANOZR was slightly lower than that of Y-TZP. This was because NANOZR contained 30 vol% of alumina and its density was also slightly lower than that of Y-TZP.
C1 [Okuda, Yuji; Noda, Makoto; Ban, Seiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, Kagoshima 8908544, Japan.
   [Kono, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Gen Dent Clin, Kagoshima 8908544, Japan.
   [Miyamoto, Motoharu] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Dent Radiol, Kagoshima 8908544, Japan.
   [Sato, Hideo] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, Kagoshima 8908544, Japan.
RP Okuda, Y (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biomat Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.
EM k2357241@kadai.jp
FU Japan Society for the Promotion of Science [B-18390521]
FX The present study was supported by a Grant-in-Aid for General Science
   Research (B-18390521) from the Japan Society for the Promotion of
   Science. The authors would also like to thank Panasonic Electric Works
   Co. Ltd. for kindly providing the zirconia specimens.
CR Ban S, 2008, J BIOMED MATER RES B, V87B, P492, DOI 10.1002/jbm.b.31131
   Ban S, 2008, JPN DENT SCI REV, V44, P3, DOI 10.1016/j.jdsr.2008.04.001
   Davy KWM, 1997, J DENT, V25, P499, DOI 10.1016/S0300-5712(96)00064-4
   DRUMMOND JL, 1989, J AM CERAM SOC, V72, P675, DOI 10.1111/j.1151-2916.1989.tb06194.x
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   GARVIE RC, 1975, NATURE, V703, P258
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   International Organization for Standardization, 2007, 99171 ISO
   International Organization for Standardization, 2000, 4049 ISO
   Lide D.R., 2002, HDB CHEM PHYS
   MENDELSON MI, 1969, J AM CERAM SOC, V52, P443, DOI 10.1111/j.1151-2916.1969.tb11975.x
   MURTY RC, 1965, NATURE, V207, P398, DOI 10.1038/207398a0
   Nawa M, 1998, CERAM INT, V24, P497, DOI 10.1016/S0272-8842(97)00048-5
   OROURKE B, 1995, J DENT, V23, P353, DOI 10.1016/0300-5712(94)00009-5
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sato H, 2008, DENT MATER J, V27, P408, DOI 10.4012/dmj.27.408
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   SOBOKBAR A, 1997, J BONE JOINT SURG BR, V79, P129
   WEBER J, 1969, BRIT J RADIOL, V42, P378, DOI 10.1259/0007-1285-42-497-378
   WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x
   Yamashita D, 2008, J CERAM SOC JPN, V116, P20, DOI 10.2109/jcersj2.116.20
NR 21
TC 15
Z9 18
U1 0
U2 3
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD JAN
PY 2010
VL 29
IS 1
BP 35
EP 40
DI 10.4012/dmj.2009-54
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 576FF
UT WOS:000276129000006
PM 20379010
OA Bronze
DA 2018-10-20
ER

PT J
AU Alijotas-Reig, J
   Miro-Mur, F
   Planells-Romeu, I
   Garcia-Aranda, N
   Garcia-Gimenez, V
   Vilardell-Tarres, M
AF Alijotas-Reig, Jaume
   Miro-Mur, Francesc
   Planells-Romeu, Irene
   Garcia-Aranda, Natalia
   Garcia-Gimenez, Victor
   Vilardell-Tarres, Miquel
TI Are Bacterial Growth and/or Chemotaxis Increased by Filler Injections?
   Implications for the Pathogenesis and Treatment of Filler-Related
   Granulomas
SO DERMATOLOGY
LA English
DT Article
DE Bacterial infection; Chemotaxis; Filler injections; Granulomas;
   Treatment
ID NONABSORBABLE HYDROGEL POLYMER; TERM-FOLLOW-UP; CLINICAL FINDINGS;
   HYALURONIC-ACID; DERMAL FILLERS; INFECTION; COMPLICATIONS; AUTOIMMUNITY;
   AUTOANTIBODIES; INFLAMMATION
AB Background: As microbial agents have been associated with late adverse effects related to fillers antibiotic treatment has been envisaged. Objective: To determine whether biomaterials favor bacterial growth and/or attract bacteria. Methods: Hyaluronic acid, semi-permanent fillers, such as calcium hydroxylapatite, and permanent fillers, such as polyalkylimide/polyacrylamide, were used. Experiments were performed with Escherichia coli, strain HVH-U47. Bacteria were transferred to Sven-Gard agar to test mobility. Striae of this bacterial strain with a MacFarland 1 turbulence pattern were seeded from a spot of inoculated biomaterial using Muller-Hinton medium. The chemoattractive properties of the biomaterials were analyzed 10 days after inoculation. Bacterial growth over the biomaterial and in-depth growth were assessed as well. Results: Semi-permanent fillers did not stimulate bacterial growth but they allowed bacterial colonization over the filler. Permanent acrylic compounds neither presented chemoattractant properties nor showed bacterial growth over the biomaterial. Similar results were obtained when performing in-depth cultures. Conclusions: Permanent and semi-permanent fillers did not facilitate bacterial growth when flagellated E. coli HVH-U47 was used. Our results do not argue in favor of antibiotics as the mainstay of therapy in late granulomas related to permanent fillers. In the case of resorbable/semi-permanent fillers, more studies are needed before recommending antibiotic therapy. Copyright (C) 2010 S. Karger AG, Basel
C1 [Alijotas-Reig, Jaume; Miro-Mur, Francesc; Garcia-Aranda, Natalia; Garcia-Gimenez, Victor; Vilardell-Tarres, Miquel] Vall Hebron Univ Hosp, Syst Autoimmune Dis Unit, CIBBIM Nanomed,Dept Internal Med 1, Aging Basic Res Grp,Mol Biol & Biochem Res Ctr Na, Barcelona, Spain.
   [Planells-Romeu, Irene] Vall Hebron Univ Hosp, Dept Microbiol, Barcelona, Spain.
   [Garcia-Gimenez, Victor] Europa Med Ctr, Barcelona, Spain.
   [Alijotas-Reig, Jaume; Planells-Romeu, Irene] Univ Autonoma Barcelona, E-08193 Barcelona, Spain.
RP Alijotas-Reig, J (reprint author), Josep Ma de Segarra 2-F, ES-08190 Barcelona, Spain.
EM jalijotase@vhebronet.net
RI Alijotas-Reig, Jaume/H-9262-2016
OI Alijotas-Reig, Jaume/0000-0002-9212-3619; Miro-Mur, Francesc
   A./0000-0003-3936-2693
FU Sociedad Espanola de Medicina y Cirugia Cosmetica (SEMCC)
FX We thank Simo Schwartz Jr., Guillem Prats and Iliana Acosta for
   laboratory assistance and scientific advice. We would also like to
   acknowledge the Sociedad Espanola de Medicina y Cirugia Cosmetica
   (SEMCC) for partial support and all of its members for their kind
   collaboration.
CR Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707
   Alijotas-Reig J, 2008, J EUR ACAD DERMATOL, V22, P150, DOI 10.1111/j.1468-3083.2007.02354.x
   Alijotas-Reig J, 2008, ARCH DERMATOL, V144, P637, DOI 10.1001/archderm.144.5.637
   Alijotas-Reig J, 2010, J BIOMED MATER RES A, V95A, P180, DOI 10.1002/jbm.a.32794
   Alijotas-Reig J, 2009, DERMATOL SURG, V35, P395, DOI 10.1111/j.1524-4725.2008.01049.x
   Alijotas-Reig J, 2009, DERMATOL SURG, V35, P360, DOI 10.1111/j.1524-4725.2008.01041.x
   Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933
   Bergeret-Galley Catherine, 2004, Aesthet Surg J, V24, P33, DOI 10.1016/j.asj.2004.01.006
   BERNAUER W, 2006, BR J OPHTHALMOL, V90, P385
   Blank M, 2002, J CLIN INVEST, V109, P797, DOI 10.1172/JCI200212337
   BRAND KG, 1993, ANN PLAS SURG, V30, P289, DOI 10.1097/00000637-199304000-00001
   Castillo-Vico MT, 2007, INT UROGYNECOL J, V18, P95, DOI 10.1007/s00192-005-0049-7
   Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016
   Chrastil-LaTowsky B, 2009, ARCH DERMATOL, V145, P1309, DOI 10.1001/archdermatol.2009.266
   Christen U, 2005, J IMMUNOL, V174, P7481, DOI 10.4049/jimmunol.174.12.7481
   Christensen L, 2005, AESTHET PLAST SURG, V29, P34, DOI 10.1007/s00266-004-0113-6
   Christensen L, 2006, EUR J PLAST SURG, V28, P464, DOI 10.1007/s00238-005-0005-2
   Christensen L, 2007, DERMATOL SURG, V33, pS168, DOI 10.1111/j.1524-4725.2007.33357.x
   Cohen JL, 2008, DERMATOL SURG, V34, pS92, DOI 10.1111/j.1524-4725.2008.34249.x
   CRISTAL RG, 2005, HARRISONS PRINCIPLES, P2017
   De Boulle Koenraad, 2004, J Cosmet Dermatol, V3, P2, DOI 10.1111/j.1473-2130.2004.00058.x
   Duffy DM, 2005, DERMATOL SURG, V31, P1626, DOI 10.2310/6350.2005.31251
   Ellis D A, 2001, Facial Plast Surg Clin North Am, V9, P405
   Engelman Dendy E, 2005, J Cosmet Laser Ther, V7, P29, DOI 10.1080/147641700510037716
   FRANK PJ, COSM S REST DERM SOC
   Getts MT, 2010, CLIN EXP IMMUNOL, V160, P15, DOI 10.1111/j.1365-2249.2010.04132.x
   Goldan O, 2007, DERMATOL SURG, V33, pS199, DOI 10.1111/j.1524-4725.2007.33361.x
   Goldan Oren, 2007, Aesthet Surg J, V27, P416, DOI 10.1016/j.asj.2007.05.002
   James DG, 2001, POSTGRAD MED J, V77, P177, DOI 10.1136/pmj.77.905.177
   Jones DH, 2007, DERMATOL SURG, V33, pS193, DOI 10.1111/j.1524-4725.2007.33360.x
   LEMINOR L, 1969, ENTEROBACTERIES
   Miro-Mur F, 2009, J BIOMED MATER RES B, V90B, P510, DOI 10.1002/jbm.b.31312
   Murray PR, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, pXXV
   Pittet B, 2005, LANCET INFECT DIS, V5, P94
   Rsachi E, 2008, LUPUS, V17, P937
   Serrano C, 2006, ACTAS DERMO-SIFILOGR, V97, P460, DOI 10.1016/S0001-7310(06)73441-X
   Serrano P, 2007, MED CUTAN IBER LAT A, V35, P209
   WEBSTER GF, 1994, ARCH DERMATOL, V130, P748, DOI 10.1001/archderm.130.6.748
   Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI14235
NR 39
TC 21
Z9 21
U1 2
U2 8
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-8665
J9 DERMATOLOGY
JI Dermatology
PY 2010
VL 221
IS 4
BP 356
EP 364
DI 10.1159/000321329
PG 9
WC Dermatology
SC Dermatology
GA 698GR
UT WOS:000285582700017
PM 21071919
DA 2018-10-20
ER

PT B
AU Fu, J
   Joshi, SB
AF Fu, Jing
   Joshi, Sanjay B.
GP ASME
TI OPTIMIZATION BASED GEOMETRIC MODELING OF NANO/MICRO SCALE ION MILLING OF
   ORGANIC MATERIALS
SO DETC2009: PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING
   TECHNICAL CONFERENCES/COMPUTERS AND INFORMATION IN ENGINEERING
   CONFERENCE
LA English
DT Proceedings Paper
CT ASME International Design Engineering Technical Conferences/Computers
   and Information in Engineering Conference
CY AUG 30-SEP 02, 2009
CL San Diego, CA
SP ASME, Design Engn Div, ASME, Computers & Info Engn Div
DE Focused Ion Beam (FIB); Simulation; Optimization; Organic Material
ID WATER ICE; SURFACE-MORPHOLOGY; BEAM; SIMULATION; YIELD; BOMBARDMENT;
   EVOLUTION; TARGETS; EROSION
AB Recently, Focused Ion Beam (FIB) instruments have begun be applied to organic materials such as polymers and biological systems. This provides a novel tool for sectioning biological samples for analysis, or microfabrication with environment friendly materials. The modeling of nano/micro scale geometry accurately sculptured by FIB milling is crucial for generating the milling plan and process control, and for computer simulation for prediction and visualization of the milled geometry. However, modeling of the ion milling process on compound materials, especially for high aspect ratio feature, is still difficult due to the complexity of target material, as well as multiple physical and chemical interactions involved. In this study, a comprehensive model of ion milling with organic targets is presented to address the challenges using a simulation based approach This platform has also been validated by milling different features on water ice in a cryogenic environment, and the simulation and experiment results show great consistency. With the proliferation of nanotechnology to biomedical and biomaterial domains, the proposed approach is expected to be a flexible tool for various applications involving novel and heterogeneous milling targets
C1 [Fu, Jing; Joshi, Sanjay B.] Penn State Univ, Dept Ind & Mfg Engn, University Pk, PA 16802 USA.
RP Joshi, SB (reprint author), Penn State Univ, Dept Ind & Mfg Engn, University Pk, PA 16802 USA.
EM sjoshi@psu.edu
RI Fu, Jing/D-8512-2012
OI Fu, Jing/0000-0002-7752-5417
CR Adams DP, 2006, J VAC SCI TECHNOL B, V24, P1766, DOI 10.1116/1.2210000
   Adams DP, 2006, APPL SURF SCI, V252, P2432, DOI 10.1016/j.apsusc.2005.06.013
   Adams DP, 2003, J VAC SCI TECHNOL B, V21, P2334, DOI 10.1116/1.1619421
   Baragiola RA, 2003, NUCL INSTRUM METH B, V209, P294, DOI 10.1016/S0168-583X(02)02052-9
   Behrisch R., 2007, SPUTTERING PARTICLE
   Fu J, 2008, J VAC SCI TECHNOL A, V26, P422, DOI 10.1116/1.2902962
   Fu J, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/9/095010
   Giannuzzi L. A., 2005, INTRO FOCUSED BEAMS
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   ISHITANI T, 1991, J VAC SCI TECHNOL A, V9, P3084, DOI 10.1116/1.577177
   ITOH F, 1990, J ELECTROCHEM SOC, V137, P983, DOI 10.1149/1.2086592
   KATARDJIEV IV, 1988, J VAC SCI TECHNOL A, V6, P2434, DOI 10.1116/1.575569
   KATARDJIEV IV, 1994, J VAC SCI TECHNOL A, V12, P61, DOI 10.1116/1.578859
   Kim HB, 2007, J MICROMECH MICROENG, V17, P1178, DOI 10.1088/0960-1317/17/6/011
   Marko M, 2006, J MICROSC-OXFORD, V222, P42, DOI 10.1111/j.1365-2818.2006.01567.x
   Moon MW, 2007, P NATL ACAD SCI USA, V104, P1130, DOI 10.1073/pnas.0610654104
   NEUREUTHER AR, 1979, J VAC SCI TECHNOL, V16, P1767, DOI 10.1116/1.570290
   SIGMUND P, 1969, PHYS REV, V184, P383, DOI 10.1103/PhysRev.184.383
   SMITH R, 1987, J VAC SCI TECHNOL B, V5, P579, DOI 10.1116/1.583952
   Szakal C, 2006, APPL SURF SCI, V252, P6526, DOI 10.1016/j.apsusc.2006.02.208
   Volkert CA, 2007, MRS BULL, V32, P389, DOI 10.1557/mrs2007.62
   YAMAMURA Y, 1983, IPPJAM26 NAG U
   Ziegler JF, 2004, NUCL INSTRUM METH B, V219, P1027, DOI 10.1016/j.nimb.2004.01.208
NR 23
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4903-3
PY 2010
BP 401
EP 408
PG 8
WC Engineering, Mechanical
SC Engineering
GA BRO61
UT WOS:000283272400048
DA 2018-10-20
ER

PT S
AU Kaya, B
   Yilmaz, S
   Ergun, C
AF Kaya, Beril
   Yilmaz, Safak
   Ergun, Celaletdin
BE Ochsner, A
   Murch, GE
   Shokuhfar, A
   Delgado, JMPQ
TI Ion Nitriding of CoCrMo Alloys
SO DIFFUSION IN SOLIDS AND LIQUIDS V, PTS 1 AND 2
SE Defect and Diffusion Forum Series
LA English
DT Proceedings Paper
CT 5th International Conference on Diffusion in Solids and Liquids
CY JUN 24-26, 2009
CL Rome, ITALY
DE Ion nitriding; CoCrMo alloy; Biomaterial
ID PLASMA; BEHAVIOR
AB Medical grade cast CoCrMo alloy (F75) was ion nitrided under different process parameters including time (2, 9 hr) and temperature (600, 800 degrees C) at a gas mixture of 80%N(2)-20%H(2). The nitrided surfaces were characterized by X-ray diffraction (XRD) and scanning electron microscopy (SEM). MicroVickers hardness tests were done on the cross sections of the nitrided specimens to investigate the hardness profile. The significant effects of nitriding temperature and time on the microstructure and hardness value of nitrided surface layers were displayed.
C1 [Kaya, Beril; Yilmaz, Safak; Ergun, Celaletdin] Istanbul Tech Univ, TR-34437 Istanbul, Turkey.
RP Kaya, B (reprint author), Istanbul Tech Univ, TR-34437 Istanbul, Turkey.
EM kayaber@itu.edu.tr; yilmazsaf@itu.edu.tr; ergunce@itu.edu.tr
RI Yilmaz, Safak/A-8208-2008
OI Yilmaz, Safak/0000-0002-7854-2921
CR Black J., 1998, HDB BIOMATERIAL PROP, P167
   Celik A, 2008, SURF COAT TECH, V202, P2433, DOI 10.1016/j.surfcoat.2007.08.030
   Davis JR, 2003, HDB MAT MED DEVICES, P31
   Hin T. S., 2004, ENG MAT BIOMEDICAL A
   KAPEZINSKI MP, 2003, MAT RES, V2, P265
   KAPEZINSKI MP, 2003, J PHYS D, V36, P1858
   LANNING BR, 2004, SURF COAT TECH, V314, P186
   Molinari A, 1997, WEAR, V203, P447, DOI 10.1016/S0043-1648(96)07419-4
   Ozturk O, 2006, SURF COAT TECH, V200, P5687, DOI 10.1016/j.surfcoat.2005.08.113
   Park J.B., 1992, BIOMATERIALS INTRO, P83
   Silva S.L.R., 1999, SURF COAT TECH, V16, P342
   Wei RH, 2004, SURF COAT TECH, V186, P305, DOI 10.1016/j.surfcoat.2004.02.052
   Yildiz F, 2008, SURF COAT TECH, V202, P2471, DOI 10.1016/j.surfcoat.2007.08.004
   Zhecheva A, 2005, SURF COAT TECH, V200, P2192, DOI 10.1016/j.surfcoat.2004.07.115
NR 14
TC 1
Z9 1
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1012-0386
J9 DEFECT DIFFUS FORUM
PY 2010
VL 297-301
BP 82
EP 87
DI 10.4028/www.scientific.net/DDF.297-301.82
PN 1-2
PG 6
WC Thermodynamics; Nanoscience & Nanotechnology; Physics, Applied
SC Thermodynamics; Science & Technology - Other Topics; Physics
GA BQD97
UT WOS:000280757400015
DA 2018-10-20
ER

PT S
AU Kim, JR
AF Kim, Jung Rae
BE Lee, JH
   Lee, H
   Kim, JS
TI Application of Bioelectrochemical Process (BES) for Electricity
   Generation and Sustainable Wastewater Treatment
SO EKC 2009 PROCEEDINGS OF EU-KOREA CONFERENCE ON SCIENCE AND TECHNOLOGY
SE Springer Proceedings in Physics
LA English
DT Proceedings Paper
CT EKC 2009 Proceedings of EU-Korea Conference on Science and Technology
CY AUG 05-07, 2009
CL Berkshire, ENGLAND
SP KSEAUK
ID MICROBIAL FUEL-CELLS; POWER-GENERATION; CATHODE; CONFIGURATION;
   EFFICIENCY; MEMBRANE; REMOVAL; MFC
AB Bioelectrochemical system such as microbial fuel cells (MFCs) and microbial electrolysis cell are an emerging technology which converts biodegradable organic matter to electrical energy or hydrogen using a biofilm on the electrode as the biocatalyst. It has recently been shown that waste-to-energy technology based on MFC can treat organic contaminant in domestic or industrial wastewater and simultaneously produce electricity. The maximum power density increased up to 1kW/m(3) based on reactor volume. Bioelectrochemical systems may reduce the energy consumption for wastewater treatment by replacing energy intensive aeration of present treatment systems, while generate electrical energy from waste. In addition, the biomass production in MFCs has been reported to be 10-50% of conventional wastewater treatment, leading to reduce environmental impact and disposal costs. Various electrochemically active bacteria metabolize biodegradable organic compounds then discharge electrons to an extracellular electron acceptor for bacterial respiration. These bacteria also transfer electrons to electrodes by direct electron transfer, electron mediators or shuttles, and electrically conductive nanowires. Investigation of bacterial electron transport mechanisms may improve understanding of the biomaterial involved and metabolic pathways as well as improving power from MFCs. Biofuel cell systems require interdisciplinary research ranging from electrochemistry, microbiology, material science and surface chemistry to engineering such as reactor design, operation and modelling. Collaboration within each study and integration of systems might increase the performance and feasibility of BES process for sustainable energy.
C1 Univ Glamorgan, Fac Adv Technol, Sustainable Environm Res Ctr, Pntryridd CF37 1DL, M Glam, Wales.
RP Kim, JR (reprint author), Univ Glamorgan, Fac Adv Technol, Sustainable Environm Res Ctr, Pntryridd CF37 1DL, M Glam, Wales.
EM jkim@glam.ac.uk
RI Kim, Jung Rae/B-6008-2011
CR Aelterman P, 2006, ENVIRON SCI TECHNOL, V40, P3388, DOI 10.1021/es0525511
   Angenent LT, 2004, TRENDS BIOTECHNOL, V22, P477, DOI 10.1016/j.tibtech.2004.07.001
   Cheng S, 2006, ENVIRON SCI TECHNOL, V40, P2426, DOI 10.1021/es051652w
   Cheng S, 2007, P NATL ACAD SCI USA, V104, P18871, DOI 10.1073/pnas.0706379104
   Fan YZ, 2007, J POWER SOURCES, V171, P348, DOI 10.1016/j.jpowsour.2007.06.220
   He Z, 2005, ENVIRON SCI TECHNOL, V39, P5262, DOI 10.1021/es0502876
   Iranpour R, 1999, SCIENCE, V285, P706, DOI 10.1126/science.285.5428.706
   Kim B.H., 2006, ENCY SENSORS, VX, P1
   KIM JR, 2009, MODULAR TUBULA UNPUB
   Kim JR, 2008, APPL ENVIRON MICROB, V74, P2540, DOI 10.1128/AEM.02268-07
   Kim JR, 2007, ENVIRON SCI TECHNOL, V41, P1004, DOI 10.1021/es062202m
   Kim JR, 2009, J POWER SOURCES, V187, P393, DOI 10.1016/j.jpowsour.2008.11.020
   Liu H, 2004, ENVIRON SCI TECHNOL, V38, P4040, DOI 10.1021/es0499344
   Liu H, 2005, ENVIRON SCI TECHNOL, V39, P5488, DOI 10.1021/es050316c
   Logan B E, 2008, MICROBIAL FUEL CELLS
   Logan BE, 2004, ENVIRON SCI TECHNOL, V38, p160A, DOI 10.1021/es040468s
   Min B, 2004, ENVIRON SCI TECHNOL, V38, P5809, DOI 10.1021/es0491026
   Oh SE, 2003, ENVIRON SCI TECHNOL, V37, P5186, DOI 10.1021/es034291y
   Park W, 2005, ENVIRON SCI TECHNOL, V39, P4416, DOI 10.1021/es048569d
   Pham TH, 2006, ENG LIFE SCI, V6, P285, DOI 10.1002/elsc.200620121
   Rabaey K, 2005, TRENDS BIOTECHNOL, V23, P291, DOI 10.1016/j.tibtech.2005.04.008
   Rabaey K, 2003, BIOTECHNOL LETT, V25, P1531, DOI 10.1023/A:1025484009367
   Rabaey K, 2005, ENVIRON SCI TECHNOL, V39, P8077, DOI 10.1021/es050986i
   Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661
   Rozendal RA, 2008, TRENDS BIOTECHNOL, V26, P450, DOI 10.1016/j.tibtech.2008.04.008
   Shimoyama T, 2008, APPL MICROBIOL BIOT, V80, P325, DOI 10.1007/s00253-008-1516-0
NR 26
TC 0
Z9 0
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0930-8989
BN 978-3-642-13623-8
J9 SPRINGER PROC PHYS
PY 2010
VL 135
BP 17
EP 23
PG 7
WC Engineering, Aerospace; Physics, Applied
SC Engineering; Physics
GA BRV85
UT WOS:000283764200002
DA 2018-10-20
ER

PT J
AU Chung, E
   Kweon, H
   Yiacoumi, S
   Lee, I
   Joy, DC
   Palumbo, AV
   Tsouris, C
AF Chung, Eunhyea
   Kweon, Hyojin
   Yiacoumi, Sotira
   Lee, Ida
   Joy, David C.
   Palumbo, Anthony V.
   Tsouris, Costas
TI Adhesion of Spores of Bacillus thuringiensis on a Planar Surface
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; BACTERIAL ADHESION; CAPILLARY FORCE; CELLS;
   QUANTIFICATION; HYDROPHOBICITY; MORPHOGENESIS; POLYSTYRENE; BIOMATERIAL;
   POLYAMIDES
AB Adhesion of spores of Bacillus thuringiensis (Bt) and spherical silica particles on surfaces was experimentally and theoretically investigated in this study. Topography analysis via atomic force microscopy (AFM) and electron microscopy indicates that Bt spores are rod shaped, similar to 1.3 mu m in length and similar to 0.8 mu m in diameter. The adhesion force of Bt spores and silica particles on gold-coated glass was measured at various relative humidity (RH) levels by AFM. It was expected that the adhesion force would vary with RH because the individual force components contributing to the adhesion force depend on RH. The adhesion force between a particle and a planar surface in atmospheric environments was modeled as the contribution of three major force components: capillary, van der Waals, and electrostatic interaction forces. Adhesion force measurements for Bt spore (silica particle) and the gold surface system were comparable with calculations. Modeling results show that there is a critical RH value, which depends on the hydrophobicity of the materials involved, below which the water meniscus does not form and the contribution of the capillary force is zero. As RH increases, the van der Waals force decreases while the capillary force increases to a maximum value.
C1 [Chung, Eunhyea; Kweon, Hyojin; Yiacoumi, Sotira; Tsouris, Costas] Georgia Inst Technol, Atlanta, GA 30332 USA.
   [Lee, Ida; Joy, David C.] Univ Tennessee, Knoxville, TN 37996 USA.
   [Joy, David C.; Palumbo, Anthony V.; Tsouris, Costas] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.
RP Tsouris, C (reprint author), Georgia Inst Technol, Atlanta, GA 30332 USA.
EM costas.tsouris@ce.gatech.edu
RI Tsouris, Costas/C-2544-2016; Palumbo, Anthony/A-4764-2011
OI Tsouris, Costas/0000-0002-0522-1027; Palumbo,
   Anthony/0000-0002-1102-3975
FU Defense Threat Reduction Agency [HDTRA1-07-1-0035]; UT-Battelle, LLC
   [DE-AC05-00OR22725]
FX Support for this work was provided by the Defense Threat Reduction
   Agency, under Grant HDTRA1-07-1-0035 to Georgia Institute of Technology.
   SEM and STEM experiments were performed at the Center for Nanophase
   Materials Sciences of Oak Ridge National Laboratory. Oak Ridge National
   Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of
   Energy under contract DE-AC05-00OR22725. We are thankful to Mr. Daniel
   Velez for editing the manuscript.
CR ASAY DB, 2009, CONTACT ANGLE WETTAB, V6, P65
   Bowen WR, 2000, COLLOID SURFACE A, V173, P205, DOI 10.1016/S0927-7757(00)00566-5
   Brown DG, 2006, ENVIRON SCI TECHNOL, V40, P195, DOI 10.1021/es051183y
   Butt HJ, 2006, J APPL PHYS, V100, DOI 10.1063/1.2210188
   Chada VGR, 2003, J BACTERIOL, V185, P6255, DOI 10.1128/JB.185.21.6255-6261.2003
   Chin CJ, 2002, ENVIRON SCI TECHNOL, V36, P343, DOI 10.1021/es010905s
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   CROSS NL, 1963, MECH CORROSION FUEL
   de Kerchove AJ, 2007, LANGMUIR, V23, P12301, DOI 10.1021/la701936x
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Faille C, 2002, CAN J MICROBIOL, V48, P728, DOI 10.1139/W02-063
   Farshchi-Tabrizi M, 2006, LANGMUIR, V22, P2171, DOI 10.1021/la052760z
   GERHARDT P, 1976, APPL ENVIRON MICROB, V32, P438
   Giorno R, 2007, J BACTERIOL, V189, P691, DOI 10.1128/JB.00921-06
   Hayashi H, 2001, COLLOID SURFACE B, V22, P149, DOI 10.1016/S0927-7765(01)00161-8
   MADIGAN MT, 2002, BROCK BIOL MICROORGA
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   ORR FM, 1975, J FLUID MECH, V67, P723, DOI 10.1017/S0022112075000572
   Ouyang Q, 2001, APPL SURF SCI, V169, P644, DOI 10.1016/S0169-4332(00)00804-7
   Prier KRS, 2001, ENVIRON ENTOMOL, V30, P1188, DOI 10.1603/0046-225X-30.6.1188
   Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0
   Sedin DL, 2000, ANAL CHEM, V72, P2183, DOI 10.1021/ac991198c
   Sheng XX, 2007, J COLLOID INTERF SCI, V310, P661, DOI 10.1016/j.jcis.2007.01.084
   Thio BJR, 2008, COLLOID SURFACE B, V65, P308, DOI 10.1016/j.colsurfb.2008.05.005
   Thio BJR, 2009, ENVIRON SCI TECHNOL, V43, P4308, DOI 10.1021/es803422s
   Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005
   Vadillo-Rodriguez V, 2006, ENVIRON SCI TECHNOL, V40, P2983, DOI 10.1021/es052365v
   Waar K, 2005, MICROBIOL-SGM, V151, P2459, DOI 10.1099/mic.0.27877-0
   Xiao XD, 2000, LANGMUIR, V16, P8153, DOI 10.1021/la000770o
NR 29
TC 12
Z9 12
U1 1
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD JAN 1
PY 2010
VL 44
IS 1
BP 290
EP 296
DI 10.1021/es902070b
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 539PB
UT WOS:000273267000049
PM 19928904
DA 2018-10-20
ER

PT J
AU Wernike, E
   Montjovent, MO
   Liu, Y
   Wismeijer, D
   Hunziker, EB
   Siebenrock, KA
   Hofstetter, W
   Klenke, FM
AF Wernike, E.
   Montjovent, M-O.
   Liu, Y.
   Wismeijer, D.
   Hunziker, E. B.
   Siebenrock, K-A.
   Hofstetter, W.
   Klenke, F. M.
TI VEGF INCORPORATED INTO CALCIUM PHOSPHATE CERAMICS PROMOTES
   VASCULARISATION AND BONE FORMATION IN VIVO
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biomaterials; calcium phosphates; drug delivery; tissue engineering;
   angiogenesis; bone formation
ID ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; CELLS; REGENERATION; DELIVERY;
   SCAFFOLDS; RELEASE; MARROW; BMP-2; OSTEOGENESIS
AB Bone formation and osseointegration of biomaterials are dependent on angiogenesis and vascularization. Angiogenic growth factors such as vascular endothelial growth factor (VEGF) were shown to promote biomaterial vascularization and enhance bone formation. However, high local concentrations of VEGF induce the formation of malformed, nonfunctional vessels. We hypothesized that a continuous delivery of low concentrations of VEGF from calcium phosphate ceramics may increase the efficacy of VEGF administration. VEGF was co-precipitated onto biphasic calcium phosphate (BCP) ceramics to achieve a sustained release of the growth factor. The co-precipitation efficacy and the release kinetics of the protein were investigated in vitro. For in vivo investigations BCP ceramics were implanted into critical size cranial defects in Balb/c mice. Angiogenesis and microvascularization were investigated over 28 days by means of intravital microscopy. The formation of new bone was determined histomorphometrically. Co-precipitation reduced the burst release of VEGF. Furthermore, a sustained, cell-mediated release of low concentrations of VEGF from BCP ceramics was mediated by resorbing osteoclasts. In vivo, sustained delivery of VEGF achieved by protein co-precipitation promoted biomaterial vascularization, osseointegration, and bone formation. Short-term release of VEGF following superficial adsorption resulted in a temporally restricted promotion of angiogenesis and did not enhance bone formation. The release kinetics of VEGF appears to be an important factor in the promotion of biomaterial vascularization and bone formation. Sustained release of VEGF increased the efficacy of VEGF delivery demonstrating that a prolonged bioavailability of low concentrations of VEGF is beneficial for bone regeneration.
C1 [Montjovent, M-O.; Siebenrock, K-A.; Klenke, F. M.] Univ Hosp Bern, Inselspital, Dept Orthoped Surg, CH-3010 Bern, Switzerland.
   [Wernike, E.; Montjovent, M-O.; Hofstetter, W.; Klenke, F. M.] Univ Bern, Dept Clin Res, Grp Bone Biol & Orthoped Res, CH-3010 Bern, Switzerland.
   [Liu, Y.; Wismeijer, D.] Acad Ctr Dent Amsterdam, Dept Oral Implantol & Prosthdont, NL-1066 EA Amsterdam, Netherlands.
   [Liu, Y.; Hunziker, E. B.] Univ Bern, Dept Clin Res, Ctr Regenerat Med Skeletal Tissues, CH-3010 Bern, Switzerland.
RP Klenke, FM (reprint author), Univ Hosp Bern, Inselspital, Dept Orthoped Surg, CH-3010 Bern, Switzerland.
EM frank.klenke@bluewin.ch
OI Hofstetter, Wilhelm/0000-0003-0126-8423
FU AO Research Foundation, Dubendorf, Switzerland [05-K82]; Novartis
   Foundation for Medicine and Biology, Basel, Switzerland [05B35]
FX The study was supported by grants from the AO Research Foundation,
   Dubendorf, Switzerland (AO Research Fund No. 05-K82) and the Novartis
   Foundation for Medicine and Biology, Basel, Switzerland (Grant No.
   05B35). Vascular endothelial growth factor (VEGF) was generously
   supplied by Genentech Inc., South San Francisco, CA, USA.
CR BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Clarke SA, 2007, BONE, V40, P939, DOI 10.1016/j.bone.2006.11.004
   Clarkin CE, 2008, J CELL PHYSIOL, V214, P537, DOI 10.1002/jcp.21234
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Gao H, 2007, J BIOMED MATER RES A, V80A, P111, DOI 10.1002/jbm.a.30861
   Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerber HP, 1999, NAT MED, V5, P623
   GERLOWSKI LE, 1986, MICROVASC RES, V31, P288, DOI 10.1016/0026-2862(86)90018-X
   Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018
   GUENTHER HL, 1986, ENDOCRINOLOGY, V119, P193, DOI 10.1210/endo-119-1-193
   GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x
   Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460
   Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42
   Horowitz JR, 1997, ARTERIOSCL THROM VAS, V17, P2793, DOI 10.1161/01.ATV.17.11.2793
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kleinheinz J, 2005, J ORAL MAXIL SURG, V63, P1310, DOI 10.1016/j.joms.2005.05.303
   Klenke FM, 2008, J BIOMED MATER RES A, V85A, P777, DOI 10.1002/jbm.a.31559
   Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024
   Lee RJ, 2000, CIRCULATION, V102, P898
   LEUNIG M, 1992, CANCER RES, V52, P6553
   Liu YL, 2001, J BIOMED MATER RES, V57, P327, DOI 10.1002/1097-4636(20011205)57:3<327::AID-JBM1175>3.0.CO;2-J
   MacNeal W. J., 1922, JAMA-J AM MED ASSOC, V78, P1122
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Nolte D, 1995, INT J MICROCIRC, V15, P244, DOI 10.1159/000179025
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Samee M, 2008, J PHARMACOL SCI, V108, P18, DOI 10.1254/jphs.08036FP
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Uchida S, 2003, BONE, V32, P491, DOI 10.1016/S8756-3282(03)00053-X
   Vajanto I, 2002, J GENE MED, V4, P371, DOI 10.1002/jgm.287
   Wernike E, 2010, J BIOMED MATER RES A, V92A, P463, DOI 10.1002/jbm.a.32411
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 45
TC 88
Z9 91
U1 1
U2 25
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2010
VL 19
BP 30
EP 40
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 610RN
UT WOS:000278752500001
PM 20178096
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Ehrmantraut, S
   Laschke, MW
   Merkel, D
   Scheuer, C
   Willnecker, V
   Meyer-Lindenberg, A
   Menger, MD
   Naumann, A
AF Ehrmantraut, S.
   Laschke, M. W.
   Merkel, D.
   Scheuer, C.
   Willnecker, V.
   Meyer-Lindenberg, A.
   Menger, M. D.
   Naumann, A.
TI PERIOPERATIVE STEROID ADMINISTRATION INHIBITS ANGIOGENIC HOST TISSUE
   RESPONSE TO POROUS POLYETHYLENE (MEDPOR (R)) IMPLANTS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Medpor (R); polyethylene; angiogenesis; vascularisation;
   biocompatibility; prednisolone; steroid therapy; incorporation; dorsal
   skinfold chamber; intravital fluorescence microscopy
ID GROWTH-FACTOR; IN-VIVO; VASCULARIZATION; RECONSTRUCTION; PREDNISOLONE;
   RHINOPLASTY; SCAFFOLDS; EDEMA; BONE; METHYLPREDNISOLONE
AB Porous polyethylene (Medpor (R)) is an alloplastic biomaterial, which is commonly used in plastic and reconstructive surgery. In the present study, we analyzed the effect of perioperative steroid administration on the inflammatory and angiogenic host tissue response to implanted Medpor (R). For this purpose, Medpor (R) was implanted into the dorsal skinfold chamber of prednisolone-treated and vehicle-treated (control) balb/c mice and analyzed by means of intravital fluorescence microscopy over a 14-day period. Incorporation of the implants was evaluated by histology. An aortic ring assay and Western blot analyses were performed to determine in vitro the effect of prednisolone on angiogenesis. Implantation of Medpor (R) did not induce a leukocytic inflammatory host tissue response. However, in prednisolone-treated and control animals giant cells could be detected at the interface between the implants and the surrounding granulation tissue as a typical indicator for a chronic foreign body reaction. Interestingly, perioperative prednisolone administration inhibited vascularisation of the implants, as indicated by a significantly decreased functional density of newly developing capillary blood vessels. Accordingly, prednisolone suppressed in vitro endothelial sprouting and tube formation in the aortic ring assay and reduced proliferating cell nuclear antigen (PCNA), Tie2, vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP)-9 expression of murine endothelioma cells. In conclusion, prednisolone treatment inhibits the early vascularisation of Medpor (R) implants due to direct inhibition of distinct angiogenic mechanisms. Therefore, perioperative steroid therapy should be avoided in case of Medpor (R) implantation to achieve a rapid incorporation of the biomaterial at the implantation site.
C1 [Ehrmantraut, S.; Laschke, M. W.; Scheuer, C.; Menger, M. D.] Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   [Ehrmantraut, S.; Meyer-Lindenberg, A.] Univ Vet Med Hannover, Small Anim Clin, D-30173 Hannover, Germany.
   [Merkel, D.; Willnecker, V.; Naumann, A.] Univ Saarland, Dept Otorhinolaryngol Head & Neck Surg, D-66421 Homburg, Germany.
RP Laschke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uniklinik-saarland.de
FU Medical Faculty of the University of Saarland [HOMFOR 2008]
FX We are grateful for the excellent technical assistance of Janine Becker
   and Julia Parakenings. This work was supported by the research program
   of the Medical Faculty of the University of Saarland (HOMFOR 2008).
CR Assimes TL, 1999, PLAST RECONSTR SURG, V103, P313, DOI 10.1097/00006534-199901000-00050
   BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   Banciu M, 2006, J CONTROL RELEASE, V113, P1, DOI 10.1016/j.jconrel.2006.03.019
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Dong ZM, 2009, CURR PHARM DESIGN, V15, P365, DOI 10.2174/138161209787315783
   Dufour A, 1998, J NEUROL SCI, V157, P117, DOI 10.1016/S0022-510X(98)00059-8
   Duman H, 1999, J CRANIO MAXILL SURG, V27, P298, DOI 10.1054/jcms.1999.0902
   Gosau M, 2008, J BIOMED MATER RES B, V87B, P83, DOI 10.1002/jbm.b.31072
   Gurlek A, 2009, J PLAST RECONSTR AES, V62, P650, DOI 10.1016/j.bjps.2007.08.030
   HABAL MB, 1985, AESTHET PLAST SURG, V9, P69, DOI 10.1007/BF01570331
   HASE S, 1989, DIGESTION, V42, P135, DOI 10.1159/000199838
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   Jordan DR, 2004, OPHTHAL PLAST RECONS, V20, P136, DOI 10.1097/01.IOP.0000117341.28846.7F
   Kara CO, 1999, PLAST RECONSTR SURG, V104, P2213, DOI 10.1097/00006534-199912000-00041
   Kargi E, 2003, ANN PLAS SURG, V51, P570, DOI 10.1097/01.sap.0000095652.35806.c5
   Kim MB, 2004, MICROCIRCULATION, V11, P55, DOI 10.1080/10739680490266199
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   MENGER MD, 1990, TRANSPLANT P, V22, P2042
   Morton AD, 2000, OPHTHAL PLAST RECONS, V16, P146, DOI 10.1097/00002341-200003000-00010
   Naik MN, 2007, OPHTHAL PLAST RECONS, V23, P463, DOI 10.1097/IOP.0b013e318158ec8e
   Niechajev I, 1999, AESTHET PLAST SURG, V23, P395, DOI 10.1007/s002669900308
   Roller J, 2008, LANGENBECK ARCH SURG, V393, P349, DOI 10.1007/s00423-008-0295-5
   Rucker M, 2008, J BIOMED MATER RES A, V86A, P1002, DOI 10.1002/jbm.a.31722
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Sloka JS, 2005, MULT SCLER, V11, P425, DOI 10.1191/1352458505ms1190oa
   Uysal A, 2003, PLAST RECONSTR SURG, V112, P540, DOI 10.1097/01.PRS.0000070967.06488.63
   WELLISZ T, 1993, AESTHET PLAST SURG, V17, P339, DOI 10.1007/BF00437109
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
   Yoshida N, 1997, LIFE SCI, V60, P2341, DOI 10.1016/S0024-3205(97)00290-7
NR 32
TC 24
Z9 24
U1 0
U2 4
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2010
VL 19
BP 107
EP 116
DI 10.22203/eCM.v019a11
PG 10
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 610RN
UT WOS:000278752500008
PM 20186670
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Komlev, VS
   Mastrogiacomo, M
   Pereira, RC
   Peyrin, F
   Rustichelli, F
   Cancedda, R
AF Komlev, V. S.
   Mastrogiacomo, M.
   Pereira, R. C.
   Peyrin, F.
   Rustichelli, F.
   Cancedda, R.
TI BIODEGRADATION OF POROUS CALCIUM PHOSPHATE SCAFFOLDS IN AN ECTOPIC BONE
   FORMATION MODEL STUDIED BY X-RAY COMPUTED MICROTOMOGRAPHY
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biodegradation; porous calcium phosphate scaffolds; X-ray computed
   microtomography; registration
ID MARROW STROMAL CELLS; BETA-TRICALCIUM PHOSPHATE; IN-VIVO; IMAGES;
   HYDROXYAPATITE; REGENERATION; TOMOGRAPHY; DEPOSITION; KINETICS; HUMANS
AB Three types of ceramic scaffolds with different composition and structure [namely synthetic 100% hydroxyapatite (HA; Engipore), synthetic calcium phosphate multiphase biomaterial containing 67% silicon stabilized tricalcium phosphate (Si-TCP; Skelite (TM)) and natural bone mineral derived scaffolds (Bio-oss (R))] were seeded with mesenchymal stem cells (MSC) and ectopically implanted for 8 and 16 weeks in immunodeficient mice. X-ray synchrotron radiation microtomography was used to derive 3D structural information on the same scaffolds both before and after implantation. Meaningful images and morphometric parameters such as scaffold and bone volume fraction, mean thickness and thickness distribution of the different phases as a function of the implantation time, were obtained. The used imaging algorithms allowed a direct comparison and registration of the 3D structure before and after implantation of the same sub-volume of a given scaffold. In this way it was possible to directly monitor the tissue engineered bone growth and the complete or partial degradation of the scaffold.
   Further, the detailed kinetics studies on Skelite (TM) scaffolds implanted for different length of times from 3 days to 24 weeks, revealed in the X-ray absorption histograms two separate peaks associated to HA and TCP. It was therefore possible to observe that the progressive degradation of the Skelite (TM) scaffolds was mainly due to the resorption of TCP. The different saturation times in the tissue engineered bone growth and in the TCP resorption confirmed that the bone growth was not limited the scaffold regions that were resorbed but continued in the inward direction with respect to the pore surface.
C1 [Komlev, V. S.; Mastrogiacomo, M.; Pereira, R. C.; Cancedda, R.] Univ Genoa, Ist Nazl Ric Canc, I-16132 Genoa, Italy.
   [Komlev, V. S.; Mastrogiacomo, M.; Pereira, R. C.; Cancedda, R.] Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy.
   [Komlev, V. S.] Russian Acad Sci, AA Baikov Inst Met & Mat Sci, Moscow, Russia.
   [Peyrin, F.] European Synchrotron Radiat Facil, F-38043 Grenoble, France.
   [Peyrin, F.] INSERM, CREATIS LRMN, U630, F-69621 Villeurbanne, France.
   [Peyrin, F.] CNRS, UMR 5220, F-69621 Villeurbanne, France.
   [Peyrin, F.] INSA Lyon, F-69621 Villeurbanne, France.
   [Peyrin, F.] Univ Lyon, F-69621 Villeurbanne, France.
   [Rustichelli, F.] Polytech Univ Marche, Sect Phys Sci, Dept SAIFET, Ancona, Italy.
   [Rustichelli, F.] CNISM Matec, Ist Nazl Biostrutture & Biosistemi, Ancona, Italy.
   [Pereira, R. C.] Univ Minho, Dept Polymer Engn, Braga, Portugal.
   [Pereira, R. C.] PT Govt Associated Lab, Inst Biotechnol & Bioengn, Braga, Portugal.
RP Cancedda, R (reprint author), Univ Genoa, Ist Nazl Ric Canc, Largo R Benzi 10, I-16132 Genoa, Italy.
EM ranieri.cancedda@unige.it
RI Peyrin, Francoise/G-2823-2013; komlev, vladimir/F-8678-2010
OI Peyrin, Francoise/0000-0002-1988-3435; komlev,
   vladimir/0000-0003-2068-7746
FU Italian (ASI); European (ESA-ERISTO) Space Agencies; FP7 EU (Angioscaff)
FX Supported by funds from the Italian (ASI) and the European (ESA-ERISTO)
   Space Agencies and from FP7 EU (Angioscaff) funds.
CR Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7
   BROWN LG, 1992, ACM COMPUT SURV, V24, P325, DOI DOI 10.1145/146370.146374
   BUMGARDNER JD, 2004, ENCY BIOMATERIALS BI, P79
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   DOUGHERTY RP, 2007, MICROSC MICROANAL S2, V13
   Duda Mariusz, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P269
   Giannoni P, 2008, J TISSUE ENG REGEN M, V2, P253, DOI 10.1002/term.90
   HAMISCH Y, 2006, ADV HEALTHCARE TECHN, P117
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Iyer S, 2006, COMPUT-AIDED CIV INF, V21, P395, DOI 10.1111/j.1467-8667.2006.00445.x
   Klinck J, 2008, CALCIFIED TISSUE INT, V83, P70, DOI 10.1007/s00223-008-9150-5
   Knabe C, 2008, BIOMATERIALS, V29, P2249, DOI 10.1016/j.biomaterials.2008.01.026
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Komlev VS, 2009, TISSUE ENG PART C-ME, V15, P425, DOI 10.1089/ten.tec.2008.0428
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Matheron G, 1975, RANDOM SETS INTEGRAL
   Merkx MAW, 1997, J CRANIO MAXILL SURG, V25, P212, DOI 10.1016/S1010-5182(97)80078-9
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   Modersitzki J., 2004, NUMERICAL METHODS IM
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Peyrin F, 2007, BIOTECHNOL BIOENG, V97, P638, DOI 10.1002/bit.21249
   Renghini C, 2009, ACTA BIOMATER, V5, P1328, DOI 10.1016/j.actbio.2008.10.017
   Rumpel E., 2006, Folia Morphologica, V65, P43
   Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736
   SCHENK RK, 1991, HEFTE UNFALLHEILKD, V216, P23
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Schmutte Timothy, 2007, Behav Sleep Med, V5, P39
   Serra J., 1982, IMAGE ANAL MATH MORP
   Sorzano COS, 2005, IEEE T BIO-MED ENG, V52, P652, DOI 10.1109/TBME.2005.844030
   Stokking R, 2003, SEMIN NUCL MED, V33, P219, DOI 10.1053/snuc.2003.127311
   Suba Z, 2006, CLIN ORAL IMPLAN RES, V17, P102, DOI 10.1111/j.1600-0501.2005.01166.x
   Tadjoedin ES, 2000, CLIN ORAL IMPLAN RES, V11, P334, DOI 10.1034/j.1600-0501.2000.011004334.x
   VANDENELSEN PA, 1993, IEEE ENG MED BIOL, V12, P26, DOI 10.1109/51.195938
   Waarsing JH, 2006, J ORTHOP RES, V24, P926, DOI 10.1002/jor.20063
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
NR 39
TC 41
Z9 42
U1 1
U2 11
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2010
VL 19
BP 136
EP 146
DI 10.22203/eCM.v019a14
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 610RN
UT WOS:000278752500011
PM 20349404
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kaivosoja, E
   Myllymaa, S
   Kouri, VP
   Myllymaa, K
   Lappalainen, R
   Konttinen, YT
AF Kaivosoja, Emilia
   Myllymaa, Sami
   Kouri, Vesa-Petteri
   Myllymaa, Katja
   Lappalainen, Reijo
   Konttinen, Yrjo T.
TI ENHANCEMENT OF SILICON USING MICRO-PATTERNED SURFACES OF THIN FILMS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biocompatibility; surface modification; micro-patterning;
   photolithography; osteoblast
ID CELL-SHAPE; OSTEOBLAST RESPONSE; TISSUE INTEGRATION; HUMAN FIBROBLASTS;
   IN-VITRO; ADHESION; GROWTH; BONE; BIOCOMPATIBILITY; TOPOGRAPHY
AB Micro-textured biomaterials might enhance cytocompatibility of silicon-based micro-electromechanical system (bio-MEMS) dummies. Photolithography-physical vapour deposition was used to produce diamond-like carbon (DLC) or Ti squares and circles on silicon, and also their inverse replicas; then DLC and Ti were compared for their guiding potential, using a SaOS-2 cell model. Scanning electron microscopy at 48 hours indicated cells were well-spread on large-sized patterns (several cells on one pattern) and assumed the geometrical architecture of underlying features. Medium-sized patterns (slightly smaller than solitary indicator cells) were inhabited by singular cells, which stretched from one island to another, assuming longitudinal or branching morphologies. On small-sized patterns (much smaller than individual cells) cells covered large micro-textured areas, but cellular filopodia bypassed the bare silicon. Immunofluorescence and confocal laser scanning microscopy indicated that the actin cytoskeleton and vinculin-containing adhesion junctions were present on the patterned areas, but not on the bare silicon. Cell density/coverage disclosed a 3.4-3.7-fold preference for the biomaterial patterns over silicon substrate (p < 0.001). Differences in the cellular response between materials were lost at 120 hours when cells were confluent. The working hypothesis was proven; enhancement by micro-patterning depends on the pattern size, shape and material and can be used to improve biocompatibility during the initial integration phase of the device.
C1 [Kaivosoja, Emilia; Kouri, Vesa-Petteri; Konttinen, Yrjo T.] Univ Helsinki, Cent Hosp, Inst Clin Med, Dept Med, FI-00029 Helsinki, Finland.
   [Kaivosoja, Emilia; Kouri, Vesa-Petteri] Univ Helsinki, Inst Biomed, Dept Anat, FI-00029 Helsinki, Finland.
   [Myllymaa, Sami; Myllymaa, Katja; Lappalainen, Reijo] Univ Kuopio, Dept Phys, FIN-70211 Kuopio, Finland.
   [Konttinen, Yrjo T.] COXA Hosp Joint Replacement Tampere, Tampere, Finland.
RP Konttinen, YT (reprint author), Univ Helsinki, Cent Hosp, Inst Clin Med, Dept Med, Haartmaninkatu 8, FI-00029 Helsinki, Finland.
EM yrjo.konttinen@helsinki.fi
RI Kouri, Vesa-Petteri/M-7436-2015; Peltola, Emilia/L-9969-2013
OI Kouri, Vesa-Petteri/0000-0001-6256-0642; Peltola,
   Emilia/0000-0002-8868-9273
FU TEKES; Danish Council for Strategic Research; European Science
   Foundation; COST Action [533]; ENT ERA Net; Sigrid Juselius Foundation;
   Evo; Helsinki University Central Hospital; Finland Lakaresallskapet;
   ORTON Orthopaedic Hospital of the Invalid Foundation; National PhD
   Graduate School in Musculoskeletal Diseases and Biomaterials
FX This study was financially supported by TEKES "Micro robotic diagnostics
   and therapy", the Danish Council for Strategic Research "Individualized
   musculoskeletal regeneration and reconstruction network", the European
   Science Foundation "Regenerative medicine" RNP, COST Action 533
   "Biotribology", ENT ERA Net "A new generation of titanium biomaterials",
   the Sigrid Juselius Foundation, Evo grants, Helsinki University Central
   Hospital, Finland Lakaresallskapet and ORTON Orthopaedic Hospital of the
   Invalid Foundation. Support for the study was also obtained from the
   National PhD Graduate School in Musculoskeletal Diseases and
   Biomaterials. We thank the Electron Microscopy Unit of the Institute of
   Biotechnology-University of Helsinki and the Microsensor Laboratory of
   the Savonia University of Applied Sciences for providing laboratory
   facilities. We also thank Hannu Korhonen for his contribution to sample
   fabrication.
CR Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Berry CC, 2007, IEEE T NANOBIOSCI, V6, P201, DOI 10.1109/TNB.2007.903457
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   BOBYN JD, 1987, CLIN ORTHOP RELAT R, P303
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   ENGH CA, 1987, J BONE JOINT SURG BR, V69, P45
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hanein Y, 2001, SENSOR ACTUAT B-CHEM, V81, P49, DOI 10.1016/S0925-4005(01)00925-X
   Hart A, 2007, J MATER SCI-MATER M, V18, P1211, DOI 10.1007/s10856-007-0157-7
   Hauptfleisch J, 2006, J BONE JOINT SURG BR, V88B, P179, DOI 10.1302/0301-620X.88B2.17055
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HENCH LL, 1986, CIBA F SYMP, V121, P231
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   Kelly S, 2008, BIOMATERIALS, V29, P2573, DOI 10.1016/j.biomaterials.2008.03.001
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kunzler TP, 2007, BIOMATERIALS, V28, P5000, DOI 10.1016/j.biomaterials.2007.08.009
   Lan S, 2005, BIOSENS BIOELECTRON, V20, P1697, DOI 10.1016/j.bios.2004.06.025
   Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118
   LEHTO VP, 1985, CELL DIFFER DEV, V16, P153, DOI 10.1016/0045-6039(85)90512-3
   Liu XY, 2004, BIOMATERIALS, V25, P5575, DOI [10.1016/j.biomarkers.2004.01.015, 10.1016/j.biomaterials.2004.01.015]
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Mwenifumbo S, 2007, J MATER SCI-MATER M, V18, P9, DOI 10.1007/s10856-006-0658-9
   MYLLYMAA A, 2010, J MATER SCI-MATER M, V21, P329
   Owen GR, 2005, BIOMATERIALS, V26, P7447, DOI 10.1016/j.biomaterials.2005.05.055
   Santavirta S, 1999, J LONG-TERM EFF MED, V9, P67
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P681
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
NR 50
TC 10
Z9 10
U1 0
U2 4
PU SWISS SOC BIOMATERIALS, AO RESEARCH INST
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INST, CLAVADELERSTRASSE
   8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2010
VL 19
BP 147
EP 157
DI 10.22203/eCM.v019a15
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 610RN
UT WOS:000278752500012
PM 20379964
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Burguera, EF
   Bitar, M
   Bruinink, A
AF Burguera, Elena F.
   Bitar, Malak
   Bruinink, Arie
TI NOVEL IN VITRO CO-CULTURE METHODOLOGY TO INVESTIGATE HETEROTYPIC
   CELL-CELL INTERACTIONS
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Biomaterial surfaces; 2D-co-culture; osteoblasts; cell proliferation;
   fibroblasts; in vitro
ID ENDOTHELIAL-CELLS; REGENERATIVE MEDICINE; BONE; CHONDROCYTES;
   FIBROBLASTS; INTERFACE; DIFFERENTIATION; OSTEOBLASTS; MIGRATION; DYES
AB Cell-cell interactions are of crucial importance for the formation of tissues, homeostasis and regeneration processes as well as reactions on foreign bodies including implants. So far, however, the importance of heterotypic cell-cell interactions in the in vitro evaluation of implant surfaces has been largely neglected. This work aims to develop an in vitro methodology that enables the in-depth investigation of heterotypic cell-cell interactions in a mixed co-culture system, and to validate it with a primary adult human bone-derived osteoblast cells (HBCs)-abdominal fibroblasts (HAFs) system. The methodology proposed combines a simple live labelling step, semiautomated fluorescence image acquisition and analysis to characterize the interactions between different cell types (cell population dynamics) in co-culture in terms of cell proliferation and cell spatial distribution of each cell type. In this co-culture system, direct cell-cell contacts between the two cell types were permitted while the determination of cell-type specific responses could still be elucidated. We could show that HAF proliferation was reduced in a way negatively correlated with the seeding HBC/HAF ratio, i.e., a high proportion of HBC in the co-culture had an inhibitory effect on HAF proliferation. In all cultures segregation was found after 4 and 7 days of co-culture. HBCs were segregated at low ratios while HAFs were segregated at high ratios. Cell-cell distances depended on the total cell number in the coculture but the dependence was different for each cell type.
C1 [Burguera, Elena F.; Bruinink, Arie] EMPA, Mat Biol Interact Lab, MaTisMed, CH-9014 St Gallen, Switzerland.
   [Bitar, Malak] Novartis Pharma AG, Tech Res & Dev, CH-4056 Basel, Switzerland.
RP Burguera, EF (reprint author), Complejo Hosp Univ A Coruna, Biomed Res Ctr INIBIC, Osteoarticular & Aging Res Lab, La Coruna 15006, Spain.
EM elena.fernandez.burguera@sergas.es
OI F. Burguera, Elena/0000-0001-9327-7639
FU MICINN; Volkswagen Foundation [I82-297]
FX We would like to thank Dr. Matthias Roesslein for his help with the
   statistical treatment of the data. We also thank Prof. Kuster of the
   Kantonsspital St. Gallen for providing the human tissue samples. EF
   Burguera was supported through a MICINN postdoctoral contract. M Bitar
   was supported by the Volkswagen Foundation (contract n#I82-297).
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BRANEMARK PI, 1977, SCAND J PLAST RECONS, P7
   Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Ferrari A, 2001, J BIOMED MATER RES, V56, P361, DOI 10.1002/1097-4636(20010905)56:3<361::AID-JBM1104>3.0.CO;2-4
   Franssen EHP, 2009, J NEUROSCI RES, V87, P1556, DOI 10.1002/jnr.21979
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Gerstenfeld LC, 2002, J BONE MINER RES, V17, P221, DOI 10.1359/jbmr.2002.17.2.221
   Heinrich L, 2007, J BIOMED MATER RES B, V81B, P153, DOI 10.1002/jbm.b.30648
   HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171
   HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002
   Kaiser JP, 2004, J MATER SCI-MATER M, V15, P429, DOI 10.1023/B:JMSM.0000021115.55254.a8
   Kirkpatrick CJ, 2006, ARTIF ORGANS, V30, P822, DOI 10.1111/j.1525-1594.2006.00306.x
   Kirkpatrick CJ, 2007, BIOMATERIALS, V28, P5193, DOI 10.1016/j.biomaterials.2007.08.012
   Krtolica A, 2002, CYTOMETRY, V49, P73, DOI 10.1002/cyto.10149
   Lu HH, 2008, BIOMEDICAL NANOSTRUCTURES, P357
   NEVO Z, 1993, CELL BIOL INT, V17, P255, DOI 10.1006/cbir.1993.1062
   Oberringer M, 2008, J MOL HISTOL, V39, P37, DOI 10.1007/s10735-007-9124-3
   Oberringer M, 2007, BIOL CELL, V99, P197, DOI 10.1042/BC20060116
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Spalazzi JP, 2003, IEEE ENG MED BIOL, V22, P27, DOI 10.1109/MEMB.2003.1256269
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Wang INE, 2007, J ORTHOP RES, V25, P1609, DOI 10.1002/jor.20475
   WINN SR, 2006, INTRO BIOMATERIALS, P63
NR 30
TC 19
Z9 20
U1 2
U2 10
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2010
VL 19
BP 166
EP 179
DI 10.22203/eCM.v019a17
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 610RN
UT WOS:000278752500014
PM 20419629
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Rohde, H
   Frankenberger, S
   Zahringer, U
   Mack, D
AF Rohde, Holger
   Frankenberger, Stephanie
   Zaehringer, Ulrich
   Mack, Dietrich
TI Structure, function and contribution of polysaccharide intercellular
   adhesin (PIA) to Staphylococcus epidermidis biofilm formation and
   pathogenesis of biomaterial-associated infections
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Article
DE Staphylococcus epidermidis; Biofilm; Polysaccharides; Polysaccharide
   intercellular adhesin; Structure; icaADBC; Foreign material-associated
   infections; Virulence
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLY-N-ACETYLGLUCOSAMINE;
   FIBRINOGEN-BINDING-PROTEIN; ACCUMULATION-ASSOCIATED PROTEIN; AMBULATORY
   PERITONEAL-DIALYSIS; CATHETER-ASSOCIATED INFECTION; BLOOD-STREAM
   INFECTIONS; FOREIGN-BODY INFECTION; SURFACE POLYSACCHARIDE; ICA LOCUS
AB Staphylococcus epidermidis is of major importance in infections associated with indwelling medical devices. The tight pathogenic association is essentially linked to the species ability to form adherent biofilms on artificial surfaces. Aiming at identifying novel targets for vaccination or therapy much effort has been made to unravel the molecular mechanisms leading to S. epidermidis biofilm formation. At present, polysaccharide intercellular adhesin (PIA) is the best studied factor involved in S. epidermidis biofilm accumulation. PIA is a glycan of beta-1,6-linked 2-acetamido-2-deoxy-D-glucopyranosyl residues of which 15 % are non-N-acetylated. PIA-producing S. epidermidis are widespread in clinical strain collections and PIA synthesis has been shown to be essential for S. epidermidis virulence. Moreover, PIA homologues have been identified in many other staphylococcal species, including the major human pathogen Staphylococcus aureus, and also Gram-negative human pathogens, suggesting that it might represent a more general pathogenicity principle in biofilm-related infections. In this review the current knowledge about the structure and biosynthesis of PIA is summarized. Additionally, information on its role in pathogenesis of biomaterial-related and other type of infections and the potential use of PIA and related compounds for prevention of infection is discussed. (C) 2009 Elsevier GmbH. All rights reserved.
C1 [Rohde, Holger; Frankenberger, Stephanie] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, D-20246 Hamburg, Germany.
   [Zaehringer, Ulrich] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, Borstel, Germany.
   [Mack, Dietrich] Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales.
RP Rohde, H (reprint author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Martinistr 52, D-20246 Hamburg, Germany.
EM rohde@uke.uni-hamburg.de
FU Deutsche Forschungsgemeinschaft [SFB 470, Ro2413/3-1];
   Forschungsforderungsfonds of the Universitatsklinikum Hamburg-Eppendorf
   [F-152]; Medical Research Council [G0801929]
FX Work of the authors was supported by the Deutsche Forschungsgemeinschaft
   (SFB 470, Teilprojekt C10, given to D. Mack and H. Rohde; Ro2413/3-1,
   given to H. Rohde; SFB 470 Teilprojekt B4, given to U. Zahringer) and
   the Forschungsforderungsfonds of the Universitatsklinikum
   Hamburg-Eppendorf (project F-152, given to H. Rohde). H. Rohde and S.
   Frankenberger would like to thank Martin Aepfelbacher for his continuous
   support.
CR Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07
   Allignet J, 2001, INFECT IMMUN, V69, P712, DOI 10.1128/IAI.69.2.712-718.2001
   Arciola CR, 2005, J BIOMED MATER RES A, V75A, P408, DOI 10.1002/jbm.a.30445
   BADDOUR LM, 1986, DIAGN MICR INFEC DIS, V5, P197, DOI 10.1016/0732-8893(86)90002-7
   Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206
   BAYSTON R, 1972, Developmental Medicine and Child Neurology, V27, P25
   BEARDPEGLER MA, 1989, EPIDEMIOL INFECT, V102, P365, DOI 10.1017/S0950268800030089
   Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057
   Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Bradford R, 2006, EUR J CLIN MICROBIOL, V25, P283, DOI 10.1007/s10096-006-0130-2
   Bustanji Y, 2003, P NATL ACAD SCI USA, V100, P13292, DOI 10.1073/pnas.1735343100
   Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217
   Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07
   Cerca N, 2006, INFECT IMMUN, V74, P4849, DOI 10.1128/IAI.00230-06
   Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y
   Chokr A, 2007, MICROB PATHOGENESIS, V42, P94, DOI 10.1016/j.micpath.2006.09.001
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Conlon KM, 2002, FEMS MICROBIOL LETT, V216, P171, DOI 10.1016/S0378-1097(02)01031-5
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a
   DIAZMITOMA F, 1987, J INFECT DIS, V156, P555
   Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289
   Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7
   Frank KL, 2004, J CLIN MICROBIOL, V42, P4846, DOI 10.1128/JCM.42.10.4846-4849.2004
   Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07
   Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877
   Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Gastmeier P, 2008, J HOSP INFECT, V70, P11, DOI 10.1016/S0195-6701(08)60005-5
   Gening ML, 2007, CARBOHYD RES, V342, P567, DOI 10.1016/j.carres.2006.08.010
   Gerberding J, 1999, AM J INFECT CONTROL, V27, P520
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hennig S, 2007, INT J MED MICROBIOL, V297, P117, DOI 10.1016/j.ijmm.2006.12.001
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   Hoiby Niels, 1997, Lancet (North American Edition), V349, P167, DOI 10.1016/S0140-6736(96)09229-X
   HUSSAIN M, 1992, J MED MICROBIOL, V37, P368, DOI 10.1099/00222615-37-6-368
   Hussain M, 2001, MICROB PATHOGENESIS, V31, P261, DOI 10.1006/mpat.2001.0469
   HUSSAIN M, 1991, J INFECT DIS, V163, P534, DOI 10.1093/infdis/163.3.534
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Joyce JG, 2003, CARBOHYD RES, V338, P903, DOI 10.1016/S0008-6215(03)00045-4
   Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004
   Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004
   Kelly-Quintos C, 2006, INFECT IMMUN, V74, P2742, DOI 10.1128/IAI.74.5.2742-2750.2006
   Kelly-Quintos C, 2005, J INFECT DIS, V192, P2012, DOI 10.1086/497604
   Klingenberg C, 2007, CLIN MICROBIOL INFEC, V13, P1100, DOI 10.1111/j.1469-0691.2007.01818.x
   KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Klug D, 2003, J CLIN MICROBIOL, V41, P3348, DOI 10.1128/JCM.41.7.3348-3350.2003
   Knoblochi KM, 2008, INT J ARTIF ORGANS, V31, P752
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   Kohlenberg A, 2008, CLIN MICROBIOL INFEC, V14, P93, DOI 10.1111/j.1469-0691.2007.01879.x
   Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992
   Lambert PA, 2000, FEMS IMMUNOL MED MIC, V29, P195, DOI 10.1016/S0928-8244(00)00205-4
   Lang S, 2000, FEMS IMMUNOL MED MIC, V29, P213, DOI 10.1016/S0928-8244(00)00207-8
   Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003
   Lauderdale KJ, 2009, INFECT IMMUN, V77, P1623, DOI 10.1128/IAI.01036-08
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Mack D., 2006, BIOFILMS INFECT ANTI, P109
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Mack D, 2009, TOP CURR CHEM, V288, P157, DOI 10.1007/128_2008_19
   Maira-Litran T, 2005, INFECT IMMUN, V73, P6752, DOI 10.1128/IAI.73.10.6752-6762.2005
   Maira-Litran T, 2002, INFECT IMMUN, V70, P4433, DOI 10.1128/IAI.70.8.4433-4440.2002
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   Monk AB, 2008, INFECT IMMUN, V76, P5127, DOI 10.1128/IAI.00606-08
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06
   PASCUAL A, 1988, EUR J CLIN MICROBIOL, V7, P161, DOI 10.1007/BF01963070
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   Pei L, 1999, INFECT IMMUN, V67, P4525
   PETERS G, 1981, ZBL BAKT MIK HYG B, V173, P293
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Petrelli D, 2006, EUR J CLIN MICROBIOL, V25, P773, DOI 10.1007/s10096-006-0226-8
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0
   Rennermalm A, 2004, INFECT IMMUN, V72, P3081, DOI 10.1128/IAI.72.5.3081-3083.2004
   Rogers KL, 2008, APPL ENVIRON MICROB, V74, P6155, DOI 10.1128/AEM.01017-08
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2001, MED MICROBIOL IMMUN, V190, P105, DOI 10.1007/s00430-001-0099-5
   Rohde H, 2001, J CLIN MICROBIOL, V39, P4595, DOI 10.1128/JCM.39.12.4595-4596.2001
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rohde H, 2006, REV MED MICROBIOL, V17, P45
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005
   Sadovskaya I, 2007, CLIN VACCINE IMMUNOL, V14, P1609, DOI 10.1128/CVI.00215-07
   Sellman BR, 2008, INFECT IMMUN, V76, P2950, DOI 10.1128/IAI.00055-08
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x
   Vergara-Irigaray M, 2008, MICROBIOL-SGM, V154, P865, DOI 10.1099/mic.0.2007/013292-0
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   Wang CZ, 2007, MICROBES INFECT, V9, P1376, DOI 10.1016/j.micinf.2007.06.012
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40
   Wisplinghoff H, 2003, CLIN INFECT DIS, V36, P1103, DOI 10.1086/374339
   Yao YF, 2005, INFECT IMMUN, V73, P1856, DOI 10.1128/IAI.73.3.1856-1860.2005
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
   Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 128
TC 109
Z9 114
U1 0
U2 42
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD JAN
PY 2010
VL 89
IS 1
BP 103
EP 111
DI 10.1016/j.ejcb.2009.10.005
PG 9
WC Cell Biology
SC Cell Biology
GA 559WO
UT WOS:000274859200012
PM 19913940
DA 2018-10-20
ER

PT J
AU Goncalves, FLL
   da Silva, R
   Schmidt, AF
   de Oliveira, MG
   Sbragia, L
AF Lanhellas Goncalves, Frances Lilian
   da Silva, Regiane
   Schmidt, Augusto Frederico
   de Oliveira, Marcelo Ganzarolli
   Sbragia, Lourenco
TI Hydrogel protection: a novel approach to reduce bowel inflammation in
   experimental gastroschisis
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Article
DE Hydrogel; Biomaterial; Gastroschisis; Scanning microscopy; Inflammation;
   Biocompatibility
ID FETAL-RAT MODEL; INTESTINAL DAMAGE; MORPHOLOGY; ETIOLOGY; REPAIR; FLUID
AB Objective: In gastroschisis there is herniation of the fetal bowel into the amniotic cavity that results in severe intestinal dysfunction. In order to reduce bowel exposure to amniotic fluid we used a hydrogel of N-isopropylacrylamide copolymerized with acrylic acid (P(NIPAAm-co-AAc)) to coat the herniated bowel through the use of a fibrin adhesive (Beriplast(R)).
   Study design: Gastroschisis was created in fetuses of 31 pregnant Sprague-Dawley rats by evisceration of the bowel through a right paramedian incision in the abdominal wall on day 18.5 of pregnancy. The fetuses were separated in four groups of 12 fetuses: control (C), gastroschisis (G), gastroschisis + fibrin adhesive (GA) and gastroschisis + fibrin adhesive + dry hydrogel (GAH). Animals were harvested at day 21.5 of pregnancy and the hydrogel was removed. Fetuses and bowels were weighed and morphometric analysis was performed. Isoelectric focusing of the amniotic fluid determined its electrical charge. We evaluated the hydrogel swelling ratio (Q) in the amniotic fluid. Histological analysis and scanning electronic microscopy (SEM) of the bowel and hydrogel were performed. Our primary outcome was bowel intactness after hydrogel removal and our secondary outcome was the effectiveness of the hydrogel in protecting the bowel against amniotic fluid and its components. Differences among the groups were tested by the ANOVA and Tukey-Kramer post-test method and the statistical significance accepted was for p values <0.05.
   Results: The mass of swollen hydrogel was 34 times the mass of dry hydrogel. Isoelectric focusing of the amniotic fluid showed that most of its proteins are negatively charged as the hydrogel. SEM showed that removal of the hydrogel did not damage bowel serosa. Bowel weight, diameter and wall thickness were similar between groups C and GAH but bowel diameter and wall thickness was significantly reduced in C and GAH compared to G and GA (p < 0.001).
   Conclusion: The P(NIPAAm-co-AAc) hydrogel does not harm the bowel and provides a safe effective protection with reduction of bowel damage in gastroschisis. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Sbragia, Lourenco] Univ Estadual Campinas, UNICAMP, Fac Med Sci,Sch Med Sci,Div Pediat Surg, Expt Lab Fetal Surg Michael R Harrison,Dept Surg, BR-13083970 Campinas, SP, Brazil.
   [da Silva, Regiane; de Oliveira, Marcelo Ganzarolli] Univ Estadual Campinas, UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil.
RP Sbragia, L (reprint author), Univ Estadual Campinas, UNICAMP, Fac Med Sci,Sch Med Sci,Div Pediat Surg, Expt Lab Fetal Surg Michael R Harrison,Dept Surg, Rua Alexander Fleming,40 Cidade Univ Zeferino Vaz, BR-13083970 Campinas, SP, Brazil.
EM sbragia@fmrp.usp.br
RI de Oliveira, Marcelo/B-4709-2013; Gonzalez, Regiane/B-6476-2018;
   Schmidt, Augusto/N-4456-2015; Sbragia, Lourenco/P-7380-2015
OI de Oliveira, Marcelo/0000-0002-9371-9975; Gonzalez,
   Regiane/0000-0003-0957-0125; Schmidt, Augusto/0000-0002-3925-9429;
   Sbragia, Lourenco/0000-0002-1881-6345
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [04/11204-4, 08/51487-9]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) project 04/11204-4, 04/11204-4 and grant 08/51487-9
   and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES).
CR Albert A, 2003, J PEDIATR SURG, V38, P1217, DOI 10.1016/S0022-3468(03)00271-9
   Albert A, 2001, PEDIATR SURG INT, V17, P116, DOI 10.1007/s003830000482
   Amadeu TP, 2007, J EUR ACAD DERMATOL, V21, P629, DOI 10.1111/j.1468-3083.2006.02032.x
   Ambrose SS, 1972, EMBRYOLOGY SURG EMBR, P414
   Berger J, 2005, INT J PHARM, V288, P17, DOI 10.1016/j.ijpharm.2004.07.036
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Correia-Pinto J, 2001, J PEDIATR SURG, V36, P213, DOI 10.1053/jpsu.2001.20057
   da Silva R, 2007, POLYMER, V48, P4114, DOI 10.1016/j.polymer.2007.05.010
   Eberhard U, 2006, INT J PHARM, V313, P1, DOI 10.1016/j.ijpharm.2005.12.001
   Franchi-Teixeira AR, 2005, FETAL DIAGN THER, V20, P494, DOI 10.1159/000088037
   Kunz LH, 2005, AM J OBSTET GYNECOL, V193, P1248, DOI 10.1016/j.ajog.2005.05.080
   LANGER JC, 1990, J PEDIATR SURG, V25, P1122, DOI 10.1016/0022-3468(90)90745-U
   Morrison JJ, 1998, BRIT J OBSTET GYNAEC, V105, P1200, DOI 10.1111/j.1471-0528.1998.tb09975.x
   Na K, 2007, BIOMATERIALS, V28, P2631, DOI 10.1016/j.biomaterials.2007.02.008
   Roelofs LAJ, 2008, TISSUE ENG PT A, V14, P2033, DOI 10.1089/ten.tea.2007.0191
   Santos MM, 2003, J PEDIATR SURG, V38, P1506, DOI 10.1016/S0022-3468(03)00504-9
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Sydorak RM, 2002, J PEDIATR SURG, V37, P1669, DOI 10.1053/jpsu.2002.36689
   TIBBOEL D, 1986, TERATOLOGY, V33, P267, DOI 10.1002/tera.1420330303
   Wilson RD, 2004, FETAL DIAGN THER, V19, P385, DOI 10.1159/000078990
   Yu JK, 2004, PEDIATR SURG INT, V19, P780, DOI 10.1007/s00383-003-0958-9
NR 21
TC 5
Z9 5
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD JAN
PY 2010
VL 148
IS 1
BP 35
EP 39
DI 10.1016/j.ejogrb.2009.10.009
PG 5
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 550BY
UT WOS:000274103500007
PM 19900744
DA 2018-10-20
ER

PT J
AU Gotz, W
   Lenz, S
   Reichert, C
   Henkel, KO
   Bienengraber, V
   Pernicka, L
   Gundlach, KKH
   Gredes, T
   Gerber, T
   Gedrange, T
   Heinemann, F
AF Goetz, Werner
   Lenz, Solvig
   Reichert, Christoph
   Henkel, Kai-Olaf
   Bienengraeber, Volker
   Pernicka, Laura
   Gundlach, Karsten K. H.
   Gredes, Tomasz
   Gerber, Thomas
   Gedrange, Tomasz
   Heinemann, Friedhelm
TI A preliminary study in osteoinduction by a nano-crystalline
   hydroxyapatite in the mini pig
SO FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
LA English
DT Article
DE Bone graft; bone remodelling; osteogenesis; silica; hydroxyapatite;
   osteoblast; osteoclast
AB To test the probable osteoinductive properties of NanoBone (R), a new highly non-sintered porous nano-crystalline hydroxylapatite bone substitute embedded into a silica gel matrix, granules were implanted subcutaneously and intramuscularly into the back region of 18 mini pigs. After periods of 5 and 10 weeks as well as 4 and 8 months, implantation sites were investigated using histological and histomorphometric procedures. Signs of early osteogenesis could already be detected after 5 weeks. The later periods were characterized by increasing membranous osteogenesis in and around the granules leading to the formation of bone-like structures showing periosteal and tendon-like structures with bone marrow and focal chondrogenesis. Bone formation was better in the subcutaneous than in the intramuscular implantation sites. This ectopic osteogenesis is discussed with regard to the nanoporosity and microporosity of the material, physico-chemical interactions at its surface, the differentiation of osteoblasts, the role of angiogenesis and the probable involvement of growth factors. The results of this preliminary study indicate that this biomaterial has osteoinductive potential and induces the formation of bone structures, mainly in subcutaneous adipose tissue in the pig.
C1 [Gredes, Tomasz; Gedrange, Tomasz] Ernst Moritz Arndt Univ Greifswald, Dept Orthodont, Dent Hosp, Greifswald, Germany.
   [Goetz, Werner; Reichert, Christoph] Univ Bonn, Dept Orthodont, Oral Biol Lab, Dent Hosp, Bonn, Germany.
   [Lenz, Solvig; Gerber, Thomas] Univ Rostock, Inst Phys, Dept Mat Res & Nanostruct, Rostock, Germany.
   [Henkel, Kai-Olaf] German Mil Hosp Hamburg, Dept Oral & Maxillofacial Surg, Hamburg, Germany.
   [Bienengraeber, Volker; Pernicka, Laura; Gundlach, Karsten K. H.] Univ Rostock, Dept Craniomaxillofacial Surg, Rostock, Germany.
   [Heinemann, Friedhelm] Ernst Moritz Arndt Univ Greifswald, Dept Dent Prosthesis Gerontostomatol & Med Mat Sc, Dent Hosp, Greifswald, Germany.
RP Gedrange, T (reprint author), Ernst Moritz Arndt Univ Greifswald, Dept Orthodont, Dent Hosp, Greifswald, Germany.
EM gedrange@uni-greifswald.de
FU German Federal Ministry of Education and Research (BMBZ) [01EZ0729]
FX This research was partly funded by the German Federal Ministry of
   Education and Research (BMBZ 01EZ0729). The authors would like to thank
   Mrs. I. Muller-Bay, D. Gutschow and S. Niemierski for technical
   assistance.
CR Abukawa H, 2006, DENT CLIN N AM, V50, pviii
   Abukawa Haru, 2006, Dent Clin North Am, V50, P205, DOI 10.1016/j.cden.2005.11.006
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Barrere F, 2006, INT J NANOMED, V1, P317
   Bienengraeber V., 2006, Folia Morphologica, V65, P84
   Bodde EWH, 2007, J BIOMED MATER RES B, V83B, P161, DOI 10.1002/jbm.b.30780
   Cutter C Suzanne, 2006, J Long Term Eff Med Implants, V16, P249
   de Bruijn JD, 2008, WOODHEAD PUBL MATER, P199, DOI 10.1533/9781845694227.1.199
   Gedrange T, 2008, J PHYSIOL PHARMACOL, V59, P87
   Gedrange T, 2008, BIOMED TECH, V53, P220, DOI 10.1515/BMT.2008.039
   Gerber T, 2003, J SOL-GEL SCI TECHN, V26
   Gerber T, 2006, EUR J TRAUMA, P132
   Gerike W., 2006, Folia Morphologica, V65, P54
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Heinemann F, 2009, J PHYSL PHARM S8, V60
   Henkel KO, 2006, ORAL SURG ORAL MED O, V102, P606, DOI 10.1016/j.tripleo.2005.10.034
   Henkel KO, 2005, J CRANIO MAXILL SURG, V33, P45, DOI 10.1016/j.jcms.2004.08.005
   Knabe C, 2008, WOODHEAD PUBL MATER, P133, DOI 10.1533/9781845694227.1.133
   Kokubo T, 2008, WOODHEAD PUBL MATER, P1
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1993, MATRIX, V13, P491, DOI 10.1016/S0934-8832(11)80115-0
   Ruhe PQ, BIOMEDICAL ENG HDB, P3831
   Rumpel E., 2006, Folia Morphologica, V65, P43
   Solheim E, 1998, INT ORTHOP, V22, P335, DOI 10.1007/s002640050273
   Sutherland D, 2005, BONE REGENERATION AND REPAIR: BIOLOGY AND CLINICAL APPLICATIONS, P133, DOI 10.1385/1-59259-863-3:133
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Zietek M, 2008, J PHYSIOL PHARMACOL, V59, P81
NR 34
TC 30
Z9 32
U1 1
U2 7
PU POLISH HISTOCHEMICAL CYTOCHEMICAL SOC
PI KRAKOW
PA VESALUIS MEDICAL PUBLISHING, WISLISKO 1, 31-538 KRAKOW, POLAND
SN 0239-8508
J9 FOLIA HISTOCHEM CYTO
JI Folia Histochem. Cytobiol.
PY 2010
VL 48
IS 4
BP 589
EP 596
DI 10.2478/v10042-010-0096-x
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA V21SH
UT WOS:000208226800014
PM 21478102
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Matiacevich, SB
   Santagapita, PR
   Buera, MD
AF Matiacevich, Silvia B.
   Santagapita, Patricio R.
   del Pilar Buera, Maria
TI The effect of MgCl2 on the kinetics of the Maillard reaction in both
   aqueous and dehydrated systems
SO FOOD CHEMISTRY
LA English
DT Article
DE Maillard reaction; MgCl2; Transversal relaxation time; Browning;
   Fluorescence; Browning inhibition
ID HIGH WATER ACTIVITY; SUGAR SYSTEMS; BIOMATERIAL STABILIZATION;
   FLUORESCENCE; STABILITY; COMPLEXATION; BEHAVIOR; CATIONS; SALTS
AB The modification of Maillard reaction kinetics induced by MgCl2 was evaluated in both liquid and dehydrated model systems with special emphasis on the interactions of the salt with water and/or the sugars. In liquid trehalose systems, browning is accelerated by the presence Of MgCl2 due to the increased sugar hydrolysis and to the reduction of water mobility caused by the salt (shown by the decrease in H-1 NMR relaxation times T-2), counteracting the inhibitory effect of water on the reaction. In water restricted trehalose systems, MgCl2 inhibited the Maillard reaction. The salt-sugar interactions, manifested by the delayed sugar crystallization, decreased the reaction rate by affecting the reactivity of reducing sugars. Molecular and supramolecular effects in the presence Of MgCl2 have been observed in the present work, and must be taken into account considering high technological interest in finding strategies to either inhibit or enhance the Maillard reaction depending on the application. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Matiacevich, Silvia B.; Santagapita, Patricio R.; del Pilar Buera, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
RP Buera, MD (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Ind, RA-1428 Buenos Aires, DF, Argentina.
EM pilar@di.fcen.uba.ar
OI Buera, Pilar/0000-0001-9290-7299; Santagapita,
   Patricio/0000-0003-1898-2199
FU Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 20545];
   CONICET [PIP 5977]; Universidad de Buenos Aires [X024]
FX This work was supported by Agencia Nacional de Promocion Cientifica y
   Tecnologica (PICT 20545), CONICET (PIP 5977) and Universidad de Buenos
   Aires (X024).
CR Acevedo N, 2006, J FOOD ENG, V77, P1108, DOI 10.1016/j.jfoodeng.2005.08.045
   AKAGAWA M, 2002, INT C SERIES, V1245, P196
   Angyal SJ, 1973, PURE APPL CHEM, V35, P131, DOI DOI 10.1351/PAC197335020131
   BAISIER WM, 1992, J AGR FOOD CHEM, V40, P707, DOI 10.1021/jf00017a001
   Bell LN, 1997, FOOD CHEM, V59, P143, DOI 10.1016/S0308-8146(96)00257-9
   BERGMEYER HU, 1983, METHOD ENZYMAT AN, V2, P205
   BURTON HS, 1962, NATURE, V98, P948
   CARR HY, 1954, PHYS REV, V94, P638
   CERRUTTI P, 1985, J FOOD SCI, V50, P627, DOI 10.1111/j.1365-2621.1985.tb13760.x
   Farroni AE, 2008, J AGR FOOD CHEM, V56, P6447, DOI 10.1021/jf800541f
   Gokmen V, 2007, FOOD CHEM, V103, P196, DOI 10.1016/j.foodchem.2006.08.011
   GREENSPAN L, 1977, J RES NBS A PHYS CH, V81, P89, DOI 10.6028/jres.081A.011
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   Kuo MI, 2001, J DAIRY SCI, V84, P1950, DOI 10.3168/jds.S0022-0302(01)74637-1
   Labuza TP, 1994, MAILLARD REACTIONS C, P176
   Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P25
   LESTER MR, 1995, J AM COLL NUTR, V14, P229
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Matiacevich SB, 2005, CRIT REV FOOD SCI, V45, P483, DOI 10.1080/10408390591034472
   Matiacevich SB, 2006, FOOD CHEM, V95, P423, DOI 10.1016/j.foodchem.2005.01.027
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   Miller DP, 2000, J PHYS CHEM B, V104, P8876, DOI 10.1021/jp000807d
   MORELDESROSIERS N, 1991, J CHEM SOC FARADAY T, V87, P2173, DOI 10.1039/ft9918702173
   OBrien J, 1997, FOOD CHEM, V58, P17, DOI 10.1016/S0308-8146(96)00162-8
   PETRIELLA C, 1988, J FOOD SCI, V53, P987, DOI 10.1111/j.1365-2621.1988.tb09008.x
   Santagapita PR, 2008, J NON-CRYST SOLIDS, V354, P1760, DOI 10.1016/j.jnoncrysol.2007.08.050
   Santagapita PR, 2006, FOOD PRESERV TECHNOL, V9, P663
   SANTAGAPITA PR, WATER PROPE IN PRESS, V10
   Schebor C, 1999, FOOD SCI TECHNOL-LEB, V32, P481
   Schmidt S. J., 2007, WATER ACTIVITY FOODS, P47
NR 31
TC 7
Z9 7
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
J9 FOOD CHEM
JI Food Chem.
PD JAN 1
PY 2010
VL 118
IS 1
BP 103
EP 108
DI 10.1016/j.foodchem.2009.04.084
PG 6
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 502XA
UT WOS:000270492500016
DA 2018-10-20
ER

PT J
AU Dodi, G
   Jongen, J
   de la Portilla, F
   Raval, M
   Altomare, DF
   Lehur, PA
AF Dodi, Giuseppe
   Jongen, Johannes
   de la Portilla, Fernando
   Raval, Manoj
   Altomare, Donato F.
   Lehur, Paul-Antoine
TI An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy
   and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal
   Incontinence
SO GASTROENTEROLOGY RESEARCH AND PRACTICE
LA English
DT Article
ID STRESS URINARY-INCONTINENCE; ANAL-SPHINCTER DYSFUNCTION;
   QUALITY-OF-LIFE; TERM-FOLLOW-UP; DEXTRANOMER/HYALURONIC ACID COPOLYMER;
   TRANSOBTURATOR TAPE IMPLANTATION; INJECTABLE SILICONE BIOMATERIAL;
   SACRAL NERVE-STIMULATION; VESICOURETERAL REFLUX; VAGINAL EROSION
AB Fecal incontinence (FI) is the involuntary loss of rectal contents through the anal canal. Reports of its prevalence vary from 1-21%. Studies, have demonstrated a positive effect on FI symptoms with injectable bulking agents. This study evaluated the safety and efficacy of NASHA/Dx gel in the treatment of FI. One hundred fifteen eligible patients suffering from FI received 4 injections of 1 mL NASHA/Dx gel. Primary efficacy was based on data from 86 patients that completed the study. This study demonstrated a >= 50% reduction from baseline in the number of FI episodes in 57.1% of patients at 6 months, and 64.0% at 12 months. Significant improvements (P < .001) were also noted in total number of both solid and loose FI episodes, FI free days, CCFIS, and FIQL scores in all 4 domains. The majority of the treatment related AEs (94.9%) were mild or moderate intensity, and (98.7%) of AEs resolved spontaneously, or following treatment, without sequelae. Results of this study indicate NASHA/Dx gel was efficacious in the treatment of FI. Treatment effect was significant both in reduction of number of FI episodes and disease specific quality of life at 6 months and lasted up to 12 months after treatment.
C1 [Dodi, Giuseppe] Univ Padua, Hosp Clin Chirurg, I-35128 Padua, Italy.
   [de la Portilla, Fernando] Virgen del Rocio Univ Hosp, Dept Surg, Coloproctol Sect, Seville 41013, Spain.
   [Raval, Manoj] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada.
   [Altomare, Donato F.] Univ Bari, Bari Policin Bari Piazza, Coloproctol Unit, I-70124 Bari, Italy.
   [Lehur, Paul-Antoine] Chu Hotel Dieu, Inst Malad Appareil Digestif, Clin Chirurg, F-44093 Nantes, France.
RP Dodi, G (reprint author), Univ Padua, Hosp Clin Chirurg, Via Giustiniani 2, I-35128 Padua, Italy.
EM giuseppe.dodi@hotmail.com
RI IBIS, COLOPROCTOLOGIA/H-9797-2016; MAESTRE, VICTORIA/E-9943-2015
OI Altomare, Donato Francesco/0000-0001-8980-2752; Portilla de Juan,
   Fernando de la/0000-0003-0603-2911
FU QMed AB, Uppsala, Sweden; Government of Spain; Q-Med AB, Uppsala,
   Sweden; CEREC, University hospital of Nantes; Government of Andalucia
FX G. Dodi, M.D., has received support in the form of research grants from
   QMed AB, Uppsala, Sweden. He has not received honoraria for lectures or
   served as a consultant. He has no other financial disclosures to
   declare. J. Jongen, M.D. has received honoraria for lectures from Dr.
   Kade, Berlin, Germany, Ethicon Endosurgery, Norderstedt, Germany,
   Boehringer-Ingelheim, Ingelheim, Germany, Dr. Falk, Freiburg, Germany,
   and Eli Lilly & Co. there are no other financial disclosures. F. de la
   Portilla, Ph.D., M.D. has received honoraria for lectures from Ethicon
   Endosurgery, Medtronic SA, PALEX medical, MSD, Nycomed, Prostrakan
   Farmaceutica. He has served as a consultant for Ethicon Endosurgery,
   Medtronic SA, PALEX medical, MSD, Prostrakan Farmaceutica; and he has
   received support in the form of research grants from the Governments of
   Spain and Andalucia. F. de la Portilla, Ph.D., M.D. has received support
   in the form of research grants from Q-Med AB, Uppsala, Sweden. He has
   not received honoraria for lectures or served as a consultant. He has no
   other financial disclosures to declare. D. F. Altomare, M.D. has
   received support in the form of research grants from Q-Med AB, Uppsala,
   Sweden. He has not received honoraria for lectures or served as a
   consultant. He has no other financial disclosures to declare. P. A.
   Lehur, M.D., has received honoraria for lectures from Ethicon
   Endosurgery, Medtronic SA, American Medical Systems. He has served as a
   consultant for Ethicon Endosurgery, Medtronic SA, American Medical
   Systems, Coloplast, THD spa; and he has received support in the form of
   research grants from CEREC, University hospital of Nantes.
CR Abramowitz L, 2000, DIS COLON RECTUM, V43, P590, DOI 10.1007/BF02235567
   Agostini A, 2006, ACTA OBSTET GYN SCAN, V85, P628, DOI 10.1080/00016340600608485
   Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   [Anonymous], 2000, JAMA-J AM MED ASSOC, V284, P3043, DOI DOI 10.1001/JAMA.284.23.3043
   Babalola EO, 2006, INT UROGYNECOL J, V17, P418, DOI 10.1007/s00192-005-0005-6
   Baessler K, 2005, OBSTET GYNECOL, V106, P713, DOI 10.1097/01.AOG.0000177970.52037.0a
   Baeten CGMI, 2002, SCAND J GASTROENTERO, V37, P72, DOI 10.1080/003655202320621490
   Bartlett L, 2009, WORLD J GASTROENTERO, V15, P3276, DOI 10.3748/wjg.15.3276
   Bech Lenette, 2009, Ugeskr Laeger, V171, P310
   Benassi G, 2007, INT UROGYNECOL J, V18, P697, DOI 10.1007/s00192-006-0211-x
   Cindolo L, 2004, Minerva Urol Nefrol, V56, P89
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   de la Portilla F, 2008, COLORECTAL DIS, V10, P89, DOI 10.1111/j.1463-1318.2007.01276.x
   Decter R M, 2001, Pediatr Rev, V22, P205, DOI 10.1542/pir.22-6-205
   Deffieux X, 2007, INT UROGYNECOL J, V18, P571, DOI 10.1007/s00192-006-0154-2
   Deval B, 2006, EUR UROL, V49, P373, DOI 10.1016/j.eururo.2005.11.012
   Deval B, 2006, CURR OPIN UROL, V16, P240, DOI 10.1097/01.mou.0000232043.95427.d6
   Efron Jonathan E, 2004, Surg Technol Int, V13, P107
   Elmore JM, 2006, J UROLOGY, V175, P712, DOI 10.1016/S0022-5347(05)00187-4
   ENCK P, 1991, INT J COLORECTAL DIS, V6, P143, DOI 10.1007/BF00341234
   Fahmy MAB, 2004, PEDIATR SURG INT, V20, P353, DOI 10.1007/s00383-004-1197-4
   Faltin DL, 2001, INT UROGYNECOL J, V12, P117, DOI 10.1007/PL00004031
   Game X, 2004, J UROLOGY, V171, P1629, DOI 10.1097/01.ju.0000115881.28311.f8
   Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362
   Ghosh T, 2004, J Obstet Gynaecol, V24, P590
   Giles DL, 2005, OBSTET GYNECOL, V105, P1193, DOI 10.1097/01.AOG.0000157756.86952.0d
   Glavind K, 2008, INT UROGYNECOL J, V19, P1081, DOI 10.1007/s00192-008-0579-x
   Goldman HB, 2006, INT UROGYNECOL J, V17, P295, DOI 10.1007/s00192-005-1335-0
   Guerra F, 2010, PELVIPERINEOLOGY, V29, P27
   Hagemeier T, 2006, Zentralbl Gynakol, V128, P68, DOI 10.1055/s-2006-921343
   Hilton P, 2009, BJOG-INT J OBSTET GY, V116, P1527, DOI 10.1111/j.1471-0528.2009.02306.x
   Ho Yik-Hong, 2005, Aust J Rural Health, V13, P28, DOI 10.1111/j.1440-1854.2004.00642.x
   Kalantar JS, 2002, MED J AUSTRALIA, V176, P54
   Kalota SJ, 2004, J UROLOGY, V172, P1349, DOI 10.1097/01.ju.0000137867.04413.38
   Karsenty G, 2007, INT UROGYNECOL J, V18, P207, DOI 10.1007/s00192-006-0129-3
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kerr Lindsey A, 2005, Rev Urol, V7 Suppl 1, pS3
   KIILHOLMA PJ, 1993, NEUROUROL URODYNAM, V12, P131, DOI 10.1002/nau.1930120206
   Lackgren G, 2001, J UROLOGY, V166, P1887, DOI 10.1016/S0022-5347(05)65713-8
   Lackgren G, 1999, ACTA PAEDIATR, V88, P62, DOI 10.1080/080352599750029628
   Lavelle MT, 2005, UROLOGY, V65, P564, DOI 10.1016/j.urology.2004.09.068
   Leach GE, 1994, ARCH ESP UROL, V2, P61
   Leanza V, 2008, Minerva Ginecol, V60, P91
   Lefebure B, 2008, INT J COLORECTAL DIS, V23, P993, DOI 10.1007/s00384-008-0514-0
   Levy BF, 2010, COLORECTAL DIS, V12, P5, DOI 10.1111/j.1463-1318.2009.01799.x
   Madjar S, 2006, INT UROGYNECOL J, V17, P180, DOI 10.1007/s00192-005-1322-5
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Marsh F, 2007, NEUROUROL URODYNAM, V26, P543, DOI 10.1002/nau.20239
   Matzel KE, 2009, COLORECTAL DIS, V11, P636, DOI 10.1111/j.1463-1318.2008.01673.x
   Melenhorst J, 2008, INT J COLORECTAL DIS, V23, P107, DOI 10.1007/s00384-007-0357-0
   Mellgren A, 2010, SURG CLIN N AM, V90, P185, DOI 10.1016/j.suc.2009.10.006
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Oliveira L, 1996, BRIT J SURG, V83, P502, DOI 10.1002/bjs.1800830421
   Oliveira L, 1998, FUNDAMENTALS ANORECT, P557
   PENNINCKX E, 2004, BRIT J SURG, V91, P872
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Pinto Rodrigo A, 2009, Gastrointest Endosc Clin N Am, V19, P83, DOI 10.1016/j.giec.2008.12.011
   Puri P, 2006, J UROLOGY, V176, P1856, DOI 10.1016/j.juro.2006.03.124
   Rafii A, 2006, OBSTET GYNECOL, V108, P720, DOI 10.1097/01.AOG.0000214672.80055.6a
   Robert M, 2006, OBSTET GYNECOL, V107, P472, DOI 10.1097/01.AOG.0000172375.57534.a9
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rongen MJGM, 2003, DIS COLON RECTUM, V46, P716, DOI 10.1097/01.DCR.0000070035.45378.BD
   Rosen H R, 2002, Acta Chir Iugosl, V49, P23
   Rossini CJ, 2009, J LAPAROENDOSC ADV S, V19, P679, DOI 10.1089/lap.2008.0189
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   Ruppert P, 1998, Krankenpfl J, V36, P376
   Sahai A, 2009, UROLOGY, V74, P486, DOI 10.1016/j.urology.2009.01.070
   Sato T, 2001, DIS COLON RECTUM, V44, P1155, DOI 10.1007/BF02234638
   Sergent F, 2003, PROG UROL, V13, P648
   Siproudhis L, 2006, DIS COLON RECTUM, V49, P219, DOI 10.1007/s10350-005-0249-8
   Sivanesan K, 2007, INT UROGYNECOL J, V18, P219, DOI 10.1007/s00192-006-0118-6
   STENBERG A, 1995, J UROLOGY, V154, P800, DOI 10.1016/S0022-5347(01)67168-4
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   TAKAHASHIMONROY M, 2008, FSDF, V51, P355
   Tariq SH, 2003, AM J MED, V115, P217, DOI 10.1016/S0002-9343(03)00327-9
   Tate SB, 2005, INT UROGYNECOL J, V16, P420, DOI 10.1007/s00192-005-1290-9
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Wadie GM, 2007, J LAPAROENDOSC ADV S, V17, P353, DOI 10.1089/lap.2006.0073
   Wexner SD, 2010, J GASTROINTEST SURG, V14, P1081, DOI 10.1007/s11605-010-1177-z
   *WORLD MED ASS DEC, 1996, NURS ETHICS, V9, P105
   *WORLD MED ASS GEN, 2004, J INT BIOETHIQUE, V15, P124
   World Medical Association Declaration of Helsinki, 2002, J POSTGRAD MED, V48, P206
   Yamada BS, 2006, J UROLOGY, V176, P651, DOI 10.1016/j.juro.2006.03.064
   Zetterstrom J, 1999, DIS COLON RECTUM, V42, P1253, DOI 10.1007/BF02234209
   Zumbe J, 2008, UROL INT, V81, P483, DOI 10.1159/000167853
   2001, Q MED AB DEFLUX PACK
NR 87
TC 19
Z9 20
U1 1
U2 8
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-6121
J9 GASTROENT RES PRACT
JI Gastroenterol. Res. Pract.
PY 2010
AR 467136
DI 10.1155/2010/467136
PG 10
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 706ZM
UT WOS:000286256300001
PM 21234379
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT S
AU Ganesh, M
   Gross, R
AF Ganesh, Manoj
   Gross, Richard
BE Cheng, HN
   Gross, RA
TI Embedding Enzymes To Control Biomaterial Lifetime
SO GREEN POLYMER CHEMISTRY: BIOCATALYSIS AND BIOMATERIALS
SE ACS Symposium Series
LA English
DT Proceedings Paper
CT 238th American-Chemical-Society National Meeting
CY AUG 16-20, 2009
CL Washington, DC
SP Amer Chem Soc, Div Chem Toxicol, Amer Chem Soc, Env Chem Inc
ID DEGRADATION; EXTRACTION; MICELLES
AB Bioresorbable materials with 'tunable' lifetimes are needed to meet a continuously expanding range of biomedical applications. Control of polymer lifetime has relied on altering intrinsic properties of synthesized polymeric materials. However, development of new biopolymer compositions is hindered by time and cost constraints. Herein we show that, biomaterials bioresorption rate can be regulated by embedding an enzyme within a bioresorbable polymer matrix when that enzyme is active for matrix hydrolysis. Poly(epsilon-caprolactone) was selected as a model system since its use has been limited due to its slow hydrolytic degradation (years). Candida antarctica Lipase B (CALB) was surfactant paired to enable its dispersion throughout PCL films. Embedded enzyme matrix hydrolysis occurs by formation of multiple enzyme-surface interfaces throughout films. Films become highly porous and crystalline as degradation proceeds. The concepts developed herein are applicable to a wide range of accepted biomaterials and can greatly expand the range of applications for which they are useful.
C1 [Ganesh, Manoj; Gross, Richard] NYU, NSF I UCRC Biocatalysis & Bioproc Macromol, Polytech Inst, Metrotech Ctr 6, Brooklyn, NY 11201 USA.
RP Ganesh, M (reprint author), NYU, NSF I UCRC Biocatalysis & Bioproc Macromol, Polytech Inst, Metrotech Ctr 6, Brooklyn, NY 11201 USA.
EM maddymanoj@gmail.com
RI Ganesh, Manoj/I-2434-2014
OI Ganesh, Manoj/0000-0001-8852-3161
CR Bolgen N, 2007, J BIOMED MATER RES B, V81B, P530, DOI 10.1002/jbm.b.30694
   Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803
   Gupta S, 2008, J PHARM SCI-US, V97, P22, DOI 10.1002/jps.21177
   Little U, 2009, POLYM DEGRAD STABIL, V94, P213, DOI 10.1016/j.polymdegradstab.2008.11.001
   Liu JG, 2006, BIOPROC BIOSYST ENG, V28, P267, DOI 10.1007/s00449-005-0032-1
   NISIDA H, 1993, J ENVIRON POLYM DEGR, V1, P227
   PARADKAR VM, 1994, BIOTECHNOL BIOENG, V43, P529, DOI 10.1002/bit.260430614
   Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   1989, PHYS DESK REFERENCE
NR 10
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 978-0-8412-2581-7
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 2010
VL 1043
BP 375
EP 384
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary;
   Engineering, Chemical; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Engineering; Polymer
   Science
GA BVR23
UT WOS:000292523300025
DA 2018-10-20
ER

PT S
AU Kamanyi, AE
   Mohamed, ETA
   Ngwa, W
   Grill, W
AF Kamanyi, Albert E.
   Mohamed, Esam T. Ahmed
   Ngwa, Wilfred
   Grill, Wolfgang
BE Kundu, T
TI Determination of sound velocity and acoustic impedance of thin chitosan
   films by phase-sensitive acoustic microscopy
SO HEALTH MONITORING OF STRUCTURAL AND BIOLOGICAL SYSTEMS 2010, PTS 1 AND 2
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Health Monitoring of Structural and Biological Systems
   2010
CY MAR 08-11, 2010
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers
DE Chitosan; acoustic microscope; V(z) curves; sound velocity; thin soft
   films; reflectivity
ID CONTRAST
AB The biomaterial chitosan is used in the paper manufacturing industry, as a wound healing agent and in filtration amongst others. In this paper the longitudinal sound velocity and acoustic impedance of thin films of chitosan of varying thicknesses are determined by vector-contrast acoustic microscopy. The exploitation of the relative reflectivity information from the maximum amplitude images and a comparison of the experimentally obtained V(z) curves with simulations using appropriate models are applied for the evaluation of the sound velocity. These results were compared to those previously obtained results with the same instrument.
C1 [Kamanyi, Albert E.; Mohamed, Esam T. Ahmed; Grill, Wolfgang] Univ Leipzig, Inst Expt Phys 2, Linnestr 5, D-04103 Leipzig, Germany.
   [Ngwa, Wilfred] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA.
RP Kamanyi, AE (reprint author), Univ Leipzig, Inst Expt Phys 2, Linnestr 5, D-04103 Leipzig, Germany.
EM kamanyi@physik.uni-leipzig.de
FU Deutsche Forschungsgemeinschaft (German Research Foundation) [GR
   566/11-2]; European Commission [Nr 228943]
FX We acknowledge support from the Deutsche Forschungsgemeinschaft (German
   Research Foundation) GR 566/11-2 (Mesoscale Acoustics) and the European
   Commission: Project Nr 228943 (MultiPlat) for this research.
CR ATALAR A, 1978, J APPL PHYS, V49, P5130, DOI 10.1063/1.324460
   Au WWL, 1996, J ACOUST SOC AM, V99, P3844, DOI 10.1121/1.415002
   Grill W, 1999, PHYSICA B, V263, P553, DOI 10.1016/S0921-4526(98)01478-1
   GRILL W, 1996, ADV ACOUSTIC MICROSC, V2
   HIRSEKORN S, 1995, APPL PHYS LETT, V67, P745, DOI 10.1063/1.115212
   Hirsekorn S, 1996, APPL PHYS LETT, V69, P2138, DOI 10.1063/1.118156
   Kamanyi AE, 2010, J MICROSC-OXFORD, V238, P134, DOI 10.1111/j.1365-2818.2009.03344.x
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Kundu T., 2003, ULTRASONIC NONDESTRU
   KUSHIBIKI J, 1982, J APPL PHYS, V53, P5509, DOI 10.1063/1.331485
   KUSHIBIKI J, 1983, P IEEE ULTR S, V2, P637
   Laforsch C, 2004, P NATL ACAD SCI USA, V101, P15911, DOI 10.1073/pnas.0404860101
   LEMONS RA, 1974, APPL PHYS LETT, V24, P163, DOI 10.1063/1.1655136
   MOHAMED A, 2008, P SPIE, V6935
   MUZZARELLI RAA, 1977, CHITIN
   Ngwa W, 2005, J MICROSC-OXFORD, V218, P208, DOI 10.1111/j.1365-2818.2005.01484.x
   Ngwa W, 2003, EUROPHYS LETT, V64, P830, DOI 10.1209/epl/i2003-00633-9
   SEUL M, 1990, THIN SOLID FILMS, V185, P287, DOI 10.1016/0040-6090(90)90093-S
   SHEPPARD CJR, 1981, APPL PHYS LETT, V38, P858, DOI 10.1063/1.92198
   TITTMANN BR, 2003, SCI TECHNOLOGY ED MI
   Yu ZL, 1995, REV MOD PHYS, V67, P863, DOI 10.1103/RevModPhys.67.863
NR 21
TC 2
Z9 2
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8065-1
J9 PROC SPIE
PY 2010
VL 7650
AR UNSP 76502A
DI 10.1117/12.847745
PG 8
WC Optics; Radiology, Nuclear Medicine & Medical Imaging
SC Optics; Radiology, Nuclear Medicine & Medical Imaging
GA BSR53
UT WOS:000285545600072
DA 2018-10-20
ER

PT S
AU Chen, L
   Yuan, XB
   Sun, HW
   Chen, MZ
   Zhao, DB
   Yu, D
   Bao, YW
AF Chen, Lan
   Yuan, Xiaobing
   Sun, Hongwei
   Chen, Mingzhao
   Zhao, Deben
   Yu, Dan
   Bao, Yiwang
BE Pan, W
   Gong, J
TI In Vivo Study of Carbon Artificial Femoral Head
SO HIGH-PERFORMANCE CERAMICS VI
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 6th China International Conference on High-Performance Ceramics (CICC-6)
CY AUG 16-19, 2009
CL Harbin, PEOPLES R CHINA
SP Chinese Ceram Soc, Harbin Inst Technol, Tsinghua Univ, State Key Lab New Ceram & Fine Processing, Adv Ceram Div
DE Carbon prosthesis; Femoral head; Cartilage; Biocompatibility
ID HIP; HEMIARTHROPLASTY; FRACTURE
AB Hip hemiarthroplasty is a popular method for curing hip joint diseases. Comparing with the total hip replacement (THR), hip hemiarthroplasty has some advantages, such as simpler operation, lower cost and less injury. However, inevitable acetabular cartilage wear, which leads to ultimately conversion to THR, has been reported by many authors. That limits its applications. To solve this problem, more suitable biomaterial should be chosen to make the femoral head. In this research, a kind of carbon femoral head, which was made of graphite coated with low temperature isotropic pyrolytic carbon, was studied in vivo. Nineteen New Zealand adult white rabbits were divided into 3 groups. Every rabbit was taken the replacement operation and time-dependently killed after certain periods. X-ray photographs of the hip joint, macroscopic apperarance and histological morphometry of the neocartilage around the prosthesis, were examined. The results proved that the coating material of the femoral head was biocompatible and the neocartilage tissue around the prothetic head might protect the acetabulum from wear. However, because of the complicated physiological environment, further research is needed.
C1 [Chen, Lan; Yuan, Xiaobing] Shanghai Univ Sci & Technol, Sch Med Instrument & Food Engn, 516 Jun Gong Rd, Shanghai 200093, Peoples R China.
   [Chen, Mingzhao; Zhao, Deben; Yu, Dan] Jilin Cent Hosp, Orthoped Dept, Jilin 200093, Peoples R China.
   [Bao, Yiwang] China Bldg Mat Acad, China Bldg Mat Test & Certificat Ctr, Beijing 100024, Peoples R China.
RP Chen, L (reprint author), Shanghai Univ Sci & Technol, Sch Med Instrument & Food Engn, 516 Jun Gong Rd, Shanghai 200093, Peoples R China.
EM lanchen@usst.edu.cn
FU National Natural Science Foundation of China [50672093]
FX The authors are grateful for the financial support by the National
   Natural Science Foundation of China (50672093), and also like to express
   the thankfulness to several medical doctors from Jilin Central Hospital,
   Yangpu Geriatric Hospital and Changchun Central Hospital for their
   contributions to this work.
CR BEKSAC B, 2008, INJURY EXTRA, V39, P264
   Bos PK, 2008, OSTEOARTHR CARTILAGE, V16, P204, DOI 10.1016/j.joca.2007.06.007
   CHEN LT, 1993, J FOOT ANKLE SURG, V32, P490
   Goh SK, 2009, J ARTHROPLASTY, V24, P400, DOI 10.1016/j.arth.2007.12.009
   [胡明 Hu Ming], 2002, [中华骨科杂志, Chinese Journal of Orthopedics], V22, P272
   Kosashvili Y, 2008, INJURY, V39, P232, DOI 10.1016/j.injury.2007.05.021
   Loir AS, 2004, SURF COAT TECH, V188, P728, DOI 10.1016/j.surfcoat.2004.07.046
NR 7
TC 3
Z9 3
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2010
VL 434-435
BP 613
EP +
DI 10.4028/www.scientific.net/KEM.434-935.613
PG 2
WC Materials Science, Ceramics
SC Materials Science
GA BPZ23
UT WOS:000280417300164
DA 2018-10-20
ER

PT S
AU Zhang, PL
   Liu, B
   Zhang, D
   Tao, YW
   Yang, SR
   Wang, JQ
AF Zhang Puliang
   Liu Bin
   Zhang Dong
   Tao Yongwei
   Yang Shengrong
   Wang Jinqing
BE Pan, W
   Gong, J
TI Ceramic Coatings of Magnesium Alloy for Biomaterial Applications
SO HIGH-PERFORMANCE CERAMICS VI
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 6th China International Conference on High-Performance Ceramics (CICC-6)
CY AUG 16-19, 2009
CL Harbin, PEOPLES R CHINA
SP Chinese Ceram Soc, Harbin Inst Technol, Tsinghua Univ, State Key Lab New Ceram & Fine Processing, Adv Ceram Div
DE Magnesium alloy; Micro-arc oxidation; Electrodeposition; Hydroxyapatite
ID MICROARC OXIDATION; IMPLANTS
AB Ceramic coatings were produced on magnesium (Mg) alloy of AZ91D for biomaterial applications by micro-arc oxidation (MAO) and electrodeposition methods. The morphology, microstructure, phase composition and corrosion properties of the prepared coatings were investigated by scanning electron microscopy (SEM), X-ray diffraction (XRD) and potentiodynamic polarization tester, etc. The results indicated that a porous oxide layer was grown on the Mg alloy sheets after MAO process and the compositions of oxides were mainly Mg2SiO4 and MgO. After further electrodeposition and alkaline treatment, a flake-like structure diverging from centre to periphery was grown on the MAO coating and the coating was mainly made up of hydroxyapatite (HA). Moreover, the corrosion resistance of the Mg alloy after being treated with MAO and electrodeposition technique increases obviously, which was evaluated in stimulated body fluid (SBF).
C1 [Zhang Puliang; Liu Bin; Zhang Dong; Tao Yongwei] Lanzhou Univ, Sch Stomatol, Lanzhou 730000, Peoples R China.
   [Yang Shengrong; Wang Jinqing] Chinese Acad Sci, Lanzhou Inst Chem Phys, State Key Lab Solid Lubricat, Lanzhou 730000, Peoples R China.
RP Zhang, PL (reprint author), Lanzhou Univ, Sch Stomatol, Lanzhou 730000, Peoples R China.
EM jqwang@lzb.ac.cn
CR Chen F, 2007, SURF COAT TECH, V201, P4905, DOI 10.1016/j.surfcoat.2006.07.079
   Guo HF, 2006, APPL SURF SCI, V252, P7911, DOI 10.1016/j.apsusc.2005.09.067
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   Revell PA, 2004, KEY ENG MAT, V254-2, P447, DOI 10.4028/www.scientific.net/KEM.254-256.447
   Shin YK, 2006, ELECTROCHEM COMMUN, V8, P465, DOI 10.1016/j.elecom.2006.01.003
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Zhang YJ, 2002, SURF COAT TECH, V161, P36, DOI 10.1016/S0257-8972(02)00342-0
   [钟涛生 Zhong Taosheng], 2005, [电镀与涂饰, Electroplationg & Finishing], V24, P47
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 13
TC 1
Z9 1
U1 0
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2010
VL 434-435
BP 634
EP +
DI 10.4028/www.scientific.net/KEM.434-435.634
PG 2
WC Materials Science, Ceramics
SC Materials Science
GA BPZ23
UT WOS:000280417300170
DA 2018-10-20
ER

PT S
AU Tanaka, K
   Nagayama, T
   Katayama, T
   Koizumi, N
AF Tanaka, K.
   Nagayama, T.
   Katayama, T.
   Koizumi, N.
BE DeWilde, WP
   Brebbia, CA
   Mander, U
TI Tensile properties of amniotic membrane
SO HIGH PERFORMANCE STRUCTURES AND MATERIALS V
SE WIT Transactions on the Built Environment
LA English
DT Proceedings Paper
CT 5th International Conference on High Performance Structures and
   Materials
CY JUL 26-28, 2010
CL Tallinn, ESTONIA
SP Wessex Inst Technol
DE amniotic membrane; tensile test; non-contact optical 3D deformation
   measuring system
ID OCULAR SURFACE RECONSTRUCTION; EPITHELIAL-CELLS
AB The amniotic membrane, which is the innermost layer of the placental membrane, is a thin and transparent tissue. Rejection rarely occurs in the amniotic membrane because it is free from vascular components. Therefore, the amniotic membrane has attracted attention as a surgical biomaterial for regenerative medicine in various medical fields. However, evaluation of mechanical properties for the amniotic membrane is not standardized because of the difficulty in handling tiny amniotic membrane materials.
   In this study, to propose the most appropriate tensile testing method for the amniotic membrane, the influence of specimen shapes and testing jig types on the mechanical properties of the amniotic membrane is examined. Moreover, for the strain measurement of the thin film like amniotic membrane, due to the low rigidity of the specimen, it is necessary to measure the strain by a non-contact measurement method. A non-contact optical 3D deformation measuring system, which can measure strain by the image correlation method using the dotted pattern of specimen's surface, is applied for the tensile testing of the amniotic membrane. The dumbbell specimen and grip jig are shown to be suitable for tensile testing of the amniotic membrane. The tensile strength of the amniotic membrane was 6.80 +/- 0.22 MPa. For strain measurement by using a non-contact optical 3D deformation measuring system, the organic solvent spray was not suitable because the ink-film was formed on the surface of the amniotic membrane. On the other hand, spray mixed with calcium carbonate and hydrophilic ink was appropriate to apply a dotted pattern on the surface of the amniotic membrane.
C1 [Tanaka, K.; Nagayama, T.; Katayama, T.; Koizumi, N.] Doshisha Univ, Dept Biomed Engn, Kyoto, Japan.
RP Tanaka, K (reprint author), Doshisha Univ, Dept Biomed Engn, Kyoto, Japan.
CR ArBlast Co. Ltd, 2006, <IT>PCT JP2006</IT>, Patent No. 2006314245
   Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506
   Koizumi N, 2003, BRIT J OPHTHALMOL, V87, P1437, DOI 10.1136/bjo.87.12.1437-a
   Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7
   Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752
   Nakamura T, 2008, BIOMATERIALS, V29, P3729, DOI 10.1016/j.biomaterials.2008.05.023
   Oyen ML, 2005, J MATER RES, V20, P2902, DOI 10.1557/JMR.2005.0382
NR 7
TC 3
Z9 3
U1 0
U2 2
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
SN 1746-4498
BN 978-1-84564-464-2
J9 WIT TRANS BUILT ENV
PY 2010
VL 112
BP 197
EP 206
DI 10.2495/HPSM100191
PG 10
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA BBY44
UT WOS:000308726300019
OA Bronze
DA 2018-10-20
ER

PT S
AU Liu, JC
   Fuh, JYH
   Lu, L
AF Liu, Jichang
   Fuh, J. Y. H.
   Lue, L.
BE Singh, UN
   Fan, D
   Yao, J
   Walter, RF
TI The State-of-the-Art Laser Bio-Cladding Technology
SO HIGH-POWER LASERS AND APPLICATIONS V
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on High-Power Lasers and Applications V
CY OCT 18-19, 2010
CL Beijing, PEOPLES R CHINA
SP SPIE, COS-Chinese Opt Soc
DE laser bio-cladding; implants; coating; scaffold; biomaterial
ID TITANIUM-ALLOYS; TA ALLOYS; TI-6AL-4V; FABRICATION; DEPOSITION;
   COMPOSITES; RESISTANCE; IMPLANTS; CO
AB The current state and future trend of laser bio-cladding technology are discussed. Laser bio-cladding is used in implants including fabrication of metal scaffolds and bio-coating on the scaffolds. Scaffolds have been fabricated from stainless steel, Co-based alloy or Ti alloy using laser cladding, and new laser-deposited Ti alloys have been developed. Calcium phosphate bioceramic coatings have been deposited on scaffolds with laser to improve the wear resistence and corrosion resistence of implants and to induce bone regeneration. The types of biomaterial devices currently available in the market include replacement heart valve prosthesis, dental implants, hip/knee implants, catheters, pacemakers, oxygenators and vascular grafts. Laser bio-cladding process is attracting more and more attentions of people.
C1 [Liu, Jichang] Hunan Univ, Inst Adv Shaping & Surface Engn, Coll Mech & Vehicle Engn, Changsha 410082, Hunan, Peoples R China.
   [Liu, Jichang; Fuh, J. Y. H.; Lue, L.] Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Liu, JC (reprint author), Hunan Univ, Inst Adv Shaping & Surface Engn, Coll Mech & Vehicle Engn, Changsha 410082, Hunan, Peoples R China.
EM liujichang2003@sohu.com
CR Alimardani M, 2008, APPL SOFT COMPUT, V8, P316, DOI 10.1016/j.asoc.2007.02.002
   Banerjee R, 2006, J BIOMED MATER RES A, V78A, P298, DOI 10.1002/jbm.a.30694
   Chen Chuan-zhong, 2004, Chinese Journal of Lasers, VA31, P1021
   Chen YB, 2008, SURF COAT TECH, V202, P4780, DOI 10.1016/j.surfcoat.2008.04.057
   Dinda GP, 2008, METALL MATER TRANS A, V39A, P2914, DOI 10.1007/s11661-008-9634-y
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Engleman PG, 2005, JOM-US, V57, P46, DOI 10.1007/s11837-005-0182-2
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   HEDGES M, 2003, ORTHOPAEDIC PRODUCT
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HU D, 2003, J ENG MANUF B, V212, P441
   Hu DM, 2003, INT J MACH TOOL MANU, V43, P51, DOI 10.1016/S0890-6955(02)00163-3
   Huang YL, 2006, J LASER APPL, V18, P42, DOI 10.2351/1.2164476
   Ion JC, 2005, LASER PROCESSING OF ENGINEERING MATERIALS: PRINCIPLES, PROCEDURE AND INDUSTRIAL APPLICATION, P1
   Keicher DM, 1997, JOM-J MIN MET MAT S, V49, P51, DOI 10.1007/BF02914686
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Kurella A, 2006, ACTA BIOMATER, V2, P677, DOI 10.1016/j.actbio.2006.05.001
   Kurella A, 2006, JOM-US, V58, P64, DOI 10.1007/s11837-006-0144-3
   Leon Betty, 2009, THIN CALCIUM PHOSPHA
   Liu JC, 2004, OPT LASER TECHNOL, V36, P477, DOI 10.1016/j.optlastec.2003.12.003
   LIU JC, 2007, TECHNIQUE EQUIPMENT
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Majumdar JD, 2006, PHYS STATUS SOLIDI A, V203, P2236, DOI 10.1002/pssa.200566022
   Majumdar JD, 2009, J MATER PROCESS TECH, V209, P2237, DOI 10.1016/j.jmatprotec.2008.05.017
   Niinomi M, 2005, JOM-US, V57, P18, DOI 10.1007/s11837-005-0076-3
   Paital SR, 2008, MATER SCI TECH-LOND, V24, P1144, DOI 10.1179/174328408X341825
   Paital SR, 2007, BIOMED MATER, V2, P274, DOI 10.1088/1748-6041/2/4/011
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Paital SR, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015009
   Pinkerton AJ, 2004, J PHYS D APPL PHYS, V37, P1885, DOI 10.1088/0022-3727/37/14/003
   Qazi JI, 2004, JOM-US, V56, P49, DOI 10.1007/s11837-004-0253-9
   Samuel S, 2008, MAT SCI ENG C-BIO S, V28, P414, DOI 10.1016/j.msec.2007.04.029
   Samuel S, 2010, J BIOMED MATER RES A, V94A, P1251, DOI 10.1002/jbm.a.32782
   SONG LJ, 2009, ADV DIRECT METAL DEP
   TOYSERKANI E, 2004, J OPTICS LASERS ENG, V4, P849
   Toyserkani E., 2005, LASER CLADDING
   Toyserkani E, 2006, MECHATRONICS, V16, P631, DOI 10.1016/j.mechatronics.2006.05.002
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhu WD, 2008, J BIOMED MATER RES A, V87A, P429, DOI 10.1002/jbm.a.31774
NR 40
TC 0
Z9 0
U1 0
U2 8
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-8373-7
J9 PROC SPIE
PY 2010
VL 7843
AR UNSP 78430W
DI 10.1117/12.870705
PG 10
WC Optics; Physics, Applied
SC Optics; Physics
GA BTQ40
UT WOS:000287765300025
DA 2018-10-20
ER

PT B
AU Zareian, R
   Saeidi, N
   Ruberti, JW
AF Zareian, Ramin
   Saeidi, Nima
   Ruberti, Jeffrey W.
GP ASME
TI STRAIN-INFLUENCED DEGRADATION OF NATIVE COLLAGENOUS TISSUE IN A VERY-LOW
   VOLUME, ENVIROMENTALLY-CONTROLLED BIOREACTOR
SO IMECE2009: PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING
   CONGRESS AND EXPOSITION, VOL 2
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 13-19, 2009
CL Lake Buena Vista, FL
SP ASME
ID ULTRASTRUCTURE; CARTILAGE; MATRIX
AB We have hypothesized that collagenous matrix is an intrinsically smart biomaterial which resists enzymatic attack when under tensile strain. Testing this hypothesis requires the ability expose native tissue to low volumes of enzyme (due to their expense) while tracking mechanical response. In this study, we have developed an environmentally-controlled, mechanochemical bioreactor which permits load/strain tracking and direct observation of degrading tissue (polarization pictures) in a very small volume chamber (similar to 500 ul). In the device, the chamber "reaction volume" is formed between two layers of inert immiscible fluids. The device permitted exposure of the native tissue strips (similar to 6.0 mm x 0.7 mm x 13.5 mm) to small volumes of enzyme solution while it tracked the degradation-induced stress relaxation (to 0.01N accuracy) and provided direct observation of the tissue polarization signal. As expected in this small series, tissue with the higher (4% and 8%) strain degraded much more slowly compared to the lower (2%) strain. The new method successfully tracked collagen degradation (at high resolution) induced by a small volume of enzyme. The ability to perform these tests will permit the use of more expensive and physiologically relevant MMPs.
C1 [Zareian, Ramin; Saeidi, Nima; Ruberti, Jeffrey W.] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.
RP Zareian, R (reprint author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.
CR Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965
   BHOLE AP, PHIL T ROY SOC A
   BRINCKMANN J, 2005, COLLAGEN PRIMER STRU, P1
   Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731
   Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318
   CHURCH K, 2007, MECH IND ENG
   Cowin SC, 2000, J BIOMECH ENG-T ASME, V122, P553, DOI 10.1115/1.1324665
   Cowin SC, 2004, ANNU REV BIOMED ENG, V6, P77, DOI 10.1146/annurev.bioeng.6.040803.140250
   GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014
   HUANG C, 1977, J BIOMED MATER RES, V11, P137, DOI 10.1002/jbm.820110113
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201
   MAROUDAS A, 1972, J PHYSIOL-LONDON, V223, pP21
   Matsushita O, 2001, J BIOL CHEM, V276, P8761, DOI 10.1074/jbc.M003450200
   MEEK KM, 1993, BIOPHYS J, V64, P273, DOI 10.1016/S0006-3495(93)81364-X
   Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055
   Nabeshima Y, 1996, J ORTHOP RES, V14, P123, DOI 10.1002/jor.1100140120
   ROUX W, 1895, GESAMMELTE ABHANDULG
   Ruberti JW, 2005, BIOCHEM BIOPH RES CO, V336, P483, DOI 10.1016/j.bbrc.2005.08.128
   Salminen-Mankonen HJ, 2007, CURR DRUG TARGETS, V8, P315, DOI 10.2174/138945007779940188
   SCHOMBERG D, 1991, ENZYME HDB
   SCOTT JE, 1988, J ANAT, V158, P95
   WEBB EC, 1992, ENZYME NOMENCLATURE
   WELGUS HG, 1981, J BIOL CHEM, V256, P9511
   WOLFF J, 1891, GESETZ TRANSFORMATIO
   WYATT K, ASME 2007 SUMM BIOEN
   ZAREIAN R, ASME C 2008
NR 27
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4375-8
PY 2010
BP 113
EP 118
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Engineering, Mechanical
SC Biotechnology & Applied Microbiology; Engineering
GA BRC33
UT WOS:000282340500022
DA 2018-10-20
ER

PT B
AU Feng, Y
   Li, W
   Yan, ZL
   Liao, YM
AF Feng, Yu
   Li, Wei
   Yan, Zhiling
   Liao, Yunmao
BE Chu, PKI
TI A Preliminary Study on A Highly Porous Nano Calcium Phosphate Bioceramic
   Scaffolds for Bone Tissue Engineering
SO INEC: 2010 3RD INTERNATIONAL NANOELECTRONICS CONFERENCE, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 3rd IEEE International Nanoelectronics Conference
CY JAN 03-08, 2010
CL City Univ Hong Kong, Hong Kong, PEOPLES R CHINA
HO City Univ Hong Kong
ID IN-VITRO; CELLS
AB In this study, a novel nano calcium phosphate biomaterial have been fabricated with the aim of finding a good candidate as scaffold for bone tissue engineering, in terms of porous structures and biocompatibility. The scaffold was investigated by a combination of X-ray diffraction, Fourier transform infrared spectroscopy, electron microscopy, mercury intrusion porosimetry and BET. It was shown that the scaffold was characterized by a uniformly dispersed porous structure. The porous scaffold has not only macropores of 0.1-1mm size but also a lot of micropores of 100 mu m -0.1 mu m size within macropore walls, as well as meso-porous under 100nm size within the walls of them. The porosity can be controlled in 70%-90%. Then we observed the biological response of pre-osteoblasts (MC 3T3-E1) on the scaffold by MTT assay. The results indicated that this scaffold maintain well-developed structure morphology, physicochemical properties and good cytocompatibility. It suggests that it can be potential candidate materials for bone regeneration and tissue engineering.
C1 [Feng, Yu; Li, Wei; Yan, Zhiling; Liao, Yunmao] Sichuan Univ, State Key Lab Oral Dis, W China Coll Stomatol, Chengdu 610041, Peoples R China.
RP Li, W (reprint author), Sichuan Univ, State Key Lab Oral Dis, W China Coll Stomatol, 14 Renminnan Rd, Chengdu 610041, Peoples R China.
EM leewei2000@sina.com
CR Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Tanimoto Y, 2008, J BIOMED MATER RES A, V85A, P427, DOI 10.1002/jbm.a.31569
NR 6
TC 2
Z9 2
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-3543-2
PY 2010
BP 801
EP 802
PG 2
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BQW82
UT WOS:000282026500404
DA 2018-10-20
ER

PT B
AU Ye, XS
   Zhou, T
   Liu, F
   Liu, J
   Sha, JA
   Xia, L
AF Ye, Xue-song
   Zhou, Tao
   Liu, Feng
   Liu, Jun
   Sha, Jian
   Xia, Ling
BE Chu, PKI
TI Investigating the Adsorption Mechanism of Bovine Serum Albumin on
   Crystal Surface by Steering Atomic Force Microscopy
SO INEC: 2010 3RD INTERNATIONAL NANOELECTRONICS CONFERENCE, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 3rd IEEE International NanoElectronics Conference (INEC)/Symposium on
   Nanoscience and Nanotechnology in China
CY JAN 03-08, 2010
CL City Univ Hong Kong, Hong Kong, PEOPLES R CHINA
SP IEEE
HO City Univ Hong Kong
AB The protein adsorption is a crucial but complex phenomenon in many applications, like biosensors, biomaterials. The amount, orientation and biological activity of adsorbed proteins are heavily dependent upon the structure of protein, like widely-applied Bovine Serum Albumin (BSA), and the properties of the substrate. At some extent, to explore the physicochemical properties and dynamics interaction process between protein / multi-proteins with crystal/biomaterial surface, it has been presented that how to dig out the potential ability of the apparatus and other methods/tools for removing the block of studying interactions and measuring these complex interactions with crystal environments efficiently. In our recent works, it was demonstrated how to detect the BSA under aqueous conditions by steering the AFM tip in contact mode to sample more abundant topographical clues. The results indicated that this approach should be available for exploring more complex interaction system and acquiring more useful interaction information without altering the current apparatus platforms.
C1 [Ye, Xue-song; Zhou, Tao; Liu, Feng; Liu, Jun; Xia, Ling] Zhejiang Univ, Dept Biomed Engn, Biosensors Natl Special Lab, Hangzhou 310003, Zhejiang, Peoples R China.
   [Sha, Jian] Zhejiang Univ, Dept Phys, Hangzhou 310003, Zhejiang, Peoples R China.
RP Liu, F (reprint author), Zhejiang Univ, Dept Biomed Engn, Biosensors Natl Special Lab, Hangzhou 310003, Zhejiang, Peoples R China.
EM bmilyf@gmail.com; liujun@zju.edu.cn
FU Program for New Century Excellent Talents in University of China
   [NCET-06-0527]; Nature Science Foundation of Zhejiang Province of China
   [Z1080300]; National Nature Science Foundation of China [30700153]
FX This work was supported in part by the Program for New Century Excellent
   Talents in University of China under Grant NCET-06-0527, Nature Science
   Foundation of Zhejiang Province of China under Grant Z1080300 and
   National Nature Science Foundation of China under Grant 30700153.
CR Liu GY, 2002, P NATL ACAD SCI USA, V99, P5165, DOI 10.1073/pnas.072695699
   Schon P, 2007, LANGMUIR, V23, P9921, DOI 10.1021/la700236z
   Tencer M, 2007, APPL SURF SCI, V253, P9209, DOI 10.1016/j.apsusc.2007.05.079
   WPPELL SJ, 1995, BIOPHYS J, V68, P671
NR 4
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-3543-2
PY 2010
BP 866
EP +
DI 10.1109/INEC.2010.5425163
PG 2
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA BQW82
UT WOS:000282026500437
DA 2018-10-20
ER

PT B
AU Chua, CK
   An, J
   Leong, KF
   Cheah, CM
   Chang, H
AF Chua, C. K.
   An, J.
   Leong, K. F.
   Cheah, C. M.
   Chang, H.
BE Bartolo, PJD
   DeLemos, ACS
   Pereira, AMH
   Mateus, AJD
   Mendes, ALA
   DeMoura, CSM
   Capela, CAB
   DaSilva, CSG
   Domingues, FAC
   Bartolo, HMCDTG
   Almeida, HD
   Ferreira, ISC
   Matias, JM
   Alves, NMF
   Rodrigues, SCSF
TI Spinning of biomaterial microfibers for tendon tissue engineering
SO INNOVATIVE DEVELOPMENTS IN DESIGN AND MANUFACTURING: ADVANCED RESEARCH
   IN VIRTUAL AND RAPID PROTOTYPING
LA English
DT Proceedings Paper
CT 4th International Conference on Advanced Research in Virtual and Rapid
   Prototyping
CY OCT 06-10, 2009
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Portuguese Fdn Sci & Technol, Int Acad Prod Engn, Global Alliance Rapid Prototyping Assoc, Rapid Mfg Platform
ID POLYCAPROLACTONE SCAFFOLDS; FIBER DIAMETER; CELLS; ORIENTATION; DESIGN;
   MESHES
AB Tendon scaffold is critical for tissue engineering-based tendon reconstruction. A novel, simple and effective method has been developed to fabricate bundles of unfused parallel poly (E-caprolactone) (PCL) microfibers (10 mu m) for tendon scaffold. The spinning process is initiated by heat-drawing. PCL microfibers are recommended to be spun under the conditions of 130 degrees C and 1000 rpm. Besides tendon scaffold, microfiber bundles can also be converted to a 3D fibrous scaffold.
C1 [Chua, C. K.; An, J.; Leong, K. F.] Nanyang Technol Univ, Rapid Prototyping Res Lab, Sch Mech & Aerosp Engn, Singapore, Singapore.
   [Cheah, C. M.; Chang, H.] Nanyang Polytech, Sch Engn Mfg, Singapore, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Rapid Prototyping Res Lab, Sch Mech & Aerosp Engn, Singapore, Singapore.
RI Leong, Kah-Fai/B-6183-2009; Chua, Chee Kai/B-6171-2009
CR Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Charuchinda A, 2003, POLYM INT, V52, P1175, DOI 10.1002/pi.1234
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Chua CK, 2005, VIRTUAL MODELING AND RAPID MANUFACTURING, P19
   Dalton PD, 2007, POLYMER, V48, P6823, DOI 10.1016/j.polymer.2007.09.037
   DULING RR, 2008, T ASME, V130
   Estelles JM, 2008, J MATER SCI-MATER M, V19, P189, DOI 10.1007/s10856-006-0101-2
   GOLZAR M, 2004, THESIS TU DRESDEN, P7
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hwang C.M., 2009, BIOMEDICAL MICRODEVI, P1
   Kohler WH, 2005, J MACROMOL SCI PHYS, VB44, P185, DOI 10.1081/MB-200049786
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Reneker DH, 2002, POLYMER, V43, P6785, DOI 10.1016/S0032-3861(02)00595-5
   RICCI JL, 1984, J BIOMED MATER RES, V18, P1073, DOI 10.1002/jbm.820180910
   RICCI JL, 1991, J BIOMED MATER RES, V25, P651, DOI 10.1002/jbm.820250508
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sanders JE, 2005, J BIOMED MATER RES A, V72A, P335, DOI 10.1002/jbm.a.30259
   Saxena S, 2008, TISSUE ENG PT A, V14, P899
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Williamson MR, 2004, BIOMATERIALS, V25, P459, DOI 10.1016/S0142-9612(03)00536-2
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   WojciakStothard B, 1997, IN VITRO CELL DEV-AN, V33, P110
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 29
TC 1
Z9 1
U1 0
U2 1
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-415-87307-9
PY 2010
BP 31
EP +
PG 3
WC Engineering, Manufacturing
SC Engineering
GA BOD33
UT WOS:000276283000004
DA 2018-10-20
ER

PT B
AU Chua, CK
   Sudarmadji, N
   Leong, KF
   Chou, SM
   Lim, SC
   Firdaus, WM
AF Chua, C. K.
   Sudarmadji, N.
   Leong, K. F.
   Chou, S. M.
   Lim, S. C.
   Firdaus, W. M.
BE Bartolo, PJD
   DeLemos, ACS
   Pereira, AMH
   Mateus, AJD
   Mendes, ALA
   DeMoura, CSM
   Capela, CAB
   DaSilva, CSG
   Domingues, FAC
   Bartolo, HMCDTG
   Almeida, HD
   Ferreira, ISC
   Matias, JM
   Alves, NMF
   Rodrigues, SCSF
TI Process flow for designing functionally graded tissue engineering
   scaffolds
SO INNOVATIVE DEVELOPMENTS IN DESIGN AND MANUFACTURING: ADVANCED RESEARCH
   IN VIRTUAL AND RAPID PROTOTYPING
LA English
DT Proceedings Paper
CT 4th International Conference on Advanced Research in Virtual and Rapid
   Prototyping
CY OCT 06-10, 2009
CL Leiria, PORTUGAL
SP Polytechn Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Portuguese Fdn Sci & Technol, Int Acad Prod Engn, Global Alliance Rapid Prototyping Assoc, Rapid Mfg Platform
ID INTERNAL ARCHITECTURE; MECHANICAL-PROPERTIES; COLLAGEN SCAFFOLD;
   STRUCTURE LIBRARY; FABRICATION; BONE; BEHAVIOR
AB The combination of Computer Aided Design (CAD) and Rapid Prototyping (RP) system have been aiding tissue engineers in designing customized tissue scaffolds to meet the biological, mechanical and anatomical requirements. Biological requirements include suitable biomaterial and pore size for cell growth, while anatomical requirement can be fulfilled by shaping the scaffold to fit the defect site. Mechanically, scaffolds should have matching mechanical properties, such as compressive stiffness and strength, with the target organ, especially in bone regeneration, as bone is a load-bearing organ. Bone possesses stiffness gradient, depending on its function and the amount of load it needs to bear. Hence scaffolds for bone regeneration should possess stiffness gradient mimicking bone by varying the scaffold porosity and structure. This article presents the sequences on designing bone scaffolds with stiffness gradient using CASTS, which stands for Computer Aided System for Tissue Scaffolds, as a platform. As a case study, the regeneration of human mandibular cancellous bone with stiffness gradient will be presented. These sequences are to be further implemented into the current CASTS system to automate the design of Functionally Graded Scaffolds (FGS).
C1 [Chua, C. K.; Sudarmadji, N.; Leong, K. F.; Chou, S. M.; Lim, S. C.; Firdaus, W. M.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RI Chou, Siaw Meng/A-3846-2011; NTU, S'gapore/F-4683-2012; Leong,
   Kah-Fai/B-6183-2009; Chua, Chee Kai/B-6171-2009
CR Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Cheah CM, 2004, TISSUE ENG, V10, P595, DOI 10.1089/107632704323061951
   Chua CK, 2008, PROC MONOGR ENG WATE, P115
   Chua CK, 2010, RAPID PROTOTYPING: PRINCIPLES AND APPLICATIONS, 3RD EDITION, P1
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P291
   Chua CK, 2003, INT J ADV MANUF TECH, V21, P302
   Ford R., 1999, FUNCTIONALLY GRADED, P7
   HOLLISTER SJ, 2001, BONE MECH HDB
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Lian Q, 2006, COMPUT AIDED DESIGN, V38, P507, DOI 10.1016/j.cad.2005.12.001
   Misch CE, 1999, J ORAL MAXIL SURG, V57, P700, DOI 10.1016/S0278-2391(99)90437-8
   Naing MW, 2005, RAPID PROTOTYPING J, V11, P249, DOI 10.1108/13552540510612938
   Ramanath HS, 2008, J MATER SCI-MATER M, V19, P2541, DOI 10.1007/s10856-007-3203-6
   Ramanath HS, 2007, KEY ENG MATER, V334-335, P1241, DOI 10.4028/www.scientific.net/KEM.334-335.1241
   Simpson RL, 2008, J BIOMED MATER RES B, V84B, P17, DOI 10.1002/jbm.b.30839
   Starly B, 2006, COMPUT AIDED DESIGN, V38, P115, DOI [10.1016/j.cad.2005.08.001, 10.1016/J.CAD.2005.08.001]
   Sun W, 2005, COMPUT AIDED DESIGN, V37, P1097, DOI 10.1016/j.cad.2005.02.002
   Tan KH, 2005, P I MECH ENG H, V219, P183, DOI 10.1243/095441105X9345
   Tan KH, 2003, BIOMATERIALS, V24, P3115, DOI 10.1016/S0142-9612(03)00131-5
   Too MH, 2002, INT J ADV MANUF TECH, V19, P217, DOI 10.1007/s001700200016
   Wettergreen MA, 2005, ANN BIOMED ENG, V33, P1333, DOI 10.1007/s10439-005-6744-1
   Wettergreen MA, 2005, COMPUT AIDED DESIGN, V37, P1141, DOI 10.1016/j.cad.2005.02.005
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Yeong WY, 2007, J BIOMED MATER RES B, V82B, P260, DOI 10.1002/jbm.b.30729
   Yeong WY, 2006, RAPID PROTOTYPING J, V12, P229, DOI 10.1108/13552540610682741
NR 26
TC 6
Z9 6
U1 1
U2 3
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-0-415-87307-9
PY 2010
BP 45
EP +
DI 10.1201/9780203859476.ch6
PG 2
WC Engineering, Manufacturing
SC Engineering
GA BOD33
UT WOS:000276283000006
DA 2018-10-20
ER

PT B
AU Okazaki, M
AF Okazaki, Masayuki
BE Sasano, T
   Suzuki, O
TI Interface affinity between apatites and biological tissues
SO INTERFACE ORAL HEALTH SCIENCE 2009
LA English
DT Proceedings Paper
CT 3rd International Symposium for Interface Oral Health Science
CY JAN 15-16, 2009
CL Sendai, JAPAN
DE interface affinity; apatites; biological tissues; BMP; angiogenesis
ID PEPTIDE SVVYGLR; BONE-FORMATION; OSTEOPONTIN; CARBONATE; ADHESION;
   SCAFFOLDS; MATRIX
AB To develop a new biodegradable scaffold biomaterial, synthesized CO(3)Ap was mixed with neutralized collagen gel and lyophilized into sponges. X-ray diffraction and FT-IR analyses, together with chemical analysis, indicated that synthesized CO(3)Ap had crystallinity and a chemical composition similar to bone. SEM observation showed that the CO(3)Ap-collagen sponge had a suitable pore size for cell invasion. When these sponge-frame complexes with rh-BMP2 were implanted beneath the periosteum cranii of rats, sufficient new bone was created at the surface of the periosteum cranii after 4 weeks' implantation. Furthermore, when a CO(3)Ap-collagen sponge containing the SVVYGLR peptide was implanted into a tissue defect created in a rat tibia, the migration of numerous vascular endothelial cells, as well as prominent angiogenesis inside the graft, could be detected after 1 week. These CO(3)Ap-collagen sponges with highly functional modifications are expected to be used as hard-tissue scaffold biomaterials for the therapeutic purpose of rapid healing.
C1 Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Hiroshima 7348553, Japan.
RP Okazaki, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biomat Sci, Hiroshima 7348553, Japan.
EM okazakix@hiroshima-u.ac.jp
CR Alberts B, 1994, MOL BIOL CELL, P949
   Fuse Y, 2007, DENT MATER J, V26, P814, DOI 10.4012/dmj.26.814
   Hamada Y, 2004, DENT MATER J, V23, P650, DOI 10.4012/dmj.23.650
   Hamada Y, 2003, BIOCHEM BIOPH RES CO, V310, P153, DOI 10.1016/j.bbrc.2003.09.001
   Hamada Y, 2007, DENT MATER J, V26, P487, DOI 10.4012/dmj.26.487
   Hirata I, 2007, J ARTIF ORGANS, V10, P212, DOI 10.1007/s10047-007-0391-2
   LANGE TS, 1994, EXP CELL RES, V214, P381, DOI 10.1006/excr.1994.1271
   LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409
   Matsuura A, 2009, DENT MATER J, V28, P234, DOI 10.4012/dmj.28.234
   OKAZAKI M, 1981, CARIES RES, V15, P477, DOI 10.1159/000260555
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328
   Yokota R, 2006, DENT MATER J, V25, P597, DOI 10.4012/dmj.25.597
NR 17
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 978-4-431-99643-9
PY 2010
BP 76
EP 82
DI 10.1007/978-4-431-99644-6_11
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BTU47
UT WOS:000288113500011
DA 2018-10-20
ER

PT B
AU Takahashi, M
   Nakajo, K
   Takahashi, N
   Sasaki, K
   Okuno, O
AF Takahashi, Masatoshi
   Nakajo, Kazuko
   Takahashi, Nobuhiro
   Sasaki, Keiichi
   Okuno, Osamu
BE Sasano, T
   Suzuki, O
TI Experimental Ti-Ag alloys inhibit biofilm formation
SO INTERFACE ORAL HEALTH SCIENCE 2009
LA English
DT Proceedings Paper
CT 3rd International Symposium for Interface Oral Health Science
CY JAN 15-16, 2009
CL Sendai, JAPAN
DE Ti-Ag alloy; dental alloy; biofilm; biomaterial
AB We prepared experimental Ti-Ag alloys and investigated their properties. The strength and hardness of the Ti-Ag alloys increased with the concentration of Ag. Moreover, the alloys exhibited sufficient elongation, making them suitable for dental applications. The machinability of the Ti-Ag alloys was superior to that of pure titanium. By canying out the anode polarization test and immersion test, we found that the corrosion resistance of the Ti-Ag alloys was comparable to that of pure titanium. Further, we performed a biofilm formation test and found that the amount of biofilm formed on the experimental Ti-Ag alloys was less than that on pure titanium, pure silver, and a dental alloy. It was concluded that the experimental Ti-Ag alloys are new types of biomaterials that have an inhibitory effect on biofilm formation as well as excellent mechanical properties and outstanding machinability.
C1 [Takahashi, Masatoshi; Okuno, Osamu] Tohoku Univ, Div Dent Biomat, Grad Sch Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
   [Nakajo, Kazuko; Takahashi, Nobuhiro] Tohoku Univ, Div Oral Ecol & Biochem, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Sasaki, Keiichi] Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan.
RP Takahashi, M (reprint author), Tohoku Univ, Div Dent Biomat, Grad Sch Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM m-tak@mail.tains.tohoku.ac.jp
CR TAKAHASHI M, 2007, INTERFACE ORAL HLTH, P311
   TAKAHASHI M, 2005, INTERFACE ORAL HLTH, P326
   Takahashi M, 2006, DENT MATER J, V25, P516, DOI 10.4012/dmj.25.516
NR 3
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 978-4-431-99643-9
PY 2010
BP 283
EP +
DI 10.1007/978-4-431-99644-6_80
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BTU47
UT WOS:000288113500080
DA 2018-10-20
ER

PT B
AU Akatsuka, R
   Zahmaty, MSS
   Noji, M
   Anada, T
   Kuriyagawa, T
   Suzuki, O
   Sasaki, K
AF Akatsuka, Ryo
   Zahmaty, Mohamamd Saeed Sepasy
   Noji, Miyoko
   Anada, Takahisa
   Kuriyagawa, Tsunemoto
   Suzuki, Osamu
   Sasaki, Keiichi
BE Sasano, T
   Suzuki, O
TI Formation of hydroxyapatite film on tooth using powder-jet-deposition
SO INTERFACE ORAL HEALTH SCIENCE 2009
LA English
DT Proceedings Paper
CT 3rd International Symposium for Interface Oral Health Science
CY JAN 15-16, 2009
CL Sendai, JAPAN
DE tooth-biomaterial interface; hydroxyapatite; powder-jet-deposition;
   bonding strength; ultrafine particle
AB Using a powder-jet-deposition process, a thick hydroxyapatite (HAp) film can be created on a human tooth surface. Two different types of HAp particles, calcinated at 1,200 and 1,300 degrees C, were used. The HAp particle was mixed with nitrogen as the carrier gas to form an aerosol flow and then accelerated and blasted from the nozzle onto the enamel substrate at room temperature and atmospheric pressure. HAp particles in the deposited film were tightly packed. There was no gap between the HAp film and the enamel substrate. The bonding strength of the HAp film is almost the same as the composite resin on the enamel.
C1 [Akatsuka, Ryo; Noji, Miyoko; Sasaki, Keiichi] Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
   [Anada, Takahisa; Suzuki, Osamu] Tohoku Univ, Div Craniofacial Funct Engn, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Kuriyagawa, Tsunemoto] Tohoku Univ, Dept Nanomech, Grad Sch Dent, Sendai, Miyagi 9808579, Japan.
   [Zahmaty, Mohamamd Saeed Sepasy] Univ Tehran, Dept Mech Engn, Tehran 113654563, Iran.
RP Akatsuka, R (reprint author), Tohoku Univ, Div Adv Prosthet Dent, Grad Sch Dent, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM akatsuka@mail.tains.tohoku.ac.jp
CR Noji Miyoko, 2009, International Journal of Abrasive Technology, V2, P83, DOI 10.1504/IJAT.2009.021640
NR 1
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 978-4-431-99643-9
PY 2010
BP 302
EP +
DI 10.1007/978-4-431-99644-6_87
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BTU47
UT WOS:000288113500087
DA 2018-10-20
ER

PT B
AU Shimizu, Y
   Yamamoto, A
   Mukai, T
   Shirai, Y
   Kano, M
   Kudo, T
   Kanetaka, H
   Kikuchi, M
AF Shimizu, Yoshinaka
   Yamamoto, Akiko
   Mukai, Toshiji
   Shirai, Yoko
   Kano, Mitsuhiro
   Kudo, Tadaaki
   Kanetaka, Hiroyasu
   Kikuchi, Masayoshi
BE Sasano, T
   Suzuki, O
TI Medical application of magnesium and its alloys as degradable
   biomaterials
SO INTERFACE ORAL HEALTH SCIENCE 2009
LA English
DT Proceedings Paper
CT 3rd International Symposium for Interface Oral Health Science
CY JAN 15-16, 2009
CL Sendai, JAPAN
DE magnesium alloy; biodegradation; biocompatibility; medical application
ID CORROSION
AB The development of a degrading biomaterial is highly desired for use in new treatment modalities. In the search for degradable materials, a new category of biomaterials made from corroding metals was noticed. Magnesium and its alloys are biodegradable metals and exhibit improved mechanical properties and corrosion resistance compared to pure magnesium and industrial magnesium alloys. Previous research has demonstrated that magnesium alloys have acceptable biocompatibility as new biodegradable biomaterials.
C1 [Shimizu, Yoshinaka; Kano, Mitsuhiro; Kikuchi, Masayoshi] Tohoku Univ, Grad Sch Dent, Div Oral & Maxillofacial Anat, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
   [Yamamoto, Akiko; Shirai, Yoko] Natl Inst Mat Sci, Biomat Ctr, Oho, Ibaraki 305, Japan.
   [Mukai, Toshiji] Natl Inst Mat Sci, Struct Metals Ctr, Oho, Ibaraki 305, Japan.
   [Kudo, Tadaaki] Tohoku Univ, Grad Sch Dentistry, Div Oral Physiol, Aoba Ku, Sendai, Miyagi 980, Japan.
   [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Biomed Engn, Dept Phys Med & Rehabilitat, Aoba Ku, Sendai, Miyagi 980, Japan.
   [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Dentistry, Div Adv Prosthet Dentistry, Aoba Ku, Sendai, Miyagi 980, Japan.
RP Shimizu, Y (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral & Maxillofacial Anat, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM shimizu@anat.dent.tohoku.ac.jp
RI Mukai, Toshiji/F-9570-2014; Kobe Univ, Engineering/D-2028-2017
OI Mukai, Toshiji/0000-0002-9628-5762; 
CR Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Maeng M, 2009, HEART, V95, P241, DOI 10.1136/hrt.2007.139261
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
NR 4
TC 1
Z9 1
U1 1
U2 7
PU SPRINGER-VERLAG TOKYO
PI TOKYO
PA 37-3, HONGO 3-CHOME BONKYO-KU, TOKYO, 113, JAPAN
BN 978-4-431-99643-9
PY 2010
BP 318
EP +
DI 10.1007/978-4-431-99644-6_93
PG 2
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA BTU47
UT WOS:000288113500093
DA 2018-10-20
ER

PT B
AU Lisal, J
   Petrtyl, M
   Danesova, J
AF Lisal, Jaroslav
   Petrtyl, Miroslav
   Danesova, Jana
BE Capek, L
TI The First Residual Strain Provides the Initial Presupplementation of
   Articular Plateaus with Synovial Fluid
SO INTERNATIONAL CONFERENCE OF THE CZECH SOCIETY OF BIOMECHANICS - HUMAN
   BIOMECHANICS 2010
LA English
DT Proceedings Paper
CT International Conference of the Czech-Society-of-Biomechanics on Human
   Biomechanics 2010
CY OCT 04-06, 2010
CL Sychrov, CZECH REPUBLIC
SP Czech Soc Biomech
DE Biomechanics; articular cartilage; viscohyperelatic model; synovial
   fluid
ID CARTILAGE; COMPRESSION; MODEL
AB Articular cartilage is a viscohyperelastic composite biomaterial. The peripheral zone of articular cartilage has two fundamental biomechanical safety functions, i. e. to regulate the lubrication of articular surfaces and to protect the chondrocytes and extracellular matrix from high loading. The viscoelastic properties of the peripheral zone of articular cartilage and its molecular structure ensure the regulation of the transport and accumulation of synovial fluid between articular plateaus. During long-term harmonic cyclic loading and unloading, the deformations stabilize at limit values. The hydrodynamic biomechanism quickly presupplements the surface localities with lubrication material. The articular cartilage tissue attempts to retain the lubrication material between the articular plateaus of synovial joints as long as possible during cyclic loading.
C1 [Lisal, Jaroslav; Petrtyl, Miroslav] Czech Tech Univ, Fac Civil Engn, Dept Mech, Lab Biomech & Biomat, Thakurova 7, Prague 16629 6, Czech Republic.
   [Danesova, Jana] Czech Tech Univ, Fac Civil Engn, Dept Math, Prague, Czech Republic.
RP Lisal, J (reprint author), Czech Tech Univ, Fac Civil Engn, Dept Mech, Lab Biomech & Biomat, Thakurova 7, Prague 16629 6, Czech Republic.
EM jaroslav.lisal@fsv.cvut.cz
FU MSM - VZ [6840770012]
FX The contents presented in this paper were partially supported by the
   Research Grant from MSM - VZ No.: 6840770012
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   ARMSTRONG CG, 1984, J BIOMECH ENG-T ASME, V106, P165, DOI 10.1115/1.3138475
   Ateshian GA, 2004, J BIOMECH, V37, P391, DOI 10.1016/S0021-9290(03)00252-5
   Benninghof A, 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   BJELLE A., 1977, CONNECTIVE TISSUE RE, V3, P141
   COHEN B., 1992, ASME ADV BIOENGNG, V22, P187
   Cohen B., 1993, T ORTHOP RES SOC, V18, P185
   Garcia JJ, 2006, J BIOMECH, V39, P2991, DOI 10.1016/j.jbiomech.2005.10.017
   JURVELIN J, 1990, J BIOMECH, V23, P1239, DOI 10.1016/0021-9290(90)90381-C
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   Li LP, 1999, CLIN BIOMECH, V14, P673, DOI 10.1016/S0268-0033(99)00013-3
   PETRTYL M., 2008, LOCOMOTOR SYSTEMS AD, V15, P173
   Wilson W, 2005, J BIOMECH, V38, P2138, DOI 10.1016/j.jbiomech.2005.04.024
   Wilson W, 2004, J BIOMECH, V37, P357, DOI 10.1016/S0021-9290(03)00267-7
NR 14
TC 0
Z9 0
U1 0
U2 2
PU TECHNICAL UNIVERSITY LIBEREC
PI LIBEREC
PA STUDENTSKA 2, LIBEREC, 00000, CZECH REPUBLIC
BN 978-80-7372-648-5
PY 2010
BP 173
EP 177
PG 5
WC Biophysics
SC Biophysics
GA BH0GU
UT WOS:000394924500030
DA 2018-10-20
ER

PT B
AU Rolin, G
   Placet, V
   Jacquet, E
   Tauzin, H
   Robin, S
   Pazart, L
   Saas, P
   Viennet, C
   Muret, P
   Binda, D
   Humbert, P
AF Rolin, Gwenael
   Placet, Vincent
   Jacquet, Emmanuelle
   Tauzin, Helene
   Robin, Sophie
   Pazart, Lionel
   Saas, Philippe
   Viennet, Celine
   Muret, Patrice
   Binda, Delphine
   Humbert, Philippe
BE Capek, L
TI Development of a Human Skin Equivalent with Original Mechanical
   Properties
SO INTERNATIONAL CONFERENCE OF THE CZECH SOCIETY OF BIOMECHANICS - HUMAN
   BIOMECHANICS 2010
LA English
DT Proceedings Paper
CT International Conference of the Czech-Society-of-Biomechanics on Human
   Biomechanics 2010
CY OCT 04-06, 2010
CL Sychrov, CZECH REPUBLIC
SP Czech Soc Biomech
DE Biomaterial; cutaneous engineering; skin equivalent; mechanical tension;
   myofibroblasts; keratinocytes
ID COLLAGEN LATTICES; FIBROBLASTS; TENSION; MMP-2
AB Different models of reconstructed skin are available but none of them takes into account mechanical properties of human skin. We attempted to construct a dermoepidermal equivalent maintained under tension on a biomaterial. It consists in 3D mesh, selected among others according to its biocompatibility, bioadhesion properties and mechanical characteristics close to skin in vivo. A dermal equivalenr(Collagen and dermal fibroblasts) is first reconstructed on ring of the biomaterial which inhibits its retraction, allowing the differentiation of fibroblasts into myofibroblasts expressing alpha-sm actin. The construct is further epidermized with human keratinocytes. The epithelial cells monolayer is placed at the air/liquid interface to allow epidermis differentiation. The immunohistochemical study reveals the presence of a differentiated epidermis similar to skin in vivo. To conclude, we report here the construction of a skin substitute maintained under tension, including functionalized cells: myofibroblasts. This original model may be attractive for in vitro experiments and for clinical treatments.
C1 [Rolin, Gwenael; Tauzin, Helene; Saas, Philippe; Viennet, Celine; Muret, Patrice; Humbert, Philippe] Univ Franche Comte, INSERM, UMR 645, Engn & Cutaneous Biol Team, Besancon, France.
   [Placet, Vincent; Jacquet, Emmanuelle] Univ Franche Comte, CNRS, UMR 6174, Dept Appl Mech,Femto St Inst, Besancon, France.
   [Robin, Sophie] Bioexigence, Besancon, France.
   [Pazart, Lionel; Binda, Delphine] Univ Hosp, Clin Invest Ctr, CIC BT 506, Besancon, France.
   [Pazart, Lionel; Binda, Delphine] Univ Hosp, CIC IT 808, Besancon, France.
RP Humbert, P (reprint author), CHU St Jacques, Dept Dermatol, 2 Pl St Jacques, F-25030 Besancon, France.
EM philippe.humbert@univ-fcomte.fr
FU Transplantation Foundation; OSEO; Regional Council of the Franche-Comte
   Region
FX This work was supported by the Transplantation Foundation, by OSEO and
   the Regional Council of the Franche-Comte Region. We are also very
   grateful to Mr Piranda from Statice Saut to have supplied us with
   biomaterial.
CR [Anonymous], 2004, MEASURING SKIN
   Balestrini JL, 2006, J BIOMECH, V39, P2983, DOI 10.1016/j.jbiomech.2005.10.025
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   Cook H, 2000, J INVEST DERMATOL, V115, P225, DOI 10.1046/j.1523-1747.2000.00044.x
   Jacquet E, 2008, SKIN RES TECHNOL, V14, P1, DOI 10.1111/j.1600-0846.2007.00259.x
   Junker JPE, 2008, BURNS, V34, P942, DOI 10.1016/j.burns.2008.01.010
   Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Parsons M, 1999, EXP CELL RES, V252, P319, DOI 10.1006/excr.1999.4618
   Raffetto JD, 2009, THROMB RES, V123, pS66, DOI 10.1016/S0049-3848(09)70147-1
   WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590
NR 12
TC 0
Z9 0
U1 1
U2 1
PU TECHNICAL UNIVERSITY LIBEREC
PI LIBEREC
PA STUDENTSKA 2, LIBEREC, 00000, CZECH REPUBLIC
BN 978-80-7372-648-5
PY 2010
BP 279
EP 285
PG 7
WC Biophysics
SC Biophysics
GA BH0GU
UT WOS:000394924500050
DA 2018-10-20
ER

PT S
AU Krishnamoorthy, G
   Stephen, P
   Prabhu, M
   Sehgal, PK
   Sadulla, S
AF Krishnamoorthy, G.
   Stephen, P.
   Prabhu, M.
   Sehgal, P. K.
   Sadulla, S.
BE Giri, PK
   Goswami, DK
   Perumal, A
   Chattopadhyay, A
TI Collagen Coated Nanoliposome as a Targeted and Controlled Drug Delivery
   System
SO INTERNATIONAL CONFERENCE ON ADVANCED NANOMATERIALS AND NANOTECHNOLOGY
   (ICANN 2009)
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 1st International Conference on Advanced Nanomaterials and
   Nanotechnology
CY DEC 09-11, 2009
CL Guwahati, INDIA
SP Govt India, Dept Biotechnol, Govt India, Dept Sci & Technol, Govt India, Min Dev NE Region, Govt India, Dept Informat Technol, Govt India, Board Res Nucl Sci, Defence Res & Dev Org, Carl Zeiss India Pvt, Laser Spectra Serv Pvt Ltd, Omicron Nanotechnol GmbH
DE Collagen; Liposome; Nanoliposome; Collagen coated nanoliposome; Drug
   delivery system
ID I COLLAGEN; BIOMEDICAL APPLICATIONS; LIPOSOMES; BIOMATERIAL; PROTEIN
AB The collagen coated nanoliposome (CCNL) have been prepared and characterized in order to develop a targeted and controlled drug delivery system. The zeta potential (ZP) measurement, Fourier transform infrared (FT-IR) spectral and Scanning Electron Microscopy (SEM) and Cell viability assay data showed that the collagen coated nanoliposome particle size and charges, structural interaction and surface morphology and high bio-cyto-compatibility of collagen coated nanoliposome. The particle sizes of nanoliposome (NL) and collagen coated nanoliposome are 20-300 nm and 0.1-10 mu m respectively. The introduction of triple helical, coiled coil and fibrous protein of collagen into nanoliposome can improves the stability of nanoliposome, resistant to phospholipase activities and decreasing the phagocytosis of liposomes by reticuloendothelial system. The collagen coated nanoliposome is expected to be used as for targeted and controlled drug delivery system, and tissue engineering application.
C1 [Krishnamoorthy, G.; Stephen, P.; Prabhu, M.; Sehgal, P. K.; Sadulla, S.] CSIR, Cent Leather Res Inst, Bioprod Lab, Madras 20, Tamil Nadu, India.
RP Krishnamoorthy, G (reprint author), CSIR, Cent Leather Res Inst, Bioprod Lab, Madras 20, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
RI Ganesan, Krishnamoorthy/A-1783-2012
CR DELPOZO AM, 1989, MATRIX, V9, P405, DOI 10.1016/S0934-8832(89)80046-0
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Ghannam MM, 1999, BIOPHYS CHEM, V80, P31, DOI 10.1016/S0301-4622(99)00058-7
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023
   Longman SA, 1995, J PHARMACOL EXP THER, V275, P1177
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Mozafari MR, 2007, PHARMAZIE, V62, P205, DOI 10.1691/ph.2007.3.6045
   PAJEAN M, 1991, INT J PHARM, V77, P31, DOI 10.1016/0378-5173(91)90298-3
   PAJEAN M, 1993, INT J PHARM, V91, P209, DOI 10.1016/0378-5173(93)90340-L
   Tabandeh H., 2003, IRAN J PHARM RES, V2, P161
   WEINER AL, 1985, J PHARM SCI, V74, P922, DOI 10.1002/jps.2600740903
   Zeugolis DI, 2008, J APPL POLYM SCI, V108, P2886, DOI 10.1002/app.27208
NR 15
TC 1
Z9 1
U1 0
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0825-8
J9 AIP CONF PROC
PY 2010
VL 1276
BP 163
EP 168
DI 10.1063/1.3504292
PG 6
WC Nanoscience & Nanotechnology; Physics, Applied
SC Science & Technology - Other Topics; Physics
GA BTF89
UT WOS:000286860800028
DA 2018-10-20
ER

PT J
AU Rauf, K
   Wickramasinghe, C
AF Rauf, Kani
   Wickramasinghe, Chandra
TI Evidence for biodegradation products in the interstellar medium
SO INTERNATIONAL JOURNAL OF ASTROBIOLOGY
LA English
DT Article
DE degradation products of biomateria; interstellar dust; panspermia;
   polycyclic aromatic hydrocarbon; interstellar molecules
ID GRAPHITE PARTICLES; GRAINS; EXTINCTION; EMISSION; SPACE; DUST
AB The interstellar absorption band centred on 2175 angstrom that is conventionally attributed to monodisperse graphite spheres of radii 0.02 mu m is more plausibly explained as arising from biologically derived aromatic molecules. On the basis of panspermia models, interstellar dust includes a substantial fraction of biomaterial in various stages of degradation. We have modeled such an ensemble of degraded biomaterial with laboratory spectroscopy of algae, grass pigments, bituminous coal and anthracite. The average ulrtraviolet absorption profile for these materials is centred at 2175 angstrom with a full width at half maximum of 250 angstrom, in precise agreement with the interstellar extinction observations. Mid-infrared spectra also display general concordance with the unidentified interstellar absorption features found in a wide variety of astronomoical sources.
C1 [Rauf, Kani; Wickramasinghe, Chandra] Cardiff Univ, Cardiff Ctr Astrobiol, Cardiff CF10 3DY, S Glam, Wales.
RP Rauf, K (reprint author), Cardiff Univ, Cardiff Ctr Astrobiol, 2 North Rd, Cardiff CF10 3DY, S Glam, Wales.
EM Wickramasinghe@cf.ac.uk
CR BOULANGER F, 1994, ASTRON ASTROPHYS, V284, P956
   Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840
   HOYLE F, 1989, ESA SP PUBL, V290, P67
   HOYLE F, 1977, NATURE, V270, P323, DOI 10.1038/270323a0
   HOYLE F, 1969, NATURE, V223, P459, DOI 10.1038/223459a0
   HOYLE F, 1962, MON NOT R ASTRON SOC, V124, P417, DOI 10.1093/mnras/124.5.417
   HOYLE F, 1999, ASTRONOMICAL ORIGINS
   MATHIS JS, 1990, ANNU REV ASTRON ASTR, V28, P37, DOI 10.1146/annurev.aa.28.090190.000345
   SAPAR A, 1978, PUBL TARTU ASTROPHYS, V46, P71
   SCHLEMMAR S, 1994, SCIENCE, V265, P1685
   Smith JDT, 2007, ASTROPHYS J, V656, P770, DOI 10.1086/510549
   STECHER TP, 1965, ASTROPHYS J, V142, P1683, DOI 10.1086/148462
   WICKRAMASINGHE JT, 2009, COMETS ORIGIN LIFE
   Wickramasinghe N. C., 1967, INTERSTELLAR GRAINS
   WICKRAMASINGHE NC, 1992, ASTROPHYS SPACE SCI, V196, P167, DOI 10.1007/BF00645249
   WICKRAMASINGHE NC, 1989, ASTROPHYS SPACE SCI, V158, P135, DOI 10.1007/BF00637448
   Witt AN, 2006, ASTROPHYS J, V636, P303, DOI 10.1086/498052
NR 17
TC 4
Z9 4
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1473-5504
J9 INT J ASTROBIOL
JI Int. J. Astrobiol.
PD JAN
PY 2010
VL 9
IS 1
BP 29
EP 34
DI 10.1017/S1473550409990334
PG 6
WC Astronomy & Astrophysics; Biology; Geosciences, Multidisciplinary
SC Astronomy & Astrophysics; Life Sciences & Biomedicine - Other Topics;
   Geology
GA 541DV
UT WOS:000273394700003
DA 2018-10-20
ER

PT J
AU Miranda, M
   Fernandez, A
   Diaz, M
   Esteban-Tejeda, L
   Lopez-Esteban, S
   Malpartida, F
   Torrecillas, R
   Moya, JS
AF Miranda, Miriam
   Fernandez, Adolfo
   Diaz, Marcos
   Esteban-Tejeda, Leticia
   Lopez-Esteban, Sonia
   Malpartida, Francisco
   Torrecillas, Ramon
   Serafin Moya, Jose
TI Silver-hydroxyapatite nanocomposites as bactericidal and fungicidal
   materials
SO INTERNATIONAL JOURNAL OF MATERIALS RESEARCH
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Interfaces - New Materials Via Interfacial
   Control
CY JUN 22-26, 2008
CL Santiago de Compostela, SPAIN
DE Hydroxyapatite; Silver; Nanocomposite; Antibacterial; Antifungal
ID ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; BONE-CEMENT; NANOPARTICLES;
   IONS
AB Silver-hydroxyapatite nanocomposites containing 1 wt.% of metallic silver have been obtained by a colloidal chemical route and subsequent chemical reduction process. The silver nanoparticles are supported on the hydroxyapatite surface without a high degree of agglomeration. The bactericidal effect against common Gram-positive and Gram-negative bacteria, as well as antifungal activity against yeast have been investigated. The results indicated a high antimicrobial activity for E. coli, M. Luteus and I. Orientalis, so this material can be a promising antimicrobial biomaterial for implant and reconstructive surgery, among other applications.
C1 [Miranda, Miriam; Fernandez, Adolfo; Lopez-Esteban, Sonia; Torrecillas, Ramon] CSIC, CINN, Oviedo, Spain.
   [Diaz, Marcos; Esteban-Tejeda, Leticia; Serafin Moya, Jose] CSIC, ICMM, Madrid, Spain.
   [Malpartida, Francisco] CSIC, Ctr Nacl Biotecnol, Madrid, Spain.
RP Torrecillas, R (reprint author), CT Mat Met, Ctr Invest Nanmat & Nanotecnol, Parque Tecnol Asturias, Llanera 33428, Asturias, Spain.
EM r.torrecillas@cinn.es
RI Moya, Jose/I-5841-2013; Fernandez, Adolfo/H-7978-2017; Torrecillas,
   Ramon/G-7851-2011; Diaz, Marcos/G-5925-2014
OI Fernandez, Adolfo/0000-0002-8742-4572; Torrecillas,
   Ramon/0000-0003-3856-0217; Diaz, Marcos/0000-0001-7751-4913
CR Arumugam SK, 2007, J BIOMED MATER RES A, V80A, P391, DOI 10.1002/jbm.a.30895
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   CHEN W, 2007, J BIOMED MATER RES A, V84, P899
   Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505
   Esteban-Cubillo A, 2006, J EUR CERAM SOC, V26, P1, DOI 10.1016/j.jeurceramsoc.2004.10.029
   Esteban-Cubillo A, 2006, J MATER SCI, V41, P5208, DOI 10.1007/s10853-006-0432-x
   Esteban-Tejeda L, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085103
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   GERHART TN, 1993, J ORTHOPAED RES, V11, P250, DOI 10.1002/jor.1100110212
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   Leach W J, 1992, J R Coll Surg Edinb, V37, P265
   Li YB, 2009, J MATER SCI, V44, P1258, DOI 10.1007/s10853-008-3239-0
   Mo AC, 2008, APPL SURF SCI, V255, P435, DOI 10.1016/j.apsusc.2008.06.083
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   NASSER S, 1992, ORTHOP CLIN N AM, V23, P265
   ORLOVSKII VP, 2002, INORGANICA MAT, V8, P1159
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   PATZAKIS MJ, 1994, CONT ORTHOP, V28, P157
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Song H. Y., 2006, EUR CELLS MATER, V11, P58
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Thomas S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075710
   Zhang WZ, 2007, COLLOID SURFACE A, V299, P22, DOI 10.1016/j.colsurfa.2006.11.012
NR 28
TC 16
Z9 16
U1 3
U2 13
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 1862-5282
J9 INT J MATER RES
JI Int. J. Mater. Res.
PD JAN
PY 2010
VL 101
IS 1
BP 122
EP 127
DI 10.3139/146.110256
PG 6
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 555PH
UT WOS:000274524600018
DA 2018-10-20
ER

PT J
AU Marques, JM
   Viegas, C
   Dias, MI
   Zagalo, C
   Gomes, P
   Fernandes, MH
   Santos, JD
   Cabrita, SC
AF Marques, J. M.
   Viegas, C.
   Dias, M., I
   Zagalo, C.
   Gomes, P.
   Fernandes, M. H.
   Santos, J. D.
   Cabrita, S. C.
TI Modified Model of Sub-Critical Size Cranial Defect in the Rabbit
SO INTERNATIONAL JOURNAL OF MORPHOLOGY
LA English
DT Article
DE Rabbit; Cranial vault; Trephine defect
ID BONE-GRAFT; OSSEOINTEGRATION
AB In medical sciences, any experimental animal model should be reproducible and adequate to the purpose of simulated human physiological response. In bone injury response research, when bone substitutes are in use, it is of primary importance that studied defects fail to heal unless treated with the tissue engineering therapy under study. This failure defines the concept of "critical size defect" (CSD) wich has different limits according to the animal species used and the location of the defect. Although this is a basic concept, when the aim of the study is to investigate the interface Bone-Biomaterial, it is of primary importance to obtain as much contact area as possible. In order to do so, we propose a modified surgical approach to the classical bi-parietal round sub-critical defect model in rabbit vault.
C1 [Viegas, C.; Dias, M., I] Univ Tras Os Montes & Alto Douro, Dept Vet Sci, 3BS Res Grp, P-5001801 Vila Real, Portugal.
EM silva.marques2006@gmail.com
RI Gomes, Pedro/K-2433-2014; Fernandes, Maria Helena/K-6917-2014; Dias,
   Isabel/B-8230-2013; Viegas, Carlos/D-2207-2014
OI Gomes, Pedro/0000-0001-5365-2123; Dias, Isabel/0000-0001-5049-4473;
   Viegas, Carlos/0000-0002-8796-5037; Fernandes, Maria
   Helena/0000-0001-9391-9574; Santos, Jose Domingos/0000-0002-6871-9850;
   Ribeiro, Carlos/0000-0001-7000-1496
CR Al Ruhaimi KA, 2001, INT J ORAL MAX IMPL, V16, P105
   Alam S, 2007, ORAL SURG ORAL MED O, V103, P16, DOI 10.1016/j.tripleo.2006.01.019
   Albee FH, 1923, J AMER MED ASSOC, V81, P1429, DOI 10.1001/jama.1923.02650170027009
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   Bayne Stephen C, 2005, J Dent Educ, V69, P571
   Hernandez-Alfaro F, 2005, INT J ORAL MAX IMPL, V20, P777
   Hofmann H, 1984, Zahn Mund Kieferheilkd Zentralbl, V72, P531
   HOLLAND AJC, 1973, CAN ANAESTH SOC J, V20, P693, DOI 10.1007/BF03026267
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Hollinger JO, 1999, ANN NY ACAD SCI, V875, P379, DOI 10.1111/j.1749-6632.1999.tb08520.x
   Hollister S J, 2005, Orthod Craniofac Res, V8, P162, DOI 10.1111/j.1601-6343.2005.00329.x
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   RAZAK NHA, 2004, MED J MALAYSIA, V59, P119
NR 14
TC 0
Z9 1
U1 0
U2 5
PU SOC CHILENA ANATOMIA
PI TEMUCO
PA CASILLA 54-D, TEMUCO, 00000, CHILE
SN 0717-9502
J9 INT J MORPHOL
JI Int. J. Morphol.
PY 2010
VL 28
IS 2
BP 525
EP 528
PG 4
WC Anatomy & Morphology
SC Anatomy & Morphology
GA 644KA
UT WOS:000281373600031
OA Bronze, Other Gold
DA 2018-10-20
ER

PT J
AU Liao, JA
   Zhu, ZM
   Mo, AC
   Li, L
   Zhang, JC
AF Liao Juan
   Zhu Zhimin
   Mo Anchun
   Li Lei
   Zhang Jingchao
TI Deposition of silver nanoparticles on titanium surface for antibacterial
   effect
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nano-silver; titanium; antibacterial activity; silanization method
ID METAL-ENHANCED FLUORESCENCE; INFECTION; ADHERENCE; TISSUE
AB Microbial colonization on implanted devices and biofilm formation is a recurrent complication in implant surgery and may result in loss of implants. The aim of this study was to deposit silver nanoparticles on a titanium surface to obtain antibacterial properties. In the present study, we prepared a silver nanoparticle-modified titanium (Ti-nAg) surface using silanization method. The morphology and chemical components of the Ti-nAg surface were characterized by scanning electron microscopy (SEM) equipped with energy-dispersive spectroscopy (EDS). Two species of bacteria, Staphylococcus aureus and Escherichia coli, were utilized to test the antibacterial effect of the Ti-nAg treated surface. The SEM examination revealed that a small quantity of silver nanoparticles was sparsely deposited on the titanium surface. The diameter of these nanoparticles ranged from ten to several hundred nm. EDS analyses revealed that there was 4.26% of Ag present on the surface. After a 24-hour incubation, 94% of Staphylococcus aureus and over 95% of Escherichia coli had been killed on the Ti-nAg surface, and the SEM examination of anti-adhesive efficacy test showed that there were less bacteria attached to Ti-nAg surface than to a control surface of untreated Titanium. These data suggest that silver nanoparticle-modified titanium is a promising material with an antibacterial property that may be used as an implantable biomaterial.
C1 [Mo Anchun] Sichuan Univ, W China Stomatol Hosp, Dept Dent Implant, Chengdu 610041, Peoples R China.
   [Liao Juan; Mo Anchun; Li Lei; Zhang Jingchao] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
   [Zhu Zhimin] Sichuan Univ, W China Stomatol Hosp, Dept Prosthodont, Chengdu 610041, Peoples R China.
RP Mo, AC (reprint author), Sichuan Univ, W China Coll Stomatol, 17 3rd Sect,Renmin Rd, Chengdu 610041, Peoples R China.
EM moanchun@163.com
CR AHEARN DG, 1995, J IND MICROBIOL, V15, P372, DOI 10.1007/BF01569993
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Arumugam SK, 2007, J BIOMED MATER RES A, V80A, P391, DOI 10.1002/jbm.a.30895
   Aslan K, 2005, J PHYS CHEM B, V109, P6247, DOI 10.1021/jp044235z
   Bacte-Koerner R.J., 2002, BIOMATERIALS, V23, P2835
   CREDE KSF, 1894, VERHUTUNG AUGENENTZU
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Feng QL, 1998, THIN SOLID FILMS, V335, P214, DOI 10.1016/S0040-6090(98)00956-0
   Geddes CD, 2003, J PHYS CHEM A, V107, P3443, DOI 10.1021/jp022040q
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Henglein A, 1999, J PHYS CHEM B, V103, P9533, DOI 10.1021/jp9925334
   Kawahara K, 2000, DENT MATER, V16, P452, DOI 10.1016/S0109-5641(00)00050-6
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Lee HY, 2007, CHEM COMMUN, P2959, DOI 10.1039/b703034g
   Meredith DO, 2005, J BIOMED MATER RES A, V75A, P541, DOI 10.1002/jbm.a.30457
   Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   SAMBHY V, 2006, J AM CHEM SOC, V128, DOI DOI 10.1021/ja061442z
   Schierholz JM, 2004, ORTHOPADE, V33, P397, DOI 10.1007/s00132-004-0643-2
   Song H. Y., 2006, EUR CELLS MATER, V11, P58
   Zheng JY, 2008, APPL SURF SCI, V254, P1630, DOI 10.1016/j.apsusc.2007.07.165
NR 22
TC 90
Z9 95
U1 3
U2 16
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-9114
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2010
VL 5
BP 261
EP 267
PG 7
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 674DW
UT WOS:000283715300026
PM 20463942
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zhang, LJ
   Chun, YW
   Webster, TJ
AF Zhang, Lijuan
   Chun, Young Wook
   Webster, Thomas J.
TI Decreased lung carcinoma cell density on select polymer nanometer
   surface features for lung replacement therapies
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanotechnology; cancer; nanotopography; lung carcinoma
ID MYOBLAST ALIGNMENT; NANOTOPOGRAPHY; MORPHOLOGY; ADHESION;
   DIFFERENTIATION; MOTILITY
AB Poly(lactic-co-glycolic) acid (PLGA) has been widely used as a biomaterial in regenerative medicine because of its biocompatibility and biodegradability properties. Previous studies have shown that cells (such as bladder smooth muscle cells, chondrocytes, and osteoblasts) respond differently to nanostructured PLGA surfaces compared with nanosmooth surfaces. The purpose of the present in vitro research was to prepare PLGA films with various nanometer surface features and determine whether lung cancer epithelial cells respond differently to such topographies. To create nanosurface features on PLGA, different sized (190 nm, 300 nm, 400 nm, and 530 nm diameter) polystyrene beads were used to cast polydimethylsiloxane (PDMS) molds which were used as templates to create nanofeatured PLGA films. Atomic force microscopy (AFM) images and root mean square roughness (RMS) values indicated that the intended spherical surface nanotopographies on PLGA with RMS values of 2.23, 5.03, 5.42, and 36.90 nm were formed by employing 190, 300, 400, and 530 nm beads. A solution evaporation method was also utilized to modify PLGA surface features by using 8 wt% (to obtain an AFM RMS value of 0.62 nm) and 4 wt% (to obtain an AFM RMS value of 2.23 nm) PLGA in chloroform solutions. Most importantly, lung cancer epithelial cells adhered less on the PLGA surfaces with RMS values of 0.62, 2.23, and 5.42 nm after four hours of culture compared with any other PLGA surface created here. After three days, PLGA surfaces with an RMS value of 0.62 nm had much lower cell density than any other sample. In this manner, PLGA with specific nanometer surface features may inhibit lung cancer cell density which may provide an important biomaterial for the treatment of lung cancer (from drug delivery to regenerative medicine).
C1 [Chun, Young Wook; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
   [Zhang, Lijuan] Brown Univ, Dept Chem, Providence, RI 02912 USA.
RP Webster, TJ (reprint author), Brown Univ, Div Engn, 184 Hope St, Providence, RI 02912 USA.
EM thomas_webster@brown.edu
FU Hermann Foundation
FX The authors would like to thank the Hermann Foundation for funding and
   the Northeastern Research Center for AFM use. The authors report no
   conflicts of interest in this work.
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Berry CC, 2005, BIOMATERIALS, V26, P4985, DOI 10.1016/j.biomaterials.2005.01.046
   Carpenter J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/50/505103
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Coletti D, 2007, CYTOM PART A, V71A, P846, DOI 10.1002/cyto.a.20447
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   George PA, 2009, BIOMATERIALS, V30, P2449, DOI 10.1016/j.biomaterials.2009.01.012
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Nomura Shinobu, 2006, J Artif Organs, V9, P90, DOI 10.1007/s10047-006-0329-0
   Turner S, 1997, J VAC SCI TECHNOL B, V15, P2848, DOI 10.1116/1.589742
   Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016
   TZVETKOVACHEVOL.T, BIOMATERIALS, V29, P1541
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   *WHO, 2009, CANC
   Wood MA, 2006, IEEE T NANOBIOSCI, V5, P20, DOI 10.1109/TNB.2005.864015
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 20
TC 11
Z9 11
U1 0
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-9114
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2010
VL 5
BP 269
EP 275
PG 7
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 674DW
UT WOS:000283715300027
PM 20517474
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Liao, J
   Anchun, M
   Zhu, ZM
   Quan, YA
AF Liao, Juan
   Anchun, Mo
   Zhu, Zhimin
   Quan, Yuan
TI Antibacterial titanium plate deposited by silver nanoparticles exhibits
   cell compatibility
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanosilver; titanium; antibacterial activity; cytocompatibility
ID IN-VITRO; FAILING IMPLANTS; CYTOTOXICITY; ATTACHMENT; BONE
AB Microbial colonization and biofilm formation on the surface of implant devices may cause peri-implantitis and lead to bone loss. The aim of this study was to develop a novel antibacterial titanium implant surface and to test its biological performance. In a previous study, we demonstrated that titanium plates deposited by nanosilver acquired antibacterial activity to Staphylococcus aureus and Escherichia coli. While antibacterial activity is important, biomaterial surfaces should be modified to achieve excellent cell compatibility as well. In the present study, using the MTT assay, fluorescence microscopy, and scanning electron microscopy, we assessed cell viability, cytoskeletal architecture and cell attachment, respectively, on our silver nanoparticle-modified titanium (Ti-nAg) plate. The results demonstrate that the Ti-nAg do not show any cytotoxicity to the human gingival fibroblasts. Our data indicate that Ti-nAg is a novel material with both good antibacterial properties and uncompromised-cytocompatibility, which can be used as an implanted biomaterial.
C1 [Zhu, Zhimin] Sichuan Univ, W China Stomatol Hosp, Dept Prosthodont, Chengdu 610041, Peoples R China.
   [Anchun, Mo] Sichuan Univ, W China Stomatol Hosp, Dept Dent Implant, Chengdu 610041, Peoples R China.
   [Liao, Juan; Anchun, Mo; Quan, Yuan] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
RP Zhu, ZM (reprint author), Sichuan Univ, W China Coll Stomatol, 17 3rd Sect,Renmin Rd, Chengdu 610041, Peoples R China.
EM zzhimin@163.com
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Boland T, 2000, HDB BACTERIAL ADHESI, P29
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Darouiche RO, 1999, CLIN INFECT DIS, V29, P1371, DOI 10.1086/313561
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Jeyachandran YL, 2006, SURF COAT TECH, V201, P3462, DOI 10.1016/j.surfcoat.2006.07.236
   Leonhardt A, 1999, CLIN ORAL IMPLAN RES, V10, P339, DOI 10.1034/j.1600-0501.1999.100501.x
   Liao JA, 2010, INT J NANOMED, V5, P261
   Listgarten MA, 1999, J PERIODONTOL, V70, P431, DOI 10.1902/jop.1999.70.4.431
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Pearce D., 1995, MICROBIAL BIOFILMS, P207
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Song H. Y., 2006, EUR CELLS MATER, V11, P58
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
NR 16
TC 38
Z9 42
U1 0
U2 13
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2010
VL 5
BP 337
EP 342
PG 6
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 674DW
UT WOS:000283715300034
PM 20517478
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Biazar, E
   Zeinali, R
   Montazeri, N
   Pourshamsian, K
   Behrouz, MJ
   Asefnejad, A
   Khoshzaban, A
   Shahhosseini, G
   Najafabadi, MS
   Abyani, R
   Jamalzadeh, H
   Fouladi, M
   Hagh, SRF
   Khamaneh, AS
   Kabiri, S
   Keshel, SH
   Mansourkiaei, A
AF Biazar, Esmaeil
   Zeinali, Reza
   Montazeri, Naser
   Pourshamsian, Khalil
   Behrouz, Mahmoud Jabarvand
   Asefnejad, Azadeh
   Khoshzaban, Ahad
   Shahhosseini, Gholamreza
   Najafabadi, Mostafa Soleimannejad
   Abyani, Reza
   Jamalzadeh, Hamidreza
   Fouladi, Mahdi
   Hagh, Sasan Rahbar F.
   Khamaneh, Aylar Shams
   Kabiri, Soudabeh
   Keshel, Saeed Heidari
   Mansourkiaei, Ana
TI Cell engineering: nanometric grafting of poly-N-isopropylacrylamide onto
   polystyrene film by different doses of gamma radiation
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE Nanometric grafting; PNIPAAm; polystyrene film; gamma ray; dose; cell
   engineering
ID POLYETHYLENE SURFACE; ACRYLAMIDE; COPOLYMERIZATION; POLYMERIZATION;
   DISCHARGE; TISSUES
AB Poly-N-isopropylacrylamide was successfully grafted onto a polystyrene cell culture dish and gamma-preirradiated in air. In this study, the effect of a gamma-pre-irradiation dose of radiation (radiation absorbed dosages of 10, 20, 30, 40 KGy) under appropriate temperature and grafting conditions was investigated. The Fourier transform infrared spectroscopy analysis showed the existence of the graft poly-N-isopropylacrylamide (PNIPAAm) on the substrate. The optimal value of the dose for grafting was 40 KGy at 50 degrees C. The scanning electron microscopy and atomic force microscopy (AFM) images clearly showed that increasing the absorbed dose of radiation would increase the amount of grafting. Surface topography and graft thickness in AFM images of the radiated samples showed that the PNIPAAm at the absorbed dose of radiation was properly grafted. The thickness of these grafts was about 50-100 nm. The drop water contact angles of the best grafted sample at 37 degrees C and 10 degrees C were 55.3 +/- 1.2 degrees and 61.2 +/- 0.9 degrees respectively, which showed the hydrophilicity and hydrophobicity of the grafted surfaces. Differential scanning calorimetry analysis also revealed the low critical solution temperature of the grafted sample to be 32 degrees C. Thermoresponsive polymers were grafted to dishes covalently which allowed fibroblast cells to attach and proliferate at 37 degrees C; the cells also detached spontaneously without using enzymes when the temperature dropped below 32 degrees C. This characteristic proves that this type of grafted material has potential as a biomaterial for cell sheet engineering.
C1 [Biazar, Esmaeil; Montazeri, Naser; Pourshamsian, Khalil; Fouladi, Mahdi; Khamaneh, Aylar Shams; Kabiri, Soudabeh] Islamic Azad Univ, Tonekabon Branch, Dept Chem, Mazandaran, Iran.
   [Jamalzadeh, Hamidreza; Mansourkiaei, Ana] Islamic Azad Univ, Tonekabon Branch, Dept Biol, Mazandaran, Iran.
   [Zeinali, Reza; Asefnejad, Azadeh; Abyani, Reza] Islamic Azad Univ, Biomed Engn Fac, Sci & Res Branch, Tehran, Iran.
   [Behrouz, Mahmoud Jabarvand; Khoshzaban, Ahad; Keshel, Saeed Heidari] Univ Tehran Med Sci, Farabi Hosp, Stem Cell Preparat Unit, Tehran, Iran.
   [Shahhosseini, Gholamreza] Nucl Sci & Tech Res Inst, Agr Med & Ind Res Sch, Karaj, Iran.
   [Najafabadi, Mostafa Soleimannejad] Islamic Azad Univ, Najafabad Branch, Mat Engn Fac, Esfahan, Iran.
RP Biazar, E (reprint author), Islamic Azad Univ, Tonekabon Branch, Dept Chem, Mazandaran, Iran.
EM e.biazar@tonekaboniau.ac.ir
RI Heidari keshel, Saeed/M-5936-2016
FU Islamic Azad University, Tonekabon Branch
FX This project was supported by a formal research grant from the Islamic
   Azad University, Tonekabon Branch.
CR Akerman S, 1998, INT J PHARM, V164, P29, DOI 10.1016/S0378-5173(97)00384-0
   Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Curti PS, 2005, APPL SURF SCI, V245, P223, DOI 10.1016/j.apsusc.2004.10.019
   Da Silva RMP, 2007, TRENDS BIOTECHNOL, V25, P577, DOI 10.1016/j.tibtech.2007.08.014
   FUJIMOTO K, 2010, J BIOMED MA IN PRESS
   GALAEV IY, 2003, LANDES BIOSCIENCE
   GIL ES, 2004, PROG POLYM SCI
   Gupta B, 2008, RADIAT PHYS CHEM, V77, P553, DOI 10.1016/j.radphyschem.2007.09.001
   Hou Y, 2008, BIOMATERIALS, V29, P3175, DOI 10.1016/j.biomaterials.2008.04.024
   IWATA H, 1988, J POLYM SCI POL CHEM, V26, P3309, DOI 10.1002/pola.1988.080261216
   Kikuchi A, 2005, J CONTROL RELEASE, V101, P69, DOI 10.1016/j.jconrel.2004.08.026
   Lim YM, 2007, J IND ENG CHEM, V13, P21
   OZYUREK Z, 2007, TAG VERT 05 09 UNPUB
   Palacios O, 2003, POLYM BULL, V51, P191, DOI 10.1007/s00289-003-0213-5
   Park KD, 1996, ASAIO J, V42, pM876, DOI 10.1097/00002480-199609000-00117
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   SUZUKI M, 1983, PHYSICOCHEMICAL ASPE, V2, P923
   UYAMA Y, 1988, J APPL POLYM SCI, V36, P1087, DOI 10.1002/app.1988.070360509
   WANG SL, 2005, RESPONSIVE BIOMATERI
   YAMATO M, 2004, CELL SHEET ENG
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
NR 21
TC 12
Z9 12
U1 0
U2 2
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-9114
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2010
VL 5
BP 549
EP 556
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 674DW
UT WOS:000283715300056
PM 20957116
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Liu, K
   Cao, GQ
   Zhang, XQ
   Liu, RF
   Zou, WW
   Wu, SM
AF Liu, Kai
   Cao, Guangqing
   Zhang, Xiquan
   Liu, Ruifang
   Zou, Weiwei
   Wu, Shuming
TI Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits
   neointimal hyperplasia in a rabbit vein graft model
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE autograft; stenosis; jugular vein; transplants
ID IN-STENT RESTENOSIS; ELUTING STENTS; PLGA NANOPARTICLES; LOCAL-DELIVERY;
   DRUG-DELIVERY; PREVENTION; SIROLIMUS; RELEASE; ARTERY
AB Purpose: Poly lactic-co-glycolic acid nanoparticles (PLGA-NP) are widely used as a biodegradable biomaterial in medicine. Rapamycin-eluting stents have been used for prevention of restenosis during surgery. This study investigated the effect of pretreatment with intraluminal perfusion of carbopol-encapsulated rapamycin-loaded PLGA nanoparticles (RAP-PLGA-NP) on neointimal hyperplasia in a rabbit vein graft model.
   Methods: A segment of common carotid artery was replaced with a segment of external jugular vein in 60 rabbits which were then separated into four treatment groups, ie, Group 1, in which vein grafts were pretreated with intraluminal RAP-PLGA-NP perfusion, Group 2 in which vein grafts underwent equivalent empty vehicle (PLGA-NP) perfusion, Group 3, in which vein grafts received no treatment, and Group 4, which served as a sham operation group receiving normal vein contrast. On postoperative day 28, the grafts and normal veins were harvested for histologic examination, flow cytometry analysis, and high-performance liquid chromatography measurement.
   Results: Compared with Group 1, the intima of the grafts were thickened, the ratio of intimal area to vessel area increased, and the collagen volume index of the vein grafts increased significantly in Groups 2 and 3. The cell proliferation index in Group 1 (21.11 +/- 3.15%) was much lower than that in Group 2 (30.35 +/- 2.69%) and in Group 3 (33.86 +/- 8.72%). By high-performance liquid chromatography measurement, retention of rapamycin was detected in Group 1 (11.2 +/- 0.37 mu g/10 mg) 28 days after single drug perfusion.
   Conclusion: Pretreatment with intraluminal RAP-PLGA-NP perfusion may inhibit neointimal hyperplasia in vein grafts by penetrating into local tissue and limiting cell proliferation.
C1 [Liu, Kai; Cao, Guangqing; Zhang, Xiquan; Wu, Shuming] Shandong Univ, Dept Cardiovasc Surg, Qilu Hosp, Jinan 250012, Shandong, Peoples R China.
   [Liu, Ruifang] Shandong Univ, Dept Anesthesia, Qilu Hosp, Jinan 250012, Shandong, Peoples R China.
   [Zou, Weiwei] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Shandong, Peoples R China.
RP Wu, SM (reprint author), Shandong Univ, Dept Cardiovasc Surg, Qilu Hosp, 107 Wenhua Xilu, Jinan 250012, Shandong, Peoples R China.
EM shumingwumd@126.com
FU Natural Science Foundation of Health Department of Shandong Province in
   China [2008HZ057]
FX This study was supported by Grant Number 2008HZ057 from the Natural
   Science Foundation of Health Department of Shandong Province in China.
CR Bauriedel G, 2008, J VASC RES, V45, P173, DOI 10.1159/000110417
   Cagiannos C, 2005, J VASC SURG, V42, P980, DOI 10.1016/j.jvs.2005.06.018
   Carter AJ, 2004, CARDIOVASC RES, V63, P617, DOI 10.1016/j.cardiores.2004.04.029
   Dong YC, 2005, BIOMATERIALS, V26, P6068, DOI 10.1016/j.biomaterials.2005.03.021
   Feng SS, 2007, NANOMEDICINE-UK, V2, P333, DOI 10.2217/17435889.2.3.333
   Grabovac V, 2005, ADV DRUG DELIVER REV, V57, P1713, DOI 10.1016/j.addr.2005.07.006
   Guzman LA, 1996, CIRCULATION, V94, P1441, DOI 10.1161/01.CIR.94.6.1441
   Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424
   Hu Xin-hua, 2006, Zhonghua Wai Ke Za Zhi, V44, P1053
   Kawatsu S, 2007, ANN THORAC SURG, V84, P560, DOI 10.1016/j.athoracsur.2007.02.034
   Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021
   KOTANI J, 2006, J AM COLL CARDIOL B, V47, pB12
   Marks AR, 2003, NEW ENGL J MED, V349, P1307, DOI 10.1056/NEJMp038141
   Mehilli J, 2008, EUR HEART J, V29, P1975, DOI 10.1093/eurheartj/ehn253
   Miao Li-fu, 2008, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V30, P491
   Rajathurai T, 2010, CIRC-CARDIOVASC INTE, V3, P157, DOI 10.1161/CIRCINTERVENTIONS.109.864660
   Rousou LJ, 2009, ANN THORAC SURG, V87, P62, DOI 10.1016/j.athoracsur.2008.08.049
   Schachner T, 2006, J THORAC CARDIOV SUR, V131, P1065, DOI 10.1016/j.jtcvs.2005.11.043
   Schachner T, 2005, EUR J CARDIO-THORAC, V27, P302, DOI 10.1016/j.ejcts.2004.11.008
   Schachner T, 2004, ANN THORAC SURG, V77, P1580, DOI 10.1016/j.athoracsur.2003.10.008
   Semsroth S, 2009, EUR J CARDIO-THORAC, V35, P515, DOI 10.1016/j.ejcts.2008.11.035
   Shah PJ, 2003, J THORAC CARDIOV SUR, V126, P1972, DOI 10.1016/S0022-5223(03)01276-5
   Shuhaiber JH, 2002, EUR J CARDIO-THORAC, V22, P387, DOI 10.1016/S1010-7940(02)00253-1
   Steffel J, 2008, ANN MED, V40, P242, DOI 10.1080/07853890801964948
   Vandervoort J, 2002, INT J PHARM, V238, P77, DOI 10.1016/S0378-5173(02)00058-3
   Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4
   Walpoth BH, 2005, ANN THORAC SURG, V79, P2201, DOI 10.1016/j.athoracsur.2004.08.040
   Westedt U, 2007, J CONTROL RELEASE, V119, P41, DOI 10.1016/j.jconrel.2007.01.009
   Yang J, 2008, EUR J PHARM SCI, V35, P427, DOI 10.1016/j.ejps.2008.09.003
   Zhang Lu-feng, 2006, Zhonghua Yi Xue Za Zhi, V86, P1706
   Zilla P, 2008, J THORAC CARDIOV SUR, V136, P717, DOI 10.1016/j.jtcvs.2008.02.068
   Zou WW, 2009, DRUG DELIV, V16, P15, DOI 10.1080/10717540802481307
NR 32
TC 5
Z9 5
U1 0
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2010
VL 5
BP 853
EP 860
DI 10.2147/IJN.S13112
PG 8
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 674DW
UT WOS:000283715300087
PM 21042547
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Liu, FJ
   Wang, SY
   Shi, XY
AF Liu, Fujuan
   Wang, Shanyuan
   Shi, Xiangyang
TI Effect of PH Values on Macromolecular Conformational Change
SO INTERNATIONAL JOURNAL OF NONLINEAR SCIENCES AND NUMERICAL SIMULATION
LA English
DT Article
DE Human serum albumin (HSA); Poly(DL-lactide-co-glycolide) (PLGA); pH
ID SFG
AB This paper investigates the conformational change of human serum albumin (HSA) macromolecules at polymer/liquid interface with different pH values using sum frequency generation (SFG) vibrational spectroscopy. SFG studies in situ demonstrate that adsorbed HSA macromolecules exhibit different conformational changes when exposed to different pH values. The results are useful for biomaterial design in the future.
C1 [Liu, Fujuan] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Peoples R China.
   [Liu, Fujuan; Wang, Shanyuan; Shi, Xiangyang] Donghua Univ, Shanghai 200051, Peoples R China.
   [Liu, Fujuan] Beijing Inst Technol, State Key Lab Explos Sci & Technol, Beijing 100081, Peoples R China.
RP Liu, FJ (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Peoples R China.
RI Shi, Xiangyang/A-1289-2007
OI Shi, Xiangyang/0000-0001-6785-6645
FU State Key Laboratory of Explosion Science and Technology, Beijing
   Institute of Technology [SKLEST-KF-09-01 (KFJJ09-01)]
FX The present work is supported by State Key Laboratory of Explosion
   Science and Technology, Beijing Institute of Technology under grant No.
   SKLEST-KF-09-01 (KFJJ09-01).
CR Carbassi F., 1994, POLYM SURFACES PHYS
   Chen XY, 2006, BBA-BIOMEMBRANES, V1758, P1257, DOI 10.1016/j.bbamem.2006.01.017
   Feast W.J, 1987, POLYM SURFACES INTER
   Kim J, 2000, J AM CHEM SOC, V122, P12371, DOI 10.1021/ja003215h
   Nguyen KT, 2009, J PHYS CHEM B, V113, P12358, DOI 10.1021/jp904154w
   PARK JB, 1992, BIOMATERIALS INTRO
   Rosenoer VM, 1977, ALBUMIN STRUCTURE FU
   SHEN YR, 1989, ANNU REV PHYS CHEM, V40, P327, DOI 10.1146/annurev.pc.40.100189.001551
   SHEN YR, 1984, PRINCIPLES NONLINEAR, pCH2
NR 9
TC 0
Z9 0
U1 0
U2 4
PU FREUND PUBLISHING HOUSE LTD
PI TEL AVIV
PA PO BOX 35010, TEL AVIV 61350, ISRAEL
SN 1565-1339
J9 INT J NONLIN SCI NUM
JI Int. J. Nonlinear Sci. Numer. Simul.
PY 2010
VL 11
SU S
BP 325
EP 326
PG 2
WC Engineering, Multidisciplinary; Mathematics, Applied; Mechanics;
   Physics, Mathematical
SC Engineering; Mathematics; Mechanics; Physics
GA 724ED
UT WOS:000287558000064
DA 2018-10-20
ER

PT J
AU Gong, FR
   Lu, Y
   Guo, H
   Cheng, SJ
   Gao, Y
AF Gong, Feirong
   Lu, Yue
   Guo, Hui
   Cheng, Shujun
   Gao, Yun
TI Hyaluronan Immobilized Polyurethane as a Blood Contacting Material
SO INTERNATIONAL JOURNAL OF POLYMER SCIENCE
LA English
DT Article
AB Hyaluronan (hyaluronic acid, HA) was immobilized onto the surface of amino-functionalized polyurethane films with the goal of obtaining a novel kind of biomaterial which had the potential in blood-contacting applications. The amino-functionalized polyurethane was prepared by synthesized acidic polyurethane whose pendant carboxyl groups were treated with an excess amount of 1,3-diaminopropane in the presence of N,N-carbonyldiimidazole (CDI). Attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), Raman spectroscopy (RS), scanning electron microscopy (SEM), and water contact angle measurement were used to confirm the surface changes at each step of treatment, both in morphologies and chemical compositions. APTT and PT results showed that HA immobilization could prolong the blood coagulation time, thus HA-immobilized polyurethane (PU-HA) exhibited improved blood compatibility. Cytotoxicity analysis showed that the PU-HA films synthesized in this study were cytocompatible and could support human vein endothelial cells (HUVECs) adhesion and proliferation.
C1 [Gong, Feirong; Lu, Yue; Guo, Hui; Cheng, Shujun; Gao, Yun] E China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
RP Cheng, SJ (reprint author), E China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
EM chshj2003@yahoo.cn
FU 863 Project from the Ministry of Science and Technology of China
   [2007AA02Z450]
FX This paper was supported by the 863 Project of 2007AA02Z450 from the
   Ministry of Science and Technology of China. The authors thank Shanghai
   Aosi Biological Technology Service Co., Ltd. for the help in cell
   culture and coagulation time test.
CR Balakrishnan B, 2005, BIOMATERIALS, V26, P3495, DOI 10.1016/j.biomaterials.2004.09.032
   Du YJ, 2007, J BIOMED MATER RES A, V80A, P216, DOI 10.1002/jbm.a.30977
   Esposito E, 2005, INT J PHARM, V288, P35, DOI 10.1016/j.ijpharm.2004.09.001
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   KANMANGNE FM, 1985, BIOMATERIALS, V6, P297, DOI 10.1016/0142-9612(85)90085-7
   Khorasani MT, 2006, COLLOID SURFACE B, V51, P112, DOI 10.1016/j.colsurfb.2006.06.002
   Kim HW, 2005, INT J BIOL MACROMOL, V35, P47, DOI 10.1016/j.ijbiomac.2004.11.007
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lee HJ, 2000, COLLOID SURFACE B, V18, P355, DOI 10.1016/S0927-7765(99)00161-7
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Lin JC, 2001, J MATER SCI-MATER M, V12, P827, DOI 10.1023/A:1017937304964
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880
   Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Surendrakumar K, 2003, J CONTROL RELEASE, V91, P385, DOI 10.1016/S0168-3659(03)00263-3
   Wang DA, 2003, J BIOMED MATER RES A, V65A, P498, DOI 10.1002/jbm.a.10533
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yuan J, 2004, COLLOID SURFACE B, V39, P87, DOI 10.1016/j.colsurfb.2004.08.019
   Yuan J, 2008, COLLOID SURFACE B, V66, P90, DOI 10.1016/j.colsurfb.2008.05.020
   Zawko SA, 2009, ACTA BIOMATER, V5, P14, DOI 10.1016/j.actbio.2008.09.012
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
NR 30
TC 4
Z9 4
U1 1
U2 19
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1687-9422
J9 INT J POLYM SCI
JI Int. J. Polym. Sci.
PY 2010
AR 807935
DI 10.1155/2010/807935
PG 8
WC Polymer Science
SC Polymer Science
GA V24QR
UT WOS:000208425400024
OA DOAJ Gold
DA 2018-10-20
ER

PT S
AU Petrtyl, M
   Danesova, J
   Lisal, J
   Sejkotova, J
AF Petrtyl, M.
   Danesova, J.
   Lisal, J.
   Sejkotova, J.
BE Lu, JWZ
   Leung, AYT
   Iu, VP
   Mok, KM
TI Biomechanical Properties of Peripheral Layer in Articular Cartilage
SO ISCM II AND EPMESC XII, PTS 1 AND 2
SE AIP Conference Proceedings
LA English
DT Proceedings Paper
CT 2nd International Symposium on Computational Mechanics
CT 12th International Conference on the Enhancement and Promotion of
   Computational Methods in Engineering and Science
CY NOV 30-DEC 03, 2009
CY DEC 02-03, 2009
CL Hong Kong, PEOPLES R CHINA
CL Macau, PEOPLES R CHINA
SP K C Wong Educ Fdn, Macao Fdn, Macau Govt Tourist Off, Sci & Technol Dev Fund Macao SAR
SP K C Wong Educ Fdn, Macao Fdn, Macau Govt Tourist Off, Sci & Technol Dev Fund Macao SAR
DE Biomechanics; Articular Cartilage; Peripheral Zone; Strain Rate;
   Residual Strain; Incompressibility
ID KNEE-JOINT CARTILAGE; COMPRESSION; MODEL
AB Articular cartilage as a complex viscohyperelastic biomaterial possessing supporting and protective functions. It transfers dynamic effects into subchondral and spongious bone and protects chondrocytes (and the matrix material) from their destruction. Under cyclic loads, it also ensures regulated long-term protection of articular cartilage plateaus. The viscoelastic properties of the peripheral zone of articular cartilage and its molecular structure ensure the regulation of the transport and accumulation of synovial fluid between articular plateaus. The viscoelastic properties of articular cartilage in the peripheral zone ensure that during cyclic loading some amount of synovial fluid is always retained accumulated between articular plateaus, which were presupplemented with it in the previous loading cycle. During long-term harmonic cyclic loading and unloading, the strains stabilize at limit values. Shortly after loading, the strain rate is always greater than before unloading. In this way, the hydrodynamic lubrication biomechanism quickly presupplements the surface localities with lubrication material. Shortly after unloading, the strain rate is high. During strain relaxation, it slows down.
C1 [Petrtyl, M.; Danesova, J.; Lisal, J.; Sejkotova, J.] Czech Tech Univ, Fac Civil Engn, Lab Biomech & Biomat Engn, Prague, Czech Republic.
RP Petrtyl, M (reprint author), Czech Tech Univ, Fac Civil Engn, Lab Biomech & Biomat Engn, Prague, Czech Republic.
EM petrtyl@fsv.cvut.cz
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   ARMSTRONG CG, 1984, J BIOMECH ENG-T ASME, V106, P165, DOI 10.1115/1.3138475
   Ateshian GA, 2004, J BIOMECH, V37, P391, DOI 10.1016/S0021-9290(03)00252-5
   Benninghof A, 1925, Z ZELLFORSCH, V2, P783, DOI DOI 10.1007/BF00583443
   BJELLE A, 1975, CONNECT TISSUE RES, V3, P141, DOI 10.3109/03008207509152172
   COHEN B., 1992, ASME ADV BIOENGNG, V22, P187
   Cohen B., 1993, T ORTHOP RES SOC, V18, P185
   Garcia JJ, 2006, J BIOMECH, V39, P2991, DOI 10.1016/j.jbiomech.2005.10.017
   JURVELIN J, 1990, J BIOMECH, V23, P1239, DOI 10.1016/0021-9290(90)90381-C
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   Li LP, 1999, CLIN BIOMECH, V14, P673, DOI 10.1016/S0268-0033(99)00013-3
   Petrtyl M., 2008, ADV RES DIAGNOSTICS, V15, P173
   Wilson W, 2005, J BIOMECH, V38, P2138, DOI 10.1016/j.jbiomech.2005.04.024
   Wilson W, 2004, J BIOMECH, V37, P357, DOI 10.1016/S0021-9290(03)00267-7
NR 14
TC 0
Z9 0
U1 0
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0778-7
J9 AIP CONF PROC
PY 2010
VL 1233
BP 1237
EP 1242
DI 10.1063/1.3452080
PG 6
WC Engineering, Civil; Engineering, Mechanical; Mathematics, Applied;
   Mechanics
SC Engineering; Mathematics; Mechanics
GA BRL16
UT WOS:000283003800211
DA 2018-10-20
ER

PT S
AU Manea, LR
   Cramariuc, B
   Scarlet, R
   Deliu, R
AF Manea, Liliana Rozemarie
   Cramariuc, Bogdan
   Scarlet, Roxana
   Deliu, Roxana
BE Sajatovic, AH
   Vujasinovic, E
TI COMPUTER-CONTROLLED ELECTROSPINNING SYSTEM FOR NANOFIBERS MANUFACTURING
SO ITC&DC: 5TH INTERNATIONAL TEXTILE, CLOTHING & DESIGN CONFERENCE 2010,
   BOOK OF PROCEEDINGS: MAGIC WORLD OF TEXTILES
SE Book of Proceedings-International Textile Clothing & Design Conference
LA English
DT Proceedings Paper
CT 5th International Textile, Clothing and Design Conference
CY OCT 03-06, 2010
CL Dubrovnik, CROATIA
SP Univ Zagreb, Fac Textile Technol, Minist Sci Educ & Sports, Croatian Chamber Econ, Croatian Acad Engn, Danube Adria Assoc Automat & Mfg, Asoc Univ Textiles, Croatian Soc Chem Engn, Amer Assoc Textile Chem & Colorists, Int Fed Knitting Technol, European Syst Cooperat Res Networks Agr, Croatian Acad & Res Network
DE electrospinning; computer-controlled; nanofibers; parameters
ID IN-VITRO; SCAFFOLD
AB Electrospinning is a spinning technique employed to manufacture nanofibers from polymer solutions or melts, respectively, by applying some high-voltage between the nozzle point and the earthing collector. The electrospun fibers have nanometric diameters with particular characteristics as compared to those obtained by the conventional fibers spinning processes. Electrospinning yields nanofibers have wide applications such as high-performance filters, biomaterial scaffolds for vascular grafts or wound dressings, barrier-type textiles, antibacterial textiles, etc. This paper presents our own results for obtaining a computer controlled spinning system for nanofibers manufacturing.
C1 [Manea, Liliana Rozemarie; Scarlet, Roxana; Deliu, Roxana] Tech Univ Gheorghe Asachi Iasi, Fac Text Leather Engn & Ind Management, 53 Blvd Mangeron,Tex 1 Bldg, Iasi 700050, Romania.
   [Cramariuc, Bogdan] IT Ctr Sci & Technol, Bucharest, Romania.
RP Manea, LR (reprint author), Tech Univ Gheorghe Asachi Iasi, Fac Text Leather Engn & Ind Management, 53 Blvd Mangeron,Tex 1 Bldg, Iasi 700050, Romania.
EM lili191065@yahoo.com; crama@ieee.org
CR Balkcom D., NOTES PACKAGING LAB
   Bertarelli C., 2007, P 6 CONV NAZ SCI TEC
   Bognitzki M., 2001, J ADV MAT, V13, P70
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Boudriot U, 2006, ARTIF ORGANS, V30, P785, DOI 10.1111/j.1525-1594.2006.00301.x
   Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   LI D, 2004, J ADV MAT, V14, P1151, DOI DOI 10.1002/ADMA.200400719
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Mengyan L., 2010, ELECTROSPUN PROTEIN
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Subbiah T., 2010, POLYM NANOFIBRES ELE
   Sumanasinghe R.D., 2003, J TEXT APPAREL TECH, V3, P1
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Venugopal J, 2005, NANOTECHNOLOGY, V16, P2138, DOI 10.1088/0957-4484/16/10/028
   Venugopal JR, 2006, ARTIF ORGANS, V30, P440, DOI 10.1111/j.1525-1594.2006.00239.x
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
NR 18
TC 0
Z9 0
U1 1
U2 2
PU UNIV ZAGREB, FAC TEXTILE TECH
PI ZAGREB
PA PO BOX 818, PRILAZ BARUNA FILIPOVICA 28A, ZAGREB, HR-10 000, CROATIA
SN 1847-7275
J9 BK PROC INT TEXT CL
PY 2010
BP 124
EP 129
PG 6
WC Materials Science, Textiles
SC Materials Science
GA BG9SA
UT WOS:000393719100021
DA 2018-10-20
ER

PT J
AU Hagenau, A
   Scheibel, T
AF Hagenau, Anja
   Scheibel, Thomas
TI Towards the Recombinant Production of Mussel Byssal Collagens
SO JOURNAL OF ADHESION
LA English
DT Review
DE Human collagen; P4H; PreCollagens; Yeast
ID YEAST PICHIA-PASTORIS; HUMAN PROLYL 4-HYDROXYLASE; HIGH-LEVEL
   PRODUCTION; TRIPLE-HELIX; ESCHERICHIA-COLI; MYTILUS-EDULIS; I
   PROCOLLAGEN; SACCHAROMYCES-CEREVISIAE; REQUIRES COEXPRESSION; CHAPERONE
   HSP47
AB Purity and biocompatibility are prerequisites for collagen-based products in medical, pharmaceutical, and cosmetic applications. Investigation of new collagen sources and development of recombinant technologies for high-yield collagen production allow the development of novel biomaterials. Here, we highlight a fascinating natural collagenous material from marine mussels as a potential new source for biomaterial research. Further, we focus on recombinant collagen production and evaluate the feasibility to adapt these technologies for the biotechnological production of mussel byssal collagens.
C1 [Scheibel, Thomas] Univ Bayreuth, FAN D, Lehrstuhl Biomaterialien, D-95440 Bayreuth, Germany.
RP Scheibel, T (reprint author), Univ Bayreuth, FAN D, Lehrstuhl Biomaterialien, Univ Str 30, D-95440 Bayreuth, Germany.
EM thomas.scheibel@uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
FU Elitenetzwerk Bayern; DFG [SCHE 603/7-1]
FX This work was supported by the Graduate Programme "Material Science of
   Complex Interfaces'' of the "Elitenetzwerk Bayern'' (AH) and the DFG
   (SCHE 603/7-1)(TS). Special thanks to Prof. Daniel Huster for NMR data
   and for proof reading to J. Hardy and A. Golser and the members of the
   Fiberlab for discussions and critical comments.
CR ALBERTS B, 2004, MOLEKULAR BIOL ZELLE
   Bauman L, 2006, DERMATOL THER, V19, P134, DOI 10.1111/j.1529-8019.2006.00067.x
   BENEDICT CV, 1986, J MORPHOL, V189, P261, DOI 10.1002/jmor.1051890305
   BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3
   Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200
   Canty EG, 2002, COMP BIOCHEM PHYS A, V133, P979, DOI 10.1016/S1095-6433(02)00212-X
   Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1016/S0168-6445(99)00029-7
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   European Commission, 2008, FACTS FIG CFP BAS DA, P18
   *GDCH LEB GES AG K, 2006, DAT BEW WIRKS WIRKST
   GELLISSEN G, 1992, ANTON LEEUW INT J G, V62, P79, DOI 10.1007/BF00584464
   Hagenau A, 2009, MACROMOL BIOSCI, V9, P162, DOI 10.1002/mabi.200800271
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Harrington M. J., 2008, FIBROUS PROTEINS, P30
   Harrington MJ, 2007, J EXP BIOL, V210, P4307, DOI 10.1242/jeb.009753
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Keizer-Gunnink I, 2000, MATRIX BIOL, V19, P29, DOI 10.1016/S0945-053X(99)00059-1
   Kersteen EA, 2004, PROTEIN EXPRES PURIF, V38, P279, DOI 10.1016/j.pep.2004.09.008
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jc.M509707200
   Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200
   Koning AJ, 1996, MOL BIOL CELL, V7, P769
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   MARUMO K, 1987, J EXP ZOOL, V244, P365, DOI 10.1002/jez.1402440303
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Neubauer A, 2005, MATRIX BIOL, V24, P59, DOI 10.1016/j.matbio.2004.11.004
   Neubauer A, 2007, J BIOTECHNOL, V128, P308, DOI 10.1016/j.jbiotec.2006.10.017
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   O'Grady JE, 2003, ADV DRUG DELIVER REV, V55, P1699, DOI 10.1016/j.addr.2003.08.006
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200
   Pakkanen O, 2006, J BIOTECHNOL, V123, P248, DOI 10.1016/j.jbiotec.2005.11.012
   Park MO, 2007, J BACTERIOL, V189, P7281, DOI 10.1128/JB.00828-07
   Pugh RA, 2008, J BIOL CHEM, V283, P1732, DOI 10.1074/jbc.M707064200
   Purna S K, 2000, Burns, V26, P54
   QIN XX, 1995, J EXP BIOL, V198, P633
   Qin XX, 1998, P NATL ACAD SCI USA, V95, P10517, DOI 10.1073/pnas.95.18.10517
   Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Sadick N, 2007, EXPERT REV MED DEVIC, V4, P559, DOI 10.1586/17434440.4.4.559
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Sudbery PE, 1996, CURR OPIN BIOTECH, V7, P517, DOI 10.1016/S0958-1669(96)80055-3
   Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200
   Sun CJ, 2002, BIOMACROMOLECULES, V3, P1240, DOI 10.1021/bm0255903
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Voet D., 2002, LEHRBUCH BIOCH
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   Vuorela A, 1999, MATRIX BIOL, V18, P519, DOI 10.1016/S0945-053X(99)00040-2
   Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3
   Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h
   Waite JH, 2002, PHILOS T R SOC B, V357, P143, DOI 10.1098/rstb.2001.1025
   Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637
   WRIGHT R, 1988, J CELL BIOL, V107, P101, DOI 10.1083/jcb.107.1.101
   Zhou XD, 2005, J IMMUNOL, V175, P4555, DOI 10.4049/jimmunol.175.7.4555
   ZUCCARELLO LV, 1980, J ULTRA MOL STRUCT R, V73, P135, DOI 10.1016/S0022-5320(80)90119-7
   MYTIBASE
NR 66
TC 8
Z9 8
U1 0
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0021-8464
J9 J ADHESION
JI J. Adhes.
PY 2010
VL 86
IS 1
SI SI
BP 10
EP 24
DI 10.1080/00218460903417701
PG 15
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 552ZZ
UT WOS:000274335100002
DA 2018-10-20
ER

PT J
AU Anselme, K
   Ploux, L
   Ponche, A
AF Anselme, Karine
   Ploux, Lydie
   Ponche, Arnaud
TI Cell/Material Interfaces: Influence of Surface Chemistry and Surface
   Topography on Cell Adhesion
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Surface topography; surface chemistry; protein adsorption; cell
   adhesion; mechanics
ID SELF-ASSEMBLED MONOLAYERS; OSTEOBLAST-LIKE CELLS; BIOCOMPATIBLE METALLIC
   MATERIALS; LONG-TERM ADHESION; IN-VITRO; PROTEIN ADSORPTION; BIOMEDICAL
   APPLICATIONS; CONFORMATIONAL-CHANGES; SYSTEMATIC VARIATION; ORTHOPEDIC
   MATERIALS
AB The need to control the adhesion of cells to material surfaces plays an important role in determining the design of biomaterial substrates for biotechnology and tissue-engineering applications. As a the first step in a cascade of cellular events, adhesion affects many aspects of cell function, including spreading, migration, proliferation and differentiation. After a short description of cell adhesion and essential molecules involved in, the present knowledge on the influence of surface topography on cell behavior will be described by considering not only the amplitude of the surface topography but also its organization at all scales (micro- and nano-scale). The biological mechanisms underlying the cell response to topography will be evoked. Secondly, the influence of surface chemistry as well as surface energy on cell adhesion will be described. Thirdly, as the cells never interact with a bare material but with materials on which the proteins from biological fluids have adsorbed, some studies on the role of proteins in cell adhesion will be used to illustrate this point. Finally, the influence of substrate mechanics on cell differentiation will be described. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Anselme, Karine; Ploux, Lydie; Ponche, Arnaud] Univ Haute Alsace, CNRS, LRC7228, Inst Sci Mat Mulhouse IS2M, Mulhouse, France.
RP Anselme, K (reprint author), Univ Haute Alsace, CNRS, LRC7228, Inst Sci Mat Mulhouse IS2M, Mulhouse, France.
EM karine.anselme@uha.fr
RI Zhou, Feng/E-9510-2011
OI Anselme, Karine/0000-0002-6669-205X; Ponche, Arnaud/0000-0002-8993-2896
FU CNRS; ANR [ANR2007 EUKA 006 01, ANR06-NANO-022]
FX The authors acknowledge the financial support given by CNRS and ANR
   (ANR2007 EUKA 006 01, ANR06-NANO-022) and Ms P. Davidson for
   contribution to some figures.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Anselme K, 2006, SURF COAT TECH, V200, P6325, DOI 10.1016/j.surfcoat.2005.11.001
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Baker JP, 1998, CURR OPIN CELL BIOL, V10, P80, DOI 10.1016/S0955-0674(98)80089-6
   Barbosa JN, 2006, J BIOMED MATER RES A, V76A, P737, DOI 10.1002/jbm.a.30602
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012
   Bigerelle M, 1996, CR ACAD SCI II B, V323, P669
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Bigerelle M, 2003, J MATER SCI, V38, P2525, DOI 10.1023/A:1023929807546
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   Chen J, 2007, J BIOMED MATER RES B, V82B, P360, DOI 10.1002/jbm.b.30741
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby M J, 2005, Eur Cell Mater, V9, P1
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Davidson PM, 2009, ADV MATER, V21, P3586, DOI 10.1002/adma.200900582
   Diniz MG, 2002, J MATER SCI-MATER M, V13, P421, DOI 10.1023/A:1014357122284
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Feinberg AW, 2008, J BIOMED MATER RES A, V86A, P522, DOI 10.1002/jbm.a.31626
   FISHER PE, 1981, EXP CELL RES, V131, P407, DOI 10.1016/0014-4827(81)90244-5
   Garcia AJ, 2003, CELL BIOCHEM BIOPHYS, V39, P61, DOI 10.1385/CBB:39:1:61
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Geiger B, 2001, SCIENCE, V294, P1661, DOI 10.1126/science.1066919
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Kriparamanan R, 2006, J NANOSCI NANOTECHNO, V6, P1905, DOI 10.1166/jnn.2006.330
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lee SJ, 2003, J COLLOID INTERF SCI, V259, P228, DOI 10.1016/S0021-9797(02)00163-7
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Links J, 1998, BIOMATERIALS, V19, P2219
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480
   Lohmann CH, 1999, J BIOMED MATER RES, V47, P139, DOI 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2
   Macdonald W, 2004, J BIOMED MATER RES B, V70B, P262, DOI 10.1002/jbm.b.30036
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mei Y, 2006, J BIOMED MATER RES A, V79A, P974, DOI 10.1002/jbm.a.30883
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mills CA, 2006, J BIOMED MATER RES A, V76A, P781, DOI 10.1002/jbm.a.30539
   MOLLER K, 1994, CELL MATER, V4, P263
   Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609
   Nebe B, 2003, MATER SCI FORUM, V426-4, P3023, DOI 10.4028/www.scientific.net/MSF.426-432.3023
   Nguyen KT, 2007, J NANOSCI NANOTECHNO, V7, P2823, DOI 10.1166/jnn.2007.610
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pierres A., 2002, European Cells & Materials, V3, P31
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Sorensen A, 2007, BIOMATERIALS, V28, P5498, DOI 10.1016/j.biomaterials.2007.08.034
   Stevenson PM, 2009, LANGMUIR, V25, P367, DOI 10.1021/la802859v
   Su WT, 2006, MICRON, V37, P699, DOI 10.1016/j.micron.2006.03.007
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126
   Trepat X, 2008, SOFT MATTER, V4, P1750, DOI 10.1039/b804866e
   UYEN HMW, 1990, J BIOMED MATER RES, V24, P1599, DOI 10.1002/jbm.820241205
   Vitte J, 2004, Eur Cell Mater, V7, P52
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   WALBOOMERS XF, 1999, J BIOMED MATER RES, V46, P220
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Wennerberg A, 1997, J MATER SCI-MATER M, V8, P757, DOI 10.1023/A:1018560528625
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Yamada KM, 2002, NATURE, V419, P790, DOI 10.1038/419790a
   YANAGISAWA I, 1989, Journal of Oral Implantology, V15, P168
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858
   Zajac AL, 2008, CURR OPIN CELL BIOL, V20, P609, DOI 10.1016/j.ceb.2008.09.006
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 117
TC 78
Z9 79
U1 6
U2 59
PU BRILL ACADEMIC PUBLISHERS
PI LEIDEN
PA PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2010
VL 24
IS 5
SI SI
BP 831
EP 852
DI 10.1163/016942409X12598231568186
PG 22
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 600VD
UT WOS:000278016100004
DA 2018-10-20
ER

PT J
AU Suzuki, S
   Ikada, Y
AF Suzuki, Shuko
   Ikada, Yoshito
TI Adhesion of Cells and Tissues to Bioabsorbable Polymeric Materials:
   Scaffolds, Surgical Tissue Adhesives and Anti-adhesive Materials
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Bioabsorbable polymers; cell and tissue adhesion; scaffolds; surgical
   tissue adhesives; anti-adhesive materials
ID ACUTE AORTIC DISSECTION; IN-VITRO; POLY(L-GLUTAMIC ACID); SURFACE
   MODIFICATION; PROTEIN ADSORPTION; BIOMATERIAL SURFACES; PERITONEAL
   ADHESION; NEURITE EXTENSION; BIOLOGICAL GLUE; PLGA SCAFFOLDS
AB Interaction between the body and implanted materials is a very complex phenomenon, and understanding the concept of cell and tissue adhesion, which is the first event that occurs when a biomaterial is implanted, is of great importance. Currently, bioabsorbable materials are preferably used as biomaterials. They are only present in the body temporary, and promote guided cell and tissue growths for the required time. Hence, the choice of the material, depending on the application, becomes crucial. This article offers an overview of cell and tissue adhesion to three types of clinically-important bioabsorbable materials from a materials perspective: scaffolds, surgical tissue adhesives, and anti-adhesive materials. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Suzuki, Shuko; Ikada, Yoshito] Nara Med Univ, Fac Med, Kashihara, Nara 6348521, Japan.
RP Suzuki, S (reprint author), Nara Med Univ, Fac Med, Shijo Cho 840, Kashihara, Nara 6348521, Japan.
EM suzukis@naramed-u.ac.jp
CR Alvarez-Barreto JF, 2007, MACROMOL BIOSCI, V7, P579, DOI 10.1002/mabi.200600280
   Anderson J. M., 1996, BIOMATERIALS SCI INT
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   BITTON R, 2009, HDB SEALANT TECHNOLO, P513
   Burns JM, 1995, J SURG RES, V59, P644, DOI 10.1006/jsre.1995.1218
   Chao HH, 2003, J CARDIAC SURG, V18, P500, DOI 10.1046/j.0886-0440.2003.00304.x
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258
   Corsi KA, 2007, J ORTHOP RES, V25, P1261, DOI 10.1002/jor.20432
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DOVE J, 1986, J AM DENT ASSOC, V112, P879
   ENNKER IC, 1994, ANN THORAC SURG, V57, P1622, DOI 10.1016/0003-4975(94)90136-8
   Fukunaga S, 1999, EUR J CARDIO-THORAC, V15, P564, DOI 10.1016/S1010-7940(99)00084-6
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gosain AK, 2002, PLAST RECONSTR SURG, V110, P1581, DOI 10.1097/01.PRS.0000033993.30838.3E
   GRANDE DA, 1988, B HOSP JOINT DIS ORT, V48, P140
   Grondahl L, 2003, J MATER SCI-MATER M, V14, P503, DOI 10.1023/A:1023403929496
   GUILMET D, 1979, J THORAC CARDIOV SUR, V77, P516
   HARRIS ES, 1995, SURGERY, V117, P663, DOI 10.1016/S0039-6060(95)80010-7
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman A. S., 1996, BIOMATERIALS SCI INT
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Ikada Y., 2006, TISSUE ENG FUNDAMENT
   *INT TC7 ADH BARR, 1989, FERTIL STERIL, V51, P933
   Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7
   Izumi Y, 2007, SURGERY, V141, P678, DOI 10.1016/j.surg.2006.12.010
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Jung HJ, 2008, ARTIF ORGANS, V32, P982, DOI 10.1111/j.1525-1594.2008.00660.x
   Kamei S, 1997, J BIOMED MATER RES, V37, P384
   Kang ET, 1996, MACROMOLECULES, V29, P6872, DOI 10.1021/ma960161g
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KATO K, 1995, COLLOID SURFACE B, V4, P221, DOI 10.1016/0927-7765(94)01172-2
   Kazui T, 2001, ANN THORAC SURG, V72, P509, DOI 10.1016/S0003-4975(01)02777-1
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Klimo P, 2007, NEUROSURGERY, V60, P305, DOI 10.1227/01.NEU.0000255416.55560.D2
   Kunihara T, 2008, ANN THORAC CARDIOVAS, V14, P88
   Lauto A, 2008, J CHEM TECHNOL BIOT, V83, P464, DOI 10.1002/jctb.1771
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   LYMAN ML, 1996, P 5 WORLD BIOM C TOR, P212
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Matsuda S, 2002, BIOMATERIALS, V23, P2901, DOI 10.1016/S0142-9612(01)00418-5
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   Mo XM, 2000, J BIOMAT SCI-POLYM E, V11, P341, DOI 10.1163/156856200743742
   Morikawa T, 2001, AM J SURG, V182, p29S, DOI 10.1016/S0002-9610(01)00774-7
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Myles JL, 2000, J BIOMAT SCI-POLYM E, V11, P69, DOI 10.1163/156856200743508
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nam YS, 1999, J BIOMAT SCI-POLYM E, V10, P1145
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1998, BIOMATERIALS, V19, P2167, DOI 10.1016/S0142-9612(98)00123-9
   Otani Y, 1999, ANN THORAC SURG, V67, P922, DOI 10.1016/S0003-4975(99)00153-8
   Otani Y, 1998, BIOMATERIALS, V19, P2091, DOI 10.1016/S0142-9612(98)00121-5
   Otani Y, 1996, J ADHESION, V59, P197, DOI 10.1080/00218469608011088
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Ranger WR, 1997, AM SURGEON, V63, P788
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   ROSEN V, 1995, CELLULAR MOL BASIS B
   SAEZ C, 1991, COMP BIOCHEM PHYS B, V98, P569, DOI 10.1016/0305-0491(91)90255-C
   Sakuma K, 2005, ANN THORAC SURG, V80, P1835, DOI 10.1016/j.athoracsur.2005.04.078
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Singer AJ, 2004, AM J SURG, V187, P238, DOI 10.1016/j.amjsurg.2003.11.017
   Smith LL, 2007, INT J NANOMED, V2, P383
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Suzuki S, 2005, BIOMATERIALS, V26, P5303, DOI 10.1016/j.biomaterilas.2005.01.061
   TAMADA Y, 1986, POLYM MED, V2, P101
   Tanaka K, 1999, ANN THORAC SURG, V68, P1308, DOI 10.1016/S0003-4975(99)00757-2
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   von Oppell UO, 2002, J HEART VALVE DIS, V11, P249
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   WEI TY, 2007, BIOMED MATER, V2, pS142
   WEST JL, 2006, SCAFFOLDING TISSUE E
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yoshioka I, 2007, ANN THORAC SURG, V84, P864, DOI 10.1016/j.athoracsur.2007.04.029
   Zehr KJ, 2007, ANN THORAC SURG, V84, P1048, DOI 10.1016/j.athoracsur.2007.01.012
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
   Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017
   Zhu YB, 2004, J BIOMED MATER RES A, V69A, P436, DOI 10.1002/jbm.a.30007
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 93
TC 5
Z9 5
U1 0
U2 16
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2010
VL 24
IS 13-14
BP 2059
EP 2077
DI 10.1163/016942410X507920
PG 19
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 679HK
UT WOS:000284152300002
DA 2018-10-20
ER

PT J
AU Ploux, L
   Ponche, A
   Anselme, K
AF Ploux, Lydie
   Ponche, Arnaud
   Anselme, Karine
TI Bacteria/Material Interfaces: Role of the Material and Cell Wall
   Properties
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Bacteria; biofilm; bacteria/material interface
ID ESCHERICHIA-COLI K-12; SELF-ASSEMBLED MONOLAYERS;
   FATTY-ACID-COMPOSITION; STAPHYLOCOCCUS-AUREUS ADHESION; AERUGINOSA
   BIOFILM DEVELOPMENT; DIFFERENT SURFACE-TOPOGRAPHY; STAINLESS-STEEL
   SURFACES; GRAM-POSITIVE BACTERIA; PSEUDOMONAS-AERUGINOSA;
   LISTERIA-MONOCYTOGENES
AB Most of the implant-associated infections are attributed to bacteria adhering to biomaterial surfaces as "biofilm" communities. Bacterial transport, first contact with the surface as well as some of the further developments can be considered and can be described using physical-chemical concepts. However, far from simple colloidal particles, bacteria have various macromolecular structures at their cell wall surface for interacting with their surroundings through specific and non-specific bindings. They are also able to modify composition and features of their cell wall in response to specific surrounding conditions. Therefore, bacteria/surface material interface is a complex topic, involving chemical and physical-chemical characteristics of both material surface and bacterial cell wall, as well as biological characteristics of bacteria. Furthermore, proteins and other biomolecules coming from surrounding medium influence the bacteria/material interface by adsorbing onto the material surface prior to any adhesion of bacteria. Finally, bacterial adhesion and biofilm formation phenomena occur at the same time as eukaryotic cell adhesion in an acute competition for adhering to and colonising the biomaterial surface. Therefore, developing biomaterials able to favour cell adhesion without promoting also bacterial adhesion appears still to be a challenge.
   In this article, we describe briefly the common development and particularities of biofilms before focusing on what for and whether bacterial features and material surface properties are likely to be involved in bacterial adhesion, the first step in biofilm formation. The influence of adsorbed biomolecules at the bacteria/material interface is finally addressed, as well as the current knowledge about the competition between bacteria and eukaryotic cells. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Ploux, Lydie] Univ Haute Alsace, Inst Sci Mat Mulhouse IS2M, LRC7228, CNRS, F-68057 Mulhouse, France.
RP Ploux, L (reprint author), Univ Haute Alsace, Inst Sci Mat Mulhouse IS2M, LRC7228, CNRS, 15 Rue Jean Starcky,BP 2488, F-68057 Mulhouse, France.
EM lydie.ploux@uha.fr
OI Anselme, Karine/0000-0002-6669-205X; Ponche, Arnaud/0000-0002-8993-2896
CR Abu-Lail NI, 2006, COLLOID SURFACE B, V51, P62, DOI 10.1016/j.colsurfb.2006.05.009
   Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Adams EW, 2004, CHEM BIOL, V11, P875, DOI 10.1016/j.chembiol.2004.04.010
   Alarcon I, 2009, INVEST OPHTH VIS SCI, V50, P2237, DOI 10.1167/iovs.08-2785
   Alvarez-Ordonez A, 2008, INT J FOOD MICROBIOL, V123, P212, DOI 10.1016/j.ijfoodmicro.2008.01.015
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2
   Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Barnes LM, 1999, APPL ENVIRON MICROB, V65, P4543
   Barth KA, 2008, ADV FUNCT MATER, V18, P1459, DOI 10.1002/adfm.200701246
   Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9
   Becker P, 2001, APPL ENVIRON MICROB, V67, P2958, DOI 10.1128/AEM.67.7.2958-2965.2001
   BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   Boonaert C. J. P., 2002, ENCY ENV MICROBIOLOG, P113, DOI [10.1002/0471263397.env154, DOI 10.1002/0471263397.ENV154]
   Bos R, 2000, FEMS MICROBIOL LETT, V189, P311, DOI 10.1016/S0378-1097(00)00298-6
   BoulangePetermann L, 1997, BIOFOULING, V11, P201, DOI 10.1080/08927019709378331
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006
   Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328
   Briandet R, 1999, J FOOD PROTECT, V62, P994, DOI 10.4315/0362-028X-62.9.994
   Bruinsma GM, 2003, BIOMATERIALS, V24, P1663, DOI 10.1016/S0142-9612(02)00542-2
   Bruinsma GM, 2002, INVEST OPHTH VIS SCI, V43, P3646
   Bundy J, 1999, ANAL CHEM, V71, P1460, DOI 10.1021/ac981119h
   Burks GA, 2003, LANGMUIR, V19, P2366, DOI 10.1021/la026375a
   Busscher HJ, 2007, J BACTERIOL, V189, P2988, DOI 10.1128/JB.01731-06
   BUSSCHER HJ, 1992, FEMS MICROBIOL LETT, V88, P199, DOI 10.1111/j.1574-6968.1992.tb04988.x
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1111/j.1574-6968.1987.tb02457.x
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Carlen A, 2003, ORAL MICROBIOL IMMUN, V18, P203, DOI 10.1034/j.1399-302X.2003.00043.x
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CHARACKLIS WG, 1981, BIOTECHNOL BIOENG, V23, P1923, DOI 10.1002/bit.260230902
   Charville GW, 2008, BIOMATERIALS, V29, P4039, DOI 10.1016/j.biomaterials.2008.07.005
   Chen G, 2003, J COLLOID INTERF SCI, V261, P283, DOI 10.1016/S0021-9797(02)00242-4
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Coil DA, 2009, FEMS MICROBIOL LETT, V293, P271, DOI 10.1111/j.1574-6968.2009.01532.x
   COLLINSON SK, 1993, J BACTERIOL, V175, P12
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cottenye N, 2008, MACROMOL BIOSCI, V8, P1161, DOI 10.1002/mabi.200800081
   Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000
   Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004
   Diaz C, 2007, LANGMUIR, V23, P11206, DOI 10.1021/la700650q
   Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Dubois-Brissonnet F, 2000, INT J FOOD MICROBIOL, V55, P79, DOI 10.1016/S0168-1605(00)00198-7
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   Faille C, 2000, BIOFOULING, V15, P261, DOI 10.1080/08927010009386317
   Feugeas F, 2001, J TRACE MICROPROBE T, V19, P375, DOI 10.1081/TMA-100105053
   Flemming CA, 1998, BIOFOULING, V13, P213
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   Fozo EM, 2004, FEMS MICROBIOL LETT, V238, P291, DOI 10.1016/j.femsle.2004.07.047
   Gaboriaud F, 2006, COLLOID SURFACE B, V52, P108, DOI 10.1016/j.colsurfb.2006.04.017
   Gallardo-Moreno AM, 2004, COLLOID SURFACE A, V249, P99, DOI 10.1016/j.colsurfa.2004.08.058
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Gophna U, 2002, FEMS MICROBIOL LETT, V212, P55, DOI 10.1016/S0378-1097(02)00703-6
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Hanna A, 2003, APPL ENVIRON MICROB, V69, P4474, DOI 10.1128/AEM.69.8.4474-4481.2003
   HANSSON L, 1995, BBA-GEN SUBJECTS, V1244, P377, DOI 10.1016/0304-4165(95)00028-A
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014
   Haznedaroglu BZ, 2008, WATER RES, V42, P1547, DOI 10.1016/j.watres.2007.10.042
   He T, 2009, BIOMATERIALS, V30, P317, DOI 10.1016/j.biomaterials.2008.09.049
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Hilbert LR, 2003, INT BIODETER BIODEGR, V52, P175, DOI 10.1016/S0964-8305(03)00104-5
   Holgers KM, 1999, BIOMATERIALS, V20, P1319, DOI 10.1016/S0142-9612(99)00033-2
   Hosoya N, 2003, J DENT, V31, P543, DOI 10.1016/S0300-5712(03)00109-X
   HOURY A, 2009, MICROBIOLOGY, DOI DOI 10.1099/MIC.0.034827
   Hua L, 2009, FOOD BIOPROD PROCESS, V87, P56, DOI 10.1016/j.fbp.2008.06.001
   Hull JR, 2008, ACTA BIOMATER, V4, P504, DOI 10.1016/j.actbio.2008.01.009
   Imberty A, 2005, CURR OPIN STRUC BIOL, V15, P525, DOI 10.1016/j.sbi.2005.08.003
   Imberty A., 2006, PROTEIN CARBOHYDRATE, P30
   ISRAELCHVILI J, 1991, INTERMOLECULAR SURFA
   Jarvis RA, 2005, J BIOMED MATER RES A, V75A, P41, DOI 10.1002/jbm.a.30404
   Kaiser D, 2007, CURR BIOL, V17, pR561, DOI 10.1016/j.cub.2007.04.050
   Kannenberg EL, 2001, MOL MICROBIOL, V39, P379, DOI 10.1046/j.1365-2958.2001.02225.x
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x
   Kirov SM, 2003, FEMS MICROBIOL LETT, V224, P151, DOI 10.1016/S0378-1097(03)00445-2
   Kives J, 2006, COLLOID SURFACE B, V52, P123, DOI 10.1016/j.colsurfb.2006.04.018
   KOMAROMY A, 2010, MICROELECTRON ENG, V86, P1431
   Koshi Y, 2006, J AM CHEM SOC, V128, P10413, DOI 10.1021/ja0613963
   Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025
   La Ragione RM, 2000, J MED MICROBIOL, V49, P327, DOI 10.1099/0022-1317-49-4-327
   LECLERCQPERLAT MN, 1994, J FOOD ENG, V23, P501, DOI 10.1016/0260-8774(94)90108-2
   Leclere V, 2006, ARCH MICROBIOL, V186, P475, DOI 10.1007/s00203-006-0163-z
   Lejeune P, 2003, TRENDS MICROBIOL, V11, P179, DOI 10.1016/S0966-842X(03)00047-7
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Li J, 1999, INT J FOOD MICROBIOL, V53, P185, DOI 10.1016/S0168-1605(99)00159-2
   Liang MN, 2000, P NATL ACAD SCI USA, V97, P13092, DOI 10.1073/pnas.230451697
   Lima EMCX, 2008, CLIN ORAL IMPLAN RES, V19, P780, DOI 10.1111/j.1600-0501.2008.01524.x
   Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044
   Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299
   Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938
   McCann MT, 2008, J PHARM PHARMACOL, V60, pA43
   Medilanski E, 2002, BIOFOULING, V18, P193, DOI 10.1080/08927010290011370
   Meinders JM, 1995, J COLLOID INTERF SCI, V176, P329, DOI 10.1006/jcis.1995.9960
   Meylheuc T, 2006, COLLOID SURFACE B, V52, P128, DOI 10.1016/j.colsurfb.2006.04.016
   Mitik-Dineva N, 2009, BIOFOULING, V25, P621, DOI 10.1080/08927010903012773
   Naitali M, 2009, INT J FOOD MICROBIOL, V130, P101, DOI 10.1016/j.ijfoodmicro.2009.01.008
   Niu C, 2005, J MICROBIOL METH, V62, P129, DOI 10.1016/j.mimet.2005.01.013
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x
   Ofek I, 2000, ADV EXP MED BIOL, V485, P183
   OFEK I, 2003, BACTERIAL ADHESION A
   OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0
   Olsen A, 1998, INFECT IMMUN, V66, P944
   Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto K, 2004, J BACTERIOL, V186, P226, DOI 10.1128/JB.186.1.226-234.2004
   Otto Karen, 2001, Journal of Bacteriology, V183, P2445, DOI 10.1128/JB.183.8.2445-2453.2001
   Pamp SJ, 2007, J BACTERIOL, V189, P2531, DOI 10.1128/JB.01515-06
   Panja S, 2008, BIOMACROMOLECULES, V9, P2501, DOI 10.1021/bm8005215
   Parsek MR, 2008, CURR OPIN MICROBIOL, V11, P560, DOI 10.1016/j.mib.2008.09.015
   Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI 10.1111/j.1365-2672.2004.02499.x
   Ploux L, 2009, LANGMUIR, V25, P8161, DOI 10.1021/la900457f
   Ploux L, 2007, COLLOID SURFACE B, V57, P174, DOI 10.1016/j.colsurfb.2007.01.018
   Poulsen L. V., 1999, Lebensmittel-Wissenschaft und -Technologie, V32, P321, DOI 10.1006/fstl.1999.0561
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   PRATTTERPSTRA IH, 1988, CURR MICROBIOL, V16, P311, DOI 10.1007/BF01568537
   Prigent-Combaret C, 1999, J BACTERIOL, V181, P5993
   Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001
   Prigent-Combaret C, 2000, ENVIRON MICROBIOL, V2, P450, DOI 10.1046/j.1462-2920.2000.00128.x
   Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Qian XP, 2002, ANAL CHEM, V74, P1805, DOI 10.1021/ac0110420
   QUINTERO EJ, 1995, APPL ENVIRON MICROB, V61, P1897
   Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x
   Roberts JA, 2004, CHEM GEOL, V212, P313, DOI 10.1016/j.chemgeo.2004.08.021
   Roy K, 2009, NATURE, V457, P594, DOI 10.1038/nature07568
   Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010
   Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Seyer D, 2005, BIOFILMS, V2, P27, DOI DOI 10.1017/S1479050505001638
   Shi ZL, 2008, J BIOMED MATER RES A, V86A, P865, DOI 10.1002/jbm.a.31648
   Simpson KH, 2004, BIOMOL ENG, V21, P105, DOI 10.1016/j.bioeng.2004.08.00l
   SJOLLEMA J, 1990, J ADHES SCI TECHNOL, V4, P765, DOI 10.1163/156856190X00658
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996
   Stoitsova S, 2004, J BASIC MICROB, V44, P296, DOI 10.1002/jobm.200410350
   Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Subramani A, 2009, J COLLOID INTERF SCI, V336, P13, DOI 10.1016/j.jcis.2009.03.063
   Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1
   Syakti AD, 2006, RES MICROBIOL, V157, P479, DOI 10.1016/j.resmic.2005.11.001
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   TEBBS SE, 1994, BRIT J ANAESTH, V72, P587, DOI 10.1093/bja/72.5.587
   Tedjo C, 2007, J BIOMED MATER RES A, V82A, P479, DOI 10.1002/jbm.a.31172
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Terada A, 2005, COLLOID SURFACE B, V43, P99, DOI 10.1016/j.colsurfb.2005.03.016
   Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   VADILLORODRIGUE.V, 2003, BIOFILMS MED IND ENV, P6
   Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005
   van Oss CJ, 2007, COLLOID SURFACE B, V54, P2, DOI 10.1016/j.colsurfb.2006.05.024
   van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   Verran J, 1997, J PROSTHET DENT, V77, P535, DOI 10.1016/S0022-3913(97)70148-3
   Verran J, 2001, J FOOD PROTECT, V64, P1183, DOI 10.4315/0362-028X-64.8.1183
   Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004
   Vidal O, 1998, J BACTERIOL, V180, P2442
   Walker SL, 2005, COLLOID SURFACE B, V45, P181, DOI 10.1016/j.colsurfb.2005.08.007
   Walker SL, 2005, APPL ENVIRON MICROB, V71, P3093, DOI 10.1128/AEM.71.6.3093-3099.2005
   Walker SL, 2004, LANGMUIR, V20, P7736, DOI 10.1021/la049511f
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Whitehead KA, 2007, INT BIODETER BIODEGR, V60, P74, DOI 10.1016/j.ibiod.2006.11.009
   Wiencek KM, 1997, BIOFOULING, V11, P293, DOI 10.1080/08927019709378338
   WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995
   Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007
   Winans SC, 1998, TRENDS MICROBIOL, V6, P382, DOI 10.1016/S0966-842X(98)01338-9
   Wuertz S, 2004, WATER SCI TECHNOL, V49, P327
   Xu CP, 2008, APPL ENVIRON MICROB, V74, P7522, DOI 10.1128/AEM.00948-08
   Zaini PA, 2009, FEMS MICROBIOL LETT, V295, P129, DOI 10.1111/j.1574-6968.2009.01597.x
NR 185
TC 54
Z9 54
U1 2
U2 62
PU BRILL ACADEMIC PUBLISHERS
PI LEIDEN
PA PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 2010
VL 24
IS 13-14
BP 2165
EP 2201
DI 10.1163/016942410X511079
PG 37
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 679HK
UT WOS:000284152300007
DA 2018-10-20
ER

PT J
AU Bucciotti, F
   Mazzocchi, M
   Bellosi, A
AF Bucciotti, Francesco
   Mazzocchi, Mauro
   Bellosi, Alida
TI Perspectives of the Si3N4-TiN ceramic composite as a biomaterial and
   manufacturing of complex-shaped implantable devices by electrical
   discharge machining (EDM)
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE Silicon nitride; Titanium nitride; Electrical discharge machining;
   Implantable devices; Ceramic composite
ID STRUCTURAL ORTHOPEDIC IMPLANTS; LONG-TERM OXIDATION; SILICON-NITRIDE;
   MECHANICAL-PROPERTIES; MICROSTRUCTURE; BIOCOMPATIBILITY; DENSIFICATION;
   DEGRADATION
AB Purpose: In this work we investigated the suitability of electroconductive silicon nitride/titanium nitride composite for biomedical implantable devices with particular attention on the processing route that allows the net-shaping of complex components by electrical discharge machining (EDM).
   Methods: The composite, constituted mainly of a beta-Si3N4, dispersed TiN grains and a glassy grain boundary phase, exhibited a low density and high hardness, strength and toughness. Bulk, surface characteristics and properties of the Si3N4-TiN composite were analyzed. After the EDM process, the microstructure of the machined surface was examined.
   Results and Conclusions: The obtained results showed that the Si3N4-TiN ceramic composite together with the EDM manufacturing process might potentially play a key role in implantable load-bearing prosthesis applications. (Journal of Applied Biomaterials & Biomechanics 2010; 8: 28-32)
C1 [Mazzocchi, Mauro; Bellosi, Alida] CNR, Inst Sci & Technol Ceram, I-48018 Faenza, Italy.
   [Bucciotti, Francesco] CNR, Ins Sci & Technol Ceram, Turin, Italy.
RP Mazzocchi, M (reprint author), CNR, Inst Sci & Technol Ceram, Via Granarolo 64, I-48018 Faenza, Italy.
EM mauro.mazzocchi@istec.cnr.it
RI Mazzocchi, Mauro/D-9631-2016; Bellosi, Alida/B-6167-2014
OI Mazzocchi, Mauro/0000-0002-0243-6890; 
CR Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   Bellosi A., 1992, Journal of the European Ceramic Society, V9, P83, DOI 10.1016/0955-2219(92)90049-J
   Guicciardi S, 2003, MAT SCI ENG A-STRUCT, V360, P35, DOI 10.1016/S0921-5093(03)00501-X
   HERRMANN M, 1993, J EUR CERAM SOC, V12, P287, DOI 10.1016/0955-2219(93)90104-Y
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Liu CC, 2003, MAT SCI ENG A-STRUCT, V363, P221, DOI 10.1016/S0921-5093(03)00630-0
   MAIER HR, 2004, CFI-CERAM FORUM INT, V81, P33
   MARTIN C, 1989, MAT SCI ENG A-STRUCT, V109, P351, DOI 10.1016/0921-5093(89)90614-X
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2881, DOI 10.1007/s10856-008-3417-2
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   Medri V, 2005, J EUR CERAM SOC, V25, P1723, DOI 10.1016/j.jeurceramsoc.2004.12.002
   Medri V, 2004, J MATER RES, V19, P1567, DOI 10.1557/JMR.2004.0210
   Neumann A, 2006, OTOLARYNG HEAD NECK, V134, P923, DOI 10.1016/j.otohns.2006.01.022
   Neumann A, 2004, J MATER SCI-MATER M, V15, P1135, DOI 10.1023/B:JMSM.0000046396.14073.92
   NEUMANN A, 2004, WERKSTOFFTECH, V35, P569
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
   ZHOU YS, 1977, MAT SCI ENG C, V5, P125
NR 19
TC 9
Z9 9
U1 1
U2 6
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD JAN-APR
PY 2010
VL 8
IS 1
BP 28
EP 32
PG 5
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 627XX
UT WOS:000280079000005
PM 20740419
DA 2018-10-20
ER

PT J
AU Kostakos, AT
   Macheras, GA
   Frangakis, CE
   Stafilas, KS
   Baltas, D
   Xenakis, TA
AF Kostakos, Athanasios T.
   Macheras, Georgios A.
   Frangakis, Constantinos E.
   Stafilas, Kosmas S.
   Baltas, Dimitrios
   Xenakis, Theodoros A.
TI Migration of the Trabecular Metal Monoblock Acetabular Cup System
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE trabecular metal; monoblock; EBRA; migration
ID TOTAL HIP-ARTHROPLASTY; ROENTGEN STEREOPHOTOGRAMMETRIC ANALYSIS; POROUS
   TANTALUM BIOMATERIAL; IMPLANT MIGRATION; DURALOC CUP; PROSTHESES; EBRA;
   REPLACEMENT; PREDICTION; COMPONENTS
AB Fifty-one primary total hip arthroplasties were performed using Trabecular Metal Monoblock Acetabular Cup System (Zimmer Inc, Warsaw, IN). In a 2-year prospective study, its behavior was closely monitored by clinical, radiologic, and component migration assessment by Ein-Bild-Rontgen-Analyse method. There were no complications. The mean Harris hip score was improved from 41 to 95. A polar gap at the postoperative radiograph was noted at 25% of the arthroplasties, most of which subsequently filled with bone within 6 months. The mean total absolute migration was 0.67 mm. The implant showed excellent early clinical and radiographic behavior. The 2-year migration rate study, as index of long-term survival and success, showed very good early implant stability and, in all cases except one, superior to the available studies for similar design acetabular cups.
C1 [Kostakos, Athanasios T.; Macheras, Georgios A.; Baltas, Dimitrios] First IKA Hosp, Dept Orthoped, Athens 15127, Greece.
   [Frangakis, Constantinos E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Stafilas, Kosmas S.; Xenakis, Theodoros A.] Univ Ioannina, Dept Orthoped, GR-45110 Ioannina, Greece.
RP Kostakos, AT (reprint author), First IKA Hosp, Dept Orthoped, 1 Zaimi St, Athens 15127, Greece.
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Elke R, 2003, J BONE JOINT SURG BR, V85B, P1114, DOI 10.1302/0301-620X.85B8.13590
   Freeman MAR, 1997, J BONE JOINT SURG BR, V79B, P342
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Hendrich C, 1997, J ARTHROPLASTY, V12, P889, DOI 10.1016/S0883-5403(97)90158-3
   Hirakawa K, 2001, CLIN ORTHOP RELAT R, P135
   Ilchmann T, 1997, Acta Orthop Scand Suppl, V276, P1
   Ilchmann T, 1992, J Arthroplasty, V7, P121, DOI 10.1016/0883-5403(92)90004-A
   Ilchmann Thomas, 1998, Acta Orthopaedica Scandinavica, V69, P119
   Karrholm J, 1997, CLIN ORTHOP RELAT R, P94
   Komarasamy Baskaran, 2006, Acta Orthop Belg, V72, P320
   KRISMER M, 1995, J BIOMECH, V28, P1225, DOI 10.1016/0021-9290(94)00177-6
   Krismer M, 1996, J BONE JOINT SURG BR, V78B, P422
   Krismer M, 1997, ORTHOPADE, V26, P229
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   MJOBERG B, 1990, ACTA ORTHOP SCAND, V61, P273
   MJOBERG B, 1986, J BONE JOINT SURG BR, V68, P770
   MJOBERG B, 1991, ACTA ORTHOP SCAND, V62, P500, DOI 10.3109/17453679108996658
   Moilanen T, 1996, J BONE JOINT SURG BR, V78B, P200
   Mulier Michiel, 2006, Acta Orthop Belg, V72, P326
   ONSTEN I, 1994, J BONE JOINT SURG AM, V76A, P185, DOI 10.2106/00004623-199402000-00004
   Phillips NJ, 2002, J ARTHROPLASTY, V17, P917, DOI 10.1054/arth.2002.34529
   SNORRASON F, 1990, J BONE JOINT SURG BR, V72, P647
   Stiehl JB, 2005, ORTHOPEDICS, V28, P662
   Stockl B, 1999, J BONE JOINT SURG BR, V81B, P51, DOI 10.1302/0301-620X.81B1.9036
   STOCKS GW, 1995, J BONE JOINT SURG BR, V77B, P853
   Stoeckl B, 2005, INT ORTHOP, V29, P14, DOI 10.1007/s00264-004-0600-z
   WETHERELL RG, 1989, J BONE JOINT SURG BR, V71, P447
   Wilkinson JM, 2002, J ARTHROPLASTY, V17, P910, DOI 10.1054/arth.2002.34530
   Wilkinson JM, 2003, INT ORTHOP, V27, pS16, DOI 10.1007/s00264-003-0436-y
NR 35
TC 12
Z9 12
U1 0
U2 1
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JAN
PY 2010
VL 25
IS 1
BP 35
EP 40
DI 10.1016/j.arth.2008.09.027
PG 6
WC Orthopedics
SC Orthopedics
GA 594ZQ
UT WOS:000277580800008
PM 19056211
DA 2018-10-20
ER

PT J
AU Zhang, H
   Ding, JD
AF Zhang, Huan
   Ding, Jiandong
TI Frequency- and Temperature-Dependent Rheological Properties of an
   Amphiphilic Block Co-polymer in Water and Including Cell-Culture Media
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Hydrogels; sol-gel transition; rheological properties; scaling;
   injectable
ID SOL-GEL TRANSITION; PPO-PEO COPOLYMERS; IN-VITRO RELEASE;
   AQUEOUS-SOLUTIONS; TRIBLOCK COPOLYMERS; DRUG-DELIVERY; LINEAR
   VISCOELASTICITY; MULTIBLOCK COPOLYMERS; GELATION PROPERTIES; HYDROGELS
AB This paper examines the effects of cell-culture media on the rheological properties of Pluronic F127, an amphiphilic triblock co-polymer of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO). In an aqueous environment, F127 exhibits a reversible sol-gel transition upon an increase of temperature and has found wide applications as an injectable biomaterial. In contrast to most of the present polymer-physics studies of hydrogels in water, we examined its rheological properties in Dulbecco's Modified Eagle Medium (DMEM), DMEM with calf serum and phosphate-buffered saline (PBS) solution, compared with those in deionized water. The critical gelation temperatures (T(gel)) were found to be lowered as compared to that in pure water. The differences among the three experimental groups were relatively less significant. The zero viscosity eta(0) of sols and equilibrium modulus G(e) of gels were enhanced at a given temperature, but they kept universal values under a given temperature difference, T-T(gel). The basic frequency-related scaling characteristics of a typical percolated network, G' similar to omega(n) and G '' similar to omega(n), remained in Pluronic hydrogels at the gel points. Two power laws, eta(0) similar to ((T(gel)-T)/T(gel))(-s) and G(e) similar to ((T-T(gel))/T(gel))(m) described well the sols and gels near T(gel), respectively. All the four systems exhibited similar critical scaling exponents. As a result, our studies illustrate that the changes of transition points and rheological properties of Pluronic hydrogels in cell-culture media should be taken into consideration but are not awfully large. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Zhang, Huan; Ding, Jiandong] Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Dept Macromolecular Sci,Adv Mat Lab, Shanghai 200433, Peoples R China.
RP Ding, JD (reprint author), Fudan Univ, Key Lab Mol Engn Polymers, Minist Educ, Dept Macromolecular Sci,Adv Mat Lab, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI Zhang, Huan/O-7352-2014
OI Zhang, Huan/0000-0001-8625-8050
FU Chinese Ministry of Science and Technology [2009CB930000, 2005CB522700];
   NSF of China [50533010, 20774020]; Chinese Ministry of Education
   [305004]; Science and Technology Developing Foundation of Shanghai
   [07JC14005]; Shanghai Education Committee [B112]
FX The authors are grateful for the financial support from Chinese Ministry
   of Science and Technology (973 Project Nos 2009CB930000 and
   2005CB522700), NSF of China (Grant Nos 50533010 and 20774020), Chinese
   Ministry of Education (a Key Grant No. 305004), Science and Technology
   Developing Foundation of Shanghai (Grant No. 07JC14005), Shanghai
   Education Committee (Project No. B112).
CR Aamer KA, 2004, BIOMATERIALS, V25, P1087, DOI 10.1016/S0142-9612(03)00632-X
   Ajiro H, 2008, BIOMACROMOLECULES, V9, P426, DOI 10.1021/bm701221c
   ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Carter FJ, 2001, MED IMAGE ANAL, V5, P231, DOI 10.1016/S1361-8415(01)00048-2
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Cho J, 2007, MACROMOL MATER ENG, V292, P571, DOI 10.1002/mame.200700009
   Choi HS, 2002, MACROMOL BIOSCI, V2, P298, DOI 10.1002/1616-5195(200208)2:6<298::AID-MABI298>3.0.CO;2-#
   CHU B, 1995, LANGMUIR, V11, P414, DOI 10.1021/la00002a009
   Chung HJ, 2008, J CONTROL RELEASE, V127, P22, DOI 10.1016/j.jconrel.2007.12.008
   Desai PR, 2001, COLLOID SURFACE A, V178, P57, DOI 10.1016/S0927-7757(00)00493-3
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dumortier G, 2006, PHARM RES, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Edsman K, 1998, EUR J PHARM SCI, V6, P105, DOI 10.1016/S0928-0987(97)00075-4
   Habas JP, 2004, J RHEOL, V48, P1, DOI 10.1122/1.1634988
   Halacheva S, 2008, J PHYS CHEM B, V112, P1899, DOI 10.1021/jp0742463
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Lee JB, 2004, J BIOMAT SCI-POLYM E, V15, P1571, DOI 10.1163/1568562042459751
   Lee SY, 2007, J BIOMAT SCI-POLYM E, V18, P1335, DOI 10.1163/156856207782177855
   Lee SJ, 2008, POLYM J, V40, P171, DOI 10.1295/polymj.PJ2007179
   Li F, 2005, MACROMOL BIOSCI, V5, P1125, DOI 10.1002/mabi.200500143
   Li F, 2007, LANGMUIR, V23, P2778, DOI 10.1021/la0629025
   MALMSTEN M, 1993, MACROMOLECULES, V26, P1282, DOI 10.1021/ma00058a014
   MALMSTEN M, 1992, MACROMOLECULES, V25, P5440, DOI 10.1021/ma00046a049
   MARTIN JE, 1991, ANNU REV PHYS CHEM, V42, P311
   Matthew JE, 2002, BIOMATERIALS, V23, P4615, DOI 10.1016/S0142-9612(02)00208-9
   Mayo L, 2008, EUR J PHARM BIOPHARM, V70, P199, DOI 10.1016/j.ejpb.2008.04.025
   Mortensen K, 1995, MACROMOLECULES, V28, P8829, DOI 10.1021/ma00130a016
   Murakami Y, 2007, J BIOMED MATER RES A, V80A, P421, DOI 10.1002/jbm.a.30911
   Nagahama K, 2008, ADV FUNCT MATER, V18, P1220, DOI 10.1002/adfm.200700587
   Pandit N, 2000, J COLLOID INTERF SCI, V222, P213, DOI 10.1006/jcis.1999.6628
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peyrelasse J, 1996, PHYS REV E, V53, P6126, DOI 10.1103/PhysRevE.53.6126
   Prudhomme RK, 1996, LANGMUIR, V12, P4651, DOI 10.1021/la951506b
   Sharma PK, 2005, J BIOMAT SCI-POLYM E, V16, P1139, DOI 10.1163/1568562054798545
   Shim WS, 2005, BIOMACROMOLECULES, V6, P2930, DOI 10.1021/bm050521k
   Song MJ, 2000, POLYM BULL, V43, P497, DOI 10.1007/s002890050007
   Sosnik A, 2003, J BIOMAT SCI-POLYM E, V14, P227, DOI 10.1163/156856203763572680
   WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yang ZG, 2008, MACROMOL RAPID COMM, V29, P751, DOI 10.1002/marc.200700872
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   YU QL, 1993, AM J PHYSIOL, V265, pH52
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhang Y, 2005, J BIOMED MATER RES A, V75A, P342, DOI 10.1002/jbm.a.30437
   Zhang Y, 2005, J CONTROL RELEASE, V105, P260, DOI 10.1016/j.jconrel.2005.04.001
NR 56
TC 19
Z9 19
U1 1
U2 25
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 2
BP 253
EP 269
DI 10.1163/156856209X415747
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 549LO
UT WOS:000274050700008
PM 20092688
DA 2018-10-20
ER

PT J
AU Yoon, H
   Kim, G
AF Yoon, Hyeon
   Kim, GeunHyung
TI Micro/Nanofibrous Scaffolds Electrospun from PCL and Small Intestinal
   Submucosa
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Biomedical scaffold; nanofibers; PCL; small intestinal submucosa; nerve
   cells
ID NANOFIBROUS SCAFFOLDS; MECHANICAL-PROPERTIES; TISSUE-RESPONSE;
   REGENERATION; DEGRADATION; CARTILAGE; ALGINATE; FIBERS; REPAIR; TENDON
AB Small intestinal submucosa (SIS) has the potential for use as a natural scaffold material because of the presence of type-I and -III collagen and various cytokines. However, although the presence of growth factors in SIS leads to superior initial cell attachment and proliferation compared to synthetic polymeric scaffolds, the lack of reliable and reproducible shape controllability is a drawback. To overcome this problem, SIS was electrospun with a biodegradable and biocompatible polymer, polycaprolactone (PCL). PCL/SIS fibrous webs were fabricated with an electrospinning process using an auxiliary conical electrode to create stable micro/nanofibrous scaffolds. The hydrophilicity, mechanical properties and cellular behavior of the PCL/SIS fibrous scaffold were analyzed. In addition, aligned PCL/SIS fibrous webs were fabricated using various collector rotation speeds. As the alignment of micro/nanofibers increased, the hydrophilicity, orthotropic mechanical properties, and cellular behavior of PC-12 cells improved. These results show the potential for using PCL/SIS fibrous scaffolds as a good natural biomaterial. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Yoon, Hyeon; Kim, GeunHyung] Chosun Univ, Dept Mech Engn, Coll Engn, Kwangju, South Korea.
RP Kim, G (reprint author), Chosun Univ, Dept Mech Engn, Coll Engn, Kwangju, South Korea.
EM gkim@chosun.ac.kr
FU Korean Grovernment [KRF-2008-521-D00582]
FX This work was supported by a Korea Research Foundation Grant funded by
   the Korean Grovernment (KRF-2008-521-D00582).
CR ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   Androjna C, 2007, TISSUE ENG, V13, P233, DOI 10.1089/ten.2006.0050
   BABA Y, 2005, EXP MOL PATHOL, V9, P229
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Dai NT, 2005, BIOCHEM BIOPH RES CO, V329, P905, DOI 10.1016/j.bbrc.2005.02.059
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   HUNT JA, 1993, BIOMATERIALS, V14, P378, DOI 10.1016/0142-9612(93)90058-A
   Kim GH, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025010
   Kim G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2210972
   Kim GH, 2006, J POLYM SCI POL PHYS, V44, P1426, DOI 10.1002/polb.20814
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   LI W, 2006, J BIOMECH ENG, V40, P686
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Long RA, 2006, BIOMATERIALS, V27, P2398, DOI 10.1016/j.biomaterials.2005.10.011
   Lu JW, 2006, POLYMER, V47, P8026, DOI 10.1016/j.polymer.2006.09.027
   Lynch HA, 2003, J BIOMECH ENG-T ASME, V125, P726, DOI 10.1115/1.1614819
   Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   Park S, 2007, POLYM INT, V56, P1361, DOI 10.1002/pi.2345
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   Wnek GE, 2003, NANO LETT, V3, P213, DOI 10.1021/nl025866c
NR 29
TC 15
Z9 16
U1 4
U2 43
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 5
BP 553
EP 562
DI 10.1163/156856209X429166
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 574ID
UT WOS:000275981700001
PM 20338091
DA 2018-10-20
ER

PT J
AU Bayer, CL
   Trenchard, IJ
   Peppas, NA
AF Bayer, Carolyn L.
   Trenchard, Isis J.
   Peppas, Nicholas A.
TI Analyzing Polyaniline-poly(2-acrylamido-2-methylpropane sulfonic acid)
   Biocompatibility with 3T3 Fibroblasts
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Conductive polymers; polyaniline; fibroblasts; biocompatibility
ID TISSUE ENGINEERING APPLICATIONS; ACID-DOPED POLYANILINE;
   ELECTRICAL-CONDUCTIVITY; CONTROLLED-RELEASE; MOLECULAR-WEIGHT; IN-VITRO;
   POLYPYRROLE; POLYMER; CELLS; POLY(3,4-ETHYLENEDIOXYTHIOPHENE)
AB Conductive polymers can be utilized as unique functional elements in future intelligent biomaterials required for tissue engineering, cell stimulation and drug delivery. Research in these areas could be limited by established methods of conductive polymer synthesis which do not provide an easy route towards large scale processing of these materials. Typically, conductive polymers are highly insoluble in biocompatible solvents, and can be mechanically brittle, making their integration with biomaterials challenging. As an alternative, the use of a water-soluble conductive polymer for integration with biomaterials, a polyaniline template synthesized with poly(2-acrylamido-2-methylpropanesulfonic acid) (PANI-PAAMPSA), is proposed. To address key fundamental questions about the biocompatibility of this conductive polymer, cell cytotoxicity and proliferation assays have been performed on NIH 3T3 fibroblasts cultured on films of PANI-PAAMPSA. It was determined that the cell cultures maintained growth habits similar to those cultured on the control surfaces. Additionally, conductivity of the PANI-PAAMPSA films subsequent to exposure to the cell culture was demonstrated, indicating the materials retain functionality after cell growth. These results indicate that this type of template synthesized PANI could be successfully implemented as a functional, conductive biomaterial. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Bayer, Carolyn L.; Trenchard, Isis J.; Peppas, Nicholas A.] Univ Texas Austin, Dept Biomed Engn, Ctr Biomat Drug Delivery Bionanotechnol & Mol Rec, Austin, TX 78712 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Dept Chem Engn, Ctr Biomat Drug Delivery Bionanotechnol & Mol Rec, Austin, TX 78712 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Dept Pharmaceut, Ctr Biomat Drug Delivery Bionanotechnol & Mol Rec, Austin, TX 78712 USA.
RP Peppas, NA (reprint author), Univ Texas Austin, Dept Biomed Engn, Ctr Biomat Drug Delivery Bionanotechnol & Mol Rec, 1 Univ Stn,C-0400, Austin, TX 78712 USA.
EM peppas@che.utexas.edu
FU National Science Foundation Integrative Graduate Education and Research
   Traineeship (IGERT) [DGE-03-33080]
FX This work was funded in part by a National Science Foundation
   Integrative Graduate Education and Research Traineeship (IGERT)
   Fellowship (to C. L. B.) DGE-03-33080.
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Arsov LD, 1998, J SOLID STATE ELECTR, V2, P355, DOI 10.1007/s100080050112
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   Brabec CJ, 1999, J APPL PHYS, V85, P6866, DOI 10.1063/1.370205
   Brozova L, 2008, POLYM DEGRAD STABIL, V93, P592, DOI 10.1016/j.polymdegradstab.2008.01.012
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Fonner J.M., 2008, BIOMED MATER, V3, P12
   FRANK AJ, 1989, J PHYS CHEM-US, V93, P3818, DOI 10.1021/j100346a088
   GANDHI MR, 1995, SYNTHETIC MET, V73, P247, DOI 10.1016/0379-6779(95)80022-0
   HAND RL, 1974, J AM CHEM SOC, V96, P850, DOI 10.1021/ja00810a034
   Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0
   Irimia-Vladu M, 2006, SYNTHETIC MET, V156, P1396, DOI 10.1016/j.synthmet.2006.11.004
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   Kim J, 2006, POLYM J, V38, P659, DOI 10.1295/polymj.PJ2005185
   Kinlen PJ, 1997, SYNTHETIC MET, V85, P1327, DOI 10.1016/S0379-6779(97)80257-3
   LAVINE M, 2007, SCIENCE, V316, pD341
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Lee KS, 2006, ADV FUNCT MATER, V16, P2409, DOI 10.1002/adfm.200600170
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li YL, 2005, J BIOMED MATER RES A, V73A, P171, DOI 10.1002/jbm.a.30286
   Lu XH, 2003, SYNTHETIC MET, V138, P429, DOI 10.1016/S0379-6779(02)00471-X
   Marinakos SM, 2001, J PHYS CHEM B, V105, P8872, DOI 10.1021/jp010820d
   MCMANUS PM, 1987, J PHYS CHEM-US, V91, P744, DOI 10.1021/j100287a050
   MILLER LL, 1987, J AM CHEM SOC, V109, P2267, DOI 10.1021/ja00242a006
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3
   Otero TF, 2003, SENSOR ACTUAT B-CHEM, V96, P152, DOI 10.1016/S0925-4005(03)00518-5
   Pringle JM, 2006, SYNTHETIC MET, V156, P979, DOI 10.1016/j.synthmet.2006.06.009
   Rannou P, 1999, SYNTHETIC MET, V101, P734, DOI 10.1016/S0379-6779(98)00207-0
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Rowlands AS, 2008, BIOMATERIALS, V29, P4510, DOI 10.1016/j.biomaterials.2008.07.052
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   Stejskal J, 1999, SYNTHETIC MET, V105, P195, DOI 10.1016/S0379-6779(99)00105-8
   Sun LF, 1997, SYNTHETIC MET, V84, P67, DOI 10.1016/S0379-6779(96)03839-8
   Wang CH, 1999, SYNTHETIC MET, V102, P1313, DOI 10.1016/S0379-6779(98)01006-6
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Yoo JE, 2007, J MATER CHEM, V17, P1268, DOI 10.1039/b618521e
NR 43
TC 12
Z9 12
U1 3
U2 27
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 5
BP 623
EP 634
DI 10.1163/156856209X434647
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 574ID
UT WOS:000275981700006
PM 20338096
DA 2018-10-20
ER

PT J
AU Yamazoe, H
   Tanabe, T
AF Yamazoe, Hironori
   Tanabe, Toshizumi
TI Drug-Carrying Albumin Film for Blood-Contacting Biomaterials
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Recombinant human serum albumin; cross-linking; antithrombogenic
   property; cilostazol; blood compatibility
ID HEART-VALVE BIOPROSTHESIS; CROSS-LINKED ALBUMIN; PROTEIN ADSORPTION;
   PLATELET-ADHESION; LIGAND-BINDING; SERUM-ALBUMIN; SURFACE;
   IMMOBILIZATION; COMPATIBILITY; CILOSTAZOL
AB Surface-induced thrombosis is a major complication in the development of blood-contacting medical devices. Serum albumin has the ability to bind to a wide variety of compounds, including drugs, and neither cells nor proteins adsorb to an albumin-coated surface. These properties of albumin are useful for improving the blood compatibility of biomaterial surfaces. In the present study, we prepared a water-insoluble film by cross-linking pharmaceutical grade recombinant human serum albumin aiming to the clinical applications, and loaded the film with a synthetic antiplatelet drug, cilostazol. The resultant film possessed native albumin characteristics such as drug binding ability and resistance to cell adhesion. Mouse fibroblast L929 cells did not adhere on the albumin film, just as they did not adhere on native albumin-coated surfaces. Furthermore, when the albumin film carrying cilostazol was placed in PBS containing Tween-80, the release of cilostazol was sustained over 144 h. The results indicate that the surface coating with thus prepared albumin film can confer the biomaterials with antithrombogenic surface by virtue of its non-adhesiveness to cells and its release of cilostazol. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Yamazoe, Hironori] Natl Inst Adv Ind Sci & Technol, NanoBio Med Technol Grp, Nanotechnol Res Inst, Tsukuba, Ibaraki 3058562, Japan.
   [Tanabe, Toshizumi] Osaka City Univ, Dept Appl Chem & Bioengn, Grad Sch Engn, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Yamazoe, H (reprint author), Natl Inst Adv Ind Sci & Technol, NanoBio Med Technol Grp, Nanotechnol Res Inst, Cent 4-1,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.
EM hironori-yamazoe@aist.go.jp
RI Yamazoe, Hironori/A-3143-2015
OI Yamazoe, Hironori/0000-0003-2948-8786
FU Otani Wataru and Matsuoka Yasushi of Mitsubishi Tanabe Pharma Co
FX The author wishes to acknowledge Otani Wataru and Matsuoka Yasushi of
   Mitsubishi Tanabe Pharma Co., and Takeshita Yoshiyuki of Otsuka
   Pharmaceutical Co., Ltd., for their assistance in our research.
CR Arima Y, 2007, J MATER CHEM, V17, P4079, DOI 10.1039/b708099a
   BENSLIMANE S, 1986, BIOMATERIALS, V7, P268, DOI 10.1016/0142-9612(86)90048-7
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   FEHSKE KJ, 1981, BIOCHEM PHARMACOL, V30, P687, DOI 10.1016/0006-2952(81)90151-9
   Frautschi JR, 1995, J BIOMAT SCI-POLYM E, V7, P563
   GUIDOIN RG, 1976, BIOMATER ARTIF CELL, V4, P205, DOI 10.3109/10731197609118651
   HAYNES R, 1967, BIOCHEMISTRY-US, V6, P541, DOI 10.1021/bi00854a023
   Hombreiro-Perez M, 2003, J CONTROL RELEASE, V88, P413, DOI 10.1016/S0168-3659(03)00030-0
   ISHIKAWA Y, 1984, THROMB RES, V35, P193, DOI 10.1016/0049-3848(84)90214-7
   ITO Y, 1990, J BIOMED MATER RES, V24, P227, DOI 10.1002/jbm.820240209
   Jinno J, 2006, J CONTROL RELEASE, V111, P56, DOI 10.1016/j.jconrel.2005.11.013
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Keogh James R., 1996, Cells and Materials, V6, P209
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Kobayashi K, 1998, Ther Apher, V2, P257, DOI 10.1111/j.1744-9987.1998.tb00118.x
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17
   LYMAN DJ, 1970, THROMB DIATH HAEMO, V42, P109
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   Potineni A, 2003, J CONTROL RELEASE, V86, P223, DOI 10.1016/S0168-3659(02)00374-7
   SHEN SH, 1994, J APPL BIOMATER, V5, P159, DOI 10.1002/jab.770050209
   SHIMIZU T, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1117
   Subramanian A, 2004, TECH PAPERS ISA, V449, P1
   Sung H W, 1994, ASAIO J, V40, P192, DOI 10.1097/00002480-199404000-00013
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Yamazoe H, 2008, LANGMUIR, V24, P8402, DOI 10.1021/la801221r
   Yamazoe H, 2008, J BIOMED MATER RES A, V86A, P228, DOI 10.1002/jbm.a.31654
NR 30
TC 9
Z9 9
U1 2
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 5
BP 647
EP 657
DI 10.1163/156856209X434665
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 574ID
UT WOS:000275981700008
PM 20338098
DA 2018-10-20
ER

PT J
AU Parrag, IC
   Woodhouse, KA
AF Parrag, Ian C.
   Woodhouse, Kimberly A.
TI Development of Biodegradable Polyurethane Scaffolds Using Amino Acid and
   Dipeptide-Based Chain Extenders for Soft Tissue Engineering
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Soft tissue engineering; biodegradable polyurethane; elastomeric;
   scaffold; cell-responsive; electrospinning; matrix metalloproteinase;
   biomaterial
ID IN-VITRO DEGRADATION; EXTRACELLULAR-MATRIX; CELL-MIGRATION; ELASTOMERIC
   SCAFFOLDS; HEART-TISSUE; CYTOCOMPATIBILITY; CARDIOMYOCYTES;
   BIOMATERIALS; FILMS
AB The inherent flexibility of polyurethane (PU) chemistry allows the incorporation of specific chemical moieties into the backbone structure conferring a unique biological function to these synthetic polymers. We describe here the synthesis and characterization of a PU containing a Gly-Leu linkage, the cleavage site of several matrix metalloproteinases. A Gly-Leu dipeptide was introduced into the chain extender of the polyurethane through the reaction with 1,4-cyclohexane dimethanol. PUs synthesized with the Gly-Leu-based chain extender had a high weight-average molecular weight (M(w) > 125 x 10(3)) and were phase segregated, semi-crystalline polymers with a low soft-segment glass-transition temperature (T(g) < -50 degrees C). Uniaxial tensile testing of PU films indicated that the polymer could withstand high ultimate tensile strengths (approx. 13 MPa) and were flexible with breaking strains of approx. 900%. The Gly-Leu PU had a significantly higher initial modulus, yield stress and ultimate stress compared to a PU previously developed in our laboratory containing a phenylalanine-based chain extender (Phe PU). The Gly-Leu-based chain extender allowed for better hard segment packing and hydrogen bonding leading to enhanced mechanical properties. Electrospinning was used to form scaffolds with randomly organized fibers and an average fiber diameter of approx. 3.6 mu m for both the Gly-Leu and Phe PUs. Mouse embryonic fibroblasts were successfully cultured on the PU scaffolds out to 28 days. Further investigations into cell-mediated polymer degradation will help to identify the suitability of this new biomaterial as scaffolds for soft tissue applications. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Parrag, Ian C.; Woodhouse, Kimberly A.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5V 3E5, Canada.
   [Parrag, Ian C.; Woodhouse, Kimberly A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Woodhouse, Kimberly A.] Queens Univ, Fac Engn, Kingston, ON K7L 3N6, Canada.
RP Woodhouse, KA (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5V 3E5, Canada.
EM Kim.Woodhouse@queensu.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR) [MOP74627]; Department of
   Chemical Engineering and Applied Chemistry at the University of Toronto
FX The authors would like to acknowledge Eric Altman, Gary Skarja and
   Joanna Fromstein for their technical advice. Funding for this work was
   provided by the Natural Sciences and Engineering Research Council of
   Canada (NSERC), the Canadian Institutes of Health Research (CIHR fund
   number MOP74627), and the Department of Chemical Engineering and Applied
   Chemistry at the University of Toronto.
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Freier T., 2006, ADV POLYM SCI, V203, P1, DOI DOI 10.1007/12_073
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Guan JJ, 2005, BIOMACROMOLECULES, V6, P2833, DOI 10.1021/bm0503322
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   HUANG SJ, 1979, J APPL POLYM SCI, V23, P429, DOI 10.1002/app.1979.070230212
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lei LJ, 2007, POLYM DEGRAD STABIL, V92, P389, DOI 10.1016/j.polymdegradstab.2006.12.004
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rockwood DN, 2007, J BIOMAT SCI-POLYM E, V18, P743, DOI 10.1163/156856207781034115
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 2001, J BIOMAT SCI-POLYM E, V12, P851, DOI 10.1163/156856201753113060
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Socrates G., 1994, INFRARED CHARACTERIS
   Tyagi SC, 1997, MOL CELL BIOCHEM, V168, P1, DOI 10.1023/A:1006850903242
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   WOESSNER J, 2000, MATRIX METALLOPROTEI, V1, P98
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
NR 30
TC 16
Z9 16
U1 1
U2 19
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 6-7
BP 843
EP 862
DI 10.1163/156856209X446743
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 600UX
UT WOS:000278015500011
PM 20482988
DA 2018-10-20
ER

PT J
AU de Guzman, RC
   Loeb, JA
   VandeVord, PJ
AF de Guzman, Roche C.
   Loeb, Jeffrey A.
   VandeVord, Pamela J.
TI Electrospinning of Matrigel to Deposit a Basal Lamina-Like Nanofiber
   Surface
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Matrigel; basal lamina; electrospinning; nanofibers; neurite elongation;
   Schwann cell migration
ID GLOBULE-LIKE STATE; MEMBRANES IN-VIVO; BASEMENT-MEMBRANE; NERVE
   REGENERATION; SCHWANN-CELLS; IV COLLAGEN; TRICHLOROACETIC-ACID;
   NEUROTROPHIC FACTORS; PROTEIN; PROTEOGLYCAN
AB Schwann cell basal lamina is a nanometer-thin extracellular matrix layer that separates the axon-bound Schwann cells from the endoneurium of the peripheral nerve. It is implicated in the promotion of nerve regeneration after transection injury by allowing Schwann cell colonization and axonal guidance. Hence, it is desired to mimic the native basal lamina for neural tissue engineering applications. In this study, basal lamina proteins from BD Matrigel T (growth factor-reduced) were extracted and electrospun to deposit nonwoven nanofiber mats. Adjustment of solute protein concentration, potential difference, air gap distance and flow rate produced a basal lamina-like construct with an average surface roughness of 23 nm and composed of 100-nm-thick irregular and relatively discontinuous fibers. Culture of embryonic chick dorsal root ganglion explants demonstrated that the fabricated nanofiber layer supported explant attachment, elongation of neurites, and migration of satellite Schwann cells in a similar fashion compared to electrospun collagen type-I fibers. Furthermore, the presence of nanorough surface features significantly increased the neurite spreading and Schwann cell growth. Sciatic nerve segment incubation also showed that the construct is promigratory to nerve Schwann cells. Results, therefore, suggest that the synthetic basal lamina fibers can be utilized as a biomaterial for induction of peripheral nerve repair. (C) Koninklijke Brill NV, Leiden, 2010
C1 [de Guzman, Roche C.; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
   [de Guzman, Roche C.; VandeVord, Pamela J.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI 48201 USA.
   [Loeb, Jeffrey A.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA.
RP VandeVord, PJ (reprint author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
EM pvord@wayne.edu
RI de Guzman, Roche/K-8832-2015; VandeVord, Pamela/B-4606-2012
OI de Guzman, Roche/0000-0001-6051-4765; 
FU VAMC RRD [B6077R]
FX This research was supported by VAMC RRD Merit Award No. B6077R. We would
   like to thank Dr. Guangzhao Mao and Jennifer Blacklock at the Department
   of Chemical Engineering for the use of AFM.
CR Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Aumailley M, 1995, Kidney Int Suppl, V49, pS4
   BARNARD K, 1993, BIOPOLYMERS, V33, P897, DOI 10.1002/bip.360330605
   Bix G, 2008, MICROSC RES TECHNIQ, V71, P339, DOI 10.1002/jemt.20562
   BORNSTEIN MB, 1958, LAB INVEST, V7, P134
   BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305
   BUNGE RP, 1987, J EXP BIOL, V132, P21
   Burger C, 2006, ANNU REV MATER RES, V36, P333, DOI 10.1146/annurev.matsci.36.011205.123537
   CHEN Z, 1990, RHEOL ACTA, V29, P385, DOI 10.1007/BF01376788
   Chen ZCC, 2008, J BIOMAT SCI-POLYM E, V19, P693, DOI 10.1163/156856208784089580
   Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593
   Court FA, 2006, CURR OPIN NEUROBIOL, V16, P501, DOI 10.1016/j.conb.2006.08.005
   Cunningham L. W., 1982, STRUCTURAL CONTRACTI
   DEYOUNG LR, 1993, BIOCHEMISTRY-US, V32, P3877, DOI 10.1021/bi00066a006
   Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   Edmond KV, 2006, LANGMUIR, V22, P9052, DOI 10.1021/1a0614987
   Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004
   Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043
   FINK AL, 1993, PROTEIN SCI, V2, P1155, DOI 10.1002/pro.5560020710
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   GATHERCOLE LJ, 1989, INT J BIOL MACROMOL, V11, P335, DOI 10.1016/0141-8130(89)90004-4
   GRIMBLEBY F, 1961, NATURE, V189, P835, DOI 10.1038/189835a0
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hirota N, 1997, PROTEIN SCI, V6, P416
   Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567
   IDE C, 1990, PROG NEUROBIOL, V34, P1, DOI 10.1016/0301-0082(90)90024-B
   IDE C, 1983, ARCH HISTOL JAPON, V46, P243, DOI 10.1679/aohc.46.243
   IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1
   INOUE S, 1994, MICROSC RES TECHNIQ, V28, P29, DOI 10.1002/jemt.1070280105
   KATZ S, 1974, J BIOL CHEM, V249, P7892
   Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Kramer James M, 2005, WormBook, P1
   KUFFLER DP, 1986, J COMP NEUROL, V250, P236, DOI 10.1002/cne.902500210
   KUMAR TKS, 1994, J BIOL CHEM, V269, P12620
   Kuprin S, 1995, BIOCHEM BIOPH RES CO, V217, P1151, DOI 10.1006/bbrc.1995.2889
   LEBLOND CP, 1989, AM J ANAT, V185, P367, DOI 10.1002/aja.1001850403
   Mackie AR, 1998, BIOPOLYMERS, V46, P245, DOI 10.1002/(SICI)1097-0282(19981005)46:4<245::AID-BIP6>3.3.CO;2-X
   Mathey E, 2007, BIOLOGY OF SCHWANN CELLS: DEVELOPMENT, DIFFERENTIATION AND IMMUNOMODULATION, P1, DOI 10.1017/CBO9780511541605.002
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MERKER HJ, 1994, MICROSC RES TECHNIQ, V28, P95, DOI 10.1002/jemt.1070280203
   Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563
   Miosge N, 2001, HISTOL HISTOPATHOL, V16, P1239, DOI 10.14670/HH-16.1239
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204
   Osawa T, 2003, J ELECTRON MICROSC, V52, P435, DOI 10.1093/jmicro/52.4.435
   PAULSSON M, 1992, CRIT REV BIOCHEM MOL, V27, P93
   Pearson RG, 2003, TISSUE ENG, V9, P201, DOI 10.1089/107632703764664675
   Quondamatteo F, 2002, HISTOCHEM J, V34, P369, DOI 10.1023/A:1023675619251
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x
   Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200
   Sirangelo I, 2003, BIOCHEMISTRY-US, V42, P312, DOI 10.1021/bi020447f
   Sivaraman T, 1997, J PROTEIN CHEM, V16, P291, DOI 10.1023/A:1026357009886
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   TIMPL R, 1984, CIBA F SYMP, V108, P25
   TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x
   Tsiper MV, 2002, J CELL SCI, V115, P1005
   USHIKI T, 1990, ARCH HISTOL CYTOL, V53, P523, DOI 10.1679/aohc.53.523
   VRACKO R, 1974, AM J PATHOL, V77, P314
   Williams PA, 2008, PEST MANAG SCI, V64, P497, DOI 10.1002/ps.1523
   Xu Z, 2003, J PROTEIN CHEM, V22, P669, DOI 10.1023/B:JOPC.0000008732.38381.16
   Yang Y, 1996, AM J REPROD IMMUNOL, V36, P25
   YURCHENCO PD, 1990, ANN NY ACAD SCI, V580, P195, DOI 10.1111/j.1749-6632.1990.tb17929.x
   YURCHENCO PD, 1990, FASEB J, V4, P1577
   BD MATRIGEL BASEMENT
NR 67
TC 8
Z9 8
U1 3
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 8-9
BP 1081
EP 1101
DI 10.1163/092050609X12457428936116
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 600UY
UT WOS:000278015600008
PM 20507710
DA 2018-10-20
ER

PT J
AU Focarete, ML
   Gualandi, C
   Scandola, M
   Govoni, M
   Giordano, E
   Foroni, L
   Valente, S
   Pasquinelli, G
   Gao, W
   Gross, RA
AF Focarete, Maria Letizia
   Gualandi, Chiara
   Scandola, Mariastella
   Govoni, Marco
   Giordano, Emanuele
   Foroni, Laura
   Valente, Sabrina
   Pasquinelli, Gianandrea
   Gao, Wei
   Gross, Richard A.
TI Electrospun Scaffolds of a Polyhydroxyalkanoate Consisting of
   omega-Hydroxylpentadecanoate Repeat Units: Fabrication and In Vitro
   Biocompatibility Studies
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Electrospinning; poly(omega-pentadecalactone); polyesters; biomaterials;
   tissue engineering; embryonic rat cardiac H9c2 cells; biocompatibility
ID RING-OPENING POLYMERIZATION; POLY(ETHYLENE OXIDE) FIBERS; TISSUE
   REGENERATION; PEPTIDE AMPHIPHILE; POLYSTYRENE FIBERS; LIPASE CATALYSIS;
   GOOD SOLVENT; NANOFIBERS; PENTADECALACTONE; BIOMATERIALS
AB Electrospinning was used to fabricate fibrous scaffolds of lipase-catalyzed poly(omega-pentadecalactone) (PPDL). The slow resorbability of this biomaterial is expected to be valuable for tissue-engineering applications requiring long healing times. The effect of solvent systems and instrumental parameters on fiber morphology was investigated. PPDL electrospinning was optimized and defect-free fibers (diameter 410 +/- 150 nm) were obtained by using a mixed three-solvent system. Scaffolds were characterized by scanning electron microscopy, thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and wide angle X-ray diffraction (WAXS). TGA showed no residual solvent in the scaffolds. DSC and WAXS results indicated that electrospun PPDL is semicrystalline. Biocompatibility of PPDL scaffolds was evaluated through indirect cytotoxicity tests using embryonic rat cardiac H9c2 cells. The ability of PPDL electrospun mats to support cell growth was verified by culturing H9c2 cells onto the scaffold. Cell adhesion, proliferation and morphology were evaluated. The results indicated that PPDL mats are not cytotoxic and they support proliferation of H9c2 cells. The cumulative results of this study suggest further exploration of PPDL fibrous mats as scaffolds for tissue-engineered constructs. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Focarete, Maria Letizia; Gualandi, Chiara; Scandola, Mariastella] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Focarete, Maria Letizia; Gualandi, Chiara; Scandola, Mariastella] RU Bologna, Natl Consortium Mat Sci & Technol, INSTM, I-40126 Bologna, Italy.
   [Govoni, Marco; Giordano, Emanuele] Univ Bologna, Dept Biochem G Moruzzi, I-40126 Bologna, Italy.
   [Govoni, Marco; Giordano, Emanuele] RU Cesena, INRC, I-40126 Bologna, Italy.
   [Foroni, Laura; Valente, Sabrina] Univ Bologna, I-40138 Bologna, Italy.
   [Pasquinelli, Gianandrea] Univ Bologna, Clin Dept Radiol & Histocytomorphol Sci, I-40138 Bologna, Italy.
   [Gao, Wei; Gross, Richard A.] NYU, NSF I UCRC Ctr Biocatalysis & Bioproc Macromol, Dept Chem & Biol Sci, Polytech Inst,Metrotech Ctr 6, Brooklyn, NY 11201 USA.
RP Focarete, ML (reprint author), Univ Bologna, Dept Chem G Ciamician, Via Selmi 2, I-40126 Bologna, Italy.
EM marialetizia.focarete@unibo.it
RI Pasquinelli, Gianandrea/I-7088-2012; gualandi, chiara/A-5935-2015;
   Focarete, Maria Letizia/B-2369-2009
OI Pasquinelli, Gianandrea/0000-0003-1506-1829; gualandi,
   chiara/0000-0002-2020-1892; Focarete, Maria Letizia/0000-0002-0458-7836;
   Govoni, Marco/0000-0002-1876-8101
FU University of Bologna; Italian Ministry of Foreign Affairs; Fondazione
   Cassa di Risparmio in Bologna [CARISBO 2007.0058]; Regione Emilia
   Romagna; National Institute for Cardiovascular Research (INRC); National
   Science Foundation Industry/University Cooperative Research Center
   (NSF-I/UCRC) for Biocatalysis and Bioprocessing of Macromolecules at
   Polytechnic Institute of NYU
FX This work was partially supported by Strategic Project SCAFELMED
   (University of Bologna), Italian Ministry of Foreign Affairs
   (Directorate General for Cultural Promotion and Cooperation -
   Significant Bilateral Project Italia-USA), Fondazione Cassa di Risparmio
   in Bologna (CARISBO 2007.0058), Regione Emilia Romagna (Programma di
   Ricerca Regione - Universita 2007-2009, Area 1b 'Medicina
   rigenerativa'). M. G. is the recipient of a fellowship awarded by
   National Institute for Cardiovascular Research (INRC) (funding from the
   Compagnia di San Paolo, Torino). R. G. and W. G. thank the National
   Science Foundation Industry/University Cooperative Research Center
   (NSF-I/UCRC) for Biocatalysis and Bioprocessing of Macromolecules at
   Polytechnic Institute of NYU for their financial support.
CR BRISHT KS, 1997, MACROMOLECULES, V30, P2705
   Ceccorulli G, 2005, BIOMACROMOLECULES, V6, P902, DOI 10.1021/bm0493279
   Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Focarete ML, 2002, MACROMOLECULES, V35, P8066, DOI 10.1021/ma0205966
   Focarete ML, 2001, J POLYM SCI POL PHYS, V39, P1721
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Hakkarainen M, 2002, ADV POLYM SCI, V157, P113
   HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Jarusuwannapoom T, 2005, EUR POLYM J, V41, P409, DOI 10.1016/j.eurpolymj.2004.10.010
   Jiang ZZ, 2007, BIOMACROMOLECULES, V8, P2262, DOI 10.1021/bm070138a
   Kakudo M., 1972, XRAY DIFFRACTION POL
   KRUMM S., 1996, ACTA U CAROLINAE GEO, V38, P253
   Lannutti J, 2007, MAT SCI ENG C-BIO S, V27, P504, DOI 10.1016/j.msec.2006.05.019
   Lee KH, 2003, POLYMER, V44, P4029, DOI 10.1016/S0032-3861(03)00345-8
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lide D. R., 2007, HDB CHEM PHYS
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nikolaychik VV, 1996, J BIOMAT SCI-POLYM E, V7, P881, DOI 10.1163/156856296X00057
   NOMURA R, 1994, MACROMOLECULES, V27, P620, DOI 10.1021/ma00080a046
   PACHENCE JM, 2007, PRINCIPLES TISSUE EN, P322
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
   Teo W. E., 2006, NANOTECHNOLOGY, V17, P89, DOI DOI 10.1088/0957-4484/17/14/R01
   van der Meulen I, 2008, BIOMACROMOLECULES, V9, P3404, DOI 10.1021/bm800898c
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhong X, 2003, POLYMER, V44, P4959
   Zhong X. H., 2002, POLYMER, V43, P4403, DOI DOI 10.1016/S0032-3861(02)00275-6
NR 40
TC 11
Z9 11
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 10
BP 1283
EP 1296
DI 10.1163/092050609X12517190417597
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 633GG
UT WOS:000280487600002
PM 20534185
DA 2018-10-20
ER

PT J
AU Jin, ZL
   Feng, W
   Zhu, SP
   Sheardown, H
   Brash, JL
AF Jin, Zhilin
   Feng, Wei
   Zhu, Shiping
   Sheardown, Heather
   Brash, John L.
TI Protein-Resistant Materials via Surface-Initiated Atom Transfer Radical
   Polymerization of 2-Methacryloyloxyethyl Phosphorylcholine
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Surface modification; atom transfer radical polymerization (ATRP);
   protein-resistant surface; phosphorylcholine; MPC
ID HEPARIN-IMMOBILIZED POLYURETHANES; OXYGEN PLASMA-TREATMENT; PHOSPHOLIPID
   POLYMERS; SILICONE-RUBBER; CHAIN DENSITY; ADSORPTION;
   POLY(DIMETHYLSILOXANE); FIBRINOGEN; COPOLYMER; PERMANENT
AB Poly(2-methacryloyloxyethyl phosphorylcholine) (poly(MPC)) was grafted from various polymeric substrates to prepare protein-resistant materials. The poly(MPC) chain length was adjusted via the ratio of monomer to sacrificial initiator in solution. The surfaces were characterized by water contact angle and X-ray photoelectron spectroscopy (XPS). The protein-resistant properties of the poly(MPC)-grafted surfaces were evaluated by single adsorption experiments with fibrinogen and lysozyme. It was shown that the simple three-step grafting method could be applied to modify various biomaterial surfaces including polyurethane and silicones. The adsorption of fibrinogen and lysozyme to the modified surfaces was greatly reduced compared to the unmodified surfaces, and adsorption decreased with increasing poly(MPC) chain length. On polyurethane film grafted with poly(MPC) of chain length 100, the reduction in adsorption was approx. 96% for lysozyme and approx. 99% for fibrinogen. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Brash, John L.] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM brashjl@mcmaster.ca
RI Zhu, Shiping/C-3754-2012
OI Zhu, Shiping/0000-0001-8551-0859
FU Natural Sciences and Engineering Research Council of Canada (NSERC)
FX This work was supported by a Strategic Grant of the Natural Sciences and
   Engineering Research Council of Canada (NSERC). We also thank the Canada
   Foundation for Innovation (CFI) for supporting the research facilities
   in our laboratories. We thank Professor K. Ishihara for providing the
   MPC monomer used in this research.
CR Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Couet J, 2006, MACROMOLECULES, V39, P7258, DOI 10.1021/ma061200j
   Cvelbar U, 2003, APPL SURF SCI, V210, P255, DOI 10.1016/S0169-4332(02)01286-2
   de Sainte Claire P., 2009, MACROMOLECULES, V42, P3469
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Feng W, 2006, BIOINTERPHASES, V1, P50, DOI 10.1116/1.2187495
   France RM, 1997, J CHEM SOC FARADAY T, V93, P3173, DOI 10.1039/a702311a
   Goda T, 2006, BIOMATERIALS, V27, P5151, DOI 10.1016/j.biomaterials.2006.05.046
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P87, DOI 10.1002/jbm.820231309
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   JIN Z, 2009, J BIOMED IN PRESS A
   Jin ZL, 2009, COLLOID SURFACE B, V70, P53, DOI 10.1016/j.colsurfb.2008.12.005
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Langowski BA, 2005, LANGMUIR, V21, P6366, DOI 10.1021/la046795v
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee SH, 2002, MACROMOL RES, V10, P85, DOI 10.1007/BF03218295
   Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6
   Lewis AL, 2002, J BIOMED MATER RES, V63, P699, DOI 10.1002/jbm.10387
   Liu P, 2005, POLYM BULL, V55, P411, DOI 10.1007/s00289-005-0454-6
   Ma XL, 2007, J MEMBRANE SCI, V292, P116, DOI 10.1016/j.memsci.2007.01.024
   MAECHLINGSTRASSER C, 1989, J BIOMED MATER RES, V23, P1385, DOI 10.1002/jbm.820231202
   Marutani E, 2004, POLYMER, V45, P2231, DOI 10.1016/j.polymer.2004.02.005
   Millare B, 2008, LANGMUIR, V24, P13218, DOI 10.1021/la801965s
   Motomura T, 2003, ARTIF ORGANS, V27, P1050, DOI 10.1046/j.1525-1594.2003.07077.x
   Roth J, 2008, LANGMUIR, V24, P12603, DOI 10.1021/la801970s
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Swaraj S, 2005, PLASMA PROCESS POLYM, V2, P572, DOI 10.1002/ppap.200500022
   Unsworth LD, 2008, LANGMUIR, V24, P1924, DOI 10.1021/la702310t
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   van Poll ML, 2007, ANGEW CHEM INT EDIT, V46, P6634, DOI 10.1002/anie.200702286
   Wu YZ, 2007, J AM CHEM SOC, V129, P7226, DOI 10.1021/ja071384x
   Xiao DQ, 2002, LANGMUIR, V18, P9971, DOI 10.1021/la0205553
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yoo HJ, 2005, BIOMATERIALS, V26, P2877, DOI 10.1016/j.biomaterials.2004.09.001
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   ZHANG H, 2007, J APPL POLYM SCI, V108, P351
NR 39
TC 16
Z9 18
U1 4
U2 23
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 10
BP 1331
EP 1344
DI 10.1163/092050609X12517190417713
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 633GG
UT WOS:000280487600005
PM 20534188
DA 2018-10-20
ER

PT J
AU Maxson, S
   Burg, KJL
AF Maxson, Scott
   Burg, Karen J. L.
TI Conditioned Media Enhance Osteogenic Differentiation on
   Poly(L-lactide-co-epsilon-caprolactone)/Hydroxyapatite Scaffolds and
   Chondrogenic Differentiation in Alginate
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Chondrogenic differentiation; conditioned media; mesenchymal stem cells;
   osteochondral tissue engineering; osteogenic differentiation
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; IN-VITRO;
   CHONDROCYTE DIFFERENTIATION; MORPHOGENETIC SIGNALS; COMPOSITE SCAFFOLDS;
   STROMAL CELLS; BONE; COCULTURE; TRANSGLUTAMINASE
AB The biochemical factors that regulate cell proliferation and differentiation can provide a means of optimizing culture conditions to develop a tissue-engineered osteochondral construct. Thus, the objectives of this study were to determine the effects of chondrocyte conditioned medium ( CM) on the osteogenic differentiation of mesenchymal stem cells (MSCs) cultured on poly(L-lactide-co-epsilon-caprolactone)/hydroxyapatite (PLA/PCL/HAP) scaffolds and to determine the effect of osteoblast CM on the chondrogenic differentiation of MSCs cultured in alginate. In addition, the biomaterial's effect on MSC differentiation was also investigated. MSCs were grown in two groups: ( 1) on porous PLA/PCL/HAP scaffolds in osteogenic differentiation medium or ( 2) encapsulated in alginate in chondrogenic differentiation medium. CM was taken from one group and administered to the 'opposite' group in volumetric concentrations of 25% or 50% at each medium change. The osteogenic group samples that were administered chondrocyte CM showed higher alkaline phosphatase activity than the controls that were not administered CM. Additionally, the cells that were given chondrocyte CM had higher osteocalcin and sialoprotein expression than the controls. Samples in the chondrogenic group that were administered osteoblast CM at a volumetric concentration of 50% produced more sGAG than the controls. The aggrecan and Sox9 expression was significantly higher in the samples given 50% CM as compared to the controls. The study also showed that culturing cells in alginate, without differentiation medium, can produce similar levels of differentiation as cells that were administered differentiation medium. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Maxson, Scott; Burg, Karen J. L.] Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501 4, Clemson, SC 29634 USA.
   [Maxson, Scott; Burg, Karen J. L.] Clemson Univ, Inst Biol Interfaces Engn, Clemson, SC 29634 USA.
RP Burg, KJL (reprint author), Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501 4, Clemson, SC 29634 USA.
EM kburg@clemson.edu
FU Hunter Endowment; DoD Era of Hope Scholar
FX This study was supported by a Hunter Endowment, DoD Era of Hope Scholar
   Award/BC044778 and NSF Presidential Early Career Award for Scientists
   and Engineers/BES 0093805.
CR AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Azevedo MC, 2003, J MATER SCI-MATER M, V14, P103, DOI 10.1023/A:1022051326282
   Baji A, 2006, MATER MANUF PROCESS, V21, P211, DOI 10.1081/AMP-200068681
   Beris AE, 2005, INJURY, V36, pS14, DOI 10.1016/j.injury.2005.10.007
   Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS116, DOI 10.1097/00003086-199810001-00013
   Brandt KD, 2006, ANN RHEUM DIS, V65, P1261, DOI 10.1136/ard.2006.058347
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Coleman RM, 2007, BIOMATERIALS, V28, P2077, DOI 10.1016/j.biomaterials.2007.01.010
   de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9
   Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726
   Gerstenfeld LC, 2003, CONNECT TISSUE RES, V44, P85, DOI 10.1080/03008200390152142
   Gimble JM, 2004, ENDOCRINE, V23, P183, DOI 10.1385/ENDO:23:2-3:183
   Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052
   Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Kurth T, 2007, OSTEOARTHR CARTILAGE, V15, P1178, DOI 10.1016/j.joca.2007.03.015
   LANGER F, 1978, CLIN ORTHOP RELAT R, P155
   LANGER R, 1993, SCIENCE, V920, P260
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Maxson S, 2008, J TISSUE ENG REGEN M, V2, P147, DOI 10.1002/term.76
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Nakaoka R, 2006, TISSUE ENG, V12, P2425, DOI 10.1089/ten.2006.12.2425
   Nurminskaya M, 2003, DEV BIOL, V263, P139, DOI 10.1016/S0012-1606(03)00445-7
   Nurminskaya M, 1996, ANN NY ACAD SCI, V785, P309, DOI 10.1111/j.1749-6632.1996.tb56293.x
   Raghunath J, 2005, CURR OPIN BIOTECH, V16, P503, DOI 10.1016/j.copbio.2005.08.004
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721
   Rosenthal AK, 2003, OSTEOARTHR CARTILAGE, V11, P463, DOI 10.1016/S1063-4584(03)00074-8
   Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Spalazzi JP, 2003, IEEE ENG MED BIOL, V22, P27, DOI 10.1109/MEMB.2003.1256269
   Thompson AD, 2009, TISSUE ENG PT A, V15, P1181, DOI 10.1089/ten.tea.2007.0275
   Tsuchiya K, 2004, MAT SCI ENG C-BIO S, V24, P391, DOI 10.1016/j.msec.2003.12.014
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Zhao J, 2008, APPL SURF SCI, V255, P2942, DOI 10.1016/j.apsusc.2008.08.056
NR 47
TC 8
Z9 8
U1 0
U2 13
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 11
BP 1441
EP 1458
DI 10.1163/092050609X12518804794703
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 633GI
UT WOS:000280487800003
PM 20534195
DA 2018-10-20
ER

PT J
AU Herath, KIK
   Tan, LP
   Chai, CLL
   Abadie, MJM
AF Herath, Kanishka I. K.
   Tan, Lay Poh
   Chai, Christina L. L.
   Abadie, Marc J. M.
TI Diallyl Tartrate as a Multifunctional Monomer for Bio-polymer Synthesis
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Photo-polymerization; differential photocalorimetry; cross-linking;
   biodegradation; cytotoxicity; polyester
ID CROSS-LINKING; DIFFERENTIAL PHOTOCALORIMETRY; CATIONIC-POLYMERIZATION;
   POLYLACTIDE OLIGOMERS; MECHANICAL-PROPERTIES; DENTAL COMPOSITES;
   PHOTOPOLYMERIZATION; NETWORKS; KINETICS; METHACRYLATE
AB This paper introduces the use of a diallyl dicarboxylate compound, diallyl tartrate, as a monomer in the synthesis of a biodegradable polymer. Although the allyl functional group is generally known for not being able to polymerize to high conversions, it was found in this study that by using photoinitiation instead of thermal initiation, a highly cross-linked polymer could be obtained from the polymerization of diallyl tartrate in a relatively short time. The details of the polymerization reaction were investigated in detail using differential photocalorimetry (DPC). The final thermoset obtained was shown to be completely amorphous and rigid, with a glass transition temperature of approx. 90 degrees C and a storage modulus of approx. 1 GPa at room temperature, via thermal analysis. It was also found to biodegrade in vitro via hydrolysis of its ester groups at a moderate rate, taking nearly 12 weeks to lose 50% of its mass. Both the photo-polymerized material and its water-soluble degradation products were further shown to be non-cytotoxic to fibroblast cells over at least 24 h of exposure. These results aim to initiate the use of this class of monomers in the synthesis of new polymers with tailored properties for biomaterial applications. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Herath, Kanishka I. K.; Tan, Lay Poh; Chai, Christina L. L.; Abadie, Marc J. M.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   ASTAR, Inst Chem & Engn Sci, Singapore 627833, Singapore.
   Univ Montpellier 2, LEMP MAO, CC 021, STL, F-34095 Montpellier 05, France.
RP Tan, LP (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, Blk N4-1,Nanyang Ave, Singapore 639798, Singapore.
EM LPTan@ntu.edu.sg
RI Tan, LP/A-2229-2011
OI Tan, LP/0000-0002-0172-1569; Chai, Christina/0000-0002-9199-851X
FU A*Star, Singapore and Institute of Chemical and Engineering Sciences,
   Singapore
FX The authors would like to thank A*Star, Singapore and Institute of
   Chemical and Engineering Sciences, Singapore for financial and
   facilities support.
CR ABADIE MJM, 1994, EUR POLYM J, V30, P1051, DOI 10.1016/0014-3057(94)90198-8
   Abadie MJM, 2003, J APPL POLYM SCI, V90, P1096, DOI 10.1002/app.12771
   Abadie MJM, 2003, EUR POLYM J, V39, P1243, DOI 10.1016/S0014-3057(02)00367-1
   ABADIE MJM, 1994, EUR POLYM J, V30, P399, DOI 10.1016/0014-3057(94)90305-0
   ABADIE MJM, 1991, EUR COAT J, V11, P788
   Anseth KS, 1999, NAT BIOTECHNOL, V17, P156
   Anseth KS, 2001, MACROMOL RAPID COMM, V22, P564, DOI 10.1002/1521-3927(20010501)22:8<564::AID-MARC564>3.0.CO;2-S
   Baroli B, 2006, J CHEM TECHNOL BIOT, V81, P491, DOI 10.1002/jctb.1468
   Belfield K.D., 2003, ACS S SERIES, V847
   BEOM SK, 2000, J POLYM SCI A, V38, P1277
   BEOM SK, 2000, BIOMATERIALS, V21, P259
   Boey FYC, 2000, POLYMER, V41, P2081, DOI 10.1016/S0032-3861(99)00409-7
   Chen S, 2007, POLYM INT, V56, P1423, DOI 10.1002/pi.2293
   Cho JD, 2005, EUR POLYM J, V41, P367, DOI 10.1016/j.europolymj.2004.10.006
   Cho JD, 2005, J POLYM SCI POL CHEM, V43, P658, DOI 10.1002/pola.20529
   DeAlmeida YMB, 1996, EUR POLYM J, V32, P1355, DOI 10.1016/S0014-3057(96)00086-9
   Decker C, 1996, PROG POLYM SCI, V21, P593, DOI 10.1016/0079-6700(95)00027-5
   Furniss B. S., 1989, VOGELS TXB PRACTICAL
   Guerra RM, 1996, J ORAL REHABIL, V23, P632
   GUTHIKONDA RN, 1987, J MED CHEM, V30, P871, DOI 10.1021/jm00388a022
   Helminen AO, 2003, J POLYM SCI POL CHEM, V41, P3788, DOI 10.1002/pola.10951
   Helminen AO, 2002, J APPL POLYM SCI, V86, P3616, DOI 10.1002/app.1193
   Kannurpatti AR, 1998, POLYMER, V39, P2507, DOI 10.1016/S0032-3861(97)00585-5
   KERR JA, 1966, CHEM REV, V66, P465, DOI 10.1021/cr60243a001
   Lang MD, 2002, J APPL POLYM SCI, V86, P2296, DOI 10.1002/app.11221
   LEE LY, 2009, EUR POLYM J IN PRESS
   Li F, 2001, POLYMER, V42, P1567, DOI 10.1016/S0032-3861(00)00546-2
   Matsumoto A, 2001, PROG POLYM SCI, V26, P189, DOI 10.1016/S0079-6700(00)00039-3
   Menard K. P., 2008, DYNAMIC MECH ANAL PR
   Naghash HJ, 1997, POLYMER, V38, P1187, DOI 10.1016/S0032-3861(96)00615-5
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   OHATA T, 1980, J POLYM SCI POL CHEM, V18, P467, DOI 10.1002/pol.1980.170180207
   OHATA T, 1975, POLYM LETT EDN, V13, P645
   Pamedytyte V, 2002, J APPL POLYM SCI, V86, P579, DOI 10.1002/app.10892
   Ruiz CSB, 2003, NUCL INSTRUM METH B, V208, P309, DOI 10.1016/S0168-583X(03)01113-3
   Ruiz CSB, 2002, J THERM ANAL CALORIM, V67, P335, DOI 10.1023/A:1013914813678
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Scherzer T, 1999, VIB SPECTROSC, V19, P385, DOI 10.1016/S0924-2031(98)00070-8
   Schliecker G, 2003, INT J PHARM, V266, P39, DOI 10.1016/S0378-5173(03)00379-X
   Schnabelrauch M, 2002, BIOMOL ENG, V19, P295, DOI 10.1016/S1389-0344(02)00034-5
   Sestak J, 1971, THERMOCHIM ACTA, V3, P1, DOI [10.1016/0040-6031(71)85051-7, DOI 10.1016/0040-6031(71)85051-7]
   STOREY RF, 1993, POLYMER, V34, P4365, DOI 10.1016/0032-3861(93)90203-M
   Sun F, 2007, NUCL INSTRUM METH B, V264, P318, DOI 10.1016/j.nimb.2007.09.027
   Vuluga DM, 1999, EUR POLYM J, V35, P2193, DOI 10.1016/S0014-3057(99)00021-X
   WANG DK, 1993, EUR POLYM J, V29, P1379, DOI 10.1016/0014-3057(93)90197-N
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Young JS, 1998, MACROMOL CHEM PHYSIC, V199, P1043, DOI 10.1002/(SICI)1521-3935(19980601)199:6<1043::AID-MACP1043>3.0.CO;2-Z
NR 47
TC 0
Z9 0
U1 0
U2 7
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 11
BP 1459
EP 1481
DI 10.1163/092050609X12518804794749
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 633GI
UT WOS:000280487800004
PM 20534196
DA 2018-10-20
ER

PT J
AU Bai, PL
   Cao, XL
   Zhang, YJ
   Yin, ZH
   Wei, Q
   Zhao, CS
AF Bai, Pengli
   Cao, Xuelian
   Zhang, Yijia
   Yin, Zehua
   Wei, Qiang
   Zhao, Changsheng
TI Modification of a Polyethersulfone Matrix by Grafting Functional Groups
   and the Research of Biomedical Performance
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Polyethersulfone; modification; chlorosulfonation; functional groups
ID SELF-ASSEMBLED MONOLAYERS; SULFONE) ULTRAFILTRATION MEMBRANES;
   POLY(DL-LACTIC ACID); AFFINITY MEMBRANES; POLYMER BRUSHES;
   PROTEIN-BINDING; HOLLOW SPHERES; HIGH-CAPACITY; SURFACE; POLYSULFONE
AB A new method for the functional modification of polyethersulfone (PES) is described in this paper in which PES was sulfonated by chlorosulfonic acid firstly and then chlorinated by phosphorus pentachloride. Thereby, chlorosulfonic groups (-SO(2)Cl) were introduced in PES successfully, and the degree of the chlorosulfonation was about 15%. Since the chlorosulfonic group is reactive enough towards the amino group (-NH(2)), the conformation of chlorosulfonic-based covalent bonding functional route could further extend the PES application area with versatile functionality. In this article, hydroxyl (-OH), carboxyl (-COOH), amino (-NH(2)) and methyl (-CH(3)) groups were grafted onto a PES matrix through the reaction of chlorosulfonic groups and the amino groups. The functional groups have effects on protein adsorption and cell behavior. The membrane modified with an amino group was in favor of cell adhesion and proliferation, and the membrane modified with hydroxyl and methyl did not so well as the membrane modified with an amino group, which will give guidance for biomaterial modification. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Bai, Pengli; Cao, Xuelian; Zhang, Yijia; Yin, Zehua; Wei, Qiang; Zhao, Changsheng] Sichuan Univ, State Key Lab Polymer Mat Engn, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
   [Bai, Pengli] Suzhou Inst Biomed Engn & Technol, Suzhou 215163, Peoples R China.
RP Zhao, CS (reprint author), Sichuan Univ, State Key Lab Polymer Mat Engn, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
EM zhaochsh70@163.com
RI Wei, Qiang/C-7745-2016
OI Wei, Qiang/0000-0001-5194-8262
FU National Natural Science Foundation of China [50673064]; Foundation of
   the State Education Ministry of China [2004527-16-14, JS20061116506327,
   NCET-05-0791]
FX This work was financially supported by the National Natural Science
   Foundation of China (No. 50673064); and the Foundation of the State
   Education Ministry of China (No. 2004527-16-14, JS20061116506327 and
   NCET-05-0791).
CR Arima Y, 2007, J MATER CHEM, V17, P4079, DOI 10.1039/b708099a
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bayramoglu G, 2006, COLLOID SURFACE A, V287, P75, DOI 10.1016/j.colsurfa.2006.03.027
   David S, 2003, CONTRIB NEPHROL, V138, P43
   Fang BH, 2009, J MEMBRANE SCI, V329, P46, DOI 10.1016/j.memsci.2008.12.008
   Guan R, 2005, EUR POLYM J, V41, P1554, DOI 10.1016/j.europolymj.2005.01.018
   Hirata I, 2003, J BIOMED MATER RES A, V66A, P669, DOI 10.1002/jbm.a.10067
   Ho JY, 2000, J BIOMAT SCI-POLYM E, V11, P1085
   Jain P, 2007, BIOMACROMOLECULES, V8, P3102, DOI 10.1021/bm700515m
   Ji J, 2004, BIOMATERIALS, V25, P1859, DOI 10.1016/j.biometerials.2003.08.031
   Kim IC, 1999, J APPL POLYM SCI, V74, P2046, DOI 10.1002/(SICI)1097-4628(19991121)74:8<2046::AID-APP20>3.0.CO;2-3
   Kim JH, 2005, J MEMBRANE SCI, V262, P60, DOI 10.1016/j.memsci.2005.04.003
   Li ZF, 2004, J COLLOID INTERF SCI, V269, P62, DOI 10.1016/S0021-9797(03)00606-4
   Liu ZB, 2009, J BIOMAT SCI-POLYM E, V20, P377, DOI 10.1163/156856209X412227
   Niu ZW, 2003, ADV FUNCT MATER, V13, P949, DOI 10.1002/adfm.200304460
   NOLTE R, 1993, J MEMBRANE SCI, V83, P211, DOI 10.1016/0376-7388(93)85268-2
   Pieracci J, 1999, J MEMBRANE SCI, V156, P223, DOI 10.1016/S0376-7388(98)00347-0
   Pieracci J, 2002, CHEM MATER, V14, P256, DOI 10.1021/cm010565+
   POZNIAK G, 1995, BIOMATERIALS, V16, P129, DOI 10.1016/0142-9612(95)98275-J
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RABIA I, 1997, POLYM ADVAN TECHNOL, V9, P107
   Samtleben W, 2003, NEPHROL DIAL TRANSPL, V18, P2382, DOI 10.1093/ndt/gfg410
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sluma H. D., 1991, Method for sulfonating aromatic polyether sulfones, Patent No. [USA: 5,013,765, 5013765]
   Sperling C, 2006, J BIOMED MATER RES A, V76A, P681, DOI 10.1002/jbm.a.30519
   Sun L, 2006, CHEM MATER, V18, P4033, DOI 10.1021/cm060554m
   Tullis RH, 2002, THER APHER, V6, P213, DOI 10.1046/j.1526-0968.2002.00407.x
   Ueda EKM, 2003, J CHROMATOGR A, V988, P1, DOI 10.1016/S0021-9673(02)02057-5
   Ulbricht M, 1996, J MEMBRANE SCI, V120, P239, DOI 10.1016/0376-7388(96)00148-2
   Ulbricht M, 1996, J MEMBRANE SCI, V111, P193, DOI 10.1016/0376-7388(95)00207-3
   Ulbricht M, 2007, SEP PURIF TECHNOL, V57, P63, DOI 10.1016/j.seppur.2007.02.012
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   WABERS HD, 1992, J BIOMAT SCI-POLYM E, V4, P107
   Wang YQ, 2005, LANGMUIR, V21, P11856, DOI 10.1021/la052052d
   WERNER C, 1995, J BIOMAT SCI-POLYM E, V7, P61, DOI 10.1163/156856295X00832
   YAMAGISHI H, 1995, J MEMBRANE SCI, V105, P237, DOI 10.1016/0376-7388(95)00063-I
   Yang KG, 2007, J APPL POLYM SCI, V106, P2791, DOI 10.1002/app.26924
   Yang M, 2005, ANGEW CHEM INT EDIT, V44, P6727, DOI 10.1002/anie.200501556
   Yoshikawa M, 2007, MACROMOL RAPID COMM, V28, P2100, DOI 10.1002/marc.200700359
   YUE J, 1992, POLYMER, V33, P4410, DOI 10.1016/0032-3861(92)90288-8
   Zhao CS, 2004, SEP PURIF TECHNOL, V40, P297, DOI 10.1016/j.seppur.2004.03.007
   Zhao CS, 2001, ARTIF ORGANS, V25, P60
   ZHAO CS, 2008, J MEMBRANE SCI, V31, P38
   Zhu HG, 2002, BIOMATERIALS, V23, P3141, DOI 10.1016/S0142-9612(02)00058-3
NR 44
TC 15
Z9 15
U1 2
U2 45
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 12
BP 1559
EP 1572
DI 10.1163/092050609X12519805626158
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 657EU
UT WOS:000282396800002
PM 20537241
DA 2018-10-20
ER

PT J
AU Kim, BS
   Choi, JS
   Kim, JD
   Yeo, TY
   Cho, Y
AF Kim, Beob Soo
   Choi, Ji Suk
   Kim, Jae Dong
   Yeo, Tae Yun
   Cho, YongWoo
TI Improvement of Stem Cell Viability in Hyaluronic Acid Hydrogels Using
   Dextran Microspheres
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Hyaluronic acid; hydrogel; dextran; microsphere; human adipose-derived
   stem cells; cell delivery; tissue engineering
ID ADIPOSE-TISSUE; IN-SITU; DELIVERY VEHICLES; ENDOTHELIAL-CELLS;
   DIFFERENTIATION; OSTEOARTHRITIS; REGENERATION; COPOLYMERS; THERAPIES;
   SCAFFOLDS
AB Although hyaluronic acid (HA) has been widely used in clinics as an injectable biomaterial, it may not be appropriate as an injectable stem cell carrier because highly hydrophilic HA hydrogels provide an unfavorable environment in which the encapsulated stem cells are likely to be constrained to a round shape, thereby losing their native morphology. Herein, we hypothesized that dextran microspheres (DMs) can improve stem cell viability in HA hydrogels because they can act as substrates for stem cell adhesion, spreading and proliferation. DMs with a mean diameter of 80 mu m were mixed with HA hydrogels. Human adipose-derived stem cells (hASCs) were isolated from human adipose tissue and seeded into the DM-incorporated HA hydrogels. When compared with the hydrogels alone, the number of viable cells was significantly increased in the presence of the DMs. Initially, hASCs appeared to be round in the HA hydrogels. At 12 h after seeding, the hASCs apparently attached onto the DMs and became slightly flattened. One day after seeding, the hASCs seemed to spread onto the surface of the DMs. Fluorescence micrography of live and dead cells confirmed that the cell viability was significantly improved by use of the DMs in HA hydrogels. Overall results demonstrated that the microsphere/hydrogel composite supported stem cell survival and spreading. These characteristics show the potential for use of the composite in cell-delivery and tissue-engineering applications. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Kim, Beob Soo; Choi, Ji Suk; Kim, Jae Dong; Yeo, Tae Yun; Cho, YongWoo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
   [Kim, Beob Soo; Choi, Ji Suk; Kim, Jae Dong; Yeo, Tae Yun; Cho, YongWoo] Hanyang Univ, Dept Bionanotechnol, Ansan 426791, Gyeonggi Do, South Korea.
RP Cho, Y (reprint author), Hanyang Univ, Dept Chem Engn, Sa 3 Dong, Ansan 426791, Gyeonggi Do, South Korea.
EM ywcho7@hanyang.ac.kr
FU Engineering Research Center [R11-2008-044-02001-0]; Ministry of
   Education, Science and Technology [M10645010003-06N4501-00310]
FX Acknowledgements This work was supported by the Engineering Research
   Center Program (grant No. R11-2008-044-02001-0) and the Bio-Signal
   Analysis Technology Innovation Program (grant No.
   M10645010003-06N4501-00310) through the National Research Foundation of
   Korea (NRF) funded by the Ministry of Education, Science and Technology.
CR Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Franssen O, 1999, J CONTROL RELEASE, V60, P211, DOI 10.1016/S0168-3659(99)00074-7
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gomes JAP, 2004, BRIT J OPHTHALMOL, V88, P821, DOI 10.1136/bjo.2003.027573
   Hegewald AA, 2004, TISSUE CELL, V36, P431, DOI 10.1016/j.tice.2004.07.003
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7
   Kang JY, 2009, INT J PHARMACEUT, V369, P114, DOI 10.1016/j.ijpharm.2008.11.008
   Kang SW, 2008, BIOTECHNOL LETT, V30, P435, DOI 10.1007/s10529-007-9576-2
   Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lin HH, 2001, MACROMOLECULES, V34, P3710, DOI 10.1021/ma001852m
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Nam JH, 2007, BIOTECHNOL PROGR, V23, P652, DOI 10.1021/bp070007l
   Nesic D, 2006, ADV DRUG DELIVER REV, V58, P300, DOI 10.1016/j.addr.2006.01.012
   Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Stenekes RJH, 2001, BIOMATERIALS, V22, P1891, DOI 10.1016/S0142-9612(00)00375-6
   Torio-Padron N, 2007, AESTHET PLAST SURG, V31, P285, DOI 10.1007/s00266-006-0221-6
   Wang Wen-dong, 2009, Huanjing Kexue, V30, P2259
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Wu H, 2008, ACTA BIOMATER, V4, P76, DOI 10.1016/j.actbio.2007.06.010
   Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 37
TC 8
Z9 9
U1 0
U2 18
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 13
BP 1701
EP 1711
DI 10.1163/092050609X12548957288848
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 661OR
UT WOS:000282738100002
PM 20537250
DA 2018-10-20
ER

PT J
AU Liu, X
   Xue, Y
   Sun, JA
AF Liu, Xin
   Xue, Yang
   Sun, Jiao
TI Indirect Induction of Endothelial Cell Injury by PU- or PTFE-Mediated
   Activation of Monocytes
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Biomaterials; human umbilical vein endothelial cell (HUVEC); monocyte;
   ROS; apoptosis; iNOS; p53
ID IN-VITRO; CYTOKINE EXPRESSION; NITRIC-OXIDE; BIOMATERIALS; APOPTOSIS;
   BIOCOMPATIBILITY; POLYURETHANES; PROCOAGULANT; SUPEROXIDE; THROMBOSIS
AB Polyurethanes (PUs) and polytetrafluoroethylene (PTFE) are widely used for making cardiovascular devices, but thrombus formation on the surfaces of these devices is inevitable. Since endothelial injury can lead to thrombosis, most of the studies on PUs or PTFE focused on their damage to endothelial cells. However, few studies have attempted to clarify whether the use of foreign objects as biomaterials can cause endothelial injury by activating the innate immune system. In this study, we aimed to investigate the roles of PU- or PTFE-stimulated immune cells in endothelial-cell injury. First, monocytes (THP-1 cells) were stimulated with PU or PTFE for 24 h and, subsequently, human umbilical vein endothelial cells (HUVECs) were treated with the supernatants of the stimulated cells for 24 h. We measured the generation of intracellular reactive oxygen species (ROS) from THP-1 cells treated with PU and PTFE for 24 h, meanwhile hydrogen dioxide (H(2)O(2)), tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta in the supernatants were also detected. Then, we assessed the apoptosis rate of the HUVECs and determined the expression of NO, inducible nitric oxide synthase (iNOS), and apoptosis-related proteins (p53, Bax, Bcl-2) in the HUVECs. The results showed that large amounts of ROS and low levels of pro-inflammatory cytokines (TNF-alpha and IL-1 beta) were produced by the stimulated THP-1 cells. After culturing with the supernatants of the PU- or PTFE-stimulated THP-1 cells, the apoptosis rate, NO production and expression of iNOS, p53 and Bax in the HUVECs were up-regulated, while Bcl-2 expression was down-regulated. In conclusion, the release of ROS by PU- or PTFE-treated THP-1 cells may induce iNOS expression and cause apoptosis in HUVECs via the p53, Bax and Bcl-2 proteins. These data provide the interesting finding that endothelial injury in the process of biomaterial-induced thrombosis can be initiated through the release of soluble mediators by monocytes. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Liu, Xin; Xue, Yang; Sun, Jiao] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Biomat Res & Testing Ctr, Shanghai 200011, Peoples R China.
RP Sun, JA (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Biomat Res & Testing Ctr, Shanghai 200011, Peoples R China.
EM jiaosun59@yahoo.com
FU Natural Science Foundation of China [30670556, 30270390]; Shanghai
   Sci-Tech Committee Foundation [08DZ2291600]; Shanghai Leading Academic
   Discipline Project [S30206]
FX This work was supported by grants from Natural Science Foundation of
   China (Nos 30670556 and 30270390), Shanghai Sci-Tech Committee
   Foundation (08DZ2291600) and Shanghai Leading Academic Discipline
   Project (No. S30206).
CR Amore A, 2000, NEPHRON, V86, P99, DOI 10.1159/000045725
   Bombeli T, 1997, BLOOD, V89, P2429
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chen YH, 2001, J CELL BIOCHEM, V82, P512, DOI 10.1002/jcb.1176
   Chung JH, 1996, CIRCULATION, V93, P2014, DOI 10.1161/01.CIR.93.11.2014
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   Dimmeler S, 2000, REGUL PEPTIDES, V90, P19, DOI 10.1016/S0167-0115(00)00105-1
   Estevez AG, 2002, ANN NY ACAD SCI, V962, P207, DOI 10.1111/j.1749-6632.2002.tb04069.x
   Heil TL, 2002, J ORAL REHABIL, V29, P401, DOI 10.1046/j.1365-2842.2002.00893.x
   HERRING MB, 1989, SEMIN THROMB HEMOST, V15, P200, DOI 10.1055/s-2007-1002706
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   Lehle K, 2009, J BIOMED MATER RES B, V90B, P312, DOI 10.1002/jbm.b.31287
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Martinesi M, 2007, J BIOMED MATER RES A, V80A, P131, DOI 10.1002/jbm.a.30846
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   MIYASHITA T, 1995, CELL, V80, P293
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   Nakaoka R, 2000, J BIOMED MATER RES, V49, P99, DOI 10.1002/(SICI)1097-4636(200001)49:1<99::AID-JBM12>3.3.CO;2-2
   Ong ATL, 2005, TEX HEART I J, V32, P372
   Ortiz PA, 2003, AM J PHYSIOL-REG I, V284, pR628, DOI 10.1152/ajpregu.00401.2002
   Rose SL, 2005, J BIOMED MATER RES A, V72A, P269, DOI 10.1002/jbm.a.30222
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747
   Simbula G, 2007, APOPTOSIS, V12, P113, DOI 10.1007/s10495-006-0487-9
   Sprague EA, 2005, J ENDOVASC THER, V12, P594, DOI 10.1583/05-1555.1
   Sun J, 2005, KEY ENG MAT, V288-289, P507, DOI 10.4028/www.scientific.net/KEM.288-289.507
   Sun J, 2008, ADV MAT RES, V47-50, P1335, DOI 10.4028/www.scientific.net/AMR.47-50.1335
   Wagner DD, 2005, ARTERIOSCL THROM VAS, V25, P1321, DOI 10.1161/01.ATV.0000166521.90532.44
   Xu F, 2009, TOHOKU J EXP MED, V218, P25, DOI 10.1620/tjem.218.25
NR 32
TC 1
Z9 1
U1 0
U2 3
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 13
BP 1783
EP 1797
DI 10.1163/092050609X12567180627536
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 661OR
UT WOS:000282738100006
PM 20557688
DA 2018-10-20
ER

PT J
AU Mochizuki, A
   Kimura, M
   Ina, A
   Tomono, Y
   Tanaka, M
AF Mochizuki, Akira
   Kimura, Maki
   Ina, Ayano
   Tomono, Yuka
   Tanaka, Masaru
TI Study on the Water Structure and Blood Compatibility of
   Poly(acryloylmorpholine-r-butyl methacrylate)
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Water structure; bound water; blood compatibility; platelets;
   coagulation system; DSC; N-substituted acrylamide co-polymer
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; PLATELET-ADHESION;
   SURFACE; BIOMATERIAL; GLYCOL); PLASMA
AB We have been studying the blood compatibility of polymeric materials from the viewpoint of their water structure, and have proposed that freezable water interacting with polymer molecules plays an important role in determining that compatibility. As we found that water-soluble poly(acryloylmorpholine) interacted with water, resulting in the formation of 'bound water', we newly prepared water-non-soluble poly(acryloylmorpholine-r-butyl methacrylate) (denoted as ACMO co-polymer) with various composition ratios. In addition, the properties of a co-polymer based on N,N-diethylacrylamide (DEA co-polymer), where DEA has a similar chemical structure to ACMO, except that DEA has no ether oxygen, were compared with that of the ACMO co-polymer. Contact angle and DSC analysis revealed that an increase in the content of an N-substituted acrylamide unit in the co-polymers enhanced the hydrophilicity of the polymer and that the hydrophilicity of the ACMO co-polymer was stronger than that of the DEA co-polymer. As for the water structure, it was found that the ACMO co-polymer had a lot of bound water compared to the DEA co-polymer. The difference in these properties between the ACMO and DEA co-polymers was due to the ether oxygen of the morpholine group. At the same time, in vitro blood compatibility tests showed that the ACMO co-polymer exhibited a much better performance than the DEA co-polymer. The water structure and blood compatibility is discussed in detail. (C) Koninklijke Brill NV, Leiden, 2010
C1 [Mochizuki, Akira; Kimura, Maki; Ina, Ayano; Tomono, Yuka] Tokai Univ, Dept Biomed Engn, Sch High Technol Human Welf, Shizuoka 4100395, Japan.
   [Tanaka, Masaru] Yamagata Univ, Dept Biochem Engn, Grad Sch Sci & Engn, Yamagata 9928510, Japan.
RP Mochizuki, A (reprint author), Tokai Univ, Dept Biomed Engn, Sch High Technol Human Welf, Nishino 317, Shizuoka 4100395, Japan.
EM azmochi@wing.ncc.u-tokai.ac.jp
OI Mochizuki, Akira/0000-0001-8104-7764; Tanaka, Masaru/0000-0002-1115-2080
CR Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Cazenave J.-P., 1986, BLOOD SURFACE INTERA
   Chuang WH, 2007, J BIOMED MATER RES A, V82A, P820, DOI 10.1002/jbm.a.31193
   Chung YC, 2005, BIOMATERIALS, V26, P2313, DOI 10.1016/j.biomaterials.2004.06.043
   GLASSER WG, 1992, ACS S SERIES, V489
   GOLBET MB, 2004, BIOMATERIALS, V22, P5681
   GRIFFIN JH, 2006, WILLIAMS HEMATOLOGY, P1703
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hirota E, 2006, J BIOMED MATER RES A, V76A, P540, DOI 10.1002/jbm.a.30563
   Hirota E, 2007, J BIOMED MATER RES A, V81A, P710, DOI 10.1002/jbm.a.31113
   Ide M, 2003, LANGMUIR, V19, P429, DOI 10.1021/1a020617p
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   MIWA Y, 2003, J JPN SOC BIOMATER, V21, P143
   Morita S, 2007, LANGMUIR, V23, P3750, DOI 10.1021/la0625998
   Morra M, 2001, WATER BIOMATERIAL SU
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Schwendel D, 2001, LANGMUIR, V17, P5717, DOI 10.1021/la010576h
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   YAMADA N, 1990, J APPL POLYM SCI, V39, P2443
NR 23
TC 3
Z9 4
U1 1
U2 6
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2010
VL 21
IS 14
BP 1895
EP 1910
DI 10.1163/092050610X489321
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 679HI
UT WOS:000284152100006
PM 20566050
DA 2018-10-20
ER

PT J
AU Chang, G
   Kim, HJ
   Vunjak-Novakovic, G
   Kaplan, DL
   Kandel, R
AF Chang, Godfrey
   Kim, Hyeon Joo
   Vunjak-Novakovic, Gordana
   Kaplan, David L.
   Kandel, Rita
TI Enhancing annulus fibrosus tissue formation in porous silk scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE annulus fibrosus; tissue engineering; silk biomaterial; scaffold;
   dynamic culture
ID INTERVERTEBRAL DISC CELLS; IN-VITRO; ENGINEERED CARTILAGE; NUCLEUS
   PULPOSUS; PORE-SIZE; EXTRACELLULAR-MATRIX; GENE-EXPRESSION;
   SPINNER-FLASK; 3-D SCAFFOLDS; CONSTRUCTS
AB There is presently no optimal treatment for patients with chronic back pain as a result of degenerative disc disease. Tissue engineering, an annulus fibrosus (AF) construct suitable to repair the damaged AF, is one novel approach to the treatment of this disease. We have previously demonstrated that porous silk scaffolds can Support AF cell attachment and extracellular matrix accumulation; however, tissue infiltration and matrix accumulation was not optimal. The purpose of this study was to determine whether the dynamic culture of AF cells seeded into larger average pore size silk scaffolds would improve tissue formation. AF cells were isolated from bovine caudal discs and seeded into porous silk scaffolds and grown in either dynamic or static flow conditions. The cell-seeded scaffolds were grown for tip to 4 weeks and evaluated for cell attachment, gene expression, histological appearance, and matrix accumulation. Dynamic Culture improved AF tissue formation as the tissue was more cellular and contained significantly more matrix than that formed in static culture. Spatial distribution of tissue was comparable for static and dynamic culture. Varying scaffold pore sizes (200-, 600-, and 1000-mu m pore size) demonstrated that an average pore size of 600 mu m resulted in the Most uniform tissue distribution with the greatest amount of type I collagen. Our study suggests that dynamic flow conditions and scaffold pore size can affect the formation of engineered AF tissue. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 43-51, 2010
C1 [Kandel, Rita] Univ Toronto, Dept Pathol & Lab Med, CIHR Bioengn Skeletal Tissues Team, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.
   [Kim, Hyeon Joo; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Boston, MA 02111 USA.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY USA.
RP Kandel, R (reprint author), Univ Toronto, Dept Pathol & Lab Med, CIHR Bioengn Skeletal Tissues Team, Mt Sinai Hosp, 600 Univ Ave,Ste 6-500-11, Toronto, ON M5G 1X5, Canada.
EM rkandel@mtsinai.on.ca
RI Kandel, Rita/E-2149-2017; vunjak-novakovic, gordana/J-9279-2012
OI Kandel, Rita/0000-0003-4047-3913; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574
FU NIH [R21AR052801-02]
FX Contract grant sponsor: NIH; contract grant number: R21AR052801-02
CR Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007
   Almarza AJ, 2004, TISSUE ENG, V10, P1787, DOI 10.1089/ten.2004.10.1787
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anderson D Greg, 2005, Spine J, V5, p260S, DOI 10.1016/j.spinee.2005.02.010
   Baer AE, 2001, J ORTHOPAED RES, V19, P2, DOI 10.1016/S0736-0266(00)00003-6
   BOGDUK N, 1997, CLIN ANATOMY LUMBAR, P13
   BROBERG KB, 1983, SPINE, V8, P151, DOI 10.1097/00007632-198303000-00006
   Bueno EM, 2005, TISSUE ENG, V11, P1699, DOI 10.1089/ten.2005.11.1699
   Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4
   Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008
   Cowan DB, 1996, CURR OPIN LIPIDOL, V7, P94, DOI 10.1097/00041433-199604000-00008
   Falsafi S, 2000, ARCH OTOLARYNGOL, V126, P759, DOI 10.1001/archotol.126.6.759
   Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q
   Gorti GK, 2003, ARCH OTOLARYNGOL, V129, P889, DOI 10.1001/archotol.129.8.889
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KLEIN JA, 1983, J BIOMECH, V16, P211, DOI 10.1016/0021-9290(83)90128-8
   Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d
   LATRIDIS JC, 2005, J BIOMECH, V38, P557
   Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Neves AA, 2005, BIOMATERIALS, V26, P4828, DOI 10.1016/j.biomaterials.2004.12.002
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   Rannou F, 2003, J CELL BIOCHEM, V90, P148, DOI 10.1002/jcb.10608
   Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Sato M, 2003, MED BIOL ENG COMPUT, V41, P365, DOI 10.1007/BF02348444
   Seguin CA, 2005, SPINE, V30, P1940, DOI 10.1097/01.brs.0000176188.40263.f9
   Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Sucosky P, 2004, BIOTECHNOL BIOENG, V85, P34, DOI 10.1002/bit.10788
   Thonar E, 2002, BIOCHEM SOC T, V30, P874, DOI 10.1042/bst0300874
   VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323
   Waldman SD, 2003, J ORTHOPAED RES, V21, P590, DOI 10.1016/S0736-0266(03)00009-3
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
NR 42
TC 46
Z9 54
U1 5
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2010
VL 92A
IS 1
BP 43
EP 51
DI 10.1002/jbm.a.32326
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 531BF
UT WOS:000272637000005
PM 19165797
DA 2018-10-20
ER

PT J
AU Xu, LC
   Siedlecki, CA
AF Xu, Li-Chong
   Siedlecki, Christopher A.
TI Microphase separation structure influences protein interactions with
   poly(urethane urea) surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE protein adsorption; poly(urethane urea); microphase separation; AFM
ID ATOMIC-FORCE MICROSCOPY; X-RAY MICROSCOPY; BLOCK-COPOLYMERS;
   PLASMA-PROTEINS; SEGMENTED POLYURETHANES; NANOPHASE SEPARATION; BLOOD
   COMPATIBILITY; ADSORBED FIBRINOGEN; AQUEOUS ENVIRONMENT;
   PLATELET-ADHESION
AB Microphase separation is an important characteristic of polyurethane copolymer biomaterials. An improved understanding of the effects of microphase structure on protein interactions with the polymeric biomaterial Surface is essential for the development and application of new biomaterials intended for implantation into the body. In this study, an array of atomic force microscopy (AFM) techniques were used to visualize the phase separation structure in a hydrated poly(urethane urea) (PUU) material and to correlate that structure with molecular interactions at the molecular level. Sequential in situ AFM phase images showed that the hard domains present a dynamic environment and undergo rearrangement and enrichment at the surface when hydrated. Adhesion forces measured using a protein-modified AFM probe suggests that the PUU surface became less adhesive to protein with hydration time, consistent with other physical characterizations. Force measurements were used to quantify and correlate mechanical properties and local adhesion forces for bovine serum albumin, and results showed that low adhesion forces were primarily associated with polar hard domain regions. A nanogold-labeled protein conjugate was used to visualize individual protein adsorption to the separate microstructures on the PUU surface, with preferential protein adsorption seen on the more apolar hydrophobic soft segment regions. Together, the results suggest that the microphase separation structure mediates local surface microenvironments that influence biological interactions with the surface. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 126-136, 2010
C1 [Xu, Li-Chong; Siedlecki, Christopher A.] Penn State Univ, Dept Surg, Coll Med, Inst Biomed Engn, Hershey, PA 17033 USA.
   [Siedlecki, Christopher A.] Penn State Univ, Dept Bioengn, Coll Med, Inst Biomed Engn, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Dept Surg, Coll Med, Inst Biomed Engn, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU Materials Research Institute; Department of Surgery at the Pennsylvania
   State University; Dorothy Foehr Huck and J. Lloyd Huck Institutes of the
   Life Sciences; Pennsylvania Department of Health
FX Contract grant sponsors: Materials Research Institute, Department of
   Surgery at the Pennsylvania State University, The Dorothy Foehr Huck and
   J. Lloyd Huck Institutes of the Life Sciences, Pennsylvania Department
   of Health
CR Agnihotri A, 2006, J BIOMAT SCI-POLYM E, V17, P227, DOI 10.1163/156856206774879036
   Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Aneja A, 2003, POLYMER, V44, P7221, DOI 10.1016/j.polymer.2003.07.007
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen X, 2002, SURF SCI, V519, pL593, DOI 10.1016/S0039-6028(02)02217-3
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   ELWING H, 1987, J BIOMED MATER RES, V21, P1023, DOI 10.1002/jbm.820210808
   EPPELL SJ, 1995, BIOPHYS J, V68, P671, DOI 10.1016/S0006-3495(95)80228-6
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Garrett JT, 2000, MACROMOLECULES, V33, P6353, DOI 10.1021/ma000600i
   GOODMAN SL, 1989, SCANNING MICROSCOPY, P285
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P497, DOI 10.1163/156856294X00464
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Hsu SH, 2005, MACROMOL BIOSCI, V5, P246, DOI 10.1002/mabi.200400163
   Hsu SH, 2004, MACROMOL BIOSCI, V4, P891, DOI 10.1002/mabi.200400062
   Huang SL, 2000, EUR POLYM J, V36, P285, DOI 10.1016/S0014-3057(99)00063-4
   Hussain MA, 2005, LANGMUIR, V21, P6979, DOI 10.1021/la046943h
   Kim JM, 2004, ANAL CHIM ACTA, V525, P151, DOI 10.1016/j.aca.2004.08.034
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEWIS KB, 1993, J COLLOID INTERF SCI, V159, P77, DOI 10.1006/jcis.1993.1299
   Li L, 2008, J PHYS CHEM B, V112, P2150, DOI 10.1021/jp076583h
   Li L, 2006, J PHYS CHEM B, V110, P16763, DOI 10.1021/jp062442o
   Lin H, 2000, BIOCHEMISTRY-US, V39, P3192, DOI 10.1021/bi991624o
   LIN HB, 1993, J BIOMAT SCI-POLYM E, V4, P183, DOI 10.1163/156856293X00519
   Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725
   Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9
   Mamunya YP, 2004, EUR POLYM J, V40, P2323, DOI 10.1016/j.eurpolymj.2004.06.007
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   Montdargent B, 2000, INFECT CONT HOSP EP, V21, P404, DOI 10.1086/501782
   Morin C, 2004, J ELECTRON SPECTROSC, V137, P785, DOI 10.1016/j.elspec.2004.02.158
   PITT WG, 1993, J BIOMAT SCI-POLYM E, V4, P337, DOI 10.1163/156856293X00023
   Raghavachari M, 2000, THROMB RES, V98, P351, DOI 10.1016/S0049-3848(00)00185-7
   Revenko I, 2001, SURF SCI, V491, P346, DOI 10.1016/S0039-6028(01)01298-5
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Soman P, 2008, MICRON, V39, P832, DOI 10.1016/j.micron.2007.12.013
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Xu LC, 2005, ENVIRON SCI TECHNOL, V39, P3592, DOI 10.1021/es048377i
   Xu LC, 2007, J BIOMAT SCI-POLYM E, V18, P353, DOI 10.1163/156856207780425013
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 53
TC 16
Z9 17
U1 2
U2 26
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2010
VL 92A
IS 1
BP 126
EP 136
DI 10.1002/jbm.a.32340
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 531BF
UT WOS:000272637000015
PM 19165784
DA 2018-10-20
ER

PT J
AU Ciardelli, G
   Gentile, P
   Chiono, V
   Mattioli-Belmonte, M
   Vozzi, G
   Barbani, N
   Giusti, P
AF Ciardelli, Gianluca
   Gentile, Piergiorgio
   Chiono, Valeria
   Mattioli-Belmonte, Monica
   Vozzi, Giovanni
   Barbani, Niccoletta
   Giusti, Paolo
TI Enzymatically crosslinked porous composite matrices for bone tissue
   regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; crosslinking; hydroxyapatite; tissue engineering;
   transglutaminase
ID ENDOTHELIAL-CELLS; HYDROXYAPATITE/COLLAGEN COMPOSITE; IN-VITRO;
   TRANSGLUTAMINASE; SCAFFOLDS; COLLAGEN; BIOMATERIAL; GELATIN; GROWTH;
   MICROORGANISMS
AB Three-dimensional porous hydroxyapatite/collagen (HA/Coll) composites with a random pore structure were obtained by freeze-drying and crosslinked by an enzymatic treatment using microbial transglutaminase (mTGase). The procedure resulted in improved mechanical strength and thermal stability of the scaffolds. The scaffolds were characterized in terms of their stability (Coll release, swelling, collagenase-mediated degradation), thermal properties (thermogravimetric analysis, differential scanning calorimetry), mechanical behavior under compression and cell compatibility. Enzymatic treatment stabilized the sponges to water vapors, with measurable swelling ratio between 100% for HA/Coll/mTGase 0/100 to 5% for HA/Coll/mTGase 80/20. Weight loss in water due to Coll release was between 2 and 10% in mTGase-cross-linked samples and decreased with increasing HA content. Cultures of MG63 osteoblast-like cells and human umbilical vein endothelial cells (HUVEC) showed good adhesion and proliferation on the scaffolds, good viability (through MTT test, 100-150% of control), and good differentiation (alkaline phosphatase, up to 40 UI/L with respect to 35 UI/L for control). (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 137-151, 2010
C1 [Ciardelli, Gianluca; Gentile, Piergiorgio; Chiono, Valeria] Politecn Torino, Dept Mech, I-10129 Turin, Italy.
   [Ciardelli, Gianluca; Vozzi, Giovanni; Barbani, Niccoletta; Giusti, Paolo] Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, I-56126 Pisa, Italy.
   [Mattioli-Belmonte, Monica] Marche Polytech Univ, Dept Mol Pathol & Innovat Therapies Histol, I-60020 Ancona, Italy.
   [Vozzi, Giovanni; Giusti, Paolo] CNR, Inst Composite & Biomed Mat, I-56126 Pisa, Italy.
RP Gentile, P (reprint author), Politecn Torino, Dept Mech, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM piergiorgio.gentile@polito.it
RI Mattioli-Belmonte, Monica/J-5861-2012; Chiono, Valeria/G-3631-2014;
   Gentile, Piergiorgio/C-8664-2014
OI Gentile, Piergiorgio/0000-0002-3036-6594; Ciardelli,
   Gianluca/0000-0003-0199-1427; vozzi, giovanni/0000-0002-9414-9994
FU European Commission [HIPER-MAX/NMP-3-CT-2003-505790]
FX Contract grant sponsor: European Commission (through STReP-Project High
   Performance Industrial Protein Matrices through Bioprocessing); contract
   grant number: HIPER-MAX/NMP-3-CT-2003-505790
CR ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735
   Bertoni F, 2006, BIOTECHNOL LETT, V28, P697, DOI 10.1007/s10529-006-9046-2
   Bose S, 2003, MAT SCI ENG C-BIO S, V23, P479, DOI 10.1016/S0928-4931(02)00129-7
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   BROWM JC, 1995, INT ARCH ALLERGY IMM, V107, P484, DOI 10.1159/000237090
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CARRINGTON JL, 1991, BIOESSAYS, V13, P403, DOI 10.1002/bies.950130807
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chen RN, 2005, BIOMATERIALS, V26, P4229, DOI 10.1016/j.biomaterials.2004.11.012
   Chen Y, 2006, SURF COAT TECH, V201, P575, DOI 10.1016/j.surfcoat.2005.12.005
   COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306
   COUSSONS PJ, 1992, BIOCHEM J, V282, P929, DOI 10.1042/bj2820929
   de Carvalho RA, 2004, FOOD HYDROCOLLOID, V18, P717, DOI 10.1016/j.foodhyd.2003.10.005
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234
   Ito A, 2003, J BIOSCI BIOENG, V95, P196, DOI 10.1016/S1389-1723(03)80129-9
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   JONES AR, 1995, J ORTHOP RES, V13, P553, DOI 10.1002/jor.1100130410
   KASHIWAGI T, 2002, J BIOL CHEM, V60, P277
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Koh YH, 2006, J MATER SCI-MATER M, V17, P773, DOI 10.1007/s10856-006-9834-1
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Mattioli-Belmonte M, 2008, J BIOMED MATER RES A, V85A, P466, DOI 10.1002/jbm.a.31483
   Miao X, 2007, MAT SCI ENG C-BIO S, V27, P257, DOI 10.1016/j.msec.2006.03.009
   Motoki M, 1998, TRENDS FOOD SCI TECH, V9, P204, DOI 10.1016/S0924-2244(98)00038-7
   NONAKA M, 1989, AGR BIOL CHEM TOKYO, V53, P2619, DOI 10.1080/00021369.1989.10869736
   REHAKOVA M, 1995, J BIOMED MATER RES, V29, P1373
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   SUHANEC W, 1998, J MATER RES, V13, P94
   Tampieri A, 2005, ACTA BIOMATER, V1, P343, DOI 10.1016/j.actbio.2005.01.001
   VILLARS F, 2000, J CELL BIOCHEM, V79, P679
   Villars F., 2002, AM J PHYSIOL-CELL PH, V282, P775
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Yunoki S, 2006, MATER LETT, V60, P999, DOI 10.1016/j.matlet.2005.10.064
   Yunoki S, 2007, J BIOMED MATER RES B, V80B, P166, DOI 10.1002/jbm.b.30581
   Zhang C, 2001, J BIOMED MATER RES, V55, P28
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
NR 46
TC 43
Z9 43
U1 3
U2 27
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2010
VL 92A
IS 1
BP 137
EP 151
DI 10.1002/jbm.a.32344
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 531BF
UT WOS:000272637000016
PM 19165785
DA 2018-10-20
ER

PT J
AU Rodriguez, A
   Anderson, JM
AF Rodriguez, Analiz
   Anderson, James M.
TI Evaluation of clinical biomaterial surface effects on T lymphocyte
   activation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE lymphocyte activation; biomaterials; interferon gamma; interleukin-2
ID BORONATE-CONTAINING POLYMER; CD40 LIGAND EXPRESSION; MTT COLORIMETRIC
   ASSAY; FOREIGN-BODY RESPONSE; INTERFERON-GAMMA; CELL ACTIVATION;
   IMPLANTATION; INDUCTION; CYTOKINE; MITOGEN
AB Previous in vitro studies in our laboratory have shown that lymphocytes can influence macrophage adhesion and fusion on biomaterial surfaces. However, few studies have evaluated how material adherent macrophages can influence lymphocyte behavior, specifically T cells. In this study, we cultured human peripheral blood mononuclear cells from healthy donors on three synthetic nonbiodegradable biomedical polymers: elasthane 80A (PEU), silicone rubber (SR), or polyethylene terephthalate (PET) and tissue Culture polystyrene (TCPS). Upregulation of T cell surface activation markers (CD69 and CD25), lymphocyte proliferation, and interleukin-2 (IL-2) and interferon-gamma (IFN gamma) concentrations were evaluated by flow cytometry, carboxy-fluorescein diacetate, succinimydyl ester (CFSE) incorporation, and Multiplex cytokine immunoassay, respectively, to assess T cell activation. Following 3 and 7 days of culture, CD4+ helper T cells from cultures of any of the material groups did not express the activation markers CD69 and CD25 and lymphocyte proliferation was not present. IL-2 and IFN gamma levels were produced, but dependent on donor. These data indicate that T cells are not activated in response to clinically relevant synthetic biomaterials. The data also suggest that lymphocyte subsets exclusive of T cells are the source of the lymphokines, IL-2 and IFN-gamma, in certain donors. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 214-220, 2010
C1 [Rodriguez, Analiz; Anderson, James M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Anderson, James M.] Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), 2103 Cornell Rd,Wolstein Res Bldg 5104, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU National Institutes of Health (NIH) [EB-000282, T32-GM007250]
FX Contract grant sponsor: National Institutes of Health (NIH); contract
   grant numbers: EB-000282, T32-GM007250
CR Aringer M, 2002, ACTA MED AUST, V29, P7, DOI 10.1046/j.1563-2571.2002.01044.x
   Borges O, 2007, INT J PHARM, V337, P254, DOI 10.1016/j.ijpharm.2007.01.021
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   CHEN CH, 1990, INT ARCH ALLER A IMM, V93, P249, DOI 10.1159/000235309
   GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159
   Gattoni A, 2006, Clin Ter, V157, P377
   GERLIER D, 1986, J IMMUNOL METHODS, V94, P57, DOI 10.1016/0022-1759(86)90215-2
   Im SH, 2004, MOL CELLS, V18, P1
   Itescu Silviu, 2003, Cardiology Clinics, V21, P119, DOI 10.1016/S0733-8651(02)00135-2
   JACKSON AL, 1990, CLIN IMMUNOL IMMUNOP, V54, P126, DOI 10.1016/0090-1229(90)90012-F
   Katzin WE, 1996, CLIN DIAGN LAB IMMUN, V3, P156
   Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632
   MIYAZAKI H, 1993, BIOCHEM BIOPH RES CO, V195, P829, DOI 10.1006/bbrc.1993.2120
   Otsuka H, 2006, EUR CELLS MATER, V12, P36, DOI 10.22203/eCM.v012a04
   Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   ROLLINO C, 1995, J IMMUNOL METHODS, V185, P141, DOI 10.1016/0022-1759(95)00171-6
   Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006
   Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2
   Schuster M, 2002, HUM IMMUNOL, V63, P211, DOI 10.1016/S0198-8859(01)00380-9
   Schuster M, 2001, TRANSPLANT P, V33, P1960, DOI 10.1016/S0041-1345(00)02754-8
NR 25
TC 15
Z9 18
U1 2
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2010
VL 92A
IS 1
BP 214
EP 220
DI 10.1002/jbm.a.32362
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 531BF
UT WOS:000272637000023
PM 19172618
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Akkouch, A
   Shi, GX
   Zhang, Z
   Rouabhia, M
AF Akkouch, Adil
   Shi, Guixin
   Zhang, Ze
   Rouabhia, Mahmoud
TI Bioactivating electrically conducting polypyrrole with fibronectin and
   bovine serum albumin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; polypyrrole; proteins; fibronectin; BSA
ID PROTEIN ADSORPTION; STIMULATION; TISSUE; CELLS; BIOCOMPATIBILITY;
   PROLIFERATION; BIOMATERIALS; TRANSDUCTION; POLYMERS; GROWTH
AB Electrically conducting polypyrrole (PPy) and its composite materials are useful in interfacing electrical components and cells or living tissue. In recent years, significant efforts have been made to bioactivate PPy by incorporating biomolecules. The main objective of this work was to chemically bioactivate PPy particules by incorporating fibronectin (IN) and bovine serum albumin (BSA). Modified PPy particles were synthesized through a water-in-oil emulsion polymerization. XPS and FTIR confirmed the presence of biomolecules on the PPy particles, and the surface morphology was observed by SEM. A four-point probe was used to measure the conductivity of the newly synthesized PPy particles, which was in the range of 10(-1) S cm(-1). Conductive biodegradable membranes were prepared with 5 and 10% (wt/wt) PPy to poly(L,L-lactide) (PPy/PLLA). The contact angles of each synthesized membrane were similar to 75 degrees, Supporting their usefulness for cell culture. The cultured human skin fibroblasts demonstrated normal morphology and significantly higher adhesion and spreading on the PPy/PLLA similar to FN membrane than on the unmodified PPy/PLLA membrane. On the other hand, the PPy/PLLA similar to BSA membranes showed decreased cell adhesion. Bioactivated PPy may be useful in tissue engineering to fabricate conducting biodegradable scaffolds with either improved or reduced cell adhesion properties for various cell culture and hi vivo applications. (C) 2009 Wiley Periodicals, Inc. J Biomed Mater Res 92A: 221-231, 2010
C1 [Akkouch, Adil; Shi, Guixin; Rouabhia, Mahmoud] Univ Laval, Fac Med Dentaire, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
   [Akkouch, Adil; Shi, Guixin; Zhang, Ze] Univ Laval, Ctr Rech, Hop St Francois Assise,Fac Med, CHUQ,Dept Chirurg, Quebec City, PQ, Canada.
RP Rouabhia, M (reprint author), Univ Laval, Fac Med Dentaire, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
EM mahmoud.rouabhia@fmd.ulaval.ca
FU Canadian Institutes of Health Research (CIHR); Natural Science and
   Engineering Research Council of Canada (NSERC); Fonds de Recherche en
   Sante du Quebec (FRSQ)
FX Contract grant sponsors: Canadian Institutes of Health Research (CIHR);
   Natural Science and Engineering Research Council of Canada (NSERC);
   Fonds de Recherche en Sante du Quebec (FRSQ)
CR ALITALO K, 1982, ADV CANCER RES, V37, P111, DOI 10.1016/S0065-230X(08)60883-0
   ASHWELL GJ, 1992, MOL ELECT, P65
   BLACK J, 1985, CLIN PLAST SURG, V12, P243
   BOURGUIGNON GJ, 1987, FASEB J, V1, P398
   BOYLE A, 1990, J ELECTROANAL CHEM, V279, P179, DOI 10.1016/0022-0728(90)85175-5
   CLARK RAF, 1988, J BIOL CHEM, V263, P12115
   CLARK RAF, 1996, MOL CELLULAR BIOL WO, P611
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   FENG Y, 1999, J APPL POLYM SCI, V77, P135
   Finne A, 2004, J POLYM SCI POL CHEM, V42, P444, DOI 10.1002/pola.10805
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   HAILIN G, 1989, ANAL CHEM, V61, P198, DOI 10.1021/ac00178a002
   Han SW, 2006, ONCOGENE, V25, P4341, DOI 10.1038/sj.onc.1209460
   HORMANN H, 1982, KLIN WOCHENSCHR, V60, P1265, DOI 10.1007/BF01727483
   HRKACH J, 1999, J MAT SCI RES, V78, P92
   KHAN W, 2006, BIOMED MATER, P235
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Li YL, 2004, J COLLOID INTERF SCI, V275, P488, DOI 10.1016/j.jcis.2004.02.060
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McClellan SJ, 2005, COLLOID SURFACE A, V260, P265, DOI 10.1016/j.colsurfa.2005.03.017
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MUTLU S, 1993, ACS SYM SER, V556, P71
   Pauthe E, 2002, BBA-PROTEIN STRUCT M, V1597, P12, DOI 10.1016/S0167-4838(02)00271-6
   PILENI MP, 1993, J PHYS CHEM-US, V97, P6961, DOI 10.1021/j100129a008
   RICHARD H, 1985, ANN REV CELL BIOL, V1, P67
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Street G.B., 1982, MOL CRYST LIQ CRYST, V83, P253
   Sun F, 1996, J AM CHEM SOC, V118, P1856, DOI 10.1021/ja952225t
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Vadgama P, 2005, ANN RP CH C, V101, P14, DOI 10.1039/b408906p
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   WEISS DS, 1990, ARCH DERMATOL, V126, P222, DOI 10.1001/archderm.126.2.222
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
   Zhang Z, 2001, J BIOMED MATER RES, V57, P63, DOI 10.1002/1097-4636(200110)57:1<63::AID-JBM1142>3.0.CO;2-L
NR 38
TC 17
Z9 19
U1 4
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2010
VL 92A
IS 1
BP 221
EP 231
DI 10.1002/jbm.a.32357
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 531BF
UT WOS:000272637000024
PM 19172617
DA 2018-10-20
ER

EF